Citrus Sinensis ID: 006083
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 662 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZNQ8 | 633 | Proline-rich receptor-lik | yes | no | 0.714 | 0.747 | 0.663 | 0.0 | |
| Q8GX23 | 670 | Proline-rich receptor-lik | no | no | 0.663 | 0.655 | 0.650 | 1e-168 | |
| Q9XI96 | 699 | Proline-rich receptor-lik | no | no | 0.764 | 0.723 | 0.620 | 1e-164 | |
| Q9LS95 | 700 | Putative proline-rich rec | no | no | 0.574 | 0.542 | 0.733 | 1e-151 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.521 | 0.677 | 0.661 | 1e-142 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.536 | 0.495 | 0.643 | 1e-137 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.658 | 0.605 | 0.511 | 1e-132 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.522 | 0.508 | 0.597 | 1e-129 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.486 | 0.627 | 0.661 | 1e-128 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.574 | 0.536 | 0.543 | 1e-126 |
| >sp|Q9ZNQ8|PERK4_ARATH Proline-rich receptor-like protein kinase PERK4 OS=Arabidopsis thaliana GN=PERK4 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 645 bits (1664), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/493 (66%), Positives = 386/493 (78%), Gaps = 20/493 (4%)
Query: 169 TYSVIGA-VGVGIFLIAMIIICAVRANKKKKKRHNQPMHYYGDHSNHFKKGGDPYYSGGH 227
T ++G VG G+ +I +II+C R K+K + +PM + + + + +
Sbjct: 150 TAIIVGVLVGAGLLMIVLIIVCLRRKKKRKDSFYPEPMK---GNQYQYYGNNNNNNASQN 206
Query: 228 APNWHGHPEHQNWHSHPQGPDHTGGNIPPPPGGNWPGPPPPPPMMSSSGEMSSQFSGPAR 287
PNWH + + QN S PPPPP M +SGE SS +SGP+R
Sbjct: 207 YPNWHLNSQGQNQQSTGGWGGGG-------------PSPPPPPRMPTSGEDSSMYSGPSR 253
Query: 288 PPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKS 347
P LPPPSP +ALGFNKSTFTY ELAAATGGF +NLLGQGGFGYVHKGVLP+GKEVAVKS
Sbjct: 254 PVLPPPSPALALGFNKSTFTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKS 313
Query: 348 LKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGEN 407
LK GSGQGEREF AEV+IISRVHHR+LVSLVGYCIA GQRMLVYEFV NKTLEYHLHG+N
Sbjct: 314 LKAGSGQGEREFQAEVDIISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLHGKN 373
Query: 408 RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467
PVM+F+TR+RIALG+AKGLAYLHEDCHPRIIHRDIK+ANIL+D NF+AMVADFGLAKL+
Sbjct: 374 LPVMEFSTRLRIALGAAKGLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLAKLT 433
Query: 468 NDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTM-MEDS 526
+DN+THVSTRVMGTFGYLAPEYASSGKLTEKSDVFS+GVMLLELITG+RPVD ++ M+D+
Sbjct: 434 SDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSITMDDT 493
Query: 527 LVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIV 586
LV+WARPL+ ALEDG ++ L D RLE NY P EMAR+V C AASIRHS RKRPKMSQIV
Sbjct: 494 LVDWARPLMARALEDGNFNELADARLEGNYNPQEMARMVTCAAASIRHSGRKRPKMSQIV 553
Query: 587 RALEGDSSLDDLNDGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDFASSDY 646
RALEG+ SLD LN+GV+PG S+ + + S++YS TSYNADMKKFRQ+AL SQ+F SD
Sbjct: 554 RALEGEVSLDALNEGVKPGHSNVYGSLGASSDYSQTSYNADMKKFRQIALSSQEFPVSDC 613
Query: 647 GGSS--DSREIPT 657
G+S DSR++ T
Sbjct: 614 EGTSSNDSRDMGT 626
|
Required during abscisic acid (ABA)-mediated activation of Ca(2+) channels. Regulates ABA signaling pathways. Modulates the expression of genes related to cell elongation and ABA signaling during root growth. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 592 bits (1527), Expect = e-168, Method: Compositional matrix adjust.
Identities = 304/467 (65%), Positives = 358/467 (76%), Gaps = 28/467 (5%)
Query: 186 IIICAVRANKKKKKRHNQPMHYYGDHSNHFKKGGDPYYSGGHAPNWHGHPEHQNWHSHPQ 245
I IC R KKK + N MHYY N+ GG P +GG+ + G P+
Sbjct: 207 ICICCNRKKKKKSPQVNH-MHYY----NNNPYGGAPSGNGGY---YKGTPQ--------- 249
Query: 246 GPDHTGGNIPPPPGGNWPGPPPPPPMMSSSGEMSSQFSGPARPPLPPPSPNIALGFNKST 305
DH N+ GGNW GP P SG S + R +P P LG N+ST
Sbjct: 250 --DHVV-NMAGQGGGNW-GPQQP-----VSGPHSDASNLTGRTAIPSPQA-ATLGHNQST 299
Query: 306 FTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEI 365
FTYDEL+ AT GFA+SNLLGQGGFGYVHKGVLP+GKEVAVKSLK GSGQGEREF AEV+I
Sbjct: 300 FTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVKSLKLGSGQGEREFQAEVDI 359
Query: 366 ISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAK 425
ISRVHHRHLVSLVGYCI+GGQR+LVYEF+ N TLE+HLHG+ RPV+D+ TRV+IALGSA+
Sbjct: 360 ISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLEFHLHGKGRPVLDWPTRVKIALGSAR 419
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL 485
GLAYLHEDCHPRIIHRDIKAANIL+D +FE VADFGLAKLS DN+THVSTRVMGTFGYL
Sbjct: 420 GLAYLHEDCHPRIIHRDIKAANILLDFSFETKVADFGLAKLSQDNYTHVSTRVMGTFGYL 479
Query: 486 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMT-MMEDSLVEWARPLLGAALEDGIY 544
APEYASSGKL++KSDVFSFGVMLLELITGR P+D+T MEDSLV+WARPL A +DG Y
Sbjct: 480 APEYASSGKLSDKSDVFSFGVMLLELITGRPPLDLTGEMEDSLVDWARPLCLKAAQDGDY 539
Query: 545 DGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSLDDLNDGVRP 604
+ L DPRLE NY EM ++ +C AA+IRHSAR+RPKMSQIVRALEGD S+DDL++G RP
Sbjct: 540 NQLADPRLELNYSHQEMVQMASCAAAAIRHSARRRPKMSQIVRALEGDMSMDDLSEGTRP 599
Query: 605 GQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDFASSDYGGSSD 651
GQS+ S + S+EY A+SY ADMKKF++LAL ++++ SS+YGG+S+
Sbjct: 600 GQSTYLSPGSVSSEYDASSYTADMKKFKKLALENKEYQSSEYGGTSE 646
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XI96|PERK7_ARATH Proline-rich receptor-like protein kinase PERK7 OS=Arabidopsis thaliana GN=PERK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 577 bits (1488), Expect = e-164, Method: Compositional matrix adjust.
Identities = 345/556 (62%), Positives = 406/556 (73%), Gaps = 50/556 (8%)
Query: 126 SPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVTY-SVIGAVGV-GIFLI 183
+PPPP+K S S S P+S + + +S +SS +D + +VIG V GI I
Sbjct: 135 TPPPPSKTSDHS------SHSQPRSLAPPTSNSGSNSSSNDGLNIGAVIGLVAAAGILFI 188
Query: 184 AMIIICAVRANKKKKKRHNQPMHYYGDHSNHF---KKGGDPYYSGGHAPNWHGHPEHQNW 240
MI++C KKKKK M YYG SN + K GGD YY+ A H +QN
Sbjct: 189 VMILLCVCCFRKKKKKSKLDQMPYYG--SNAYPAGKTGGDQYYNQNAATQQQQH-YNQN- 244
Query: 241 HSHPQGPDHTGGNIPPPPG---------------GNW-PGPPPPPPM-----MSSSGEMS 279
DH N+PPPPG GNW P P PP P+ + SGEMS
Sbjct: 245 -------DHIV-NLPPPPGSMGTNWVSSPPPPPPGNWQPMPSPPAPVSGGANVIQSGEMS 296
Query: 280 SQFS-GPARPPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLP 338
S FS GP P LPPP P++ALGFN STFTY+ELA+AT GF+K LLGQGGFGYVHKG+LP
Sbjct: 297 SNFSSGPYAPSLPPPHPSVALGFNNSTFTYEELASATQGFSKDRLLGQGGFGYVHKGILP 356
Query: 339 NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI-AGGQRMLVYEFVSNK 397
NGKE+AVKSLK GSGQGEREF AEVEIISRVHHRHLVSLVGYC AGGQR+LVYEF+ N
Sbjct: 357 NGKEIAVKSLKAGSGQGEREFQAEVEIISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPND 416
Query: 398 TLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAM 457
TLE+HLHG++ VMD+ TR++IALGSAKGLAYLHEDCHP+IIHRDIKA+NIL+D NFEA
Sbjct: 417 TLEFHLHGKSGTVMDWPTRLKIALGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAK 476
Query: 458 VADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
VADFGLAKLS DN+THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR P
Sbjct: 477 VADFGLAKLSQDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGP 536
Query: 518 VDMTM-MEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSA 576
VD++ MEDSLV+WARPL +DG Y LVDP LEH Y P+EMAR+VAC AA++RHS
Sbjct: 537 VDLSGDMEDSLVDWARPLCMRVAQDGEYGELVDPFLEHQYEPYEMARMVACAAAAVRHSG 596
Query: 577 RKRPKMSQIVRALEGDSSLDDLNDGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLAL 636
R+RPKMSQIVR LEGD+SLDDL+DGV+P QSS S S++Y +Y A+M+KFR++ L
Sbjct: 597 RRRPKMSQIVRTLEGDASLDDLDDGVKPKQSS--SGGEGSSDYEMGTYGAEMRKFRKVTL 654
Query: 637 GSQDF-ASSDYGGSSD 651
S+D+ ASS+YG +S+
Sbjct: 655 ESRDYGASSEYGATSE 670
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LS95|PERK6_ARATH Putative proline-rich receptor-like protein kinase PERK6 OS=Arabidopsis thaliana GN=PERK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 535 bits (1378), Expect = e-151, Method: Compositional matrix adjust.
Identities = 281/383 (73%), Positives = 337/383 (87%), Gaps = 3/383 (0%)
Query: 271 MMSSSGEMSSQFSGPARPPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFG 330
M +S + SS +SGP P +PPP P++ALGFNKSTFTYDELAAAT GF++S LLGQGGFG
Sbjct: 290 MNGNSSDFSSNYSGPHGPSVPPPHPSVALGFNKSTFTYDELAAATQGFSQSRLLGQGGFG 349
Query: 331 YVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390
YVHKG+LPNGKE+AVKSLK GSGQGEREF AEV+IISRVHHR LVSLVGYCIAGGQRMLV
Sbjct: 350 YVHKGILPNGKEIAVKSLKAGSGQGEREFQAEVDIISRVHHRFLVSLVGYCIAGGQRMLV 409
Query: 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI 450
YEF+ N TLE+HLHG++ V+D+ TR++IALGSAKGLAYLHEDCHPRIIHRDIKA+NIL+
Sbjct: 410 YEFLPNDTLEFHLHGKSGKVLDWPTRLKIALGSAKGLAYLHEDCHPRIIHRDIKASNILL 469
Query: 451 DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLE 510
D++FEA VADFGLAKLS DN THVSTR+MGTFGYLAPEYASSGKLT++SDVFSFGVMLLE
Sbjct: 470 DESFEAKVADFGLAKLSQDNVTHVSTRIMGTFGYLAPEYASSGKLTDRSDVFSFGVMLLE 529
Query: 511 LITGRRPVDMT-MMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGA 569
L+TGRRPVD+T MEDSLV+WARP+ A +DG Y LVDPRLE+ Y PHEMA++VAC A
Sbjct: 530 LVTGRRPVDLTGEMEDSLVDWARPICLNAAQDGDYSELVDPRLENQYEPHEMAQMVACAA 589
Query: 570 ASIRHSARKRPKMSQIVRALEGDSSLDDLNDGVRPGQSSAFSASNTSTEYSATSYNADMK 629
A++RHSAR+RPKMSQIVRALEGD++LDDL++G + GQSS F +S++Y +++Y+ADMK
Sbjct: 590 AAVRHSARRRPKMSQIVRALEGDATLDDLSEGGKAGQSS-FLGRGSSSDYDSSTYSADMK 648
Query: 630 KFRQLALGSQDF-ASSDYGGSSD 651
KFR++AL S ++ ASS+YG +S+
Sbjct: 649 KFRKVALDSHEYGASSEYGNTSE 671
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 507 bits (1305), Expect = e-142, Method: Compositional matrix adjust.
Identities = 231/349 (66%), Positives = 293/349 (83%), Gaps = 4/349 (1%)
Query: 303 KSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAE 362
++ FTY++L+ AT F+ +NLLGQGGFGYVH+GVL +G VA+K LK+GSGQGEREF AE
Sbjct: 128 QNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAE 187
Query: 363 VEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALG 422
++ ISRVHHRHLVSL+GYCI G QR+LVYEFV NKTLE+HLH + RPVM+++ R++IALG
Sbjct: 188 IQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALG 247
Query: 423 SAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTF 482
+AKGLAYLHEDC+P+ IHRD+KAANILIDD++EA +ADFGLA+ S D THVSTR+MGTF
Sbjct: 248 AAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTF 307
Query: 483 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTM---MEDSLVEWARPLLGAAL 539
GYLAPEYASSGKLTEKSDVFS GV+LLELITGRRPVD + +DS+V+WA+PL+ AL
Sbjct: 308 GYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQAL 367
Query: 540 EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSLDDLN 599
DG +DGLVDPRLE+++ +EM R+VAC AAS+RHSA++RPKMSQIVRA EG+ S+DDL
Sbjct: 368 NDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEGNISIDDLT 427
Query: 600 DGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDFASSDYGG 648
+G PGQS+ +S + S++YS+T Y D+KKF+++A S+ F SS+ G
Sbjct: 428 EGAAPGQSTIYSL-DGSSDYSSTQYKEDLKKFKKMAFESKTFGSSECSG 475
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 488 bits (1256), Expect = e-137, Method: Compositional matrix adjust.
Identities = 231/359 (64%), Positives = 289/359 (80%), Gaps = 4/359 (1%)
Query: 290 LPPPSPNIALGFN--KSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKS 347
LPPPSP +ALG + TF Y+EL+ AT GF+++NLLGQGGFGYV KG+L NGKEVAVK
Sbjct: 324 LPPPSPGLALGLGIYQGTFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQ 383
Query: 348 LKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGEN 407
LK GS QGEREF AEV IISRVHHRHLV+LVGYCIA QR+LVYEFV N TLE+HLHG+
Sbjct: 384 LKEGSSQGEREFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKG 443
Query: 408 RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467
RP M++++R++IA+GSAKGL+YLHE+C+P+IIHRDIKA+NILID FEA VADFGLAK++
Sbjct: 444 RPTMEWSSRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIA 503
Query: 468 NDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMM--ED 525
+D +THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV+LLELITGRRP+D+ + ++
Sbjct: 504 SDTNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADN 563
Query: 526 SLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQI 585
SLV+WARPLL E G ++ +VD +L + Y EMAR+VAC AA +R +A +RP+M Q+
Sbjct: 564 SLVDWARPLLNQVSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQV 623
Query: 586 VRALEGDSSLDDLNDGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDFASS 644
R LEG+ S DLN G+ PG S+ + +S ST+Y ++ N M KFR++ L +QD S+
Sbjct: 624 ARVLEGNISPSDLNQGITPGHSNVYGSSGGSTDYDSSQDNEGMNKFRKVGLETQDLYSN 682
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 474 bits (1219), Expect = e-132, Method: Compositional matrix adjust.
Identities = 247/483 (51%), Positives = 324/483 (67%), Gaps = 47/483 (9%)
Query: 171 SVIGAVGVGIFLIAMI-IICAVRANKKKK---KRHNQPMHY--YGDHSNHFKKGGDPYYS 224
+++G G ++A+I ++ VR KK+ H+Q + + + S+ F G DP
Sbjct: 246 TMVGMAVAGFAIMALIGVVFLVRRKKKRNIDSYNHSQYLPHPNFSVKSDGFLYGQDPGKG 305
Query: 225 GGHAPNWHGHPEHQNWHSHPQGPDHTGGNIPPPPGGNWPGPPPPPPMMSSSGEMSSQFSG 284
PN + +++ Q + GN GG +P M SSG
Sbjct: 306 YSSGPNG-------SMYNNSQQQQSSMGNSYGTAGGGYP-----HHQMQSSG-------- 345
Query: 285 PARPPLPPPSPNIA-LGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEV 343
+P+ A LG ++ F+Y+ELA T GFA+ N+LG+GGFG V+KG L +GK V
Sbjct: 346 ---------TPDSAILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVV 396
Query: 344 AVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHL 403
AVK LK GSGQG+REF AEVEIISRVHHRHLVSLVGYCI+ R+L+YE+VSN+TLE+HL
Sbjct: 397 AVKQLKAGSGQGDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHL 456
Query: 404 HGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGL 463
HG+ PV++++ RVRIA+GSAKGLAYLHEDCHP+IIHRDIK+ANIL+DD +EA VADFGL
Sbjct: 457 HGKGLPVLEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGL 516
Query: 464 AKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMT-- 521
A+L++ THVSTRVMGTFGYLAPEYASSGKLT++SDVFSFGV+LLEL+TGR+PVD T
Sbjct: 517 ARLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQP 576
Query: 522 MMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPK 581
+ E+SLVEWARPLL A+E G L+D RLE YV HE+ R++ AA +RHS KRP+
Sbjct: 577 LGEESLVEWARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPR 636
Query: 582 MSQIVRALEGDSSLDDLNDGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDF 641
M Q+VRAL+ D D+++G++ GQ ST Y + YN D+ KFR++A G +
Sbjct: 637 MVQVVRALDCDGDSGDISNGIKIGQ---------STTYDSGQYNEDIMKFRKMAFGGDNS 687
Query: 642 ASS 644
S
Sbjct: 688 VES 690
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 464 bits (1193), Expect = e-129, Method: Compositional matrix adjust.
Identities = 220/368 (59%), Positives = 282/368 (76%), Gaps = 22/368 (5%)
Query: 302 NKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSA 361
+S F+YDEL+ T GF++ NLLG+GGFG V+KGVL +G+EVAVK LK G QGEREF A
Sbjct: 323 QRSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKA 382
Query: 362 EVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIAL 421
EVEIISRVHHRHLV+LVGYCI+ R+LVY++V N TL YHLH RPVM + TRVR+A
Sbjct: 383 EVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAA 442
Query: 422 GSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN--DNHTHVSTRVM 479
G+A+G+AYLHEDCHPRIIHRDIK++NIL+D++FEA+VADFGLAK++ D +THVSTRVM
Sbjct: 443 GAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVM 502
Query: 480 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMT--MMEDSLVEWARPLLGA 537
GTFGY+APEYA+SGKL+EK+DV+S+GV+LLELITGR+PVD + + ++SLVEWARPLLG
Sbjct: 503 GTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQ 562
Query: 538 ALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSLDD 597
A+E+ +D LVDPRL N++P EM R+V AA +RHSA KRPKMSQ+VRAL+ D
Sbjct: 563 AIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEATD 622
Query: 598 LNDGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDFAS---------SDYGG 648
+ +G+RPGQS F + S A ++ F+++A GSQD++S S +G
Sbjct: 623 ITNGMRPGQSQVFDSRQQS---------AQIRMFQRMAFGSQDYSSDFFDRSQSHSSWGS 673
Query: 649 SSDSREIP 656
SR +P
Sbjct: 674 RDQSRFVP 681
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 460 bits (1183), Expect = e-128, Method: Compositional matrix adjust.
Identities = 215/325 (66%), Positives = 266/325 (81%), Gaps = 3/325 (0%)
Query: 290 LPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLK 349
LP P + LG ++STFTY ELA AT F+++NLLG+GGFG+V+KG+L NG EVAVK LK
Sbjct: 156 LPAP-IGLVLGIHQSTFTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLK 214
Query: 350 TGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRP 409
GS QGE+EF AEV IIS++HHR+LVSLVGYCIAG QR+LVYEFV N TLE+HLHG+ RP
Sbjct: 215 VGSAQGEKEFQAEVNIISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHGKGRP 274
Query: 410 VMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469
M+++ R++IA+ S+KGL+YLHE+C+P+IIHRDIKAANILID FEA VADFGLAK++ D
Sbjct: 275 TMEWSLRLKIAVSSSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAKIALD 334
Query: 470 NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDM--TMMEDSL 527
+THVSTRVMGTFGYLAPEYA+SGKLTEKSDV+SFGV+LLELITGRRPVD +DSL
Sbjct: 335 TNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSL 394
Query: 528 VEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587
V+WARPLL ALE+ ++GL D +L + Y EMAR+VAC AA +R++AR+RP+M Q+VR
Sbjct: 395 VDWARPLLVQALEESNFEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVR 454
Query: 588 ALEGDSSLDDLNDGVRPGQSSAFSA 612
LEG+ S DLN G+ PG S+ S
Sbjct: 455 VLEGNISPSDLNQGITPGHSNTVSV 479
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1160), Expect = e-126, Method: Compositional matrix adjust.
Identities = 218/401 (54%), Positives = 301/401 (75%), Gaps = 21/401 (5%)
Query: 264 GPPPPPPMMSSSGEMSSQFSGPARPPLPP-------PSPNIALGFNKSTFTYDELAAATG 316
G P PM S++ S+ F + P+ S + LG +K+ F+Y+EL AT
Sbjct: 316 GDVTPSPMSSTARSDSAFFRMQSSAPVGASKRSGSYQSQSGGLGNSKALFSYEELVKATN 375
Query: 317 GFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVS 376
GF++ NLLG+GGFG V+KG+LP+G+ VAVK LK G GQG+REF AEVE +SR+HHRHLVS
Sbjct: 376 GFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVS 435
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
+VG+CI+G +R+L+Y++VSN L +HLHGE + V+D+ATRV+IA G+A+GLAYLHEDCHP
Sbjct: 436 IVGHCISGDRRLLIYDYVSNNDLYFHLHGE-KSVLDWATRVKIAAGAARGLAYLHEDCHP 494
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLT 496
RIIHRDIK++NIL++DNF+A V+DFGLA+L+ D +TH++TRV+GTFGY+APEYASSGKLT
Sbjct: 495 RIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLT 554
Query: 497 EKSDVFSFGVMLLELITGRRPVDMT--MMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554
EKSDVFSFGV+LLELITGR+PVD + + ++SLVEWARPL+ A+E +D L DP+L
Sbjct: 555 EKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLGG 614
Query: 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSLDDLNDGVRPGQSSAFSASN 614
NYV EM R++ A +RH A KRP+M QIVRA E ++ +DL +G+R G+S F+++
Sbjct: 615 NYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESLAA-EDLTNGMRLGESEVFNSAQ 673
Query: 615 TSTEYSATSYNADMKKFRQLALGSQDFASSDYGGSS-DSRE 654
S A+++ FR++A GSQ++++ + SS +SR+
Sbjct: 674 QS---------AEIRLFRRMAFGSQNYSTDFFSHSSYNSRD 705
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 662 | ||||||
| 224134338 | 575 | predicted protein [Populus trichocarpa] | 0.682 | 0.786 | 0.718 | 0.0 | |
| 449462888 | 638 | PREDICTED: proline-rich receptor-like pr | 0.848 | 0.880 | 0.627 | 0.0 | |
| 449516230 | 812 | PREDICTED: proline-rich receptor-like pr | 0.848 | 0.692 | 0.627 | 0.0 | |
| 255561130 | 620 | somatic embryogenesis receptor kinase, p | 0.719 | 0.767 | 0.726 | 0.0 | |
| 15224182 | 633 | roline-rich extensin-like receptor kinas | 0.714 | 0.747 | 0.663 | 0.0 | |
| 297836582 | 640 | predicted protein [Arabidopsis lyrata su | 0.705 | 0.729 | 0.661 | 1e-178 | |
| 359476577 | 630 | PREDICTED: proline-rich receptor-like pr | 0.669 | 0.703 | 0.700 | 1e-177 | |
| 359475172 | 664 | PREDICTED: proline-rich receptor-like pr | 0.746 | 0.743 | 0.659 | 1e-174 | |
| 255536819 | 482 | somatic embryogenesis receptor kinase, p | 0.667 | 0.917 | 0.661 | 1e-168 | |
| 30690042 | 670 | protein kinase family protein [Arabidops | 0.663 | 0.655 | 0.650 | 1e-166 |
| >gi|224134338|ref|XP_002327813.1| predicted protein [Populus trichocarpa] gi|222836898|gb|EEE75291.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 664 bits (1712), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/476 (71%), Positives = 391/476 (82%), Gaps = 24/476 (5%)
Query: 180 IFLIAMIIICAVRANKKKKKRHNQPMHYYGDHSNHFKKGGDPYYSGGHAPNWHGHPEHQN 239
IFLIAMI ICA + +KK+K MHYYG++ +GG +S + P+ N
Sbjct: 118 IFLIAMIFICAYCSRRKKRKN----MHYYGEN----PQGGSEQFS-------YNSPQQSN 162
Query: 240 WHSHPQGPDHTGGNI---PPPPGGNWPGPPPPPPMMSSSGEMSSQFSGPARPPLPPPSPN 296
WH+ P G + P P G WP PPPPMM+SS +MSS +SGP RPPLPPPSPN
Sbjct: 163 WHNGL--PTEHGMKLSQSPGPMGSGWP--APPPPMMNSS-DMSSNYSGPYRPPLPPPSPN 217
Query: 297 IALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGE 356
IALGFNKSTFTYDELAAAT GF ++NLLGQGGFGYVHKGVLPNGK++AVKSLK GSGQGE
Sbjct: 218 IALGFNKSTFTYDELAAATNGFDQANLLGQGGFGYVHKGVLPNGKDIAVKSLKLGSGQGE 277
Query: 357 REFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATR 416
REF AEV+IISRVHHRHLVSLVGYCIAGGQRMLVYEFV NKTLE+HLHG+ PVMD+ TR
Sbjct: 278 REFQAEVDIISRVHHRHLVSLVGYCIAGGQRMLVYEFVPNKTLEHHLHGKGLPVMDWPTR 337
Query: 417 VRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476
+RIALGSAKGLAYLHEDCHPRIIHRDIKAANILID+NFEAMVADFGLAKLS+DN+THVST
Sbjct: 338 LRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDNNFEAMVADFGLAKLSSDNYTHVST 397
Query: 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVD-MTMMEDSLVEWARPLL 535
RVMGTFGYLAPEYASSGKLT+KSDVFS+GVMLLELITG++PVD + MEDSLV+WARPL+
Sbjct: 398 RVMGTFGYLAPEYASSGKLTDKSDVFSYGVMLLELITGKKPVDPSSAMEDSLVDWARPLM 457
Query: 536 GAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSL 595
+L+ G Y+ LVDP LE+NY EM R++AC AASIRHSARKRPKMSQ+ RALEGD L
Sbjct: 458 ITSLDTGNYNELVDPMLENNYNHQEMQRMIACAAASIRHSARKRPKMSQVARALEGDVLL 517
Query: 596 DDLNDGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDFASSDYGGSSD 651
DDLN+G +PGQSS FS SN S +Y A+SYNADMKKFRQ+AL SQ+F S++ G SS+
Sbjct: 518 DDLNEGTKPGQSSVFSGSNGSADYDASSYNADMKKFRQVALNSQEFGSNELGTSSN 573
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462888|ref|XP_004149167.1| PREDICTED: proline-rich receptor-like protein kinase PERK4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 663 bits (1711), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/614 (62%), Positives = 446/614 (72%), Gaps = 52/614 (8%)
Query: 58 SSPPPS-KSPPSSPPPATS-SSPPPASPP--TSDNNKPDPPKNSPPPPPPSSQSSPTPPS 113
+SPPPS ++ SSPPP TS +SP P SP +SD++K P P +S ++ +PPS
Sbjct: 55 TSPPPSPENDDSSPPPPTSDNSPSPKSPSDGSSDDHKSHPAPKEGGSSPLTSPAAHSPPS 114
Query: 114 PSNNKSPSPPVFSPPP-PAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVTYSV 172
S++ FSPP P K+SP P + + + + SS S+ + G +
Sbjct: 115 RSSSAGDE---FSPPALPEGKASPRSPAKQQGTPSSEKDSSPSEINPG----------II 161
Query: 173 IG-AVGVGIFLIAMIIICAVRANKKKKKRHNQPMHYYGDHSNHFKKGGDPYYSGGHAPNW 231
IG AVGVG+F+I +I + AV + KKK+KR PM YYGDH + KGGD Y S
Sbjct: 162 IGVAVGVGVFIIVLISVIAVCSKKKKRKR--DPMPYYGDHGHGGPKGGDYYNSSLQ---- 215
Query: 232 HGHPEHQNWHSHPQGPDHTGGNIPP----PPGGNWPGPPPPPPMMSSSGEMSSQFSGPAR 287
+ QNWH+ GP PP P G WP SGE + S A
Sbjct: 216 ----QQQNWHNGMHGPGTDQFGRPPVSGSPAGTGWP----------MSGENMTTGSSYAG 261
Query: 288 PPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKS 347
PPLPPPSP+IA GFNKSTFTYDELAAATGGFA NLLGQGGFGYVHKGVLPNGKEVAVKS
Sbjct: 262 PPLPPPSPSIAFGFNKSTFTYDELAAATGGFAHGNLLGQGGFGYVHKGVLPNGKEVAVKS 321
Query: 348 LKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGEN 407
LK GSGQGEREF AEVEIISRVHHRHLVSLVG+CIAGGQRMLVYEFV N T+E+HLH +
Sbjct: 322 LKVGSGQGEREFMAEVEIISRVHHRHLVSLVGFCIAGGQRMLVYEFVPNNTMEHHLHAKG 381
Query: 408 RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467
PVMD+ R+RIA+GSAKGLAYLHEDCHP+IIHRDIK+ANILID NFEAMVADFGLAKLS
Sbjct: 382 LPVMDWPARLRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILIDANFEAMVADFGLAKLS 441
Query: 468 NDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMT-MMEDS 526
DNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG+RPVD T MEDS
Sbjct: 442 TDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGKRPVDPTHTMEDS 501
Query: 527 LVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIV 586
LV+WARPL+ AL +GIYD LVD RLE + EMAR+VAC AASIRHSARKRPKMSQ+V
Sbjct: 502 LVDWARPLMTRALMEGIYDELVDIRLEREFNTQEMARMVACAAASIRHSARKRPKMSQVV 561
Query: 587 RALEGDSSLDDLNDGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALG--SQDFASS 644
RALEGD SLDDLN+G RPGQSS FSA TS++Y +++Y+ADM KFR++AL S + A+S
Sbjct: 562 RALEGDVSLDDLNEGTRPGQSSIFSA--TSSDYDSSAYHADMSKFRKIALSDDSSELATS 619
Query: 645 DYGGSSDSREIPTP 658
S+DSRE+ P
Sbjct: 620 ----SNDSREMNHP 629
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449516230|ref|XP_004165150.1| PREDICTED: proline-rich receptor-like protein kinase PERK4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 662 bits (1709), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/614 (62%), Positives = 446/614 (72%), Gaps = 52/614 (8%)
Query: 58 SSPPPS-KSPPSSPPPATS-SSPPPASPP--TSDNNKPDPPKNSPPPPPPSSQSSPTPPS 113
+SPPPS ++ SSPPP TS +SP P SP +SD++K P P +S ++ +PPS
Sbjct: 229 TSPPPSPENDDSSPPPPTSDNSPSPKSPSDGSSDDHKSHPAPKEGGSSPLTSPAAHSPPS 288
Query: 114 PSNNKSPSPPVFSPPP-PAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVTYSV 172
S++ FSPP P K+SP P + + + + SS S+ + G +
Sbjct: 289 RSSSAGDE---FSPPALPEGKASPRSPAKQQGTPSSEKDSSPSEINPG----------II 335
Query: 173 IG-AVGVGIFLIAMIIICAVRANKKKKKRHNQPMHYYGDHSNHFKKGGDPYYSGGHAPNW 231
IG AVGVG+F+I +I + AV + KKK+KR PM YYGDH + KGGD Y S
Sbjct: 336 IGVAVGVGVFIIVLISVIAVCSKKKKRKR--DPMPYYGDHGHGGPKGGDYYNSSLQ---- 389
Query: 232 HGHPEHQNWHSHPQGPDHTGGNIPP----PPGGNWPGPPPPPPMMSSSGEMSSQFSGPAR 287
+ QNWH+ GP PP P G WP SGE + S A
Sbjct: 390 ----QQQNWHNGMHGPGTDQFGRPPVSGSPAGTGWP----------MSGENMTTGSSYAG 435
Query: 288 PPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKS 347
PPLPPPSP+IA GFNKSTFTYDELAAATGGFA NLLGQGGFGYVHKGVLPNGKEVAVKS
Sbjct: 436 PPLPPPSPSIAFGFNKSTFTYDELAAATGGFAHGNLLGQGGFGYVHKGVLPNGKEVAVKS 495
Query: 348 LKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGEN 407
LK GSGQGEREF AEVEIISRVHHRHLVSLVG+CIAGGQRMLVYEFV N T+E+HLH +
Sbjct: 496 LKVGSGQGEREFMAEVEIISRVHHRHLVSLVGFCIAGGQRMLVYEFVPNNTMEHHLHAKG 555
Query: 408 RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467
PVMD+ R+RIA+GSAKGLAYLHEDCHP+IIHRDIK+ANILID NFEAMVADFGLAKLS
Sbjct: 556 LPVMDWPARLRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILIDANFEAMVADFGLAKLS 615
Query: 468 NDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMT-MMEDS 526
DNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG+RPVD T MEDS
Sbjct: 616 TDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGKRPVDPTHTMEDS 675
Query: 527 LVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIV 586
LV+WARPL+ AL +GIYD LVD RLE + EMAR+VAC AASIRHSARKRPKMSQ+V
Sbjct: 676 LVDWARPLMTRALMEGIYDELVDIRLEREFNTQEMARMVACAAASIRHSARKRPKMSQVV 735
Query: 587 RALEGDSSLDDLNDGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALG--SQDFASS 644
RALEGD SLDDLN+G RPGQSS FSA TS++Y +++Y+ADM KFR++AL S + A+S
Sbjct: 736 RALEGDVSLDDLNEGTRPGQSSIFSA--TSSDYDSSAYHADMSKFRKIALSDDSSELATS 793
Query: 645 DYGGSSDSREIPTP 658
S+DSRE+ P
Sbjct: 794 ----SNDSREMNHP 803
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255561130|ref|XP_002521577.1| somatic embryogenesis receptor kinase, putative [Ricinus communis] gi|223539255|gb|EEF40848.1| somatic embryogenesis receptor kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 654 bits (1686), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/500 (72%), Positives = 401/500 (80%), Gaps = 24/500 (4%)
Query: 172 VIGA-VGVGIFLIAMIIICAVRANKKKKKRHNQPMHYYGDHSNHFKKGGDPYYSGGHAPN 230
++G VGVG+ +I M+I A KKKKK + M YYG + +G D YY+ N
Sbjct: 131 IVGVSVGVGLLIIVMLICGATLCKKKKKKH--KHMQYYGG----YPEGNDQYYNSSMQQN 184
Query: 231 WHGHPEHQNWHSHPQGPDHTG-------GNIPPPPGGNWPGPPPPPPMMSSSGEMSSQFS 283
WH P P GPDH G + PGG W PP PP MM SGEMS FS
Sbjct: 185 WHNGP--------PVGPDHIMKINSSSPGQMGSSPGGGWHAPPTPPQMMMMSGEMSGNFS 236
Query: 284 GPARPPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEV 343
GP RPPLPPPSPNIALGFNKSTFTYDELAAATGGF ++NLLGQGGFGYVHKGVLPNGKE+
Sbjct: 237 GPHRPPLPPPSPNIALGFNKSTFTYDELAAATGGFDQANLLGQGGFGYVHKGVLPNGKEI 296
Query: 344 AVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHL 403
AVKSLK+GSGQGEREF AEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHL
Sbjct: 297 AVKSLKSGSGQGEREFQAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHL 356
Query: 404 HGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGL 463
HG+ PVMDF TR+RIALGSAKGLAYLHEDCHPRIIHRDIKAANIL+D NFEAMVADFGL
Sbjct: 357 HGKGLPVMDFPTRLRIALGSAKGLAYLHEDCHPRIIHRDIKAANILLDFNFEAMVADFGL 416
Query: 464 AKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVD-MTM 522
AKLS+DN+THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG++PVD
Sbjct: 417 AKLSSDNYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGKKPVDPTNA 476
Query: 523 MEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKM 582
MEDSLV+WARPLL +LEDG Y+ L D RLE+NY P EM R+VAC AASIRHSARKRP+M
Sbjct: 477 MEDSLVDWARPLLNQSLEDGNYNELADFRLENNYNPEEMQRMVACAAASIRHSARKRPRM 536
Query: 583 SQIVRALEGDSSLDDLNDGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDFA 642
SQIVRALEGD SLD LN+G +PGQSS FS+SN S++Y +SYNADMKKFRQ+AL SQ+F
Sbjct: 537 SQIVRALEGDVSLDALNEGTKPGQSSMFSSSNGSSDYDTSSYNADMKKFRQVALSSQEFG 596
Query: 643 SSDYGGSS-DSREIPTPKQR 661
SS+ G SS DSR++ R
Sbjct: 597 SSELGTSSNDSRDMSLTGIR 616
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15224182|ref|NP_179437.1| roline-rich extensin-like receptor kinase 4 [Arabidopsis thaliana] gi|75338798|sp|Q9ZNQ8.1|PERK4_ARATH RecName: Full=Proline-rich receptor-like protein kinase PERK4; AltName: Full=Proline-rich extensin-like receptor kinase 4; Short=AtPERK4 gi|4218011|gb|AAD12219.1| putative protein kinase [Arabidopsis thaliana] gi|20197810|gb|AAM15257.1| putative protein kinase [Arabidopsis thaliana] gi|330251678|gb|AEC06772.1| roline-rich extensin-like receptor kinase 4 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 645 bits (1664), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/493 (66%), Positives = 386/493 (78%), Gaps = 20/493 (4%)
Query: 169 TYSVIGA-VGVGIFLIAMIIICAVRANKKKKKRHNQPMHYYGDHSNHFKKGGDPYYSGGH 227
T ++G VG G+ +I +II+C R K+K + +PM + + + + +
Sbjct: 150 TAIIVGVLVGAGLLMIVLIIVCLRRKKKRKDSFYPEPMK---GNQYQYYGNNNNNNASQN 206
Query: 228 APNWHGHPEHQNWHSHPQGPDHTGGNIPPPPGGNWPGPPPPPPMMSSSGEMSSQFSGPAR 287
PNWH + + QN S PPPPP M +SGE SS +SGP+R
Sbjct: 207 YPNWHLNSQGQNQQSTGGWGGGG-------------PSPPPPPRMPTSGEDSSMYSGPSR 253
Query: 288 PPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKS 347
P LPPPSP +ALGFNKSTFTY ELAAATGGF +NLLGQGGFGYVHKGVLP+GKEVAVKS
Sbjct: 254 PVLPPPSPALALGFNKSTFTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKS 313
Query: 348 LKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGEN 407
LK GSGQGEREF AEV+IISRVHHR+LVSLVGYCIA GQRMLVYEFV NKTLEYHLHG+N
Sbjct: 314 LKAGSGQGEREFQAEVDIISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLHGKN 373
Query: 408 RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467
PVM+F+TR+RIALG+AKGLAYLHEDCHPRIIHRDIK+ANIL+D NF+AMVADFGLAKL+
Sbjct: 374 LPVMEFSTRLRIALGAAKGLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLAKLT 433
Query: 468 NDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTM-MEDS 526
+DN+THVSTRVMGTFGYLAPEYASSGKLTEKSDVFS+GVMLLELITG+RPVD ++ M+D+
Sbjct: 434 SDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSITMDDT 493
Query: 527 LVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIV 586
LV+WARPL+ ALEDG ++ L D RLE NY P EMAR+V C AASIRHS RKRPKMSQIV
Sbjct: 494 LVDWARPLMARALEDGNFNELADARLEGNYNPQEMARMVTCAAASIRHSGRKRPKMSQIV 553
Query: 587 RALEGDSSLDDLNDGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDFASSDY 646
RALEG+ SLD LN+GV+PG S+ + + S++YS TSYNADMKKFRQ+AL SQ+F SD
Sbjct: 554 RALEGEVSLDALNEGVKPGHSNVYGSLGASSDYSQTSYNADMKKFRQIALSSQEFPVSDC 613
Query: 647 GGSS--DSREIPT 657
G+S DSR++ T
Sbjct: 614 EGTSSNDSRDMGT 626
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297836582|ref|XP_002886173.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297332013|gb|EFH62432.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 631 bits (1628), Expect = e-178, Method: Compositional matrix adjust.
Identities = 328/496 (66%), Positives = 381/496 (76%), Gaps = 29/496 (5%)
Query: 169 TYSVIGA-VGVGIFLIAMIIICAVRANKKKKKRHNQPMHYYGDHSNHFKKGGDPYYSGGH 227
T ++G VG G+ +I +II+C R KKK+K P G+ ++ + + +
Sbjct: 156 TAIIVGVLVGAGLLMIVLIIVCLRR--KKKRKDSFYPESMKGNQYQYYGNNNNNNNASQN 213
Query: 228 APNWHGHPEHQNWHSHPQGPDHTGGNIPPPPGGNWPGPPPPPPMMSSSGEMSSQFSGPAR 287
PNWH + + QN S PPPPP M +SGE S+ +SGP+R
Sbjct: 214 YPNWHLNAQGQNQQSTGGWGGGGP-------------SPPPPPRMPTSGEDSALYSGPSR 260
Query: 288 PPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKS 347
P LPPPSP +ALGFNKSTFTY ELAAATGGF +NLLGQGGFGYVHKGVLP+GKEVAVKS
Sbjct: 261 PVLPPPSPALALGFNKSTFTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKS 320
Query: 348 LKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGEN 407
LK GSGQGEREF AEV+IISRVHHR+LVSLVGYCIA GQRMLVYEFV N TLEYHLHG+N
Sbjct: 321 LKAGSGQGEREFQAEVDIISRVHHRYLVSLVGYCIADGQRMLVYEFVPNNTLEYHLHGKN 380
Query: 408 RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467
PVMDF+TR+RIALG+AKGLAYLHEDCHPRIIHRDIK+ANIL+D NF+AMVADFGLAKL+
Sbjct: 381 LPVMDFSTRLRIALGAAKGLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLAKLT 440
Query: 468 NDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVD-MTMMEDS 526
+DN+THVSTRVMGTFGYLAPEYASSGKLTEKSDVFS+GVMLLELITG+RPVD + M+D+
Sbjct: 441 SDNYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSSTMDDT 500
Query: 527 LVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIV 586
LV+WARPL+ ALEDG ++ L D RLE NY P EMAR+V C AASIRHS RKRPKMSQIV
Sbjct: 501 LVDWARPLMARALEDGNFNELADARLEGNYNPQEMARMVTCAAASIRHSGRKRPKMSQIV 560
Query: 587 RALEGDSSLDDLNDGVRPGQSSAFSASNTS-----TEYSATSYNADMKKFRQLALGSQDF 641
RALEG+ SLD LN+GV+PG S+ + S TS TSYNADMKKFRQ+AL SQ+F
Sbjct: 561 RALEGEVSLDALNEGVKPGHSNVYGTSGTSSDYSQ-----TSYNADMKKFRQIALSSQEF 615
Query: 642 ASSDYGGSS--DSREI 655
SD G+S DSRE+
Sbjct: 616 PISDCEGTSSNDSREM 631
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359476577|ref|XP_002267433.2| PREDICTED: proline-rich receptor-like protein kinase PERK4-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 629 bits (1621), Expect = e-177, Method: Compositional matrix adjust.
Identities = 325/464 (70%), Positives = 368/464 (79%), Gaps = 21/464 (4%)
Query: 186 IIICAVRANKKKKKRHNQPMHYYGDHSNHFKKGGDPYYSGGHAPNWHGHPEHQNWHSHPQ 245
+ CA K++KKR+ Q SN GD YY+ + NW++ PQ
Sbjct: 170 CVTCA----KRRKKRNQQASQATQYQSN---PSGDNYYNS---------SQQSNWYNSPQ 213
Query: 246 GPDHTGGNIPPPPGGNWPGPPPPPPMMSSSGEMSSQFSGPARPPLPPPSPNIALGFNKST 305
DH + G PPPP M SSG+MSS +SGP PPLPPPSPN+ALGFNKST
Sbjct: 214 SADH----VVKLHQPPGGGWAPPPPPMISSGDMSSNYSGPRHPPLPPPSPNLALGFNKST 269
Query: 306 FTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEI 365
FTY+ELAAATGGFA++NLLGQGGFGYVHKGVLPNGKE+AVKSLK+GSGQGEREF AEVEI
Sbjct: 270 FTYEELAAATGGFAQANLLGQGGFGYVHKGVLPNGKEIAVKSLKSGSGQGEREFQAEVEI 329
Query: 366 ISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAK 425
ISRVHHRHLVSLVGYCIA GQRMLVYEFV NKTLE+HLHG RP+MD+A+R+RIALGSAK
Sbjct: 330 ISRVHHRHLVSLVGYCIADGQRMLVYEFVHNKTLEHHLHGSGRPIMDWASRMRIALGSAK 389
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL 485
GLAYLHEDCHP+IIHRDIK ANIL+D NFEAMVADFGLAKLS DN THVSTRVMGTFGYL
Sbjct: 390 GLAYLHEDCHPKIIHRDIKTANILLDYNFEAMVADFGLAKLSTDNCTHVSTRVMGTFGYL 449
Query: 486 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545
APEYASSGKLTEKSDVFS+GVMLLELITGRRPVD + E+SLV+WARPLL AL DG YD
Sbjct: 450 APEYASSGKLTEKSDVFSYGVMLLELITGRRPVDNAIFEESLVDWARPLLSRALADGNYD 509
Query: 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSLDDLNDGVRPG 605
LVD LE+NY EMAR+VAC AASIRHSA++RPKMSQIVRALEGD SL+DLND +
Sbjct: 510 ELVDRFLENNYNTQEMARMVACAAASIRHSAKRRPKMSQIVRALEGDVSLEDLNDVTKTN 569
Query: 606 QSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDFASSDYGGS 649
QS A+S S S+EY+ YNADM+KF+++AL SQ+F SS+ G S
Sbjct: 570 QSPAYSTS-MSSEYNTRMYNADMEKFKKMALSSQEFGSSEDGTS 612
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475172|ref|XP_003631608.1| PREDICTED: proline-rich receptor-like protein kinase PERK7-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 617 bits (1590), Expect = e-174, Method: Compositional matrix adjust.
Identities = 350/531 (65%), Positives = 402/531 (75%), Gaps = 37/531 (6%)
Query: 131 AKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVTYSVIGAVGVGIFLIAMIIICA 190
A + SPPPP + S+ KS+ SS+ SSS + V+ G L+ +++
Sbjct: 135 ATRKSPPPPHKSWPSNHGKSTPPPPPSSSSSSSSKLPIIIGVVAGAG----LLLFVMVIF 190
Query: 191 VRANKKKKKRHNQPMHYYGDHSNHFKKGGDPYYSGGHAPNWHGHPEHQNWHSHPQGPDHT 250
+ KKKKR N + YY D + KG + YYS NW S PQ
Sbjct: 191 LCCCNKKKKRKNDQIQYYHDPPYDY-KGAEQYYS--------------NWSSGPQNS--- 232
Query: 251 GGNIPPPPGG--------NWPGPPPPPPMMSSSGEM-SSQFSGPARPPLPPPSPNIALGF 301
+PPPPG WP PPPPPP M SGEM SS FSGP +PPLPPP P++ALGF
Sbjct: 233 --KLPPPPGAIMGVQHGVGWPSPPPPPPNM-MSGEMSSSNFSGPFQPPLPPPHPSLALGF 289
Query: 302 NKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSA 361
+KSTF YDELA AT GF+++NLLGQGGFGYVHKGVLPNGKE+AVKSLK GSGQGEREF A
Sbjct: 290 SKSTFNYDELAVATAGFSQANLLGQGGFGYVHKGVLPNGKEIAVKSLKAGSGQGEREFQA 349
Query: 362 EVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIAL 421
EVEIISRVHHRHLVSLVGYCIAG QRMLVYEFV N TLEYHLHG+ RP M+++TR++IA+
Sbjct: 350 EVEIISRVHHRHLVSLVGYCIAGSQRMLVYEFVPNNTLEYHLHGKGRPTMEWSTRLKIAM 409
Query: 422 GSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGT 481
GSAKGLAYLHEDCHPRIIHRDIK ANIL+D NFEA VADFGLAKLS+D +THVSTR+MGT
Sbjct: 410 GSAKGLAYLHEDCHPRIIHRDIKTANILLDFNFEAKVADFGLAKLSSDTNTHVSTRIMGT 469
Query: 482 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALED 541
FGYLAPEYASSGKLTEKSDVFSFGVMLLELITG+RPV+ + MEDSLV+WARP+L ALED
Sbjct: 470 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGKRPVE-SDMEDSLVDWARPILLRALED 528
Query: 542 GIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSLDDLNDG 601
G Y+ LVDPRLE NY P EM RL+AC AA IRHSAR+RPKMSQ VRALEGD SLDDLN+G
Sbjct: 529 GNYEELVDPRLEKNYKPQEMVRLIACAAACIRHSARRRPKMSQTVRALEGDVSLDDLNEG 588
Query: 602 VRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDFASS-DYGGSSD 651
V+PGQSS F S+ ST+Y SYNADMKKFR++AL SQD+ SS +YG +SD
Sbjct: 589 VKPGQSSVF-GSDGSTDYDKGSYNADMKKFRRMALSSQDYESSTEYGFTSD 638
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255536819|ref|XP_002509476.1| somatic embryogenesis receptor kinase, putative [Ricinus communis] gi|223549375|gb|EEF50863.1| somatic embryogenesis receptor kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 599 bits (1545), Expect = e-168, Method: Compositional matrix adjust.
Identities = 312/472 (66%), Positives = 376/472 (79%), Gaps = 30/472 (6%)
Query: 193 ANKKKKKRHNQPMHYYGDHSNHFKKGGDPYYSGGHAPNWHGHPEH--QNWHSHPQGPDHT 250
A+KKKKKR YY D + GG+A N+ NW + Q
Sbjct: 3 ASKKKKKR--IEYDYYADQT-----------PGGNAGNYFNSSTQPVNNWQAGSQ----K 45
Query: 251 GGNIPPPPG--GNWPGPPPPPPMMS-------SSGEMSSQFSGPARPPLPPPSPNIALGF 301
G N+PPPPG G WP PPPPP + +S ++SS FSGP PPLPPP P++ALGF
Sbjct: 46 GTNLPPPPGVYGGWPSPPPPPGPQTPLPLGAMTSSDLSSNFSGPYGPPLPPPHPSVALGF 105
Query: 302 NKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSA 361
+S+F+YDELAA TG F+++NLLGQGGFGYVHKGVLPNGKE+AVKSLK GSGQG+REF A
Sbjct: 106 TQSSFSYDELAAVTGNFSQANLLGQGGFGYVHKGVLPNGKEIAVKSLKAGSGQGDREFQA 165
Query: 362 EVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIAL 421
EVEIISRVHHRHLVSLVGYCIAGG+R+LVYEF+ N TLE+HL+G+ RP MD+ TR++IAL
Sbjct: 166 EVEIISRVHHRHLVSLVGYCIAGGKRLLVYEFLPNSTLEFHLYGKGRPTMDWPTRLKIAL 225
Query: 422 GSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGT 481
GSA+GLAYLHEDCHPRIIHRDIKAANIL+D NFEA VADFGLAKLSNDN+THVSTRVMGT
Sbjct: 226 GSARGLAYLHEDCHPRIIHRDIKAANILLDYNFEAKVADFGLAKLSNDNNTHVSTRVMGT 285
Query: 482 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTM-MEDSLVEWARPLLGAALE 540
FGYLAPEYASSGKLT+KSDVFSFGVMLLELITGRRPVD+T M++SLV+WARP+ +ALE
Sbjct: 286 FGYLAPEYASSGKLTDKSDVFSFGVMLLELITGRRPVDLTSDMDESLVDWARPICASALE 345
Query: 541 DGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSLDDLND 600
+G + L DPRLE NY P EMAR+VAC A++RHSAR+R KMSQIVRALEGD SL+ LN+
Sbjct: 346 NGDFSELADPRLEGNYDPAEMARMVACAGAAVRHSARRRAKMSQIVRALEGDVSLEHLNE 405
Query: 601 GVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLAL-GSQDFASSDYGGSSD 651
GV+PGQS+ FS+++ S++ TSY+ADM+KFR++ + SQ++ SS+YG +S+
Sbjct: 406 GVKPGQSTVFSSTSGSSDNDTTSYSADMRKFRKVVMDNSQEYESSEYGHTSE 457
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30690042|ref|NP_195170.2| protein kinase family protein [Arabidopsis thaliana] gi|75328931|sp|Q8GX23.1|PERK5_ARATH RecName: Full=Proline-rich receptor-like protein kinase PERK5; AltName: Full=Proline-rich extensin-like receptor kinase 5; Short=AtPERK5 gi|26452004|dbj|BAC43092.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|29029022|gb|AAO64890.1| At4g34440 [Arabidopsis thaliana] gi|332660977|gb|AEE86377.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1527), Expect = e-166, Method: Compositional matrix adjust.
Identities = 304/467 (65%), Positives = 358/467 (76%), Gaps = 28/467 (5%)
Query: 186 IIICAVRANKKKKKRHNQPMHYYGDHSNHFKKGGDPYYSGGHAPNWHGHPEHQNWHSHPQ 245
I IC R KKK + N MHYY N+ GG P +GG+ + G P+
Sbjct: 207 ICICCNRKKKKKSPQVNH-MHYY----NNNPYGGAPSGNGGY---YKGTPQ--------- 249
Query: 246 GPDHTGGNIPPPPGGNWPGPPPPPPMMSSSGEMSSQFSGPARPPLPPPSPNIALGFNKST 305
DH N+ GGNW GP P SG S + R +P P LG N+ST
Sbjct: 250 --DHVV-NMAGQGGGNW-GPQQP-----VSGPHSDASNLTGRTAIPSPQA-ATLGHNQST 299
Query: 306 FTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEI 365
FTYDEL+ AT GFA+SNLLGQGGFGYVHKGVLP+GKEVAVKSLK GSGQGEREF AEV+I
Sbjct: 300 FTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVKSLKLGSGQGEREFQAEVDI 359
Query: 366 ISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAK 425
ISRVHHRHLVSLVGYCI+GGQR+LVYEF+ N TLE+HLHG+ RPV+D+ TRV+IALGSA+
Sbjct: 360 ISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLEFHLHGKGRPVLDWPTRVKIALGSAR 419
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL 485
GLAYLHEDCHPRIIHRDIKAANIL+D +FE VADFGLAKLS DN+THVSTRVMGTFGYL
Sbjct: 420 GLAYLHEDCHPRIIHRDIKAANILLDFSFETKVADFGLAKLSQDNYTHVSTRVMGTFGYL 479
Query: 486 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMT-MMEDSLVEWARPLLGAALEDGIY 544
APEYASSGKL++KSDVFSFGVMLLELITGR P+D+T MEDSLV+WARPL A +DG Y
Sbjct: 480 APEYASSGKLSDKSDVFSFGVMLLELITGRPPLDLTGEMEDSLVDWARPLCLKAAQDGDY 539
Query: 545 DGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSLDDLNDGVRP 604
+ L DPRLE NY EM ++ +C AA+IRHSAR+RPKMSQIVRALEGD S+DDL++G RP
Sbjct: 540 NQLADPRLELNYSHQEMVQMASCAAAAIRHSARRRPKMSQIVRALEGDMSMDDLSEGTRP 599
Query: 605 GQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDFASSDYGGSSD 651
GQS+ S + S+EY A+SY ADMKKF++LAL ++++ SS+YGG+S+
Sbjct: 600 GQSTYLSPGSVSSEYDASSYTADMKKFKKLALENKEYQSSEYGGTSE 646
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 662 | ||||||
| TAIR|locus:2046268 | 633 | PERK4 "proline-rich extensin-l | 0.546 | 0.571 | 0.775 | 3.7e-159 | |
| TAIR|locus:2093999 | 700 | PERK6 "proline-rich extensin-l | 0.536 | 0.507 | 0.751 | 2.8e-152 | |
| TAIR|locus:2139474 | 670 | PERK5 "proline-rich extensin-l | 0.533 | 0.526 | 0.757 | 3.5e-152 | |
| TAIR|locus:2010282 | 699 | PERK7 "proline-rich extensin-l | 0.534 | 0.506 | 0.746 | 1.2e-151 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.536 | 0.548 | 0.713 | 8.9e-143 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.536 | 0.544 | 0.693 | 1.2e-140 | |
| TAIR|locus:2018209 | 509 | PERK15 "proline-rich extensin- | 0.542 | 0.705 | 0.645 | 1.8e-126 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.522 | 0.480 | 0.614 | 2.5e-119 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.524 | 0.488 | 0.624 | 9.7e-118 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.513 | 0.499 | 0.618 | 5.8e-114 |
| TAIR|locus:2046268 PERK4 "proline-rich extensin-like receptor kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1471 (522.9 bits), Expect = 3.7e-159, Sum P(2) = 3.7e-159
Identities = 286/369 (77%), Positives = 326/369 (88%)
Query: 297 IALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGE 356
+ALGFNKSTFTY ELAAATGGF +NLLGQGGFGYVHKGVLP+GKEVAVKSLK GSGQGE
Sbjct: 263 LALGFNKSTFTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGSGQGE 322
Query: 357 REFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATR 416
REF AEV+IISRVHHR+LVSLVGYCIA GQRMLVYEFV NKTLEYHLHG+N PVM+F+TR
Sbjct: 323 REFQAEVDIISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLHGKNLPVMEFSTR 382
Query: 417 VRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476
+RIALG+AKGLAYLHEDCHPRIIHRDIK+ANIL+D NF+AMVADFGLAKL++DN+THVST
Sbjct: 383 LRIALGAAKGLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLAKLTSDNNTHVST 442
Query: 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTM-MEDSLVEWARPLL 535
RVMGTFGYLAPEYASSGKLTEKSDVFS+GVMLLELITG+RPVD ++ M+D+LV+WARPL+
Sbjct: 443 RVMGTFGYLAPEYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSITMDDTLVDWARPLM 502
Query: 536 GAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSL 595
ALEDG ++ L D RLE NY P EMAR+V C AASIRHS RKRPKMSQIVRALEG+ SL
Sbjct: 503 ARALEDGNFNELADARLEGNYNPQEMARMVTCAAASIRHSGRKRPKMSQIVRALEGEVSL 562
Query: 596 DDLNDGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDFASSDYGGSS--DSR 653
D LN+GV+PG S+ + + S++YS TSYNADMKKFRQ+AL SQ+F SD G+S DSR
Sbjct: 563 DALNEGVKPGHSNVYGSLGASSDYSQTSYNADMKKFRQIALSSQEFPVSDCEGTSSNDSR 622
Query: 654 EI----PTP 658
++ PTP
Sbjct: 623 DMGTKSPTP 631
|
|
| TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1415 (503.2 bits), Expect = 2.8e-152, Sum P(2) = 2.8e-152
Identities = 269/358 (75%), Positives = 321/358 (89%)
Query: 296 NIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQG 355
++ALGFNKSTFTYDELAAAT GF++S LLGQGGFGYVHKG+LPNGKE+AVKSLK GSGQG
Sbjct: 315 SVALGFNKSTFTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQG 374
Query: 356 EREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFAT 415
EREF AEV+IISRVHHR LVSLVGYCIAGGQRMLVYEF+ N TLE+HLHG++ V+D+ T
Sbjct: 375 EREFQAEVDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPT 434
Query: 416 RVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475
R++IALGSAKGLAYLHEDCHPRIIHRDIKA+NIL+D++FEA VADFGLAKLS DN THVS
Sbjct: 435 RLKIALGSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVS 494
Query: 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMT-MMEDSLVEWARPL 534
TR+MGTFGYLAPEYASSGKLT++SDVFSFGVMLLEL+TGRRPVD+T MEDSLV+WARP+
Sbjct: 495 TRIMGTFGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEMEDSLVDWARPI 554
Query: 535 LGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSS 594
A +DG Y LVDPRLE+ Y PHEMA++VAC AA++RHSAR+RPKMSQIVRALEGD++
Sbjct: 555 CLNAAQDGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALEGDAT 614
Query: 595 LDDLNDGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDF-ASSDYGGSSD 651
LDDL++G + GQSS F +S++Y +++Y+ADMKKFR++AL S ++ ASS+YG +S+
Sbjct: 615 LDDLSEGGKAGQSS-FLGRGSSSDYDSSTYSADMKKFRKVALDSHEYGASSEYGNTSE 671
|
|
| TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1410 (501.4 bits), Expect = 3.5e-152, Sum P(2) = 3.5e-152
Identities = 268/354 (75%), Positives = 313/354 (88%)
Query: 299 LGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGERE 358
LG N+STFTYDEL+ AT GFA+SNLLGQGGFGYVHKGVLP+GKEVAVKSLK GSGQGERE
Sbjct: 293 LGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVKSLKLGSGQGERE 352
Query: 359 FSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVR 418
F AEV+IISRVHHRHLVSLVGYCI+GGQR+LVYEF+ N TLE+HLHG+ RPV+D+ TRV+
Sbjct: 353 FQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLEFHLHGKGRPVLDWPTRVK 412
Query: 419 IALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRV 478
IALGSA+GLAYLHEDCHPRIIHRDIKAANIL+D +FE VADFGLAKLS DN+THVSTRV
Sbjct: 413 IALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVADFGLAKLSQDNYTHVSTRV 472
Query: 479 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMT-MMEDSLVEWARPLLGA 537
MGTFGYLAPEYASSGKL++KSDVFSFGVMLLELITGR P+D+T MEDSLV+WARPL
Sbjct: 473 MGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLDLTGEMEDSLVDWARPLCLK 532
Query: 538 ALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSLDD 597
A +DG Y+ L DPRLE NY EM ++ +C AA+IRHSAR+RPKMSQIVRALEGD S+DD
Sbjct: 533 AAQDGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHSARRRPKMSQIVRALEGDMSMDD 592
Query: 598 LNDGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDFASSDYGGSSD 651
L++G RPGQS+ S + S+EY A+SY ADMKKF++LAL ++++ SS+YGG+S+
Sbjct: 593 LSEGTRPGQSTYLSPGSVSSEYDASSYTADMKKFKKLALENKEYQSSEYGGTSE 646
|
|
| TAIR|locus:2010282 PERK7 "proline-rich extensin-like receptor kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1384 (492.3 bits), Expect = 1.2e-151, Sum P(2) = 1.2e-151
Identities = 268/359 (74%), Positives = 311/359 (86%)
Query: 296 NIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQG 355
++ALGFN STFTY+ELA+AT GF+K LLGQGGFGYVHKG+LPNGKE+AVKSLK GSGQG
Sbjct: 314 SVALGFNNSTFTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQG 373
Query: 356 EREFSAEVEIISRVHHRHLVSLVGYCI-AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFA 414
EREF AEVEIISRVHHRHLVSLVGYC AGGQR+LVYEF+ N TLE+HLHG++ VMD+
Sbjct: 374 EREFQAEVEIISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLEFHLHGKSGTVMDWP 433
Query: 415 TRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474
TR++IALGSAKGLAYLHEDCHP+IIHRDIKA+NIL+D NFEA VADFGLAKLS DN+THV
Sbjct: 434 TRLKIALGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKLSQDNNTHV 493
Query: 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTM-MEDSLVEWARP 533
STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR PVD++ MEDSLV+WARP
Sbjct: 494 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGDMEDSLVDWARP 553
Query: 534 LLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593
L +DG Y LVDP LEH Y P+EMAR+VAC AA++RHS R+RPKMSQIVR LEGD+
Sbjct: 554 LCMRVAQDGEYGELVDPFLEHQYEPYEMARMVACAAAAVRHSGRRRPKMSQIVRTLEGDA 613
Query: 594 SLDDLNDGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDF-ASSDYGGSSD 651
SLDDL+DGV+P QSS S S++Y +Y A+M+KFR++ L S+D+ ASS+YG +S+
Sbjct: 614 SLDDLDDGVKPKQSS--SGGEGSSDYEMGTYGAEMRKFRKVTLESRDYGASSEYGATSE 670
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 1347 (479.2 bits), Expect = 8.9e-143, Sum P(2) = 8.9e-143
Identities = 256/359 (71%), Positives = 309/359 (86%)
Query: 297 IALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGE 356
+ LGF+KSTFTY+ELA AT GF+++NLLGQGGFGYVHKGVLP+GKEVAVK LK GSGQGE
Sbjct: 254 LVLGFSKSTFTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSGQGE 313
Query: 357 REFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATR 416
REF AEVEIISRVHHRHLVSLVGYCIAG +R+LVYEFV N LE HLHGE RP M+++TR
Sbjct: 314 REFQAEVEIISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLHGEGRPTMEWSTR 373
Query: 417 VRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476
++IALGSAKGL+YLHEDC+P+IIHRDIKA+NILID FEA VADFGLAK+++D +THVST
Sbjct: 374 LKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVST 433
Query: 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMT--MMEDSLVEWARPL 534
RVMGTFGYLAPEYA+SGKLTEKSDVFSFGV+LLELITGRRPVD ++DSLV+WARPL
Sbjct: 434 RVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPL 493
Query: 535 LGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSS 594
L A E G ++GL D ++ + Y EMAR+VAC AA +RHSAR+RP+MSQIVRALEG+ S
Sbjct: 494 LNRASEQGDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVS 553
Query: 595 LDDLNDGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDF-ASSDYGG-SSD 651
L DLN+G+RPGQS+ +S+ ST+Y ++ YN DMKKFR++ALG+Q++ A+ +Y +SD
Sbjct: 554 LSDLNEGMRPGQSNVYSSYGGSTDYDSSQYNEDMKKFRKMALGTQEYNATGEYSNPTSD 612
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1322 (470.4 bits), Expect = 1.2e-140, Sum P(2) = 1.2e-140
Identities = 249/359 (69%), Positives = 308/359 (85%)
Query: 297 IALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGE 356
+ LGF+KSTFTY+EL+ AT GF+++NLLGQGGFGYVHKG+LP+GKEVAVK LK GSGQGE
Sbjct: 259 LVLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGE 318
Query: 357 REFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATR 416
REF AEVEIISRVHHRHLVSL+GYC+AG QR+LVYEFV N LE+HLHG+ RP M+++TR
Sbjct: 319 REFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTR 378
Query: 417 VRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476
++IALGSAKGL+YLHEDC+P+IIHRDIKA+NILID FEA VADFGLAK+++D +THVST
Sbjct: 379 LKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVST 438
Query: 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMT--MMEDSLVEWARPL 534
RVMGTFGYLAPEYA+SGKLTEKSDVFSFGV+LLELITGRRPVD ++DSLV+WARPL
Sbjct: 439 RVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPL 498
Query: 535 LGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSS 594
L A E+G ++GL D ++ + Y EMAR+VAC AA +RHSAR+RP+MSQIVRALEG+ S
Sbjct: 499 LNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVS 558
Query: 595 LDDLNDGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDFASS-DYGG-SSD 651
L DLN+G+RPG S+ +S+ ST+Y + YN DM KFR++ALG+Q++ ++ +Y +SD
Sbjct: 559 LSDLNEGMRPGHSNVYSSYGGSTDYDTSQYNDDMIKFRKMALGTQEYGTTGEYSNPTSD 617
|
|
| TAIR|locus:2018209 PERK15 "proline-rich extensin-like receptor kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1242 (442.3 bits), Expect = 1.8e-126, P = 1.8e-126
Identities = 235/364 (64%), Positives = 300/364 (82%)
Query: 303 KSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAE 362
++ FTY++L+ AT F+ +NLLGQGGFGYVH+GVL +G VA+K LK+GSGQGEREF AE
Sbjct: 128 QNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAE 187
Query: 363 VEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALG 422
++ ISRVHHRHLVSL+GYCI G QR+LVYEFV NKTLE+HLH + RPVM+++ R++IALG
Sbjct: 188 IQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALG 247
Query: 423 SAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTF 482
+AKGLAYLHEDC+P+ IHRD+KAANILIDD++EA +ADFGLA+ S D THVSTR+MGTF
Sbjct: 248 AAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTF 307
Query: 483 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMM---EDSLVEWARPLLGAAL 539
GYLAPEYASSGKLTEKSDVFS GV+LLELITGRRPVD + +DS+V+WA+PL+ AL
Sbjct: 308 GYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQAL 367
Query: 540 EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSLDDLN 599
DG +DGLVDPRLE+++ +EM R+VAC AAS+RHSA++RPKMSQIVRA EG+ S+DDL
Sbjct: 368 NDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEGNISIDDLT 427
Query: 600 DGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDFASSDYGG-SSDSREIPTP 658
+G PGQS+ +S +S +YS+T Y D+KKF+++A S+ F SS+ G +SD+ + P+
Sbjct: 428 EGAAPGQSTIYSLDGSS-DYSSTQYKEDLKKFKKMAFESKTFGSSECSGLTSDNGQNPSG 486
Query: 659 KQRI 662
I
Sbjct: 487 SSSI 490
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1135 (404.6 bits), Expect = 2.5e-119, Sum P(2) = 2.5e-119
Identities = 220/358 (61%), Positives = 278/358 (77%)
Query: 299 LGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGERE 358
LG ++ F+Y+ELA T GFA+ N+LG+GGFG V+KG L +GK VAVK LK GSGQG+RE
Sbjct: 352 LGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDRE 411
Query: 359 FSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVR 418
F AEVEIISRVHHRHLVSLVGYCI+ R+L+YE+VSN+TLE+HLHG+ PV++++ RVR
Sbjct: 412 FKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVR 471
Query: 419 IALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRV 478
IA+GSAKGLAYLHEDCHP+IIHRDIK+ANIL+DD +EA VADFGLA+L++ THVSTRV
Sbjct: 472 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRV 531
Query: 479 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMT--MMEDSLVEWARPLLG 536
MGTFGYLAPEYASSGKLT++SDVFSFGV+LLEL+TGR+PVD T + E+SLVEWARPLL
Sbjct: 532 MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLL 591
Query: 537 AALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSLD 596
A+E G L+D RLE YV HE+ R++ AA +RHS KRP+M Q+VRAL+ D
Sbjct: 592 KAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGDSG 651
Query: 597 DLNDGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDFASSD-YGGSSDSR 653
D+++G++ GQS T Y + YN D+ KFR++A G + S Y G+ ++
Sbjct: 652 DISNGIKIGQS---------TTYDSGQYNEDIMKFRKMAFGGDNSVESGLYSGNYSAK 700
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1141 (406.7 bits), Expect = 9.7e-118, Sum P(2) = 9.7e-118
Identities = 226/362 (62%), Positives = 280/362 (77%)
Query: 299 LGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGERE 358
+G ++ FTY+EL T GF+K N+LG+GGFG V+KG L +GK VAVK LK GSGQG+RE
Sbjct: 334 MGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDRE 393
Query: 359 FSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVR 418
F AEVEIISRVHHRHLVSLVGYCIA +R+L+YE+V N+TLE+HLHG+ RPV+++A RVR
Sbjct: 394 FKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVR 453
Query: 419 IALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRV 478
IA+GSAKGLAYLHEDCHP+IIHRDIK+ANIL+DD FEA VADFGLAKL++ THVSTRV
Sbjct: 454 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRV 513
Query: 479 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDM--TMMEDSLVEWARPLLG 536
MGTFGYLAPEYA SGKLT++SDVFSFGV+LLELITGR+PVD + E+SLVEWARPLL
Sbjct: 514 MGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLH 573
Query: 537 AALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSLD 596
A+E G + LVD RLE +YV +E+ R++ AA +RHS KRP+M Q+VRAL+ + +
Sbjct: 574 KAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMG 633
Query: 597 DLNDGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDFASSD-YGGS---SDS 652
D+++G + GQSSA Y + YN D KFR++A G D + S Y G DS
Sbjct: 634 DISNGNKVGQSSA---------YDSGQYNNDTMKFRKMAFGFDDSSDSGMYSGDYSVQDS 684
Query: 653 RE 654
R+
Sbjct: 685 RK 686
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1124 (400.7 bits), Expect = 5.8e-114, P = 5.8e-114
Identities = 219/354 (61%), Positives = 279/354 (78%)
Query: 303 KSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAE 362
+S F+YDEL+ T GF++ NLLG+GGFG V+KGVL +G+EVAVK LK G QGEREF AE
Sbjct: 324 RSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAE 383
Query: 363 VEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALG 422
VEIISRVHHRHLV+LVGYCI+ R+LVY++V N TL YHLH RPVM + TRVR+A G
Sbjct: 384 VEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAG 443
Query: 423 SAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN--DNHTHVSTRVMG 480
+A+G+AYLHEDCHPRIIHRDIK++NIL+D++FEA+VADFGLAK++ D +THVSTRVMG
Sbjct: 444 AARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMG 503
Query: 481 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMT--MMEDSLVEWARPLLGAA 538
TFGY+APEYA+SGKL+EK+DV+S+GV+LLELITGR+PVD + + ++SLVEWARPLLG A
Sbjct: 504 TFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQA 563
Query: 539 LEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSLDDL 598
+E+ +D LVDPRL N++P EM R+V AA +RHSA KRPKMSQ+VRAL+ D+
Sbjct: 564 IENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEATDI 623
Query: 599 NDGVRPGQSSAFSASNTSTEYSATSYNADMKKFRQLALGSQDFASSDYGGSSDS 652
+G+RPGQS F + S A ++ F+++A GSQD+ SSD+ S S
Sbjct: 624 TNGMRPGQSQVFDSRQQS---------AQIRMFQRMAFGSQDY-SSDFFDRSQS 667
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9ZNQ8 | PERK4_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6632 | 0.7145 | 0.7472 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 662 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-51 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-41 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-35 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-34 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-33 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-33 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-29 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-28 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-27 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-25 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-23 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-20 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-17 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-15 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-15 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-14 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-14 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-14 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 5e-14 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 5e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-14 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 6e-14 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 7e-14 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 8e-14 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 8e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-14 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-13 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-13 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-13 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 5e-13 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 6e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-13 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 8e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-13 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-12 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 3e-12 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-12 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-12 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 4e-12 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 4e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-12 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 5e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-12 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 8e-12 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 8e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-12 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-11 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 1e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-11 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-11 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 6e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 6e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-11 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 7e-11 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 7e-11 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 7e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-10 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 2e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-10 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 4e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-10 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 5e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-10 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 6e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-10 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 7e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-09 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 1e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-09 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-09 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-09 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-09 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-09 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 3e-09 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-09 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-09 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-09 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 3e-09 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-09 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-09 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 5e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-09 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 6e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-09 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 6e-09 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 7e-09 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 7e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-09 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 8e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-09 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 9e-09 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 9e-09 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 1e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-08 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 1e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-08 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-08 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-08 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 2e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-08 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 2e-08 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 2e-08 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-08 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 3e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 4e-08 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 4e-08 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 4e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-08 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 5e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-08 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-08 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 6e-08 | |
| PTZ00108 | 1388 | PTZ00108, PTZ00108, DNA topoisomerase 2-like prote | 6e-08 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 6e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-08 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 7e-08 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 7e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-08 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 8e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-08 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 1e-07 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-07 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 1e-07 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-07 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 2e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-07 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 2e-07 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 2e-07 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 2e-07 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 2e-07 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 2e-07 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 2e-07 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 2e-07 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 2e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-07 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 3e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-07 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 3e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-07 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 4e-07 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 4e-07 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 4e-07 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 4e-07 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 4e-07 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 4e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-07 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 4e-07 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 5e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-07 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 5e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 6e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-07 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 6e-07 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 6e-07 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 7e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-07 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 9e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 9e-07 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 9e-07 | |
| pfam09507 | 427 | pfam09507, CDC27, DNA polymerase subunit Cdc27 | 9e-07 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 1e-06 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 1e-06 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 1e-06 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 1e-06 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-06 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-06 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-06 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 2e-06 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 2e-06 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 2e-06 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 2e-06 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 2e-06 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-06 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 2e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-06 | |
| PTZ00108 | 1388 | PTZ00108, PTZ00108, DNA topoisomerase 2-like prote | 3e-06 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 3e-06 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 3e-06 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 3e-06 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 3e-06 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 3e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-06 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 3e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-06 | |
| COG0810 | 244 | COG0810, TonB, Periplasmic protein TonB, links inn | 3e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-06 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 4e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 4e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 4e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-06 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 5e-06 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 5e-06 | |
| COG0810 | 244 | COG0810, TonB, Periplasmic protein TonB, links inn | 5e-06 | |
| PRK10819 | 246 | PRK10819, PRK10819, transport protein TonB; Provis | 5e-06 | |
| pfam05505 | 717 | pfam05505, Ebola_NP, Ebola nucleoprotein | 5e-06 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 5e-06 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 6e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 6e-06 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 6e-06 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 6e-06 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 6e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 7e-06 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 7e-06 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 7e-06 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 7e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-06 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 8e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-06 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 9e-06 | |
| TIGR02927 | 579 | TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogena | 9e-06 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 9e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-05 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 1e-05 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 1e-05 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 1e-05 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 1e-05 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 1e-05 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 1e-05 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 1e-05 | |
| pfam01690 | 460 | pfam01690, PLRV_ORF5, Potato leaf roll virus readt | 1e-05 | |
| PHA02682 | 280 | PHA02682, PHA02682, ORF080 virion core protein; Pr | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-05 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-05 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 2e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-05 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 2e-05 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 2e-05 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 2e-05 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 2e-05 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 2e-05 | |
| pfam09507 | 427 | pfam09507, CDC27, DNA polymerase subunit Cdc27 | 2e-05 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 2e-05 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 2e-05 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 2e-05 | |
| PRK12495 | 226 | PRK12495, PRK12495, hypothetical protein; Provisio | 2e-05 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 2e-05 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 2e-05 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-05 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 3e-05 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 3e-05 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 3e-05 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 3e-05 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 3e-05 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 3e-05 | |
| PHA02682 | 280 | PHA02682, PHA02682, ORF080 virion core protein; Pr | 3e-05 | |
| PRK12495 | 226 | PRK12495, PRK12495, hypothetical protein; Provisio | 3e-05 | |
| PRK00708 | 209 | PRK00708, PRK00708, sec-independent translocase; P | 3e-05 | |
| PRK00708 | 209 | PRK00708, PRK00708, sec-independent translocase; P | 3e-05 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 3e-05 | |
| PHA03269 | 566 | PHA03269, PHA03269, envelope glycoprotein C; Provi | 3e-05 | |
| PHA03419 | 200 | PHA03419, PHA03419, E4 protein; Provisional | 3e-05 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 3e-05 | |
| pfam05110 | 1154 | pfam05110, AF-4, AF-4 proto-oncoprotein | 3e-05 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 3e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-05 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 4e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-05 | |
| COG5422 | 1175 | COG5422, ROM1, RhoGEF, Guanine nucleotide exchange | 4e-05 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 4e-05 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 5e-05 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 5e-05 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 5e-05 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 5e-05 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 5e-05 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 5e-05 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 5e-05 | |
| PHA03201 | 318 | PHA03201, PHA03201, uracil DNA glycosylase; Provis | 5e-05 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 6e-05 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 6e-05 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 6e-05 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 6e-05 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 6e-05 | |
| pfam13254 | 414 | pfam13254, DUF4045, Domain of unknown function (DU | 6e-05 | |
| pfam12526 | 115 | pfam12526, DUF3729, Protein of unknown function (D | 6e-05 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 7e-05 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 7e-05 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 7e-05 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 7e-05 | |
| PRK12495 | 226 | PRK12495, PRK12495, hypothetical protein; Provisio | 7e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 8e-05 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 8e-05 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 8e-05 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 8e-05 | |
| pfam04929 | 381 | pfam04929, Herpes_DNAp_acc, Herpes DNA replication | 8e-05 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 8e-05 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 9e-05 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 9e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-05 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-04 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 1e-04 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 1e-04 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 1e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 1e-04 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 1e-04 | |
| PRK12438 | 991 | PRK12438, PRK12438, hypothetical protein; Provisio | 1e-04 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 1e-04 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 1e-04 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| pfam09786 | 559 | pfam09786, CytochromB561_N, Cytochrome B561, N ter | 1e-04 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 2e-04 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 2e-04 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 2e-04 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 2e-04 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 2e-04 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 2e-04 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 2e-04 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 2e-04 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 2e-04 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 2e-04 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 2e-04 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 2e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 2e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 2e-04 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 2e-04 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 2e-04 | |
| pfam04929 | 381 | pfam04929, Herpes_DNAp_acc, Herpes DNA replication | 2e-04 | |
| pfam04929 | 381 | pfam04929, Herpes_DNAp_acc, Herpes DNA replication | 2e-04 | |
| TIGR03490 | 541 | TIGR03490, Mycoplas_LppA, mycoides cluster lipopro | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| pfam12737 | 418 | pfam12737, Mating_C, C-terminal domain of homeodom | 2e-04 | |
| pfam05308 | 248 | pfam05308, Mito_fiss_reg, Mitochondrial fission re | 2e-04 | |
| pfam04621 | 336 | pfam04621, ETS_PEA3_N, PEA3 subfamily ETS-domain t | 2e-04 | |
| COG5178 | 2365 | COG5178, PRP8, U5 snRNP spliceosome subunit [RNA p | 2e-04 | |
| pfam04388 | 667 | pfam04388, Hamartin, Hamartin protein | 2e-04 | |
| pfam06070 | 777 | pfam06070, Herpes_UL32, Herpesvirus large structur | 2e-04 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 3e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-04 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 3e-04 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 3e-04 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 3e-04 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 3e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 3e-04 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 3e-04 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 3e-04 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 3e-04 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 3e-04 | |
| PLN02258 | 590 | PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygen | 3e-04 | |
| PHA03269 | 566 | PHA03269, PHA03269, envelope glycoprotein C; Provi | 3e-04 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 3e-04 | |
| COG5178 | 2365 | COG5178, PRP8, U5 snRNP spliceosome subunit [RNA p | 3e-04 | |
| COG5178 | 2365 | COG5178, PRP8, U5 snRNP spliceosome subunit [RNA p | 3e-04 | |
| COG5178 | 2365 | COG5178, PRP8, U5 snRNP spliceosome subunit [RNA p | 3e-04 | |
| pfam06070 | 777 | pfam06070, Herpes_UL32, Herpesvirus large structur | 3e-04 | |
| pfam03999 | 619 | pfam03999, MAP65_ASE1, Microtubule associated prot | 3e-04 | |
| pfam03999 | 619 | pfam03999, MAP65_ASE1, Microtubule associated prot | 3e-04 | |
| PLN02328 | 808 | PLN02328, PLN02328, lysine-specific histone demeth | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 3e-04 | |
| PRK11855 | 547 | PRK11855, PRK11855, dihydrolipoamide acetyltransfe | 3e-04 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 3e-04 | |
| PRK08581 | 619 | PRK08581, PRK08581, N-acetylmuramoyl-L-alanine ami | 3e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-04 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 4e-04 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 4e-04 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 4e-04 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 4e-04 | |
| PHA02682 | 280 | PHA02682, PHA02682, ORF080 virion core protein; Pr | 4e-04 | |
| PRK00708 | 209 | PRK00708, PRK00708, sec-independent translocase; P | 4e-04 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 4e-04 | |
| pfam12526 | 115 | pfam12526, DUF3729, Protein of unknown function (D | 4e-04 | |
| pfam09786 | 559 | pfam09786, CytochromB561_N, Cytochrome B561, N ter | 4e-04 | |
| pfam12737 | 418 | pfam12737, Mating_C, C-terminal domain of homeodom | 4e-04 | |
| COG3147 | 226 | COG3147, DedD, Uncharacterized protein conserved i | 4e-04 | |
| COG5373 | 931 | COG5373, COG5373, Predicted membrane protein [Func | 4e-04 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 5e-04 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-04 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 5e-04 | |
| TIGR03490 | 541 | TIGR03490, Mycoplas_LppA, mycoides cluster lipopro | 5e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-04 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 6e-04 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 6e-04 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 6e-04 | |
| PHA03269 | 566 | PHA03269, PHA03269, envelope glycoprotein C; Provi | 6e-04 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 6e-04 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 6e-04 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 6e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-04 | |
| COG5391 | 524 | COG5391, COG5391, Phox homology (PX) domain protei | 6e-04 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 7e-04 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 7e-04 | |
| pfam05110 | 1154 | pfam05110, AF-4, AF-4 proto-oncoprotein | 7e-04 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 7e-04 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 7e-04 | |
| TIGR03490 | 541 | TIGR03490, Mycoplas_LppA, mycoides cluster lipopro | 7e-04 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 7e-04 | |
| COG3456 | 430 | COG3456, COG3456, Predicted component of the type | 7e-04 | |
| pfam06075 | 564 | pfam06075, DUF936, Plant protein of unknown functi | 7e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-04 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 8e-04 | |
| TIGR02927 | 579 | TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogena | 8e-04 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 8e-04 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 8e-04 | |
| PRK11892 | 464 | PRK11892, PRK11892, pyruvate dehydrogenase subunit | 8e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 9e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 9e-04 | |
| PRK11892 | 464 | PRK11892, PRK11892, pyruvate dehydrogenase subunit | 9e-04 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 0.001 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 0.001 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 0.001 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 0.001 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 0.001 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.001 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 0.001 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 0.001 | |
| COG0810 | 244 | COG0810, TonB, Periplasmic protein TonB, links inn | 0.001 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 0.001 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 0.001 | |
| PHA03201 | 318 | PHA03201, PHA03201, uracil DNA glycosylase; Provis | 0.001 | |
| pfam13254 | 414 | pfam13254, DUF4045, Domain of unknown function (DU | 0.001 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 0.001 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 0.001 | |
| pfam11725 | 1771 | pfam11725, AvrE, Pathogenicity factor | 0.001 | |
| PLN03237 | 1465 | PLN03237, PLN03237, DNA topoisomerase 2; Provision | 0.001 | |
| pfam06346 | 160 | pfam06346, Drf_FH1, Formin Homology Region 1 | 0.001 | |
| PLN00122 | 170 | PLN00122, PLN00122, serine/threonine protein phosp | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| pfam11702 | 509 | pfam11702, DUF3295, Protein of unknown function (D | 0.001 | |
| PRK13042 | 291 | PRK13042, PRK13042, superantigen-like protein; Rev | 0.001 | |
| TIGR01347 | 403 | TIGR01347, sucB, 2-oxoglutarate dehydrogenase comp | 0.001 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 0.002 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 0.002 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 0.002 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.002 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 0.002 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 0.002 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 0.002 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 0.002 | |
| pfam05110 | 1154 | pfam05110, AF-4, AF-4 proto-oncoprotein | 0.002 | |
| pfam05110 | 1154 | pfam05110, AF-4, AF-4 proto-oncoprotein | 0.002 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 0.002 | |
| pfam12526 | 115 | pfam12526, DUF3729, Protein of unknown function (D | 0.002 | |
| PRK12438 | 991 | PRK12438, PRK12438, hypothetical protein; Provisio | 0.002 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 0.002 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 0.002 | |
| pfam09786 | 559 | pfam09786, CytochromB561_N, Cytochrome B561, N ter | 0.002 | |
| TIGR03490 | 541 | TIGR03490, Mycoplas_LppA, mycoides cluster lipopro | 0.002 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 0.002 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 0.002 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 0.002 | |
| COG3147 | 226 | COG3147, DedD, Uncharacterized protein conserved i | 0.002 | |
| pfam11725 | 1771 | pfam11725, AvrE, Pathogenicity factor | 0.002 | |
| PHA01929 | 306 | PHA01929, PHA01929, putative scaffolding protein | 0.002 | |
| PRK14666 | 694 | PRK14666, uvrC, excinuclease ABC subunit C; Provis | 0.002 | |
| PRK13335 | 356 | PRK13335, PRK13335, superantigen-like protein; Rev | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| pfam11711 | 377 | pfam11711, Tim54, Inner membrane protein import co | 0.002 | |
| pfam05616 | 502 | pfam05616, Neisseria_TspB, Neisseria meningitidis | 0.002 | |
| PLN02744 | 539 | PLN02744, PLN02744, dihydrolipoyllysine-residue ac | 0.002 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 0.003 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 0.003 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 0.003 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 0.003 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 0.003 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 0.003 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 0.003 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 0.003 | |
| pfam05110 | 1154 | pfam05110, AF-4, AF-4 proto-oncoprotein | 0.003 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 0.003 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 0.003 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 0.003 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 0.003 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 0.003 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 0.003 | |
| PRK11892 | 464 | PRK11892, PRK11892, pyruvate dehydrogenase subunit | 0.003 | |
| pfam11725 | 1771 | pfam11725, AvrE, Pathogenicity factor | 0.003 | |
| pfam11702 | 509 | pfam11702, DUF3295, Protein of unknown function (D | 0.003 | |
| PRK13042 | 291 | PRK13042, PRK13042, superantigen-like protein; Rev | 0.003 | |
| TIGR01348 | 546 | TIGR01348, PDHac_trf_long, pyruvate dehydrogenase | 0.003 | |
| PRK10672 | 361 | PRK10672, PRK10672, rare lipoprotein A; Provisiona | 0.003 | |
| COG5099 | 777 | COG5099, COG5099, RNA-binding protein of the Puf f | 0.003 | |
| pfam11696 | 641 | pfam11696, DUF3292, Protein of unknown function (D | 0.003 | |
| pfam08601 | 344 | pfam08601, PAP1, Transcription factor PAP1 | 0.003 | |
| PRK08691 | 709 | PRK08691, PRK08691, DNA polymerase III subunits ga | 0.003 | |
| pfam07415 | 489 | pfam07415, Herpes_LMP2, Gammaherpesvirus latent me | 0.003 | |
| TIGR02031 | 589 | TIGR02031, BchD-ChlD, magnesium chelatase ATPase s | 0.003 | |
| PTZ00429 | 746 | PTZ00429, PTZ00429, beta-adaptin; Provisional | 0.003 | |
| PRK12372 | 413 | PRK12372, PRK12372, ribonuclease III; Reviewed | 0.003 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 0.004 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 0.004 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 0.004 | |
| pfam13254 | 414 | pfam13254, DUF4045, Domain of unknown function (DU | 0.004 | |
| pfam04929 | 381 | pfam04929, Herpes_DNAp_acc, Herpes DNA replication | 0.004 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 0.004 | |
| pfam05308 | 248 | pfam05308, Mito_fiss_reg, Mitochondrial fission re | 0.004 | |
| PRK11855 | 547 | PRK11855, PRK11855, dihydrolipoamide acetyltransfe | 0.004 | |
| PRK14666 | 694 | PRK14666, uvrC, excinuclease ABC subunit C; Provis | 0.004 | |
| pfam11711 | 377 | pfam11711, Tim54, Inner membrane protein import co | 0.004 | |
| PLN02744 | 539 | PLN02744, PLN02744, dihydrolipoyllysine-residue ac | 0.004 | |
| TIGR01348 | 546 | TIGR01348, PDHac_trf_long, pyruvate dehydrogenase | 0.004 | |
| COG5099 | 777 | COG5099, COG5099, RNA-binding protein of the Puf f | 0.004 | |
| PRK08691 | 709 | PRK08691, PRK08691, DNA polymerase III subunits ga | 0.004 | |
| pfam04502 | 321 | pfam04502, DUF572, Family of unknown function (DUF | 0.004 | |
| pfam05053 | 618 | pfam05053, Menin, Menin | 0.004 | |
| pfam01213 | 313 | pfam01213, CAP_N, Adenylate cyclase associated (CA | 0.004 | |
| pfam10349 | 111 | pfam10349, WWbp, WW-domain ligand protein | 0.004 | |
| PHA03264 | 416 | PHA03264, PHA03264, envelope glycoprotein D; Provi | 0.004 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.004 | |
| PRK12757 | 256 | PRK12757, PRK12757, cell division protein FtsN; Pr | 0.004 | |
| pfam01140 | 129 | pfam01140, Gag_MA, Matrix protein (MA), p15 | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 7e-53
Identities = 74/192 (38%), Positives = 106/192 (55%), Gaps = 9/192 (4%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE-FSAEVEIISRVHHRHLVSLVGYC 381
LG+GGFG V+ GK+VA+K +K E E+EI+ +++H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441
LV E+ +L+ L EN + +RI L +GL YLH + IIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHS--NG-IIHR 116
Query: 442 DIKAANILID-DNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE-YASSGKLTEKS 499
D+K NIL+D DN + +ADFGL+KL + + + T V GT Y+APE G +EKS
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKS 175
Query: 500 DVFSFGVMLLEL 511
D++S GV+L EL
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 1e-51
Identities = 88/276 (31%), Positives = 135/276 (48%), Gaps = 35/276 (12%)
Query: 324 LGQGGFGYVHKGVL--PNGK---EVAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVSL 377
LG+G FG V+KG L GK EVAVK+LK + + + EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
+G C +V E++ L +L +NRP + + + AL A+G+ YL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLESK---N 122
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTE 497
IHRD+ A N L+ +N ++DFGL++ D+ + ++APE GK T
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTS 182
Query: 498 KSDVFSFGVMLLELIT-GRRP-VDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH- 554
KSDV+SFGV+L E+ T G +P M+ E ++E+ L++G RL
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQPYPGMSNEE--VLEY--------LKNGY-------RLPQP 225
Query: 555 NYVPHEMARLV-ACGAASIRHSARKRPKMSQIVRAL 589
P E+ L+ C RP S++V L
Sbjct: 226 PNCPPELYDLMLQC----WAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 2e-50
Identities = 88/277 (31%), Positives = 135/277 (48%), Gaps = 36/277 (12%)
Query: 324 LGQGGFGYVHKGVL-----PNGKEVAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVSL 377
LG+G FG V+KG L +VAVK+LK G+ + ER EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
+G C G +V E++ L L ++ + +++AL AKG+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGMEYLESK---N 122
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTFGYLAPEYASSGKLT 496
+HRD+ A N L+ +N ++DFGL++ + D++ ++APE GK T
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182
Query: 497 EKSDVFSFGVMLLELIT-GRRP-VDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE- 553
KSDV+SFGV+L E+ T G +P M+ E ++E LEDG RL
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEQPYPGMSNEE--VLEL--------LEDG-------YRLPR 225
Query: 554 HNYVPHEMARL-VACGAASIRHSARKRPKMSQIVRAL 589
P E+ L + C + RP S++V L
Sbjct: 226 PENCPDELYELMLQC----WAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 2e-50
Identities = 86/276 (31%), Positives = 128/276 (46%), Gaps = 34/276 (12%)
Query: 324 LGQGGFGYVHKGVL-----PNGKEVAVKSLKTG-SGQGEREFSAEVEIISRVHHRHLVSL 377
LG+G FG V+KG L EVAVK+LK S Q EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
+G C M+V E++ L +L + + + AL A+G+ YL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---N 123
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTE 497
IHRD+ A N L+ +N ++DFGL++ D+ + ++APE GK T
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS 183
Query: 498 KSDVFSFGVMLLELIT-GRRP-VDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH- 554
KSDV+SFGV+L E+ T G P M+ E ++E+ L+ G RL
Sbjct: 184 KSDVWSFGVLLWEIFTLGEEPYPGMSNAE--VLEY--------LKKGY-------RLPKP 226
Query: 555 NYVPHEMARL-VACGAASIRHSARKRPKMSQIVRAL 589
P E+ +L + C RP S++V L
Sbjct: 227 PNCPPELYKLMLQC----WAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 2e-49
Identities = 82/295 (27%), Positives = 128/295 (43%), Gaps = 59/295 (20%)
Query: 322 NLLGQGGFGYVHKGVL----PNGKEVAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVS 376
LG+G FG V+KG L EVAVK+LK + + ER +F E ++ ++ H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHL-------HGENRPVMDFATRVRIALGSAKGLAY 429
L+G C LV E++ L +L + + + A+ AKG+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 430 LHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST-------RVMGTF 482
L + +HRD+ A N L+ ++ ++DFGL++ D+ + R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----- 172
Query: 483 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP----VDMTMMEDSLVEWARPLLGA 537
++APE G T KSDV+SFGV+L E+ T G P + ++E
Sbjct: 173 -WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE------------- 218
Query: 538 ALEDGIYDGLVDPRLEH-NYVPHEMARLVA-CGAASIRHSARKRPKMSQIVRALE 590
L G RL Y P E+ L+ C + RP S++V LE
Sbjct: 219 YLRKGY-------RLPKPEYCPDELYELMLSC----WQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 6e-48
Identities = 62/198 (31%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 322 NLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE-FSAEVEIISRVHHRHLVSLVG 379
LG+G FG V+ GK VA+K +K + +RE E++I+ ++ H ++V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
+ LV E+ L L R + L YLH I+
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLK--KRGRLSEDEARFYLRQILSALEYLHSK---GIV 119
Query: 440 HRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKS 499
HRD+K NIL+D++ +ADFGLA+ + +T V GT Y+APE +
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFV-GTPEYMAPEVLLGKGYGKAV 177
Query: 500 DVFSFGVMLLELITGRRP 517
D++S GV+L EL+TG+ P
Sbjct: 178 DIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 3e-43
Identities = 73/199 (36%), Positives = 102/199 (51%), Gaps = 12/199 (6%)
Query: 324 LGQGGFGYVHKGVLPN-GKEVAVKSLK---TGSGQGEREFSAEVEIISRVHHRHLVSLVG 379
LG G FG V+K GK VAVK LK S + ++ E+ I+ R+ H ++V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPNIVRLID 65
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
LV E+ L +L + +IAL +GL YLH + II
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSN---GII 120
Query: 440 HRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE-YASSGKLTEK 498
HRD+K NIL+D+N +ADFGLAK + + ++T V GT Y+APE K
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPK 179
Query: 499 SDVFSFGVMLLELITGRRP 517
DV+S GV+L EL+TG+ P
Sbjct: 180 VDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 4e-41
Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 320 KSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGE--REFSAEVEIISRVHHRHLVS 376
+ LLG+G FG V+ + G+ +AVKS++ E E+ I+S + H ++V
Sbjct: 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR 63
Query: 377 LVGYCIAGGQRML-VY-EFVSNKTLEYHLH---GENRPVM-DFATRVRIALGSAKGLAYL 430
G + L ++ E+VS +L L PV+ + ++ +GLAYL
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI------LEGLAYL 117
Query: 431 HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM-GTFGYLAPEY 489
H + I+HRDIK ANIL+D + +ADFG AK D T T + GT ++APE
Sbjct: 118 HSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 490 ASSGKLTEKSDVFSFGVMLLELITGRRP 517
+ +D++S G ++E+ TG+ P
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 73/203 (35%), Positives = 106/203 (52%), Gaps = 21/203 (10%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
LG G FG V G +VAVK+LK G+ E F E +I+ ++ H LV L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 384 GGQRMLVYEFVSNKTLEYHLH-GENR-----PVMDFATRVRIALGSAKGLAYLHEDCHPR 437
+V E++S +L L GE + ++D A ++ A+G+AYL
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI------AEGMAYLESR---N 123
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH--THVSTRVMGTFGYLAPEYASSGKL 495
IHRD+ A NIL+ +N +ADFGLA+L D+ + + APE A+ G+
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRF 181
Query: 496 TEKSDVFSFGVMLLELIT-GRRP 517
T KSDV+SFG++L E++T GR P
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 8e-35
Identities = 68/199 (34%), Positives = 106/199 (53%), Gaps = 10/199 (5%)
Query: 320 KSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVG 379
+G+G FG V G G++VAVK LK S + F AE +++ + H +LV L+G
Sbjct: 10 LGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLG 67
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
+ G +V E+++ +L +L R V+ A ++ AL +G+ YL E +
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFV 124
Query: 440 HRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKS 499
HRD+ A N+L+ ++ A V+DFGLAK ++ V T APE K + KS
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKS 180
Query: 500 DVFSFGVMLLELIT-GRRP 517
DV+SFG++L E+ + GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 66/208 (31%), Positives = 108/208 (51%), Gaps = 8/208 (3%)
Query: 318 FAKSNLLGQGGFGYVHKG-VLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVS 376
F +G+GGFG V+K GKEVA+K +K S + + + E++I+ + H ++V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
G + + +V EF S +L+ L N+ + + + KGL YLH +
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLHSN--- 117
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLT 496
IIHRDIKAANIL+ + E + DFGL+ + T ++GT ++APE +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 497 EKSDVFSFGVMLLELITGRRP-VDMTMM 523
K+D++S G+ +EL G+ P ++ M
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELPPM 203
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 69/197 (35%), Positives = 108/197 (54%), Gaps = 6/197 (3%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSL 377
F LG G FG V +G+ N VA+K LK+ +++F EV+ + R+ H+HL+SL
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
C G ++ E + +L L V+ A+ + +A A+G+AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---N 124
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLAKLSNDN-HTHVSTRVMGTFGYLAPEYASSGKLT 496
IHRD+ A NIL+ ++ VADFGLA+L ++ + ++ + + APE AS G +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFS 182
Query: 497 EKSDVFSFGVMLLELIT 513
KSDV+SFG++L E+ T
Sbjct: 183 TKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 7e-33
Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 5/195 (2%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
LG G FG V +G+ N VAVK+LK G+ + +F AE +I+ ++ H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 384 GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDI 443
+V E + +L +L G + + +A A G+AYL + IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY---IHRDL 129
Query: 444 KAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 503
A N+L+ +N VADFGLA++ ++ + APE A + + KSDV+S
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWS 189
Query: 504 FGVMLLELIT-GRRP 517
FG++L E++T GR P
Sbjct: 190 FGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 64/209 (30%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 320 KSNLLGQGGFGYVHKGV-LPNGK----EVAVKSLKTGSG-QGEREFSAEVEIISRVHHRH 373
K +LG G FG V+KGV +P G+ VA+K L+ + + +E E +++ V H H
Sbjct: 11 KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPH 70
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED 433
+V L+G C+ Q L+ + + L ++ ++ + + + AKG++YL E
Sbjct: 71 VVRLLGICL-SSQVQLITQLMPLGCLLDYVR-NHKDNIGSQYLLNWCVQIAKGMSYLEEK 128
Query: 434 CHPRIIHRDIKAANILIDDNFEAMVADFGLAKL--SNDNHTHVSTRVMGTFGYLAPEYAS 491
R++HRD+ A N+L+ + DFGLAKL ++ H + ++A E
Sbjct: 129 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV-PIKWMALESIL 184
Query: 492 SGKLTEKSDVFSFGVMLLELIT-GRRPVD 519
T KSDV+S+GV + EL+T G +P +
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 320 KSNLLGQGGFGYVHKGVLPN-----GKEVAVKSLKT-GSGQGEREFSAEVEIISRVHHRH 373
LG+G FG V G++VAVKSL G Q +F E+EI+ + H +
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 374 LVSLVGYCIAGGQR--MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLH 431
+V G C G R L+ E++ + +L +L +R ++ + + KG+ YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMG---TFGYLAPE 488
R IHRD+ A NIL++ ++DFGLAK+ ++ + + G F Y APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 489 YASSGKLTEKSDVFSFGVMLLELITGRRP 517
+ K + SDV+SFGV L EL T P
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLK-TGSGQGEREFS-AEVEIISRVHHRHL 374
+ +G+G FG V+ +GK +K + + + ERE + EV+I+ +++H ++
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHLH---GENRP-----VMDFATRVRIALGSAKG 426
+ G+ +V E+ L + E +P ++D+ V++ L
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCLA---- 115
Query: 427 LAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLA 486
L YLH +I+HRDIK NI + N + DFG++K+ + T V GT YL+
Sbjct: 116 LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLS 171
Query: 487 PEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
PE + KSD++S G +L EL T + P
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 6/197 (3%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
+G G FG V G ++VA+K+++ G+ E +F E +++ ++ H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 384 GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDI 443
LV+EF+ + L +L + R T + + L +G+AYL +IHRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126
Query: 444 KAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 503
A N L+ +N V+DFG+ + D+ ST + +PE S K + KSDV+S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 504 FGVMLLELIT-GRRPVD 519
FGV++ E+ + G+ P +
Sbjct: 187 FGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 14/202 (6%)
Query: 324 LGQGGFGYVHKGV--LPNGKE--VAVKSLKTG-SGQGEREFSAEVEIISRVHHRHLVSLV 378
LG G FG V KGV + +GKE VAVK+LK G++EF E +++++ H +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 379 GYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRI 438
G C G MLV E L +L + R + + +A A G+AYL E H
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYL-ESKH--F 116
Query: 439 IHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTF--GYLAPEYASSGKLT 496
+HRD+ A N+L+ + +A ++DFG+++ + G + + APE + GK +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 497 EKSDVFSFGVMLLELIT-GRRP 517
KSDV+S+GV L E + G +P
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 324 LGQGGFGYVHKGVL-PNGKEVAVKSLK-TGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
LGQG G V+K P GK A+K + G + ++ E++ + ++V G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 382 IAGGQRMLVYEFVSNKTLE---YHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRI 438
G+ +V E++ +L + PV+ + R +I KGL YLH H I
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIAR-QIL----KGLDYLHTKRH--I 121
Query: 439 IHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEK 498
IHRDIK +N+LI+ E +ADFG++K+ + +T V GT Y++PE +
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYA 180
Query: 499 SDVFSFGVMLLELITGRRP 517
+D++S G+ LLE G+ P
Sbjct: 181 ADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVK--SLKTGSGQGEREFSAEVEIISRVHHRHL 374
+ +L+G+G FG V+KG+ L G VA+K SL+ + + E++++ + H ++
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKTLE-----YHLHGENRPVMDFATRVRIALGSAKGLAY 429
V +G ++ E+ N +L + E+ V + +V +GLAY
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-VAVYVYQV------LQGLAY 114
Query: 430 LHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEY 489
LHE +IHRDIKAANIL + +ADFG+A ND V+GT ++APE
Sbjct: 115 LHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS-KDDASVVGTPYWMAPEV 170
Query: 490 ASSGKLTEKSDVFSFGVMLLELITGRRP 517
+ SD++S G ++EL+TG P
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 5e-28
Identities = 74/196 (37%), Positives = 105/196 (53%), Gaps = 8/196 (4%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
LGQG FG V G VA+K+LK G+ E F E +++ ++ H LV L Y +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAVV 70
Query: 384 GGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRD 442
+ + +V E++S +L L GE + V +A A G+AY+ + +HRD
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 127
Query: 443 IKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 502
++AANIL+ +N VADFGLA+L DN + APE A G+ T KSDV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 503 SFGVMLLELIT-GRRP 517
SFG++L EL T GR P
Sbjct: 188 SFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 71/212 (33%), Positives = 112/212 (52%), Gaps = 20/212 (9%)
Query: 322 NLLGQGGFGYVHKGVL--PNGKE--VAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVS 376
++G G FG V +G L P KE VA+K+LK GS +R +F E I+ + H +++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
L G M++ E++ N +L+ L EN V + G A G+ YL E +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTR-----VMGTFGYLAPEYAS 491
+HRD+ A NIL++ N V+DFGL++ D+ +T+ + T APE +
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIA 181
Query: 492 SGKLTEKSDVFSFGVMLLELIT-GRRPV-DMT 521
K T SDV+SFG+++ E+++ G RP DM+
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 324 LGQGGFGYVHKGVLPNGKE------VAVKSLK-TGSGQGEREFSAEVEIISRVHHRHLVS 376
LG+G FG V G + + VAVK+LK T S ++F E E+++ H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHL--HG-------ENRPVMDFATR---VRIALGSA 424
G C G ++V+E++ + L L HG M T ++IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGT--- 481
G+ YL +HRD+ N L+ + + DFG +S D +T RV G
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFG---MSRDVYTTDYYRVGGHTML 186
Query: 482 -FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
++ PE K T +SDV+SFGV+L E+ T G++P
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 6/197 (3%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
LG G FG VH G +VA+K ++ G+ E +F E +++ ++ H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 384 GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDI 443
+V E+++N L +L E + + + + + + YL + IHRD+
Sbjct: 71 QRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126
Query: 444 KAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 503
A N L+ ++ V+DFGLA+ D+ S + PE + + KSDV+S
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWS 186
Query: 504 FGVMLLELIT-GRRPVD 519
FGV++ E+ + G+ P +
Sbjct: 187 FGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 74/197 (37%), Positives = 107/197 (54%), Gaps = 10/197 (5%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
LG G FG V G +VAVK+LK G+ E F E +I+ ++ H LV L Y +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQL--YAVV 70
Query: 384 GGQRM-LVYEFVSNKTL-EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441
+ + +V E++S +L ++ GE R + V +A A G+AY+ + IHR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIERMNY---IHR 126
Query: 442 DIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 501
D+++ANIL+ D +ADFGLA+L DN + APE A G+ T KSDV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 502 FSFGVMLLELIT-GRRP 517
+SFG++L EL+T GR P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 68/208 (32%), Positives = 106/208 (50%), Gaps = 14/208 (6%)
Query: 319 AKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGE--REFSAEVEIISRVHHRHLV 375
+ N +G G FG V+ V L G+ +AVK ++ + +E + E++++ + H +LV
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
G + + + E+ S TLE L E+ ++D L +GLAYLH
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAYLHSH-- 118
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRV---MGTFGYLAPEYASS 492
I+HRDIK ANI +D N + DFG A +N T + V GT Y+APE +
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 493 GKLTEK---SDVFSFGVMLLELITGRRP 517
GK +D++S G ++LE+ TG+RP
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 69/217 (31%), Positives = 99/217 (45%), Gaps = 19/217 (8%)
Query: 317 GFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLK---TGSGQGEREFSAEVEIISRV-HHR 372
+ LG+G FG V+ K VA+K L + F E++I++ + H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 373 HLVSLVGYCIAGGQRMLVYEFVSNKTLEYHL-HGENRPVMDFATRVRIALGSAKGLAYLH 431
++V L + G LV E+V +LE L + + + + I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 432 EDCHPRIIHRDIKAANILID-DNFEAMVADFGLAKLSNDNHTHVSTR-----VMGTFGYL 485
IIHRDIK NIL+D D + DFGLAKL D + S +GT GY+
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 486 APEYASSGKL---TEKSDVFSFGVMLLELITGRRPVD 519
APE L + SD++S G+ L EL+TG P +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212
|
Length = 384 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 68/196 (34%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
LG G FG V G +VA+KSLK GS E F AE ++ ++ H LV L Y +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRL--YAVV 70
Query: 384 GGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRD 442
+ + ++ E++ N +L L + + +A A+G+A++ + IHRD
Sbjct: 71 TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRD 127
Query: 443 IKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 502
++AANIL+ + +ADFGLA+L DN + APE + G T KSDV+
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 503 SFGVMLLELIT-GRRP 517
SFG++L E++T GR P
Sbjct: 188 SFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 7/205 (3%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNGKEV-AVKSLK-TGSGQGEREFSA-EVEIISRVHHRHL 374
F N +G+G FG V K V K V A+K + + + ERE + E +++++ ++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
+ + G+ +V E+ N L L + + R + GLA+LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK- 120
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGK 494
+I+HRDIK+ N+ +D + D G+AKL +DN +T ++GT YL+PE
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCEDKP 177
Query: 495 LTEKSDVFSFGVMLLELITGRRPVD 519
EKSDV++ GV+L E TG+ P D
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 74/196 (37%), Positives = 105/196 (53%), Gaps = 8/196 (4%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
LGQG FG V G +VA+K+LK G+ E F E +I+ ++ H LV L Y +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPL--YAVV 70
Query: 384 GGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRD 442
+ + +V EF+ +L L + + V +A A G+AY+ + IHRD
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY---IHRD 127
Query: 443 IKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 502
++AANIL+ DN +ADFGLA+L DN + APE A G+ T KSDV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 503 SFGVMLLELIT-GRRP 517
SFG++L EL+T GR P
Sbjct: 188 SFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 3e-25
Identities = 68/208 (32%), Positives = 93/208 (44%), Gaps = 30/208 (14%)
Query: 324 LGQGGFGYV----HKGVLPNGKEVAVKSLKTGS----GQGEREFSAEVEIISRVHHRHLV 375
LG+G FG V K GK A+K LK + E E I+SR++H +V
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTL-TERNILSRINHPFIV 56
Query: 376 SLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVR-----IALGSAKGLAY 429
L Y +++ LV E+ L HL R R I L L Y
Sbjct: 57 KLH-YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFS-EERARFYAAEIVLA----LEY 108
Query: 430 LHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEY 489
LH II+RD+K NIL+D + + DFGLAK + + +T GT YLAPE
Sbjct: 109 LHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEV 164
Query: 490 ASSGKLTEKSDVFSFGVMLLELITGRRP 517
+ D +S GV+L E++TG+ P
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 324 LGQGGFGYVHKGVLPN------GKEVAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVS 376
LGQG FG V++G+ VA+K++ + ER EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHG-----ENRPVMDFATRVRI---ALGSAKGLA 428
L+G G ++V E ++ L+ +L EN P + T + A A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 429 YLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTFGYLAP 487
YL + +HRD+ A N ++ ++ + DFG+ + + ++ + + ++AP
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 488 EYASSGKLTEKSDVFSFGVMLLELIT 513
E G T KSDV+SFGV+L E+ T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 66/201 (32%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 323 LLGQGGFGYVHKGVLP-----NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSL 377
LG+G FG V G+ VAVK L+ + + R+F E+EI+ + H ++V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 378 VGYCIAGGQR--MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
G C + G+R LV E++ +L +L ++R +D + A KG+ YL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSK-- 127
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMG---TFGYLAPEYASS 492
R +HRD+ NIL++ + DFGL K+ + + R G F Y APE +
Sbjct: 128 -RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTE 185
Query: 493 GKLTEKSDVFSFGVMLLELIT 513
K + SDV+SFGV+L EL T
Sbjct: 186 SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 64/203 (31%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 323 LLGQGGFGYVHKG--VLPNGK--EVAVKSLKTGSGQG-EREFSAEVEIISRVHHRHLVSL 377
LG G FG V +G GK VAVK LK+ +F E I+ + H +L+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
G + M+V E +L L + +T A+ A G+ YL R
Sbjct: 62 YGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---R 117
Query: 438 IIHRDIKAANILIDDNFEAMVADFGL--AKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL 495
IHRD+ A NIL+ + + + DFGL A N++H + + F + APE +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 496 TEKSDVFSFGVMLLELIT-GRRP 517
+ SDV+ FGV L E+ T G P
Sbjct: 178 SHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 67/204 (32%), Positives = 113/204 (55%), Gaps = 15/204 (7%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTG-SGQGEREFSAEVEIISRVHHRHLVSLVGYCI 382
+G+G FG V +G G++VAVK++K + Q F E +++++HH++LV L+G +
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVIL 69
Query: 383 AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRD 442
G +V E +S L L R ++ ++ +L A+G+ YL +++HRD
Sbjct: 70 HNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRD 125
Query: 443 IKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 502
+ A NIL+ ++ A V+DFGLA++ + + V T APE K + KSDV+
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSDVW 181
Query: 503 SFGVMLLELIT-GRRPV-DMTMME 524
S+GV+L E+ + GR P M++ E
Sbjct: 182 SYGVLLWEVFSYGRAPYPKMSLKE 205
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 9/211 (4%)
Query: 322 NLLGQGGFGYVHKGVLPN-GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGY 380
+ LG G +G V++GV VAVK+LK + + E EF E ++ + H +LV L+G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70
Query: 381 CIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIH 440
C ++ EF++ L +L NR ++ + +A + + YL + IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 127
Query: 441 RDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSD 500
RD+ A N L+ +N VADFGL++L + + APE + K + KSD
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187
Query: 501 VFSFGVMLLELIT-GRRP---VDMTMMEDSL 527
V++FGV+L E+ T G P +D++ + + L
Sbjct: 188 VWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 7e-24
Identities = 79/277 (28%), Positives = 127/277 (45%), Gaps = 37/277 (13%)
Query: 323 LLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGERE-FSAEVEIISRVHHRHLVSLVGYC 381
+G+G FG V+KGVL EVAVK+ ++ + F E EI+ + H ++V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGE-NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIH 440
+ +V E V +L L + NR + ++++L +A G+ YL IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 441 RDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGT----FGYLAPEYASSGKLT 496
RD+ A N L+ +N ++DFG+ S + + T G + APE + G+ T
Sbjct: 117 RDLAARNCLVGENNVLKISDFGM---SREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 497 EKSDVFSFGVMLLELIT-GRRPV-DMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554
+SDV+S+G++L E + G P M+ + R + I G P +
Sbjct: 174 SESDVWSYGILLWETFSLGDTPYPGMSNQQ------TR--------ERIESGYRMPAPQL 219
Query: 555 NYVPHEMARLV-ACGAASIRHSARKRPKMSQIVRALE 590
P E+ RL+ C A RP S+I L+
Sbjct: 220 --CPEEIYRLMLQCWAY----DPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 70/218 (32%), Positives = 116/218 (53%), Gaps = 13/218 (5%)
Query: 316 GGFAKSNLLGQGGFGYVHKGVL--PNGKE--VAVKSLKTGSGQGER-EFSAEVEIISRVH 370
K ++G G FG V +G+L P KE VA+K+LK G + +R +F +E I+ +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 371 HRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYL 430
H +++ L G M++ E++ N L+ +L + + V + G A G+ YL
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYL 123
Query: 431 HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFG--YLAPE 488
+ + +HRD+ A NIL++ N E V+DFGL+++ D+ T G + APE
Sbjct: 124 SDMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180
Query: 489 YASSGKLTEKSDVFSFGVMLLELIT-GRRPV-DMTMME 524
+ K T SDV+SFG+++ E+++ G RP DM+ E
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 5e-23
Identities = 70/211 (33%), Positives = 103/211 (48%), Gaps = 30/211 (14%)
Query: 320 KSNLLGQGGFGYVHKGVL----PN----GKEVAVKSLKTGSGQGERE-FSAEVEIISRVH 370
K +LG+G FG V L P G+ VAVK+LK GQ + E+ I+ ++
Sbjct: 8 KIRVLGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64
Query: 371 HRHLVSLVGYCIAGGQR--MLVYEFVSNKTLEYHLHGEN---RPVMDFATRVRIALGSAK 425
H ++V G C G + L+ E+V +L +L ++ FA ++ +
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQI------CE 118
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMG---TF 482
G+AYLH IHRD+ A N+L+D++ + DFGLAK + H + R G F
Sbjct: 119 GMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 175
Query: 483 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT 513
Y A E K + SDV+SFGV L EL+T
Sbjct: 176 WY-AVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 6e-23
Identities = 70/217 (32%), Positives = 111/217 (51%), Gaps = 25/217 (11%)
Query: 322 NLLGQGGFGYVHKG----VLPNGKE---VAVKSLKTGSGQGER-EFSAEVEIISRVHHRH 373
N LG G FG V++G +L G VAVK+L+ G+ E+ EF E ++S +H +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENR-----PVMDFATRVRIALGSAKGLA 428
+V L+G C+ + ++ E + L +L P++ + I L AKG
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 429 YLHEDCHPRIIHRDIKAANILI-----DDNFEAMVADFGLAK--LSNDNHTHVSTRVMGT 481
YL E H IHRD+ A N L+ D + + DFGLA+ +D + ++
Sbjct: 121 YL-EQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL-P 176
Query: 482 FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
++APE GK T +SDV+SFGV++ E++T G++P
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 61/195 (31%), Positives = 99/195 (50%), Gaps = 5/195 (2%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
LG G FG V G N +VAVK+LK G+ + F E ++ + H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 384 GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDI 443
++ E+++ +L L + + + + A+G+AY+ + IHRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY---IHRDL 129
Query: 444 KAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 503
+AAN+L+ ++ +ADFGLA++ DN + APE + G T KSDV+S
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 189
Query: 504 FGVMLLELIT-GRRP 517
FG++L E++T G+ P
Sbjct: 190 FGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 36/210 (17%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
LG+G +G V+K + G+ VA+K + +E E+ I+ + ++V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL--QEIIKEISILKQCDSPYIVKYYGSY 67
Query: 382 IAGGQRMLVYEFVS-----------NKTLEYHLHGENRPVMDFATRVRIAL---GSAKGL 427
+V E+ NKTL T IA + KGL
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTL---------------TEEEIAAILYQTLKGL 112
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAP 487
YLH + + IHRDIKA NIL+++ +A +ADFG++ D +T V+GT ++AP
Sbjct: 113 EYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAP 168
Query: 488 EYASSGKLTEKSDVFSFGVMLLELITGRRP 517
E K+D++S G+ +E+ G+ P
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-22
Identities = 78/270 (28%), Positives = 120/270 (44%), Gaps = 28/270 (10%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
LG G FG V G +VA+K +K GS E EF E +++ ++ H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 384 GGQRMLVYEFVSNKTL-EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRD 442
+V E++SN L Y R + + + +G+AYL + IHRD
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLESK---QFIHRD 125
Query: 443 IKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 502
+ A N L+DD V+DFGL++ D+ S + PE K + KSDV+
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185
Query: 503 SFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEM 561
+FGV++ E+ + G+ P + + + + GL RL Y PH
Sbjct: 186 AFGVLMWEVYSLGKMPYER-------------FNNSETVEKVSQGL---RL---YRPHLA 226
Query: 562 ARLVACGAASIRHS-ARKRPKMSQIVRALE 590
+ V S H A +RP Q++ ++E
Sbjct: 227 SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 319 AKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGE-----REFSAEVEIISRVHHR 372
K LLG G FG V++G+ L +G AVK + ++ E+ ++S++ H
Sbjct: 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 373 HLVSLVGYCIAGGQRMLVYEFVSNKTLE--YHLHGENR-PVMDFATRVRIALGSAKGLAY 429
++V +G + E V +L +G PV+ TR + GL Y
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL-----LGLEY 117
Query: 430 LHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEY 489
LH+ +HRDIK ANIL+D N +ADFG+AK + S G+ ++APE
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEV 172
Query: 490 -ASSGKLTEKSDVFSFGVMLLELITGRRP 517
A G +D++S G +LE+ TG+ P
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 5e-22
Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 12/202 (5%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGE-REFSAEVEIISRVHHRHLVSLVGYC 381
+G G V+ + LPN ++VA+K + Q E EV+ +S+ +H ++V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 382 IAGGQRMLVYEFVSNKTLEYHL--HGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
+ G + LV ++S +L + R +D A + KGL YLH + I
Sbjct: 69 VVGDELWLVMPYLSGGSL-LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---I 124
Query: 440 HRDIKAANILIDDNFEAMVADFGL-AKLSN--DNHTHVSTRVMGTFGYLAPEYASSGK-L 495
HRDIKA NIL+ ++ +ADFG+ A L++ D V +GT ++APE
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184
Query: 496 TEKSDVFSFGVMLLELITGRRP 517
K+D++SFG+ +EL TG P
Sbjct: 185 DFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 9e-22
Identities = 65/200 (32%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 324 LGQGGFGYVHK-GVLPNGKEVAVKSL---KTGSGQGEREFSAEVEIISRVHHRHLVSLVG 379
LG+GGFG V V GK A K L + +GE+ E +I+ +V R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 380 YCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRI 438
Y + LV ++ L+YH++ P A + A GL +LH+ RI
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RI 116
Query: 439 IHRDIKAANILIDDNFEAMVADFGLA-KLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTE 497
++RD+K N+L+DD+ ++D GLA +L GT GY+APE
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVYDF 173
Query: 498 KSDVFSFGVMLLELITGRRP 517
D F+ G L E+I GR P
Sbjct: 174 SVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 44/220 (20%)
Query: 324 LGQGGFGYVHKGV--LPNGKEVAVKSLKTGS-GQGERE-FSAEVEIISRVHHRHLVSLVG 379
+G+G FG V K V +GK + K + G+ + E++ +EV I+ + H ++V
Sbjct: 8 IGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---R 63
Query: 380 YCIAGGQRMLVYEFVSNKTL----EYHLHG-----------ENRPV-MDFATRVRIALGS 423
Y R++ SN+TL EY G E + + +F R+ L
Sbjct: 64 YY----DRIIDR---SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 424 AKGLAYLHEDCH------PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTR 477
A L+E CH ++HRD+K ANI +D N + DFGLAK+ + + T
Sbjct: 117 A-----LYE-CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY 170
Query: 478 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
V GT Y++PE + EKSD++S G ++ EL P
Sbjct: 171 V-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 62/199 (31%), Positives = 104/199 (52%), Gaps = 10/199 (5%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVSLVGYC 381
LG G G V K + P GK +AVK+++ + + + E++I+ + + ++V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441
G + E++ +L+ L E + + +IA+ KGL YLHE IIHR
Sbjct: 69 YNNGDISICMEYMDGGSLDKILK-EVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHR 125
Query: 442 DIKAANILIDDNFEAMVADFGLA-KLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSD 500
D+K +NIL++ + + DFG++ +L N ++ +GT Y+APE + KSD
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQLVNS----LAKTFVGTSSYMAPERIQGNDYSVKSD 181
Query: 501 VFSFGVMLLELITGRRPVD 519
++S G+ L+EL TGR P
Sbjct: 182 IWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 24/215 (11%)
Query: 324 LGQGGFGYVH----KGVLPNGKE--VAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSL 377
LG+G FG V +LP + VAVK+LK S ++F E E+++ + H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHL--HGENRPVMD-----------FATRVRIALGSA 424
G C G ++V+E++ + L L HG + ++ + IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTFG 483
G+ YL H +HRD+ N L+ + DFG+++ + + ++ V R M
Sbjct: 133 SGMVYL-ASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 484 YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
++ PE K T +SD++SFGV+L E+ T G++P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 11/214 (5%)
Query: 317 GFAKSNLLGQGGFGYVHK-GVLPNGKEVAVKSLKTGS-GQGEREFSA-EVEIISRVHHRH 373
F LG+G +G V+K L + + A+K + GS Q ERE + E+ I++ V+H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRV--RIALGSAKGLAYLH 431
++S + G + +V E+ L + + + RI + +GL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYAS 491
E +I+HRD+K+ANIL+ N + D G++K+ N +GT Y+APE
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT---QIGTPHYMAPEVWK 174
Query: 492 SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMED 525
+ KSD++S G +L E+ T P + M+D
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 22/213 (10%)
Query: 324 LGQGGFGYVH----KGVLPNGKE--VAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSL 377
LG+G FG V + P + VAVK+LK S ++F E E+++ + H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 378 VGYCIAGGQRMLVYEFVS----NKTLEYH-----LHGENRPVMDF--ATRVRIALGSAKG 426
G C+ G ++V+E++ NK L H L E + + + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 427 LAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTFGYL 485
+ YL +HRD+ N L+ +N + DFG+++ + + ++ V M ++
Sbjct: 133 MVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 486 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
PE K T +SDV+S GV+L E+ T G++P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 49/217 (22%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE-FSA----EVEIISRVHHRHLVSL 377
+G+G +G V+K G+ VA+K ++ + E+E F E++++ ++ H ++V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRM---ENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 378 VGYCI----AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAK-------- 425
I G +V+E+ +++ L G ++D + V+ K
Sbjct: 64 --KEIVTSKGKGSIYMVFEY-----MDHDLTG----LLD-SPEVKFTESQIKCYMKQLLE 111
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL 485
GL YLH I+HRDIK +NILI+++ +ADFGLA+ ++ T + T Y
Sbjct: 112 GLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR 168
Query: 486 APE-------YASSGKLTEKSDVFSFGVMLLELITGR 515
PE Y + D++S G +L EL G+
Sbjct: 169 PPELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 324 LGQGGFGYVHKG--VLPNGKE----VAVKSLK-TGSGQGEREFSAEVEIISRVHHRHLVS 376
LG+G FG V+KG PN + VA+K+LK + ++EF E E++S + H ++V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHL--------------HGENRPVMDFATRVRIALG 422
L+G C +++E++++ L L + +D + + IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 423 SAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL--SNDNHTHVSTRVMG 480
A G+ YL +HRD+ A N L+ + ++DFGL++ S D + S ++
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL- 188
Query: 481 TFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 511
++ PE GK T +SD++SFGV+L E+
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 69/210 (32%), Positives = 113/210 (53%), Gaps = 15/210 (7%)
Query: 323 LLGQGGFGYVHKGVL--PNGKE--VAVKSLKTG-SGQGEREFSAEVEIISRVHHRHLVSL 377
++G G FG V +G L P +E VA+K+LK+G + + R+F +E I+ + H +++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
G M++ EF+ N L+ L +N V + G A G+ YL E +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLSEMNY-- 127
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMG---TFGYLAPEYASSG 493
+HRD+ A NIL++ N V+DFGL++ L +D T +G + APE +
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 494 KLTEKSDVFSFGVMLLELIT-GRRPV-DMT 521
K T SDV+S+G+++ E+++ G RP DM+
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWDMS 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 71/207 (34%), Positives = 108/207 (52%), Gaps = 25/207 (12%)
Query: 322 NLLGQGGFGYVHKGVL--PNGKEV--AVKSLKTGSGQGERE-FSAEVEIISRVHHRHLVS 376
++G+G FG V+ G L +G+++ AVKSL + E E F E I+ H +++S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 377 LVGYCIAG-GQRMLVYEFVSNKTLEYHLHGE--NRPVMDFATRVRIALGSAKGLAYLHED 433
L+G C+ G ++V ++ + L + E N V D + L AKG+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYLASK 117
Query: 434 CHPRIIHRDIKAANILIDDNFEAMVADFGLAK-------LSNDNHTHVSTRVMGTFGYLA 486
+ +HRD+ A N ++D++F VADFGLA+ S NHT V ++A
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WMA 170
Query: 487 PEYASSGKLTEKSDVFSFGVMLLELIT 513
E + K T KSDV+SFGV+L EL+T
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 7e-21
Identities = 84/301 (27%), Positives = 132/301 (43%), Gaps = 63/301 (20%)
Query: 323 LLGQGGFGYVHKGV---LPNGKE---VAVKSLKTGSGQGEREFS---AEVEIISRV-HHR 372
LG+G FG V K L N E VAVK LK E++ S +E+E++ + H+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 373 HLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATR---------------V 417
++++L+G C G +V E+ ++ L L RP ++A+ V
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLR-ARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 418 RIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTR 477
A A+G+ +L + IHRD+ A N+L+ ++ +ADFGLA+ + + T
Sbjct: 136 SFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT- 191
Query: 478 VMGTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWA 531
T G L APE T +SDV+SFGV+L E+ T G P +E+
Sbjct: 192 ---TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------ 242
Query: 532 RPLLGAALEDGIYDGLVDPRLEH-NYVPHEMARLV-ACGAASIRHSARKRPKMSQIVRAL 589
L L++G R+E E+ L+ C +RP Q+V L
Sbjct: 243 ---LFKLLKEG-------YRMEKPQNCTQELYHLMRDCW----HEVPSQRPTFKQLVEDL 288
Query: 590 E 590
+
Sbjct: 289 D 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 13/206 (6%)
Query: 320 KSNLLGQGGFGYVHKGV-LPNGKE----VAVKSLKTGSG-QGEREFSAEVEIISRVHHRH 373
K LLG G FG VHKG+ +P G VA+K+++ SG Q +E + + + + H +
Sbjct: 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAY 70
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED 433
+V L+G C G LV + +L H+ ++R +D + + AKG+ YL E
Sbjct: 71 IVRLLGIC-PGASLQLVTQLSPLGSLLDHVR-QHRDSLDPQRLLNWCVQIAKGMYYLEEH 128
Query: 434 CHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTFGYLAPEYASS 492
++HR++ A NIL+ + +ADFG+A L D+ + + ++A E
Sbjct: 129 R---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185
Query: 493 GKLTEKSDVFSFGVMLLELIT-GRRP 517
G+ T +SDV+S+GV + E+++ G P
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI 382
+G+G G V+K GKEVA+K ++ E + E+ I+ H ++V +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYDSYL 85
Query: 383 AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRD 442
G + +V E++ +L + +N M+ + +GL YLH +IHRD
Sbjct: 86 VGDELWVVMEYMDGGSLTDIIT-QNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRD 141
Query: 443 IKAANILIDDNFEAMVADFGL-AKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 501
IK+ NIL+ + +ADFG A+L+ + S V+GT ++APE K D+
Sbjct: 142 IKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYGPKVDI 199
Query: 502 FSFGVMLLELITGRRP-VDMTMME 524
+S G+M +E+ G P + +
Sbjct: 200 WSLGIMCIEMAEGEPPYLREPPLR 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 324 LGQGGFGYVHK-GVLPNGKEVAVK--SLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGY 380
+G+G G V K G+ VA+K +L+ G + E++ + H ++V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 381 CIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIH 440
G +LV E++ + L L E RP+ + + KG+AY+H + I+H
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVK-SYMRMLLKGVAYMHAN---GIMH 122
Query: 441 RDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE--YASSGKLTEK 498
RD+K AN+LI + +ADFGLA+L ++ + + + T Y APE Y + K
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR-KYDPG 181
Query: 499 SDVFSFGVMLLELITGR 515
D+++ G + EL+ G
Sbjct: 182 VDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
+G+G FG V G G +VAVK +K + + F AE +++++ H +LV L+G +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 384 -GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRD 442
G +V E+++ +L +L R V+ ++ +L + + YL + +HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRD 127
Query: 443 IKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 502
+ A N+L+ ++ A V+DFGL K ++ V T APE K + KSDV+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVW 183
Query: 503 SFGVMLLELIT-GRRP 517
SFG++L E+ + GR P
Sbjct: 184 SFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 45/227 (19%)
Query: 323 LLGQGGFGYVHKGVL-PNGKEVAVKSL---------KTGSGQGEREFSAEVEIISRV-HH 371
++G+G F V KE A+K L K + E+E +++R+ H
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKE------VLTRLNGH 61
Query: 372 RHLVSLVGYCIAGGQRML--VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAY 429
++ L Y + L V E+ N L ++ +D A L Y
Sbjct: 62 PGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIR--KYGSLDEKCTRFYAAEILLALEY 117
Query: 430 LHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM---------- 479
LH IIHRD+K NIL+D + + DFG AK+ + N + S +
Sbjct: 118 LHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 480 ---------GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
GT Y++PE + + SD+++ G ++ +++TG+ P
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 67/210 (31%), Positives = 112/210 (53%), Gaps = 17/210 (8%)
Query: 323 LLGQGGFGYVHKGVL--PNGKE--VAVKSLKTG-SGQGEREFSAEVEIISRVHHRHLVSL 377
++G G FG V G L P +E VA+K+LK G + + R+F +E I+ + H +++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHL--HGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
G M+V E++ N +L+ L H V+ +R G A G+ YL + +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYLSDMGY 127
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFG--YLAPEYASSG 493
+HRD+ A NIL++ N V+DFGL+++ D+ T G + APE +
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 494 KLTEKSDVFSFGVMLLELIT-GRRPV-DMT 521
K T SDV+S+G+++ E+++ G RP +M+
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERPYWEMS 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 2e-20
Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSA----EVEIISRVHHR 372
+ K LG+G +G V+K G+ VA+K ++ E + E+ ++ + H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHP 58
Query: 373 HLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHG---ENRPVMDFATRVRIALGSAKGLAY 429
++V L+ + LV+E+ + L + + I +GLAY
Sbjct: 59 NIVKLLDVIHTERKLYLVFEY-----CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 430 LHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN---DNHTHVSTRVMGTFGYLA 486
H H RI+HRD+K NILI+ + +ADFGLA+ +TH V+ T Y A
Sbjct: 114 CHS--H-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH---EVV-TLWYRA 166
Query: 487 PE-------YASSGKLTEKSDVFSFGVMLLELITGR 515
PE Y+++ D++S G + E+ITG+
Sbjct: 167 PEILLGSKHYSTA------VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 2e-20
Identities = 81/320 (25%), Positives = 135/320 (42%), Gaps = 56/320 (17%)
Query: 340 GKEVAVKSLKTGSGQGERE---FSAEVEIISRVHHRHLVSLVGYCIAGGQRML-VYEFVS 395
G EVA+K L+T + + E + F E + +R++H ++V+L+ A + V+E+V
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI---DD 452
+TL L + + R+ L LA H I+HRD+K NI++
Sbjct: 63 GRTLREVLAADG--ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGV 117
Query: 453 NFEAMVADFGLAKLSNDNHTHVSTR------VMGTFGYLAPEYASSGKLTEKSDVFSFGV 506
A V DFG+ L V+GT Y APE +T SD++++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 507 MLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL--VDPRLEHNYVPHEMARL 564
+ LE +TG+R V GA++ + +Y L VD L H + ++
Sbjct: 178 IFLECLTGQRVVQ----------------GASVAEILYQQLSPVDVSLPPWIAGHPLGQV 221
Query: 565 VACGAASIRHSARKRPK--------MSQIVRALEGDSSLDDLNDGVRPGQSSAFSASNTS 616
+R + K P+ +++ RALE L L +R G+ + A
Sbjct: 222 -------LRKALNKDPRQRAASAPALAERFRALE----LCALVGILRMGEGAGREAIAAP 270
Query: 617 TEYSATSYNADMKKFRQLAL 636
S T + + + RQL
Sbjct: 271 LVASGTL-DGETGERRQLTA 289
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 61/190 (32%), Positives = 99/190 (52%), Gaps = 7/190 (3%)
Query: 323 LLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVSLVGYC 381
LLG+G FG V KG L + VAVK+ K Q + +F +E I+ + H ++V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLH-EDCHPRIIH 440
+V E V L + + + V+ AL +A G+AYL ++C IH
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLESKNC----IH 116
Query: 441 RDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSD 500
RD+ A N L+ +N ++DFG+++ +D S + APE + G+ + +SD
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 501 VFSFGVMLLE 510
V+S+G++L E
Sbjct: 177 VWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 4e-20
Identities = 74/281 (26%), Positives = 129/281 (45%), Gaps = 31/281 (11%)
Query: 322 NLLGQGGFGYVHKG-VLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGY 380
N++ +G G +KG + NG + VK + + E + + ++ H ++V L+G
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGL 751
Query: 381 CIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIH 440
C + L++E++ K L L + + R +IA+G AK L +LH C P ++
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 441 RDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSD 500
++ I+ID E + L D +S+ Y+APE + +TEKSD
Sbjct: 807 GNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISS------AYVAPETRETKDITEKSD 860
Query: 501 VFSFGVMLLELITGRRPVDMTM-MEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPH 559
++ FG++L+EL+TG+ P D + S+VEWAR D D +DP + + +
Sbjct: 861 IYGFGLILIELLTGKSPADAEFGVHGSIVEWAR----YCYSDCHLDMWIDPSIRGDVSVN 916
Query: 560 E------MARLVACGAASIRHSARKRPKMSQIVRALEGDSS 594
+ M + C A RP + +++ LE S
Sbjct: 917 QNEIVEVMNLALHCTAT----DPTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-20
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 323 LLGQGGFGYVHKGV--LPNGKE--VAVKSLKTGSGQGERE-FSAEVEIISRVHHRHLVSL 377
+G+G FG V++GV P ++ VAVK+ K + RE F E I+ + H H+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 378 VGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
+G + +V E L +L N+ +D A+ + + + LAYL
Sbjct: 73 IGVITE--NPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLESK--- 126
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLT 496
R +HRDI A N+L+ + DFGL++ D + +++ ++APE + + T
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186
Query: 497 EKSDVFSFGVMLLE-LITGRRP 517
SDV+ FGV + E L+ G +P
Sbjct: 187 SASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 322 NLLGQGGFGYVHKGVL------PNGKEVAVKSL-KTGSGQGEREFSAEVEIISRVHHRHL 374
LG G FG V++G+ +VAVK+L ++ S Q E +F E I+S+ +H+++
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHL-HGENRPVMDFATRVR----IALGSAKGLAY 429
V L+G R ++ E ++ L+ L RP + ++ A AKG Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 430 LHEDCHPRIIHRDIKAANILIDDNFE---AMVADFGLAK-LSNDNHTHVSTRVMGTFGYL 485
L E+ IHRDI A N L+ A +ADFG+A+ + ++ R M ++
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 486 APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
PE G T K+DV+SFGV+L E+ + G P
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-20
Identities = 58/195 (29%), Positives = 95/195 (48%), Gaps = 6/195 (3%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
LG G FG VH G +VA+K++ G+ E +F E +++ ++ H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 384 GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDI 443
+V EF+ N L +L + + + + + +G+ YL + IHRD+
Sbjct: 71 QKPLYIVTEFMENGCLLNYLR-QRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDL 126
Query: 444 KAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 503
A N L+ V+DFG+ + D+ S+ + PE + K + KSDV+S
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 504 FGVMLLELIT-GRRP 517
FGV++ E+ T G+ P
Sbjct: 187 FGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSA-EVEIISRVHHRHLV 375
F +G+G FG V+K + + VA+K + + E E E++ +S+ ++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 376 SLVGYCIAGGQRM-LVYEFVSNKT----LEYHLHGENRPVMDFATRVRIALGSAKGLAYL 430
G G ++ ++ E+ + L+ E A +R L GL YL
Sbjct: 63 KYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY----IAFILREVL---LGLEYL 114
Query: 431 HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYA 490
HE+ IHRDIKAANIL+ + + +ADFG++ + +T V GT ++APE
Sbjct: 115 HEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVI 170
Query: 491 SSGKLTEKSDVFSFGVMLLELITGRRP 517
EK+D++S G+ +EL G P
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 65/225 (28%), Positives = 110/225 (48%), Gaps = 29/225 (12%)
Query: 320 KSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE---------FSAEVEIISRV 369
K L+G G FG V+ G+ +G+ +AVK ++ S + + E+ ++ +
Sbjct: 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 370 HHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHG----ENRPVMDFATRVRIALGSAK 425
H ++V +G + + E+V ++ L+ E V +F VR L K
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNF---VRQIL---K 117
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTR-----VMG 480
GL YLH IIHRDIK ANIL+D+ ++DFG++K N T + G
Sbjct: 118 GLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174
Query: 481 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPV-DMTMME 524
+ ++APE T K+D++S G +++E++TG+ P D T ++
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 7e-20
Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 322 NLLGQGGFGYVHKGVLPNGKEV-------AVKSLKTGSGQGEREFSAEVEIISRVHHRHL 374
++G+G FG V + K++ K ++ GS + E I+ ++H L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN---ERRILQELNHPFL 62
Query: 375 VSLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIA-LGSAKGLAYLHE 432
V+L Y + M LV + + L YHL + + + I + A L YLH
Sbjct: 63 VNLW-YSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWICEIVLA--LEYLHS 118
Query: 433 DCHPRIIHRDIKAANILIDDNFEAMVADFGLA-KLSNDNHTHVSTRVMGTFGYLAPEYAS 491
IIHRDIK NIL+D+ + DF +A K++ D T T GT GY+APE
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLC 172
Query: 492 SGKLTEKSDVFSFGVMLLELITGRRP 517
+ D +S GV E + G+RP
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 7e-20
Identities = 74/286 (25%), Positives = 132/286 (46%), Gaps = 42/286 (14%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQ---GEREFSA---EVEIISRVHH 371
+ K +LG+G +G V+ G+ G+ +AVK ++ + E+E+ EV+++ + H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 372 RHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENR----PVMDFATRVRIALGSAKGL 427
++V +G C+ + EFV ++ L NR P F + L G+
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQIL---DGV 115
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL-----SNDNHTHVSTRVMGTF 482
AYLH +C ++HRDIK N+++ N + DFG A+ + H+++ + GT
Sbjct: 116 AYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172
Query: 483 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWAR-PLLGAALED 541
++APE + KSD++S G + E+ TG+ P A L A
Sbjct: 173 YWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP------------LASMDRLAAMFYI 220
Query: 542 GIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587
G + GL+ PRL ++ + + +C + +RP Q++R
Sbjct: 221 GAHRGLM-PRLPDSFSAAAIDFVTSC----LTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 12/208 (5%)
Query: 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEV-AVKSLKTGSGQG-EREFSAEVEIISRVHHRH 373
+ + LG+G G V K L N + A+K++ T +++ E+EI +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 374 LVSLVGYCIAGGQRML--VYEFVSNKTLEYHLHGENRPVMDFATRV--RIALGSAKGLAY 429
+V G + + E+ +L+ + +V +IA KGL+Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 430 LHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEY 489
LH +IIHRDIK +NIL+ + + DFG +S + ++ GT Y+APE
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFG---VSGELVNSLAGTFTGTSFYMAPER 174
Query: 490 ASSGKLTEKSDVFSFGVMLLELITGRRP 517
+ SDV+S G+ LLE+ R P
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 324 LGQGGFGYVHKGV------LPNGKEVAVKSLKTGSGQGE-REFSAEVEIISRVHHRHLVS 376
LG+G FG V K VAVK LK + E R+ +E ++ +V+H H++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLH-------------GENRPVMDFATRVR----- 418
L G C G +L+ E+ +L L G R
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 419 ----IALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474
A ++G+ YL E +++HRD+ A N+L+ + + ++DFGL++ + ++V
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 475 S-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 513
++ ++A E T +SDV+SFGV+L E++T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 63/213 (29%), Positives = 109/213 (51%), Gaps = 28/213 (13%)
Query: 322 NLLGQGGFGYVHKG-VLPNG--KEVAVKSLKTGSGQGE-REFSAEVEIISRV-HHRHLVS 376
+++G+G FG V K + +G + A+K +K + + + R+F+ E+E++ ++ HH ++++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHG----ENRPVMDFATRVRIALGS--------- 423
L+G C G L E+ + L L E P A L S
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 424 -AKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTF 482
A+G+ YL + + IHRD+ A NIL+ +N+ A +ADFG LS +V + MG
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG---LSRGQEVYVK-KTMGRL 185
Query: 483 G--YLAPEYASSGKLTEKSDVFSFGVMLLELIT 513
++A E + T SDV+S+GV+L E+++
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 25/216 (11%)
Query: 324 LGQGGFGYVH----KGVLPNGKE--VAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSL 377
LG+G FG V + P + VAVK+LK + ++F E E+++ + H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHL--HG-------ENRPV-----MDFATRVRIALGS 423
G C G ++V+E++ + L L HG + +P + + + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 424 AKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTF 482
A G+ YL +HRD+ N L+ N + DFG+++ + + ++ V M
Sbjct: 133 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 483 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
++ PE K T +SDV+SFGV+L E+ T G++P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 324 LGQGGFGYVH------KGVLPNGKEVAVKSLKTGSGQGE-REFSAEVEIISRVHHRHLVS 376
LG+G FG V +G G++VAVKSLK SG + E+EI+ ++H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 377 LVGYCIAGGQR--MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
G C G L+ EF+ + +L+ +L N+ ++ +++ A+ KG+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGSR- 128
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN---HTHVSTRVMGTFGYLAPEYAS 491
+ +HRD+ A N+L++ + + DFGL K + +T F Y APE
Sbjct: 129 --QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLI 185
Query: 492 SGKLTEKSDVFSFGVMLLELIT 513
K SDV+SFGV L EL+T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 324 LGQGGFG----YVHK--GVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSL 377
LG+G FG Y L KEV + L S + R+ E+ I+S + H ++++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRL---SEKERRDALNEIVILSLLQHPNIIAY 64
Query: 378 VGYCIAGGQRMLVYEFVSNKTL------EYHLHGENRPVMDFATRVRIALGSAKGLAYLH 431
+ + ++ E+ + TL + E V+ + + SA ++Y+H
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL----FQIVSA--VSYIH 118
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYAS 491
+ I+HRDIK NI + + DFG++K+ ++ T V+GT Y++PE
Sbjct: 119 KA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQ 174
Query: 492 SGKLTEKSDVFSFGVMLLELITGRRPVDMT 521
K KSD+++ G +L EL+T +R D T
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 67/212 (31%), Positives = 112/212 (52%), Gaps = 21/212 (9%)
Query: 320 KSNLLGQGGFGYVHKGV-LPNGKEV----AVKSLKTGSG-QGEREFSAEVEIISRVHHRH 373
+ +LG G FG V+KG+ +P G+ V A+K L +G + EF E I++ + H H
Sbjct: 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPH 70
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEY-HLHGEN---RPVMDFATRVRIALGSAKGLAY 429
LV L+G C++ +++ L+Y H H +N + ++++ ++ AKG+ Y
Sbjct: 71 LVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMY 124
Query: 430 LHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTFGYLAPE 488
L E R++HRD+ A N+L+ + DFGLA+ L D + + ++A E
Sbjct: 125 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181
Query: 489 YASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 519
K T +SDV+S+GV + EL+T G +P D
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 65/201 (32%), Positives = 106/201 (52%), Gaps = 18/201 (8%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
LG G FG V +VAVK++K GS E F AE ++ + H LV L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA-VVT 71
Query: 384 GGQRMLVYEFVSNKTLEYHLHGE--NR----PVMDFATRVRIALGSAKGLAYLHEDCHPR 437
++ EF++ +L L + ++ ++DF+ ++ A+G+A++ + +
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAFIEQRNY-- 123
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTE 497
IHRD++AANIL+ + +ADFGLA++ DN + APE + G T
Sbjct: 124 -IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 182
Query: 498 KSDVFSFGVMLLELIT-GRRP 517
KSDV+SFG++L+E++T GR P
Sbjct: 183 KSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 78/292 (26%), Positives = 139/292 (47%), Gaps = 52/292 (17%)
Query: 321 SNLLGQGGFGYVHKGVL-----PNGKEVAVKSLKTGSGQGERE-FSAEVEIISRVHHRHL 374
S+LL +G FG + G+L +EV VK++K + + + E ++ + H+++
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 375 VSLVGYCIAGGQR-MLVYEFVSNKTLEYHL----HGENRPVMDFATR--VRIALGSAKGL 427
+ ++ CI G+ ++Y +++ L+ L GE +T+ V +A+ A G+
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK--LSNDNHTHVSTRVMGT---- 481
+YLH+ +IH+DI A N +ID+ + + D L++ D H +G
Sbjct: 131 SYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC------LGDNENR 181
Query: 482 -FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP-VDMTMMEDSLVEWARPLLGAA 538
++A E + + + SDV+SFGV+L EL+T G+ P V++ E + A
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE----------MAAY 231
Query: 539 LEDGIYDGLVDPRLEH-NYVPHEMARLVACGAASIRHSARKRPKMSQIVRAL 589
L+DG RL P E+ ++AC A +RP SQ+V+ L
Sbjct: 232 LKDGY-------RLAQPINCPDELFAVMACCWAL---DPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 27/213 (12%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGE-REFSAEVEIISRVHHRHLV 375
+ + L+G+G +G V++G +P G+ VA+K + + + + EV ++S++
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 376 SLVGY--CIAGGQRMLVYEFVSNKTLEYHLHGENRPVMD--------FATRVRIALGSAK 425
++ Y G R+ + +EY G R +M + +R L
Sbjct: 63 NITKYYGSYLKGPRLWI-------IMEYAEGGSVRTLMKAGPIAEKYISVIIREVL---V 112
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL 485
L Y+H+ +IHRDIKAANIL+ + + DFG+A L N N + ST V GT ++
Sbjct: 113 ALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWM 168
Query: 486 APEYASSGKLTE-KSDVFSFGVMLLELITGRRP 517
APE + GK + K+D++S G+ + E+ TG P
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 5e-19
Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 30/217 (13%)
Query: 324 LGQGGFGYVHK----------GVLPNGKE-----VAVKSLKTGSGQGER-EFSAEVEIIS 367
LG+G FG VH G + VAVK L+ + R +F E++I+S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 368 RVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHL----------HGENRPVMDFATRV 417
R+ + +++ L+G C++ ++ E++ N L L H N P + A +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 418 RIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVST 476
+A+ A G+ YL +HRD+ N L+ +++ +ADFG+++ L + ++ +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 513
R + ++A E GK T SDV++FGV L E+ T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 6e-19
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE---FSA--EVEIISRVHH 371
+ K LG+G + V+K G+ VA+K +K G + ++ F+A E++++ + H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 372 RHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLH 431
+++ L+ LV+EF+ LE + + V+ A L + +GL YLH
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMETD-LE-KVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE--- 488
+ I+HRD+K N+LI + +ADFGLA+ + ++ +V+ T Y APE
Sbjct: 120 SN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLF 175
Query: 489 ----YASSGKLTEKSDVFSFGVMLLELITGRRP 517
Y D++S G + EL+ R P
Sbjct: 176 GARHYGVG------VDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 8e-19
Identities = 59/215 (27%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 320 KSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFS----------AEVEIISR 368
K L+G+G +G V+ + + G+ +AVK ++ + R S +E+E +
Sbjct: 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 369 VHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLE--YHLHGE-NRPVMDFATRVRIALGSAK 425
+ H ++V +G+ + E+V ++ +G ++ F T + +
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-----E 119
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM-GTFGY 484
GLAYLH I+HRD+KA N+L+D + ++DFG++K S+D + + M G+ +
Sbjct: 120 GLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 485 LAPEYASSGK--LTEKSDVFSFGVMLLELITGRRP 517
+APE S + K D++S G ++LE+ GRRP
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 323 LLGQGGFGYVHKGVL--PNGK--EVAVKSLK-TGSGQGE-REFSAEVEIISRVHHRHLVS 376
+LG+G FG V +G L +G +VAVK++K E EF +E + H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 377 LVGYCIAGGQR------MLVYEFVSNKTLEYHLH----GENRPVMDFATRVRIALGSAKG 426
L+G C M++ F+ + L L G + T ++ + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 427 LAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK--LSND--NHTHVSTRVMGTF 482
+ YL IHRD+ A N ++ ++ VADFGL+K S D ++ +
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV--- 179
Query: 483 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
++A E + T KSDV++FGV + E+ T G+ P
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 9/204 (4%)
Query: 318 FAKSNLLGQGGFGYVHK-GVLPNGKEVAVKSL---KTGSGQGEREFSAEVEIISRVHHRH 373
F + +LG+GGFG V V GK A K L + +GE E +I+ +V+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED 433
+VSL LV ++ L++H++ + V A GL LH++
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 434 CHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSG 493
RI++RD+K NIL+DD+ ++D GLA + T + RV GT GY+APE +
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNE 176
Query: 494 KLTEKSDVFSFGVMLLELITGRRP 517
+ T D ++ G +L E+I G+ P
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 19/211 (9%)
Query: 318 FAKSNL-----LGQGGFGYVHKGVLPN-GKE-----VAVKSLKTGSGQGERE-FSAEVEI 365
F ++NL LG G FG V + K VAVK LK + ERE +E++I
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91
Query: 366 ISRV-HHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSA 424
+S + +H ++V+L+G C GG +++ E+ L L + + + + A
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 425 KGLAYL-HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTF 482
KG+A+L ++C IHRD+ A N+L+ + DFGLA+ + ND++ V
Sbjct: 152 KGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207
Query: 483 GYLAPEYASSGKLTEKSDVFSFGVMLLELIT 513
++APE + T +SDV+S+G++L E+ +
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 323 LLGQGGFGYVHKG-VLPNGKEVAVKSLKTGSGQGE-REFSA-EVEIISRVHHRHLVSLVG 379
++G+G +G V K G+ VA+K K + ++ + EV+++ ++ H ++V+L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPV-MDFATRVRIALGSAKGLAYLHEDCHPRI 438
G+ LV+E+V LE E P + + +AY H I
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCHSH---NI 121
Query: 439 IHRDIKAANILIDDNFEAMVADFGLAKL----SNDNHT-HVSTRVMGTFGYLAPE----Y 489
IHRDIK NIL+ ++ + DFG A+ T +V+TR Y APE
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR-----WYRAPELLVGD 176
Query: 490 ASSGKLTEKSDVFSFGVMLLELITGR 515
+ GK DV++ G ++ EL+ G
Sbjct: 177 TNYGK---PVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 12/201 (5%)
Query: 324 LGQGGFGYVHKGVLPNGK---EVAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVSLVG 379
LG G FG V KGV K +VA+K LK + + R E E EI+ ++ + ++V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
C A MLV E S L L G+ + + + V + + G+ YL +
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFV 117
Query: 440 HRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTF--GYLAPEYASSGKLTE 497
HRD+ A N+L+ + A ++DFGL+K + ++ R G + + APE + K +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 498 KSDVFSFGVMLLELIT-GRRP 517
+SDV+S+G+ + E + G++P
Sbjct: 178 RSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 324 LGQGGFGYVH---KGVLPNGKEVAVKSLKTGSGQGEREFS---AEVEIISRVHHRHLVSL 377
+ +G +G V K G A+K +K + + E +I+S+ ++V L
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 378 VGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMD-FATRVRIALGSAKGLAYLHEDCH 435
Y G + + LV E++ L L +D R+ IA L YLH +
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLENVG--SLDEDVARIYIA-EIVLALEYLHSN-- 112
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKL-SNDNHTHVS------TRVMGTFGYLAPE 488
IIHRD+K NILID N + DFGL+K+ +++ R++GT Y+APE
Sbjct: 113 -GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 489 YASSGKLTEKSDVFSFGVMLLELITGRRP 517
++ D +S G +L E + G P
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 61/211 (28%), Positives = 108/211 (51%), Gaps = 23/211 (10%)
Query: 320 KSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTG--SGQGEREFSA---EVEIISRVHHRH 373
+ LLGQG FG V+ + G+E+AVK + S + ++E +A E++++ + H
Sbjct: 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER 65
Query: 374 LVSLVGYCIAGGQRMLVY-EFVSNKTLEYHL--HGENRPVMDFATR--VRIALGSAKGLA 428
+V G C+ + + ++ E++ +++ L +G + + TR R L +G+
Sbjct: 66 IVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQIL---EGVE 118
Query: 429 YLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS--TRVMGTFGYLA 486
YLH + I+HRDIK ANIL D + DFG +K + + V GT +++
Sbjct: 119 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 487 PEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
PE S K+DV+S G ++E++T + P
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 21/204 (10%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI 382
+G G +G V+K + G+ VA+K +K G E+ ++ H ++V+ G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 383 AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIAL---GSAKGLAYLHEDCHPRII 439
+ +V E+ +L+ P+ + ++IA + KGLAYLHE I
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPL----SELQIAYVCRETLKGLAYLHET---GKI 123
Query: 440 HRDIKAANILIDDNFEAMVADFGL-AKLSNDNHTHVSTR--VMGTFGYLAPEYA---SSG 493
HRDIK ANIL+ ++ + +ADFG+ A+L+ ++ R +GT ++APE A G
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQLTAT----IAKRKSFIGTPYWMAPEVAAVERKG 179
Query: 494 KLTEKSDVFSFGVMLLELITGRRP 517
K D+++ G+ +EL + P
Sbjct: 180 GYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 28/213 (13%)
Query: 322 NLLGQGGFGYVHKGVLP---NGKEVAVKSLKT-GSGQGEREFSAEVEIISRV-HHRHLVS 376
+++G+G FG V + ++ A+K LK S R+F+ E+E++ ++ HH ++++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 377 LVGYCIAGGQRMLVYEFV----------SNKTLEYH--LHGENRPVMDFATR--VRIALG 422
L+G C G + E+ ++ LE E+ ++ ++ A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 423 SAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTF 482
A G+ YL E + IHRD+ A N+L+ +N + +ADFG LS +V + MG
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFG---LSRGEEVYVK-KTMGRL 180
Query: 483 G--YLAPEYASSGKLTEKSDVFSFGVMLLELIT 513
++A E + T KSDV+SFGV+L E+++
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 60/206 (29%), Positives = 107/206 (51%), Gaps = 19/206 (9%)
Query: 324 LGQGGFGYVH----KGVLPNGKE--VAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVS 376
LGQG FG V+ KGV+ + E VA+K++ + ER EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHG-----ENRPVMDFAT---RVRIALGSAKGLA 428
L+G G +++ E ++ L+ +L EN PV + +++A A G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 429 YLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTFGYLAP 487
YL+ + + +HRD+ A N ++ ++F + DFG+ + + ++ + + +++P
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 488 EYASSGKLTEKSDVFSFGVMLLELIT 513
E G T SDV+SFGV+L E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 66/204 (32%), Positives = 98/204 (48%), Gaps = 9/204 (4%)
Query: 318 FAKSNLLGQGGFGYVHK-GVLPNGKEVAVKSL---KTGSGQGEREFSAEVEIISRVHHRH 373
F +LG+GGFG V V GK A K L + +GE E +I+ +V+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED 433
+VSL LV ++ L++H++ P D V A GL LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 434 CHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSG 493
RI++RD+K NIL+DD ++D GLA + T + RV GT GY+APE +
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVKNE 176
Query: 494 KLTEKSDVFSFGVMLLELITGRRP 517
+ T D + G ++ E+I G+ P
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 7e-18
Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQG-EREFSAEVEIISRVHHRHLVSLVGYC 381
LG G G V K +P G +A K + G+ ++ E++I+ ++VS G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 382 IAGGQRMLVYEFVSNKTLE--YHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
+ + EF+ +L+ Y G +IA+ +GL YL+ + H RI+
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPV----EILGKIAVAVVEGLTYLY-NVH-RIM 126
Query: 440 HRDIKAANILIDDNFEAMVADFGLA-KLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEK 498
HRDIK +NIL++ + + DFG++ +L N ++ +GT Y++PE GK T K
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTVK 182
Query: 499 SDVFSFGVMLLELITGRRPVDM 520
SDV+S G+ ++EL G+ P
Sbjct: 183 SDVWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 9e-18
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 324 LGQGGFGYVHKGVL---PNGKEVAVKSLKTGSGQG--EREFSAEVEIISRVHHRHLVSLV 378
LG G FG V KG+ + K VAVK LK + + E E ++ ++ + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 379 GYCIAGGQRMLVYEFVS----NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
G C MLV E NK L+ + H + + + +V + G+ YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLEET- 114
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKL--SNDNHTHVSTRVMGTFGYLAPEYASS 492
+HRD+ A N+L+ A ++DFGL+K +++N+ T + APE +
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 493 GKLTEKSDVFSFGVMLLELIT-GRRP 517
K + KSDV+SFGV++ E + G++P
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 31/218 (14%)
Query: 324 LGQGGFGYVHK----GVLPNGKE--VAVKSLKTG-SGQGEREFSAEVEIISRVHHRHLVS 376
+GQG FG V + G+LP VAVK LK S + +F E +++ H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 377 LVGYCIAGGQRMLVYEFV--------------------SNKTLEYHLHGENRPVMDFATR 416
L+G C G L++E++ S+ T G N + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 417 VRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA-KLSNDNHTHVS 475
+ IA A G+AYL E + +HRD+ N L+ +N +ADFGL+ + + ++ S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 513
++ PE + T +SDV+++GV+L E+ +
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 67/205 (32%), Positives = 99/205 (48%), Gaps = 11/205 (5%)
Query: 318 FAKSNLLGQGGFGYVHK-GVLPNGKEVAVKSL---KTGSGQGEREFSAEVEIISRVHHRH 373
F +LG+GGFG V V GK A K L + +GE E I+ +V+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 374 LVSLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHE 432
+VSL Y + LV ++ L++H++ P D + A GL L
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 433 DCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS 492
+ RI++RD+K NIL+DD ++D GLA + T V RV GT GY+APE ++
Sbjct: 121 E---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINN 175
Query: 493 GKLTEKSDVFSFGVMLLELITGRRP 517
K T D + G ++ E+I G+ P
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 324 LGQGGFGYVHKGVLPN-GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI 382
LG G FG V+K G A K ++ S + +F E++I+S H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 383 AGGQRMLVYEFVSNKTLEYHL----HGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRI 438
+ ++ EF L+ + G P + + R + + L +LH ++
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML-----EALNFLHSH---KV 124
Query: 439 IHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYA-----SSG 493
IHRD+KA NIL+ + + +ADFG++ + T + GT ++APE
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDN 183
Query: 494 KLTEKSDVFSFGVMLLELITGRRP 517
K+D++S G+ L+EL P
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNGKEV-AVKSLKTGSGQGERE-FSAEVEIISRVHHRHLV 375
F K +G+G FG V+KG+ KEV A+K + + E E E+ ++S+ ++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
G + G + ++ E++ + L AT +R L KGL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL---KGLDYLHSE-- 120
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL 495
R IHRDIKAAN+L+ + + +ADFG+A D +T V GT ++APE
Sbjct: 121 -RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 178
Query: 496 TEKSDVFSFGVMLLELITGRRP 517
K+D++S G+ +EL G P
Sbjct: 179 DFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 3e-17
Identities = 59/213 (27%), Positives = 109/213 (51%), Gaps = 28/213 (13%)
Query: 322 NLLGQGGFGYVHKGVLPNG---KEVAVKSLKTGSGQGE-REFSAEVEIISRV-HHRHLVS 376
+++G+G FG V K + + A+K +K + + + R+F+ E+E++ ++ HH ++++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 377 LVGYCIAGGQRMLVYEFV----------SNKTLEYH--LHGENRPVMDFATR--VRIALG 422
L+G C G L E+ ++ LE N +++ + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 423 SAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTF 482
A+G+ YL + + IHRD+ A NIL+ +N+ A +ADFG LS +V + MG
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG---LSRGQEVYVK-KTMGRL 173
Query: 483 G--YLAPEYASSGKLTEKSDVFSFGVMLLELIT 513
++A E + T SDV+S+GV+L E+++
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 10/209 (4%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNGKEV-AVKSLKTGSGQGERE-FSAEVEIISRVHHRHLV 375
F K +G+G FG V KG+ ++V A+K + + E E E+ ++S+ ++
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
G + G + ++ E++ + L AT ++ L KGL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE-- 120
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL 495
+ IHRDIKAAN+L+ + + +ADFG+A D +T V GT ++APE
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAY 178
Query: 496 TEKSDVFSFGVMLLELITGRRP-VDMTMM 523
K+D++S G+ +EL G P DM M
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 32/223 (14%)
Query: 324 LGQGGFGYVH------------KGVLPNGKE-----VAVKSLKTGSGQGER-EFSAEVEI 365
LG+G FG VH K N VAVK L+ + R +F EV+I
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 366 ISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLH---------GENRPVMDFATR 416
+SR+ ++ L+G C ++ E++ N L L N + F+T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 417 VRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVS 475
+ +A A G+ YL +HRD+ N L+ N+ +ADFG+++ L + ++ V
Sbjct: 133 LYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
R ++A E GK T KSDV++FGV L E++T R
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 64/214 (29%), Positives = 110/214 (51%), Gaps = 21/214 (9%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKE----VAVKSLKTG-SGQGEREFSAEVEIISRVHH 371
F K +LG G FG V+KG+ +P G++ VA+K L+ S + +E E +++ V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 372 RHLVSLVGYCIAGGQRMLVYEFVSNKTLEY-HLHGEN---RPVMDFATRVRIALGSAKGL 427
H+ L+G C+ +++ L+Y H +N + ++++ ++ AKG+
Sbjct: 69 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 122
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN-DNHTHVSTRVMGTFGYLA 486
YL E R++HRD+ A N+L+ + DFGLAKL D + + ++A
Sbjct: 123 NYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 487 PEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 519
E T +SDV+S+GV + EL+T G +P D
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 67/209 (32%), Positives = 91/209 (43%), Gaps = 35/209 (16%)
Query: 324 LGQGGFGYV----HKGVLPNGKEVAVKSLKTG----SGQGEREFSAEVEIISRVHHRHLV 375
LG G FG V HK +GK A+K L Q E + E I+ + H LV
Sbjct: 9 LGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVLN-EKRILQSIRHPFLV 64
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENR---PVMDF-ATRVRIALGSAKGLAYLH 431
+L G LV E+V L HL R PV F A +V +AL YLH
Sbjct: 65 NLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE------YLH 118
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM---GTFGYLAPE 488
I++RD+K N+L+D + + DFG AK V R GT YLAPE
Sbjct: 119 -SLD--IVYRDLKPENLLLDSDGYIKITDFGFAK-------RVKGRTYTLCGTPEYLAPE 168
Query: 489 YASSGKLTEKSDVFSFGVMLLELITGRRP 517
S + D ++ G+++ E++ G P
Sbjct: 169 IILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 320 KSNLLGQGGFG--YVHKGVLPNGKEVAVKSLK----TGSGQGE--REFSAEVEIISRVHH 371
K LG G F Y + V G +AVK + T S Q E E+ +++R++H
Sbjct: 4 KGQQLGTGAFSSCYQARDVK-TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62
Query: 372 RHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLH 431
H++ ++G L E+++ ++ + L A + +GL+YLH
Sbjct: 63 PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS--KYGAFKEAVIINYTEQLLRGLSYLH 120
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAM-VADFGLAKLSNDNHT---HVSTRVMGTFGYLAP 487
E+ +IIHRD+K AN+LID + + +ADFG A T +++GT ++AP
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 488 EYASSGKLTEKSDVFSFGVMLLELITGRRP 517
E + DV+S G +++E+ T + P
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 31/218 (14%)
Query: 324 LGQGGFGYVH----KGVLPNGKE-------------VAVKSLKTGSGQGER-EFSAEVEI 365
LG+G FG VH +G+ + VAVK L+ + + R +F E++I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 366 ISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHL---------HGENRPVMDFATR 416
+SR+ +++ L+ CI ++ E++ N L L + + ++T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 417 VRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVS 475
+ +A A G+ YL +HRD+ N L+ N+ +ADFG+++ L + ++ +
Sbjct: 133 IFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 513
R + +++ E GK T SDV++FGV L E++T
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 62/202 (30%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 324 LGQGGFGYVH------KGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSL 377
LG+GGFG V G L K++ K LK +G E I+++VH R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK--KRKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHG--ENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
LV ++ L YH++ E P GL +LH+
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL 495
RII+RD+K N+L+D++ ++D GLA D + + GT G++APE +
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEY 174
Query: 496 TEKSDVFSFGVMLLELITGRRP 517
D F+ GV L E+I R P
Sbjct: 175 DFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 63/210 (30%), Positives = 110/210 (52%), Gaps = 17/210 (8%)
Query: 320 KSNLLGQGGFGYVHKGV-LPNGKE----VAVKSLKTG-SGQGEREFSAEVEIISRVHHRH 373
K +LG G FG V+KG+ +P+G+ VA+K L+ S + +E E +++ V +
Sbjct: 11 KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY 70
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED 433
+ L+G C+ + LV + + L ++ EN+ + + + AKG++YL E
Sbjct: 71 VCRLLGICLTSTVQ-LVTQLMPYGCLLDYVR-ENKDRIGSQDLLNWCVQIAKGMSYLEE- 127
Query: 434 CHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST---RVMGTFGYLAPEYA 490
R++HRD+ A N+L+ + DFGLA+L + + T +V ++A E
Sbjct: 128 --VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALESI 183
Query: 491 SSGKLTEKSDVFSFGVMLLELIT-GRRPVD 519
+ T +SDV+S+GV + EL+T G +P D
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 9/204 (4%)
Query: 318 FAKSNLLGQGGFGYVHK-GVLPNGKEVAVKSL---KTGSGQGEREFSAEVEIISRVHHRH 373
F + +LG+GGFG V V GK A K L + +GE E +I+ +V+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED 433
+V+L LV ++ L++H++ P + + A GL LH +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 434 CHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSG 493
++RD+K NIL+DD ++D GLA + + + RV GT GY+APE ++
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGYMAPEVLNNQ 176
Query: 494 KLTEKSDVFSFGVMLLELITGRRP 517
+ T D + G ++ E+I G+ P
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 68/254 (26%), Positives = 112/254 (44%), Gaps = 34/254 (13%)
Query: 317 GFAKSNLLGQGGFGYVHKGVLPNG-------KEVAVKSLKTGSGQGEREFS-----AEVE 364
+A LG G FG V+K N KE+ V + G + ER+ S +EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 365 II-SRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATR------V 417
II ++ H ++V + + +V + + L H + F V
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 418 RIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTR 477
++ L L YLH++ RI+HRD+ NI++ ++ + + DFGLAK S
Sbjct: 121 QMVLA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS-- 172
Query: 478 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP---VDMTMMEDSLVEWARPL 534
V+GT Y PE + EK+DV++FG +L ++ T + P +M + +VE
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE----A 228
Query: 535 LGAALEDGIYDGLV 548
+ L +G+Y V
Sbjct: 229 VYEPLPEGMYSEDV 242
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 318 FAKSNL-----LGQGGFGYVHKGVLPNGKE------VAVKSL-KTGSGQGEREFSAEVEI 365
F +SNL LG+G FG V +E V VK+L KT + EF E+++
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 366 ISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHL-------HGENRPVMDFATRVR 418
++ H+++V L+G C ++ E+ L+ L P + +V
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 419 IALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK--LSNDNHTHVST 476
+ A G+ +L R +HRD+ A N L+ E V+ L+K +++ + +
Sbjct: 122 LCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178
Query: 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 513
+ +LAPE + KSDV+SFGV++ E+ T
Sbjct: 179 LI--PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 324 LGQGGFGYVHKGVLPN------GKEVAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVS 376
LGQG FG V++G + VAVK++ + ER EF E ++ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLH-----GEN---RPVMDFATRVRIALGSAKGLA 428
L+G G ++V E +++ L+ +L EN RP +++A A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 429 YLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTFGYLAP 487
YL+ + +HRD+ A N ++ +F + DFG+ + + ++ + + ++AP
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 488 EYASSGKLTEKSDVFSFGVMLLELIT 513
E G T SD++SFGV+L E+ +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 44/213 (20%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSA--------EVEIISRV-HHRH 373
LG G FG V+ G+ VA+K +K ++F + EV+ + ++ H +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVR-IALGSAKGLAYLHE 432
+V L + V+E++ L Y L + + + +R I +GLA++H+
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 433 DCHPRIIHRDIKAANILIDDNFEAMVADFGLAK--LSNDNHT-HVSTRVMGTFGYLAPE- 488
H HRD+K N+L+ +ADFGLA+ S +T +VSTR Y APE
Sbjct: 118 --H-GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAPEI 169
Query: 489 ------YASSGKLTEKSDVFSFGVMLLELITGR 515
Y+S D+++ G ++ EL T R
Sbjct: 170 LLRSTSYSS------PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 324 LGQGGFGYV-HKGVLPNGKEVAVKSLKTGSGQGEREFS---AEVEIISRVHHRHLVSLVG 379
+G G FG V + + VA+K + Q ++ EV + ++ H + + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 380 YCIAGGQRMLVYEFV---SNKTLEYHLHGENRPVMDFATRVRIA---LGSAKGLAYLHED 433
+ LV E+ ++ LE H +P+ + V IA G+ +GLAYLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILEVH----KKPLQE----VEIAAICHGALQGLAYLHSH 134
Query: 434 CHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEY---A 490
IHRDIKA NIL+ + +ADFG A L + ++ V GT ++APE
Sbjct: 135 ER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAM 186
Query: 491 SSGKLTEKSDVFSFGVMLLELITGRRPV-DMTMM 523
G+ K DV+S G+ +EL + P+ +M M
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 23/219 (10%)
Query: 318 FAKSNLLGQGGFGYVHKGVLP----NGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHH 371
F +LG+G FG V + L + ++VAVK LK S EF E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 372 RHLVSLVGYCIAGGQR------MLVYEFVSNKTLEYHLH----GENRPVMDFATRVRIAL 421
+++ L+G + + M++ F+ + L L GE + T VR +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 422 GSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK--LSNDNHTHVSTRVM 479
A G+ YL IHRD+ A N ++++N VADFGL+K S D + +
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 480 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
+LA E + T SDV++FGV + E++T G+ P
Sbjct: 178 -PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 28/215 (13%)
Query: 324 LGQGGFGYV--------HKGVLPNGKEVAVKSLKTGSGQGE-REFSAEVEIISRV-HHRH 373
LG+G FG V K VAVK LK + + + + +E+E++ + H++
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMD--------------FATRVRI 419
+++L+G C G ++ E+ S L +L P M+ F V
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 420 ALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRV 478
A+G+ YL + IHRD+ A N+L+ +N +ADFGLA+ ++N ++ +T
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 479 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 513
++APE T +SDV+SFGV++ E+ T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 35/130 (26%), Positives = 45/130 (34%), Gaps = 6/130 (4%)
Query: 14 EGSPPAPPSS----NSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSS 69
EG P P + +S S + P ASP P SPP
Sbjct: 144 EGEDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPED 203
Query: 70 PPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPP 129
P + SS PPA P+S + PP P P PP P + P P P
Sbjct: 204 PSSPSDSSLPPA--PSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTP 261
Query: 130 PAKKSSPPPP 139
P+ ++P P
Sbjct: 262 PSASATPAPI 271
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 34/125 (27%), Positives = 49/125 (39%), Gaps = 1/125 (0%)
Query: 6 NVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKS 65
+ E+E+ S NS ++ S S PPSS P PS P S P S
Sbjct: 152 PPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSS 211
Query: 66 PPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTP-PSPSNNKSPSPPV 124
P +P S +PPP+ ++ + P P PPPP T P+P + + P+
Sbjct: 212 LPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASATPAPI 271
Query: 125 FSPPP 129
Sbjct: 272 GGITL 276
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 51/213 (23%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNG-KEVAVKSLKTGSGQGEREFSA--EVEIISRVHHRHL 374
+ K ++G+G FG VH K V +K + + +A E +++ + H ++
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRP------VMDFATRVRIALGSAKGLA 428
+ + M+V E+ TL ++ ++ F ++ +AL
Sbjct: 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL------H 115
Query: 429 YLHEDCHPRIIHRDIKAANILIDDNFEAM-VADFGLAK-LSNDNHTHVSTRVMGTFGYLA 486
++H I+HRD+K NIL+D + + + DFG++K LS+ + + V+GT Y++
Sbjct: 116 HVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYIS 169
Query: 487 PEYASSGKLTEKSDVFSFGVMLLELITGRRPVD 519
PE +KSD+++ G +L EL + +R +
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 60/225 (26%), Positives = 108/225 (48%), Gaps = 39/225 (17%)
Query: 324 LGQGGFGYVHKGVLPNGKE-----------------VAVKSLKTGSGQGER-EFSAEVEI 365
LG+G FG VH + N ++ VAVK L+ + + R +F EV+I
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 366 ISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHL---HGENR-------------- 408
+SR+ +++ L+G C+ ++ E++ N L L H +++
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 409 PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LS 467
P + +++ + +AL A G+ YL +HRD+ N L+ +N +ADFG+++ L
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 468 NDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 512
++ + R + ++A E GK T SDV++FGV L E++
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 324 LGQGGFGYVHKG--VLP---NGKEVAVKSLKT-GSGQGEREFSAEVEIISRVHHRHLVSL 377
LG+ FG ++KG LP + + VA+K+LK + Q EF E +++ +HH ++V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHL---------------HGENRPVMDFATRVRIALG 422
+G +++E+++ L L G + +D + IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 423 SAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGT 481
A G+ YL +H+D+ A NILI + ++D GL++ + + ++ V + +
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 482 FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
++ PE GK + SD++SFGV+L E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 76/278 (27%), Positives = 125/278 (44%), Gaps = 38/278 (13%)
Query: 323 LLGQGGFGYVHKGVL--PNGKE--VAVKSLKTG-SGQGEREFSAEVEIISRVHHRHLVSL 377
+LG G FG + +G L P+ +E VA+ +L+ G S + R F AE + + H ++V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHL--HGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
G G M+V E++SN L+ L H + G A G+ YL E +
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP---GLASGMKYLSEMGY 128
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL--APEYASSG 493
+H+ + A +L++ + ++ F +L D + T + G L APE
Sbjct: 129 ---VHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 494 KLTEKSDVFSFGVMLLELIT-GRRPV-DMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551
+ SDV+SFG+++ E+++ G RP DM+ + + A+EDG L PR
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD----------VIKAVEDGFR--LPAPR 231
Query: 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRAL 589
N ++ C + +RP+ SQI L
Sbjct: 232 ---NCPNLLHQLMLDCW----QKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 9/198 (4%)
Query: 324 LGQGGFGYVHKGVLPN-GKEVAVKSL---KTGSGQGEREFSAEVEIISRVHHRHLVSLVG 379
LG+GGFG V + N GK A K L + GE+ E EI+ +V+ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
+ LV ++ L+YH++ ++ + + G+ +LH I+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117
Query: 440 HRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKS 499
+RD+K N+L+DD ++D GLA D T T+ GT GY+APE +
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 500 DVFSFGVMLLELITGRRP 517
D F+ G + E++ GR P
Sbjct: 176 DWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 54/230 (23%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE---FSA--EVEIISRVHHRHLVSL 377
LG+G FG V+K + G+ VA+K + + E++ +A E++I+ ++ H ++V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHN---EKDGFPITALREIKILKKLKHPNVVPL 72
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGEN---RPVMDF-------ATRVRIALGSAK-- 425
+ + E G P MD V++ K
Sbjct: 73 ID---------MAVERPDKSK---RKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCY 120
Query: 426 ------GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN--------- 470
G+ YLHE+ I+HRDIKAANILID+ +ADFGLA+ +
Sbjct: 121 MLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 471 -HTHVSTRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVMLLELITGRRPV 518
T T ++ T Y PE + T D++ G + E+ T RRP+
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 57/191 (29%), Positives = 92/191 (48%), Gaps = 9/191 (4%)
Query: 324 LGQGGFGYVHKGVL-PNGKEVAVKSLK-TGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
+G+G FG V G L + VAVKS + T + +F E I+ + H ++V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441
+V E V L E P + +++ +A G+ YL IHR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHR 118
Query: 442 DIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTF--GYLAPEYASSGKLTEKS 499
D+ A N L+ + ++DFG+++ D + ST M + APE + G+ + +S
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDG-VYASTGGMKQIPVKWTAPEALNYGRYSSES 177
Query: 500 DVFSFGVMLLE 510
DV+SFG++L E
Sbjct: 178 DVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSA--EVEIISRVHHRHLVSLVGY 380
+G+G +G V+K G+ VA+K +K +A E++++ ++H +++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 381 CIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVR-IALGSAKGLAYLHEDCHPRII 439
G LV+EF+ + L + R + + + ++ +GLA+ H I+
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPE--SLIKSYLYQLLQGLAFCHSH---GIL 120
Query: 440 HRDIKAANILIDDNFEAMVADFGLAKL---SNDNHTH-VSTRVMGTFGYLAPE-YASSGK 494
HRD+K N+LI+ +ADFGLA+ +TH V TR Y APE
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKG 175
Query: 495 LTEKSDVFSFGVMLLELITGR 515
+ D++S G + EL++ R
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 324 LGQGGFGYV--------HKGVLPNGKEVAVKSLKT-GSGQGEREFSAEVEIISRV-HHRH 373
LG+G FG V K VAVK LK + + + +E+E++ + H++
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMD--------------FATRVRI 419
+++L+G C G ++ E+ S L +L P MD F V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 420 ALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRV 478
A A+G+ YL + IHRD+ A N+L+ ++ +ADFGLA+ + N ++ +T
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 479 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 513
++APE T +SDV+SFGV+L E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 16/197 (8%)
Query: 324 LGQGGFGYVHKG-VLPNGKEVAVKSLKTG-SGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
LG G G V+K L + +AVK + + + +++ +E+EI+ + +++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441
+ + EF+ +L+ + V+ RIA+ KGL YL +I+HR
Sbjct: 69 FVENRISICTEFMDGGSLDVY-RKIPEHVLG-----RIAVAVVKGLTYLWS---LKILHR 119
Query: 442 DIKAANILIDDNFEAMVADFGLA-KLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSD 500
D+K +N+L++ + + DFG++ +L N ++ +GT Y+APE S + SD
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSD 175
Query: 501 VFSFGVMLLELITGRRP 517
V+S G+ +EL GR P
Sbjct: 176 VWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 23/241 (9%)
Query: 324 LGQGGFGYVHKGVLPNGK---EVAVKSLKTG-SGQGERE-FSAEVEIISRVHHRHLVSLV 378
LG+G FG V +G L +VAVK++K + E E F +E + H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 379 GYCIAGGQR------MLVYEFVSNKTLE----YHLHGENRPVMDFATRVRIALGSAKGLA 428
G C+ + +++ F+ + L Y G+ + V+ A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 429 YLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGT-FGYLAP 487
YL IHRD+ A N ++++N VADFGL+K + + R+ ++A
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 488 EYASSGKLTEKSDVFSFGVMLLELIT-GRRP---VDMTMMEDSLVEWARPLLGAALEDGI 543
E + T KSDV+SFGV + E+ T G+ P V+ + + D L + R DG+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGL 243
Query: 544 Y 544
Y
Sbjct: 244 Y 244
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 9/202 (4%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE-FSAEVEIISRVHHRHLV 375
F K +G+G FG V KG+ K VA+K + + E E E+ ++S+ ++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
G + + ++ E++ + L AT +R L KGL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSE-- 120
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL 495
+ IHRDIKAAN+L+ ++ E +ADFG+A D +T V GT ++APE
Sbjct: 121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 178
Query: 496 TEKSDVFSFGVMLLELITGRRP 517
K+D++S G+ +EL G P
Sbjct: 179 DSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 22/209 (10%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSA--EVEIISRVHHRHL 374
F K N +G+G +G V++ +G+ VA+K ++ + + S+ E+ ++ + H ++
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 375 VSLVGYCIAGGQRM----LVYEFVSNKTLEYHLHG--ENRPVMDFATRVR-IALGSAKGL 427
V L + G+ + LV E+ E L +N P ++V+ + L +GL
Sbjct: 69 VELKE--VVVGKHLDSIFLVMEYC-----EQDLASLLDNMPTPFSESQVKCLMLQLLRGL 121
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAP 487
YLHE+ IIHRD+K +N+L+ D +ADFGLA+ ++ +V+ T Y AP
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAP 177
Query: 488 EYA-SSGKLTEKSDVFSFGVMLLELITGR 515
E T D+++ G +L EL+ +
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 68/232 (29%), Positives = 111/232 (47%), Gaps = 37/232 (15%)
Query: 324 LGQGGFGYVHKGVL-------PNG-KEVAVKSLKTGSGQGE-REFSAEVEIISRV-HHRH 373
LG+G FG V PN +VAVK LK+ + + + + +E+E++ + H++
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATR--------------VRI 419
+++L+G C G ++ E+ S L +L P M++ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 420 ALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM 479
A A+G+ YL + IHRD+ A N+L+ ++ +ADFGLA+ D H H+
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR---DIH-HIDYYKK 198
Query: 480 GTFG-----YLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMED 525
T G ++APE T +SDV+SFGV+L E+ T G P +E+
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 59/273 (21%), Positives = 121/273 (44%), Gaps = 43/273 (15%)
Query: 331 YVHKGVLPNGKEVAVKSLK---TGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQR 387
++KG+ N KEV +++ K G E++ + R+ +++ + G+ I
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 388 M----LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHE-DCHPRIIHRD 442
+ L+ E+ + L L E + F T++ +A+ KGL L++ P +++
Sbjct: 94 LPRLSLILEYCTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKN 148
Query: 443 IKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTFGYLAPEYASS--GKLTEKS 499
+ + + L+ +N++ + GL K LS+ +V+ V Y + + + + T K
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKD 203
Query: 500 DVFSFGVMLLELITGRRPVD-MTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVP 558
D++S GV+L E+ TG+ P + +T E IYD +++ +P
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKE------------------IYDLIINKNNSL-KLP 244
Query: 559 HEMARLVACGAASIR-HSARKRPKMSQIVRALE 590
+ + C + H + KRP + +I+ L
Sbjct: 245 LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 9/210 (4%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSA-EVEIISRVHHRHLVSLVGYC 381
LG+G + V+KG G+ VA+K + + +G + E+ ++ + H ++V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 382 IAGGQRMLVYEFVSNKTLEY-HLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIH 440
+ MLV+E++ +Y HG +D T KG+A+ HE+ R++H
Sbjct: 68 HTENKLMLVFEYMDKDLKKYMDTHGVRGA-LDPNTVKSFTYQLLKGIAFCHEN---RVLH 123
Query: 441 RDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKS- 499
RD+K N+LI+ E +ADFGLA+ S V+ T Y AP+ + S
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTSI 182
Query: 500 DVFSFGVMLLELITGRRPVDMTMMEDSLVE 529
D++S G ++ E+ITGR T ED L++
Sbjct: 183 DIWSVGCIMAEMITGRPLFPGTNNEDQLLK 212
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
+LG+G +G V+ L +A+K + + + E+ + S + HR++V +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 382 IAGGQRMLVYEFVSNKTLEYHLH------GENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
G + E V +L L +N + F T+ + +GL YLH++
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLHDN-- 127
Query: 436 PRIIHRDIKAANILIDDNFEAM-VADFGLAK-LSNDNHTHVSTRVMGTFGYLAPEYASSG 493
+I+HRDIK N+L++ + ++DFG +K L+ N + GT Y+APE G
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEVIDKG 184
Query: 494 K--LTEKSDVFSFGVMLLELITGRRP 517
+D++S G ++E+ TG+ P
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-14
Identities = 44/167 (26%), Positives = 58/167 (34%), Gaps = 26/167 (15%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSP--------------- 60
+ P + A PP +S PPP+S P +PPP PP
Sbjct: 2805 ADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDVRR 2864
Query: 61 -PPSKSPPSSP-----PPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSP 114
PPS+SP + P PP + P S T P PP P P P P
Sbjct: 2865 RPPSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPPDQPERPPQPQAPPPPQPQPQPP 2924
Query: 115 SNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGS 161
P P PPPP + PP P + + S + + G+
Sbjct: 2925 -----PPPQPQPPPPPPPRPQPPLAPTTDPAGAGEPSGAVPQPWLGA 2966
|
Length = 3151 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 60/232 (25%), Positives = 96/232 (41%), Gaps = 49/232 (21%)
Query: 320 KSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSA--------------EVE 364
K LG+G +G V K GK VA+K +K + E++
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 365 IISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVR------ 418
I++ + H +++ LV + G LV + + + + V+D R+
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDI---------MASDLKKVVDRKIRLTESQVKC 123
Query: 419 IALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA----------KLSN 468
I L GL LH+ +HRD+ ANI I+ +ADFGLA LS
Sbjct: 124 ILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 469 DNHT----HVSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 515
D ++++V+ T Y APE + K D++S G + EL+TG+
Sbjct: 181 DETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 324 LGQGGFGYVHK----GVLPNGKE----VAVKSLK-TGSGQGEREFSAEVEIISRV-HHRH 373
LG+G FG V + G+ + + VAVK LK + + + +E+E++ + H++
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMD--------------FATRVRI 419
+++L+G C G ++ E+ + L L P D F V
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 420 ALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND-NHTHVSTRV 478
A A+G+ YL R IHRD+ A N+L+ ++ +ADFGLA+ +D ++ ++
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 479 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 513
++APE T +SDV+SFG+++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 67/211 (31%), Positives = 91/211 (43%), Gaps = 37/211 (17%)
Query: 324 LGQGGFGYVHK-GVLPNGKEVAVKSLK----TGSGQGEREFSAEVEIISRVHHRHLVSLV 378
LG GGFG V V + A+K +K +GQ E FS E EI+ +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKLY 59
Query: 379 GYCIAGGQRMLVYEFVSNKTL----EYHLHGENRPVM-------DFATRVRIALGSAKGL 427
F K + EY L GE ++ ++ R IA
Sbjct: 60 RT------------FKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIA-CVVLAF 106
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTFGYLA 486
YLH II+RD+K N+L+D N + DFG AK L + T GT Y+A
Sbjct: 107 EYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVA 160
Query: 487 PEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
PE + D +S G++L EL+TGR P
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 38/213 (17%)
Query: 324 LGQGGFGYV----HKGVLPNGKEVAVKSLKTG---------SGQGE-REFSAEVEIISRV 369
LG+G FG V +K G+ A+K+LK G S E R F E +
Sbjct: 7 LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIF----ETANSE 59
Query: 370 HHRHLVSLVGYCIAGGQRM-LVYEFVSNKTLEYHLH----GENRPVMDFATRVRIALGSA 424
H LV+L C + V E+ + L H+H E R V +A V +
Sbjct: 60 RHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF-YAACVVL----- 112
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGY 484
GL YLHE+ +I++RD+K N+L+D +ADFGL K ++ GT +
Sbjct: 113 -GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEF 167
Query: 485 LAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
LAPE + T D + GV++ E++ G P
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 31/104 (29%), Positives = 33/104 (31%)
Query: 2 AKGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPP 61
P SS + P P PSS S PP S S PP SP
Sbjct: 170 NSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPPAPSSFQSDTPPPSPE 229
Query: 62 PSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSS 105
+P P PA PP P KP PP S P P
Sbjct: 230 SPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASATPAPIGG 273
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 5e-14
Identities = 25/132 (18%), Positives = 48/132 (36%), Gaps = 15/132 (11%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPP---PASPPP--SSPPPSSPPPSKSPPS 68
+ A + P ++ P+++P + PA+ P +S P + P + P
Sbjct: 367 AAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPV 426
Query: 69 SPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPP 128
+ P A + + PA+ P + P P +Q++P + +P P V S
Sbjct: 427 AAPAAAAPAAAPAAAPAA----------VALAPAPPAQAAPETVAIPVRVAPEPAVASAA 476
Query: 129 PPAKKSSPPPPP 140
P +
Sbjct: 477 PAPAAAPAAARL 488
|
Length = 618 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 26/209 (12%)
Query: 324 LGQGGFG--YVHKGVLPNGKEVAVKSLK-TGSGQGEREFSA-EVEIISRVHHRHLVSLVG 379
+G+G FG Y+ K + + +K + T E+E S EV +++++ H ++V+
Sbjct: 8 IGEGSFGKIYLAKAKSDS-EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATR------VRIALGSAKGLAYLHED 433
G+ +V E+ L ++ + R V+ F+ V+I+LG L ++H+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQ-RGVL-FSEDQILSWFVQISLG----LKHIHDR 120
Query: 434 CHPRIIHRDIKAANILIDDNFEAMVA---DFGLAKLSNDNHTHVSTRVMGTFGYLAPEYA 490
+I+HRDIK+ NI + N MVA DFG+A+ ND+ ++ +GT YL+PE
Sbjct: 121 ---KILHRDIKSQNIFLSKN--GMVAKLGDFGIARQLNDS-MELAYTCVGTPYYLSPEIC 174
Query: 491 SSGKLTEKSDVFSFGVMLLELITGRRPVD 519
+ K+D++S G +L EL T + P +
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 45/230 (19%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVG- 379
++G+G +G V+K G+ VA+K + E E E I+ + +H ++ + G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 380 -----YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVR-------------IAL 421
Q LV E + V D +R I
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGS-----------VTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 422 GSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGL-AKLSNDNHTHVSTRVMG 480
+ +GLAYLHE+ ++IHRDIK NIL+ N E + DFG+ A+L + + +G
Sbjct: 121 ETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--FIG 175
Query: 481 TFGYLAPEY-ASSGKLTE----KSDVFSFGVMLLELITGRRPV-DMTMME 524
T ++APE A + +SDV+S G+ +EL G+ P+ DM M
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR 225
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-14
Identities = 43/160 (26%), Positives = 55/160 (34%), Gaps = 3/160 (1%)
Query: 10 TENEEGSPPAPPSSNSSDATPPPSS---TPSSSPPPSSPPPASPPPSSPPPSSPPPSKSP 66
P +N S +TP S P+S SP P P PPP +PPP+ P
Sbjct: 68 PTGPPPGPGTEAPANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPPPPTPPPASPP 127
Query: 67 PSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFS 126
PS P + P SP P SP + SS P ++ + S
Sbjct: 128 PSPAPDLSEMLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETARAPS 187
Query: 127 PPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDD 166
PP S PP S S+S SS + G
Sbjct: 188 SPPAEPPPSTPPAAASPRPPRRSSPISASASSPAPAPGRS 227
|
Length = 1352 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 7e-14
Identities = 26/127 (20%), Positives = 49/127 (38%), Gaps = 7/127 (5%)
Query: 4 GNNVTETENEEGSPPAPPSSNSSDATPPPSST--PSSSPPP---SSPPPASPPPSSPPPS 58
E PA P + + A P + P+ + P +S P A P + P P
Sbjct: 367 AAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPV 426
Query: 59 SPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPD--PPKNSPPPPPPSSQSSPTPPSPSN 116
+ P + +P ++P A ++ +PP + P + +P P S+ +P +
Sbjct: 427 AAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAAPAAA 486
Query: 117 NKSPSPP 123
+P+
Sbjct: 487 RLTPTEE 493
|
Length = 618 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 34/130 (26%), Positives = 45/130 (34%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
P P + D ++T S + P + S PPSS P S PS P +S
Sbjct: 148 PNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSP 207
Query: 77 SPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSP 136
S P S PP + P PS P P P + P + P P S+
Sbjct: 208 SDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASAT 267
Query: 137 PPPPLKYSSS 146
P P +
Sbjct: 268 PAPIGGITLD 277
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-14
Identities = 53/169 (31%), Positives = 71/169 (42%), Gaps = 11/169 (6%)
Query: 6 NVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKS 65
T T + PA P+ S P PSS PPP +PPPASPPPS P S
Sbjct: 85 RSTPTWSLSTLAPASPAREGSPTPPGPSSPD---PPPPTPPPASPPPSPAPDLSEMLRPV 141
Query: 66 PPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPP--PPPSSQSSPTPPSPSNNKSPSPP 123
PPPA S ASP ++ + + P P ++++ +PP+ +P
Sbjct: 142 GSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEPPPSTPPAA 201
Query: 124 VFSPPPP------AKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDD 166
PP A SSP P P + ++ +SSS S SS S G
Sbjct: 202 ASPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSSSSESSGCGWG 250
|
Length = 1352 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 63/213 (29%), Positives = 89/213 (41%), Gaps = 33/213 (15%)
Query: 323 LLGQGGFGYVHKGVLPNGKEV-AVKSLKTG---------SGQGEREFSAEVEIISRVHHR 372
+LG+G FG V L E+ AVK LK E+ A H
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----KHP 56
Query: 373 HLVSLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENR---PVMDFATRVRIALGSAKGLA 428
L L C R+ V E+V+ L +H+ R P F I LG L
Sbjct: 57 FLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYA-AEIVLG----LQ 110
Query: 429 YLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK--LSNDNHTHVSTRVMGTFGYLA 486
+LHE II+RD+K N+L+D +ADFG+ K + T + GT Y+A
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIA 164
Query: 487 PEYASSGKLTEKSDVFSFGVMLLELITGRRPVD 519
PE S D ++ GV+L E++ G+ P +
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-13
Identities = 44/173 (25%), Positives = 62/173 (35%), Gaps = 25/173 (14%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPP--------PSSPPPASPPPSSPPPSSPPPSKSPPS 68
PPA P + + PPP P S P P +PP ++ P + P +PPS
Sbjct: 2556 PPAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQSARPRAPVDDRGDPRGPAPPS 2615
Query: 69 SPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPP---------SPSNNKS 119
PP T + PP P+ N+PDP PPP + P P
Sbjct: 2616 PLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVSRPRRARRLGRAAQ 2675
Query: 120 PSPPVFSPPPPAKK--------SSPPPPPLKYSSSTPKSSSSSSKSSNGSSSG 164
S P P A + + PPPP P + S++ G ++
Sbjct: 2676 ASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPPGPAAA 2728
|
Length = 3151 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 30/206 (14%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLKTGSGQGEREFSA--EVEIISRVHHRHLVS 376
L+G+G +G V HK G+ VA+K + A E+ ++ ++ H +LV+
Sbjct: 8 LVGEGSYGMVMKCKHK---ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVN 64
Query: 377 LVGYCIAGGQRMLVYEFVSNKTL---EYHLHGENRPVMDFATRVRIALGSAKGLAYLHED 433
L+ + LV+EFV + L E + +G +D + + +G+ + H
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCHSH 119
Query: 434 CHPRIIHRDIKAANILIDDNFEAMVADFGLAKL---SNDNHT-HVSTRVMGTFGYLAPEY 489
IIHRDIK NIL+ + + DFG A+ + +T +V+TR Y APE
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPEL 171
Query: 490 -ASSGKLTEKSDVFSFGVMLLELITG 514
K D+++ G ++ E++TG
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 324 LGQGGFGYVHKGVLPNGKEVA---VKSLK-TGSGQGEREFSAEVEIISRVHHRHLVSLVG 379
+G G FG V G G A VK L+ + + + F EV+ ++H +++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPV-MDFATRV--RIALGSAKGLAYLHEDCHP 436
CI +LV EF L+ +L V V R+A A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFG--YLAPEYASS-- 492
IH D+ N + + + D+GLA L + T+ +LAPE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 493 -----GKLTEKSDVFSFGVMLLELIT-GRRP 517
T+KS+++S GV + EL T +P
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 43/197 (21%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE-FSA----EVEIISRVHH 371
+ K +GQG FG V K + VA+K + + E+E F E++I+ + H
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN---EKEGFPITALREIKILQLLKH 70
Query: 372 RHLVSLVGYCIA--------GGQRMLVYEF--------VSNKTLEYHLHGENRPVMDFAT 415
++V+L+ C G LV+EF +SNK +++ L E + VM
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL-SEIKKVM---- 125
Query: 416 RVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL----SNDNH 471
++ L GL Y+H + +I+HRD+KAANILI + +ADFGLA+ N
Sbjct: 126 --KMLL---NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177
Query: 472 THVSTRVMGTFGYLAPE 488
+ RV+ T Y PE
Sbjct: 178 NRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 323 LLGQGGFGYVHKGVLPN-GKEVAVKSLKTGSGQGE-REFSAEVEIISRVHH-RHLVSLVG 379
+G+G FG V+K + G +AVK +++ + E + +++++ R ++V G
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 380 YCIAGGQRMLVYEF--VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
G + E +S +++ + V+ +IA+ + K L YL E+
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK-- 128
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLA-KLSNDNHTHVSTRVMGTFGYLAPE-YASSG-- 493
IIHRD+K +NIL+D N + DFG++ +L + + TR G Y+APE S
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSARD 185
Query: 494 KLTEKSDVFSFGVMLLELITGRRP 517
+SDV+S G+ L E+ TG+ P
Sbjct: 186 GYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 37/126 (29%), Positives = 48/126 (38%), Gaps = 7/126 (5%)
Query: 35 TPSSSPPPSSPPP--ASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPD 92
P+ PP +S + +SP SSSP S P+ +
Sbjct: 147 DPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSS 206
Query: 93 PPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSS 152
P +S PP P S QS PPSP SP SPPP PPP ST K +
Sbjct: 207 PSDSSLPPAPSSFQSDTPPPSP-----ESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTP 261
Query: 153 SSSKSS 158
S+ ++
Sbjct: 262 PSASAT 267
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 37/90 (41%), Positives = 53/90 (58%), Gaps = 1/90 (1%)
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKL-SNDNHTHVSTRVMGTFGYLAPEYASSGKL 495
+IHRDIK+ANIL+ N + DFG +K+ + V GT Y+APE
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY 222
Query: 496 TEKSDVFSFGVMLLELITGRRPVDMTMMED 525
++K+D+FS GV+L EL+T +RP D ME+
Sbjct: 223 SKKADMFSLGVLLYELLTLKRPFDGENMEE 252
|
Length = 496 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 54/194 (27%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI 382
LG G FG V+K G A K ++T S + ++ E+EI++ +H ++V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 383 AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRD 442
G+ ++ EF ++ + +R + + +V I + L YLH +IIHRD
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEALQYLHSM---KIIHRD 135
Query: 443 IKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTE----- 497
+KA N+L+ + + +ADFG++ N +GT ++APE + +
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDY 194
Query: 498 KSDVFSFGVMLLEL 511
K+D++S G+ L+E+
Sbjct: 195 KADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 67/202 (33%), Positives = 101/202 (50%), Gaps = 14/202 (6%)
Query: 323 LLGQGGFG---YVHKGVLPN-GKEVAVKSLKTGSGQGEREFSAEVE--IISRVHHRHLVS 376
+LGQG FG V K P+ G+ A+K LK + + ++E I++ V+H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGS-AKGLAYLHEDCH 435
L G+ L+ +F+ L L E VM V+ L A L +LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHS--- 116
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL 495
II+RD+K NIL+D+ + DFGL+K S D H + GT Y+APE +
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-HEKKAYSFCGTVEYMAPEVVNRRGH 175
Query: 496 TEKSDVFSFGVMLLELITGRRP 517
T+ +D +SFGV++ E++TG P
Sbjct: 176 TQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 60/230 (26%), Positives = 108/230 (46%), Gaps = 50/230 (21%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE---FSA--EVEIISRVHH 371
F +G+G +G V+K G+ VA+K ++ E+E +A E++I+ +++H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL---DNEKEGFPITAIREIKILRQLNH 65
Query: 372 RHLVSL----------VGYCIAGGQRMLVYEFVSNKTL-----------EYHLHGENRPV 410
R++V+L + + G LV+E++ + + E H+ + +
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125
Query: 411 MDFATRVRIALGSAKGLAYLHEDCHPR-IIHRDIKAANILIDDNFEAMVADFGLAKLSND 469
++ GL Y CH + +HRDIK +NIL+++ + +ADFGLA+L N
Sbjct: 126 LE-------------GLNY----CHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 470 NHTHVSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGRRPV 518
+ T + T Y PE + DV+S G +L EL T ++P+
Sbjct: 169 EESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-13
Identities = 45/173 (26%), Positives = 67/173 (38%), Gaps = 10/173 (5%)
Query: 2 AKGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPP 61
+++E+ SP P ++ P + P++SP PPP S P++PPP P
Sbjct: 2786 PAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPGP 2845
Query: 62 PSKSPPS----SPPPATSSSPPPASPPTSDNNKPDPP--KNSPPPPPPSSQSSPTPPS-- 113
P S P +P PP SP PP + + P S++S PP
Sbjct: 2846 PPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPPDQP 2905
Query: 114 --PSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSG 164
P ++P PP P PP PPPP P + ++ + S
Sbjct: 2906 ERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAPTTDPAGAGEPSGA 2958
|
Length = 3151 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 325 GQGGFGYVHKGVLPN---GKEVAVKSLKTGSGQGEREFSA----EVEIISRVHHRHLVSL 377
G+G +G V+K N GKE A+K K Q S E+ ++ + H ++VSL
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT-GISQSACREIALLRELKHENVVSL 67
Query: 378 VGYCIAGGQRM--LVYEFVSNKTLE---YHLHGENRPVMDFATRVRIALGSAKGLAYLHE 432
V + + L++++ + + +H + + + + G+ YLH
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK-SLLWQILNGVHYLHS 126
Query: 433 DCHPRIIHRDIKAANILI--DDNFEAMV--ADFGLAKLSNDNHTHVST--RVMGTFGYLA 486
+ ++HRD+K ANIL+ + +V D GLA+L N ++ V+ T Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRA 183
Query: 487 PEYASSGK-LTEKSDVFSFGVMLLELIT 513
PE + T+ D+++ G + EL+T
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 72/280 (25%), Positives = 126/280 (45%), Gaps = 35/280 (12%)
Query: 263 PGPPPPPPMMSSSGEMSSQFSGPARP---------------PLPPPSPNIALGFNKSTFT 307
P PPP + S+ +++ RP PLP P P+ + + S+
Sbjct: 3 PIQPPPGVPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSA 62
Query: 308 YDELAAATGGFA---KSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQG-EREFSAE 362
+A + + N +G G G V+K + P G+ A+K + R+ E
Sbjct: 63 SGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICRE 122
Query: 363 VEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALG 422
+EI+ V+H ++V G+ ++ EF+ +LE + + + D A ++
Sbjct: 123 IEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQI----- 177
Query: 423 SAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTF 482
G+AYLH I+HRDIK +N+LI+ +ADFG++++ ++ V GT
Sbjct: 178 -LSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTI 232
Query: 483 GYLAPEYASS----GKLTEKS-DVFSFGVMLLELITGRRP 517
Y++PE ++ G + D++S GV +LE GR P
Sbjct: 233 AYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-13
Identities = 55/292 (18%), Positives = 80/292 (27%), Gaps = 10/292 (3%)
Query: 9 ETENEEGSPPAPPSSNSSDATPPP--SSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSP 66
NE S P S + A+P S TP P PPP PP S PP +P S+
Sbjct: 79 APANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPPPPTPPPASPPPSPAPDLSEML 138
Query: 67 PSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFS 126
P + P + S +S P S T +PS+ + PP S
Sbjct: 139 RPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEPPP--S 196
Query: 127 PPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVTYSVIGAV-GVGIFLIAM 185
PP A PP S+S + + +S+ + + S + G G
Sbjct: 197 TPPAAASPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSSSSESSGCGWGPENECP 256
Query: 186 IIICAVRANKKKKKRHNQPMHYYGDHSNHFKKGGDPYYSGGHAPNWHGHPEHQNWHSH-- 243
+ A + + S +P+ G +
Sbjct: 257 LPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASS 316
Query: 244 PQGPDHTGGNIPPPPGGNWPGPPPPPPMMSSSGEMSSQFSGPARPPLPPPSP 295
+ P S PP P SP
Sbjct: 317 SSSSSRESSSSSTSSSSESSRGAAVSP---GPSPSRSPSPSRPPPPADPSSP 365
|
Length = 1352 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-13
Identities = 64/298 (21%), Positives = 85/298 (28%), Gaps = 9/298 (3%)
Query: 9 ETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSS---PPPSKS 65
E P S A + +SSPP A+ P S PPP +
Sbjct: 2648 PPERPRDDPAPGRVSRPRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPT 2707
Query: 66 PPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVF 125
P +P S++P P P + P P PP P+ ++P P+ +
Sbjct: 2708 PEPAPHALVSATPLPPGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPP 2767
Query: 126 SPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVTYSVIGAVGVGIFLIAM 185
+P PPA ++ PP L + S S S S D A A
Sbjct: 2768 APAPPAAPAAGPPRRLTRPAVASLSESRESLPS-PWDPADPPAAVLAPAAALPPAASPAG 2826
Query: 186 IIICAVRANKKKKKRHNQPMHYYGDHSNHFKKGGD-----PYYSGGHAPNWHGHPEHQNW 240
+ A P GGD P S P P +
Sbjct: 2827 PLPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRL 2886
Query: 241 HSHPQGPDHTGGNIPPPPGGNWPGPPPPPPMMSSSGEMSSQFSGPARPPLPPPSPNIA 298
+PP P P PPP P PP P P P +A
Sbjct: 2887 ARPAVSRSTESFALPPDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLA 2944
|
Length = 3151 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 320 KSNLLGQGGFGYVHKGV-LPNGKEVAVKSLK--TGSGQGEREFSA---EVEIISRVHHRH 373
+ LLGQG FG V+ + G+E+A K ++ S + +E SA E++++ + H
Sbjct: 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHER 65
Query: 374 LVSLVGYCIAGGQRMLV--YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLH 431
+V G ++ L E++ +++ L + + TR + +G++YLH
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTR-KYTRQILEGMSYLH 123
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTR-VMGTFGYLAPEY 489
+ I+HRDIK ANIL D + DFG +K L + R V GT +++PE
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 490 ASSGKLTEKSDVFSFGVMLLELITGRRP 517
S K+DV+S G ++E++T + P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 324 LGQGGFGYVHKGVLPNGKE-VAVKSLKTGSGQGEREFS---AEVEIISRVHHRHLVSLVG 379
+G G FG V+ + E VAVK + Q ++ EV+ + ++ H + + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 380 YCIAGGQRMLVYEFV---SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
+ LV E+ ++ LE H +P+ + I G+ +GLAYLH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAA-ITHGALQGLAYLHSHN-- 141
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEY---ASSG 493
+IHRDIKA NIL+ + + +ADFG A S+ ++ V GT ++APE G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195
Query: 494 KLTEKSDVFSFGVMLLELITGRRPV-DMTMM 523
+ K DV+S G+ +EL + P+ +M M
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAM 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 5/101 (4%)
Query: 418 RIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTR 477
+I++ +GL YL E H +I+HRD+K +NIL++ E + DFG+ S ++
Sbjct: 103 KISIAVLRGLTYLREK-H-KIMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANS 157
Query: 478 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPV 518
+GT Y++PE T +SD++S G+ L+E+ GR P+
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 32/119 (26%), Positives = 45/119 (37%), Gaps = 4/119 (3%)
Query: 6 NVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPP--PS 63
+V T ++ P S+ + PPSS+P PS P S P S P +P S
Sbjct: 162 DVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPPAPSSFQS 221
Query: 64 KSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSP 122
+PP SP T+ SPPP P P+ S+ P+P +
Sbjct: 222 DTPPPSPESPTNPSPPPGPAAPP--PPPVQQVPPLSTAKPTPPSASATPAPIGGITLDD 278
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 17/197 (8%)
Query: 324 LGQGGFGYVHKGVLPNGKEV----AVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVG 379
LG G FG V+K KE A K + T S + ++ E++I++ H ++V L+
Sbjct: 13 LGDGAFGKVYKA---QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
++ EF + ++ + RP+ + RV + + + L YLHE+ +II
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLHEN---KII 125
Query: 440 HRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTE-- 497
HRD+KA NIL + + +ADFG++ N +GT ++APE +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 498 ---KSDVFSFGVMLLEL 511
K+DV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 32/92 (34%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL 485
G+ LH+ IIHRDIK N+LID + DFGL++ + + +GT YL
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG-----LENKKFVGTPDYL 160
Query: 486 APEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
APE + SD +S G ++ E + G P
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 13/209 (6%)
Query: 323 LLGQGGFGYVHKG-VLPNGKEVAVKSL-KTGSGQGEREFSAEVEIISRVHH-RHLVSLVG 379
+G G G V+K G +AVK + +TG+ + + +++++ + H ++V G
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
Y I + E +S L+ L P+ + ++ + K L YL E H +I
Sbjct: 82 YFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILG-KMTVAIVKALHYLKEK-H-GVI 137
Query: 440 HRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEK- 498
HRD+K +NIL+D + + DFG++ D+ TR G Y+APE K
Sbjct: 138 HRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKY 195
Query: 499 ---SDVFSFGVMLLELITGRRPVDMTMME 524
+DV+S G+ L+EL TG+ P E
Sbjct: 196 DIRADVWSLGISLVELATGQFPYKNCKTE 224
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 9e-13
Identities = 35/99 (35%), Positives = 55/99 (55%), Gaps = 16/99 (16%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT-------HVSTR 477
+GL YLH + +IHRD+K +NIL++ N + + DFGLA+ + + +V TR
Sbjct: 114 RGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 478 VMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 515
Y APE SS + T+ D++S G + EL+T +
Sbjct: 171 W-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-12
Identities = 41/154 (26%), Positives = 56/154 (36%), Gaps = 16/154 (10%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA 73
P APP S A P PPS PP + P PPP SP P+ + P PP
Sbjct: 2586 ARRPDAPPQSARPRAPVDDRGDPRGPAPPSPLPPDTHAP-DPPPPSPSPAANEPDPHPPP 2644
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPP------PPPPSSQSSPTPPSPSNNKSPSPPVFS- 126
PP + P P + S P + S P P + + S
Sbjct: 2645 ------TVPPPERPRDDPAPGRVSRPRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSL 2698
Query: 127 --PPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSS 158
PPPP P P L ++ P +++ ++S
Sbjct: 2699 ADPPPPPPTPEPAPHALVSATPLPPGPAAARQAS 2732
|
Length = 3151 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 35/99 (35%), Positives = 56/99 (56%), Gaps = 22/99 (22%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFG 483
+GL Y+H IIHRD+K +NI ++++ E + DFGLA+ ++D T +V+TR
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 484 YLAPE-------YASSGKLTEKSDVFSFGVMLLELITGR 515
Y APE Y + D++S G ++ EL+TG+
Sbjct: 181 YRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 52/189 (27%), Positives = 88/189 (46%), Gaps = 29/189 (15%)
Query: 340 GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTL 399
G++VAVK + Q EV I+ H ++V + + G + +V EF+ L
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103
Query: 400 EYHLHGENRPVMDFATRVR--------IALGSAKGLAYLHEDCHPRIIHRDIKAANILID 451
D T R + L K L++LH +IHRDIK+ +IL+
Sbjct: 104 -----------TDIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLT 149
Query: 452 DNFEAMVADFGL-AKLSNDNHTHVSTR--VMGTFGYLAPEYASSGKLTEKSDVFSFGVML 508
+ ++DFG A++S + V R ++GT ++APE S + D++S G+M+
Sbjct: 150 SDGRVKLSDFGFCAQVSKE----VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 205
Query: 509 LELITGRRP 517
+E++ G P
Sbjct: 206 IEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 12/212 (5%)
Query: 323 LLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSA---EVEIISRVHHRHLVSLV 378
+LG+G FG V L +G+ AVK LK + + E I+S + ++ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 379 GYCIAGGQRML-VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
C R+ V EFV+ L +H+ R A + SA L +LH+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA--LMFLHDK---G 116
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTE 497
II+RD+K N+L+D +ADFG+ K N ST GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEMLYGP 175
Query: 498 KSDVFSFGVMLLELITGRRPVDMTMMEDSLVE 529
D ++ GV+L E++ G P + ED L E
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAE-NEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 67/277 (24%), Positives = 127/277 (45%), Gaps = 44/277 (15%)
Query: 324 LGQGGFGYV----HKGVLPNGKEVAVK--SLKTGSGQGEREFSAEVEIISRVHHRHLVSL 377
+G+G +G V H+ +GK+ +K +L+ S + + E +++S++ H ++V+
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 378 VGYCIAG-GQRMLVYEFVSNKTLEYHLHGEN------RPVMDFATRVRIALGSAKGLAYL 430
G +V F L + L + V+++ ++ +AL YL
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------QYL 118
Query: 431 HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYA 490
HE I+HRD+K N+ + V D G+A++ +N +++ ++GT Y++PE
Sbjct: 119 HEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPYYMSPELF 174
Query: 491 SSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550
S+ KSDV++ G + E+ T + + M +SLV I +G + P
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-NSLVY------------RIIEGKL-P 220
Query: 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587
+ +Y P E+ L+ A + KRP + I+R
Sbjct: 221 PMPKDYSP-ELGELI---ATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 316 GGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRH 373
G F L+G G +G V+KG + G+ A+K + +G E E E+ ++ + HHR+
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRN 64
Query: 374 LVSLVGYCIAGG------QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGL 427
+ + G I Q LV EF ++ + + I +GL
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAP 487
++LH+ ++IHRDIK N+L+ +N E + DFG++ D +GT ++AP
Sbjct: 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAP 180
Query: 488 EYASSGKLTE-----KSDVFSFGVMLLELITGRRPV-DMTMM 523
E + + + KSD++S G+ +E+ G P+ DM M
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 54/188 (28%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 339 NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKT 398
GK+VAVK + Q EV I+ HH ++V + + G + +V EF+
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL---- 101
Query: 399 LEYHLHGENRPVMDFATRVR--------IALGSAKGLAYLHEDCHPRIIHRDIKAANILI 450
E + D T R + L + L+YLH +IHRDIK+ +IL+
Sbjct: 102 -------EGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILL 151
Query: 451 DDNFEAMVADFGL-AKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLL 509
+ ++DFG A++S + S ++GT ++APE S + D++S G+M++
Sbjct: 152 TSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVI 209
Query: 510 ELITGRRP 517
E+I G P
Sbjct: 210 EMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 3e-12
Identities = 27/134 (20%), Positives = 47/134 (35%), Gaps = 2/134 (1%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
P PP S + A+ ++ P+++ P P PPP + P P P ++ +
Sbjct: 367 EPEVPPQSAAPAASAQATAAPTAAVAPPQAPAV-PPPPASAPQQAPAVPLPETTSQLLAA 425
Query: 76 SSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSS 135
+ + K +P S P S+ P+ + P K++
Sbjct: 426 RQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPA-KKEAYRWKAT 484
Query: 136 PPPPPLKYSSSTPK 149
P K +TPK
Sbjct: 485 NPVEVKKEPVATPK 498
|
Length = 647 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 3e-12
Identities = 23/122 (18%), Positives = 46/122 (37%), Gaps = 2/122 (1%)
Query: 19 APPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSP 78
+ + S +++P + P PA+ P++ +P + P +P PA +
Sbjct: 385 LGVAGGAGAPAAAAPSAAAAAPAAA-PAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPS 443
Query: 79 PPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPP 138
P + P PP +P P + ++ P+ + +P PA ++P
Sbjct: 444 PAGNAPAGGAP-SPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAA 502
Query: 139 PP 140
P
Sbjct: 503 PA 504
|
Length = 824 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 3e-12
Identities = 30/150 (20%), Positives = 57/150 (38%), Gaps = 2/150 (1%)
Query: 21 PSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPP 80
P+ ++ PP+ S P ++ P A P++P +P + + P+ A +
Sbjct: 590 PAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAA 649
Query: 81 ASPPTSDNNKPDPPKNSPPPPPPSSQSSPT--PPSPSNNKSPSPPVFSPPPPAKKSSPPP 138
PD P + ++P PP+P+ +P +P PA + P
Sbjct: 650 PEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAATP 709
Query: 139 PPLKYSSSTPKSSSSSSKSSNGSSSGDDYV 168
P + + ++ +S S + DD V
Sbjct: 710 PAGQADDPAAQPPQAAQGASAPSPAADDPV 739
|
Length = 824 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSA--EVEIISRVHHRHL 374
+ K +G+G +G V+KG G+ VA+K ++ S + +A E+ ++ + H ++
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED- 433
V L + + L++EF+S +Y MD A V+ +YL++
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMD-AELVK---------SYLYQIL 111
Query: 434 -----CHP-RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAP 487
CH R++HRD+K N+LID+ +ADFGLA+ + V T + T Y AP
Sbjct: 112 QGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVVTLWYRAP 170
Query: 488 E-YASSGKLTEKSDVFSFGVMLLELITGRRPV 518
E S + + D++S G + E+ T ++P+
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-12
Identities = 36/140 (25%), Positives = 50/140 (35%), Gaps = 3/140 (2%)
Query: 19 APPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSP 78
P + P S PSS P + SSP SP PS S P S P + S
Sbjct: 255 CPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRERSPSPSPSSPGSGP---APSS 311
Query: 79 PPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPP 138
P AS +S + + S + PSPS + SPS P P + + P P
Sbjct: 312 PRASSSSSSSRESSSSSTSSSSESSRGAAVSPGPSPSRSPSPSRPPPPADPSSPRKRPRP 371
Query: 139 PPLKYSSSTPKSSSSSSKSS 158
S + + ++
Sbjct: 372 SRAPSSPAASAGRPTRRRAR 391
|
Length = 1352 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 4e-12
Identities = 27/100 (27%), Positives = 39/100 (39%), Gaps = 11/100 (11%)
Query: 41 PPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPP 100
P +P PA P ++P P P P+ PS+ P A +++ P P + P P
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPA---PSTRPKAAAAANIPPKEP-----VRETATPPPVP 413
Query: 101 PPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPP 140
P P + P P + P K +PP PP
Sbjct: 414 PRPVAPPVPHTPESA---PKLTRAAIPVDEKPKYTPPAPP 450
|
Length = 585 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNGKE-VAVKSLKTGSGQGEREFSA--EVEIISRVHHRHL 374
+ K +G+G +G V K E VA+K ++ SA E+ ++ + H+++
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKTLEY--HLHGENRPVMDFATRVRIALGSAKGLAYLHE 432
V L + + LV+E+ +Y +G+ +D KGLA+ H
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGD----IDPEIVKSFMFQLLKGLAFCHS 117
Query: 433 DCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS 492
++HRD+K N+LI+ N E +ADFGLA+ S V+ T Y P+
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFG 173
Query: 493 GKLTEKS-DVFSFGVMLLELITGRRPV 518
KL S D++S G + EL RP+
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 5e-12
Identities = 29/128 (22%), Positives = 55/128 (42%), Gaps = 4/128 (3%)
Query: 13 EEGSPPAPPSSNS-SDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPP 71
E A + + A ++ P+++P P++ PA+ +P +P P+ +P +P
Sbjct: 382 ERRLGVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAA-APQPAPAPAPAPA 440
Query: 72 PATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPA 131
P + + PA S P P P P ++ P+P+ +P+P +P PA
Sbjct: 441 PPSPAGNAPAGGAPSPPPAAAPSA-QPAPAPAAAPEPTAAPAPAPPAAPAPAA-APAAPA 498
Query: 132 KKSSPPPP 139
++P
Sbjct: 499 APAAPAGA 506
|
Length = 824 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 76/297 (25%), Positives = 127/297 (42%), Gaps = 33/297 (11%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFS---AEVEIISRVHHRH 373
F+ +G G FG V+ + N + VA+K + Q ++ EV + ++ H +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 374 LVSLVGYCIAGGQRMLVYEFV---SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYL 430
+ G + LV E+ ++ LE H +P+ + + G+ +GLAYL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAA-VTHGALQGLAYL 131
Query: 431 HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEY- 489
H +IHRD+KA NIL+ + + DFG A + + V GT ++APE
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 490 --ASSGKLTEKSDVFSFGVMLLELITGRRPV-DMTMMED--SLVEWARPLLGAALEDGIY 544
G+ K DV+S G+ +EL + P+ +M M + + P L + +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243
Query: 545 DGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPK---MSQIVRALEGDSSLDDL 598
VD L+ +P + R + R R+RP M I R + LD+L
Sbjct: 244 RNFVDSCLQK--IPQD--RPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNL 296
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNGKEV-AVKSLKTGSGQGEREFS---AEVEIISRVHHRH 373
F +G G FG V+ EV A+K + Q ++ EV+ + R+ H +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 374 LVSLVGYCIAGGQRMLVYEFV---SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYL 430
+ G + LV E+ ++ LE H +P+ + I G+ +GLAYL
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAA-ITHGALQGLAYL 141
Query: 431 HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEY- 489
H +IHRDIKA NIL+ + + +ADFG A +++ ++ V GT ++APE
Sbjct: 142 HSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI 193
Query: 490 --ASSGKLTEKSDVFSFGVMLLELITGRRPV 518
G+ K DV+S G+ +EL + P+
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 32/215 (14%)
Query: 321 SNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEI-----ISRVHHRHL 374
+G+G +G V+K L G+ VA+K ++ + S EI + H ++
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 375 VSLVGYCIAGGQR------MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLA 428
V L+ C G + LV+E V ++ L +L +P + T + +G+
Sbjct: 64 VRLLDVC-HGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 429 YLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE 488
+LH H RI+HRD+K NIL+ + + +ADFGLA++ + T V+ T Y APE
Sbjct: 122 FLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRAPE 176
Query: 489 ------YASSGKLTEKSDVFSFGVMLLELITGRRP 517
YA+ D++S G + EL RRP
Sbjct: 177 VLLQSSYATP------VDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 323 LLGQGGFGYVHKGVLPN-GKEVAVKSL---KTGSGQGEREFSAEVEIISRVHHRH--LVS 376
++G+GGFG V+ + GK A+K L + QGE E ++S V +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 377 LVGYCIAGGQRM-LVYEFVSNKTLEYHL--HG--ENRPVMDFATRVRIALGSAKGLAYLH 431
+ Y ++ + + ++ L YHL HG + + +AT + + L
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGL---------- 110
Query: 432 EDCHPR-IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYA 490
E H R +++RD+K ANIL+D++ ++D GLA + H S +GT GY+APE
Sbjct: 111 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVL 167
Query: 491 SSGKLTEKS-DVFSFGVMLLELITGRRP 517
G + S D FS G ML +L+ G P
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 68/285 (23%), Positives = 122/285 (42%), Gaps = 49/285 (17%)
Query: 318 FAKSNLLGQGGFGYVHKGVL----PNGKEVAVKSLKTGSGQG-EREFS-AEVEIISRVHH 371
+ K +G+G FG K +L +GK+ +K + ERE S EV ++S + H
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 372 RHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGE------NRPVMDFATRVRIALGSAK 425
++V G +V ++ L ++ + ++D+ V+I L
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF--VQICLA--- 113
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL 485
L ++H+ +I+HRDIK+ NI + + + DFG+A++ N + ++ +GT YL
Sbjct: 114 -LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCIGTPYYL 168
Query: 486 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545
+PE + KSD+++ G +L E+ T L A E G
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCT---------------------LKHAFEAGNMK 207
Query: 546 GLVDPRLEHNYVP---HEMARLVACGAASIRHSARKRPKMSQIVR 587
LV + +Y P H L + + + R RP ++ I+
Sbjct: 208 NLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL---SNDNHTHVSTRVMGT 481
+GL Y+H +IHRD+K +N+L++++ E + DFG+A+ S H + T + T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 482 FGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGRRPV 518
Y APE S + T D++S G + E++ GRR +
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 52/216 (24%), Positives = 95/216 (43%), Gaps = 12/216 (5%)
Query: 315 TGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKT---GSGQGEREFSAEVEIISRVH 370
G F +G+G F V+K + L +G+ VA+K ++ + ++ E++++ ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 371 HRHLVSLVGYCIAGGQRMLVYEFVSNKTLEY---HLHGENRPVMDFATRVRIALGSAKGL 427
H +++ + I + +V E L H + R + T + + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLI-PERTIWKYFVQLCSAL 119
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAP 487
++H RI+HRDIK AN+ I + D GL + + T + V GT Y++P
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 488 EYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMM 523
E KSD++S G +L E+ + P M
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 324 LGQGGFGYVHKGVL--PNGKEVAVKSLKTGSGQGE-REFSAEVEIISRVHHRHLVSLVGY 380
LG+G +G V+K VL P G +A+K ++ + + + E++I+ + ++V G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 381 CIAGGQRMLVYEFVSNKTLE-YHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
G + E++ +L+ + G + RI KGL +L E+ + II
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 440 HRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTE-- 497
HRD+K N+L++ N + + DFG +S + ++ +G Y+APE SG +
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFG---VSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNP 182
Query: 498 ----KSDVFSFGVMLLELITGRRP 517
+SDV+S G+ +LE+ GR P
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 8e-12
Identities = 45/165 (27%), Positives = 62/165 (37%), Gaps = 21/165 (12%)
Query: 15 GSPPAPPSSNSS--DATPPPSSTPSSSPPPSSP----PPASPPPSSPPPSSPPPSKSPP- 67
G P P + D P PS SP + P PP PPP P P S P
Sbjct: 2606 GDPRGPAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVSRPR 2665
Query: 68 -----------SSPP--PATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSP 114
SSPP P ++ P TS + P PP P P ++P PP P
Sbjct: 2666 RARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPPGP 2725
Query: 115 SNNKSPSPPV-FSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSS 158
+ + SP + +P PPA + P P + P +++ +
Sbjct: 2726 AAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPA 2770
|
Length = 3151 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 8e-12
Identities = 27/115 (23%), Positives = 51/115 (44%), Gaps = 6/115 (5%)
Query: 32 PSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPP-SSPPPATSSSPPPASPPTSDNNK 90
P++ ++ P PA P ++P + + + P + PA ++S P A P +
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAP 425
Query: 91 PD-PPKNSPPPPPPSSQSS----PTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPP 140
P +P P ++ ++ P PP+ + ++ + PV P PA S+ P P
Sbjct: 426 VAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPA 480
|
Length = 618 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 9e-12
Identities = 49/195 (25%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI 382
+GQG G V+ + + G+EVA+K + + E+ ++ + ++V+ + +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 383 AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRD 442
G + +V E+++ +L + MD + + L +LH + ++IHRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSN---QVIHRD 140
Query: 443 IKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 502
IK+ NIL+ + + DFG + ST V GT ++APE + K D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 503 SFGVMLLELITGRRP 517
S G+M +E++ G P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 9e-12
Identities = 49/201 (24%), Positives = 96/201 (47%), Gaps = 8/201 (3%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVS 376
+ + +GQG G V + + G+EVA+K + + E+ ++ + + ++V+
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
+ + G + +V E+++ +L + MD A + + L +LH +
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHAN--- 134
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLT 496
++IHRDIK+ N+L+ + + DFG + ST V GT ++APE +
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 497 EKSDVFSFGVMLLELITGRRP 517
K D++S G+M +E++ G P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-11
Identities = 40/150 (26%), Positives = 53/150 (35%), Gaps = 14/150 (9%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSP--PPSKSPPSSPPP 72
+P + ++ A PP + S+ A PP P P PP P PPP
Sbjct: 2866 PPSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPPDQPERPPQPQAPPPPQPQPQPPP 2925
Query: 73 ATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNN-------KSPSPPVF 125
PPP PP +P PP P + + S P P P V
Sbjct: 2926 PPQPQPPPPPPP-----RPQPPLAPTTDPAGAGEPSGAVPQPWLGALVPGRVAVPRFRVP 2980
Query: 126 SPPPPAKKSSPPPPPLKYSSSTPKSSSSSS 155
P P + + PPL S + SS +SS
Sbjct: 2981 QPAPSREAPASSTPPLTGHSLSRVSSWASS 3010
|
Length = 3151 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 323 LLGQGGFGYVHKGVL----PNGKEVAVKSLKTG----SGQGEREFSAEVEIISRVHHRHL 374
+LG+GG+G V + GK A+K LK + + AE I+ V H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFA----TRVRIALGSAKGLAYL 430
V L+ GG+ L+ E++S L HL E + D A + + +AL +L
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE------HL 116
Query: 431 HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK--LSNDNHTHVSTRVMGTFGYLAPE 488
H II+RD+K NIL+D + DFGL K + TH GT Y+APE
Sbjct: 117 H---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPE 170
Query: 489 YASSGKLTEKSDVFSFGVMLLELITGRRP 517
+ D +S G ++ +++TG P
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-11
Identities = 23/123 (18%), Positives = 44/123 (35%), Gaps = 1/123 (0%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
+ +S P + P+ +P + P A+ P ++ P + + P+ PA + +
Sbjct: 432 ALAAARQASARGPGGAPAPAPAPAAA-PAAAARPAAAGPRPVAAAAAAAPARAAPAAAPA 490
Query: 78 PPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPP 137
P PP + P+ +P P + P + F PA ++P
Sbjct: 491 PADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAAPA 550
Query: 138 PPP 140
P
Sbjct: 551 PRA 553
|
Length = 700 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 57/195 (29%), Positives = 99/195 (50%), Gaps = 16/195 (8%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI 382
+G G +G V+K L G+ AVK +K G E+ ++ H ++V+ G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 383 AGGQRMLVYEFVSNKTLE--YHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIH 440
+ + + E+ +L+ YH+ G P+ + + + +GLAYLH +H
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTG---PLSELQI-AYVCRETLQGLAYLHSKGK---MH 129
Query: 441 RDIKAANILIDDNFEAMVADFGL-AKLSNDNHTHVSTRVMGTFGYLAPEYAS---SGKLT 496
RDIK ANIL+ DN + +ADFG+ AK++ S +GT ++APE A+ +G
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVEKNGGYN 187
Query: 497 EKSDVFSFGVMLLEL 511
+ D+++ G+ +EL
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 4/92 (4%)
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL 485
GL +LH+ II+RD+K N+L+D + +ADFG+ K + + ST GT Y+
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYI 163
Query: 486 APEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
APE K E D +SFGV+L E++ G+ P
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 26/218 (11%)
Query: 323 LLGQGGFGYVHKGVLPN-GKEVAVKSL---KTGSGQGEREFSAEVEIISRVHHRH--LVS 376
++G+GGFG V+ + GK A+K L + QGE E ++S V +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 377 LVGYCIAGGQRM-LVYEFVSNKTLEYHL--HG--ENRPVMDFATRVRIALGSAKGLAYLH 431
+ Y ++ + + ++ L YHL HG + +A + + L
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGL---------- 110
Query: 432 EDCHPR-IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYA 490
E H R +++RD+K ANIL+D++ ++D GLA + H S +GT GY+APE
Sbjct: 111 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVL 167
Query: 491 SSGKLTEKS-DVFSFGVMLLELITGRRPVDMTMMEDSL 527
G + S D FS G ML +L+ G P +D
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSA--EVEIISRVHHRHL 374
F K +G+G +G V+K G+ VA+K ++ + +A E+ ++ ++H ++
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAK--------G 426
V L+ + LV+EF LH + + MD + I L K G
Sbjct: 62 VKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 427 LAYLHEDCHP-RIIHRDIKAANILIDDNFEAMVADFGLAK---LSNDNHTHVSTRVMGTF 482
LA+ CH R++HRD+K N+LI+ +ADFGLA+ + +TH V+ T
Sbjct: 113 LAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVV-TL 164
Query: 483 GYLAPEYASSGKL-TEKSDVFSFGVMLLELITGR 515
Y APE K + D++S G + E++T R
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGS-AKGLAYLHEDCHPRIIHRDIKAAN 447
L+ ++V+ L HL+ VR+ + L +LH+ II+RDIK N
Sbjct: 82 LILDYVNGGELFTHLYQREHFTES---EVRVYIAEIVLALDHLHQ---LGIIYRDIKLEN 135
Query: 448 ILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKS--DVFSFG 505
IL+D ++ DFGL+K + GT Y+APE G D +S G
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG 195
Query: 506 VMLLELITGRRPVDMTMMEDSLVEWARPLL 535
V+ EL+TG P + ++S E +R +L
Sbjct: 196 VLTFELLTGASPFTVDGEQNSQSEISRRIL 225
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 2e-11
Identities = 28/86 (32%), Positives = 41/86 (47%)
Query: 34 STPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDP 93
+ S S ++ P P S PPP+ PP P ++ PP T PPP + S N
Sbjct: 511 ESQSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQI 570
Query: 94 PKNSPPPPPPSSQSSPTPPSPSNNKS 119
P +S PPPP + +P+P S+ +
Sbjct: 571 PADSSPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 324 LGQGGFGYVHKGVLPNGKEV-AVKSLKTGSGQGEREFS---AEVEIISRVHHRHLVSLVG 379
+G+G FG V + + + + A+K+++ E + AE ++++V+ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP-RI 438
+ + LV F++ L +HL E R F R +A+ L L E+ H +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGR----FDL-SRARFYTAELLCAL-ENLHKFNV 114
Query: 439 IHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEK 498
I+RD+K NIL+D + DFGL KL+ + +T GT YLAPE T+
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGYTKA 173
Query: 499 SDVFSFGVMLLELITGRRP 517
D ++ GV+L E++TG P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-11
Identities = 42/138 (30%), Positives = 60/138 (43%), Gaps = 12/138 (8%)
Query: 33 SSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS------PPPASPPTS 86
+S + PPP P P + PP++P S PPP +P S P TS + P A P
Sbjct: 2544 ASDDAGDPPP--PLPPAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQSARPRAP 2601
Query: 87 DNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSS 146
+++ DP +PP P P +P PP P SPSP P P + PPP + +
Sbjct: 2602 VDDRGDPRGPAPPSPLPPDTHAPDPPPP----SPSPAANEPDPHPPPTVPPPERPRDDPA 2657
Query: 147 TPKSSSSSSKSSNGSSSG 164
+ S G ++
Sbjct: 2658 PGRVSRPRRARRLGRAAQ 2675
|
Length = 3151 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 3e-11
Identities = 29/140 (20%), Positives = 50/140 (35%), Gaps = 2/140 (1%)
Query: 15 GSPPAPPSSNSSDATP-PPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA 73
PPAP SS + P + ++P +P A+ P+ + P +P P
Sbjct: 598 EGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAAPEHHPKHV 657
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKK 133
P PP P P++ ++P +P+ +P+P P A
Sbjct: 658 AVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQP-APAPAATPPAGQADD 716
Query: 134 SSPPPPPLKYSSSTPKSSSS 153
+ PP +S P ++
Sbjct: 717 PAAQPPQAAQGASAPSPAAD 736
|
Length = 824 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 59/227 (25%), Positives = 110/227 (48%), Gaps = 9/227 (3%)
Query: 318 FAKSNLLGQGGFGYVHK-GVLPNGKEVAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLV 375
F + + LG G G V K P+G +A K + R + E++++ + ++V
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
G + G+ + E + +L+ L R + +V IA+ +GLAYL E
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAYLREK-- 122
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL 495
+I+HRD+K +NIL++ E + DFG++ D+ ++ +GT Y++PE
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHY 179
Query: 496 TEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDG 542
+ +SD++S G+ L+EL GR P+ ++ + RP++ +
Sbjct: 180 SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEP 226
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 323 LLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFS---AEVEIISRV-HHRHLVSL 377
+LG+G FG V L + A+K+LK + + E ++S H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 378 VGYCIAGGQRML--VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
YC + L V E+++ L +H+ ++ D A GL +LH
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSK-- 115
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL 495
I++RD+K NIL+D + +ADFG+ K + T GT Y+APE K
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQKY 173
Query: 496 TEKSDVFSFGVMLLELITGRRP 517
D +SFGV+L E++ G+ P
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 52/202 (25%), Positives = 98/202 (48%), Gaps = 10/202 (4%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSA-EVEIISRVHHRHLV 375
+ + +GQG G V+ + + G+EVA+K + Q ++E E+ ++ H ++V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPNIV 79
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
+ + + G + +V E+++ +L + MD + + L +LH +
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN-- 134
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL 495
++IHRDIK+ NIL+ + + DFG + ST V GT ++APE +
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 192
Query: 496 TEKSDVFSFGVMLLELITGRRP 517
K D++S G+M +E++ G P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 39/107 (36%), Positives = 57/107 (53%), Gaps = 10/107 (9%)
Query: 418 RIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA-KLSNDNHTHVST 476
+IA+ K L YLH +IHRD+K +N+LI+ N + + DFG++ L + T
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKT 161
Query: 477 RVMGTFGYLAPEY----ASSGKLTEKSDVFSFGVMLLELITGRRPVD 519
G Y+APE + KSDV+S G+ ++EL TGR P D
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 33/221 (14%)
Query: 324 LGQGGFGYVH-KGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI 382
+G+G G V V +GK VAVK + Q EV I+ H ++V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 383 AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVR--------IALGSAKGLAYLHEDC 434
G + +V EF+ E + D T R + L K L+ LH
Sbjct: 88 VGDELWVVMEFL-----------EGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ- 135
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGL-AKLSNDNHTHVSTRVMGTFGYLAPEYASSG 493
+IHRDIK+ +IL+ + ++DFG A++S + S ++GT ++APE S
Sbjct: 136 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRL 191
Query: 494 KLTEKSDVFSFGVMLLELITGRRPV-------DMTMMEDSL 527
+ D++S G+M++E++ G P M M+ D+L
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL 232
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 4e-11
Identities = 49/195 (25%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI 382
+GQG G V+ + + G+EVA++ + + E+ ++ + ++V+ + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 383 AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRD 442
G + +V E+++ +L + MD + + L +LH + ++IHRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 443 IKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 502
IK+ NIL+ + + DFG + ST V GT ++APE + K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 200
Query: 503 SFGVMLLELITGRRP 517
S G+M +E+I G P
Sbjct: 201 SLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 6e-11
Identities = 27/133 (20%), Positives = 42/133 (31%)
Query: 8 TETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPP 67
G PA+PPP+ P + P+ + P
Sbjct: 639 ASAAPAPGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAP 698
Query: 68 SSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSP 127
+ P PA +++PP P + + P P + P PP P + P+ P
Sbjct: 699 AQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQP 758
Query: 128 PPPAKKSSPPPPP 140
PPP + P
Sbjct: 759 PPPPAPAPAAAPA 771
|
Length = 824 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 6e-11
Identities = 33/140 (23%), Positives = 53/140 (37%), Gaps = 1/140 (0%)
Query: 1 MAKGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSP 60
A V E+ P +S+ D P + + + PP +P PA+P +
Sbjct: 641 AAPAPGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAA-PA 699
Query: 61 PPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSP 120
P+ +P ++PP + P P + P P P P P P+ + + P
Sbjct: 700 QPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPP 759
Query: 121 SPPVFSPPPPAKKSSPPPPP 140
PP +P + PP PP
Sbjct: 760 PPPAPAPAAAPAAAPPPSPP 779
|
Length = 824 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 32/94 (34%), Positives = 56/94 (59%), Gaps = 6/94 (6%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS--TRVMGTF 482
+GL Y+H ++HRD+K +N+L++ N + + DFGLA++++ H H T + T
Sbjct: 117 RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 483 GYLAPEYASSGKLTEKS-DVFSFGVMLLELITGR 515
Y APE + K K+ D++S G +L E+++ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 6e-11
Identities = 34/96 (35%), Positives = 53/96 (55%), Gaps = 8/96 (8%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK----LSNDNHTHVSTRVMG 480
K L Y+H +IHRD+K +NIL++ + +ADFGLA+ L + V T +
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 481 TFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 515
T Y APE S + T+ D++S G +L E++ G+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-11
Identities = 50/200 (25%), Positives = 65/200 (32%), Gaps = 38/200 (19%)
Query: 2 AKGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSP----------------PPSSP 45
+ P PP +++ PPP P PPS
Sbjct: 2811 VLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRS 2870
Query: 46 PPASPPPSSPPP----SSPPPSKSPPSSP----PPATSSSPPPASPPTSDNNKPDPPKNS 97
P A P + PP + P S+S S P P PP P PP+
Sbjct: 2871 PAAKPAAPARPPVRRLARPAVSRSTESFALPPDQPERPPQPQAPPPPQPQPQPPPPPQPQ 2930
Query: 98 PPP-PPPSSQSSPTP-PSPSNNKSPSPPVFSP----------PPPAKKSSPPPP--PLKY 143
PPP PPP Q P P+ PS V P P + P P
Sbjct: 2931 PPPPPPPRPQPPLAPTTDPAGAGEPSGAVPQPWLGALVPGRVAVPRFRVPQPAPSREAPA 2990
Query: 144 SSSTPKSSSSSSKSSNGSSS 163
SS+ P + S S+ S+ +SS
Sbjct: 2991 SSTPPLTGHSLSRVSSWASS 3010
|
Length = 3151 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 7e-11
Identities = 42/160 (26%), Positives = 60/160 (37%), Gaps = 12/160 (7%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPP-PSKSPPSSPPPA 73
PA SS+ + +P PS + S P S P AS SS SS S S SS A
Sbjct: 281 RPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAA 340
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKK 133
S P P+ P+ P + PP P S + P P ++ + S P +
Sbjct: 341 VSPGPSPSRSPS-------PSRPPPPADPSSPRKRPRPSRAPSSPAASAG--RPTRRRAR 391
Query: 134 SSPPPPPLKY--SSSTPKSSSSSSKSSNGSSSGDDYVTYS 171
++ + + P S G++SG Y Y
Sbjct: 392 AAVAGRARRRDATGRFPAGRPRPSPLDAGAASGAFYARYP 431
|
Length = 1352 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-11
Identities = 28/96 (29%), Positives = 37/96 (38%), Gaps = 6/96 (6%)
Query: 16 SPPAPPSSNSSDATPPPSS-TPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
PAP + + A P P TP+ S P + A+ PP P + P PP P A
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPP--RPVAP 419
Query: 75 SSSPPPASPPTSDNNK---PDPPKNSPPPPPPSSQS 107
P S P + PK +PP PP +
Sbjct: 420 PVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKEEEK 455
|
Length = 585 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 7e-11
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 25/208 (12%)
Query: 318 FAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSA--EVEIISRVHHRHL 374
+ K LG+G + V+KG NGK VA+K ++ +G F+A E ++ + H ++
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHANI 65
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYH------LHGENRPVMDFATRVRIALGSAKGLA 428
V L LV+E+V +Y LH EN + F +GL+
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQL--------LRGLS 117
Query: 429 YLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL-SNDNHTHVSTRVMGTFGYLAP 487
Y+H+ I+HRD+K N+LI D E +ADFGLA+ S +HT+ + V T Y P
Sbjct: 118 YIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPP 172
Query: 488 E-YASSGKLTEKSDVFSFGVMLLELITG 514
+ S + + D++ G + +E+I G
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 28/230 (12%)
Query: 323 LLGQGGFGYV--------HKGVLPNGKEVAVKSLKTGS----GQGEREFSAEVEIISRVH 370
+LG G +G V H +GK A+K LK + + E +++ +
Sbjct: 7 VLGTGAYGKVFLVRKVSGHD----SGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 62
Query: 371 HRHLVSLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATR-VRIALGS-AKGL 427
+ + Y ++ L+ ++++ L HL R F + V+I G L
Sbjct: 63 QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVLAL 118
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAP 487
+LH+ II+RDIK NIL+D N ++ DFGL+K +++ + GT Y+AP
Sbjct: 119 EHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 488 EYASSGKLTEKS--DVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL 535
+ G D +S GV++ EL+TG P + ++S E +R +L
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL 225
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 67/239 (28%), Positives = 102/239 (42%), Gaps = 32/239 (13%)
Query: 323 LLGQGGFGYVHKGVL----PNGKEVAVKSLKTGSGQGEREFS---AEVEIISRVHHRHLV 375
LLG+G FG V +L GK A+K LK + E + E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 376 SLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
+L Y R+ V E+ + L +HL E D A + SA L YLH
Sbjct: 59 AL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LGYLHSC- 114
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGK 494
+++RD+K N+++D + + DFGL K + + T GT YLAPE
Sbjct: 115 --DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDND 171
Query: 495 LTEKSDVFSFGVMLLELITGRRP---------VDMTMMED-----SLVEWARPLLGAAL 539
D + GV++ E++ GR P ++ +ME+ +L A+ LL L
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLL 230
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 323 LLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFS---AEVEIISRVHHRHLVSLV 378
+LG+G FG V L G+ AVK+LK + + E +++ ++ +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 379 GYCIAGGQRML--VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
YC + L V EF++ L +H+ + R D A GL +LH
Sbjct: 62 -YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSK--- 115
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLT 496
II+RD+K N+++D + +ADFG+ K + ST GT Y+APE K T
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKYT 174
Query: 497 EKSDVFSFGVMLLELITGRRP 517
D +SFGV+L E++ G+ P
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLK--TGSGQGEREFSA---EVEIISRVHHRHLVS 376
LLGQG FG V+ G+E+AVK ++ S + +E +A E++++ + H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 377 LVGYCIAGGQRML--VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
G +R L E + +++ L + + TR + +G++YLH +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTR-KYTRQILEGVSYLHSN- 125
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAK------LSNDNHTHVSTRVMGTFGYLAPE 488
I+HRDIK ANIL D + DFG +K LS V+ GT +++PE
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT----GTPYWMSPE 179
Query: 489 YASSGKLTEKSDVFSFGVMLLELITGRRP 517
S K+D++S G ++E++T + P
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 50/180 (27%), Positives = 87/180 (48%), Gaps = 9/180 (5%)
Query: 339 NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKT 398
+G++VAVK + Q EV I+ H+++V + + G + ++ EF+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 399 LEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMV 458
L + AT L + L YLH +IHRDIK+ +IL+ + +
Sbjct: 105 LTDIVSQTRLNEEQIATVCESVL---QALCYLHSQ---GVIHRDIKSDSILLTLDGRVKL 158
Query: 459 ADFGL-AKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
+DFG A++S D S ++GT ++APE S + D++S G+M++E++ G P
Sbjct: 159 SDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 318 FAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSA-EVEIISRVHHRHLV 375
+ K + LG+G + V KG VA+K ++ +G + EV ++ + H ++V
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66
Query: 376 SL-----VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSA-KGLAY 429
+L C+ LV+E++ + +Y + N M V+I + +GL+Y
Sbjct: 67 TLHDIIHTERCLT-----LVFEYLDSDLKQYLDNCGNLMSMH---NVKIFMFQLLRGLSY 118
Query: 430 LHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE- 488
H +I+HRD+K N+LI++ E +ADFGLA+ + S V+ T Y P+
Sbjct: 119 CH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDV 174
Query: 489 YASSGKLTEKSDVFSFGVMLLELITGR 515
S + + D++ G +L E+ TGR
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-10
Identities = 38/149 (25%), Positives = 59/149 (39%), Gaps = 17/149 (11%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
N + P P+S+ SSSP SP P+ P S P S P + S SS ++
Sbjct: 267 TRIWEASGWNGPSSRPGPASS-SSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESS 325
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKS 134
SSS +S + + P PS SP+P P PP P P K+
Sbjct: 326 SSSTSSSSESSRG---------AAVSPGPSPSRSPSPSRP-------PPPADPSSPRKRP 369
Query: 135 SPPPPPLKYSSSTPKSSSSSSKSSNGSSS 163
P P ++S + + ++++ +
Sbjct: 370 RPSRAPSSPAASAGRPTRRRARAAVAGRA 398
|
Length = 1352 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 31/133 (23%), Positives = 46/133 (34%), Gaps = 5/133 (3%)
Query: 13 EEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPP 72
E P AP + + A P + + + ++P P P P P S P
Sbjct: 611 EAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAAPEHHPKHVAVPDASDGGDGWP 670
Query: 73 ATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPV-----FSP 127
A + PA+PP + P P+ + TPP+ + + P S
Sbjct: 671 AKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASA 730
Query: 128 PPPAKKSSPPPPP 140
P PA P PP
Sbjct: 731 PSPAADDPVPLPP 743
|
Length = 824 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 25/134 (18%), Positives = 51/134 (38%), Gaps = 1/134 (0%)
Query: 22 SSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPA 81
S+ P P+ P+++P ++ P A+ P ++ P+++ P++ P PPP
Sbjct: 440 SARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAAAPAPADDDPPPW 499
Query: 82 SPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPL 141
+ P P + P ++S P P+ ++ + P A
Sbjct: 500 EELPPEFASPAPAQPDAAPAGWVAESIPD-PATADPDDAFETLAPAPAAAPAPRAAAATE 558
Query: 142 KYSSSTPKSSSSSS 155
+ P +S+S
Sbjct: 559 PVVAPRPPRASASG 572
|
Length = 700 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 21/223 (9%)
Query: 316 GGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRH 373
G F ++G G +G V+KG + G+ A+K + + E E E+ ++ + HHR+
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRN 74
Query: 374 LVSLVGYCIAGG------QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGL 427
+ + G I Q LV EF ++ + + I +GL
Sbjct: 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGL-AKLSNDNHTHVSTRVMGTFGYLA 486
A+LH ++IHRDIK N+L+ +N E + DFG+ A+L D +GT ++A
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMA 189
Query: 487 PEYASSGKLTE-----KSDVFSFGVMLLELITGRRPV-DMTMM 523
PE + + + +SD++S G+ +E+ G P+ DM M
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 66/220 (30%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 323 LLGQGGFGYVHKGVL----PNGKEVAVKSLKTGSGQGEREFS---AEVEIISRVHHRHLV 375
LLG+G FG V +L +GK A+K LK + E + E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 376 SLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
SL Y R+ V E+V+ L +HL E R + TR A L YLH
Sbjct: 59 SL-KYSFQTKDRLCFVMEYVNGGELFFHLSRE-RVFSEDRTRFYGA-EIVSALDYLHSG- 114
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGK 494
+I++RD+K N+++D + + DFGL K + + T GT YLAPE
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDND 171
Query: 495 LTEKSDVFSFGVMLLELITGRRP---------VDMTMMED 525
D + GV++ E++ GR P ++ +MED
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED 211
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 54/219 (24%), Positives = 102/219 (46%), Gaps = 42/219 (19%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE-FSA----EVEIISRVHH 371
+ K N + +G +G V++ G+ VA+K LK E+E F E+ I+ ++ H
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKLQH 63
Query: 372 RHLVSLVGYCIAGGQRM----LVYEFVSN--KTLEYHLHGENRPVMDFATRVRIALGSAK 425
++V++ + G + +V E+V + K+L + F K
Sbjct: 64 PNIVTVKE--VVVGSNLDKIYMVMEYVEHDLKSLMETMKQP------FLQ------SEVK 109
Query: 426 --------GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTR 477
G+A+LH++ I+HRD+K +N+L+++ + DFGLA+ T+
Sbjct: 110 CLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYTQ 165
Query: 478 VMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 515
++ T Y APE + + + D++S G + EL+T +
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 32/95 (33%), Positives = 57/95 (60%), Gaps = 6/95 (6%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGY 484
+GL Y+H ++HRD+K +N+L++ N + + DFGLA+ +++ ++ V+ T Y
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 485 LAPE-YASSGKLTEKSDVFSFGVMLLELITGRRPV 518
APE + + T DV+S G + EL+ GR+P+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 4e-10
Identities = 21/125 (16%), Positives = 47/125 (37%), Gaps = 2/125 (1%)
Query: 1 MAKGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPP--S 58
+ + V + ++ + A P P++ ++ +P A P +P P +
Sbjct: 381 LERRLGVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPA 440
Query: 59 SPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNK 118
P P+ + P+ P+ + P++ P P +P P PP++ + P+
Sbjct: 441 PPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAP 500
Query: 119 SPSPP 123
+
Sbjct: 501 AAPAG 505
|
Length = 824 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-10
Identities = 31/165 (18%), Positives = 62/165 (37%), Gaps = 25/165 (15%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASP--PPSSPPPSSPPPSKSPPSSPPP 72
G+ PA ++ P ++ P+++ P + PPA+P P++ + + SP P
Sbjct: 371 GAGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAPARRSPAP 430
Query: 73 AT-------------SSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKS 119
+ P +P + P P P ++ ++P +P+ +
Sbjct: 431 EALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAAAPA 490
Query: 120 PS----------PPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSS 154
P+ PP F+ P PA+ + P + S P ++
Sbjct: 491 PADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPD 535
|
Length = 700 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 64/207 (30%), Positives = 88/207 (42%), Gaps = 19/207 (9%)
Query: 318 FAKSNLLGQGGFGYV----HKGVLPNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVH 370
F LG G FG V HKG G+ A+K LK + + + E I+ +
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 371 HRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYL 430
H +V+++ + + EFV L HL R D A L A YL
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA--FEYL 134
Query: 431 HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYA 490
H II+RD+K N+L+D+ V DFG AK D + + GT YLAPE
Sbjct: 135 HSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPEVI 187
Query: 491 SSGKLTEKSDVFSFGVMLLELITGRRP 517
S + D ++ GV+L E I G P
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-10
Identities = 24/106 (22%), Positives = 35/106 (33%), Gaps = 5/106 (4%)
Query: 27 DATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTS 86
DA+ P + P A P ++ S P S + P S++ P +PPT
Sbjct: 368 DASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTV 427
Query: 87 DNNKPD-----PPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSP 127
+ P PP +P P+ S S P P
Sbjct: 428 SVDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPVSKVSSLGPSTLRP 473
|
Length = 614 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 70/225 (31%), Positives = 101/225 (44%), Gaps = 28/225 (12%)
Query: 324 LGQGGFGYV----HKGVLPNGKEVAVKSLKTGSGQGEREFS---AEVEI-ISRVHHRHLV 375
+G+G FG V HK +GK AVK L+ + ++E AE + + V H LV
Sbjct: 3 IGKGSFGKVLLAKHK---ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 376 SLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFA-TRVRI-ALGSAKGLAYLHE 432
L Y ++ V ++V+ L +HL E F R R A A L YLH
Sbjct: 60 GL-HYSFQTADKLYFVLDYVNGGELFFHLQRERS----FPEPRARFYAAEIASALGYLHS 114
Query: 433 DCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS 492
II+RD+K NIL+D ++ DFGL K H+ ++ GT YLAPE
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRK 170
Query: 493 GKLTEKSDVFSFGVMLLELITGRRPV---DMTMMEDSLVEWARPL 534
D + G +L E++ G P D M D+++ +PL
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN--KPL 213
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 324 LGQGGFGYVHKGVLPN-GKEVAVKSLKTGSGQGEREFSA--EVEIISRVH---HRHLVSL 377
+G G +G V+K P+ G VA+KS++ + + S EV ++ R+ H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 378 VGYCIAG-----GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHE 432
+ C + LV+E V ++ L +L P + T + +GL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 433 DCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS 492
+C I+HRD+K NIL+ + +ADFGLA++ + T V+ T Y APE
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYRAPEVLLQ 181
Query: 493 GKLTEKSDVFSFGVMLLELITGRRPV 518
D++S G + E+ R+P+
Sbjct: 182 STYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 6e-10
Identities = 22/127 (17%), Positives = 43/127 (33%), Gaps = 7/127 (5%)
Query: 21 PSSNSSDATPPPSSTPSSS---PPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS-- 75
P + A P ++ + P ++P A+P P++PP + + ++ A +
Sbjct: 365 PGQSGGGAGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAPA 424
Query: 76 --SSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKK 133
S P A + P P P P++ + + P + P
Sbjct: 425 RRSPAPEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAA 484
Query: 134 SSPPPPP 140
+ P P
Sbjct: 485 PAAAPAP 491
|
Length = 700 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSL--KTGSGQGEREFSA---EVEIISRVHHRHLVS 376
LLG+G FG V+ G+E+AVK + S + +E +A E++++ + H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 377 LVGYCIAGGQRML--VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
G ++ L E++ +++ L + + TR R +G++YLH +
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTR-RYTRQILQGVSYLHSN- 125
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND---NHTHVSTRVMGTFGYLAPEYAS 491
I+HRDIK ANIL D + DFG +K + T + + V GT +++PE S
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSPEVIS 182
Query: 492 SGKLTEKSDVFSFGVMLLELITGRRP 517
K+DV+S ++E++T + P
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 67/232 (28%), Positives = 104/232 (44%), Gaps = 19/232 (8%)
Query: 301 FNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREF 359
+N S + L T + +G+G +G V+K +G AVK L S E E
Sbjct: 7 YNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EI 65
Query: 360 SAEVEIISRV-HHRHLVSLVGYC-----IAGGQRMLVYEFVSNKTLEYHLHGENR--PVM 411
AE I+ + +H ++V G + GGQ LV E + ++ + G +
Sbjct: 66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRL 125
Query: 412 DFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471
D A I G+ GL +LH + RIIHRD+K NIL+ + DFG++
Sbjct: 126 DEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182
Query: 472 THVSTRVMGTFGYLAPEYASSGKLTEKS-----DVFSFGVMLLELITGRRPV 518
+T V GT ++APE + + + S DV+S G+ +EL G P+
Sbjct: 183 LRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-10
Identities = 39/134 (29%), Positives = 49/134 (36%), Gaps = 20/134 (14%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPP-------PSSPPPSSPPPSKSPPSS 69
PP PP A PP + S PP +P P+ P P +PP S+ P +
Sbjct: 2553 PPLPP------AAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQSARPRAPVDDRG 2606
Query: 70 PPPATSSSPPPASPPTSDNNKPDPPKNSPPP---PPPSSQSSPTPPSPSNNKSPSPPVFS 126
P P P SP D + PDPP SP P P PP P+P S
Sbjct: 2607 DPRG----PAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVS 2662
Query: 127 PPPPAKKSSPPPPP 140
P A++
Sbjct: 2663 RPRRARRLGRAAQA 2676
|
Length = 3151 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 10/93 (10%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFG 483
+GL Y+H ++HRD+K +NILI++N + + DFGLA++ + T +VSTR
Sbjct: 119 RGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----- 170
Query: 484 YLAPEYASS-GKLTEKSDVFSFGVMLLELITGR 515
Y APE + K + D++S G + E++ G+
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 1e-09
Identities = 29/125 (23%), Positives = 44/125 (35%), Gaps = 5/125 (4%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
+P APP + + A P+ + P P+ + P + PP + S+P PA
Sbjct: 677 APAAPPPAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAAD 736
Query: 76 SSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSS 135
P P + P PPPP P+ ++P P PSPP +
Sbjct: 737 DPVPLPPEPDDPPDPAGAPAQPPPPPAPAPAAAPAAAPP-----PSPPSEEEEMAEDDAP 791
Query: 136 PPPPP 140
Sbjct: 792 SMDDE 796
|
Length = 824 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 27/126 (21%), Positives = 45/126 (35%), Gaps = 3/126 (2%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPP---PSSPPPSKSPPSSPPPA 73
P P++ + A P ++ P ++ PA P++ P PPP + P
Sbjct: 450 PAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAAAPAPADDDPPPWEELPPEFASP 509
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKK 133
+ P A + PDP P + +P + + PV +P PP
Sbjct: 510 APAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAAPAPRAAAATEPVVAPRPPRAS 569
Query: 134 SSPPPP 139
+S P
Sbjct: 570 ASGLPD 575
|
Length = 700 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 65/247 (26%), Positives = 108/247 (43%), Gaps = 29/247 (11%)
Query: 324 LGQGGFGYVHKGVLPNG---KEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVG 379
+G G FG V G + +G +V VK L+ + Q + +F E + + H +L+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRP---VMDFATRVRIALGSAKGLAYLHEDCHP 436
C +LV EF L+ +L + D T R+A A GL +LH++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV-STRVMGTFGYLAPEYASS--G 493
IH D+ N L+ + + D+GL+ +V ++ ++APE G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 494 KL-----TEKSDVFSFGVMLLELIT-GRRP---------VDMTMMEDSLVEWARPLLGAA 538
L T++S+V+S GV + EL G +P + T+ E L + +P L
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL-KLPKPRLKLP 238
Query: 539 LEDGIYD 545
L D Y+
Sbjct: 239 LSDRWYE 245
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI 382
+G G +G V+K + G+ A+K +K G+ E+ ++ H ++V+ G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 383 AGGQRMLVYEFVSNKTLE--YHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIH 440
+ + EF +L+ YH+ G P+ + ++ + +GL YLH +H
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTG---PLSESQI-AYVSRETLQGLYYLHSKGK---MH 129
Query: 441 RDIKAANILIDDNFEAMVADFGL-AKLSNDNHTHVSTRVMGTFGYLAPEYAS---SGKLT 496
RDIK ANIL+ DN +ADFG+ A+++ S +GT ++APE A+ G
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAAVERKGGYN 187
Query: 497 EKSDVFSFGVMLLELITGRRPV 518
+ D+++ G+ +EL + P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 43/212 (20%)
Query: 324 LGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSA--EVEIISRVHHRHLVSLVGY 380
LG+G + V+KG G+ VA+K ++ +G F+A E ++ + H ++V+L +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTL--H 69
Query: 381 CIAGGQRML--VYEFVSN---KTLEYH---LHGENRPVMDFATRVRIALGS-AKGLAYLH 431
I ++ L V+E++ + ++ L N VR+ L +GLAY H
Sbjct: 70 DIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHN---------VRLFLFQLLRGLAYCH 120
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL-SNDNHTHVSTRVMGTFGYLAP--- 487
R++HRD+K N+LI + E +ADFGLA+ S + T+ + V T Y P
Sbjct: 121 ---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVL 175
Query: 488 ----EYASSGKLTEKSDVFSFGVMLLELITGR 515
EY++S D++ G + E+ TGR
Sbjct: 176 LGSTEYSTS------LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN-DNHTHVSTRVMGTFG 483
+GL YLH I+HRDIK N+L++ N + DFGLA++ D H++ V+ +
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 484 YLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 515
Y APE S T D++S G + EL+ R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 49/206 (23%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 324 LGQGGFGYVHKGVLPNGK--------EVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLV 375
LGQG F + KG+ EV +K L F ++S++ H+HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
G C+ G + ++V E+V +L+ +L +N+ +++ + ++ +A A L +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEVAKQLAWALHFLEDK-- 119
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGT------FGYLAPEY 489
+ H ++ A N+L+ + + KLS+ +S V+ ++ PE
Sbjct: 120 -GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG---ISITVLPKEILLERIPWVPPEC 175
Query: 490 ASSGK-LTEKSDVFSFGVMLLELITG 514
+ + L+ +D +SFG L E+ +G
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 1e-09
Identities = 16/89 (17%), Positives = 36/89 (40%), Gaps = 6/89 (6%)
Query: 22 SSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPA 81
+ +T P++ +++ +S P A+P +P +P P + + PP +++ A
Sbjct: 34 ADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAA 93
Query: 82 SPPTSDNNKPDPPKNSPPPPPPSSQSSPT 110
+ P PP + P ++
Sbjct: 94 AAP------AAPPAAAAAAAPAAAAVEDE 116
|
Length = 1228 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 35/155 (22%), Positives = 61/155 (39%), Gaps = 8/155 (5%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
GS S ++ A + ++ PP+ PPP + + S P
Sbjct: 38 GSQGQLVSDSAELAAVTVVAGAAACDRF-------EPPTGPPPGPGTEAPANESRSTPTW 90
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKS 134
S S + P + + P +SP PPPP+ + PPSP+ + S P P +
Sbjct: 91 SLSTLAPASPAREGSPTPPGPSSPDPPPPTPPPASPPPSPAPDLSEMLRPVGSPGPPPAA 150
Query: 135 SPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVT 169
SPP ++ ++SS +++ SS ++
Sbjct: 151 SPPAAGAS-PAAVASDAASSRQAALPLSSPEETAR 184
|
Length = 1352 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 30/143 (20%), Positives = 40/143 (27%), Gaps = 14/143 (9%)
Query: 10 TENEEGSPPAPPSSNSSDATPPP--------------SSTPSSSPPPSSPPPASPPPSSP 55
+ E P+P S S A P SST SSS + P S
Sbjct: 290 SPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAAVSPGPSPSR 349
Query: 56 PPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPS 115
PS P S P S P + +P + + + T P+
Sbjct: 350 SPSPSRPPPPADPSSPRKRPRPSRAPSSPAASAGRPTRRRARAAVAGRARRRDATGRFPA 409
Query: 116 NNKSPSPPVFSPPPPAKKSSPPP 138
PSP A + P
Sbjct: 410 GRPRPSPLDAGAASGAFYARYPL 432
|
Length = 1352 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 44/157 (28%), Positives = 82/157 (52%), Gaps = 7/157 (4%)
Query: 362 EVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIAL 421
E++++ + ++V G + G+ + E + +L+ L R +V IA+
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 422 GSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGT 481
KGL YL E +I+HRD+K +NIL++ E + DFG++ D+ ++ +GT
Sbjct: 113 --IKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGT 165
Query: 482 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPV 518
Y++PE + +SD++S G+ L+E+ GR P+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 44/221 (19%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE---FSA--EVEIISRVHH 371
+ K +G+G +G V+K G+ VA+K ++ + E E +A E+ ++ ++H
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRL---ETEDEGVPSTAIREISLLKELNH 57
Query: 372 RHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSA------- 424
++V L+ + + LV+EF+ +Y MD + L
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEFLDLDLKKY---------MD--SSPLTGLDPPLIKSYLY 106
Query: 425 ---KGLAYLHEDCHP-RIIHRDIKAANILIDDNFEAMVADFGLAK---LSNDNHTHVSTR 477
+G+AY CH R++HRD+K N+LID +ADFGLA+ + +TH
Sbjct: 107 QLLQGIAY----CHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---E 159
Query: 478 VMGTFGYLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRP 517
V+ T Y APE + D++S G + E++ RRP
Sbjct: 160 VV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 34/133 (25%), Positives = 41/133 (30%), Gaps = 7/133 (5%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
PP + PP P PP P P P PS++P P P
Sbjct: 181 PQGMPPRQAAFPQQGPPEQPPGYPQPPQGHPEQVQPQQFLPA----PSQAPAQPPLPP-- 234
Query: 76 SSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSS 135
P PP P + PPPPP Q PP P P P + +
Sbjct: 235 -QLPQQPPPLQQPQFPGLSQQMPPPPPQPPQQQQQPPQPQAQPPPQNQPTPHPGLPQGQN 293
Query: 136 PPPPPLKYSSSTP 148
P PP + P
Sbjct: 294 APLPPPQQPQLLP 306
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 42/133 (31%), Positives = 64/133 (48%), Gaps = 12/133 (9%)
Query: 390 VYEFVSNKTLEYHLHGENR---PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAA 446
V E+V+ L YH+ + P F A A GL +LH II+RD+K
Sbjct: 79 VMEYVNGGDLMYHIQQVGKFKEPHAVF-----YAAEIAIGLFFLHSK---GIIYRDLKLD 130
Query: 447 NILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 506
N+++D +ADFG+ K N + GT Y+APE + + D ++FGV
Sbjct: 131 NVMLDAEGHIKIADFGMCK-ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 189
Query: 507 MLLELITGRRPVD 519
+L E++ G+ P D
Sbjct: 190 LLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 3e-09
Identities = 19/128 (14%), Positives = 39/128 (30%), Gaps = 4/128 (3%)
Query: 14 EGSPPAPPSSNSSD-ATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPP 72
+ + PA + ++ + PPP + P P P ++ +
Sbjct: 373 QSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTSQLLAARQQLQRA 432
Query: 73 ATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAK 132
++ + P + P NS S + +P+ + K + + P
Sbjct: 433 QGATKAKKSEPAAAS---RARPVNSALERLASVRPAPSALEKAPAKKEAYRWKATNPVEV 489
Query: 133 KSSPPPPP 140
K P P
Sbjct: 490 KKEPVATP 497
|
Length = 647 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 3e-09
Identities = 24/129 (18%), Positives = 51/129 (39%), Gaps = 9/129 (6%)
Query: 35 TPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPP 94
+ + S ++P + P + +P ++ PA +++P PA P P
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAP-------APA 438
Query: 95 KNSPPPP--PPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSS 152
P P P+ + PP+ + + P+P + P P +P PP ++ P + +
Sbjct: 439 PAPPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPA 498
Query: 153 SSSKSSNGS 161
+ + +
Sbjct: 499 APAAPAGAD 507
|
Length = 824 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-09
Identities = 24/127 (18%), Positives = 42/127 (33%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA 73
+ + + A + P++PPP+ +P + PA
Sbjct: 635 APAEASAAPAPGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPA 694
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKK 133
++ PA P + + PP + +S P+ + P PP PA
Sbjct: 695 GAAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGA 754
Query: 134 SSPPPPP 140
+ PPPP
Sbjct: 755 PAQPPPP 761
|
Length = 824 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 3e-09
Identities = 18/81 (22%), Positives = 39/81 (48%), Gaps = 2/81 (2%)
Query: 13 EEGSPPAPPSSNSSDATPPPSSTPSS--SPPPSSPPPASPPPSSPPPSSPPPSKSPPSSP 70
+ P ++ ++ A P++ P++ P+ PPA+ P++PP + + + +
Sbjct: 39 GSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAA 98
Query: 71 PPATSSSPPPASPPTSDNNKP 91
PPA +++ PA+ D P
Sbjct: 99 PPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL 485
G+ ++HE R++HRDIK+ NI + N + + DFG A+L + T V GT Y+
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167
Query: 486 APEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
PE + KSD++S G +L EL T + P
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLK---TGSGQGEREFSAEVEIISRVHHRHLVSLVG 379
+G+G F V++ L + K VA+K ++ + ++ E++++ +++H +++ +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 380 YCIAGGQRMLVYEFVSNKTLEY---HLHGENRPVMDFAT-RVRIALGSAKGLAYLHEDCH 435
I + +V E L + + R + + + + L SA + ++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--VEHMHSR-- 125
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL 495
R++HRDIK AN+ I + D GL + + T + V GT Y++PE
Sbjct: 126 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY 183
Query: 496 TEKSDVFSFGVMLLELITGRRP 517
KSD++S G +L E+ + P
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 54/217 (24%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 324 LGQGGFGYVHKGVL------PNGKEVAVKSLK-TGSGQGEREFSAEVEIISRVHHRHLVS 376
LG+ FG V+KG L + VA+K+LK G EF E + SR+ H ++V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHL-----HGEN---------RPVMDFATRVRIALG 422
L+G +++ + S+ L L H + + ++ A V I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 423 SAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGT 481
A G+ +L ++H+D+ N+L+ D ++D GL + + ++ + +
Sbjct: 133 IAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 482 FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
+++PE GK + SD++S+GV+L E+ + G +P
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 31/88 (35%), Positives = 47/88 (53%), Gaps = 5/88 (5%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGY 484
+GL YLH RIIHRD+K NI I+D + + D G A+ + + GT
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAGTVET 222
Query: 485 LAPEYASSGKLTEKSDVFSFGVMLLELI 512
APE + K K+D++S G++L E++
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-09
Identities = 29/125 (23%), Positives = 49/125 (39%), Gaps = 1/125 (0%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
P P + P++ + PP++ P + PP++ P + PP+ +P + PPA +
Sbjct: 703 PMRPPAAPPGRAQRPAAATGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPG 762
Query: 78 PPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPP 137
P PP +PP P + +PT P P P+ P + P
Sbjct: 763 RARPPAAAPGAPTPQPPPQAPPAPQQRPRGAPT-PQPPPQAGPTSMQLMPRAAPGQQGPT 821
Query: 138 PPPLK 142
L+
Sbjct: 822 KQILR 826
|
Length = 991 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 4e-09
Identities = 22/80 (27%), Positives = 31/80 (38%)
Query: 38 SSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNS 97
S S AS P + P +P P +P P T + SPP + + P P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 98 PPPPPPSSQSSPTPPSPSNN 117
P P P+ ++ PS N
Sbjct: 421 PTEPSPTPPANAANAPPSLN 440
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 4e-09
Identities = 23/84 (27%), Positives = 37/84 (44%), Gaps = 3/84 (3%)
Query: 22 SSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPA 81
S S+ A PP S PP +PP P ++PPP+ PPP PP++ ++++
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPP---PPTATQASSNAPAQIP 571
Query: 82 SPPTSDNNKPDPPKNSPPPPPPSS 105
+ + P+ P SP
Sbjct: 572 ADSSPPPPIPEEPTPSPTKDSSPE 595
|
Length = 620 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 323 LLGQGGFGYVHKGVL----PNGKEVAVKSLKTGSGQGEREFS---AEVEIISRVHHRHLV 375
LLG+G FG V +L G+ A+K L+ + E + E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 376 SLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
+L Y R+ V E+ + L +HL E + A + SA L YLH
Sbjct: 59 AL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYLHSR- 114
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGK 494
+++RDIK N+++D + + DFGL K + + T GT YLAPE
Sbjct: 115 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDND 171
Query: 495 LTEKSDVFSFGVMLLELITGRRP 517
D + GV++ E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 24/81 (29%), Positives = 31/81 (38%), Gaps = 3/81 (3%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPP---PSSPPPASPPPSSPPPSSPPPSKSPPSSPP 71
P P S + S P PSS S +PP S P+ PP + PP P P S+
Sbjct: 199 SPPEDPSSPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAK 258
Query: 72 PATSSSPPPASPPTSDNNKPD 92
P S+ +P D
Sbjct: 259 PTPPSASATPAPIGGITLDDD 279
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 35/207 (16%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKT------GSGQGEREFSAEVE--IISRVHHRHLV 375
LG+G FG V+ ++ + K VA + LK G A E ++S++ H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTL-----EYHLHGENRP---VMDFATRVRIALGSAKGL 427
+ ++ E+ + L E G+ V ++ ++ + G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GV 119
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL---SNDNHTHVSTRVMGTFGY 484
Y+H+ RI+HRD+KA NI + +N + DFG+++L S D ++T GT Y
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD----LATTFTGTPYY 171
Query: 485 LAPEYASSGKLTEKSDVFSFGVMLLEL 511
++PE KSD++S G +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 36/97 (37%), Positives = 56/97 (57%), Gaps = 8/97 (8%)
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS---TRVMGTF 482
GL Y+H ++HRD+K N+L++ + E + DFGLA+ ++N + T + T
Sbjct: 117 GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 483 GYLAPEYASSGKLTEKS-DVFSFGVMLLELITGRRPV 518
Y APE S + K+ DV+S G +L EL+ GR+PV
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 13/208 (6%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNGKEV-AVKSLKTGSGQGEREFS---AEVEIISRVHHRH 373
F +LG+G FG V E+ A+K LK + + E +++
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 374 LVSLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHE 432
++ + C R+ V E+V+ L YH+ + V A + GL +LH
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHR 119
Query: 433 DCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM-GTFGYLAPEYAS 491
II+RD+K N+++D +ADFG+ K V+TR GT Y+APE +
Sbjct: 120 R---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIA 174
Query: 492 SGKLTEKSDVFSFGVMLLELITGRRPVD 519
+ D +++GV+L E++ G+ P D
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 46/132 (34%), Positives = 68/132 (51%), Gaps = 11/132 (8%)
Query: 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANI 448
LV +++S L +HL E R D A + IA L +LH+ I++RD+K NI
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRA-KFYIA-ELVLALEHLHKY---DIVYRDLKPENI 127
Query: 449 LIDDNFEAMVADFGLAK--LSNDNHTHVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFG 505
L+D + DFGL+K L+++ T+ GT YLAPE K T+ D +S G
Sbjct: 128 LLDATGHIALCDFGLSKANLTDNKTTNT---FCGTTEYLAPEVLLDEKGYTKHVDFWSLG 184
Query: 506 VMLLELITGRRP 517
V++ E+ G P
Sbjct: 185 VLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 26/144 (18%), Positives = 45/144 (31%), Gaps = 20/144 (13%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPP------------SSPPPASPPPSSPPPS---SPP 61
+ ++ A ++ P+ P P A P +P + +
Sbjct: 404 AAPAAAPAAAAAARAVAAAPARRSPAPEALAAARQASARGPGGAPAPAPAPAAAPAAAAR 463
Query: 62 PSKSPPSSPPPATSSSPPPASPPTSDNNKPD--PPKNSPPPPPPS---SQSSPTPPSPSN 116
P+ + P A +++P A+P + D PP PP S +Q P
Sbjct: 464 PAAAGPRPVAAAAAAAPARAAPAAAPAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVA 523
Query: 117 NKSPSPPVFSPPPPAKKSSPPPPP 140
P P P + +P P
Sbjct: 524 ESIPDPATADPDDAFETLAPAPAA 547
|
Length = 700 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 65/229 (28%), Positives = 108/229 (47%), Gaps = 14/229 (6%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNGKE-VAVKSLKTGSGQGEREFSA-EVEIISRVHHRHLV 375
+ K LG+G + V KG + VA+K ++ +G + EV ++ + H ++V
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSA-KGLAYLHEDC 434
+L LV+E++ +Y N M V+I L +GLAY C
Sbjct: 68 TLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMH---NVKIFLYQILRGLAY----C 120
Query: 435 HPR-IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE-YASS 492
H R ++HRD+K N+LI++ E +ADFGLA+ + S V+ T Y P+ S
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGS 179
Query: 493 GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALED 541
+ + + D++ G + E+ +GR + +ED L R LLG E+
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR-LLGTPTEE 227
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 20/115 (17%), Positives = 38/115 (33%), Gaps = 1/115 (0%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSP-PSSPPPA 73
P + DA + P+ + +S + PP+ + +P +PP A
Sbjct: 429 APAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGSASAPASDAPPDA 488
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPP 128
P A+ P++ P +P + P + P+P +P
Sbjct: 489 AFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPAPEARPPTPAAAAPA 543
|
Length = 830 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 7e-09
Identities = 30/117 (25%), Positives = 48/117 (41%), Gaps = 2/117 (1%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
G + ++ A PPP+ P++ P+ PA P P+ + P + PP A
Sbjct: 666 GDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADDPAAQPPQAA 725
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPA 131
+ P P +D+ P PP+ PP P + + P PP + P PP+
Sbjct: 726 QGASAP--SPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPAPAAAPAAAPPPSPPS 780
|
Length = 824 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 7e-09
Identities = 19/91 (20%), Positives = 35/91 (38%), Gaps = 7/91 (7%)
Query: 57 PSSPPPS-------KSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSP 109
P+S PS P S+ P +++ A+ +P P PP++ +
Sbjct: 22 PNSVDPSWREFFADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPA 81
Query: 110 TPPSPSNNKSPSPPVFSPPPPAKKSSPPPPP 140
PP P+ + + +PP A ++P
Sbjct: 82 APPKPAAAAAAAAAPAAPPAAAAAAAPAAAA 112
|
Length = 1228 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 29/223 (13%)
Query: 318 FAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSA-EVEIISRVHHRHLV 375
+ K + LG+G + V+KG VA+K ++ +G + EV ++ + H ++V
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTLEY--------HLHGENRPVMDFATRVRIALGSA-KG 426
+L LV+E++ +Y ++H V++ L +G
Sbjct: 68 TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN-----------VKLFLFQLLRG 116
Query: 427 LAYLHEDCHPR-IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL 485
L Y CH R ++HRD+K N+LI++ E +ADFGLA+ + S V+ T Y
Sbjct: 117 LNY----CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYR 171
Query: 486 APE-YASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSL 527
P+ S + + D++ G + E+ TGR + +E+ L
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 7e-09
Identities = 51/228 (22%), Positives = 92/228 (40%), Gaps = 39/228 (17%)
Query: 323 LLGQGGFGYVHKGVLPN-GKEVAVKSLKTGSGQGER---EFSAEVEIISRVHHRHLVSLV 378
L+G+GG G V+ P + VA+K ++ + F E +I + + H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 379 GYCIAGGQRMLVYEFVSNKTLEYHL------------HGENRPVMDFATRVRIALGSAKG 426
C G ++ TL+ L E V F + I
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF---LSIFHKICAT 125
Query: 427 LAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN-------------DNHTH 473
+ Y+H ++HRD+K NIL+ E ++ D+G A N +
Sbjct: 126 IEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 474 ----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
+ +++GT Y+APE +E +D+++ GV+L +++T P
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 8e-09
Identities = 28/87 (32%), Positives = 41/87 (47%), Gaps = 3/87 (3%)
Query: 23 SNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPAS 82
+ S + + TP PP +PP P ++PPP+ PP PP AT +S +
Sbjct: 511 ESQSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPT--PPPPPPTATQASSNAPA 568
Query: 83 PPTSDNNKPDPPKNSPPPPPPSSQSSP 109
+D++ P PP P P P+ SSP
Sbjct: 569 QIPADSS-PPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 10/93 (10%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFG 483
KGL Y+H IIHRD+K N+ ++++ E + DFGLA+ ++ T +V TR
Sbjct: 129 KGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 484 YLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 515
Y APE + T+ D++S G ++ E++TG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 17/156 (10%)
Query: 377 LVGY--CIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMD----FATRVRIALGSAKGLAY 429
LVG C R+ V EFVS L +H+ + + + ++ + +AL +
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN------F 111
Query: 430 LHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEY 489
LHE II+RD+K N+L+D + D+G+ K ST GT Y+APE
Sbjct: 112 LHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYIAPEI 167
Query: 490 ASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMED 525
D ++ GV++ E++ GR P D+ M D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 9e-09
Identities = 15/78 (19%), Positives = 36/78 (46%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
GS AP ++ ++ A + + + + P +PP ++ P + P P+ + ++ PA
Sbjct: 39 GSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAA 98
Query: 75 SSSPPPASPPTSDNNKPD 92
+ A+ P + + +
Sbjct: 99 PPAAAAAAAPAAAAVEDE 116
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 9e-09
Identities = 15/75 (20%), Positives = 36/75 (48%)
Query: 10 TENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSS 69
+ A ++ ++ A + + + P +PP A+ P + P P++ + + P++
Sbjct: 39 GSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAA 98
Query: 70 PPPATSSSPPPASPP 84
PP A +++ P A+
Sbjct: 99 PPAAAAAAAPAAAAV 113
|
Length = 1228 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 21/132 (15%), Positives = 45/132 (34%), Gaps = 12/132 (9%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKS------PPSSP 70
A +++ A + ++ P + A+ + PP++P P +
Sbjct: 387 AAAAVGASAVPAVTAVTGAAGAALAPKAAAAAAATRAEAPPAAPAPPATADRGDDAADGD 446
Query: 71 PPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSN-NKSPSPPVFSPPP 129
P + + AS + +++ PP S S+P +P + P+P +P
Sbjct: 447 APVPAKANARASADS-----RCDERDAQPPADSGSASAPASDAPPDAAFEPAPRAAAPSA 501
Query: 130 PAKKSSPPPPPL 141
+ P
Sbjct: 502 ATPAAVPDARAP 513
|
Length = 830 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 28/220 (12%)
Query: 323 LLGQGGFGYVHKGVLPNGKEV-AVKSLKTGSGQGEREFS---AEVEIIS-RVHHRHLVSL 377
+LG+G FG V L EV A+K LK + + E I++ H L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 378 VGYCIAGGQRML-VYEFVSNKTLEYHLH-----GENRPVMDFATRVRIALGSAKGLAYLH 431
C R+ V E+V+ L + + E R +A V +AL +LH
Sbjct: 62 HC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLAL------MFLH 113
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK--LSNDNHTHVSTRVMGTFGYLAPEY 489
+I+RD+K NIL+D +ADFG+ K + N T T GT Y+APE
Sbjct: 114 RH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEI 167
Query: 490 ASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVE 529
+ D ++ GV++ E++ G+ P + ED L E
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEAD-NEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 37/148 (25%), Positives = 50/148 (33%), Gaps = 4/148 (2%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSK---SPPSSPPP 72
P +++ P TP + PP P P P P SP + PP+SP P
Sbjct: 329 PPKESDAADGPKPVPTKPVTPEAPSPPIEEEPPQPKAVVPRPLSPYTAYEDLKPPTSPIP 388
Query: 73 ATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTP-PSPSNNKSPSPPVFSPPPPA 131
SS P +S KP P P P S+ P + P P
Sbjct: 389 TPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKKTRPLSPYARYEDLK 448
Query: 132 KKSSPPPPPLKYSSSTPKSSSSSSKSSN 159
+SP P S + S+SS +
Sbjct: 449 PPTSPSPTAPTGVSPSVSSTSSVPAVPD 476
|
Length = 576 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 35/168 (20%)
Query: 362 EVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN---KTLEYHLHGENRPVMDFATRVR 418
E+ ++ ++ H +LV+L+ + LV+E+ + LE + G + +
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-----VPEHLIKK 104
Query: 419 IALGSAKGLAYLHE-DCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN---DNHT-H 473
I + + + + H+ +C IHRD+K NILI + + DFG A++ D++T +
Sbjct: 105 IIWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160
Query: 474 VSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELITG 514
V+TR Y APE Y DV++ G + EL+TG
Sbjct: 161 VATR-----WYRAPELLVGDTQYGPP------VDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 61/221 (27%), Positives = 84/221 (38%), Gaps = 55/221 (24%)
Query: 324 LGQGGFGYVHKGVLPNGKE-VAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLVSLVG 379
+GQGG+G V + E VA+K +K R E +I++ LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 380 YCIAGGQRMLVYEFVSNKTL----EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
Y F ++ L EY G DF T L + G+ L ED H
Sbjct: 68 -----------YAFQDDEYLYLAMEYVPGG------DFRT-----LLNNLGV--LSED-H 102
Query: 436 PR-----------------IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRV 478
R IHRD+K N LID + + DFGL+K + V
Sbjct: 103 ARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSV 158
Query: 479 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVD 519
+G+ Y+APE D +S G ML E + G P
Sbjct: 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 27/110 (24%), Positives = 35/110 (31%), Gaps = 6/110 (5%)
Query: 55 PPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSP 114
P PP + + T+S DP SP PP SS P+ PSP
Sbjct: 147 DPNPGPPLDEEDEDADVATTNSDNSFPGED------ADPASASPSDPPSSSPGVPSFPSP 200
Query: 115 SNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSG 164
+ S PP P+ S PPP S + P +
Sbjct: 201 PEDPSSPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQ 250
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 45/169 (26%), Positives = 59/169 (34%), Gaps = 21/169 (12%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSP-----------PPASPPPSSPPPSSPPPS 63
+ P+ S A +S+ SS SS P +P
Sbjct: 216 SASSPAPAPGRSAADDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGW 275
Query: 64 KSPPSSPPPATSSSPPPA-SPPTSDNNKPDPPKNSPP-------PPPPSSQSSPTPPSPS 115
P S P PA+SSS P SP S ++ P S P SS SS + S S
Sbjct: 276 NGPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSES 335
Query: 116 NNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSG 164
+ + P SP S PPPP SS K S S+ ++S
Sbjct: 336 SRGAAVSPGPSPSRSPSPSRPPPPAD--PSSPRKRPRPSRAPSSPAASA 382
|
Length = 1352 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 24/114 (21%), Positives = 34/114 (29%), Gaps = 24/114 (21%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
P P P + + SP +P P++ P ++ P K P
Sbjct: 362 PVPA------PQPAKPTAAAPSPVRPTPAPSTRPK--AAAAANIPPKEPVRETATPPPVP 413
Query: 78 PPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPA 131
P P +PP P P S+ P + K P P PP
Sbjct: 414 PRPVAPP-------------VPHTPESAPKLTRAAIPVDEKPKYTP---PAPPK 451
|
Length = 585 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 23/79 (29%), Positives = 33/79 (41%)
Query: 26 SDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPT 85
A + S+ P+ P SPPP+ PS+P ++ + PP +SPP P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 86 SDNNKPDPPKNSPPPPPPS 104
P PP N+ PP
Sbjct: 421 PTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 2e-08
Identities = 13/83 (15%), Positives = 32/83 (38%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
P + + ++ A +++ ++ P + P A P + P K ++ A
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 76 SSPPPASPPTSDNNKPDPPKNSP 98
++PP A+ + + +P
Sbjct: 97 AAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 2e-08
Identities = 15/82 (18%), Positives = 35/82 (42%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
P ++ ++ A ++ + + P++ PA+P P+ P ++P P ++ A + +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 78 PPPASPPTSDNNKPDPPKNSPP 99
PPA+ + P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 20/138 (14%), Positives = 44/138 (31%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
P ++ + A+ P+ T + ++ P + ++ + PP+ P + +
Sbjct: 383 PGARAAAAVGASAVPAVTAVTGAAGAALAPKAAAAAAATRAEAPPAAPAPPATADRGDDA 442
Query: 78 PPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPP 137
+P + N + + S + +P F P P A S
Sbjct: 443 ADGDAPVPAKANARASADSRCDERDAQPPADSGSASAPASDAPPDAAFEPAPRAAAPSAA 502
Query: 138 PPPLKYSSSTPKSSSSSS 155
P + P ++S
Sbjct: 503 TPAAVPDARAPAAASRED 520
|
Length = 830 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-08
Identities = 43/155 (27%), Positives = 55/155 (35%), Gaps = 9/155 (5%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPP---- 72
P P + + P SP P P PPP+ P SS P + PPS+ PP
Sbjct: 350 PTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNLPPPPALKPLSSLP-THHPPSAHPPPLQL 408
Query: 73 ---ATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSP-SPPVFSPP 128
+ PA PP ++ PPK S P P P + + P PP
Sbjct: 409 MPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHSGPPQSPFAQHPFTSGGLPAIGPP 468
Query: 129 PPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSS 163
P S+P PP S S P S+ S
Sbjct: 469 PSLPTSTPAAPPRASSGSQPPGSALPSSGGCAGPG 503
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 37/164 (22%), Positives = 57/164 (34%), Gaps = 20/164 (12%)
Query: 5 NNVTETENEEGSPPAPPSSNSSDATPPP-------SSTPSSSPPPSSPPPASPPPSSPPP 57
+ T + E S P PS + + P ++ SS P + + P
Sbjct: 174 TSKTTSWPTEVSHPTYPSQVTPQSQPATQGHQTATANQRLSSTEPVGTQGTTTSSNPEPQ 233
Query: 58 SSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPP--PPSSQSSPTPPSPS 115
+ PPPS+ PS P S+ T D + + +PP S S+ TPP
Sbjct: 234 TEPPPSQRGPSGSPQHPPSTTSQDQSTTGDGQEHTQRRKTPPATSNRRSPHSTATPP--- 290
Query: 116 NNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSN 159
P+ + +P P S S+P SS +N
Sbjct: 291 ----PTTKRQE----TGRPTPRPTATTQSGSSPPHSSPPGVQAN 326
|
Length = 408 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 66/240 (27%), Positives = 104/240 (43%), Gaps = 31/240 (12%)
Query: 323 LLGQGGFGYVHKGVL----PNGKEVAVKSLKTGSGQGEREFS---AEVEIISRVHHRHLV 375
LLG+G FG V +L G+ A+K LK + E + E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 376 SLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
+L Y R+ V E+ + L +HL E D A + SA L YLH +
Sbjct: 59 AL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYLHSE- 114
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGK 494
+++RD+K N+++D + + DFGL K + + T GT YLAPE
Sbjct: 115 -KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDND 172
Query: 495 LTEKSDVFSFGVMLLELITGRRP---------VDMTMMED-----SLVEWARPLLGAALE 540
D + GV++ E++ GR P ++ +ME+ +L A+ LL L+
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLK 232
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 17/203 (8%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLKTGSGQGERE----FSAEVEIISRVHHRHL 374
++G+G FG V HK K AVK L+ + ++E S ++ V H L
Sbjct: 2 VIGKGSFGKVLLARHKA---EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
V L + V ++++ L YHL E R ++ R A A L YLH
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARF-YAAEIASALGYLHS-- 114
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGK 494
I++RD+K NIL+D ++ DFGL K N H ++ GT YLAPE
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 495 LTEKSDVFSFGVMLLELITGRRP 517
D + G +L E++ G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 16/215 (7%)
Query: 323 LLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGERE---FSAEVEIISR-VHHRHLVSL 377
++G+G FG V +GK AVK L+ +E AE ++ + V H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 378 VGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
Y +++ V +FV+ L +HL E R + R A A L YLH
Sbjct: 62 -HYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAA-EIASALGYLHS---I 115
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLT 496
I++RD+K NIL+D ++ DFGL K + +T GT YLAPE
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 497 EKSDVFSFGVMLLELITGRRPV---DMTMMEDSLV 528
D + G +L E++ G P D+ M D+++
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 10/197 (5%)
Query: 323 LLGQGGFGYVHKGVLPNGKE-VAVKSLKTGSGQGEREFSA--EVEIISRVHHRHLVSLVG 379
++G+G +G V K KE VA+K K E + + E++++ + ++V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGS-AKGLAYLHEDCHPRI 438
G+ LV+E+V LE E P +VR + K + + H++ I
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DI 121
Query: 439 IHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEK 498
+HRDIK N+LI N + DFG A+ ++ T + T Y +PE +
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 499 SDVFSFGVMLLELITGR 515
D++S G +L EL G+
Sbjct: 182 VDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 16/136 (11%)
Query: 389 LVYEFVSNKTLEYHLHGENR----PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIK 444
V E+V+ L Y + R + +A + I GL +LH II+RD+K
Sbjct: 78 FVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GLFFLHSK---GIIYRDLK 128
Query: 445 AANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM-GTFGYLAPEYASSGKLTEKSDVFS 503
N+++D +ADFG+ K + V+T+ GT Y+APE + + D ++
Sbjct: 129 LDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWA 186
Query: 504 FGVMLLELITGRRPVD 519
FGV+L E++ G+ P +
Sbjct: 187 FGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 31/82 (37%), Positives = 52/82 (63%), Gaps = 1/82 (1%)
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKL 495
+++HRD+K+ANI + + DFG +K +D+ + V++ GT YLAPE +
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 496 TEKSDVFSFGVMLLELITGRRP 517
++K+D++S GV+L EL+T RP
Sbjct: 249 SKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS---- 492
+HRDIK N+L+D N +ADFG N + T S+ +GT Y++PE +
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 493 -GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVE 529
GK + D +S GV + E++ G P +SLVE
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETP----FYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 377 LVGY--CIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMD----FATRVRIALGSAKGLAY 429
LVG C R+ LV E+V+ L +H+ + + + +A + IAL +
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALN------F 111
Query: 430 LHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEY 489
LHE II+RD+K N+L+D + + D+G+ K ST GT Y+APE
Sbjct: 112 LHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEI 167
Query: 490 ASSGKLTEKSDVFSFGVMLLELITGRRPVDM 520
+ D ++ GV++ E++ GR P D+
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 34/93 (36%), Positives = 56/93 (60%), Gaps = 10/93 (10%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFG 483
+GL Y+H IIHRD+K +N+ ++++ E + DFGLA+ ++D T +V+TR
Sbjct: 131 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 484 YLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 515
Y APE + + D++S G ++ EL+TGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 19/87 (21%), Positives = 36/87 (41%), Gaps = 1/87 (1%)
Query: 68 SSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSP 127
++ PAT+ +P T N++ +P P Q++ PS +N + + P
Sbjct: 168 TTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTAATPA-PA 226
Query: 128 PPPAKKSSPPPPPLKYSSSTPKSSSSS 154
P + P P + STP + ++
Sbjct: 227 APATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 23/202 (11%)
Query: 324 LGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSA--EVEIISRVHHRHLVSLVGY 380
LG+G + V+KG+ NG+ VA+K + + +G F+A E ++ + H ++V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDI 71
Query: 381 CIAGGQRMLVYEFVSNKTLEYH------LHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
V+E++ +Y LH N V F ++ +GLAY+H
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYN--VRLFMFQL------LRGLAYIH--- 120
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE-YASSG 493
I+HRD+K N+LI E +ADFGLA+ + S+ V+ T Y P+ +
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGAT 179
Query: 494 KLTEKSDVFSFGVMLLELITGR 515
+ D++ G + +E++ G+
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 4e-08
Identities = 13/82 (15%), Positives = 32/82 (39%)
Query: 11 ENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSP 70
+ A P++ ++ A S+ ++ + PA PP++ P++PP + ++
Sbjct: 34 ADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAA 93
Query: 71 PPATSSSPPPASPPTSDNNKPD 92
+ A+ + D
Sbjct: 94 AAPAAPPAAAAAAAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 21/159 (13%), Positives = 55/159 (34%), Gaps = 9/159 (5%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPS-------SPPPSSPPPSKSPPS 68
P + ++ A P + +++ + PPA+P P P +
Sbjct: 396 VPAVTAVTGAAGAALAPKAAAAAAATRAEAPPAAPAPPATADRGDDAADGDAPVPAKANA 455
Query: 69 SPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPP--PSSQSSPTPPSPSNNKSPSPPVFS 126
+ A PP + P ++PP P+ +++ + + +
Sbjct: 456 RASADSRCDERDAQPPADSGSASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAA 515
Query: 127 PPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGD 165
++ PP + TP +++ ++++ +++ D
Sbjct: 516 ASREDAPAAAAPPAPEARPPTPAAAAPAARAGGAAAALD 554
|
Length = 830 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 14/84 (16%), Positives = 29/84 (34%)
Query: 33 SSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPD 92
++ P+++P P++P +P S P + P+ + + S +
Sbjct: 169 TTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTAATPAPAAP 228
Query: 93 PPKNSPPPPPPSSQSSPTPPSPSN 116
+ P P TP + N
Sbjct: 229 ATPDGAAPLPTDQAGVSTPAADPN 252
|
Length = 331 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS-NDNHTHVS-TRVMGTF 482
+ L Y+H + HRD+K NIL + + + + DFGLA+++ ND T + T + T
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 483 GYLAPEYASS--GKLTEKSDVFSFGVMLLELITGR 515
Y APE S K T D++S G + E++TG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 36/207 (17%)
Query: 324 LGQGGFGYVHKG-VLPNGKEVAVKSLK-TGSGQGEREFSAEVEIISRV-HHRHLVSL--V 378
+G+G F V K GK A+K +K + E++ + R+ H +++ L V
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 379 GYCIAGGQRMLV--------YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYL 430
+ G+ LV YE + + + L E R V + ++ K L ++
Sbjct: 67 LFDRKTGRLALVFELMDMNLYELIKGR--KRPL-PEKR-VKSYMYQL------LKSLDHM 116
Query: 431 HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH---VSTRVMGTFGYLAP 487
H I HRDIK NILI D+ +ADFG + + +STR Y AP
Sbjct: 117 H---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-----WYRAP 167
Query: 488 E-YASSGKLTEKSDVFSFGVMLLELIT 513
E + G K D+++ G + E+++
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 30/222 (13%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLKTGSGQGEREFS---AEVEIISR-VHHRHL 374
++G+G FG V K +G AVK L+ + ++E + AE ++ + + H L
Sbjct: 2 VIGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFL 58
Query: 375 VSLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENR---PVMDF-ATRVRIALGSAKGLAY 429
V L Y +++ V ++V+ L +HL E P F A V A+G Y
Sbjct: 59 VGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIG------Y 111
Query: 430 LHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEY 489
LH II+RD+K NIL+D ++ DFGL K + ST GT YLAPE
Sbjct: 112 LHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEV 167
Query: 490 ASSGKLTEKSDVFSFGVMLLELITGRRPV---DMTMMEDSLV 528
D + G +L E++ G P D++ M D+++
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 324 LGQGGFGYVHKG--VLPNGKEVAVKSLKTGSGQGEREFSA--EVEIISRVH---HRHLVS 376
+G+G +G V K + G+ VA+K ++ +G+ S EV ++ + H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 377 LVGYCIAG-----GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLH 431
L C + LV+E V ++ L +L P + T + +GL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYAS 491
R++HRD+K NIL+ + + +ADFGLA++ + T V+ T Y APE
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVLL 182
Query: 492 SGKLTEKSDVFSFGVMLLELITGRRPV 518
D++S G + E+ R+P+
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 8/158 (5%)
Query: 370 HHRHLVSLVGYCIAGGQRML-VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLA 428
+H LV L C R+ V E+V+ L +H+ + + + A + A L
Sbjct: 54 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LN 110
Query: 429 YLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE 488
YLHE II+RD+K N+L+D + D+G+ K ++ GT Y+APE
Sbjct: 111 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPE 166
Query: 489 YASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDS 526
D ++ GV++ E++ GR P D+ D+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 7/110 (6%)
Query: 411 MDFATRVRIALGSAKGLAYL-HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSN 468
+D +R + A+G+ +L ++C IHRD+ A N+L+ D A + DFGLA+ + N
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 469 DNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
D++ V ++APE T +SDV+S+G++L E+ + G+ P
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 24/83 (28%), Positives = 33/83 (39%), Gaps = 5/83 (6%)
Query: 5 NNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSK 64
+ ++ PPAP S S P P S + SPPP P PP PP S
Sbjct: 201 PEDPSSPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLS----- 255
Query: 65 SPPSSPPPATSSSPPPASPPTSD 87
+ +PP A+++ P D
Sbjct: 256 TAKPTPPSASATPAPIGGITLDD 278
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 5e-08
Identities = 25/81 (30%), Positives = 34/81 (41%), Gaps = 3/81 (3%)
Query: 33 SSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPD 92
S S +S P P +P P P S P + AT+ SPPPA P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKAS---PPIPV 417
Query: 93 PPKNSPPPPPPSSQSSPTPPS 113
P + + P P P + ++ PPS
Sbjct: 418 PAEPTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 5e-08
Identities = 19/80 (23%), Positives = 27/80 (33%)
Query: 62 PSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPS 121
S S + PP SPPP +P PPPPP + + + +P+ + S
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 122 PPVFSPPPPAKKSSPPPPPL 141
P P S
Sbjct: 575 SPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 56/218 (25%), Positives = 100/218 (45%), Gaps = 20/218 (9%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQG-EREFSAEVEIISRVHHRHLVSLVGYCI 382
+G+G +G+V+K +GK+ +LK G G E+ ++ + H +++SL +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 383 AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAK--------GLAYLHEDC 434
+ R + F + +H+ +R V++ G K G+ YLH +
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 435 HPRIIHRDIKAANILI----DDNFEAMVADFGLAKLSNDNHTHVS--TRVMGTFGYLAPE 488
++HRD+K ANIL+ + +AD G A+L N ++ V+ TF Y APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 489 YASSGK-LTEKSDVFSFGVMLLELITGRRPVDMTMMED 525
+ T+ D+++ G + EL+T P+ ED
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 324 LGQGGFGYVHKGVLPN---------GKEVAV--KSLKTGSGQGEREFSAEVEIISRVHHR 372
LGQG F ++KGVL G+EV+V K L + + F ++S++ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD-HRDSLAFFETASLMSQLSHK 61
Query: 373 HLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHE 432
HLV L G C+ M V E+V L+ LH E V ++ +A A L YL +
Sbjct: 62 HLVKLYGVCVRDENIM-VEEYVKFGPLDVFLHREKNNV-SLHWKLDVAKQLASALHYLED 119
Query: 433 DCHPRIIHRDIKAANILI--DDNFEAMVADFGLAKLSNDNHT----HVSTRVMGTFGYLA 486
+++H ++ NIL+ E V KLS+ RV ++A
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPF---IKLSDPGIPITVLSREERVERI-PWIA 172
Query: 487 PEYASSG--KLTEKSDVFSFGVMLLEL 511
PE +G LT +D +SFG LLE+
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-08
Identities = 38/140 (27%), Positives = 58/140 (41%), Gaps = 7/140 (5%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSS-PPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA 73
G P PS ++ P P + PPP +P P PP + P + P + + + PP A
Sbjct: 670 GHIPYQPSPTGANTMLPIQWAPGTMQPPPRAPTPMRPPAAPPGRAQRPAAATGRARPPAA 729
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPP---PPPPSSQSSPTPPSPSNNKSPSPPVFSPPPP 130
P A PP + + PP +P PP + + P + +P PP +PP P
Sbjct: 730 A---PGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGAPTPQPPPQAPPAP 786
Query: 131 AKKSSPPPPPLKYSSSTPKS 150
++ P P + P S
Sbjct: 787 QQRPRGAPTPQPPPQAGPTS 806
|
Length = 991 |
| >gnl|CDD|240271 PTZ00108, PTZ00108, DNA topoisomerase 2-like protein; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 6e-08
Identities = 23/164 (14%), Positives = 37/164 (22%), Gaps = 11/164 (6%)
Query: 3 KGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPP 62
+ N+S + + SS P + P PP
Sbjct: 1227 DDEEQKTKPKKSSVKRLKSKKNNSSKSSEDNDEFSSDDLSKEGKPKNAPKRVSAVQYSPP 1286
Query: 63 SKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSP 122
S S P +S K + + + KS +
Sbjct: 1287 PPSKRPDGESNGGSKP------SSPTKKKVKKRLEGSLAALKKKKKSEKKTARKKKSKTR 1340
Query: 123 PVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDD 166
+ + + P K SSS S S D+
Sbjct: 1341 VKQASASQSSRLLRRPRKKK-----SDSSSEDDDDSEVDDSEDE 1379
|
Length = 1388 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 6e-08
Identities = 18/75 (24%), Positives = 33/75 (44%), Gaps = 5/75 (6%)
Query: 13 EEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPP 72
E G+P P + A P+ ++PPP++ PP P + P ++ P P +
Sbjct: 378 ERGAPAPPSA-----AWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAA 432
Query: 73 ATSSSPPPASPPTSD 87
+ S PA+ ++
Sbjct: 433 PPARSADPAAAASAG 447
|
Length = 576 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 23/209 (11%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNGKE-VAVKSLKTG---SGQGEREFSAEVEIISRVHHRH 373
+ +G G FG VH + A+K + + E+ E ++ V H
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 374 LVSLVGYCIAGGQRML--VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGS--AKGLAY 429
++ L + QR L + E+V L +L R F+ + S L Y
Sbjct: 63 IIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR----FSNSTGLFYASEIVCALEY 116
Query: 430 LHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTFGYLAPE 488
LH I++RD+K NIL+D + DFG AK L + T + GT YLAPE
Sbjct: 117 LHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----LCGTPEYLAPE 168
Query: 489 YASSGKLTEKSDVFSFGVMLLELITGRRP 517
S + D ++ G+++ E++ G P
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 34/215 (15%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNGKE-VAVKSLKTGSGQGEREFSA-------EVEIISRV 369
+ K +G+G +G V+K E +A+K ++ E+E E+ ++ +
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL-----EQEDEGVPSTAIREISLLKEM 58
Query: 370 HHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIA----LGSAK 425
H ++V L + + LV+E++ L+ H ++ P DFA R+ +
Sbjct: 59 QHGNIVRLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSP--DFAKNPRLIKTYLYQILR 113
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAM-VADFGLAK---LSNDNHTHVSTRVMGT 481
G+AY H R++HRD+K N+LID A+ +ADFGLA+ + TH T
Sbjct: 114 GIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----T 166
Query: 482 FGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 515
Y APE S + D++S G + E++ +
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 7e-08
Identities = 17/118 (14%), Positives = 31/118 (26%), Gaps = 3/118 (2%)
Query: 40 PPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPP 99
P P P PP S+ P +S + +P ++ P + + PP P P
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQ---APAVPLPE 417
Query: 100 PPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKS 157
+ + A+ + L P + +
Sbjct: 418 TTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAK 475
|
Length = 647 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-08
Identities = 44/152 (28%), Positives = 57/152 (37%), Gaps = 7/152 (4%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
S PP + + + PPP+ + + PP P A+ P P SP S PS P
Sbjct: 180 SIQVPPGAALAPSAPPPT-PSAQAVPPQGSPIAAQPAPQPQQPSPLSLISAPSLHPQRLP 238
Query: 76 SSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKS-----PSPPVFSPPPP 130
S PP P T+ P PP P SS P PP P + P P P
Sbjct: 239 SPHPPLQPQTASQQSPQPPA-PSSRHPQSSHHGPGPPMPHALQQGPVFLQHPSSNPPQPF 297
Query: 131 AKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSS 162
S PP S + P S + S+S+
Sbjct: 298 GLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQ 329
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 14/208 (6%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKT---GSGQGEREFSAEVEIISRVHHRH 373
F +G+G F V++ L +G VA+K ++ + + E++++ +++H +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEY---HLHGENRPVMDFAT-RVRIALGSAKGLAY 429
++ I + +V E L H + R + + + + L SA L +
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LEH 121
Query: 430 LHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEY 489
+H R++HRDIK AN+ I + D GL + + T + V GT Y++PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 490 ASSGKLTEKSDVFSFGVMLLELITGRRP 517
KSD++S G +L E+ + P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 8e-08
Identities = 39/143 (27%), Positives = 56/143 (39%), Gaps = 14/143 (9%)
Query: 25 SSDATPPPSSTPSSSPPPS---SPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSP--P 79
S DA PP P ++PP + S PP P P P+ ++ P + P A +P
Sbjct: 2545 SDDAGDPPPPLPPAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQSARPRAPVDD 2604
Query: 80 PASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPP 139
P P PP P P P PSP+ N+ P + PPP + P P
Sbjct: 2605 RGDPRGPAPPSPLPP--DTHAPDP----PPPSPSPAANEPDPHPPPTVPPPERPRDDPAP 2658
Query: 140 PLKYSSSTPKSSSSSSKSSNGSS 162
S P+ + +++ SS
Sbjct: 2659 G---RVSRPRRARRLGRAAQASS 2678
|
Length = 3151 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 8/149 (5%)
Query: 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSA-KGLAYLHEDCHPRIIHRDIKAAN 447
L+ ++VS + HL+ + D VR G L +LH+ I++RDIK N
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSED---EVRFYSGEIILALEHLHK---LGIVYRDIKLEN 135
Query: 448 ILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGV 506
IL+D ++ DFGL+K + GT Y+APE G + D +S G+
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGI 195
Query: 507 MLLELITGRRPVDMTMMEDSLVEWARPLL 535
++ EL+TG P + ++ E +R +L
Sbjct: 196 LIFELLTGASPFTLEGERNTQSEVSRRIL 224
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 46/168 (27%), Positives = 69/168 (41%), Gaps = 9/168 (5%)
Query: 348 LKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGEN 407
+K G G + E I+ ++H ++ L G L+ Y N
Sbjct: 122 IKAGQRGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRN 178
Query: 408 RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467
+ D R L + + YLHE+ RIIHRDIKA NI I+ + + DFG A
Sbjct: 179 IAICDILAIERSVL---RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFP 232
Query: 468 NDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR 515
D + + GT APE + D++S G++L E+ T
Sbjct: 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 1e-07
Identities = 21/127 (16%), Positives = 35/127 (27%), Gaps = 7/127 (5%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
A + PPP+S P +P P S ++ + PA +
Sbjct: 387 PTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTSQLLAARQQLQRAQGATKAKKSEPAAA 446
Query: 76 SSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSS 135
S P + S P P + + +P K+ +P P A +
Sbjct: 447 SRARPVNSAL-------ERLASVRPAPSALEKAPAKKEAYRWKATNPVEVKKEPVATPKA 499
Query: 136 PPPPPLK 142
Sbjct: 500 LKKALEH 506
|
Length = 647 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 1e-07
Identities = 27/103 (26%), Positives = 44/103 (42%), Gaps = 4/103 (3%)
Query: 13 EEGSPPAPPSSNSSDATPPPSSTPSSSPPPS-SPPPASPPPSSPPPSSPPPSKSPPSSPP 71
PA P++ + A P+ P+++PP + PA+ PP + +S P + P
Sbjct: 682 PPAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPL 741
Query: 72 PATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSP 114
P PP + + P PP P P++ P+PPS
Sbjct: 742 PPEPDDPPDPAGAPAQ---PPPPPAPAPAAAPAAAPPPSPPSE 781
|
Length = 824 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 20/79 (25%), Positives = 32/79 (40%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
P+ S ++A+ P + TP+ +P P P P + ++ P +SPP +
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 78 PPPASPPTSDNNKPDPPKN 96
P SP N PP
Sbjct: 421 PTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 36/216 (16%)
Query: 324 LGQGGFGYVHKGVLPN-GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI 382
LG G G V V + K VAVK + Q + E++II R+ H ++V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 383 AGGQRM--------------LVYEFVSN---KTLEYHLHGENRPVMDFATRVRIALGSAK 425
G + +V E++ LE E + +R
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------- 125
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMV---ADFGLAKLSNDNHTHVSTRVMG-- 480
GL Y+H ++HRD+K AN+ I N E +V DFGLA++ + +++H G
Sbjct: 126 GLKYIHS---ANVLHRDLKPANVFI--NTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 481 TFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGR 515
T Y +P S T+ D+++ G + E++TG+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 34/95 (35%), Positives = 47/95 (49%), Gaps = 10/95 (10%)
Query: 439 IHRDIKAANILIDDNFEAMVADFGLA-KLSNDNHTHVSTRVMGTFGYLAPEYASS----G 493
IHRD+K N+L+D + +ADFG K+ + T V GT Y++PE S G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 494 KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLV 528
+ D +S GV L E++ G P DSLV
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP----FYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 39/150 (26%), Positives = 46/150 (30%), Gaps = 18/150 (12%)
Query: 9 ETENEEGSPPAPPSSNSSDATPPPSSTPSSSP-----PPSSPPPASPPPSSPPPSSPPPS 63
+ E EEG S+ P T P P+ P S P P
Sbjct: 526 DKEGEEGEHEDSKESDEPKEGGKPGETKEGEVGKKPGPAKEHKPSKIPTLSKKPEFPKDP 585
Query: 64 KSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPP 123
K P P P A PT P P + P SP +SP P
Sbjct: 586 KHPKDPEEPKKPKRPRSAQRPTR------------PKSPKLPELLDIPKSPKRPESPKSP 633
Query: 124 VFSPPPPAKKSSPPPPPLKYSSSTPKSSSS 153
PPPP + SSP P +PK S
Sbjct: 634 K-RPPPPQRPSSPERPEGPKIIKSPKPPKS 662
|
Length = 943 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 33/147 (22%), Positives = 49/147 (33%), Gaps = 2/147 (1%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
PP P + P P P PPP PP PP + + S P +
Sbjct: 2908 PPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAPTTDPAGAGEPSGAVPQPWLGAL 2967
Query: 77 SPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPA--KKS 134
P + P +P P + +P P S S + + PPP K++
Sbjct: 2968 VPGRVAVPRFRVPQPAPSREAPASSTPPLTGHSLSRVSSWASSLALHEETDPPPVSLKQT 3027
Query: 135 SPPPPPLKYSSSTPKSSSSSSKSSNGS 161
PP + S + S S +S +
Sbjct: 3028 LWPPDDTEDSDADSLFDSDSERSDLEA 3054
|
Length = 3151 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 44/191 (23%), Positives = 63/191 (32%), Gaps = 41/191 (21%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPAS--PPPSSPPP-------------- 57
E P AP ++A P ++ + P PP P PS P
Sbjct: 2472 ELFPGAPVYRRPAEARFPFAAGAAPDPGGGGPPDPDAPPAPSRLAPAILPDEPVGEPVHP 2531
Query: 58 ----------------SSPPPSKSPPSSPPPATSSSPPPASPP--------TSDNNKPD- 92
+ PP PP++PP A S PP P TS +PD
Sbjct: 2532 RMLTWIRGLEELASDDAGDPPPPLPPAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDA 2591
Query: 93 PPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSS 152
PP+++ P P + P P+P + P PPPP+ + P + P
Sbjct: 2592 PPQSARPRAPVDDRGDPRGPAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPER 2651
Query: 153 SSSKSSNGSSS 163
+ G S
Sbjct: 2652 PRDDPAPGRVS 2662
|
Length = 3151 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-07
Identities = 23/78 (29%), Positives = 31/78 (39%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
S +N+S P + S PP P A + SPPP+K+ P P PA
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 75 SSSPPPASPPTSDNNKPD 92
+ P P P + N P
Sbjct: 421 PTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-07
Identities = 23/96 (23%), Positives = 33/96 (34%), Gaps = 10/96 (10%)
Query: 51 PPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPT 110
+S +PPP + P P P PP PT+ P PP P SS +
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAP-----TPPLPQPTATAPPPTPPPPPPTATQASSNAPAQ 569
Query: 111 PPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSS 146
P+ S+ P P P + P + +
Sbjct: 570 IPADSSPPPP-----IPEEPTPSPTKDSSPEEIDKA 600
|
Length = 620 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 24/107 (22%), Positives = 40/107 (37%), Gaps = 7/107 (6%)
Query: 39 SPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSP 98
S P + P + P + + S P +S++ P++P ++ PP S
Sbjct: 370 SGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVSV 429
Query: 99 PPPPPSSQSSPTPPSPSNNKSPSPPVFS---PPPPAKKSSPPPPPLK 142
PP P P + ++ P F P +K SS P L+
Sbjct: 430 DPPAA----VPVNPPSTAPQAVRPAQFKEEKKIPVSKVSSLGPSTLR 472
|
Length = 614 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 2e-07
Identities = 15/84 (17%), Positives = 33/84 (39%), Gaps = 5/84 (5%)
Query: 39 SPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSP 98
P ++ P A+ ++ S+P + P + P A + +PP A+ P + P P +
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAA--PAAKAPAAPAPAPPAAAAPAAP---PKPAAAAA 91
Query: 99 PPPPPSSQSSPTPPSPSNNKSPSP 122
P++ + + +
Sbjct: 92 AAAAPAAPPAAAAAAAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 2e-07
Identities = 22/115 (19%), Positives = 40/115 (34%), Gaps = 25/115 (21%)
Query: 42 PSSPPPA--------SPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDP 93
P+S P+ P ++ P ++ + + S+P A ++ P A P P
Sbjct: 22 PNSVDPSWREFFADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPA-------P 74
Query: 94 PKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTP 148
P + P PP ++ + + PP A ++ P TP
Sbjct: 75 PAAAAPAAPPKPAAAAAAAAAP----------AAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 23/149 (15%), Positives = 50/149 (33%), Gaps = 5/149 (3%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSP--PSSPPP 72
G+P + + A P P + +++ S+ P + + + P + + +
Sbjct: 366 GAPGGGVPARVAGAVPAPGARAAAAVGASAVPAVTAVTGAAGAALAPKAAAAAAATRAEA 425
Query: 73 ATSSSPPPASPPTSDNNKPDP---PKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPP 129
++ PPA+ D+ P + S+ P + + S P
Sbjct: 426 PPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGSASAPASDAP 485
Query: 130 PAKKSSPPPPPLKYSSSTPKSSSSSSKSS 158
P P P S++TP + + +
Sbjct: 486 PDAAFEPAPRAAAPSAATPAAVPDARAPA 514
|
Length = 830 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 40/184 (21%), Positives = 66/184 (35%), Gaps = 30/184 (16%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPAS--PPPSSPPPSSPPPSKSPPSSPPPA-- 73
A + DA PP S +S+P +PP A+ P P + PS+ P+ P + P A
Sbjct: 458 SADSRCDERDAQPPADSGSASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAAS 517
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPP--------------------------PPPPSSQS 107
+P A+PP + P P +P +++
Sbjct: 518 REDAPAAAAPPAPEARPPTPAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKP 577
Query: 108 SPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDY 167
+ P + +P V P P A+ ++ PP + + + S + DDY
Sbjct: 578 AAAPAAAPKPAAPRVAVQVPTPRARAATGDAPPNGAARAEQAAESRGAPPPWEDIPPDDY 637
Query: 168 VTYS 171
V S
Sbjct: 638 VPLS 641
|
Length = 830 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 43/139 (30%), Positives = 54/139 (38%), Gaps = 10/139 (7%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
P PP S + PP +ST S S PP SP P S P+ PP S P +T
Sbjct: 418 VPAQPPVLTQSQSLPPKASTHPHSGLHSGPP-QSPFAQHPFTSGGLPAIGPPPSLPTSTP 476
Query: 76 SSPPPASP---PTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAK 132
++PP AS P P PP P Q P + SPPPP +
Sbjct: 477 AAPPRASSGSQPPGSALPSSGGCAGPGPPLPPIQIKEEPLDEAEEPE------SPPPPPR 530
Query: 133 KSSPPPPPLKYSSSTPKSS 151
SP P + S +S+
Sbjct: 531 SPSPEPTVVNTPSHASQSA 549
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 40/121 (33%), Positives = 44/121 (36%), Gaps = 9/121 (7%)
Query: 11 ENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSP 70
E E G P P + P S P P P P P S P S
Sbjct: 554 EGEVGKKPGPAKEHKPSKIPTLSKKPEFPKDPKHPKDPEEPKKPKRPRSAQRPTRPKS-- 611
Query: 71 PPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPT-PPSPSNNKSPSPPVFSPPP 129
P P SP +P+ PK+ PPPP SSP P P KSP PP SP P
Sbjct: 612 PKLPELLDIPKSP-----KRPESPKSPKRPPPPQRPSSPERPEGPKIIKSPKPPK-SPKP 665
Query: 130 P 130
P
Sbjct: 666 P 666
|
Length = 943 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 32/156 (20%), Positives = 48/156 (30%), Gaps = 3/156 (1%)
Query: 21 PSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPP 80
+ SS TP S + S P P S S + S + + P
Sbjct: 388 SNPGSSIDTPSSSPSSSVIMTPPDSGPGSNVSSRRVGTPGSKSDRVGAVLLRRMNIKPTL 447
Query: 81 ASPPTSDN---NKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPP 137
AS P + + + SP P + P+ P F+ S PP
Sbjct: 448 ASIPDEKPSNISVFEDSETSPNSSTLLRDPPPKKCGEESGHLPNNPFFNKLKLTLSSIPP 507
Query: 138 PPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVTYSVI 173
P + + P S +S+ S+ S Y V
Sbjct: 508 LSPRQSIITLPTPSRPASRISSLSLRLGSYSGSIVS 543
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 12/178 (6%)
Query: 341 KEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLE 400
K+V VK++ TG RE ++I+ + HR +++L+ A + V + +
Sbjct: 120 KKVIVKAV-TGGKTPGRE----IDILKTISHRAIINLIH---AYRWKSTVCMVMPKYKCD 171
Query: 401 YHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVAD 460
+ + + + I + LAYLH IIHRD+K NI +D+ A++ D
Sbjct: 172 LFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGD 228
Query: 461 FGLA-KLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
FG A KL T GT +PE + K+D++S G++L E+
Sbjct: 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 28/126 (22%), Positives = 40/126 (31%), Gaps = 12/126 (9%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
AP ++ +A P +P P P PP + P P +P PA
Sbjct: 70 RVNHAPANAQEHEAARP---SPQHQYQPPYASAQPRQPVQQPPEAQVP---PQHAPRPAQ 123
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKS 134
+ P P +P+ P P P + P +P P+ F P P
Sbjct: 124 PAPQPVQQPAYQP--QPEQPLQQPVSPQVAPAPQPVHSAPQ----PAQQAFQPAEPVAAP 177
Query: 135 SPPPPP 140
P P
Sbjct: 178 QPEPVA 183
|
Length = 333 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 33/136 (24%), Positives = 42/136 (30%), Gaps = 12/136 (8%)
Query: 11 ENEEGSPPAPPSSNSSDATPPPS-STPSSSPPPSSPPPASPPPSSPP-----PSSPPPSK 64
+ P S+S ST +SS P PASPP SSP SS SK
Sbjct: 7 SGSTSGDASSPRSSSRRRLSSSFLSTSASSRPRRLNAPASPPSSSPARNTSSSSSFGLSK 66
Query: 65 SPPSSPPPATSSSPPPASPPTSDNNKPDPP------KNSPPPPPPSSQSSPTPPSPSNNK 118
PSS SS + S + S P S+ + + S N
Sbjct: 67 QRPSSLSRGRLSSRFVSPSRGSPSAAASLNGSLATASTSGSSSPSRSRRTTSSDLSSGNG 126
Query: 119 SPSPPVFSPPPPAKKS 134
+ KK
Sbjct: 127 PSVLSFMADVKRGKKG 142
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 33/145 (22%), Positives = 45/145 (31%), Gaps = 11/145 (7%)
Query: 21 PSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPP 80
+S SS +T +S+P SS +S P SPPSS P +SS
Sbjct: 2 AASVSSGSTSGDASSPRSSSRRRLSSSFLSTSASSRPRRLNAPASPPSSSPARNTSSSSS 61
Query: 81 ASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPP 140
K P SS SPS + + +S P
Sbjct: 62 FG----------LSKQRPSSLSRGRLSSRF-VSPSRGSPSAAASLNGSLATASTSGSSSP 110
Query: 141 LKYSSSTPKSSSSSSKSSNGSSSGD 165
+ +T SS + S S D
Sbjct: 111 SRSRRTTSSDLSSGNGPSVLSFMAD 135
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 18/65 (27%), Positives = 27/65 (41%), Gaps = 2/65 (3%)
Query: 25 SSDATPPPSSTPSSSPPPSSPPPASPPPSS--PPPSSPPPSKSPPSSPPPATSSSPPPAS 82
+ PP++TP+S+P P+ PPASP P S+ S SP +
Sbjct: 80 GTGKVAPPAATPTSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAPESPSTSV 139
Query: 83 PPTSD 87
P +
Sbjct: 140 PSSGS 144
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 32/85 (37%), Positives = 42/85 (49%), Gaps = 6/85 (7%)
Query: 439 IHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEK 498
+HRDIK N+LID +ADFG A N S +GT Y+APE ++ K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 499 S------DVFSFGVMLLELITGRRP 517
D +S GV+ E+I GR P
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 3e-07
Identities = 26/80 (32%), Positives = 32/80 (40%), Gaps = 3/80 (3%)
Query: 46 PPASPPPSSPPP---SSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPP 102
AS +PPP S PPP+ +PP P AT+ P P PP + P
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 103 PSSQSSPTPPSPSNNKSPSP 122
P P+PS K SP
Sbjct: 575 SPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 3e-07
Identities = 17/102 (16%), Positives = 34/102 (33%), Gaps = 18/102 (17%)
Query: 41 PPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPP 100
P S+ P + ++ +S P + +P + P A+P PPK +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAA-------PPKPAAAA 90
Query: 101 PPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLK 142
++ ++P + + P A PL+
Sbjct: 91 AAAAAPAAPPAAAA-----------AAAPAAAAVEDEVTPLR 121
|
Length = 1228 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 32/159 (20%), Positives = 48/159 (30%), Gaps = 9/159 (5%)
Query: 6 NVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPP----SSPP 61
N+ T S D+ P+S+ PP P
Sbjct: 442 NIKPTLASIPDEKPSNISVFEDSETSPNSSTLLRDPPPKKCGEESGHLPNNPFFNKLKLT 501
Query: 62 PSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKN-----SPPPPPPSSQSSPTPPSPSN 116
S PP SP + + P P+ P + ++ + PPP P+ S S
Sbjct: 502 LSSIPPLSPRQSIITLPTPSRPASRISSLSLRLGSYSGSIVSPPPYPTLVSRKGAAGLSF 561
Query: 117 NKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSS 155
N+S S P L + + + SS SS
Sbjct: 562 NRSVSDIEGERIGRYNLLPTRIPALPFKAESTTSSRRSS 600
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 424 AKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV---STRVMG 480
A+G+ +L + IHRD+ A NIL+ +N + DFGLA+ + +V R+
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 237
Query: 481 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 513
++APE T +SDV+SFGV+L E+ +
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 49/166 (29%), Positives = 75/166 (45%), Gaps = 22/166 (13%)
Query: 20 PPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS---- 75
P+SN+ PP S+TP S+PP S+PP ++ P S+ P S+ P S +PPSS S
Sbjct: 427 APNSNTPYNNPPNSNTPYSNPPNSNPPYSNLPYSNTPYSNAPLSNAPPSSAKDHHSAYHA 486
Query: 76 ------SSPPPASPPTSDNNKPDP---PKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFS 126
++ P A+ PT++ + + P +S+ + P N + + P
Sbjct: 487 AYQHRAANQPAANLPTANQPAANNFHGAAGNSVGNPFASRPFGSAPYGGNAATTADPNGI 546
Query: 127 PPPPAKKSSPPPPPL---KYSSSTPKSSSSSSKSSNGSSSGDDYVT 169
AK+ P KY S +S SS SS SS ++ VT
Sbjct: 547 ----AKREDHPEGGTNRQKYEQSDEESVESS--SSENSSENENEVT 586
|
Length = 1560 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 32/93 (34%), Positives = 55/93 (59%), Gaps = 10/93 (10%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFG 483
+GL Y+H IIHRD+K +N+ ++++ E + DFGLA+ ++D T +V+TR
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 484 YLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 515
Y APE + + D++S G ++ EL+ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 4e-07
Identities = 18/124 (14%), Positives = 29/124 (23%), Gaps = 8/124 (6%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPP--PASPPPSSPPPSSPPPSKSP--PSSPPP 72
P + P P+ P ++ A ++ P S P
Sbjct: 392 APPQAPAVPPPPASAPQQAPAVPLPETTSQLLAARQQLQRAQGATKAKKSEPAAASRARP 451
Query: 73 ATSSSPPPASPPTSDNNKPDPPKNSPP----PPPPSSQSSPTPPSPSNNKSPSPPVFSPP 128
S+ AS + + P P +P K +P
Sbjct: 452 VNSALERLASVRPAPSALEKAPAKKEAYRWKATNPVEVKKEPVATPKALKKALEHEKTPE 511
Query: 129 PPAK 132
AK
Sbjct: 512 LAAK 515
|
Length = 647 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 4e-07
Identities = 21/127 (16%), Positives = 49/127 (38%), Gaps = 7/127 (5%)
Query: 45 PPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPS 104
+ P++ PS+ + + +P A ++ +P + +P P P PP
Sbjct: 387 VAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAA--PQPAPAPAPAPAPPSP 444
Query: 105 SQSSPTPPSPSNNKSPSP-----PVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSN 159
+ ++P +PS + +P P + P + P PP + + ++ ++ +
Sbjct: 445 AGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPA 504
Query: 160 GSSSGDD 166
G+
Sbjct: 505 GADDAAT 511
|
Length = 824 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 4e-07
Identities = 16/79 (20%), Positives = 28/79 (35%)
Query: 11 ENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSP 70
+ S A S+ ++ P S P + PS+P + PP + P +
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 71 PPATSSSPPPASPPTSDNN 89
P S +PP + +
Sbjct: 421 PTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 4e-07
Identities = 15/70 (21%), Positives = 23/70 (32%)
Query: 71 PPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPP 130
+ + A + P PP P P ++ + T PSP K+ P P
Sbjct: 363 AFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPT 422
Query: 131 AKKSSPPPPP 140
+PP
Sbjct: 423 EPSPTPPANA 432
|
Length = 620 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 27/101 (26%), Positives = 37/101 (36%), Gaps = 19/101 (18%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSS---PPPSKSPPSSPP 71
AP S ++ A+P PS + S++ PS+P A+ P +PP S P P
Sbjct: 385 QPAAAPQPSAAAAASPSPSQS-SAAAQPSAPQSATQPAGTPPTVSVDPPAAVPVNP---- 439
Query: 72 PATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPP 112
S+ P A P P S SS P
Sbjct: 440 ---PSTAPQAVRP--------AQFKEEKKIPVSKVSSLGPS 469
|
Length = 614 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 20/112 (17%), Positives = 35/112 (31%), Gaps = 2/112 (1%)
Query: 10 TENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSS 69
T + + + A S+ + PP S S+P +PP + P+
Sbjct: 435 TADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGSASAPASDAPPDAAFEPAP 494
Query: 70 PPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPS 121
A S++ P A P + P PP+P+ +
Sbjct: 495 RAAAPSAATPAAVPDARAPAA--ASREDAPAAAAPPAPEARPPTPAAAAPAA 544
|
Length = 830 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-07
Identities = 30/123 (24%), Positives = 48/123 (39%), Gaps = 1/123 (0%)
Query: 20 PPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPP 79
PP+S S A S + SS+ + P +P ++ ++PPP+ P SP P
Sbjct: 449 PPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANMRPLSPYAVYDDLKP 508
Query: 80 PASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPP-SPSNNKSPSPPVFSPPPPAKKSSPPP 138
P SP + P ++ + + PT ++ P P SP + PP
Sbjct: 509 PTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTALADEQHHAQPKPRPLSPYTMYEDLKPPT 568
Query: 139 PPL 141
P
Sbjct: 569 SPT 571
|
Length = 576 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 4e-07
Identities = 34/158 (21%), Positives = 67/158 (42%), Gaps = 18/158 (11%)
Query: 23 SNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPAS 82
SN++ + S+ S+P S+P + P S+ P ++PP S +P S+PP +S+PP ++
Sbjct: 400 SNAAQSNAGFSNAGYSNPGNSNPGYNNAPNSNTPYNNPPNSNTPYSNPP---NSNPPYSN 456
Query: 83 PPTSDNNKPDPPKNSPPPPPPSSQSS-------------PTPPSPSNNKSPSPPVFSPPP 129
P S+ + P ++ PP S P P+ N+ +
Sbjct: 457 LPYSNTPYSNAPLSNAPPSSAKDHHSAYHAAYQHRAANQPAANLPTANQPAANNFHG--A 514
Query: 130 PAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDY 167
P + S+ +++++ NG + +D+
Sbjct: 515 AGNSVGNPFASRPFGSAPYGGNAATTADPNGIAKREDH 552
|
Length = 1560 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 38/178 (21%), Positives = 54/178 (30%), Gaps = 46/178 (25%)
Query: 21 PSSNSSDATPPPSSTPSSSPP---PSSPPPASPPPSSPPPSSPPPSKSPPSSPP------ 71
SS SS PS+ ++S A P S PP SP P+++ P P
Sbjct: 84 SSSLSSGNQSSPSAANNTSDGHDASGVKNTAPPQDISAPPISPTPTQAAPPQTPNGQQRI 143
Query: 72 --------------------------PATSSSPPPASPPTSDNNKPDPPKNSPP-PPPPS 104
++ PA+ S K + P PP
Sbjct: 144 ELPGNISDALSQQQGQVNAASQNAQGNTSTLPTAPATVAPSKGAKVPATAETHPTPPQKP 203
Query: 105 SQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSS-----SSSSKS 157
+ P N + V PP + K + SS P S SS+S+S
Sbjct: 204 ATKKPAV-----NHHKTATVAVPPATSGKPKSGAASARALSSAPASHYTLQLSSASRS 256
|
Length = 327 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 38/119 (31%), Positives = 47/119 (39%), Gaps = 32/119 (26%)
Query: 439 IHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT-----------------------HVS 475
IHRDIK NILID + +ADFGL K N H
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 476 TRVM-----GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVE 529
RV GT Y+APE + D +S GV+L E++ G P D+L E
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP----FYSDTLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 27/85 (31%), Positives = 40/85 (47%), Gaps = 8/85 (9%)
Query: 19 APPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSP 78
A P++ ++D PPP +++ P+ P PPP + PP+ P + PPPA ++P
Sbjct: 32 ALPATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAP 91
Query: 79 PPASPPTSDNNKPDPPKNSPPPPPP 103
PP DP PP P P
Sbjct: 92 PPPP--------VDPNAPPPPAPEP 108
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 34/168 (20%), Positives = 51/168 (30%), Gaps = 12/168 (7%)
Query: 8 TETENEEGSPPAPPSSNSSDATPPPSST--PSSSPPPSSPPPASPPPSSPP----PSSPP 61
++ + +P +DA + P + P S P +PP PS P
Sbjct: 44 VDSTKQPPAPEQVAKHELADAPLQQVNAALPPAPAPQSPQPDQQQQSQAPPSHQYPSQLP 103
Query: 62 PSKSP---PSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPS---PS 115
P + P PPP+ P +P + PPP P Q +PP
Sbjct: 104 PQQVQSVPQQPTPQQEPYYPPPSQPQPPPAQQPQAQQPQPPPQVPQQQQYQSPPQQPQYQ 163
Query: 116 NNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSS 163
N P P P Y + P SS + + +
Sbjct: 164 QNPPPQAQSAPQVSGLYPEESPYQPQSYPPNEPLPSSMAMQPPYSGAP 211
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 10/93 (10%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFG 483
GL Y+H IIHRD+K N+ ++++ E + DFGLA+ ++ T +V TR
Sbjct: 128 CGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 484 YLAPEYASSG-KLTEKSDVFSFGVMLLELITGR 515
Y APE + + D++S G ++ E++TG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 54/218 (24%), Positives = 104/218 (47%), Gaps = 20/218 (9%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQG-EREFSAEVEIISRVHHRHLVSLVGYCI 382
+G+G +G+V+K +GK+ +LK G G E+ ++ + H ++++L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 383 AGGQRM--LVYEFVSNK---TLEYHL--HGENRPVMDFATRVRIALGSA-KGLAYLHEDC 434
+ R L++++ + +++H +P+ + V+ L G+ YLH +
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 435 HPRIIHRDIKAANILI----DDNFEAMVADFGLAKLSNDNHTHVS--TRVMGTFGYLAPE 488
++HRD+K ANIL+ + +AD G A+L N ++ V+ TF Y APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 489 YASSGK-LTEKSDVFSFGVMLLELITGRRPVDMTMMED 525
+ T+ D+++ G + EL+T P+ ED
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 9/98 (9%)
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS---- 492
+HRDIK N+L+D N +ADFG + T S +GT Y++PE +
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDG 181
Query: 493 -GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVE 529
G+ + D +S GV + E++ G P +SLVE
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETP----FYAESLVE 215
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 33/75 (44%), Positives = 42/75 (56%), Gaps = 8/75 (10%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPP-PSSPPPSKSPPSSPPPATS- 75
P PP+ PPP + P +SPP + P P++P S PP P+SPPP+K+P SS PP S
Sbjct: 144 PPPPAPVVMMQPPPPHAMPPASPPAAQPAPSAPASSPPPTPASPPPAKAPKSSHPPLKSP 203
Query: 76 ------SSPPPASPP 84
SP P PP
Sbjct: 204 MAGTFYRSPAPGEPP 218
|
Length = 274 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 6e-07
Identities = 17/77 (22%), Positives = 26/77 (33%), Gaps = 2/77 (2%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
+S ++ TP P+ +P +P S P PS PP SPP P +
Sbjct: 365 ISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAA--TTPSPPPAKASPPIPVPAEPT 422
Query: 76 SSPPPASPPTSDNNKPD 92
P ++
Sbjct: 423 EPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 20/96 (20%), Positives = 32/96 (33%), Gaps = 9/96 (9%)
Query: 61 PPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSP 120
+ P P + P + P P ++S P + QS+ P +
Sbjct: 370 SGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQP-------AG 422
Query: 121 SPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSK 156
+PP S PPA + P PP + + K
Sbjct: 423 TPPTVSVDPPA--AVPVNPPSTAPQAVRPAQFKEEK 456
|
Length = 614 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT---HVSTRVMGTF 482
G+ +LH IIHRD+K +NI++ + + DFGLA+ + + +V TR
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 483 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGR 515
Y APE E D++S G ++ E+I G
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 28/163 (17%), Positives = 46/163 (28%), Gaps = 7/163 (4%)
Query: 6 NVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKS 65
+ +E +E+ PP S S+ + PP P P S P S P
Sbjct: 42 STSEATSEDDDDLYPPRETGSGGGVATSTIYTVPRPPRGPEQTLDKPDSLPASRELP--- 98
Query: 66 PPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVF 125
P +P P + +D+ P P + S ++
Sbjct: 99 PGPTPVPPGGFRGASSPRLGADSTSPRFLYQVNFPVILAPIGESNSSSEELSEEEEHSRP 158
Query: 126 SPPPPAKKSSP----PPPPLKYSSSTPKSSSSSSKSSNGSSSG 164
P K + P K+ + S +K + G
Sbjct: 159 PPSESLKVKNGGKVYPKGFSKHKTHKRSEFSGLTKKAARKRKG 201
|
Length = 580 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 24/103 (23%), Positives = 37/103 (35%), Gaps = 5/103 (4%)
Query: 36 PSSSPPPSSPPPASPP-PSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPP 94
P P P A+ P+ PP + + A S P P + +P+P
Sbjct: 47 PGDRDEPDMMPAATQALPTQPPEGA----AEAVRAGDAAAPSLDPATVAPPNTPVEPEPA 102
Query: 95 KNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPP 137
PP P P + P P ++P P P P ++ + P
Sbjct: 103 PVEPPKPKPVEKPKPKPKPQQKVEAPPAPKPEPKPVVEEKAAP 145
|
Length = 226 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 7e-07
Identities = 19/100 (19%), Positives = 38/100 (38%), Gaps = 3/100 (3%)
Query: 52 PSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPP--PPPSSQSSP 109
P++ ++ P K P+ P A ++ P A + P + P PP ++ +P
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAP 425
Query: 110 TPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPK 149
+ + +P +P A +PP + + P
Sbjct: 426 VAAPAAAAPAAAPAA-APAAVALAPAPPAQAAPETVAIPV 464
|
Length = 618 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 6/92 (6%)
Query: 424 AKGLAYL-HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGT 481
AKG+++L ++C IHRD+ A NIL+ + DFGLA+ + ND++ V
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 482 FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 513
++APE + T +SDV+S+G++L E+ +
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 31/217 (14%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGE--------REFSAEVEIISR 368
+ K +G+G +G V+K GK VA+K KT E RE S +
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALK--KTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 369 VHHRHLVSLVGYCIAGGQRML--VYEFVSN---KTLEYHLHGENRPVMDFATRVRIALGS 423
++ L+ + G+ L V+E++ + K ++ + G RP + T
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP-LPAKTIKSFMYQL 119
Query: 424 AKGLAYLHEDCHPR-IIHRDIKAANILIDDNFEAM-VADFGLAK---LSNDNHTHVSTRV 478
KG+A+ CH ++HRD+K N+L+D + +AD GL + + ++TH
Sbjct: 120 LKGVAH----CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----E 171
Query: 479 MGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITG 514
+ T Y APE S + D++S G + E+
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 9e-07
Identities = 15/79 (18%), Positives = 25/79 (31%)
Query: 11 ENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSP 70
+ + P PS P+ P + + SPPP+ P P+ P
Sbjct: 362 SAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEP 421
Query: 71 PPATSSSPPPASPPTSDNN 89
+ + P A+ N
Sbjct: 422 TEPSPTPPANAANAPPSLN 440
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 9e-07
Identities = 10/76 (13%), Positives = 26/76 (34%)
Query: 8 TETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPP 67
+ A + + A P + P+ + P P ++ ++P +
Sbjct: 44 PTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAAPPAAA 103
Query: 68 SSPPPATSSSPPPASP 83
++ PA ++ +P
Sbjct: 104 AAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 9e-07
Identities = 21/71 (29%), Positives = 30/71 (42%), Gaps = 9/71 (12%)
Query: 42 PSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPP 101
P+ P A P+ P++PPP+ +PP PPA + P A P P P
Sbjct: 382 PAPPSAAWGAPTPAAPAAPPPAAAPP--VPPAAPARPAAARP------APAPAP-PAAAA 432
Query: 102 PPSSQSSPTPP 112
PP+ + P
Sbjct: 433 PPARSADPAAA 443
|
Length = 576 |
| >gnl|CDD|220271 pfam09507, CDC27, DNA polymerase subunit Cdc27 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 23/153 (15%), Positives = 40/153 (26%), Gaps = 11/153 (7%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSP------PPSSPPPSKSPPS 68
G PP P+++ + PSS PP S P S+ ++ ++ S
Sbjct: 142 GLPPVAPAASPALKPTANGKRPSSKPPKSIMSPEVKVKSAKKTQDTSKETTTEKTEGKTS 201
Query: 69 SPPPATSSSPPPASPPTSD-----NNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPP 123
+ +PP S S + K + + + S
Sbjct: 202 VKAASLKRNPPKKSNIMSSFFKKKTKEKKEKKEASESTVKEESEEESGKRDVILEDESAE 261
Query: 124 VFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSK 156
+ P P + S K
Sbjct: 262 PTGLDEDEDEDEPKPSGERSDSEEETEEKEKEK 294
|
This protein forms the C subunit of DNA polymerase delta. It carries the essential residues for binding to the Pol1 subunit of polymerase alpha, from residues 293-332, which are characterized by the motif D--G--VT, referred to as the DPIM motif. The first 160 residues of the protein form the minimal domain for binding to the B subunit, Cdc1, of polymerase delta, the final 10 C-terminal residues, 362-372, being the DNA sliding clamp, PCNA, binding motif. Length = 427 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 32/129 (24%), Positives = 38/129 (29%), Gaps = 9/129 (6%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
P P PS P+ P P P PP P PP PP
Sbjct: 208 QGHPEQVQPQQFLPAPSQAPAQPPLPPQLPQQPPPLQQPQFPGLSQQMPPPPPQPPQQQQ 267
Query: 77 SPP-PASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSS 135
PP P + P PP+N P P P Q P P P V P +
Sbjct: 268 QPPQPQAQP--------PPQNQPTPHPGLPQGQNAPLPPPQQPQLLPLVQQPQGQQRGPQ 319
Query: 136 PPPPPLKYS 144
++ S
Sbjct: 320 FREQLVQLS 328
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 27/82 (32%), Positives = 39/82 (47%), Gaps = 2/82 (2%)
Query: 22 SSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPA 81
+ S+ A P++ + PP PP + +P PPP + P +P P ++ PP
Sbjct: 24 AGASAVAIALPATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPP- 82
Query: 82 SPPTSDNNKPDPPKNSPPPPPP 103
PP +D N P PP P PPP
Sbjct: 83 -PPPADPNAPPPPPVDPNAPPP 103
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 26/149 (17%), Positives = 38/149 (25%), Gaps = 13/149 (8%)
Query: 26 SDATPPPSSTPSSS------PPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPP 79
TP S++ ++S PP +S + P + P
Sbjct: 35 DFLTPLGSTSEATSEDDDDLYPPRETGSGGGVATSTIYTVP---RPPRGPEQTLDKPDSL 91
Query: 80 PASPPTSDNNKPDPP----KNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSS 135
PAS P PP S P S S + +P S + S
Sbjct: 92 PASRELPPGPTPVPPGGFRGASSPRLGADSTSPRFLYQVNFPVILAPIGESNSSSEELSE 151
Query: 136 PPPPPLKYSSSTPKSSSSSSKSSNGSSSG 164
S + K + G S
Sbjct: 152 EEEHSRPPPSESLKVKNGGKVYPKGFSKH 180
|
Length = 580 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 25/149 (16%), Positives = 37/149 (24%), Gaps = 9/149 (6%)
Query: 7 VTETENEEGSPP---APPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPS 63
++ET + E P A S+ PP + P P P P
Sbjct: 70 ISETLSRELGRPIRIAITVDPSAGEPAPPPPHARRTSEPELPRP--GRRPYEGYGGPRAD 127
Query: 64 KSPPSSPPPATSSSPPPASPPTSDNNKP----DPPKNSPPPPPPSSQSSPTPPSPSNNKS 119
PP P + PA P +P + P + + +
Sbjct: 128 DRPPGLPRQDQLPTARPAYPAYQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYA 187
Query: 120 PSPPVFSPPPPAKKSSPPPPPLKYSSSTP 148
P P A + Y P
Sbjct: 188 PEQERDREPYDAGRPEYDQRRRDYDHPRP 216
|
Length = 617 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 424 AKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV---STRVMG 480
AKG+ +L + IHRD+ A NIL+ +N + DFGLA+ + +V R+
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243
Query: 481 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 513
++APE T +SDV+SFGV+L E+ +
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 25/84 (29%), Positives = 34/84 (40%), Gaps = 4/84 (4%)
Query: 12 NEEGSPPAPPSSNSSD--ATPPPSSTPSSSPPPSSP--PPASPPPSSPPPSSPPPSKSPP 67
N+ G P+P S A P P P P+ P P A P P S+P P + PP
Sbjct: 376 NDGGVAPSPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPASAPTPEQQPP 435
Query: 68 SSPPPATSSSPPPASPPTSDNNKP 91
+ SP ++P + KP
Sbjct: 436 VARSAPLPPSPQASAPRNVASGKP 459
|
Length = 620 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 60/305 (19%), Positives = 83/305 (27%), Gaps = 64/305 (20%)
Query: 13 EEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPP----------- 61
E P A ++ PP P + P PS PA P P
Sbjct: 2485 EARFPFAAGAAPDPGGGGPPD--PDAPPAPSRLAPAILPDEPVGEPVHPRMLTWIRGLEE 2542
Query: 62 -PSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPT----PPSPSN 116
S PPP PP A P D + P PP+ +P P P+ S PP +
Sbjct: 2543 LASDDAGDPPPPL----PPAAPPAAPDRSVP-PPRPAPRPSEPAVTSRARRPDAPPQSAR 2597
Query: 117 NKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVTYSVIGAV 176
++P P PA SP PP P S S ++ +
Sbjct: 2598 PRAPVDDRGDPRGPAP-PSPLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDP 2656
Query: 177 GVGIFLIAMIIICAVRANKKKKKRHNQPMHYYGDHSNHFKKGGDPYYSGGHAPNWHGHPE 236
G R ++ ++ R G A P+
Sbjct: 2657 APG------------RVSRPRRAR-----------------------RLGRAAQASSPPQ 2681
Query: 237 HQNWHSHPQGPDHTGGNIPPPPGGNWPGPPPPPPMMSSSGEMSSQFSGPARP-----PLP 291
+ PPP P P P + ++ + A P P P
Sbjct: 2682 RPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPPGPAAARQASPALPAAPAP 2741
Query: 292 PPSPN 296
P P
Sbjct: 2742 PAVPA 2746
|
Length = 3151 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 29/136 (21%), Positives = 44/136 (32%), Gaps = 11/136 (8%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
G+ +PP + P S ++ AS S S P+ PP A
Sbjct: 783 GAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTASKRKSRSHTPDGGSESSGPARPPGAA 842
Query: 75 SSSPPPASPPTSDNNKP--------DPPKNSPPPPPPSSQSSPTPPSPSNN---KSPSPP 123
+ PP S +S + + P PP P ++ P + + +P
Sbjct: 843 ARPPPARSSESSKSKPAAAGGRARGKNGRRRPRPPEPRARPGAAAPPKAAAAAPPAGAPA 902
Query: 124 VFSPPPPAKKSSPPPP 139
P P K P PP
Sbjct: 903 PRPRPAPRVKLGPMPP 918
|
Length = 1352 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 24/110 (21%), Positives = 44/110 (40%), Gaps = 13/110 (11%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTPSS--SPPPSSP-PPASPPPSSPPPSSPPPSKSPPSSP 70
+ PA ++ + A P P+ P+ +PP + PA PS PP ++P +P +
Sbjct: 413 AAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAA 472
Query: 71 PPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSP 120
P +++P PA P +P P + + P + +
Sbjct: 473 APEPTAAPAPAPPAAP----------APAAAPAAPAAPAAPAGADDAATL 512
|
Length = 824 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 2e-06
Identities = 23/84 (27%), Positives = 30/84 (35%), Gaps = 3/84 (3%)
Query: 2 AKGNNVTETENEEGSPPAPPSSNSSDATPPPSST-PSSSPPPSSPPPASPPPSSPPPSSP 60
G+ + PP + P P T + P P PPP + SS P+
Sbjct: 513 QSGSASNTAKTPP--PPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQI 570
Query: 61 PPSKSPPSSPPPATSSSPPPASPP 84
P SPP P + SP S P
Sbjct: 571 PADSSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 25/81 (30%), Positives = 34/81 (41%)
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKS 134
S+S +PP + P P P P P ++ PTPP P + + PA S
Sbjct: 516 SASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSS 575
Query: 135 SPPPPPLKYSSSTPKSSSSSS 155
PPP P + + S K SS
Sbjct: 576 PPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 29/158 (18%), Positives = 51/158 (32%), Gaps = 26/158 (16%)
Query: 9 ETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSP-P 67
++ S PA + + P P + S+ P++ P A P ++ +P + P P
Sbjct: 471 PADSGSASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPAP 530
Query: 68 SSPPPATSSSPPPA-------------------------SPPTSDNNKPDPPKNSPPPPP 102
+ PP +++ P A + P P P
Sbjct: 531 EARPPTPAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAAAPKPAAP 590
Query: 103 PSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPP 140
+ PTP + + P + A +S PPP
Sbjct: 591 RVAVQVPTPRARAATGDAPPNGAARAEQAAESRGAPPP 628
|
Length = 830 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 19/100 (19%), Positives = 36/100 (36%), Gaps = 15/100 (15%)
Query: 24 NSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASP 83
+ + P T +++ P ++P PA+P ++P S P + PA
Sbjct: 155 SQNSGQSVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAV-------------ATAPAPA 201
Query: 84 PTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPP 123
N P S ++ +P P+ + +P P
Sbjct: 202 VDPQQNAVVAP--SQANVDTAATPAPAAPATPDGAAPLPT 239
|
Length = 331 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 27/138 (19%), Positives = 32/138 (23%), Gaps = 11/138 (7%)
Query: 5 NNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSK 64
+ V A S PP S+ P P P
Sbjct: 69 HRVNHAPANAQEHEAARPSPQHQYQPP---YASAQPRQPVQQPPEAQVPPQHAPRPAQPA 125
Query: 65 SPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPV 124
P P P P S P P+ P P+ Q+ P P P P
Sbjct: 126 PQPVQQPAYQPQPEQPLQQPVSPQVAP-APQPVHSAPQPAQQAFQ-PAEPVAAPQPEPVA 183
Query: 125 FSPPPPAKKSSPPPPPLK 142
P P P K
Sbjct: 184 --EPAPVMD----KPKRK 195
|
Length = 333 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 31/120 (25%), Positives = 45/120 (37%), Gaps = 15/120 (12%)
Query: 15 GSPPAPPSSNSSDATPPP------SSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPS 68
GS P+S + P P + P++ PSS PA+P PS+ P P +PP+
Sbjct: 383 GSAAEGPASGGAATIPTPGTQGPQGTAPAAGMTPSSAAPATPAPSAAPSPRVPWDDAPPA 442
Query: 69 SPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPP 128
P P P P S P P + +S PP+ + + S P
Sbjct: 443 PPRSGIPPRPAPRMPEAS---------PVPGAPDSVASASDAPPTLGDPSDTAEHTPSGP 493
|
Length = 624 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 2e-06
Identities = 14/74 (18%), Positives = 26/74 (35%)
Query: 13 EEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPP 72
+EG P P+++ P + A + P + ++ PP
Sbjct: 388 QEGPPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPP 447
Query: 73 ATSSSPPPASPPTS 86
A +++P PA S
Sbjct: 448 APAAAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 29/111 (26%), Positives = 44/111 (39%), Gaps = 5/111 (4%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTPSSSP---PPSSPPPASPPPSSPPPSSPPPSKSPPS-- 68
EG+ APP S + P S+P P PA+P P+ +SP + +P +
Sbjct: 169 EGTLAAPPLGEGSADGSCDPALPLSAPRLGPADVFVPATPRPTPRTTASPETTPTPSTTT 228
Query: 69 SPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKS 119
SPP T +P P+ PP P ++ P +P+ S
Sbjct: 229 SPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPGGGEAPPANATPAPEAS 279
|
Length = 401 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 8/93 (8%)
Query: 424 AKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV---STRVMG 480
A+G+ +L + IHRD+ A NIL+ +N + DFGLA+ + +V S R+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL-- 238
Query: 481 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 513
++APE T +SDV+SFGV+L E+ +
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 51/233 (21%)
Query: 323 LLGQGGFGYVHKGVLPNGKEV----------AVKSLKTGSGQGEREF--SAEVEIISRVH 370
++G+G FG V L N +V +K +T + ER+ + + + I+ +H
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 371 H-----RHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFA----TRVRIAL 421
+ +L ++ Y + G L+ +F E+R D A + IA+
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKF------------EDRLPEDMARFYLAEMVIAI 115
Query: 422 GSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGT 481
S L Y +HRDIK NIL+D N +ADFG ++ T S+ +GT
Sbjct: 116 DSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 166
Query: 482 FGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVE 529
Y++PE + GK + D +S GV + E++ G P +SLVE
Sbjct: 167 PDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP----FYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 10/96 (10%)
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLA-KLSNDNHTHVSTRVMGTFGYLAPEYASS---- 492
+IHRD+K N+L+D + +ADFG K+ T V GT Y++PE S
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGD 221
Query: 493 GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLV 528
G + D +S GV L E++ G P DSLV
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTP----FYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 19/93 (20%), Positives = 26/93 (27%), Gaps = 3/93 (3%)
Query: 48 ASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQS 107
+ PS ++ + + P P + P + PP P
Sbjct: 352 SLTAPSRVLAAAAKVAVIAAPQTHTGPADRQRPQRPDGIPYSVPARSPMTAYPPVPQFCG 411
Query: 108 SPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPP 140
P SP N P P S P PP P
Sbjct: 412 DPGLVSPYN---PQSPGTSYGPEPVGPVPPQPT 441
|
Length = 663 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 3e-06
Identities = 27/83 (32%), Positives = 31/83 (37%)
Query: 63 SKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSP 122
S+ A + PP SPP P P + PPP PT S+N
Sbjct: 511 ESQSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQI 570
Query: 123 PVFSPPPPAKKSSPPPPPLKYSS 145
P S PPP P P P K SS
Sbjct: 571 PADSSPPPPIPEEPTPSPTKDSS 593
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 3e-06
Identities = 24/78 (30%), Positives = 33/78 (42%), Gaps = 1/78 (1%)
Query: 12 NEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPP 71
N +PP P S A PP P+++ PP +PPP P + ++P SSPP
Sbjct: 519 NTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIP-ADSSPP 577
Query: 72 PATSSSPPPASPPTSDNN 89
P P P+ S
Sbjct: 578 PPIPEEPTPSPTKDSSPE 595
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 20/76 (26%), Positives = 28/76 (36%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
+ PP S P P + P P PPP++ SS P++ P S PP
Sbjct: 521 AKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSSPPPPI 580
Query: 76 SSPPPASPPTSDNNKP 91
P SP + +
Sbjct: 581 PEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|240271 PTZ00108, PTZ00108, DNA topoisomerase 2-like protein; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 26/166 (15%), Positives = 40/166 (24%), Gaps = 5/166 (3%)
Query: 2 AKGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPP 61
+ ++ + + S S + SS S
Sbjct: 1210 DDKPDNKKSNSSGSDQEDDEEQKTKPKKSSVKRLKSKKNNSSKSSEDNDEFSSDDLSKEG 1269
Query: 62 PSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPS 121
K+ P SPPP S + +SP + + + K
Sbjct: 1270 KPKNAPKRVSAV-QYSPPPPSKRPDGESNGGSKPSSPTKKKVKKRLEGSLAALKKKKKSE 1328
Query: 122 PPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDY 167
KKS S S+ K S+ SS DD
Sbjct: 1329 KKTA----RKKKSKTRVKQASASQSSRLLRRPRKKKSDSSSEDDDD 1370
|
Length = 1388 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 18/68 (26%), Positives = 35/68 (51%), Gaps = 1/68 (1%)
Query: 32 PSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKP 91
P+ ++ P+ PA+PPP++ PP P + P++ PA + +PP A+ P + + P
Sbjct: 382 PAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAP-ARPAAARPAPAPAPPAAAAPPARSADP 440
Query: 92 DPPKNSPP 99
++
Sbjct: 441 AAAASAGD 448
|
Length = 576 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 32/167 (19%), Positives = 42/167 (25%), Gaps = 15/167 (8%)
Query: 11 ENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSS----PPPASPPPSSPPPSSPPPSKSP 66
S P S+ TP S + P AS P P S
Sbjct: 407 MTPPDSGPGSNVSSRRVGTPGSKSDRVGAVLLRRMNIKPTLASIPDEKPSNISVFEDSET 466
Query: 67 PSSPPPATSSSPPPASP---PTSDNNK---PDPPKNSPPPPPPSSQS---SPTPPSPSNN 117
+ PP NN S PP QS PTP P++
Sbjct: 467 SPNSSTLLRDPPPKKCGEESGHLPNNPFFNKLKLTLSSIPPLSPRQSIITLPTPSRPASR 526
Query: 118 KSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSG 164
S + PPP S + S ++S +
Sbjct: 527 ISSLS--LRLGSYSGSIVSPPPYPTLVSRKGAAGLSFNRSVSDIEGE 571
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 41/158 (25%), Positives = 51/158 (32%), Gaps = 14/158 (8%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
P S PPP+ P + P PPP P SPP +PPP
Sbjct: 116 PQQEPYYPPPSQPQPPPAQQPQAQQPQ--PPPQ--VPQQQQYQSPPQQPQYQQNPPPQAQ 171
Query: 76 SSPPPA--SPPTSDNNKPDPPKNSPPPP--PPSSQSSPTPPSPSNNKSPSPPVF------ 125
S+P + P S P N P P S PPS P P +
Sbjct: 172 SAPQVSGLYPEESPYQPQSYPPNEPLPSSMAMQPPYSGAPPSQQFYGPPQPSPYMYGGPG 231
Query: 126 SPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSS 163
P S PPP + S SK ++GS +
Sbjct: 232 GRPNSGFPSGQQPPPSQGQEGYGYSGPPPSKGNHGSVA 269
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 25/81 (30%), Positives = 30/81 (37%), Gaps = 7/81 (8%)
Query: 35 TPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPP 94
+P+ SP P P P P P+K PA SP AS PT + P
Sbjct: 383 SPAGSPDVKKKAPEPDLPQ--PDRHPGPAKPEAPGARPAELPSP--ASAPTPEQQPPVAR 438
Query: 95 KNSPPPPPPSSQSSPTPPSPS 115
P PPS Q+S S
Sbjct: 439 ---SAPLPPSPQASAPRNVAS 456
|
Length = 620 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 18/59 (30%), Positives = 28/59 (47%)
Query: 46 PPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPS 104
P P+ P P++ P P + PAT ++ P A+ P ++ K D P+ P P S
Sbjct: 13 EAEQPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPAS 71
|
Length = 475 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 45/221 (20%), Positives = 84/221 (38%), Gaps = 33/221 (14%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVK--SLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
++ K P VAVK +L + S + + E+ ++ H +++ V
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 382 IAGGQRMLVYEFV---SNKTL--EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
I + +V + S + L + G + F I L Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-----ILKDVLNALDYIH---SK 120
Query: 437 RIIHRDIKAANILIDDNFEAMVADF---------GLAKLSNDNHTHVSTRVMGTFGYLAP 487
IHR +KA++IL+ + + +++ G + + S + + +L+P
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL---PWLSP 177
Query: 488 E--YASSGKLTEKSDVFSFGVMLLELITGRRP---VDMTMM 523
E + EKSD++S G+ EL G P + T M
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 29/91 (31%), Positives = 39/91 (42%), Gaps = 9/91 (9%)
Query: 4 GNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPS--SPPPASPPPSSPPPSSPP 61
GN + GS A ++ S +P PS+SPP PPA+P P +SPP
Sbjct: 564 GNPGSTNSTPTGSA-ASSNTTFSSDSPSTVVAPSTSPPAGHLGSPPATPSKIVSPSTSPP 622
Query: 62 ------PSKSPPSSPPPATSSSPPPASPPTS 86
PS +P S +S ASP +S
Sbjct: 623 ASHLGSPSTTPSSPESSIKVASTETASPESS 653
|
Length = 670 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 11/92 (11%)
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT---HVSTRVMGTF 482
G+ +LH IIHRD+K +NI++ + + DFGLA+ + N +V TR
Sbjct: 135 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY---- 187
Query: 483 GYLAPEYASSGKLTEKSDVFSFGVMLLELITG 514
Y APE E D++S G ++ EL+ G
Sbjct: 188 -YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 61/235 (25%), Positives = 101/235 (42%), Gaps = 33/235 (14%)
Query: 305 TFTYDELAAATGGFAKSNLLGQGGFGYVHKGVL--PNGKEVAVKSLKTGSGQGEREFSAE 362
T +D + + +G+G +G V K VL NG + AVK L E E AE
Sbjct: 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDE-EIEAE 64
Query: 363 VEIISRVH-HRHLVSLVGY-----CIAGGQRMLVYEFVSNKTLEYHLHG-------ENRP 409
I+ + H ++V G G Q LV E + ++ + G P
Sbjct: 65 YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP 124
Query: 410 VMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGL-AKLSN 468
++ + I + GL +LH + + IHRD+K NIL+ + DFG+ A+L++
Sbjct: 125 IIAY-----ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176
Query: 469 DNHTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPV 518
++ +GT ++APE + + DV+S G+ +EL G P+
Sbjct: 177 TRLRRNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|223880 COG0810, TonB, Periplasmic protein TonB, links inner and outer membranes [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 26/109 (23%), Positives = 36/109 (33%), Gaps = 3/109 (2%)
Query: 40 PPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPP 99
P P PP P P + P + P+ P P P KP P
Sbjct: 52 PTEEPQPEPEPPEEQPKPPTEPETPPEPTPPKPKEKPKPEKKPKKPKPKPKPKPKPKPKV 111
Query: 100 PPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTP 148
P P + PPS + K+P+ P PP+ S+ +S
Sbjct: 112 KPQPKPK---KPPSKTAAKAPAAPNQPARPPSAASASGAATGPSASYLS 157
|
Length = 244 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 4e-06
Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 2/86 (2%)
Query: 9 ETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPS 68
E+++ S A + PPP+ TP P ++ PP +PPP PPP++ S + P+
Sbjct: 511 ESQSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPP--PPPTATQASSNAPA 568
Query: 69 SPPPATSSSPPPASPPTSDNNKPDPP 94
P +S PP PT K P
Sbjct: 569 QIPADSSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 22/69 (31%), Positives = 30/69 (43%), Gaps = 5/69 (7%)
Query: 20 PPSSNSSDATPP--PSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
P + A P P+S P+ +P SPP + S P+S KSP AT+
Sbjct: 77 PKTGTGKVAPPAATPTSAPTPTP---SPPASPASGMSAAPASAVEEKSPSEESATATAPE 133
Query: 78 PPPASPPTS 86
P S P+S
Sbjct: 134 SPSTSVPSS 142
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 4e-06
Identities = 18/105 (17%), Positives = 31/105 (29%), Gaps = 7/105 (6%)
Query: 28 ATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSD 87
A P ++ ++ PPP++ P A P++P P A
Sbjct: 52 APPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHA--KRLTAQREQLVARAA--- 106
Query: 88 NNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAK 132
P P+ P P ++ + + P P A
Sbjct: 107 --APAAPEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAA 149
|
Length = 484 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 14/103 (13%), Positives = 28/103 (27%), Gaps = 7/103 (6%)
Query: 38 SSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNS 97
+ P ++P A PPP++ P + P+ P + + +
Sbjct: 52 APPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQ-------REQLVAR 104
Query: 98 PPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPP 140
P +P P+ + + A P
Sbjct: 105 AAAPAAPEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPAD 147
|
Length = 484 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 34/95 (35%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 439 IHRDIKAANILIDDNFEAMVADFGLA-KLSNDNHTHVSTRVMGTFGYLAPEYASS----G 493
IHRD+K N+L+D + +ADFG K++ + T V GT Y++PE S G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 494 KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLV 528
+ D +S GV L E++ G P DSLV
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP----FYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 5e-06
Identities = 17/77 (22%), Positives = 26/77 (33%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
PAPPS + S P ++ P + P PA P + P + P+ +
Sbjct: 437 PAPAPPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAA 496
Query: 76 SSPPPASPPTSDNNKPD 92
+ P A D
Sbjct: 497 PAAPAAPAGADDAATLR 513
|
Length = 824 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 14/63 (22%), Positives = 25/63 (39%), Gaps = 3/63 (4%)
Query: 30 PPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNN 89
P + + P++PPPA+ PP P + P + P +P P + ++D
Sbjct: 385 PSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPP---AAAAPPARSADPA 441
Query: 90 KPD 92
Sbjct: 442 AAA 444
|
Length = 576 |
| >gnl|CDD|223880 COG0810, TonB, Periplasmic protein TonB, links inner and outer membranes [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 23/122 (18%), Positives = 34/122 (27%), Gaps = 2/122 (1%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
P+ PP P P +PP +PP P K P P P
Sbjct: 49 LEAPTEEPQPEPEPPEEQPKPPTEPETPPEPTPPKPKEKPKPEKKPKKPKPKPKPKPKPK 108
Query: 78 PPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPP 137
P P KP + P P+ + P + ++ + P +
Sbjct: 109 PKVKPQPKPK--KPPSKTAAKAPAAPNQPARPPSAASASGAATGPSASYLSGLRRAIRRA 166
Query: 138 PP 139
P
Sbjct: 167 PR 168
|
Length = 244 |
| >gnl|CDD|236768 PRK10819, PRK10819, transport protein TonB; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 25/108 (23%), Positives = 33/108 (30%)
Query: 32 PSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKP 91
P+ P P P P P PP ++P P P P P P
Sbjct: 55 PADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIPKPEPKPKPKPKPKPKPVKKVE 114
Query: 92 DPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPP 139
+ PK P P S +P+ S + + P SS P
Sbjct: 115 EQPKREVKPVEPRPASPFENTAPARPTSSTATAAASKPVTSVSSGPRA 162
|
Length = 246 |
| >gnl|CDD|147601 pfam05505, Ebola_NP, Ebola nucleoprotein | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 26/152 (17%), Positives = 54/152 (35%), Gaps = 3/152 (1%)
Query: 9 ETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPS 68
E+++ S P P + S+ PPP S P + +S ++ + S
Sbjct: 470 LDEDDDDSKPIPEQAASTYGQTSRERQGIPEPPPGSHQPGNR--ASQDLNNNNQKQEDES 527
Query: 69 SPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPP 128
+ P +S P + ++P+ + P +S P S N + +PP
Sbjct: 528 TNPIGKTSLRYQELTPVQEEDEPEDQTDDDDSSLPPLESDDDPGS-DNEQGVDLTEVAPP 586
Query: 129 PPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNG 160
P + + + + P+ + S + +
Sbjct: 587 APVYRDEKEQDEIPHPAQNPQDPTGSIGNVDS 618
|
This family consists of Ebola and Marburg virus nucleoproteins. These proteins are responsible for encapsidation of genomic RNA. It has been found that nucleoprotein DNA vaccines can offer protection from the virus. Length = 717 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 34/134 (25%), Positives = 46/134 (34%), Gaps = 15/134 (11%)
Query: 5 NNVTETENEEGSPPAP-PSSNSSDATPPPSSTPSSSPPPSS---PPPASP----PPSSPP 56
++ E N S P T PSS + + P S P +P PSS P
Sbjct: 136 GSIMELRNAWSSLGPPLQHRKRDAVTASPSSMIARNTPISDRLRPRSVTPTRGRRPSSSP 195
Query: 57 PSSPPPSKSPPSSPPPATSSSPPP-------ASPPTSDNNKPDPPKNSPPPPPPSSQSSP 109
S P+ S T+ PPP +S +S N + P S +S+P
Sbjct: 196 RSLSNPTTLESPSNLQVTTDVPPPYSNGTSRSSTMSSSANLSIISSLATPRSGESFRSTP 255
Query: 110 TPPSPSNNKSPSPP 123
T S S N
Sbjct: 256 TSGSSSINPVSGLD 269
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-06
Identities = 29/134 (21%), Positives = 43/134 (32%), Gaps = 16/134 (11%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
+PP+ S+ P ++ + S+ A+P P +P + P +
Sbjct: 360 TPPSSLEDLSAGRHHPKRASLPTRKRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPA 419
Query: 76 SSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSS 135
+P PAS P PP P P S P PP +P+ P
Sbjct: 420 PTPVPAS-------APPPPATPLPSAEPGSDDGPAPPPERQPPAPATEPAPDDPDDATRK 472
Query: 136 ---------PPPPP 140
PP PP
Sbjct: 473 ALDALRERRPPEPP 486
|
Length = 3151 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 6e-06
Identities = 12/70 (17%), Positives = 30/70 (42%)
Query: 6 NVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKS 65
+ AP ++ ++ A P+ P ++ P++PP + ++ + PP+ +
Sbjct: 44 PTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAAPPAAA 103
Query: 66 PPSSPPPATS 75
++P A
Sbjct: 104 AAAAPAAAAV 113
|
Length = 1228 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 23/90 (25%), Positives = 31/90 (34%), Gaps = 5/90 (5%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
P PP + ++ PS P +PP P P P PP K P P P
Sbjct: 64 PTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEP-EPAPVEPPKPK-PVEKPKPKPKP 121
Query: 77 SPPPASPPTSDNNKPDPPKNSPPPPPPSSQ 106
+PP KP+P P+ +
Sbjct: 122 QQKVEAPPAP---KPEPKPVVEEKAAPTGK 148
|
Length = 226 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 6e-06
Identities = 30/163 (18%), Positives = 54/163 (33%), Gaps = 10/163 (6%)
Query: 9 ETENEEGSPP--APPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSP 66
+ + +PP APP+S S A+ P +S S+S + S P ++ +P
Sbjct: 640 SADRKPKTPPSRAPPASLSKPASSPDASQTSASFDLDPDFELATHQSVPE-AALASGSAP 698
Query: 67 PSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPV-- 124
P P PP P + P + S + + + + +
Sbjct: 699 APPPVPDPYDRPPWEEAPEVASANDGPNNAAEGNLSESVEDASNSELQAVEQQATHQPQV 758
Query: 125 -FSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDD 166
PA ++ SS + + S+GS +G
Sbjct: 759 QAEAQSPASTTALTQT----SSEVQDTELNLVLLSSGSITGHP 797
|
Length = 944 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (114), Expect = 6e-06
Identities = 28/129 (21%), Positives = 61/129 (47%), Gaps = 4/129 (3%)
Query: 11 ENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPS-- 68
++ + + PA ++ + A PP+ ++ ++ P + P + + P + +PP+
Sbjct: 215 KSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAAAPPAKA 274
Query: 69 SPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPP 128
+ PPA +++PP + P K + P ++ + P+ K+ +PP +
Sbjct: 275 AAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPA--KAAAPPAKAAT 332
Query: 129 PPAKKSSPP 137
PPAK ++PP
Sbjct: 333 PPAKAAAPP 341
|
Length = 357 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 7e-06
Identities = 17/76 (22%), Positives = 23/76 (30%)
Query: 2 AKGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPP 61
A + + PAP S P + + SPPPA P P P+ P
Sbjct: 363 AFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPT 422
Query: 62 PSKSPPSSPPPATSSS 77
P + S
Sbjct: 423 EPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 7e-06
Identities = 19/143 (13%), Positives = 47/143 (32%), Gaps = 6/143 (4%)
Query: 21 PSSNSSDATPPPSSTPSSSPPPSSPPPASP-----PPSSPPPSSPPPSKSPPS-SPPPAT 74
+ + P+ + P P + A+ P + + + +P + + AT
Sbjct: 362 VTGGGAPGGGVPARVAGAVPAPGARAAAAVGASAVPAVTAVTGAAGAALAPKAAAAAAAT 421
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKS 134
+ PPA+P P P+ ++ ++ + P + +
Sbjct: 422 RAEAPPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGSASAPA 481
Query: 135 SPPPPPLKYSSSTPKSSSSSSKS 157
S PP + + ++ S++
Sbjct: 482 SDAPPDAAFEPAPRAAAPSAATP 504
|
Length = 830 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 7e-06
Identities = 43/159 (27%), Positives = 66/159 (41%), Gaps = 11/159 (6%)
Query: 11 ENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSP 70
++ S P+ PS +++ S+ P P PP ++ PS+PPP+ S + P
Sbjct: 145 QDNRSSSPSIPSPQDNESDSDSSAQQQLLQPQGPPSIQVPPGAALAPSAPPPTPSAQAVP 204
Query: 71 P---PATSSSPPPASPPTSDNNKPDP---PKNSPPPPPP-----SSQSSPTPPSPSNNKS 119
P P + P P+ + P P+ P P PP +SQ SP PP+PS+
Sbjct: 205 PQGSPIAAQPAPQPQQPSPLSLISAPSLHPQRLPSPHPPLQPQTASQQSPQPPAPSSRHP 264
Query: 120 PSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSS 158
S PP P L++ SS P ++S
Sbjct: 265 QSSHHGPGPPMPHALQQGPVFLQHPSSNPPQPFGLAQSQ 303
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 7e-06
Identities = 12/71 (16%), Positives = 23/71 (32%), Gaps = 2/71 (2%)
Query: 36 PSSSPPPSSPPPA--SPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDP 93
P S PP P + ++P + + P++ PA + + P + +
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 94 PKNSPPPPPPS 104
P S
Sbjct: 451 AAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 7e-06
Identities = 32/98 (32%), Positives = 43/98 (43%), Gaps = 19/98 (19%)
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDN-FEAMVADFGLAKLSNDNHTHVSTRVMGTFGY 484
L LH+ H IIH DIK N+L D + D+GL K + GT Y
Sbjct: 121 ALNDLHK--H-NIIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDY 172
Query: 485 LAPEYASSGKLTEKSDVFSF-----GVMLLELITGRRP 517
+PE K+ + SF GV+ EL+TG+ P
Sbjct: 173 FSPE-----KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 24/204 (11%)
Query: 324 LGQGGFGYVHKGVLPNGK--EVAVKSLKTG----SGQGEREFSAEVEIISRVHHRHLVSL 377
LG G FG V N VA+K + Q + FS E +I++ ++H V+L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS-ERKILNYINHPFCVNL 96
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMD----FATRVRIALGSAKGLAYLHED 433
G LV EFV L R D +A ++ + + L
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL------ 150
Query: 434 CHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSG 493
I++RD+K N+L+D + + DFG AK+ D T+ + GT Y+APE +
Sbjct: 151 ---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-DTRTYT---LCGTPEYIAPEILLNV 203
Query: 494 KLTEKSDVFSFGVMLLELITGRRP 517
+ +D ++ G+ + E++ G P
Sbjct: 204 GHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 25/133 (18%), Positives = 39/133 (29%), Gaps = 8/133 (6%)
Query: 16 SPPAPPS----SNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPP 71
+ PA P+ PP A + + P +
Sbjct: 142 ARPAYPAYQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYDAGR 201
Query: 72 PATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSP--TPPSPSNNKSPSPPVFS--P 127
P P D ++P + P PPP + P P + +P P+ P
Sbjct: 202 PEYDQRRRDYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIRPSAP 261
Query: 128 PPPAKKSSPPPPP 140
P A + +P P P
Sbjct: 262 GPLAAQPAPAPGP 274
|
Length = 617 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 322 NLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGY 380
N++G G FG V++ + + ++VA+K + Q + + E+ I+ ++H +++ L Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVL----QDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 381 ----CIAGGQRML----VYEFVSNKTLEY--HLHGENRPVMDFATRVRIALGSAKGLAYL 430
C ++ + V EF+ +Y H N + F ++ + + LAY+
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL-YSYQLCRALAYI 186
Query: 431 HEDCHPRIIHRDIKAANILIDDNFEAM-VADFGLAKLSNDNHTHVSTRVMGTFGYLAPEY 489
H I HRD+K N+LID N + + DFG AK VS + F Y APE
Sbjct: 187 HSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY-ICSRF-YRAPEL 241
Query: 490 A-SSGKLTEKSDVFSFGVMLLELITG 514
+ T D++S G ++ E+I G
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 25/75 (33%), Positives = 33/75 (44%)
Query: 40 PPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPP 99
P ++ PA PPP ++ P +PP PPPA +P P P + P P PP
Sbjct: 34 PATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPP 93
Query: 100 PPPPSSQSSPTPPSP 114
PP + P P P
Sbjct: 94 PPVDPNAPPPPAPEP 108
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|200219 TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 17/70 (24%), Positives = 26/70 (37%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
G A P+ + + P PS S P + P P P+ P + P++ P +
Sbjct: 201 GDANAAPAEPAEEEAPAPSEAGSEPAPDPAARAPHAAPDPPAPAPAPAKTAAPAAAAPVS 260
Query: 75 SSSPPPASPP 84
S P P
Sbjct: 261 SGDSGPYVTP 270
|
This model represents an Actinobacterial clade of E2 enzyme, a component of the 2-oxoglutarate dehydrogenase complex involved in the TCA cycle. These proteins have multiple domains including the catalytic domain (pfam00198), one or two biotin domains (pfam00364) and an E3-component binding domain (pfam02817). Length = 579 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 26/136 (19%), Positives = 39/136 (28%), Gaps = 2/136 (1%)
Query: 7 VTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPP-SKS 65
V E + PP + P P T + P+ P+ P ++PP
Sbjct: 44 VAEFPWDPSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFAL 103
Query: 66 PPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVF 125
P P + P P P NS P P+ Q + S +
Sbjct: 104 PAGPAGPTIQTEPGQLYPVQVPVMVTQNPANS-PLDQPAQQRALQQLQQRYGAPASGQLP 162
Query: 126 SPPPPAKKSSPPPPPL 141
S A+K+
Sbjct: 163 SQQQSAQKNDESQLQQ 178
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 1e-05
Identities = 14/76 (18%), Positives = 21/76 (27%)
Query: 65 SPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPV 124
S S S+ P P ++P ++ SP P S
Sbjct: 362 SAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEP 421
Query: 125 FSPPPPAKKSSPPPPP 140
P P ++ PP
Sbjct: 422 TEPSPTPPANAANAPP 437
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 1e-05
Identities = 17/84 (20%), Positives = 26/84 (30%), Gaps = 8/84 (9%)
Query: 48 ASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQS 107
S S +S P + +P +P P + P A + P PPP+ S
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKT--------KQAATTPSPPPAKAS 412
Query: 108 SPTPPSPSNNKSPSPPVFSPPPPA 131
P P + P +
Sbjct: 413 PPIPVPAEPTEPSPTPPANAANAP 436
|
Length = 620 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 1e-05
Identities = 9/75 (12%), Positives = 22/75 (29%)
Query: 2 AKGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPP 61
AP + + P P + + + PP A+ + P +
Sbjct: 44 PTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAAPPAAA 103
Query: 62 PSKSPPSSPPPATSS 76
+ +P ++ +
Sbjct: 104 AAAAPAAAAVEDEVT 118
|
Length = 1228 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 39/173 (22%), Positives = 54/173 (31%), Gaps = 17/173 (9%)
Query: 18 PAPPSSNSSDATPP--PSSTPSSSPPPSSPP---PASPPPSSPPPSSPPPSKSPPSSPPP 72
P P + D PP P TP SS P SS A P PS S P P
Sbjct: 370 PLSPYTAYEDLKPPTSPIPTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQ 429
Query: 73 ATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQS------------SPTPPSPSNNKSP 120
+ P SP + P SP P S S + + ++ +P
Sbjct: 430 VEAKKTRPLSPYARYEDLKPPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAP 489
Query: 121 SPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVTYSVI 173
P P P PP S + P + S ++ G+ ++
Sbjct: 490 PPANMRPLSPYAVYDDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTALA 542
|
Length = 576 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 41/144 (28%), Positives = 53/144 (36%), Gaps = 10/144 (6%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
P S A PP + S PP +S P S S PP S P
Sbjct: 410 PQSQPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHSGPPQSPFAQHPFTSGGLPAIG--- 466
Query: 78 PPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVF---SPPPPAKKS 134
PP S PTS PP+ S PP S + + P PP+ P A++
Sbjct: 467 -PPPSLPTS--TPAAPPRASSGSQPPGSALPSSGGC-AGPGPPLPPIQIKEEPLDEAEEP 522
Query: 135 SPPPPPLKYSSSTPKSSSSSSKSS 158
PPPP + S P ++ S +S
Sbjct: 523 ESPPPPPRSPSPEPTVVNTPSHAS 546
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 20/75 (26%), Positives = 33/75 (44%), Gaps = 6/75 (8%)
Query: 29 TPPPSSTPSSSPPPSSPPPASPPPSSPPPS------SPPPSKSPPSSPPPATSSSPPPAS 82
+ P + T +PP ++P A P SPP S + P S SP ++++ P S
Sbjct: 75 SKPKTGTGKVAPPAATPTSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAPES 134
Query: 83 PPTSDNNKPDPPKNS 97
P TS + ++
Sbjct: 135 PSTSVPSSGSDAAST 149
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 21/76 (27%), Positives = 30/76 (39%), Gaps = 1/76 (1%)
Query: 7 VTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSP 66
V++ + G P ++ +S TP PS P+S S PAS P + +P
Sbjct: 74 VSKPKTGTGKVAPPAATPTSAPTPTPS-PPASPASGMSAAPASAVEEKSPSEESATATAP 132
Query: 67 PSSPPPATSSSPPPAS 82
S SS AS
Sbjct: 133 ESPSTSVPSSGSDAAS 148
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 35/145 (24%), Positives = 44/145 (30%), Gaps = 6/145 (4%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
PP P +PP +PPP + P S P PP+ P P++ +
Sbjct: 144 PPQVPQQ-QQYQSPPQQPQYQQNPPPQAQSAPQVSGLYPEESPYQPQSYPPNEPLPSSMA 202
Query: 77 SPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSP 136
PP S P PP P P P S S P S S
Sbjct: 203 MQPPYSGAP-----PSQQFYGPPQPSPYMYGGPGGRPNSGFPSGQQPPPSQGQEGYGYSG 257
Query: 137 PPPPLKYSSSTPKSSSSSSKSSNGS 161
PPP S + S S +
Sbjct: 258 PPPSKGNHGSVASYAPQGSSQSYST 282
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 25/116 (21%), Positives = 35/116 (30%), Gaps = 12/116 (10%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
P P + D P + + PP + ++ P P +PP++P
Sbjct: 45 PKPGDRDEPDMMPAATQALPTQPPEGAAEAVRAGDAAAPSLDPATV-APPNTPVEP---E 100
Query: 78 PPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKK 133
P P PP PK P P P+ P P V P K
Sbjct: 101 PAPVEPP--------KPKPVEKPKPKPKPQQKVEAPPAPKPEPKPVVEEKAAPTGK 148
|
Length = 226 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 12/97 (12%), Positives = 31/97 (31%)
Query: 19 APPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSP 78
P ++ + A PPP++ P++ P++P P + + A ++
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPE 112
Query: 79 PPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPS 115
A ++ + ++ P +
Sbjct: 113 AQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAA 149
|
Length = 484 |
| >gnl|CDD|216648 pfam01690, PLRV_ORF5, Potato leaf roll virus readthrough protein | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 24/162 (14%), Positives = 37/162 (22%), Gaps = 13/162 (8%)
Query: 5 NNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSK 64
+T + S + S S +PP + + +
Sbjct: 274 RQTFKTPPQPESSSDAENGLVSLVDEDDKEEVSRDSESDAPPDDTDLTRALAEYEAAAPE 333
Query: 65 SPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPV 124
P ++ P P S P P +S + V
Sbjct: 334 VPDAARTVLQGKEQPSPDPVESPG---------PDLTPGYPKS----DEVAGTYLGGGSV 380
Query: 125 FSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDD 166
P + P L SSS S S G+ G
Sbjct: 381 AEGRDPLEADPTPSTVLDARKEKGPSSSGSGSLSGGTLKGKA 422
|
This family consists mainly of the potato leaf roll virus readthrough protein. This is generated via a readthrough of open reading frame 3 a coat protein allowing transcription of open reading frame 5 to give an extended coat protein with a large c-terminal addition or read through domain. The readthrough protein is thought to play a role in the circulative aphid transmission of potato leaf roll virus. Also in the family is open reading frame 6 from beet western yellows virus and potato leaf roll virus both luteovirus and an unknown protein from cucurbit aphid-borne yellows virus a closterovirus. Length = 460 |
| >gnl|CDD|177464 PHA02682, PHA02682, ORF080 virion core protein; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (111), Expect = 1e-05
Identities = 35/124 (28%), Positives = 56/124 (45%), Gaps = 9/124 (7%)
Query: 21 PSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA---TSSS 77
PS S A P + P+ + P +P +P + P P+ P + P+ PPPA +
Sbjct: 76 PSGQSPLAPSPACAAPAPACPACAPAAPAPAVTCPAPAPACPPATAPTCPPPAVCPAPAR 135
Query: 78 PPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPP 137
P PA PP++ P PP +P P P + P +N+ P P + P +++P
Sbjct: 136 PAPACPPSTRQCPPAPPLPTPKPAPAAK------PIFLHNQLPPPDYPAASCPTIETAPA 189
Query: 138 PPPL 141
P+
Sbjct: 190 ASPV 193
|
Length = 280 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 32/108 (29%), Positives = 57/108 (52%), Gaps = 8/108 (7%)
Query: 409 PVMDFATRVRIALGSAKGLAYL-HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-- 465
P + + V + A G+ +L ++C +HRD+ A N+LI + + DFGLA+
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDI 289
Query: 466 LSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 513
+ + N+ + + ++APE + T SDV+SFG++L E+ T
Sbjct: 290 MRDSNYISKGSTFL-PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-05
Identities = 20/118 (16%), Positives = 33/118 (27%), Gaps = 4/118 (3%)
Query: 10 TENEEGSPPAPPSSNSSDATP----PPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKS 65
+ A + + P + P P +P P+ P S
Sbjct: 369 SAGRHHPKRASLPTRKRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPAPTPVPASAP 428
Query: 66 PPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPP 123
PP + P ++ P +P P P P P + + + P PP
Sbjct: 429 PPPATPLPSAEPGSDDGPAPPPERQPPAPATEPAPDDPDDATRKALDALRERRPPEPP 486
|
Length = 3151 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 38/189 (20%), Positives = 57/189 (30%), Gaps = 43/189 (22%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPS---------SPPPSKSPPS 68
PAPP A P + ++ PP P A+P ++ PP +P +PP
Sbjct: 255 PAPPPVVGEGADRAPETARGATGPPPPPEAAAPNGAAAPPDGVWGAALAGAPLALPAPPD 314
Query: 69 SPPPATSSSP--------------------------------PPASPPTS--DNNKPDPP 94
PPPA + P +PP+S D +
Sbjct: 315 PPPPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLGFPKRRRPTWTPPSSLEDLSAGRHH 374
Query: 95 KNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSS 154
P +S+ +P P P S P P P +S P ++
Sbjct: 375 PKRASLPTRKRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPAPTPVPASAPPPPATP 434
Query: 155 SKSSNGSSS 163
S+ S
Sbjct: 435 LPSAEPGSD 443
|
Length = 3151 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 2e-05
Identities = 17/103 (16%), Positives = 35/103 (33%), Gaps = 3/103 (2%)
Query: 67 PSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFS 126
P++P P P A+P S P PP P+ P +P+ P+
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQ---APAVPLPE 417
Query: 127 PPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVT 169
+ + ++ KS +++ + +S + +
Sbjct: 418 TTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLA 460
|
Length = 647 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-05
Identities = 16/78 (20%), Positives = 26/78 (33%)
Query: 2 AKGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPP 61
+ P P + S P S P + ++P P S P P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 62 PSKSPPSSPPPATSSSPP 79
P++ P+ P A ++ P
Sbjct: 421 PTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 20/77 (25%), Positives = 33/77 (42%), Gaps = 1/77 (1%)
Query: 6 NVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKS 65
++E N P+ N S P P + ++ P+ PP + PP P +
Sbjct: 364 FISEIANASAPANPTPAPNPS-PPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPT 422
Query: 66 PPSSPPPATSSSPPPAS 82
PS PPA +++ PP+
Sbjct: 423 EPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 27/132 (20%), Positives = 36/132 (27%), Gaps = 6/132 (4%)
Query: 36 PSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSP---PPATSSSPPPASPPTSDNNKPD 92
+P PP P PP + P + PP P P P P P
Sbjct: 166 RQQAPQLPQPPQQVLPQGMPPRQAAFPQQGPPEQPPGYPQPPQGHPEQVQPQQFL---PA 222
Query: 93 PPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSS 152
P + PP P PP PPPP PP + P++
Sbjct: 223 PSQAPAQPPLPPQLPQQPPPLQQPQFPGLSQQMPPPPPQPPQQQQQPPQPQAQPPPQNQP 282
Query: 153 SSSKSSNGSSSG 164
+ +
Sbjct: 283 TPHPGLPQGQNA 294
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 25/113 (22%), Positives = 42/113 (37%), Gaps = 4/113 (3%)
Query: 7 VTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSP 66
T + ++ + A PP + P S P + PP+SP P++P +P
Sbjct: 467 STSSVPAVPDTAPATAATDAAAPPPANMRPLS---PYAVYDDLKPPTSPSPAAPVGKVAP 523
Query: 67 PSSPP-PATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNK 118
S+ +S PP + ++ P+ P PT P+PS
Sbjct: 524 SSTNEVVKVGNSAPPTALADEQHHAQPKPRPLSPYTMYEDLKPPTSPTPSPVL 576
|
Length = 576 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 25/78 (32%), Positives = 36/78 (46%), Gaps = 6/78 (7%)
Query: 42 PSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPP 101
P + PP++ P S+P P+ SPP+SP S++P A S P + S
Sbjct: 77 PKTGTGKVAPPAATPTSAPTPTPSPPASPASGMSAAPASAVEEKS------PSEESATAT 130
Query: 102 PPSSQSSPTPPSPSNNKS 119
P S S+ P S S+ S
Sbjct: 131 APESPSTSVPSSGSDAAS 148
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 54/272 (19%), Positives = 71/272 (26%), Gaps = 50/272 (18%)
Query: 25 SSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPP--SKSPPSSPPPATSSSPPPAS 82
+A PP+ P S P +PP P PP P P PPP+
Sbjct: 68 QVNAALPPAPAPQSPQPDQQQQSQAPPSHQYPSQLPPQQVQSVPQQPTPQQEPYYPPPSQ 127
Query: 83 PPTSDNNKPDPPKNSPPPPPPSSQSSPTPPS---PSNNKSPSPPVFSPPPPAKKSSPPPP 139
P +P + PPP P Q +PP N P P
Sbjct: 128 PQPPPAQQPQAQQPQPPPQVPQQQQYQSPPQQPQYQQNPPPQAQSAPQVSGLYPEESPYQ 187
Query: 140 PLKYSSSTPKSSSSSSKSSNGSSSGDDYVTYSVIGAVGVGIFLIAMIIICAVRANKKKKK 199
P Y + P SS + + + ++
Sbjct: 188 PQSYPPNEPLPSSMAMQPPYSGAP--------------------------------PSQQ 215
Query: 200 RHNQPMHYYGDHSNHFKKGGDPYYSGGHAPNWHGHPEHQNWHSHPQGPDHTGGNIPPPPG 259
+ P + G PN Q S Q G PPP
Sbjct: 216 FYGPPQPSPYMYGG-----------PGGRPNSGFPSGQQPPPSQGQEGYGYSG--PPPSK 262
Query: 260 GNWPGPPPPPPMMSSSGEMSSQFSGPARPPLP 291
GN P SS ++ S PA LP
Sbjct: 263 GNHGSVASYAPQGSSQSYSTAYPSLPAATVLP 294
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 40/149 (26%), Positives = 55/149 (36%), Gaps = 5/149 (3%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
P A + S P S S PP+ P P+S PP S PPS+ P P+
Sbjct: 167 PPQAQSAPQVSGLYPEESPYQPQSYPPNEPLPSSMAMQ-PPYSGAPPSQQFYGPPQPSPY 225
Query: 76 SSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSS 135
P P S P PPP + P PS S ++P ++ S
Sbjct: 226 MYGGPGGRPNSGF----PSGQQPPPSQGQEGYGYSGPPPSKGNHGSVASYAPQGSSQSYS 281
Query: 136 PPPPPLKYSSSTPKSSSSSSKSSNGSSSG 164
P L ++ P++ SS +G SG
Sbjct: 282 TAYPSLPAATVLPQALPMSSAPMSGGGSG 310
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|220271 pfam09507, CDC27, DNA polymerase subunit Cdc27 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 26/140 (18%), Positives = 38/140 (27%), Gaps = 7/140 (5%)
Query: 28 ATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS--PPPASPPT 85
P + P+ P P +SP K P S PP + S ++ T
Sbjct: 125 KQAGPITNPNVKRRTGVGLPPVAPAASPALKPTANGKRPSSKPPKSIMSPEVKVKSAKKT 184
Query: 86 SDNNKP-DPPKNSPPPPPPSSQSSPTPPSPSNNKSP----SPPVFSPPPPAKKSSPPPPP 140
D +K K ++ PP SN S A +S+
Sbjct: 185 QDTSKETTTEKTEGKTSVKAASLKRNPPKKSNIMSSFFKKKTKEKKEKKEASESTVKEES 244
Query: 141 LKYSSSTPKSSSSSSKSSNG 160
+ S S G
Sbjct: 245 EEESGKRDVILEDESAEPTG 264
|
This protein forms the C subunit of DNA polymerase delta. It carries the essential residues for binding to the Pol1 subunit of polymerase alpha, from residues 293-332, which are characterized by the motif D--G--VT, referred to as the DPIM motif. The first 160 residues of the protein form the minimal domain for binding to the B subunit, Cdc1, of polymerase delta, the final 10 C-terminal residues, 362-372, being the DNA sliding clamp, PCNA, binding motif. Length = 427 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 20/89 (22%), Positives = 27/89 (30%), Gaps = 8/89 (8%)
Query: 24 NSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSP---PP 80
N P P+ +P P P P P P P PA++ +P PP
Sbjct: 376 NDGGVAPSPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPASAPTPEQQPP 435
Query: 81 ASPPTSDNNKPDPPKNSPPPPPPSSQSSP 109
+ P PP P + P
Sbjct: 436 VARSA-----PLPPSPQASAPRNVASGKP 459
|
Length = 620 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 24/83 (28%), Positives = 30/83 (36%), Gaps = 6/83 (7%)
Query: 45 PPPASPPPS---SPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPP 101
P PA P +P P P P + P + P A + P P S P P + P
Sbjct: 382 PSPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPAS---APTPEQQPPVAR 438
Query: 102 PPSSQSSPTPPSPSNNKSPSPPV 124
SP +P N S P V
Sbjct: 439 SAPLPPSPQASAPRNVASGKPGV 461
|
Length = 620 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 22/105 (20%), Positives = 31/105 (29%), Gaps = 7/105 (6%)
Query: 42 PSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS------SPPPASPPTSDNNKPDPPK 95
P+ A+PP P S+P + P S P P
Sbjct: 167 PAEGTLAAPPLGEGSADGSCDPALPLSAPRLGPADVFVPATPRPTPRTTASPETTPTPST 226
Query: 96 NSPPPPPPSSQSSPTPPSPSNNKSPSPP-VFSPPPPAKKSSPPPP 139
+ PP S T +P +P +PP P +PP
Sbjct: 227 TTSPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPGGGEAPPAN 271
|
Length = 401 |
| >gnl|CDD|183558 PRK12495, PRK12495, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 20/90 (22%), Positives = 32/90 (35%), Gaps = 1/90 (1%)
Query: 34 STPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDP 93
+ PS + +SP + P + + S+ +++ PPA+ D PDP
Sbjct: 85 TAPSDAGSQASPDDDAQPAAEAEAADQSAPPEASSTSATDEAATDPPATAAARDGPTPDP 144
Query: 94 PKNSPPPPPPSSQSSPTPPSPSNNKSPSPP 123
P P PP +PS P
Sbjct: 145 TAQ-PATPDERRSPRQRPPVSGEPPTPSTP 173
|
Length = 226 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 16/66 (24%), Positives = 30/66 (45%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
G+PPA + ++ A ++ +P P + +PP ++ PP +P + PPP
Sbjct: 122 GAPPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPPPTP 181
Query: 75 SSSPPP 80
+ P
Sbjct: 182 VARADP 187
|
Length = 418 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 30/96 (31%), Positives = 35/96 (36%), Gaps = 15/96 (15%)
Query: 45 PPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPS 104
PPPSS P SS P+ SS+P P S N P + P PP+
Sbjct: 179 GGNIPGAIQPPPPSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPSAPPA 238
Query: 105 SQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPP 140
S +P P PPV P PP PP
Sbjct: 239 SIPAP----------PIPPVIQYVAP-----PPVPP 259
|
Length = 582 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 36/215 (16%), Positives = 60/215 (27%), Gaps = 50/215 (23%)
Query: 13 EEGSPPAPPSSNSSDATPPPSSTPSSSPPPSS---------PPPASPPPSSPPPSSPP-- 61
P + PP ++ P+ + P P A P P PPP +P
Sbjct: 264 GADRAPETARGATGPPPPPEAAAPNGAAAPPDGVWGAALAGAPLALPAPPDPPPPAPAGD 323
Query: 62 ---------------------------------PSKSPPSSPPPATSSS-PPPASPPTSD 87
P+ +PPSS ++ P + +
Sbjct: 324 AEEEDDEDGAMEVVSPLPRPRQHYPLGFPKRRRPTWTPPSSLEDLSAGRHHPKRASLPTR 383
Query: 88 NNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSP-----PVFSPPPPAKKSSPPPPPLK 142
+ +P P P +P P+P P +PPPPA P
Sbjct: 384 KRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPAPTPVPASAPPPPATPLPSAEPGSD 443
Query: 143 YSSSTPKSSSSSSKSSNGSSSGDDYVTYSVIGAVG 177
+ P + ++ + D T + A+
Sbjct: 444 DGPAPPPERQPPAPATEPAPDDPDDATRKALDALR 478
|
Length = 3151 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 21/79 (26%), Positives = 26/79 (32%), Gaps = 5/79 (6%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSP----PPSSPPPASPPPSSPPPSSPPPSKSPPSSPP 71
P AP S+ TPP S + PPS+ P A P P SK S P
Sbjct: 410 QPSAPQSATQPAGTPPTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPVSKV-SSLGP 468
Query: 72 PATSSSPPPASPPTSDNNK 90
A T + +
Sbjct: 469 STLRPIQEKAEQATGNIKE 487
|
Length = 614 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 24/117 (20%), Positives = 27/117 (23%), Gaps = 7/117 (5%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
PP P P PPP PP P + PPP P P
Sbjct: 233 PPQLPQQPPPLQQPQFPGLSQQMPPPPPQPPQQQQQPPQPQAQPPPQNQPTPHPGLPQGQ 292
Query: 77 SPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKK 133
+ P P P P Q P S AK+
Sbjct: 293 NAPLPPPQ-------QPQLLPLVQQPQGQQRGPQFREQLVQLSQQQREALSQEEAKR 342
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 20/65 (30%), Positives = 27/65 (41%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
PP PPS+ ++ P P P +P P P + PPP + P + PP P A
Sbjct: 44 PPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPPPPVDPNAPPP 103
Query: 77 SPPPA 81
P
Sbjct: 104 PAPEP 108
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 16/73 (21%), Positives = 21/73 (28%)
Query: 13 EEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPP 72
+ A S PP++ P P PP P P P P +P P
Sbjct: 74 AVRAGDAAAPSLDPATVAPPNTPVEPEPAPVEPPKPKPVEKPKPKPKPQQKVEAPPAPKP 133
Query: 73 ATSSSPPPASPPT 85
+ PT
Sbjct: 134 EPKPVVEEKAAPT 146
|
Length = 226 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 21/75 (28%), Positives = 39/75 (52%), Gaps = 2/75 (2%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
P P ++ S + TP PS+T +SPP ++ P S ++P + P ++ P+ P P
Sbjct: 208 PRPTPRTTASPETTPTPSTT--TSPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPGGG 265
Query: 76 SSPPPASPPTSDNNK 90
+PP + P + ++
Sbjct: 266 EAPPANATPAPEASR 280
|
Length = 401 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 20/130 (15%), Positives = 32/130 (24%), Gaps = 6/130 (4%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPP---PASPPPSSPPPSSPPPSKSPPSSPPPA 73
PP PPP+ + P P P ++PP + P+ +
Sbjct: 56 PPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFALPAGPAGPTIQTE 115
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSP---PPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPP 130
P P N + P + P Q P S +
Sbjct: 116 PGQLYPVQVPVMVTQNPANSPLDQPAQQRALQQLQQRYGAPASGQLPSQQQSAQKNDESQ 175
Query: 131 AKKSSPPPPP 140
++ P
Sbjct: 176 LQQQPNGETP 185
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|177464 PHA02682, PHA02682, ORF080 virion core protein; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (108), Expect = 3e-05
Identities = 30/116 (25%), Positives = 46/116 (39%)
Query: 42 PSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPP 101
PS P +P P+ P+ P+ +P + P T +P PA PP + P P P
Sbjct: 76 PSGQSPLAPSPACAAPAPACPACAPAAPAPAVTCPAPAPACPPATAPTCPPPAVCPAPAR 135
Query: 102 PPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKS 157
P + T P P+P P + PPP ++S P ++ + S
Sbjct: 136 PAPACPPSTRQCPPAPPLPTPKPAPAAKPIFLHNQLPPPDYPAASCPTIETAPAAS 191
|
Length = 280 |
| >gnl|CDD|183558 PRK12495, PRK12495, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 21/108 (19%), Positives = 40/108 (37%), Gaps = 6/108 (5%)
Query: 10 TENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSS 69
+ +G+ PS S A+P + P++ A+ + P SS + +
Sbjct: 76 DDAGDGAEATAPSDAGSQASPDDDAQPAA------EAEAADQSAPPEASSTSATDEAATD 129
Query: 70 PPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNN 117
PP ++ P PT+ PD ++ PP S + ++
Sbjct: 130 PPATAAARDGPTPDPTAQPATPDERRSPRQRPPVSGEPPTPSTPDAHV 177
|
Length = 226 |
| >gnl|CDD|234818 PRK00708, PRK00708, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 14/101 (13%), Positives = 36/101 (35%), Gaps = 3/101 (2%)
Query: 25 SSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPP 84
+ +T + ++P P +PP P ++ +++P + P
Sbjct: 97 QKATSMSEPATENKPAEVTTPVEPMGLPETPPAVPVPAPAPAVAAAAAQAAAAPKAPAKP 156
Query: 85 TSDNNKPDPPKNSPP---PPPPSSQSSPTPPSPSNNKSPSP 122
+ + +P P ++ + P P+ +K+ +P
Sbjct: 157 RAKSPRPAAKAAPKPTETITAKKAKKTAAAPKPTADKTATP 197
|
Length = 209 |
| >gnl|CDD|234818 PRK00708, PRK00708, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 27/124 (21%), Positives = 41/124 (33%), Gaps = 15/124 (12%)
Query: 33 SSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPD 92
S S P + PA ++P P +PP +P PA +
Sbjct: 97 QKATSMSEPATENKPA-------EVTTPVEPMGLPETPPAVPVPAPAPA-VAAAAAQAAA 148
Query: 93 PPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSS 152
PK P P P+ +P P AKK++ P P ++TP +
Sbjct: 149 APKAPAKP-------RAKSPRPAAKAAPKPTETITAKKAKKTAAAPKPTADKTATPAKKT 201
Query: 153 SSSK 156
+ K
Sbjct: 202 TKKK 205
|
Length = 209 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 22/81 (27%), Positives = 31/81 (38%), Gaps = 2/81 (2%)
Query: 47 PASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQ 106
+S P+S S S S S P +S+SP P S ++ P S P P S
Sbjct: 1 SSSSNPTSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTP--SILPLPKLSS 58
Query: 107 SSPTPPSPSNNKSPSPPVFSP 127
SP + + P +P
Sbjct: 59 PSPPSVTLPPAATTQTPQLNP 79
|
Length = 590 |
| >gnl|CDD|165527 PHA03269, PHA03269, envelope glycoprotein C; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 29/124 (23%), Positives = 44/124 (35%), Gaps = 6/124 (4%)
Query: 29 TPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTS-D 87
T + P +P P +P P+ P S+ +P PA S PA P
Sbjct: 33 TSAATQKPDPAPAPHQAASRAPDPAVAPTSAASRKPDLAQAPTPAASEKFDPAPAPHQAA 92
Query: 88 NNKPDPPK-----NSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLK 142
+ PDP +P P + +S + + + P PA + PPP
Sbjct: 93 SRAPDPAVAPQLAAAPKPDAAEAFTSAAQAHEAPADAGTSAASKKPDPAAHTQHSPPPFA 152
Query: 143 YSSS 146
Y+ S
Sbjct: 153 YTRS 156
|
Length = 566 |
| >gnl|CDD|223079 PHA03419, PHA03419, E4 protein; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 30/114 (26%), Positives = 39/114 (34%), Gaps = 4/114 (3%)
Query: 13 EEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPP 72
E G P PP++ + PPP PP ++ PPP K + P
Sbjct: 46 ETGYPFCPPTTPHPSSQPPPCPPSPGHPPQTNDTHEKDLALQPPPGGKKKEKKKKETEKP 105
Query: 73 ATSSSPPPASP---PTSDNNKP-DPPKNSPPPPPPSSQSSPTPPSPSNNKSPSP 122
A P P + ++P DPP PPPP PSP P
Sbjct: 106 AQGGEKPDQGPEAKGEGEGHEPEDPPPEDTPPPPGGEGEVEGGPSPGPGPGPLD 159
|
Length = 200 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 26/77 (33%), Positives = 35/77 (45%), Gaps = 3/77 (3%)
Query: 31 PPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS---SPPPASPPTSD 87
PP +PS PP + PP PPS+ P PS P PP+T + PP S
Sbjct: 552 PPKVSPSDRGPPKASPPVMAPPSTGPRVMATPSTGPRDMAPPSTGPRQQAKCKDGPPASG 611
Query: 88 NNKPDPPKNSPPPPPPS 104
++ PP ++P PS
Sbjct: 612 PHEKQPPSSAPRDMAPS 628
|
Length = 1000 |
| >gnl|CDD|218440 pfam05110, AF-4, AF-4 proto-oncoprotein | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 32/136 (23%), Positives = 48/136 (35%)
Query: 8 TETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPP 67
E ++ SP + S + S + + + P P+SP SS P P K P
Sbjct: 768 LEEKSSSCSPSSSSSHHHSSSNKESRKSSRNKEEEMLPSPSSPLSSSSPKPEHPSRKRPR 827
Query: 68 SSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSP 127
++SS P AS S + K+ SS S S + + + P
Sbjct: 828 RQEDTSSSSGPFSASSTKSSSKSSSTSKHRKTEGKGSSTSKEHKGSSGDTPNKASSFPVP 887
Query: 128 PPPAKKSSPPPPPLKY 143
P S P P L +
Sbjct: 888 PLSNGSSKPRRPKLVF 903
|
This family consists of AF4 (Proto-oncogene AF4) and FMR2 (Fragile X E mental retardation syndrome) nuclear proteins. These proteins have been linked to human diseases such as acute lymphoblastic leukaemia and mental retardation. The family also contains a Drosophila AF4 protein homologue Lilliputian which contains an AT-hook domain. Lilliputian represents a novel pair-rule gene that acts in cytoskeleton regulation, segmentation and morphogenesis in Drosophila. Length = 1154 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 25/131 (19%), Positives = 44/131 (33%), Gaps = 5/131 (3%)
Query: 5 NNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPS--SPPPASPPPSSPPPSSPPP 62
+ +++GS + P + PPP P P + P + + P+ P
Sbjct: 288 GETADLADDDGSEHSDPEPLPASLPPPPVRRPRVKHPEAGKEEPDGARNAEAKEPAQPAT 347
Query: 63 SKSPPSSP---PPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKS 119
S S S + S+ P +S + + D SPP +S PS ++
Sbjct: 348 STSSKGSSSAQNKDSGSTGPGSSLAAASSFLEDDDFGSPPLDLTTSLRHMPSPSVTSAPE 407
Query: 120 PSPPVFSPPPP 130
P +
Sbjct: 408 PPSIPLTYLSD 418
|
Length = 418 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 17/105 (16%)
Query: 427 LAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL------SN--DNHTHVSTR- 477
L YLH + I+HRD+K N+LI + DFGL+K+ +N + H TR
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 478 -----VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
V GT Y+APE + D ++ G++L E + G P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 4e-05
Identities = 18/56 (32%), Positives = 22/56 (39%)
Query: 29 TPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPP 84
TPP P + P SP PA P P + PP+ + P A P PP
Sbjct: 83 TPPAPPEPVTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPPPSDPPQPP 138
|
Length = 141 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 324 LGQGGFGYVHKGVL-----------PNGKEVAV--KSLKTGSGQGEREFSAEVEIISRVH 370
LG+G ++ G+L KE+ V K L F ++ +V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 371 HRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYL 430
H+H+V L G C+ + ++V EFV L+ +H ++ + + ++A A L+YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDV-LTTPWKFKVAKQLASALSYL 121
Query: 431 HEDCHPRIIHRDIKAANILIDDNFEAMVADFG-LAKLSNDN-HTHVSTR--VMGTFGYLA 486
ED ++H ++ NIL+ E + + G KLS+ V +R + ++A
Sbjct: 122 -ED--KDLVHGNVCTKNILLAR--EGIDGECGPFIKLSDPGIPITVLSRQECVERIPWIA 176
Query: 487 PEYASSGK-LTEKSDVFSFGVMLLEL-ITGRRPV-DMTMME 524
PE K L+ +D +SFG L E+ G P+ D T+ E
Sbjct: 177 PECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|227709 COG5422, ROM1, RhoGEF, Guanine nucleotide exchange factor for Rho/Rac/Cdc42-like GTPases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-05
Identities = 44/165 (26%), Positives = 55/165 (33%), Gaps = 22/165 (13%)
Query: 19 APPSSNSSDATPPPSSTPSSSPPPSSP--PPASPPPSS--------PPPSSPPPSKSPPS 68
A P ++S AT SS S+ SP S PSS P SP + P
Sbjct: 89 AGPITHSPSATSSTSSLNSNDGDQFSPASDSLSFNPSSTQSRKDSGPGDGSPVQKRKNPL 148
Query: 69 SPPPATSSSPPPASPPTSDNN---KPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVF 125
P +T + PP +DNN P S P S PSP + S
Sbjct: 149 LPSSSTHGTHPPIV--FTDNNGSHAGAPNARSRKEIPSLGSQSMQLPSPHFRQKFSSSDT 206
Query: 126 SPP---PPAKK----SSPPPPPLKYSSSTPKSSSSSSKSSNGSSS 163
S P +K SS P +SS+ S S S
Sbjct: 207 SNGFSYPSIRKNSRHSSNSMPSFPHSSTAVLLKRHSGSSGASLIS 251
|
Length = 1175 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 27/133 (20%), Positives = 38/133 (28%), Gaps = 5/133 (3%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA 73
EG P + + P P P P A P P + P + P P A
Sbjct: 378 EGYPQQSQYAQPAVQYNEPLQQPVQPQQPYYAPAAEQPAQQPYYA--PAPEQPAQQPYYA 435
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPS---PPVFSPPPP 130
+ P A + + P P + PV P P
Sbjct: 436 PAPEQPVAGNAWQAEEQQSTFAPQSTYQTEQTYQQPAAQEPLYQQPQPVEQQPVVEPEPV 495
Query: 131 AKKSSPPPPPLKY 143
+++ P PPL Y
Sbjct: 496 VEETKPARPPLYY 508
|
Length = 1355 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 5e-05
Identities = 22/100 (22%), Positives = 32/100 (32%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
G+ PA P+ + P + ++ PP + AS P + P P + P
Sbjct: 695 GAAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGA 754
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSP 114
+ PPP P P SPP P
Sbjct: 755 PAQPPPPPAPAPAAAPAAAPPPSPPSEEEEMAEDDAPSMD 794
|
Length = 824 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 20/62 (32%), Positives = 27/62 (43%), Gaps = 2/62 (3%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSP-PPASPPPSSPPPSSP-PPSKSPPSSPPPAT 74
P S+ + +PP S S P+S SP S ++P PS S PSS A
Sbjct: 88 AATPTSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAPESPSTSVPSSGSDAA 147
Query: 75 SS 76
S+
Sbjct: 148 ST 149
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 32/118 (27%), Positives = 51/118 (43%), Gaps = 12/118 (10%)
Query: 22 SSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSP--- 78
S+ S A P+S +++ P P P + P + PS + P++P P+ + SP
Sbjct: 379 SAPSGSAAEGPASGGAATIP---TPGTQGPQGTAPAAGMTPSSAAPATPAPSAAPSPRVP 435
Query: 79 ----PPASPPTSDNNKPDP--PKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPP 130
PPA P + +P P P+ SP P P S +S + P+ +P P
Sbjct: 436 WDDAPPAPPRSGIPPRPAPRMPEASPVPGAPDSVASASDAPPTLGDPSDTAEHTPSGP 493
|
Length = 624 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 29/92 (31%), Positives = 40/92 (43%), Gaps = 2/92 (2%)
Query: 10 TENEEGSPPAPPSSNSS--DATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPP 67
T+ +G+ PA + SS ATP PS+ PS P PPA P PP +P ++ P
Sbjct: 402 TQGPQGTAPAAGMTPSSAAPATPAPSAAPSPRVPWDDAPPAPPRSGIPPRPAPRMPEASP 461
Query: 68 SSPPPATSSSPPPASPPTSDNNKPDPPKNSPP 99
P + +S A P D + S P
Sbjct: 462 VPGAPDSVASASDAPPTLGDPSDTAEHTPSGP 493
|
Length = 624 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 18/69 (26%), Positives = 27/69 (39%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
S +S+SS ++ S S+SP P P++ P P P S PS P
Sbjct: 7 TSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTPSILPLPKLSSPSPPSVTL 66
Query: 75 SSSPPPASP 83
+ +P
Sbjct: 67 PPAATTQTP 75
|
Length = 590 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 21/71 (29%), Positives = 24/71 (33%), Gaps = 2/71 (2%)
Query: 30 PPPSSTPSSSPPPSSPPPASPPPS-SPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDN 88
P S +S SS +SPP S SP P PS S P P +SP
Sbjct: 6 PTSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTPSIL-PLPKLSSPSPPSV 64
Query: 89 NKPDPPKNSPP 99
P P
Sbjct: 65 TLPPAATTQTP 75
|
Length = 590 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 16/60 (26%), Positives = 22/60 (36%), Gaps = 7/60 (11%)
Query: 46 PPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSS 105
PA+ P+ + SKS S P A ++ PP +PP P P S
Sbjct: 271 QPATAAPAPSRMTDTNDSKSVTSQPAAAAAAPAPPPNPPA-------TPPEPPARRGRGS 323
|
Length = 656 |
| >gnl|CDD|165468 PHA03201, PHA03201, uracil DNA glycosylase; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 28/85 (32%), Positives = 35/85 (41%), Gaps = 4/85 (4%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
SPP PS P ++P +PP S P P + PP P + P P T
Sbjct: 10 SPPRRPSPPRPTPPRSPDASPEETPP-SPPGPGAEPPPGRAAGPAAPRRRPRGCPAGVTF 68
Query: 76 SSPPPASPPTSDNNKPDPPKNSPPP 100
SS P PP + D P +PPP
Sbjct: 69 SSSAPPRPPLGLD---DAPAATPPP 90
|
Length = 318 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 6e-05
Identities = 22/100 (22%), Positives = 36/100 (36%), Gaps = 8/100 (8%)
Query: 15 GSPPAPPSSNSSDATPPP------SSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPS 68
PP+ + D P +S PS + P P P P +P PP+
Sbjct: 704 APAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPA 763
Query: 69 SPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSS 108
P A ++ PP SPP+ + ++P + +
Sbjct: 764 PAPAAAPAAAPPPSPPSEEE--EMAEDDAPSMDDEDRRDA 801
|
Length = 824 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 22/99 (22%), Positives = 36/99 (36%)
Query: 50 PPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSP 109
P P P ++P P+ +++ P+ +S +P P+++ P S
Sbjct: 370 SGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVSV 429
Query: 110 TPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTP 148
PP+ PS + P K P K SS P
Sbjct: 430 DPPAAVPVNPPSTAPQAVRPAQFKEEKKIPVSKVSSLGP 468
|
Length = 614 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 36/155 (23%), Positives = 51/155 (32%), Gaps = 16/155 (10%)
Query: 19 APPSSNSSDATPPPSS-TPSSSPPPSSPPPASPPPSSPP----PSSP--------PPSKS 65
+P SS S DA P+ SP +S P P P SP PP+
Sbjct: 394 SPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKKTRPLSPYARYEDLKPPTSP 453
Query: 66 PPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVF 125
P++P + S +S P + P PPP ++ P SP P
Sbjct: 454 SPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPP---ANMRPLSPYAVYDDLKPPT 510
Query: 126 SPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNG 160
SP P A P S+ ++ +
Sbjct: 511 SPSPAAPVGKVAPSSTNEVVKVGNSAPPTALADEQ 545
|
Length = 576 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 33/157 (21%), Positives = 44/157 (28%), Gaps = 16/157 (10%)
Query: 22 SSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSP--------PPSKSPPSSPPPA 73
S +SS PP S P S+ +P S + P S P P
Sbjct: 400 SPSSSVIMTPPDSGPGSNVSSRRVG--TPGSKSDRVGAVLLRRMNIKPTLASIPDEKPSN 457
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPP---SPSNNKSPSPPVFSPPPP 130
S + P S DPP P S P P S PP+
Sbjct: 458 ISVFEDSETSPNSSTLLRDPP---PKKCGEESGHLPNNPFFNKLKLTLSSIPPLSPRQSI 514
Query: 131 AKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDY 167
+P P + SS + + S S +
Sbjct: 515 ITLPTPSRPASRISSLSLRLGSYSGSIVSPPPYPTLV 551
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 27/136 (19%), Positives = 42/136 (30%), Gaps = 3/136 (2%)
Query: 42 PSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPP 101
+S S + P S + S + SS P + P S + S
Sbjct: 2 AASVSSGSTSGDASSPRSSSRRRLSSSFLSTSASSRPRRLNAPASPPSSSPARNTSSSSS 61
Query: 102 PPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGS 161
S+ P+ S S SP + ++ ++ST SSS S S
Sbjct: 62 FGLSKQRPSSLSRGRLSSRFV---SPSRGSPSAAASLNGSLATASTSGSSSPSRSRRTTS 118
Query: 162 SSGDDYVTYSVIGAVG 177
S SV+ +
Sbjct: 119 SDLSSGNGPSVLSFMA 134
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|222010 pfam13254, DUF4045, Domain of unknown function (DUF4045) | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 32/127 (25%), Positives = 46/127 (36%), Gaps = 7/127 (5%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASP---PPSSPPPSSPPPSKSPPSSPP 71
GS PS + P + + P +S S+P P KSP +PP
Sbjct: 213 GSHSKSPSKSGIPDLPSSRDSEKTKPEKPQQETSSMDTEKSSAPKPRETLDPKSPEKAPP 272
Query: 72 PATSSSPPPASPPTSDNNKPDP-PKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPP 130
T+ + + ++ K SP PS ++ P S KSP P+ P P
Sbjct: 273 IDTTEEELKSPEASPKESEEASARKRSPSLLSPSPKAESPKPLASPGKSPRDPLSPRPKP 332
Query: 131 AKKSSPP 137
SPP
Sbjct: 333 ---QSPP 336
|
This presumed domain is functionally uncharacterized. This domain family is found in bacteria and eukaryotes, and is typically between 384 and 430 amino acids in length. Length = 414 |
| >gnl|CDD|152960 pfam12526, DUF3729, Protein of unknown function (DUF3729) | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 6e-05
Identities = 30/84 (35%), Positives = 34/84 (40%), Gaps = 4/84 (4%)
Query: 25 SSDATPPPSSTPSSSPP--PSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPAS 82
SS +PP S+ P PP PP PP PP P + PP P PA
Sbjct: 26 SSCFSPPESAHPDDPPPVGDPRPPVVDTPPPVSAVWVLPPPSEPAAPPPDPEPPVPGPAG 85
Query: 83 PPTSDNNKPDPPKNSPPPPPPSSQ 106
PP+ P P PP PPP Q
Sbjct: 86 PPSP--LAPPAPARKPPLPPPRPQ 107
|
This family of proteins is found in viruses. Proteins in this family are typically between 145 and 1707 amino acids in length. The family is found in association with pfam01443, pfam01661, pfam05417, pfam01660, pfam00978. There is a single completely conserved residue L that may be functionally important. Length = 115 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 31/76 (40%), Positives = 39/76 (51%), Gaps = 8/76 (10%)
Query: 48 ASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQS 107
A P P PPPS+ + +P + PPP PPPA+PP +PD P +PPPPP +
Sbjct: 39 ADPAPPPPPPSTAAAAPAPAAPPPP-----PPPAAPPAP---QPDDPNAAPPPPPADPNA 90
Query: 108 SPTPPSPSNNKSPSPP 123
P PP N P P
Sbjct: 91 PPPPPVDPNAPPPPAP 106
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 26/81 (32%), Positives = 40/81 (49%), Gaps = 6/81 (7%)
Query: 57 PSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSN 116
P++ +PP PP +++P PA+PP P PP +PP P P ++ PP P++
Sbjct: 34 PATANADPAPPPPPPSTAAAAPAPAAPP------PPPPPAAPPAPQPDDPNAAPPPPPAD 87
Query: 117 NKSPSPPVFSPPPPAKKSSPP 137
+P PP P P + P
Sbjct: 88 PNAPPPPPVDPNAPPPPAPEP 108
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 7e-05
Identities = 16/71 (22%), Positives = 25/71 (35%)
Query: 45 PPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPS 104
PP PP P ++ P A +++P P + PD + PP P+
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 105 SQSSPTPPSPS 115
+ P S
Sbjct: 451 AAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 14/60 (23%), Positives = 23/60 (38%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA 73
E PAP + + A PP +++P + PA+ P + P P + P
Sbjct: 13 EAEQPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPASL 72
|
Length = 475 |
| >gnl|CDD|183558 PRK12495, PRK12495, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 20/109 (18%), Positives = 33/109 (30%), Gaps = 2/109 (1%)
Query: 2 AKGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPP 61
A + E S +S DA P + + P S + + PP
Sbjct: 74 AGDDAGDGAEATAPSDAGSQASPDDDAQPAAEAEAADQSAPPEASSTSATDEAA--TDPP 131
Query: 62 PSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPT 110
+ + P P ++ P S +P P P P + + T
Sbjct: 132 ATAAARDGPTPDPTAQPATPDERRSPRQRPPVSGEPPTPSTPDAHVAGT 180
|
Length = 226 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 8e-05
Identities = 13/71 (18%), Positives = 26/71 (36%)
Query: 5 NNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSK 64
N + N +P P + P + +++P P + P P P+ P P+
Sbjct: 369 ANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTEPSPTP 428
Query: 65 SPPSSPPPATS 75
++ P +
Sbjct: 429 PANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 8e-05
Identities = 16/65 (24%), Positives = 26/65 (40%), Gaps = 6/65 (9%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA 73
PA P+ PPP++ P P + P A+ P +P P + + + P A
Sbjct: 390 GAPTPAAPA------APPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARSADPAAA 443
Query: 74 TSSSP 78
S+
Sbjct: 444 ASAGD 448
|
Length = 576 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 21/136 (15%), Positives = 33/136 (24%), Gaps = 6/136 (4%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
P P + + PP + + P P
Sbjct: 152 RPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYDAGRPEYDQRRRDY 211
Query: 77 SPPPAS---PPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKK 133
P P ++P+PP + +P PS P P A+
Sbjct: 212 DHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIRPSAPG---PLAAQP 268
Query: 134 SSPPPPPLKYSSSTPK 149
+ P P + PK
Sbjct: 269 APAPGPGEPTARLNPK 284
|
Length = 617 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 23/96 (23%), Positives = 27/96 (28%), Gaps = 14/96 (14%)
Query: 56 PPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPS 115
P SP K P P P PA P + P SP P Q P S
Sbjct: 384 PAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELP--SPASAPTPEQQPPVARSA- 440
Query: 116 NNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSS 151
P PP+ ++S P S
Sbjct: 441 -----------PLPPSPQASAPRNVASGKPGVDLGS 465
|
Length = 620 |
| >gnl|CDD|218332 pfam04929, Herpes_DNAp_acc, Herpes DNA replication accessory factor | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 21/101 (20%), Positives = 30/101 (29%), Gaps = 10/101 (9%)
Query: 20 PPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPP 79
SS ++ P + S P +SP P S P +PPPA+ S P
Sbjct: 289 ADSSVEANGVEPEPTGSVSDRPRHLSSDSSPSPPDTSDSDP-----STETPPPASLSHSP 343
Query: 80 PASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSP 120
PA+ P + Q +P
Sbjct: 344 PAAFERPLALSPKRKREGDK-----KQKKKKSKKLKLTFNP 379
|
Replicative DNA polymerases are capable of polymerising tens of thousands of nucleotides without dissociating from their DNA templates. The high processivity of these polymerases is dependent upon accessory proteins that bind to the catalytic subunit of the polymerase or to the substrate. The Epstein-Barr virus (EBV) BMRF1 protein is an essential component of the viral DNA polymerase and is absolutely required for lytic virus replication. BMRF1 is also a transactivator. This family is predicted to have a UL42 like structure. Length = 381 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 8e-05
Identities = 19/114 (16%), Positives = 38/114 (33%), Gaps = 12/114 (10%)
Query: 19 APPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSP 78
PSS + ++ S+ + P P + ++ + + P+ + P
Sbjct: 304 VTPSSAVTQSSAITPSSAAIPSPAVIPSSVTTQSAT--TTQASAVALSSAGVLPSDVTLP 361
Query: 79 PPASPPTSDNNKPDPPKNSPPPPPPSSQSSPT----------PPSPSNNKSPSP 122
+ P ++ P S SS + T P +P++N SP
Sbjct: 362 GTVALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPTTSLPAAPASNIPVSP 415
|
Length = 421 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 9e-05
Identities = 26/89 (29%), Positives = 30/89 (33%), Gaps = 2/89 (2%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSP--PSSPPPATS 75
P P P P S+ P+ P P P SP +SP P PPP
Sbjct: 582 PKDPKHPKDPEEPKKPKRPRSAQRPTRPKSPKLPELLDIPKSPKRPESPKSPKRPPPPQR 641
Query: 76 SSPPPASPPTSDNNKPDPPKNSPPPPPPS 104
S P P PPK+ PP P
Sbjct: 642 PSSPERPEGPKIIKSPKPPKSPKPPFDPK 670
|
Length = 943 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 22/115 (19%), Positives = 34/115 (29%), Gaps = 5/115 (4%)
Query: 54 SPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPS 113
S K + P++ + P + P P S S+PT
Sbjct: 146 SSLGPPLQHRKRDAVTASPSSMIARNTPISDRLRPRSVTPTRGRRPSSSPRSLSNPTTLE 205
Query: 114 PSNNK-----SPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSS 163
+N P P + SS + S +TP+S S + SS
Sbjct: 206 SPSNLQVTTDVPPPYSNGTSRSSTMSSSANLSIISSLATPRSGESFRSTPTSGSS 260
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 60/243 (24%), Positives = 92/243 (37%), Gaps = 57/243 (23%)
Query: 318 FAKSNLLGQGGFGYVH----KGVLPNGKEVAVKSLKTGSGQGEREF---SAEVEIISRVH 370
F K LLG+G G V KG GK A+K L + E EI++ +
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59
Query: 371 HRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRP--------VMDFATRVRIALG 422
H L +L LV ++ E + +P +A V +AL
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGG--ELFRLLQRQPGKCLSEEVARFYAAEVLLAL- 116
Query: 423 SAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRV---- 478
YLH I++RD+K NIL+ ++ M++DF L+K S+ VS +
Sbjct: 117 -----EYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 479 ------------------------MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG 514
+GT Y+APE S D ++ G++L E++ G
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
Query: 515 RRP 517
P
Sbjct: 229 TTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 25/141 (17%), Positives = 42/141 (29%), Gaps = 2/141 (1%)
Query: 25 SSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPP 84
++ P ++P ++ S S + + A PP PP
Sbjct: 13 AAAEGGEFFPRPPATPGDAADDLLSGSQGQLVSDSAELAAVTVVAGAAACDRFEPPTGPP 72
Query: 85 TSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSP--SPPVFSPPPPAKKSSPPPPPLK 142
+ ++ P S +P P+ + +P PPP +SPPP P
Sbjct: 73 PGPGTEAPANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPPPPTPPPASPPPSPAP 132
Query: 143 YSSSTPKSSSSSSKSSNGSSS 163
S + S S
Sbjct: 133 DLSEMLRPVGSPGPPPAASPP 153
|
Length = 1352 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 16/67 (23%), Positives = 21/67 (31%)
Query: 2 AKGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPP 61
A N P PS+ + S P + P P PA P SP P +
Sbjct: 373 APANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTEPSPTPPANA 432
Query: 62 PSKSPPS 68
+ P
Sbjct: 433 ANAPPSL 439
|
Length = 620 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 34/159 (21%), Positives = 54/159 (33%), Gaps = 14/159 (8%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSP--PPASPPPSSPPPSSPPP---SKSPPSSP- 70
PP P ++P S + + P+ P P+ S+ P P K+ P SP
Sbjct: 382 PPTSPIPTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKKTRPLSPY 441
Query: 71 ------PPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNK--SPSP 122
P TS SP + + + P P ++ + P P+N + SP
Sbjct: 442 ARYEDLKPPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANMRPLSPYA 501
Query: 123 PVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGS 161
PP S P SST + + + +
Sbjct: 502 VYDDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTA 540
|
Length = 576 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 47/148 (31%), Positives = 55/148 (37%), Gaps = 22/148 (14%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSS---PPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
P P + TPP S PP PP S P PPP++P P S P
Sbjct: 308 PLPSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMPHIKPPPTTPIPQLPNQSHKHPPH 367
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPP---PPSSQSSPTPPSPSNNKSPSPPVFSPPPPA 131
P P P P N PPPP P SS + PPS + PP+ P
Sbjct: 368 LQGPSPF---------PQMPSNLPPPPALKPLSSLPTHHPPS-----AHPPPLQLMPQSQ 413
Query: 132 KKSSPP--PPPLKYSSSTPKSSSSSSKS 157
S P PP L S S P +S+ S
Sbjct: 414 PLQSVPAQPPVLTQSQSLPPKASTHPHS 441
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 37/163 (22%), Positives = 47/163 (28%), Gaps = 10/163 (6%)
Query: 9 ETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPS 68
E ++ PP P ++ P S P P +
Sbjct: 502 EDSDKHDEPPEGPEASGLPPKAPGDKEGEEGEHEDSKESDEPKEGGKPGETKEGEVG--K 559
Query: 69 SPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSP-TPPSPSNNKSPSPPVF-- 125
P PA P + P PK+ P P P + P+ KSP P
Sbjct: 560 KPGPAKEHKPSKIPTLSKKPEFPKDPKHPKDPEEPKKPKRPRSAQRPTRPKSPKLPELLD 619
Query: 126 ---SPPPPAKKSSP--PPPPLKYSSSTPKSSSSSSKSSNGSSS 163
SP P SP PPPP + SS KS S
Sbjct: 620 IPKSPKRPESPKSPKRPPPPQRPSSPERPEGPKIIKSPKPPKS 662
|
Length = 943 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 25/68 (36%), Positives = 32/68 (47%), Gaps = 2/68 (2%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
P PP S+ A P + P PPP++PP P P P + PPP P + PPP
Sbjct: 41 PAPPPPPPSTAAAAPAPAAPPPPPPPAAPPA--PQPDDPNAAPPPPPADPNAPPPPPVDP 98
Query: 77 SPPPASPP 84
+ PP P
Sbjct: 99 NAPPPPAP 106
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 31/149 (20%), Positives = 46/149 (30%), Gaps = 3/149 (2%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
+PP+ + S +P P PPPS P P ++ PPP
Sbjct: 92 APPSHQYPSQLPPQQVQSVPQQPTPQ---QEPYYPPPSQPQPPPAQQPQAQQPQPPPQVP 148
Query: 76 SSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSS 135
SPP + +PP + P S P + P+ P+ S S
Sbjct: 149 QQQQYQSPPQQPQYQQNPPPQAQSAPQVSGLYPEESPYQPQSYPPNEPLPSSMAMQPPYS 208
Query: 136 PPPPPLKYSSSTPKSSSSSSKSSNGSSSG 164
PP ++ S +SG
Sbjct: 209 GAPPSQQFYGPPQPSPYMYGGPGGRPNSG 237
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|171499 PRK12438, PRK12438, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 18/48 (37%), Positives = 25/48 (52%), Gaps = 1/48 (2%)
Query: 34 STPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPA 81
+T S+PPP + PP+ PP + PPP + P + PP PP A
Sbjct: 903 ATAPGGDAASAPPPGAGPPA-PPQAVPPPRTTQPPAAPPRGPDVPPAA 949
|
Length = 991 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 45.2 bits (106), Expect = 1e-04
Identities = 30/162 (18%), Positives = 52/162 (32%), Gaps = 10/162 (6%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
+PP+ +S SP ++ P S S+ + S P +
Sbjct: 540 TSPPTGTTSVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQHGTGSSPTSQQPG 599
Query: 78 PP-PASPPTSDNNKP-DPPKNSPPPPPPSSQSSPTPPSPSNNK----SPSPPVFS----P 127
P + N+ P S P + + TP PS SP P +
Sbjct: 600 IPSSSHSTPRSNSTSTTPLLTSAHPTGGENITEETPSVPSTTHVSTLSPGPGPGTTSQVS 659
Query: 128 PPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVT 169
P +S P + + P +++S + +G + VT
Sbjct: 660 GPGNSSTSRYPGEVHVTEGMPNPNATSPSAPSGQKTAVPTVT 701
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 44.8 bits (105), Expect = 1e-04
Identities = 37/157 (23%), Positives = 54/157 (34%), Gaps = 14/157 (8%)
Query: 19 APPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSP--------PSSP 70
P ++ T P S+ P S+ P S P+ S+ P SP P++
Sbjct: 441 VEPHKTTAVPTTPSLPPASTGPTVSTADPTSGTPTGTTSSTLPEDTSPTSRTTSATPNAT 500
Query: 71 PPATSSSPPPASPPTSDNNKPDPPKNSPPP----PPPSSQSSPT-PPSPSNNKSPSPPVF 125
P + + P A+ PT+ P SP P ++ S PT S N SP
Sbjct: 501 SPTPAVTTPNATSPTTQKTSDTPNATSPTPIVIGVTTTATSPPTGTTSVPNATSPQVTEE 560
Query: 126 SPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSS 162
SP P +S + + SS S
Sbjct: 561 SPVNNTNTPVVTSAP-SVLTSAVTTGQHGTGSSPTSQ 596
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 23/117 (19%), Positives = 33/117 (28%), Gaps = 8/117 (6%)
Query: 30 PPPSSTPSSSPPPSSPPPAS-PPPSSPPPSSPPPSKSPPSSP------PPATSSSPPPAS 82
PP T P + A P P P P + PS P + A
Sbjct: 636 PPVFKTALPRPDYNRGGEAGGPGVPGPVPVGMPAHTARPSRVARGDPVRPTAHHAALRAP 695
Query: 83 PPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPP 139
P PPPP + ++ P S+ + P PP + +
Sbjct: 696 QAPRPGGPPGGGGGLPPPPDLPA-AAGPAPCGSSLIASPTAPPEPEPPGAEQADGAE 751
|
Length = 753 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 39/147 (26%), Positives = 61/147 (41%), Gaps = 17/147 (11%)
Query: 373 HLVSLVGYCIAGGQRMLVYEFVSNKTLEYH----LHGENRPVMDFATRVRIALGSAKGLA 428
++V L Y ++ LV + L H L+ V +A + +AL +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 429 YLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE 488
LH + I+ RD+ NIL+DD + F D+ + M Y APE
Sbjct: 101 -LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPE 152
Query: 489 YASSGKLTEKSDVFSFGVMLLELITGR 515
+ TE D +S G +L EL+TG+
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|220401 pfam09786, CytochromB561_N, Cytochrome B561, N terminal | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 35/164 (21%), Positives = 57/164 (34%), Gaps = 24/164 (14%)
Query: 25 SSDATPPPSSTPSSSPPPSSPP--PASPPPSSPPPSSPPPS-KSPPSSPPPATSSSPPPA 81
S A P ++ +S+P +S P P S P S PS K PSS + P
Sbjct: 113 VSQAKKSPPASKTSTPMNTSEPLVPGHSSFSDSPSRSASPSRKFSPSSTIQQSPQLTPSN 172
Query: 82 SPPTSDNNKPDPPKNSPPPPPPSSQ-SSPTPPSPSNNKSPSPP----------------- 123
P + ++ P +S P SS S SP +S
Sbjct: 173 KPASPSSSYQSPSYSSSLGPVNSSGNRSNLRSSPWALRSSGDKKDITTDEKYLETFLAEV 232
Query: 124 ---VFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSG 164
A K++ PP + S+ S + S++++ ++
Sbjct: 233 DEEQHMITSSAGKNATPPETINSFGSSSPSFWNYSRNASDAARS 276
|
Members of this family are found in the N terminal region of cytochrome B561, as well as in various other putative uncharacterized proteins. Length = 559 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 36/167 (21%), Positives = 47/167 (28%), Gaps = 29/167 (17%)
Query: 2 AKGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPP 61
AK + P+ + S P S +S P P P PS
Sbjct: 69 AKLSAAVRYNQNAPGAPSVGPDSDLSQKTSTFS-PCQSGYEASTDPEYIPDLQPDPSLWG 127
Query: 62 PSKSPPSSPPPATSSSPPPASP----------------PTSDNNKPDPPKNSPPPP-PPS 104
+ P PP A S P P +P P PP+ P PP
Sbjct: 128 TAPKPEPQPPQAPESQPQPQTPAQKMLSLEEVEAQLQQRQQAPQLPQPPQQVLPQGMPPR 187
Query: 105 SQSSP-----------TPPSPSNNKSPSPPVFSPPPPAKKSSPPPPP 140
+ P P + + P F P P + PP PP
Sbjct: 188 QAAFPQQGPPEQPPGYPQPPQGHPEQVQPQQFLPAPSQAPAQPPLPP 234
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 28/170 (16%), Positives = 53/170 (31%), Gaps = 42/170 (24%)
Query: 11 ENEEGSPPAPPSSNSSDATPPPSSTPSSS----------------------------PPP 42
+ + APP+ + TP ++ + + P
Sbjct: 518 REDAPAAAAPPAPEARPPTPAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKP 577
Query: 43 SSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPP- 101
++ P A+P P++P + P+ ++ A + A +++ PP PP
Sbjct: 578 AAAPAAAPKPAAPRVAVQVPTPRARAATGDAPPNGAARA-EQAAESRGAPPPWEDIPPDD 636
Query: 102 --PPSSQSSPTPP----------SPSNNKSPSPPVFSPPPPAKKSSPPPP 139
P S+ P P + + P +P PP PP
Sbjct: 637 YVPLSADEGFGGPDDGFVPVFDSGPDDVRVAPKPADAPAPPVDTRPLPPA 686
|
Length = 830 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 38/144 (26%), Positives = 48/144 (33%), Gaps = 10/144 (6%)
Query: 15 GSPPAPPSSNSSDATPPPSST--PSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPP 72
P PP+ +S P P P S+PP P P P
Sbjct: 251 QQSPQPPAPSSRHPQSSHHGPGPPMPHALQQGPVFLQHPSSNPPQPFGLAQSQVPPLPLP 310
Query: 73 ATSSSPPPASPPTSDNNKPDPPKNSPPPP--------PPSSQSSPTPPSPSNNKSPSPPV 124
+ + P S PP+ P PP PP + P P+ S+ P
Sbjct: 311 SQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMPHIKPPPTTPIPQLPNQSHKHPPHLQG 370
Query: 125 FSPPPPAKKSSPPPPPLKYSSSTP 148
SP P + PPPP LK SS P
Sbjct: 371 PSPFPQMPSNLPPPPALKPLSSLP 394
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 28/121 (23%), Positives = 42/121 (34%), Gaps = 8/121 (6%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
P + S + S P PPP+ P + P P +S
Sbjct: 437 THPHSGLHSGPPQSPFAQHPFTSGGLPAIGPPPSLPTSTPAAP--------PRASSGSQP 488
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKS 134
S P+S + P PP P ++ +PP P + SP P V + P A +S
Sbjct: 489 PGSALPSSGGCAGPGPPLPPIQIKEEPLDEAEEPESPPPPPRSPSPEPTVVNTPSHASQS 548
Query: 135 S 135
+
Sbjct: 549 A 549
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 36/176 (20%), Positives = 54/176 (30%), Gaps = 28/176 (15%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSP--------PPSKSPPSS 69
P+ S P P S P SP PP PSSP S PP S
Sbjct: 603 AQRPTRPKSPKLPELLDIPKSPKRPESPKSPKRPPPPQRPSSPERPEGPKIIKSPKPPKS 662
Query: 70 PPP----------------ATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPS 113
P P A + S + D + K + P P + ++P P
Sbjct: 663 PKPPFDPKFKEKFYDDYLDAAAKSKETKTTVVLDESFESILKETLPETPGTPFTTPRPLP 722
Query: 114 PSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVT 169
P K P F P + P +++ + P+ + + + D +
Sbjct: 723 P---KLPRDEEFPFEPIGDPDAEQPDDIEFFTP-PEEERTFFHETPADTPLPDILA 774
|
Length = 943 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 20/114 (17%), Positives = 27/114 (23%), Gaps = 8/114 (7%)
Query: 35 TPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPP 94
+ P++ SP PP S P P P
Sbjct: 68 VHRVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPR---PAQP 124
Query: 95 KNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTP 148
P P P P P +P P S+P P + + P
Sbjct: 125 APQPVQQPAYQPQPEQPLQQ-----PVSPQVAPAPQPVHSAPQPAQQAFQPAEP 173
|
Length = 333 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 30/69 (43%), Positives = 35/69 (50%), Gaps = 11/69 (15%)
Query: 30 PPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNN 89
PP PPP + PPASPP + P PS+P S PP +P SPPPA P S +
Sbjct: 146 PPAPVVMMQPPPPHAMPPASPPAAQPAPSAPASS--PPPTPA-----SPPPAKAPKSSH- 197
Query: 90 KPDPPKNSP 98
PP SP
Sbjct: 198 ---PPLKSP 203
|
Length = 274 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 36/124 (29%), Positives = 59/124 (47%), Gaps = 9/124 (7%)
Query: 324 LGQGGFGYVHK----GV--LPNGKEVAVKSLKTGSGQGE-REFSAEVEIISRV-HHRHLV 375
LG+G FG V + G+ + VAVK LK G+ E R +E++I+ + HH ++V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 376 SLVGYCIA-GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
+L+G C GG M++ EF L +L + + + T+ G + ED
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134
Query: 435 HPRI 438
R+
Sbjct: 135 KRRL 138
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 38/126 (30%), Positives = 50/126 (39%), Gaps = 8/126 (6%)
Query: 38 SSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA---TSSSPPPASPPTSDNNKPDPP 94
+S P S P S + P P P PA T SS PA+P S P P
Sbjct: 378 ASAPSGSAAEG--PASGGAATIPTPGTQGPQGTAPAAGMTPSSAAPATPAPSAAPSPRVP 435
Query: 95 KNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSS 154
+ PP PP S PP P+ + PV P +S PP L S T + + S
Sbjct: 436 WDDAPPAPPR---SGIPPRPAPRMPEASPVPGAPDSVASASDAPPTLGDPSDTAEHTPSG 492
Query: 155 SKSSNG 160
++ +G
Sbjct: 493 PRTWDG 498
|
Length = 624 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 15/61 (24%), Positives = 22/61 (36%)
Query: 23 SNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPAS 82
+ P P S ++ PP A+P + P++ P P P P PAS
Sbjct: 12 GEAEQPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPAS 71
Query: 83 P 83
Sbjct: 72 L 72
|
Length = 475 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 27/95 (28%), Positives = 41/95 (43%), Gaps = 9/95 (9%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPS--SPPPSSPPPSKSPPSSPPP 72
G+P + S+ + A ++ S SP P SPP PP++P SP +SPP
Sbjct: 564 GNPGSTNSTPTGSAASSNTTFSSDSPSTVVAPSTSPPAGHLGSPPATPSKIVSPSTSPPA 623
Query: 73 ATSSSPP--PASPPTSDNNKPDPPKNSPPPPPPSS 105
+ SP P+SP + ++ P SS
Sbjct: 624 SHLGSPSTTPSSPES-----SIKVASTETASPESS 653
|
Length = 670 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (103), Expect = 2e-04
Identities = 32/138 (23%), Positives = 64/138 (46%), Gaps = 14/138 (10%)
Query: 32 PSSTPSSSPPPSSPPPASPPPSSPPPS--SPPPSKSPPSSPPPATSSSPPPASPPTSDNN 89
PS S+ + A+P ++ PP+ + P+K+ + PA +++PP +
Sbjct: 211 PSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKA---AAAPAKAAAPPAKAAAPPAKA 267
Query: 90 KPDPPKNSPPP-----PPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPP----PPP 140
P K + PP PP + + P + + K+ + P + PAK ++PP PP
Sbjct: 268 AAPPAKAAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKAAAPP 327
Query: 141 LKYSSSTPKSSSSSSKSS 158
K ++ K+++ +K++
Sbjct: 328 AKAATPPAKAAAPPAKAA 345
|
Length = 357 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 24/120 (20%), Positives = 36/120 (30%), Gaps = 10/120 (8%)
Query: 42 PSSPPPASPPPSSPPPSS---PPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSP 98
P P P +PPP + P PPP+++ + P P P ++ P
Sbjct: 48 PWDPSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFALPAGP 107
Query: 99 PPP---PPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSS 155
P Q P ++P+ PA L+ P S S
Sbjct: 108 AGPTIQTEPGQLYPVQVPVMVTQNPANS--PLDQPA--QQRALQQLQQRYGAPASGQLPS 163
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 19/144 (13%), Positives = 33/144 (22%), Gaps = 4/144 (2%)
Query: 12 NEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPP 71
PP +TP+ SP + P + P P+
Sbjct: 65 PLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFALPAGPAGPTIQTEPGQLYPVQV 124
Query: 72 PATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPA 131
P + P SP + + P+S P+ + S
Sbjct: 125 PVMVTQNPANSPLDQPAQQRALQQLQQRYGAPASGQLPSQQQSAQKNDESQ----LQQQP 180
Query: 132 KKSSPPPPPLKYSSSTPKSSSSSS 155
+PP ++
Sbjct: 181 NGETPPQQTDGAGDDESEALVRLR 204
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 19/79 (24%), Positives = 34/79 (43%), Gaps = 4/79 (5%)
Query: 32 PSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKP 91
P S + P + PA+ + ++P K+ +P P +S P P + P
Sbjct: 114 PLSEIDTGGAPPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKP----P 169
Query: 92 DPPKNSPPPPPPSSQSSPT 110
+P + PPP P +++ P
Sbjct: 170 EPAPAAKPPPTPVARADPR 188
|
Length = 418 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 18/70 (25%), Positives = 27/70 (38%), Gaps = 5/70 (7%)
Query: 70 PPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPP 129
PP A ++ A + KP +P PP ++ P P+ K P P + PP
Sbjct: 124 PPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPP-----AASKPTPPAAAKPPEPAPAAKPP 178
Query: 130 PAKKSSPPPP 139
P + P
Sbjct: 179 PTPVARADPR 188
|
Length = 418 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 30/70 (42%), Positives = 34/70 (48%), Gaps = 1/70 (1%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
S P P +SS A P SSTP + P S P P PS PS+PP S P PP
Sbjct: 192 SSLPGLPPGSSSLA-PSASSTPGNRLPRVSFNPFLPGPSPAQPSAPPASIPAPPIPPVIQ 250
Query: 75 SSSPPPASPP 84
+PPP PP
Sbjct: 251 YVAPPPVPPP 260
|
Length = 582 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 24/82 (29%), Positives = 32/82 (39%), Gaps = 4/82 (4%)
Query: 36 PSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPK 95
SSS P S + SS S PPS + P S+S +P P P
Sbjct: 1 SSSSNPTSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTPSIL----PLPKL 56
Query: 96 NSPPPPPPSSQSSPTPPSPSNN 117
+SP PP + + T +P N
Sbjct: 57 SSPSPPSVTLPPAATTQTPQLN 78
|
Length = 590 |
| >gnl|CDD|218332 pfam04929, Herpes_DNAp_acc, Herpes DNA replication accessory factor | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 25/90 (27%), Positives = 34/90 (37%), Gaps = 5/90 (5%)
Query: 6 NVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKS 65
N + G P P S S P S+ SS PP + + P +PPP+S S S
Sbjct: 288 NADSSVEANGVEPEPTGSVSDR--PRHLSSDSSPSPPDTSD-SDPSTETPPPAS--LSHS 342
Query: 66 PPSSPPPATSSSPPPASPPTSDNNKPDPPK 95
PP++ + SP K K
Sbjct: 343 PPAAFERPLALSPKRKREGDKKQKKKKSKK 372
|
Replicative DNA polymerases are capable of polymerising tens of thousands of nucleotides without dissociating from their DNA templates. The high processivity of these polymerases is dependent upon accessory proteins that bind to the catalytic subunit of the polymerase or to the substrate. The Epstein-Barr virus (EBV) BMRF1 protein is an essential component of the viral DNA polymerase and is absolutely required for lytic virus replication. BMRF1 is also a transactivator. This family is predicted to have a UL42 like structure. Length = 381 |
| >gnl|CDD|218332 pfam04929, Herpes_DNAp_acc, Herpes DNA replication accessory factor | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 19/71 (26%), Positives = 26/71 (36%), Gaps = 5/71 (7%)
Query: 4 GNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASP---PPSSPP-PSS 59
N E E P +S + PP T S P +PPPAS PP++ P +
Sbjct: 294 EANGVEPEPTGSVSDRPRHLSSDSSPSPPD-TSDSDPSTETPPPASLSHSPPAAFERPLA 352
Query: 60 PPPSKSPPSSP 70
P +
Sbjct: 353 LSPKRKREGDK 363
|
Replicative DNA polymerases are capable of polymerising tens of thousands of nucleotides without dissociating from their DNA templates. The high processivity of these polymerases is dependent upon accessory proteins that bind to the catalytic subunit of the polymerase or to the substrate. The Epstein-Barr virus (EBV) BMRF1 protein is an essential component of the viral DNA polymerase and is absolutely required for lytic virus replication. BMRF1 is also a transactivator. This family is predicted to have a UL42 like structure. Length = 381 |
| >gnl|CDD|234229 TIGR03490, Mycoplas_LppA, mycoides cluster lipoprotein, LppA/P72 family | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 19/98 (19%), Positives = 28/98 (28%), Gaps = 2/98 (2%)
Query: 8 TETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPP--SSPPPASPPPSSPPPSSPPPSKS 65
+ T + P P ++ TP P + P ++ + PSS P K
Sbjct: 25 STTSSNSKQPEKKPEIKPNENTPKIPKKPDNKEPSENNNNKSNNENKDEENPSSTNPEKK 84
Query: 66 PPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPP 103
P S P + D P N P
Sbjct: 85 PDPSKNKEEIEKPKDEPKKPDKKPQADQPNNVHADQPN 122
|
Members of this protein family occur in Mycoplasma mycoides, Mycoplasma hyopneumoniae, and related Mycoplasmas in small paralogous families that may also include truncated forms and/or pseudogenes. Members are predicted lipoproteins with a conserved signal peptidase II processing and lipid attachment site. Note that the name for certain characterized members, p72, reflects an anomalous apparent molecular weight, given a theoretical MW of about 61 kDa. Length = 541 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN---HTHVSTRVMGTF 482
G+ +LH IIHRD+K +NI++ + + DFGLA+ + + +V TR
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 190
Query: 483 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGR 515
Y APE E D++S G ++ E+I G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|221745 pfam12737, Mating_C, C-terminal domain of homeodomain 1 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 29/121 (23%), Positives = 37/121 (30%), Gaps = 1/121 (0%)
Query: 35 TPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPP 94
+P SP SS SP PS S S ++ S + S + D
Sbjct: 73 SPERSPALSSERLLSPSPSVLDLSPVLASPQTGKRRRSSSPSDDEDEAERPSKRPRSDSI 132
Query: 95 KNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSS 154
+S P P P P+ S S +P P S P P S K S
Sbjct: 133 SSSSSPAKPPEACLP-SPAASTQDELSEASAAPLPTPSLSPPHTPTDTAPSGKRKRRLSD 191
Query: 155 S 155
Sbjct: 192 G 192
|
Mating in fungi is controlled by the loci that determine the mating type of an individual, and only individuals with differing mating types can mate. Basidiomycete fungi have evolved a unique mating system, termed tetrapolar or bifactorial incompatibility, in which mating type is determined by two unlinked loci; compatibility at both loci is required for mating to occur. The multi-allelic tetrapolar mating system is considered to be a novel innovation that could have only evolved once, and is thus unique to the mushroom fungi. This domain is C-terminal to the homeodomain transcription factor region. Length = 418 |
| >gnl|CDD|218549 pfam05308, Mito_fiss_reg, Mitochondrial fission regulator | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 24/89 (26%), Positives = 30/89 (33%), Gaps = 3/89 (3%)
Query: 13 EEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPP 72
+E S SSD + P SST S P + P P PPP PPP PPS
Sbjct: 145 QEQSNSTTSDLLSSDESVPSSSTTSFPISPPTEEPVLEVPPPPPPPPPPP---PPSLQQS 201
Query: 73 ATSSSPPPASPPTSDNNKPDPPKNSPPPP 101
++ + P P
Sbjct: 202 TSAIDLIKERKGQRSAAGKTLVLSKPKSP 230
|
In eukaryotes, this family of proteins induces mitochondrial fission. Length = 248 |
| >gnl|CDD|218181 pfam04621, ETS_PEA3_N, PEA3 subfamily ETS-domain transcription factor N terminal domain | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 38/140 (27%), Positives = 50/140 (35%), Gaps = 16/140 (11%)
Query: 13 EEGSPPAPPSSNSSDATPPP--------SSTPSSSPPPSSPPPASPPPSSPPPSSPPPSK 64
E SP +S+ S PP S + P S P +PP + P +P +
Sbjct: 90 EPQSPSKELNSSCSQKQPPYPYGEKCLYSYSAYDRKPASGFKPPTPPSTPCSPVNPQETV 149
Query: 65 SPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPV 124
P ++SSPP P P SP PPP SS S P + S P
Sbjct: 150 RQLQPSGPLSNSSPPSPHTPL--------PNQSPLPPPMSSPDSSYPSEHRFQRQLSEPC 201
Query: 125 FSPPPPAKKSSPPPPPLKYS 144
PPP + S P +
Sbjct: 202 LPFPPPPGRGSRDGRPPYHR 221
|
The N terminus of the PEA3 transcription factors is implicated in transactivation and in inhibition of DNA binding. Transactivation is potentiated by activation of the Ras/MAP kinase and protein kinase A signalling cascades. The N terminal region contains conserved MAP kinase phosphorylation sites. Length = 336 |
| >gnl|CDD|227505 COG5178, PRP8, U5 snRNP spliceosome subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 20/43 (46%), Positives = 22/43 (51%), Gaps = 4/43 (9%)
Query: 48 ASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNK 90
AS PP +PPP PPP PPS PPP PPP + K
Sbjct: 2 ASLPPGNPPPPPPPPGFEPPSQPPP----PPPPGVNVKKRSRK 40
|
Length = 2365 |
| >gnl|CDD|218056 pfam04388, Hamartin, Hamartin protein | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 40/164 (24%), Positives = 59/164 (35%), Gaps = 32/164 (19%)
Query: 7 VTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSP 66
TET +E+G S + SS+ P SSP A PP S P + +
Sbjct: 265 PTETSSEDGY----------------SFSRSSAYPNSSPRQALPPSI----SLPQNTSTS 304
Query: 67 PSSPPPATSSSPPPASPPTSDNNKPDP---PKN-----SPPPPPPSSQSS-PTPPSPSNN 117
S TS P + + D P + +PP S PS +
Sbjct: 305 GSLHSAQTSRRPNTTFDKAASSGTKDSLWSPSSLCGMATPPSSIGMSPLILSLSPSHLSG 364
Query: 118 KSPSPPVFSPPPPAKKSSP---PPPPLKYSSSTPKSSSSSSKSS 158
++P PA +S+P PPPP ++SS+S+
Sbjct: 365 RAPGTTGSGKGEPASESTPSTSPPPPGLADDIVRAIFATSSRSA 408
|
This family includes the hamartin protein which is thought to function as a tumour suppressor. The hamartin protein interacts with the tuberin protein pfam03542. Tuberous sclerosis complex (TSC) is an autosomal dominant disorder and is characterized by the presence of hamartomas in many organs, such as brain, skin, heart, lung, and kidney. It is caused by mutation either TSC1 or TSC2 tumour suppressor gene. TSC1 encodes a protein, hamartin, containing two coiled-coil regions, which have been shown to mediate binding to tuberin. The TSC2 gene codes for tuberin pfam03542. These two proteins function within the same pathway(s) regulating cell cycle, cell growth, adhesion, and vesicular trafficking. Length = 667 |
| >gnl|CDD|218881 pfam06070, Herpes_UL32, Herpesvirus large structural phosphoprotein UL32 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 36/201 (17%), Positives = 52/201 (25%), Gaps = 21/201 (10%)
Query: 21 PSSNSSDATPPPSSTPSSSP-----PPSSPPPASPPPSSPPPSSPPPSK------SPPSS 69
S+S SS P SPPP SPP S+ +S
Sbjct: 498 SGSDSEGGASGREDETSSDAESVVSIKELRPRIGFINKSPPPKSPPKSRRTLIVALSLAS 557
Query: 70 PPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPP 129
P A S P P+ P + S+ K S P
Sbjct: 558 PSTAGSPRPKPSLGKFV---IGTDPFAFANTVRLTDNMRGGNGVGSSVK--PKGSASSKP 612
Query: 130 PAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVTYSVIGAVGVGIFLIAMIIIC 189
+ P LK ++ K+ SSS + ++G G G + +
Sbjct: 613 L----TGPGSDLKPATLNGKTPSSSLVGA-ARNAGASSKVKIPSGLGGFTSPISLLESAL 667
Query: 190 AVRANKKKKKRHNQPMHYYGD 210
+ Y D
Sbjct: 668 EDVLTSATSTPVKKNDPYLWD 688
|
The large phosphorylated protein (UL32-like) of herpes viruses is the polypeptide most frequently reactive in immuno-blotting analyses with antisera when compared with other viral proteins. Length = 777 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 34/160 (21%), Positives = 48/160 (30%), Gaps = 9/160 (5%)
Query: 9 ETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSS---PPPSSPPPSKS 65
E E G P + DA S S A+ + PP+
Sbjct: 12 EAAAEGGEFFPRPPATPGDAADDLLSGSQGQLVSDSAELAAVTVVAGAAACDRFEPPTGP 71
Query: 66 PPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVF 125
PP A P S T + SP + P+ P P PP
Sbjct: 72 PPGPGTEA----PANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPP--PPTPPPAS 125
Query: 126 SPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGD 165
PP PA S P+ P +S ++ +S + + D
Sbjct: 126 PPPSPAPDLSEMLRPVGSPGPPPAASPPAAGASPAAVASD 165
|
Length = 1352 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 3e-04
Identities = 18/84 (21%), Positives = 28/84 (33%), Gaps = 2/84 (2%)
Query: 86 SDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSS 145
S + PP P + P +P P PPP A ++S P +
Sbjct: 514 SGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPAD 573
Query: 146 STPKSSSSS--SKSSNGSSSGDDY 167
S+P + S SS ++
Sbjct: 574 SSPPPPIPEEPTPSPTKDSSPEEI 597
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 3e-04
Identities = 22/86 (25%), Positives = 30/86 (34%), Gaps = 4/86 (4%)
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPP-PPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKK 133
S AS P PP+ SPPPP P PT +P P PP +
Sbjct: 511 ESQSGSASNTA---KTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAP 567
Query: 134 SSPPPPPLKYSSSTPKSSSSSSKSSN 159
+ P + + S +K S+
Sbjct: 568 AQIPADSSPPPPIPEEPTPSPTKDSS 593
|
Length = 620 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 27/123 (21%), Positives = 31/123 (25%), Gaps = 8/123 (6%)
Query: 13 EEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPP---ASPPPSSPPPSSPPPSKSPP-- 67
P P + PP P P PPP PP
Sbjct: 206 PPQGHPEQVQPQQFLPAPSQAPAQPPLPPQLPQQPPPLQQPQFPGLSQQMPPPPPQPPQQ 265
Query: 68 SSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSP 127
PP + PPP + PT P P+ P PP Q P P F
Sbjct: 266 QQQPPQPQAQPPPQNQPTPH---PGLPQGQNAPLPPPQQPQLLPLVQQPQGQQRGPQFRE 322
Query: 128 PPP 130
Sbjct: 323 QLV 325
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 33/143 (23%), Positives = 47/143 (32%), Gaps = 15/143 (10%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
P P + TP + P P P P +P + PP +P P
Sbjct: 649 PTPHQPPQVEITPYKPTWTQIGHIPYQPSPTGANTMLPIQWAPGTMQPPPRAPTPM---- 704
Query: 78 PPPASPPTSDNNKPDPPKNSPPPP-------PPSSQSSPTPPSPSNNKSPSPPVFSP--- 127
PPA+PP + PP PP++ P + PP +P
Sbjct: 705 RPPAAPPGRAQRPAAATGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGRA 764
Query: 128 -PPPAKKSSPPPPPLKYSSSTPK 149
PP A +P P P + P+
Sbjct: 765 RPPAAAPGAPTPQPPPQAPPAPQ 787
|
Length = 991 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 27/135 (20%), Positives = 42/135 (31%), Gaps = 2/135 (1%)
Query: 8 TETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPP 67
+T P P ++ + P +S P P P P P P P + +P
Sbjct: 593 AQTPWPVPHPSQTPEPPTTQSHIPETSAPRQWPMPLRPIPMRPLRMQPITFNVLVFPTPH 652
Query: 68 SSPPPATSSSPPPASPPTSDNNKPDP--PKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVF 125
P + P + +P P P P P +P+ + P+ P
Sbjct: 653 QPPQVEITPYKPTWTQIGHIPYQPSPTGANTMLPIQWAPGTMQPPPRAPTPMRPPAAPPG 712
Query: 126 SPPPPAKKSSPPPPP 140
PA + PP
Sbjct: 713 RAQRPAAATGRARPP 727
|
Length = 991 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 17/74 (22%), Positives = 29/74 (39%)
Query: 44 SPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPP 103
S P +PP ++P + +P SPP + +S A + P + P
Sbjct: 75 SKPKTGTGKVAPPAATPTSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAPES 134
Query: 104 SSQSSPTPPSPSNN 117
S S P+ S + +
Sbjct: 135 PSTSVPSSGSDAAS 148
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 20/58 (34%), Positives = 26/58 (44%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA 73
A + + PPP +P P P A PPP + P + PPP P + PPPA
Sbjct: 48 PSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPPPPVDPNAPPPPA 105
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 27/156 (17%), Positives = 39/156 (25%), Gaps = 11/156 (7%)
Query: 10 TENEEGSPPAPPSSNSSDATPP--PSSTPSSSPPPSSPPPASPPPSSPPPSSP-PPSKSP 66
+ G P + A P P + P + PP +P S
Sbjct: 127 DDRPPGLPRQDQLPTARPAYPAYQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASY 186
Query: 67 PSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTP-PSPSNNK-----SP 120
P P A P D + D P P + P P P
Sbjct: 187 A--PEQERDREPYDAGRPEYDQRRRDYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPG 244
Query: 121 SPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSK 156
P P + S P P + P +++
Sbjct: 245 PPERDDAPVVPIRPSAPGPLAAQPAPAPGPGEPTAR 280
|
Length = 617 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 30/116 (25%), Positives = 47/116 (40%), Gaps = 7/116 (6%)
Query: 54 SPPPSSPPPSKSPPSSPPPATSSSPPPASP--PTSDNNKPDPPKNSPPPP--PPSSQSSP 109
SP S K+P P P PA P P + + P ++P P PP ++S+P
Sbjct: 383 SPAGSPDVKKKAPEPD-LPQPDRHPGPAKPEAPGARPAELPSPASAPTPEQQPPVARSAP 441
Query: 110 TPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGD 165
PPSP S V S P S + ++ + + + SS+ + +G
Sbjct: 442 LPPSPQ--ASAPRNVASGKPGVDLGSWQGKFMNFTRNGSRKQPVQASSSDAAQTGV 495
|
Length = 620 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 23/77 (29%), Positives = 31/77 (40%)
Query: 22 SSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPA 81
SSN + + +S+ SSS SSPP ++ P S PS P SSP P
Sbjct: 3 SSNPTSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTPSILPLPKLSSPSPP 62
Query: 82 SPPTSDNNKPDPPKNSP 98
S P+ +P
Sbjct: 63 SVTLPPAATTQTPQLNP 79
|
Length = 590 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 22/74 (29%), Positives = 28/74 (37%), Gaps = 3/74 (4%)
Query: 21 PSSNSSDATPPPSSTPSSSPPPSSPPPASPPPS---SPPPSSPPPSKSPPSSPPPATSSS 77
P+S S SS+ S S PPSS P S +P P S P S +
Sbjct: 6 PTSRSQSHASSSSSSSSQSSPPSSTSPRPRRRKPSASSLLHTPSILPLPKLSSPSPPSVT 65
Query: 78 PPPASPPTSDNNKP 91
PPA+ + P
Sbjct: 66 LPPAATTQTPQLNP 79
|
Length = 590 |
| >gnl|CDD|215145 PLN02258, PLN02258, 9-cis-epoxycarotenoid dioxygenase NCED | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 21/85 (24%), Positives = 28/85 (32%), Gaps = 7/85 (8%)
Query: 58 SSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNN 117
SS S S ++SSS +SPP+S P PS+ S PS
Sbjct: 1 SSSSNPTSRSQSHASSSSSSSSQSSPPSS-------TSPRPRRRKPSASSLLHTPSILPL 53
Query: 118 KSPSPPVFSPPPPAKKSSPPPPPLK 142
S P ++ P L
Sbjct: 54 PKLSSPSPPSVTLPPAATTQTPQLN 78
|
Length = 590 |
| >gnl|CDD|165527 PHA03269, PHA03269, envelope glycoprotein C; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 3e-04
Identities = 34/161 (21%), Positives = 54/161 (33%), Gaps = 19/161 (11%)
Query: 22 SSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPA 81
++ T P +S P PA P P +P P+ +P S A S P A
Sbjct: 17 LIIANLNTNIPIPELHTSAATQKPDPA-PAPHQAASRAPDPAVAPTS----AASRKPDLA 71
Query: 82 SPPTSD-NNKPDPPKNSPPPPPPSSQSSPTP---PSPSNNKSPSPPVFSPPPPAKKSSPP 137
PT + K D P P P +S P +P +P P A ++
Sbjct: 72 QAPTPAASEKFD------PAPAPHQAASRAPDPAVAPQLAAAPKPDAAEAFTSAAQAHEA 125
Query: 138 PPPLKYSS----STPKSSSSSSKSSNGSSSGDDYVTYSVIG 174
P S+ P + + S + +++ + G
Sbjct: 126 PADAGTSAASKKPDPAAHTQHSPPPFAYTRSMEHIACTHGG 166
|
Length = 566 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 25/62 (40%), Positives = 34/62 (54%), Gaps = 4/62 (6%)
Query: 35 TPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPP 94
TP + P P +PP A P + P +PPP+ +P P PA + P A+PP SD P PP
Sbjct: 83 TPPAPPEPVTPPTAQSPAPAVP--TPPPTSTPAVPPAPAAAVPAPAAAPPPSD--PPQPP 138
Query: 95 KN 96
+
Sbjct: 139 RA 140
|
Length = 141 |
| >gnl|CDD|227505 COG5178, PRP8, U5 snRNP spliceosome subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 16/29 (55%), Positives = 18/29 (62%)
Query: 33 SSTPSSSPPPSSPPPASPPPSSPPPSSPP 61
+S P +PPP PPP PPS PPP PP
Sbjct: 2 ASLPPGNPPPPPPPPGFEPPSQPPPPPPP 30
|
Length = 2365 |
| >gnl|CDD|227505 COG5178, PRP8, U5 snRNP spliceosome subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 16/29 (55%), Positives = 19/29 (65%)
Query: 43 SSPPPASPPPSSPPPSSPPPSKSPPSSPP 71
+S PP +PPP PPP PPS+ PP PP
Sbjct: 2 ASLPPGNPPPPPPPPGFEPPSQPPPPPPP 30
|
Length = 2365 |
| >gnl|CDD|227505 COG5178, PRP8, U5 snRNP spliceosome subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 16/29 (55%), Positives = 18/29 (62%)
Query: 38 SSPPPSSPPPASPPPSSPPPSSPPPSKSP 66
+S PP +PPP PPP PPS PPP P
Sbjct: 2 ASLPPGNPPPPPPPPGFEPPSQPPPPPPP 30
|
Length = 2365 |
| >gnl|CDD|218881 pfam06070, Herpes_UL32, Herpesvirus large structural phosphoprotein UL32 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 28/167 (16%), Positives = 46/167 (27%), Gaps = 14/167 (8%)
Query: 7 VTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSP 66
++ E+ P + +PPP S P S + P ++ P P
Sbjct: 514 SSDAESVVSIKELRPRIGFINKSPPPKSPPKSRRTLIVALSLASPSTAGSPRPKPSLGKF 573
Query: 67 PSSPPPAT---SSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPP 123
P + + PK S P + S P+ N K+PS
Sbjct: 574 VIGTDPFAFANTVRLTDNMRGGNGVGSSVKPKGSASSKPLTGPGSDLKPATLNGKTPSSS 633
Query: 124 VFSPP-----------PPAKKSSPPPPPLKYSSSTPKSSSSSSKSSN 159
+ P P L S+ +S++S
Sbjct: 634 LVGAARNAGASSKVKIPSGLGGFTSPISLLESALEDVLTSATSTPVK 680
|
The large phosphorylated protein (UL32-like) of herpes viruses is the polypeptide most frequently reactive in immuno-blotting analyses with antisera when compared with other viral proteins. Length = 777 |
| >gnl|CDD|217835 pfam03999, MAP65_ASE1, Microtubule associated protein (MAP65/ASE1 family) | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 30/172 (17%), Positives = 49/172 (28%), Gaps = 20/172 (11%)
Query: 1 MAKGNNVTETENE------EGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSS 54
K N T T E E S P+ PS+ +D ++ P + S S
Sbjct: 446 RKKLANKTSTVMEPPYGSTESSVPSTPSTRRNDRNITSNTPSLKRTPNLTKSSLSQEASL 505
Query: 55 PPPSS------PPPSKSPPSSPPPATSSS-----PPPASPPTSDNNKPDPPKNSPPPPPP 103
S+ P + PA S S + + ++ P + P
Sbjct: 506 ISKSTGNTHKHSTPRRLTTLPKLPAASRSSKGNLIRSGANGNASSDLSSPGSINSKSPEH 565
Query: 104 SSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSS 155
S + +P KK + S PK S +++
Sbjct: 566 SVPLVRVFDIHLRASTTKGRHSTPSTNEKKKRLLK---RSPLSPPKESVATT 614
|
Length = 619 |
| >gnl|CDD|217835 pfam03999, MAP65_ASE1, Microtubule associated protein (MAP65/ASE1 family) | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 33/154 (21%), Positives = 46/154 (29%), Gaps = 20/154 (12%)
Query: 21 PSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPP 80
+ S+ PP ST SS P S +S PS K P+ + S
Sbjct: 450 ANKTSTVMEPPYGSTESSVPSTPSTRRNDRNITSNTPS----LKRTPNLTKSSLSQEASL 505
Query: 81 ASPPTSDNNKPDPPKN---SPPPPPPSSQSSPTPPSPSNN-----KSPSPP---VFSPPP 129
S T + +K P+ P P S S N SP SP
Sbjct: 506 ISKSTGNTHKHSTPRRLTTLPKLPAASRSSKGNLIRSGANGNASSDLSSPGSINSKSPEH 565
Query: 130 PAKKSSPPPPPLKYSS-----STPKSSSSSSKSS 158
L+ S+ STP ++ +
Sbjct: 566 SVPLVRVFDIHLRASTTKGRHSTPSTNEKKKRLL 599
|
Length = 619 |
| >gnl|CDD|215187 PLN02328, PLN02328, lysine-specific histone demethylase 1 homolog | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 28/95 (29%), Positives = 37/95 (38%), Gaps = 5/95 (5%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTP---SSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSP 70
E P P+ N +D SS S SP S + +SP SP P P
Sbjct: 4 ETKEPEDPADNVNDVVSEASSPETDLSLSPSQSEQNIENDGQNSPETQSPLTELQPSPLP 63
Query: 71 PPATSSSPPPAS--PPTSDNNKPDPPKNSPPPPPP 103
P T +P S +S +P P ++ P PPP
Sbjct: 64 PNTTLDAPVSDSQGDESSSEQQPQNPNSTEPAPPP 98
|
Length = 808 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 29/167 (17%)
Query: 359 FSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVR 418
F ++S+V H HL + G C+ G + ++V EFV + L+ L E V A ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV-PVAWKIT 121
Query: 419 IALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA-------KLSNDNH 471
+A A L+YL + ++H ++ A NIL+ A GLA KLS+
Sbjct: 122 VAQQLASALSYLEDK---NLVHGNVCAKNILL--------ARLGLAEGTSPFIKLSDPG- 169
Query: 472 THVSTRVMG------TFGYLAPEYASSG-KLTEKSDVFSFGVMLLEL 511
VS + ++APE G L+ +D +SFG LLE+
Sbjct: 170 --VSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 24/84 (28%), Positives = 31/84 (36%), Gaps = 4/84 (4%)
Query: 47 PASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQ 106
P +PP +P P P K+ SS +P P PT N P + P P Q
Sbjct: 173 PPNPPREAPAPGLP---KTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQN-PAQQPQQQ 228
Query: 107 SSPTPPSPSNNKSPSPPVFSPPPP 130
P P+ +P P PP
Sbjct: 229 PQQQPVQPAQQPTPQNPAQQPPQT 252
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|237000 PRK11855, PRK11855, dihydrolipoamide acetyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 3e-04
Identities = 9/51 (17%), Positives = 22/51 (43%)
Query: 33 SSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASP 83
++ +++ P ++ P A+ + P + + + + A P ASP
Sbjct: 197 AAPAAAAAPAAAAPAAAAAAAPAPAPAAAAAPAAAAPAAAAAPGKAPHASP 247
|
Length = 547 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 19/63 (30%), Positives = 26/63 (41%)
Query: 11 ENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSP 70
E + S P PPP+S ++ PP PP + S PPP +P + P
Sbjct: 41 EAKLASIPGLEDVTVQTTPPPPASAITNGGPPPPPPARAEAASPPPPEAPAEPPAEPEPE 100
Query: 71 PPA 73
PA
Sbjct: 101 APA 103
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|236304 PRK08581, PRK08581, N-acetylmuramoyl-L-alanine amidase; Validated | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 23/138 (16%), Positives = 47/138 (34%), Gaps = 4/138 (2%)
Query: 22 SSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPA 81
+S+ SD P +S S++ + + + S K+ P + ++ P +
Sbjct: 130 NSDISDYEQPRNSEKSTNDSNKNSDSSIKNDTDT--QSSKQDKADNQKAPSSNNTKPSTS 187
Query: 82 SPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPL 141
+ N+ N P S ++ S +N+S S
Sbjct: 188 N--KQPNSPKPTQPNQSNSQPASDDTANQKSSSKDNQSMSDSALDSILDQYSEDAKKTQK 245
Query: 142 KYSSSTPKSSSSSSKSSN 159
Y+S + K + +S + N
Sbjct: 246 DYASQSKKDKTETSNTKN 263
|
Length = 619 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 4e-04
Identities = 17/80 (21%), Positives = 25/80 (31%), Gaps = 1/80 (1%)
Query: 76 SSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSS 135
S + + P +P PPP Q S +PSPP PP +
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQ-AATTPSPPPAKASPPIPVPA 419
Query: 136 PPPPPLKYSSSTPKSSSSSS 155
P P + ++ S
Sbjct: 420 EPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 35/147 (23%), Positives = 46/147 (31%), Gaps = 4/147 (2%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
P PS + S P PSS P S PP + P P+++
Sbjct: 234 PQRLPSPHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPPMPHALQQGPVFLQHPSSNP 293
Query: 77 SPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNK----SPSPPVFSPPPPAK 132
P + P P + P P SQS+ P P + +PS P PPP
Sbjct: 294 PQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMPHIKPPPTTP 353
Query: 133 KSSPPPPPLKYSSSTPKSSSSSSKSSN 159
P K+ S SN
Sbjct: 354 IPQLPNQSHKHPPHLQGPSPFPQMPSN 380
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 30/182 (16%), Positives = 49/182 (26%), Gaps = 32/182 (17%)
Query: 8 TETENEEGSPPAPPSSNS--SDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKS 65
TE E+++ S A N S ++ S SS ++ + P +
Sbjct: 62 TEHESQQSSNNAGAEKNIDLSGSSSLSSGNQSSPSAANNTSDGHDASGVKNTAPPQDISA 121
Query: 66 PPSSPPPATSSSPPPASPPTSD------------------------NNKPDPPKNSPPPP 101
PP SP P + P P N P P
Sbjct: 122 PPISPTP---TQAAPPQTPNGQQRIELPGNISDALSQQQGQVNAASQNAQGNTSTLPTAP 178
Query: 102 PPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGS 161
+ S + P+PP P KK + + P +S + +
Sbjct: 179 ATVAPSKGAKVPATAETHPTPP---QKPATKKPAVNHHKTATVAVPPATSGKPKSGAASA 235
Query: 162 SS 163
+
Sbjct: 236 RA 237
|
Length = 327 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 4e-04
Identities = 32/112 (28%), Positives = 48/112 (42%), Gaps = 10/112 (8%)
Query: 62 PSKSPPSSP------PPATSSSPPPASPPTSDNNKPDPPKN--SPPPPPPSSQSSPTPPS 113
P K P P P +T+S+P ++ ++ D P +P PP+ P +
Sbjct: 551 PGKGVPYIPGLFAGNPGSTNSTPTGSAASSNTTFSSDSPSTVVAPSTSPPAGHLGSPPAT 610
Query: 114 PSNNKSP--SPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSS 163
PS SP SPP P+ S P +K +S+ S SS K ++ SS
Sbjct: 611 PSKIVSPSTSPPASHLGSPSTTPSSPESSIKVASTETASPESSIKVASTESS 662
|
Length = 670 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 4e-04
Identities = 26/91 (28%), Positives = 39/91 (42%), Gaps = 5/91 (5%)
Query: 25 SSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPP 84
S+++TP S+ S++ S P PS+ PP+ SPP++P S S SPP
Sbjct: 568 STNSTPTGSAASSNTTFSSDSPSTVVAPSTSPPAGHL--GSPPATPSKIVSPS---TSPP 622
Query: 85 TSDNNKPDPPKNSPPPPPPSSQSSPTPPSPS 115
S P +SP + + P S
Sbjct: 623 ASHLGSPSTTPSSPESSIKVASTETASPESS 653
|
Length = 670 |
| >gnl|CDD|177464 PHA02682, PHA02682, ORF080 virion core protein; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (99), Expect = 4e-04
Identities = 33/101 (32%), Positives = 44/101 (43%), Gaps = 8/101 (7%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPP---PSSPPPSSPPPSKSPPSSPPP 72
SP + + A P + P+ + P +P PA PP P+ PPP+ P P + PP
Sbjct: 85 SPACAAPAPACPACAPAAPAPAVTCP--APAPACPPATAPTCPPPAVCPAPARPAPACPP 142
Query: 73 ATSSSPPPASPPTSD---NNKPDPPKNSPPPPPPSSQSSPT 110
+T PP PT KP N PPP + S PT
Sbjct: 143 STRQCPPAPPLPTPKPAPAAKPIFLHNQLPPPDYPAASCPT 183
|
Length = 280 |
| >gnl|CDD|234818 PRK00708, PRK00708, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 7/104 (6%)
Query: 8 TETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPP 67
+ +E + PA ++ P TP + P P+ P + + + P+K
Sbjct: 101 SMSEPATENKPAEVTTPVEPMGLP--ETPPAVPVPAPAPAVAAAAAQAAAAPKAPAKPRA 158
Query: 68 SSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTP 111
SP PA ++P P T K + P P++ + TP
Sbjct: 159 KSPRPAAKAAPKPTETIT-----AKKAKKTAAAPKPTADKTATP 197
|
Length = 209 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 23/79 (29%), Positives = 30/79 (37%), Gaps = 2/79 (2%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
P PS PP P S+ P P++ P PPS+ P ++ PPA S
Sbjct: 553 PKVSPSDRGPPKASPPVMAPPSTGPRVMATPSTGPRDMAPPSTGPRQQAKCKDGPPA--S 610
Query: 77 SPPPASPPTSDNNKPDPPK 95
P PP+S P
Sbjct: 611 GPHEKQPPSSAPRDMAPSV 629
|
Length = 1000 |
| >gnl|CDD|152960 pfam12526, DUF3729, Protein of unknown function (DUF3729) | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 4e-04
Identities = 25/77 (32%), Positives = 30/77 (38%), Gaps = 1/77 (1%)
Query: 65 SPPSSPPPATSSSPPPASPPTSDNNKPDPPKNS-PPPPPPSSQSSPTPPSPSNNKSPSPP 123
S S P A PPP P PP ++ PPPS ++P P P+ P
Sbjct: 27 SCFSPPESAHPDDPPPVGDPRPPVVDTPPPVSAVWVLPPPSEPAAPPPDPEPPVPGPAGP 86
Query: 124 VFSPPPPAKKSSPPPPP 140
PPA PP PP
Sbjct: 87 PSPLAPPAPARKPPLPP 103
|
This family of proteins is found in viruses. Proteins in this family are typically between 145 and 1707 amino acids in length. The family is found in association with pfam01443, pfam01661, pfam05417, pfam01660, pfam00978. There is a single completely conserved residue L that may be functionally important. Length = 115 |
| >gnl|CDD|220401 pfam09786, CytochromB561_N, Cytochrome B561, N terminal | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 24/114 (21%), Positives = 34/114 (29%), Gaps = 4/114 (3%)
Query: 24 NSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASP 83
S T + S +S P + P P SS S S +SP S S
Sbjct: 106 KDSQFTVVSQAKKSPPASKTSTPMNTSEPLVPGHSSFSDSPSRSASPSRKFSPSSTIQQS 165
Query: 84 PTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPP 137
P + + P S S + P N+ + S P + S
Sbjct: 166 PQLTPSNK----PASPSSSYQSPSYSSSLGPVNSSGNRSNLRSSPWALRSSGDK 215
|
Members of this family are found in the N terminal region of cytochrome B561, as well as in various other putative uncharacterized proteins. Length = 559 |
| >gnl|CDD|221745 pfam12737, Mating_C, C-terminal domain of homeodomain 1 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 46/180 (25%), Positives = 65/180 (36%), Gaps = 31/180 (17%)
Query: 20 PPSSNSSDATPPPSSTPSSSP---PPSSPPPASPPPS-SPPPSSPPPS------------ 63
SS+SS A PP + PS + S A+P P+ S P P
Sbjct: 131 SISSSSSPAKPPEACLPSPAASTQDELSEASAAPLPTPSLSPPHTPTDTAPSGKRKRRLS 190
Query: 64 --------KSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPP-------PPPSSQSS 108
K P +S P T S P P T + +S P PPP S +
Sbjct: 191 DGFQLPAPKRPQTSSRPQTVSDPLPLHATTDWDTWFQATVSSSPSLLLTGDIPPPVSVFA 250
Query: 109 PTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYV 168
P +P + + P+ PP P P + SSST + +S S + S++ D
Sbjct: 251 PDDSTPLDISLFNFPLIPLLPPEALDLPAPTAVSSSSSTFAVPALTSSSVDQSATPLDQG 310
|
Mating in fungi is controlled by the loci that determine the mating type of an individual, and only individuals with differing mating types can mate. Basidiomycete fungi have evolved a unique mating system, termed tetrapolar or bifactorial incompatibility, in which mating type is determined by two unlinked loci; compatibility at both loci is required for mating to occur. The multi-allelic tetrapolar mating system is considered to be a novel innovation that could have only evolved once, and is thus unique to the mushroom fungi. This domain is C-terminal to the homeodomain transcription factor region. Length = 418 |
| >gnl|CDD|225689 COG3147, DedD, Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 18/75 (24%), Positives = 25/75 (33%)
Query: 19 APPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSP 78
A ++ DA + PP PA P ++ P P K PP+ PA +
Sbjct: 75 AQEIQDAGDAAAASVDPQPVAQPPVESTPAGVPVAAQTPKPVKPPKQPPAGAVPAKPTPK 134
Query: 79 PPASPPTSDNNKPDP 93
P P P
Sbjct: 135 PEPKPVAEPAAAPTG 149
|
Length = 226 |
| >gnl|CDD|227665 COG5373, COG5373, Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 21/84 (25%), Positives = 32/84 (38%), Gaps = 4/84 (4%)
Query: 1 MAKGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSP 60
A G E P A ++ A +S P P +P P++ PS+
Sbjct: 42 GAAGPVAKAAEQMAA-PEAAEAAPLPAAAESIASPEVPPPVPPAPAQEGEAPAAEQPSAV 100
Query: 61 PPSKSPPSSPPPATSSSPPPASPP 84
P +P ++P PA P A+ P
Sbjct: 101 P---APSAAPAPAEPVEPSLAANP 121
|
Length = 931 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 21/97 (21%), Positives = 37/97 (38%), Gaps = 2/97 (2%)
Query: 2 AKGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPP 61
A+G + PA + + P + P ++P PS+ P + P+ PP PP
Sbjct: 396 ARGPGGDDQTRPAAPVPASVPTPAPTPVPASAPPPPATPLPSAEPGSDDGPAPPPERQPP 455
Query: 62 PSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSP 98
+ P+ P ++ A + P+PP
Sbjct: 456 APATEPAPDDPDDAT--RKALDALRERRPPEPPGADL 490
|
Length = 3151 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 26/141 (18%), Positives = 48/141 (34%), Gaps = 1/141 (0%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
PA + + P + S PP A P S P + ++ + S
Sbjct: 765 PAKLAEALALLEPAEPQRGAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTASKRKSRSH 824
Query: 78 PPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPP 137
P +S +P P + PPP SS+SS + P+ + ++ P P + + P
Sbjct: 825 TPDGGSESSGPARP-PGAAARPPPARSSESSKSKPAAAGGRARGKNGRRRPRPPEPRARP 883
Query: 138 PPPLKYSSSTPKSSSSSSKSS 158
++ + +
Sbjct: 884 GAAAPPKAAAAAPPAGAPAPR 904
|
Length = 1352 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 13/91 (14%)
Query: 318 FAKSNL-----LGQGGFGYVHK------GVLPNGKEVAVKSLKTGSGQGERE-FSAEVEI 365
F + NL LG G FG V + G N VAVK LK + ERE +E++I
Sbjct: 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKI 94
Query: 366 ISRV-HHRHLVSLVGYCIAGGQRMLVYEFVS 395
+S + H+++V+L+G C GG +++ E+
Sbjct: 95 LSHLGQHKNIVNLLGACTHGGPVLVITEYCC 125
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 29/175 (16%), Positives = 46/175 (26%), Gaps = 21/175 (12%)
Query: 12 NEEGSPPAPPSSN--SSDATPPPSSTPS---SSPPPSSPPPAS------------PPPSS 54
P N SSD +P S + +P ++ PP +
Sbjct: 1 GPGKPRGQPGRWNYDSSDESPEGSRDENFDAERDDFLTPLGSTSEATSEDDDDLYPPRET 60
Query: 55 PPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSP 114
S + P P S + P P PP + + +P
Sbjct: 61 GSGGGVATS--TIYTVPRPPRGPEQTLDKPDSLPASRELPPGPTPVPPGGFRGASSPRLG 118
Query: 115 SNNKSPSPPVFSPPPP--AKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDY 167
+++ SP P A + S S S+S + G Y
Sbjct: 119 ADSTSPRFLYQVNFPVILAPIGESNSSSEELSEEEEHSRPPPSESLKVKNGGKVY 173
|
Length = 580 |
| >gnl|CDD|234229 TIGR03490, Mycoplas_LppA, mycoides cluster lipoprotein, LppA/P72 family | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 36/138 (26%), Positives = 50/138 (36%), Gaps = 17/138 (12%)
Query: 33 SSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDN--NK 90
S+T S+S P P P ++P P +K P + +++ P+S N K
Sbjct: 25 STTSSNSKQPEKKPEIKPNENTPKIPKKPDNKEPSENNNNKSNNENKDEENPSSTNPEKK 84
Query: 91 PDPPKN--------SPPP----PPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPP 138
PDP KN P P + Q + NN FS KK
Sbjct: 85 PDPSKNKEEIEKPKDEPKKPDKKPQADQPNNVHADQPNNNKVD---FSDLDKLKKELSFE 141
Query: 139 PPLKYSSSTPKSSSSSSK 156
YS PK++ SS K
Sbjct: 142 NFTLYSQKDPKTALSSLK 159
|
Members of this protein family occur in Mycoplasma mycoides, Mycoplasma hyopneumoniae, and related Mycoplasmas in small paralogous families that may also include truncated forms and/or pseudogenes. Members are predicted lipoproteins with a conserved signal peptidase II processing and lipid attachment site. Note that the name for certain characterized members, p72, reflects an anomalous apparent molecular weight, given a theoretical MW of about 61 kDa. Length = 541 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 27/92 (29%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 424 AKGLAYL-HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGT 481
A+G+ +L ++C +HRD+ A N+L+ + DFGLA+ + +D++
Sbjct: 247 ARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 482 FGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 513
++APE T SDV+S+G++L E+ +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 36/115 (31%), Positives = 54/115 (46%), Gaps = 27/115 (23%)
Query: 419 IALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH--VST 476
I G+ +GL YLH++ + IHR+IKA++ILI + GL LS +H + V
Sbjct: 106 ILFGALRGLNYLHQNGY---IHRNIKASHILISGD--------GLVSLSGLSHLYSLVRN 154
Query: 477 RVMGTFGYLAPEYASS--------------GKLTEKSDVFSFGVMLLELITGRRP 517
Y P++++S KSD++S G+ EL TGR P
Sbjct: 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 6e-04
Identities = 26/102 (25%), Positives = 47/102 (46%), Gaps = 6/102 (5%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
G P + S N + + S + S S S P +S P + P+ + P + PP +
Sbjct: 381 GGPHSNASYNCAAYSNAAQSNAAQSNAGFSNAGYSNPGNSNPGYNNAPNSNTPYNNPPNS 440
Query: 75 S---SSPPPASPPTSDNNKPDPPKNSPP---PPPPSSQSSPT 110
+ S+PP ++PP S+ + P ++ P PP S++ +
Sbjct: 441 NTPYSNPPNSNPPYSNLPYSNTPYSNAPLSNAPPSSAKDHHS 482
|
Length = 1560 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 6e-04
Identities = 26/85 (30%), Positives = 35/85 (41%), Gaps = 3/85 (3%)
Query: 43 SSPPPASPPPSSPPPSSPPPSKS-PPSSPPPATSSSPPPASPPTSDNNKPDPPKNS--PP 99
+S P S S+ SS PS PS+ PPA PPA+P + PP + P
Sbjct: 570 NSTPTGSAASSNTTFSSDSPSTVVAPSTSPPAGHLGSPPATPSKIVSPSTSPPASHLGSP 629
Query: 100 PPPPSSQSSPTPPSPSNNKSPSPPV 124
PSS S + + SP +
Sbjct: 630 STTPSSPESSIKVASTETASPESSI 654
|
Length = 670 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 31/90 (34%), Positives = 36/90 (40%), Gaps = 13/90 (14%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
P PPSS P + S +P SS P P S P P PS + PS+PP
Sbjct: 185 AIQPPPPSSLPG----LPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPSAPP--- 237
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPPPPS 104
+S P P PP PP PPP
Sbjct: 238 ASIPAPPIPP------VIQYVAPPPVPPPQ 261
|
Length = 582 |
| >gnl|CDD|165527 PHA03269, PHA03269, envelope glycoprotein C; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 23/111 (20%), Positives = 42/111 (37%), Gaps = 13/111 (11%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSS---PPPSSPPPSKS-----PP 67
PAP ++ P P+ P+S+ +P P++ P+ P + P
Sbjct: 40 PDPAPAPHQAASRAPDPAVAPTSAASRKPDLAQAPTPAASEKFDPAPAPHQAASRAPDPA 99
Query: 68 SSPPPATSSSPPPASPPTSDNNKPDPPKNSPPP-----PPPSSQSSPTPPS 113
+P A + P A TS + P ++ P P++ + +PP
Sbjct: 100 VAPQLAAAPKPDAAEAFTSAAQAHEAPADAGTSAASKKPDPAAHTQHSPPP 150
|
Length = 566 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 24/122 (19%), Positives = 41/122 (33%), Gaps = 7/122 (5%)
Query: 24 NSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASP 83
++ P + TPSS+ SS S P P + ++ A++ + A
Sbjct: 294 DTHGTVPVAAVTPSSAVTQSSAITPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGV 353
Query: 84 PTSDNNKPDP-------PKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSP 136
SD P P N P P ++++ + + + P P PA
Sbjct: 354 LPSDVTLPGTVALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPTTSLPAAPASNIPV 413
Query: 137 PP 138
P
Sbjct: 414 SP 415
|
Length = 421 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 6e-04
Identities = 36/149 (24%), Positives = 59/149 (39%), Gaps = 7/149 (4%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPS-KSPPSSPPPA 73
G+P SS + T P S T S++P +SP PA P++ P++ S +SP P
Sbjct: 472 GTPTGTTSSTLPEDTSPTSRTTSATPNATSPTPAVTTPNATSPTTQKTSDTPNATSPTPI 531
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKK 133
A+ P + + P + +S P + + + +P V + +
Sbjct: 532 VIGVTTTATSPPTGTTSV----PNATSPQVTEES-PVNNTNTPVVTSAPSVLTSAVTTGQ 586
Query: 134 SSPPPPPLKYSSSTPKSSSSSSKSSNGSS 162
P P SSS S+ SN +S
Sbjct: 587 HGTGSSPTSQQPGIP-SSSHSTPRSNSTS 614
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 42.5 bits (99), Expect = 6e-04
Identities = 39/171 (22%), Positives = 65/171 (38%), Gaps = 19/171 (11%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPP-AT 74
+ P+ + +AT P + S +P +SP P ++ S P + S P++ P T
Sbjct: 499 ATSPTPAVTTPNATSPTTQKTSDTPNATSPTPIVIGVTTTATSPPTGTTSVPNATSPQVT 558
Query: 75 SSSPPP-------ASPPTSDNNKPDPPKNSPPPPPPSSQSSP---TPPSP-SNNKSPSPP 123
SP S P+ + ++ P S Q + +P SN+ S +P
Sbjct: 559 EESPVNNTNTPVVTSAPSVLTSAVTTGQHGTGSSPTSQQPGIPSSSHSTPRSNSTSTTPL 618
Query: 124 VFSPPPPAKK-------SSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDY 167
+ S P + S P + S P ++S S G+SS Y
Sbjct: 619 LTSAHPTGGENITEETPSVPSTTHVSTLSPGPGPGTTSQVSGPGNSSTSRY 669
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 5/87 (5%)
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL 485
G+ +LH IIHRD+K +NI++ + + DFGLA+ + + + T + T Y
Sbjct: 131 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYR 185
Query: 486 APEYASSGKLTEKSDVFSFGVMLLELI 512
APE E D++S G ++ E++
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|227680 COG5391, COG5391, Phox homology (PX) domain protein [Intracellular trafficking and secretion / General function prediction only] | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 33/160 (20%), Positives = 50/160 (31%), Gaps = 12/160 (7%)
Query: 23 SNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPAS 82
++ ++ P + + +S PS S S+ + P S S P
Sbjct: 1 NSPDASSSPKNESSASDSGPSGSSSESQESSTVKNNDGSPVNSSIKSTPLDIQKRYSGFE 60
Query: 83 PPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPP---- 138
D P PPP S T ++K S S P
Sbjct: 61 SSAKLPRISDAPSFV--PPPGGHTISYTIAIH-DSKIHSRASEFRSLRDMLSLLLPTSLQ 117
Query: 139 PPLKYSSSTPKSSSSSSKSSNGS-----SSGDDYVTYSVI 173
PPL S + SS+ S+ S S D + +Y +I
Sbjct: 118 PPLSTSHTILDYFISSTVSNPQSLTLLVDSRDKHTSYEII 157
|
Length = 524 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 7e-04
Identities = 72/289 (24%), Positives = 96/289 (33%), Gaps = 24/289 (8%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPP-----PSSPPPSSPPPSKSPPSSPP 71
P S+ PP P P ++PP S P P PS++ P S
Sbjct: 260 SSRHPQSSHHGPGPPMPHALQQGPVFLQHPSSNPPQPFGLAQSQVPPLPLPSQAQPHSHT 319
Query: 72 PATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPA 131
P + S+ P PP P P PPP + S + P SP P
Sbjct: 320 PPSQSALQPQQPPREQPLPPAPSMPHIKPPPTTPIPQLPNQSHKHPPHLQGP--SPFPQM 377
Query: 132 KKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVTYSVIGAVGVGIFLIAMIIICAV 191
+ PPPP LK SS P S+ SV V +
Sbjct: 378 PSNLPPPPALKPLSSLPTHHPPSAHPPPLQLMPQSQPLQSVPAQPPV---------LTQS 428
Query: 192 RANKKKKKRHNQPMHYYGDHSNHFKKGGDPYYSGGHAPNWHGHPEHQNWHSHPQGPDHTG 251
++ K H + G + F + P+ SGG G P + P +
Sbjct: 429 QSLPPKASTHPHSGLHSGPPQSPFAQ--HPFTSGGLPAI--GPPPSLPTSTPAAPPRASS 484
Query: 252 GNIPP----PPGGNWPGPPPPPPMMSSSGEMSSQFSGPARPPLPPPSPN 296
G+ PP P G GP PP P + E + P PP PP SP+
Sbjct: 485 GSQPPGSALPSSGGCAGPGPPLPPIQIKEEPLDEAEEPESPPPPPRSPS 533
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 28/70 (40%), Positives = 31/70 (44%), Gaps = 10/70 (14%)
Query: 45 PPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPS 104
PPP +P PP PP PP+SPP A + PAS P P P SPPP
Sbjct: 144 PPPPAPVVMMQPP---PPHAMPPASPPAAQPAPSAPASSPP-----PTPA--SPPPAKAP 193
Query: 105 SQSSPTPPSP 114
S P SP
Sbjct: 194 KSSHPPLKSP 203
|
Length = 274 |
| >gnl|CDD|218440 pfam05110, AF-4, AF-4 proto-oncoprotein | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 39/175 (22%), Positives = 52/175 (29%), Gaps = 24/175 (13%)
Query: 5 NNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSK 64
N+V ++ N +G P PSS S+ P P+ S S P
Sbjct: 80 NSVPQSPNNKGKPSFFGDQRGRSI---PSSHQSTHTSAPGPAPSGNISQSQKRSQPRSQW 136
Query: 65 SPPSSPPPATSSSPPPASPPTS------DNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNK 118
+ PP SSS +S ++K SP + QS PP
Sbjct: 137 TKAGHPPSTVSSSQRHGQQGSSHSHSGDHHSKEICRSKSPRDLEVNVQSPERPPDSLVLL 196
Query: 119 SPSPP---VFSPPPPAKKSSPPPPPLKY------------SSSTPKSSSSSSKSS 158
S F P +K S+ P Y S KSS S
Sbjct: 197 PSSQHSVQNFPPSLMSKSSAMQQKPTAYVRPMDGQDQAPDESPELKSSIEESYGQ 251
|
This family consists of AF4 (Proto-oncogene AF4) and FMR2 (Fragile X E mental retardation syndrome) nuclear proteins. These proteins have been linked to human diseases such as acute lymphoblastic leukaemia and mental retardation. The family also contains a Drosophila AF4 protein homologue Lilliputian which contains an AT-hook domain. Lilliputian represents a novel pair-rule gene that acts in cytoskeleton regulation, segmentation and morphogenesis in Drosophila. Length = 1154 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 7e-04
Identities = 12/49 (24%), Positives = 19/49 (38%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKS 65
AP S +D S T + ++P P PP++PP +
Sbjct: 274 TAAPAPSRMTDTNDSKSVTSQPAAAAAAPAPPPNPPATPPEPPARRGRG 322
|
Length = 656 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 7e-04
Identities = 14/61 (22%), Positives = 21/61 (34%), Gaps = 9/61 (14%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
PA + S + S S + PA+ + PP +PP + P PP
Sbjct: 271 QPATAAPAPSR---MTDTNDSKSV---TSQPAAAAAAPAPPPNPP---ATPPEPPARRGR 321
Query: 77 S 77
Sbjct: 322 G 322
|
Length = 656 |
| >gnl|CDD|234229 TIGR03490, Mycoplas_LppA, mycoides cluster lipoprotein, LppA/P72 family | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 17/91 (18%), Positives = 28/91 (30%), Gaps = 2/91 (2%)
Query: 33 SSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPD 92
S S+ +S P P P ++P K P + P +++ +N
Sbjct: 20 SVVSCSTTSSNSKQPEKKPEIKPNENTPKIPKKPDNKEPSENNNNKSNNENKDEENPSST 79
Query: 93 PPKNSPPPPPPSSQSSPTPPSPSNNKSPSPP 123
P+ P P + P K P
Sbjct: 80 NPEKKPDPSKN--KEEIEKPKDEPKKPDKKP 108
|
Members of this protein family occur in Mycoplasma mycoides, Mycoplasma hyopneumoniae, and related Mycoplasmas in small paralogous families that may also include truncated forms and/or pseudogenes. Members are predicted lipoproteins with a conserved signal peptidase II processing and lipid attachment site. Note that the name for certain characterized members, p72, reflects an anomalous apparent molecular weight, given a theoretical MW of about 61 kDa. Length = 541 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 7e-04
Identities = 18/65 (27%), Positives = 26/65 (40%), Gaps = 4/65 (6%)
Query: 53 SSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPP 112
+S P ++ P P A ++ PP PP PP +P PP P P
Sbjct: 45 ASIPGLEDVTVQTTPPPPASAITNGGPPPPPPARAEAASPPPPEAPAEPPA----EPEPE 100
Query: 113 SPSNN 117
+P+ N
Sbjct: 101 APAEN 105
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|225987 COG3456, COG3456, Predicted component of the type VI protein secretion system, contains a FHA domain [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 31/126 (24%), Positives = 40/126 (31%), Gaps = 2/126 (1%)
Query: 27 DATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTS 86
D P S+ S+ P P PP + P + P P S+ P A S
Sbjct: 115 DTGSPQSAVSSTDMDDDFLADIEPEPRLPPGLTDPLQLADPV--PNGFSADPLSALQSES 172
Query: 87 DNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSS 146
+PDP +P S P S +P P PP A P S+S
Sbjct: 173 LIAQPDPAGGAPSISRNSEAPLSDPASAGGIDTPFPDDLDVPPIAASPPGPQEGPTISAS 232
Query: 147 TPKSSS 152
P
Sbjct: 233 QPAQRD 238
|
Length = 430 |
| >gnl|CDD|218883 pfam06075, DUF936, Plant protein of unknown function (DUF936) | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 26/152 (17%), Positives = 46/152 (30%), Gaps = 5/152 (3%)
Query: 13 EEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPP---ASPPPSSPPPSSP--PPSKSPP 67
E P+ S + + +PS S +S S+
Sbjct: 171 ELNLTDRTPAKVRSSRSELGAPSPSGGTSCPSSSGGRRSSIGSRRLRGSASLRKKVAVLS 230
Query: 68 SSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSP 127
+ P + SS +SP ++ P K+S + S + + + S S
Sbjct: 231 APRKPGSRSSDCKSSPRARSSSAKSPFKSSIQRKATKALSKLSLRASPKDTSKSSKSEVA 290
Query: 128 PPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSN 159
PP ++ P K++ S S S
Sbjct: 291 PPKKSEAKVPSSSKKWTDGNVSWDSLPSSLSK 322
|
This family consists of several hypothetical proteins from Arabidopsis thaliana and Oryza sativa. The function of this family is unknown. Length = 564 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 31/121 (25%), Positives = 44/121 (36%), Gaps = 42/121 (34%)
Query: 439 IHRDIKAANILIDDNFEAMVADFGL------------------------------AKLSN 468
IHRDIK NILID + + DFGL +++
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 469 DNHTHVSTRVM------------GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRR 516
+ R GT Y+APE T+ D +S GV+L E++ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 517 P 517
P
Sbjct: 243 P 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 8e-04
Identities = 17/107 (15%), Positives = 36/107 (33%), Gaps = 2/107 (1%)
Query: 60 PPPSKSPPSSPPPATSS--SPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNN 117
+ + +++ +P A P + P P+ +P P PS
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPA 445
Query: 118 KSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSG 164
+ PPPA S P P ++ P ++ + + + + +
Sbjct: 446 GNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAA 492
|
Length = 824 |
| >gnl|CDD|200219 TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 35/184 (19%), Positives = 50/184 (27%), Gaps = 49/184 (26%)
Query: 11 ENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSP 70
E GS PAP + A P + P+ +P +P PA+P ++ S
Sbjct: 79 PGEAGSEPAPAAPEPEAAPEPEAPAPAPTPAAEAPAPAAPQAGGSGEATEVKMPELGESV 138
Query: 71 PPATSSS---------------------------PPPAS--------------------P 83
T +S P P +
Sbjct: 139 TEGTVTSWLKAVGDTVEVDEPLLEVSTDKVDTEIPSPVAGTLLEIRAPEDDTVEVGTVLA 198
Query: 84 PTSDNNKPDPPKNSPPPPPPS-SQSSPTP-PSPSNNKSPSPPVFSPPPPAKKSSPPPPPL 141
D N P PS + S P P P+ + P P PAK ++P
Sbjct: 199 IIGDANAAPAEPAEEEAPAPSEAGSEPAPDPAARAPHAAPDPPAPAPAPAKTAAPAAAAP 258
Query: 142 KYSS 145
S
Sbjct: 259 VSSG 262
|
This model represents an Actinobacterial clade of E2 enzyme, a component of the 2-oxoglutarate dehydrogenase complex involved in the TCA cycle. These proteins have multiple domains including the catalytic domain (pfam00198), one or two biotin domains (pfam00364) and an E3-component binding domain (pfam02817). Length = 579 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 18/69 (26%), Positives = 27/69 (39%), Gaps = 8/69 (11%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
+PP P S+ ++ PP PPP+ ASPPP P P + + T
Sbjct: 57 TTPPPPASAITNGGPPP--------PPPARAEAASPPPPEAPAEPPAEPEPEAPAENTVT 108
Query: 75 SSSPPPASP 83
+ P +
Sbjct: 109 VAKDPRYAK 117
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 16/83 (19%), Positives = 26/83 (31%), Gaps = 2/83 (2%)
Query: 2 AKGNNVTETENEEGSPPAPPSSNSSDATP--PPSSTPSSSPPPSSPPPASPPPSSPPPSS 59
A G +E P P+ + + S+P ++ +P P P
Sbjct: 341 ALGGAPSEGVAAVAPPAPAPADLTQRLNRLEKEVRSLRSAPTAAATAAGAPLPDFDPRPR 400
Query: 60 PPPSKSPPSSPPPATSSSPPPAS 82
PP+ P S +P A
Sbjct: 401 GPPAPEPARSAEAPPLVAPAAAP 423
|
Length = 504 |
| >gnl|CDD|237011 PRK11892, PRK11892, pyruvate dehydrogenase subunit beta; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 8e-04
Identities = 13/58 (22%), Positives = 24/58 (41%), Gaps = 6/58 (10%)
Query: 37 SSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPP 94
S+S ++P A+ ++ P ++ + + P A PA+P PD P
Sbjct: 83 SASDAGAAPAAAAEAAAAAPAAAAAAAAKKAAPAPAA------PAAPAAEVAADPDIP 134
|
Length = 464 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 9e-04
Identities = 17/102 (16%), Positives = 33/102 (32%)
Query: 81 ASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPP 140
AS P P P S ++ PSPS + + + P +PP
Sbjct: 369 ASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVS 428
Query: 141 LKYSSSTPKSSSSSSKSSNGSSSGDDYVTYSVIGAVGVGIFL 182
+ ++ P + S++ + + + V +G
Sbjct: 429 VDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPVSKVSSLGPST 470
|
Length = 614 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 9e-04
Identities = 9/63 (14%), Positives = 18/63 (28%)
Query: 27 DATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTS 86
D P + ++ + +P +P P + +PP A P +
Sbjct: 119 DTGGAPPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPP 178
Query: 87 DNN 89
Sbjct: 179 PTP 181
|
Length = 418 |
| >gnl|CDD|237011 PRK11892, PRK11892, pyruvate dehydrogenase subunit beta; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 9e-04
Identities = 9/50 (18%), Positives = 22/50 (44%)
Query: 34 STPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASP 83
S ++P ++ A+ P ++ ++ + +P + PA + P P
Sbjct: 85 SDAGAAPAAAAEAAAAAPAAAAAAAAKKAAPAPAAPAAPAAEVAADPDIP 134
|
Length = 464 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 14/96 (14%), Positives = 34/96 (35%), Gaps = 3/96 (3%)
Query: 60 PPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKS 119
P + + T + P A+P + + P ++ + PP+ +
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAP 425
Query: 120 PSPPVFSPPPPAKKSSP---PPPPLKYSSSTPKSSS 152
+ P + P A ++P P + + P++ +
Sbjct: 426 VAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVA 461
|
Length = 618 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 15/131 (11%), Positives = 30/131 (22%), Gaps = 5/131 (3%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
+ ++PP + + P ++ +S S+S
Sbjct: 773 ALLEPAEPQRGAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTASKRKSRSHTPDGGSE- 831
Query: 75 SSSPPPASPPTSD----NNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPP 130
SS P + + + + P +PP
Sbjct: 832 SSGPARPPGAAARPPPARSSESSKSKPAAAGGRARGKNGRRRPRPPEPRARPGAAAPPKA 891
Query: 131 AKKSSPPPPPL 141
A + P P
Sbjct: 892 AAAAPPAGAPA 902
|
Length = 1352 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 15/66 (22%), Positives = 23/66 (34%), Gaps = 1/66 (1%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
PP P ++ P P P + P P +P A + P P +PP+ P +
Sbjct: 398 PPKEPVRETATPPPVPPR-PVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKEEEKA 456
Query: 77 SPPPAS 82
Sbjct: 457 LIADGD 462
|
Length = 585 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 19/81 (23%), Positives = 24/81 (29%), Gaps = 11/81 (13%)
Query: 7 VTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPP---PSSPPPSSPPPS 63
V T P A ++N P + PPP P P +PP P
Sbjct: 379 VRPTPAPSTRPKAAAAANIPPKEPVRETAT---PPPVPPRPVAPPVPHTPESAPKLT--- 432
Query: 64 KSPPSSPPPATSSSPPPASPP 84
+ P PPA P
Sbjct: 433 --RAAIPVDEKPKYTPPAPPK 451
|
Length = 585 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 24/117 (20%), Positives = 38/117 (32%), Gaps = 5/117 (4%)
Query: 16 SPPAPPSSNSSDATPPPSSTPS-SSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
A ++ + A P + P+ PPP P +P P+ S P
Sbjct: 471 PVAAAAAAAPARAAPAAAPAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPA 530
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPA 131
++ P A P P P +++ P P + S P +F PA
Sbjct: 531 TADPDDAFETL----APAPAAAPAPRAAAATEPVVAPRPPRASASGLPDMFDGDWPA 583
|
Length = 700 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 0.001
Identities = 16/61 (26%), Positives = 23/61 (37%)
Query: 10 TENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSS 69
P A + PP ++ SS+ P P +SPPP P +P P+K
Sbjct: 536 PTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSSPPPPIPEEPTPSPTKDSSPE 595
Query: 70 P 70
Sbjct: 596 E 596
|
Length = 620 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 14/78 (17%), Positives = 25/78 (32%), Gaps = 12/78 (15%)
Query: 63 SKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSP 122
+P + +P + P P P PP ++ + P+P
Sbjct: 379 RGAPAPPSAAWGAPTPAAPAAPP-------PAAAPPVPPAAPARPAAARPAP-----APA 426
Query: 123 PVFSPPPPAKKSSPPPPP 140
P + PPA+ + P
Sbjct: 427 PPAAAAPPARSADPAAAA 444
|
Length = 576 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 19/123 (15%), Positives = 30/123 (24%), Gaps = 3/123 (2%)
Query: 46 PPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSS 105
P A P PP + P P + + P P+
Sbjct: 90 PSAGEPAPPPPHARRTSEPELPRPGRRPYEGYGGPRADDRPPGLPRQDQLPTARPAYPAY 149
Query: 106 QSSPTP---PSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSS 162
Q P P P +++ PP A +SP + + +
Sbjct: 150 QQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYDAGRPEYDQRRR 209
Query: 163 SGD 165
D
Sbjct: 210 DYD 212
|
Length = 617 |
| >gnl|CDD|223880 COG0810, TonB, Periplasmic protein TonB, links inner and outer membranes [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 28/124 (22%), Positives = 38/124 (30%), Gaps = 11/124 (8%)
Query: 34 STPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDP 93
+ + P P P PP P + P +PP T P KP P
Sbjct: 40 AVFLLAAKVLEAPTEEPQPEPEPPEEQPKPPTEPETPPEPTPPKPKE---------KPKP 90
Query: 94 PKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSS 153
K P P P P P P AK + P P + S+ S ++
Sbjct: 91 EK--KPKKPKPKPKPKPKPKPKVKPQPKPKKPPSKTAAKAPAAPNQPARPPSAASASGAA 148
Query: 154 SSKS 157
+ S
Sbjct: 149 TGPS 152
|
Length = 244 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 33/118 (27%), Positives = 44/118 (37%), Gaps = 6/118 (5%)
Query: 8 TETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPP 67
T E E + PA P D + PP P PP + PP PPS P
Sbjct: 519 TTEEEESVTQPAKPHRKVQDGFQRSGRRQKRATPPKVSPSDRGPPKASPPVMAPPSTGPR 578
Query: 68 SSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVF 125
P+T P +PP++ + K+ PP S PPS S + +P V
Sbjct: 579 VMATPST--GPRDMAPPSTGPRQQAKCKDG---PPASGPHEKQPPS-SAPRDMAPSVV 630
|
Length = 1000 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 18/57 (31%), Positives = 25/57 (43%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA 73
PPAPP + P+ + PP S+P P ++ P + P S P PP A
Sbjct: 84 PPAPPEPVTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPPPSDPPQPPRA 140
|
Length = 141 |
| >gnl|CDD|165468 PHA03201, PHA03201, uracil DNA glycosylase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 30/94 (31%), Positives = 37/94 (39%), Gaps = 11/94 (11%)
Query: 37 SSSPPPSSPPPASPPPSSPPPSSP--PPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPP 94
S SP P P PP PP SP P ++PPS P P P A+ P + +P
Sbjct: 6 SRSPSPPRRPS---PPRPTPPRSPDASPEETPPSPPGPGAEPPPGRAAGPAAPRRRPR-- 60
Query: 95 KNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPP 128
P + SS PP P +P PP
Sbjct: 61 ----GCPAGVTFSSSAPPRPPLGLDDAPAATPPP 90
|
Length = 318 |
| >gnl|CDD|222010 pfam13254, DUF4045, Domain of unknown function (DUF4045) | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 31/121 (25%), Positives = 40/121 (33%), Gaps = 8/121 (6%)
Query: 36 PSSSPPPSSPPPASPPPSSP-PPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPP 94
+PPP S + P PSS K+ P P TSS S DP
Sbjct: 206 LMRTPPPGSHSKSPSKSGIPDLPSSRDSEKTKPEKPQQETSSMDTEKSSAPKPRETLDPK 265
Query: 95 KNSPPPPPPSSQSSPTPPSPSNNKSP-------SPPVFSPPPPAKKSSPPPPPLKYSSST 147
PP +++ P S +S SP + SP P A+ P P K
Sbjct: 266 SPEKAPPIDTTEEELKSPEASPKESEEASARKRSPSLLSPSPKAESPKPLASPGKSPRDP 325
Query: 148 P 148
Sbjct: 326 L 326
|
This presumed domain is functionally uncharacterized. This domain family is found in bacteria and eukaryotes, and is typically between 384 and 430 amino acids in length. Length = 414 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 16/66 (24%), Positives = 24/66 (36%), Gaps = 1/66 (1%)
Query: 19 APPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSP 78
P + + S+P A+ +P P P + PP +P PA S+
Sbjct: 355 PPAPAPADLTQRLNRLEKEVRSLRSAPTAAATAAGAPLPDFDPRPRGPP-APEPARSAEA 413
Query: 79 PPASPP 84
PP P
Sbjct: 414 PPLVAP 419
|
Length = 504 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 15/72 (20%), Positives = 24/72 (33%), Gaps = 1/72 (1%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPP-PSKSPPSSPPPAT 74
PA + + S S+ ++ A P P P PP P + + PP
Sbjct: 358 PAPADLTQRLNRLEKEVRSLRSAPTAAATAAGAPLPDFDPRPRGPPAPEPARSAEAPPLV 417
Query: 75 SSSPPPASPPTS 86
+ + PA
Sbjct: 418 APAAAPAGLALR 429
|
Length = 504 |
| >gnl|CDD|221188 pfam11725, AvrE, Pathogenicity factor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 27/177 (15%), Positives = 52/177 (29%), Gaps = 22/177 (12%)
Query: 12 NEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSS--------PPPASPPPSSPPPSSPPPS 63
+ P ++ S+ A + S +S P S+P
Sbjct: 8 TATKTAVQPEATPSAGAPTGLQQSSESPTQRASHSLASEGKKNRKKMPKVFQKSSAPRQI 67
Query: 64 KSPPSSPPPATSSSPPPASPPT--SDNNKP--DPPKNSPPPPPPSSQSSPTPPSPSNNKS 119
++ P T+++P + PT P D +P P + + + + +
Sbjct: 68 QAAPPQALNPTAAAPQSSRGPTLRELLALPEDDGETQAPESSPSARRLTRSEGVARHEME 127
Query: 120 P---SPPVFSPPPP-------AKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDD 166
P V K SS PP+ T +++ +S D+
Sbjct: 128 DLAGRPVVKPDADRQLRQDILNKSSSSRRPPVSKEEGTSSKMPATALASAALFKDDE 184
|
This family is secreted by gram-negative Gammaproteobacteria such as Pseudomonas syringae of tomato and the fire blight plant pathogen Erwinia amylovora, amongst others. It is an essential pathogenicity factor of approximately 198 kDa. Its injection into the host-plant is dependent upon the bacterial type III or Hrp secretion system. The family is long and carries a number of predicted functional regions, including an ERMS or endoplasmic reticulum membrane retention signal at both the C- and the N-termini, a leucine-zipper motif from residues 539-560, and a nuclear localisation signal at 1358-1361. this conserved AvrE-family of effectors is among the few that are required for full virulence of many phytopathogenic pseudomonads, erwinias and pantoeas. Length = 1771 |
| >gnl|CDD|215641 PLN03237, PLN03237, DNA topoisomerase 2; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 30/179 (16%), Positives = 44/179 (24%), Gaps = 42/179 (23%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSS-----PPPSSPPPSKSPPSS 69
S PA + P+ ++ P + S
Sbjct: 1276 DSAPAQSAKMEETVKAVPARRAAARKKPLASVSVISDSDDDDDDFAVEVSLAERLKKKGG 1335
Query: 70 PPPATSSSPPPASPPTSDNNKPDPPKNSPPPP---------------PPSSQSSPTPPSP 114
PA +++ A PP + K P P + SP
Sbjct: 1336 RKPA-AANKKAAKPPAA--AKKRGPATVQSGQKLLTEMLKPAEAIGISPEKKVRKMRASP 1392
Query: 115 SNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVTYSVI 173
N KS S ++T K + SS S SSS D + S
Sbjct: 1393 FNKKSGSV-------------------LGRAATNKETESSENVSGSSSSEKDEIDVSAK 1432
|
Length = 1465 |
| >gnl|CDD|148139 pfam06346, Drf_FH1, Formin Homology Region 1 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 47/144 (32%), Positives = 51/144 (35%), Gaps = 3/144 (2%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
G PP PP PPP + PP P P PPP PP P AT
Sbjct: 11 GIPPPPPLPGGVCIPPPPPLPGGTGIPPPPPLPGGAAIPPPPPLPGVAGIPPPPPLPGAT 70
Query: 75 SSSPPPASPPTSDNNKPDPPKNS---PPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPA 131
+ PPP P + P P PPPPPP + PP P P P PP P
Sbjct: 71 AIPPPPPLPGAAGIPPPPPLPGGAGIPPPPPPLPGGAAVPPPPPLPGGPGVPPPPPPFPG 130
Query: 132 KKSSPPPPPLKYSSSTPKSSSSSS 155
PPPPP S P
Sbjct: 131 APGIPPPPPGMGSPPPPPFGFGVP 154
|
This region is found in some of the Diaphanous related formins (Drfs). It consists of low complexity repeats of around 12 residues. Length = 160 |
| >gnl|CDD|215064 PLN00122, PLN00122, serine/threonine protein phosphatase 2A; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 15/58 (25%), Positives = 22/58 (37%)
Query: 30 PPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSD 87
+S+ SS+P +S P +S S S S P+S P P S+
Sbjct: 1 SSSASSGSSAPAVNSSPSSSSSGKSSNSSKSASSAVNPASVVAGYEPLPSFRDVPNSE 58
|
Length = 170 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 30/124 (24%), Positives = 64/124 (51%), Gaps = 9/124 (7%)
Query: 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANIL 449
+Y F+ ++ ++ ++RP++ + L A + Y+H+ ++IHRDIK NI
Sbjct: 249 LYSFMYDEAFDW----KDRPLLKQTRAIMKQLLCA--VEYIHDK---KLIHRDIKLENIF 299
Query: 450 IDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLL 509
++ + + ++ DFG A +GT +PE + E +D++S G++LL
Sbjct: 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILL 359
Query: 510 ELIT 513
++++
Sbjct: 360 DMLS 363
|
Length = 501 |
| >gnl|CDD|221173 pfam11702, DUF3295, Protein of unknown function (DUF3295) | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 34/140 (24%), Positives = 49/140 (35%), Gaps = 12/140 (8%)
Query: 39 SPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSP 98
+ P + P +PP S P P+ P + +P P + S T+ + D ++S
Sbjct: 80 ALPMPNLAPITPPSSEPTPAPPSSESTATRTPDPNQQALESTESTSTTSADCNDSEQSST 139
Query: 99 PPPPPSSQS---SPTPPSPSNNKSPSPP-----VFSPPPPAKKSSPPPPPLKYSSSTPKS 150
P S S S PS S + SP S K SP ++ K
Sbjct: 140 PNLNSSDTSTSSSGALPSTSVVRGFSPSHISSSYRSTAQLNKAPSPTKSAEPTAAPQAKP 199
Query: 151 SSSSSKSS----NGSSSGDD 166
K + GSS DD
Sbjct: 200 ELPKKKQAMFTLGGSSGDDD 219
|
This family is conserved in fungi but the function is not known. Length = 509 |
| >gnl|CDD|183854 PRK13042, PRK13042, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 20/79 (25%), Positives = 37/79 (46%), Gaps = 6/79 (7%)
Query: 22 SSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPA 81
++ +++AT P S+ + P S PP++ + P S P + +PPS+ A +P
Sbjct: 24 TTQAANATTPSSTKVEA---PQSTPPSTKVEA---PQSKPNATTPPSTKVEAPQQTPNAT 77
Query: 82 SPPTSDNNKPDPPKNSPPP 100
+P ++ P P P
Sbjct: 78 TPSSTKVETPQSPTTKQVP 96
|
Length = 291 |
| >gnl|CDD|233365 TIGR01347, sucB, 2-oxoglutarate dehydrogenase complex dihydrolipoamide succinyltransferase (E2 component) | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 18/103 (17%), Positives = 29/103 (28%), Gaps = 14/103 (13%)
Query: 13 EEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPP 72
EEG+ S P +S A ++ P SP + +
Sbjct: 75 EEGNDATAAPPAKSGEEKEE-------TPAASAAAAPTAAANRPSLSPAARR---LAKEH 124
Query: 73 ATSSSPPPASPPTSDNNKPDPPK----NSPPPPPPSSQSSPTP 111
S P + T K D K + P + ++ P
Sbjct: 125 GIDLSAVPGTGVTGRVTKEDIIKKTEAPASAQQPAPAAAAKAP 167
|
This model describes the TCA cycle 2-oxoglutarate system E2 component, dihydrolipoamide succinyltransferase. It is closely related to the pyruvate dehydrogenase E2 component, dihydrolipoamide acetyltransferase. The seed for this model includes mitochondrial and Gram-negative bacterial forms. Mycobacterial candidates are highly derived, differ in having and extra copy of the lipoyl-binding domain at the N-terminus. They score below the trusted cutoff, but above the noise cutoff and above all examples of dihydrolipoamide acetyltransferase [Energy metabolism, TCA cycle]. Length = 403 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 16/75 (21%), Positives = 23/75 (30%), Gaps = 7/75 (9%)
Query: 7 VTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSP 66
+ + PP + PP P PP P S P ++ P + P
Sbjct: 385 PSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPPVPHTPESAPKL--TRAAIPVDEKP 442
Query: 67 PSSPPPATSSSPPPA 81
+PP PP
Sbjct: 443 KYTPPA-----PPKE 452
|
Length = 585 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 40/167 (23%), Positives = 64/167 (38%), Gaps = 36/167 (21%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
A P + + PP++ P + PP++ P A P P PP + P P + P +P P
Sbjct: 743 RARPPAAAPGRARPPAAAPGRARPPAAAPGA-PTPQPPPQAPPAPQQRPRGAPTP----Q 797
Query: 78 PPPASPPTSDNNKPDPPKNSPPPPP---------------PSSQS------------SPT 110
PPP + PTS P P PS + +P+
Sbjct: 798 PPPQAGPTSMQLMPRAAPGQQGPTKQILRQLLTGGVKRGRPSLKKPAALERQAAAGPTPS 857
Query: 111 PPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKS 157
P S +++K PVF PP P + S ++S+ +++
Sbjct: 858 PGSGTSDKIVQAPVFYPP----VLQPIQVMRQLGSVRAAAASTVTQA 900
|
Length = 991 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 44/146 (30%), Positives = 51/146 (34%), Gaps = 22/146 (15%)
Query: 17 PPAPPSSNSSDATPPPS-------STPSSSPP--PSSPPP--------ASPPPSSPPPSS 59
PP + A P S PS P PS PP SP P +P
Sbjct: 204 PPQGSPIAAQPAPQPQQPSPLSLISAPSLHPQRLPSPHPPLQPQTASQQSPQPPAPSSRH 263
Query: 60 PPPSKSPPSSP-PPATSSSPPPASPPTSDNNKPDPPKNSPPPPPP----SSQSSPTPPSP 114
P S P P P A P P+S+ +P S PP P + S TPPS
Sbjct: 264 PQSSHHGPGPPMPHALQQGPVFLQHPSSNPPQPFGLAQSQVPPLPLPSQAQPHSHTPPSQ 323
Query: 115 SNNKSPSPPVFSPPPPAKKSSPPPPP 140
S + PP P PPA PP
Sbjct: 324 SALQPQQPPREQPLPPAPSMPHIKPP 349
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 9/91 (9%)
Query: 324 LGQGGFGYVHK------GVLPNGKEVAVKSLKTGSGQGE-REFSAEVEIISRV-HHRHLV 375
LG+G FG V + + + VAVK LK G+ E + E++I+ + HH ++V
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 376 SLVGYCI-AGGQRMLVYEFVSNKTLEYHLHG 405
+L+G C GG M++ E+ L +L
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRS 105
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 33/142 (23%), Positives = 45/142 (31%), Gaps = 7/142 (4%)
Query: 9 ETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPS 68
E ++ E S+ A + + P A PP +P P SP P + S
Sbjct: 33 EAQSSEAHSFHVDSTKQPPAPEQVAKHELADAPLQQVNAALPP--APAPQSPQPDQQQQS 90
Query: 69 SPPPATSSSPPPASPPTSDNNKPDPPKNSPPPP--PPSSQSSPTPPSPSNNKSPSPPVFS 126
PP S P+ P P PP SQ P P + P PP
Sbjct: 91 QAPP---SHQYPSQLPPQQVQSVPQQPTPQQEPYYPPPSQPQPPPAQQPQAQQPQPPPQV 147
Query: 127 PPPPAKKSSPPPPPLKYSSSTP 148
P +S P P + +
Sbjct: 148 PQQQQYQSPPQQPQYQQNPPPQ 169
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 27/92 (29%), Positives = 32/92 (34%), Gaps = 19/92 (20%)
Query: 47 PASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQ 106
P PPP+ PPP P + PP SPP A P P
Sbjct: 142 PQPPPPAPVVMMQPPP---PHAMPPA----SPPAAQPA------------PSAPASSPPP 182
Query: 107 SSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPP 138
+ +PP KS PP+ SP SP P
Sbjct: 183 TPASPPPAKAPKSSHPPLKSPMAGTFYRSPAP 214
|
Length = 274 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 26/65 (40%), Positives = 34/65 (52%), Gaps = 7/65 (10%)
Query: 78 PPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPP 137
PPP +P +P PP PP PP++Q +P+ P+ S P+P PPPAK
Sbjct: 144 PPPPAPVVM--MQPPPPHAMPPASPPAAQPAPSAPASS--PPPTPAS---PPPAKAPKSS 196
Query: 138 PPPLK 142
PPLK
Sbjct: 197 HPPLK 201
|
Length = 274 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 21/77 (27%), Positives = 30/77 (38%), Gaps = 5/77 (6%)
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKK 133
T +PP A+P + K + P PTP P+ +K P PP PA
Sbjct: 120 TGGAPPAAAPAAAAAAKAEKTTPEKPKAAA-----PTPEPPAASKPTPPAAAKPPEPAPA 174
Query: 134 SSPPPPPLKYSSSTPKS 150
+ PPP P+ +
Sbjct: 175 AKPPPTPVARADPRETR 191
|
Length = 418 |
| >gnl|CDD|218440 pfam05110, AF-4, AF-4 proto-oncoprotein | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 28/140 (20%), Positives = 35/140 (25%), Gaps = 8/140 (5%)
Query: 31 PPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNK 90
P P A +S S SK + + +
Sbjct: 714 PYKKGVPPKPAEKDSLSAPKKQTSKTASEKSSSKGKRKHKNDEEADKIESKKQRLEEKSS 773
Query: 91 PDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSP-----PPPAKKSSPPPPPLKYSS 145
P +S SS S + + P SP P P S P
Sbjct: 774 SCSPSSSSSHHHSSSNKESRKSSRNKEEEMLPSPSSPLSSSSPKPEHPSRKRPRR---QE 830
Query: 146 STPKSSSSSSKSSNGSSSGD 165
T SS S SS SSS
Sbjct: 831 DTSSSSGPFSASSTKSSSKS 850
|
This family consists of AF4 (Proto-oncogene AF4) and FMR2 (Fragile X E mental retardation syndrome) nuclear proteins. These proteins have been linked to human diseases such as acute lymphoblastic leukaemia and mental retardation. The family also contains a Drosophila AF4 protein homologue Lilliputian which contains an AT-hook domain. Lilliputian represents a novel pair-rule gene that acts in cytoskeleton regulation, segmentation and morphogenesis in Drosophila. Length = 1154 |
| >gnl|CDD|218440 pfam05110, AF-4, AF-4 proto-oncoprotein | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 42/159 (26%), Positives = 53/159 (33%), Gaps = 28/159 (17%)
Query: 8 TETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPAS--------------PPPS 53
TE +PP+ PSSN A S+ SSS SS S P +
Sbjct: 374 TEKPPSRNTPPSAPSSNPEPAASSSGSSSSSSGSESSSGSDSESESSSSDSEENEPPRTA 433
Query: 54 SPPPSSPPPSK----------SPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPP--- 100
SP P P +K +P P + SS PP P K + P
Sbjct: 434 SPEPEPPSTNKWQLDNWLNKVNPHKVSPAESVSSNPPIKQPMEKEGKVKSSGSQYHPESK 493
Query: 101 -PPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPP 138
PPP S S + K P PA+ +PP
Sbjct: 494 EPPPKSSSKEKRRPRTAQKGPESGRGKQKSPAQSEAPPQ 532
|
This family consists of AF4 (Proto-oncogene AF4) and FMR2 (Fragile X E mental retardation syndrome) nuclear proteins. These proteins have been linked to human diseases such as acute lymphoblastic leukaemia and mental retardation. The family also contains a Drosophila AF4 protein homologue Lilliputian which contains an AT-hook domain. Lilliputian represents a novel pair-rule gene that acts in cytoskeleton regulation, segmentation and morphogenesis in Drosophila. Length = 1154 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 18/50 (36%), Positives = 24/50 (48%)
Query: 13 EEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPP 62
E +PP S + TPPP+STP+ P P++ PA P PP
Sbjct: 89 EPVTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPPPSDPPQPP 138
|
Length = 141 |
| >gnl|CDD|152960 pfam12526, DUF3729, Protein of unknown function (DUF3729) | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.002
Identities = 22/71 (30%), Positives = 27/71 (38%), Gaps = 1/71 (1%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPP-PSSPPPSKSPPSSPPPAT 74
SPP + P +PPP S PPPS P P P P + PP+
Sbjct: 30 SPPESAHPDDPPPVGDPRPPVVDTPPPVSAVWVLPPPSEPAAPPPDPEPPVPGPAGPPSP 89
Query: 75 SSSPPPASPPT 85
+ P PA P
Sbjct: 90 LAPPAPARKPP 100
|
This family of proteins is found in viruses. Proteins in this family are typically between 145 and 1707 amino acids in length. The family is found in association with pfam01443, pfam01661, pfam05417, pfam01660, pfam00978. There is a single completely conserved residue L that may be functionally important. Length = 115 |
| >gnl|CDD|171499 PRK12438, PRK12438, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 14/46 (30%), Positives = 21/46 (45%), Gaps = 2/46 (4%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSP 60
G P ++ A+ PP +PP + PPP + P + PP P
Sbjct: 900 GRVATAPGGDA--ASAPPPGAGPPAPPQAVPPPRTTQPPAAPPRGP 943
|
Length = 991 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 41.3 bits (96), Expect = 0.002
Identities = 29/147 (19%), Positives = 53/147 (36%), Gaps = 5/147 (3%)
Query: 8 TETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPP 67
T T + P S S + P++T + +P SP + S +P
Sbjct: 473 TPTGTTSSTLPEDTSPTSRTTSATPNATSPTPAVT-TPNATSPTTQKTSDTPNATSPTPI 531
Query: 68 SSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSP 127
T++SPP + + P + SP + + P ++ +
Sbjct: 532 VIGVTTTATSPPTGTTSVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQHGTGS 591
Query: 128 PPPAKKSSPPPPPLKYSSSTPKSSSSS 154
P +++ P S STP+S+S+S
Sbjct: 592 SPTSQQPGIP----SSSHSTPRSNSTS 614
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 19/100 (19%), Positives = 25/100 (25%), Gaps = 2/100 (2%)
Query: 49 SPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSS 108
PP P P + P P P + P P +
Sbjct: 635 FPPVFKTAL--PRPDYNRGGEAGGPGVPGPVPVGMPAHTARPSRVARGDPVRPTAHHAAL 692
Query: 109 PTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTP 148
P +P P PPPP ++ P P S
Sbjct: 693 RAPQAPRPGGPPGGGGGLPPPPDLPAAAGPAPCGSSLIAS 732
|
Length = 753 |
| >gnl|CDD|220401 pfam09786, CytochromB561_N, Cytochrome B561, N terminal | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 36/155 (23%), Positives = 55/155 (35%), Gaps = 28/155 (18%)
Query: 22 SSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPA 81
S S A+P +PSS+ S S P+SP S PS S P ++ +
Sbjct: 144 DSPSRSASPSRKFSPSSTIQQSPQLTPSNKPASPSSSYQSPSYSSSLGPVNSSGNRSNLR 203
Query: 82 SPPTSDNNKPDP----------------------------PKNSPPPPPPSSQSSPTPPS 113
S P + + D KN+ PP +S S +P
Sbjct: 204 SSPWALRSSGDKKDITTDEKYLETFLAEVDEEQHMITSSAGKNATPPETINSFGSSSPSF 263
Query: 114 PSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTP 148
+ +++ S S + + SP P P K +ST
Sbjct: 264 WNYSRNASDAARSLKKRSYQLSPSPVPSKQKASTS 298
|
Members of this family are found in the N terminal region of cytochrome B561, as well as in various other putative uncharacterized proteins. Length = 559 |
| >gnl|CDD|234229 TIGR03490, Mycoplas_LppA, mycoides cluster lipoprotein, LppA/P72 family | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 19/86 (22%), Positives = 26/86 (30%), Gaps = 6/86 (6%)
Query: 11 ENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSP 70
EN P P + S+ S+ + P ++ P P PS P
Sbjct: 44 ENTPKIPKKPDNKEPSENNNNKSN---NENKDEENPSSTNPEKKPDPSKNKEEIEKPKDE 100
Query: 71 PPATSSSPPPASPPTSDNNKPDPPKN 96
P P P +N D P N
Sbjct: 101 PKKPDKKPQADQP---NNVHADQPNN 123
|
Members of this protein family occur in Mycoplasma mycoides, Mycoplasma hyopneumoniae, and related Mycoplasmas in small paralogous families that may also include truncated forms and/or pseudogenes. Members are predicted lipoproteins with a conserved signal peptidase II processing and lipid attachment site. Note that the name for certain characterized members, p72, reflects an anomalous apparent molecular weight, given a theoretical MW of about 61 kDa. Length = 541 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 19/95 (20%), Positives = 30/95 (31%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
PA + + T P + P +P P P + +P P++ P P +
Sbjct: 159 PAGGTYILASGTYIPPNPPREAPAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTV 218
Query: 78 PPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPP 112
PA P + P P +Q P
Sbjct: 219 QNPAQQPQQQPQQQPVQPAQQPTPQNPAQQPPQTE 253
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 15/56 (26%), Positives = 18/56 (32%), Gaps = 3/56 (5%)
Query: 33 SSTPSSSPPPSSPPPASPPP---SSPPPSSPPPSKSPPSSPPPATSSSPPPASPPT 85
+S P P P + PP PP S PPP + PP P
Sbjct: 45 ASIPGLEDVTVQTTPPPPASAITNGGPPPPPPARAEAASPPPPEAPAEPPAEPEPE 100
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.002
Identities = 16/66 (24%), Positives = 24/66 (36%), Gaps = 5/66 (7%)
Query: 71 PPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPP 130
++ PPPAS T+ P PP + PP ++ PP+ P P +
Sbjct: 53 VTVQTTPPPPASAITNGGPPPPPPARAEAASPPPPEAPAEPPAE-----PEPEAPAENTV 107
Query: 131 AKKSSP 136
P
Sbjct: 108 TVAKDP 113
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|225689 COG3147, DedD, Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 21/81 (25%), Positives = 30/81 (37%), Gaps = 2/81 (2%)
Query: 6 NVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKS 65
V + + G A A PP STP+ P ++ P P PP+ P+K
Sbjct: 73 GVAQEIQDAGDAAAASVDPQPVAQPPVESTPAG-VPVAAQTPKPVKPPKQPPAGAVPAKP 131
Query: 66 PPSSPPPATSSSPPPASPPTS 86
P P P + P A +
Sbjct: 132 TP-KPEPKPVAEPAAAPTGQA 151
|
Length = 226 |
| >gnl|CDD|221188 pfam11725, AvrE, Pathogenicity factor | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.002
Identities = 27/151 (17%), Positives = 39/151 (25%), Gaps = 8/151 (5%)
Query: 20 PPSSNSSDATPPPSSTPSSSPPPSSPPPA-----SPPPSSPPPSSPPPSKSPPSSPPPAT 74
+ A PP + P+++ P SS P + P +P S S
Sbjct: 61 SSAPRQIQAAPPQALNPTAAAPQSSRGPTLRELLALPEDDGETQAPESSPSARRLTRSEG 120
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSP-PVFSPPP--PA 131
+ KPD + S SS PP + S P +
Sbjct: 121 VARHEMEDLAGRPVVKPDADRQLRQDILNKSSSSRRPPVSKEEGTSSKMPATALASAALF 180
Query: 132 KKSSPPPPPLKYSSSTPKSSSSSSKSSNGSS 162
K S S S N +
Sbjct: 181 KDDEIRQEVDAARSDQASQSRLSRSRGNPPA 211
|
This family is secreted by gram-negative Gammaproteobacteria such as Pseudomonas syringae of tomato and the fire blight plant pathogen Erwinia amylovora, amongst others. It is an essential pathogenicity factor of approximately 198 kDa. Its injection into the host-plant is dependent upon the bacterial type III or Hrp secretion system. The family is long and carries a number of predicted functional regions, including an ERMS or endoplasmic reticulum membrane retention signal at both the C- and the N-termini, a leucine-zipper motif from residues 539-560, and a nuclear localisation signal at 1358-1361. this conserved AvrE-family of effectors is among the few that are required for full virulence of many phytopathogenic pseudomonads, erwinias and pantoeas. Length = 1771 |
| >gnl|CDD|177328 PHA01929, PHA01929, putative scaffolding protein | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 31/119 (26%), Positives = 42/119 (35%), Gaps = 16/119 (13%)
Query: 10 TENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSS 69
T+NE+ PP A PP++ P+ P P P A P P +P
Sbjct: 2 TQNEQQLPPGLAGL---VANVPPAAAPTPQPNPVIQPQA--------PVQPGQPGAPQQL 50
Query: 70 PPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPP 128
P P P S T + P + +P PP P + P PP F+P
Sbjct: 51 AIPTQQPQPVPTSAMTPHVVQQAPAQPAPAAPPA-----AGAALPEALEVPPPPAFTPN 104
|
Length = 306 |
| >gnl|CDD|237782 PRK14666, uvrC, excinuclease ABC subunit C; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 23/89 (25%), Positives = 33/89 (37%), Gaps = 4/89 (4%)
Query: 10 TENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPP--PSSPPPSKSP- 66
TE EG AP ++ +DA P + P S P P ++ P S P
Sbjct: 319 TEGREGDDLAP-TAVCTDAGLLPDTPLLPDAPEGSSDPVVPVAAATPVDASLPDVRTGTA 377
Query: 67 PSSPPPATSSSPPPASPPTSDNNKPDPPK 95
P+S + + P A P + PK
Sbjct: 378 PTSLANVSHADPAVAQPTQAATLAGAAPK 406
|
Length = 694 |
| >gnl|CDD|139494 PRK13335, PRK13335, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.002
Identities = 18/108 (16%), Positives = 37/108 (34%), Gaps = 7/108 (6%)
Query: 7 VTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSP 66
+ P++N T +S S P S ++P P +
Sbjct: 66 ANTRQERTPKLEKAPNTNEEK-------TSASKIEKISQPKQEEQKSLNISATPAPKQEQ 118
Query: 67 PSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSP 114
+ +T+ +PP+++ +P S P P+ + + T +P
Sbjct: 119 SQTTTESTTPKTKVTTPPSTNTPQPMQSTKSDTPQSPTIKQAQTDMTP 166
|
Length = 356 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 26/90 (28%), Positives = 41/90 (45%), Gaps = 9/90 (10%)
Query: 427 LAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK--LSNDNHTHVSTRVM----G 480
L Y+HE I H DIK NI++D N + D+G+A + + H S G
Sbjct: 139 LEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRG 195
Query: 481 TFGYLAPEYASSGKLTEKSDVFSFGVMLLE 510
T Y + + +T + D+ S G +L+
Sbjct: 196 TLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|221179 pfam11711, Tim54, Inner membrane protein import complex subunit Tim54 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 22/93 (23%), Positives = 32/93 (34%), Gaps = 1/93 (1%)
Query: 36 PSSSPPPSSPPPASPPPSSPPPSSP-PPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPP 94
P P P P P + ++P S + P+ T+ +P +N PP
Sbjct: 194 PLDPPEPPEPTVDEAAPETEVEATPAAESPAEPAEETAETTPEETEDAPEEENNKPVKPP 253
Query: 95 KNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSP 127
P P S+P PP PS + P
Sbjct: 254 VPKPYISPDEYPSAPLPPELPQLLQPSLVIPFP 286
|
Mitochondrial function depends on the import of hundreds of different proteins synthesised in the cytosol. Protein import is a multi-step pathway which includes the binding of precursor proteins to surface receptors, translocation of the precursor across one or both mitochondrial membranes, and folding and assembly of the imported protein inside the mitochondrion. Most precursor proteins carry amino-terminal targeting signals, called pre-sequences, and are imported into mitochondria via import complexes located in both the outer and the inner membrane (IM). The IM complex, TIM, is made up of at least two proteins which mediate translocation of proteins into the matrix by removing their signal peptide and another pair of proteins, Tim54 and Tim22, that insert the polytopic proteins, that carry internal targetting information, into the inner membrane. Length = 377 |
| >gnl|CDD|218658 pfam05616, Neisseria_TspB, Neisseria meningitidis TspB protein | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 23/93 (24%), Positives = 36/93 (38%), Gaps = 9/93 (9%)
Query: 30 PPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNN 89
P P TP S+ P + P P+ P ++P P ++P + P P P N
Sbjct: 315 PRPDLTPGSAEAPEAQPLPEVSPAENPANNPNPRENPGTRPNP---------EPDPDLNP 365
Query: 90 KPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSP 122
+P + P P S + P P+ + K
Sbjct: 366 DANPDTDGQPGTRPDSPAVPDRPNGRHRKERKE 398
|
This family consists of several Neisseria meningitidis TspB virulence factor proteins. Length = 502 |
| >gnl|CDD|215397 PLN02744, PLN02744, dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 13/46 (28%), Positives = 19/46 (41%)
Query: 42 PSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSD 87
PSS + P + P P P + + P +S P A P + D
Sbjct: 202 PSSSAAPAAPKAKPSPPPPKEEEVEKPASSPEPKASKPSAPPSSGD 247
|
Length = 539 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.003
Identities = 13/65 (20%), Positives = 24/65 (36%)
Query: 9 ETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPS 68
G P+PP + + A P P+ + P + P P+ + P + + P+
Sbjct: 445 AGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPA 504
Query: 69 SPPPA 73
A
Sbjct: 505 GADDA 509
|
Length = 824 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 29/140 (20%), Positives = 39/140 (27%), Gaps = 20/140 (14%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSP----------------PPSSPPPASPPPSSPPPSSP 60
P P TP P P P P P +P
Sbjct: 632 PMRPLRMQPITFNVLVFPTPHQPPQVEITPYKPTWTQIGHIPYQPSPTGANTMLPIQWAP 691
Query: 61 PPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSP 120
+ PP +P P PPA+PP + PP ++ P +P + P
Sbjct: 692 GTMQPPPRAPTPM----RPPAAPPGRAQRPAAATGRARPPAAAPGRARPPAAAPGRARPP 747
Query: 121 SPPVFSPPPPAKKSSPPPPP 140
+ PPA PP
Sbjct: 748 AAAPGRARPPAAAPGRARPP 767
|
Length = 991 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 30/147 (20%), Positives = 51/147 (34%), Gaps = 15/147 (10%)
Query: 30 PPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNN 89
P + T S + + PS P S P ++ ++ SS P + +
Sbjct: 168 PKTAVTTSKTTSWPTEVSHPTYPSQVTPQSQPATQGHQTATANQRLSSTEPVGTQGTTTS 227
Query: 90 KPDPPKNSPPP----PPPSSQSSPTPPSPSNN----------KSPSPPVFSPP-PPAKKS 134
P+ PPP P S Q P+ S + + +PP S P +
Sbjct: 228 SNPEPQTEPPPSQRGPSGSPQHPPSTTSQDQSTTGDGQEHTQRRKTPPATSNRRSPHSTA 287
Query: 135 SPPPPPLKYSSSTPKSSSSSSKSSNGS 161
+PPP + + P +++ S S
Sbjct: 288 TPPPTTKRQETGRPTPRPTATTQSGSS 314
|
Length = 408 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 29/138 (21%), Positives = 48/138 (34%), Gaps = 36/138 (26%)
Query: 20 PPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS--- 76
++N ++ P T ++ + P PPPS PS P + PPS+ S+
Sbjct: 206 TATANQRLSSTEPVGTQGTTTSSNPEPQTEPPPSQRGPSGSP--QHPPSTTSQDQSTTGD 263
Query: 77 ----SPPPASPPTSDNNKPDPPKNSPPP---------------------------PPPSS 105
+ +PP + N + +PPP PP
Sbjct: 264 GQEHTQRRKTPPATSNRRSPHSTATPPPTTKRQETGRPTPRPTATTQSGSSPPHSSPPGV 323
Query: 106 QSSPTPPSPSNNKSPSPP 123
Q++PT + + K PP
Sbjct: 324 QANPTTQNLVDCKELDPP 341
|
Length = 408 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 25/96 (26%), Positives = 32/96 (33%), Gaps = 8/96 (8%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPP--PASPPPSSPPPSSPPPSKSPPSSPPPA 73
A + + A P + P+ P P P S P SP + PP + P
Sbjct: 358 RVLAAAAKVAVIAAPQTHTGPADRQRPQRPDGIPYSVPARSPMTAYPPVPQFCGD---PG 414
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSP 109
S P SP TS P PP P + P
Sbjct: 415 LVSPYNPQSPGTS---YGPEPVGPVPPQPTNPYVMP 447
|
Length = 663 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.003
Identities = 32/106 (30%), Positives = 40/106 (37%), Gaps = 8/106 (7%)
Query: 53 SSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPP 112
+S P S S + SS P+T +P SPP SPP P S T P
Sbjct: 570 NSTPTGSAASSNTTFSSDSPSTVVAPS-TSPPAGH-------LGSPPATPSKIVSPSTSP 621
Query: 113 SPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSS 158
S+ SPS SP K +S + S + SS S S
Sbjct: 622 PASHLGSPSTTPSSPESSIKVASTETASPESSIKVASTESSVSMVS 667
|
Length = 670 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 33/183 (18%), Positives = 52/183 (28%), Gaps = 30/183 (16%)
Query: 9 ETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPA-------------------- 48
++E S+ S+ P S + S ++ +
Sbjct: 566 ALSDDEQHSANVQSAQSAAEAQPSSQSLSPISAVTTAAASLADDDILDAVLAARDSLLSD 625
Query: 49 ----SPPPSSPPPSSPP-PSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPP 103
SP SS K+PPS PPA+ S P +SP S +
Sbjct: 626 LDALSPKEGDGKKSSADRKPKTPPSRAPPASLSK-PASSPDASQTSASFDLDPDFELATH 684
Query: 104 SSQSSPTPPSPSN-NKSPSPPVFSPPP---PAKKSSPPPPPLKYSSSTPKSSSSSSKSSN 159
S S S P P + PP + +S P + S + +S
Sbjct: 685 QSVPEAALASGSAPAPPPVPDPYDRPPWEEAPEVASANDGPNNAAEGNLSESVEDASNSE 744
Query: 160 GSS 162
+
Sbjct: 745 LQA 747
|
Length = 944 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 21/79 (26%), Positives = 24/79 (30%), Gaps = 2/79 (2%)
Query: 36 PSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPK 95
PP S P S P +S P P P PA P + P PP
Sbjct: 186 IQPPPPSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPSAPPASIPAPP- 244
Query: 96 NSPPPPPPSSQSSPTPPSP 114
PP + PP P
Sbjct: 245 -IPPVIQYVAPPPVPPPQP 262
|
Length = 582 |
| >gnl|CDD|218440 pfam05110, AF-4, AF-4 proto-oncoprotein | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.003
Identities = 35/161 (21%), Positives = 48/161 (29%), Gaps = 6/161 (3%)
Query: 3 KGNNVTETENEEGSPPAPPSSNSSDATP-PPSSTPSSSPPPSSPPPASPPPSSPPPSSPP 61
K + + E P P SS+ P P S P S P
Sbjct: 480 KVKSSGSQYHPESKEPPPKSSSKEKRRPRTAQKGPESGRGKQKSPAQSEAPPQRRTVGKK 539
Query: 62 PSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPS 121
K P + + P S P + +PP P ++ PSP S
Sbjct: 540 QPKKPEKASAGDERTGLRPESEPGTLPYGSSV--QTPPDRPKAATKGSRKPSPRKEPKSS 597
Query: 122 PPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSS 162
P P +K P + S ++ SSSS S S
Sbjct: 598 VP---PAAEKRKYKSPSKIVPKSREFIETDSSSSDSPEDES 635
|
This family consists of AF4 (Proto-oncogene AF4) and FMR2 (Fragile X E mental retardation syndrome) nuclear proteins. These proteins have been linked to human diseases such as acute lymphoblastic leukaemia and mental retardation. The family also contains a Drosophila AF4 protein homologue Lilliputian which contains an AT-hook domain. Lilliputian represents a novel pair-rule gene that acts in cytoskeleton regulation, segmentation and morphogenesis in Drosophila. Length = 1154 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 27/126 (21%), Positives = 43/126 (34%), Gaps = 9/126 (7%)
Query: 46 PPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSS 105
A SS P S+P + A + A S+++ P+P S PPPP
Sbjct: 259 SSAFMLNSSLPTSAPKRRSRRAGAMRAAAGETADLADDDGSEHSDPEPLPASLPPPPVRR 318
Query: 106 QSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGD 165
P + + + P + S+S+ SSS+ +K S + G
Sbjct: 319 PRVKHPEAGKEEPDGARNAEAKEPAQPAT---------STSSKGSSSAQNKDSGSTGPGS 369
Query: 166 DYVTYS 171
S
Sbjct: 370 SLAAAS 375
|
Length = 418 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 21/57 (36%), Positives = 28/57 (49%), Gaps = 2/57 (3%)
Query: 46 PPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPP 102
PPA P P +PP + P P +PPP ++ + PPA PP + PP PP
Sbjct: 84 PPAPPEPVTPPTAQSPAPAVP--TPPPTSTPAVPPAPAAAVPAPAAAPPPSDPPQPP 138
|
Length = 141 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 16/59 (27%), Positives = 23/59 (38%)
Query: 65 SPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPP 123
+P + P P +PP A P P P PP P++ +P + P PP
Sbjct: 80 APLTPPAPPEPVTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPPPSDPPQPP 138
|
Length = 141 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.003
Identities = 18/101 (17%), Positives = 34/101 (33%), Gaps = 4/101 (3%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
P+ + S P +T S++ +S S P + P + + P++ P
Sbjct: 317 TPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGVLPSDVTLPGTVALPAAEPVNMQP 376
Query: 77 SPPPASPPTSDNNKPDPPKNSPP----PPPPSSQSSPTPPS 113
P + + + P P P+S +P S
Sbjct: 377 QPMSTTETQQSSTGNITSTANGPTTSLPAAPASNIPVSPTS 417
|
Length = 421 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 16/82 (19%), Positives = 27/82 (32%)
Query: 42 PSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPP 101
P +PP +P P P + +P P + + + N P+ P
Sbjct: 173 PPNPPREAPAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQNPAQQPQQQPQQQ 232
Query: 102 PPSSQSSPTPPSPSNNKSPSPP 123
P PTP +P+ +
Sbjct: 233 PVQPAQQPTPQNPAQQPPQTEQ 254
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 17/84 (20%), Positives = 25/84 (29%), Gaps = 9/84 (10%)
Query: 13 EEGSPPAPPSSNSSDA-----TPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPP 67
E +P P + SS P P+ P+ P P +P P +
Sbjct: 179 EAPAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQNPAQQPQQQPQQQPVQPAQ 238
Query: 68 SSPPPATSSSPPPASPPTSDNNKP 91
P +P P T +K
Sbjct: 239 QPTPQ----NPAQQPPQTEQGHKR 258
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|237011 PRK11892, PRK11892, pyruvate dehydrogenase subunit beta; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.003
Identities = 6/52 (11%), Positives = 19/52 (36%), Gaps = 3/52 (5%)
Query: 27 DATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSP 78
A+ ++ + + A ++ P+ + P++P ++ P
Sbjct: 83 SASDAGAA---PAAAAEAAAAAPAAAAAAAAKKAAPAPAAPAAPAAEVAADP 131
|
Length = 464 |
| >gnl|CDD|221188 pfam11725, AvrE, Pathogenicity factor | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 26/129 (20%), Positives = 35/129 (27%), Gaps = 2/129 (1%)
Query: 2 AKGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPP 61
A + ET+ E SP A + S + P SS
Sbjct: 95 ALPEDDGETQAPESSPSARRLTRSEGVARHEMEDLAGRPVVKPDADRQLRQDILNKSSSS 154
Query: 62 PSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPS 121
PP S TSS P + ++ K D + S N
Sbjct: 155 RR--PPVSKEEGTSSKMPATALASAALFKDDEIRQEVDAARSDQASQSRLSRSRGNPPAI 212
Query: 122 PPVFSPPPP 130
PP +P P
Sbjct: 213 PPDAAPRQP 221
|
This family is secreted by gram-negative Gammaproteobacteria such as Pseudomonas syringae of tomato and the fire blight plant pathogen Erwinia amylovora, amongst others. It is an essential pathogenicity factor of approximately 198 kDa. Its injection into the host-plant is dependent upon the bacterial type III or Hrp secretion system. The family is long and carries a number of predicted functional regions, including an ERMS or endoplasmic reticulum membrane retention signal at both the C- and the N-termini, a leucine-zipper motif from residues 539-560, and a nuclear localisation signal at 1358-1361. this conserved AvrE-family of effectors is among the few that are required for full virulence of many phytopathogenic pseudomonads, erwinias and pantoeas. Length = 1771 |
| >gnl|CDD|221173 pfam11702, DUF3295, Protein of unknown function (DUF3295) | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 32/137 (23%), Positives = 50/137 (36%), Gaps = 7/137 (5%)
Query: 29 TPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDN 88
P + PSS P P+ P S +P P+ + +S A + +S P ++
Sbjct: 85 NLAPITPPSSEPTPAPPSSESTATRTPDPNQQALESTESTSTTSADCNDSEQSSTPNLNS 144
Query: 89 NKPDPPKNSPPPPP-------PSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPL 141
+ + P PS SS + NK+PSP + P A ++ P P
Sbjct: 145 SDTSTSSSGALPSTSVVRGFSPSHISSSYRSTAQLNKAPSPTKSAEPTAAPQAKPELPKK 204
Query: 142 KYSSSTPKSSSSSSKSS 158
K + T SS
Sbjct: 205 KQAMFTLGGSSGDDDED 221
|
This family is conserved in fungi but the function is not known. Length = 509 |
| >gnl|CDD|183854 PRK13042, PRK13042, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 23/74 (31%), Positives = 37/74 (50%), Gaps = 6/74 (8%)
Query: 48 ASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQS 107
A+ P S+ + P +PPS+ A S P +PP++ K + P+ +P PSS
Sbjct: 30 ATTPSSTKVEA---PQSTPPSTKVEAPQSKPNATTPPST---KVEAPQQTPNATTPSSTK 83
Query: 108 SPTPPSPSNNKSPS 121
TP SP+ + P+
Sbjct: 84 VETPQSPTTKQVPT 97
|
Length = 291 |
| >gnl|CDD|233366 TIGR01348, PDHac_trf_long, pyruvate dehydrogenase complex dihydrolipoamide acetyltransferase, long form | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 16/62 (25%), Positives = 31/62 (50%), Gaps = 6/62 (9%)
Query: 25 SSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSP---PPA 81
+ +TP + P+S+ P + P A+ P P ++P +K+ +P A + +P A
Sbjct: 191 VAGSTPATAPAPASAQPAAQSPAATQP---EPAAAPAAAKAQAPAPQQAGTQNPAKVDHA 247
Query: 82 SP 83
+P
Sbjct: 248 AP 249
|
This model describes a subset of pyruvate dehydrogenase complex dihydrolipoamide acetyltransferase specifically close by both phylogenetic and per cent identity (UPGMA) trees. Members of this set include two or three copies of the lipoyl-binding domain. E. coli AceF is a member of this model, while mitochondrial and some other bacterial forms belong to a separate model [Energy metabolism, Pyruvate dehydrogenase]. Length = 546 |
| >gnl|CDD|236733 PRK10672, PRK10672, rare lipoprotein A; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 23/94 (24%), Positives = 34/94 (36%), Gaps = 4/94 (4%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSP---PPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
PA P + TP P+ P S+ S P+ P +S +P + P
Sbjct: 195 PARPDLSGGMGTPSVQPAPAPQGDVLPVSNSTLKSEDPTGAPVTSSGFLGAPTTLAPGVL 254
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSS 108
S P + P+S P +P SS +S
Sbjct: 255 EGSEPTPTAPSSAPATA-PAAAAPQAAATSSSAS 287
|
Length = 361 |
| >gnl|CDD|227430 COG5099, COG5099, RNA-binding protein of the Puf family, translational repressor [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 40/153 (26%), Positives = 53/153 (34%), Gaps = 12/153 (7%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
P P SNS+ SS ++ SS P + SS S SP + SS
Sbjct: 152 PNPNHSNSATTNQSGSSFINTPASSSSQPLTNLVVSSIKRFPYLTSLSPFFNYLIDPSSD 211
Query: 78 PPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNN-------KSPSPPVFSPPPP 130
AS TS + P PP SP +S SP P + S S + S
Sbjct: 212 SATASADTSPSFNP-PPNLSPNNLFSTSDLSPLPDTQSVENNIILNSSSSINELTSIYGS 270
Query: 131 AKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSS 163
L+ +S S + S SS S+
Sbjct: 271 VPS----IRNLRGLNSALVSFLNVSSSSLAFSA 299
|
Length = 777 |
| >gnl|CDD|221170 pfam11696, DUF3292, Protein of unknown function (DUF3292) | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 17/56 (30%), Positives = 22/56 (39%), Gaps = 2/56 (3%)
Query: 40 PPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPK 95
PPPSS PSSP S +++P P +P K +PPK
Sbjct: 407 PPPSSSLR--KAPSSPASIDHKQLNLGASEEEIDQAAAPEPEAPVAEAEEKAEPPK 460
|
This eukaryotic family of proteins has no known function. Length = 641 |
| >gnl|CDD|219927 pfam08601, PAP1, Transcription factor PAP1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 35/148 (23%), Positives = 57/148 (38%), Gaps = 6/148 (4%)
Query: 23 SNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPAS 82
NSS ++P P S+ SSP +SP ++ + + P A +S+ S
Sbjct: 49 KNSSVSSPVPGLLNSTESNVSSPNNNPNGYTSPSSAAMNNKSNNRAVDPSANASAASTNS 108
Query: 83 PPTSD--NNKPDPPKNSPPPPPPSSQSSPTPPSPSNNK-SPSPPVFSPPPPAKKSSPPPP 139
P + + NS P S T S+ SP P SPP A ++
Sbjct: 109 PNGLQSSATQYNSNDNSSSDSPSSGSDGFTNQLLSSLGTSPEPSTESPPQLASVNN---F 165
Query: 140 PLKYSSSTPKSSSSSSKSSNGSSSGDDY 167
+++ S+ S+ SS + G D+
Sbjct: 166 AAIRNNAESNSNVPSAASSTPNIPGIDF 193
|
The transcription factor Pap1 regulates antioxidant-gene transcription in response to H2O2. This region is cysteine rich. Alkylation of cysteine residues following treatment with a cysteine alkylating agent can mask the accessibility of the nuclear exporter Crm1, triggering nuclear accumulation and Pap1 dependent transcriptional expression. Length = 344 |
| >gnl|CDD|236333 PRK08691, PRK08691, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.003
Identities = 25/162 (15%), Positives = 52/162 (32%), Gaps = 13/162 (8%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA 73
EG P S+ ++ PP P + ++ + + S +PP
Sbjct: 418 EGKTAGPVSNQENNDVPPWEDAPD--------EAQTAAGTAQTSAKSIQTASEAETPPEN 469
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPP----P 129
S A T D + P +P P+ ++ T + + P P
Sbjct: 470 QVSKNKAADNET-DAPLSEVPSENPIQATPNDEAVETETFAHEAPAEPFYGYGFPDNDCP 528
Query: 130 PAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVTYS 171
P + PPP ++++ + + + + G + +
Sbjct: 529 PEDGAEIPPPDWEHAAPADTAGGGADEEAEAGGIGGNNTPSA 570
|
Length = 709 |
| >gnl|CDD|219404 pfam07415, Herpes_LMP2, Gammaherpesvirus latent membrane protein (LMP2) protein | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 23/107 (21%), Positives = 31/107 (28%), Gaps = 9/107 (8%)
Query: 47 PASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQ 106
P P + SS PP D P + PPP S+
Sbjct: 8 PLGAGGPRSHGGPDGDEGDSNPYYPSSFGSSWDRPGPP--VPEDYDAPSHRPPPYGGSNG 65
Query: 107 SSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSS 153
P + PS +++ PPPP YS P+ S
Sbjct: 66 DRHGGYQPLGQQDPS--LYAGLGQNGGGGLPPPP--YS---PRDQGS 105
|
This family consists of several Gammaherpesvirus latent membrane protein (LMP2) proteins. Epstein-Barr virus is a human Gammaherpesvirus that infects and establishes latency in B lymphocytes in vivo. The latent membrane protein 2 (LMP2) gene is expressed in latently infected B cells and encodes two protein isoforms, LMP2A and LMP2B, that are identical except for an additional N-terminal 119 aa cytoplasmic domain which is present in the LMP2A isoform. LMP2A is thought to play a key role in either the establishment or the maintenance of latency and/or the reactivation of productive infection from the latent state. The significance of LMP2B and its role in pathogenesis remain unclear. Length = 489 |
| >gnl|CDD|233692 TIGR02031, BchD-ChlD, magnesium chelatase ATPase subunit D | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 13/49 (26%), Positives = 14/49 (28%)
Query: 31 PPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPP 79
P +T P P PPP PP P P T P
Sbjct: 260 LPRATRLPEPEPQPPPPPPPPEPPEPEEEPDEPDQTDPDDGEETDQIPE 308
|
This model represents one of two ATPase subunits of the trimeric magnesium chelatase responsible for insertion of magnesium ion into protoporphyrin IX. This is an essential step in the biosynthesis of both chlorophyll and bacteriochlorophyll. This subunit is found in green plants, photosynthetic algae, cyanobacteria and other photosynthetic bacteria. Unlike subunit I (TIGR02030), this subunit is not found in archaea [Biosynthesis of cofactors, prosthetic groups, and carriers, Chlorophyll and bacteriochlorphyll]. Length = 589 |
| >gnl|CDD|240415 PTZ00429, PTZ00429, beta-adaptin; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 30/121 (24%), Positives = 45/121 (37%), Gaps = 19/121 (15%)
Query: 9 ETENEEGSP-PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPP 67
+TE+++ P+ PS + D +P PS+ P+ + P S + P
Sbjct: 612 DTEDDDAVELPSTPSMGTQDGSPAPSAAPAGYDIFEFAGDGTGAPHPVASGSNGAQHADP 671
Query: 68 ------SSPPPATSSSPP---------PASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPP 112
P +SSP PASPPT+ + D N SQ+ P P
Sbjct: 672 LGDLFSGLPSTVGASSPAFQAASGSQAPASPPTAASAIEDLFANG---MGSGSQTVPLPI 728
Query: 113 S 113
S
Sbjct: 729 S 729
|
Length = 746 |
| >gnl|CDD|237081 PRK12372, PRK12372, ribonuclease III; Reviewed | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 20/102 (19%), Positives = 34/102 (33%), Gaps = 3/102 (2%)
Query: 9 ETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPS 68
ET ++G A P++ A P ++ P A+P + P S +
Sbjct: 308 ETAADKGERAAKPAAADKAADKPADRPDAAEKAAEKPAEAAPRAADKPAGQAADPASSSA 367
Query: 69 SPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPT 110
P A++ + D PD PP S ++
Sbjct: 368 DKPGASADAAARTPARARDAAAPDA---DTPPGGASLAAAQA 406
|
Length = 413 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.004
Identities = 32/120 (26%), Positives = 38/120 (31%), Gaps = 1/120 (0%)
Query: 19 APPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSP 78
AP + + P PS TP S P S P P P P P + P
Sbjct: 589 APSYAQTPWPVPHPSQTPEPPTTQSHIPETSAPRQWPMPLRPIPMRPLRMQPITFNVLVF 648
Query: 79 PPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPP 138
P P P P + P Q SPT + +P PPP A PP
Sbjct: 649 PTPHQPPQVEITPYKPTWTQIGHIP-YQPSPTGANTMLPIQWAPGTMQPPPRAPTPMRPP 707
|
Length = 991 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 25/133 (18%), Positives = 55/133 (41%), Gaps = 4/133 (3%)
Query: 36 PSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPK 95
P S+ + ++ S+ S+ S + S+P +S+P + P S+ +PP
Sbjct: 383 PHSNASYNCAAYSNAAQSNAAQSNAGFSNAGYSNPG---NSNPGYNNAPNSNTPYNNPPN 439
Query: 96 NSPPPPPPSSQSSPTPPSPSNNKSPS-PPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSS 154
++ P P + + P P +N S P+ + PP + K Y +++
Sbjct: 440 SNTPYSNPPNSNPPYSNLPYSNTPYSNAPLSNAPPSSAKDHHSAYHAAYQHRAANQPAAN 499
Query: 155 SKSSNGSSSGDDY 167
++N ++ + +
Sbjct: 500 LPTANQPAANNFH 512
|
Length = 1560 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 33/146 (22%), Positives = 42/146 (28%), Gaps = 20/146 (13%)
Query: 9 ETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPP--------SSPPPASPPPSSPPPSSP 60
E S SD P P+S PPP P + +
Sbjct: 285 AAAGETADLADDDGSEHSD----PEPLPASLPPPPVRRPRVKHPEAGKEEPDGARNAEAK 340
Query: 61 PPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSP 120
P++ S+ +SS+ S T S S P + S P
Sbjct: 341 EPAQPATSTSSKGSSSAQNKDSGSTGPG--SSLAAASSFLEDDDFGSPPLDLTTSLRHMP 398
Query: 121 SPPVFSPPPPAKKSSPPPPPLKYSSS 146
SP V S P PP PL Y S
Sbjct: 399 SPSVTSAP------EPPSIPLTYLSD 418
|
Length = 418 |
| >gnl|CDD|222010 pfam13254, DUF4045, Domain of unknown function (DUF4045) | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 20/101 (19%), Positives = 29/101 (28%), Gaps = 3/101 (2%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA 73
P SS ++ + P + P P S K +
Sbjct: 238 PEKPQQETSSMDTEKSSAPKPRETLDPKSPEKAPPIDTTEEELKSPEASPKESEEASARK 297
Query: 74 TSSSPPPASP-PTSDNNKPDPPKNSPPPPPPSSQSSPTPPS 113
SP SP P +++ KP P P S + P P
Sbjct: 298 --RSPSLLSPSPKAESPKPLASPGKSPRDPLSPRPKPQSPP 336
|
This presumed domain is functionally uncharacterized. This domain family is found in bacteria and eukaryotes, and is typically between 384 and 430 amino acids in length. Length = 414 |
| >gnl|CDD|218332 pfam04929, Herpes_DNAp_acc, Herpes DNA replication accessory factor | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 22/90 (24%), Positives = 32/90 (35%), Gaps = 4/90 (4%)
Query: 72 PATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPA 131
P SS S N + + P P+ S P S++ SPSPP S P
Sbjct: 271 PLKQSSLLDVSLSVVLLNADSSVEANGVEPEPTGSVSDRPRHLSSDSSPSPPDTSDSDP- 329
Query: 132 KKSSPPPPPLKYSSSTPKSSSSSSKSSNGS 161
S PP S +P ++ + +
Sbjct: 330 ---STETPPPASLSHSPPAAFERPLALSPK 356
|
Replicative DNA polymerases are capable of polymerising tens of thousands of nucleotides without dissociating from their DNA templates. The high processivity of these polymerases is dependent upon accessory proteins that bind to the catalytic subunit of the polymerase or to the substrate. The Epstein-Barr virus (EBV) BMRF1 protein is an essential component of the viral DNA polymerase and is absolutely required for lytic virus replication. BMRF1 is also a transactivator. This family is predicted to have a UL42 like structure. Length = 381 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 40.2 bits (93), Expect = 0.004
Identities = 29/145 (20%), Positives = 49/145 (33%), Gaps = 3/145 (2%)
Query: 28 ATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPA-SPPTS 86
+ P +T S+ P +SP + + S P +P ++ P +S P + PT
Sbjct: 471 SGTPTGTTSSTLPEDTSPTSRTTSATPNATSPTPAVTTPNATSPTTQKTSDTPNATSPTP 530
Query: 87 DNNKPDPPKNSPP--PPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYS 144
SPP + +SP S + + PV + P S+
Sbjct: 531 IVIGVTTTATSPPTGTTSVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQHGTG 590
Query: 145 SSTPKSSSSSSKSSNGSSSGDDYVT 169
SS SS+ + + T
Sbjct: 591 SSPTSQQPGIPSSSHSTPRSNSTST 615
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|218549 pfam05308, Mito_fiss_reg, Mitochondrial fission regulator | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.004
Identities = 21/63 (33%), Positives = 25/63 (39%), Gaps = 3/63 (4%)
Query: 52 PSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTP 111
+S +S PSS + SPP P P PP PPPPPPS Q S +
Sbjct: 148 SNSTTSDLLSSDESVPSSSTTSFPISPPTEEPVLEVPPPPPPP---PPPPPPSLQQSTSA 204
Query: 112 PSP 114
Sbjct: 205 IDL 207
|
In eukaryotes, this family of proteins induces mitochondrial fission. Length = 248 |
| >gnl|CDD|237000 PRK11855, PRK11855, dihydrolipoamide acetyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 0.004
Identities = 12/57 (21%), Positives = 27/57 (47%), Gaps = 4/57 (7%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSP 70
+ PA ++ + +++ P +P A+ P ++ P ++ P K+P +SP
Sbjct: 195 AAAAPAAAAA----PAAAAPAAAAAAAPAPAPAAAAAPAAAAPAAAAAPGKAPHASP 247
|
Length = 547 |
| >gnl|CDD|237782 PRK14666, uvrC, excinuclease ABC subunit C; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 11/90 (12%), Positives = 23/90 (25%), Gaps = 1/90 (1%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSP-PPATS 75
P P + P++ + + P P P + + P P
Sbjct: 314 PWLPDTEGREGDDLAPTAVCTDAGLLPDTPLLPDAPEGSSDPVVPVAAATPVDASLPDVR 373
Query: 76 SSPPPASPPTSDNNKPDPPKNSPPPPPPSS 105
+ P S + P + + +
Sbjct: 374 TGTAPTSLANVSHADPAVAQPTQAATLAGA 403
|
Length = 694 |
| >gnl|CDD|221179 pfam11711, Tim54, Inner membrane protein import complex subunit Tim54 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 17/88 (19%), Positives = 26/88 (29%), Gaps = 5/88 (5%)
Query: 41 PPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPP 100
PP P P + P + + + S PA ++ + + PP
Sbjct: 197 PPEPPEP--TVDEAAPETEVEATPAAESPAEPAEETAETTPEETEDAPEEENNKPVKPPV 254
Query: 101 PPPSSQSSPTPPSPSNNKSPSPPVFSPP 128
P P P +P P P P
Sbjct: 255 PKPYISPDEYPSAPL---PPELPQLLQP 279
|
Mitochondrial function depends on the import of hundreds of different proteins synthesised in the cytosol. Protein import is a multi-step pathway which includes the binding of precursor proteins to surface receptors, translocation of the precursor across one or both mitochondrial membranes, and folding and assembly of the imported protein inside the mitochondrion. Most precursor proteins carry amino-terminal targeting signals, called pre-sequences, and are imported into mitochondria via import complexes located in both the outer and the inner membrane (IM). The IM complex, TIM, is made up of at least two proteins which mediate translocation of proteins into the matrix by removing their signal peptide and another pair of proteins, Tim54 and Tim22, that insert the polytopic proteins, that carry internal targetting information, into the inner membrane. Length = 377 |
| >gnl|CDD|215397 PLN02744, PLN02744, dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 24/67 (35%), Positives = 30/67 (44%), Gaps = 2/67 (2%)
Query: 27 DATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS--SPPPASPP 84
D P S+ P++ SPPP P SSP P S PS+PP + + P A
Sbjct: 199 DYKPSSSAAPAAPKAKPSPPPPKEEEVEKPASSPEPKASKPSAPPSSGDRIFASPLARKL 258
Query: 85 TSDNNKP 91
DNN P
Sbjct: 259 AEDNNVP 265
|
Length = 539 |
| >gnl|CDD|233366 TIGR01348, PDHac_trf_long, pyruvate dehydrogenase complex dihydrolipoamide acetyltransferase, long form | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 14/70 (20%), Positives = 30/70 (42%), Gaps = 6/70 (8%)
Query: 4 GNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPP-- 61
G+ + +P P+ S+ P + +P+++ P + PA+ +P P
Sbjct: 183 GDLILTLSVAGSTPATAPAPASA---QPAAQSPAATQPEPAAAPAAAKAQAPAPQQAGTQ 239
Query: 62 -PSKSPPSSP 70
P+K ++P
Sbjct: 240 NPAKVDHAAP 249
|
This model describes a subset of pyruvate dehydrogenase complex dihydrolipoamide acetyltransferase specifically close by both phylogenetic and per cent identity (UPGMA) trees. Members of this set include two or three copies of the lipoyl-binding domain. E. coli AceF is a member of this model, while mitochondrial and some other bacterial forms belong to a separate model [Energy metabolism, Pyruvate dehydrogenase]. Length = 546 |
| >gnl|CDD|227430 COG5099, COG5099, RNA-binding protein of the Puf family, translational repressor [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 28/148 (18%), Positives = 42/148 (28%), Gaps = 8/148 (5%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
S +S PS + + SS S+ K + P+T
Sbjct: 259 SSINELTSIYGSV---PSIRNLRGLNSALVSFLNVSSSSLAFSA-LNGKEVSPTGSPSTR 314
Query: 76 SSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSS-PTPPSPSNN---KSPSPPVFSPPPPA 131
S + +N + PP P S S + S +
Sbjct: 315 SFARVLPKSSPNNLLTEILTTGVNPPQSLPSLLNPVFLSTSTGFSLTNLSGYLNPNKNLK 374
Query: 132 KKSSPPPPPLKYSSSTPKSSSSSSKSSN 159
K + L YSS+ P SSS S +
Sbjct: 375 KNTLSSLSNLGYSSNVPSPSSSESTRNI 402
|
Length = 777 |
| >gnl|CDD|236333 PRK08691, PRK08691, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.004
Identities = 20/132 (15%), Positives = 36/132 (27%), Gaps = 5/132 (3%)
Query: 11 ENEEGSPPAPPSSNSSDA-----TPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKS 65
E + + A S+ S TPP + + + S P P+
Sbjct: 442 EAQTAAGTAQTSAKSIQTASEAETPPENQVSKNKAADNETDAPLSEVPSENPIQATPNDE 501
Query: 66 PPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVF 125
+ A + P +N P + PPP ++P + +
Sbjct: 502 AVETETFAHEAPAEPFYGYGFPDNDCPPEDGAEIPPPDWEHAAPADTAGGGADEEAEAGG 561
Query: 126 SPPPPAKKSSPP 137
+ PP
Sbjct: 562 IGGNNTPSAPPP 573
|
Length = 709 |
| >gnl|CDD|218115 pfam04502, DUF572, Family of unknown function (DUF572) | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 26/101 (25%), Positives = 32/101 (31%), Gaps = 10/101 (9%)
Query: 22 SSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPA 81
+D TP P S SS P+S S S PSS K+ P P + S
Sbjct: 219 DEEDNDNTPSPKSGSSSPAKPTSILKKSAAKRSEAPSSSKAKKNSRGIPKPRDALSSLVV 278
Query: 82 SPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSP 122
K P S + PT SP + S
Sbjct: 279 R-------KKAAP---ESTSQSPSSAEPTSESPQTAGNSSL 309
|
Family of eukaryotic proteins with undetermined function. Length = 321 |
| >gnl|CDD|191179 pfam05053, Menin, Menin | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 15/66 (22%), Positives = 27/66 (40%), Gaps = 1/66 (1%)
Query: 72 PATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSP-PPP 130
P+ SP P P ++N+ + N+ ++ ++ + SN S P+ PP
Sbjct: 492 PSGGESPNPELPANNNNSNSNNNNNNGADRKEAAATTGNATTTSNGSGTSVPLPVSSEPP 551
Query: 131 AKKSSP 136
K P
Sbjct: 552 QHKEGP 557
|
MEN1, the gene responsible for multiple endocrine neoplasia type 1, is a tumour suppressor gene that encodes a protein called Menin which may be an atypical GTPase stimulated by nm23. Length = 618 |
| >gnl|CDD|216368 pfam01213, CAP_N, Adenylate cyclase associated (CAP) N terminal | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 29/102 (28%), Positives = 39/102 (38%), Gaps = 2/102 (1%)
Query: 21 PSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPP 80
P + + A P SS+ S+PPP PPP PP +S + S A +
Sbjct: 214 PVAAAKSALPAVSSSAPSAPPP--PPPPPPPSVPTISNSVESASSDSKGGRGAVFAELNK 271
Query: 81 ASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSP 122
TS K + P +QS PT P K P+P
Sbjct: 272 GEGITSGLKKVTDDMKTHKNPELRAQSGPTSSGPKPGKPPAP 313
|
Length = 313 |
| >gnl|CDD|220708 pfam10349, WWbp, WW-domain ligand protein | Back alignment and domain information |
|---|
Score = 37.0 bits (86), Expect = 0.004
Identities = 29/82 (35%), Positives = 35/82 (42%), Gaps = 7/82 (8%)
Query: 19 APPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSP 78
A P S S PPP + P P+ A+PPP PPP P PP + P
Sbjct: 37 AQPVSRESGYYPPPGAYVHLEPLPAYGQYAAPPPYGPPPPYYPA-------PPGVYPTPP 89
Query: 79 PPASPPTSDNNKPDPPKNSPPP 100
PP S +D +P PP PP
Sbjct: 90 PPNSGYMADPQEPPPPYPGPPQ 111
|
The WWbp domain is characterized by several short PY and PT-like motifs of the PPPPY form. These appear to bind directly to the WW domains of WWP1 and WWP2 and other such diverse proteins as dystrophin and YAP (Yes-associated protein). This is the WW-domain binding protein WWbp via PY and PY_like motifs. The presence of a phosphotyrosine residue in the pWBP-1 peptide abolishes WW domain binding which suggests a potential regulatory role for tyrosine phosphorylation in modulating WW domain-ligand interactions. Given the likelihood that WWP1 and WWP2 function as E3 ubiquitin-protein ligases, it is possible that initial substrate-specific recognition occurs via WW domain-substrate protein interaction followed by ubiquitin transfer and subsequent proteolysis. This domain lies just downstream of the GRAM (pfam02893) in many members. Length = 111 |
| >gnl|CDD|223029 PHA03264, PHA03264, envelope glycoprotein D; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 24/100 (24%), Positives = 30/100 (30%), Gaps = 1/100 (1%)
Query: 33 SSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPD 92
S PP S +PP P + P P +P T P D
Sbjct: 260 ESKGYEPPPAPSGGSPAPPGDDRPEAKPEPGPVEDGAPGRETGGEGEGPEPAGRDGAAGG 319
Query: 93 PPKNSPPPP-PPSSQSSPTPPSPSNNKSPSPPVFSPPPPA 131
PK PP P P + + P + P P P A
Sbjct: 320 EPKPGPPRPAPDADRPEGWPSLEAITFPPPTPATPAVPRA 359
|
Length = 416 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 29/116 (25%), Positives = 45/116 (38%), Gaps = 37/116 (31%)
Query: 439 IHRDIKAANILIDDNFEAMVADFGLAK-----------------LSNDNHTHVST----- 476
IHRDIK N+L+D ++DFGL L ++ +S
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 477 ----------RVM-----GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
R + GT Y+APE ++ D +S GV++ E++ G P
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|237191 PRK12757, PRK12757, cell division protein FtsN; Provisional | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.004
Identities = 13/69 (18%), Positives = 20/69 (28%)
Query: 27 DATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTS 86
+ TP + + + P P +PP + P P PA+P T
Sbjct: 109 EQTPQVPRSTVQIQQQAQQQQPPATTAQPQPVTPPRQTTAPVQPQTPAPVRTQPAAPVTQ 168
Query: 87 DNNKPDPPK 95
P
Sbjct: 169 AVEAPKVEA 177
|
Length = 256 |
| >gnl|CDD|216325 pfam01140, Gag_MA, Matrix protein (MA), p15 | Back alignment and domain information |
|---|
Score = 37.5 bits (87), Expect = 0.004
Identities = 16/36 (44%), Positives = 19/36 (52%)
Query: 30 PPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKS 65
PPP P PP P ++P P SP PS+PP S
Sbjct: 92 PPPWVKPFVDPPKVLLPSSTPKPVSPSPSAPPRPSS 127
|
The matrix protein, p15, is encoded by the gag gene. MA is involved in pathogenicity. Length = 129 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 662 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.63 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.48 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.46 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.43 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.41 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.35 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.27 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.24 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.23 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.17 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.15 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.1 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.1 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.02 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.88 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.84 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.84 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.82 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.81 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.8 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.72 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.7 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.59 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.58 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.52 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.45 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.43 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.36 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.34 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.33 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.29 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.27 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.24 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.2 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.17 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.13 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.07 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.05 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.04 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.97 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.94 | |
| PF04478 | 154 | Mid2: Mid2 like cell wall stress sensor; InterPro: | 97.91 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.85 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.79 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.68 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.53 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.52 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.49 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.47 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.44 | |
| PLN02236 | 344 | choline kinase | 97.42 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.42 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.38 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.26 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.18 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.1 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 97.09 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 97.08 | |
| KOG1924 | 1102 | consensus RhoA GTPase effector DIA/Diaphanous [Sig | 97.07 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 97.07 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.02 | |
| KOG0260 | 1605 | consensus RNA polymerase II, large subunit [Transc | 96.92 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-55 Score=468.97 Aligned_cols=288 Identities=59% Similarity=0.982 Sum_probs=253.1
Q ss_pred CCCCcCHHHHHHHhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEE
Q 006083 302 NKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381 (662)
Q Consensus 302 ~~~~~~~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 381 (662)
....|+++||..+|++|...++||+|+||.||+|.+.+|..||||++.....+..++|.+|+++|.+++|+|||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 35679999999999999999999999999999999999999999988776543145699999999999999999999999
Q ss_pred EeCC-eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEe
Q 006083 382 IAGG-QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVAD 460 (662)
Q Consensus 382 ~~~~-~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~D 460 (662)
.+++ +.+|||||+.+|+|+++|+......++|..|++|+.++|+||+|||+.|.+.|||||||+.|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 599999999999999999876543789999999999999999999999888899999999999999999999999
Q ss_pred eccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCch--hhhHHHHHHHHHhHHH
Q 006083 461 FGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTM--MEDSLVEWARPLLGAA 538 (662)
Q Consensus 461 FGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~--~~~~~~~~~~~~~~~~ 538 (662)
||+|+.......+......||.+|++||++..+.++.|+|||||||||+||++|+.+.+... ....+++|+...+
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~--- 297 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL--- 297 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH---
Confidence 99997665412222111189999999999999999999999999999999999999988653 4556899986654
Q ss_pred hhcCccccccCcccC-CCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 539 LEDGIYDGLVDPRLE-HNYVP-HEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 539 ~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
.++.+.+++|+++. ..+.. .++.+++.++++|++.++++||+|.||+++|+...
T Consensus 298 -~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 298 -EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred -HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 55689999999987 66654 78999999999999999999999999999996543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=399.35 Aligned_cols=206 Identities=29% Similarity=0.451 Sum_probs=185.3
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
.++|...+.||+|.||+||+|++ +++..||||.+.+. ..+..+.+..|+.||+.|+|+|||+|+++++.++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35788899999999999999994 47899999999776 4556677899999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC------CcEEEEeecccc
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN------FEAMVADFGLAK 465 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~------~~vkl~DFGla~ 465 (662)
|||+||+|.+||+..+ .+++..++.++.||+.||++||++ +||||||||+||||+.. -.+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999997655 489999999999999999999999 99999999999999764 568999999999
Q ss_pred ccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHH
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSL 527 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~ 527 (662)
.+.... .....||++.|||||+++.++|+.|+|+||+|+|||+|++|+.||+.....+.+
T Consensus 164 ~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~ 223 (429)
T KOG0595|consen 164 FLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELL 223 (429)
T ss_pred hCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence 987543 346689999999999999999999999999999999999999999876655433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=411.96 Aligned_cols=248 Identities=23% Similarity=0.397 Sum_probs=214.2
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
..|..+++||+|||+.||+++. .+|+.||+|++.+. .....+.+.+||+|.+.|+|+|||+|+++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4599999999999999999996 89999999999764 3344678999999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
|+|.+++|..+++ .+..+++.++++++.||+.||.|||++ +|||||||..||||+++.+|||+|||||..+....
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999999999986 556799999999999999999999999 99999999999999999999999999998876443
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
. ...+.|||+.|+|||++....++..+||||+|||||-||+|++||+.....+.+..+... .|.
T Consensus 173 E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~---------~Y~------ 236 (592)
T KOG0575|consen 173 E-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN---------EYS------ 236 (592)
T ss_pred c-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc---------Ccc------
Confidence 2 235689999999999999999999999999999999999999999988766665543221 111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.......+.++|+. .+|+.||.+||++.+|+..
T Consensus 237 -~P~~ls~~A~dLI~---~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 237 -MPSHLSAEAKDLIR---KLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -cccccCHHHHHHHH---HHhcCCcccCCCHHHHhcC
Confidence 11134456666665 7999999999999999963
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=404.04 Aligned_cols=254 Identities=32% Similarity=0.518 Sum_probs=206.2
Q ss_pred CCccceeeccCceEEEEEEecCCCEEEEEEeecCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEeCC-eEEEEEEec
Q 006083 318 FAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQG--EREFSAEVEIISRVHHRHLVSLVGYCIAGG-QRMLVYEFV 394 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~~lv~E~~ 394 (662)
+...+.||+|+||+||+|.+.....||||++....... .+.|.+|+.+|.+|+|||||+|+|+|.+.. .++|||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34456699999999999999544449999998653222 568999999999999999999999999887 799999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc-eeecCCccCcEEECCCC-cEEEEeeccccccCCCCC
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR-IIHRDIKAANILIDDNF-EAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-ivHrDIkp~NILl~~~~-~vkl~DFGla~~~~~~~~ 472 (662)
.+|+|.++|+...+..+++..+++|+++|++||.|||++ + |||||||++||||+.++ .+||+|||+++......
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999875566799999999999999999999998 7 99999999999999997 99999999998765432
Q ss_pred ccccccccCccccCccccc--CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 473 HVSTRVMGTFGYLAPEYAS--SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~--~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
...+...||+.|||||++. ...|+.|+||||||||||||+||+.||......+.....+. .+. .+
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~--------~~~-----Rp 265 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVV--------GGL-----RP 265 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------cCC-----CC
Confidence 1223478999999999999 56899999999999999999999999987654221111111 111 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.+.. .+...+..|++ +||+.||.+||++.+|+..|+..
T Consensus 266 ~~p~-~~~~~l~~l~~---~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 266 PIPK-ECPPHLSSLME---RCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred CCCc-cCCHHHHHHHH---HhCCCCCCcCCCHHHHHHHHHHH
Confidence 1111 14455555554 79999999999999999999843
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=386.45 Aligned_cols=251 Identities=28% Similarity=0.435 Sum_probs=205.5
Q ss_pred CCccceeeccCceEEEEEEec-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-eEEEEEEec
Q 006083 318 FAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGG-QRMLVYEFV 394 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~~lv~E~~ 394 (662)
++..+.||+|..|+||+++++ +++.+|+|++..+. ....+++.+|++++++.+||+||.+||.|...+ .++|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 445789999999999999965 78999999996553 344678999999999999999999999999988 599999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHE-DCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
++|+|++++...+ .+++...-+|+.++++||.|||+ + +||||||||.||||+..|+|||||||.++.+-..
T Consensus 161 DgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 9999999997653 48999999999999999999996 5 8999999999999999999999999999877654
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
....++||..|||||.+.++.|+.++||||||+.|+||++|+.||-... +....|+..+ .... .+. -+++.
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~--~~~~~~~~Ll-~~Iv-----~~p-pP~lP 303 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN--PPYLDIFELL-CAIV-----DEP-PPRLP 303 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC--CCCCCHHHHH-HHHh-----cCC-CCCCC
Confidence 4567899999999999999999999999999999999999999996641 1111222211 1111 110 11333
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
......++..++. .||+.||.+|++++|+++.
T Consensus 304 ~~~fS~ef~~FV~---~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 304 EGEFSPEFRSFVS---CCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred cccCCHHHHHHHH---HHhcCCcccCCCHHHHhcC
Confidence 3334555556555 8999999999999999863
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=386.02 Aligned_cols=242 Identities=28% Similarity=0.405 Sum_probs=203.9
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.++||+|+||+||.++. ++++.+|+|++++... .+.+..++|..||.+++||+||+|+..|++.+.+|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 4599999999999999999984 4789999999987633 34567889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.||.|+.+|.+++. +.+..+..++.+|+.||.|||++ +||||||||+|||||++|+++|+||||++......
T Consensus 105 d~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred eccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 99999999999976654 78888899999999999999999 99999999999999999999999999998654433
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
.....+|||..|||||++.+..|+.++|+|||||+|||||+|..||...+....+..+.+ +. ..
T Consensus 180 -~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~---------~k------~~ 243 (357)
T KOG0598|consen 180 -DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK---------GK------LP 243 (357)
T ss_pred -CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc---------Cc------CC
Confidence 234558999999999999999999999999999999999999999987654433322211 11 12
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPK 581 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 581 (662)
....+...+.++++. ..|..||++|-.
T Consensus 244 ~~p~~ls~~ardll~---~LL~rdp~~RLg 270 (357)
T KOG0598|consen 244 LPPGYLSEEARDLLK---KLLKRDPRQRLG 270 (357)
T ss_pred CCCccCCHHHHHHHH---HHhccCHHHhcC
Confidence 233445566666665 789999999974
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=389.37 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=202.2
Q ss_pred HhCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCch-------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQ-------GEREFSAEVEIISRVHHRHLVSLVGYCIAGG 385 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~-------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 385 (662)
..+.|.+.+.||+|+||.|-+|. .++|+.||||++++.... ....+++|++||++|+|||||+++++|++.+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34568889999999999999998 568999999999764221 1234679999999999999999999999999
Q ss_pred eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC---CcEEEEeec
Q 006083 386 QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN---FEAMVADFG 462 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkl~DFG 462 (662)
..|+||||+.||+|.+++-+.+ .+.+.....+++|++.||.|||++ ||+||||||+||||..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999996554 377778889999999999999999 99999999999999765 789999999
Q ss_pred cccccCCCCCccccccccCccccCcccccCCC---CCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHh
Q 006083 463 LAKLSNDNHTHVSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAAL 539 (662)
Q Consensus 463 la~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 539 (662)
+|+..+.. ....++|||+.|.|||++.++. +..+.||||||||||-+|+|..||........+.+ .+
T Consensus 325 lAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e--------QI 394 (475)
T KOG0615|consen 325 LAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE--------QI 394 (475)
T ss_pred hhhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH--------HH
Confidence 99998743 4467799999999999998654 34588999999999999999999976643332221 11
Q ss_pred hcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 540 EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 540 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..|.|.-. .+......++. ..++.+||..||++||++.|+++
T Consensus 395 ~~G~y~f~---p~~w~~Iseea---~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 395 LKGRYAFG---PLQWDRISEEA---LDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hcCccccc---ChhhhhhhHHH---HHHHHHhhEeCcccCcCHHHHhc
Confidence 12222110 01111123344 44555999999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=376.87 Aligned_cols=256 Identities=23% Similarity=0.354 Sum_probs=205.8
Q ss_pred CCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEE-EEE-eCCeEEEEEE
Q 006083 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVG-YCI-AGGQRMLVYE 392 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~-~~~-~~~~~~lv~E 392 (662)
|++.+.||+|.||.||++. +.+|..||.|.++.+.. +..+.+..|+.+|++|+|||||++++ -+. +.+.++||||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE 100 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME 100 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence 7778999999999999998 66999999999986533 34567899999999999999999998 344 4445899999
Q ss_pred ecCCcchhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-ceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 393 FVSNKTLEYHLHG--ENRPVMDFATRVRIALGSAKGLAYLHEDCHP-RIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 393 ~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||.+|+|..+|+. +.+..+++..+++++.|++.||..||.+... -|+||||||.||+|+.+|.|||+||||++++..
T Consensus 101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s 180 (375)
T KOG0591|consen 101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS 180 (375)
T ss_pred hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence 9999999999853 4566799999999999999999999994221 299999999999999999999999999998875
Q ss_pred CCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
.. .....++||+.||+||++.+..|+.|+||||+||++|||+.-+.||.+.. +.+ +...++.+.+..
T Consensus 181 ~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n----~~~-----L~~KI~qgd~~~--- 247 (375)
T KOG0591|consen 181 KT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN----LLS-----LCKKIEQGDYPP--- 247 (375)
T ss_pred hh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc----HHH-----HHHHHHcCCCCC---
Confidence 43 34566899999999999999999999999999999999999999998762 222 222334443322
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
+...+....+ .+++..|+..|++.||+...++..+..
T Consensus 248 --~p~~~YS~~l---~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 --LPDEHYSTDL---RELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --CcHHHhhhHH---HHHHHHHccCCcccCCCcchHHHHHHH
Confidence 2222333444 445557999999999996555555443
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=386.38 Aligned_cols=264 Identities=27% Similarity=0.421 Sum_probs=214.3
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchh-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQG-EREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
.....+.++||+|-||.|.++....+..||||+++.+.... .++|..|+++|.+|+|||||+|+|+|..++-+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34466789999999999999999788999999999875554 48999999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC-C
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH-T 472 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~-~ 472 (662)
+++|+|..+|.+..-..+.....++|+.||+.||+||.+. ++|||||.++|||+++++++||+|||+++.+-.+. .
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999999876555567778889999999999999997 99999999999999999999999999999654433 3
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHH--hCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI--TGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLl--tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
+...+.+-...|||+|.+..++++.++|||+|||+|||++ +...||....+++.+.+ ...++ ..+-...+
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven-~~~~~----~~~~~~~~--- 765 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN-AGEFF----RDQGRQVV--- 765 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh-hhhhc----CCCCccee---
Confidence 4555677788999999999999999999999999999975 57888876554443322 11111 11111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
......++.. |.+++++||+.+-++||++++|...|..+
T Consensus 766 l~~P~~cp~~---lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 LSRPPACPQG---LYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ccCCCcCcHH---HHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1122334444 44666799999999999999999998753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=364.69 Aligned_cols=266 Identities=22% Similarity=0.291 Sum_probs=213.3
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc-h-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG-Q-GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
+.|+...++|+|+||+||+++. .+|+.||||++..... . ..+-.++|+++|++|+|+|+|.|+.+|.....++||||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4588889999999999999994 4799999999965432 2 34556899999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
||+..-|.++-+ ..+ .++.+.+.+++.|+++|+.|||++ ++|||||||+||||+.++.+||||||+|+.+... .
T Consensus 82 ~~dhTvL~eLe~-~p~-G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-g 155 (396)
T KOG0593|consen 82 YCDHTVLHELER-YPN-GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-G 155 (396)
T ss_pred ecchHHHHHHHh-ccC-CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC-c
Confidence 998766655433 222 378899999999999999999999 9999999999999999999999999999988753 3
Q ss_pred ccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH---hHH----HhhcCcc
Q 006083 473 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL---LGA----ALEDGIY 544 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~---~~~----~~~~~~~ 544 (662)
...+.++.|.+|.|||++.+ ..|....|||++|||+.||++|..-|-+..+-|.+..+.+-+ +.+ +-...+|
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 45677899999999999887 789999999999999999999999999887777665443321 111 1123344
Q ss_pred ccccCcccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 545 DGLVDPRLEHN-----YVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 545 ~~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.++.-+...+. ..+....-++.++..||+.||.+|.+-+|++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 44433322221 12333445677888999999999999999884
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=389.08 Aligned_cols=261 Identities=33% Similarity=0.495 Sum_probs=220.1
Q ss_pred CCCCcCHHHHHHHhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEE
Q 006083 302 NKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381 (662)
Q Consensus 302 ~~~~~~~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 381 (662)
+...+..+++ .+++.||+|.||.||.|.+.....||||.++... ...+.|.+|+++|++|+|+|||+|+++|
T Consensus 199 d~wei~r~~l-------~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~ 270 (468)
T KOG0197|consen 199 DPWEIPREEL-------KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVC 270 (468)
T ss_pred CCeeecHHHH-------HHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEE
Confidence 3444555554 3468899999999999999777799999998763 3456788999999999999999999999
Q ss_pred EeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEee
Q 006083 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADF 461 (662)
Q Consensus 382 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DF 461 (662)
..++.+|||||||..|+|.++|+...+..+...+.+.++.|||+|++||+++ ++|||||.++||||++++.+||+||
T Consensus 271 ~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDF 347 (468)
T KOG0197|consen 271 TKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDF 347 (468)
T ss_pred ecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccc
Confidence 9988999999999999999999886677899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhh
Q 006083 462 GLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALE 540 (662)
Q Consensus 462 Gla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 540 (662)
|||+...++.........-...|.|||.+..+.++.|+|||||||+||||+| |+.|+......+.+.. ++
T Consensus 348 GLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~---------le 418 (468)
T KOG0197|consen 348 GLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL---------LE 418 (468)
T ss_pred ccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH---------Hh
Confidence 9999766655444444445778999999999999999999999999999998 8888887765554332 22
Q ss_pred cCccccccCccc-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 541 DGIYDGLVDPRL-EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 541 ~~~~~~~~d~~l-~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.|. +| ....+++++.+||. .||+.+|++|||+..+...|+..
T Consensus 419 ~Gy-------Rlp~P~~CP~~vY~lM~---~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 419 RGY-------RLPRPEGCPDEVYELMK---SCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred ccC-------cCCCCCCCCHHHHHHHH---HHhhCCcccCCCHHHHHHHHHHh
Confidence 222 22 23457777777766 89999999999999999988853
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=377.33 Aligned_cols=266 Identities=24% Similarity=0.298 Sum_probs=214.9
Q ss_pred HhCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCchhH-HHHHHHHHHHHhcC-CCCcceEEEEEEeCC-eEEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGE-REFSAEVEIISRVH-HRHLVSLVGYCIAGG-QRML 389 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~-~~~~~E~~il~~l~-HpnIv~l~~~~~~~~-~~~l 389 (662)
..++|.+.+.||.|.||.||+|+ ..+|+.||||++++.-.... ..-.+|++.|++|+ |+|||+|++++.+.+ .+||
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 34568889999999999999999 56899999999987543322 23468999999999 999999999999888 9999
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||||| ..+|.+++++. +..+.+..++.|+.||++||+|+|++ |++||||||+||||..+..+||+|||+|+....
T Consensus 88 VfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc
Confidence 99999 57899988776 66899999999999999999999999 999999999999999888999999999998765
Q ss_pred CCCccccccccCccccCccccc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH-------------h
Q 006083 470 NHTHVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL-------------L 535 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~-------------~ 535 (662)
.. -.+.++.|.+|.|||++. .+.|+.+.|||++|||++|+.+-+..|-+....|.+..+..-+ +
T Consensus 163 kp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 163 KP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred CC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 43 346688999999999775 6789999999999999999999999999887777765544321 0
Q ss_pred HHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 536 GAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 536 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
...+ .-.+..+....+. ...+....+.++++.+|+.+||.+||++.|.++.
T Consensus 241 a~~m-nf~~P~~~~~~l~-~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 241 ASAM-NFRFPQVKPSPLK-DLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHh-ccCCCcCCCCChH-HhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0000 0011111111121 2233455667777789999999999999999975
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=378.81 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=206.0
Q ss_pred HhCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSG---QGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 388 (662)
.-.+|.+++.||+|.|++||+|+ ...++.||||++.+... ...+.+.+|-.+|.+| +||.||+|+..|+|...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 34579999999999999999998 55799999999976422 2234578899999999 7999999999999999999
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
+|+||+.+|+|.++|++.+ .+++...+.++.+|+.||+|||++ |||||||||+|||||+|+++||+|||.|+.+.
T Consensus 151 FvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 9999999999999997654 589999999999999999999998 99999999999999999999999999998775
Q ss_pred CCCCc----------cc--cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhH
Q 006083 469 DNHTH----------VS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLG 536 (662)
Q Consensus 469 ~~~~~----------~~--~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 536 (662)
..... .. ..++||..|++||+|..+..+..+|||+||||||+|+.|..||.....-..+..+...
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l--- 302 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL--- 302 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh---
Confidence 33221 11 3489999999999999999999999999999999999999999876533222222110
Q ss_pred HHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 537 AALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 537 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+-.+... .++...+|+ .+.|..||.+|.+..||.+.
T Consensus 303 ------------~y~fp~~-fp~~a~dLv---~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 303 ------------DYEFPEG-FPEDARDLI---KKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ------------cccCCCC-CCHHHHHHH---HHHHccCccccccHHHHhhC
Confidence 1111122 234444544 48899999999999888764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=369.36 Aligned_cols=263 Identities=25% Similarity=0.334 Sum_probs=202.8
Q ss_pred CCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAG--GQRMLVY 391 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lv~ 391 (662)
.|+..++||+|.||.||+|+ +.+|+.||+|+++.+.. .......+||.||++|+|+||++|.+...+. +.+||||
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 47778999999999999999 66899999999987643 3345678999999999999999999998765 7999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
|||+.+ |.-++.. ..-.+++.++..++.||++||+|||.+ +|+|||||..|||||++|.+||+|||||+++....
T Consensus 198 eYMdhD-L~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 198 EYMDHD-LSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred ecccch-hhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999764 4444432 334589999999999999999999999 99999999999999999999999999999887666
Q ss_pred CccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccc-----
Q 006083 472 THVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD----- 545 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 545 (662)
....+..+-|.+|.+||++++ ..|+.+.|+||+||||.||+.|+..|.+...-+.+..+.+. ++.- .+..+.
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfkl-cGSP-~e~~W~~~kLP 350 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKL-CGSP-TEDYWPVSKLP 350 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHH-hCCC-ChhccccccCC
Confidence 555677788999999999886 47999999999999999999999999887655554433321 1100 000000
Q ss_pred --ccc------CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 --GLV------DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 --~~~------d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..+ ..++...+ ...-...+.|+..+|..||.+|.++.++|+
T Consensus 351 ~~~~~kp~~~y~r~l~E~~-~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETF-KDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCCCcccchHHHHh-ccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 000 11111110 011122244555789999999999998875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=344.81 Aligned_cols=266 Identities=26% Similarity=0.364 Sum_probs=213.2
Q ss_pred CCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQG--EREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.+|...++||+|.||.||+|+ ..+|+.||||+++..+..+ .....+|+++|+.++|+||+.|+++|-..+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 357788999999999999999 5689999999998764332 3567899999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+ ..+|+..|+.+.. .+...++..++.++++||+|||++ .|+||||||+|+||+.+|.+||+|||+|+.+.....
T Consensus 82 fm-~tdLe~vIkd~~i-~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKNI-ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred ec-cccHHHHhccccc-ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 99 5788888876544 678899999999999999999999 899999999999999999999999999999876554
Q ss_pred ccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH----------hHHHhhc
Q 006083 473 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL----------LGAALED 541 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~----------~~~~~~~ 541 (662)
.. ...+-|.+|.|||++.+ ..|+...||||.|||+.||+-|..-|.+..+-|.+..+.+-+ +....+.
T Consensus 157 ~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 157 IQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 33 33477999999998876 579999999999999999999999898887777766554422 1111111
Q ss_pred CccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 542 GIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 542 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
..++..-...+ +.+.+..-.+.++++..++..||.+|.++.|.+++
T Consensus 236 ~~~~~~P~~~~-~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPL-NNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCcc-ccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111111112 22334444555777779999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=377.24 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=205.4
Q ss_pred HHhCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecC----Cc-hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCC
Q 006083 313 AATGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTG----SG-QGEREFSAEVEIISRVH-HRHLVSLVGYCIAGG 385 (662)
Q Consensus 313 ~~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~----~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~ 385 (662)
...++|.+++.||+|.||.||+|. ..+|+.||||+++.. .. ...+.+.+|+.+|++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 456789999999999999999997 457899999987664 12 23456779999999999 999999999999999
Q ss_pred eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC-CcEEEEeeccc
Q 006083 386 QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN-FEAMVADFGLA 464 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkl~DFGla 464 (662)
.+|+|||||.||+|++++.. ...+.+.++.+++.|++.|++|||++ +|+|||||++||||+.+ +++||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999976 34588899999999999999999999 99999999999999999 99999999999
Q ss_pred cccCCCCCccccccccCccccCcccccCCC-CC-chHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcC
Q 006083 465 KLSNDNHTHVSTRVMGTFGYLAPEYASSGK-LT-EKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDG 542 (662)
Q Consensus 465 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~-~~-~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 542 (662)
.... .........+|++.|+|||++.+.. |+ .++||||||||||.|++|+.||+.......+.. +..+
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k---------i~~~ 238 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK---------IRKG 238 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH---------HhcC
Confidence 8774 2223456789999999999999877 76 899999999999999999999987543322221 1111
Q ss_pred ccccccCcccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 543 IYDGLVDPRLEHNYV-PHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 543 ~~~~~~d~~l~~~~~-~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+. + ..+. ..++.. ++.+||..+|.+|+++.+|++
T Consensus 239 ~~~------~-p~~~~S~~~~~---Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 239 EFK------I-PSYLLSPEARS---LIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred Ccc------C-CCCcCCHHHHH---HHHHHcCCCcccCCCHHHHhh
Confidence 111 1 1111 334444 445899999999999999994
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=390.46 Aligned_cols=256 Identities=26% Similarity=0.450 Sum_probs=210.2
Q ss_pred CCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 388 (662)
.+.+..+.||+|.||+||+|+.. +...||||.++..... ..++|++|+++|..|+|+|||+|+|+|.+++-.+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34556788999999999999832 3467999999987655 6789999999999999999999999999999999
Q ss_pred EEEEecCCcchhhhhccC--------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcE
Q 006083 389 LVYEFVSNKTLEYHLHGE--------N----RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA 456 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~--------~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 456 (662)
+|+|||..|||.++|... . ...|+..+.+.|+.|||.|++||-++ .+|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 999999999999999531 1 23388899999999999999999998 89999999999999999999
Q ss_pred EEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHH
Q 006083 457 MVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPL 534 (662)
Q Consensus 457 kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~ 534 (662)
||+||||++..-..+. +....-.-...||+||.++.++|+.++|||||||||||+++ |+.||.+...++.+...
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i---- 718 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI---- 718 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH----
Confidence 9999999986543322 22223334678999999999999999999999999999997 89999877665544322
Q ss_pred hHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 535 LGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 535 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
..+.+- -..+.++.++.+||. .||+.+|++||+++||-..|+..
T Consensus 719 -----~~g~lL------~~Pe~CP~~vY~LM~---~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 719 -----RAGQLL------SCPENCPTEVYSLML---ECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred -----HcCCcc------cCCCCCCHHHHHHHH---HHhhcCcccCCCHHHHHHHHHHH
Confidence 122211 113345666666655 89999999999999999999853
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=358.14 Aligned_cols=260 Identities=23% Similarity=0.299 Sum_probs=207.4
Q ss_pred CCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+.|++.+.||.|..+.||+|+ ...++.||||++..+... +.+.+++|++.|..++||||+.++..|..+..+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 459999999999999999998 567899999999876433 358899999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
|.+|++.++++..-...+++..+..|++++++||.|||++ |.||||||+.||||+++|.|||+|||.+-.+......
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 9999999999876555699999999999999999999999 9999999999999999999999999987655443322
Q ss_pred c---ccccccCccccCcccccC--CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 474 V---STRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 474 ~---~~~~~Gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
. ...++||++|||||+++. ..|+.|+||||||+...||.+|..||.....-..+..-.+ .... .+.
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--------n~pp-~~~ 253 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--------NDPP-TLL 253 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--------CCCC-Ccc
Confidence 1 155799999999999653 4699999999999999999999999976543332221111 1110 000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...+..+.....-+.+.+++..||+.||++||+++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 011111111112224555666899999999999999995
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=374.35 Aligned_cols=249 Identities=22% Similarity=0.382 Sum_probs=209.7
Q ss_pred CCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
..|.....||+|..|.||.+. ..+++.||||++.......++.+.+|+.+|+.++|+|||++++.|..++++|+||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 347777899999999999998 5578999999998877777788999999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
+||+|.|.+... .+++.++..|++++++||+|||.+ +|+|||||.+||||+.+|.+||+|||||..+..... .
T Consensus 353 ~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred CCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 999999988543 489999999999999999999999 999999999999999999999999999988766543 3
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC-
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE- 553 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~- 553 (662)
....+||++|||||++....|..|.||||||++++||+-|..||-....-..+..++ ..|. +.+.
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa--------~ng~------P~lk~ 491 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--------TNGT------PKLKN 491 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh--------hcCC------CCcCC
Confidence 456899999999999999999999999999999999999999996533222111111 1111 1222
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.+....++++++. +||+.|+++|+++.|+|+.
T Consensus 492 ~~klS~~~kdFL~---~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 PEKLSPELKDFLD---RCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccccCHHHHHHHH---HHhhcchhcCCCHHHHhcC
Confidence 2234556666666 8999999999999999973
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=361.61 Aligned_cols=255 Identities=28% Similarity=0.430 Sum_probs=203.4
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--eEEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGG--QRMLVYE 392 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~lv~E 392 (662)
.+|..++.||+|.||.||++... +|+.+|||.+...+....+.+.+|+++|.+|+|+|||+++|.....+ .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35788899999999999999954 59999999998764444677999999999999999999999855444 6899999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC-CCcEEEEeeccccccCC--
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-NFEAMVADFGLAKLSND-- 469 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~~~~~-- 469 (662)
|+.+|+|.+++.+.+. .+++..++++..||++||+|||++ +|||||||++||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999987766 699999999999999999999999 9999999999999999 79999999999987763
Q ss_pred CCCccccccccCccccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
........+.||+.|||||++.++.. ..++|||||||++.||+||+.||.... +. .++ ++.. .....
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~--~~-~~~---~~~i-g~~~~----- 240 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF--EE-AEA---LLLI-GREDS----- 240 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc--ch-HHH---HHHH-hccCC-----
Confidence 11122345789999999999996433 359999999999999999999997531 11 111 0100 00110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
.+. .......+..+++. .|+..+|++||++.++++..-
T Consensus 241 ~P~-ip~~ls~~a~~Fl~---~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 241 LPE-IPDSLSDEAKDFLR---KCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCC-CCcccCHHHHHHHH---HHhhcCcccCcCHHHHhhChh
Confidence 111 12234566666665 899999999999999998644
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=342.28 Aligned_cols=236 Identities=26% Similarity=0.335 Sum_probs=197.4
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch---hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ---GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|+..+.||.|+||+|.+++. .+|..+|+|++++.... ..+...+|..+|+.+.||+++++++.|.+.+.+|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 3588899999999999999984 47899999999875432 3355778999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.||.|+.+|++.++ +++..++.++.+|+.||+|||+. +|++|||||+|||||.+|.+||+|||+|+.....
T Consensus 124 eyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred eccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 99999999999976655 88899999999999999999998 9999999999999999999999999999987653
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
..+.|||+.|+|||++....|..++|+|+|||++|||+.|..||......+.+..++.. .+ .
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~--------~v-------~ 259 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG--------KV-------K 259 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC--------cc-------c
Confidence 35689999999999999999999999999999999999999999776543333322211 00 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKR 579 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~R 579 (662)
-..+...++++|+. ..|+.|-.+|
T Consensus 260 -fP~~fs~~~kdLl~---~LL~vD~t~R 283 (355)
T KOG0616|consen 260 -FPSYFSSDAKDLLK---KLLQVDLTKR 283 (355)
T ss_pred -CCcccCHHHHHHHH---HHHhhhhHhh
Confidence 12233445555554 6677777777
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=375.09 Aligned_cols=247 Identities=25% Similarity=0.365 Sum_probs=208.7
Q ss_pred CCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
+-|++++.||.|+.|.|.+|+ ..+|+.+|||++.+.. ......+.+|+-||+.|+|+|+++||++++++.++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 569999999999999999998 4689999999997642 122356889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.||.|+++|.+++ .+.+.++.+++.||+.|+.|||.. +|+||||||+|+|||.++++||+|||+|.....+
T Consensus 92 Eyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred EecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 9999999999996554 488999999999999999999998 9999999999999999999999999999765543
Q ss_pred CccccccccCccccCcccccCCCCC-chHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
....+.||.+.|.+||++++..|+ .++||||+|||||.||+|++||+..+....+.. +..|.|+..
T Consensus 166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlK---------V~~G~f~MP--- 232 (786)
T KOG0588|consen 166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLK---------VQRGVFEMP--- 232 (786)
T ss_pred -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHH---------HHcCcccCC---
Confidence 345668999999999999998886 799999999999999999999986543332222 234444432
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.....+...|+. +||.+||.+|-+++||++.
T Consensus 233 ----s~Is~eaQdLLr---~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 233 ----SNISSEAQDLLR---RMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ----CcCCHHHHHHHH---HHhccCccccccHHHHhhC
Confidence 334455555555 8999999999999999974
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=372.73 Aligned_cols=242 Identities=27% Similarity=0.383 Sum_probs=202.6
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l 389 (662)
.++|.+.++||+|.||+|+++.++ +++.+|||+++++. .++.+..+.|.+|+...+ ||.+++|+.+|+..+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 357999999999999999999954 68899999999874 355678899999998885 9999999999999999999
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||||+.||++..+++ ...+++..+..++..++.||+|||++ +|||||||.+|||||.+|.+||+|||+++....
T Consensus 447 vmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC
Confidence 999999999554443 34589999999999999999999999 999999999999999999999999999997653
Q ss_pred CCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
... ...++|||+.|||||++.++.|+.++|+|+|||+|||||.|..||.+.+.++.+..+.. |
T Consensus 521 ~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~----------------d 583 (694)
T KOG0694|consen 521 QGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN----------------D 583 (694)
T ss_pred CCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc----------------C
Confidence 332 45679999999999999999999999999999999999999999998765554332211 1
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKM 582 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 582 (662)
..+-..+...+...++ .++|..+|++|.-+
T Consensus 584 ~~~yP~~ls~ea~~il---~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 EVRYPRFLSKEAIAIM---RRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCcccHHHHHHH---HHHhccCcccccCC
Confidence 1122233344444444 48999999999876
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=363.54 Aligned_cols=243 Identities=22% Similarity=0.295 Sum_probs=197.3
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch---hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ---GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
.++|+++..||+|+||.||+|+. .+|+.+|+|+|++.... ..+.++.|-+||...++++||+|+..|++.+.+|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 45799999999999999999994 57999999999886443 345688999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC-
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND- 469 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~- 469 (662)
|||++||++..+|... ..|++..+..++.+++.||+.||+. |+|||||||+|+|||..|++||+||||+.-+..
T Consensus 220 MEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999999654 4689999999999999999999999 999999999999999999999999999852210
Q ss_pred ---------------------CCCc-------c-----------------ccccccCccccCcccccCCCCCchHHHHHH
Q 006083 470 ---------------------NHTH-------V-----------------STRVMGTFGYLAPEYASSGKLTEKSDVFSF 504 (662)
Q Consensus 470 ---------------------~~~~-------~-----------------~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSl 504 (662)
.... . ....+||+.|||||++++..|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000 0 012479999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCchhhhHH---HHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 006083 505 GVMLLELITGRRPVDMTMMEDSL---VEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPK 581 (662)
Q Consensus 505 Gvvl~eLltG~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 581 (662)
||||||||.|.+||......+.. ..|...+ ... .......+..+|+. +||. |+++|-.
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l----------~fP-----~~~~~s~eA~DLI~---rll~-d~~~RLG 435 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETL----------KFP-----EEVDLSDEAKDLIT---RLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc----------cCC-----CcCcccHHHHHHHH---HHhc-CHHHhcC
Confidence 99999999999999887655533 3332211 111 11112255555554 7777 9999986
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=366.75 Aligned_cols=246 Identities=26% Similarity=0.390 Sum_probs=205.2
Q ss_pred CCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
++|.+.+.||+|.||+||||+ ..+.+.||||.+.+.. .++.+.+.+|++|+++|+|+|||.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 468888999999999999998 4478999999997643 3445779999999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
||.| +|+.+|... ..+.++.+..|+.+++.||.|||++ +|+|||+||.||||+.++.+|+||||+|+....+ +
T Consensus 82 ~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-T 154 (808)
T ss_pred hhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC-c
Confidence 9988 999999544 4599999999999999999999999 9999999999999999999999999999987654 4
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
.+.+.+.||+.|||||++.++.|+..+|+||||||||||++|+.||..... .+..+..+ .+ +..
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si----~~Lv~~I~----~d--------~v~ 218 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI----TQLVKSIL----KD--------PVK 218 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH----HHHHHHHh----cC--------CCC
Confidence 566778999999999999999999999999999999999999999965432 22222111 11 111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. ....-..+..++...|..||.+|-+..+++.
T Consensus 219 ~---p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 P---PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred C---cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1 1123334455555789999999999988885
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=366.46 Aligned_cols=258 Identities=26% Similarity=0.442 Sum_probs=201.3
Q ss_pred hCCCCccceeeccCceEEEEEEe------cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEe-CC
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL------PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRV-HHRHLVSLVGYCIA-GG 385 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~-~~ 385 (662)
.++|++.++||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+++|+++ +|+|||+++++|.. ++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 35688999999999999999973 2356899999975432 3346789999999999 89999999998875 44
Q ss_pred eEEEEEEecCCcchhhhhccCC----------------------------------------------------------
Q 006083 386 QRMLVYEFVSNKTLEYHLHGEN---------------------------------------------------------- 407 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~---------------------------------------------------------- 407 (662)
.+++||||+.+|+|.++|....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 6899999999999999886432
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc-cccccccCccc
Q 006083 408 --RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH-VSTRVMGTFGY 484 (662)
Q Consensus 408 --~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~Gt~~y 484 (662)
...+.+..+++++.||++||+|||++ +|+||||||+||||++++.+||+|||+++........ ......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 12477888999999999999999998 9999999999999999999999999999865432221 12234567889
Q ss_pred cCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHH
Q 006083 485 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMAR 563 (662)
Q Consensus 485 ~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 563 (662)
||||++.+..++.++|||||||+||||++ |+.||......+.+.. .+..+... ... .... ..
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~--------~~~~~~~~-----~~~-~~~~---~~ 305 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ--------RLKDGTRM-----RAP-ENAT---PE 305 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH--------HHhcCCCC-----CCC-CCCC---HH
Confidence 99999999999999999999999999997 9999976543222211 11111111 111 1122 34
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 564 LVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 564 l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
+.+++.+||+.||++||++.||++.|+..
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 55666699999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=366.95 Aligned_cols=268 Identities=26% Similarity=0.446 Sum_probs=212.1
Q ss_pred cCHHHHHHHhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 006083 306 FTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIA 383 (662)
Q Consensus 306 ~~~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 383 (662)
...+++++..+.+.++..||+|.||+||+|++.. .||||+++.... +..+.|+.|+.+|++-+|.||+-|.|||..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 3345556666667788999999999999999733 699999987643 446789999999999999999999999998
Q ss_pred CCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecc
Q 006083 384 GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGL 463 (662)
Q Consensus 384 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 463 (662)
... .||..||+|-+|+.+||..+ ..+++...+.|+.||++|+.|||.+ +|||||||..||||.+++.|||+||||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence 877 99999999999999998654 4589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC-CCccccccccCccccCcccccC---CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHh
Q 006083 464 AKLSNDN-HTHVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAAL 539 (662)
Q Consensus 464 a~~~~~~-~~~~~~~~~Gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 539 (662)
+.....- .......--|...|||||+++. ..|++.+||||||||+|||++|..||.....+..+-.
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm---------- 604 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM---------- 604 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE----------
Confidence 8643321 1122233457889999999974 3589999999999999999999999984432221110
Q ss_pred hcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCCC
Q 006083 540 EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSS 594 (662)
Q Consensus 540 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 594 (662)
-|.-....|.......++.++++|+. .||..++++||.+.+|+..|+....
T Consensus 605 -VGrG~l~pd~s~~~s~~pk~mk~Ll~---~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 605 -VGRGYLMPDLSKIRSNCPKAMKRLLS---DCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -ecccccCccchhhhccCHHHHHHHHH---HHHhcCcccCccHHHHHHHHHHhhh
Confidence 01111112222233345666666665 8999999999999999998876543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=350.96 Aligned_cols=248 Identities=24% Similarity=0.391 Sum_probs=209.2
Q ss_pred HhCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCchhH---HHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGE---REFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~---~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
...+|++.+.||+|.||.|-++. ...|+.||||.|+++...+. -.+.+|++||..|+||||++++.+|++.+.+.|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 34568999999999999999998 46899999999988755443 457899999999999999999999999999999
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||||..+|.|.||+.+. +.|++.+..+++.||..|+.|||++ +|+|||||.+|||||+|+++||+||||+.++..
T Consensus 131 vMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 131 VMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999999654 4599999999999999999999999 999999999999999999999999999988766
Q ss_pred CCCccccccccCccccCcccccCCCCC-chHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
.. ....+||++-|.+||++.+..|. ...|-|||||+||.|+.|..||++.+....+.+ +..|.|.+.-
T Consensus 206 ~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQ---------Is~GaYrEP~ 274 (668)
T KOG0611|consen 206 KK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQ---------ISRGAYREPE 274 (668)
T ss_pred cc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHH---------hhcccccCCC
Confidence 43 35679999999999999998875 789999999999999999999998754332221 2233333321
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.+....-| +.|||.++|++|-++.+|...
T Consensus 275 --------~PSdA~gL---IRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 275 --------TPSDASGL---IRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred --------CCchHHHH---HHHHHhcCcccchhHHHHhhh
Confidence 22333334 448999999999999999864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=364.43 Aligned_cols=246 Identities=28% Similarity=0.440 Sum_probs=202.9
Q ss_pred CCcCHHHHHHHhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 006083 304 STFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383 (662)
Q Consensus 304 ~~~~~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 383 (662)
..+.|++|. .++-||.|+.|.||+|++ .++.||||+++. .-..+|+-|++|+|+||+.|.|+|..
T Consensus 119 WeiPFe~Is-------ELeWlGSGaQGAVF~Grl-~netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 119 WEIPFEEIS-------ELEWLGSGAQGAVFLGRL-HNETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred ccCCHHHhh-------hhhhhccCcccceeeeec-cCceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecC
Confidence 345556653 246799999999999998 568999998863 22458899999999999999999999
Q ss_pred CCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecc
Q 006083 384 GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGL 463 (662)
Q Consensus 384 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 463 (662)
.-.+|||||||..|-|...|+..+ .+.....+.|..+||.|+.|||.+ +|||||||.-||||..+..|||+|||-
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred CceeEEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccc
Confidence 999999999999999999996543 578889999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCc
Q 006083 464 AKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGI 543 (662)
Q Consensus 464 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (662)
++...+.. ....++||..|||||++++...++|+|||||||||||||||..||..... ..+
T Consensus 259 S~e~~~~S--TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds-----------------sAI 319 (904)
T KOG4721|consen 259 SKELSDKS--TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS-----------------SAI 319 (904)
T ss_pred hHhhhhhh--hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch-----------------hee
Confidence 99877652 23458999999999999999999999999999999999999999965321 112
Q ss_pred cccccCcccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 544 YDGLVDPRLEH---NYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 544 ~~~~~d~~l~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
+..+....|.- .-+++-++-| ++.||+..|..||++++|+..|+-
T Consensus 320 IwGVGsNsL~LpvPstcP~GfklL---~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 320 IWGVGSNSLHLPVPSTCPDGFKLL---LKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred EEeccCCcccccCcccCchHHHHH---HHHHHhcCCCCCccHHHHHHHHhh
Confidence 22222222222 2234444444 458999999999999999998873
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=353.77 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=200.4
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.|+..+.||+|+||.||++.. .+|+.||||++..... .....+.+|+++|++++|+||+.+++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999984 5799999999875422 223467889999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.+|+|.+++.......+++..++.++.|++.||+|||++ +|+||||||+||||++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999999888655555689999999999999999999998 99999999999999999999999999998754322
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
......|+..|||||++.+..++.++|||||||+||||++|+.||...........+.... ..... .+
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~------~~ 224 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV-----KEDQE------EY 224 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh-----hcccc------cC
Confidence 1234579999999999999999999999999999999999999998654322111111110 00000 11
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPK-----MSQIVR 587 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 587 (662)
...+ .. .+..++..||+.||++|++ +.++++
T Consensus 225 ~~~~-s~---~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 225 SEKF-SE---DAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CccC-CH---HHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1111 23 4455566899999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=364.21 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=212.4
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-EEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQ-RMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-~~lv~ 391 (662)
++|..+++||+|+||.+++.+. .++..|++|.+..... ...+....|+.++++++|||||.+++.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5688899999999999999884 4678999999976533 334567899999999999999999999999888 89999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
+||+||+|.+.|.+.+...+.++.+.+|+.|++.||.|||++ .|+|||||+.|||++.++.|||.|||+|+......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999999888777899999999999999999999988 89999999999999999999999999999887654
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
. ....++||+.||.||++.+..|..|+|||||||++|||++-+.+|+..+....+..+.+. .+. -
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~-------------~~~-P 225 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG-------------LYS-P 225 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc-------------cCC-C
Confidence 2 345689999999999999999999999999999999999999999887655433332221 111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+...| ..+++. ++..||+.+|..||++.++|..
T Consensus 226 lp~~y-s~el~~---lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 LPSMY-SSELRS---LVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCccc-cHHHHH---HHHHHhhcCCccCCCHHHHhhC
Confidence 22222 234444 4458999999999999999975
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=359.17 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=207.5
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
.|...++||+|.||.||+|.. ..++.||||++..+.. ...+++++|+.+|..++++||.++|+.+..+..+|++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 377779999999999999994 5789999999987644 44678999999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.||++.+.|... ..+++..+..|+.+++.||.|||.+ +.+|||||+.||||..+|.|||+|||++..........
T Consensus 94 ~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 94 GGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred cCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 999999999543 3458888889999999999999999 99999999999999999999999999998776554333
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
.+++||+.|||||++.+..|+.|+||||||++.+||++|..|+........+ -.+-+-.-+.+.+
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl--------------flIpk~~PP~L~~ 233 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL--------------FLIPKSAPPRLDG 233 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE--------------EeccCCCCCcccc
Confidence 6789999999999999889999999999999999999999998654321100 0112222234555
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.....++++++ .||+.||+.||++.++++.
T Consensus 234 -~~S~~~kEFV~---~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 -DFSPPFKEFVE---ACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -ccCHHHHHHHH---HHhhcCcccCcCHHHHhhh
Confidence 34455566665 7999999999999999953
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=360.13 Aligned_cols=247 Identities=26% Similarity=0.400 Sum_probs=191.4
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
+|+..+.||+|+||.||+++. .+|+.||||++..... ...+.+.+|+++|++++|+||+++++++.+++.+++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 356678999999999999985 4789999999975433 33467899999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.... .+.+..+..++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....... .
T Consensus 155 ~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 224 (353)
T PLN00034 155 DGGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P 224 (353)
T ss_pred CCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence 999986532 346778889999999999999998 999999999999999999999999999987643321 2
Q ss_pred ccccccCccccCcccccC-----CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 475 STRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
....+|+..|+|||++.. ...+.++|||||||+||||++|+.||......+ |........ ... .
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~~~~~~--~~~-----~ 293 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD----WASLMCAIC--MSQ-----P 293 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc----HHHHHHHHh--ccC-----C
Confidence 234679999999998743 234568999999999999999999997433221 111111000 000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
... ...... .+.+++.+||+.||++||++.||++.
T Consensus 294 ~~~-~~~~~~---~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 PEA-PATASR---EFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCC-CCccCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011 112233 34555568999999999999999874
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=353.25 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=200.5
Q ss_pred HhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch--------------hHHHHHHHHHHHHhcCCCCcceEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ--------------GEREFSAEVEIISRVHHRHLVSLV 378 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--------------~~~~~~~E~~il~~l~HpnIv~l~ 378 (662)
..+.|++.+.||+|.||.|.+|+. .+++.||||++.+.... ..+++.+||.||++|+|+|||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 446799999999999999999994 47899999999653211 135788999999999999999999
Q ss_pred EEEEe--CCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcE
Q 006083 379 GYCIA--GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA 456 (662)
Q Consensus 379 ~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 456 (662)
.+..+ .+.+|||+|||..|.+...- .....+.+.++++++.+++.||+|||.+ +||||||||.|+||+++|.|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcE
Confidence 99875 57899999999999886432 2233389999999999999999999999 99999999999999999999
Q ss_pred EEEeeccccccCCC----CCccccccccCccccCcccccCCC----CCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHH
Q 006083 457 MVADFGLAKLSNDN----HTHVSTRVMGTFGYLAPEYASSGK----LTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLV 528 (662)
Q Consensus 457 kl~DFGla~~~~~~----~~~~~~~~~Gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~ 528 (662)
||+|||.+..+... ........+||+.|||||.+.++. ...+.||||+||+||.|+.|+.||......+.+
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~- 328 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF- 328 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH-
Confidence 99999999866322 112334478999999999887643 357899999999999999999999766433322
Q ss_pred HHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006083 529 EWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRAL 589 (662)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 589 (662)
++++...|.-...+++-.++-.+++++|+.||++|-+..+|....
T Consensus 329 ----------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 329 ----------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ----------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 222222222222223344555666799999999999999998653
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=326.40 Aligned_cols=248 Identities=25% Similarity=0.323 Sum_probs=210.6
Q ss_pred CCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++++.||+|.||.||.|+ .+++-.||+|++.+... +...++.+|++|-.+|+||||++++++|.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 458999999999999999999 45778899999976532 23467999999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||..+|.|+..|.......+++.....++.|+|.||.|||.. +||||||||+|+|++.++.+||+|||.+.....+
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~- 177 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN- 177 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCC-
Confidence 999999999999877777789999999999999999999998 8999999999999999999999999999876532
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
.....|||..|++||...+..++.+.|+|++|++.||++.|..||......+.+.++.+..+ ..
T Consensus 178 --kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~------------~~-- 241 (281)
T KOG0580|consen 178 --KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL------------KF-- 241 (281)
T ss_pred --CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc------------cC--
Confidence 23568999999999999999999999999999999999999999988765555544333111 00
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.........+ ++..|+..+|.+|....||++.
T Consensus 242 --p~~is~~a~d---lI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 --PSTISGGAAD---LISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --CcccChhHHH---HHHHHhccCccccccHHHHhhh
Confidence 1223344444 4458999999999999999863
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=347.58 Aligned_cols=248 Identities=21% Similarity=0.318 Sum_probs=198.6
Q ss_pred CCccceeeccCceEEEEEEecCCCEEEEEEeecCCchh---HHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeEEEE
Q 006083 318 FAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQG---EREFSAEVEIISRVHHRHLVSLVGYCIA----GGQRMLV 390 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~lv 390 (662)
......||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+++|++++|+|||++++++.+ ...+++|
T Consensus 22 ~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv 100 (283)
T PHA02988 22 KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLI 100 (283)
T ss_pred CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEE
Confidence 33347899999999999998 78999999997653332 4678899999999999999999999876 4578999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+|+|.+++... ..+++...++++.+++.||.|||+.. +++|||||++|||+++++.+||+|||+++.....
T Consensus 101 ~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 101 LEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred EEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 9999999999999654 35889999999999999999999742 6889999999999999999999999999865432
Q ss_pred CCccccccccCccccCcccccC--CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
. ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+.+..+. ..+. .
T Consensus 177 ~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~--------~~~~-~--- 240 (283)
T PHA02988 177 P----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII--------NKNN-S--- 240 (283)
T ss_pred c----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--------hcCC-C---
Confidence 2 23568899999999976 689999999999999999999999998654333222111 0110 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
..+. ...+.++. +++.+||+.||++||++.||++.|+.
T Consensus 241 -~~~~-~~~~~~l~---~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 241 -LKLP-LDCPLEIK---CIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred -CCCC-CcCcHHHH---HHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 0111 11234444 45558999999999999999999985
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=345.79 Aligned_cols=267 Identities=22% Similarity=0.288 Sum_probs=202.8
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
++|++.+.||+|+||.||+++.. +++.||||+++... ....+.+.+|++++++++|+||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999964 68899999997642 2334678899999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.++.|..+... ...+++..++.++.|++.||.|||+. +|+|||||++||||+.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9999877765432 23588899999999999999999998 999999999999999999999999999987654332
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHH---HH----hHHHhhcCccc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWAR---PL----LGAALEDGIYD 545 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~---~~----~~~~~~~~~~~ 545 (662)
.......|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+..... .. +........+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 233446789999999999988999999999999999999999999976543332222111 00 00000000111
Q ss_pred cccCcccC------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GLVDPRLE------HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~~d~~l~------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
........ ..+....-..+.+++.+||+.||++|++++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 0011111234566677999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=354.94 Aligned_cols=253 Identities=23% Similarity=0.253 Sum_probs=203.2
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+++|.+++|+||+++++++.+++..||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999964 68999999997542 233467889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.|++|.+++.... .+.+..++.++.||+.||.|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999996443 478899999999999999999998 999999999999999999999999999986543
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
.....+|+..|+|||++.+..++.++||||||||||||++|+.||......+.+..+... ...+.......
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------~~~~~~~~~~~ 224 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW-------KETLQRPVYDD 224 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc-------cccccCCCCCc
Confidence 224467999999999999999999999999999999999999999876544332221110 00011000000
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.. ..... .+.+++.+||..++.+|+++.+|++.
T Consensus 225 ~~-~~~s~---~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 PR-FNLSD---EAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cc-cccCH---HHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 11223 34455568999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=350.29 Aligned_cols=261 Identities=26% Similarity=0.421 Sum_probs=201.2
Q ss_pred CCCCccceeeccCceEEEEEEecC-----------------CCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPN-----------------GKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSL 377 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l 377 (662)
++|.+.++||+|+||.||++.+.+ +..||||+++.... .....|.+|+++|.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 468889999999999999997432 34699999976532 335679999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCcchhhhhccCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceee
Q 006083 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGEN-----------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIH 440 (662)
Q Consensus 378 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH 440 (662)
++++.+.+..+|||||+.+++|.+++.... ...+.+..+++++.||+.||.|||++ +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999885321 12467888999999999999999998 8999
Q ss_pred cCCccCcEEECCCCcEEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh--CCCC
Q 006083 441 RDIKAANILIDDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT--GRRP 517 (662)
Q Consensus 441 rDIkp~NILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt--G~~P 517 (662)
|||||+||||++++.+||+|||+++....... .......++..|||||++.++.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543321 12233456889999999998899999999999999999987 5667
Q ss_pred CCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 518 VDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 518 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
|......+.+. .....+.. ....... ......+ ..+.+++.+||+.+|++||++.||++.|+
T Consensus 242 ~~~~~~~~~~~-~~~~~~~~----~~~~~~~---~~~~~~~---~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQVIE-NAGEFFRD----QGRQVYL---FRPPPCP---QGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHHHHH-HHHHHhhh----ccccccc---cCCCCCC---HHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 76544333222 22211111 0000000 0011223 34556667999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=355.28 Aligned_cols=201 Identities=25% Similarity=0.403 Sum_probs=177.2
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.++|++.+.||+|+||.||+++.. +|..||+|+++.... ...+.+.+|+++|++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367999999999999999999954 688999999976532 335679999999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.+++|.+++.... .+++..+.+++.+++.||.|||+.+ +|+|||||++||||++++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 999999999996543 4789999999999999999999852 69999999999999999999999999997654322
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCch
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTM 522 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~ 522 (662)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 234579999999999999899999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=341.50 Aligned_cols=254 Identities=28% Similarity=0.456 Sum_probs=207.7
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+++..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 4588999999999999999998788899999987543 345788999999999999999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
+++|.++++......+.+..++.++.++++||+|||+. +++||||||+|||+++++.+||+|||++...........
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99999999765555688999999999999999999998 899999999999999999999999999987654332222
Q ss_pred cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
....++..|+|||++.++.++.++|||||||++|+|++ |+.||......+....+. .+... ... .
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~---------~~~~~----~~~-~ 227 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ---------RGYRM----PRM-E 227 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH---------cCCCC----CCC-C
Confidence 33446778999999998899999999999999999998 999997654333222111 11100 011 1
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
..+ ..+.+++.+|++.+|++||++.+|++.|+.
T Consensus 228 -~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 -NCP---DELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCC---HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 122 345566679999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=361.58 Aligned_cols=256 Identities=26% Similarity=0.418 Sum_probs=202.5
Q ss_pred CCCCccceeeccCceEEEEEEe------cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL------PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 387 (662)
++|++++.||+|+||.||+|.. .++..||||+++... ....+.+.+|+++|+.+ +|+|||+++++|.+++..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4588899999999999999862 245689999997543 33456788999999999 899999999999999999
Q ss_pred EEEEEecCCcchhhhhccCC------------------------------------------------------------
Q 006083 388 MLVYEFVSNKTLEYHLHGEN------------------------------------------------------------ 407 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~------------------------------------------------------------ 407 (662)
++|||||.+|+|.++++...
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999999886422
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc-
Q 006083 408 -------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH- 473 (662)
Q Consensus 408 -------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~- 473 (662)
...+++..+++++.||++||+|||++ +|+||||||+||||++++.+||+|||+++........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 12478889999999999999999998 9999999999999999999999999999866443221
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
......++..|+|||++.+..++.++|||||||+||||++ |..||........+..+.. .+... .
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~--------~~~~~------~ 337 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK--------EGYRM------L 337 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH--------hCccC------C
Confidence 1122345678999999999999999999999999999998 8889876543332222211 11100 0
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.....+. ++.+++.+||+.||++||++.||++.|+.
T Consensus 338 ~~~~~~~---~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 338 SPECAPS---EMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCCCH---HHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1112233 45556669999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=349.27 Aligned_cols=245 Identities=21% Similarity=0.243 Sum_probs=199.2
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.+.||+|+||.||++... +|+.||||+++... ....+.+.+|+++|++++|+||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36889999999999999999954 68999999997532 233456889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.+++|.+++.... .+.+..++.++.|++.||+|||++ +|+||||||+||||++++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 9999999999986543 478899999999999999999998 99999999999999999999999999998764321
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
...+|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+.... .+.. .
T Consensus 156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~---------~~~~------~ 216 (291)
T cd05612 156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL---------AGKL------E 216 (291)
T ss_pred ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---------hCCc------C
Confidence 23579999999999999899999999999999999999999997654332222111 1110 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPK-----MSQIVRA 588 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~~ 588 (662)
+...+ ... +.+++.+||+.||.+|++ +.++++.
T Consensus 217 ~~~~~-~~~---~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 FPRHL-DLY---AKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCccC-CHH---HHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11111 233 445556999999999995 7776643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=354.13 Aligned_cols=241 Identities=24% Similarity=0.310 Sum_probs=194.4
Q ss_pred ceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCc
Q 006083 322 NLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNK 397 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g 397 (662)
++||+|+||.||++.. .+|+.||||+++... ......+.+|+++|++++|+||+++++++.+++.+||||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 478999999997542 233456788999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccccc
Q 006083 398 TLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTR 477 (662)
Q Consensus 398 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 477 (662)
+|.+++... ..+.+..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~ 154 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cccc
Confidence 999988653 3588999999999999999999998 999999999999999999999999999975432221 2234
Q ss_pred cccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCC
Q 006083 478 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYV 557 (662)
Q Consensus 478 ~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 557 (662)
.+|+..|+|||++.+..++.++|||||||+||||++|+.||........+.... .+. ..+... .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~---------~~~------~~~p~~-~ 218 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL---------MEE------IRFPRT-L 218 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH---------cCC------CCCCCC-C
Confidence 679999999999999999999999999999999999999997654322211110 000 011111 2
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006083 558 PHEMARLVACGAASIRHSARKRP-----KMSQIVR 587 (662)
Q Consensus 558 ~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 587 (662)
..+ +.+++.+||+.||++|+ ++.++++
T Consensus 219 ~~~---~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 219 SPE---AKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CHH---HHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 333 44555599999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=355.21 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=197.0
Q ss_pred CCCccceeeccCceEEEEEEe----cCCCEEEEEEeecCC----chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL----PNGKEVAVKSLKTGS----GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 387 (662)
+|++.+.||+|+||.||+++. .+++.||||+++... ....+.+..|+++|+++ +|+||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999874 368899999997532 22345678899999999 499999999999999999
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
++||||+.+|+|.+++... ..+++..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999998653 3488999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccc
Q 006083 468 NDNHTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 468 ~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
...........+||..|||||++.+. .++.++||||||||||||++|+.||...........+....+ .
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-----~----- 225 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL-----K----- 225 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh-----c-----
Confidence 44333333456899999999999865 478999999999999999999999975432222211111111 0
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRP-----KMSQIVRA 588 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 588 (662)
.+..+.. ..... +.+++.+||+.||++|+ ++.++++.
T Consensus 226 -~~~~~~~-~~~~~---~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 -CDPPFPS-FIGPE---AQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -CCCCCCC-CCCHH---HHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0111111 12333 34455599999999999 66676653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=338.07 Aligned_cols=255 Identities=29% Similarity=0.436 Sum_probs=206.9
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
.++|++.+.||+|+||.||+|...+++.||||.++... ...+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688999999999999999998778899999997643 33567899999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.+++.......+++..+.+++.+++.||.|||++ +|+|||||++|||+++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 999999999765545689999999999999999999998 89999999999999999999999999998765332211
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
.....+...|+|||++.+..++.++|||||||++|||++ |+.||......+.+..+ .... .. .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~---------~~~~-~~----~-- 224 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV---------DQGY-RM----P-- 224 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---------HcCC-CC----C--
Confidence 111223457999999998899999999999999999999 99999765433222211 1110 00 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
........+.+++.+||+.+|++||++.+|++.|+.
T Consensus 225 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 --CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 011122456666779999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=354.88 Aligned_cols=244 Identities=25% Similarity=0.313 Sum_probs=198.3
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|.+.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++|++++|+||+++++++.+++..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 45889999999999999999954 68999999997532 233457889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.+++|.+++.... .+.+..+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 9999999999996543 478888999999999999999998 99999999999999999999999999998764332
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
...+|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+... ..+.+.
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i---------~~~~~~------ 233 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI---------LAGRLK------ 233 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH---------hcCCcC------
Confidence 2357999999999999999999999999999999999999999765432211111 111110
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPK-----MSQIVR 587 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 587 (662)
+. ...... +.+++..||+.||++|++ +.++++
T Consensus 234 ~p-~~~~~~---~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 234 FP-NWFDGR---ARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CC-CCCCHH---HHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11 112233 445556999999999997 566654
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=332.13 Aligned_cols=260 Identities=23% Similarity=0.308 Sum_probs=201.7
Q ss_pred CCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEEEEE
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQG--EREFSAEVEIISRVHHRHLVSLVGYCIA--GGQRMLVYE 392 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lv~E 392 (662)
|++++.|++|.||.||+|++ ++++.||+|+++.+.... --.-.+||.+|.+++|+|||.+..+... -+.+|||||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 77789999999999999994 578999999998764221 1245789999999999999999988764 467999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
||+ -+|..+++... +.+...++..+++|+++||+|||.+ .|+|||||++|+|+++.|.+||+|||+|+.++....
T Consensus 158 ~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 158 YVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred HHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 995 57777776544 4578889999999999999999999 899999999999999999999999999999987643
Q ss_pred ccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc---
Q 006083 473 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV--- 548 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 548 (662)
..+..+-|.+|.|||++.+ ..|+.+.||||+|||+.||++++..|.+...-+.+..+.+.+ +.- .+.++..+.
T Consensus 233 -~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ll-GtP-te~iwpg~~~lp 309 (419)
T KOG0663|consen 233 -PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLL-GTP-SEAIWPGYSELP 309 (419)
T ss_pred -cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHh-CCC-ccccCCCccccc
Confidence 3456778999999999886 569999999999999999999999999887666665554422 100 011111110
Q ss_pred -----------CcccCCCC----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 549 -----------DPRLEHNY----VPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 549 -----------d~~l~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
-..+...+ ..+.-.+|+ ...|..||++|-|+.|-|+.
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Ll---n~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLL---NKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHH---HHHhccCccccccHHHhhcc
Confidence 01111111 223344444 47899999999999988753
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=340.71 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=202.0
Q ss_pred CCCCccceeeccCceEEEEEEec----CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP----NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
++|++.++||+|+||.||+|.+. .+..||+|+++.... ...+.+.+|+++|++++|+||+++++++..++..+||
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45888999999999999999742 457899999986533 3346789999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+++|.+++.... ..+++..+++++.+++.||+|||++ +|+|||||++||||+.++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999986543 3578999999999999999999998 9999999999999999999999999987654322
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
.........++..|+|||++.++.++.++|||||||++|||++ |+.||......+.+.. +..+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~---------~~~~~~~---- 227 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA---------VEDGFRL---- 227 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH---------HHCCCCC----
Confidence 2111122345678999999999999999999999999999775 9999976543322211 1111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.. ....+. .+.+++..||+.+|.+||++.||++.|+.
T Consensus 228 -~~-~~~~~~---~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 228 -PA-PRNCPN---LLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -CC-CCCCCH---HHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 01 111233 34555668999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=341.03 Aligned_cols=255 Identities=30% Similarity=0.476 Sum_probs=210.8
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
..+|.+.++||.|+||.||+|...+++.+++|+++.........+.+|+++|+.++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 34588899999999999999998789999999998776656778999999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.++++......+++..+++++.+++.||.|||++ +|+|||||++||||++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~- 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL- 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc-
Confidence 999999999876556689999999999999999999998 8999999999999999999999999999876543221
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
.....++..|++||++.++.++.++|||||||++|+|++ |+.||......+.+.... .+. .. ...
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~---------~~~-~~----~~~ 226 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT---------AGY-RM----PCP 226 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH---------hCC-cC----CCC
Confidence 123446778999999998899999999999999999998 899997654333222111 010 00 011
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...+ ..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 227 -~~~~---~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 227 -AKCP---QEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -CCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1112 345566679999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=337.44 Aligned_cols=251 Identities=25% Similarity=0.414 Sum_probs=202.8
Q ss_pred CCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
+|++.+.||+|+||.||++...++..+|+|.++... ...+.+.+|+++|++++|+||++++++|.+++..++||||+.+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 478889999999999999998788899999987543 3356788999999999999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
|+|.++++... ..+++..++.++.+++.||.|||++ +|+|||||++||+|++++.+||+|||+++...........
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 84 GCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99999986533 2588999999999999999999998 8999999999999999999999999999865433222222
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHN 555 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 555 (662)
...++..|+|||++.+..++.++|||||||+||||++ |+.||......+.+.... .+. .... ..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~---------~~~--~~~~----~~ 224 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS---------RGF--RLYR----PK 224 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---------CCC--CCCC----CC
Confidence 2345678999999998899999999999999999999 899997654332222111 111 0001 11
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 556 YVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 556 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
... ..+.+++.+||+.+|++||++.++++.|.
T Consensus 225 ~~~---~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 LAS---MTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCC---HHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 122 34566777999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=395.98 Aligned_cols=259 Identities=28% Similarity=0.516 Sum_probs=210.6
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
..|...++||+|+||.||+|+. .+|..||||+++.... ....|+++|++++|+|||+++++|.+.+..|+||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577888999999999999985 5789999999875432 1235688999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+|+|.++++. ++|..+.+|+.++++||+|||..+..+|+|||||++|||+++++..++. ||........
T Consensus 766 ~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 766 EGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred CCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence 99999999953 7899999999999999999997666699999999999999999888875 7765443221
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCch-hhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTM-MEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
....|+..|||||++.+..++.++|||||||+||||++|+.||+... ....+.+|.+... .......++|+.+.
T Consensus 836 -~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 910 (968)
T PLN00113 836 -TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCY----SDCHLDMWIDPSIR 910 (968)
T ss_pred -CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhc----CccchhheeCcccc
Confidence 22368899999999999999999999999999999999999996542 2345666765432 22223334444443
Q ss_pred C--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 554 H--NYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 554 ~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
. .....+..++++++.+||+.+|++||+|.||++.|+...
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 2 234567778889999999999999999999999998643
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=350.46 Aligned_cols=241 Identities=23% Similarity=0.320 Sum_probs=194.2
Q ss_pred ceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCc
Q 006083 322 NLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNK 397 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g 397 (662)
++||+|+||.||++.. .+|+.||+|+++... ......+.+|+++|++++|+||++++++|..++.+||||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4799999999999984 478999999997542 233456788999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccccc
Q 006083 398 TLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTR 477 (662)
Q Consensus 398 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 477 (662)
+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 154 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cccc
Confidence 9998886543 588999999999999999999998 999999999999999999999999999875432221 2234
Q ss_pred cccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCC
Q 006083 478 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYV 557 (662)
Q Consensus 478 ~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 557 (662)
..|+..|+|||++.++.++.++|||||||+||||++|+.||......+.+..+.. ... .+... .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~---------~~~------~~p~~-~ 218 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM---------EEI------RFPRT-L 218 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------CCC------CCCCC-C
Confidence 6799999999999999999999999999999999999999976543332221110 000 11111 2
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006083 558 PHEMARLVACGAASIRHSARKRP-----KMSQIVR 587 (662)
Q Consensus 558 ~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 587 (662)
..++. +++.+||+.||++|+ ++.++++
T Consensus 219 ~~~~~---~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 219 SPEAK---SLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CHHHH---HHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 33444 455589999999998 7888775
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=341.33 Aligned_cols=266 Identities=21% Similarity=0.314 Sum_probs=199.6
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
++|.+.++||+|+||.||+|... +++.||||+++.... .....+.+|+++|++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46899999999999999999854 789999999975432 2345678999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+ +|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 975 8888875433 3478899999999999999999998 999999999999999999999999999976543221
Q ss_pred cccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH---hHHHh----hcCccc
Q 006083 474 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL---LGAAL----EDGIYD 545 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~---~~~~~----~~~~~~ 545 (662)
......|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+.+....+.. ....+ ....+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 2234578999999998875 568999999999999999999999997765444333222110 00000 000011
Q ss_pred cccCcccCCCC----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GLVDPRLEHNY----VPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~~d~~l~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
....+...... ......++.+++.+||+.||.+|++++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11110000000 0001123455666999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=366.27 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=201.7
Q ss_pred CCccceeeccCceEEEEEEec-C-CCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 318 FAKSNLLGQGGFGYVHKGVLP-N-GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
|.+.++||+|+||.||++... + ++.||+|++..........+++|+++|+.++|+|||+++++|..++.+||||||+.
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 888999999999999999843 3 67899998866555555678899999999999999999999999999999999999
Q ss_pred CcchhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC-
Q 006083 396 NKTLEYHLHGE--NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT- 472 (662)
Q Consensus 396 ~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~- 472 (662)
||+|.++|+.. ....+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988542 344588899999999999999999998 999999999999999999999999999987654321
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
......+||..|+|||++.+..++.++|||||||+||||++|+.||......+.+.. .+ .+.+.. +
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~----~~-----~~~~~~-----~ 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ----VL-----YGKYDP-----F 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HH-----hCCCCC-----C
Confidence 223456799999999999999999999999999999999999999976543222111 11 111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...... .+.+++..||+.+|++||++.+++.
T Consensus 292 -~~~~s~---~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 -PCPVSS---GMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CccCCH---HHHHHHHHHhccChhhCcCHHHHHh
Confidence 111223 3455556899999999999999874
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=359.27 Aligned_cols=258 Identities=29% Similarity=0.454 Sum_probs=206.8
Q ss_pred CCCCccceeeccCceEEEEEEec--CC--CE-EEEEEeecC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP--NG--KE-VAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~--~g--~~-vavK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 387 (662)
.+..+.++||+|+||.||+|.+. ++ .. ||||..+.. ......+|++|+++|+.++|+|||+|+|++....-+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 34455689999999999999854 22 23 899999863 345567899999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
|||||+|.||+|.++|+.... .++..+++++++++++||+|||++ ++|||||..+|+|++.++.+||+|||+++..
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 999999999999999976554 589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCcccc
Q 006083 468 NDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 468 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
....... ....-...|+|||.+..+.|+.++|||||||++||+++ |..||.+....+....... .+ +..
T Consensus 313 ~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~--------~~-~r~ 382 (474)
T KOG0194|consen 313 SQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK--------NG-YRM 382 (474)
T ss_pred cceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh--------cC-ccC
Confidence 5222111 01123678999999999999999999999999999998 8889987654432222111 11 111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCCCC
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSL 595 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 595 (662)
. .....+.++..++. .|+..+|++|++|.+|.+.|+.....
T Consensus 383 ~-----~~~~~p~~~~~~~~---~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 383 P-----IPSKTPKELAKVMK---QCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred C-----CCCCCHHHHHHHHH---HhccCChhhccCHHHHHHHHHHHHhc
Confidence 1 11244566666655 89999999999999999999864443
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=358.36 Aligned_cols=256 Identities=26% Similarity=0.439 Sum_probs=200.7
Q ss_pred CCCCccceeeccCceEEEEEEe------cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL------PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 387 (662)
++|++.+.||+|+||.||+++. .+++.||||+++.... .....+.+|+++|+.+ +|+|||+++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 4688899999999999999873 2345799999976432 3346788999999999 899999999999999999
Q ss_pred EEEEEecCCcchhhhhccCC------------------------------------------------------------
Q 006083 388 MLVYEFVSNKTLEYHLHGEN------------------------------------------------------------ 407 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~------------------------------------------------------------ 407 (662)
+||||||.+|+|.++++...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999885321
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc-ccccc
Q 006083 408 --------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH-VSTRV 478 (662)
Q Consensus 408 --------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~ 478 (662)
...+++..+++++.||++||+|||++ +|+|||||++|||+++++.+||+|||+++........ .....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 12478889999999999999999998 9999999999999999999999999999865433211 11223
Q ss_pred ccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCC
Q 006083 479 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYV 557 (662)
Q Consensus 479 ~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 557 (662)
.++..|||||++.+..++.++|||||||+||||++ |+.||........+... +..+. .. . .....
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~--------~~~~~-~~----~-~~~~~ 340 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM--------VKRGY-QM----S-RPDFA 340 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH--------HHccc-Cc----c-CCCCC
Confidence 45678999999998999999999999999999997 99999765332221111 11111 00 0 01112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 558 PHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 558 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
+. ++.+++.+||+.||++||++.+|++.|+.
T Consensus 341 ~~---~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 341 PP---EIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred CH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 33 44555569999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=357.30 Aligned_cols=194 Identities=24% Similarity=0.343 Sum_probs=169.4
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
.++|.+.+.||+|+||.||++.. .+++.||||+... ..+.+|+++|++|+|+|||+++++|..++..++|||+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 46799999999999999999984 4789999997542 3578899999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+. ++|..++.... .+++..++.|+.||++||+|||++ +||||||||+||||+.++.+||+|||+++........
T Consensus 165 ~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 165 YK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred CC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 85 67877775433 478999999999999999999998 9999999999999999999999999999754332222
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDM 520 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~ 520 (662)
.....+||..|+|||++.+..++.++||||||||||||++|+.||..
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 33446899999999999999999999999999999999999988643
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=354.09 Aligned_cols=204 Identities=23% Similarity=0.325 Sum_probs=176.8
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.+.||+|+||.||++.. .+++.||||+++... ......+++|+.+|.+++|+||+++++++.+++.+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3688999999999999999985 468999999997532 223456888999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
|||.||+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999996543 588999999999999999999998 99999999999999999999999999987543211
Q ss_pred C----------------------------------ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCC
Q 006083 472 T----------------------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517 (662)
Q Consensus 472 ~----------------------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~P 517 (662)
. ......+||..|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 011235799999999999999999999999999999999999999
Q ss_pred CCCchhh
Q 006083 518 VDMTMME 524 (662)
Q Consensus 518 f~~~~~~ 524 (662)
|......
T Consensus 236 f~~~~~~ 242 (363)
T cd05628 236 FCSETPQ 242 (363)
T ss_pred CCCCCHH
Confidence 9765443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=341.16 Aligned_cols=266 Identities=22% Similarity=0.288 Sum_probs=198.0
Q ss_pred CCCCccceeeccCceEEEEEEe-c-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhc---CCCCcceEEEEEE-----e
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-P-NGKEVAVKSLKTGSG--QGEREFSAEVEIISRV---HHRHLVSLVGYCI-----A 383 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~~~~~-----~ 383 (662)
.+|++.+.||+|+||.||+|+. . +++.||||+++.... .....+.+|+.+++++ +|+||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688999999999999999985 2 468899999875432 2234566788887776 6999999999985 3
Q ss_pred CCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecc
Q 006083 384 GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGL 463 (662)
Q Consensus 384 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 463 (662)
...+++||||+. ++|.+++.......+++..++.++.|++.||.|||++ +|+||||||+||||++++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 5888888765555689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh---HHHhh
Q 006083 464 AKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL---GAALE 540 (662)
Q Consensus 464 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~---~~~~~ 540 (662)
++..... .......|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+.......- ...+.
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9866433 223446789999999999988999999999999999999999999987655444433322110 00000
Q ss_pred c--CccccccCcccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 541 D--GIYDGLVDPRLE---HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 541 ~--~~~~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. ............ ....+.....+.+++.+||+.||++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 000000000000 0000111233456677999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=349.85 Aligned_cols=242 Identities=25% Similarity=0.328 Sum_probs=194.9
Q ss_pred ceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCc
Q 006083 322 NLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNK 397 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g 397 (662)
++||+|+||.||++.. .+|+.||||+++... ......+.+|+++|+.++|+||+++++++.+++.+||||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 478999999997642 233467888999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccccc
Q 006083 398 TLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTR 477 (662)
Q Consensus 398 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 477 (662)
+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~ 154 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKT 154 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cccc
Confidence 999888654 3588999999999999999999998 999999999999999999999999999876432221 2234
Q ss_pred cccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCC
Q 006083 478 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYV 557 (662)
Q Consensus 478 ~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 557 (662)
.+|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+.. .. .+. ..+... .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~----~~-----~~~------~~~p~~-~ 218 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----IL-----MED------IKFPRT-L 218 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH----hc-----cCC------ccCCCC-C
Confidence 6799999999999999999999999999999999999999976543221111 00 000 011111 2
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006083 558 PHEMARLVACGAASIRHSARKRP-----KMSQIVRA 588 (662)
Q Consensus 558 ~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 588 (662)
..+ +.+++.+||+.||++|+ ++.|+++.
T Consensus 219 ~~~---~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 SAD---AKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHH---HHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 233 44555689999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=336.13 Aligned_cols=254 Identities=28% Similarity=0.407 Sum_probs=205.2
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
.+|.+.+.||+|+||.||+|... +++.||+|+++.. ......+.+|+++|++++|+||+++++++..++.+++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34788899999999999999854 6889999998754 334567899999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.+++.......+++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999999766556689999999999999999999998 89999999999999999999999999998765433222
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
.....++..|++||++.+..++.++|||||||+||||++ |..||......+.... +..+. . ....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~---------~~~~~-~----~~~~ 227 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---------LEKGY-R----MERP 227 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---------HHCCC-C----CCCC
Confidence 222334668999999998899999999999999999998 9999976543221111 11111 0 0111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...+. .+.+++.+||+.+|++||++.++++.|+.
T Consensus 228 -~~~~~---~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 228 -EGCPP---KVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred -CCCCH---HHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 11233 45556669999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=368.13 Aligned_cols=256 Identities=22% Similarity=0.311 Sum_probs=204.5
Q ss_pred hCCCCccceeeccCceEEEEEEecCC-CEEEEEEeecCCchhHHHHHHHHHHHHhcC-CCCcceEEE-EEE---e---CC
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNG-KEVAVKSLKTGSGQGEREFSAEVEIISRVH-HRHLVSLVG-YCI---A---GG 385 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~-~~~---~---~~ 385 (662)
..++.+.+.|.+|||+.||++.+..+ ..||+|++-..+....+.+++||++|++|. |+|||.|++ ... . .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34577889999999999999997665 999999998877788899999999999997 999999999 322 1 24
Q ss_pred eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccc
Q 006083 386 QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
+++|+||||.||.|-|++.......|.+.++++|++++++|+++||. +.+.|||||||-+||||..++..||||||.|.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 67899999999999999975544459999999999999999999999 46679999999999999999999999999986
Q ss_pred ccCCCCCccc--------cccccCccccCcccc---cCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH
Q 006083 466 LSNDNHTHVS--------TRVMGTFGYLAPEYA---SSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL 534 (662)
Q Consensus 466 ~~~~~~~~~~--------~~~~Gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~ 534 (662)
.......... -...-|+.|.+||.+ .+..+++|+|||+|||+||-||....||+......
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la--------- 265 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA--------- 265 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---------
Confidence 4332221100 113468999999976 46789999999999999999999999997653110
Q ss_pred hHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 535 LGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 535 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
+-.+.|. -.-.+....+|..|+..||+.||.+||.+-||++.+...
T Consensus 266 ----Ilng~Y~--------~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 266 ----ILNGNYS--------FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ----EEecccc--------CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 0111111 111244556666777799999999999999999876543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=339.61 Aligned_cols=254 Identities=27% Similarity=0.454 Sum_probs=203.2
Q ss_pred CCCccceeeccCceEEEEEEecC------CCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLPN------GKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
+|++.+.||+|+||.||+|.... ...|++|.++.... .....|.+|+++|.+++|+||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 57888999999999999998532 25799999975433 334678999999999999999999999999999999
Q ss_pred EEEecCCcchhhhhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCc
Q 006083 390 VYEFVSNKTLEYHLHGENR--------------PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE 455 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 455 (662)
+|||+.+++|.+++..... ..+++..++.++.|++.||.|||++ +|+||||||+||||++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCc
Confidence 9999999999999864321 4578899999999999999999998 8999999999999999999
Q ss_pred EEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHH
Q 006083 456 AMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARP 533 (662)
Q Consensus 456 vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~ 533 (662)
+||+|||+++....... .......++..|+|||++.++.++.++|||||||+||||++ |..||......+... +.
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~-~i-- 239 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE-MI-- 239 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HH--
Confidence 99999999986543221 22334567889999999998899999999999999999998 999997654333211 11
Q ss_pred HhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 534 LLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 534 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
..+.... . ....+ .++.+++.+||+.||.+||++.||++.|+.
T Consensus 240 ------~~~~~~~-----~-~~~~~---~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 ------RSRQLLP-----C-PEDCP---ARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ------HcCCcCC-----C-cccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111111 0 11223 445556669999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.51 Aligned_cols=201 Identities=25% Similarity=0.402 Sum_probs=176.3
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.++|++.+.||+|+||.||++... ++..+|+|+++.... .....+.+|+++|++++|+||++++++|.+++.++||||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467999999999999999999965 688999999876532 334678999999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.+++|.+++.... .+++..+..++.+++.||.|||+.+ +|+|||||++||||++++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 999999999996543 4788999999999999999999752 69999999999999999999999999987654321
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCch
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTM 522 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~ 522 (662)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred --cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 233578999999999998899999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=340.66 Aligned_cols=252 Identities=27% Similarity=0.362 Sum_probs=200.6
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
+|++.++||+|+||.||++.. .+++.||||++..... .....+.+|+++|++++|+||+++++++.+++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999985 4689999999975422 223457889999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.+++|.+++.......+++..+..++.|++.||.|||+. +|+|||||++|||+++++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999988665555689999999999999999999998 899999999999999999999999999987543221
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
....+|+..|++||++.+..++.++|||||||+||||++|+.||..........++... +....
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~-----~~~~~--------- 221 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR-----VKEDQ--------- 221 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH-----hhhcc---------
Confidence 23357899999999999889999999999999999999999999865433222211111 01100
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRP-----KMSQIVRA 588 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 588 (662)
..+.......+.+++..||+.||++|| ++.++++.
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 001111223345566699999999999 77777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=342.19 Aligned_cols=202 Identities=25% Similarity=0.364 Sum_probs=171.4
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.++|++.+.||+|+||.||+|... +++.||||+++.... .....+.+|+++|++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999954 789999999975432 223467889999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+. ++|.+++... ...+.+..+..++.|++.||+|||++ +|+||||||+||||++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 996 5666666543 23478889999999999999999999 99999999999999999999999999997543322
Q ss_pred ccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCch
Q 006083 473 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTM 522 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~ 522 (662)
.......|+..|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 12234578999999998865 458899999999999999999999997653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=363.06 Aligned_cols=255 Identities=29% Similarity=0.467 Sum_probs=208.8
Q ss_pred CCCccceeeccCceEEEEEEec----CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP----NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
...+.++||.|.||.||+|+++ ....||||.||.... +.+.+|+.|+.||.++.||||++|.|+.....-.+||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3566889999999999999964 235799999998743 44678999999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
|||++|.|+.+|+..+. .+.+.+++-++++|+.|+.||-+. ++|||||..+||||+.+...||+||||++.+.++.
T Consensus 710 EyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 99999999999987664 488999999999999999999998 99999999999999999999999999999876554
Q ss_pred Ccccccccc--CccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 472 THVSTRVMG--TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 472 ~~~~~~~~G--t~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
....+..-| ...|.|||.+..++++.++|||||||||||.++ |.+||-....+|.+..+ +++.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI---------e~gy----- 851 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI---------EQGY----- 851 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH---------Hhcc-----
Confidence 322222222 468999999999999999999999999999665 99998665555544332 2222
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
+|-.. .+....|.+|+++||++|-.+||.+.||+..|+..+
T Consensus 852 --RLPpP--mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 852 --RLPPP--MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred --CCCCC--CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 22211 223344555666999999999999999999887433
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=333.06 Aligned_cols=266 Identities=24% Similarity=0.313 Sum_probs=205.3
Q ss_pred CCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCch-h-HHHHHHHHHHHHhcCCCC-cceEEEEEEeCC------e
Q 006083 317 GFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQ-G-EREFSAEVEIISRVHHRH-LVSLVGYCIAGG------Q 386 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~-~-~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~------~ 386 (662)
.|...++||+|.||+||+|+ ..+|+.||+|+++....+ + -....+|+.+|++|+|.| ||+|++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 46667889999999999999 558899999999876442 2 245689999999999999 999999999877 8
Q ss_pred EEEEEEecCCcchhhhhccCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENR--PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
++|||||+ .-+|..++..... ..++...+..++.||++||+|||++ +|+||||||+||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 89999998 5678888865432 3577788999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhc--
Q 006083 465 KLSNDNHTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALED-- 541 (662)
Q Consensus 465 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-- 541 (662)
+...-... ..+..++|.+|.|||++.+. .|+...||||+|||++||++++..|.+....+.+..+.+-+ +.--++
T Consensus 168 ra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l-GtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL-GTPNEKDW 245 (323)
T ss_pred HHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc-CCCCccCC
Confidence 97664432 34567889999999999876 79999999999999999999999999887766655544321 110000
Q ss_pred -C-----ccccccCcccCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 542 -G-----IYDGLVDPRLEHNYV----PHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 542 -~-----~~~~~~d~~l~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+ .++......-..... +....+..+++.+||+.+|.+|.+++..++.
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 001000000001111 1111355677779999999999999998875
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=348.10 Aligned_cols=241 Identities=24% Similarity=0.303 Sum_probs=191.9
Q ss_pred eeccCceEEEEEEec-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCcch
Q 006083 324 LGQGGFGYVHKGVLP-NGKEVAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTL 399 (662)
Q Consensus 324 iG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L 399 (662)
||+|+||.||++... +++.||||+++.. .......+.+|+++|++++|+||+++++++.+.+..|+||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999854 6889999999753 223446678899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccccccc
Q 006083 400 EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM 479 (662)
Q Consensus 400 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 479 (662)
.+++.... .+++..+..++.|+++||.|||++ +|+||||||+||||+.++.+||+|||+++...... ......+
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 99996543 488999999999999999999998 99999999999999999999999999997643322 2234467
Q ss_pred cCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHH
Q 006083 480 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPH 559 (662)
Q Consensus 480 Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 559 (662)
|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+.. .+ .. .+ .+.. ....
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~----~~----~~-~~------~~~~-~~~~ 218 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK----IL----QE-PL------RFPD-GFDR 218 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHH----HH----cC-CC------CCCC-cCCH
Confidence 99999999999999999999999999999999999999976543322211 11 10 00 1111 1223
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006083 560 EMARLVACGAASIRHSARKRPKMSQIVRAL 589 (662)
Q Consensus 560 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 589 (662)
+ +.+++.+||+.||++|+++..+.+.|
T Consensus 219 ~---~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 219 D---AKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred H---HHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 3 44455689999999998654443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=378.84 Aligned_cols=256 Identities=31% Similarity=0.498 Sum_probs=210.5
Q ss_pred CCCccceeeccCceEEEEEEec--CCC----EEEEEEeecC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP--NGK----EVAVKSLKTG-SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~--~g~----~vavK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
+..+++.||+|.||.||.|... +|. .||||.++.. +.++..+|.+|..+|+.++|||||+++|+|.+.+..+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 3556789999999999999854 343 4999999876 44567889999999999999999999999999999999
Q ss_pred EEEecCCcchhhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 390 VYEFVSNKTLEYHLHGE-----NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~-----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
++|||+||+|..+|++. ....+...+.+.++++||+|+.||+++ ++|||||..+|+||++...|||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999754 234689999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcC
Q 006083 465 KLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDG 542 (662)
Q Consensus 465 ~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 542 (662)
+.+.+.... ......-...|||||.++.+.++.|+|||||||+|||+++ |..||......+.+..|. +.+
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~--------~gg 921 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL--------EGG 921 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH--------hCC
Confidence 955433221 1122233468999999999999999999999999999998 888997766555443332 233
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 543 IYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 543 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
.+ -...|+++.+.+||. .||+.+|++||++..|++.+....
T Consensus 922 RL-------~~P~~CP~~ly~lM~---~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 922 RL-------DPPSYCPEKLYQLML---QCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred cc-------CCCCCCChHHHHHHH---HHccCChhhCccHHHHHhhhhhhh
Confidence 21 134567777776665 899999999999999999877544
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=355.67 Aligned_cols=252 Identities=20% Similarity=0.283 Sum_probs=197.6
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.++||+|+||.||+++. .+|+.||||+++... ......+.+|+++|..++|+||+++++++.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4689999999999999999995 468999999997532 233456788999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
|||.+|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999996543 489999999999999999999998 99999999999999999999999999987543211
Q ss_pred Cc-------------------------------------cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhC
Q 006083 472 TH-------------------------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG 514 (662)
Q Consensus 472 ~~-------------------------------------~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG 514 (662)
.. .....+||+.|+|||++.+..++.++|||||||+||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 01124699999999999999999999999999999999999
Q ss_pred CCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 006083 515 RRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPK---MSQIVRA 588 (662)
Q Consensus 515 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~evl~~ 588 (662)
+.||......+.+..... . ...+. . ........++.+|+. +|+. +|.+|++ +.|+++.
T Consensus 236 ~~Pf~~~~~~~~~~~i~~------~-~~~~~--~---~~~~~~s~~~~~li~---~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNPQETYRKIIN------W-KETLQ--F---PDEVPLSPEAKDLIK---RLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCHHHHHHHHHc------C-CCccC--C---CCCCCCCHHHHHHHH---HHcc-CHhhcCCCCCHHHHhcC
Confidence 999976543332221110 0 00000 0 001122344445444 6776 8999998 8887763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=333.43 Aligned_cols=253 Identities=30% Similarity=0.428 Sum_probs=204.1
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
++|++.+.||+|+||.||++...++..||+|.++.... ..+.+.+|++++++++|+||+++++++. .+..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 45888999999999999999987888999999976433 3467899999999999999999999885 456899999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
+++|.++++......+++..+++++.+++.||.|||++ +|+|||||++|||+++++.+||+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 99999999765555689999999999999999999998 899999999999999999999999999987654332222
Q ss_pred cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
....++..|+|||++.+..++.++|||||||++|||++ |+.||......+.+..+. .+.. .....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~---------~~~~-----~~~~~ 226 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE---------RGYR-----MPCPQ 226 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---------cCCC-----CCCCC
Confidence 22345678999999988899999999999999999999 889997654333222111 1100 00111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.....+.+++.+|++.+|++||++.++++.|+.
T Consensus 227 ----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 227 ----DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 112346666779999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=350.61 Aligned_cols=245 Identities=22% Similarity=0.274 Sum_probs=198.2
Q ss_pred CCCCccceeeccCceEEEEEEecC--CCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPN--GKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~--g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
++|.+.+.||+|+||.||+|...+ +..||||++.... ....+.+.+|+++|+.++|+||+++++++.+.+.+|||
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 458899999999999999998533 3689999986532 23345788999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999996543 488999999999999999999998 9999999999999999999999999999875432
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
....+||..|||||++.+..++.++||||||||||||++|+.||........+... ..+..
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i---------~~~~~------ 245 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI---------LEGII------ 245 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH---------hcCCC------
Confidence 23467999999999999888999999999999999999999999765432221111 11111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRP-----KMSQIVRA 588 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 588 (662)
.+ .......+. .++.+||+.||++|+ +++++++.
T Consensus 246 ~~-p~~~~~~~~---~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 YF-PKFLDNNCK---HLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CC-CCCCCHHHH---HHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01 112233444 455589999999995 78887754
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=334.30 Aligned_cols=251 Identities=28% Similarity=0.437 Sum_probs=202.0
Q ss_pred CCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
+|.+.+.||+|+||.||++...++..||||.++... .....+.+|++++++++|+||+++++++.+.+..++||||+.+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 478889999999999999987777789999987543 2346789999999999999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
++|.+++..... .+.+..+++++.+++.||+|||+. +|+|||||++|||+++++.+||+|||+++...........
T Consensus 84 ~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 84 GCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 999999865433 589999999999999999999998 9999999999999999999999999998866543322222
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHN 555 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 555 (662)
...++..|++||++.+..++.++|||||||+||||++ |+.||......+.... . ..+... ....
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~-~--------~~~~~~-----~~~~- 224 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK-V--------SQGLRL-----YRPH- 224 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-H--------hcCCCC-----CCCC-
Confidence 2345678999999998889999999999999999998 9999975543221111 0 111100 0001
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 556 YVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 556 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
.. ...+.+++.+||+.+|.+||++.+|++.|+
T Consensus 225 ~~---~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 LA---SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CC---CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11 245566666999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=354.39 Aligned_cols=258 Identities=22% Similarity=0.365 Sum_probs=202.7
Q ss_pred hCCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQ 386 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~ 386 (662)
.++|.++++||+|+||.||+|... .+..||||+++.... ...+.+.+|+++|++++ |+|||+++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 456889999999999999999742 235799999975433 33467899999999996 9999999999999999
Q ss_pred EEEEEEecCCcchhhhhccCC-----------------------------------------------------------
Q 006083 387 RMLVYEFVSNKTLEYHLHGEN----------------------------------------------------------- 407 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~----------------------------------------------------------- 407 (662)
+|||||||.+|+|.++|+...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999885421
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC
Q 006083 408 -----------------------------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD 452 (662)
Q Consensus 408 -----------------------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~ 452 (662)
...+++..+++++.|+++||+|||++ +|+|||||++|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 12467888899999999999999998 9999999999999999
Q ss_pred CCcEEEEeeccccccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHH
Q 006083 453 NFEAMVADFGLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEW 530 (662)
Q Consensus 453 ~~~vkl~DFGla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~ 530 (662)
++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||......+.+...
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 999999999999865433221 1223457788999999998899999999999999999997 99998754322222111
Q ss_pred HHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 531 ARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
. ..+... ... ...+ ..+.+++.+||+.+|++||++.+|+++|+..
T Consensus 353 ~--------~~~~~~-----~~~-~~~~---~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 353 I--------KSGYRM-----AKP-DHAT---QEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred H--------hcCCCC-----CCC-ccCC---HHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 1 111100 011 1122 3455666799999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=353.65 Aligned_cols=254 Identities=22% Similarity=0.246 Sum_probs=196.7
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.|++.+.||+|+||.||+|+. .+++.||||+++... ......+.+|+++|++++|+|||++++++.+++.+|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999984 478999999997542 2334578899999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
||.||+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999986543 478888999999999999999998 999999999999999999999999999764311000
Q ss_pred ----------------------------------------------ccccccccCccccCcccccCCCCCchHHHHHHHH
Q 006083 473 ----------------------------------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 506 (662)
Q Consensus 473 ----------------------------------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGv 506 (662)
......+||..|||||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012357999999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 006083 507 MLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIV 586 (662)
Q Consensus 507 vl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 586 (662)
|||||++|+.||......+....... ....+. .. .......++.+|+.- +.|+..++..|+++.+|+
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~-------~~~~~~----~~-~~~~~s~~~~dli~~-ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVIN-------WENTLH----IP-PQVKLSPEAVDLITK-LCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHc-------cccccC----CC-CCCCCCHHHHHHHHH-HccCcccccCCCCHHHHh
Confidence 99999999999976543322211100 000000 00 011123444454442 136667777799999998
Q ss_pred HH
Q 006083 587 RA 588 (662)
Q Consensus 587 ~~ 588 (662)
+.
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.85 Aligned_cols=266 Identities=19% Similarity=0.274 Sum_probs=202.6
Q ss_pred HHhCCCCccceeeccCceEEEEEE-ecCCCEEEEEEee--cCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe-----C
Q 006083 313 AATGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLK--TGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA-----G 384 (662)
Q Consensus 313 ~~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~--~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~ 384 (662)
.+...|...+.||+|+||.|..+. ..+|+.||||++. ....-..++..+|+++|++++|+||+.+++++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 344567778999999999999998 4578999999997 3344556788999999999999999999998864 4
Q ss_pred CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
..+|+|+|+| +.+|...|+.+. .+....+..+++|+++||.|+|+. +|+||||||.|||++.+..+||||||+|
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 6889999999 788988886543 388999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCC-CCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH--------
Q 006083 465 KLSNDN-HTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL-------- 534 (662)
Q Consensus 465 ~~~~~~-~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~-------- 534 (662)
+..... .....+.++.|.+|.|||++.. ..|+.+.||||+||||.|||+|+.-|.+.+.-+.+..+...+
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 987542 1123466788999999998864 689999999999999999999999998775444333221110
Q ss_pred -------hHHHhhc-CccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 535 -------LGAALED-GIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 535 -------~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
....+.. ......--..+-... ..+. ++++.+||..||++|.|++|.++.
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a-~p~A---idLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNA-NPLA---IDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCC-CHHH---HHHHHHHhccCccccCCHHHHhcC
Confidence 0000100 000000000111111 2223 344458999999999999998864
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=333.24 Aligned_cols=253 Identities=32% Similarity=0.454 Sum_probs=204.1
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
++|.+.+.||+|+||.||+|...++..||||+++.... ..+.+.+|++++++++|+||+++++++.+ +..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 46899999999999999999876767899999986432 34678999999999999999999998754 56799999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
+++|.+++.......+++..+++++.++++||+|||+. +|+||||||+|||+++++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 99999999765445678999999999999999999998 899999999999999999999999999986654332222
Q ss_pred cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
....++..|++||++.++.++.++|||||||++|||++ |+.||......+.+.. ...+...
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~---------~~~~~~~--------- 222 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---------VERGYRM--------- 222 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH---------HhcCCCC---------
Confidence 23456778999999998899999999999999999999 8888876543222111 0111000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.........+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 0111223456677779999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.63 Aligned_cols=264 Identities=19% Similarity=0.340 Sum_probs=194.7
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAG-----GQRM 388 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~ 388 (662)
+|++.++||+|+||.||+|+. .+|+.||||+++.. .......+.+|+++|++++|+||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 488899999999999999984 47899999998743 223345788999999999999999999988643 3589
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
+|||||. ++|.+++.... .+++..+..++.||++||.|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 68888885433 488999999999999999999998 99999999999999999999999999997653
Q ss_pred CCCC--ccccccccCccccCcccccC--CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhH-------H
Q 006083 469 DNHT--HVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLG-------A 537 (662)
Q Consensus 469 ~~~~--~~~~~~~Gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~-------~ 537 (662)
.... ......+|+..|+|||++.+ ..++.++|||||||++|||++|+.||........+... ...+. .
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLI-TDLLGTPSPETIS 233 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHH-HHHhCCCCHHHHH
Confidence 2211 12234679999999999875 67899999999999999999999999765432211110 00000 0
Q ss_pred HhhcC----cccccc---CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 538 ALEDG----IYDGLV---DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 538 ~~~~~----~~~~~~---d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.+... .+..+. ...+... .+.....+.+++.+||+.||++||++.|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQK-FPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHh-cCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 000000 0000000 00111334566679999999999999999963
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.26 Aligned_cols=244 Identities=26% Similarity=0.383 Sum_probs=193.2
Q ss_pred CCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHH---HhcCCCCcceEEEEEEeCCeEEEE
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEII---SRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il---~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
|++.+.||+|+||.||++.. .+|+.||||+++... ....+.+.+|++++ ++++|+||+++++++.+++..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 66789999999999999985 468999999997542 22345677776665 456799999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+++|..+++. ..+++..++.++.||+.||.|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988854 2489999999999999999999998 9999999999999999999999999998754332
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
.. .....+|+..|||||++.+..++.++|||||||+||||++|+.||......+.+..+.. +..
T Consensus 155 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~---------~~~------ 218 (324)
T cd05589 155 GD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN---------DEV------ 218 (324)
T ss_pred CC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------CCC------
Confidence 21 22346799999999999999999999999999999999999999986644332221111 100
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPK-----MSQIVR 587 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 587 (662)
.+. ..... .+.+++.+||+.||.+||+ +.++++
T Consensus 219 ~~p-~~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 RYP-RFLSR---EAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCC-CCCCH---HHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 011 11223 3445566999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=354.24 Aligned_cols=252 Identities=24% Similarity=0.259 Sum_probs=201.9
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|.+.+.||+|+||.||+|+.. +|+.||||+++... ......+.+|+++|..++|+||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46899999999999999999954 78999999997542 234567889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.+++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999655 4588999999999999999999998 99999999999999999999999999998665432
Q ss_pred ----------------------------CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchh
Q 006083 472 ----------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMM 523 (662)
Q Consensus 472 ----------------------------~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~ 523 (662)
........||..|+|||++.+..++.++||||||||||||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122346799999999999999999999999999999999999999977653
Q ss_pred hhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 006083 524 EDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPK-MSQIVRA 588 (662)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~evl~~ 588 (662)
.+....... . ...+. . .... ....++. .++..||. +|.+|++ +.++++.
T Consensus 236 ~~~~~~i~~-----~--~~~~~---~-p~~~-~~~~~~~---~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QETYNKIIN-----W--KESLR---F-PPDP-PVSPEAI---DLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHHhc-----c--CCccc---C-CCCC-CCCHHHH---HHHHHHcc-ChhhcCCCHHHHhcC
Confidence 322211110 0 00000 0 0000 1233444 44457887 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=347.81 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=209.3
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCch---hHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQ---GEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l 389 (662)
...|++.+.||+|.||.||+++.. +|+.+|+|++.+.... ..+.+.+|++||++|. |+|||+|+++|++...++|
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456889999999999999999955 5999999999876443 3468999999999998 9999999999999999999
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC----CCcEEEEeecccc
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD----NFEAMVADFGLAK 465 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~----~~~vkl~DFGla~ 465 (662)
|||+|.||.|++.|... .+++..+..++.|++.++.|||+. +|+||||||+|||+.. ++.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999765 289999999999999999999998 9999999999999964 3579999999999
Q ss_pred ccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
.... .......+||++|+|||++....|+..+||||+||++|.|++|..||........+.+.. .+.+
T Consensus 188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~---------~~~~- 255 (382)
T KOG0032|consen 188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL---------RGDF- 255 (382)
T ss_pred EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH---------cCCC-
Confidence 8876 234567899999999999999999999999999999999999999998876544433221 1222
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.+.+ ..... ....+++++. .|+..||.+|.++.++++.
T Consensus 256 ~f~~-~~w~~-is~~akd~i~---~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 DFTS-EPWDD-ISESAKDFIR---KLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCC-CCccc-cCHHHHHHHH---HhcccCcccCCCHHHHhcC
Confidence 1111 11111 2455556555 8999999999999999983
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=336.83 Aligned_cols=249 Identities=31% Similarity=0.531 Sum_probs=193.6
Q ss_pred ccceeeccCceEEEEEEec-----CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 320 KSNLLGQGGFGYVHKGVLP-----NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 320 ~~~~iG~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+.+.||.|.||.||+|.+. .+..|+||+++.... ...+.|.+|+++|++++|+||++++|+|...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999965 357899999976433 3468899999999999999999999999988889999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC-
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT- 472 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~- 472 (662)
|.+|+|.++|+......+++..+++|+.||++||.|||++ +|+||||+++||||++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999887556789999999999999999999998 899999999999999999999999999987632221
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
.......+...|+|||++.+..++.++||||||+++|||++ |+.||......+..... ..+....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~---------~~~~~~~----- 225 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL---------KQGQRLP----- 225 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH---------HTTEETT-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---------cccccce-----
Confidence 22233456788999999998889999999999999999999 77888665333222111 1111100
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRAL 589 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 589 (662)
.....+.. +..++..||+.+|++||++.+|++.|
T Consensus 226 -~~~~~~~~---~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 -IPDNCPKD---IYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -SBTTSBHH---HHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -eccchhHH---HHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 01122333 44555699999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=354.95 Aligned_cols=254 Identities=20% Similarity=0.249 Sum_probs=197.7
Q ss_pred HhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
..++|++.+.||+|+||.||++... +++.||+|++++.. ......+.+|+.+++.++|+||+++++++.+++.+|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3467999999999999999999954 68899999997531 2234568899999999999999999999999999999
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
|||||.+|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 99999999999998543 378889999999999999999998 999999999999999999999999999987654
Q ss_pred CCCccccccccCccccCcccccCC----CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
.........+||..|||||++.+. .++.++|||||||+||||++|+.||........+..+... ...+.
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~-------~~~~~ 267 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH-------KNSLN 267 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------CcccC
Confidence 332223456799999999998753 3789999999999999999999999765433322221110 00000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARK--RPKMSQIVRA 588 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~ 588 (662)
+ .........+..++ ..||..++++ |+++.|+++.
T Consensus 268 -~----p~~~~~s~~~~~li---~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 -F----PEDVEISKHAKNLI---CAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -C----CCcccCCHHHHHHH---HHHccCchhccCCCCHHHHhcC
Confidence 0 00112234444444 4677655543 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.87 Aligned_cols=241 Identities=27% Similarity=0.395 Sum_probs=193.2
Q ss_pred ceeeccCceEEEEEEe----cCCCEEEEEEeecCC----chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 322 NLLGQGGFGYVHKGVL----PNGKEVAVKSLKTGS----GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
++||+|+||.||++.. .+++.||||+++... ......+.+|+++|++++|+||++++++|..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999974 367899999997532 22335678899999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+++|.+++.... .+.+..+..++.|++.||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 99999999986543 477888899999999999999998 999999999999999999999999999875433222
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
......|+..|+|||++.+..++.++|||||||+||||++|+.||........+.... .+.+ .+.
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~---------~~~~------~~~ 220 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL---------KGKL------NLP 220 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH---------cCCC------CCC
Confidence 2234679999999999998889999999999999999999999997654332221111 1111 111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRP-----KMSQIVR 587 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 587 (662)
...... +.+++.+||+.+|++|+ ++.++++
T Consensus 221 -~~~~~~---~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 221 -PYLTPE---ARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -CCCCHH---HHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 112233 44555699999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=337.67 Aligned_cols=262 Identities=24% Similarity=0.319 Sum_probs=200.0
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC---C--eEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAG---G--QRMLV 390 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~---~--~~~lv 390 (662)
.|...++||.|.||.||+|++ .+++.||||++..+. +.-.+|++||++++|||||+|+.+|... + ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 366789999999999999994 467999999997542 2336799999999999999999988632 2 23489
Q ss_pred EEecCCcchhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC-CcEEEEeecccccc
Q 006083 391 YEFVSNKTLEYHLHG--ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN-FEAMVADFGLAKLS 467 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkl~DFGla~~~ 467 (662)
||||. .+|.++++. ..+..++...+.-+..||++||.|||+. +|+||||||.|||||.+ |.+||||||.|+.+
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99995 577777753 2344577788888999999999999998 99999999999999975 99999999999988
Q ss_pred CCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh---HHHhh---
Q 006083 468 NDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL---GAALE--- 540 (662)
Q Consensus 468 ~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~---~~~~~--- 540 (662)
..+.... .+.-+..|.|||++.+ ..|+.+.||||.|||+.||+-|+.-|.+....+.++++++-+= .+.+.
T Consensus 177 ~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 177 VKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred ccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 7665443 3455889999998886 5799999999999999999999999999888888887766320 01111
Q ss_pred ----cCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 541 ----DGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 541 ----~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+..+..+...-+..-+....-.+.++++.++|..+|.+|-++.|++..
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111122222111111222233445556668999999999999998853
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=355.53 Aligned_cols=252 Identities=20% Similarity=0.229 Sum_probs=199.4
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
.++|++.++||+|+||.||++.. .+++.||||+++... ......+.+|+.+|++++|+||+++++++.+++.+|||
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 45799999999999999999985 468999999997532 22345578899999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
||||.||+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||++......
T Consensus 122 ~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 122 MEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999988543 378888999999999999999998 9999999999999999999999999999876543
Q ss_pred CCccccccccCccccCcccccCC----CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
........+|++.|||||++.+. .++.++|||||||+||||++|+.||........+..... ... .
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~--------~~~--~ 265 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD--------HKN--S 265 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc--------CCC--c
Confidence 32223446799999999998653 478999999999999999999999987544332222111 000 0
Q ss_pred ccCcccC-CCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006083 547 LVDPRLE-HNYVPHEMARLVACGAASIRHSARK--RPKMSQIVRA 588 (662)
Q Consensus 547 ~~d~~l~-~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~ 588 (662)
+ .+. ......++.+ ++..||+.+|++ |+++.|+++.
T Consensus 266 ~---~~~~~~~~s~~~~~---li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 L---TFPDDIEISKQAKD---LICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred C---CCCCcCCCCHHHHH---HHHHHccChhhccCCCCHHHHhcC
Confidence 0 011 1112344444 445899988987 9999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=351.30 Aligned_cols=252 Identities=23% Similarity=0.263 Sum_probs=200.2
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|.+.+.||+|+||.||++.. .+|+.||||+++... ....+.+.+|+.+++.++|+||+++++++.+++..||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4689999999999999999985 478999999998642 234466889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.+++|.+++.... ..+++..+..++.|+++||.|||++ +|+||||||+||||+.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999996542 3588999999999999999999999 99999999999999999999999999998765443
Q ss_pred CccccccccCccccCccccc------CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 472 THVSTRVMGTFGYLAPEYAS------SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
........|+..|+|||++. ...++.++||||||||||||++|+.||........+.... ......
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~--------~~~~~~ 228 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM--------NFQRFL 228 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH--------cCCCcc
Confidence 33334457999999999986 4568899999999999999999999997654333222111 111000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+- .......++.+|+ ..||+ +|++|+++.++++
T Consensus 229 ~~~----~~~~~~~~~~~li---~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 KFP----EDPKVSSDFLDLI---QSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCC----CCCCCCHHHHHHH---HHHcc-ChhhCCCHHHHhC
Confidence 000 0111234444444 47887 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=334.93 Aligned_cols=254 Identities=25% Similarity=0.435 Sum_probs=204.0
Q ss_pred CCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 388 (662)
++|.+.+.||+|+||.||+|... +++.||||+++..... ..+.+.+|+++|++++|+||+++++++..++..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45788899999999999999853 3478999999865444 4578999999999999999999999999999999
Q ss_pred EEEEecCCcchhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcE
Q 006083 389 LVYEFVSNKTLEYHLHGEN------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA 456 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 456 (662)
+||||+.+++|.++|.... ...+.+..+..++.+++.||.|||++ +|+|||||++||||+.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999996432 24578889999999999999999998 89999999999999999999
Q ss_pred EEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHH
Q 006083 457 MVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPL 534 (662)
Q Consensus 457 kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~ 534 (662)
||+|||+++....... .......++..|+|||++.++.++.++|||||||+||||++ |+.||......+.+. ..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~-~~--- 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE-CI--- 237 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HH---
Confidence 9999999976533221 12233456788999999999999999999999999999998 999986654333221 11
Q ss_pred hHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 535 LGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 535 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
..+..... ....+ ..+.+++.+||+.||.+||++.||++.|+
T Consensus 238 -----~~~~~~~~------~~~~~---~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 -----TQGRLLQR------PRTCP---SEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -----HcCCcCCC------CCCCC---HHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111111 11122 34455666999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=347.92 Aligned_cols=242 Identities=23% Similarity=0.311 Sum_probs=194.0
Q ss_pred ceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCc
Q 006083 322 NLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNK 397 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g 397 (662)
++||+|+||.||++.. .+|+.||||+++... ......+.+|+++++.++|+||+++++++.+++.+||||||+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 478999999997642 233456788999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 398 TLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHE-DCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 398 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
+|.+++.... .+++..++.++.||+.||+|||+ + +|+||||||+||||++++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMK 154 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccc
Confidence 9998885443 58899999999999999999997 6 899999999999999999999999999875433222 223
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNY 556 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 556 (662)
..+|+..|||||++.++.++.++|||||||+||||++|+.||......+..... ....+ .+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i---------~~~~~------~~p~~- 218 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---------LMEEI------RFPRT- 218 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH---------hcCCC------CCCCC-
Confidence 467999999999999999999999999999999999999999765432221110 00000 11111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006083 557 VPHEMARLVACGAASIRHSARKRP-----KMSQIVRA 588 (662)
Q Consensus 557 ~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 588 (662)
...+ +.+++.+||+.||++|+ ++.++++.
T Consensus 219 ~~~~---~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 LSPE---AKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCHH---HHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 2233 44455589999999996 88888854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=355.40 Aligned_cols=203 Identities=25% Similarity=0.309 Sum_probs=174.5
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|.+.+.||+|+||.||++.. .+|+.||||++.... ....+.+++|+++|++++|+|||++++++.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688999999999999999984 478999999986532 233456889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.||+|.+++... ..+.+..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999998653 3478889999999999999999998 99999999999999999999999999996332110
Q ss_pred Cc----------------------------------------------cccccccCccccCcccccCCCCCchHHHHHHH
Q 006083 472 TH----------------------------------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFG 505 (662)
Q Consensus 472 ~~----------------------------------------------~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlG 505 (662)
.. .....+||..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 00124799999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCchh
Q 006083 506 VMLLELITGRRPVDMTMM 523 (662)
Q Consensus 506 vvl~eLltG~~Pf~~~~~ 523 (662)
||||||++|+.||.....
T Consensus 236 vil~elltG~~Pf~~~~~ 253 (377)
T cd05629 236 AIMFECLIGWPPFCSENS 253 (377)
T ss_pred hhhhhhhcCCCCCCCCCH
Confidence 999999999999976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=331.17 Aligned_cols=250 Identities=24% Similarity=0.411 Sum_probs=200.4
Q ss_pred CCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
+|.+.+.||+|+||.||++...++..+|||+++.... ....+.+|++++++++|+||+++++++.+.+..|+||||+.+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4778899999999999999987778899999875432 345688899999999999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
++|.+++..... .+++..+++++.|++.||+|||++ +|+|||||++|||+++++.+||+|||+++...........
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 84 GCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 999999865433 588999999999999999999998 8999999999999999999999999999866433221111
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHN 555 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 555 (662)
...++..|++||++.+..++.++|||||||+||||++ |+.||+.....+.... +..+. ..... .
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---------~~~~~-----~~~~~-~ 224 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES---------VSAGY-----RLYRP-K 224 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH---------HHcCC-----cCCCC-C
Confidence 2234457999999998899999999999999999999 8999976543322211 11110 00011 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006083 556 YVPHEMARLVACGAASIRHSARKRPKMSQIVRAL 589 (662)
Q Consensus 556 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 589 (662)
..+ ..+.+++.+||+.+|++||++.||++.|
T Consensus 225 ~~~---~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAP---TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCC---HHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 122 3455666699999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=329.73 Aligned_cols=253 Identities=32% Similarity=0.455 Sum_probs=202.7
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
++|.+.+.||+|+||.||++....+..||+|++.... ...+.+.+|++++++++|+||+++++++.. +..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 4588899999999999999998777789999987543 334678899999999999999999998854 56789999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
+++|.++++......+++..++.++.+++.||.|||+. +|+|||||++||||++++.+||+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999765555688999999999999999999998 899999999999999999999999999986644322222
Q ss_pred cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
....++..|++||++.++.++.++|||||||+||||++ |+.||......+.+.. . ..+. .. ...
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-~--------~~~~-~~----~~~- 225 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ-V--------ERGY-RM----PCP- 225 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-H--------HcCC-CC----CCC-
Confidence 23446778999999998899999999999999999999 8999976543322211 1 1110 00 000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...+ ..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 226 ~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCP---ESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccC---HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122 345556669999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=334.48 Aligned_cols=251 Identities=26% Similarity=0.349 Sum_probs=197.2
Q ss_pred eeccCceEEEEEEe-cCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCcch
Q 006083 324 LGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTL 399 (662)
Q Consensus 324 iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L 399 (662)
||+|+||.||++.. .+|+.||+|++..... .....+..|+++|++++|+||+++++++.++..+|+||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999985 4689999999964321 2234566799999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccccccc
Q 006083 400 EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM 479 (662)
Q Consensus 400 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 479 (662)
.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||+++++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 9988766555689999999999999999999998 99999999999999999999999999998765432 223457
Q ss_pred cCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHH
Q 006083 480 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPH 559 (662)
Q Consensus 480 Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 559 (662)
|+..|+|||++.+..++.++|||||||+||||++|+.||...........+.+..+ ... +. ........
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~----~~~-----~~--~~~~~~~~ 224 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL----EDE-----VK--FEHQNFTE 224 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh----ccc-----cc--cccccCCH
Confidence 89999999999988899999999999999999999999975432221111111111 110 10 11112233
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 560 EMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 560 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
++ .+++..||+.||++||++.|+++.+....
T Consensus 225 ~~---~~li~~~L~~~P~~R~~~~~~~~~~~~h~ 255 (277)
T cd05607 225 ES---KDICRLFLAKKPEDRLGSREKNDDPRKHE 255 (277)
T ss_pred HH---HHHHHHHhccCHhhCCCCccchhhhhcCh
Confidence 44 45555899999999999988876555433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=331.86 Aligned_cols=254 Identities=29% Similarity=0.433 Sum_probs=206.2
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
.++|++.++||+|+||.||+|...+++.||+|.+..... ....+.+|+++|++++|+||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 456899999999999999999988899999999976443 3567899999999999999999999874 45689999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.+++.......+++..++.++.+++.||+|||+. +|+|||||++||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 999999999766666789999999999999999999998 89999999999999999999999999998765333222
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
.....++..|++||++....++.++|||||||++|||++ |+.||......+.+..+ ..+... ...
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---------~~~~~~-----~~~ 225 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL---------ERGYRM-----PRP 225 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH---------HcCCCC-----CCC
Confidence 233456778999999998889999999999999999999 99999765433222111 111100 011
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...+ .++.+++.+||+.+|++||++++|++.|+.
T Consensus 226 -~~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 -DNCP---EELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCC---HHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1122 345666669999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=324.53 Aligned_cols=251 Identities=26% Similarity=0.378 Sum_probs=205.5
Q ss_pred hCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
.+.|++.+.||+|.|+.||++. ..+|+.+|+|+++.. ...+.+++.+|+.|-+.|+|||||+|++.+...+..|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 3458888999999999999987 457999999988643 4456788999999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC---CCCcEEEEeeccccccC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID---DNFEAMVADFGLAKLSN 468 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~---~~~~vkl~DFGla~~~~ 468 (662)
|+|.|++|..-|-. +...++..+-..+.||+++|.|||.+ +|||||+||+|+||. ...-+||+|||+|...+
T Consensus 90 e~m~G~dl~~eIV~--R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA--REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999999776633 24578888999999999999999999 999999999999994 35579999999999888
Q ss_pred CCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 469 DNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 469 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
.+ ......+||++|||||++....|+..+|||+.|||||.||.|++||.+....+.+..+ ..+.++-
T Consensus 165 ~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I---------~~g~yd~-- 231 (355)
T KOG0033|consen 165 DG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQI---------KAGAYDY-- 231 (355)
T ss_pred Cc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH---------hccccCC--
Confidence 33 3445689999999999999999999999999999999999999999775444333222 1222221
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+.. .-....++.+.|++ +||..||.+|.++.|.|+
T Consensus 232 ~~~-~w~~is~~Ak~Lvr---rML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 232 PSP-EWDTVTPEAKSLIR---RMLTVNPKKRITADEALK 266 (355)
T ss_pred CCc-ccCcCCHHHHHHHH---HHhccChhhhccHHHHhC
Confidence 111 11234566777766 899999999999998874
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=342.57 Aligned_cols=238 Identities=26% Similarity=0.394 Sum_probs=188.7
Q ss_pred ceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
++||+|+||.||+|.. .+++.||||+++... ....+.+..|..++..+ +|+||+++++++..++.+|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999985 468899999997542 22344556677777654 799999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
|+|.+++.... .+++..+..++.|++.||.|||++ +|+|||||++||||+.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 99999886543 488899999999999999999998 99999999999999999999999999997654322 2234
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNY 556 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 556 (662)
..+|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+.... ... ..+ ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~---------~~~------~~~-~~~ 218 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL---------NDR------PHF-PRW 218 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH---------cCC------CCC-CCC
Confidence 4679999999999998899999999999999999999999998664433222110 000 011 111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 006083 557 VPHEMARLVACGAASIRHSARKRPKMSQ 584 (662)
Q Consensus 557 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e 584 (662)
...++ .+++.+||+.+|++|+++.+
T Consensus 219 ~~~~~---~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 219 ISKEA---KDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCHHH---HHHHHHHccCCHHHcCCChH
Confidence 23333 44555899999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.29 Aligned_cols=241 Identities=24% Similarity=0.309 Sum_probs=193.1
Q ss_pred CCCccceeeccCceEEEEEEec-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhcCC-CCcceEEEEEEeCCeEEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTG---SGQGEREFSAEVEIISRVHH-RHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lv~ 391 (662)
+|++.+.||+|+||.||+|... +++.||||+++.. .....+.+..|++++..++| ++|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4888999999999999999854 6789999999754 22345677889999999976 56888999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.+|+|.+++.... .+.+..++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999886543 478899999999999999999998 99999999999999999999999999987543222
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
. .....+|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+..+. .... .
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~---------~~~~------~ 219 (324)
T cd05587 156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM---------EHNV------S 219 (324)
T ss_pred C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH---------cCCC------C
Confidence 1 2234679999999999999999999999999999999999999998665433222211 1100 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKM 582 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 582 (662)
+... .. ..+.+++.+||+.||.+|++.
T Consensus 220 ~~~~-~~---~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 YPKS-LS---KEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCC-CC---HHHHHHHHHHhhcCHHHcCCC
Confidence 1111 12 234555668999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=355.32 Aligned_cols=203 Identities=24% Similarity=0.303 Sum_probs=174.3
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
+|++.+.||+|+||.||+++. .+++.||||++.... ......+.+|+++|++++|+||+++++++.+++.+|||||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 689999999999999999984 468999999996532 1234568899999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC-
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH- 471 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~- 471 (662)
||.+|+|.+++... ..+.+..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999999654 3578888999999999999999998 99999999999999999999999999975321000
Q ss_pred -----------------------------------------CccccccccCccccCcccccCCCCCchHHHHHHHHHHHH
Q 006083 472 -----------------------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLE 510 (662)
Q Consensus 472 -----------------------------------------~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~e 510 (662)
.......+||..|||||++.+..++.++|||||||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000123579999999999999999999999999999999
Q ss_pred HHhCCCCCCCchhh
Q 006083 511 LITGRRPVDMTMME 524 (662)
Q Consensus 511 LltG~~Pf~~~~~~ 524 (662)
|++|+.||......
T Consensus 237 ll~G~~Pf~~~~~~ 250 (376)
T cd05598 237 MLVGQPPFLADTPA 250 (376)
T ss_pred hhhCCCCCCCCCHH
Confidence 99999999776543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=329.09 Aligned_cols=255 Identities=31% Similarity=0.456 Sum_probs=207.7
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
.++|.+.+.||+|+||.||++...+++.||||.++... ...+++.+|++++++++|+||+++++++..+...++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 45789999999999999999998788899999997643 34567899999999999999999999999989999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.+++.......+++..+..++.+++.||.|||++ +|+|||||++||||++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 999999999776555689999999999999999999998 89999999999999999999999999998765432221
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
.....++..|++||.+.+..++.++|||||||++|||++ |+.||........+..+.. +. ... ..
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~---------~~-~~~----~~ 226 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER---------GY-RMP----RP 226 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---------CC-CCC----CC
Confidence 222334678999999998899999999999999999998 9999976543332222111 10 000 00
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...+ ..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 227 -~~~~---~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 -PNCP---EELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCC---HHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1112 345566679999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=343.60 Aligned_cols=242 Identities=24% Similarity=0.335 Sum_probs=193.6
Q ss_pred ceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
++||+|+||.||+|+.. +++.||||+++... ....+.+..|++++..+ +|+||+++++++.+.+.+||||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999854 67899999997642 23345677899999876 799999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
++|..++.... .+++..+..++.||+.||.|||++ +|+||||||+||||++++.+||+|||++........ ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT 154 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence 99999886543 478899999999999999999998 999999999999999999999999999876433222 223
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNY 556 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 556 (662)
..+|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+.... .... . ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~--------~~~~-------~-~p~~ 218 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL--------HDDV-------L-YPVW 218 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH--------cCCC-------C-CCCC
Confidence 4679999999999998899999999999999999999999998765433322211 1110 0 0111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 006083 557 VPHEMARLVACGAASIRHSARKRP-------KMSQIVRA 588 (662)
Q Consensus 557 ~~~~~~~l~~l~~~cl~~~p~~RP-------s~~evl~~ 588 (662)
... .+.+++..||+.||++|+ ++.++++.
T Consensus 219 ~~~---~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 LSK---EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCH---HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 223 344555689999999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=330.33 Aligned_cols=254 Identities=29% Similarity=0.453 Sum_probs=202.9
Q ss_pred CCCCccceeeccCceEEEEEEec----CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP----NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
++|.+.+.||+|+||.||+|.+. +...||||+++.... .....|.+|+.++++++|+||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 46888999999999999999864 245799999876533 3346789999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+++|.+++..... .+++..+++++.+++.||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999865433 588999999999999999999998 8999999999999999999999999999877522
Q ss_pred CC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 471 HT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 471 ~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
.. .......++..|++||.+.+..++.++|||||||++|||++ |..||......+. .+.. ..+....
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~-~~~~--------~~~~~~~-- 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV-IKAV--------EDGYRLP-- 228 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH-HHHH--------HcCCCCC--
Confidence 11 11222345678999999998899999999999999999998 9999865432221 1111 1111000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.. ...+ ..+.+++.+||+.+|++||++.||++.|+.
T Consensus 229 ---~~-~~~~---~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 229 ---PP-MDCP---SALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred ---CC-CCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 00 1112 345666779999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=354.03 Aligned_cols=202 Identities=25% Similarity=0.302 Sum_probs=173.9
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.|++.++||+|+||.||+|+. .+++.||||++.... ......+.+|+++|++++|+|||+++++|.+++.+|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999984 478899999997532 2234578899999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC-
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH- 471 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~- 471 (662)
||.+|+|.+++.+.. .+.+..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999986543 478888999999999999999998 99999999999999999999999999975321000
Q ss_pred ---------------------------------------------CccccccccCccccCcccccCCCCCchHHHHHHHH
Q 006083 472 ---------------------------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 506 (662)
Q Consensus 472 ---------------------------------------------~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGv 506 (662)
.......+||..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012357999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCchh
Q 006083 507 MLLELITGRRPVDMTMM 523 (662)
Q Consensus 507 vl~eLltG~~Pf~~~~~ 523 (662)
|||||++|+.||.....
T Consensus 237 il~elltG~~Pf~~~~~ 253 (382)
T cd05625 237 ILYEMLVGQPPFLAQTP 253 (382)
T ss_pred HHHHHHhCCCCCCCCCH
Confidence 99999999999976543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.60 Aligned_cols=237 Identities=26% Similarity=0.348 Sum_probs=190.1
Q ss_pred ceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
++||+|+||.||++... +++.||||+++... ....+.+..|+.++..+ +|+||+++++++.+.+.+||||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999854 68899999997532 23345677888888877 699999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||||++++.+||+|||+++....... ...
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTS 154 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-ccc
Confidence 99999886543 488999999999999999999998 999999999999999999999999999876432221 223
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNY 556 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 556 (662)
..+|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+..+. .+.. .+ ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~---------~~~~------~~-~~~ 218 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL---------NDEV------VY-PTW 218 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh---------cCCC------CC-CCC
Confidence 4679999999999999899999999999999999999999998664333222111 1110 00 111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006083 557 VPHEMARLVACGAASIRHSARKRPKMS 583 (662)
Q Consensus 557 ~~~~~~~l~~l~~~cl~~~p~~RPs~~ 583 (662)
...+ +.+++.+||+.||++|+++.
T Consensus 219 ~~~~---~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 219 LSQD---AVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCHH---HHHHHHHHcccCHHHCCCCC
Confidence 2333 44555589999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=344.95 Aligned_cols=256 Identities=27% Similarity=0.459 Sum_probs=201.0
Q ss_pred CCCCccceeeccCceEEEEEEe------cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEe-CCe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL------PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRV-HHRHLVSLVGYCIA-GGQ 386 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~-~~~ 386 (662)
++|++.++||+|+||.||+|.. .+++.||+|+++.... ...+.+..|++++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 4688899999999999999963 2357899999975432 3345688899999999 79999999998864 467
Q ss_pred EEEEEEecCCcchhhhhccCC-----------------------------------------------------------
Q 006083 387 RMLVYEFVSNKTLEYHLHGEN----------------------------------------------------------- 407 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~----------------------------------------------------------- 407 (662)
++++|||+.+++|.++|....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 889999999999999885321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc-ccccccCccccC
Q 006083 408 RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV-STRVMGTFGYLA 486 (662)
Q Consensus 408 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~-~~~~~Gt~~y~a 486 (662)
...+++..+++++.||+.||+|||++ +|+||||||+||||++++.+||+|||++.......... .....++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 12578999999999999999999998 99999999999999999999999999998764332221 223456778999
Q ss_pred cccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHH
Q 006083 487 PEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLV 565 (662)
Q Consensus 487 PE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 565 (662)
||++.+..++.++|||||||+||||++ |+.||......+.+... +..+.... . ... ....+.
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~--------~~~~~~~~-----~-~~~---~~~~~~ 306 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR--------LKEGTRMR-----A-PEY---ATPEIY 306 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH--------HhccCCCC-----C-Ccc---CCHHHH
Confidence 999999999999999999999999998 99999764332222111 11111110 0 111 124566
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 566 ACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 566 ~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
+++.+||+.+|++||++.||++.|+.
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHH
Confidence 67779999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=361.31 Aligned_cols=258 Identities=25% Similarity=0.337 Sum_probs=204.0
Q ss_pred HHHHHhCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-
Q 006083 310 ELAAATGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGG- 385 (662)
Q Consensus 310 ei~~~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~- 385 (662)
++....++|.+.++||+|+||.||++. ..+|+.||||+++... ......+++|+.+|..++|+||+++++.+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 344456789999999999999999998 4579999999997643 334567889999999999999999988765332
Q ss_pred -------eEEEEEEecCCcchhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcE
Q 006083 386 -------QRMLVYEFVSNKTLEYHLHGE--NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA 456 (662)
Q Consensus 386 -------~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 456 (662)
.+++||||+.+|+|.++|+.. ....+.+..+..++.|++.||.|||++ +|+||||||+||||++++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence 368999999999999998643 234688999999999999999999998 99999999999999999999
Q ss_pred EEEeeccccccCCCC-CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh
Q 006083 457 MVADFGLAKLSNDNH-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL 535 (662)
Q Consensus 457 kl~DFGla~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~ 535 (662)
||+|||+++...... .......+||..|+|||++.+..++.++|||||||+||||++|+.||......+.+.. .+
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~----~~ 258 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK----TL 258 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH----Hh
Confidence 999999998654322 1223446899999999999999999999999999999999999999976543322111 11
Q ss_pred HHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 536 GAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 536 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.+.+.. +. ..... .+..++..||+.+|++||++.++++.
T Consensus 259 -----~~~~~~-----~~-~~~~~---~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 -----AGRYDP-----LP-PSISP---EMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -----cCCCCC-----CC-CCCCH---HHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111 11 11233 34455569999999999999999864
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=330.54 Aligned_cols=262 Identities=23% Similarity=0.257 Sum_probs=209.2
Q ss_pred CCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchh---HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQG---EREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.|++.++||+|.-|.||+++++ ++..+|+|++.+..... ..+.+.|.+||+.++||.++.||..|+.++..|||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 4677899999999999999965 45899999998764333 3456779999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC---
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND--- 469 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~--- 469 (662)
||.||+|..+++++....+++..++.++.+++.||+|||-. |||.|||||+||||.++|++.|+||.|+.....
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 99999999999998888999999999999999999999999 999999999999999999999999998753210
Q ss_pred ------------------------------CCC----------------------ccccccccCccccCcccccCCCCCc
Q 006083 470 ------------------------------NHT----------------------HVSTRVMGTFGYLAPEYASSGKLTE 497 (662)
Q Consensus 470 ------------------------------~~~----------------------~~~~~~~Gt~~y~aPE~~~~~~~~~ 497 (662)
... .....++||-.|+|||++.+..++.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 000 0112368999999999999999999
Q ss_pred hHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCC
Q 006083 498 KSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSAR 577 (662)
Q Consensus 498 ~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~ 577 (662)
++|+|+|||+|||||.|.-||.+....+.+.+++...+ .+- ........+++|+ ...|..||+
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l-------~Fp-------~~~~vs~~akDLI---r~LLvKdP~ 377 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL-------KFP-------EEPEVSSAAKDLI---RKLLVKDPS 377 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC-------cCC-------CCCcchhHHHHHH---HHHhccChh
Confidence 99999999999999999999999887776655433211 000 0112334445554 488999999
Q ss_pred CCCCHHHHHHHhhCCCCCccc
Q 006083 578 KRPKMSQIVRALEGDSSLDDL 598 (662)
Q Consensus 578 ~RPs~~evl~~L~~~~~~~~~ 598 (662)
+|-....=...++....++.+
T Consensus 378 kRlg~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHPFFEGV 398 (459)
T ss_pred hhhccccchHHhhcCccccCC
Confidence 999833333333334444433
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=343.65 Aligned_cols=246 Identities=22% Similarity=0.333 Sum_probs=192.7
Q ss_pred ceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
++||+|+||.||++.. .+++.||||+++... ....+.+.+|+.++.++ +|+||++++++|.+.+.+|||||||.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999985 468999999998642 23345688999999998 699999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+||||++++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccc
Confidence 9999888544 3589999999999999999999998 99999999999999999999999999987532221 1223
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhh----HHHHHHHHHhHHHhhcCccccccCccc
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMED----SLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
..+|+..|+|||++.+..++.++|||||||+||||++|+.||+.....+ ...++....+ ....+ .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~------~~ 224 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI----LEKQI------RI 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH----HcCCC------CC
Confidence 4689999999999999999999999999999999999999997432111 1112221111 11111 11
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPK------MSQIVR 587 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs------~~evl~ 587 (662)
.. ..... +..++.+||+.||.+|++ +.++++
T Consensus 225 p~-~~~~~---~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 PR-SLSVK---ASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CC-CCCHH---HHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 11 12233 445556899999999997 556653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=334.72 Aligned_cols=245 Identities=27% Similarity=0.363 Sum_probs=191.8
Q ss_pred eeccCceEEEEEEe-cCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCcch
Q 006083 324 LGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTL 399 (662)
Q Consensus 324 iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L 399 (662)
||+|+||.||++.. .+|+.||||++..... ...+.+..|+++|++++|+||+++++++..++..|+||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999985 4789999999975422 2235678899999999999999999999999999999999999999
Q ss_pred hhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccccc
Q 006083 400 EYHLHG--ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTR 477 (662)
Q Consensus 400 ~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 477 (662)
.+++.. .....+++..++.++.||+.||.|||++ +|+|||||++||||++++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 888743 2334689999999999999999999998 999999999999999999999999999976654322 2234
Q ss_pred cccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCC
Q 006083 478 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYV 557 (662)
Q Consensus 478 ~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 557 (662)
..|+..|+|||++.+..++.++|||||||+||||++|+.||................ +...+ .+.. ..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~---------~~~~~--~~~~-~~ 224 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI---------LNDSV--TYPD-KF 224 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh---------cccCC--CCcc-cC
Confidence 578999999999999999999999999999999999999997643221111111111 11100 1111 12
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006083 558 PHEMARLVACGAASIRHSARKRP-----KMSQIVR 587 (662)
Q Consensus 558 ~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 587 (662)
.. .+.+++..||+.||++|+ +++++++
T Consensus 225 ~~---~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 225 SP---ASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CH---HHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 23 344555689999999999 5556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=335.10 Aligned_cols=256 Identities=25% Similarity=0.417 Sum_probs=206.4
Q ss_pred CCCCccceeeccCceEEEEEEe------cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL------PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
++|.+.+.||+|+||.||++.. .++..+++|.++.......+.+.+|++++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 3578889999999999999973 2356799999987666666789999999999999999999999999999999
Q ss_pred EEEecCCcchhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCc
Q 006083 390 VYEFVSNKTLEYHLHGEN--------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE 455 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 455 (662)
||||+.+++|.+++.... ...+++..+++++.+|+.||+|||++ +|+||||||+||||++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999986432 23478999999999999999999999 8999999999999999999
Q ss_pred EEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHH
Q 006083 456 AMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARP 533 (662)
Q Consensus 456 vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~ 533 (662)
+||+|||++........ .......|+..|+|||++.+..++.++||||||||+|||++ |+.||......+.+..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~---- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC---- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----
Confidence 99999999976544322 12233557888999999999999999999999999999998 9999866543322111
Q ss_pred HhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 534 LLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 534 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
+..+..... ....+ ..+.+++.+||+.+|++||++.+|+++|+..
T Consensus 238 -----~~~~~~~~~------~~~~~---~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 238 -----ITQGRVLER------PRVCP---KEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred -----HhCCCCCCC------CccCC---HHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111111111 11122 3455666699999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=350.87 Aligned_cols=260 Identities=21% Similarity=0.249 Sum_probs=200.8
Q ss_pred HHHHHHhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 006083 309 DELAAATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAG 384 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 384 (662)
.++....++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++|+||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 444555688999999999999999999854 68899999986431 22345678999999999999999999999999
Q ss_pred CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
+.+|+|||||.||+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 9999999999999999988543 378888999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccccccCccccCcccccCC----CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhh
Q 006083 465 KLSNDNHTHVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALE 540 (662)
Q Consensus 465 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 540 (662)
+.............+||..|||||++.+. .++.++|||||||+||||++|+.||........+..+..
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~-------- 261 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN-------- 261 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHc--------
Confidence 87654333333456899999999998753 378999999999999999999999986544332222111
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 006083 541 DGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARK--RPKMSQIVRAL 589 (662)
Q Consensus 541 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~L 589 (662)
......+. .......++..|+ ..||..++.+ |+++.+|++..
T Consensus 262 ~~~~~~~~----~~~~~s~~~~~li---~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 262 HKNSLTFP----DDNDISKEAKNLI---CAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCcccCC----CcCCCCHHHHHHH---HHHcCChhhhcCCCCHHHHhcCc
Confidence 10000000 1112234444444 4788744433 77888888753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=342.73 Aligned_cols=241 Identities=23% Similarity=0.300 Sum_probs=193.3
Q ss_pred CCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
+|.+.+.||+|+||.||+|+.. +++.||||+++... ....+.+..|..++..+ +|++|+++++++.+.+.+||||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999854 67899999998642 22334567788888887 5899999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999999886543 478899999999999999999998 99999999999999999999999999997643222
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
. .....+|+..|+|||++.++.++.++|||||||+||||++|+.||......+.+..+.. ... .
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~---------~~~------~ 219 (323)
T cd05616 156 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME---------HNV------A 219 (323)
T ss_pred C-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh---------CCC------C
Confidence 1 22346799999999999999999999999999999999999999987654332222111 110 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKM 582 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 582 (662)
+... .. .++.+++.+||+.+|.+|++.
T Consensus 220 ~p~~-~s---~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 YPKS-MS---KEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCc-CC---HHHHHHHHHHcccCHHhcCCC
Confidence 1111 12 344556669999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=333.31 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=196.3
Q ss_pred CCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
|...++||+|+||.||++.. .+++.||||++..... .....+.+|+++|++++|+||+.+++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 67789999999999999985 4789999999975432 2234578899999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+++|.+++.......+++..++.++.|++.||.|||+. +|+|||||++|||+++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 9999999988765555689999999999999999999998 999999999999999999999999999976543221
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...........+..... ... . .+.
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~-----~~~--~----~~~ 225 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVL-----ETE--E----VYS 225 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhh-----ccc--c----ccC
Confidence 2345789999999999988999999999999999999999999976543332222222111 100 0 011
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKM 582 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 582 (662)
.. ... .+.+++..||+.||++||++
T Consensus 226 ~~-~~~---~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05632 226 AK-FSE---EAKSICKMLLTKDPKQRLGC 250 (285)
T ss_pred cc-CCH---HHHHHHHHHccCCHhHcCCC
Confidence 11 122 34455568999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.28 Aligned_cols=240 Identities=26% Similarity=0.339 Sum_probs=188.8
Q ss_pred ceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVE-IISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
++||+|+||.||+++. .+|+.||||++.... ....+.+..|.. +++.++|+||+++++++.+++..||||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4799999999999995 478999999997532 122344555544 56889999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
|+|.+++... ..+.+..+..++.||++||.|||++ +|+|||||++||||++++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTS 154 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccc
Confidence 9999988654 3578899999999999999999998 99999999999999999999999999987543222 2234
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNY 556 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 556 (662)
..+|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+.... .+.. .+...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~---------~~~~------~~~~~~ 219 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL---------NKPL------RLKPNI 219 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH---------cCCC------CCCCCC
Confidence 4679999999999999999999999999999999999999997654333222111 1110 111112
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 006083 557 VPHEMARLVACGAASIRHSARKRPKMSQIV 586 (662)
Q Consensus 557 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 586 (662)
... +.+++.+||+.||++|+++.+.+
T Consensus 220 -~~~---~~~li~~~l~~~p~~R~~~~~~~ 245 (323)
T cd05575 220 -SVS---ARHLLEGLLQKDRTKRLGAKDDF 245 (323)
T ss_pred -CHH---HHHHHHHHhhcCHHhCCCCCCCH
Confidence 333 44555589999999999986333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=349.60 Aligned_cols=263 Identities=24% Similarity=0.293 Sum_probs=209.8
Q ss_pred CCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-C-----CCcceEEEEEEeCCeEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-H-----RHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-H-----pnIv~l~~~~~~~~~~~l 389 (662)
+|+++++||+|.||.|.+|. ..+++.||||++++.. ...++-+.|+.||.+|+ | -|||+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 68999999999999999999 4579999999998743 44566678999999997 4 589999999999999999
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC--CCcEEEEeecccccc
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD--NFEAMVADFGLAKLS 467 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~--~~~vkl~DFGla~~~ 467 (662)
|+|.+ .-+|.++|+..+...++...++.|+.||+.||.+||+. +|||+||||+||||.+ ..+|||+|||.+...
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99977 78999999988878899999999999999999999998 9999999999999975 447999999999876
Q ss_pred CCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH-------hHHH--
Q 006083 468 NDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL-------LGAA-- 538 (662)
Q Consensus 468 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~-------~~~~-- 538 (662)
.... ..++-+..|.|||++.+..|+.+.||||||||++||++|...|.+....|.+..+..-+ +...
T Consensus 342 ~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~ 417 (586)
T KOG0667|consen 342 SQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK 417 (586)
T ss_pred CCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 5432 25677889999999999999999999999999999999999898876666554433211 1000
Q ss_pred ----hhc--Cccc---------------------cccCc--------ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006083 539 ----LED--GIYD---------------------GLVDP--------RLEHNYVPHEMARLVACGAASIRHSARKRPKMS 583 (662)
Q Consensus 539 ----~~~--~~~~---------------------~~~d~--------~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 583 (662)
.+. +... ...+. .+.......+-..+++++++||..||.+|.+..
T Consensus 418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~ 497 (586)
T KOG0667|consen 418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA 497 (586)
T ss_pred cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence 000 0000 00000 011111224556678899999999999999999
Q ss_pred HHHHH
Q 006083 584 QIVRA 588 (662)
Q Consensus 584 evl~~ 588 (662)
|.++.
T Consensus 498 qal~H 502 (586)
T KOG0667|consen 498 QALNH 502 (586)
T ss_pred HHhcC
Confidence 99864
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=333.70 Aligned_cols=258 Identities=24% Similarity=0.414 Sum_probs=206.7
Q ss_pred hCCCCccceeeccCceEEEEEEe------cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL------PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 388 (662)
.++|.+.+.||+|+||.||++.. .++..||+|.++.......+.+.+|+++|++++|+||+++++++..++.++
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 35688999999999999999974 234569999998765556678999999999999999999999999999999
Q ss_pred EEEEecCCcchhhhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEE
Q 006083 389 LVYEFVSNKTLEYHLHGEN-----------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAM 457 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 457 (662)
+||||+.+++|.+++.... ...+++..+++++.|++.||+|||++ +|+||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999986432 23489999999999999999999998 899999999999999999999
Q ss_pred EEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHh
Q 006083 458 VADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLL 535 (662)
Q Consensus 458 l~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~ 535 (662)
|+|||+++....... .......++..|+|||++.+..++.++|||||||++|+|++ |+.||......+.+...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i----- 235 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI----- 235 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----
Confidence 999999986543221 11223446788999999998899999999999999999998 89998765433322211
Q ss_pred HHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 536 GAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 536 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
..+.... +... .. ..+.+++.+||+.+|.+||++.+|++.|+...
T Consensus 236 ----~~~~~~~-----~~~~-~~---~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 236 ----TQGRVLQ-----RPRT-CP---KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred ----HcCCcCC-----CCCC-CC---HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1111111 1111 22 34566677999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=347.03 Aligned_cols=266 Identities=21% Similarity=0.272 Sum_probs=198.0
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-----eEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGG-----QRM 388 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~~ 388 (662)
+|++.+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+++|+.++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999985 47899999998653 2234467889999999999999999999998766 789
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||||++++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 5677766443 3588999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH-------hH---H
Q 006083 469 DNHTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL-------LG---A 537 (662)
Q Consensus 469 ~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~-------~~---~ 537 (662)
...........|+..|+|||++.+. .++.++||||||||||||++|+.||......+.+......+ +. .
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 4333233445789999999998864 58999999999999999999999998765433322211100 00 0
Q ss_pred HhhcCccccccCc-ccCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 538 ALEDGIYDGLVDP-RLEH--NYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 538 ~~~~~~~~~~~d~-~l~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
......+...... .+.. .........+.+++.+||+.||++||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000000 0000 0001112345566679999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=325.75 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=204.8
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+|.+.+.||+|+||.||++.. .+++.|++|.+... .......+.+|++++++++|+||+++++++.+++..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477889999999999999985 47899999998754 234456789999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+++|.++++......+++..+++++.+++.||.|||+. +|+|||||++|||+++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999999765455789999999999999999999998 999999999999999999999999999987654332
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
......|+..|+|||++.++.++.++|||||||++|+|++|+.||......+.+... ..+.+.. +.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~~-----~~ 222 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI---------IRGVFPP-----VS 222 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---------HcCCCCC-----Cc
Confidence 223457889999999999989999999999999999999999999765432211110 1111111 11
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
. .....+.+++.+||+.+|++||++.+|++.
T Consensus 223 ~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 Q----MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred c----ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1 122345666679999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=331.09 Aligned_cols=256 Identities=24% Similarity=0.406 Sum_probs=201.7
Q ss_pred HhCCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQ 386 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 386 (662)
..++|++.+.||+|+||.||+|... .+..||||+++.... ....++.+|+.+++.++|+||+++++++.+++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998742 356799999865432 345578899999999999999999999999999
Q ss_pred EEEEEEecCCcchhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEE
Q 006083 387 RMLVYEFVSNKTLEYHLHGEN--------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMV 458 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl 458 (662)
.++||||+.+++|.+++.... ...+++..++.++.++++||.|||+. +|+||||||+||||++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 999999999999999986432 12357788999999999999999998 8999999999999999999999
Q ss_pred EeeccccccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhH
Q 006083 459 ADFGLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLG 536 (662)
Q Consensus 459 ~DFGla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 536 (662)
+|||+++........ ......++..|||||++.++.++.++|||||||+||||++ |..||......+.+...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~------ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV------ 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------
Confidence 999998765432221 1122456788999999998899999999999999999999 78888765433222111
Q ss_pred HHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 537 AALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 537 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
..+.+.. +. .... ..+.+++.+||+.+|++||++.|+++.|+
T Consensus 235 ---~~~~~~~-----~~-~~~~---~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 ---MEGGLLD-----KP-DNCP---DMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ---HcCCcCC-----CC-CCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0111111 11 1122 34556666999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=324.14 Aligned_cols=247 Identities=28% Similarity=0.411 Sum_probs=198.4
Q ss_pred ceeeccCceEEEEEEecCCCEEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCcchh
Q 006083 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLE 400 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~ 400 (662)
++||+|+||.||+|...++..||+|+++..... ....+.+|++++++++|+||+++++++...+..++||||+.+++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 469999999999999878899999998765433 3457889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccccccc
Q 006083 401 YHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMG 480 (662)
Q Consensus 401 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~G 480 (662)
+++.... ..+++..++.++.+++.+|.|||++ +++|||||++||++++++.+||+|||++...............+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9886543 3578999999999999999999998 99999999999999999999999999997654332222222344
Q ss_pred CccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHH
Q 006083 481 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPH 559 (662)
Q Consensus 481 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 559 (662)
+..|+|||++.++.++.++|||||||++|+|++ |..||............ ..+... .... .
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~---------~~~~~~-----~~~~-~--- 218 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV---------EKGYRM-----SCPQ-K--- 218 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH---------HcCCCC-----CCCC-C---
Confidence 678999999998899999999999999999998 99999755332211111 111100 0111 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 560 EMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 560 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
....+.+++.+|++.+|++||++.++++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1245566667999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.86 Aligned_cols=248 Identities=21% Similarity=0.308 Sum_probs=207.1
Q ss_pred HhCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQG--EREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
+.+-|++.+.||+|.|.+|-+++ .-+|+.||||++.+...+. ...+.+|++-|+.++|||||+||.+......+|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 34568999999999999999997 3489999999998765443 35788999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC-CCcEEEEeeccccccCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-NFEAMVADFGLAKLSND 469 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~~~~~ 469 (662)
+|+-.+|+|++||..... .+.+....+++.||+.||.|||+. .||||||||+||++-+ -|-|||.|||++..+..
T Consensus 96 LELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999999965443 378899999999999999999998 7999999999998854 67899999999988776
Q ss_pred CCCccccccccCccccCcccccCCCCC-chHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
+.. ....||...|.|||++.+..|+ .+.||||||||||.|+||+.||...++.+.+.-+ +
T Consensus 172 G~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI-----------------m 232 (864)
T KOG4717|consen 172 GKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI-----------------M 232 (864)
T ss_pred cch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh-----------------h
Confidence 543 4668999999999999998887 5889999999999999999999888776655421 1
Q ss_pred Ccc-cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 549 DPR-LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 549 d~~-l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
|=. -.......+.++|+ ..||..||++|-+.+||+.
T Consensus 233 DCKYtvPshvS~eCrdLI---~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 233 DCKYTVPSHVSKECRDLI---QSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cccccCchhhhHHHHHHH---HHHHhcCchhhccHHHHhc
Confidence 100 01122344555554 4899999999999999885
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=340.20 Aligned_cols=257 Identities=20% Similarity=0.221 Sum_probs=196.6
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.+.||+|+||.||++.. .+++.||||++++. .....+.+.+|+.++..++|+||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4689999999999999999995 46899999999752 1223456889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.|++|.+++... ...+.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999643 23478899999999999999999999 99999999999999999999999999997665433
Q ss_pred CccccccccCccccCcccccC-----CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccc
Q 006083 472 THVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
.......+|+..|||||++.. +.++.++|||||||+||||++|+.||......+.+..+. .......
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~--------~~~~~~~ 228 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--------NHKEHFQ 228 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH--------cCCCccc
Confidence 322333579999999999863 457889999999999999999999997654333222111 1100000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+ .........++..|+.-+ .|...++..|+++.++++.
T Consensus 229 ~---~~~~~~~~~~~~~li~~l-l~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 F---PPDVTDVSEEAKDLIRRL-ICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C---CCccCCCCHHHHHHHHHH-ccCcccccCCCCHHHHhcC
Confidence 0 001112345556665521 1344444558888888865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=331.73 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=201.3
Q ss_pred CCCCccceeeccCceEEEEEEe-----cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-----PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
.+|++.+.||+|+||.||+|.. .+++.|++|.++... .+....+.+|++++++++|+||+++++++..++..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3578889999999999999973 356789999997543 3344678999999999999999999999999999999
Q ss_pred EEEecCCcchhhhhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC
Q 006083 390 VYEFVSNKTLEYHLHGEN---------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF 454 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~---------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~ 454 (662)
||||+.+++|.+++.... ...+++..++.++.+++.||+|||++ +|+||||||+||||++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999985321 23478889999999999999999998 899999999999999999
Q ss_pred cEEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHH
Q 006083 455 EAMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWAR 532 (662)
Q Consensus 455 ~vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~ 532 (662)
.+||+|||+++....... .......++..|++||++.++.++.++|||||||+||||++ |..||......+ +.+...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~-~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE-VIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHH
Confidence 999999999986543221 12233456778999999998899999999999999999998 999986543222 111111
Q ss_pred HHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 533 PLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
..... .... .... ++.+++.+||+.+|.+||++.+|++.|+.
T Consensus 241 --------~~~~~-----~~~~-~~~~---~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 --------KRQLL-----PCSE-DCPP---RMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --------cCCcC-----CCCC-CCCH---HHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11110 0111 1223 44556669999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=344.91 Aligned_cols=238 Identities=26% Similarity=0.343 Sum_probs=191.9
Q ss_pred ceeeccCceEEEEEEe----cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 322 NLLGQGGFGYVHKGVL----PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
+.||+|+||.||++.. .+|+.||||+++.... .....+.+|+++|++++|+||+++++++.+++.+||||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 3688999999975422 234567789999999999999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
+++|.+++... ..+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....... ..
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~ 155 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KA 155 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ce
Confidence 99999998543 3589999999999999999999998 999999999999999999999999999986544322 22
Q ss_pred cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCC
Q 006083 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHN 555 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 555 (662)
....|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+.... ...+ .+. .
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~---------~~~~------~~p-~ 219 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL---------KAKL------GMP-Q 219 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH---------cCCC------CCC-C
Confidence 34679999999999998889999999999999999999999997654333222111 1110 011 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 006083 556 YVPHEMARLVACGAASIRHSARKRPKMSQ 584 (662)
Q Consensus 556 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e 584 (662)
.....+ ..++.+||+.||++||++.+
T Consensus 220 ~~~~~~---~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEA---QSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHH---HHHHHHHhhcCHhHcCCCCC
Confidence 123333 44555899999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=352.97 Aligned_cols=193 Identities=25% Similarity=0.346 Sum_probs=167.2
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
..+|.+.+.||+|+||.||++... .++.||||.... ..+.+|+++|++|+|+|||++++++..++..+||||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999954 578999996432 3467899999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+. ++|..++.... ..+++..++.|+.||++||.|||++ +|||||||++||||+.++.+||+|||+++........
T Consensus 242 ~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 YR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred cC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 95 67777775432 3589999999999999999999998 9999999999999999999999999999866433221
Q ss_pred -cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCC
Q 006083 474 -VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPV 518 (662)
Q Consensus 474 -~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf 518 (662)
.....+||..|||||++.+..++.++||||||||||||++|..++
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 223467999999999999999999999999999999999988765
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=341.83 Aligned_cols=241 Identities=20% Similarity=0.334 Sum_probs=188.4
Q ss_pred ceeeccCceEEEEEEe-cCCCEEEEEEeecC---CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG---SGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
++||+|+||.||++.. .+++.||+|+++.. .....+.+.+|+.++.++ +|+||+++++++.+++.+||||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999985 46889999999864 223345678899998877 799999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
++|..++.... .+++..++.++.+++.||+|||++ +|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTS 154 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccc
Confidence 99998885443 488999999999999999999998 999999999999999999999999999975432221 223
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhh----hHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMME----DSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
..+|+..|+|||++.+..++.++|||||||+||||++|+.||+..... .....+....+ ..... .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i----~~~~~------~~ 224 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI----LEKQI------RI 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH----hcCCC------CC
Confidence 467999999999999999999999999999999999999999642111 11111111111 11110 11
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKM 582 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 582 (662)
... ... .+..++.+||+.||++|+++
T Consensus 225 p~~-~~~---~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 PRS-LSV---KAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCC-CCH---HHHHHHHHHhcCCHHHcCCC
Confidence 111 223 34455569999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=354.65 Aligned_cols=263 Identities=22% Similarity=0.297 Sum_probs=192.4
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--------C
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAG--------G 385 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--------~ 385 (662)
.++|.+.++||+|+||.||+|+. .+++.||||++.... ....+|+.+|++++|+|||++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45799999999999999999985 478999999986532 2345799999999999999999876432 2
Q ss_pred eEEEEEEecCCcchhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC-cEEEEeec
Q 006083 386 QRMLVYEFVSNKTLEYHLHG--ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF-EAMVADFG 462 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkl~DFG 462 (662)
.+++||||+.+ +|.+++.. .....+++..++.++.||+.||+|||++ +|+||||||+||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46799999975 56555532 2344688999999999999999999998 899999999999998654 79999999
Q ss_pred cccccCCCCCccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh---HHH
Q 006083 463 LAKLSNDNHTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL---GAA 538 (662)
Q Consensus 463 la~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~---~~~ 538 (662)
+++....... ....+|+..|||||++.+. .|+.++||||||||||||++|+.||......+.+......+- ...
T Consensus 217 la~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 217 SAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred cchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 9987654322 2335789999999998754 699999999999999999999999987655544443332110 000
Q ss_pred hh--cCcc-----ccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 539 LE--DGIY-----DGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 539 ~~--~~~~-----~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+. ...+ ..+....+...+......++.+++.+||+.||.+|+++.|+++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00 0000 0000001110010011134556666999999999999999985
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=330.37 Aligned_cols=268 Identities=27% Similarity=0.384 Sum_probs=195.9
Q ss_pred CCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhc--CCCCcceEEEEEEeCC----eEEEEE
Q 006083 318 FAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV--HHRHLVSLVGYCIAGG----QRMLVY 391 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l--~HpnIv~l~~~~~~~~----~~~lv~ 391 (662)
..+.++||+|.||.||+|.+ +++.||||++.. +++..|++|.+|++.. +|+||++|+++-..+. +++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 34467899999999999998 569999999965 5677899999998765 7999999999877655 899999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCceeecCCccCcEEECCCCcEEEEeecccc
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED------CHPRIIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
||..+|+|.+||+.+ .++|....+|+..+++||+|||+. ..+.|+|||||.+||||.+|+...|+|||||.
T Consensus 288 ~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999999654 589999999999999999999984 34579999999999999999999999999998
Q ss_pred ccCCCCCc-cccccccCccccCcccccCCC-CC-----chHHHHHHHHHHHHHHhCCCCCCCchhhh---HHHH--HHHH
Q 006083 466 LSNDNHTH-VSTRVMGTFGYLAPEYASSGK-LT-----EKSDVFSFGVMLLELITGRRPVDMTMMED---SLVE--WARP 533 (662)
Q Consensus 466 ~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~-~~-----~~sDvwSlGvvl~eLltG~~Pf~~~~~~~---~~~~--~~~~ 533 (662)
.+...... .....+||..|||||++.+.. +. .+.||||+|.|||||++...-++.....+ .+.+ -..+
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 77643221 223378999999999998632 22 36899999999999998755443110000 0000 0001
Q ss_pred HhHHHhh---cCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCCCC
Q 006083 534 LLGAALE---DGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSL 595 (662)
Q Consensus 534 ~~~~~~~---~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 595 (662)
.+.++.+ ....+-.+...+..+ ..+.-|.+.+..||+.|++.|-|+.=|-+.+.....+
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 1111000 011111111122222 2334445556699999999999998888887755444
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=339.39 Aligned_cols=240 Identities=25% Similarity=0.360 Sum_probs=190.0
Q ss_pred ceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
++||+|+||.||+++.. +|+.||||+++... ....+.+..|..++..+ +|+||+++++++.+++.+||||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999954 68899999997642 23345667788888765 899999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
++|.+++... ..+++..+..++.|+++||+|||++ +|+||||||+||||++++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 9999988654 3478899999999999999999998 99999999999999999999999999987533221 1234
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNY 556 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 556 (662)
..+|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+... ..+. ..+. ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~---------~~~~------~~~~-~~ 218 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI---------RVDT------PHYP-RW 218 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---------HhCC------CCCC-CC
Confidence 467999999999999999999999999999999999999999765432221111 0000 0111 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 006083 557 VPHEMARLVACGAASIRHSARKRPKMS-QIV 586 (662)
Q Consensus 557 ~~~~~~~l~~l~~~cl~~~p~~RPs~~-evl 586 (662)
...++. +++.+||+.||++|+++. +++
T Consensus 219 ~~~~~~---~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ITKESK---DILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCHHHH---HHHHHHccCCHHHcCCChHHHH
Confidence 233444 455589999999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=341.85 Aligned_cols=247 Identities=23% Similarity=0.312 Sum_probs=191.1
Q ss_pred ceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHH-HHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEV-EIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~-~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
+.||+|+||.||+++.. +++.||+|++.... ......+..|. .+++.++|+||+++++++.+++.+|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999854 67889999997532 12223444444 457889999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
++|.+++.... .+.+..+..++.||++||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~ 154 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTS 154 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Ccc
Confidence 99999986543 477888889999999999999998 999999999999999999999999999975432221 234
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNY 556 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 556 (662)
..+|+..|||||++.+..++.++|||||||+||||++|+.||......+.+..... ... .+.. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---------~~~------~~~~-~ 218 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN---------KPL------QLKP-N 218 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh---------CCc------CCCC-C
Confidence 46799999999999999999999999999999999999999976543332221110 000 1111 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 557 VPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 557 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
....+. +++.+||+.||.+|+++.+.+..+....
T Consensus 219 ~~~~~~---~li~~~l~~~p~~R~~~~~~~~~i~~~~ 252 (325)
T cd05602 219 ITNSAR---HLLEGLLQKDRTKRLGAKDDFMEIKNHI 252 (325)
T ss_pred CCHHHH---HHHHHHcccCHHHCCCCCCCHHHHhcCc
Confidence 233444 4445899999999999876555544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=338.11 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=199.7
Q ss_pred CCCCccceeeccCceEEEEEEec-CCC----EEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGK----EVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
.+|++.+.||+|+||.||+|++. +++ .||||+++... ....+++.+|+.+++.++|+||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 35889999999999999999843 344 38999997543 34456789999999999999999999999864 5689
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
|+||+.+|+|.++++... ..+++..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999987543 3478899999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcc-ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 470 NHTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 470 ~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
..... .....++..|++||++.+..++.++|||||||+||||++ |+.||+.....+ +..+. ..+...
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~--------~~~~~~-- 230 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSIL--------EKGERL-- 230 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHH--------hCCCCC--
Confidence 33221 122334678999999999999999999999999999997 999997653222 11111 111100
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.. ..... ..+..++.+||..+|.+||++.+|+..|...
T Consensus 231 ---~~-~~~~~---~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 231 ---PQ-PPICT---IDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred ---CC-CCCCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 01112 3455666799999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=324.39 Aligned_cols=249 Identities=30% Similarity=0.486 Sum_probs=204.9
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
++|++.+.||+|+||.||++.. .|+.||||.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 4688899999999999999987 578999999987644 56788999999999999999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
+++|.+++.......+.+..+..++.|++.||.|||++ +|+|||||++|||+++++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 99999999766555689999999999999999999998 999999999999999999999999999987643221
Q ss_pred cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
...++..|++||++.++.++.++|||||||++|||++ |+.||......+.... +..+.... ..
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---------~~~~~~~~-----~~- 221 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH---------VEKGYRME-----AP- 221 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH---------HhcCCCCC-----Cc-
Confidence 2345678999999998899999999999999999997 9999876543321111 11111000 00
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...+ ..+.+++.+||+.+|++||++.+|+++|+.
T Consensus 222 ~~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 EGCP---PEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cCCC---HHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1122 345556668999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=342.69 Aligned_cols=246 Identities=24% Similarity=0.321 Sum_probs=191.9
Q ss_pred ceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVE-IISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
++||+|+||.||+++. .+|+.||||++.... ......+..|.. +++.++|+||+++++++..++.+||||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999984 478999999997531 223345555554 57789999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
++|..++... ..+.+..+..++.||++||+|||++ +|+|||||++||||++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTT 154 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcc
Confidence 9999888543 3588999999999999999999998 99999999999999999999999999987543222 1224
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNY 556 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 556 (662)
..+|+..|||||++.++.++.++|||||||+||||++|+.||......+.+.... .... .+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~--------~~~~-------~~~~~- 218 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL--------HKPL-------VLRPG- 218 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH--------cCCc-------cCCCC-
Confidence 4679999999999999999999999999999999999999997654333222111 1100 11111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 557 VPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 557 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.. ..+.+++.+||+.+|.+||++.+.++.+...
T Consensus 219 ~~---~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 219 AS---LTAWSILEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred CC---HHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence 12 3344556689999999999987555544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=324.33 Aligned_cols=247 Identities=25% Similarity=0.397 Sum_probs=195.1
Q ss_pred ceeeccCceEEEEEEe-cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCcch
Q 006083 322 NLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTL 399 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L 399 (662)
+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+++|++++|+||++++++|...+..+|||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999985 478999999886543 23456799999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc-ccc
Q 006083 400 EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS-TRV 478 (662)
Q Consensus 400 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~-~~~ 478 (662)
.+++.... ..+++..++.++.|++.||+|||++ +|+|||||++|||++.++.+||+|||++........... ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99986432 3578999999999999999999998 899999999999999999999999999876543211111 111
Q ss_pred ccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCC
Q 006083 479 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYV 557 (662)
Q Consensus 479 ~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 557 (662)
.++..|+|||++.++.++.++|||||||++|||++ |..||......+.... +...... .... ..
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~---------~~~~~~~-----~~~~-~~ 221 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA---------IEQGVRL-----PCPE-LC 221 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH---------HHcCCCC-----CCcc-cC
Confidence 23457999999998899999999999999999998 8888865432221110 1111100 0111 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 558 PHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 558 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
...+.+++.+||+.+|++||++.+|+++|+
T Consensus 222 ---~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 ---PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ---CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 234566667999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=337.31 Aligned_cols=240 Identities=25% Similarity=0.356 Sum_probs=190.0
Q ss_pred ceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
+.||+|+||.||+|... +++.||||+++... ....+.+..|..++..+ +|+||+++++++.+.+.+||||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 57899999997642 22345567788888764 899999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
|+|.+++... ..+++..+..++.|+++||.|||++ +|+|||||++||||+.++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTC 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-cee
Confidence 9999998653 3478899999999999999999998 999999999999999999999999999875432221 223
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNY 556 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 556 (662)
..+|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+... . ... ..+. ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i-~--------~~~------~~~~-~~ 218 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI-R--------MDN------PCYP-RW 218 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH-H--------hCC------CCCC-cc
Confidence 467999999999999989999999999999999999999999765433222111 0 000 0011 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 006083 557 VPHEMARLVACGAASIRHSARKRPKMS-QIV 586 (662)
Q Consensus 557 ~~~~~~~l~~l~~~cl~~~p~~RPs~~-evl 586 (662)
...+ +.+++.+||+.+|++|+++. +++
T Consensus 219 ~~~~---~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 219 LTRE---AKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCHH---HHHHHHHHhccCHhhcCCChHHHH
Confidence 2333 34455689999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=338.83 Aligned_cols=241 Identities=26% Similarity=0.362 Sum_probs=193.4
Q ss_pred ceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
++||+|+||.||++... +++.||||+++... ......+.+|++++..+ +|+||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999854 67899999998642 23345678899999888 699999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
++|.+++.... .+++..+..++.|++.||.|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTS 154 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-ccc
Confidence 99999886543 489999999999999999999998 999999999999999999999999999875432221 223
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNY 556 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 556 (662)
..+|+..|+|||++.+..++.++|||||||+||+|++|+.||......+.+.... .... .+. ..
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~--------~~~~-------~~~-~~ 218 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL--------EDEV-------RYP-RW 218 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH--------cCCC-------CCC-Cc
Confidence 4679999999999999999999999999999999999999997654332221110 1100 011 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 006083 557 VPHEMARLVACGAASIRHSARKRPKM-----SQIVR 587 (662)
Q Consensus 557 ~~~~~~~l~~l~~~cl~~~p~~RPs~-----~evl~ 587 (662)
...+ +.+++.+||+.||++||++ .++++
T Consensus 219 ~~~~---~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 219 LSKE---AKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCHH---HHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 2333 4455569999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=335.95 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=204.3
Q ss_pred HhCCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGS-GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGG 385 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~ 385 (662)
..++|++.+.||+|+||.||++... ....||+|+++... ......+.+|+++++++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3456888999999999999999853 23689999987643 23446788999999999 7999999999999999
Q ss_pred eEEEEEEecCCcchhhhhcc--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC
Q 006083 386 QRMLVYEFVSNKTLEYHLHG--------------ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID 451 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~--------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~ 451 (662)
.+++||||+.+++|.++++. .....+++..+++++.|++.||.|||++ +|+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 99999999999999999854 2234688999999999999999999998 999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHH
Q 006083 452 DNFEAMVADFGLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVE 529 (662)
Q Consensus 452 ~~~~vkl~DFGla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~ 529 (662)
+++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......+.+..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 9999999999999876543221 1122345678999999998899999999999999999997 9999876543322211
Q ss_pred HHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 530 WARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
+..+... . ........+.+++.+||+.+|++||++.||++.|+..
T Consensus 247 ---------~~~~~~~-----~----~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 247 ---------LKEGYRM-----E----KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---------HHcCCcC-----C----CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1111100 0 0111123566677799999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=324.56 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=200.0
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc-----hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG-----QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
++|.+.+.||+|+||.||++.. .+++.||+|.+..... .....+.+|++++++++|+||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4689999999999999999985 4689999999875422 123568899999999999999999999999999999
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||||+.+++|.+++.... .+++..+.+++.+++.||.|||+. +|+|||||++||||+++++++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999886433 478899999999999999999998 999999999999999999999999999976543
Q ss_pred CCCccc--cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 470 NHTHVS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 470 ~~~~~~--~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
...... ....|+..|+|||++.+..++.++|||||||++|||++|+.||......+.+..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--------~~~---- 224 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT--------QPT---- 224 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc--------cCC----
Confidence 221111 235688899999999998899999999999999999999999965432222111100 000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
...+.. .... .+.+++..||+.+|++||++.|+++.
T Consensus 225 -~~~~~~-~~~~---~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 -NPQLPS-HVSP---DARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCCc-cCCH---HHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 001111 1223 34455569999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.06 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=204.7
Q ss_pred CCCCccceeeccCceEEEEEEe------cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL------PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 387 (662)
++|.+.+.||+|+||.||++.. ..+..||||+++.... ...+.+.+|+++++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4588999999999999999873 1345799999876532 3346789999999999 799999999999999999
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
|+||||+.+++|.++++......+++..+++++.+++.||+|||++ +|+|||||++|||+++++.+||+|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 9999999999999999765544589999999999999999999998 8999999999999999999999999999866
Q ss_pred CCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 468 NDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 468 ~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
...... ......++..|+|||++.++.++.++|||||||++|||++ |+.||......+.+.++. ..+...
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~--------~~~~~~ 263 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI--------KEGYRM 263 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH--------HcCCcC
Confidence 443221 1222345778999999998899999999999999999998 999987654333222211 111100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.. ..... .++.+++.+||+.+|++||++.||++.|+.
T Consensus 264 -----~~-~~~~~---~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 264 -----AQ-PEHAP---AEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred -----CC-CCCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 00 11122 345556669999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.47 Aligned_cols=252 Identities=29% Similarity=0.436 Sum_probs=199.9
Q ss_pred CCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHH--HHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 318 FAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGER--EFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~--~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
|++.+.||+|+||.||++... +++.||+|++......... ...+|+.++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567899999999999999954 5678999999876544332 3456999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.++|. ....+++..++.++.|+++||.|||++ +|+||||||+|||+++++.++|+|||++...... ...
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-NEN 154 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST-TSE
T ss_pred cccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-ccc
Confidence 9999999997 334589999999999999999999998 9999999999999999999999999999764221 223
Q ss_pred ccccccCccccCccccc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 475 STRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
.....|+..|+|||++. +..++.++||||||+++|+|++|+.||......+................ ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~ 225 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS---------SQQ 225 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH---------TTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc---------ccc
Confidence 34567899999999998 88899999999999999999999999987622222221111111000000 000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..... ..+.+++..||+.||++||++.++++
T Consensus 226 ~~~~~---~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SREKS---EELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSH---HHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhH---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011 55666667999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.65 Aligned_cols=255 Identities=27% Similarity=0.406 Sum_probs=205.6
Q ss_pred HhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
..++|.+.+.||+|+||.||++...++..+++|.++... .....+.+|++++++++|+||+++++++.+ +..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 346799999999999999999997778889999987542 345678899999999999999999999887 778999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+++|.+++.......+++..++.++.+++.||.|||+. +++|||||++||+|+.++.+||+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999999765555688899999999999999999998 8999999999999999999999999999766443322
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
......++..|++||++..+.++.++|||||||++|+|++ |+.||......+... +. ..+.... .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~-~~--------~~~~~~~-----~ 224 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR-AL--------ERGYRMP-----R 224 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH-HH--------hCCCCCC-----C
Confidence 2223446678999999998889999999999999999998 899997654322211 11 1111000 0
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.. .....+.+++.+|++.+|++||++.+|++.|+.
T Consensus 225 ~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 PE----NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cc----cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01 112345566679999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=325.01 Aligned_cols=258 Identities=21% Similarity=0.336 Sum_probs=204.6
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.+.||+|+||.||+|+. .+++.||||.++... ......+.+|+++|++++|+||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999984 478999999886532 233456889999999999999999999999999999999
Q ss_pred EecCCcchhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 392 EFVSNKTLEYHLHG--ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 392 E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||+.+++|.+++.. .....+++..+++++.++++||.|||++ +|+|||||++||||+.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988853 2334578899999999999999999998 999999999999999999999999999887654
Q ss_pred CCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
... ......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ...+... +....+.
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~-----~~~~~~~---- 226 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQK-----IEQCDYP---- 226 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHH-----HhcCCCC----
Confidence 321 122356889999999999888999999999999999999999998644211 1111111 1111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.+.. ......+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 227 -~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 -PLPT---EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -CCCh---hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1111 11123455666699999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=356.17 Aligned_cols=269 Identities=21% Similarity=0.272 Sum_probs=194.9
Q ss_pred HHHHHHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCC------CCcceEEEEE
Q 006083 309 DELAAATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHH------RHLVSLVGYC 381 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~H------pnIv~l~~~~ 381 (662)
+++....++|++.++||+|+||.||+|.. .+++.||||+++... ...+.+..|+++++.++| .+|++++++|
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 34445568899999999999999999985 468899999997532 234456778888887755 4588899988
Q ss_pred EeC-CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC------
Q 006083 382 IAG-GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF------ 454 (662)
Q Consensus 382 ~~~-~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~------ 454 (662)
... +.+|||||++ +++|.+++... ..+.+..+..|+.||+.||+|||+++ +||||||||+||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccc
Confidence 754 5788999988 77788877543 35889999999999999999999732 899999999999998765
Q ss_pred ----------cEEEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhh
Q 006083 455 ----------EAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMME 524 (662)
Q Consensus 455 ----------~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~ 524 (662)
.+||+|||++..... .....+||..|||||++.+..|+.++||||||||||||++|+.||+.....
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998864322 224478999999999999999999999999999999999999999876543
Q ss_pred hHHHHHHHHH--hHHHh--------------hcCccccccCcc----c-CCCCC--HHHHHHHHHHHHHhcccCCCCCCC
Q 006083 525 DSLVEWARPL--LGAAL--------------EDGIYDGLVDPR----L-EHNYV--PHEMARLVACGAASIRHSARKRPK 581 (662)
Q Consensus 525 ~~~~~~~~~~--~~~~~--------------~~~~~~~~~d~~----l-~~~~~--~~~~~~l~~l~~~cl~~~p~~RPs 581 (662)
+.+..+...+ +...+ ..+.+....+.. + ..... ...-..+.+++..||+.||++|++
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 3322211100 00000 000000000000 0 00000 001234557778999999999999
Q ss_pred HHHHHH
Q 006083 582 MSQIVR 587 (662)
Q Consensus 582 ~~evl~ 587 (662)
+.|+++
T Consensus 432 a~e~L~ 437 (467)
T PTZ00284 432 ARQMTT 437 (467)
T ss_pred HHHHhc
Confidence 999996
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=330.20 Aligned_cols=264 Identities=23% Similarity=0.293 Sum_probs=196.2
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhc---CCCCcceEEEEEEe-----CC
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRV---HHRHLVSLVGYCIA-----GG 385 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~-----~~ 385 (662)
+|++.+.||+|+||.||+|.. .+|+.||||.++.... .....+.+|+++++++ +|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 488899999999999999985 4789999999875422 2234566777777766 69999999998864 35
Q ss_pred eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccc
Q 006083 386 QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
..++||||+.+ +|.+++.......+++..++.++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 67999999975 788888665555689999999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh---HHHhh--
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL---GAALE-- 540 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~---~~~~~-- 540 (662)
...... ......|+..|+|||++.+..++.++|||||||++|||++|+.+|......+.+........ ...+.
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 764322 12345789999999999988999999999999999999999999977654443333222110 00000
Q ss_pred ----cCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 541 ----DGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 541 ----~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...+.......+ ..........+.+++.+||+.||++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPV-QSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCch-HHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000000 0001112234556677999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=341.24 Aligned_cols=237 Identities=24% Similarity=0.331 Sum_probs=186.5
Q ss_pred ceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHH-HHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEV-EIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~-~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
++||+|+||.||+++. .+|+.||||++.... ......+.+|+ .+++.++|+||+++++++.+.+..|||||||.+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999995 468899999997532 12233455555 467889999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
++|..++... ..+.+..+..++.||++||.|||++ +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS 154 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence 9999888543 3478888999999999999999998 99999999999999999999999999987543222 1234
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNY 556 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 556 (662)
..+|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+..+ + ...+ .+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i----~-----~~~~------~~~~-- 217 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI----L-----HKPL------QLPG-- 217 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH----h-----cCCC------CCCC--
Confidence 467999999999999889999999999999999999999999765432221111 0 0100 1111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006083 557 VPHEMARLVACGAASIRHSARKRPKMS 583 (662)
Q Consensus 557 ~~~~~~~l~~l~~~cl~~~p~~RPs~~ 583 (662)
.....+.+++.+||+.||.+|+++.
T Consensus 218 --~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 --GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1123455666699999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=331.42 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=199.7
Q ss_pred CCccceeeccCceEEEEEEec------CCCEEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 318 FAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
|++.+.||+|+||.||+|... +++.||||+++..... ..+.+.+|+.++..++|+||+++++++...+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 667889999999999999843 3578999999865433 346788999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcE
Q 006083 391 YEFVSNKTLEYHLHGE--------------NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA 456 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 456 (662)
+||+.+++|.+++... ....+++..+++++.|+++||+|||++ +|+||||||.|||+++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCce
Confidence 9999999999988421 123478889999999999999999998 99999999999999999999
Q ss_pred EEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHH
Q 006083 457 MVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPL 534 (662)
Q Consensus 457 kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~ 534 (662)
||+|||+++....... .......++..|+|||++.++.++.++|||||||+||||++ |..||......+.+.. .
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-i--- 239 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM-I--- 239 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-H---
Confidence 9999999886543321 12233456789999999998899999999999999999998 8888866543322111 1
Q ss_pred hHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 535 LGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 535 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
..+.... + ....+.+ +..++..||+.+|++||++.+|+..|+.
T Consensus 240 -----~~~~~~~-----~-~~~~~~~---~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 -----RNRQVLP-----C-PDDCPAW---VYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -----HcCCcCC-----C-CCCCCHH---HHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111111 0 1122333 4556669999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=332.60 Aligned_cols=200 Identities=27% Similarity=0.419 Sum_probs=175.0
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
++|++.+.||+|+||.||++.. .+++.||+|.++.... ....++.+|+++|++++|+||++++++|.+++.++|||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3689999999999999999984 4688899999876533 3345688999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+++|.++++.. ..+++..+..++.|+++||.|||+.+ +|+|||||++|||+++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 9999999999654 34788999999999999999999743 79999999999999999999999999987654322
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCch
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTM 522 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~ 522 (662)
.....|+..|++||++.+..++.++|||||||++|+|++|+.||....
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 234678999999999988889999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=323.31 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=203.2
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
+|++.+.||+|+||.||++.. .+++.||+|.++... ....+.+.+|++++++++|+||+++++++.+++.+|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 478899999999999999984 478999999986542 334567889999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.+++.......+++..++.++.+++.||.|||++ +|+|+|||++|||+++++.++|+|||++........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 999999988765555678999999999999999999998 999999999999999999999999999976643321 2
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||........+... ..+.+.. +..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~~-----~~~ 222 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV---------CQGSYKP-----LPS 222 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH---------hcCCCCC-----CCc
Confidence 23467899999999999888999999999999999999999999765432221111 1111111 111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.... .+.+++.+||+.||++||++.+|+..
T Consensus 223 -~~~~---~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 -HYSY---ELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -ccCH---HHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1122 34556669999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.82 Aligned_cols=262 Identities=26% Similarity=0.384 Sum_probs=203.7
Q ss_pred hCCCCccceeeccCceEEEEEEecC-----------------CCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcce
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPN-----------------GKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVS 376 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~ 376 (662)
.++|++.+.||+|+||.||++...+ +..||+|++..... ...+.+.+|+++|++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3568899999999999999987432 24689999876533 34567899999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCcchhhhhccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCc
Q 006083 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHGEN---------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAAN 447 (662)
Q Consensus 377 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~N 447 (662)
++++|..++..++||||+.+++|.+++.... ...+++..+++++.+++.||+|||++ +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999986543 12588999999999999999999998 89999999999
Q ss_pred EEECCCCcEEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh--CCCCCCCchhh
Q 006083 448 ILIDDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT--GRRPVDMTMME 524 (662)
Q Consensus 448 ILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt--G~~Pf~~~~~~ 524 (662)
|||++++.++|+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999976543321 22334566789999999998899999999999999999998 67788654433
Q ss_pred hHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 525 DSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
+.+... ...+ .......... .....+ .++.+++.+||+.+|.+||++.||++.|+
T Consensus 241 ~~~~~~-~~~~----~~~~~~~~~~---~~~~~~---~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIENA-GHFF----RDDGRQIYLP---RPPNCP---KDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHH-Hhcc----ccccccccCC---CccCCC---HHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 322111 1110 0000000000 011122 35666777999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.05 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=200.5
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
++|++.+.||+|+||.||+|.. .+++.||+|+++.........+++|+.++++++|+||+++++++..++..|+||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4689999999999999999995 578899999998665555667889999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.++++.. ..+++..+..++.|++.||.|||++ +|+|||||++|||+++++.+||+|||++........ .
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 89 GGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 999999998643 3478999999999999999999998 999999999999999999999999999986643221 1
Q ss_pred ccccccCccccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 475 STRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
.....|+..|++||.+. ...++.++|||||||++|||++|+.||......+....+. ...+. ...
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~---------~~~~~---~~~ 230 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS---------KSNFQ---PPK 230 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee---------cCCCC---CCC
Confidence 23356889999999884 3457889999999999999999999985433221111100 00000 011
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRAL 589 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 589 (662)
+... ......+.+++.+||+.+|++||++.+|++.|
T Consensus 231 ~~~~--~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LKDK--TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Cccc--cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1110 01123455566699999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=330.18 Aligned_cols=254 Identities=26% Similarity=0.417 Sum_probs=201.2
Q ss_pred CCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
+|++.+.||+|+||.||+|... ....+++|.+..... ...+.+.+|+++|+.++|+||++++++|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999842 235799998876543 345678999999999999999999999999999999
Q ss_pred EEEecCCcchhhhhccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCc
Q 006083 390 VYEFVSNKTLEYHLHGEN----------------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAAN 447 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~N 447 (662)
||||+.+++|.+++.... ...+++..++.++.+++.||+|||++ +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999875321 13478899999999999999999998 99999999999
Q ss_pred EEECCCCcEEEEeeccccccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhh
Q 006083 448 ILIDDNFEAMVADFGLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMED 525 (662)
Q Consensus 448 ILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~ 525 (662)
|||++++.+||+|||+++........ ......++..|++||++.+..++.++|||||||++|||++ |+.||......+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999765432221 1122345778999999998899999999999999999998 999997654332
Q ss_pred HHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 526 SLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
+.++. ..+. . ..... ... ..+.+++.+||+.+|++||++.||++.|+.
T Consensus 238 -~~~~~--------~~~~-~----~~~~~-~~~---~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 238 -LFNLL--------KTGY-R----MERPE-NCS---EEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred -HHHHH--------hCCC-C----CCCCC-CCC---HHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 22111 1111 0 01111 112 355666779999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.20 Aligned_cols=261 Identities=24% Similarity=0.411 Sum_probs=201.0
Q ss_pred CCCCccceeeccCceEEEEEEecC---------------CCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPN---------------GKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVG 379 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~---------------g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~ 379 (662)
++|++.+.||+|+||.||++...+ ...||||+++... ......|.+|+++|++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468899999999999999987432 2358999997653 233467899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCcchhhhhccCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEE
Q 006083 380 YCIAGGQRMLVYEFVSNKTLEYHLHGEN----------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANIL 449 (662)
Q Consensus 380 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NIL 449 (662)
++..++..++||||+.+++|.+++.... ...+.+..+++++.++++||+|||++ +|+||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 9999999999999999999999985431 12368889999999999999999998 9999999999999
Q ss_pred ECCCCcEEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh--CCCCCCCchhhhH
Q 006083 450 IDDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT--GRRPVDMTMMEDS 526 (662)
Q Consensus 450 l~~~~~vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt--G~~Pf~~~~~~~~ 526 (662)
|++++.+||+|||++........ .......++..|+|||++.++.++.++|||||||++|+|++ |..||......+.
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999976543221 12223455778999999998899999999999999999998 6677766543333
Q ss_pred HHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 527 LVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
+..+.. .+.. .+. .... . .....+ ..+.+++.+||+.+|++||++.+|++.|+
T Consensus 242 ~~~~~~-~~~~---~~~-~~~~--~-~~~~~~---~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 IENTGE-FFRN---QGR-QIYL--S-QTPLCP---SPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHH-hhhh---ccc-cccC--C-CCCCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 222211 1100 000 0000 0 011122 35666677999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=346.67 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=202.1
Q ss_pred hCCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCch-hHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSGQ-GEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQ 386 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~ 386 (662)
.++|.++++||+|+||.||+|++. .++.||||+++..... ..+.+++|+++|.++. |+|||+++++|...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 345778899999999999999843 3468999999865332 3457889999999997 9999999999999999
Q ss_pred EEEEEEecCCcchhhhhccCCC----------------------------------------------------------
Q 006083 387 RMLVYEFVSNKTLEYHLHGENR---------------------------------------------------------- 408 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~---------------------------------------------------------- 408 (662)
.++|||||.+|+|.++|+....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999964321
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE
Q 006083 409 --------------------------------------PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI 450 (662)
Q Consensus 409 --------------------------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl 450 (662)
..+++..+++++.+|+.||+|||+. +|+|||||++|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 2467778899999999999999998 99999999999999
Q ss_pred CCCCcEEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHH
Q 006083 451 DDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLV 528 (662)
Q Consensus 451 ~~~~~vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~ 528 (662)
++++.+||+|||+++....... .......|+..||+||++.+..++.++|||||||+||||++ |+.||......+.+.
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 9999999999999986543221 11223457889999999998889999999999999999998 899987644333221
Q ss_pred HHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 529 EWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
+.. ..+.. ... ...... .+.+++.+||..+|.+||++++|++.|+..
T Consensus 353 ~~~--------~~~~~-----~~~-p~~~~~---~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 353 NAI--------KRGYR-----MAK-PAHASD---EIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHH--------HcCCC-----CCC-CCCCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 11110 000 111233 445555699999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=330.66 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=197.7
Q ss_pred CCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
|+..++||+|+||.||++.. .+++.||||.+..... .....+.+|+.+|++++|+||+.+++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 67789999999999999985 4789999999875422 2234577899999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+++|.+++.......+.+..++.++.|++.||.|||+. +|+|||||++|||+++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 9999999988655545688999999999999999999998 999999999999999999999999999876543321
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+ ...+.. . ...+.
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~-~~~~~~-----~-----~~~~~ 225 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-ERLVKE-----V-----QEEYS 225 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH-Hhhhhh-----h-----hhhcC
Confidence 12357899999999999989999999999999999999999999764321111111 000000 0 00111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPK-----MSQIVR 587 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 587 (662)
.. ...+ +.+++..||+.||++|++ +.|+++
T Consensus 226 ~~-~~~~---~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 EK-FSPD---ARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cc-CCHH---HHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 11 1233 445556899999999999 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=339.86 Aligned_cols=200 Identities=26% Similarity=0.339 Sum_probs=169.8
Q ss_pred HhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAG------ 384 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------ 384 (662)
..++|.+.+.||+|+||.||++.. .+|+.||||+++.. .......+.+|+.+++.++|+||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457799999999999999999985 46899999999754 223456788999999999999999999998644
Q ss_pred CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
..+|+||||+.++ |..+++. .+++..+..++.|+++||.|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 3579999999764 5555532 378888999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchh
Q 006083 465 KLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMM 523 (662)
Q Consensus 465 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~ 523 (662)
+...... ......|+..|+|||++.+..++.++|||||||+||+|++|+.||.....
T Consensus 171 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~ 227 (359)
T cd07876 171 RTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH 227 (359)
T ss_pred cccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 7654322 22346789999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.60 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=199.6
Q ss_pred hCCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 387 (662)
+++|.+.+.||+|+||.||+|.+. .+..|++|.+..... .....+.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 356889999999999999999864 356799998875432 3345789999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC---cEEEE
Q 006083 388 MLVYEFVSNKTLEYHLHGENR-----PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF---EAMVA 459 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkl~ 459 (662)
++||||+.+++|.+++..... ..+++..+++++.+|+.||+|||++ +|+|||||++|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 999999999999999865431 2588999999999999999999998 899999999999998654 58999
Q ss_pred eeccccccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHH
Q 006083 460 DFGLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGA 537 (662)
Q Consensus 460 DFGla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 537 (662)
|||+++........ ......++..|+|||++.++.++.++|||||||+||||++ |+.||......+.... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~----~~-- 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF----VT-- 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HH--
Confidence 99999876332211 1112234568999999998999999999999999999997 9999976543322111 00
Q ss_pred HhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 538 ALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 538 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
..... ... ...+ ..+.+++.+||+.+|++||++.+|++.|+
T Consensus 236 --~~~~~------~~~-~~~~---~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 --GGGRL------DPP-KGCP---GPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --cCCcC------CCC-CCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00000 011 1122 34555666999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=340.41 Aligned_cols=265 Identities=21% Similarity=0.252 Sum_probs=198.3
Q ss_pred HhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAG------ 384 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------ 384 (662)
..++|.+.+.||+|+||.||++.. ..++.||||++.... ......+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 356799999999999999999984 468899999997542 23446788999999999999999999987543
Q ss_pred CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
...|+||||+.+ +|.+++.. .+++..+..++.|+++||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 457999999975 56666532 378889999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH----------
Q 006083 465 KLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL---------- 534 (662)
Q Consensus 465 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~---------- 534 (662)
+...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+.......
T Consensus 174 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 174 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred cccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 8654322 2234578999999999999999999999999999999999999998765443333222110
Q ss_pred ----hHHHhhc-Cccc-----cccCccc---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 535 ----LGAALED-GIYD-----GLVDPRL---EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 535 ----~~~~~~~-~~~~-----~~~d~~l---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+....+. ..+. .+....+ ...........+.+++.+||+.||++||++.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 0000 0000000 000001112345667779999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=328.65 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=202.1
Q ss_pred CCCCccceeeccCceEEEEEEe------cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL------PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
.+|...+.||+|+||.||++.. .++..+++|.++.........+.+|++++++++|+||+++++++.+++..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4577889999999999999863 2456899999887666667789999999999999999999999999999999
Q ss_pred EEEecCCcchhhhhccCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcE
Q 006083 390 VYEFVSNKTLEYHLHGENR-------------PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA 456 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~-------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 456 (662)
||||+.+++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999864321 3478899999999999999999998 99999999999999999999
Q ss_pred EEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHH
Q 006083 457 MVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPL 534 (662)
Q Consensus 457 kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~ 534 (662)
||+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||......+.+...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---- 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI---- 237 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH----
Confidence 9999999976543221 11223345778999999998899999999999999999998 89998654332221110
Q ss_pred hHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 535 LGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 535 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
..+... .. ....+.. +.+++.+||+.||.+||++.+|++.|+
T Consensus 238 -----~~~~~~-----~~-~~~~~~~---~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 -----TQGREL-----ER-PRTCPPE---VYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -----HcCccC-----CC-CCCCCHH---HHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111100 00 1112233 445556999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=323.09 Aligned_cols=248 Identities=28% Similarity=0.445 Sum_probs=199.8
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEE-eCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI-AGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~~lv~E~~ 394 (662)
.+|.+.+.||+|+||.||++.. .|..|++|.++.. ...+.+.+|+.++++++|+||+++++++. +++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 3588899999999999999986 5788999998754 33567899999999999999999999764 566789999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.++++......+++..+++++.+++.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 999999999766555688999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
....++..|+|||++.+..++.++|||||||++|||++ |+.||......+. ..+. ..+... .+.
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~-~~~~--------~~~~~~-----~~~ 221 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-VPRV--------EKGYKM-----DAP 221 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHH--------hcCCCC-----CCC
Confidence 22344678999999998899999999999999999997 9999865432221 1111 111100 111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...+. .+.+++.+|++.+|++||++.++++.|+.
T Consensus 222 -~~~~~---~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 222 -DGCPP---VVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -CCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11233 44555669999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=326.34 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=199.3
Q ss_pred HHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC------
Q 006083 313 AATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAG------ 384 (662)
Q Consensus 313 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~------ 384 (662)
.+.+.|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+|+.++.++ +|+||++++++|...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3456788999999999999999985 468899999987643 3456788999999999 699999999998753
Q ss_pred CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
..+|+||||+.+++|.+++.......+.+..+..++.|++.||+|||++ +|+|||||++|||+++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4689999999999999999765555689999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCCccccccccCccccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHh
Q 006083 465 KLSNDNHTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAAL 539 (662)
Q Consensus 465 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 539 (662)
+....... ......|+..|+|||++. +..++.++|||||||+||||++|+.||+.......... .
T Consensus 159 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~-----~---- 228 (272)
T cd06637 159 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-----I---- 228 (272)
T ss_pred eecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-----H----
Confidence 86543221 223467899999999986 34688899999999999999999999965432211110 0
Q ss_pred hcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 540 EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 540 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.... ...+.......+ +.+++.+||..+|.+||++.+|++
T Consensus 229 ~~~~-----~~~~~~~~~~~~---~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PRNP-----APRLKSKKWSKK---FQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hcCC-----CCCCCCCCcCHH---HHHHHHHHcCCChhhCCCHHHHhh
Confidence 0011 111111122333 445556999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=331.09 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=198.6
Q ss_pred CCCCccceeeccCceEEEEEEec-CCC--EEEEEEeecC-CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGK--EVAVKSLKTG-SGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv 390 (662)
++|.+.++||+|+||.||+|... ++. .+++|.++.. .....+.+.+|++++.++ +|+||+++++++.+.+..|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 56889999999999999999864 333 4788888743 234456789999999999 799999999999999999999
Q ss_pred EEecCCcchhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcE
Q 006083 391 YEFVSNKTLEYHLHGEN--------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA 456 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 456 (662)
|||+.+++|.++++... ...+.+..+++++.|++.||+|||++ +|+||||||+||||++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999986432 12478899999999999999999998 99999999999999999999
Q ss_pred EEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHh
Q 006083 457 MVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLL 535 (662)
Q Consensus 457 kl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~ 535 (662)
||+|||++........ ......+..|++||++.+..++.++|||||||+||||++ |+.||......+.+...
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~----- 231 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL----- 231 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-----
Confidence 9999999864322111 111223567999999998899999999999999999997 99999765433222111
Q ss_pred HHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 536 GAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 536 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
..+... .+. ..... .+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 232 ----~~~~~~-----~~~-~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 232 ----PQGYRM-----EKP-RNCDD---EVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred ----hcCCCC-----CCC-CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111100 011 11223 345566699999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.03 Aligned_cols=241 Identities=23% Similarity=0.308 Sum_probs=192.5
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lv~ 391 (662)
+|+..+.||+|+||.||++.. .+|+.||||+++... ....+.+..|+.++..+. |++|+++++++.+.+.+||||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 377889999999999999984 478999999997542 233456788999998886 577888999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.||+|.+++.... .+++..++.++.|++.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999986543 488999999999999999999998 99999999999999999999999999987643322
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
. .....+|+..|+|||++.++.++.++|||||||+||||++|+.||........+.... . ... .
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--------~-~~~------~ 219 (323)
T cd05615 156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM--------E-HNV------S 219 (323)
T ss_pred c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--------h-CCC------C
Confidence 1 2234679999999999998899999999999999999999999997764332221111 1 010 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKM 582 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 582 (662)
+... .. ..+.+++.+||+.+|.+|++.
T Consensus 220 ~p~~-~~---~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 YPKS-LS---KEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCcc-CC---HHHHHHHHHHcccCHhhCCCC
Confidence 1111 12 234556669999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=331.97 Aligned_cols=263 Identities=21% Similarity=0.309 Sum_probs=197.6
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
++|.+.+.||+|+||.||+|... +++.||||+++.... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46889999999999999999854 678999999975432 2335678899999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+ +|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||||++++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 975 7777765433 3478899999999999999999998 999999999999999999999999999976543321
Q ss_pred cccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh---HHHh----h-----
Q 006083 474 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL---GAAL----E----- 540 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~---~~~~----~----- 540 (662)
......|+..|+|||++.+ ..++.++|||||||+||||++|+.||......+.+....+..- ...+ .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 2233568999999998865 4689999999999999999999999977654443322211100 0000 0
Q ss_pred cCccccccCcccCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 541 DGIYDGLVDPRLEH--NYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 541 ~~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...+.......+.. ..... .+.+++.+||+.||++|+++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDT---EGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCH---HHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000000 01122 3445666999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=325.45 Aligned_cols=257 Identities=21% Similarity=0.341 Sum_probs=204.6
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|.+.+.||+|+||.||++.. .+++.|+||.+.... .....++.+|+++++.++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999994 588999999886532 233457889999999999999999999999999999999
Q ss_pred EecCCcchhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 392 EFVSNKTLEYHLHG--ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 392 E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||+.+++|.+++.. .....+++..+++++.++++||.|||++ +|+|+|||++|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998863 2334689999999999999999999998 999999999999999999999999999876654
Q ss_pred CCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
... ......|+..|+|||++.+..++.++|||||||++|+|++|..||...... ...+... +.... .
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~-----~~~~~-----~ 225 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKK-----IEQCD-----Y 225 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch--HHHHhhh-----hhcCC-----C
Confidence 322 123356899999999999888999999999999999999999999654221 1111111 01111 1
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
..+....... .+.+++.+||+.+|.+||++.+|++.++.
T Consensus 226 ~~~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 226 PPLPSDHYSE---ELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCCCcccccH---HHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 1111122233 34455568999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=324.21 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=195.4
Q ss_pred CCccceeeccCceEEEEEEecC-CC--EEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------Ce
Q 006083 318 FAKSNLLGQGGFGYVHKGVLPN-GK--EVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAG------GQ 386 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~~-g~--~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~~ 386 (662)
|.++++||+|+||.||+|.+.+ +. .||||.++.. .....+.+.+|+++|++++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999998643 33 6899988754 234456789999999999999999999987532 25
Q ss_pred EEEEEEecCCcchhhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeec
Q 006083 387 RMLVYEFVSNKTLEYHLHG----ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFG 462 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFG 462 (662)
.++||||+.+++|.+++.. .....+++..++.++.|++.||+|||++ +|+|||||++|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999988742 1234578999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCcc-ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhh
Q 006083 463 LAKLSNDNHTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALE 540 (662)
Q Consensus 463 la~~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 540 (662)
+++......... .....++..|++||++.+..++.++|||||||++|||++ |+.||......+.... +.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~---------~~ 228 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY---------LR 228 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---------HH
Confidence 998764432211 122346778999999999899999999999999999999 8889865433221111 11
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 541 DGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 541 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.+.... . ..... ..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 229 ~~~~~~-----~-~~~~~---~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 229 QGNRLK-----Q-PPDCL---DGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred cCCCCC-----C-CCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 111100 0 11122 335566669999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=335.63 Aligned_cols=200 Identities=20% Similarity=0.270 Sum_probs=168.2
Q ss_pred ccceeecc--CceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 320 KSNLLGQG--GFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 320 ~~~~iG~G--~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
++++||+| +||+||++.. .+|+.||||+++... ....+.+++|+++++.++|+||++++++|..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 6889999984 578999999997643 233457888999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc-
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH- 473 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~- 473 (662)
.+++|.+++.......+++..+++++.|++.||+|||++ +|+|||||++||||+.++.++|+||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999654444589999999999999999999998 8999999999999999999999999875433211110
Q ss_pred -----cccccccCccccCcccccC--CCCCchHHHHHHHHHHHHHHhCCCCCCCch
Q 006083 474 -----VSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPVDMTM 522 (662)
Q Consensus 474 -----~~~~~~Gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~ 522 (662)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 1122456788999999976 458999999999999999999999997644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=338.75 Aligned_cols=257 Identities=28% Similarity=0.411 Sum_probs=207.3
Q ss_pred HhCCCCccceeeccCceEEEEEEec---CC--CEEEEEEeecC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP---NG--KEVAVKSLKTG-SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~---~g--~~vavK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 387 (662)
.+......++||+|-||.||+|++. .| -.||||..+.+ ..+..+.|+.|..+|+.++|||||+|+|+|.+ .-.
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 3344556788999999999999843 23 35999999885 45567889999999999999999999999976 467
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
|||||++..|.|..+|+.++. .++......++.||+.||+|||+. ++|||||..+||||.....|||+|||++++.
T Consensus 466 WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 999999999999999976544 588899999999999999999999 9999999999999999999999999999998
Q ss_pred CCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCcccc
Q 006083 468 NDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 468 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
.+..........-...|||||.+.-.+++.++|||-|||++||+|. |..||.+-...|.+.. +++|.
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~---------iEnGe--- 609 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH---------IENGE--- 609 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE---------ecCCC---
Confidence 7765444444445778999999999999999999999999999765 9999977544332211 11111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
+.-....++..+.. +..+||..+|.+||.+.||...|....
T Consensus 610 ---RlP~P~nCPp~LYs---lmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 610 ---RLPCPPNCPPALYS---LMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred ---CCCCCCCCChHHHH---HHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 11123344555544 445999999999999999999988644
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=332.11 Aligned_cols=257 Identities=27% Similarity=0.397 Sum_probs=201.1
Q ss_pred hCCCCccceeeccCceEEEEEEec--------CCCEEEEEEeecCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP--------NGKEVAVKSLKTGS-GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAG 384 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~ 384 (662)
.++|.+.+.||+|+||.||++... ++..||+|+++... ......+.+|+++++++ +|+||++++++|..+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 356999999999999999998742 23579999998643 23456788899999999 799999999999999
Q ss_pred CeEEEEEEecCCcchhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGEN--------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI 450 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl 450 (662)
+..|+||||+.+++|.+++.... ...+++..+++++.|++.||+|||++ +|+|||||++|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 99999999999999999996532 13478899999999999999999998 99999999999999
Q ss_pred CCCCcEEEEeeccccccCCCCCcc-ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHH
Q 006083 451 DDNFEAMVADFGLAKLSNDNHTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLV 528 (662)
Q Consensus 451 ~~~~~vkl~DFGla~~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~ 528 (662)
++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||+||||++ |+.||......+...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 999999999999997654322111 112234568999999998899999999999999999998 888886544322111
Q ss_pred HHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 529 EWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
. +..+.... . ..... ..+.+++.+||..+|++||++.+|++.|+..
T Consensus 254 ~---------~~~~~~~~-----~-~~~~~---~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 254 L---------LKEGHRMD-----K-PSNCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred H---------HHcCCCCC-----C-CCcCC---HHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1 11111000 0 01122 3455566699999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=322.91 Aligned_cols=257 Identities=23% Similarity=0.379 Sum_probs=206.0
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|.+.+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999965 8899999988643 2233567899999999999999999999999999999999
Q ss_pred EecCCcchhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 392 EFVSNKTLEYHLHG--ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 392 E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||+.+++|..++.. .....+.+..+++++.+++.||.|||+. +|+|||||++|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998854 2334578999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||..... .+.++... +..+.+...
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~-----~~~~~~~~~-- 228 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKK-----IEKCDYPPL-- 228 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc--cHHHHHhh-----hhcCCCCCC--
Confidence 322 12335688999999999988899999999999999999999999865421 11111111 111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.. ......+.+++.+||..+|.+||++.+|+++|+.
T Consensus 229 ---~~---~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~ 264 (267)
T cd08224 229 ---PA---DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264 (267)
T ss_pred ---Ch---hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence 11 1122345566669999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=345.11 Aligned_cols=203 Identities=23% Similarity=0.331 Sum_probs=176.1
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.+.||+|+||.||++.. .+++.||||+++... ......+.+|+++|.+++|+||+++++.+.+++.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688999999999999999985 468999999997532 233457888999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
|||.||+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999986543 488999999999999999999998 99999999999999999999999999987543211
Q ss_pred C----------------------------------ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCC
Q 006083 472 T----------------------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517 (662)
Q Consensus 472 ~----------------------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~P 517 (662)
. ......+||..|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 011235799999999999999999999999999999999999999
Q ss_pred CCCchh
Q 006083 518 VDMTMM 523 (662)
Q Consensus 518 f~~~~~ 523 (662)
|.....
T Consensus 236 f~~~~~ 241 (360)
T cd05627 236 FCSETP 241 (360)
T ss_pred CCCCCH
Confidence 976544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=338.07 Aligned_cols=266 Identities=21% Similarity=0.261 Sum_probs=198.3
Q ss_pred HHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----
Q 006083 313 AATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAG----- 384 (662)
Q Consensus 313 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~----- 384 (662)
...++|.+.+.||+|+||.||++.. ..++.||||+++... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3557899999999999999999985 468899999997542 23346788999999999999999999988643
Q ss_pred -CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecc
Q 006083 385 -GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGL 463 (662)
Q Consensus 385 -~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 463 (662)
...|+||||+.+ +|.+++.. .+++..+..++.|+++||+|||++ +|+||||||+||||++++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999976 55555532 378889999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH---------
Q 006083 464 AKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL--------- 534 (662)
Q Consensus 464 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~--------- 534 (662)
++...... ......|+..|+|||++.+..++.++|||||||+||+|++|+.||......+.+......+
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98654332 2234678999999999999899999999999999999999999997654333222211110
Q ss_pred -----hHHHhhc-CccccccCc-----cc---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 535 -----LGAALED-GIYDGLVDP-----RL---EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 535 -----~~~~~~~-~~~~~~~d~-----~l---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
....++. ..+..+... .+ ...........+.+++.+||+.||++||++.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 000000000 00 000011112345566779999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=323.84 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=198.3
Q ss_pred CCccceeeccCceEEEEEEec-C---CCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-----
Q 006083 318 FAKSNLLGQGGFGYVHKGVLP-N---GKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQ----- 386 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~-~---g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~----- 386 (662)
|.+++.||+|+||.||+|... + +..||||+++... ......+.+|+++|+.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567899999999999999853 2 3679999997543 2334678999999999999999999998876554
Q ss_pred -EEEEEEecCCcchhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEee
Q 006083 387 -RMLVYEFVSNKTLEYHLHGE----NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADF 461 (662)
Q Consensus 387 -~~lv~E~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DF 461 (662)
.++||||+.+++|..++... ....+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 79999999999999888532 234688999999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHh
Q 006083 462 GLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAAL 539 (662)
Q Consensus 462 Gla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 539 (662)
|+++........ ......++..|++||++.+..++.++|||||||++|||++ |..||......+.+ ++.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~-~~~-------- 228 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY-DYL-------- 228 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHH--------
Confidence 999866433221 1122345678999999988899999999999999999999 88888664432211 111
Q ss_pred hcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 540 EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 540 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
..+... .+.. .....+.+++.+||+.||++||++.||++.|+.
T Consensus 229 ~~~~~~-----~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 229 RHGNRL-----KQPE----DCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred HcCCCC-----CCCc----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 111111 0111 122355666668999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=321.07 Aligned_cols=251 Identities=27% Similarity=0.467 Sum_probs=202.1
Q ss_pred CCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
+|.+.+.||+|+||.||++.+.+++.+|||+++... .....+.+|++++++++|+||+++++++......++||||+.+
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 577889999999999999997778899999987543 2345789999999999999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
++|.+++.... ..+.+..++.++.+++.+|+|||+. +|+|||||++||+++.++.+||+|||++............
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 84 GCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999986543 3478899999999999999999998 8999999999999999999999999998765433221122
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHN 555 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 555 (662)
...++..|+|||++.++.++.++|||||||++|||++ |+.||......+.+.. +..+. .... ..
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~---------~~~~~--~~~~----~~ 224 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET---------INAGF--RLYK----PR 224 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH---------HhCCC--CCCC----CC
Confidence 2345678999999998899999999999999999998 9999976543322211 11110 0011 11
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 556 YVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 556 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
... ..+.+++.+||+.+|++||++.+|++.|.
T Consensus 225 ~~~---~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 LAS---QSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCC---HHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 122 45666777999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.38 Aligned_cols=258 Identities=26% Similarity=0.439 Sum_probs=202.1
Q ss_pred HhCCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQ 386 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 386 (662)
..++|++.+.||+|+||.||+|... .+..||||.++.... .....+.+|+.++++++|+||+++++++.+++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3467999999999999999998742 245799999875432 334568899999999999999999999999999
Q ss_pred EEEEEEecCCcchhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEE
Q 006083 387 RMLVYEFVSNKTLEYHLHGEN--------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMV 458 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl 458 (662)
.++||||+.+|+|.+++.... ...+.+..+.+++.|++.||.|||++ +|+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996422 23456778899999999999999998 9999999999999999999999
Q ss_pred EeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhH
Q 006083 459 ADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLG 536 (662)
Q Consensus 459 ~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 536 (662)
+|||+++....... .......++..|++||++.++.++.++|||||||++|||++ |..||......+.+...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~------ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV------ 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------
Confidence 99999986543221 11222345778999999998899999999999999999998 78888765433221110
Q ss_pred HHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 537 AALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 537 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
...+... .. .... ..+.+++.+||+.+|++||++.++++.|+..
T Consensus 235 --~~~~~~~------~~-~~~~---~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 235 --MDGGYLD------QP-DNCP---ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred --HcCCCCC------CC-CCCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 0111110 00 1112 3555666699999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=323.59 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=201.4
Q ss_pred CCCCccceeeccCceEEEEEEec-CC---CEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NG---KEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g---~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
++|...+.||+|+||.||+|... ++ ..++||+++... ....+.+..|++++++++|+||+++++++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 45888899999999999999854 33 379999987653 33456789999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+++|.+++.... ..+++..++.++.+++.||+|||+. +|+|||||++|||+++++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 85 TEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999986533 4588999999999999999999998 8999999999999999999999999999766433
Q ss_pred CCcccc--ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 471 HTHVST--RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 471 ~~~~~~--~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
...... ....+..|++||++.++.++.++|||||||++|||++ |+.||......+....+ ..+...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i---------~~~~~~-- 229 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI---------NDGFRL-- 229 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH---------hcCCCC--
Confidence 221111 1223457999999998899999999999999999997 99999655432211111 111000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.. .. +....+.+++.+||+.+|++||++.+|++.|+.
T Consensus 230 --~~-~~----~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 230 --PA-PM----DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred --CC-CC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 00 01 112445677779999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=335.74 Aligned_cols=241 Identities=21% Similarity=0.326 Sum_probs=188.7
Q ss_pred ceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
++||+|+||.||++.. .+++.||||+++... ....+.+.+|+.++.++ +|+||+++++++.+.+.+||||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999985 467899999998642 23345688999999988 699999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS 154 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence 99998885443 489999999999999999999998 99999999999999999999999999997543222 1224
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhh--HHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMED--SLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
..+|+..|+|||++.+..++.++|||||||+||||++|+.||+...... ...++..... ..... .+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~------~~p~ 224 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI----LEKPI------RIPR 224 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH----HhCCC------CCCC
Confidence 4679999999999999999999999999999999999999996432111 1111111111 01100 1111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKM 582 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 582 (662)
..... +..++.+||+.||++|+++
T Consensus 225 -~~~~~---~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 225 -FLSVK---ASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred -CCCHH---HHHHHHHHhccCHHHcCCC
Confidence 12233 3455568999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=329.36 Aligned_cols=261 Identities=27% Similarity=0.368 Sum_probs=199.1
Q ss_pred CCCCccceeeccCceEEEEEEe-----cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-----PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA--GGQRM 388 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ 388 (662)
..|++.+.||+|+||.||++.. .+++.||||+++.......+.+.+|+++|++++|+||+++++++.. ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 3588889999999999999874 3578999999987666666789999999999999999999998753 45689
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
+||||+.+++|.+++.... ..+++..++.++.+++.||+|||++ +|+|||||++||||++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999986543 3588999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCc--cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHH---------HHHHHhHH
Q 006083 469 DNHTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVE---------WARPLLGA 537 (662)
Q Consensus 469 ~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~---------~~~~~~~~ 537 (662)
..... ......+...|++||++.+..++.++|||||||++|||++|..++...... .... +... +..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~ 237 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVYH-LIE 237 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchHH-HHH
Confidence 43221 111223455699999999889999999999999999999988765432110 0000 0000 000
Q ss_pred HhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 538 ALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 538 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.+..+.. ... ..... ..+.+++.+||+.+|++||++.||++.|+.
T Consensus 238 ~~~~~~~-----~~~-~~~~~---~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 238 LLKNNGR-----LPA-PPGCP---AEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HHhcCCc-----CCC-CCCCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 0011000 000 01122 345666679999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=326.53 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=196.4
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
+|++.++||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++|++++|+||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 578889999999999999984 578999999987653 334567899999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|..+. .+++..+.+++.|++.||.|||+. +|+|||||++|||++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 999997543 367888999999999999999998 99999999999999999999999999997654332
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
....+|+..|+|||++.+..++.++|||||||++|+|++|+.||......+....+. .... .+.... ...+..
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~~-~~~~~~-----~~~~~~ 222 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL-QLLQ-CIVDED-----PPVLPV 222 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH-HHHH-HHhccC-----CCCCCC
Confidence 233578999999999998899999999999999999999999996532211111000 0000 000000 011111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
..... ++.+++.+||+.+|++||++.|+++.
T Consensus 223 ~~~~~---~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 GQFSE---KFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CcCCH---HHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11222 34555668999999999999998864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=328.70 Aligned_cols=250 Identities=21% Similarity=0.340 Sum_probs=203.1
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
.+|.+.+.||+|+||.||+|+. .+++.|++|.+........+.+.+|+.+++.++|+||++++++|.++...|+||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4688899999999999999984 578999999998766566678899999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.+++... .+.+.++..++.|++.||+|||+. +|+|||||++||||+.++.+||+|||++........ .
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 999999998542 478899999999999999999998 999999999999999999999999999876543221 1
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+.. .+. . .+.
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~--------~~~-~-----~~~- 237 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT--------NGT-P-----ELQ- 237 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc--------CCC-C-----CCC-
Confidence 2335789999999999988899999999999999999999999976543222211110 000 0 000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
........+.+++.+||..+|++||++.+|++.
T Consensus 238 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 -NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 011112345566679999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=310.29 Aligned_cols=253 Identities=24% Similarity=0.359 Sum_probs=200.7
Q ss_pred HHhCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCc----hh----HHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 006083 313 AATGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSG----QG----EREFSAEVEIISRV-HHRHLVSLVGYCI 382 (662)
Q Consensus 313 ~~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~----~~----~~~~~~E~~il~~l-~HpnIv~l~~~~~ 382 (662)
...++|.-.++||+|..+.|.++. ..+|+++|+|++..... .. .+.-.+|+.||+++ .||+|++|.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 344567888899999999999987 45789999999864311 11 23456799999998 5999999999999
Q ss_pred eCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeec
Q 006083 383 AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFG 462 (662)
Q Consensus 383 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFG 462 (662)
.+..+++|+|.|..|.|+|+|... -.+++.+..+|+.|+++|++|||.+ +||||||||+|||+++|.++||+|||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 999999999999999999999654 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccCccccCcccccC------CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhH
Q 006083 463 LAKLSNDNHTHVSTRVMGTFGYLAPEYASS------GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLG 536 (662)
Q Consensus 463 la~~~~~~~~~~~~~~~Gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 536 (662)
++..+..+.. ....|||++|+|||.+.. ..|+...|+|++|||||-||.|..||-....- ++-
T Consensus 169 Fa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm---------lML 237 (411)
T KOG0599|consen 169 FACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM---------LML 237 (411)
T ss_pred eeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH---------HHH
Confidence 9998876643 466899999999998863 35888999999999999999999999543211 111
Q ss_pred HHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 537 AALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 537 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..+.+|.|+- -.+.+. ......+ +++.+||++||.+|-+++|+|.
T Consensus 238 R~ImeGkyqF-~speWa--dis~~~K---dLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 238 RMIMEGKYQF-RSPEWA--DISATVK---DLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHhccccc-CCcchh--hccccHH---HHHHHHHeeCchhcccHHHHhc
Confidence 2222333321 111111 1123333 4555899999999999999985
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=330.39 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=202.9
Q ss_pred hCCCCccceeeccCceEEEEEEe--------cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL--------PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAG 384 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~--------~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~ 384 (662)
.++|.+.+.||+|+||.||++.. .++..||||.++... ....+.+.+|+.+++.+ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 45688899999999999999963 134579999987542 34456789999999999 799999999999999
Q ss_pred CeEEEEEEecCCcchhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGEN--------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI 450 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl 450 (662)
+..|+||||+.+++|.+++.... ...+++..++.++.||++||+|||++ +|+|||||++||||
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 99999999999999999986532 23478889999999999999999998 99999999999999
Q ss_pred CCCCcEEEEeeccccccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHH
Q 006083 451 DDNFEAMVADFGLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLV 528 (662)
Q Consensus 451 ~~~~~vkl~DFGla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~ 528 (662)
++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |..||......+.+.
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 250 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 99999999999999876543222 1222445678999999998899999999999999999998 788886553322111
Q ss_pred HHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCCC
Q 006083 529 EWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSS 594 (662)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 594 (662)
.. ..+... .. ..... ..+..++.+||+.+|.+||++.||++.|+....
T Consensus 251 ----~~-----~~~~~~-----~~-~~~~~---~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 251 ----LL-----KEGHRM-----DK-PANCT---NELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ----HH-----HcCCcC-----CC-CCCCC---HHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 11 111100 00 11122 345556669999999999999999999986443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=308.42 Aligned_cols=261 Identities=23% Similarity=0.328 Sum_probs=204.4
Q ss_pred hCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAG-----GQRM 388 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~ 388 (662)
..+|.+.++||+|||..||+++ ..+++.||+|++.....++.+..++|++..++++|+|++++++++..+ ...|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4579999999999999999998 678999999999987778888999999999999999999999876543 4589
Q ss_pred EEEEecCCcchhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 389 LVYEFVSNKTLEYHLHGE--NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
|++.|...|+|.+.+... +...+++.++++|+.++++||++||+. .+.+.||||||.|||+.+.+.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999988643 334689999999999999999999997 23499999999999999999999999999875
Q ss_pred cCCCC---Ccc-----ccccccCccccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhh-hHHHHHHHHH
Q 006083 467 SNDNH---THV-----STRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDMTMME-DSLVEWARPL 534 (662)
Q Consensus 467 ~~~~~---~~~-----~~~~~Gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~-~~~~~~~~~~ 534 (662)
..-.- ... .....-|..|.|||++. +...++++|||||||+||+|+.|..||+..... +++
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl------- 251 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL------- 251 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE-------
Confidence 43111 000 01123588899999886 456789999999999999999999999754211 110
Q ss_pred hHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 535 LGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 535 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.-++..+.+.-. ........|.+++.+||+.||.+||++.+++..++..
T Consensus 252 -aLAv~n~q~s~P--------~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 252 -ALAVQNAQISIP--------NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -EEeeeccccccC--------CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 000111111111 1111334566667799999999999999999998753
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=336.69 Aligned_cols=204 Identities=23% Similarity=0.285 Sum_probs=175.9
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|.+.+.||+|+||.||+++.. +++.||||+++... ......+.+|+.++..++|+||+++++++.+++..||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46899999999999999999854 68899999997531 223355788999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.||+|.+++.... ..+.+..+..++.|++.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999996532 3578899999999999999999998 99999999999999999999999999998765443
Q ss_pred CccccccccCccccCcccccC-----CCCCchHHHHHHHHHHHHHHhCCCCCCCchh
Q 006083 472 THVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDMTMM 523 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~ 523 (662)
.......+|+..|||||++.+ +.++.++|||||||+||||++|+.||.....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 213 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH
Confidence 322334679999999999875 5688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=326.20 Aligned_cols=255 Identities=25% Similarity=0.428 Sum_probs=202.9
Q ss_pred hCCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 387 (662)
.++|.+.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+++|+.++|+||+++++++..++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 346888999999999999999853 246899999875532 3456788999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEE
Q 006083 388 MLVYEFVSNKTLEYHLHGEN--------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVA 459 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~ 459 (662)
++||||+.+++|.+++.... ...+.+..+++++.|++.||.|||+. +|+||||||+||||++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 99999999999999986432 23468889999999999999999998 99999999999999999999999
Q ss_pred eeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHH
Q 006083 460 DFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGA 537 (662)
Q Consensus 460 DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 537 (662)
|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ |+.||......+. ..+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~------ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV-LKFV------ 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH-HHHH------
Confidence 9999876543321 12233457889999999998899999999999999999998 9999865443222 1111
Q ss_pred HhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 538 ALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 538 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
..+.... +.. ..+ ..+.+++.+||+.+|++||++.+|++.|+
T Consensus 235 --~~~~~~~-----~~~-~~~---~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 --IDGGHLD-----LPE-NCP---DKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred --hcCCCCC-----CCC-CCC---HHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111111 111 122 34556666999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=320.47 Aligned_cols=248 Identities=28% Similarity=0.430 Sum_probs=199.8
Q ss_pred ceeeccCceEEEEEEecC--C--CEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVLPN--G--KEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~--g--~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
++||+|+||.||+|.+.+ + ..||||.++.... ...+.+.+|++++++++|+||+++++++.+ ...++||||+.+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998532 3 3699999987765 556789999999999999999999999988 889999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc--c
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH--V 474 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~--~ 474 (662)
++|.+++.......+++..++.++.|+++||+|||++ +|+|||||++||||+.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999999765434689999999999999999999998 9999999999999999999999999999876543221 1
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
.....++..|++||++.+..++.++|||||||++|||++ |+.||......+.+..+.. .. ... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~--------~~--~~~----~~ 222 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK--------EG--ERL----ER 222 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh--------cC--CcC----CC
Confidence 123457889999999998899999999999999999998 9999976544332222111 00 000 00
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
....+ ..+.+++.+||+.+|++||++.+|++.|.
T Consensus 223 ~~~~~---~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEACP---QDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccCC---HHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11122 34556667999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=323.52 Aligned_cols=254 Identities=29% Similarity=0.455 Sum_probs=201.3
Q ss_pred CCCCccceeeccCceEEEEEEec-C---CCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-N---GKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~---g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
++|++.+.||+|+||.||+|... + +..||+|.++... ....+.+.+|+.+|++++|+||+++++++..++..|+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45888999999999999999853 2 3379999987643 23356789999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+++|.+++.... ..+++.++++++.|++.||.|||++ +|+|||||++|||++.++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999996543 3578999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCccc--cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 471 HTHVS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 471 ~~~~~--~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
..... ....++..|++||++.++.++.++|||||||++|||++ |+.||......+.+.. . ..+. . .
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~-~--------~~~~-~-~ 228 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA-I--------EEGY-R-L 228 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH-H--------hCCC-c-C
Confidence 22211 11233568999999998899999999999999999886 9999966543322111 1 1110 0 0
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
... ...+ ..+.+++.+|++.+|.+||++.+|++.|+.
T Consensus 229 ---~~~-~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 ---PAP-MDCP---AALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ---CCC-CCCC---HHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 000 1112 345566669999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=318.53 Aligned_cols=248 Identities=26% Similarity=0.333 Sum_probs=200.5
Q ss_pred hCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCchh---HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQG---EREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
.++|+.+++||+|.||.|-+++ ..+|+.||||+++++-.-. ...-..|-++|+..+||.+..|...|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4678899999999999999998 5589999999999864333 34456799999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||++||.|+.+|.++ ..+++.....+-..|+.||.|||++ +||.||||.+|+|||++|++||+||||++..-..
T Consensus 247 MeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999999999654 3578888888899999999999998 9999999999999999999999999999875543
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
. .....+|||+.|+|||++....|..+.|+|.+|||||||+||++||...+.+..+.-+.. ++ .
T Consensus 322 g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~-------ed--------~ 385 (516)
T KOG0690|consen 322 G-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM-------ED--------L 385 (516)
T ss_pred c-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh-------hh--------c
Confidence 3 234669999999999999999999999999999999999999999976543322111100 00 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPK-----MSQIVR 587 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 587 (662)
++.. ....+.+.|+. ..|..||++|.. ++||.+
T Consensus 386 kFPr-~ls~eAktLLs---GLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 386 KFPR-TLSPEAKTLLS---GLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred cCCc-cCCHHHHHHHH---HHhhcChHhhcCCCchhHHHHHh
Confidence 1112 22344555544 568899999963 555554
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=318.33 Aligned_cols=250 Identities=22% Similarity=0.359 Sum_probs=201.0
Q ss_pred CCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeEEEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIA-GGQRMLVYE 392 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lv~E 392 (662)
+|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++|+||+++++.+.. +..+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999854 67899999997543 2345678899999999999999999998764 456899999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.+++|.+++.......+++.+++.++.+++.||+|||+. +|+|||||++|||+++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 99999999999765555689999999999999999999998 99999999999999999999999999998664322
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
.......|+..|+|||++.+..++.++|||||||++|+|++|+.||+..........+. .+.+.. +
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~---------~~~~~~-----~ 222 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII---------EGKLPP-----M 222 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---------hcCCCC-----C
Confidence 22334578999999999999999999999999999999999999997654322211111 111110 1
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
. ......+.+++.+||+.+|++||++.++++.
T Consensus 223 ~----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 P----KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred c----cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1 1122345566679999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=319.28 Aligned_cols=248 Identities=31% Similarity=0.485 Sum_probs=201.4
Q ss_pred ceeeccCceEEEEEEecC----CCEEEEEEeecCCchh-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVLPN----GKEVAVKSLKTGSGQG-EREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
+.||+|+||.||++.... +..|+||+++...... .+.+.+|++++++++|+||+++++++.+++..++||||+.+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999643 7899999998764443 67899999999999999999999999999999999999999
Q ss_pred cchhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 397 KTLEYHLHGEN-------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 397 g~L~~~l~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
++|.+++.... ...+++..+++++.+++.||+|||++ +|+|||||++||||++++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997542 35689999999999999999999998 999999999999999999999999999987754
Q ss_pred CCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 470 NHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 470 ~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
... .......++..|+|||.+....++.++|||||||++|||++ |+.||......+.+.. +..+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---------~~~~~~~-- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY---------LRKGYRL-- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH---------HHcCCCC--
Confidence 321 12234567889999999998899999999999999999999 6999976633221111 1111100
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
.... .. ..++.+++.+||+.+|++||++.|+++.|+
T Consensus 227 ---~~~~-~~---~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 ---PKPE-YC---PDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCc-cC---ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111 11 234556666999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=320.58 Aligned_cols=245 Identities=27% Similarity=0.403 Sum_probs=193.7
Q ss_pred eeeccCceEEEEEEe---cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCc
Q 006083 323 LLGQGGFGYVHKGVL---PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNK 397 (662)
Q Consensus 323 ~iG~G~~g~Vy~~~~---~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g 397 (662)
.||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+.+|++++|+||+++++++. ++..++||||+.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 3678999999875432 23567899999999999999999999886 45678999999999
Q ss_pred chhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc--c
Q 006083 398 TLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV--S 475 (662)
Q Consensus 398 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~--~ 475 (662)
+|.+++.... .+++..+.+++.|++.||+|||++ +|+||||||.|||+++++.+||+|||+++......... .
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999986433 488999999999999999999998 89999999999999999999999999998765433211 1
Q ss_pred cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
....++..|+|||++....++.++|||||||++|||++ |+.||......+ +.+. +..+... .+..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~--------i~~~~~~-----~~~~ 221 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-VTQM--------IESGERM-----ECPQ 221 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHH--------HHCCCCC-----CCCC
Confidence 22334678999999988889999999999999999998 999997654322 1111 1111111 1111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
..+.+ +.+++.+||+.||++||++.+|++.|++
T Consensus 222 -~~~~~---l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 222 -RCPPE---MYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCHH---HHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 12334 4455569999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=342.38 Aligned_cols=196 Identities=23% Similarity=0.294 Sum_probs=170.2
Q ss_pred hCCCCccceeeccCceEEEEEEec---CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP---NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
..+|.+.+.||+|+||.||++... .++.||||.+... +.+.+|+++|++|+|+|||++++++...+..|+||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999743 4578999988653 34568999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+. ++|.+++. ....+.+..++.++.||+.||.|||++ +|||||||++||||+.++.+||+|||++.......
T Consensus 166 e~~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9985 67777773 334589999999999999999999998 99999999999999999999999999997665432
Q ss_pred Cc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCc
Q 006083 472 TH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMT 521 (662)
Q Consensus 472 ~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~ 521 (662)
.. ......||..|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 21 223467999999999999999999999999999999999999999654
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=327.45 Aligned_cols=264 Identities=27% Similarity=0.370 Sum_probs=197.9
Q ss_pred CCccceeeccCceEEEEEEe-----cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEE
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-----PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIA--GGQRML 389 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~l 389 (662)
|.+.+.||+|+||.||++.. .+++.||+|+++.... .....+.+|+++|++++|+||+++++++.. ...+++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48889999999999988652 3678899999976533 345678899999999999999999998865 346899
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||||+.+++|.+++... .+++..++.++.+++.||.|||++ +|+||||||+||||++++.+||+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999998643 389999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc--cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhh-hHHHHHHHHHhHHHhhcCcccc
Q 006083 470 NHTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMME-DSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 470 ~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
.... ......++..|++||++.+..++.++|||||||++|||++|+.||...... ..+..+..... ....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~ 235 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM----TVVRLIE 235 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccccc----chhhhhh
Confidence 3221 112234567799999999889999999999999999999999998643211 00000000000 0000000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.++..............+.+++..||+.+|++||++++|++.|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 011111100111122355566679999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=325.86 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=203.9
Q ss_pred hCCCCccceeeccCceEEEEEEecC-----CCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPN-----GKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIA-GGQR 387 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~ 387 (662)
.++|.+.++||+|+||.||+|...+ +..|++|+++... ....+.+.+|+++|++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578899999999999999999655 6889999987543 3345678899999999999999999998775 5778
Q ss_pred EEEEEecCCcchhhhhccCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEee
Q 006083 388 MLVYEFVSNKTLEYHLHGENR------PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADF 461 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DF 461 (662)
++++||+.+++|.+++..... ..+.+..++.++.+++.||+|||++ +|+|||||++|||+++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999865322 4588999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHh
Q 006083 462 GLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAAL 539 (662)
Q Consensus 462 Gla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 539 (662)
|+++.+...... ......++..|+|||++.+..++.++|||||||++|||++ |+.||+.....+ +..+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~------- 233 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLK------- 233 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHHHHH-------
Confidence 999865433222 1122346778999999998889999999999999999998 999997653322 222111
Q ss_pred hcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 540 EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 540 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.+.. + .. ....+. .+.+++.+||..+|++||++.+|++.|+..
T Consensus 234 -~~~~--~---~~-~~~~~~---~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 234 -DGYR--L---AQ-PINCPD---ELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred -cCCC--C---CC-CCcCCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1110 0 00 011223 345566699999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=335.24 Aligned_cols=204 Identities=24% Similarity=0.290 Sum_probs=174.8
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|.+.++||+|+||.||+++.. +++.||+|++.+.. ......+.+|+.++..++|+||+++++++.+.+.+||||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36889999999999999999854 57889999986421 222345888999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.+|+|.+++.... ..+.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999996532 3478889999999999999999998 99999999999999999999999999997654433
Q ss_pred CccccccccCccccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCchh
Q 006083 472 THVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDMTMM 523 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~ 523 (662)
.......+||..|||||++. .+.++.++|||||||+||||++|+.||.....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~ 213 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence 32333467999999999986 34688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=335.43 Aligned_cols=251 Identities=21% Similarity=0.361 Sum_probs=199.4
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lv~ 391 (662)
...|+++++||+||.+.||++...+.+.||+|++... +.+...-|..|+.+|.+|+ |.+||+|++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 3458889999999999999999878888998887543 4455678999999999996 999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
|| ...+|..+|.........| .++.+..||+.|+.++|++ ||||.||||.|+||- .|++||+|||+|..+..+.
T Consensus 440 E~-Gd~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 EC-GDIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ec-ccccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 95 5779999997665544445 7788899999999999999 999999999999998 4599999999999887765
Q ss_pred Ccc-ccccccCccccCcccccCCC-----------CCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHh
Q 006083 472 THV-STRVMGTFGYLAPEYASSGK-----------LTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAAL 539 (662)
Q Consensus 472 ~~~-~~~~~Gt~~y~aPE~~~~~~-----------~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 539 (662)
+.. ....+||+.||+||.+.... ...++||||||||||+|+.|+.||.... ..|.+
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~aK------- 581 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQIAK------- 581 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHHHH-------
Confidence 543 34579999999999886322 5679999999999999999999995421 12222
Q ss_pred hcCccccccCccc--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 540 EDGIYDGLVDPRL--EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 540 ~~~~~~~~~d~~l--~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+..+.++.. .-.+.+.- ..+++++..||..||++||+..+||+.
T Consensus 582 ----l~aI~~P~~~Iefp~~~~~-~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 ----LHAITDPNHEIEFPDIPEN-DELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHhhcCCCccccccCCCCc-hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 222333322 11111111 127777779999999999999999974
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=340.37 Aligned_cols=236 Identities=24% Similarity=0.286 Sum_probs=183.7
Q ss_pred eeccCceEEEEEEe-cCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhc---CCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 324 LGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG---QGEREFSAEVEIISRV---HHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 324 iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
||+|+||.||+|+. .+|+.||||++..... .....+..|..++.++ +|+||+++++++.+.+.+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999985 4689999999965321 2223455677777665 699999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
|+|.+++... ..+++..++.++.||++||+|||++ +|+||||||+||||++++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~ 154 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTN 154 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Ccc
Confidence 9999988654 3488999999999999999999998 999999999999999999999999999876433221 223
Q ss_pred ccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCC
Q 006083 477 RVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHN 555 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 555 (662)
..+|+..|||||++.+. .++.++|||||||+||||++|+.||......+.+..+ ..+.. .+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i---------~~~~~------~~~~~ 219 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI---------AFGKV------RFPKN 219 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH---------HcCCC------CCCCc
Confidence 46799999999998764 4899999999999999999999999765433222111 11111 11112
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006083 556 YVPHEMARLVACGAASIRHSARKRPKMS 583 (662)
Q Consensus 556 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 583 (662)
....++.+ ++.+||+.||++|+++.
T Consensus 220 ~~~~~~~~---li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 220 VLSDEGRQ---FVKGLLNRNPQHRLGAH 244 (330)
T ss_pred cCCHHHHH---HHHHHcCCCHHHCCCCC
Confidence 22344444 45589999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=327.10 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=200.7
Q ss_pred CCCCccceeeccCceEEEEEEec-----------------CCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-----------------NGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSL 377 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-----------------~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l 377 (662)
++|++.+.||+|+||.||++... ++..||||+++... ......+.+|+++|++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999997532 24469999997643 3345689999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCcchhhhhccCCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcE
Q 006083 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENR---------PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANI 448 (662)
Q Consensus 378 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NI 448 (662)
++++..++..++||||+.+++|.+++..... ..+++..+++++.+++.||+|||++ +|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999999865321 2467889999999999999999998 899999999999
Q ss_pred EECCCCcEEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh--CCCCCCCchhhh
Q 006083 449 LIDDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT--GRRPVDMTMMED 525 (662)
Q Consensus 449 Ll~~~~~vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt--G~~Pf~~~~~~~ 525 (662)
||++++.+||+|||+++....... .......++..|++||++.++.++.++|||||||+||||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999976543221 11223345678999999888899999999999999999998 778886544333
Q ss_pred HHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 526 SLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
.+..... .+. ........ ......+ ..+.+++.+||+.||++||++.+|++.|+
T Consensus 242 ~~~~~~~-~~~----~~~~~~~~---~~~~~~~---~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VIENTGE-FFR----DQGRQVYL---PKPALCP---DSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHH-HHh----hccccccC---CCCCCCC---HHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 2221111 110 00000000 0011122 34556667999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=321.57 Aligned_cols=240 Identities=23% Similarity=0.371 Sum_probs=188.7
Q ss_pred ceeeccCceEEEEEEecC-------------CCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 006083 322 NLLGQGGFGYVHKGVLPN-------------GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 388 (662)
+.||+|+||.||+|.... ...|++|.+..........+.+|+.+++.++|+||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998422 2358999887655555567889999999999999999999999999999
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCc-------EEEEee
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE-------AMVADF 461 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~-------vkl~DF 461 (662)
+||||+.+++|..+++... ..+++..+++++.||++||+|||++ +|+||||||+||||+.++. +||+||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999988886433 3588999999999999999999998 9999999999999986654 899999
Q ss_pred ccccccCCCCCccccccccCccccCccccc-CCCCCchHHHHHHHHHHHHHH-hCCCCCCCchhhhHHHHHHHHHhHHHh
Q 006083 462 GLAKLSNDNHTHVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELI-TGRRPVDMTMMEDSLVEWARPLLGAAL 539 (662)
Q Consensus 462 Gla~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~eLl-tG~~Pf~~~~~~~~~~~~~~~~~~~~~ 539 (662)
|++...... ....|+..|+|||++. +..++.++|||||||+||||+ .|+.||......+... .
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~--------- 221 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-F--------- 221 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-H---------
Confidence 998765322 2246788999999887 467899999999999999998 5888876543221110 0
Q ss_pred hcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 540 EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 540 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
..+.+. +.. .....+..++.+||+.||.+||++.+|++.|+
T Consensus 222 ~~~~~~------~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 YEGQCM------LVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HhcCcc------CCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 001110 001 11234556667999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=330.71 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=197.7
Q ss_pred CCCCccceeeccCceEEEEEEec-CCC--EEEEEEeecCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGK--EVAVKSLKTGS-GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~--~vavK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv 390 (662)
++|++.+.||+|+||.||+|... ++. .+++|.++... ....+.+.+|+++|.++ +|+||+++++++..++.+|+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46888999999999999999853 454 45777776432 33456788999999999 899999999999999999999
Q ss_pred EEecCCcchhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcE
Q 006083 391 YEFVSNKTLEYHLHGEN--------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA 456 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 456 (662)
|||+.+++|.++++... ...+++..++.++.|+++||+|||++ +|+||||||+||||++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999996432 23578999999999999999999998 99999999999999999999
Q ss_pred EEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHh
Q 006083 457 MVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLL 535 (662)
Q Consensus 457 kl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~ 535 (662)
||+|||++........ .....++..|+|||++.+..++.++|||||||+||||++ |..||......+.+..
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~------ 235 (303)
T cd05088 164 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------ 235 (303)
T ss_pred EeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH------
Confidence 9999999864322111 111234667999999988889999999999999999998 9999975543221111
Q ss_pred HHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 536 GAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 536 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
+..+... ... .... ..+.+++.+||+.+|++||++.++++.|+.
T Consensus 236 ---~~~~~~~-----~~~-~~~~---~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 236 ---LPQGYRL-----EKP-LNCD---DEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred ---HhcCCcC-----CCC-CCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0111000 000 1112 245566679999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.72 Aligned_cols=247 Identities=28% Similarity=0.456 Sum_probs=197.5
Q ss_pred ceeeccCceEEEEEEecCCCEEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCcchh
Q 006083 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLE 400 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~ 400 (662)
++||+|+||.||++...+++.|++|+++..... ..+.+.+|++++++++|+||+++++++.+.+..++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999766999999998765443 5578999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc-cccc
Q 006083 401 YHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS-TRVM 479 (662)
Q Consensus 401 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~-~~~~ 479 (662)
+++..... .+++..++.++.+++.+|+|||++ +|+|||||++||||++++.+||+|||++........... ....
T Consensus 81 ~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 99865432 478899999999999999999998 899999999999999999999999999986543222111 1223
Q ss_pred cCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCH
Q 006083 480 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVP 558 (662)
Q Consensus 480 Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 558 (662)
++..|++||++.++.++.++|||||||++|||++ |..||......+.... +..+. .. . .....+
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~---------~~~~~--~~---~-~~~~~~ 221 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER---------IESGY--RM---P-APQLCP 221 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH---------HhcCC--CC---C-CCccCC
Confidence 4567999999998899999999999999999999 8888865432221111 11110 00 0 011122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 559 HEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 559 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
. .+.+++.+||+.+|++||++.||++.|+
T Consensus 222 ~---~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 E---EIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred H---HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 3 4555666999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=360.57 Aligned_cols=257 Identities=20% Similarity=0.316 Sum_probs=199.0
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.++||+|+||.||+|+.. +|+.||||+++.... ...+++.+|++++++++|+||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999854 689999999975422 23467899999999999999999999999999999999
Q ss_pred EecCCcchhhhhccC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeec
Q 006083 392 EFVSNKTLEYHLHGE---------NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFG 462 (662)
Q Consensus 392 E~~~~g~L~~~l~~~---------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFG 462 (662)
||+.|++|.+++... ....+++..+++++.||++||+|||++ +|+||||||+||||+.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988531 112356678899999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCC-----------------ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhh
Q 006083 463 LAKLSNDNHT-----------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMED 525 (662)
Q Consensus 463 la~~~~~~~~-----------------~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~ 525 (662)
+++....... ......+||..|||||++.+..++.++|||||||+||||++|+.||......+
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 01123579999999999999999999999999999999999999997643221
Q ss_pred HHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhhC
Q 006083 526 SLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRP-KMSQIVRALEG 591 (662)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~ 591 (662)
.... . ........ ......+. .+.+++.+||+.||++|+ +++++++.|+.
T Consensus 239 i~~~--~----------~i~~P~~~-~p~~~iP~---~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 ISYR--D----------VILSPIEV-APYREIPP---FLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hhhh--h----------hccChhhc-cccccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1110 0 00000000 00011223 345566699999999996 56667666653
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.78 Aligned_cols=251 Identities=22% Similarity=0.360 Sum_probs=204.7
Q ss_pred CCCccceeeccCceEEEEEE-ecCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 317 GFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+|+..+.||+|+||.||.+. ..+++.|++|.+... .....+++.+|+++|++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47889999999999999988 446899999998754 234456788999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+++|.+++.......+++..++.++.+++++|.|||+. +|+|||||++||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999765455689999999999999999999998 899999999999999999999999999987654332
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
......|+..|+|||++.+..++.++|||||||++|||++|+.||+.....+....+. .+.+...
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~---------~~~~~~~------ 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV---------QGNYTPV------ 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---------cCCCCCC------
Confidence 2234678999999999998889999999999999999999999997654333222111 1111111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRAL 589 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 589 (662)
..... ..+.+++.+||+.+|.+||++.++++.+
T Consensus 222 ~~~~~---~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 VSVYS---SELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccccC---HHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 01122 3345555689999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.74 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=197.4
Q ss_pred CCCCccceeeccCceEEEEEEec-CCC----EEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGK----EVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
++|++.+.||+|+||.||+|.+. +++ .|++|.+..... ....++..|+.++++++|+||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 35788899999999999999853 454 477888764332 23467888999999999999999999886 456789
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
++||+.+|+|.++++... ..+++..++.|+.|++.||+|||++ +|+|||||++|||+++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999996543 3589999999999999999999998 899999999999999999999999999986643
Q ss_pred CCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 470 NHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 470 ~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
.... ......|+..|++||++.++.++.++|||||||++|||++ |+.||....... +.++. ..+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~--------~~~~~~~- 231 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDLL--------EKGERLA- 231 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHH--------HCCCcCC-
Confidence 3221 2233557789999999998899999999999999999998 999997653222 11111 1111110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
. ..... ..+..++.+||..+|.+||++.|+++.|+.
T Consensus 232 -~----~~~~~---~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 232 -Q----PQICT---IDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred -C----CCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 0 11122 234455669999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=323.69 Aligned_cols=263 Identities=23% Similarity=0.295 Sum_probs=196.9
Q ss_pred CCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+|.+.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++|+||+++++++.+++.+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999854 78999999987542 22346788999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 394 VSNKTLEYHLHGEN-RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 394 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
+. ++|.+++.... ...+++..++.++.|+++||+|||++ +|+|||||++||||++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 57877775432 35689999999999999999999998 99999999999999999999999999997654322
Q ss_pred ccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh---HHHh------h--
Q 006083 473 HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL---GAAL------E-- 540 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~---~~~~------~-- 540 (662)
.......|+..|+|||++.+. .++.++|||||||++|+|++|+.||......+.+........ ...+ .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 122334678899999988654 578999999999999999999999976543332222111100 0000 0
Q ss_pred cCccccccCcccC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 541 DGIYDGLVDPRLE--HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 541 ~~~~~~~~d~~l~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...+.......+. ...... ++.+++.+||+.||.+||++.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDE---DGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCH---HHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000 001223 3345566999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=340.23 Aligned_cols=243 Identities=26% Similarity=0.381 Sum_probs=193.1
Q ss_pred CCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
|.-++.||.|.||.||.++ ..+.+.||||++..... ..+.++..|+.+|++|+|||+|.+.|||......||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 6677899999999999999 45789999999976533 3457889999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
|-| +-.|+|.-. ++.+-+.++..|..+.+.||+|||++ +.||||||..||||.+.|.|||+|||.|.+....
T Consensus 108 ClG-SAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 108 CLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred Hhc-cHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 965 444554322 23578889999999999999999999 8999999999999999999999999999776543
Q ss_pred cccccccCccccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 474 VSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
..++||++|||||++. .|.|+-|+||||||+++.||.-.++|+...+--.-+..++... .+
T Consensus 180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe--------------sP 243 (948)
T KOG0577|consen 180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--------------SP 243 (948)
T ss_pred --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC--------------CC
Confidence 4589999999999886 5789999999999999999999999965443222222222210 01
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.|....-.+. +..++-.||+.-|.+||+..++++
T Consensus 244 tLqs~eWS~~---F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 244 TLQSNEWSDY---FRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCchhHHH---HHHHHHHHHhhCcccCCcHHHHhh
Confidence 1221111233 344555899999999999998874
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.25 Aligned_cols=256 Identities=21% Similarity=0.323 Sum_probs=199.7
Q ss_pred HHHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 312 AAATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 312 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
+.+++++....+||+|+||.||+|.. .++..|++|.+........+.+.+|++++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 44556677778999999999999984 46788999999876666677899999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC-CCcEEEEeeccccccC
Q 006083 391 YEFVSNKTLEYHLHGENRP-VMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-NFEAMVADFGLAKLSN 468 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~-~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~~~~ 468 (662)
|||+.+++|.++++..... ..++..+..++.|+++||+|||++ +|+|||||++||||+. ++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999999999754221 227788889999999999999998 9999999999999976 6799999999987654
Q ss_pred CCCCccccccccCccccCcccccCCC--CCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccc
Q 006083 469 DNHTHVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 469 ~~~~~~~~~~~Gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
.... ......|+..|++||++.+.. ++.++|||||||++|+|++|+.||........ ..+..... ..
T Consensus 161 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-~~~~~~~~---------~~ 229 (268)
T cd06624 161 GINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-AMFKVGMF---------KI 229 (268)
T ss_pred cCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-hHhhhhhh---------cc
Confidence 3222 122346889999999987543 78999999999999999999999965322111 11111000 00
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...+. .....++..++.+||+.+|.+||++.||++
T Consensus 230 --~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 230 --HPEIP----ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --CCCCC----cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00111 112234555666999999999999999886
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=330.21 Aligned_cols=256 Identities=27% Similarity=0.412 Sum_probs=200.5
Q ss_pred CCCCccceeeccCceEEEEEEec--------CCCEEEEEEeecCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP--------NGKEVAVKSLKTGS-GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGG 385 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~ 385 (662)
++|.+.+.||+|+||.||++... .+..||+|+++... ......+..|+++++++ +|+||++++++|.+++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 45888999999999999998731 24579999987543 23456788999999999 5999999999999999
Q ss_pred eEEEEEEecCCcchhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC
Q 006083 386 QRMLVYEFVSNKTLEYHLHGEN--------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID 451 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~ 451 (662)
.+|+||||+.+++|.+++.... ...+.+..+++++.|++.||.|||++ +|+|||||++||||+
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 9999999999999999986432 23588899999999999999999998 999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHH
Q 006083 452 DNFEAMVADFGLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVE 529 (662)
Q Consensus 452 ~~~~vkl~DFGla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~ 529 (662)
+++.+||+|||+++........ ......++..||+||++.++.++.++|||||||++|||++ |+.||......+.+..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999999866432211 1122234567999999998899999999999999999999 8899866543322211
Q ss_pred HHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 530 WARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
+..+... ... .... ..+.+++.+||+.+|++||++.+|++.|+..
T Consensus 249 ---------~~~~~~~-----~~~-~~~~---~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 249 ---------LREGHRM-----DKP-SNCT---HELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred ---------HHcCCCC-----CCC-CCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111100 001 1122 3445566799999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=325.06 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=199.8
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
+.|++.+.||+|+||.||+|... +++.|++|++........+.+.+|+++++.++|+||+++++++..++.+++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45888999999999999999854 58999999998776666778999999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|..++.+.. ..+++..++.++.|++.+|.|||++ +|+|||||++|||++.++.+||+|||++....... ..
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 9999988875433 3588999999999999999999998 99999999999999999999999999987543322 11
Q ss_pred ccccccCccccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 475 STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
.....|+..|++||++. ...++.++|||||||++|||++|+.||........+..+.. .....+
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---------~~~~~~-- 235 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---------SEPPTL-- 235 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---------CCCccC--
Confidence 23456889999999985 34578899999999999999999999965432222211110 000000
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. ... ....++.+++.+||..+|++||++.+|++
T Consensus 236 -~-~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 -S-QPS---KWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -C-CCc---ccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 001 11224555666999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.74 Aligned_cols=250 Identities=24% Similarity=0.415 Sum_probs=198.7
Q ss_pred CCCccceeeccCceEEEEEEecCCCEEEEEEeecCCc------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSG------QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
+|.+.+.||+|+||.||+|...+|+.+|||.++.... .....+.+|+++|++++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788899999999999999987899999999875421 1235688999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+++|.+++.+.. .+.+..+..++.|++.||+|||+. +|+|+|||++|||+++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999996543 478899999999999999999998 8999999999999999999999999998765321
Q ss_pred C-----CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 471 H-----THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 471 ~-----~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
. ........|+..|++||++.+..++.++|||||||++|+|++|+.||.............. .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~~- 227 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA-------HRGLM- 227 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh-------ccCCC-
Confidence 1 1112335689999999999988999999999999999999999999975432211111000 00111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..+... ... .+..++.+||+.+|.+||++.|+++
T Consensus 228 ----~~~~~~-~~~---~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 ----PRLPDS-FSA---AAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ----CCCCCC-CCH---HHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111111 223 3455556999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=322.36 Aligned_cols=253 Identities=29% Similarity=0.472 Sum_probs=199.4
Q ss_pred CCCccceeeccCceEEEEEEec-CC---CEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-NG---KEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~g---~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
.|++.+.||+|+||.||+|... ++ ..||||+++... ....+.|..|++++++++|+||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4788999999999999999854 33 369999997653 334568999999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.+++|.+++.... ..+++..++.++.|++.||.|||++ +|+|||||++||||++++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999986543 3578999999999999999999998 99999999999999999999999999987654322
Q ss_pred Ccc--cccc--ccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCcccc
Q 006083 472 THV--STRV--MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 472 ~~~--~~~~--~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
... .... .++..|++||++.++.++.++|||||||++|||++ |..||......+ +..+.. .. +.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-~~~~i~--------~~-~~- 229 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-VINAIE--------QD-YR- 229 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-HHHHHH--------cC-Cc-
Confidence 111 1111 12457999999999999999999999999999886 999997654322 221111 00 00
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.... ...+ ..+.+++..||..+|.+||++.+|+..|+.
T Consensus 230 ---~~~~-~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 230 ---LPPP-MDCP---TALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ---CCCc-ccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0000 1122 334556669999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=335.06 Aligned_cols=256 Identities=28% Similarity=0.467 Sum_probs=198.2
Q ss_pred CCCCccceeeccCceEEEEEEe------cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEe-CCe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL------PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRV-HHRHLVSLVGYCIA-GGQ 386 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~-~~~ 386 (662)
++|++.+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+.+|.++ +|+||++++++|.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4689999999999999999973 3578899999976432 3346788999999999 68999999998865 456
Q ss_pred EEEEEEecCCcchhhhhccCC-----------------------------------------------------------
Q 006083 387 RMLVYEFVSNKTLEYHLHGEN----------------------------------------------------------- 407 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~----------------------------------------------------------- 407 (662)
.++|||||.+|+|.++++...
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999886421
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc-ccccccc
Q 006083 408 ------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH-VSTRVMG 480 (662)
Q Consensus 408 ------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~G 480 (662)
...+++..+.+++.|+++||+|||++ +|+||||||+|||+++++.+||+|||++......... ......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 12367888899999999999999998 9999999999999999999999999999765432211 1122345
Q ss_pred CccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHH
Q 006083 481 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPH 559 (662)
Q Consensus 481 t~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 559 (662)
+..|++||++.+..++.++|||||||+||||++ |..||........+.. .+..+... ... ....
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~--------~~~~~~~~-----~~~-~~~~- 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR--------RLKEGTRM-----RAP-DYTT- 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHH--------HHhccCCC-----CCC-CCCC-
Confidence 678999999998899999999999999999997 9999865432221111 11111110 011 1112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 560 EMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 560 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
..+.+++..||+.+|++||++.||++.|+.
T Consensus 309 --~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 309 --PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred --HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 245666679999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.29 Aligned_cols=251 Identities=31% Similarity=0.468 Sum_probs=201.1
Q ss_pred CCccceeeccCceEEEEEEecC-----CCEEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 318 FAKSNLLGQGGFGYVHKGVLPN-----GKEVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
|.+.+.||+|+||.||+++..+ +..||+|+++..... ..+.+..|+++|++++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999998543 388999999766443 5678999999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.+++|.+++.......+++..++.++.|++.||+|||+. +|+|||||++|||+++++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999765443389999999999999999999998 99999999999999999999999999998765542
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
........++..|++||.+.+..++.++|||||||++|+|++ |+.||......+.+.. . ..+...
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~-~--------~~~~~~----- 223 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY-L--------KKGYRL----- 223 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-H--------hcCCCC-----
Confidence 222212336789999999988889999999999999999998 7888875433222111 1 111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRAL 589 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 589 (662)
.... ..+ .++.+++.+||+.+|++||++.|+++.|
T Consensus 224 ~~~~-~~~---~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PKPE-NCP---PEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCC-cCC---HHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0011 122 3455566699999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.14 Aligned_cols=247 Identities=29% Similarity=0.448 Sum_probs=195.2
Q ss_pred ceeeccCceEEEEEEec--C--CCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVLP--N--GKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~--~--g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
++||+|+||.||+|... + +..||+|.++.... ...+.+.+|+++|++++|+|||++++++. ++..++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999742 2 26899999986544 34567899999999999999999999876 4568999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc-
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS- 475 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~- 475 (662)
++|.++|.... .+++..+++++.|++.||+|||.. +|+|||||++||||++++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999996544 588999999999999999999998 899999999999999999999999999986644332211
Q ss_pred -cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 476 -TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 476 -~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||+.....+ +..+.. .+... ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-~~~~~~--------~~~~~------~~ 219 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-VIAMLE--------SGERL------PR 219 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH-HHHHHH--------cCCcC------CC
Confidence 11223567999999998899999999999999999998 999997654332 222211 11100 01
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
..... ..+.+++.+||..+|++||++.+|++.|++.
T Consensus 220 ~~~~~---~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 220 PEECP---QEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCC---HHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11122 3455666699999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=324.97 Aligned_cols=255 Identities=26% Similarity=0.416 Sum_probs=201.2
Q ss_pred hCCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 387 (662)
.++|++.+.||+|+||.||++... ++..||||+++.... ...+.+.+|++++++++|+||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356889999999999999999853 467899999976533 3456789999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCc
Q 006083 388 MLVYEFVSNKTLEYHLHGEN--------------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAAN 447 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~N 447 (662)
++||||+.+++|.+++.... ...+++..++.++.+++.||+|||++ +|+|||||++|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999985321 12467888999999999999999998 89999999999
Q ss_pred EEECCCCcEEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhh
Q 006083 448 ILIDDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMED 525 (662)
Q Consensus 448 ILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~ 525 (662)
||+++++.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875533211 11122344667999999998899999999999999999997 888886543322
Q ss_pred HHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 526 SLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
.+ .. +..+.... . ....+ .++.+++.+||+.+|.+||++.||++.|+
T Consensus 241 ~~----~~-----~~~~~~~~-----~-~~~~~---~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 241 VI----YY-----VRDGNVLS-----C-PDNCP---LELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HH----HH-----HhcCCCCC-----C-CCCCC---HHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 11 11 11111110 0 01122 34556667999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=335.55 Aligned_cols=265 Identities=20% Similarity=0.267 Sum_probs=198.0
Q ss_pred HHHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC----
Q 006083 312 AAATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAG---- 384 (662)
Q Consensus 312 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~---- 384 (662)
....++|.+.+.||+|+||.||++.. .+++.||||+++.... ...+.+.+|+++|++++|+||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 34567899999999999999999984 4788999999975422 2345678899999999999999999987543
Q ss_pred --CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeec
Q 006083 385 --GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFG 462 (662)
Q Consensus 385 --~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFG 462 (662)
...|++||++ +++|.+++.. ..+++..+..++.||++||+|||++ +|+||||||+||||++++.+||+|||
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 4578999987 7888887743 2488999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh------
Q 006083 463 LAKLSNDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL------ 535 (662)
Q Consensus 463 la~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~------ 535 (662)
+++..... ....+|+..|+|||++.+ ..++.++|||||||+||+|++|+.||......+.+..+....-
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99865432 234578999999999876 5689999999999999999999999976544433333221100
Q ss_pred HHHhhcCcccccc-------CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 536 GAALEDGIYDGLV-------DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 536 ~~~~~~~~~~~~~-------d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
...+........+ ...+...+ ......+.+++.+||+.||.+||++.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000 00000000 0001234567779999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=316.96 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=204.8
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
++|++.+.||+|+||.||++.. .+++.+++|++........+.+.+|++++++++|+||+++++++.+++.+|++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5688999999999999999985 467899999998766566788999999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.+++.... ..+++..+..++.|++.||.|||++ +|+|||||++||+|++++.+||+|||++........ .
T Consensus 83 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 83 GGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred CCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 9999999886542 3588999999999999999999998 999999999999999999999999999876543221 2
Q ss_pred ccccccCccccCcccccCC---CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 475 STRVMGTFGYLAPEYASSG---KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
.....|+..|++||++.+. .++.++|||||||+||||++|+.||.............. ..+.. ..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~---------~~~~~---~~ 225 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK---------SNFPP---PK 225 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------ccCCC---cc
Confidence 2345788999999999876 889999999999999999999999976543332221111 10000 01
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+. ........+.+++.+||..+|.+||++.+|+.
T Consensus 226 ~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 LK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11 11122234666777999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=362.19 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=197.1
Q ss_pred HHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeE
Q 006083 313 AATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIA--GGQR 387 (662)
Q Consensus 313 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~ 387 (662)
...++|.+.+.||+|+||.||++.. .+++.||+|++.... ......|..|+.+|++|+|+|||+++++|.+ .+.+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3456899999999999999999985 467889999987542 2345678999999999999999999998854 4678
Q ss_pred EEEEEecCCcchhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CceeecCCccCcEEECC---------
Q 006083 388 MLVYEFVSNKTLEYHLHGE--NRPVMDFATRVRIALGSAKGLAYLHEDCH----PRIIHRDIKAANILIDD--------- 452 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~----~~ivHrDIkp~NILl~~--------- 452 (662)
|||||||.+++|.++|... ....+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999998642 23468999999999999999999998521 25999999999999964
Q ss_pred --------CCcEEEEeeccccccCCCCCccccccccCccccCcccccC--CCCCchHHHHHHHHHHHHHHhCCCCCCCch
Q 006083 453 --------NFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPVDMTM 522 (662)
Q Consensus 453 --------~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~ 522 (662)
.+.+||+|||++....... .....+||+.|+|||++.+ ..++.++||||||||||||++|+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3348999999998764332 2234679999999999864 458899999999999999999999997543
Q ss_pred hhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 523 MEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
....+... +..+. .+...... ..|..++..||+.+|.+||++.|++.
T Consensus 248 ~~~qli~~--------lk~~p-------~lpi~~~S---~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NFSQLISE--------LKRGP-------DLPIKGKS---KELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cHHHHHHH--------HhcCC-------CCCcCCCC---HHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 32222111 11110 01101112 34555666999999999999999984
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.31 Aligned_cols=246 Identities=26% Similarity=0.427 Sum_probs=192.4
Q ss_pred eeeccCceEEEEEEec---CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCcc
Q 006083 323 LLGQGGFGYVHKGVLP---NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKT 398 (662)
Q Consensus 323 ~iG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~ 398 (662)
.||+|+||.||+|.+. .+..||||+++.... ...+.+.+|+++|++++|+||+++++++. .+..++||||+.+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 456799999976533 33467899999999999999999999986 457899999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc--cc
Q 006083 399 LEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV--ST 476 (662)
Q Consensus 399 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~--~~ 476 (662)
|.+++... ...+++..+++++.++++||.|||++ +|+|||||++|||++.++.+||+|||++.......... ..
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99998643 33589999999999999999999998 99999999999999999999999999998654332211 11
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHN 555 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 555 (662)
...++..|+|||++.++.++.++|||||||++|||++ |+.||......+... . +..+... . ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~--------~~~~~~~-----~-~~~ 221 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-F--------IEQGKRL-----D-CPA 221 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-H--------HHCCCCC-----C-CCC
Confidence 1233578999999988889999999999999999996 999997654332111 1 1111100 0 111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 556 YVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 556 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
....++. +++.+||..++++||++.+|++.|+.
T Consensus 222 ~~~~~l~---~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 222 ECPPEMY---ALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCHHHH---HHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 2234444 45559999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=325.22 Aligned_cols=267 Identities=24% Similarity=0.357 Sum_probs=207.4
Q ss_pred HHhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHh--cCCCCcceEEEEEEeC----Ce
Q 006083 313 AATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISR--VHHRHLVSLVGYCIAG----GQ 386 (662)
Q Consensus 313 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~~~~~~~----~~ 386 (662)
.......+.+.||+|.||+||+|.+ .|+.||||++.. .+++.+.+|.+|.+. |+|+||+.|++.-..+ .+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3455678889999999999999998 789999999976 456778889888876 4999999999886543 47
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCceeecCCccCcEEECCCCcEEEEee
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED-----CHPRIIHRDIKAANILIDDNFEAMVADF 461 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----~~~~ivHrDIkp~NILl~~~~~vkl~DF 461 (662)
+|||.+|.+.|+|+|||.+ ..++.+..+++++.+|.||++||-. +.+.|.|||||..||||.+++...|+||
T Consensus 284 LwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 8999999999999999955 4689999999999999999999973 5678999999999999999999999999
Q ss_pred ccccccCCCCCc---cccccccCccccCcccccCCC----C--CchHHHHHHHHHHHHHHhC----------CCCCCCch
Q 006083 462 GLAKLSNDNHTH---VSTRVMGTFGYLAPEYASSGK----L--TEKSDVFSFGVMLLELITG----------RRPVDMTM 522 (662)
Q Consensus 462 Gla~~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~----~--~~~sDvwSlGvvl~eLltG----------~~Pf~~~~ 522 (662)
|||......... .....+||-.|||||++.... + -..+||||||.||||++.. +.||...-
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 999876654322 234578999999999996432 1 1468999999999999853 45664432
Q ss_pred hhhHHHHHHHHHhHHHhhcCccccccCcccCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCCC
Q 006083 523 MEDSLVEWARPLLGAALEDGIYDGLVDPRLEHN-YVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSS 594 (662)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 594 (662)
..|.-.+- +.+-+..+-+.+.+... .....+..|.+++..||..+|..|-++-.|.+.|.....
T Consensus 441 p~DPs~ee--------MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 441 PSDPSFEE--------MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCHHH--------HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 22211111 12223333333333332 245677888889999999999999999999988876543
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.56 Aligned_cols=248 Identities=25% Similarity=0.444 Sum_probs=197.6
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch---------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ---------GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQ 386 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 386 (662)
+|.+.+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|++++++++|+||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999985 46889999988654221 12568899999999999999999999999999
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
.++||||+.+++|.+++... ..+++..+..++.+++.||+|||++ +|+||||||+||||++++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999654 3478889999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCCc-----cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhc
Q 006083 467 SNDNHTH-----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALED 541 (662)
Q Consensus 467 ~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 541 (662)
....... ......|+..|++||++.++.++.++|||||||++|+|++|+.||........+... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---------~~ 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI---------GE 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH---------hc
Confidence 6532111 112346889999999999888999999999999999999999999764322221110 00
Q ss_pred CccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 542 GIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 542 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. ....+... .. ..+..++.+||+.+|.+||++.||++
T Consensus 227 ~-----~~~~~~~~-~~---~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 N-----ASPEIPSN-IS---SEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c-----CCCcCCcc-cC---HHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1 01111111 22 34445556999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=329.39 Aligned_cols=195 Identities=23% Similarity=0.360 Sum_probs=160.7
Q ss_pred cceeeccCceEEEEEEec---CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEEEEEecC
Q 006083 321 SNLLGQGGFGYVHKGVLP---NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA--GGQRMLVYEFVS 395 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lv~E~~~ 395 (662)
+++||+|+||.||+|+.. +++.||+|.++... ....+.+|+++|++++|+||+++++++.. +...|+||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 56789999987542 23457889999999999999999998854 567899999986
Q ss_pred CcchhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE----CCCCcEEEEeeccc
Q 006083 396 NKTLEYHLHGE-------NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI----DDNFEAMVADFGLA 464 (662)
Q Consensus 396 ~g~L~~~l~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkl~DFGla 464 (662)
+ +|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||| +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 676666321 123578899999999999999999999 89999999999999 45678999999999
Q ss_pred cccCCCCCc--cccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCc
Q 006083 465 KLSNDNHTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMT 521 (662)
Q Consensus 465 ~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~ 521 (662)
+........ ......||..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876543221 2234678999999999876 45899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.07 Aligned_cols=248 Identities=27% Similarity=0.436 Sum_probs=193.3
Q ss_pred ceeeccCceEEEEEEec-CCC--EEEEEEeecCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVLP-NGK--EVAVKSLKTGS-GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~-~g~--~vavK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
++||+|+||.||+|.+. ++. .+++|.++... ....+.+.+|++++.++ +|+||++++++|...+..|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46999999999999864 343 47888887532 34456789999999999 799999999999999999999999999
Q ss_pred cchhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeec
Q 006083 397 KTLEYHLHGEN--------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFG 462 (662)
Q Consensus 397 g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFG 462 (662)
++|.++++... ...+.+..+++++.+++.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 12478899999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhc
Q 006083 463 LAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALED 541 (662)
Q Consensus 463 la~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 541 (662)
++........ ......+..|+|||++.+..++.++|||||||+||||++ |+.||......+.+.. +..
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~---------~~~ 226 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK---------LPQ 226 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH---------HhC
Confidence 9864321111 111233567999999988899999999999999999997 9999965433221111 011
Q ss_pred CccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 542 GIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 542 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
+... .... ... ..+.+++.+||+.+|.+||++.++++.|+..
T Consensus 227 ~~~~-----~~~~-~~~---~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 227 GYRL-----EKPL-NCD---DEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCCC-----CCCC-cCC---HHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 1100 0111 112 3455677799999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.56 Aligned_cols=256 Identities=23% Similarity=0.281 Sum_probs=202.3
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCch---hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQ---GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.+.||+|+||.||++... +++.||||.+...... ..+.+.+|+++|++++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999854 5899999999765332 4467889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.+++|.+++.......+++..++.++.|+++||+|||+. +|+|||||++||||+.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999999765556689999999999999999999998 99999999999999999999999999987543221
Q ss_pred Cc----------------------------cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchh
Q 006083 472 TH----------------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMM 523 (662)
Q Consensus 472 ~~----------------------------~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~ 523 (662)
.. .....+|+..|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11234789999999999988899999999999999999999999976644
Q ss_pred hhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 524 EDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...+.+... ... .+... ......+.+++.+||..+|++||+....++.|..
T Consensus 238 ~~~~~~~~~--------~~~-------~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DETFSNILK--------KEV-------TFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHHHHhc--------CCc-------cCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 333222110 000 00000 0022345555669999999999994444444433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=318.32 Aligned_cols=247 Identities=28% Similarity=0.495 Sum_probs=198.7
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
++|.+.+.||+|+||.||++.. +++.||+|+++.. .....+.+|+.++++++|+||+++++++..+ ..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3488899999999999999875 7788999998754 2346789999999999999999999998765 4799999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
+++|.+++.......+++..+++++.|++.||.|||+. +++|||||++|||++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 99999999765555688999999999999999999998 99999999999999999999999999987654321
Q ss_pred cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
........|++||++.++.++.++|||||||++|||++ |+.||......+... ....+.... ...
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~---------~~~~~~~~~-----~~~ 220 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE---------CVEKGYRME-----PPE 220 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH---------HHhCCCCCC-----CCC
Confidence 12234567999999998899999999999999999997 999997654322111 111111111 111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
. .+ ..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 221 ~-~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 G-CP---ADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred c-CC---HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1 12 344566669999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.07 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=200.6
Q ss_pred CCCCccceeeccCceEEEEEEecC----CCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPN----GKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
.+|.+.++||+|+||.||+|...+ ...|+||...... ....+.+.+|+.++++++|+||+++++++.+ +..|+|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457888999999999999998533 2468999887654 3455689999999999999999999999875 557899
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+++|.+++.... ..+++..++.++.+++.||+|||+. +++|||||++|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999996543 2489999999999999999999998 8999999999999999999999999999876544
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
.........+...|+|||++....++.++|||||||++|||++ |+.||......+.+... ..+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~---------~~~~~~---- 227 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI---------ENGERL---- 227 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---------HcCCcC----
Confidence 3222223344568999999988889999999999999999986 99999765433322111 111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.+. ...+. .+.+++.+|+..+|.+||++.++++.|++.
T Consensus 228 -~~~-~~~~~---~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 228 -PMP-PNCPP---TLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred -CCC-CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011 11223 455566699999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.24 Aligned_cols=265 Identities=28% Similarity=0.399 Sum_probs=214.6
Q ss_pred HHHHHHhCCCCccceeeccCceEEEEEEecC-CCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 006083 309 DELAAATGGFAKSNLLGQGGFGYVHKGVLPN-GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 387 (662)
++++....+....++||-|.||.||.|+++. ...||||.|+.+. ...++|+.|+.+|+.|+|+|+|+|+|+|...--+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4444445556667889999999999999754 5679999998654 4578899999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
|||.|||..|+|.+||++.++..+..-..++++.||..|++||..+ ++|||||..+|+||.++..|||+||||+++.
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 9999999999999999998888888888999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCcccc
Q 006083 468 NDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 468 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
..+....-........|.|||.+.-..++.|+|||+|||+|||+.| |-.||-+.+..+.+ ..++++.-.+
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY---------~LLEkgyRM~ 486 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---------GLLEKGYRMD 486 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH---------HHHhcccccc
Confidence 6543322222334678999999998899999999999999999988 77787664322211 1223333111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCCCC
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSL 595 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 595 (662)
..+.++....+||. .||+++|.+||++.||.+.++....-
T Consensus 487 ------~PeGCPpkVYeLMr---aCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 487 ------GPEGCPPKVYELMR---ACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred ------CCCCCCHHHHHHHH---HHhcCCcccCccHHHHHHHHHHHhcc
Confidence 12345555555554 89999999999999999998854433
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.51 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=199.1
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
++|.+.+.||+|+||.||++.. .+++.||+|+++.........+.+|+.+++.++|+||+++++++.+++..|+||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 3578889999999999999984 468999999998765555567889999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.+++.... .+++..++.++.+++.||.|||++ +|+|||||++|||++.++.+||+|||++....... ..
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 89 GGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 9999999886443 488999999999999999999998 99999999999999999999999999987654322 12
Q ss_pred ccccccCccccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 475 STRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
.....|+..|+|||++. .+.++.++|||||||++|+|++|+.||........+.... ...... ..
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~--------~~~~~~----~~ 230 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT--------KSNFQP----PK 230 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh--------ccCCCC----Cc
Confidence 23457899999999874 4568899999999999999999999985443221111100 000000 01
Q ss_pred cCC-CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 552 LEH-NYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 552 l~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+.. ..... .+.+++.+||..+|++||++.+|++
T Consensus 231 ~~~~~~~~~---~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKDKMKWSN---SFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccccCCCCH---HHHHHHHHHccCCchhCcCHHHHhc
Confidence 111 01122 3445666999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=320.00 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=202.3
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
++|++.+.||.|+||.||+|+.. +++.||+|++.... ......+.+|+++++.++|+||+++++++.++..+|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35888899999999999999854 68999999997653 34456788999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+++|.+++... .+++..+..++.|++.||.|||++ +|+||||+++||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 9999999998654 589999999999999999999998 899999999999999999999999999987754322
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
......|+..|++||++.+..++.++|||||||+||+|++|+.||......+.+... ..+.. ..+.
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~---------~~~~~-----~~~~ 219 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI---------PKNNP-----PSLE 219 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh---------hhcCC-----CCCc
Confidence 223457889999999999888999999999999999999999999754322211110 01111 1111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
...... .+.+++.+||..+|++||+++++++.
T Consensus 220 ~~~~~~---~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 220 GNKFSK---PFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ccccCH---HHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111222 34555668999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.28 Aligned_cols=254 Identities=25% Similarity=0.393 Sum_probs=199.1
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCC----EEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGK----EVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
.+|++.++||+|+||.||+|.. .+|+ .||||+++.... ...+.+.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 4588899999999999999984 3554 489999876433 345678999999999999999999999975 45689
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
+|||+.+|+|.++++... ..+.+..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999986532 3588999999999999999999998 999999999999999999999999999987653
Q ss_pred CCCcc-ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 470 NHTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 470 ~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
..... .....++..|++||++.+..++.++|||||||+||||++ |..||+..... .+..+.. .+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~--------~~~~~~- 231 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-EIPDLLE--------KGERLP- 231 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHH--------CCCcCC-
Confidence 32211 112334678999999998899999999999999999998 89998754322 2222211 111100
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
... .. ...+.+++.+||+.||++||++.++++.|+..
T Consensus 232 ----~~~-~~---~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 232 ----QPP-IC---TIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred ----CCc-cC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 011 11 23455666799999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=323.97 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=201.9
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
++|++.+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+++++.++|+||+++++++...+.++|||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4578889999999999999985 468999999987543 33457889999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+++|.+++... ..+.+..+..++.+++.+|.|||+.. +|+|||||++|||+++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 9999999988653 35889999999999999999999732 79999999999999999999999999986543221
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhh-------HHHHHHHHHhHHHhhcCcccc
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMED-------SLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 546 (662)
.....|+..|++||++.++.++.++|||||||++|+|++|+.||......+ .+.++..... ...
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~---- 229 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV----QEP---- 229 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh----hcc----
Confidence 134578999999999988899999999999999999999999997643221 1111111110 000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
...+.... ....+.+++.+||+.||.+||++.||++...
T Consensus 230 --~~~~~~~~---~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 230 --PPRLPSSD---FPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred --CCCCCchh---cCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 00111111 2234556666999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=327.15 Aligned_cols=247 Identities=28% Similarity=0.371 Sum_probs=203.3
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
.+.|..-++||+||||.||-++. .+|+-||+|++.+.. .++....++|.+||.+++.+.||.+-..|+..+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 35688889999999999999984 479999999986542 23345578899999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|..|+||+|..+|...+...+++..++.++.+|+.||++||+. +||.|||||+|||||+.|+++|+|+|||..+.++
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 9999999999999888878899999999999999999999999 9999999999999999999999999999998776
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
... ...+||.+|||||++.++.|+...|+|+|||+||||+.|+.||.......-..+..+..+. . ..
T Consensus 341 ~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~---------~--~~ 407 (591)
T KOG0986|consen 341 KPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE---------D--PE 407 (591)
T ss_pred Ccc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc---------c--hh
Confidence 543 2348999999999999999999999999999999999999999765433222222222111 0 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPK 581 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 581 (662)
.+. +...++++.|.+ ..|..||.+|--
T Consensus 408 ey~-~kFS~eakslc~---~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 408 EYS-DKFSEEAKSLCE---GLLTKDPEKRLG 434 (591)
T ss_pred hcc-cccCHHHHHHHH---HHHccCHHHhcc
Confidence 112 233456666666 568899998864
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.71 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=202.3
Q ss_pred CCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 388 (662)
.+|++.+.||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|+++|++++|+||+++++++.+.+..|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 45888999999999999999853 3467999998765443 4567999999999999999999999999999999
Q ss_pred EEEEecCCcchhhhhccCCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEee
Q 006083 389 LVYEFVSNKTLEYHLHGENR-------PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADF 461 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DF 461 (662)
+||||+.+++|.++++.... ..+.+..++.++.|++.||+|||++ +|+||||||+||||++++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999965441 2589999999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhh
Q 006083 462 GLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALE 540 (662)
Q Consensus 462 Gla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 540 (662)
|+++..............++..|++||.+.+..++.++|||||||++|+|++ |..||......+ +.... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-~~~~~--------~ 232 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-VLNRL--------Q 232 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-HHHHH--------H
Confidence 9987553322222233456788999999988889999999999999999998 788886543322 11111 1
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 541 DGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 541 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
.+.+... . ....+. .+.+++.+||+.+|.+||++.|+++.|.
T Consensus 233 ~~~~~~~----~-~~~~~~---~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 AGKLELP----V-PEGCPS---RLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCcCCC----C-CCCCCH---HHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111110 0 111223 4555666999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.91 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=198.7
Q ss_pred CCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 318 FAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
|++.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++|+||++++++|..++..++||||+.+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 667789999999999999954 5788999998766555667889999999999999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
++|..++.+.. ..+++..+..++.|+++||.|||+. +|+|||||++|||++.++++||+|||++....... ....
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 99998876432 3589999999999999999999998 99999999999999999999999999987654322 1223
Q ss_pred ccccCccccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 477 RVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
...|+..|++||++. +..++.++|||||||++|||++|+.||......+.+..+.. .....+.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---------~~~~~~~--- 229 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---------SEPPTLA--- 229 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh---------cCCCCCC---
Confidence 357899999999984 34578899999999999999999999976543332222111 0000100
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.......++ .+++.+||+.+|.+||++.++++.
T Consensus 230 -~~~~~~~~~---~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 -QPSRWSSEF---KDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -CccccCHHH---HHHHHHHccCChhhCcCHHHHhcC
Confidence 111123344 445569999999999999988754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.19 Aligned_cols=250 Identities=20% Similarity=0.344 Sum_probs=203.0
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
.+|.+.+.||.|+||.||+++. .+|+.|+||.+........+.+.+|+.+++.++|+||+++++++.+++.+|+||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3589999999999999999984 578999999997665555678899999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.+++... .+++.++..++.+++.||+|||++ +|+|||||++|||+++++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 999999988542 478999999999999999999999 999999999999999999999999999876543322 1
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
.....|+..|++||.+.+..++.++|||||||++|+|++|+.||......+.+..+.. .....+ . ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~---------~~~~~~---~-~~ 238 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---------NGTPEL---Q-NP 238 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------cCCccc---C-Cc
Confidence 2335688999999999988899999999999999999999999977643332221110 000000 0 00
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
..... .+.+++.+||..+|.+||++.+|++.
T Consensus 239 ~~~~~---~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 239 EKLSP---IFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ccCCH---HHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 11223 34455669999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.57 Aligned_cols=249 Identities=22% Similarity=0.382 Sum_probs=203.1
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+|++.+.||+|+||.||++.. .+|+.||+|.+... .....+++.+|++++++++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 488899999999999999984 47899999998754 233456789999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+++|.+++.......+++..+++++.|++.||.|||++ +|+|+||+++||||+.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999998765544578999999999999999999998 999999999999999999999999999976644322
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
......|+..|+|||++.++.++.++|||||||++|+|++|+.||......+.+..+.. +.... ..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~---------~~~~~-----~~ 222 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR---------GSYPP-----VS 222 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc---------CCCCC-----Cc
Confidence 12335688999999999988999999999999999999999999976544333222211 11110 11
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.... ..+.+++.+||+.+|.+||++.+|++
T Consensus 223 -~~~~---~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 223 -SHYS---YDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -ccCC---HHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1112 34555666999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=321.42 Aligned_cols=265 Identities=25% Similarity=0.327 Sum_probs=202.7
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|++++++++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478899999999999999985 478999999997654 23356789999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+ +++|.+++.... ..+++..++.++.||++||+|||++ +|+|+|||++||++++++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999886543 4589999999999999999999998 9999999999999999999999999999876544322
Q ss_pred cccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHH----Hh----hcCcc
Q 006083 474 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGA----AL----EDGIY 544 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~----~~----~~~~~ 544 (662)
......|+..|+|||++.+. .++.++|||||||++|||++|+.+|........+...... +.. .+ +...+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRT-LGTPNEETWPGLTSLPDY 234 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHH-cCCCChHHHhhccCcchh
Confidence 23345789999999998654 4689999999999999999998888665433322211110 000 00 00000
Q ss_pred ccccCc-----ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 545 DGLVDP-----RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 545 ~~~~d~-----~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
..+... .+. ....+....+.+++.+||+.+|.+||+++++++.
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLE-EIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHH-HhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 000 0011122556677779999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=318.05 Aligned_cols=252 Identities=25% Similarity=0.336 Sum_probs=191.2
Q ss_pred ceeeccCceEEEEEEec---CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCc
Q 006083 322 NLLGQGGFGYVHKGVLP---NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNK 397 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g 397 (662)
+.||+|+||.||+|... .+..+|+|.++.... .....+.+|+.++++++|+||+++++++.+....++||||+.+|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46999999999999853 346799999876543 33457889999999999999999999999999999999999999
Q ss_pred chhhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc-
Q 006083 398 TLEYHLHGEN---RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH- 473 (662)
Q Consensus 398 ~L~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~- 473 (662)
+|.++++... ....++..+.+++.|+++||+|||+. +|+|||||++|||+++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986432 23456778889999999999999998 8999999999999999999999999999754433221
Q ss_pred cccccccCccccCcccccCC-------CCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 474 VSTRVMGTFGYLAPEYASSG-------KLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~-------~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
......|+..|+|||++.+. .++.++|||||||++|||++ |+.||......+.+.... .+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~---------~~~~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV---------REQQL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh---------hcccC
Confidence 12235678889999988642 35789999999999999996 999997654333221110 01111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
.+.+..+. ......+.++++ .|+ .+|++||++.||++.|.
T Consensus 229 ~~~~~~~~-~~~~~~~~~l~~---~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLK-LPLSDRWYEVMQ---FCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccC-CCCChHHHHHHH---HHh-cCcccCCCHHHHHHHhc
Confidence 11112221 122344455554 788 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=316.63 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=201.8
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
++|+..+.||+|+||.||++... +++.|++|.++.... .+.+.+|++++++++|+||+++++++.++...|++|||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 46888999999999999999965 478999999976432 678999999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.+++.... ..+++..++.++.++++||.|||+. +|+||||+++||++++++.+||+|||++........ .
T Consensus 81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 9999999986433 4589999999999999999999998 899999999999999999999999999987654321 2
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
.....|+..|++||++.+..++.++||||||||+|+|++|+.||......+....+. ... ...+.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~---------~~~-----~~~~~- 220 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP---------NKP-----PPTLS- 220 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc---------cCC-----CCCCC-
Confidence 233568899999999998899999999999999999999999997643322111100 000 00010
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
........+.+++.+||+.+|++||++.||++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 -DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 01111234556666999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=322.18 Aligned_cols=240 Identities=23% Similarity=0.406 Sum_probs=188.9
Q ss_pred ceeeccCceEEEEEEecC--------CCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 322 NLLGQGGFGYVHKGVLPN--------GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+.||+|+||.||+|.... ...|++|.+........+.+.+|+.+|+.++|+||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998532 234888888765555567889999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCc--------EEEEeecccc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE--------AMVADFGLAK 465 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~--------vkl~DFGla~ 465 (662)
+.+|+|..+++.... .+++..+++++.||+.||+|||++ +|+|||||++|||++.++. ++|+|||++.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999975433 578999999999999999999998 9999999999999987665 6899999986
Q ss_pred ccCCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCC-CCCCCchhhhHHHHHHHHHhHHHhhcCc
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGR-RPVDMTMMEDSLVEWARPLLGAALEDGI 543 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (662)
..... ....|+..|+|||++.+ ..++.++|||||||++|||++|. .||......... .. . .. .
T Consensus 157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~----~----~~-~ 221 (258)
T cd05078 157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QF----Y----ED-R 221 (258)
T ss_pred ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HH----H----Hc-c
Confidence 55432 23567889999999986 45899999999999999999995 555433221111 00 0 00 0
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 544 YDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 544 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
..+.. .....+.+++.+||+.+|++||++++|++.|+
T Consensus 222 ------~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ------HQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------ccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01111 11234566667999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.00 Aligned_cols=239 Identities=25% Similarity=0.376 Sum_probs=187.2
Q ss_pred eeeccCceEEEEEEecC-------------------------CCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceE
Q 006083 323 LLGQGGFGYVHKGVLPN-------------------------GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSL 377 (662)
Q Consensus 323 ~iG~G~~g~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l 377 (662)
+||+|+||.||+|.+.. ...|++|+++.........|.+|++++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999987321 13589999876544445678899999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC---
Q 006083 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF--- 454 (662)
Q Consensus 378 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~--- 454 (662)
+++|.++...+|||||+.+++|..++... ...+++..+++++.|+++||+|||++ +|+|||||++||||++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999988643 33578999999999999999999998 999999999999997643
Q ss_pred ----cEEEEeeccccccCCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHH-hCCCCCCCchhhhHHH
Q 006083 455 ----EAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELI-TGRRPVDMTMMEDSLV 528 (662)
Q Consensus 455 ----~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLl-tG~~Pf~~~~~~~~~~ 528 (662)
.+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|+.||......+. .
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~ 231 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-E 231 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-H
Confidence 4899999998654322 12357788999998875 56899999999999999985 69999876533221 1
Q ss_pred HHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 529 EWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
.+.. . .. .+..... ..+.+++.+||+.+|++||++.+|++.|.
T Consensus 232 ~~~~----~---~~--------~~~~~~~----~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 232 RFYE----K---KH--------RLPEPSC----KELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHH----h---cc--------CCCCCCC----hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1110 0 00 1111111 24566777999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=321.48 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=197.3
Q ss_pred CCCccceeeccCceEEEEEEec-CCCEEEEEEeecC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTG-SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
+|++.+.||+|+||.||++... +|+.||+|.++.. .......+.+|+++|++++|+||+++++++..++.+|+||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5788899999999999999964 7899999998754 2233467889999999999999999999999999999999999
Q ss_pred CCcchhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 395 SNKTLEYHLHGE-NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 395 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
.+++|..++... ....+++..+.+++.+++.||.|||+.+ +|+|||||++|||++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 999999888653 1235899999999999999999999743 89999999999999999999999999997654322
Q ss_pred cccccccCccccCcccccCC------CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 474 VSTRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
.....|+..|++||++.+. .++.++|||||||+||+|++|+.||............ ... ..+...
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-----~~~-~~~~~~-- 228 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL-----SAI-VDGDPP-- 228 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH-----HHH-hhcCCC--
Confidence 2335688899999998543 3588999999999999999999999654322211110 000 011111
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+.. .....+.+++.+||+.+|++||++.++++
T Consensus 229 ---~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 229 ---TLPS----GYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ---CCCc----ccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1111 12234455666999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.31 Aligned_cols=250 Identities=21% Similarity=0.354 Sum_probs=202.1
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
..+|.+.+.||+|+||.||+++. .+++.||||.+........+.+.+|+.+++.++|+||++++++|..++..|+||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 35799999999999999999994 57999999999876555667789999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+++|.+++.. ..+++..+..++.+++.||.|||+. +|+|||||++||||+.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 98 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence 999999999854 2478899999999999999999998 999999999999999999999999999876543322
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
......|+..|++||.+.+..++.++|||||||++|+|++|+.||........+..+.. .+ ...+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~--------~~------~~~~~ 236 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--------NG------TPELQ 236 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc--------CC------CCCCC
Confidence 12335688999999999988899999999999999999999999965432211110000 00 00000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
........+.+++.+||+.+|++||++.+|++
T Consensus 237 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 --NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111123445666999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=333.28 Aligned_cols=192 Identities=26% Similarity=0.373 Sum_probs=164.9
Q ss_pred HhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
...+|.+.+.||+|+||.||+|... +++.||+|+.... ....|+.+|++++|+||+++++++..++..++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4467999999999999999999954 5788999986442 23569999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+. ++|.+++... ...+++..+++|+.||+.||.|||++ +|||||||++||||+.++.+||+|||+++......
T Consensus 138 ~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 138 HYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred ccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 995 5777777543 33589999999999999999999998 99999999999999999999999999997543221
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCC
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPV 518 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf 518 (662)
......||..|+|||++.+..++.++|||||||+||||+++..++
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 123467999999999999999999999999999999999866554
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.35 Aligned_cols=257 Identities=27% Similarity=0.394 Sum_probs=201.5
Q ss_pred CCCCccceeeccCceEEEEEEec--------CCCEEEEEEeecCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP--------NGKEVAVKSLKTGS-GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGG 385 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~ 385 (662)
.+|.+++.||+|+||.||++... .+..||+|+++... ....+.+.+|+++++++ +|+||++++++|..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 45889999999999999999732 12368999887543 23456889999999999 7999999999999999
Q ss_pred eEEEEEEecCCcchhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC
Q 006083 386 QRMLVYEFVSNKTLEYHLHGEN--------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID 451 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~ 451 (662)
..++||||+.+++|.++|.... ...+.+..+++++.|+++||.|||++ +|+||||||+||||+
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 9999999999999999986421 23478889999999999999999998 999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHH
Q 006083 452 DNFEAMVADFGLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVE 529 (662)
Q Consensus 452 ~~~~vkl~DFGla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~ 529 (662)
+++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||......+.+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~- 247 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK- 247 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH-
Confidence 9999999999999866432211 1122334567999999999999999999999999999998 888887654332211
Q ss_pred HHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 530 WARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
.. ..+.... ... ... ..+..++.+||+.+|.+||++.||++.|+...
T Consensus 248 ---~~-----~~~~~~~-----~~~-~~~---~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 248 ---LL-----KEGHRMD-----KPA-NCT---HELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred ---HH-----HcCCCCC-----CCC-CCC---HHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 11 1111000 011 112 34556667999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=318.05 Aligned_cols=266 Identities=21% Similarity=0.299 Sum_probs=202.3
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
++|++.+.||+|+||.||++... +|+.||+|++.... ....+.+.+|++++++++|+||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999965 68999999986542 2234568899999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.++.|..++.... .+++..++.++.|++.+|+|||++ +|+|||||++||||++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999999988775433 489999999999999999999998 999999999999999999999999999987654332
Q ss_pred ccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH---hHH---Hhhc-Ccc
Q 006083 473 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL---LGA---ALED-GIY 544 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~---~~~---~~~~-~~~ 544 (662)
......++..|++||++.+ ..++.++|||||||++|||++|+.||......+.+..+.... ... .... ..+
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 1233567889999999876 568899999999999999999999997665444333222111 000 0000 000
Q ss_pred ccccCcccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 545 DGLVDPRLEHNY-----VPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 545 ~~~~d~~l~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
............ .......+.+++.+||+.+|++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 111111110000 0111244567777999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=322.45 Aligned_cols=262 Identities=23% Similarity=0.341 Sum_probs=203.2
Q ss_pred cCHHHHHHHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEE-
Q 006083 306 FTYDELAAATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYCI- 382 (662)
Q Consensus 306 ~~~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~- 382 (662)
+.++.+..+.++|++.+.||+|+||.||++.. .+++.||+|+++... .....+.+|+.+++++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 44566777888999999999999999999985 468899999886532 2345688899999999 6999999999874
Q ss_pred ----eCCeEEEEEEecCCcchhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcE
Q 006083 383 ----AGGQRMLVYEFVSNKTLEYHLHG--ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA 456 (662)
Q Consensus 383 ----~~~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 456 (662)
.++.++|||||+.+++|.++++. .....+++..+..++.++++||.|||++ +|+|||||++||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 45678999999999999988753 2334578899999999999999999998 99999999999999999999
Q ss_pred EEEeeccccccCCCCCccccccccCccccCcccccC-----CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHH
Q 006083 457 MVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWA 531 (662)
Q Consensus 457 kl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~ 531 (662)
||+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.||........+..+.
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 242 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc
Confidence 9999999986643221 2233568999999998853 457899999999999999999999997543222211110
Q ss_pred HHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 532 RPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
........ ...... ..+..++.+||+.+|++||++.||++.
T Consensus 243 ---------~~~~~~~~----~~~~~~---~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 243 ---------RNPPPTLH----QPELWS---NEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ---------ccCCCccc----CCCCcC---HHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00000000 111112 235556669999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=314.37 Aligned_cols=248 Identities=23% Similarity=0.391 Sum_probs=201.5
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+|+..+.||+|+||.||++.. .+++.+|||.+.... ....+.+.+|+++|++++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 488899999999999999984 478899999987642 33456789999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC-CcEEEEeeccccccCCCCC
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN-FEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkl~DFGla~~~~~~~~ 472 (662)
+.+++|.+++.......+++..+++++.+++++|.|||++ +|+|||||++||||+++ +.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999765555689999999999999999999998 99999999999999854 4689999999987654322
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.+|+..........+.. +.... +
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~---------~~~~~-----~ 221 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS---------GTFAP-----I 221 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh---------cCCCC-----C
Confidence 2335688999999999988899999999999999999999999976543332221111 11111 1
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.. ... ..+.+++..||+.+|.+||++.|+++
T Consensus 222 ~~-~~~---~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 SD-RYS---PDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CC-CcC---HHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 112 33455666999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.36 Aligned_cols=252 Identities=24% Similarity=0.334 Sum_probs=188.1
Q ss_pred ceeeccCceEEEEEEecC---CCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCc
Q 006083 322 NLLGQGGFGYVHKGVLPN---GKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNK 397 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~---g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g 397 (662)
+.||+|+||.||+|...+ ...+++|.+..... .....+.+|+++++.++|+||++++++|...+..++||||+.+|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997433 35688888765432 33467889999999999999999999999999999999999999
Q ss_pred chhhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC-c
Q 006083 398 TLEYHLHGEN---RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT-H 473 (662)
Q Consensus 398 ~L~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~-~ 473 (662)
+|.+++.... .....+...++++.||+.||+|||++ +|+||||||+||||++++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999986532 22346778889999999999999998 999999999999999999999999999875433211 1
Q ss_pred cccccccCccccCcccccC-------CCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 474 VSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
......++..|+|||++.. ..++.++|||||||+||||++ |+.||......+.+.... ..+ ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~--------~~~-~~ 228 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV--------REQ-DI 228 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh--------hcc-Cc
Confidence 1223456778999998742 457889999999999999999 788886554333222111 111 11
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
.+.+..+.. .....+..++ ..|+ .||++||++++|++.|.
T Consensus 229 ~~~~~~~~~-~~~~~~~~~~---~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQLDL-KYSDRWYEVM---QFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCcccc-cCCHHHHHHH---HHHh-cCcccccCHHHHHHHhc
Confidence 111222222 2233444444 4677 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=322.21 Aligned_cols=262 Identities=25% Similarity=0.351 Sum_probs=205.3
Q ss_pred CcCHHHHHHHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 006083 305 TFTYDELAAATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYCI 382 (662)
Q Consensus 305 ~~~~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~ 382 (662)
.+.+.++..+.++|.+.+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.+++++ +|+||+++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 355677777889999999999999999999985 478899999987542 2345678899999999 7999999999987
Q ss_pred eC-----CeEEEEEEecCCcchhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCc
Q 006083 383 AG-----GQRMLVYEFVSNKTLEYHLHG--ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE 455 (662)
Q Consensus 383 ~~-----~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 455 (662)
.. +.+|+||||+.+++|.++++. .....+.+..++.++.|++.||.|||+. +|+|||||++|||+++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 43 468999999999999998853 2334588999999999999999999998 9999999999999999999
Q ss_pred EEEEeeccccccCCCCCccccccccCccccCcccccCC-----CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHH
Q 006083 456 AMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEW 530 (662)
Q Consensus 456 vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~ 530 (662)
+||+|||++........ ......|+..|++||++..+ .++.++|||||||++|||++|+.||......+.+..+
T Consensus 167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~ 245 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245 (291)
T ss_pred EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH
Confidence 99999999886543221 12235688999999998643 3689999999999999999999999765433333222
Q ss_pred HHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 531 ARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+ .....+.+. ......+.+++.+||+.+|++||++.|+++
T Consensus 246 ~~---------~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 246 PR---------NPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred hc---------CCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 111111110 111234666777999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=321.38 Aligned_cols=263 Identities=22% Similarity=0.319 Sum_probs=197.5
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
++|.+.+.||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46889999999999999999854 688999999975432 2345678899999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+. ++|.+++.... ..+++..+..++.|+++||+|||++ +|+|||||++||||++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 97 57888776533 3478899999999999999999998 999999999999999999999999999976543221
Q ss_pred cccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH-------hHHHhhcCccc
Q 006083 474 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL-------LGAALEDGIYD 545 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 545 (662)
......++..|++||++.+ ..++.++|||||||+||||++|+.||......+.+......+ +...+....+.
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 1233467889999998875 457899999999999999999999997665433322211100 00000000000
Q ss_pred cccCcccC-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GLVDPRLE-------HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~~d~~l~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
........ ...... .+.+++.+||+.||.+||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~---~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDS---DGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccCccccccHHhhcCCCCH---HHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000 011222 3445566999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.90 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=201.3
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
++|++.+.||+|+||.||++... +++.||+|+++.......+.+.+|++++++++|+||+++++++..++..|+||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 45888999999999999999854 68999999998766566678999999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.+++.... ..+++..+++++.|++.||.|||++ +|+|||||++|||++.++.++|+|||++........ .
T Consensus 85 ~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (280)
T cd06611 85 DGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K 159 (280)
T ss_pred CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence 9999999886533 3589999999999999999999999 899999999999999999999999999876543222 2
Q ss_pred ccccccCccccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 475 STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
.....|+..|++||++. ...++.++|||||||++|||++|+.||......+.+..+. .+....+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------~~~~~~~~- 229 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL---------KSEPPTLD- 229 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh---------cCCCCCcC-
Confidence 23457899999999875 3447789999999999999999999997654332222211 11100000
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
....... .+.+++..||+.+|.+||++.+|++.
T Consensus 230 ---~~~~~~~---~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 ---QPSKWSS---SFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CcccCCH---HHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0111223 34455568999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.71 Aligned_cols=238 Identities=27% Similarity=0.417 Sum_probs=189.1
Q ss_pred ceeeccCceEEEEEEecCCC-----------EEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 322 NLLGQGGFGYVHKGVLPNGK-----------EVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
+.||+|+||.||+|...+.. .|++|.++..... ...+.+|+++|++++|+||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999965432 5788887654333 6788999999999999999999999988 778999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC-------cEEEEeecc
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF-------EAMVADFGL 463 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~-------~vkl~DFGl 463 (662)
|||+.+++|.+++..... .+++..+++++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999975443 588999999999999999999998 999999999999999887 799999999
Q ss_pred ccccCCCCCccccccccCccccCcccccCC--CCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhh
Q 006083 464 AKLSNDNHTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALE 540 (662)
Q Consensus 464 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 540 (662)
+...... ....+...|++||++.+. .++.++|||||||++|||++ |..||......+... +..
T Consensus 155 a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-~~~-------- 220 (259)
T cd05037 155 PITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-FYQ-------- 220 (259)
T ss_pred ccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-HHh--------
Confidence 9865431 224567789999999876 78999999999999999999 577775543221111 110
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 541 DGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 541 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
... .+.. ... ..+.+++.+||..+|.+||++.+|++.|+
T Consensus 221 ~~~-------~~~~-~~~---~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQH-------RLPM-PDC---AELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCC-------CCCC-CCc---hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0000 001 45666777999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=324.14 Aligned_cols=195 Identities=23% Similarity=0.360 Sum_probs=160.3
Q ss_pred cceeeccCceEEEEEEec---CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEE--eCCeEEEEEEecC
Q 006083 321 SNLLGQGGFGYVHKGVLP---NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI--AGGQRMLVYEFVS 395 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~~lv~E~~~ 395 (662)
+.+||+|+||.||+|+.. ++..||+|.++... ....+.+|+++|++++|+||+++++++. .+...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 468999999999999854 45789999987542 2346789999999999999999999885 4567899999987
Q ss_pred Ccchhhhhcc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE----CCCCcEEEEeeccc
Q 006083 396 NKTLEYHLHG-------ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI----DDNFEAMVADFGLA 464 (662)
Q Consensus 396 ~g~L~~~l~~-------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkl~DFGla 464 (662)
+ +|.+++.. .....+++..++.++.||+.||.|||++ +|+||||||+|||| ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 66665532 1223578889999999999999999998 89999999999999 45678999999999
Q ss_pred cccCCCCCc--cccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCc
Q 006083 465 KLSNDNHTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMT 521 (662)
Q Consensus 465 ~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~ 521 (662)
+........ ......|+..|+|||++.+ ..++.++|||||||+||||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876543221 1234678999999999876 45899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=313.53 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=199.3
Q ss_pred CCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC-----chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS-----GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
+|...+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|++++++++|+||+++++++.+++.+++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999965 78999999987543 23456789999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+++|.+++.... .+++..+..++.++++||.|||+. +|+|||||++||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999986543 478999999999999999999998 8999999999999999999999999998765443
Q ss_pred CCccccccccCccccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
. ......|+..|++||.+.... ++.++|||||||++|+|++|+.||+.....+.+..+.. .....
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--------~~~~~---- 221 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR--------SKELP---- 221 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh--------cccCC----
Confidence 2 223456899999999988766 89999999999999999999999976542222211110 00000
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+.. ... ..+.+++.+||+.+|.+||++.++++
T Consensus 222 -~~~~-~~~---~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 -PIPD-HLS---DEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -CcCC-CcC---HHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1111 112 33445566999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=316.04 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=187.8
Q ss_pred ceeeccCceEEEEEEecCC---CEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCc
Q 006083 322 NLLGQGGFGYVHKGVLPNG---KEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNK 397 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g 397 (662)
+.||+|+||.||++...++ ..+++|.++... ....+.+.+|+++++.++|+||++++++|.+....|+||||+.+|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975443 346677766543 234568999999999999999999999999999999999999999
Q ss_pred chhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC-Ccc
Q 006083 398 TLEYHLHGEN--RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH-THV 474 (662)
Q Consensus 398 ~L~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~-~~~ 474 (662)
+|.++++... ...+.+..++.++.||++||+|||+. +|+|||||++|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997532 23456677889999999999999998 89999999999999999999999999986432211 112
Q ss_pred ccccccCccccCcccccC-------CCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCcccc
Q 006083 475 STRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
....+|+..|+|||++.. ..++.++|||||||++|||++ |..||......+.+..... . ....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~--------~-~~~~ 228 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK--------D-QQVK 228 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh--------h-cccc
Confidence 234578899999998853 245789999999999999997 5667765433322222111 1 1112
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
+.+..+...+. ..+.+ ++..|+ .+|++||++.||++.|-
T Consensus 229 ~~~~~~~~~~~-~~~~~---l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELPYS-ERWYE---VLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCCCc-HHHHH---HHHHHh-hCcccCCCHHHHHHHhc
Confidence 22333333332 33333 444788 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=320.79 Aligned_cols=267 Identities=23% Similarity=0.322 Sum_probs=203.1
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
++|++.+.||+|+||.||+|... +++.|+||+++... ....+.+.+|+++|++++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999854 68899999987542 2335678999999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.++.|..++... ..+++..+..++.+++.||.|||++ +|+|||||++||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99998887666433 3478999999999999999999998 999999999999999999999999999987665443
Q ss_pred ccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHH---HhHHHh----hcCcc
Q 006083 473 HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARP---LLGAAL----EDGIY 544 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~---~~~~~~----~~~~~ 544 (662)
.......|+..|+|||++.+. .++.++|||||||+||+|++|+.+|......+.+...... +..... ....+
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 233446788999999999887 8899999999999999999999999765433322211110 000000 00000
Q ss_pred cc-----ccCc-ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 545 DG-----LVDP-RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 545 ~~-----~~d~-~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.. ..+. .+...+.......+.+++.+||..+|++||++++|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 0000 0000111111345666777999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=314.85 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=193.3
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc-----hhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG-----QGEREFSAEVEIISRVHHRHLVSLVGYCIA--GGQR 387 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~ 387 (662)
.+|...+.||+|+||.||++.. .+++.|++|+++.... ...+.+.+|++++++++|+||+++++++.+ +..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688999999999999999985 4689999999865321 234568899999999999999999998875 4678
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
+++|||+.+++|.+++.... .+++..++.++.|++.||+|||+. +|+|||||++|||++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 89999999999999986543 478899999999999999999998 8999999999999999999999999998765
Q ss_pred CCCCC--ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 468 NDNHT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 468 ~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||........+.. .. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~----~~----~~~--- 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK----IA----TQP--- 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH----Hh----cCC---
Confidence 32111 111235688999999999988899999999999999999999999975432221111 00 000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
....+.. .....+..+ ..||..+|++||+++||++
T Consensus 226 --~~~~~~~-~~~~~~~~l----i~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 --TNPQLPS-HISEHARDF----LGCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCCCCch-hcCHHHHHH----HHHhcCChhhCcCHHHHhc
Confidence 0111111 112233333 3588899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=319.98 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=202.3
Q ss_pred CHHHHHHHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEe-
Q 006083 307 TYDELAAATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYCIA- 383 (662)
Q Consensus 307 ~~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~- 383 (662)
++.++....+.|++.+.||+|+||.||+|.. .+++.||+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4455556678899999999999999999995 468899999986543 3345688999999999 69999999999853
Q ss_pred -----CCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEE
Q 006083 384 -----GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMV 458 (662)
Q Consensus 384 -----~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl 458 (662)
+..+|+||||+.+++|.+++.......+.+..+..++.|+++||.|||++ +|+|||||++||||++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 56789999999999999999765555688888999999999999999998 9999999999999999999999
Q ss_pred EeeccccccCCCCCccccccccCccccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHH
Q 006083 459 ADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARP 533 (662)
Q Consensus 459 ~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~ 533 (662)
+|||++........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||........+...
T Consensus 163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~--- 238 (282)
T cd06636 163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI--- 238 (282)
T ss_pred eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH---
Confidence 99999876543221 123357899999999886 346888999999999999999999999654322211110
Q ss_pred HhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 534 LLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 534 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.......+.....+. .+.+++.+||+.||.+||++.||++
T Consensus 239 -----------~~~~~~~~~~~~~~~---~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 -----------PRNPPPKLKSKKWSK---KFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -----------hhCCCCCCcccccCH---HHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000011111112233 3455556999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.42 Aligned_cols=266 Identities=24% Similarity=0.370 Sum_probs=200.2
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQ--GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
++|++.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+++|++++|+||+++++++.+++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888999999999999999965 5899999998654322 34578899999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.++.|.+++.... .+++..++.++.|+++||.|||+. +|+||||+++||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999988775432 389999999999999999999998 89999999999999999999999999998764433
Q ss_pred ccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHH---HHhHH---Hhh-cCcc
Q 006083 473 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWAR---PLLGA---ALE-DGIY 544 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~---~~~~~---~~~-~~~~ 544 (662)
.......|+..|+|||++.+ ..++.++|||||||++|||++|+.+|......+.+..... .+... ... ...+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 22334568899999999875 4578899999999999999999999975543222211110 00000 000 0000
Q ss_pred ccccCcccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 545 DGLVDPRLEHN-----YVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 545 ~~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
........... ........+.+++.+||+.+|.+||++.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000000 00112244666777999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=313.41 Aligned_cols=255 Identities=25% Similarity=0.366 Sum_probs=204.1
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
++|++.+.||.|+||.||+|.. .++..+++|++.... ....+.+.+|+++|+.++|+||+++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4689999999999999999984 468899999997543 23457899999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 394 VSNKTLEYHLHGENR-PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
+.+++|.+++..... ..+++..+..++.|++.||+|||++ +|+|||||++||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999965432 4689999999999999999999998 999999999999999999999999999876654322
Q ss_pred c---cccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 473 H---VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 473 ~---~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
. .....+|+..|++||++... .++.++|||||||++|||++|+.||........+.++... .
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---------~----- 223 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---------D----- 223 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---------C-----
Confidence 2 22345789999999998876 7899999999999999999999999765433322222111 0
Q ss_pred CcccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 549 DPRLEHNY-VPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 549 d~~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...+.... .......+.+++..||+.||++||++.+|++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00111000 0122244556666999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.03 Aligned_cols=257 Identities=26% Similarity=0.400 Sum_probs=199.4
Q ss_pred CCCccceeeccCceEEEEEEe-----cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-----PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAG--GQRM 388 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~ 388 (662)
.|.+.+.||+|+||.||++.. .+++.||+|.++... ......+.+|+++|++++|+||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 377889999999999999973 357899999997553 33456799999999999999999999998865 6789
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
+||||+.|++|.+++.... ..+++..++.++.+++.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 85 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999986543 3579999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCc--cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchh-----------hhHHHHHHHHHh
Q 006083 469 DNHTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMM-----------EDSLVEWARPLL 535 (662)
Q Consensus 469 ~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~-----------~~~~~~~~~~~~ 535 (662)
..... ......|+..|+|||++.+..++.++|||||||++|||++++.++..... +..+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 236 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV---- 236 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH----
Confidence 43221 12235567789999999988999999999999999999998776432110 00001110
Q ss_pred HHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 536 GAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 536 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
..+..+... ..... ....+.+++.+||+.+|++||++.+|++.|+.
T Consensus 237 -~~~~~~~~~-----~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 237 -RVLEEGKRL-----PRPPN----CPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred -HHHHcCccC-----CCCCC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 111111110 01111 12356666779999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=319.24 Aligned_cols=265 Identities=22% Similarity=0.290 Sum_probs=199.3
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+|+..+.||.|+||.||+|+. .+|+.||||+++.... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488899999999999999985 4789999999875432 2335788999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+. ++|..++.......+++..++.++.++++||+|||+. +|+|||||++|||+++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 6788888765556789999999999999999999998 899999999999999999999999999876543321
Q ss_pred cccccccCccccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh----------HHHh-hc
Q 006083 474 VSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL----------GAAL-ED 541 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~----------~~~~-~~ 541 (662)
......++..|+|||++.+.. ++.++|||||||++|||++|+.||......+.+.+.....- .... ..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 123345788999999887644 68899999999999999999999976544333332221100 0000 00
Q ss_pred CccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 542 GIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 542 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..+.......+... ....-..+.+++.+||+.||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 236 PSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00111111000000 0011123445667999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=333.55 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=206.6
Q ss_pred HhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
..+.|.+.+.||+|.|+.|.+++. .++..||||.+++... .....+.+|+++|+.|+|||||+|+.+.+....+|||
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 346799999999999999999984 4799999999987633 3345689999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+|.++++|...++ +.+..+..++.|+.+|++|||++ +|||||||.+||||+.+.++||+|||++..+...
T Consensus 134 ~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc
Confidence 999999999999976655 56688889999999999999999 8999999999999999999999999999988744
Q ss_pred CCccccccccCccccCcccccCCCCC-chHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
.....++|++.|.|||++.+..|+ ..+|+|++|+|||-|++|.+||++....+. ....+...
T Consensus 209 --~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-------------r~rvl~gk-- 271 (596)
T KOG0586|consen 209 --LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-------------RPRVLRGK-- 271 (596)
T ss_pred --ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------------cchheeee--
Confidence 345668999999999999987765 899999999999999999999987642211 00011110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.-...+...+.+.|+. ++|-.+|.+|.++++|.+.
T Consensus 272 -~rIp~~ms~dce~lLr---k~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 272 -YRIPFYMSCDCEDLLR---KFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -ecccceeechhHHHHH---HhhccCccccCCHHHhhhh
Confidence 1112344455555554 7888999999999999864
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.18 Aligned_cols=266 Identities=23% Similarity=0.264 Sum_probs=201.0
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch-----hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ-----GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
+|++.+.||+|+||.||+|.. .+|+.||||.++..... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999985 46899999999765332 235677899999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+ +++|.+++.... ..+++..+++++.||++||.|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999996544 3589999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhH---HHh-hcCccc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLG---AAL-EDGIYD 545 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~---~~~-~~~~~~ 545 (662)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|..+|......+.+......... ... ......
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 156 NR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred Cc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 22 1233456888999998864 46789999999999999999998888765443333222111000 000 000000
Q ss_pred cccCcccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 546 GLVDPRLEHN-----YVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 546 ~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.......... ........+.+++.+||+.+|++||++.||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000 011223456677779999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.05 Aligned_cols=247 Identities=23% Similarity=0.368 Sum_probs=198.4
Q ss_pred CCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
|.....||+|+||.||++.. .+++.||||++........+.+.+|+.++++++|+||+++++++..++..|+||||+.+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 44456799999999999985 46889999999765555567789999999999999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
++|.+++... .+++..+..++.+|+.||+|||++ +|+|||||++||||++++.+||+|||++........ ...
T Consensus 104 ~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 176 (292)
T cd06658 104 GALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRK 176 (292)
T ss_pred CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCc
Confidence 9999988532 478899999999999999999998 899999999999999999999999999876543222 223
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC-C
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH-N 555 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~ 555 (662)
...|+..|+|||++.+..++.++|||||||++|||++|+.||......+.+..+. .. +...+.. .
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~---------~~-----~~~~~~~~~ 242 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR---------DN-----LPPRVKDSH 242 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---------hc-----CCCcccccc
Confidence 4578999999999998899999999999999999999999997654322221110 00 0111111 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 556 YVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 556 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.....+. .++..||..+|.+||++.|+++.
T Consensus 243 ~~~~~~~---~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 KVSSVLR---GFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccCHHHH---HHHHHHccCChhHCcCHHHHhhC
Confidence 1233344 44558999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=317.24 Aligned_cols=248 Identities=29% Similarity=0.494 Sum_probs=194.7
Q ss_pred ceeeccCceEEEEEEecC-------CCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 322 NLLGQGGFGYVHKGVLPN-------GKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~-------g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+.||+|+||.||+|...+ ++.|+||.+.... ......+.+|+++|++++|+||++++++|.+.+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998532 2579999886543 23456789999999999999999999999999999999999
Q ss_pred cCCcchhhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC-----cEEEEeecc
Q 006083 394 VSNKTLEYHLHGE-----NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF-----EAMVADFGL 463 (662)
Q Consensus 394 ~~~g~L~~~l~~~-----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~-----~vkl~DFGl 463 (662)
+.+++|.+++... ....+.+..++.++.+++.||.|||+. +|+|||||++||||+.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999643 223478899999999999999999998 899999999999999877 899999999
Q ss_pred ccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhc
Q 006083 464 AKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALED 541 (662)
Q Consensus 464 a~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 541 (662)
++....... .......++..|++||++.++.++.++|||||||++|||++ |+.||......+... ... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~-~~~-------~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ-HVT-------AG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHH-HHh-------cC
Confidence 976543221 11223345788999999999999999999999999999998 999996543322111 110 00
Q ss_pred CccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 542 GIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 542 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
..+ .. ....+. .+.+++.+||..+|.+||++.+|++.|+
T Consensus 230 ~~~------~~-~~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 GRL------QK-PENCPD---KIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred Ccc------CC-cccchH---HHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 100 01 111233 4456666999999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.73 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=193.1
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC-----chhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS-----GQGEREFSAEVEIISRVHHRHLVSLVGYCIA--GGQR 387 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~ 387 (662)
.+|.+.++||+|+||.||++.. .+|+.||||.++... ....+.+.+|++++++++|+||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688999999999999999985 468999999986432 1234578899999999999999999999876 3567
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
++||||+.+++|.+++.... .+++..+++++.+++.||+|||++ +|+|||||++|||++.++.+||+|||++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999986543 478888999999999999999998 8999999999999999999999999998765
Q ss_pred CCCCC--ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 468 NDNHT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 468 ~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||........+.+. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~--------~~~~--- 225 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI--------ATQP--- 225 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH--------hcCC---
Confidence 32211 1123356899999999999888999999999999999999999999654222211110 0000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
....+ .......+..++.+|+. +|++||++.||++
T Consensus 226 --~~~~~----~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 --TNPVL----PPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred --CCCCC----chhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00111 11222334445557774 8999999999886
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=316.61 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=200.7
Q ss_pred CCCCccceeeccCceEEEEEEec-CCC----EEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGK----EVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
++|++.+.||+|+||.||+|... +|+ .||+|.++.... .....+.+|+.+|++++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45888899999999999999853 333 589998876543 345678999999999999999999999987 78899
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||||+.+|+|.++++.... .+++..+++++.|++.||+|||++ +|+|||||++|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999975433 489999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCccc-cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 470 NHTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 470 ~~~~~~-~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
...... ....++..|++||.+..+.++.++|||||||++|||++ |+.||+.....+. .... ..+.. .
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~--------~~~~~--~ 230 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI-PDLL--------EKGER--L 230 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH-HHHH--------hCCCC--C
Confidence 332211 11223568999999988899999999999999999998 9999976543321 1111 11110 0
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.. ..... ..+..++.+||..+|.+||++.++++.|+..
T Consensus 231 ---~~-~~~~~---~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 231 ---PQ-PPICT---IDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ---CC-CCCCC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00 01111 3455666699999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=313.00 Aligned_cols=248 Identities=31% Similarity=0.467 Sum_probs=190.1
Q ss_pred ceeeccCceEEEEEEec----CCCEEEEEEeecC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEE-eCCeEEEEEEecC
Q 006083 322 NLLGQGGFGYVHKGVLP----NGKEVAVKSLKTG-SGQGEREFSAEVEIISRVHHRHLVSLVGYCI-AGGQRMLVYEFVS 395 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~~lv~E~~~ 395 (662)
++||+|+||.||+|... ++..||||++... .....+.+.+|+.+++.++|+||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46999999999999843 2357999998643 2344568889999999999999999999876 4566899999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC---
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT--- 472 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~--- 472 (662)
+++|.+++.... ..+.+..++.++.++++||.|||+. +|+|||||++||||++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999986543 2367788899999999999999998 999999999999999999999999999976543211
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhC-CCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG-RRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
.......++..|+|||++.+..++.++|||||||++|||++| ..+|......+ +... +..+.. .
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-~~~~--------~~~~~~------~ 221 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD-ITVY--------LLQGRR------L 221 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHH--------HhcCCC------C
Confidence 111234567789999999988999999999999999999995 45564432221 1111 111110 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
......+. .+.+++..||+.+|++||++.+|++.|+.
T Consensus 222 ~~~~~~~~---~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 222 LQPEYCPD---PLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred CCCCcCCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 01112233 45556669999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=312.37 Aligned_cols=250 Identities=29% Similarity=0.441 Sum_probs=199.8
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ--GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+|...+.||+|+||.||++.. .+++.|++|.++..... ..+.+.+|++++++++|+||+++++++.+.+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 478889999999999999985 47899999999866443 567899999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+++|.+++... ..+.+..+.+++.++++||.|||+. +|+|||||++||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999998654 3478899999999999999999998 8999999999999999999999999999876543322
Q ss_pred cc---cccccCccccCcccccCCC---CCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 474 VS---TRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 474 ~~---~~~~Gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
.. ....|+..|++||++.+.. ++.++|||+|||++|+|++|+.||............. ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~--------~~~~---- 223 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHV--------GAGH---- 223 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHH--------hcCC----
Confidence 11 1356788999999998766 8899999999999999999999996543221111100 0010
Q ss_pred cCcccCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 548 VDPRLEHN-YVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 548 ~d~~l~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...+... ... ..+.+++.+||+.+|.+||++.+++.
T Consensus 224 -~~~~~~~~~~~---~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 -KPPIPDSLQLS---PEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCcccccC---HHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0011111 112 33445666999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=314.00 Aligned_cols=253 Identities=25% Similarity=0.398 Sum_probs=199.6
Q ss_pred CCCccceeeccCceEEEEEEecC--CCEEEEEEeecCC----------chhHHHHHHHHHHHHh-cCCCCcceEEEEEEe
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLPN--GKEVAVKSLKTGS----------GQGEREFSAEVEIISR-VHHRHLVSLVGYCIA 383 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~~--g~~vavK~l~~~~----------~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~ 383 (662)
+|.+.+.||+|+||.||++.... ++.+|||.+.... .....++.+|++++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999654 6889999886321 2233557789988875 799999999999999
Q ss_pred CCeEEEEEEecCCcchhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEee
Q 006083 384 GGQRMLVYEFVSNKTLEYHLHG--ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADF 461 (662)
Q Consensus 384 ~~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DF 461 (662)
++..++||||+.+++|.+++.. .....+++..+++++.+++.+|.|||+.+ +|+|||||++|||+++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988743 23345889999999999999999999632 7999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhc
Q 006083 462 GLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALED 541 (662)
Q Consensus 462 Gla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 541 (662)
|++....... ......|+..|++||++.++.++.++|||||||++|||++|+.||............ ..
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~---------~~ 227 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI---------VE 227 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHH---------hh
Confidence 9998765432 234467899999999999888999999999999999999999999654322211111 11
Q ss_pred CccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 542 GIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 542 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
+.+... ....... .+.+++.+||+.||++||++.||..+|+
T Consensus 228 ~~~~~~-----~~~~~~~---~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 AVYEPL-----PEGMYSE---DVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCCcC-----CcccCCH---HHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111111 1111223 3455566999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=321.05 Aligned_cols=255 Identities=20% Similarity=0.245 Sum_probs=200.5
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.+.||+|+||.||++... .++.|+||.+..... .....+.+|+++++.++|+||+++++.+..++..+|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36889999999999999999854 678999999876532 23457889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.|++|.+++... ..+.+..+..++.++++||.|||++ +|+||||||+||||++++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999999654 3488899999999999999999998 99999999999999999999999999987421110
Q ss_pred C--------------ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHH
Q 006083 472 T--------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGA 537 (662)
Q Consensus 472 ~--------------~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 537 (662)
. .......|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~----- 230 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS----- 230 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----
Confidence 0 011124678899999999988999999999999999999999999976543322221111
Q ss_pred HhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 538 ALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 538 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
+.+. .... ....+.+ +..++.+||+.+|++||++.++.+.|+.
T Consensus 231 ----~~~~---~~~~-~~~~~~~---~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 ----DDIE---WPEG-DEALPAD---AQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ----cccC---CCCc-cccCCHH---HHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1000 0011 1122333 4455569999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=319.37 Aligned_cols=246 Identities=26% Similarity=0.386 Sum_probs=198.5
Q ss_pred CCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
|...+.||+|+||.||+|.. .+++.||||.++... ....+.+.+|++++++++|+||+++++++..+...|+||||+.
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 66678899999999999985 467899999987543 3345678999999999999999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
+++|.+++.. ..+.+..+..++.++++||.|||++ +|+|+||+++||++++++.+||+|||++........ ..
T Consensus 86 ~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06642 86 GGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-hh
Confidence 9999998854 3478899999999999999999998 999999999999999999999999999976653321 12
Q ss_pred cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCC
Q 006083 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHN 555 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 555 (662)
....|+..|++||++.+..++.++|||||||++|||++|+.||........+.. +..+. ...+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~---------~~~~~-----~~~~~~- 223 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL---------IPKNS-----PPTLEG- 223 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh---------hhcCC-----CCCCCc-
Confidence 235688999999999998999999999999999999999999865432211110 00110 111111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 556 YVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 556 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.....+.+++.+||+.+|.+||++.+|++.
T Consensus 224 ---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 224 ---QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 122345566679999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=320.27 Aligned_cols=265 Identities=22% Similarity=0.263 Sum_probs=194.2
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+|++.+.||+|+||.||+++. .+|+.||+|+++.... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478889999999999999995 4789999999975422 2235678899999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+ +|.+++... ...+++..++.++.||++||.|||++ +|+|||||++|||++.++++||+|||+++.......
T Consensus 81 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CDQ-DLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 975 676766543 23589999999999999999999998 999999999999999999999999999986543322
Q ss_pred cccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCch-hhhHHHHHHHHH----------hHHHhhc
Q 006083 474 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTM-MEDSLVEWARPL----------LGAALED 541 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~-~~~~~~~~~~~~----------~~~~~~~ 541 (662)
......++..|+|||++.+. .++.++|||||||++|||++|+.||.... ..+.+....+.. +......
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 12335678999999998764 47899999999999999999999864332 222221111000 0000000
Q ss_pred CccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 542 GIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 542 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..+...................+.+++.+||+.||.+||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000000000111112234455666999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=322.86 Aligned_cols=248 Identities=21% Similarity=0.316 Sum_probs=199.1
Q ss_pred CCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
|+....||+|+||.||++.. .+++.||||+++.......+.+.+|+.+++.++|+||+++++++..++..|+||||+.+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 44456899999999999985 47899999999765555567789999999999999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
++|..++.. ..+++..++.++.|++.||+|||++ +|+|||||++||||+.++.+||+|||++........ ...
T Consensus 103 ~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 175 (297)
T cd06659 103 GALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 175 (297)
T ss_pred CCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence 999988744 2478999999999999999999998 899999999999999999999999999876543321 123
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNY 556 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 556 (662)
...|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+..+. ....... .. ...
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---------~~~~~~~---~~-~~~ 242 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR---------DSPPPKL---KN-AHK 242 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---------ccCCCCc---cc-cCC
Confidence 4678999999999998899999999999999999999999997654332222110 0000000 00 011
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 557 VPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 557 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
... .+.+++..||+.+|++||++.+|++.
T Consensus 243 ~~~---~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISP---VLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCH---HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 122 34455669999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=317.45 Aligned_cols=263 Identities=26% Similarity=0.373 Sum_probs=202.1
Q ss_pred CCCccceeeccCceEEEEEEec-----CCCEEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-----NGKEVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYCIA--GGQRM 388 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ 388 (662)
.|.+.+.||+|+||.||++.+. +++.||||+++..... ..+.|.+|++++++++|+||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4677899999999999999843 3688999999866443 46789999999999999999999999887 56789
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
+||||+.+++|.+++..... .+++..++.++.+++.||+|||++ +|+|||||++|||++.++.+||+|||++....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 99999999999999965432 589999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCCc--cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHH------HHHHHHHhHHHhh
Q 006083 469 DNHTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSL------VEWARPLLGAALE 540 (662)
Q Consensus 469 ~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~------~~~~~~~~~~~~~ 540 (662)
..... ......++..|++||++.+..++.++|||||||++|||++|+.||......... ..+....+...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 33221 111234566799999999889999999999999999999999998653211100 0000000111111
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 541 DGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 541 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.+... .. ....+ ..+.+++.+||+.+|++||++.||+++|+..
T Consensus 241 ~~~~~-----~~-~~~~~---~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGERL-----PR-PPSCP---DEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCCcC-----CC-CccCC---HHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11100 00 01112 4566677799999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=318.42 Aligned_cols=266 Identities=21% Similarity=0.297 Sum_probs=196.2
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
++|++.+.||+|+||.||+|... +++.||||.+...... ....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56899999999999999999954 7899999998754322 234567899999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+ +|.+++..... .+++..++.++.|+++||.|||++ +|+|||||++|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 85 LDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred CCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 985 88888865433 578999999999999999999998 999999999999999999999999999875432211
Q ss_pred cccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchh-hhHHHHHHHHH---hHHHh----hc---
Q 006083 474 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMM-EDSLVEWARPL---LGAAL----ED--- 541 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~-~~~~~~~~~~~---~~~~~----~~--- 541 (662)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.+|..... .+.+....+.+ ....+ ..
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1122456889999998875 4589999999999999999999999965532 22111111100 00000 00
Q ss_pred --CccccccCcccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 542 --GIYDGLVDPRLEHNY-VPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 542 --~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..+.......+.... .......+.+++.+||+.+|++||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000000000 0001145566777999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.15 Aligned_cols=247 Identities=23% Similarity=0.353 Sum_probs=201.4
Q ss_pred CCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
.|+..+.||.|+||.||+|... +++.||||+++... ......+.+|++++++++|+||+++++++.++...|+||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4777889999999999999854 68899999987543 344567899999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.+++... .+++..+..++.+++.||+|||+. +++|+||+++|||+++++.++|+|||++........ .
T Consensus 85 ~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06640 85 GGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence 999999988542 478889999999999999999998 999999999999999999999999999976644322 2
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
.....++..|+|||++.+..++.++|||||||++|||++|+.||........+.. ...+. ..
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~---------~~~~~---------~~ 219 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL---------IPKNN---------PP 219 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh---------hhcCC---------CC
Confidence 2335688899999999988899999999999999999999999975432221110 00000 01
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.........+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1122334556677779999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=341.43 Aligned_cols=201 Identities=18% Similarity=0.280 Sum_probs=160.1
Q ss_pred HhCCCCccceeeccCceEEEEEEec--CCCEEEEEEee--------------c---CCchhHHHHHHHHHHHHhcCCCCc
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP--NGKEVAVKSLK--------------T---GSGQGEREFSAEVEIISRVHHRHL 374 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~--~g~~vavK~l~--------------~---~~~~~~~~~~~E~~il~~l~HpnI 374 (662)
..++|++.+.||+|+||.||++..+ .+..+++|.+. + ........+++|+++|++|+|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3568999999999999999998743 22222222110 0 111234568899999999999999
Q ss_pred ceEEEEEEeCCeEEEEEEecCCcchhhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC
Q 006083 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGEN---RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID 451 (662)
Q Consensus 375 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~ 451 (662)
|++++++.+.+..|+|+|++.+ +|.+++.... ........+++|+.||+.||+|||++ +||||||||+||||+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 9999999999999999999854 5555553321 12234567788999999999999998 999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCC
Q 006083 452 DNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPV 518 (662)
Q Consensus 452 ~~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf 518 (662)
.++.+||+|||+++.+...........+|+..|+|||++.+..++.++||||||||||||++|+.++
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999877544333334468999999999999999999999999999999999988653
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=312.59 Aligned_cols=250 Identities=22% Similarity=0.392 Sum_probs=201.4
Q ss_pred CCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+|.+.+.||+|+||.||++... +|..||+|.+.... ....+.+.+|++++++++|+||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788999999999999999954 68899999987542 23456788999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC-cEEEEeeccccccCCCCC
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF-EAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkl~DFGla~~~~~~~~ 472 (662)
+.+++|.+++.......+++..++.++.++++||.|||+. +|+|||||++|||+++++ .+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999765555689999999999999999999998 899999999999998875 469999999987654322
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......+.+.. .. .+.+.. +
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~-----~~~~~~-----~ 222 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK----IC-----QGYFAP-----I 222 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----Hh-----cccCCC-----C
Confidence 22335689999999999888899999999999999999999999976543222211 11 111111 0
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.. .....+.+++.+|+..+|++||++.+|++.
T Consensus 223 ~~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 SP----NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CC----CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11 112345566669999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=308.96 Aligned_cols=264 Identities=24% Similarity=0.390 Sum_probs=206.9
Q ss_pred HHHHHHHhCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCC
Q 006083 308 YDELAAATGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-HRHLVSLVGYCIAGG 385 (662)
Q Consensus 308 ~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~ 385 (662)
++++..++ .++||+|+|+.|--++ +.+|.+||||++.+.....+.++.+|++++.+.+ |+||++|++||++++
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 56665444 4679999999999988 7799999999999887777889999999999995 999999999999999
Q ss_pred eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC---cEEEEeec
Q 006083 386 QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF---EAMVADFG 462 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkl~DFG 462 (662)
.+|||||.|.||.|..+|+... .+++.++.++..+|+.||.|||.+ ||.||||||+|||..+.. -||||||.
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred eEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccc
Confidence 9999999999999999996544 489999999999999999999999 999999999999996543 48999999
Q ss_pred cccccCCCCC------ccccccccCccccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhh------
Q 006083 463 LAKLSNDNHT------HVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMED------ 525 (662)
Q Consensus 463 la~~~~~~~~------~~~~~~~Gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~------ 525 (662)
|..-...... ......+|+..|||||+.. ...|+.++|.||||||||.||+|..||.+.+.++
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 8754322111 1123468999999999763 2468999999999999999999999998765433
Q ss_pred HHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 526 SLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..-+..+..+.+.+.+|.|.- -|.. -.....+.++|+. ..+..++.+|-++.+++.
T Consensus 305 e~Cr~CQ~~LFesIQEGkYeF-Pdkd--WahIS~eakdlis---nLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQEGKYEF-PDKD--WAHISSEAKDLIS---NLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccHHHHHHHHHHHhccCCcC-Chhh--hHHhhHHHHHHHH---HHHhccHHhhhhhhhccC
Confidence 112223333444445554432 2211 1224566666665 456689999999999886
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=314.53 Aligned_cols=254 Identities=23% Similarity=0.371 Sum_probs=197.1
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc----------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG----------QGEREFSAEVEIISRVHHRHLVSLVGYCIAGG 385 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 385 (662)
+|.+.+.||+|+||.||+|.. .+|+.||||.++.... ...+.+.+|++++++++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999984 4789999998864211 11246788999999999999999999999999
Q ss_pred eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccc
Q 006083 386 QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
..++||||+.+++|.+++.+. ..+++..+..++.+++.||.|||++ +++|||||++||+++.++.++|+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999654 3588899999999999999999998 89999999999999999999999999997
Q ss_pred ccCCCCCc-cccccccCccccCcccccCCC--CCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcC
Q 006083 466 LSNDNHTH-VSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDG 542 (662)
Q Consensus 466 ~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 542 (662)
........ ......|+..|++||++.... ++.++|||||||++|||++|+.||......+.+.+.. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---------~~ 227 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG---------NK 227 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhh---------cc
Confidence 65432211 123356889999999987654 8899999999999999999999996443222111110 01
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 543 IYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 543 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.....+...+.. .....+.+++..||+.+|.+||++.+|++.
T Consensus 228 ~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 RSAPPIPPDVSM----NLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCcCCccccc----cCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111111111 122345555669999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=313.71 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=199.2
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG------QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
+|+..++||+|+||.||++.. .+++.||+|+++.... ...+.+++|+++|++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999984 5789999999975321 134678999999999999999999999999999999
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC-cEEEEeeccccccC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF-EAMVADFGLAKLSN 468 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkl~DFGla~~~~ 468 (662)
||||+.+++|.+++.... .+++..++.++.|++.||.|||++ +|+|||||++||+++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999986533 578899999999999999999998 999999999999998765 59999999987665
Q ss_pred CCCCc---cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 469 DNHTH---VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 469 ~~~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
..... ......|+..|++||++.+..++.++|||+|||++|+|++|+.||...........+.+ .. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~-----~~~~- 228 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK-IA-----SATT- 228 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHH-Hh-----ccCC-
Confidence 33211 12235688999999999888899999999999999999999999965432222111111 00 0000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. ..........+.+++.+||+.+|.+||++.++++
T Consensus 229 ---~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ---A----PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---C----CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0 0111122345666777999999999999999885
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.67 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=200.5
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEE--eCCeEEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCI--AGGQRMLVY 391 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~~lv~ 391 (662)
+|++.+.||.|+||.||++.. .+++.||+|+++... ....+.+..|++++++++|+||+++++++. .+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999984 478899999987543 234567889999999999999999999876 346689999
Q ss_pred EecCCcchhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 392 EFVSNKTLEYHLHGE--NRPVMDFATRVRIALGSAKGLAYLH-----EDCHPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 392 E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH-----~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
||+.+++|.+++... ....+++..++.++.+|++||.||| +. +|+|||||++|||+++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998643 2346899999999999999999999 65 8999999999999999999999999999
Q ss_pred cccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcc
Q 006083 465 KLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIY 544 (662)
Q Consensus 465 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (662)
........ ......|+..|++||++.+..++.++|||||||++|+|++|+.||......+ +.+. +..+.+
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~--------~~~~~~ 227 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-LASK--------IKEGKF 227 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-HHHH--------HhcCCC
Confidence 87654432 1233578999999999998889999999999999999999999998654222 1111 111111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 545 DGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 545 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
. .+.. .....+.+++.+||+.+|++||++.+|++.
T Consensus 228 ~-----~~~~----~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 R-----RIPY----RYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred C-----CCcc----ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1 1111 222455666779999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=316.03 Aligned_cols=253 Identities=26% Similarity=0.381 Sum_probs=198.9
Q ss_pred HhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC------C
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAG------G 385 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~------~ 385 (662)
.+++|++.+.||+|+||.||+|... +++.|++|++..... ..+.+.+|+.+++++ +|+||+++++++... +
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999964 678999999876543 346789999999999 699999999999754 4
Q ss_pred eEEEEEEecCCcchhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecc
Q 006083 386 QRMLVYEFVSNKTLEYHLHGEN--RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGL 463 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 463 (662)
.+|+||||+.+++|.+++.... ...+++..+..++.|+++||.|||++ +|+||||+++||+|++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 5899999999999999886533 45689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCccccCcccccC-----CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHH
Q 006083 464 AKLSNDNHTHVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAA 538 (662)
Q Consensus 464 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 538 (662)
+........ ......|+..|+|||++.. ..++.++|||||||+||+|++|+.||........+..+.
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------- 231 (275)
T cd06608 160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP------- 231 (275)
T ss_pred ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh-------
Confidence 876543221 2234568999999998753 347789999999999999999999996543222221111
Q ss_pred hhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 539 LEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 539 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+... .+.. .......+.+++.+||..||++||++.||++
T Consensus 232 --~~~~~-----~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 --RNPPP-----TLKS--PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred --ccCCC-----CCCc--hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 1110 1112234556666999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.19 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=201.1
Q ss_pred CCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 318 FAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
|++...||.|+||.||+++.+ .+-..|.|+|........++|+-||+||...+||+||+|++.|...+.+|++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 777888999999999999854 4566788999887778889999999999999999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
|-++.++..-++ .|.+.++..++++++.||.|||++ +|||||||..|||++-+|.++|+|||.+-..... .....
T Consensus 114 GAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkRD 188 (1187)
T KOG0579|consen 114 GAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKRD 188 (1187)
T ss_pred chHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-Hhhhc
Confidence 999887765443 689999999999999999999999 9999999999999999999999999997543221 12235
Q ss_pred ccccCccccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 477 RVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
.++||++|||||+++ ...|+.++||||||+.|.||..+..|...-..-..+..+++. .---++.+
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS---------ePPTLlqP- 258 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---------EPPTLLQP- 258 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---------CCCcccCc-
Confidence 589999999999886 457999999999999999999999997544333223222221 00111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...-..+-+++.+||..||..||++.|+++
T Consensus 259 ------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 259 ------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 122234555666899999999999999985
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.70 Aligned_cols=244 Identities=25% Similarity=0.291 Sum_probs=197.9
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|.+.+.||+|+||.||++... +++.||||+++... ....+.+.+|+++|++++|+||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888999999999999999854 68999999997542 233467889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.+++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||||++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999998654 3588999999999999999999998 9999999999999999999999999999876543
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
.....|+..|++||.+.++.++.++|||||||++|+|++|+.||......+...... .+.. .
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------~~~~------~ 216 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL---------EGKV------R 216 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---------cCCc------c
Confidence 234578999999999988889999999999999999999999997654222111110 1110 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRP-----KMSQIVR 587 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 587 (662)
+... .. ..+.+++.+||..+|.+|+ ++.|+++
T Consensus 217 ~~~~-~~---~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 217 FPSF-FS---PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CCcc-CC---HHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1111 12 3444555689999999998 5666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=314.73 Aligned_cols=202 Identities=22% Similarity=0.330 Sum_probs=169.6
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++..... ....+.+|+++|+.++|+||+++++++.+++..|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46799999999999999999985 46899999999754322 23467889999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+. ++|.+++.... ..+.+..+..++.|++.||.|||++ +|+|||||++||||+.++++||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 84 YMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred ccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 996 56666654332 3467888899999999999999998 899999999999999999999999999976533221
Q ss_pred ccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCch
Q 006083 473 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTM 522 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~ 522 (662)
......++..|+|||++.+ ..++.++|||||||+||||++|+.||+...
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 1233467899999999875 358899999999999999999999997653
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.64 Aligned_cols=251 Identities=26% Similarity=0.369 Sum_probs=204.4
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
++|++.+.||+|+||.||+++.. +++.|+||++..... ...+.+.+|++++.+++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999965 589999999987644 4467899999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHE-DCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
+.+++|.+++... ..+++..+++++.++++||+|||+ . +++||||+++||+|+.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999654 458999999999999999999999 8 999999999999999999999999999987654332
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchh--hhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMM--EDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
. .....|+..|++||.+.++.++.++|||+||+++|+|++|+.||..... ...+..+.. .... .
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------~~~~-----~ 221 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC--------DGPP-----P 221 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh--------cCCC-----C
Confidence 2 2245688999999999998999999999999999999999999976532 111111110 0000 1
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.+.... ....+.+++..||..+|++||++.|+++.
T Consensus 222 ~~~~~~---~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 SLPAEE---FSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCccc---CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111110 22455566668999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=305.40 Aligned_cols=254 Identities=22% Similarity=0.302 Sum_probs=199.7
Q ss_pred HhCCCCc-cceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEe----CCe
Q 006083 314 ATGGFAK-SNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYCIA----GGQ 386 (662)
Q Consensus 314 ~~~~~~~-~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~----~~~ 386 (662)
.+++|.+ -++||-|-.|.|..+.. .+|+.+|+|+|.. ....++|+++..+. .|+|||+++++|++ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 4556666 45799999999999984 5899999999964 35568899988777 49999999998863 467
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC---CCcEEEEeecc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD---NFEAMVADFGL 463 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~DFGl 463 (662)
+++|||+++||.|+..|..++...+++.++..|+.||+.|+.|||+. +|.||||||+|+|... |..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence 78999999999999999988888899999999999999999999999 9999999999999964 67899999999
Q ss_pred ccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCc
Q 006083 464 AKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGI 543 (662)
Q Consensus 464 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (662)
|+....... ....+.|++|.|||++...+|+..+|+||+|||+|.||+|..||...... .+. +-+...+..|.
T Consensus 211 AK~t~~~~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-ais----pgMk~rI~~gq 283 (400)
T KOG0604|consen 211 AKETQEPGD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-AIS----PGMKRRIRTGQ 283 (400)
T ss_pred ccccCCCcc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc-cCC----hhHHhHhhccC
Confidence 998765332 34467899999999999999999999999999999999999999765321 111 11112222222
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 544 YDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 544 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
|. +-+ -+-....+..+++++ .+|+.+|.+|-++.|+++.
T Consensus 284 y~-FP~--pEWs~VSe~aKdlIR---~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 YE-FPE--PEWSCVSEAAKDLIR---KLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cc-CCC--hhHhHHHHHHHHHHH---HHhcCCchhheeHHHhhcC
Confidence 22 111 111223444455544 6789999999999999863
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.58 Aligned_cols=253 Identities=25% Similarity=0.388 Sum_probs=196.2
Q ss_pred CCccceeeccCceEEEEEEec----CCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 006083 318 FAKSNLLGQGGFGYVHKGVLP----NGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGG------ 385 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------ 385 (662)
|.+.++||+|+||.||+|.+. +++.||||+++... ....+++.+|+++|++++|+||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999843 46889999997642 234567889999999999999999999886432
Q ss_pred eEEEEEEecCCcchhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEee
Q 006083 386 QRMLVYEFVSNKTLEYHLHGE----NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADF 461 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DF 461 (662)
..++++||+.+++|.+++... ....+++..+++++.|++.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 347899999999998887432 223478899999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHh
Q 006083 462 GLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAAL 539 (662)
Q Consensus 462 Gla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 539 (662)
|+++........ ......++..|++||.+.++.++.++|||||||++|||++ |+.||......+ +..+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~-~~~~~~------- 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-IYNYLI------- 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH-HHHHHH-------
Confidence 999865433211 1122345678999999998899999999999999999999 888886543322 111111
Q ss_pred hcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 540 EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 540 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
....+. .. ......+.+++.+||+.+|++||++.+|++.|++
T Consensus 230 ~~~~~~------~~----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 230 KGNRLK------QP----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred cCCcCC------CC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 000000 00 1122456667779999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.30 Aligned_cols=247 Identities=28% Similarity=0.442 Sum_probs=203.4
Q ss_pred CccceeeccCceEEEEEEec--CCC--EEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 319 AKSNLLGQGGFGYVHKGVLP--NGK--EVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 319 ~~~~~iG~G~~g~Vy~~~~~--~g~--~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
.+.++||+|.||.|++|.+. +|+ .||||+++.+... ...+|.+|+.+|.+|+|+|+|+|||+..+ ....+|||+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 34688999999999999864 344 5899999877544 56889999999999999999999999987 778899999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+..|+|.+.|++..+..+-......++.|||.||.||..+ ++|||||..+||||-....||||||||.+.++.++.+
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 9999999999887777788889999999999999999999 8999999999999999989999999999988765443
Q ss_pred c--ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 474 V--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 474 ~--~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
. .....-.+.|+|||.+..+.++.++|||+|||+||||++ |..||.+-...+.+..+ ++ ..
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i---------D~-------~e 332 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI---------DA-------GE 332 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc---------cc-------cc
Confidence 2 112234678999999999999999999999999999998 78899776544433221 10 01
Q ss_pred cc-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 551 RL-EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 551 ~l-~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+| +..++++.+.. +++.||..+|.+||++..|.+.
T Consensus 333 rLpRPk~csedIY~---imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQ---IMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred cCCCCCCChHHHHH---HHHHhccCCccccccHHHHHHh
Confidence 22 24456555554 5559999999999999999744
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.49 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=199.1
Q ss_pred CCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
|++.+.||.|++|.||+|.. .+|+.||||++..... ...+.+.+|++++++++|+||+++++++.+++..|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999985 4799999999975432 23456888999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
. ++|.+++.......+++..+++++.|+++||+|||++ +++||||+++|||+++++.++|+|||++........ .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence 5 6899888665545689999999999999999999998 899999999999999999999999999976543221 1
Q ss_pred ccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhH---HHh----h-cC---
Q 006083 475 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLG---AAL----E-DG--- 542 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~---~~~----~-~~--- 542 (662)
.....++..|+|||++.+. .++.++|||||||++|+|++|+.||......+.+.++.+.... ..+ . .+
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 2234568899999988654 5789999999999999999999999766543333332221000 000 0 00
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 543 IYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 543 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+.......+. .........+.+++.+||+.+|.+||++.|+++
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 236 TFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000000 011112234566777999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.11 Aligned_cols=266 Identities=20% Similarity=0.270 Sum_probs=198.1
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQ--GEREFSAEVEIISRVHHRHLVSLVGYCIAG--GQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lv 390 (662)
++|++.+.||+|+||.||+|... +++.|+||.++..... ....+.+|++++++++|+||+++++++... +..|||
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 35888899999999999999964 6889999999754322 234567899999999999999999999877 899999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+ +|.+++.... ..+++..+++++.|++.||+|||++ +|+|||||++||||++++.+||+|||++......
T Consensus 85 ~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999975 8888876533 2589999999999999999999998 8999999999999999999999999999876543
Q ss_pred CCccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH----------hHH--
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL----------LGA-- 537 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~----------~~~-- 537 (662)
.. ......++..|+|||++.+. .++.++|||||||++|+|++|+.||......+.+....... +..
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred cc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 22 12335678899999998754 46899999999999999999999997664433322211100 000
Q ss_pred HhhcCccccccCcccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 538 ALEDGIYDGLVDPRLEHNYVPH-EMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 538 ~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
......+.......+...+... ....+.+++..||+.+|++||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000011111111111111111 1233455666999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=311.83 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=204.3
Q ss_pred CCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
|.++++||+|.||.||++.+ ..|+.||||.+-.+ .+.+++..|+.||++.+.+++|++||.+.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 77889999999999999984 57999999999765 4567889999999999999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
|++.++++. ++..+.+.++..++...++||+|||.. +-||||||..||||+.+|.+||+|||.|..+.+... ...
T Consensus 113 GSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KRN 187 (502)
T KOG0574|consen 113 GSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KRN 187 (502)
T ss_pred CcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hhC
Confidence 999998864 455799999999999999999999998 889999999999999999999999999987654332 335
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNY 556 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 556 (662)
.++||+.|||||++..-.|+.++||||||+...||..|+.||..-..- ..+|.-...+.- ...
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----------------RAIFMIPT~PPP-TF~ 250 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM----------------RAIFMIPTKPPP-TFK 250 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc----------------ceeEeccCCCCC-CCC
Confidence 589999999999999999999999999999999999999998543210 011111111110 111
Q ss_pred CHHHH-HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 557 VPHEM-ARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 557 ~~~~~-~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
-++++ .++-+++..||-..|++|-++.++++.
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 23333 345667779999999999999998863
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=311.86 Aligned_cols=256 Identities=23% Similarity=0.290 Sum_probs=199.6
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIA--GGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lv~ 391 (662)
++|+..+.||.|+||.||++.. .+++.||+|.+..... .....+.+|+++|++++|+||++++++|.+ .+.++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4688899999999999999996 4688999999976433 345678999999999999999999998864 44789999
Q ss_pred EecCCcchhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 392 EFVSNKTLEYHLHG--ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 392 E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||+.+++|.+++.. .....+.+..+..++.+++.||.|||+. +++||||+++||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988753 2334578889999999999999999998 999999999999999999999999999876543
Q ss_pred CCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchh----hhHHHHHHHHHhHHHhhcCccc
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMM----EDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
... ....++..|++||.+.+..++.++|||+|||++|+|++|+.||+.... ...+..+.... ...
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~~ 226 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM--------PNP 226 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC--------Cch
Confidence 221 235678899999999989999999999999999999999999976522 11111221110 000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
. +....... ......+.+++.+||+.+|.+||++.||++.
T Consensus 227 ~-~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 227 E-LKDEPGNG--IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred h-hccCCCCC--CchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0 11111100 0122345666779999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.99 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=201.3
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
++|+..+.||+|+||.||++... +++.|++|++..... ...+++.+|++++++++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35788899999999999999864 689999999976543 4456789999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHE-DCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
+.+++|.+++.... ..+++..+.+++.++++||+|||+ . +|+|||||++||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999986543 458889999999999999999999 7 999999999999999999999999999876543221
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchh-hhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMM-EDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
....|+..|++||++.+..++.++|||||||++|+|++|+.||..... .+...+...... .. . ...
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~-~-----~~~ 223 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV----NE-P-----PPR 223 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh----cC-C-----CCC
Confidence 126788999999999988999999999999999999999999965421 111222111111 00 0 001
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+...... ..+.+++..||..+|++||++.+++..
T Consensus 224 ~~~~~~~---~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 LPSGKFS---PDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CChhhcC---HHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1111122 335556669999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=325.43 Aligned_cols=265 Identities=20% Similarity=0.257 Sum_probs=198.1
Q ss_pred HhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAG------ 384 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------ 384 (662)
..++|+..+.||+|+||.||++.. .+|+.||||++... .....+.+.+|++++++++|+||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457799999999999999999984 47899999998653 223445678899999999999999999988643
Q ss_pred CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
...|+||||+.+ +|.+++... +++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 357999999964 777777432 78889999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHH-----------
Q 006083 465 KLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARP----------- 533 (662)
Q Consensus 465 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~----------- 533 (662)
+....... .....|+..|+|||++.+..++.++|||||||+||+|++|+.||......+.+......
T Consensus 166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 166 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 87654321 23356889999999999999999999999999999999999999765432222111110
Q ss_pred ---HhHHHhhcC------ccccccCcccC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 534 ---LLGAALEDG------IYDGLVDPRLE----HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 534 ---~~~~~~~~~------~~~~~~d~~l~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
......... .+..+....+. ..........+.+++.+||+.||++||++.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 00111111000 00011123345567779999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=317.70 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=197.4
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCC----EEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGK----EVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
++|+..+.||+|+||.||+|.. .+|+ .||+|.++.... .....+.+|+.++++++|+||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 4577889999999999999984 3454 478898876533 2234788999999999999999999998754 4679
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
++||+.+|+|.+++.... ..+.+..++.++.|++.||.|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999986543 2478899999999999999999998 999999999999999999999999999987653
Q ss_pred CCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 470 NHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 470 ~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
.... ......++..|++||++.+..++.++|||||||++|||++ |+.||...... .+.++.. .+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-~~~~~~~--------~~~~~-- 230 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-EIPDLLE--------KGERL-- 230 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH--------CCCCC--
Confidence 3221 1122345778999999998899999999999999999997 99999654322 1222211 11100
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
..... . ...+..++..||..+|++||++.+|++.|+..
T Consensus 231 ---~~~~~-~---~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 231 ---PQPPI-C---TIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ---CCCCC-C---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00011 1 23455667799999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=303.65 Aligned_cols=249 Identities=29% Similarity=0.437 Sum_probs=203.7
Q ss_pred CCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
+|...+.||+|+||.||++... +++.|++|++..........+.+|++++++++|+||+++++++..++..+++|||+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3778899999999999999964 689999999987655566789999999999999999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
+++|.+++.... ..+++..+..++.++++||.|||++ +++||||+++||++++++.++|+|||++........ .
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999986543 4589999999999999999999998 999999999999999999999999999987665432 2
Q ss_pred cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCC
Q 006083 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHN 555 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 555 (662)
....|+..|++||++.+..++.++|||||||+||+|++|+.||........+.... ......+.. ..
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------~~~~~~~~~----~~ 221 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA---------TNGPPGLRN----PE 221 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---------hcCCCCcCc----cc
Confidence 34678999999999998889999999999999999999999997653222111110 011111110 11
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 556 YVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 556 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
... ..+.+++..||+.||++||++.++++
T Consensus 222 ~~~---~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 222 KWS---DEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccC---HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 112 34556666999999999999999886
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=315.18 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=201.7
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
++|.+.+.||+|+||.||++.. .+++.|++|.+........+.+.+|+.++++++|+||++++++|..++..|+||||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788999999999999999984 478899999987655555677899999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.+++... .+++..+..++.+++.||.|||++ +|+|||||++||++++++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 999999998543 378889999999999999999999 999999999999999999999999999876544322 2
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
.....|+..|++||++.++.++.++|||||||++|+|++|+.||......+.+..+.. .+. ..+.
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~--------~~~------~~~~- 236 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--------NGT------PELQ- 236 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--------CCC------CCCC-
Confidence 2335688999999999888899999999999999999999999976543222111000 000 0000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
........+.+++..||+.+|.+||++.+++..
T Consensus 237 -~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 -NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001112234556669999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=309.89 Aligned_cols=247 Identities=25% Similarity=0.421 Sum_probs=198.5
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC-CchhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeEEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG-SGQGEREFSAEVEIISRVH---HRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~~~~lv~ 391 (662)
.|+..+.||+|+||.||+|.. .+++.||||.++.. ......++.+|++++++++ |+||+++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477789999999999999995 57899999998754 2344567889999999997 999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.+++|.+++... .+++..++.++.+++.||.|||+. +|+||||+++||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999988543 588999999999999999999998 99999999999999999999999999998765443
Q ss_pred CccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 472 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
. ......|+..|+|||++.++ .++.++|||||||++|+|++|+.||........... +... ...
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~---------~~~~-----~~~ 220 (277)
T cd06917 156 S-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML---------IPKS-----KPP 220 (277)
T ss_pred c-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc---------cccC-----CCC
Confidence 2 22345789999999988754 468999999999999999999999976532211110 0000 011
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+..... ...+.+++.+||+.||++||++.++++
T Consensus 221 ~~~~~~~---~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLEDNGY---SKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCcccC---CHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111112 234556666999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=309.57 Aligned_cols=246 Identities=26% Similarity=0.390 Sum_probs=198.6
Q ss_pred CCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++|+||+++++++.+++..|+||||+.
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 77889999999999999985 478899999986543 2334678899999999999999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
+++|.+++... .+++..+..++.+++.+|.|||++ +|+|+|||++||++++++.++|+|||++........ ..
T Consensus 86 ~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06641 86 GGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-hh
Confidence 99999988542 478999999999999999999998 999999999999999999999999999876643321 12
Q ss_pred cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCC
Q 006083 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHN 555 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 555 (662)
....|+..|++||++.+..++.++|||||||++|+|++|..||........+.. +..+.. ..+...
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---------~~~~~~-----~~~~~~ 224 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL---------IPKNNP-----PTLEGN 224 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH---------HhcCCC-----CCCCcc
Confidence 335688999999999988899999999999999999999999975432211110 001110 011111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 556 YVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 556 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
....+.+++.+||+.+|.+||++.++++.
T Consensus 225 ----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 225 ----YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 12345556669999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=312.14 Aligned_cols=263 Identities=23% Similarity=0.318 Sum_probs=198.8
Q ss_pred CCccceeeccCceEEEEEEec-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEEEEEE
Q 006083 318 FAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAG--GQRMLVYE 392 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lv~E 392 (662)
|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++|+||+++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999854 58899999998753 33346788999999999999999999999988 89999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.+ +|..++.... ..+++..++.++.++++||+|||++ +++|+|||++||||++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9975 7888775442 3589999999999999999999998 899999999999999999999999999987655432
Q ss_pred ccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc----
Q 006083 473 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL---- 547 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 547 (662)
.......++..|++||.+.+ ..++.++|||||||++|||++|+.||......+.+...... .... ....+..+
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~ 233 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFEL-CGSP-TDENWPGVSKLP 233 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCC-chhhccccccch
Confidence 22233567889999998764 46789999999999999999999999766543322221110 0000 00000000
Q ss_pred ----------cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 548 ----------VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 548 ----------~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
....+...+...+...+++++..||+.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000001345677778999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=312.28 Aligned_cols=246 Identities=23% Similarity=0.366 Sum_probs=198.6
Q ss_pred CCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
|...+.||+|+||.||++.. .+++.|++|+++.......+.+.+|+.++++++|+||+++++++..++..++||||+.+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 55567999999999999984 47889999998765555566789999999999999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
++|.+++.. ..+++..+..++.+++.||+|||++ +|+|||||++||+++.++.++|+|||++........ ...
T Consensus 101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~ 173 (285)
T cd06648 101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK 173 (285)
T ss_pred CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence 999999865 3478999999999999999999998 999999999999999999999999999876543221 223
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC-C
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH-N 555 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~ 555 (662)
...|+..|++||++.+..++.++|||||||++|||++|+.||........+. .. ...... .+.. .
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~----~~-----~~~~~~-----~~~~~~ 239 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK----RI-----RDNLPP-----KLKNLH 239 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH----HH-----HhcCCC-----CCcccc
Confidence 3568999999999998889999999999999999999999996543222111 11 011100 1111 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 556 YVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 556 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
... ..+.+++.+||+.+|++||++.++++
T Consensus 240 ~~~---~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 KVS---PRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cCC---HHHHHHHHHHcccChhhCcCHHHHcc
Confidence 122 34555666999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=333.70 Aligned_cols=259 Identities=27% Similarity=0.343 Sum_probs=201.0
Q ss_pred CCCccceeeccCceEEEEEE-ecCCCEEEEEEeecC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------CeEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTG-SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAG------GQRM 388 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~~~~ 388 (662)
.|...+.||+|+||.||+|+ ..+|+.||||.++.. .....+...+|+++|++|+|+|||+++++-++. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 46778899999999999999 668999999999864 345567889999999999999999999987654 3568
Q ss_pred EEEEecCCcchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC--CCC--cEEEEeecc
Q 006083 389 LVYEFVSNKTLEYHLHG-ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID--DNF--EAMVADFGL 463 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~--~~~--~vkl~DFGl 463 (662)
+|||||.||+|+..|.+ ++...|++.+.+.++.+++.||.|||++ +||||||||.||++- ++| ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999965 3445689999999999999999999998 999999999999993 233 468999999
Q ss_pred ccccCCCCCccccccccCccccCccccc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHh---
Q 006083 464 AKLSNDNHTHVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAAL--- 539 (662)
Q Consensus 464 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~--- 539 (662)
|+...++. ....++||..|++||+.. .+.|+..+|.|||||++||++||.+||.......+..+.....+....
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 99987765 456789999999999998 488999999999999999999999999665433322222222211100
Q ss_pred -------hcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 006083 540 -------EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRP 580 (662)
Q Consensus 540 -------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP 580 (662)
+.|.+..-..-..-...+.....++..++..+|..++++|-
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 01111111111112334455666677777788899999998
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=329.02 Aligned_cols=244 Identities=24% Similarity=0.364 Sum_probs=197.6
Q ss_pred eeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCcchhh
Q 006083 323 LLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEY 401 (662)
Q Consensus 323 ~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~ 401 (662)
+||+|.||+||.|++. +...+|||.+...+.+..+-+.+|+.+.++|+|.|||+++|.|.+++.+-|.||.+.||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999954 566799999987777777889999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC-CCcEEEEeeccccccCCCCCcccccc
Q 006083 402 HLHGENRPVM--DFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-NFEAMVADFGLAKLSNDNHTHVSTRV 478 (662)
Q Consensus 402 ~l~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~ 478 (662)
+|+..- +++ ++..+-.+..||++||.|||++ .|||||||-+||||+. .|.+||.|||-++.+..- ......+
T Consensus 662 LLrskW-GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKW-GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETF 736 (1226)
T ss_pred HHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Ccccccc
Confidence 997543 334 6677788899999999999999 8999999999999975 789999999999876432 2345668
Q ss_pred ccCccccCcccccCC--CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCC
Q 006083 479 MGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNY 556 (662)
Q Consensus 479 ~Gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 556 (662)
.||..|||||++..| .|..++|||||||.+.||.||+.||-.....+ . .+..-|.|.. . ...
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--A--------AMFkVGmyKv--H----P~i 800 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--A--------AMFKVGMYKV--H----PPI 800 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--H--------hhhhhcceec--C----CCC
Confidence 899999999999765 59999999999999999999999996543211 0 1111222221 1 112
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 557 VPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 557 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..+.-.+...++++|+..+|.+||+++++++
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 2233344556778999999999999999986
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=311.54 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=204.6
Q ss_pred HhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.++.|+..+.||+|+||.||++... +++.|++|+++.... ..+.+.+|++++++++|+||+++++++...+..|+|||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999965 689999999986544 46678899999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.+++|.+++.... ..+++..++.++.+++.||.|||+. +|+|+|||++||+|+.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999997644 3589999999999999999999998 999999999999999999999999999876543321
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
......|+..|++||++.+..++.++||||||||||+|++|+.||...........+.. ...... .
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~---------~~~~~~----~ 237 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT---------KGIPPL----K 237 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------cCCCCC----c
Confidence 12334678899999999988899999999999999999999999976543322221111 001100 0
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
...... ..+.+++.+||+.+|.+||++.+|++.
T Consensus 238 ~~~~~~---~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 238 NPEKWS---PEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred chhhCC---HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011122 344556669999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=311.53 Aligned_cols=247 Identities=27% Similarity=0.352 Sum_probs=191.8
Q ss_pred eeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCcch
Q 006083 324 LGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTL 399 (662)
Q Consensus 324 iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L 399 (662)
||+|+||.||++.. .+|+.||||++.... ......+..|+++|++++|+||+++++++...+..|+||||+.+++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999984 478999999987532 12344667899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccccccc
Q 006083 400 EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM 479 (662)
Q Consensus 400 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 479 (662)
.+++.......+.+..++.++.|++.||.|||+. +|+|||||++|||+++++.+||+|||++....... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 9999766555689999999999999999999998 99999999999999999999999999987654321 123356
Q ss_pred cCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHH
Q 006083 480 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPH 559 (662)
Q Consensus 480 Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 559 (662)
|+..|++||++.++.++.++|||||||++|+|++|+.||...........+.. ...... ..+...+ ..
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------~~~~~~--~~~~~~~-~~ 223 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR---------RTLEMA--VEYPDKF-SP 223 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---------cccccc--ccCCccC-CH
Confidence 78899999999888899999999999999999999999976532111111111 111100 0111111 23
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHH-HHHHhh
Q 006083 560 EMARLVACGAASIRHSARKRPKMSQ-IVRALE 590 (662)
Q Consensus 560 ~~~~l~~l~~~cl~~~p~~RPs~~e-vl~~L~ 590 (662)
.+.+++.+||+.+|.+||++.+ ..+.|.
T Consensus 224 ---~~~~li~~~l~~~p~~R~~~~~~~~~~ll 252 (277)
T cd05577 224 ---EAKDLCEALLQKDPEKRLGCRGGSADEVR 252 (277)
T ss_pred ---HHHHHHHHHccCChhHccCCCcccHHHHH
Confidence 3445556999999999995554 333333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=312.47 Aligned_cols=251 Identities=25% Similarity=0.331 Sum_probs=195.1
Q ss_pred CCCccceeeccCceEEEEEEe----cCCCEEEEEEeecCCc----hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL----PNGKEVAVKSLKTGSG----QGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~----~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 387 (662)
+|++.+.||+|+||.||++.. .+|+.||+|+++.... ...+.+.+|+++|+++ +|+||+.+++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999985 3789999999975322 2346688899999999 599999999999999999
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
|+||||+.+++|.+++.... .+.+..+..++.|+++||.|||+. +|+|||||++||||++++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999986543 478889999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCccccccccCccccCcccccCC--CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 468 NDNHTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 468 ~~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
............|+..|++||++.+. .++.++|||||||+||+|++|+.||..........++...... ..
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~----~~--- 228 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK----SE--- 228 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc----cC---
Confidence 54332223346789999999998753 4788999999999999999999999754332222222221110 00
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRP-----KMSQIVR 587 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 587 (662)
..+ .......+..++.+||+.+|++|+ ++.+++.
T Consensus 229 ----~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ----PPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----CCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 001 111123445566699999999997 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=318.00 Aligned_cols=263 Identities=21% Similarity=0.272 Sum_probs=193.5
Q ss_pred ceeecc--CceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQG--GFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G--~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
..||+| +||.||++.. .+|+.||||+++... ....+.+.+|+.+++.++|+||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999985 479999999987543 23346789999999999999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc--
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV-- 474 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~-- 474 (662)
++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998765445688999999999999999999998 89999999999999999999999998654322111100
Q ss_pred ----ccccccCccccCcccccCC--CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH---------hH---
Q 006083 475 ----STRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL---------LG--- 536 (662)
Q Consensus 475 ----~~~~~Gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~---------~~--- 536 (662)
.....++..||+||++.++ .++.++|||||||++|||++|+.||........+.+..... +.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 0112356679999999763 47899999999999999999999997654333222211100 00
Q ss_pred H-------HhhcCccc---------cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 537 A-------ALEDGIYD---------GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 537 ~-------~~~~~~~~---------~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. ....++.. .+.+..+...........+.+++.+||+.||++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 00000000 011111111112233455677888999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=317.03 Aligned_cols=202 Identities=25% Similarity=0.357 Sum_probs=169.1
Q ss_pred CCCccceeeccCceEEEEEEec---CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP---NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAG--GQRM 388 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~---~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~ 388 (662)
+|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++|+||+++++++.+. +.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999954 47899999998743 33346788899999999999999999999988 8899
Q ss_pred EEEEecCCcchhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC----CCcEEEEee
Q 006083 389 LVYEFVSNKTLEYHLHGE---NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD----NFEAMVADF 461 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~----~~~vkl~DF 461 (662)
+||||+.+ +|.+++... ....+.+..++.++.|++.||.|||+. +|+|||||++||||+. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 555555321 223678899999999999999999999 8999999999999999 999999999
Q ss_pred ccccccCCCCC--ccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCch
Q 006083 462 GLAKLSNDNHT--HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTM 522 (662)
Q Consensus 462 Gla~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~ 522 (662)
|++........ .......++..|+|||++.+. .++.++|||||||+||+|++|+.||....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99986644322 112345788999999988764 58899999999999999999999997553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=313.31 Aligned_cols=265 Identities=23% Similarity=0.278 Sum_probs=195.5
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ--GEREFSAEVEIISRVHHRHLVSLVGYCIAG--GQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lv 390 (662)
++|++.+.||+|+||.||+|.. .+|+.||+|+++..... ....+.+|+++|++++|+||+++++++.+. +.+++|
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 5699999999999999999995 46899999999754322 233567899999999999999999998754 568999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+ +|.+++.... ..+.+..++.++.|+++||+|||+. +|+|||||++|||+++++.+||+|||++......
T Consensus 87 ~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 87 MEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 999975 7777775432 4589999999999999999999998 8999999999999999999999999999876543
Q ss_pred CCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh---HHH---hhcCc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL---GAA---LEDGI 543 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~---~~~---~~~~~ 543 (662)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+.+.......- ... +....
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 AK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred cC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 21 1223446788999999865 5689999999999999999999999976654433322221100 000 00000
Q ss_pred cccccCcccCCC---C----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 544 YDGLVDPRLEHN---Y----VPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 544 ~~~~~d~~l~~~---~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
..... .+... . .......+.+++.+||+.||++||++.|+++.
T Consensus 241 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 241 LVGKF--TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccc--cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 00000 0 00012334456679999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=315.87 Aligned_cols=267 Identities=18% Similarity=0.224 Sum_probs=196.1
Q ss_pred CCccceeeccCceEEEEEEecCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 318 FAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
|.+++.+|.|+++.||++.. +++.||||+++.. .....+.+.+|+++|++++|+||+++++++.+++..+++|||+.
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 33455566666666666655 7899999999765 33455789999999999999999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC---
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT--- 472 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~--- 472 (662)
+++|.+++.......+++..+..++.|+++||+|||++ +|+|||||++|||++.++.+||+|||.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999999765445688999999999999999999999 899999999999999999999999999865432211
Q ss_pred ---ccccccccCccccCcccccC--CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCc----
Q 006083 473 ---HVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGI---- 543 (662)
Q Consensus 473 ---~~~~~~~Gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 543 (662)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||........+.+.........+....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 11123457888999999875 358899999999999999999999997654333222211110000000000
Q ss_pred ---ccc----ccCc----ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 544 ---YDG----LVDP----RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 544 ---~~~----~~d~----~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
... ..+. .....+....-.++.+++.+||+.||++||++.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 0000 00111112222456667779999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=310.65 Aligned_cols=265 Identities=22% Similarity=0.318 Sum_probs=196.6
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
++|++.+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|++++++++|+||+++++++.+++..|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46889999999999999999854 789999999865432 234578899999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC-CCcEEEEeeccccccCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-NFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~~~~~~~ 471 (662)
|+. ++|.+++.......+++..+..++.||+.||+|||++ +|+|||||++||||++ ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 5777777554444467888899999999999999998 8999999999999985 5679999999997654322
Q ss_pred CccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc--
Q 006083 472 THVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV-- 548 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 548 (662)
.......|+..|++||++.+ ..++.++|||||||++|+|++|+.||......+.+.+.... +... ....+....
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~ 234 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRI-LGTP-NEETWPGVTSL 234 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCCC-Chhhccccccc
Confidence 12233567889999998876 45789999999999999999999999765433332221110 0000 000000000
Q ss_pred ------CcccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 549 ------DPRLEH----NYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 549 ------d~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...... .........+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 001111233556677999999999999999986
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=310.09 Aligned_cols=250 Identities=25% Similarity=0.387 Sum_probs=191.1
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC-chhHHHHHHHHHH-HHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS-GQGEREFSAEVEI-ISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~i-l~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
++|++.+.||+|+||.||++... +|+.||||+++... ......+..|+.+ ++.++|+||+++++++..++..|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999854 69999999997653 2334456666665 566789999999999999999999999
Q ss_pred ecCCcchhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 393 FVSNKTLEYHLHG--ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 393 ~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|+. ++|.+++.. .....+++..++.++.|++.||+|||+++ +++|||||++|||+++++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 577766643 23346899999999999999999999864 7999999999999999999999999999865432
Q ss_pred CCccccccccCccccCcccccC----CCCCchHHHHHHHHHHHHHHhCCCCCCCchh-hhHHHHHHHHHhHHHhhcCccc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASS----GKLTEKSDVFSFGVMLLELITGRRPVDMTMM-EDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
. ......|+..|++||++.+ ..++.++|||||||+||||++|+.||..... .+.+.... . +..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------~-~~~- 225 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--------E-EPS- 225 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH--------h-cCC-
Confidence 2 1233568899999998864 4568899999999999999999999964321 11111110 0 100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..+.....+. .+.+++.+||..+|++||++.+|++
T Consensus 226 ----~~~~~~~~~~---~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 ----PQLPAEKFSP---EFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ----CCCCccccCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111223 3555666899999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=311.02 Aligned_cols=259 Identities=18% Similarity=0.208 Sum_probs=182.5
Q ss_pred hCCCCccceeeccCceEEEEEEecC----CCEEEEEEeecCCchhH-----------HHHHHHHHHHHhcCCCCcceEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPN----GKEVAVKSLKTGSGQGE-----------REFSAEVEIISRVHHRHLVSLVG 379 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~-----------~~~~~E~~il~~l~HpnIv~l~~ 379 (662)
.++|.+.++||+|+||.||+|...+ +..+|+|+......... .....++..+..+.|.||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3579999999999999999998543 45667776443322111 11122334455668999999999
Q ss_pred EEEeCC----eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCc
Q 006083 380 YCIAGG----QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE 455 (662)
Q Consensus 380 ~~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 455 (662)
++.... ..+++||++. .++.+.+... ....+..++.|+.|+++||+|||++ +|+||||||+||||+.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCc
Confidence 776543 3467788764 3455555332 2246788899999999999999998 9999999999999999999
Q ss_pred EEEEeeccccccCCCCCc------cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHH
Q 006083 456 AMVADFGLAKLSNDNHTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVE 529 (662)
Q Consensus 456 vkl~DFGla~~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~ 529 (662)
+||+|||+++........ ......||..|+|||++.+..++.++|||||||+||||++|+.||........+..
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999999866432211 11234699999999999999999999999999999999999999976633332222
Q ss_pred HHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 530 WARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
.....+...+..+ .+.-...+.++.++ +..|+..++++||++.+|++.|+
T Consensus 245 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~~---~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 245 AAKCDFIKRLHEG--------KIKIKNANKFIYDF---IECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HhHHHHHHHhhhh--------hhccCCCCHHHHHH---HHHHHhCCCCCCCCHHHHHHhhC
Confidence 1111111111111 11112234444444 45899999999999999999864
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=308.86 Aligned_cols=265 Identities=25% Similarity=0.346 Sum_probs=198.9
Q ss_pred CCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
+|++.+.||+|+||.||+|+.. +|+.||||+++..... ....+.+|++++++++|+||+++++++.+.+..+|||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4888999999999999999964 6899999999765332 3456788999999999999999999999999999999999
Q ss_pred CCcchhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 395 SNKTLEYHLHGEN-RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 395 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
.+ +|.+++.... ...+++..+.+++.|+++||.|||+. +|+|||||++|||+++++.+||+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 7777775432 34589999999999999999999998 899999999999999999999999999976543221
Q ss_pred cccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh---HHH---hh-cCccc
Q 006083 474 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL---GAA---LE-DGIYD 545 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~---~~~---~~-~~~~~ 545 (662)
......++..|++||++.+ ..++.++|||+|||++|+|++|+.||......+.+........ ... +. ...+.
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 1233467889999998865 4578999999999999999999999976654433332211100 000 00 00000
Q ss_pred c----ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 G----LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~----~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. ..+..+ ..........+.+++.+||+.||.+||++.||++
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 000000 0001112234556777999999999999999885
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=303.49 Aligned_cols=249 Identities=23% Similarity=0.373 Sum_probs=204.2
Q ss_pred CCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+|.+.+.||+|+||.||++... +++.|++|++..... ...+.+.+|+++++.++|+|++++++.+..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999954 689999999986543 4567789999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 394 VSNKTLEYHLHGEN--RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 394 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
+.+++|.+++.... ...+++..++.++.+++.||.|||++ +|+|+||+++|||+++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999986543 35689999999999999999999998 99999999999999999999999999998765443
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
.......|+..|++||.+.+..++.++|||+||+++|+|++|+.||+.....+....+. ...+..
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~---------~~~~~~----- 222 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL---------KGQYPP----- 222 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh---------cCCCCC-----
Confidence 22334578999999999998889999999999999999999999997654322221111 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+.. ... ..+..++.+||..+|++||++.++++
T Consensus 223 ~~~-~~~---~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 IPS-QYS---SELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCC-CCC---HHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111 112 34555666999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=312.33 Aligned_cols=262 Identities=24% Similarity=0.303 Sum_probs=193.3
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-------
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGG------- 385 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------- 385 (662)
++|++.+.||+|+||.||++... +++.||||++..... .....+.+|++++++++|+||++++++|...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46999999999999999999854 789999999865422 22345678999999999999999999987643
Q ss_pred -eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 386 -QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 386 -~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
..++||||+.+ +|.+++.... ..+++.++++++.|++.||.|||++ +|+|||||++||||+.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 45999999965 6777765432 3579999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCc---cccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhh
Q 006083 465 KLSNDNHTH---VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALE 540 (662)
Q Consensus 465 ~~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 540 (662)
......... ......++..|+|||++.+. .++.++|||||||++|||++|+.+|........+.. ....... +.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~-~~~~~~~-~~ 244 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL-ISQLCGS-IT 244 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCC-CC
Confidence 766432221 12234678899999988764 478899999999999999999999976543322211 1111100 00
Q ss_pred cCccc------------------cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 541 DGIYD------------------GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 541 ~~~~~------------------~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...+. ..+...+...... ..+.+++.+||+.||.+||++.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKD---PHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCC---HHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 0000111111111 23446677999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=317.96 Aligned_cols=267 Identities=21% Similarity=0.348 Sum_probs=195.8
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAG-----GQR 387 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~ 387 (662)
.++|.+.++||+|+||.||+|+. .+|+.||||+++... ......+.+|+.+|++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46799999999999999999984 478999999997532 23456688899999999999999999987644 357
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
|+||||+.+ +|.+++.. ..+++..++.++.|+++||+|||++ +|+|||||++||||+.++.+||+|||++...
T Consensus 84 ~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 999999965 77776643 2488999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCCc--cccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH-------hHH
Q 006083 468 NDNHTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL-------LGA 537 (662)
Q Consensus 468 ~~~~~~--~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~-------~~~ 537 (662)
...... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||........+..+...+ +..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 432221 1233578999999998764 568999999999999999999999997654322222111100 000
Q ss_pred Hhh---cCcccccc-CcccC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 538 ALE---DGIYDGLV-DPRLE-HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 538 ~~~---~~~~~~~~-d~~l~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
... .+.+.... ...+. ....+....++.+++.+||+.+|++||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00000000 00000 00001112345667779999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=311.62 Aligned_cols=265 Identities=20% Similarity=0.242 Sum_probs=194.5
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCe-----
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG--QGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQ----- 386 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~----- 386 (662)
++|++.+.||+|+||.||+|... +|+.||||+++.... .....+.+|+.+++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999954 689999999865422 23457888999999995 6999999999987665
Q ss_pred EEEEEEecCCcchhhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC-CCcEEEEeec
Q 006083 387 RMLVYEFVSNKTLEYHLHGEN---RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-NFEAMVADFG 462 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFG 462 (662)
.|+||||+.+ +|.+++.... ...+++..++.++.||++||.|||++ +|+|||||++||||+. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 7877775432 34579999999999999999999998 9999999999999998 8999999999
Q ss_pred cccccCCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhc
Q 006083 463 LAKLSNDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALED 541 (662)
Q Consensus 463 la~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 541 (662)
+++....... ......++..|+|||++.+ ..++.++|||||||+||+|++|..||......+.+.......- . ...
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~-~~~ 233 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG-T-PTE 233 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC-C-CCh
Confidence 9876543211 1223457889999998865 4579999999999999999999999976543332222111000 0 000
Q ss_pred CccccccCcc-------cC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 542 GIYDGLVDPR-------LE----HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 542 ~~~~~~~d~~-------l~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..+....... .. ..........+.+++.+||+.+|.+||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000000 00 0000112234556777999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.59 Aligned_cols=247 Identities=25% Similarity=0.300 Sum_probs=198.8
Q ss_pred CCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
+|++.+.||.|+||.||++... +++.||+|++.... ....+.+.+|++++++++|+||+++++++.++...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999964 68999999997543 2345788999999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.+++|.+++... ..+.+..+..++.++++||.|||++ +|+|+|||++|||+++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999998654 4588999999999999999999998 89999999999999999999999999988765432
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
......|+..|++||++.+..++.++|||||||++|+|++|+.||...... ...+..... .. ... ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~----~~--~~~----~~ 221 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQ----ET--ADV----LY 221 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHh----cc--ccc----cC
Confidence 123456888999999999888999999999999999999999999765431 111111110 00 000 00
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKM--SQIV 586 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~--~evl 586 (662)
....+ ..+.+++.+||+.||.+|+++ +|++
T Consensus 222 -~~~~~---~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 222 -PATWS---TEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -cccCc---HHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11122 445556669999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=311.28 Aligned_cols=255 Identities=25% Similarity=0.293 Sum_probs=199.0
Q ss_pred CCCccceeeccCceEEEEEEe----cCCCEEEEEEeecCCc----hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL----PNGKEVAVKSLKTGSG----QGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~----~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 387 (662)
+|.+.+.||+|+||.||+++. .+++.||||+++.... ...+.+.+|++++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999873 3578899999975321 2335688999999999 599999999999999999
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
++||||+.+++|.+++... ..+.+..+..++.|++++|.|||+. +++|||||++||||+.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999998643 3478899999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCCccccccccCccccCcccccCCC--CCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 468 NDNHTHVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 468 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
............|+..|++||++.+.. ++.++||||||+++|||++|+.||..........++.+... ...
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-----~~~-- 228 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL-----KSK-- 228 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH-----ccC--
Confidence 543322223356899999999987655 78899999999999999999999964322111122221111 000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
..+.. .... .+.+++.+||+.+|++||++.++.+.|+.
T Consensus 229 ----~~~~~-~~~~---~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 ----PPFPK-TMSA---EARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ----CCCCc-ccCH---HHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 01111 1223 34455669999999999999999888775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=311.78 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=191.7
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEEe
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+|...+.||+|+||.||++.. .+++.||||.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 355678899999999999985 468999999987543 234567889999999996 99999999999999999999999
Q ss_pred cCCc--chhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 394 VSNK--TLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 394 ~~~g--~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
+... +|..++.......+++..+.+++.+++.||+|||+.+ +|+|||||++|||++.++.+||+|||+++......
T Consensus 85 ~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 85 MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred ccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 8642 3333333334456899999999999999999999743 79999999999999999999999999997654332
Q ss_pred CccccccccCccccCcccccCC---CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 472 THVSTRVMGTFGYLAPEYASSG---KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
. .....|+..|+|||++.+. .++.++|||||||++|||++|+.||..... .... .. ... .+..
T Consensus 163 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~-~~----~~~-~~~~---- 228 (288)
T cd06616 163 A--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQ-LT----QVV-KGDP---- 228 (288)
T ss_pred c--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHH-Hh----hhc-CCCC----
Confidence 1 1234688999999999865 689999999999999999999999965421 1110 00 000 0000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
..+...........+.+++.+||+.+|.+||++.+|++.
T Consensus 229 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 -PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111101122345556669999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.86 Aligned_cols=246 Identities=25% Similarity=0.388 Sum_probs=194.3
Q ss_pred CCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
|...+.||+|+||.||+++. .+++.||||++..... .....+.+|+++|++++|+|++++++++.+++..+|||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 77788999999999999985 4789999999875422 2345788999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.| +|.+++... ...+++..+..++.+++.||.|||++ +|+|||||++||++++++.+||+|||++......
T Consensus 107 ~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 107 CLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 975 666666433 23489999999999999999999998 8999999999999999999999999998765432
Q ss_pred cccccccCccccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 474 VSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
....|+..|++||++. .+.++.++|||||||++|||++|+.||........+..+.. .+. .
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~--------~~~------~ 242 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------NES------P 242 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh--------ccC------C
Confidence 2356888999999874 45789999999999999999999999865433222222211 010 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
........ ..+..++.+||+.+|.+||++.+|++.+-
T Consensus 243 ~~~~~~~~---~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 243 TLQSNEWS---DYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred CCCCcccc---HHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 01111122 23455666999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.13 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=193.3
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
..|...+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+++++.++|+||++++++|.+++..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 34888899999999999999854 689999999865432 23457889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.| +|.+++.... ..+.+..+..++.|++.||.|||+. +|+||||+++||++++++.+||+|||++......
T Consensus 95 e~~~g-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCLG-SASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhCC-CHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 99974 5555554322 3589999999999999999999998 8999999999999999999999999998765432
Q ss_pred CccccccccCccccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 472 THVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||........+.... ....
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~---------~~~~---- 231 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---------QNDS---- 231 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh---------cCCC----
Confidence 2356788999999874 4568899999999999999999999997653322111100 0000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
..+... .....+..++.+||..+|++||++.+|+..
T Consensus 232 -~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 -PTLSSN---DWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -CCCCch---hhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011111 112345666679999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=303.57 Aligned_cols=247 Identities=27% Similarity=0.404 Sum_probs=202.1
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+|++.+.||+|+||.||++.. .+++.++||.+.... ......+.+|++++++++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999974 478899999987542 23356778899999999999999999999999999999999
Q ss_pred cCCcchhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 394 VSNKTLEYHLHGE--NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 394 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
+.+++|.+++... ....+++..++.++.+++.||.|||+. +|+|||||+.||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988552 234688999999999999999999998 9999999999999999999999999999876544
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
......|+..|++||.+.+..++.++|+||||+++|||++|+.||......+....+ ..+.+..+
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~~~---- 221 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV---------QRGKYPPI---- 221 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---------hcCCCCCC----
Confidence 223356889999999999989999999999999999999999999765432211111 11111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
......++..++.+||..+|++||++.++++
T Consensus 222 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 222 -----PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -----chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1122345666777999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.92 Aligned_cols=242 Identities=26% Similarity=0.347 Sum_probs=183.8
Q ss_pred eeeccCceEEEEEEe-cCCCEEEEEEeecCCc---hhHHHHHHHHHHHHh---cCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 323 LLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG---QGEREFSAEVEIISR---VHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 323 ~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~---l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
+||+|+||.||++.. .+++.||||.+..... .....+.+|..+++. .+|+||+.+++++..++..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999985 4689999999875422 222334455544443 479999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
+++|.+++.... .+.+..+..++.|++.||+|||++ +|+|||||++|||+++++.+||+|||++....... .
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 152 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence 999999886443 489999999999999999999998 89999999999999999999999999987654322 1
Q ss_pred cccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 476 TRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
....|+..|+|||.+.+ ..++.++|||||||+||||++|+.||......... .+.... .. ....+..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~---------~~--~~~~~~~ 220 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMT---------LT--VNVELPD 220 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHh---------hc--CCcCCcc
Confidence 23568999999999864 56899999999999999999999999754322111 110000 00 0111111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRP-----KMSQIVRA 588 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 588 (662)
. .. .++..++..||+.||.+|+ +++|+++.
T Consensus 221 ~-~~---~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 221 S-FS---PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred c-cC---HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1 12 3444555699999999999 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=299.64 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=202.3
Q ss_pred CCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAG--GQRMLVY 391 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lv~ 391 (662)
+|.+.+.||+|+||.||+|... +++.|++|+++.... ...+.+.+|++++++++|+||+++++++.+. +.+++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999965 789999999976543 4467889999999999999999999999988 8999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.+++|.+++.... .+++..++.++.+++++|+|||+. +++||||+++||+|++++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999986544 689999999999999999999998 99999999999999999999999999998776543
Q ss_pred Cc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 472 TH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 472 ~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
.. ......++..|++||.+.+..++.++|||+|||+||+|++|+.||.......... ... .......
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~----~~~~~~~----- 223 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL---YKI----GSSGEPP----- 223 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH---Hhc----cccCCCc-----
Confidence 21 1234568899999999998889999999999999999999999997654111100 000 0000100
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+.. .. ...+.+++.+|+..+|.+||++.++++
T Consensus 224 ~~~~-~~---~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 EIPE-HL---SEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCc-cc---CHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1111 11 244555666999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=304.70 Aligned_cols=244 Identities=21% Similarity=0.230 Sum_probs=189.4
Q ss_pred ceeeccCceEEEEEEe-cCCCEEEEEEeecCCch---hHHHHHHHHHHH-HhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ---GEREFSAEVEII-SRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~il-~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
+.||+|+||.||+|.. .+|+.||||+++..... ....+..|..++ ..++|+||+++++++..++.+|+||||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999985 46899999999754321 223345555544 445899999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
++|.+++.... .+++..+.+++.|++.||.|||+. +|+||||+++||||++++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 99999986543 478999999999999999999998 999999999999999999999999999876443 12
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNY 556 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 556 (662)
...|+..|++||.+.+..++.++|||||||+||||++|..||......+.+..+.. +... ....+. ..
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------~~~~--~~~~~~-~~ 219 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS---------RRIN--WPEEVK-EF 219 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---------cccC--CCCccc-cc
Confidence 35688899999999988899999999999999999999999976544332222111 1100 000111 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 557 VPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 557 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
.. ..+.+++.+||+.+|++||++.++.+.|.
T Consensus 220 ~~---~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 220 CS---PEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred CC---HHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 22 34556666999999999998877766655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=306.14 Aligned_cols=263 Identities=23% Similarity=0.315 Sum_probs=198.7
Q ss_pred CCccceeeccCceEEEEEEec-CCCEEEEEEeecCCch--hHHHHHHHHHHHHhc---CCCCcceEEEEEEeCCe-----
Q 006083 318 FAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQ--GEREFSAEVEIISRV---HHRHLVSLVGYCIAGGQ----- 386 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l---~HpnIv~l~~~~~~~~~----- 386 (662)
|++.+.||+|+||.||+|+.. +++.||||+++..... ....+.+|+.+++++ +|+||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 667899999999999999965 5899999999754222 234567788888776 59999999999988776
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
.+++|||+.+ +|.+++.......+++..++.++.++++||.|||+. +|+|+|||++|||+++++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999999975 788888654444689999999999999999999998 899999999999999999999999999977
Q ss_pred cCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHH---Hhh---
Q 006083 467 SNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGA---ALE--- 540 (662)
Q Consensus 467 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~---~~~--- 540 (662)
...... .....++..|++||++.+..++.++|||||||++|||++|+.+|......+.+..+....... ...
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 644321 123457889999999999899999999999999999999999998765544443332211000 000
Q ss_pred ---cCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 541 ---DGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 541 ---~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...+.......+ ..........+.+++.+||+.||.+||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 235 SLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000000 1111222345566777999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=306.16 Aligned_cols=246 Identities=24% Similarity=0.303 Sum_probs=197.2
Q ss_pred eeccCceEEEEEEec-CCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCcch
Q 006083 324 LGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTL 399 (662)
Q Consensus 324 iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L 399 (662)
||+|+||.||+++.. +|+.|++|++..... ...+.+.+|++++++++|+||+++++++..++..|+||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999965 589999999976543 3456789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC-------
Q 006083 400 EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT------- 472 (662)
Q Consensus 400 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~------- 472 (662)
.+++.+.. .+++..+++++.|+++||+|||++ +|+||||+++|||+++++.+||+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99996544 589999999999999999999998 999999999999999999999999999876543311
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
.......++..|++||++.+..++.++|||||||++|+|++|+.||......+.+... ..+.+...
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~~~----- 221 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI---------LNGKIEWP----- 221 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---------hcCCcCCC-----
Confidence 1223456888999999999888999999999999999999999999765433222111 11111100
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...... ..+..++.+||+.+|++||++.+|.+.|+.
T Consensus 222 ~~~~~~---~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 222 EDVEVS---DEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred ccccCC---HHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 000012 344556669999999999999777777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=303.83 Aligned_cols=261 Identities=23% Similarity=0.270 Sum_probs=192.6
Q ss_pred CCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeC--CeEEEEEE
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRVH-HRHLVSLVGYCIAG--GQRMLVYE 392 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~--~~~~lv~E 392 (662)
|.+.+.||+|+||.||++.. .+++.||||+++.... .......+|+.++.++. |+||+++++++.++ +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56788999999999999984 4789999999876422 22334557999999985 99999999999987 89999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.+ +|.+++.... ..+++..++.++.|++.||+|||+. +|+|||||++||||++ +.+||+|||+++.......
T Consensus 81 ~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCCc-cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 9975 7777775432 3589999999999999999999998 9999999999999999 9999999999987643322
Q ss_pred ccccccccCccccCccccc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHH-------HhhcCcc
Q 006083 473 HVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGA-------ALEDGIY 544 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~-------~~~~~~~ 544 (662)
.....++..|+|||++. ++.++.++|||||||+||||++|+.||......+.+... ...+.. .......
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI-HDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHH-HHHcCCCCHHHHHhhccccc
Confidence 13356789999999765 456789999999999999999999999765433322221 111100 0000000
Q ss_pred ccccCcccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 545 DGLVDPRLEH----NYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 545 ~~~~d~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.......... .........+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000 001122355667777999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=302.64 Aligned_cols=249 Identities=23% Similarity=0.338 Sum_probs=193.6
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC-----CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG-----SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAG--GQR 387 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~ 387 (662)
.+|.+.++||+|+||.||++.. .+++.||+|.+... .......+++|++++++++|+||+++++++.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 3688999999999999999985 46899999988542 123346788999999999999999999998764 568
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
++||||+.+++|.+++.... .+++..+++++.+++.||.|||++ +|+|||||++||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999986433 378889999999999999999998 8999999999999999999999999999765
Q ss_pred CCCCC--ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 468 NDNHT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 468 ~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
..... .......|+..|+|||++.+..++.++|||||||+||+|++|+.||......+.+.+... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~--- 225 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT--------QP--- 225 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc--------CC---
Confidence 32111 111235689999999999988899999999999999999999999975432222211110 00
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
....+ .....++ +.+++..|++ ++.+||++.+++.
T Consensus 226 --~~~~~-p~~~~~~---~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 --TKPML-PDGVSDA---CRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --CCCCC-CcccCHH---HHHHHHHHhc-CcccCccHHHHhc
Confidence 00111 1122233 4444558888 4699999998775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.82 Aligned_cols=265 Identities=23% Similarity=0.306 Sum_probs=197.9
Q ss_pred HHhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----
Q 006083 313 AATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGG---- 385 (662)
Q Consensus 313 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---- 385 (662)
...++|++.+.||+|+||.||+|... +|+.||||+++.... .....+.+|++++++++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567999999999999999999964 689999999976432 23456788999999999999999999987654
Q ss_pred ------eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEE
Q 006083 386 ------QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVA 459 (662)
Q Consensus 386 ------~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~ 459 (662)
.++|||||+.+ +|..++... ...+++..++.++.|++.||+|||+. +|+|||||++||||++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999987 565655443 33589999999999999999999998 99999999999999999999999
Q ss_pred eeccccccCCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHH
Q 006083 460 DFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAA 538 (662)
Q Consensus 460 DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 538 (662)
|||++...............++..|++||++.+ ..++.++|||||||++|||++|+.||......+.+..+..... ..
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~-~~ 237 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG-SP 237 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CC
Confidence 999998765433222233456788999998864 4578999999999999999999999976544333332222110 00
Q ss_pred hhcCccccc--------cC------cccC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 539 LEDGIYDGL--------VD------PRLE--HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 539 ~~~~~~~~~--------~d------~~l~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. ...+..+ .+ ..+. ....+ ..+.+++..||+.+|.+||++.+|++
T Consensus 238 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 238 C-PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIP---TPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred C-hhhcccccccccccccccccccccchhhhcCCCC---HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0000000 00 0000 01122 34556666999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=299.36 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=201.2
Q ss_pred CCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+|.+.+.||+|+||.||+++.. +++.|+||.+..... .....+.+|++++.+++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999854 678999999987644 4557899999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+++|.+++... ..+++..+..++.+++.+|.|||++ +|+|||||++||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999998654 4589999999999999999999998 9999999999999999999999999999877554322
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
.....|+..|++||++.+..++.++|||+||+++|+|++|+.||........+... ...... .+.
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~-----~~~ 220 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI---------VQDDHP-----PLP 220 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---------hccCCC-----CCC
Confidence 23356889999999998888899999999999999999999999754321111110 001111 111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. ... ..+..++.+||..+|++||++.+++.
T Consensus 221 ~-~~~---~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 E-GIS---PELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C-CCC---HHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 122 34455666999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=308.82 Aligned_cols=243 Identities=24% Similarity=0.366 Sum_probs=195.5
Q ss_pred cceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCcch
Q 006083 321 SNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTL 399 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L 399 (662)
...||+|+||.||++.. .+|+.||||++..........+.+|+.++++++|+||+++++++..++..++||||+.+++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 46799999999999985 47899999998765545567789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccccccc
Q 006083 400 EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM 479 (662)
Q Consensus 400 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 479 (662)
.+++... .+++..+..++.|++.+|+|||++ +|+|||||++||+|++++.++|+|||++....... .......
T Consensus 105 ~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 177 (292)
T cd06657 105 TDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV 177 (292)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence 9987432 478899999999999999999998 99999999999999999999999999987654322 1223356
Q ss_pred cCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC-CCCH
Q 006083 480 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH-NYVP 558 (662)
Q Consensus 480 Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~ 558 (662)
|+..|++||++.+..++.++|||||||++|+|++|+.||......+.+.. .. ... ...+.. ....
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-~~--------~~~-----~~~~~~~~~~~ 243 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-IR--------DNL-----PPKLKNLHKVS 243 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HH--------hhC-----CcccCCcccCC
Confidence 89999999999888899999999999999999999999975433222111 11 000 001100 1112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 559 HEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 559 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. .+..++.+||+.+|.+||++.+|++
T Consensus 244 ~---~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 P---SLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred H---HHHHHHHHHHhCCcccCcCHHHHhc
Confidence 2 3445556899999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.97 Aligned_cols=262 Identities=22% Similarity=0.301 Sum_probs=200.0
Q ss_pred CCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ--GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
|++.+.||+|++|.||++.. .+|+.+++|+++..... ....+.+|+++|++++|+||+++++++.+++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999985 47899999998765332 3567889999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+ +|.+++.... ..+++..++.++.++++||.|||++ +|+|||||++|||+++++.+||+|||++....... ..
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 75 7777775533 4689999999999999999999998 89999999999999999999999999998765543 12
Q ss_pred ccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC----
Q 006083 475 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD---- 549 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d---- 549 (662)
.....++..|++||.+.+. .++.++|||||||+||+|++|+.+|......+.+......+-.. ....+..+.+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 232 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTP--DPEVWPKFTSLARN 232 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC--chHhcccchhhhhh
Confidence 2335678899999998876 78999999999999999999999997665433332221110000 0000000000
Q ss_pred -------c-ccC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 550 -------P-RLE-HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 550 -------~-~l~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. ... ..........+..++..||+.||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 000 0011122345667777999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.56 Aligned_cols=243 Identities=24% Similarity=0.372 Sum_probs=191.1
Q ss_pred ccceeeccCceEEEEEEec-CCCEEEEEEeecC----CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe--EEEEEE
Q 006083 320 KSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTG----SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQ--RMLVYE 392 (662)
Q Consensus 320 ~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~--~~lv~E 392 (662)
+..+||+|.|-+||+|.+. +|-+||--.++.. .....++|..|+.+|+.|+|+|||+|+++|.+... +.+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3567999999999999953 6777774443321 23445789999999999999999999999987554 789999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC-CCcEEEEeeccccccCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-NFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~~~~~~~ 471 (662)
++..|+|..|+++.++ ++...++.|++||++||.|||++ ++.|||||||.+||||+. -|.|||+|+|||.......
T Consensus 124 L~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred cccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999976554 78889999999999999999997 788999999999999986 5899999999998876532
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCc-hhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMT-MMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
...++||+.|||||+.. ..|++.+||||||++|+||+|+..||..= ...+.+....... ...-+.++-
T Consensus 201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGi-----KP~sl~kV~-- 269 (632)
T KOG0584|consen 201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGI-----KPAALSKVK-- 269 (632)
T ss_pred ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCC-----CHHHhhccC--
Confidence 24489999999999887 79999999999999999999999999532 2222222211111 011111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..+.++ ++.+||.. ..+|+++.|+|+
T Consensus 270 -------dPevr~---fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 -------DPEVRE---FIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -------CHHHHH---HHHHHhcC-chhccCHHHHhh
Confidence 233444 44599999 999999999996
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=314.15 Aligned_cols=268 Identities=22% Similarity=0.332 Sum_probs=197.7
Q ss_pred HhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEe--CCeE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTG--SGQGEREFSAEVEIISRV-HHRHLVSLVGYCIA--GGQR 387 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~~~ 387 (662)
..++|.+.+.||+|+||.||+|... +|+.||||++... .......+.+|+.+++++ +|+||++++++|.. +..+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467889999999999999999964 6889999988643 223345678899999999 99999999999864 3468
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
|+||||+. ++|..++... .+++..++.++.|++.||+|||++ +|+|||||++||||++++.+||+|||++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999997 5888888543 578899999999999999999998 9999999999999999999999999999866
Q ss_pred CCCCC----ccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH--------
Q 006083 468 NDNHT----HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL-------- 534 (662)
Q Consensus 468 ~~~~~----~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~-------- 534 (662)
..... .......|+..|++||++.+ ..++.++|||||||++|+|++|+.||......+.+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 43322 12234678999999998764 568899999999999999999999997654333222111100
Q ss_pred --hHHHhhcCccccccCcccC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 535 --LGAALEDGIYDGLVDPRLE--HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 535 --~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+........+..+...... ..........+.+++.+||+.+|.+||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000011100000000 00011122445666779999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=299.34 Aligned_cols=261 Identities=26% Similarity=0.341 Sum_probs=211.5
Q ss_pred HHHHHHHhCCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEE
Q 006083 308 YDELAAATGGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGY 380 (662)
Q Consensus 308 ~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~ 380 (662)
..++..-..++....++-+|.||+||.|++. +.+.|-||.++.... -....|..|..+|..+.|+|+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4566666778888899999999999999753 345678888876533 334678899999999999999999998
Q ss_pred EE-eCCeEEEEEEecCCcchhhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC
Q 006083 381 CI-AGGQRMLVYEFVSNKTLEYHLHG------ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN 453 (662)
Q Consensus 381 ~~-~~~~~~lv~E~~~~g~L~~~l~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~ 453 (662)
+. +.+..+++|.++.-|+|..+|.. ...+.+...+.+.++.|++.|++|||++ +|||.||..+|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 86 56678899999999999999962 2234577788999999999999999999 99999999999999999
Q ss_pred CcEEEEeeccccccCCCCCcccc-ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHH
Q 006083 454 FEAMVADFGLAKLSNDNHTHVST-RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWA 531 (662)
Q Consensus 454 ~~vkl~DFGla~~~~~~~~~~~~-~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~ 531 (662)
.+|||+|-.+++.+...+.+..+ .......||++|.+.+..|+.++|||||||+||||+| |+.|+..-+..+..
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~---- 508 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME---- 508 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH----
Confidence 99999999999987766555332 3445778999999999999999999999999999998 88998665544321
Q ss_pred HHHhHHHhhcCccccccCcccCC-CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 532 RPLLGAALEDGIYDGLVDPRLEH-NYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
..+.+|. ++.+ ..+++++..+|. .||...|++||+++|++..|.
T Consensus 509 -----~ylkdGy-------RlaQP~NCPDeLf~vMa---cCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 509 -----HYLKDGY-------RLAQPFNCPDELFTVMA---CCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred -----HHHhccc-------eecCCCCCcHHHHHHHH---HHHhcCcccCCCHHHHHHHHH
Confidence 1122222 3333 347888877776 699999999999999999886
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=353.11 Aligned_cols=256 Identities=29% Similarity=0.412 Sum_probs=202.6
Q ss_pred HhCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
.+-+|..+..||.|.||.||.|. ..+|+..|||.++.... ...+.+.+|+.+|..|+|||||+++|+-...+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 44578889999999999999999 67899999999875433 3346788999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
||||++|+|.+.+...+ .+++.....+..|++.||.|||++ ||||||||++||||+.+|-+|+.|||.|+.+...
T Consensus 1313 MEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999985432 356666667788999999999999 9999999999999999999999999999987655
Q ss_pred CCcc---ccccccCccccCcccccCC---CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcc
Q 006083 471 HTHV---STRVMGTFGYLAPEYASSG---KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIY 544 (662)
Q Consensus 471 ~~~~---~~~~~Gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (662)
.... ....+||+.|||||++.+. ...-+.||||||||++||+||+.||...+. +|+-.+. ...|-.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-----e~aIMy~---V~~gh~ 1459 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-----EWAIMYH---VAAGHK 1459 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-----hhHHHhH---HhccCC
Confidence 3222 2347899999999999753 456799999999999999999999965432 2322111 111111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 545 DGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 545 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
+.+-.. ...+-+++++ .||..||++|.++.|+++.--+
T Consensus 1460 -----Pq~P~~-ls~~g~dFle---~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1460 -----PQIPER-LSSEGRDFLE---HCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred -----CCCchh-hhHhHHHHHH---HHHhcCchhhhHHHHHHHhhcc
Confidence 111111 3444555555 8999999999999888876443
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=302.19 Aligned_cols=242 Identities=25% Similarity=0.324 Sum_probs=192.3
Q ss_pred eeccCceEEEEEEec-CCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCcch
Q 006083 324 LGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTL 399 (662)
Q Consensus 324 iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L 399 (662)
||.|+||.||+++.. +++.|+||++..... ...+.+.+|++++++++|+||+++++++.++..+++||||+.+++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999964 589999999975432 3346789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccccccc
Q 006083 400 EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM 479 (662)
Q Consensus 400 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 479 (662)
.+++.+.. .+++..+..++.+++.||.|||++ +++|+|||++||+|++++.+||+|||++....... ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 99996543 478899999999999999999998 99999999999999999999999999998765432 123357
Q ss_pred cCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHH
Q 006083 480 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPH 559 (662)
Q Consensus 480 Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 559 (662)
|+..|++||++.+..++.++|||+|||++|+|++|..||....... .++..... .+.. ...... ..
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~-----~~~~----~~~~~~-~~-- 219 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIYNDIL-----KGNG----KLEFPN-YI-- 219 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHHHHHh-----ccCC----CCCCCc-cc--
Confidence 8899999999988889999999999999999999999997654211 11111110 0000 001111 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006083 560 EMARLVACGAASIRHSARKRPK-----MSQIVR 587 (662)
Q Consensus 560 ~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 587 (662)
...+..++..||+.+|++|++ +.|+++
T Consensus 220 -~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 -DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred -CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 234556666999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=317.08 Aligned_cols=267 Identities=19% Similarity=0.302 Sum_probs=198.3
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEE----eCCeE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCI----AGGQR 387 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~----~~~~~ 387 (662)
.++|++.+.||+|+||.||++.. .+|+.||||++.... ......+.+|+.+|++++|+||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36799999999999999999984 468999999997642 234567788999999999999999998875 34578
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
++||||+. ++|.+++.... .+++..+++++.||++||.|||++ +|+|||||++|||+++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 58888885443 489999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCCc---cccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHH------
Q 006083 468 NDNHTH---VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGA------ 537 (662)
Q Consensus 468 ~~~~~~---~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~------ 537 (662)
...... ......|+..|++||++.+ ..++.++|||||||++|||++|+.||........+..+... +..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~-~g~~~~~~~ 236 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSV-LGSPSEEVL 236 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHH-hCCChhHhh
Confidence 432211 1234578999999998865 46899999999999999999999999765433222211110 000
Q ss_pred -HhhcCccccccCc-ccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 538 -ALEDGIYDGLVDP-RLEH-----NYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 538 -~~~~~~~~~~~d~-~l~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
......+....+. .... .........+..++..||+.+|.+||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000000 0000 0011223456667779999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=339.83 Aligned_cols=251 Identities=27% Similarity=0.422 Sum_probs=189.3
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEe----------
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIA---------- 383 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~---------- 383 (662)
.+|+..++||+||||.||+++.+ ||+.||||+|.... ......+.+|+++|++|+|||||+++..|.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 45788899999999999999944 99999999997553 3334678999999999999999999840000
Q ss_pred --------------------------------------------------------------------C-----------
Q 006083 384 --------------------------------------------------------------------G----------- 384 (662)
Q Consensus 384 --------------------------------------------------------------------~----------- 384 (662)
+
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 0
Q ss_pred ------------------------------CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 006083 385 ------------------------------GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434 (662)
Q Consensus 385 ------------------------------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 434 (662)
..+||-||||+...|.++++++.... .....++++.+|++||.|+|++
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~- 716 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQ- 716 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhC-
Confidence 13578999999999999886654321 4678899999999999999999
Q ss_pred CCceeecCCccCcEEECCCCcEEEEeeccccccC------C-----------CCCccccccccCccccCcccccCC---C
Q 006083 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN------D-----------NHTHVSTRVMGTFGYLAPEYASSG---K 494 (662)
Q Consensus 435 ~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~------~-----------~~~~~~~~~~Gt~~y~aPE~~~~~---~ 494 (662)
|||||||||.||||++++.|||+|||+|.... + ......+..+||.-|+|||++.+. .
T Consensus 717 --giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 717 --GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred --ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 89999999999999999999999999998611 0 000022457899999999999764 4
Q ss_pred CCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhccc
Q 006083 495 LTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRH 574 (662)
Q Consensus 495 ~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~ 574 (662)
|+.|+|||||||||+||+. ||...+....... .+..+.+... ..+..+.+..=..++.++++.
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~--------~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILT--------NLRKGSIPEP------ADFFDPEHPEEASLIRWLLSH 857 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHH--------hcccCCCCCC------cccccccchHHHHHHHHHhcC
Confidence 9999999999999999984 6776654332221 1122332221 111222233334455689999
Q ss_pred CCCCCCCHHHHHH
Q 006083 575 SARKRPKMSQIVR 587 (662)
Q Consensus 575 ~p~~RPs~~evl~ 587 (662)
||.+||++.|+|.
T Consensus 858 dP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 858 DPSKRPTATELLN 870 (1351)
T ss_pred CCccCCCHHHHhh
Confidence 9999999999985
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.81 Aligned_cols=264 Identities=23% Similarity=0.268 Sum_probs=198.1
Q ss_pred CCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEEec
Q 006083 318 FAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
|.+.+.||+|+||.||+|+.. +++.|+||++..... .......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999964 578999999875432 22334567999999999 999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
+++|.+++.......+++..++.++.|++.+|.|||++ +|+|+|||++||||++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 88998888765545689999999999999999999998 999999999999999999999999999986654322
Q ss_pred ccccccCccccCccccc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHH---H----hHHHh-hcCccc
Q 006083 475 STRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARP---L----LGAAL-EDGIYD 545 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~---~----~~~~~-~~~~~~ 545 (662)
.....|+..|+|||++. +..++.++|||||||++|||++|+.+|......+.+...... . +.... ....+.
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 23356888999999885 456889999999999999999999999765443332211110 0 00000 000000
Q ss_pred cccCcccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GLVDPRLE---HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..+..... .........++..++.+||+.+|++||++.||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000 0001111245667777999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=312.82 Aligned_cols=261 Identities=20% Similarity=0.316 Sum_probs=193.2
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAG------G 385 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~ 385 (662)
.++|...+.||+|+||.||+|+. .+|+.||||+++... ......+.+|++++++++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999985 478999999987532 22345688999999999999999999998754 3
Q ss_pred eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccc
Q 006083 386 QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
.+|+||||+.+ +|..++. ..+.+..+..++.|+++||+|||++ +|+|||||++|||++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 56999999864 6665542 2478899999999999999999998 89999999999999999999999999997
Q ss_pred ccCCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHH------HhHHH
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARP------LLGAA 538 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~------~~~~~ 538 (662)
..... .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||........+...... .+...
T Consensus 166 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 166 HADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 65432 123567889999999876 46899999999999999999999999865433322221110 00000
Q ss_pred hhcCcccccc-------CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 539 LEDGIYDGLV-------DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 539 ~~~~~~~~~~-------d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+........+ ...+.. ..+.....+.+++.+||+.||++||++.+++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred hcccchHHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 000000 001112345667779999999999999999853
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=272.91 Aligned_cols=211 Identities=24% Similarity=0.345 Sum_probs=178.7
Q ss_pred CCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 317 GFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQG--EREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+|...++||+|.||+||+++ ..+++.||+|.++.++.++ -....+|+.+|+.|+|.|||+++++...+..+.||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46777899999999999999 5578999999998764332 24678999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
|. .+|..++.. .++.++.+.+..+++|+++||.|||++ +++||||||.|+||+.+|++||+|||+++.++-...
T Consensus 83 cd-qdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr- 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR- 156 (292)
T ss_pred hh-HHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE-
Confidence 94 566666543 344689999999999999999999999 999999999999999999999999999998775432
Q ss_pred cccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHH
Q 006083 474 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARP 533 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~ 533 (662)
.....+-|.+|.+|+++.+. .|+...|+||.|||+.||.. |+..|.+.+..+.+..+.+.
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~ 218 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHH
Confidence 23345679999999998874 58899999999999999986 77778888877777766553
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=302.51 Aligned_cols=241 Identities=25% Similarity=0.360 Sum_probs=184.3
Q ss_pred eeeccCceEEEEEEe-cCCCEEEEEEeecCCch---hHHHHHHHH---HHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 323 LLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ---GEREFSAEV---EIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 323 ~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~---~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
+||+|+||.||++.. .+++.||||++...... ....+..|. ++++..+|+||+.+++++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 46899999998754221 122334444 34445679999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
|++|.+++... ..+.+..++.++.|+++||.|||+. +|+|||||++|||+++++.+||+|||++....... .
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~ 152 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence 99999988543 3589999999999999999999998 89999999999999999999999999987654322 2
Q ss_pred cccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 476 TRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
....|+..|++||++.++ .++.++|||||||+||||++|+.||......+... ...... .....+..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~-----------~~~~~~~~ 220 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTL-----------TMAVELPD 220 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhh-----------ccCCCCCC
Confidence 335789999999998754 68999999999999999999999997653221111 000000 00111111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRP-----KMSQIVR 587 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 587 (662)
.+ .. .+.+++.+||..+|.+|+ ++.++++
T Consensus 221 ~~-s~---~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 SF-SP---ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred cC-CH---HHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 12 23 344455589999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.28 Aligned_cols=250 Identities=29% Similarity=0.435 Sum_probs=200.4
Q ss_pred CCccceeeccCceEEEEEEe-cCCC----EEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGK----EVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
+..+++||.|+||+||+|.+ ..|+ .||||++..... +...+|++|+-+|.+|+|+||++|+++|.... +.||.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 45678999999999999983 3444 589998876543 44578999999999999999999999998766 88999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
+|+.+|.|.++++.++. .+-....+.|..||++||.|||++ ++|||||..+||||..-..+||.|||+++....+.
T Consensus 777 q~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999976443 577788999999999999999999 99999999999999999999999999999876554
Q ss_pred Ccccc-ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 472 THVST-RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 472 ~~~~~-~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
..... ...-.+.|||-|.+....|+.++|||||||.+|||+| |..|+++...++. .+ .++.+.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-~d--------lle~ge------ 917 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-PD--------LLEKGE------ 917 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-hH--------HHhccc------
Confidence 43221 1233678999999999999999999999999999998 8999987654331 11 112221
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
+|.. .+..-.++..++++||..|+..||.++++...+.
T Consensus 918 -RLsq--PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs 955 (1177)
T KOG1025|consen 918 -RLSQ--PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFS 955 (1177)
T ss_pred -cCCC--CCCccHHHHHHHHHHhccCcccCccHHHHHHHHH
Confidence 2221 1223345566667899999999999999987654
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=304.78 Aligned_cols=248 Identities=21% Similarity=0.293 Sum_probs=199.7
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lv 390 (662)
++|.+.+.||+|+||.||++... +|+.||+|++.... ....+.+.+|++++++++ |+||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36889999999999999999854 78999999987532 233467889999999998 99999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+++|.+++.... .+.+..++.++.|++.||.|||++ +++|+|||++||+|+.+++++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999996543 589999999999999999999998 9999999999999999999999999998765433
Q ss_pred CC-------------------ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHH
Q 006083 471 HT-------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWA 531 (662)
Q Consensus 471 ~~-------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~ 531 (662)
.. .......|+..|++||++.+..++.++|||+|||++|+|++|+.||........+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 21 12233568899999999998889999999999999999999999998654222111100
Q ss_pred HHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 006083 532 RPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKM----SQIVR 587 (662)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~----~evl~ 587 (662)
... ..+.. .....+..++.+||+.+|.+||++ .++++
T Consensus 236 ---------~~~------~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 ---------KLE------YSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---------hcC------CCCCC----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 000 00111 112445666679999999999999 66553
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=312.54 Aligned_cols=265 Identities=19% Similarity=0.326 Sum_probs=196.5
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----Ce
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAG-----GQ 386 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~ 386 (662)
.++|.+.+.||+|+||.||+++. .+++.||||.++.. .......+.+|+.+|++++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999984 47899999998753 223345678899999999999999999988644 35
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
.||||||+. ++|.+++... ..+++..+..++.|++.||.|||++ +|+|||||++|||++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999996 6788887543 3589999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhH----HHh--
Q 006083 467 SNDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLG----AAL-- 539 (662)
Q Consensus 467 ~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~----~~~-- 539 (662)
..... .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||........+..+.. .+. ..+
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~ 235 (337)
T cd07858 158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITE-LLGSPSEEDLGF 235 (337)
T ss_pred cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH-HhCCCChHHhhh
Confidence 65432 12234568899999998865 4688999999999999999999999976532222111110 000 000
Q ss_pred -hcCcccccc-------CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 540 -EDGIYDGLV-------DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 540 -~~~~~~~~~-------d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
........+ +..+.. ........+.+++.+||+.+|++||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000000 000000 001122345566779999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.60 Aligned_cols=248 Identities=21% Similarity=0.262 Sum_probs=189.7
Q ss_pred HHHHHHhCCCCcccee--eccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 006083 309 DELAAATGGFAKSNLL--GQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAG 384 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~i--G~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~ 384 (662)
.++....++|++.+.+ |+|+||.||++.. .+++.+|+|.+....... .|+.++..+ +|+||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444455677777776 9999999999984 478899999987532211 123233223 699999999999999
Q ss_pred CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC-cEEEEeecc
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF-EAMVADFGL 463 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkl~DFGl 463 (662)
+..|+||||+.+++|.+++.... .+++..++.++.|+++||.|||+. +|+|||||++|||++.++ .++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 99999999999999999996543 689999999999999999999999 899999999999999988 999999999
Q ss_pred ccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhh-HHHHHHHHHhHHHhhcC
Q 006083 464 AKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMED-SLVEWARPLLGAALEDG 542 (662)
Q Consensus 464 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~ 542 (662)
+...... ....|+..|+|||++.+..++.++|||||||++|||++|+.||......+ .+..|....
T Consensus 157 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 223 (267)
T PHA03390 157 CKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-------- 223 (267)
T ss_pred ceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--------
Confidence 8765432 22468899999999998899999999999999999999999997543222 111221110
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 006083 543 IYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPK-MSQIVR 587 (662)
Q Consensus 543 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~evl~ 587 (662)
.... .... ... ..+..++.+||+.+|.+|++ ++|+++
T Consensus 224 --~~~~--~~~~-~~~---~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 --QKKL--PFIK-NVS---KNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --cccC--Cccc-ccC---HHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000 0111 122 33445556899999999996 588874
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=312.40 Aligned_cols=266 Identities=20% Similarity=0.265 Sum_probs=194.7
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC---------
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAG--------- 384 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--------- 384 (662)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+++|++++|+||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36799999999999999999985 46899999999876666667889999999999999999999776543
Q ss_pred -----CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC-CCcEEE
Q 006083 385 -----GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-NFEAMV 458 (662)
Q Consensus 385 -----~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl 458 (662)
...|+||||+. ++|.+++.. ..+.+..++.++.||++||.|||++ +|+|||||++||||+. ++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 588877743 2478899999999999999999998 9999999999999974 567899
Q ss_pred EeeccccccCCCCCc--cccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh
Q 006083 459 ADFGLAKLSNDNHTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL 535 (662)
Q Consensus 459 ~DFGla~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~ 535 (662)
+|||++......... ......|+..|+|||++.+ ..++.++|||||||+||+|++|+.||......+.+.......-
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999765432111 1123467889999998754 5688999999999999999999999976543333222211100
Q ss_pred ------HHHhhcCccccccCcccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 536 ------GAALEDGIYDGLVDPRLEHN-----YVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 536 ------~~~~~~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...........+........ .......++.+++..||+.||++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000000000000000000 00112234556777999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=307.95 Aligned_cols=267 Identities=24% Similarity=0.268 Sum_probs=194.3
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeC-------
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ--GEREFSAEVEIISRVHHRHLVSLVGYCIAG------- 384 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------- 384 (662)
.++|.+.+.||+|+||.||++.. .+++.||||++...... ....+.+|+++|++++|+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46799999999999999999985 46899999998654322 234678899999999999999999987543
Q ss_pred -CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecc
Q 006083 385 -GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGL 463 (662)
Q Consensus 385 -~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 463 (662)
..+++||||+.+ +|..++... ...+++..+..++.|+++||.|||++ +|+|||||++|||+++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 356999999875 566655432 33589999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCc----------cccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHH
Q 006083 464 AKLSNDNHTH----------VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWAR 532 (662)
Q Consensus 464 a~~~~~~~~~----------~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~ 532 (662)
++........ ......|+..|+|||++.+ ..++.++||||||||+|||++|+.+|........+..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9765432211 1123567889999998765 4588999999999999999999999976554333222211
Q ss_pred HHh---HHHhh-----cC----ccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 533 PLL---GAALE-----DG----IYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 533 ~~~---~~~~~-----~~----~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
... ...+. .. .........+... .......+.+++.+||+.+|++||++.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 100 00000 00 0000000011000 0111245667777999999999999998875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=336.05 Aligned_cols=145 Identities=29% Similarity=0.353 Sum_probs=130.9
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|.+.++||+|+||.||+|... +++.||||+++.... .....+.+|+++++.++|+||+++++++...+.+||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57899999999999999999964 689999999975432 23467889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccc
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
||+.|++|.+++.... .+.+..+++|+.||+.||+|||.+ +||||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999986543 478899999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=310.89 Aligned_cols=266 Identities=21% Similarity=0.299 Sum_probs=200.5
Q ss_pred CCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-----eEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGG-----QRM 388 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~~ 388 (662)
+|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++|+||+++++++...+ .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788999999999999999954 58999999997643 344567899999999999999999999988765 789
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
+||||+. ++|.+++.... .+++..++.++.+++.||.|||++ +|+|||||++||||++++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 47888885443 689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCC--ccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH---hHHHh---
Q 006083 469 DNHT--HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL---LGAAL--- 539 (662)
Q Consensus 469 ~~~~--~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~---~~~~~--- 539 (662)
.... .......++..|+|||++.+. .++.++|||||||++|+|++|+.||......+.+....... ....+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 4321 122345688999999999887 89999999999999999999999997765433222211100 00000
Q ss_pred hcCccccccCc-ccC-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 540 EDGIYDGLVDP-RLE-----HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 540 ~~~~~~~~~d~-~l~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
........+.. ... ..........+.+++.+||+.+|.+||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000000 000 00001122345566669999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.45 Aligned_cols=269 Identities=21% Similarity=0.282 Sum_probs=199.2
Q ss_pred HHHHHHHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 006083 308 YDELAAATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAG 384 (662)
Q Consensus 308 ~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 384 (662)
..++..+.++|.+.+.||+|+||.||++.. .+|+.||||+++... ....+.+.+|++++++++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 356677889999999999999999999984 578999999997542 22346688899999999999999999988643
Q ss_pred ------CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEE
Q 006083 385 ------GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMV 458 (662)
Q Consensus 385 ------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl 458 (662)
...|++++++ +++|.+++... .+++..+..++.|+++||+|||++ +|+|||||++||++++++.+||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEE
Confidence 3467888876 78898877532 478999999999999999999998 9999999999999999999999
Q ss_pred EeeccccccCCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH---
Q 006083 459 ADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL--- 534 (662)
Q Consensus 459 ~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~--- 534 (662)
+|||+++..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||........+.......
T Consensus 162 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (345)
T cd07877 162 LDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237 (345)
T ss_pred eccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999998765432 233568899999998876 568899999999999999999999997654333222211100
Q ss_pred ---hHHHhhcCc-------cccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 535 ---LGAALEDGI-------YDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 535 ---~~~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+...+.... +.......+.... ......+.+++.+||+.||.+|+++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhc-CCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000000 0000000000000 0112245566669999999999999988864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=283.98 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=192.5
Q ss_pred CccceeeccCceEEEEEEe-cCCCEEEEEEeecC-CchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEEecC
Q 006083 319 AKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG-SGQGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 319 ~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
+.+..||.|..|.|++++. ..|..+|||.+... +.++.++++..++++..-+ +|.||+.+|||..+...++.||.|
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM- 173 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM- 173 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-
Confidence 3456799999999999985 46899999999765 4455678888898887765 899999999999999999999987
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
...++.+|++- ...+++..+-++...++.||.||.+++ +|||||+||.|||||+.|++||||||++..+-+... .
T Consensus 174 s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA--h 248 (391)
T KOG0983|consen 174 STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--H 248 (391)
T ss_pred HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc--c
Confidence 34444444433 335788888899999999999999875 899999999999999999999999999987655432 3
Q ss_pred cccccCccccCcccccC---CCCCchHHHHHHHHHHHHHHhCCCCCCCch-hhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 476 TRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDMTM-MEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
++..|.+.|||||.+.- -.|+-++||||||+.|+||.||+.||.+.. +.+.+...+.. . - +.
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--------e--P----P~ 314 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--------E--P----PL 314 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--------C--C----CC
Confidence 55789999999999863 469999999999999999999999998753 33333322211 0 0 12
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
|.... ..-..+.+++..||+.|+.+||...++++.
T Consensus 315 L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 315 LPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 22111 012334455558999999999999988864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.28 Aligned_cols=262 Identities=21% Similarity=0.269 Sum_probs=191.3
Q ss_pred CCCccceeeccCceEEEEEEec-C--CCEEEEEEeecCC--chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC----Ce
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-N--GKEVAVKSLKTGS--GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAG----GQ 386 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~--g~~vavK~l~~~~--~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~----~~ 386 (662)
+|.+.+.||+|+||.||++... . ++.||||++.... ....+.+.+|+++++++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999954 3 7899999987532 22346788899999999 599999999875432 45
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
+|++|||+. ++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788999885 6888888543 3588999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCc---cccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHH---------
Q 006083 467 SNDNHTH---VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARP--------- 533 (662)
Q Consensus 467 ~~~~~~~---~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~--------- 533 (662)
....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||......+.+......
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5432211 1233578999999998765 46899999999999999999999999765433222211110
Q ss_pred ------HhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 534 ------LLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 534 ------~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
........ +...-...+.. ........+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIRS--LPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHHh--ccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 00000000000 00011234556667999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.01 Aligned_cols=265 Identities=21% Similarity=0.296 Sum_probs=197.0
Q ss_pred HHHHhCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--
Q 006083 311 LAAATGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGG-- 385 (662)
Q Consensus 311 i~~~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-- 385 (662)
+....++|.+.+.||+|+||.||++. ..+|+.||||+++... ......+.+|+++|++++|+||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 34456789999999999999999998 4478999999986532 223456889999999999999999999987543
Q ss_pred ----eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEee
Q 006083 386 ----QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADF 461 (662)
Q Consensus 386 ----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DF 461 (662)
.+++||||+ +++|.+++.. ..+++..++.++.|+++||+|||+. +|+|||||++|||+++++.+||+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 468999998 7788888753 2478999999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHH------H
Q 006083 462 GLAKLSNDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARP------L 534 (662)
Q Consensus 462 Gla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~------~ 534 (662)
|++....... ....++..|++||++.+ ..++.++|||||||++|+|++|+.||........+.+.... .
T Consensus 163 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 163 GLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9998654322 23467889999999876 46889999999999999999999999765433222221110 0
Q ss_pred hHHHhhcCcccc-------ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 535 LGAALEDGIYDG-------LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 535 ~~~~~~~~~~~~-------~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+...+....... +....+. .........+.+++.+|++.||++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000 0000000 000111223556777999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=303.94 Aligned_cols=242 Identities=25% Similarity=0.328 Sum_probs=196.8
Q ss_pred HhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 388 (662)
...+|.++.+||+|+||.|.++..+ +.+.||||+|+++- .++.+--+.|.++|+.. +-|.+++|+.+|+.-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 3456889999999999999999854 56889999998862 23345557788888877 4789999999999999999
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
+||||+.||+|-.+|+.-++ +.+..++.++..|+-||-+||++ +||.||||.+|||||.+|.+||+|||+++.--
T Consensus 427 FVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999999999976554 67778899999999999999999 99999999999999999999999999998654
Q ss_pred CCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 469 DNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 469 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
... .....++||+.|+|||++.-+.|...+|+|+|||+|||||.|+.||++.+.++.+..+.. ..+
T Consensus 502 ~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e--------hnv----- 567 (683)
T KOG0696|consen 502 FDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME--------HNV----- 567 (683)
T ss_pred cCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH--------ccC-----
Confidence 333 234568999999999999999999999999999999999999999998865554433222 111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRP 580 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP 580 (662)
.|......+.+.+....|...|.+|.
T Consensus 568 ------syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 568 ------SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ------cCcccccHHHHHHHHHHhhcCCcccc
Confidence 12222234445555577888888885
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=309.65 Aligned_cols=265 Identities=25% Similarity=0.301 Sum_probs=195.3
Q ss_pred CCCC-ccceeeccCceEEEEEEec-CCCEEEEEEeecCCchh--------------HHHHHHHHHHHHhcCCCCcceEEE
Q 006083 316 GGFA-KSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQG--------------EREFSAEVEIISRVHHRHLVSLVG 379 (662)
Q Consensus 316 ~~~~-~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--------------~~~~~~E~~il~~l~HpnIv~l~~ 379 (662)
++|. +.+.||+|+||.||++... +++.||||+++...... ...+.+|+++|++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 4577999999999999854 78999999987542221 125778999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEE
Q 006083 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVA 459 (662)
Q Consensus 380 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~ 459 (662)
++..++..++||||+. ++|.+++... ..+++..+..++.|++.||.|||+. +|+|||||++||||+.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 5888888543 3488999999999999999999998 99999999999999999999999
Q ss_pred eeccccccCCCC-------------CccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhh
Q 006083 460 DFGLAKLSNDNH-------------THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMED 525 (662)
Q Consensus 460 DFGla~~~~~~~-------------~~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~ 525 (662)
|||++....... ........++..|++||++.+. .++.++|||||||++|||++|+.||......+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999997654111 0111224568899999998764 47899999999999999999999998765444
Q ss_pred HHHHHHHHHhHHHhhc--------Ccc---ccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 526 SLVEWARPLLGAALED--------GIY---DGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 526 ~~~~~~~~~~~~~~~~--------~~~---~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.+...... +...... ..+ .......+.. ........+.+++..||+.+|++||++.|++..
T Consensus 242 ~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 242 QLGRIFEL-LGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHH-hCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 33222110 0000000 000 0000000000 001112345567779999999999999999964
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=337.74 Aligned_cols=258 Identities=22% Similarity=0.252 Sum_probs=208.2
Q ss_pred HHHHHHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 006083 309 DELAAATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAG 384 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 384 (662)
+++....++|++.++||+|+||.|.+++. .+++.||+|++++.. ..+...|.+|-+||..-+.+=||+|+..|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 45555678999999999999999999985 478999999998732 23345789999999999999999999999999
Q ss_pred CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
.++||||||+.||+|..++.... .+++..++.++..|+.||.-||+. |+|||||||+|||||..|++||+|||.|
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhH
Confidence 99999999999999999996655 588888999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccccccCccccCccccc----C-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHh
Q 006083 465 KLSNDNHTHVSTRVMGTFGYLAPEYAS----S-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAAL 539 (662)
Q Consensus 465 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~----~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 539 (662)
.....++.-.....+||+.|++||++. + +.|+..+|+||+||++||||.|..||.....-+.+..+....
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk----- 297 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK----- 297 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh-----
Confidence 888877666667789999999999986 3 679999999999999999999999997654444333332210
Q ss_pred hcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 006083 540 EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPK---MSQIVR 587 (662)
Q Consensus 540 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~evl~ 587 (662)
+.-.|-. ......+.+.|+.- |--+++.|-. +.++..
T Consensus 298 ~~l~FP~-------~~~VSeeakdLI~~----ll~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 298 ESLSFPD-------ETDVSEEAKDLIEA----LLCDREVRLGRNGIEDIKN 337 (1317)
T ss_pred hhcCCCc-------ccccCHHHHHHHHH----HhcChhhhcccccHHHHHh
Confidence 0001111 11256677777652 2336777776 766654
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.37 Aligned_cols=267 Identities=19% Similarity=0.271 Sum_probs=196.6
Q ss_pred HHHHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCe
Q 006083 311 LAAATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIA-GGQ 386 (662)
Q Consensus 311 i~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~ 386 (662)
+...+++|.+.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++|+||++++++|.. ++.
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 344678899999999999999999984 478999999886432 2335678899999999999999999998865 567
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
.|+||||+ +++|..+++.. .+.+..+..++.|+++||.|||++ +|+|||||+.|||+++++.+||+|||++..
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 89999998 56888877532 367888889999999999999998 999999999999999999999999999875
Q ss_pred cCCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHH---HhHHHhh--
Q 006083 467 SNDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARP---LLGAALE-- 540 (662)
Q Consensus 467 ~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~---~~~~~~~-- 540 (662)
.... .....++..|++||++.+ ..++.++|||||||++|+|++|+.||........+..+... ...+...
T Consensus 158 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 158 QDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 4332 123467889999998865 56899999999999999999999999765432222111110 0000000
Q ss_pred --cCccccccCcccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 541 --DGIYDGLVDPRLEHNY-----VPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 541 --~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
......+......... .......+.+++.+||+.+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000000 01112445566679999999999999988764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=303.76 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=191.0
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lv~E 392 (662)
++|++.+.||+|+||.||++... +++.||||+++.... .....+.+|+.++.++. |+||++++++|.++...|+|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 55888999999999999999975 489999999976432 33456677887777775 9999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+. ++|.+++.... ..+++..+.+++.++++||+|||+.+ +|+||||+++|||+++++.+||+|||++........
T Consensus 95 ~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 95 LMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred ccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 985 46666554322 36889999999999999999999732 899999999999999999999999999876543222
Q ss_pred ccccccccCccccCcccccCCC----CCchHHHHHHHHHHHHHHhCCCCCCCchhh-hHHHHHHHHHhHHHhhcCccccc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGK----LTEKSDVFSFGVMLLELITGRRPVDMTMME-DSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
.....|+..|+|||++.+.. ++.++|||||||+||+|++|+.||...... +.+..+ +... ...+
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--------~~~~-~~~~ 239 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI--------LQEE-PPSL 239 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH--------hcCC-CCCC
Confidence 12345788999999987543 889999999999999999999999653221 111111 1111 0000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
- ...... .++.+++.+||+.+|++||++.++++.
T Consensus 240 ~----~~~~~~---~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 P----PNEGFS---PDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C----CCCCCC---HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 000112 345566669999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.89 Aligned_cols=245 Identities=24% Similarity=0.358 Sum_probs=192.0
Q ss_pred CCccceeeccCceEEEEEEe-cCCCEEEEEEeecC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
|...+.||+|+||.||+|+. .+++.|+||.+... .....+++.+|+++++.++|+|++++++++......++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 66678899999999999995 46889999998643 223345788999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+. ++|.+++.... ..+++..++.++.+++.||.|||++ +|+|||||++|||+++++.+||+|||++......
T Consensus 97 ~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 97 CL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred cC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 96 57776664333 3478899999999999999999998 8999999999999999999999999998765432
Q ss_pred cccccccCccccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 474 VSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
....|+..|+|||++. .+.++.++|||||||++|+|++|+.||......+.+..+.. +.. .
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---------~~~-----~ 232 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---------NES-----P 232 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh---------cCC-----C
Confidence 2356888999999875 35688999999999999999999999865432222221111 110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRAL 589 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 589 (662)
.......... +.+++.+||+.+|++||++.+|++..
T Consensus 233 ~~~~~~~~~~---~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 233 ALQSGHWSEY---FRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CcCcccccHH---HHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 1111112233 44555699999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=302.60 Aligned_cols=244 Identities=26% Similarity=0.365 Sum_probs=190.7
Q ss_pred CCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
|...+.||+|+||.||+|+. .+|+.|+||++..... .....+.+|++++++++|+||+++++++.++...|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66677899999999999985 4688999999875422 2335688899999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+. ++|.+++.... ..+++..++.++.|++.+|.|||++ +|+|||||++||++++++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--- 174 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--- 174 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC---
Confidence 96 46666664432 3588999999999999999999998 8999999999999999999999999998654321
Q ss_pred cccccccCccccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 474 VSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
....|+..|++||++. .+.++.++|||||||+||+|++|+.||........+.... .....
T Consensus 175 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~---------~~~~~----- 238 (313)
T cd06633 175 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---------QNDSP----- 238 (313)
T ss_pred --CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---------hcCCC-----
Confidence 2356889999999984 4568899999999999999999999986653222221110 00000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.+....... .+..++.+||+.+|.+||++.+++..
T Consensus 239 ~~~~~~~~~---~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 TLQSNEWTD---SFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCccccCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111122 34455569999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=293.67 Aligned_cols=204 Identities=25% Similarity=0.356 Sum_probs=169.5
Q ss_pred HhCCCCccceeeccCceEEEEEEec---C--CCEEEEEEeecCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEe-CC
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP---N--GKEVAVKSLKTGSGQG--EREFSAEVEIISRVHHRHLVSLVGYCIA-GG 385 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~---~--g~~vavK~l~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~ 385 (662)
....|+....||+|.||.||++... + .+.+|||+++...... .....+|+.+++.|+|+|||.|..+|.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3456999999999999999999632 2 2379999998753321 3456789999999999999999999887 88
Q ss_pred eEEEEEEecCCcchhhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC----CcEEE
Q 006083 386 QRMLVYEFVSNKTLEYHLHG---ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN----FEAMV 458 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~----~~vkl 458 (662)
.++|++||.+. +|..+|+- .....++...+..|+.||+.|+.|||++ -|+||||||.||||..+ |+|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence 99999999865 45555532 2334688889999999999999999999 79999999999999877 99999
Q ss_pred EeeccccccCCCCCcc--ccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCc
Q 006083 459 ADFGLAKLSNDNHTHV--STRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMT 521 (662)
Q Consensus 459 ~DFGla~~~~~~~~~~--~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~ 521 (662)
+|||+++.+...-... ...++-|++|.|||++.+ ..|+.+.|||++|||+.|||+-+.-|.+.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9999999887654332 345788999999999887 46999999999999999999998888654
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=301.76 Aligned_cols=263 Identities=24% Similarity=0.306 Sum_probs=199.9
Q ss_pred CCccceeeccCceEEEEEEec-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 318 FAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
|+..+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999954 58999999998653 233467889999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
. ++|.+++.... ..+++..+++++.+++.||.|||++ +|+||||+++||++++++.+||+|||+++....... .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 7 58999886543 3589999999999999999999998 899999999999999999999999999987654322 1
Q ss_pred ccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH---hHHHh--------hcC
Q 006083 475 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL---LGAAL--------EDG 542 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~---~~~~~--------~~~ 542 (662)
.....++..|+|||++.+. .++.++|||||||++|||++|+.+|......+.+....... ....+ ...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2234567889999998766 88999999999999999999999997765433322211100 00000 000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 543 IYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 543 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+........ ....+.....+.+++..||+.+|++||++.+|+.
T Consensus 235 ~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0111100000 0011112345677777999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=307.50 Aligned_cols=255 Identities=26% Similarity=0.410 Sum_probs=197.2
Q ss_pred hCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCc-------hhHHHHHHHHHHHHhcCCCCcceEEEEEE-eCC
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSG-------QGEREFSAEVEIISRVHHRHLVSLVGYCI-AGG 385 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~-------~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~ 385 (662)
.++|-++++||+|||+.||++. +...+.||||+-..+.. ...+...+|.+|.+.|.|+.||++|++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3467778899999999999998 55788999998754321 12245678999999999999999999986 667
Q ss_pred eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC---CCcEEEEeec
Q 006083 386 QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD---NFEAMVADFG 462 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~DFG 462 (662)
.+|-|+|||+|.+|+.+|+.. ..+++.++..|++||+.||.||.+. .+.|||-||||.||||.+ -|.+||.|||
T Consensus 542 sFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 889999999999999999654 4589999999999999999999996 567999999999999954 5789999999
Q ss_pred cccccCCCCC------ccccccccCccccCcccccCC----CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHH
Q 006083 463 LAKLSNDNHT------HVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWAR 532 (662)
Q Consensus 463 la~~~~~~~~------~~~~~~~Gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~ 532 (662)
|++...++.. .......||++|++||+|.-+ .++.|+||||+|||+|.++.|+.||........+.+..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN- 697 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN- 697 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh-
Confidence 9998764432 223457899999999988643 57899999999999999999999998765443332211
Q ss_pred HHhHHHhhcCccccccCccc-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 006083 533 PLLGAALEDGIYDGLVDPRL-EHNYVPHEMARLVACGAASIRHSARKRPKMSQIV 586 (662)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 586 (662)
.+-......+ ....+..+...+++ +||...-++|-...|+.
T Consensus 698 ----------TIlkAtEVqFP~KPvVsseAkaFIR---RCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 698 ----------TILKATEVQFPPKPVVSSEAKAFIR---RCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ----------chhcceeccCCCCCccCHHHHHHHH---HHHHhhhhhhhhHHHHc
Confidence 1111011111 12234556666655 89999999998766554
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=297.18 Aligned_cols=248 Identities=21% Similarity=0.320 Sum_probs=192.8
Q ss_pred CCCccceeeccCceEEEEEEec-CCCEEEEEEeecC-----CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTG-----SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
+|.+.+.||+|+||.||++... .+..+++|+++.. .......+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999853 3455666666532 122344677899999999999999999999999999999
Q ss_pred EEecCCcchhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 391 YEFVSNKTLEYHLHG--ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
|||+.+++|.+++.. .....+++..++.++.|+++||.|||+. +|+|+|||++||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 2334689999999999999999999998 9999999999999985 569999999987664
Q ss_pred CCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 469 DNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 469 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
.... ......|+..|++||++.+..++.++||||||+++|+|++|+.+|...........+ ..+...
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~---------~~~~~~--- 223 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI---------VEGPTP--- 223 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---------HcCCCC---
Confidence 3322 223456889999999998888999999999999999999999999754322211111 011111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+. ......+.+++.+||+.+|++||++.|+++
T Consensus 224 --~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 --SLP----ETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --CCc----chhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111 112234555666999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=320.01 Aligned_cols=261 Identities=23% Similarity=0.359 Sum_probs=212.0
Q ss_pred CHHHHHHHhCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEE--
Q 006083 307 TYDELAAATGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYCI-- 382 (662)
Q Consensus 307 ~~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~-- 382 (662)
.++.+..-++-|++.+.||+|.||.||+++ .++|+.+|||++.... ...++++.|.+||+.+ +|+|++.++|+|.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344444556779999999999999999998 6689999999987653 3456788899999988 5999999999886
Q ss_pred ---eCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEE
Q 006083 383 ---AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVA 459 (662)
Q Consensus 383 ---~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~ 459 (662)
.++++|||||||.||+..|+++.-....+.|+.+..|++.+++||.+||++ .+||||||=.||||+.++.|||+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 468999999999999999999877777899999999999999999999999 89999999999999999999999
Q ss_pred eeccccccCCCCCccccccccCccccCcccccCC-----CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH
Q 006083 460 DFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL 534 (662)
Q Consensus 460 DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~ 534 (662)
|||++..+.... ......+||++|||||++... .|+..+|+||||++..||.-|.+|+.....-.-+
T Consensus 166 DFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL------- 237 (953)
T KOG0587|consen 166 DFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL------- 237 (953)
T ss_pred eeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-------
Confidence 999987765432 234558999999999998643 4788999999999999999999998654321111
Q ss_pred hHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 535 LGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 535 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
|.-.-.+...-.....-.+++.+++..||..|.++||++.++++.
T Consensus 238 ---------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 238 ---------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111111122222234455677888889999999999999998864
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=307.59 Aligned_cols=265 Identities=20% Similarity=0.306 Sum_probs=197.2
Q ss_pred HHhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe---
Q 006083 313 AATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQ--- 386 (662)
Q Consensus 313 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~--- 386 (662)
...++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999964 6889999998753 22334667889999999999999999988765554
Q ss_pred ---EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecc
Q 006083 387 ---RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGL 463 (662)
Q Consensus 387 ---~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 463 (662)
.++|+||+ +++|.+++.. ..+++..+.+++.|+++||+|||+. +|+|||||++|||+++++.+||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 6789888854 3489999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH---hHHHh
Q 006083 464 AKLSNDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL---LGAAL 539 (662)
Q Consensus 464 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~---~~~~~ 539 (662)
+...... .....++..|++||++.+ ..++.++|||||||++|||++|+.||......+.+..+.... ....+
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 9866433 233567889999998865 367899999999999999999999997654333222211100 00000
Q ss_pred h---cCccccccC---cccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 540 E---DGIYDGLVD---PRLEHNY---VPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 540 ~---~~~~~~~~d---~~l~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
. ......++. ......+ .......+.+++.+||+.+|++||++.+|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 000000000 0000000 00112456667779999999999999998763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=311.31 Aligned_cols=240 Identities=23% Similarity=0.300 Sum_probs=196.2
Q ss_pred hCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
+..|.+...||.|+|+.|..+. ..+++..+||++.+. ..+..+|+.++.+. +|+||+.+++.+.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 4568888889999999999998 457899999999764 23345677666666 69999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE-CCCCcEEEEeeccccccCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI-DDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl-~~~~~vkl~DFGla~~~~~~~ 471 (662)
++.|+.|.+.+..... ...++..|+.+|+.|+.|||++ +||||||||+|||+ ++.+.++|+|||+++.....
T Consensus 397 ~l~g~ell~ri~~~~~---~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE---FCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch---hHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999999988865443 2267788999999999999998 99999999999999 58899999999999887654
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
...-+-|..|.|||++....|++++||||||++||+||+|+.||.....+..+. ..+..+.+.
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~--------~~i~~~~~s------ 532 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIH--------TRIQMPKFS------ 532 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHH--------HhhcCCccc------
Confidence 223456889999999999999999999999999999999999997764431111 111122222
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
....++.++|+. .||+.||.+|++|.++...
T Consensus 533 ---~~vS~~AKdLl~---~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 ---ECVSDEAKDLLQ---QLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ---cccCHHHHHHHH---HhccCChhhCcChhhhccC
Confidence 345677788777 8999999999999998753
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=325.30 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=204.2
Q ss_pred CCCCccceeeccCceEEEEEEec----C----CCEEEEEEeecCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP----N----GKEVAVKSLKTGSG-QGEREFSAEVEIISRV-HHRHLVSLVGYCIAGG 385 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~----~----g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~ 385 (662)
.+..+.+.||+|.||.|++|... . ...||||+++.... .+.+.+..|+++|+.+ +|+||+.++|+|...+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34455669999999999999732 1 45799999986533 4567899999999999 5999999999999999
Q ss_pred eEEEEEEecCCcchhhhhccCC------------C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC
Q 006083 386 QRMLVYEFVSNKTLEYHLHGEN------------R--PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID 451 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~------------~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~ 451 (662)
..++|+|||..|+|..+|+..+ . ..+...+.+.++.|||.|++||++. ++|||||..+||||.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEec
Confidence 9999999999999999997654 0 1388899999999999999999999 899999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCcccccccc--CccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHH
Q 006083 452 DNFEAMVADFGLAKLSNDNHTHVSTRVMG--TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLV 528 (662)
Q Consensus 452 ~~~~vkl~DFGla~~~~~~~~~~~~~~~G--t~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~ 528 (662)
++..+||+|||+|+..............| ...|||||.+....|+.|+|||||||+|||+++ |..||.+......+.
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 99999999999999755433322222222 446999999999999999999999999999998 788887643222233
Q ss_pred HHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 529 EWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
++. ..|.. .-...++.+++..+|. .||+.+|++||++.|+++.|+.
T Consensus 533 ~~l--------~~G~r------~~~P~~c~~eiY~iM~---~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 533 EFL--------KEGNR------MEQPEHCSDEIYDLMK---SCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHH--------hcCCC------CCCCCCCCHHHHHHHH---HHhCCCcccCCCHHHHHHHHHH
Confidence 222 22221 1123445566665555 8999999999999999999987
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=306.53 Aligned_cols=195 Identities=27% Similarity=0.422 Sum_probs=172.5
Q ss_pred cceeeccCceEEEEEE-ecCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCc
Q 006083 321 SNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNK 397 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g 397 (662)
+++||.|-||+||-|+ .++|+.||||+|.+. ..+....+++|+.||+.++||.||.|...|+..+.+++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 6889999999999998 458999999999764 3344578999999999999999999999999999999999999776
Q ss_pred chhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC---CcEEEEeeccccccCCCCCcc
Q 006083 398 TLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN---FEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 398 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkl~DFGla~~~~~~~~~~ 474 (662)
-|+-+|.. ....+++.....++.||+.||.|||-+ +|+|+||||+||||... -++||||||+|+++++..+
T Consensus 649 MLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-- 722 (888)
T KOG4236|consen 649 MLEMILSS-EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-- 722 (888)
T ss_pred HHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence 66666644 444688888888999999999999999 99999999999999653 4699999999999987543
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCc
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMT 521 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~ 521 (662)
...++||+.|+|||+++++.|...-|+||.|||+|--|.|..||+..
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 45689999999999999999999999999999999999999999765
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=297.38 Aligned_cols=265 Identities=22% Similarity=0.313 Sum_probs=208.0
Q ss_pred HhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCC--C----CcceEEEEEEeCCe
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHH--R----HLVSLVGYCIAGGQ 386 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~H--p----nIv~l~~~~~~~~~ 386 (662)
..++|.+..++|+|.||.|-++.+ +.+..||||+++.-. ...+..+-|+++|++|++ | -+|++.++|+..++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 478899999999999999999984 357899999998632 445667789999999942 2 36788899999999
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC---------------
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID--------------- 451 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~--------------- 451 (662)
.|||+|.+ |.+++++|..+....+....+..++.|++++++|||+. +++|-||||+|||+.
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999976 78999999988888899999999999999999999999 999999999999993
Q ss_pred -----CCCcEEEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhH
Q 006083 452 -----DNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDS 526 (662)
Q Consensus 452 -----~~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~ 526 (662)
++..+||+|||.|....... ..++.|..|.|||++++-.++..+||||+||||+||++|...|....+.+.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 24468999999998765543 446789999999999999999999999999999999999999977655554
Q ss_pred HHHHHHHHhHH----Hhhc---------Cccc-----------cccCc----ccCCCCCHHHHHHHHHHHHHhcccCCCC
Q 006083 527 LVEWARPLLGA----ALED---------GIYD-----------GLVDP----RLEHNYVPHEMARLVACGAASIRHSARK 578 (662)
Q Consensus 527 ~~~~~~~~~~~----~~~~---------~~~~-----------~~~d~----~l~~~~~~~~~~~l~~l~~~cl~~~p~~ 578 (662)
+ +.....++. ++.. +.++ .+.+. ...-.....+..+|++|+..||..||.+
T Consensus 318 L-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 318 L-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred H-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 4 222222111 1111 0000 00000 0011123566777889999999999999
Q ss_pred CCCHHHHHHH
Q 006083 579 RPKMSQIVRA 588 (662)
Q Consensus 579 RPs~~evl~~ 588 (662)
|.++.|++..
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999998863
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=287.44 Aligned_cols=236 Identities=28% Similarity=0.329 Sum_probs=190.7
Q ss_pred eeccCceEEEEEEec-CCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCcch
Q 006083 324 LGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTL 399 (662)
Q Consensus 324 iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L 399 (662)
||+|+||.||++... +++.|++|+++.... .....+..|++++++++|+||+++++.+..++..++||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999854 589999999876532 2345789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccccccc
Q 006083 400 EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM 479 (662)
Q Consensus 400 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 479 (662)
.+++.... .+++..+..++.|++.||.|||+. +++|+|||++||++++++.++|+|||++....... .......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 99996543 488999999999999999999998 99999999999999999999999999997765432 1223456
Q ss_pred cCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHH
Q 006083 480 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPH 559 (662)
Q Consensus 480 Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 559 (662)
|+..|++||.+.+...+.++|+|+||+++|+|++|+.||........+.. .. . .. ..+.. ..+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~----~~----~-~~------~~~~~-~~~- 217 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEK----IL----K-DP------LRFPE-FLS- 217 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH----Hh----c-CC------CCCCC-CCC-
Confidence 88999999999988899999999999999999999999976543211111 00 0 00 01111 112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHH
Q 006083 560 EMARLVACGAASIRHSARKRPKMSQ 584 (662)
Q Consensus 560 ~~~~l~~l~~~cl~~~p~~RPs~~e 584 (662)
..+.+++.+||..||++||++.+
T Consensus 218 --~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 --PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred --HHHHHHHHHHhcCCHhhCCCccc
Confidence 34455666999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=286.89 Aligned_cols=200 Identities=23% Similarity=0.374 Sum_probs=177.6
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC---CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG---SGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv 390 (662)
++|.++++||+|.|.+|.++++ ++.+.||+|+++++ +.++..-++.|..++..- +||.+|.|+.+|.....+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 5799999999999999999984 57889999999875 334445567788887776 799999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
.||++||+|-.++++++ .++++.+..+...|+.||.|||++ |||.||||.+|+|||.+|.+||.|+|+++.....
T Consensus 330 ieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 99999999988776554 489999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMT 521 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~ 521 (662)
. .....++||+.|+|||++++..|....|+|+|||+|+||+.|+.||+..
T Consensus 405 g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 405 G-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred C-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 3 3446699999999999999999999999999999999999999999864
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=289.98 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=190.3
Q ss_pred cceeeccCceEEEEEEe-cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHh-cCCCCcceEEEEEEeCCeEEEEEEecCCc
Q 006083 321 SNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG-QGEREFSAEVEIISR-VHHRHLVSLVGYCIAGGQRMLVYEFVSNK 397 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~~~~~~lv~E~~~~g 397 (662)
+..||.|.||+|++..+ ..|+..|||+++.... .+.++|+.|++...+ -+.+|||+|+|.+-..+..|+.||+|. -
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 46899999999999874 5799999999987655 455678888886544 479999999999999999999999984 4
Q ss_pred chhhhh---ccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 398 TLEYHL---HGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 398 ~L~~~l---~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
+|+.+. ....+..+++..+-+|....+.||.||-+.. .||||||||+||||+..|.+||||||++..+.+.. .
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si--A 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI--A 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH--H
Confidence 554433 3334455888888889999999999998865 89999999999999999999999999998765432 2
Q ss_pred ccccccCccccCcccccC--CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 475 STRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
.+.-+|...|||||.+.. ..|+-++||||||++|||+.||+.|+...+. +.+....+ -.|-...++
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~V-----v~gdpp~l~---- 291 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQV-----VIGDPPILL---- 291 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHHHHH-----HcCCCCeec----
Confidence 344678999999999863 3599999999999999999999999976532 11111111 111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
....+.+....|...+..||..|-.+||...++++.
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111122233445555668999999999999988864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=306.67 Aligned_cols=200 Identities=25% Similarity=0.331 Sum_probs=170.8
Q ss_pred CCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCch---hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQ---GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
|.+++.||-|+||+|.+++ .++...||+|.|++.+.- ....++.|.+||..-+.+=||+||..|.+++.+|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 7778889999999999998 446778999999875332 234578899999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc------
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS------ 467 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~------ 467 (662)
+.||++-.+|.+.+ .+.+..++.++.++.+|+++.|+. |+|||||||+|||||.+|.+||+|||||.-+
T Consensus 711 IPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred cCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccc
Confidence 99999999886544 477788888899999999999999 9999999999999999999999999998522
Q ss_pred ---CCCCCcc--------------------------------ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHH
Q 006083 468 ---NDNHTHV--------------------------------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 512 (662)
Q Consensus 468 ---~~~~~~~--------------------------------~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLl 512 (662)
..+..+. ....+||..|+|||++....|+.-+|+|+.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 1110000 01247999999999999999999999999999999999
Q ss_pred hCCCCCCCch
Q 006083 513 TGRRPVDMTM 522 (662)
Q Consensus 513 tG~~Pf~~~~ 522 (662)
.|+.||-...
T Consensus 866 ~g~~pf~~~t 875 (1034)
T KOG0608|consen 866 VGQPPFLADT 875 (1034)
T ss_pred hCCCCccCCC
Confidence 9999997654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=280.19 Aligned_cols=263 Identities=25% Similarity=0.356 Sum_probs=193.5
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEe--------C
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ--GEREFSAEVEIISRVHHRHLVSLVGYCIA--------G 384 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~--------~ 384 (662)
+.|+...+||+|.||.||+++. .+|+.||+|++..++.. .-....+|+++|..|+|+|++.|+..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3477788999999999999984 46788999987543221 12456789999999999999999988753 3
Q ss_pred CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
..+||||+||+. +|.-+|.. ....+...++.+++.++..||.|+|+. .|+|||+|++|+||+.++.+||+|||++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 458999999964 55555533 234588899999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCC---ccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHH--
Q 006083 465 KLSNDNHT---HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAA-- 538 (662)
Q Consensus 465 ~~~~~~~~---~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~-- 538 (662)
+.+..... ...+..+-|.+|..||.+.+ .+|+.+.|||..||||.||++|.+-|.++.....+.. +..+++..
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~-Is~LcGs~tk 250 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHL-ISQLCGSITK 250 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHH-HHHHhccCCc
Confidence 76543221 12344567999999998876 5799999999999999999999999987765444332 22222211
Q ss_pred --------------h-----hcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 539 --------------L-----EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 539 --------------~-----~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+ .++.+. .+..++....-.++..+|++ .++..||.+|+.+.+++..
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~r-kv~n~~kp~~kd~~a~dLle---~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKR-KVKNRLKPYVKDDEALDLLE---KLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhh-hhhhhcccccCChhHHHHHH---HHhccCcccCcchHhhhch
Confidence 0 011111 11112222222334444554 7889999999999998864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=265.54 Aligned_cols=207 Identities=25% Similarity=0.407 Sum_probs=171.2
Q ss_pred HHHHhCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecC-CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 006083 311 LAAATGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTG-SGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 311 i~~~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 387 (662)
++...+.......||+|+||.|-+.+ ..+|...|+|.++.. +.+..+++.+|+++..+- .+|.+|.|+|.+...+..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 33444455667889999999998887 458999999999765 445667788899987665 699999999999999999
Q ss_pred EEEEEecCCcchhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccc
Q 006083 388 MLVYEFVSNKTLEYHLHG--ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
|+.||.| ..+|+.+... .....+++..+-+|+..+.+||.|||++. .|||||+||.||||+.+|+|||||||++.
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999988 4566555432 24456888999999999999999999986 89999999999999999999999999998
Q ss_pred ccCCCCCccccccccCccccCcccccC----CCCCchHHHHHHHHHHHHHHhCCCCCCCch
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYASS----GKLTEKSDVFSFGVMLLELITGRRPVDMTM 522 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~ 522 (662)
.+.+... .+.-.|.-.|||||.+.. ..|+-|+||||||+.++||.+++.||+...
T Consensus 198 ~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 198 YLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred eehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 7765321 223568889999998853 369999999999999999999999998754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=304.96 Aligned_cols=203 Identities=24% Similarity=0.336 Sum_probs=155.1
Q ss_pred hCCCCccceeeccCceEEEEEEe-----------------cCCCEEEEEEeecCCchhHHH--------------HHHHH
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-----------------PNGKEVAVKSLKTGSGQGERE--------------FSAEV 363 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~--------------~~~E~ 363 (662)
.++|++.++||+|+||.||+|.+ ..++.||||+++.......++ ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 45799999999999999999963 245689999997543322222 33477
Q ss_pred HHHHhcCCCCc-----ceEEEEEEe--------CCeEEEEEEecCCcchhhhhccCCC----------------------
Q 006083 364 EIISRVHHRHL-----VSLVGYCIA--------GGQRMLVYEFVSNKTLEYHLHGENR---------------------- 408 (662)
Q Consensus 364 ~il~~l~HpnI-----v~l~~~~~~--------~~~~~lv~E~~~~g~L~~~l~~~~~---------------------- 408 (662)
.++.+++|.++ ++++++|.. .+..||||||+.+++|.++|+....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77778876554 677787753 3568999999999999999864311
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccccccccCccccCcc
Q 006083 409 PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE 488 (662)
Q Consensus 409 ~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE 488 (662)
..+++..++.++.+++++|.|||++ +|+|||||++|||++.++.+||+|||+++..............+++.|++||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 1246678889999999999999998 8999999999999999999999999999765433221222234588999999
Q ss_pred cccCCC--------------------C--CchHHHHHHHHHHHHHHhCCC-CCCC
Q 006083 489 YASSGK--------------------L--TEKSDVFSFGVMLLELITGRR-PVDM 520 (662)
Q Consensus 489 ~~~~~~--------------------~--~~~sDvwSlGvvl~eLltG~~-Pf~~ 520 (662)
.+.... | ..+.||||+|||||+|++|.. +|..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 876422 1 235799999999999999986 6643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=267.94 Aligned_cols=275 Identities=20% Similarity=0.313 Sum_probs=207.4
Q ss_pred ccCCCCCCCcCHHHHHHHh---CCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-C
Q 006083 297 IALGFNKSTFTYDELAAAT---GGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-H 371 (662)
Q Consensus 297 ~~~~~~~~~~~~~ei~~~~---~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-H 371 (662)
+........|+++.....+ ++|++.+.+|+|.|+.||.|. ..+++.++||+++. ...+.+.+|++||..|. |
T Consensus 16 vn~~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg 92 (338)
T KOG0668|consen 16 VNEERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGG 92 (338)
T ss_pred ccccCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCC
Confidence 3344445567777655443 579999999999999999998 56889999999986 45678999999999997 9
Q ss_pred CCcceEEEEEEeC--CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEE
Q 006083 372 RHLVSLVGYCIAG--GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANIL 449 (662)
Q Consensus 372 pnIv~l~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NIL 449 (662)
+||+.|+++..+. ....||+||+++.+...+. +.+...++..++.++++||.|||+. ||+|||+||.|++
T Consensus 93 ~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvm 164 (338)
T KOG0668|consen 93 PNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVM 164 (338)
T ss_pred CCeeehhhhhcCccccCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceee
Confidence 9999999998764 5567999999998887655 2477788999999999999999999 9999999999999
Q ss_pred ECC-CCcEEEEeeccccccCCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCC-chhhhH
Q 006083 450 IDD-NFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDM-TMMEDS 526 (662)
Q Consensus 450 l~~-~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~-~~~~~~ 526 (662)
||. ...++|+|||+|.++..+.. ....+.+..|.-||++.. ..|+..-|+|||||+|..|+..+.||.. ....+.
T Consensus 165 Idh~~rkLrlIDWGLAEFYHp~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ 242 (338)
T KOG0668|consen 165 IDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 242 (338)
T ss_pred echhhceeeeeecchHhhcCCCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH
Confidence 996 45689999999988765432 233456788999999875 4688999999999999999999999754 455667
Q ss_pred HHHHHHHHhHHHhh----c------CccccccCc----cc-------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 006083 527 LVEWARPLLGAALE----D------GIYDGLVDP----RL-------EHNYVPHEMARLVACGAASIRHSARKRPKMSQI 585 (662)
Q Consensus 527 ~~~~~~~~~~~~~~----~------~~~~~~~d~----~l-------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 585 (662)
++.+++-+-...+. + ..+..++.. .+ .......+..+|++ ..|..|-++|+|++|.
T Consensus 243 LVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlld---klLrYDHqeRlTakEa 319 (338)
T KOG0668|consen 243 LVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLD---KLLRYDHQERLTAKEA 319 (338)
T ss_pred HHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHH---HHHhhccccccchHHH
Confidence 77766643111111 0 111111111 00 01122344444444 6789999999999987
Q ss_pred HH
Q 006083 586 VR 587 (662)
Q Consensus 586 l~ 587 (662)
+.
T Consensus 320 m~ 321 (338)
T KOG0668|consen 320 MA 321 (338)
T ss_pred hc
Confidence 64
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.25 Aligned_cols=203 Identities=25% Similarity=0.296 Sum_probs=178.1
Q ss_pred CCCCccceeeccCceEEEEEEecCCC-EEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGK-EVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~-~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
.+++....||-||||.|-++...... .+|+|++++... ...+.+..|.+||...+.+.||+||.-|.+...+|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34556677999999999998864433 389999987533 33456788999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
|-|-||.|...|+.. +.++......++..+++|++|||++ +||.|||||+|+||+.+|-+||.|||+|+.+..+.
T Consensus 500 EaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 500 EACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999999999544 4588888889999999999999999 99999999999999999999999999999988765
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhh
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMED 525 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~ 525 (662)
. .-.+|||+.|.|||++.++.++.++|.|+||+++||||+|+.||.+.+.-.
T Consensus 575 K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk 626 (732)
T KOG0614|consen 575 K--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK 626 (732)
T ss_pred c--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH
Confidence 4 345899999999999999999999999999999999999999998765433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=275.16 Aligned_cols=238 Identities=26% Similarity=0.292 Sum_probs=193.8
Q ss_pred CceEEEEEEec-CCCEEEEEEeecCCchh-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCcchhhhhcc
Q 006083 328 GFGYVHKGVLP-NGKEVAVKSLKTGSGQG-EREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHG 405 (662)
Q Consensus 328 ~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~ 405 (662)
+||.||+|+.. +|+.|++|++....... .+.+.+|++++++++|+||+++++++..+...+++|||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999965 58999999998765444 67899999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccccccccCcccc
Q 006083 406 ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL 485 (662)
Q Consensus 406 ~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~ 485 (662)
... +++..++.++.+++++|.|||+. +|+|+||++.||++++++.++|+|||++....... ......|+..|+
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 433 78999999999999999999998 99999999999999999999999999998766542 234466889999
Q ss_pred CcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHH
Q 006083 486 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLV 565 (662)
Q Consensus 486 aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 565 (662)
+||.+.+..++.++|||+||+++|+|++|+.||......+.+.++.. .+.... ...... ...++.
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~--------~~~~~~----~~~~~~---~~~~~~ 218 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG--------KPKPPF----PPPEWK---ISPEAK 218 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh--------ccCCCC----cccccc---CCHHHH
Confidence 99999888899999999999999999999999976432322222211 111110 000000 224566
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 006083 566 ACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 566 ~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 6777999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=313.93 Aligned_cols=258 Identities=20% Similarity=0.255 Sum_probs=170.8
Q ss_pred HhCCCCccceeeccCceEEEEEEec-C----CCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEE------EE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP-N----GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGY------CI 382 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~----g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~------~~ 382 (662)
..++|++.++||+|+||.||+|.+. + +..||||+++.... .+.+..| .+.+..+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4567999999999999999999964 4 68999999864321 1111111 1222223333322221 24
Q ss_pred eCCeEEEEEEecCCcchhhhhccCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCc
Q 006083 383 AGGQRMLVYEFVSNKTLEYHLHGENRP------------------VMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIK 444 (662)
Q Consensus 383 ~~~~~~lv~E~~~~g~L~~~l~~~~~~------------------~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIk 444 (662)
.+..++|||||+.+++|.++++..... ......+..++.||++||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 567899999999999999988643211 111234567999999999999998 89999999
Q ss_pred cCcEEECC-CCcEEEEeeccccccCCCCCccccccccCccccCcccccCC----------------------CCCchHHH
Q 006083 445 AANILIDD-NFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSG----------------------KLTEKSDV 501 (662)
Q Consensus 445 p~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~----------------------~~~~~sDv 501 (662)
|+||||++ ++.+||+|||+++.............+|++.|||||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 67999999999987654433344567899999999965322 34567799
Q ss_pred HHHHHHHHHHHhCCCCCCCchhhh---------HHHHHHHHHhHHHhhcCccccccCcccCCCC--CHHHHHHHHHHHHH
Q 006083 502 FSFGVMLLELITGRRPVDMTMMED---------SLVEWARPLLGAALEDGIYDGLVDPRLEHNY--VPHEMARLVACGAA 570 (662)
Q Consensus 502 wSlGvvl~eLltG~~Pf~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~l~~~ 570 (662)
||||||||||+++..+++...... .+..|.... ... ....+...+ .........+++.+
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-----~~~-----~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLV-----EPR-----ASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhh-----ccc-----cchhhhhhhhhccccchHHHHHHHH
Confidence 999999999999887764321100 011111110 000 000000000 00011223356679
Q ss_pred hcccCCCCCCCHHHHHHH
Q 006083 571 SIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 571 cl~~~p~~RPs~~evl~~ 588 (662)
||+.||++||++.|+++.
T Consensus 433 mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 433 MMRFKGRQRISAKAALAH 450 (566)
T ss_pred HccCCcccCCCHHHHhCC
Confidence 999999999999999974
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=279.38 Aligned_cols=219 Identities=22% Similarity=0.206 Sum_probs=173.4
Q ss_pred cCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCcchhhhhcc
Q 006083 327 GGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHG 405 (662)
Q Consensus 327 G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~ 405 (662)
|.||.||+++. .+++.||+|+++... .+.+|...+....|+||+++++++.+++..++||||+.|++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999984 478999999997642 234455555666799999999999999999999999999999999865
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccccccccCcccc
Q 006083 406 ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL 485 (662)
Q Consensus 406 ~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~ 485 (662)
.. .+++..+..++.|+++||+|||+. +|+||||||+|||+++++.++|+|||++....... ....++..|+
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~ 149 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYC 149 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcccc
Confidence 43 488999999999999999999998 99999999999999999999999999886654321 2234577899
Q ss_pred CcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHH
Q 006083 486 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLV 565 (662)
Q Consensus 486 aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 565 (662)
+||++.++.++.++|||||||++|||++|+.+|...... + .......+... ... .+.
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~--------------~~~~~~~~~~~-~~~---~~~ 206 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I--------------NTHTTLNIPEW-VSE---EAR 206 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c--------------ccccccCCccc-CCH---HHH
Confidence 999998888999999999999999999999887532110 0 00000011111 223 344
Q ss_pred HHHHHhcccCCCCCCCH
Q 006083 566 ACGAASIRHSARKRPKM 582 (662)
Q Consensus 566 ~l~~~cl~~~p~~RPs~ 582 (662)
+++.+||+.||++|+++
T Consensus 207 ~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 207 SLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHccCCHHHhcCC
Confidence 55568999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=280.47 Aligned_cols=264 Identities=23% Similarity=0.321 Sum_probs=203.6
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-----C---CCcceEEEEEE----
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-----H---RHLVSLVGYCI---- 382 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-----H---pnIv~l~~~~~---- 382 (662)
++|.+.++||.|.|++||++.+ .+.+.||+|+++.. ....+..+.||++|++++ | .+||+|+++|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6788999999999999999984 46789999999864 344566788999999984 2 47999999997
Q ss_pred eCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC---------
Q 006083 383 AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN--------- 453 (662)
Q Consensus 383 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~--------- 453 (662)
.+.++|+|+|++ |.+|..+|.....+.+....+.+|++||+.||.|||+.| +|||-||||+||||..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhh
Confidence 567999999987 889999998887788999999999999999999999999 99999999999998300
Q ss_pred --------------------------------------------------------------------------------
Q 006083 454 -------------------------------------------------------------------------------- 453 (662)
Q Consensus 454 -------------------------------------------------------------------------------- 453 (662)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred -----------------------------------------------------------------------------CcE
Q 006083 454 -----------------------------------------------------------------------------FEA 456 (662)
Q Consensus 454 -----------------------------------------------------------------------------~~v 456 (662)
.++
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 025
Q ss_pred EEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCc------hhhhHHHHH
Q 006083 457 MVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMT------MMEDSLVEW 530 (662)
Q Consensus 457 kl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~------~~~~~~~~~ 530 (662)
||+|||.|.+.... .+.-+.|..|.|||++.+..|...+||||++|++|||+||...|+.. .+++.+..+
T Consensus 394 KIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 394 KIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred EEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 66666666654322 12335678899999999999999999999999999999999999643 344444433
Q ss_pred HHHHhHHH----hh-----------cCccccccCcc-------cC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 006083 531 ARPLLGAA----LE-----------DGIYDGLVDPR-------LE--HNYVPHEMARLVACGAASIRHSARKRPKMSQIV 586 (662)
Q Consensus 531 ~~~~~~~~----~~-----------~~~~~~~~d~~-------l~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 586 (662)
.. ++... .. .|.+..+-... |. ..+..++..++..++.-||+.+|++|+++.+.+
T Consensus 470 ~E-LLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl 548 (590)
T KOG1290|consen 470 ME-LLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL 548 (590)
T ss_pred HH-HHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh
Confidence 22 22211 11 12222221111 11 224677888899999999999999999999998
Q ss_pred HH
Q 006083 587 RA 588 (662)
Q Consensus 587 ~~ 588 (662)
+.
T Consensus 549 ~h 550 (590)
T KOG1290|consen 549 KH 550 (590)
T ss_pred cC
Confidence 63
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=300.06 Aligned_cols=243 Identities=26% Similarity=0.379 Sum_probs=185.7
Q ss_pred CCccceeeccCce-EEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 318 FAKSNLLGQGGFG-YVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 318 ~~~~~~iG~G~~g-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
|.-.+++|.|..| .||+|.+ +|+.||||++-. .......+|++.|+.- +|+|||++++.-.+.+..||+.|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 4445668999886 6799998 789999999864 2334568999999988 5999999999999999999999999
Q ss_pred CcchhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC-----CCcEEEEeeccccccC
Q 006083 396 NKTLEYHLHGE--NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-----NFEAMVADFGLAKLSN 468 (662)
Q Consensus 396 ~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-----~~~vkl~DFGla~~~~ 468 (662)
..+|.+++... ..........+.++.|+++||++||+. +||||||||.||||.. ..+++|+|||+++...
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 67999998653 222222245678899999999999996 9999999999999964 3678999999999887
Q ss_pred CCCCcc--ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhC-CCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 469 DNHTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG-RRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 469 ~~~~~~--~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
.+.... .....||.+|+|||++....-+.++||||||||+|+.++| .+||......+ .+++.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~---------------~NIl~ 727 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ---------------ANILT 727 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh---------------hhhhc
Confidence 654433 2347899999999999988888899999999999998886 89996543221 01111
Q ss_pred cccCc-ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GLVDP-RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~~d~-~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..... .|.... ..+..+|+ .+|++.+|..||++.+|+.
T Consensus 728 ~~~~L~~L~~~~-d~eA~dLI---~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 728 GNYTLVHLEPLP-DCEAKDLI---SRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred CccceeeeccCc-hHHHHHHH---HHhcCCCcccCCCHHHHhC
Confidence 11111 111111 11455554 4899999999999999983
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-33 Score=267.92 Aligned_cols=266 Identities=21% Similarity=0.278 Sum_probs=191.2
Q ss_pred CCccceeeccCceEEEEEEe-cCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeEEE
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAG-----GQRML 389 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~l 389 (662)
.+-++-||-|+||.||...+ ++|+.||+|++-.- +....+.+.+|+++|..++|.|++..+++..-. +++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 45578899999999999884 48999999988643 222346788999999999999999988866532 34577
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
|.|++ ..+|..+|-. -+.++...+.-+++||++||.|||+. +|+||||||.|+||+.|..+||||||+++....
T Consensus 135 ~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 77776 4566665532 33477778888999999999999999 999999999999999999999999999997665
Q ss_pred CCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH-------hHHHhhc
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL-------LGAALED 541 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~-------~~~~~~~ 541 (662)
+.....+..+-|-+|.|||++++ ..|+.+.||||.|||+.|||-.+..|.....-+.+.-+...+ ++.+- +
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC-E 287 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC-E 287 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh-h
Confidence 54444455667899999999987 469999999999999999999999897765444332221110 00010 1
Q ss_pred CccccccCc-----ccCCCC---C-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 542 GIYDGLVDP-----RLEHNY---V-PHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 542 ~~~~~~~d~-----~l~~~~---~-~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
|-...+++. .+...| . .+.-.+-+.+.+.++..|+++|-+..+.+..+.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111111111 111111 1 112223344556789999999999888876654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=283.35 Aligned_cols=196 Identities=24% Similarity=0.374 Sum_probs=169.7
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchh--------HHHHHHHHHHHHhcC---CCCcceEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQG--------EREFSAEVEIISRVH---HRHLVSLVGYCIA 383 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--------~~~~~~E~~il~~l~---HpnIv~l~~~~~~ 383 (662)
.+|...+.+|+|+||.|++|+++ +...|+||++.++..-. .-.+-.|++||.+|+ |+||+++++||++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35888999999999999999954 67789999998752211 112456999999998 9999999999999
Q ss_pred CCeEEEEEEec-CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeec
Q 006083 384 GGQRMLVYEFV-SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFG 462 (662)
Q Consensus 384 ~~~~~lv~E~~-~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFG 462 (662)
++.+||+||-. +|-+|+++|..+ ..+++.+...|+.|++.|+++||++ +|||||||-+|++|+.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeecc
Confidence 99999999965 456899999544 4599999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccCccccCcccccCCCCC-chHHHHHHHHHHHHHHhCCCCCC
Q 006083 463 LAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPVD 519 (662)
Q Consensus 463 la~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~eLltG~~Pf~ 519 (662)
.+.+...+.+ ..++||..|.|||++.+..|- ..-|||+||++||-++....||.
T Consensus 716 saa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9988776654 457899999999999988775 56799999999999999888874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=251.39 Aligned_cols=199 Identities=31% Similarity=0.416 Sum_probs=174.6
Q ss_pred CCccceeeccCceEEEEEEecC-CCEEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 318 FAKSNLLGQGGFGYVHKGVLPN-GKEVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
|.+.+.||.|+||.||++...+ ++.++||.+...... ..+.+.+|++.+++++|+|++++++++......++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999754 899999999876554 67789999999999999999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
+++|.+++...... +++..+..++.+++.+|.|||++ +++|+||++.||+++.++.++|+|||++...........
T Consensus 81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 99999998654322 78899999999999999999998 999999999999999999999999999987754421122
Q ss_pred cccccCccccCcccc-cCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Q 006083 476 TRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGRRPVDM 520 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~ 520 (662)
....+...|++||.+ ....++.++|||+||+++|||++|+.||+.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 345678899999998 666788899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=246.26 Aligned_cols=211 Identities=35% Similarity=0.537 Sum_probs=182.9
Q ss_pred eeccCceEEEEEEec-CCCEEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCcchhh
Q 006083 324 LGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEY 401 (662)
Q Consensus 324 iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~ 401 (662)
||+|.+|.||++... +++.++||++...... ..+.+.+|+++++++.|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999964 4899999999875432 35679999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC-CCcEEEEeeccccccCCCCCcccccccc
Q 006083 402 HLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-NFEAMVADFGLAKLSNDNHTHVSTRVMG 480 (662)
Q Consensus 402 ~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~G 480 (662)
++.... ..+++..++.++.+++++|.|||+. +++|+||++.||+++. ++.++|+|||++........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 986542 3578999999999999999999999 9999999999999999 89999999999987654321 1233567
Q ss_pred CccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHH
Q 006083 481 TFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPH 559 (662)
Q Consensus 481 t~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 559 (662)
...|++||.+... .++.+.|+|+||++||+|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999999877 888999999999999999
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 006083 560 EMARLVACGAASIRHSARKRPKMSQIVRAL 589 (662)
Q Consensus 560 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 589 (662)
..+.+++..|++.+|.+||++.++++.|
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3455666689999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=273.45 Aligned_cols=209 Identities=23% Similarity=0.255 Sum_probs=175.2
Q ss_pred HHHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC------CCCcceEEEEEEeC
Q 006083 312 AAATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH------HRHLVSLVGYCIAG 384 (662)
Q Consensus 312 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~~~~~~~ 384 (662)
+.+.++|.+....|+|-|++|..|.. ..|+.||||+|.++... .+.=+.|++||++|+ --|+++|+-.|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 44667899899999999999999984 35789999999875432 234467999999996 36899999999999
Q ss_pred CeEEEEEEecCCcchhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC-CCcEEEEeec
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGE-NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-NFEAMVADFG 462 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFG 462 (662)
+++|||||-+ ..+|.+.|+.. .+-.|....+..++.|++.||..|-+. +|+|.||||+||||++ ...+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCc
Confidence 9999999966 67888888654 334577788899999999999999885 9999999999999987 4568999999
Q ss_pred cccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHH
Q 006083 463 LAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLV 528 (662)
Q Consensus 463 la~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~ 528 (662)
.|....++.. +.+.-+..|.|||++++..|+...|+||+||+||||+||+..|.+....++|.
T Consensus 583 SA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 583 SASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred cccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 9988776543 33445667999999999999999999999999999999999998876665553
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=254.72 Aligned_cols=195 Identities=26% Similarity=0.345 Sum_probs=162.9
Q ss_pred CCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe------CCe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIA------GGQ 386 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------~~~ 386 (662)
.+|..++.+|.|.- .|..+. .-.++.||+|++... .....++..+|+.+|..++|+||++++.+|.- -.+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34777788899888 454444 236889999988543 23445778899999999999999999999863 346
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
.|+||||+ ..+|...++. .++-+.+.+|++|+++|+.|||+. +|+||||||+||+|+.+..+||+|||+|+.
T Consensus 96 ~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 79999998 5677766652 256678889999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCc
Q 006083 467 SNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMT 521 (662)
Q Consensus 467 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~ 521 (662)
.+.. ...+.++.+..|.|||++.+..|.+.+||||+|||+.||++|+.-|.+.
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 5543 3456688999999999999888999999999999999999999999754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-31 Score=283.18 Aligned_cols=252 Identities=22% Similarity=0.333 Sum_probs=201.5
Q ss_pred hCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
.++|++...||.|.||.||+++ ...++..|||+++........-++.|+-+++..+|+|||.++|-+...+.+|++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 4568899999999999999999 457899999999988778888899999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
|.||+|.+..+. ...+.+.++..+.+..+++|.|||++ +-+|||||-.|||+++.|.+||+|||.+-.+...- .
T Consensus 94 cgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-A 167 (829)
T ss_pred cCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh-h
Confidence 999999998854 44688899999999999999999999 88999999999999999999999999987665432 2
Q ss_pred cccccccCccccCcccc---cCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 474 VSTRVMGTFGYLAPEYA---SSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
....+.||++|||||+. +.+.|..++|||++|+...||---+.|.........+. .+....++..
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~---------LmTkS~~qpp--- 235 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF---------LMTKSGFQPP--- 235 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH---------HhhccCCCCC---
Confidence 33568999999999976 46789999999999999999988777743322211111 0111122221
Q ss_pred ccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 551 RLEHNY-VPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 551 ~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+++.. =.+. +-++++.|+..+|++||++..++.
T Consensus 236 ~lkDk~kws~~---fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TLKDKTKWSEF---FHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccCCccchHH---HHHHHHHHhcCCCccCCChhhhee
Confidence 121111 1222 334556899999999999887764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=249.83 Aligned_cols=198 Identities=26% Similarity=0.382 Sum_probs=165.9
Q ss_pred HhCCCCccceeeccCceEEEEEEec----CCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP----NGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~ 388 (662)
..+.|...++||+|.|+.||++.+. .++.||+|.+...+ .-..+.+|+++|.++. +.||+++.+++..++...
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 4467889999999999999999843 46889999997653 3456899999999995 999999999999999999
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC-CCcEEEEeecccccc
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-NFEAMVADFGLAKLS 467 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~~~ 467 (662)
+||||++.....+++.. ++..++..++..++.||.++|.+ |||||||||.|||.+. .++-.|+|||+|...
T Consensus 112 ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred EEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHH
Confidence 99999999999888754 56889999999999999999999 9999999999999975 567889999999721
Q ss_pred CCCC------------------Cc-------------------------cccccccCccccCcccccC-CCCCchHHHHH
Q 006083 468 NDNH------------------TH-------------------------VSTRVMGTFGYLAPEYASS-GKLTEKSDVFS 503 (662)
Q Consensus 468 ~~~~------------------~~-------------------------~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwS 503 (662)
.... .. ......||++|.|||++.. ...+.+.||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 1000 00 0011469999999998875 56788999999
Q ss_pred HHHHHHHHHhCCCCCCCc
Q 006083 504 FGVMLLELITGRRPVDMT 521 (662)
Q Consensus 504 lGvvl~eLltG~~Pf~~~ 521 (662)
.|||++.+++++.||...
T Consensus 264 ~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKA 281 (418)
T ss_pred ccceeehhhccccccccC
Confidence 999999999999998654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=235.52 Aligned_cols=250 Identities=19% Similarity=0.324 Sum_probs=182.8
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEE-EEeCCeEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGY-CIAGGQRMLVY 391 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~-~~~~~~~~lv~ 391 (662)
.+.|.+.+.||+|.||.+.++.++ ....+++|.+... ....++|.+|...--.| .|.||+.-+++ |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 345999999999999999999865 5778999998753 23467888998776666 49999987764 67778889999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC--CCCcEEEEeeccccccCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID--DNFEAMVADFGLAKLSND 469 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~--~~~~vkl~DFGla~~~~~ 469 (662)
||+..|+|..-+... .+-+....+++.|++.||.|+|++ ++||||||.+||||- +..+|||||||+.+..+.
T Consensus 102 E~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999999877543 367788899999999999999999 999999999999994 345899999999876553
Q ss_pred CCCccccccccCccccCcccccC---C--CCCchHHHHHHHHHHHHHHhCCCCCCCch-hhhHHHHHHHHHhHHHhhcCc
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASS---G--KLTEKSDVFSFGVMLLELITGRRPVDMTM-MEDSLVEWARPLLGAALEDGI 543 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~---~--~~~~~sDvwSlGvvl~eLltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~ 543 (662)
.. ....-+..|.+||++.. + ......|||.||+|+|.+|+|+.||.... ....+.+|..=. .+.
T Consensus 176 tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~------~rk 245 (378)
T KOG1345|consen 176 TV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL------KRK 245 (378)
T ss_pred ee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh------ccc
Confidence 22 22333567999997752 2 24578899999999999999999997543 333455543311 111
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 544 YDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 544 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
... -++.-..+. .+++++..+.|..++++|=-..++.+
T Consensus 246 ~~~--~P~~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 246 NPA--LPKKFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred Ccc--CchhhcccC----HHHHHHHHHhcCCcccccchhHHHHH
Confidence 111 111222222 34445555788999999944444443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=278.87 Aligned_cols=195 Identities=14% Similarity=0.186 Sum_probs=137.3
Q ss_pred hcCC-CCcceEEEEE-------EeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcee
Q 006083 368 RVHH-RHLVSLVGYC-------IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439 (662)
Q Consensus 368 ~l~H-pnIv~l~~~~-------~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iv 439 (662)
+++| .||++++++| ...+.++++|||+ +++|.++|... ...+++.+++.++.||++||+|||++ +||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 4455 5888888877 2334677889987 66999999643 34589999999999999999999998 999
Q ss_pred ecCCccCcEEECCCC-------------------cEEEEeeccccccCCCCC---------------ccccccccCcccc
Q 006083 440 HRDIKAANILIDDNF-------------------EAMVADFGLAKLSNDNHT---------------HVSTRVMGTFGYL 485 (662)
Q Consensus 440 HrDIkp~NILl~~~~-------------------~vkl~DFGla~~~~~~~~---------------~~~~~~~Gt~~y~ 485 (662)
||||||+||||+..+ .+||+|||+++....... ......+||..||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999996544 455555665543211000 0011246899999
Q ss_pred CcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHH
Q 006083 486 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLV 565 (662)
Q Consensus 486 aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 565 (662)
|||++.+..|+.++||||||||||||++|..++.... ..+..+.. .. +.... .....++.
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~---------~~----~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRH---------RV----LPPQI-----LLNWPKEA 242 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHH---------hh----cChhh-----hhcCHHHH
Confidence 9999999999999999999999999999988864321 11111100 00 00000 01122344
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 006083 566 ACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 566 ~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.++.+||+.+|.+||++.||++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 5667899999999999999985
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=237.95 Aligned_cols=165 Identities=21% Similarity=0.258 Sum_probs=130.5
Q ss_pred HHhCCCCccceeeccCceEEEEEEec--CCCEEEEEEeecC-----CchhHHHHHHHHHHHHhcCCCCcce-EEEEEEeC
Q 006083 313 AATGGFAKSNLLGQGGFGYVHKGVLP--NGKEVAVKSLKTG-----SGQGEREFSAEVEIISRVHHRHLVS-LVGYCIAG 384 (662)
Q Consensus 313 ~~~~~~~~~~~iG~G~~g~Vy~~~~~--~g~~vavK~l~~~-----~~~~~~~~~~E~~il~~l~HpnIv~-l~~~~~~~ 384 (662)
...++|.+.+.||+|+||.||+|+.. +++.||||++... .....+.|.+|+++|++|+|+||+. +++ .
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~ 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----T 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----c
Confidence 45577999999999999999999853 5778899987533 1223567899999999999999985 443 2
Q ss_pred CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCC-ccCcEEECCCCcEEEEeecc
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDI-KAANILIDDNFEAMVADFGL 463 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDI-kp~NILl~~~~~vkl~DFGl 463 (662)
+..|||||||.|++|... ... . ...++.+++++|.|||++ +|+|||| ||+||||+.++++||+|||+
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~~-----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RPH-----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Ccc-----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 457999999999999632 111 1 146788999999999998 9999999 99999999999999999999
Q ss_pred ccccCCCCCcc-------ccccccCccccCcccccCC
Q 006083 464 AKLSNDNHTHV-------STRVMGTFGYLAPEYASSG 493 (662)
Q Consensus 464 a~~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~~ 493 (662)
|+.+....... ....+|++.|++||++...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 98765432111 1356789999999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-24 Score=229.76 Aligned_cols=257 Identities=23% Similarity=0.288 Sum_probs=194.4
Q ss_pred CCCccceeeccCceEEEEEEecCC--CEEEEEEeecCCchhHHHHHHHHHHHHhcCC----CCcceEEEEE-EeCCeEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLPNG--KEVAVKSLKTGSGQGEREFSAEVEIISRVHH----RHLVSLVGYC-IAGGQRML 389 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~E~~il~~l~H----pnIv~l~~~~-~~~~~~~l 389 (662)
+|.+.+.||+|+||.||++..... ..+|+|+...........+..|+++|..+.+ .++..+++.. ..+...|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996443 5789998876533333378889999999873 6899999998 47788899
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC-----CcEEEEeeccc
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN-----FEAMVADFGLA 464 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~-----~~vkl~DFGla 464 (662)
||+.+ |.+|.++........++..+.++|+.|++.+|++||+. |+|||||||.|+++... ..+.|+|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99976 89999987655556799999999999999999999999 99999999999999754 46889999999
Q ss_pred c--ccC-CCCC---cc---ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh
Q 006083 465 K--LSN-DNHT---HV---STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL 535 (662)
Q Consensus 465 ~--~~~-~~~~---~~---~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~ 535 (662)
+ .+. .... .. ...+.||..|++++...+...+.+.|+||++.++.||+.|..||.................
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 321 1111 01 1235699999999999999999999999999999999999999965543222222111110
Q ss_pred HHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 536 GAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 536 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...... .....+.++..++. .+-..+...+|....+...|+.
T Consensus 255 -----~~~~~~------~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 255 -----KLLTDR------FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred -----hhcccc------ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHH
Confidence 111110 12233455555554 3444789999999999888764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=208.96 Aligned_cols=164 Identities=15% Similarity=0.125 Sum_probs=123.7
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
|+|.++++.. +..+++..+++|+.|+++||.|||++ + |++|||+++++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-----
Confidence 6888888643 33589999999999999999999998 5 999999999999999 99998765422
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhh-hHHHHHHHHHhHHHhhcCccccccCcccCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMME-DSLVEWARPLLGAALEDGIYDGLVDPRLEHN 555 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 555 (662)
..|+..|||||++.+..++.++|||||||+||||++|+.||...... ..+..+.... . .. .....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~----~-----~~----~~~~~ 129 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM----P-----AD----DPRDR 129 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHh----c-----cC----Ccccc
Confidence 26899999999999999999999999999999999999999654321 1122111110 0 00 00000
Q ss_pred CCHHHH---HHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 556 YVPHEM---ARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 556 ~~~~~~---~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...... ..+.+++.+||+.+|++||++.|+++.+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 011111 246777789999999999999999998763
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-23 Score=218.65 Aligned_cols=257 Identities=28% Similarity=0.346 Sum_probs=197.0
Q ss_pred CCccceeeccCceEEEEEEecCCCEEEEEEeecCCch---hHHHHHHHHHHHHhcCCC-CcceEEEEEEeCCeEEEEEEe
Q 006083 318 FAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQ---GEREFSAEVEIISRVHHR-HLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~Hp-nIv~l~~~~~~~~~~~lv~E~ 393 (662)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|. +|+++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667889999999999999875 88999999765333 367899999999999988 799999999888888999999
Q ss_pred cCCcchhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC-cEEEEeeccccccCCCC
Q 006083 394 VSNKTLEYHLHGENR-PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF-EAMVADFGLAKLSNDNH 471 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkl~DFGla~~~~~~~ 471 (662)
+.+++|.+++..... ..+.......++.+++.+|.|+|+. +++||||||+|||++.++ .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976644321 2588899999999999999999999 899999999999999988 79999999998655433
Q ss_pred Cc-----cccccccCccccCcccccC---CCCCchHHHHHHHHHHHHHHhCCCCCCCchh---hhHHHHHHHHHhHHHhh
Q 006083 472 TH-----VSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDMTMM---EDSLVEWARPLLGAALE 540 (662)
Q Consensus 472 ~~-----~~~~~~Gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~---~~~~~~~~~~~~~~~~~ 540 (662)
.. .....+|+..|++||.+.+ ..+....|+|++|++++++++|..||..... .....+.....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~------ 230 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL------ 230 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc------
Confidence 22 2356789999999999987 5788999999999999999999999766543 11221111111
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 541 DGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 541 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
... .....+...........+..++..|+..++..|.++.+....
T Consensus 231 --~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 231 --PTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --CCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000 000000000001222445566668899999999998887764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=212.54 Aligned_cols=200 Identities=23% Similarity=0.308 Sum_probs=171.0
Q ss_pred CCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
-.|.++++||+|.||++|.|. +-+++.||||.--.. ....++..|.+..+.|. .++|.+++.|...+.+-.||||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 359999999999999999998 668999999975432 23456888999999885 79999999999999999999997
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC-----CCcEEEEeeccccccC
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-----NFEAMVADFGLAKLSN 468 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-----~~~vkl~DFGla~~~~ 468 (662)
+ |-+|+|++.-.++ .++...++.|+.|++.-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+.+.
T Consensus 106 L-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred h-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 7 8888887754444 589999999999999999999999 8999999999999953 3457799999999887
Q ss_pred CCCCcc------ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCch
Q 006083 469 DNHTHV------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTM 522 (662)
Q Consensus 469 ~~~~~~------~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~ 522 (662)
+..+.. .....||..||+-...++.+.+.+.|+-|||-|++++|-|.+||.+-.
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 654421 234679999999999999999999999999999999999999997653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-24 Score=203.05 Aligned_cols=203 Identities=24% Similarity=0.314 Sum_probs=170.4
Q ss_pred HHhCCCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEE
Q 006083 313 AATGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 313 ~~~~~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lv 390 (662)
...++|.+++.||.|+||.+|+|. ..+|+.||||+-... ....++..|.++...|+ ...|..+..|..+...-.||
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 356789999999999999999998 678999999987653 22356888999999997 47888888888888889999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC---CCcEEEEeecccccc
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD---NFEAMVADFGLAKLS 467 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~DFGla~~~ 467 (662)
||++ |-+|++++.-..+ .++..+++-++-|++.-|+|+|.+ ++|||||||+|+|..= -..+.|+|||+++.+
T Consensus 90 MdLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 9976 8899988754332 478889999999999999999999 8999999999999953 456889999999877
Q ss_pred CCCCC--c----cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCch
Q 006083 468 NDNHT--H----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTM 522 (662)
Q Consensus 468 ~~~~~--~----~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~ 522 (662)
.+... + ......||..|.+-....+.+.+.+.|+-|+|.||.++.-|..||.+-.
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 54332 1 2245789999999888888888899999999999999999999997653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=9e-24 Score=208.42 Aligned_cols=171 Identities=13% Similarity=0.136 Sum_probs=135.7
Q ss_pred HhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHH---------HHHHHHHHHhcCCCCcceEEEEEEeC
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGERE---------FSAEVEIISRVHHRHLVSLVGYCIAG 384 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~---------~~~E~~il~~l~HpnIv~l~~~~~~~ 384 (662)
..++|...++||.|+||.||+... ++..+|||+++......... +++|++.+.+++|++|..+.+++.+.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 578999999999999999999665 67789999997553333222 68999999999999999998886643
Q ss_pred --------CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcE
Q 006083 385 --------GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA 456 (662)
Q Consensus 385 --------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 456 (662)
+..+|||||++|.+|.++.. ++. .++.+++.+|..||+. +|+||||||+|||++.++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-E
Confidence 35789999999999987641 222 2456899999999999 999999999999999888 9
Q ss_pred EEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHH
Q 006083 457 MVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 512 (662)
Q Consensus 457 kl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLl 512 (662)
+|+|||.......... ... +++...|..++|||+|||.|..+.
T Consensus 174 ~liDfg~~~~~~e~~a--~d~-----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKA--KDR-----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhh--HHH-----------HHHHhHhcccccccceeEeehHHH
Confidence 9999999876532211 110 344456778999999999988764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=243.66 Aligned_cols=252 Identities=20% Similarity=0.247 Sum_probs=185.1
Q ss_pred CccceeeccCceEEEEEEe-cCCCEEEEEEee----cCCc-hh-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 319 AKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLK----TGSG-QG-EREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 319 ~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~----~~~~-~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
...+++|.|.||.|+.... ...+.++.|..+ .... .. ...+..|+.+-..|+|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3467899999998877763 234444444332 2111 11 123677888899999999998888777766666679
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
|||.+ +|+.++... ..+...++..++.|++.||.|||.. ||.|||||++|||+..++.+||+|||.+..+.-..
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 999988654 3478888999999999999999999 99999999999999999999999999987664332
Q ss_pred C---ccccccccCccccCcccccCCCCCc-hHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 472 T---HVSTRVMGTFGYLAPEYASSGKLTE-KSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 472 ~---~~~~~~~Gt~~y~aPE~~~~~~~~~-~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
. .....++|.-.|+|||++.+..|+. ..||||.|+|+..|++|+.||......+..... ..+..-
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~-----------~~~~~~ 543 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT-----------NNYSDQ 543 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-----------hccccc
Confidence 2 4566789999999999999999885 679999999999999999999876544322100 000000
Q ss_pred cCcccC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 548 VDPRLE-HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 548 ~d~~l~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.....+ .........+...++.++|+.+|.+|-++.+|++
T Consensus 544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000000 0011222333445667899999999999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=197.91 Aligned_cols=140 Identities=16% Similarity=0.171 Sum_probs=109.2
Q ss_pred cceeeccCceEEEEEEecCCCEEEEEEeecCCch--h------------------------HHHHHHHHHHHHhcCCCCc
Q 006083 321 SNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQ--G------------------------EREFSAEVEIISRVHHRHL 374 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~------------------------~~~~~~E~~il~~l~HpnI 374 (662)
.+.||+|+||.||+|...+|+.||||+++..... . ......|+++|.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999778999999999764211 0 0122459999999988776
Q ss_pred ceEEEEEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCceeecCCccCcEEECCC
Q 006083 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYL-HEDCHPRIIHRDIKAANILIDDN 453 (662)
Q Consensus 375 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivHrDIkp~NILl~~~ 453 (662)
.....+... ..+|||||+.|++|...+.. ...+++..+..++.|++.+|.|| |+. +|+||||||+||||+ +
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence 443332222 23899999999877654322 23578899999999999999999 687 899999999999998 4
Q ss_pred CcEEEEeeccccccC
Q 006083 454 FEAMVADFGLAKLSN 468 (662)
Q Consensus 454 ~~vkl~DFGla~~~~ 468 (662)
+.++|+|||+|....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-23 Score=201.81 Aligned_cols=246 Identities=22% Similarity=0.324 Sum_probs=186.0
Q ss_pred CccceeeccCceEEEEEEecCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 319 AKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 319 ~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
.+.-+|.+...|+.|+|++ .|..+++|+++... ....++|.+|.-.|+-+.||||+.+++.|...-++.++..||..
T Consensus 193 nl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 3345688899999999998 56677888886542 23346899999999999999999999999999999999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEE--EeeccccccCCCCCcc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMV--ADFGLAKLSNDNHTHV 474 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl--~DFGla~~~~~~~~~~ 474 (662)
|+|+..||+......+-.+++++++++++|++|||+. .+-|.---|....++||++..++| +|--++...
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe------- 343 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE------- 343 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeec-------
Confidence 9999999998888889999999999999999999995 444555678999999999988775 343332211
Q ss_pred ccccccCccccCcccccCCCC---CchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 475 STRVMGTFGYLAPEYASSGKL---TEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~---~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
....-.+.||+||.++...- -.++|+|||+++||||.|...||.....-+.-.. +.-+.
T Consensus 344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk-----------------ialeg 405 (448)
T KOG0195|consen 344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK-----------------IALEG 405 (448)
T ss_pred -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh-----------------hhhcc
Confidence 11233678999999986543 3689999999999999999999965432111000 00011
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
|.....+.....+.+++.-|++.||.+||.+..|+-.||.
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 2222222223344445557999999999999999999885
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.1e-22 Score=190.16 Aligned_cols=186 Identities=17% Similarity=0.100 Sum_probs=141.9
Q ss_pred CCccceeeccCceEEEEEEecCCCEEEEEEeecCCchh----HHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEE
Q 006083 318 FAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQG----EREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~----~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lv~E 392 (662)
+..+..|++|+||+||.+.. .+..++.+.+.....-. ...+.+|+++|++|+ |++|++++++ +..+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34568899999999997765 77888888776543211 225789999999995 5889999886 34699999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCC-ccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDI-KAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDI-kp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
|+.|.+|...+.. ....++.+++++|.+||++ ||+|||| |++|||++.++.++|+|||++.......
T Consensus 79 yI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 79 YLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred eecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9999998754311 1235778999999999999 9999999 7999999999999999999998655433
Q ss_pred Cc----c--------ccccccCccccCcccccCC-CCC-chHHHHHHHHHHHHHHhCCCCCCC
Q 006083 472 TH----V--------STRVMGTFGYLAPEYASSG-KLT-EKSDVFSFGVMLLELITGRRPVDM 520 (662)
Q Consensus 472 ~~----~--------~~~~~Gt~~y~aPE~~~~~-~~~-~~sDvwSlGvvl~eLltG~~Pf~~ 520 (662)
.. . .....++..|+.|+...-- ..+ ...++++.|+-+|.++|++.++-.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 10 0 1113367888888854321 223 678999999999999999988643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-23 Score=232.57 Aligned_cols=251 Identities=23% Similarity=0.249 Sum_probs=181.1
Q ss_pred CCCccceeeccCceEEEEEEecCCCEEEEEEeecCC-chhHHHH---HHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGS-GQGEREF---SAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~---~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
+|...+.||.+.|=+|.+|++++|. |+||++-+.. .-..+.| .+|++ ...++|||++.+..+...+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5778899999999999999987776 8999885543 2223333 34555 556689999999888777778889989
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc--CCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS--NDN 470 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~--~~~ 470 (662)
|+ ..+|+|+| ..++.+...+.+.|+.|++.||..||+. ||+|||||.+||||+.-..+.|+||...+-. .++
T Consensus 102 yv-khnLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 102 YV-KHNLYDRL--STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HH-hhhhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 87 56888888 5677788999999999999999999999 9999999999999999999999999877532 222
Q ss_pred CCcc----ccccccCccccCcccccCC-----------CCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHH
Q 006083 471 HTHV----STRVMGTFGYLAPEYASSG-----------KLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPL 534 (662)
Q Consensus 471 ~~~~----~~~~~Gt~~y~aPE~~~~~-----------~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~ 534 (662)
+... ..+-..-.+|+|||.+... .++.+-||||+|||++||++ |+.+|.... +.++-+
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~-- 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRS-- 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhc--
Confidence 1111 1111223479999988542 26678999999999999988 677786431 111110
Q ss_pred hHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 535 LGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 535 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
+. .......|++-.+ ..+..+++.|++.||.+|-+++++|+...+..
T Consensus 250 -------~~-~~~~e~~Le~Ied----~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 250 -------GN-ADDPEQLLEKIED----VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred -------cC-ccCHHHHHHhCcC----ccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 00 0000001111011 13455667899999999999999999866544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=190.97 Aligned_cols=141 Identities=16% Similarity=0.142 Sum_probs=111.8
Q ss_pred cceeeccCceEEEEEEecCCCEEEEEEeecCCch---------------------h-----HHHHHHHHHHHHhcCCCCc
Q 006083 321 SNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQ---------------------G-----EREFSAEVEIISRVHHRHL 374 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---------------------~-----~~~~~~E~~il~~l~HpnI 374 (662)
.+.||+|+||.||+|...+|+.||||+++..... . ...+..|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5789999999999999778999999999865211 0 1224679999999999987
Q ss_pred ceEEEEEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCccCcEEECCC
Q 006083 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHE-DCHPRIIHRDIKAANILIDDN 453 (662)
Q Consensus 375 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDIkp~NILl~~~ 453 (662)
.....+... ..+|||||+.|+++...+... ..++.....+++.+++.+|.|||+ + +|+||||||+||||+ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence 544443332 248999999988654432222 246788899999999999999999 7 999999999999999 7
Q ss_pred CcEEEEeeccccccCC
Q 006083 454 FEAMVADFGLAKLSND 469 (662)
Q Consensus 454 ~~vkl~DFGla~~~~~ 469 (662)
+.++|+|||++.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.3e-23 Score=220.51 Aligned_cols=186 Identities=30% Similarity=0.344 Sum_probs=159.5
Q ss_pred eeeccCceEEEEEE----ecCCCEEEEEEeecCCchh--HHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEEecC
Q 006083 323 LLGQGGFGYVHKGV----LPNGKEVAVKSLKTGSGQG--EREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 323 ~iG~G~~g~Vy~~~----~~~g~~vavK~l~~~~~~~--~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
.+|+|.||.|+++. .+.|..+|+|++++..... ......|.+++..++ |+.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999865 3357889999987653221 124567889999997 9999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
||+|..++.... .+++.....+...++-+++++|+. +|+|||+|++||+++.+|.+|+.|||+++..-+...
T Consensus 81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 999998885443 366777777888999999999999 999999999999999999999999999987654432
Q ss_pred cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Q 006083 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDM 520 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~ 520 (662)
.|||..|||||++. .+..++|+||||++++||++|..||..
T Consensus 153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28999999999988 577889999999999999999999976
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=183.67 Aligned_cols=136 Identities=18% Similarity=0.194 Sum_probs=107.4
Q ss_pred CccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhc-----CCCCcceEEEEEEeCC---eEE-E
Q 006083 319 AKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-----HHRHLVSLVGYCIAGG---QRM-L 389 (662)
Q Consensus 319 ~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~~---~~~-l 389 (662)
...++||+|+||.||. ...++.. +||++........+.+.+|+++|+.+ .|+||++++|+++++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4457899999999996 4334444 79998765555567899999999999 5799999999998763 433 7
Q ss_pred EEEe--cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCceeecCCccCcEEECC----CCcEEEEeec
Q 006083 390 VYEF--VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGL-AYLHEDCHPRIIHRDIKAANILIDD----NFEAMVADFG 462 (662)
Q Consensus 390 v~E~--~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL-~yLH~~~~~~ivHrDIkp~NILl~~----~~~vkl~DFG 462 (662)
|||| +.+++|.+++.+. .+++. ..++.+++.++ +|||++ +||||||||+|||++. +++++|+||+
T Consensus 83 I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 8999 5579999999553 24444 45678888777 999999 9999999999999974 3489999955
Q ss_pred cc
Q 006083 463 LA 464 (662)
Q Consensus 463 la 464 (662)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=214.49 Aligned_cols=200 Identities=23% Similarity=0.233 Sum_probs=159.5
Q ss_pred HHHHHHhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCC
Q 006083 309 DELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH---HRHLVSLVGYCIAGG 385 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~ 385 (662)
.+++.-...|.+.+.||+|+||.||+|...+|+.||+|+-+.....+ |---.+++.||+ -+.|..+..++...+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 34445566789999999999999999998789999999887653321 111233444444 244555555556667
Q ss_pred eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC-------CCCcEEE
Q 006083 386 QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID-------DNFEAMV 458 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~-------~~~~vkl 458 (662)
.-+||+||...|+|.+++. ....+++..++.+.+++++.++.||.. +|||+||||+|+||. +..-++|
T Consensus 768 ~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred cceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 7799999999999999996 555699999999999999999999998 999999999999994 2446899
Q ss_pred EeeccccccCC-CCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCC
Q 006083 459 ADFGLAKLSND-NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRR 516 (662)
Q Consensus 459 ~DFGla~~~~~-~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~ 516 (662)
||||.+....- .........++|-.|-.+|...|+.++...|.|.|+.+++-||.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999865431 11223455788999999999999999999999999999999999986
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=182.44 Aligned_cols=143 Identities=17% Similarity=0.174 Sum_probs=112.7
Q ss_pred CCCccceeeccCceEEEEEE--ecCCCEEEEEEeecCCch------------------------hHHHHHHHHHHHHhcC
Q 006083 317 GFAKSNLLGQGGFGYVHKGV--LPNGKEVAVKSLKTGSGQ------------------------GEREFSAEVEIISRVH 370 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~E~~il~~l~ 370 (662)
.|.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+..|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 568999999999754210 1123578999999997
Q ss_pred CCC--cceEEEEEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc-eeecCCccCc
Q 006083 371 HRH--LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR-IIHRDIKAAN 447 (662)
Q Consensus 371 Hpn--Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-ivHrDIkp~N 447 (662)
+.+ +.+++++ ...+|||||+.|++|..++... ..+.......++.+++.+|.|||++ + |+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence 532 3344443 2348999999998887655322 2355666788999999999999999 8 9999999999
Q ss_pred EEECCCCcEEEEeeccccccCC
Q 006083 448 ILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 448 ILl~~~~~vkl~DFGla~~~~~ 469 (662)
|||+ +++++|+|||++.....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCC
Confidence 9999 88999999999876543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=183.17 Aligned_cols=197 Identities=21% Similarity=0.344 Sum_probs=129.0
Q ss_pred CCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCC----------CCcceEEE----
Q 006083 318 FAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHH----------RHLVSLVG---- 379 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~H----------pnIv~l~~---- 379 (662)
+..++.||.|+|+.||.+.+. +|+.+|||++.... ....+++++|......+.+ -.++--++
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 456789999999999999964 68999999986443 2335666666654444322 11111111
Q ss_pred -----EEEeC---C-----eEEEEEEecCCcchhhhhc---cC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeec
Q 006083 380 -----YCIAG---G-----QRMLVYEFVSNKTLEYHLH---GE--NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441 (662)
Q Consensus 380 -----~~~~~---~-----~~~lv~E~~~~g~L~~~l~---~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHr 441 (662)
++... . ..+++|.-+ -++|.+++. .. ....+....++.+..|+++.+++||.+ ||||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 11111 1 235677766 567766642 21 112234455666778999999999999 99999
Q ss_pred CCccCcEEECCCCcEEEEeeccccccCCCCCccccccccCccccCcccccC--------CCCCchHHHHHHHHHHHHHHh
Q 006083 442 DIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS--------GKLTEKSDVFSFGVMLLELIT 513 (662)
Q Consensus 442 DIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--------~~~~~~sDvwSlGvvl~eLlt 513 (662)
|||++||||+.+|.++|.||+.....+.... . ...+..|.+||.... -.++.+.|.|+||+++|.|+|
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEE---G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceee---c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999998876654221 1 334578999997643 247899999999999999999
Q ss_pred CCCCCCCch
Q 006083 514 GRRPVDMTM 522 (662)
Q Consensus 514 G~~Pf~~~~ 522 (662)
|+.||+...
T Consensus 246 ~~lPf~~~~ 254 (288)
T PF14531_consen 246 GRLPFGLSS 254 (288)
T ss_dssp SS-STCCCG
T ss_pred ccCCCCCCC
Confidence 999998653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.4e-20 Score=196.39 Aligned_cols=216 Identities=24% Similarity=0.377 Sum_probs=161.2
Q ss_pred HHhcCCCCcceEEEEEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCce-eecCCc
Q 006083 366 ISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRI-IHRDIK 444 (662)
Q Consensus 366 l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i-vHrDIk 444 (662)
|+.+.|.|+.+|+|.+.++...++|.+||..|+|.|.+.. ....+++.....++.+|++||+|||+. .| +|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence 4567899999999999999999999999999999999976 345689999999999999999999987 44 999999
Q ss_pred cCcEEECCCCcEEEEeeccccccCCC-CCccccccccCccccCcccccCCC-------CCchHHHHHHHHHHHHHHhCCC
Q 006083 445 AANILIDDNFEAMVADFGLAKLSNDN-HTHVSTRVMGTFGYLAPEYASSGK-------LTEKSDVFSFGVMLLELITGRR 516 (662)
Q Consensus 445 p~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~~~~Gt~~y~aPE~~~~~~-------~~~~sDvwSlGvvl~eLltG~~ 516 (662)
..|+++|..+.+||.|||+....... .........-..-|.|||.+.+.. .+.+.||||||+|++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998766421 001111122345699999987631 4678999999999999999999
Q ss_pred CCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 517 PVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 517 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
||+.........+.+..+ ++ .....+.+.+.... +....++.++..||..+|.+||++.+|-..++...
T Consensus 157 ~~~~~~~~~~~~eii~~~-----~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRV-----KK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccccCChHHHHHHH-----Hh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 998753222212222221 11 11122222222221 22225777778999999999999999999887543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.8e-19 Score=175.53 Aligned_cols=134 Identities=19% Similarity=0.305 Sum_probs=114.1
Q ss_pred ceeeccCceEEEEEEecCCCEEEEEEeecCCch--------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQ--------GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+.||+|++|.||+|.. +|..|+||+....... ....+.+|++++..++|.||.....++.+.+..+|||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 7788999986543211 124578899999999999988877777777888999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
+.|++|.+++.... . .+..++.+++.+|.+||+. +|+||||++.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999885421 2 7888999999999999998 899999999999999 78899999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.5e-19 Score=173.51 Aligned_cols=131 Identities=22% Similarity=0.342 Sum_probs=107.2
Q ss_pred eeeccCceEEEEEEecCCCEEEEEEeecCCch--------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 323 LLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQ--------GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 323 ~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
+||+|+||.||+|.+ +|..|+||+....... ....+.+|++++..++|.++.....++.+.+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 6788999986543211 1256778999999999887665555555666779999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
.|++|.+++.... ..++.+++++|.+||+. +|+|||||++|||++ ++.++|+|||++...
T Consensus 80 ~g~~l~~~~~~~~---------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN---------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH---------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998874321 17899999999999999 999999999999999 789999999998763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-19 Score=183.99 Aligned_cols=197 Identities=23% Similarity=0.293 Sum_probs=131.3
Q ss_pred CCCCcceEEEEEEeC---------------------------CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHH
Q 006083 370 HHRHLVSLVGYCIAG---------------------------GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALG 422 (662)
Q Consensus 370 ~HpnIv~l~~~~~~~---------------------------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ 422 (662)
+|||||+++++|.+. ..+||||..+ ..+|..+|..+. .+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 599999998876532 4568888866 467777774332 455677778999
Q ss_pred HHHHHHHHHhcCCCceeecCCccCcEEE--CCCC--cEEEEeeccccccCCCCC-----ccccccccCccccCcccccCC
Q 006083 423 SAKGLAYLHEDCHPRIIHRDIKAANILI--DDNF--EAMVADFGLAKLSNDNHT-----HVSTRVMGTFGYLAPEYASSG 493 (662)
Q Consensus 423 ia~aL~yLH~~~~~~ivHrDIkp~NILl--~~~~--~vkl~DFGla~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~ 493 (662)
+++|+.|||++ +|.|||||.+|||| |+|+ .++|+|||.+.......- ...-..-|...-||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999 99999999999999 3333 567999998854332111 111224578889999988632
Q ss_pred --C----CCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHH
Q 006083 494 --K----LTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVAC 567 (662)
Q Consensus 494 --~----~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 567 (662)
. .-.|+|.|+.|.+.||++....||.... +.+.+ ...|++---+.+.. .++..++ ++
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG--em~L~-----------~r~Yqe~qLPalp~-~vpp~~r---ql 489 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG--EMLLD-----------TRTYQESQLPALPS-RVPPVAR---QL 489 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccc--hheec-----------hhhhhhhhCCCCcc-cCChHHH---HH
Confidence 1 2368999999999999999999997632 11110 00111111111211 2233333 34
Q ss_pred HHHhcccCCCCCCCHHHHHHHhh
Q 006083 568 GAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 568 ~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
+...|+.||.+|++..-....|+
T Consensus 490 V~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHhcCCccccCCccHHHhHHH
Confidence 45789999999998655444443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.8e-19 Score=171.74 Aligned_cols=146 Identities=17% Similarity=0.180 Sum_probs=114.2
Q ss_pred HHHHHHhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCch----------------------hHHHHHHHHHHH
Q 006083 309 DELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQ----------------------GEREFSAEVEII 366 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~----------------------~~~~~~~E~~il 366 (662)
.++......|.+.+.||+|+||.||++...+|+.||||+++..... ....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444444458889999999999999999878999999987653210 012367799999
Q ss_pred HhcCCCC--cceEEEEEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCc
Q 006083 367 SRVHHRH--LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIK 444 (662)
Q Consensus 367 ~~l~Hpn--Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIk 444 (662)
..+.|.+ +...++. +..++||||+.|++|..++.. ....+++.++++++.+||+. +|+|||||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 9998774 4444442 345899999999999765421 34567889999999999998 99999999
Q ss_pred cCcEEECCCCcEEEEeeccccccCC
Q 006083 445 AANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 445 p~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
|+||||++++.++|+|||++.....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-19 Score=203.52 Aligned_cols=208 Identities=23% Similarity=0.310 Sum_probs=142.8
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
.+|+.+++|..|+||.||..+++ ..+.+|+| +++.+ .+.+- ||.....+.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee-------------------
Confidence 46888999999999999999854 56778884 43321 11110 22223333333
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC--
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT-- 472 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~-- 472 (662)
|+-...++..+. +... ++.+++|||+. +|+|||+|++|+||+.-|++|+.|||+.+.......
T Consensus 136 --gDc~tllk~~g~--lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 --GDCATLLKNIGP--LPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred --chhhhhcccCCC--Ccch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 444444433222 3322 26789999999 999999999999999999999999999875431111
Q ss_pred ----------c--cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhh
Q 006083 473 ----------H--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALE 540 (662)
Q Consensus 473 ----------~--~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 540 (662)
+ ....++||+.|.|||++..+.|...+|+|+||+|+||++.|+.||++...++.+...+...+
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i----- 275 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI----- 275 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc-----
Confidence 0 12346999999999999999999999999999999999999999998876665443332211
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 006083 541 DGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPK 581 (662)
Q Consensus 541 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 581 (662)
.+. . .......+.++|+. ..|+.+|..|--
T Consensus 276 --~wp-----E-~dea~p~Ea~dli~---~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 276 --EWP-----E-EDEALPPEAQDLIE---QLLRQNPLCRLG 305 (1205)
T ss_pred --ccc-----c-cCcCCCHHHHHHHH---HHHHhChHhhcc
Confidence 111 1 12233455555555 678888888853
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=196.37 Aligned_cols=138 Identities=22% Similarity=0.334 Sum_probs=112.6
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEe-ecC-Cc------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSL-KTG-SG------QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQ 386 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l-~~~-~~------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 386 (662)
...|...++||+|+||.||+|.+.+. .+++|+. .+. .. ...+.+.+|+++|++++|+||+..+.++.+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34456789999999999999987443 4444432 211 11 123568899999999999999988888887778
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
.+|||||+.|++|.+++. ....++.+++++|.|||+. +|+||||||+|||| +++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999998874 4577899999999999998 99999999999999 577999999999976
Q ss_pred c
Q 006083 467 S 467 (662)
Q Consensus 467 ~ 467 (662)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 4
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-19 Score=191.36 Aligned_cols=190 Identities=21% Similarity=0.268 Sum_probs=134.4
Q ss_pred CCccceeeccCceEEEEEEecC----CCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEE-------EEE----
Q 006083 318 FAKSNLLGQGGFGYVHKGVLPN----GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVG-------YCI---- 382 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~-------~~~---- 382 (662)
..+.+.+++.+++.++.....+ .+.++.|..+.++........+++-.+....|-+..-+.+ .+.
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v 325 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV 325 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence 3334455566666665554222 2344555544443222333444554444444333332222 111
Q ss_pred -eCCeEEEEEEecCCcchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEe
Q 006083 383 -AGGQRMLVYEFVSNKTLEYHLHG-ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVAD 460 (662)
Q Consensus 383 -~~~~~~lv~E~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~D 460 (662)
....+||.|++|...+|.+||.+ ......++.....++.|++.+++| + +.+|||+|+.||++..+..+||.|
T Consensus 326 ~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 326 GKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred ccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhh
Confidence 13457899999999999999964 333456778899999999999999 5 799999999999999999999999
Q ss_pred eccccccCCCC-----CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh
Q 006083 461 FGLAKLSNDNH-----THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 513 (662)
Q Consensus 461 FGla~~~~~~~-----~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt 513 (662)
||+........ ....+..+||..||+||.+.+..|+.|+|||+||+||+||+.
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 99987665443 122345789999999999999999999999999999999986
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.3e-17 Score=150.11 Aligned_cols=136 Identities=21% Similarity=0.169 Sum_probs=115.8
Q ss_pred ccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCCeEEEEEEecCCc
Q 006083 320 KSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHH--RHLVSLVGYCIAGGQRMLVYEFVSNK 397 (662)
Q Consensus 320 ~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~~~~~lv~E~~~~g 397 (662)
+.+.||+|.++.||++... +..++||.++.... ...+.+|+.++..++| .++.++++++...+..+++|||+.++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 3578999999999999974 47899999876533 5678999999999976 58999999988888999999999988
Q ss_pred chhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 398 TLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 398 ~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
.+..+ +......++.+++++|.+||.....+++|||||++|||+++++.++|+|||++...
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 87643 45667788999999999999864347999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.9e-17 Score=157.90 Aligned_cols=138 Identities=19% Similarity=0.207 Sum_probs=100.6
Q ss_pred cceeeccCceEEEEEEecCCCEEEEEEeecCCchh--HHH----------------------HHHHHHHHHhcCCCC--c
Q 006083 321 SNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQG--ERE----------------------FSAEVEIISRVHHRH--L 374 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--~~~----------------------~~~E~~il~~l~Hpn--I 374 (662)
.+.||+|+||.||+|...+|+.||||+++...... ... ...|.+.+.++.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 56899999999999998789999999987542211 111 135666677765433 4
Q ss_pred ceEEEEEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCccCcEEECCC
Q 006083 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHE-DCHPRIIHRDIKAANILIDDN 453 (662)
Q Consensus 375 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDIkp~NILl~~~ 453 (662)
.+.+++ ...+|||||+.++.+......... .. ....+++.+++.++.+||. . +|+||||||+||||+ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C
Confidence 444443 245899999999554322111100 11 5678899999999999999 7 899999999999999 8
Q ss_pred CcEEEEeeccccccCC
Q 006083 454 FEAMVADFGLAKLSND 469 (662)
Q Consensus 454 ~~vkl~DFGla~~~~~ 469 (662)
+.++|+|||.+.....
T Consensus 151 ~~~~liDfg~a~~~~~ 166 (187)
T cd05119 151 GKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcEEEEECcccccccC
Confidence 8999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.3e-16 Score=158.01 Aligned_cols=137 Identities=18% Similarity=0.245 Sum_probs=105.9
Q ss_pred cceee-ccCceEEEEEEecCCCEEEEEEeecCC-------------chhHHHHHHHHHHHHhcCCCCc--ceEEEEEEeC
Q 006083 321 SNLLG-QGGFGYVHKGVLPNGKEVAVKSLKTGS-------------GQGEREFSAEVEIISRVHHRHL--VSLVGYCIAG 384 (662)
Q Consensus 321 ~~~iG-~G~~g~Vy~~~~~~g~~vavK~l~~~~-------------~~~~~~~~~E~~il~~l~HpnI--v~l~~~~~~~ 384 (662)
..+|| .||.|.||++.. ++..++||.++... ......+.+|++++.+|+|.+| +..++++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45787 889999999887 57889999885421 1123467889999999998775 6777765432
Q ss_pred -Ce---EEEEEEecCC-cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEE
Q 006083 385 -GQ---RMLVYEFVSN-KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVA 459 (662)
Q Consensus 385 -~~---~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~ 459 (662)
+. .+|||||+.| .+|.+++... .++.. .+.+|+.+|.+||++ ||+||||||+||||+.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 22 2599999997 6888887542 24433 357899999999999 99999999999999988899999
Q ss_pred eeccccccC
Q 006083 460 DFGLAKLSN 468 (662)
Q Consensus 460 DFGla~~~~ 468 (662)
|||.+....
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999987643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.8e-17 Score=186.80 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=186.3
Q ss_pred CCccceeeccCceEEEEEEec--CCCEEEEEEeecCC--chhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEE
Q 006083 318 FAKSNLLGQGGFGYVHKGVLP--NGKEVAVKSLKTGS--GQGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~--~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lv~E 392 (662)
|.+.+.||+|.|+.|-..... ....+|+|.+.... ....+....|..+-+.+. |.|++++++...+.+..+++++
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 666778999999999887743 34567777775543 223345566888888887 9999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCceeecCCccCcEEECCCC-cEEEEeeccccccCC-
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLH-EDCHPRIIHRDIKAANILIDDNF-EAMVADFGLAKLSND- 469 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~ivHrDIkp~NILl~~~~-~vkl~DFGla~~~~~- 469 (662)
|..|+++++.+........+....-.++.|+..+|.|+| +. ++.||||||+|.+++..+ .++++|||+|..+..
T Consensus 102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999883222223556677889999999999999 76 899999999999999999 999999999987765
Q ss_pred -CCCcccccccc-CccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhH-HHHHHHHHhHHHhhcCccc
Q 006083 470 -NHTHVSTRVMG-TFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDS-LVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 470 -~~~~~~~~~~G-t~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 545 (662)
+........+| ++.|+|||...+. ......|+||+|+++.-+++|..|++.....+. +..|...-
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~----------- 247 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK----------- 247 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc-----------
Confidence 33334455788 9999999999874 456788999999999999999999976643331 12221110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
............ ...+.+..+++..++..|.+.+++..
T Consensus 248 ~~~~~~~~~~~~----~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 GRFTQLPWNSIS----DQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccCccccCC----hhhhhcccccccCCchhccccccccc
Confidence 000111122222 22333444677789999988877664
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1e-14 Score=159.77 Aligned_cols=142 Identities=23% Similarity=0.281 Sum_probs=101.0
Q ss_pred cceeeccCceEEEEEEecCCCEEEEEEeecCCchhH----------------------------------------HHHH
Q 006083 321 SNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGE----------------------------------------REFS 360 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~----------------------------------------~~~~ 360 (662)
.+.||.|++|.||+|++.+|+.||||+.+.+..... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999865421110 0244
Q ss_pred HHHHHHHhcC----CCCcceEEEEEE-eCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 006083 361 AEVEIISRVH----HRHLVSLVGYCI-AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAK-GLAYLHEDC 434 (662)
Q Consensus 361 ~E~~il~~l~----HpnIv~l~~~~~-~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~-aL~yLH~~~ 434 (662)
+|++.+.+++ |.+-+.+-.++. ..+..+|||||+.|++|.+++...... . .+.+++..+++ .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~---~~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-L---DRKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-C---CHHHHHHHHHHHHHHHHHhC-
Confidence 4555555552 333333333332 345579999999999998876432111 1 23456666665 46788887
Q ss_pred CCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 435 ~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
|++|+|+||.||+++++++++|+|||++.....
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999977653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.9e-14 Score=157.91 Aligned_cols=147 Identities=18% Similarity=0.212 Sum_probs=94.2
Q ss_pred hCCCCccceeeccCceEEEEEEecC-CCEEEEEEeecCCch----------------------------------hHHH-
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPN-GKEVAVKSLKTGSGQ----------------------------------GERE- 358 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~----------------------------------~~~~- 358 (662)
...|+. +.||.|++|.||+|++++ |+.||||+++.+-.. ..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 789999999999999877 999999999754211 0111
Q ss_pred -----HHHHHHHHHhcC----CCCcceEEEEEEe-CCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHH-H
Q 006083 359 -----FSAEVEIISRVH----HRHLVSLVGYCIA-GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKG-L 427 (662)
Q Consensus 359 -----~~~E~~il~~l~----HpnIv~l~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~a-L 427 (662)
|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||+.|+.|.++..-... ..+.. .++...++. +
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~-g~d~~---~la~~~v~~~~ 273 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA-GTDMK---LLAERGVEVFF 273 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc-CCCHH---HHHHHHHHHHH
Confidence 333444444442 3333443333332 4566899999999999764211111 12211 222222221 2
Q ss_pred HHHHhcCCCceeecCCccCcEEECCCC----cEEEEeeccccccCC
Q 006083 428 AYLHEDCHPRIIHRDIKAANILIDDNF----EAMVADFGLAKLSND 469 (662)
Q Consensus 428 ~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkl~DFGla~~~~~ 469 (662)
.-++.. |++|+|+||.||||+.++ +++++|||++.....
T Consensus 274 ~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 333445 899999999999999887 999999999987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.4e-14 Score=153.66 Aligned_cols=247 Identities=22% Similarity=0.259 Sum_probs=182.3
Q ss_pred CCCccceeec--cCceEEEEEEe---cCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEE
Q 006083 317 GFAKSNLLGQ--GGFGYVHKGVL---PNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 317 ~~~~~~~iG~--G~~g~Vy~~~~---~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~ 388 (662)
.|...+.+|. |.+|.||.+.. .++..+|+|.-+.. .......=.+|+...+.++ |.|.|+.+..++.++..|
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3777889999 99999999875 46788999984432 2233334466777777775 999999999999999999
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCceeecCCccCcEEECCC-CcEEEEeecc
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAK----GLAYLHEDCHPRIIHRDIKAANILIDDN-FEAMVADFGL 463 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~----aL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkl~DFGl 463 (662)
+-.|+|. .+|..+.+... ..+.....+.++.+... ||.++|.. .++|-|+|+.||++.++ ...+++|||+
T Consensus 195 iqtE~~~-~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeecccc-chhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcce
Confidence 9999985 67766665432 24667788888888888 99999998 89999999999999998 8889999999
Q ss_pred ccccCCCCCcc----ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHh
Q 006083 464 AKLSNDNHTHV----STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAAL 539 (662)
Q Consensus 464 a~~~~~~~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 539 (662)
...+....... ..+..|...|++||++. +.++.+.|||+||.++.+-.+|...+...... .|...
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~----~W~~~------ 338 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS----SWSQL------ 338 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC----Ccccc------
Confidence 98887655322 22346888999999887 58999999999999999999887765433111 12110
Q ss_pred hcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 540 EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 540 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+.+. +..+++.....++......+++.++..|++.+.++.
T Consensus 339 r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 RQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0000 122222222233334566789999999998877664
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.2e-13 Score=129.79 Aligned_cols=131 Identities=18% Similarity=0.082 Sum_probs=97.8
Q ss_pred cceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcc-eEEEEEEeCCeEEEEEEecCCcch
Q 006083 321 SNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLV-SLVGYCIAGGQRMLVYEFVSNKTL 399 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv-~l~~~~~~~~~~~lv~E~~~~g~L 399 (662)
.+.|+.|.++.||++.. .++.|++|+...... ....+..|+++++.+.+.+++ +++.++. +..++||||+.|..+
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 35788999999999986 478899998765432 223568899999999765554 4555432 345899999999888
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 400 EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC--HPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 400 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
.... .....++.+++++|..||... ..+++|+|+|+.|||++ ++.++|+|||.+..
T Consensus 79 ~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6430 112345678999999999972 12369999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.2e-12 Score=142.95 Aligned_cols=166 Identities=18% Similarity=0.256 Sum_probs=127.8
Q ss_pred ecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHH
Q 006083 337 LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATR 416 (662)
Q Consensus 337 ~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~ 416 (662)
..++..|.|+..+...........+-++.|+.|+||||+++++.++..+.+|||.|.|. -|..+|... ....+
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHHHH
Confidence 45788999999887766445667889999999999999999999999999999999875 344455432 25667
Q ss_pred HHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccccccccCccccCcccccCCCCC
Q 006083 417 VRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLT 496 (662)
Q Consensus 417 ~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~ 496 (662)
...+.||+.||.|||+.| +++|++|.-.-|+|+..|+.||.+|-++........ ......---.|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence 778899999999999887 899999999999999999999999998765432211 001111122355665544322
Q ss_pred chHHHHHHHHHHHHHHhC
Q 006083 497 EKSDVFSFGVMLLELITG 514 (662)
Q Consensus 497 ~~sDvwSlGvvl~eLltG 514 (662)
-..|.|.|||+++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 457999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.5e-12 Score=124.51 Aligned_cols=138 Identities=15% Similarity=0.158 Sum_probs=101.0
Q ss_pred cceeeccCceEEEEEEecC-------CCEEEEEEeecCCc----------------------hhHHHHH----HHHHHHH
Q 006083 321 SNLLGQGGFGYVHKGVLPN-------GKEVAVKSLKTGSG----------------------QGEREFS----AEVEIIS 367 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~-------g~~vavK~l~~~~~----------------------~~~~~~~----~E~~il~ 367 (662)
...||.|.-+.||.|...+ +..+|||+.+.... ...+.+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998543 47999998753210 0112233 7999999
Q ss_pred hcC--CCCcceEEEEEEeCCeEEEEEEecCCcchhh-hhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCceeecCC
Q 006083 368 RVH--HRHLVSLVGYCIAGGQRMLVYEFVSNKTLEY-HLHGENRPVMDFATRVRIALGSAKGLAYL-HEDCHPRIIHRDI 443 (662)
Q Consensus 368 ~l~--HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivHrDI 443 (662)
++. .-++...+++ ..-+|||||+.++.+.. .|+. ..++..+...++.+++.+|.+| |+. +||||||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 995 3566677765 34589999998764422 2221 1244556777889999999999 777 9999999
Q ss_pred ccCcEEECCCCcEEEEeeccccccCC
Q 006083 444 KAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 444 kp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
++.|||++ ++.++|+|||.+.....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999997 46899999999986653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.8e-12 Score=125.89 Aligned_cols=143 Identities=21% Similarity=0.289 Sum_probs=112.2
Q ss_pred ceeeccCceEEEEEEecCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCC--CCcceEEEEEEeC---CeEEEEEEecC
Q 006083 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHH--RHLVSLVGYCIAG---GQRMLVYEFVS 395 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~---~~~~lv~E~~~ 395 (662)
+.|+.|.++.||++...+|+.++||+...... .....+..|+++++.+++ .++.+++.++... +..++||||+.
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999886778999999865432 235678999999999975 4467788877654 36789999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED------------------------------------------ 433 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------------------------------------------ 433 (662)
|.+|.+.+.. ..++...+..++.+++++|.+||+.
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9998776532 2467777888888888888888852
Q ss_pred -----------CCCceeecCCccCcEEECC--CCcEEEEeecccccc
Q 006083 434 -----------CHPRIIHRDIKAANILIDD--NFEAMVADFGLAKLS 467 (662)
Q Consensus 434 -----------~~~~ivHrDIkp~NILl~~--~~~vkl~DFGla~~~ 467 (662)
....++|+|+++.|||++. ++.+.|+||+.+...
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 0246899999999999998 566889999988643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.7e-13 Score=146.67 Aligned_cols=246 Identities=21% Similarity=0.193 Sum_probs=176.8
Q ss_pred HhCCCCccceeeccCceEEEEEEe--cCCCEEEEEEeecCCchhHHH--HHHHHHHHHhcC-CCCcceEEEEEEeCCeEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVL--PNGKEVAVKSLKTGSGQGERE--FSAEVEIISRVH-HRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~--~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~ 388 (662)
..++|.++..||.|.|+.||+... .++..|++|.+.+.......+ -..|+.+...+. |.++++++..|......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 456799999999999999999874 468899999987764333322 356777777775 999999998888888889
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC-CcEEEEeecccccc
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN-FEAMVADFGLAKLS 467 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkl~DFGla~~~ 467 (662)
+-.|||.++++...+ .-...+++..++++..+++.++.++|+. .++|+|+|+.||++..+ +..++.|||++..+
T Consensus 343 ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred CchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccc
Confidence 999999999988766 2333477888999999999999999998 89999999999999876 77889999998642
Q ss_pred CCCCCccccccccCcccc--CcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 468 NDNHTHVSTRVMGTFGYL--APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 468 ~~~~~~~~~~~~Gt~~y~--aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
.... ....+.-+++ +++.+....+..+.|+|+||.-+.+.++|..--.. .+.|... ..+.+
T Consensus 418 ~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~------~~~~~~i------~~~~~- 480 (524)
T KOG0601|consen 418 AFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES------GVQSLTI------RSGDT- 480 (524)
T ss_pred ceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcc------cccceee------ecccc-
Confidence 2111 1122233344 55556677888999999999999999998764221 1112110 00100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
.++ ......+..++..++..++..|+.+.++....+
T Consensus 481 ----p~~-----~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 481 ----PNL-----PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ----cCC-----CchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 011 111133444555788899999999877766544
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.4e-12 Score=130.53 Aligned_cols=151 Identities=21% Similarity=0.320 Sum_probs=115.5
Q ss_pred HHHhcCCCCcceEEEEEEeCC-----eEEEEEEecCCcchhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 006083 365 IISRVHHRHLVSLVGYCIAGG-----QRMLVYEFVSNKTLEYHLHGE--NRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437 (662)
Q Consensus 365 il~~l~HpnIv~l~~~~~~~~-----~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 437 (662)
-|-++.|-|||+++.|+.+.+ +..++.||+.-|+|..+|++. ....+....-.+|+.||+.||.|||+ |.+.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence 344556999999999987543 467999999999999999753 33457777888999999999999999 7899
Q ss_pred eeecCCccCcEEECCCCcEEEEeeccccccCC----CCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh
Q 006083 438 IIHRDIKAANILIDDNFEAMVADFGLAKLSND----NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 513 (662)
Q Consensus 438 ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~----~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt 513 (662)
|+|+++..+-|++..++-+||. .+.-..... ..........|-++|.+||+=...+.+-++|||+||+..+||..
T Consensus 199 iihgnlTc~tifiq~ngLIkig-~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIG-SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEec-ccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999888863 221111100 00011122346789999999777778889999999999999988
Q ss_pred CCCC
Q 006083 514 GRRP 517 (662)
Q Consensus 514 G~~P 517 (662)
|..-
T Consensus 278 lEiq 281 (458)
T KOG1266|consen 278 LEIQ 281 (458)
T ss_pred heec
Confidence 7653
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=8.2e-11 Score=109.60 Aligned_cols=144 Identities=19% Similarity=0.265 Sum_probs=106.1
Q ss_pred ccceeeccCceEEEEEEecCCCEEEEEEeecCC--------chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 320 KSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGS--------GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 320 ~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
...+|-+|+-+.|+++.+ .|+.+.||.-.... .-..++.++|+++|.+++--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999988 77888888542211 112356788999999987555554444444555557899
Q ss_pred EecCC-cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC---cEEEEeecccccc
Q 006083 392 EFVSN-KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF---EAMVADFGLAKLS 467 (662)
Q Consensus 392 E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkl~DFGla~~~ 467 (662)
||+.| .++.+++...............++..|-+.|.-||.+ +|||+||..+||||..++ .+.|+|||++...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99987 4777777654333334444477888999999999998 999999999999996543 3479999998654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.9e-12 Score=146.64 Aligned_cols=205 Identities=20% Similarity=0.230 Sum_probs=151.7
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
+|.+.+-+-.|.|+.++.+.- ..|...++|+...... ...+....+-.++...+||.+++...-+.-....+|||+
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~ 884 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGH 884 (1205)
T ss_pred cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhH
Confidence 456666788899999988763 2455556665543321 122344555555555667777777666666778899999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC---
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND--- 469 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~--- 469 (662)
|+++++|...|+... ..+.+-....+..+..+++|||.. .++|||+++.|+|+..++..++.|||.......
T Consensus 885 ~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 885 YLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred HhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccC
Confidence 999999999987654 345555556667778899999997 799999999999999999999999984321110
Q ss_pred ------------------CC---------CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCch
Q 006083 470 ------------------NH---------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTM 522 (662)
Q Consensus 470 ------------------~~---------~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~ 522 (662)
.. ........||..|.+||.+.+......+|+|++|++++|.++|..||+...
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 00 001223679999999999999999999999999999999999999998765
Q ss_pred hhhH
Q 006083 523 MEDS 526 (662)
Q Consensus 523 ~~~~ 526 (662)
.++.
T Consensus 1040 pq~~ 1043 (1205)
T KOG0606|consen 1040 PQQI 1043 (1205)
T ss_pred hhhh
Confidence 5443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.1e-10 Score=109.41 Aligned_cols=132 Identities=20% Similarity=0.317 Sum_probs=96.7
Q ss_pred ceeeccCceEEEEEEecCCCEEEEEEeecCC---ch-----hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGS---GQ-----GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~---~~-----~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
.+|++|+-+.+|.+.+. |..+++|.-.... .. ..+...+|+++|.+++--.|..-+-++.+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999998763 4446666432211 11 123567899999998754444433344455666899999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
++|..|.+.|... ...++..+-+.+.-||+. +|||+||.++||+|.++ ++.++||||+...
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~-~i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGG-RIYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCC-cEEEEECCccccc
Confidence 9999999888543 245667777778899999 99999999999999876 4999999998743
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.6e-10 Score=113.59 Aligned_cols=141 Identities=16% Similarity=0.084 Sum_probs=103.1
Q ss_pred ceeeccCceEEEEEEecCCCEEEEEEeecCCchh-HH----------HHHHHHHHHHhcCC--CCcceEEEEEEe-----
Q 006083 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQG-ER----------EFSAEVEIISRVHH--RHLVSLVGYCIA----- 383 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-~~----------~~~~E~~il~~l~H--pnIv~l~~~~~~----- 383 (662)
+.+-+.....|++..+ +|+.|.||......... .+ .+.+|...+.+|.. -.....+++++.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4555555556777666 77899999775432111 11 37789999998853 334455666543
Q ss_pred CCeEEEEEEecCCc-chhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC-------CCc
Q 006083 384 GGQRMLVYEFVSNK-TLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-------NFE 455 (662)
Q Consensus 384 ~~~~~lv~E~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-------~~~ 455 (662)
...-+||+|++.+. +|.+++........+...+..++.+++..+.-||.. ||+|+||++.||||+. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 23568999999986 888887532223355677888999999999999999 9999999999999975 468
Q ss_pred EEEEeeccccc
Q 006083 456 AMVADFGLAKL 466 (662)
Q Consensus 456 vkl~DFGla~~ 466 (662)
+.||||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998853
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1e-09 Score=116.53 Aligned_cols=167 Identities=17% Similarity=0.222 Sum_probs=131.0
Q ss_pred eEEEEEE-ecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEE----eCCeEEEEEEecCC-cchhhhh
Q 006083 330 GYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI----AGGQRMLVYEFVSN-KTLEYHL 403 (662)
Q Consensus 330 g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~----~~~~~~lv~E~~~~-g~L~~~l 403 (662)
.+.|++. ..+|..|++|+++.+..+.......-+++++++.|.|||.|.++|. .+..++|||+|..+ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 5788887 4589999999997665555555667789999999999999998876 45678899999876 4666654
Q ss_pred ccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 404 HGE-------------NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 404 ~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
... ....+.++.+|.++.|+..||.++|+. |+..+-|.+.+||++++.+++|...|+......+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 321 223467889999999999999999999 8999999999999999989999888877665543
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCC
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~P 517 (662)
.. |-+. --.+-|.=.||.+++.|.||..-
T Consensus 447 ~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 21 1111 12457888999999999999664
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.4e-09 Score=112.81 Aligned_cols=193 Identities=19% Similarity=0.240 Sum_probs=131.2
Q ss_pred CccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEE------E-EeCCeEEEE
Q 006083 319 AKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGY------C-IAGGQRMLV 390 (662)
Q Consensus 319 ~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~------~-~~~~~~~lv 390 (662)
..++.||+|+.+.+|..- .-...+.|+.+.-......+. +..|... .||-+-.-+.+ . ..+..+.++
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 346789999999999743 112345576665433322222 2223333 35544331111 1 122336688
Q ss_pred EEecCCcc-hhhhhc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccc
Q 006083 391 YEFVSNKT-LEYHLH----GENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 391 ~E~~~~g~-L~~~l~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
|..+.|.. +.+++. ++.....+|...++++..++.+++-||++ |.+-+|++.+||||.+++.|.|+|-....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 88877652 222331 23445689999999999999999999999 89999999999999999999999866544
Q ss_pred ccCCCCCccccccccCccccCccccc-----CCCCCchHHHHHHHHHHHHHHhC-CCCCCCc
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITG-RRPVDMT 521 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~eLltG-~~Pf~~~ 521 (662)
....+ ......+|...|.+||.-. +-.-+...|.|.|||++++||.| ++||.+.
T Consensus 166 i~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 166 INANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 33222 2234468999999999654 34566789999999999999887 9999764
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.3e-10 Score=106.97 Aligned_cols=126 Identities=25% Similarity=0.330 Sum_probs=83.3
Q ss_pred EEEEEEecCCCEEEEEEeecCCc-------------h-------------hHHHHHHHHHHHHhcCCC--CcceEEEEEE
Q 006083 331 YVHKGVLPNGKEVAVKSLKTGSG-------------Q-------------GEREFSAEVEIISRVHHR--HLVSLVGYCI 382 (662)
Q Consensus 331 ~Vy~~~~~~g~~vavK~l~~~~~-------------~-------------~~~~~~~E~~il~~l~Hp--nIv~l~~~~~ 382 (662)
.||.|...+|..+|||+.+.... . .....++|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988999999998753210 0 013456899999999755 556666553
Q ss_pred eCCeEEEEEEecC--CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCceeecCCccCcEEECCCCcEEEE
Q 006083 383 AGGQRMLVYEFVS--NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAY-LHEDCHPRIIHRDIKAANILIDDNFEAMVA 459 (662)
Q Consensus 383 ~~~~~~lv~E~~~--~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~y-LH~~~~~~ivHrDIkp~NILl~~~~~vkl~ 459 (662)
.-+|||||+. |..+..+.... +.......++.+++..+.. +|+. ||||+||...|||++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 2379999998 65554433211 1123456677778776655 4676 99999999999999987 99999
Q ss_pred eeccccccC
Q 006083 460 DFGLAKLSN 468 (662)
Q Consensus 460 DFGla~~~~ 468 (662)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.2e-09 Score=106.44 Aligned_cols=138 Identities=20% Similarity=0.240 Sum_probs=99.9
Q ss_pred CCccceeeccCceEEEEEEecCCCEEEEEEeecCCch----------------------hHHHHHHHHHHHHhcCCC--C
Q 006083 318 FAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQ----------------------GEREFSAEVEIISRVHHR--H 373 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~----------------------~~~~~~~E~~il~~l~Hp--n 373 (662)
..++..||.|.-+.||.|....|..+|||.-+..... .+...++|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 5567899999999999999989999999975432110 113456899999999643 5
Q ss_pred cceEEEEEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC
Q 006083 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN 453 (662)
Q Consensus 374 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~ 453 (662)
+.+-+++ +.-.+||||++|-.|...- ++.+..-.|+..|++-+.-+-+. ||||+|+..-||||++|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence 6666553 3457999999997775432 12333444455555545444454 89999999999999999
Q ss_pred CcEEEEeeccccccCC
Q 006083 454 FEAMVADFGLAKLSND 469 (662)
Q Consensus 454 ~~vkl~DFGla~~~~~ 469 (662)
|.++|+||--+.....
T Consensus 239 g~~~vIDwPQ~v~~~h 254 (304)
T COG0478 239 GDIVVIDWPQAVPISH 254 (304)
T ss_pred CCEEEEeCcccccCCC
Confidence 9999999998865543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.5e-08 Score=100.06 Aligned_cols=124 Identities=20% Similarity=0.195 Sum_probs=92.3
Q ss_pred CCCEEEEEEeecCCc-------hhHHHHHHHHHHHHhcC--CCCcceEEEEEEeC----CeEEEEEEecCCc-chhhhhc
Q 006083 339 NGKEVAVKSLKTGSG-------QGEREFSAEVEIISRVH--HRHLVSLVGYCIAG----GQRMLVYEFVSNK-TLEYHLH 404 (662)
Q Consensus 339 ~g~~vavK~l~~~~~-------~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~----~~~~lv~E~~~~g-~L~~~l~ 404 (662)
.++.+.+|.+..... -......+|...+.+|. .-.+...+++.+.. ...+||+|++.+. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 455666665432111 12346788999888885 34455667766542 2458999999884 7988886
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC---cEEEEeecccccc
Q 006083 405 GENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF---EAMVADFGLAKLS 467 (662)
Q Consensus 405 ~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkl~DFGla~~~ 467 (662)
.... ++......++.++++.+.-||.+ ||+|+|+++.||||+.+. .+.|+||+-++..
T Consensus 111 ~~~~--~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQ--LDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcc--cchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 5332 56677888999999999999999 999999999999999876 8999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.84 E-value=5.3e-08 Score=95.92 Aligned_cols=153 Identities=19% Similarity=0.230 Sum_probs=104.9
Q ss_pred CHHHHHHHhCCCCccce---eeccCceEEEEEEecCCCEEEEEEeecCCchhH-------------------HH-----H
Q 006083 307 TYDELAAATGGFAKSNL---LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGE-------------------RE-----F 359 (662)
Q Consensus 307 ~~~ei~~~~~~~~~~~~---iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~-------------------~~-----~ 359 (662)
+++.|..+..+..+..+ |..|.-..||+|...++..||||+.+....... ++ .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 44556666666666555 456667799999987899999999875322111 11 2
Q ss_pred HHHHHHHHhcC--CCCcceEEEEEEeCCeEEEEEEecCCcch-hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 006083 360 SAEVEIISRVH--HRHLVSLVGYCIAGGQRMLVYEFVSNKTL-EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436 (662)
Q Consensus 360 ~~E~~il~~l~--HpnIv~l~~~~~~~~~~~lv~E~~~~g~L-~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~ 436 (662)
+.|+.-|+++. +-.+.+-+++..+ .|||||+...-+ .-.|.. ..+...+...+..++++.+.-|-..+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~~n----VLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFRNN----VLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeecCC----eEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 45777888874 5555566665543 799999865421 112211 12333366777788888887777644
Q ss_pred ceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 437 ~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
++||+||..-|||+. ++.+.|||||-|.....
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 899999999999999 77999999999976653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=6.8e-08 Score=93.94 Aligned_cols=149 Identities=16% Similarity=0.103 Sum_probs=108.5
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecC---C---chhHHHHHHHHHHHHhcCC--CCcceEEEEEE--e-
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTG---S---GQGEREFSAEVEIISRVHH--RHLVSLVGYCI--A- 383 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~---~---~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~--~- 383 (662)
.+.+...---|+||-+-||.-.+ +|+.+-||.-..- . ......|.+|+..|.+|.. -.+.+.+.+.. .
T Consensus 17 ~~~wve~pN~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~ 95 (216)
T PRK09902 17 EGDWVEEPNYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIE 95 (216)
T ss_pred CCceecCCCcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccC
Confidence 34444444467899999999776 5557888876521 1 2356789999999999963 33445442221 1
Q ss_pred -CCeEEEEEEecCC-cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCc--EEEE
Q 006083 384 -GGQRMLVYEFVSN-KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE--AMVA 459 (662)
Q Consensus 384 -~~~~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~--vkl~ 459 (662)
.-.-+||.|-+.| .+|.+++........+...+..++.+++++|.-||.. ++.|+|+.+.|||++.++. ++++
T Consensus 96 ~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lI 172 (216)
T PRK09902 96 GEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFL 172 (216)
T ss_pred CceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEE
Confidence 1235789997754 5888888654444567788889999999999999999 9999999999999986666 9999
Q ss_pred eecccccc
Q 006083 460 DFGLAKLS 467 (662)
Q Consensus 460 DFGla~~~ 467 (662)
||--++..
T Consensus 173 DlEk~r~~ 180 (216)
T PRK09902 173 DLEKSRRR 180 (216)
T ss_pred Ehhccchh
Confidence 99877643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=8.9e-10 Score=121.17 Aligned_cols=152 Identities=22% Similarity=0.322 Sum_probs=102.0
Q ss_pred HHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC--------ccccccccCccccCccccc
Q 006083 420 ALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT--------HVSTRVMGTFGYLAPEYAS 491 (662)
Q Consensus 420 ~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~--------~~~~~~~Gt~~y~aPE~~~ 491 (662)
+.+++.||.|||+.. ++||+.|.|++|.++.++..||+.|+++........ ...-...-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 344558999999875 899999999999999999999999999875543111 1111133467899999999
Q ss_pred CCCCCchHHHHHHHHHHHHHHhCCCC-CCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHH
Q 006083 492 SGKLTEKSDVFSFGVMLLELITGRRP-VDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAA 570 (662)
Q Consensus 492 ~~~~~~~sDvwSlGvvl~eLltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~ 570 (662)
+...+.++|+|||||++|-+..|+.+ |....... .....+.. +..-...+..+...+|.+.+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~~~~~~~~--------------~~~~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-SYSFSRNL--------------LNAGAFGYSNNLPSELRESLKK 247 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcc-hhhhhhcc--------------cccccccccccCcHHHHHHHHH
Confidence 98899999999999999999954444 43332111 11111111 0000111222333444555557
Q ss_pred hcccCCCCCCCHHHHHHH
Q 006083 571 SIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 571 cl~~~p~~RPs~~evl~~ 588 (662)
++..+...||++.+++..
T Consensus 248 ~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred HhcCCcccCcchhhhhcc
Confidence 899999999988777654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.9e-08 Score=96.64 Aligned_cols=139 Identities=18% Similarity=0.224 Sum_probs=88.4
Q ss_pred ceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCC--cceEEEEEEeCCeEEEEEEecCCcc-
Q 006083 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRH--LVSLVGYCIAGGQRMLVYEFVSNKT- 398 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~~~~~~~~~~~lv~E~~~~g~- 398 (662)
..||+|..+.||+. .|..+++|...... ....+.+|.++|+.+..-+ +.+.++++.+.+...+|||++.|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 35567889876532 3455789999999997444 4678888888888899999999963
Q ss_pred hhhh---------------------hccCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhc-CCCceeecCCc
Q 006083 399 LEYH---------------------LHGENRPVMDFATRVR-IAL----------GSAK-GLAYLHED-CHPRIIHRDIK 444 (662)
Q Consensus 399 L~~~---------------------l~~~~~~~l~~~~~~~-i~~----------~ia~-aL~yLH~~-~~~~ivHrDIk 444 (662)
+... ||.-............ +.. .+.+ ...+|... ....++|+|++
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 2111 1211000111111110 000 0111 12233221 12357899999
Q ss_pred cCcEEECCCCcEEEEeeccccc
Q 006083 445 AANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 445 p~NILl~~~~~vkl~DFGla~~ 466 (662)
+.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999887 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.8e-08 Score=109.89 Aligned_cols=141 Identities=21% Similarity=0.262 Sum_probs=92.4
Q ss_pred ceeeccCceEEEEEEecCCCEEEEEEeecCCchhH----------------------------------------HHHHH
Q 006083 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGE----------------------------------------REFSA 361 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~----------------------------------------~~~~~ 361 (662)
+-|+.++-|.||+|++.+|+.||||+.+.+-.... -++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57899999999999999999999999765421100 01233
Q ss_pred HHHHHHhcC----CCCcceEEEEE-EeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHH-HHHHHhcCC
Q 006083 362 EVEIISRVH----HRHLVSLVGYC-IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKG-LAYLHEDCH 435 (662)
Q Consensus 362 E~~il~~l~----HpnIv~l~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~a-L~yLH~~~~ 435 (662)
|..-+.+++ +..-+.+=.+| +-.+...|+|||+.|-.+.+...-+. ..++... ++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~~~d-- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQLLRD-- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHHHhc--
Confidence 444444442 22222222233 33566789999999999988742222 2244333 33333332 2333334
Q ss_pred CceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 436 ~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
|++|.|.+|.||+|+.++++.+.|||+......
T Consensus 285 -gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 -GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999876654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.1e-07 Score=90.79 Aligned_cols=138 Identities=16% Similarity=0.206 Sum_probs=93.9
Q ss_pred HhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHH---------HHHHHHHHhcCC---CCcceEEEEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREF---------SAEVEIISRVHH---RHLVSLVGYC 381 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~---------~~E~~il~~l~H---pnIv~l~~~~ 381 (662)
..++|...+++-......|.+-.. +|+.+++|..+......++.| .+++..+.+++. -.++.++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 457788888887777777777665 779999999876544433333 234444444432 2333323222
Q ss_pred E-----eCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcE
Q 006083 382 I-----AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA 456 (662)
Q Consensus 382 ~-----~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 456 (662)
+ .....+|||||++|..|.+... ++. .++..+.++|.-||+. |++|+|++|.|++|.++ .+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cE
Confidence 2 2245568999999998876541 222 2445567789999999 99999999999999965 59
Q ss_pred EEEeeccccc
Q 006083 457 MVADFGLAKL 466 (662)
Q Consensus 457 kl~DFGla~~ 466 (662)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.9e-07 Score=93.34 Aligned_cols=143 Identities=17% Similarity=0.169 Sum_probs=87.2
Q ss_pred cceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCC--CcceEEEEEE---eCCeEEEEEEecC
Q 006083 321 SNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHR--HLVSLVGYCI---AGGQRMLVYEFVS 395 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~~~~~---~~~~~~lv~E~~~ 395 (662)
.+.|+.|..+.||+....+ ..+++|+.... .....+.+|+.+++.|... .+.+++.++. .....+++|+|+.
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4679999999999999866 69999997653 4567788999999998533 3557776553 3456789999999
Q ss_pred Ccchhh----------------hh---ccC--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 006083 396 NKTLEY----------------HL---HGE--NRPVMDFAT---------RVRI------------ALGSAK-GLAYLHE 432 (662)
Q Consensus 396 ~g~L~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~ia~-aL~yLH~ 432 (662)
|..+.. .+ |.. ......... .... +..+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 111 110111100 0000 111222 3333332
Q ss_pred c----CCCceeecCCccCcEEEC-CCCcEEEEeeccccc
Q 006083 433 D----CHPRIIHRDIKAANILID-DNFEAMVADFGLAKL 466 (662)
Q Consensus 433 ~----~~~~ivHrDIkp~NILl~-~~~~vkl~DFGla~~ 466 (662)
. ....++|+|+.+.|||++ +++++-|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1 223699999999999999 666778999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.59 E-value=5.9e-07 Score=91.09 Aligned_cols=140 Identities=17% Similarity=0.129 Sum_probs=87.4
Q ss_pred eeeccCc-eEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEEecCCcchh
Q 006083 323 LLGQGGF-GYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRMLVYEFVSNKTLE 400 (662)
Q Consensus 323 ~iG~G~~-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~ 400 (662)
.|-.|.+ ..||+... ++..+.||+..... ...+.+|+++++.+. +--+.++++++..++..++||||+.|..|.
T Consensus 5 ~~~~g~~~~~v~~~~~-~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDG-KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcC-CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3445555 78999876 34788889876543 345778999998884 444567888887777789999999998775
Q ss_pred hhh-------------------ccCCC--CCCC--HHHHHHHHH--------------------HHHHHHHHHHhc----
Q 006083 401 YHL-------------------HGENR--PVMD--FATRVRIAL--------------------GSAKGLAYLHED---- 433 (662)
Q Consensus 401 ~~l-------------------~~~~~--~~l~--~~~~~~i~~--------------------~ia~aL~yLH~~---- 433 (662)
... |.... ..+. ....+.... .+...+..|-..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 11110 0111 000000000 011112222111
Q ss_pred CCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 434 CHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 434 ~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123699999999999999887778999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.6e-09 Score=114.99 Aligned_cols=186 Identities=17% Similarity=0.128 Sum_probs=135.5
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCC-cceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRH-LVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~lv~E~~ 394 (662)
.-+..-+.+++|+++.+||.+-...+....|.+... ....-++++|.+++||| .+..++-++.+...+++|+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 334445668899999999987433334446666542 44566899999999999 777777777788889999999
Q ss_pred CCc-chhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 395 SNK-TLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 395 ~~g-~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
.++ +....... ....+...+...+.+.-.++|+|||+. .=+||| |||..+ +..|+.||+....+....
T Consensus 317 s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 317 STGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred cCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--
Confidence 887 22211110 111123334455666677899999987 458999 888775 578999999987776543
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCC
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~P 517 (662)
......++..|++||+.....+..+.|+|++|+--.+|.-|-.|
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 23457899999999999999999999999999877777776655
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=5.7e-07 Score=84.02 Aligned_cols=128 Identities=20% Similarity=0.272 Sum_probs=90.8
Q ss_pred ccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcce-EEEEEEeCCeEEEEEEecCCcc
Q 006083 320 KSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVS-LVGYCIAGGQRMLVYEFVSNKT 398 (662)
Q Consensus 320 ~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~-l~~~~~~~~~~~lv~E~~~~g~ 398 (662)
..+.||+|.+|.||+|.+ .|..+|+|+-+.+ .....++.|+++|..++.-++.. ++.|..+ ++.|||+.|..
T Consensus 26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeec-cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence 457899999999999998 4568999987765 34577999999999998777654 5544333 45699999988
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCc-c-CcEEECCCCcEEEEeecccccc
Q 006083 399 LEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIK-A-ANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 399 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIk-p-~NILl~~~~~vkl~DFGla~~~ 467 (662)
|.++.... + .+-+..+++.---|... ||-|+.|. + .||++. ++++.|+||.-|.+.
T Consensus 99 L~~~~~~~-----~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~-~~~~~iIDFd~At~k 156 (201)
T COG2112 99 LGKLEIGG-----D----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVN-DRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhcc-----c----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEec-CCcEEEEEccchhhc
Confidence 87655321 1 22234445553445555 89999995 4 455555 449999999998743
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=6.4e-07 Score=98.80 Aligned_cols=143 Identities=21% Similarity=0.294 Sum_probs=89.8
Q ss_pred cceeeccCceEEEEEEecCCCEEEEEEeecCCchh-------------------------------HH------HHHHHH
Q 006083 321 SNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQG-------------------------------ER------EFSAEV 363 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-------------------------------~~------~~~~E~ 363 (662)
.+-||.-..|.||+|++++|+.||||+-+.+-... .+ +|..|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36799999999999999999999999876432111 01 133344
Q ss_pred HHHHh----cCCCCcce---EEEEE-EeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006083 364 EIISR----VHHRHLVS---LVGYC-IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435 (662)
Q Consensus 364 ~il~~----l~HpnIv~---l~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 435 (662)
+-..+ ++|-++.. +=.++ .-.....|+||||+|.-+.|.-.-... .++...+...+.++ |++....
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~-----~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEA-----YLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHH-----HHHHHHh
Confidence 33333 23444111 21222 234567999999999887665321111 24444433333332 2222222
Q ss_pred CceeecCCccCcEEEC----CCCcEEEEeeccccccCC
Q 006083 436 PRIIHRDIKAANILID----DNFEAMVADFGLAKLSND 469 (662)
Q Consensus 436 ~~ivHrDIkp~NILl~----~~~~vkl~DFGla~~~~~ 469 (662)
.|++|+|=+|.||||+ .++++.+.|||+......
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 2899999999999998 377899999999887654
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.7e-06 Score=101.11 Aligned_cols=147 Identities=17% Similarity=0.283 Sum_probs=93.4
Q ss_pred cceeeccCceEEEEEEecCC---CEEEEEEeecCC-chhHHHHHHHHHHHHhcC-CCCc--ceEEEEEEeC---CeEEEE
Q 006083 321 SNLLGQGGFGYVHKGVLPNG---KEVAVKSLKTGS-GQGEREFSAEVEIISRVH-HRHL--VSLVGYCIAG---GQRMLV 390 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~il~~l~-HpnI--v~l~~~~~~~---~~~~lv 390 (662)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.|. |.+| .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999876543 467777764432 123457889999999995 6665 7888888764 567899
Q ss_pred EEecCCcchhh-----------------------hhccCCCC---------CCCH--HHHHHHHH---------------
Q 006083 391 YEFVSNKTLEY-----------------------HLHGENRP---------VMDF--ATRVRIAL--------------- 421 (662)
Q Consensus 391 ~E~~~~g~L~~-----------------------~l~~~~~~---------~l~~--~~~~~i~~--------------- 421 (662)
|||+.|..+.+ .||.-... ...+ .++.++..
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99999865321 11221100 0011 11111111
Q ss_pred HHHHHHHHHHhcC--------CCceeecCCccCcEEECC-CCc-EEEEeecccccc
Q 006083 422 GSAKGLAYLHEDC--------HPRIIHRDIKAANILIDD-NFE-AMVADFGLAKLS 467 (662)
Q Consensus 422 ~ia~aL~yLH~~~--------~~~ivHrDIkp~NILl~~-~~~-vkl~DFGla~~~ 467 (662)
.+.+.+.+|..+. ...+||+|+++.|||++. +++ +-|+||.++...
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 1233456675432 135999999999999985 344 459999998654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.36 E-value=9.5e-06 Score=79.10 Aligned_cols=132 Identities=20% Similarity=0.279 Sum_probs=93.5
Q ss_pred ccceeeccCceEEEEEEecCCCEEEEEEeecCC----------------chhHHHHHHHHHHHHhcC------CCCcceE
Q 006083 320 KSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGS----------------GQGEREFSAEVEIISRVH------HRHLVSL 377 (662)
Q Consensus 320 ~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~----------------~~~~~~~~~E~~il~~l~------HpnIv~l 377 (662)
....||+|+.-.||. +.++...+||+++... ....++..+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346799999999997 4466778999987655 112355667777666665 7889999
Q ss_pred EEEEEeCCeEEEEEEecCC------cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC
Q 006083 378 VGYCIAGGQRMLVYEFVSN------KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID 451 (662)
Q Consensus 378 ~~~~~~~~~~~lv~E~~~~------g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~ 451 (662)
+|+.+.+....+|+|.+.+ -+|.+++... .++. ...+.+. +-..||-++ .|+.+||++.||++.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~---~f~~~l~~~---~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALD---EFKRYLLDH---HIVIRDLNPHNIVVQ 152 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHH---HHHHHHHHc---CCeecCCCcccEEEE
Confidence 9999999999999998754 3467777433 2443 3333333 335777777 899999999999995
Q ss_pred C--CC--cEEEEe-ecc
Q 006083 452 D--NF--EAMVAD-FGL 463 (662)
Q Consensus 452 ~--~~--~vkl~D-FGl 463 (662)
. ++ .+.|+| ||.
T Consensus 153 ~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGE 169 (199)
T ss_pred ecCCCceEEEEEeCCCC
Confidence 3 22 577777 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.34 E-value=3e-06 Score=85.44 Aligned_cols=73 Identities=15% Similarity=0.205 Sum_probs=47.9
Q ss_pred ceeeccCce-EEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCC---CcceEEEEEEeC---CeEEEEEEec
Q 006083 322 NLLGQGGFG-YVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHR---HLVSLVGYCIAG---GQRMLVYEFV 394 (662)
Q Consensus 322 ~~iG~G~~g-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~Hp---nIv~l~~~~~~~---~~~~lv~E~~ 394 (662)
+.|+.||.. .||+. +..+++|+.+.. .....+.+|+++|..|... .+.++++.+... +..++||+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467777776 58874 345778876542 2345789999999988632 344455544332 2458899999
Q ss_pred CCcchh
Q 006083 395 SNKTLE 400 (662)
Q Consensus 395 ~~g~L~ 400 (662)
.|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.33 E-value=8.1e-06 Score=85.29 Aligned_cols=79 Identities=9% Similarity=0.070 Sum_probs=58.6
Q ss_pred CCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCC---CCcceEEEEEEe---CCeEEEEE
Q 006083 318 FAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHH---RHLVSLVGYCIA---GGQRMLVY 391 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~H---pnIv~l~~~~~~---~~~~~lv~ 391 (662)
....+.||.|..+.||+....++ .+++|..+.. .....+.+|.+.|+.|.. -.+.+++++|.+ .+..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 33456799999999999876455 4677775431 123578999999999953 467788988764 36689999
Q ss_pred EecCCcch
Q 006083 392 EFVSNKTL 399 (662)
Q Consensus 392 E~~~~g~L 399 (662)
|++.|+.+
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998754
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.29 E-value=6.8e-06 Score=79.49 Aligned_cols=125 Identities=26% Similarity=0.397 Sum_probs=89.9
Q ss_pred CCCCccceeeccCc-eEEEEEEecCCCEEEEEEeec---CCc------------------hhHHHHHHHHHHHHhcC---
Q 006083 316 GGFAKSNLLGQGGF-GYVHKGVLPNGKEVAVKSLKT---GSG------------------QGEREFSAEVEIISRVH--- 370 (662)
Q Consensus 316 ~~~~~~~~iG~G~~-g~Vy~~~~~~g~~vavK~l~~---~~~------------------~~~~~~~~E~~il~~l~--- 370 (662)
.+++..+.||.|.- |.||++.+ +|+.||+|+++. ... ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999998 788999999432 000 11134778998888885
Q ss_pred CCCc--ceEEEEEEeC------------------CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 006083 371 HRHL--VSLVGYCIAG------------------GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYL 430 (662)
Q Consensus 371 HpnI--v~l~~~~~~~------------------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yL 430 (662)
+.++ |+.+||..-. -...||.||+.... .+ ..+-+.+|.+-|..|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~----~~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PL----QIRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------cc----chhHHHHHHHHHHHH
Confidence 4566 8888887422 12246777765432 11 233445667778889
Q ss_pred HhcCCCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 431 HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 431 H~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
|+. +|+-+|+|..|.. .-||+|||.+
T Consensus 181 ~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC---CeeeccCcccccc-----CCEEEecccC
Confidence 998 9999999999997 4599999965
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.27 E-value=3.7e-06 Score=81.55 Aligned_cols=104 Identities=17% Similarity=0.149 Sum_probs=82.2
Q ss_pred HHHHHHHHhcCC-CCcceEEEEEEeCCeEEEEEEecCCcchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 006083 360 SAEVEIISRVHH-RHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHG-ENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437 (662)
Q Consensus 360 ~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 437 (662)
..|.-+|+.+.+ .++.+++|+|-. ++|.||+..+.+...... ......+|..|.+|+.++++.+++|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999976 699999999933 779999987755321000 11123689999999999999999999854446
Q ss_pred eeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 438 IIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 438 ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
+.-.|++++||-|++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 899999999999999999999999987544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.24 E-value=6e-06 Score=86.21 Aligned_cols=142 Identities=16% Similarity=0.126 Sum_probs=87.0
Q ss_pred cceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCC--cceEEE------EEEeCCeEEEEEE
Q 006083 321 SNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRH--LVSLVG------YCIAGGQRMLVYE 392 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~~------~~~~~~~~~lv~E 392 (662)
.+.|..|....+|+.... +..+++|+... .....+..|++++..|.+.+ +.+++. +...++..++||+
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 455777777899998763 45788898764 23456778899888885332 445443 2233456789999
Q ss_pred ecCCcchhh--------------hhccC----CC-----CCCCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 006083 393 FVSNKTLEY--------------HLHGE----NR-----PVMDFATRV----------RIALGSAKGLAYLHE----DCH 435 (662)
Q Consensus 393 ~~~~g~L~~--------------~l~~~----~~-----~~l~~~~~~----------~i~~~ia~aL~yLH~----~~~ 435 (662)
|++|..+.. .||.. .. ....|.... .....+..++.+|.+ ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 11110 00 011221111 011122334455543 123
Q ss_pred CceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 436 ~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
.+++|+|+++.|||+++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3799999999999999887778999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.4e-05 Score=80.50 Aligned_cols=140 Identities=18% Similarity=0.166 Sum_probs=82.7
Q ss_pred ceeeccCceEEEEEEecC--CCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCC-cceEEEEEEeCCeEEEEEEecCCcc
Q 006083 322 NLLGQGGFGYVHKGVLPN--GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRH-LVSLVGYCIAGGQRMLVYEFVSNKT 398 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~lv~E~~~~g~ 398 (662)
+.|..|-...||+....+ ++.|++|+....... .-...+|+.+++.+...+ ..++++.+. + .+||||++|..
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCc
Confidence 567778888999988654 678999977543221 123457999999885433 445555443 2 48999999876
Q ss_pred hhhh-----------------hccCCC---------CCCC-HHHHHHHHH----------------------HHHHHHHH
Q 006083 399 LEYH-----------------LHGENR---------PVMD-FATRVRIAL----------------------GSAKGLAY 429 (662)
Q Consensus 399 L~~~-----------------l~~~~~---------~~l~-~~~~~~i~~----------------------~ia~aL~y 429 (662)
+... ||.... .... +..+..+.. .+...+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5321 121111 0111 122112111 11111112
Q ss_pred H----Hhc-CCCceeecCCccCcEEECC-CCcEEEEeeccccc
Q 006083 430 L----HED-CHPRIIHRDIKAANILIDD-NFEAMVADFGLAKL 466 (662)
Q Consensus 430 L----H~~-~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~~ 466 (662)
| ... ....++|+|+++.|||+++ ++.+.|+||..|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 2 111 1236999999999999998 57899999998754
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.17 E-value=8.5e-06 Score=83.27 Aligned_cols=137 Identities=12% Similarity=0.066 Sum_probs=80.5
Q ss_pred eeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeEEEEEEecCCcchhhh
Q 006083 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHL-VSLVGYCIAGGQRMLVYEFVSNKTLEYH 402 (662)
Q Consensus 324 iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lv~E~~~~g~L~~~ 402 (662)
+..|-.+.+|+... +++.+++|+.........-...+|.++|+.+..-++ .++++++. -++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677789998874 677888997654322211235789999999864434 34554432 2689999998765421
Q ss_pred -----------------hccCC--CCCCCHHH-HHHHHHHH---------HHHHHHHHhc-----CCCceeecCCccCcE
Q 006083 403 -----------------LHGEN--RPVMDFAT-RVRIALGS---------AKGLAYLHED-----CHPRIIHRDIKAANI 448 (662)
Q Consensus 403 -----------------l~~~~--~~~l~~~~-~~~i~~~i---------a~aL~yLH~~-----~~~~ivHrDIkp~NI 448 (662)
||... ...++... +..+..++ ...+..+-.. ....++|+|+.+.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 12221 11122221 11111111 1112222111 123589999999999
Q ss_pred EECCCCcEEEEeeccccc
Q 006083 449 LIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 449 Ll~~~~~vkl~DFGla~~ 466 (662)
|+++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.13 E-value=7.6e-05 Score=80.46 Aligned_cols=76 Identities=18% Similarity=0.135 Sum_probs=54.5
Q ss_pred cceeeccCceEEEEEEecCC-CEEEEEEeecC-----C--chhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeEEE
Q 006083 321 SNLLGQGGFGYVHKGVLPNG-KEVAVKSLKTG-----S--GQGEREFSAEVEIISRVH---HRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~g-~~vavK~l~~~-----~--~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~~~~l 389 (662)
.+.||.|.+..||++...+| +.|+||.-... . ....+++..|.+.|+.+. ..++.+++.+. .+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 35799999999999998776 58999985311 1 123456777888888873 24566777763 355789
Q ss_pred EEEecCCcc
Q 006083 390 VYEFVSNKT 398 (662)
Q Consensus 390 v~E~~~~g~ 398 (662)
||||+.+..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997643
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=5.4e-06 Score=84.37 Aligned_cols=147 Identities=18% Similarity=0.175 Sum_probs=100.7
Q ss_pred cCHHHHHHHhC---CCCccceeeccCceEEEEEEecCCCEEEEEEeecCCc------------------h--h--HHHHH
Q 006083 306 FTYDELAAATG---GFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSG------------------Q--G--EREFS 360 (662)
Q Consensus 306 ~~~~ei~~~~~---~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~------------------~--~--~~~~~ 360 (662)
++|-.|..... -+.+++.||-|.-+.||++...+|+..++|+-+.+.. . . +-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 45555554443 3678999999999999999998999999996432100 0 0 11245
Q ss_pred HHHHHHHhcC-CCC-cceEEEEEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 006083 361 AEVEIISRVH-HRH-LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRI 438 (662)
Q Consensus 361 ~E~~il~~l~-Hpn-Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 438 (662)
+|+..|+.|. |-. +...+++ ..-++|||++.|-.|...-+ ..+...+ ...+..-|.-|-++ |+
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-----v~d~~~l---y~~lm~~Iv~la~~---Gl 223 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH-----VEDPPTL---YDDLMGLIVRLANH---GL 223 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee-----cCChHHH---HHHHHHHHHHHHHc---Cc
Confidence 6888888885 322 3344444 34589999999988864332 2233333 33334445666666 99
Q ss_pred eecCCccCcEEECCCCcEEEEeecccccc
Q 006083 439 IHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 439 vHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
||+|++--||+|++++.+++|||--+...
T Consensus 224 IHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 224 IHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred eecccchheeEEecCCCEEEeechHhhcc
Confidence 99999999999999999999999766543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.05 E-value=7.8e-05 Score=78.36 Aligned_cols=157 Identities=16% Similarity=0.165 Sum_probs=92.2
Q ss_pred CHHHHHHHhCCCCc-----cceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCC--CCcceEEE
Q 006083 307 TYDELAAATGGFAK-----SNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHH--RHLVSLVG 379 (662)
Q Consensus 307 ~~~ei~~~~~~~~~-----~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~ 379 (662)
+.++|......|.+ .+.|+.|....||+....+| .+++|+.+... ....+..|++++..|.. -.+.+++.
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~ 84 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVK 84 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCcccc
Confidence 34566555555655 34566777789999876444 67788775421 23456678888888742 22444443
Q ss_pred E------EEeCCeEEEEEEecCCcchhh--------------hhccCCCC----------CCCHHHHHH-----------
Q 006083 380 Y------CIAGGQRMLVYEFVSNKTLEY--------------HLHGENRP----------VMDFATRVR----------- 418 (662)
Q Consensus 380 ~------~~~~~~~~lv~E~~~~g~L~~--------------~l~~~~~~----------~l~~~~~~~----------- 418 (662)
. ...++..+++|||++|..+.. .+|..... ...|.....
T Consensus 85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 2 223567789999998855321 11211000 011111100
Q ss_pred -HHHHHHHHHHHHHh----cCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 419 -IALGSAKGLAYLHE----DCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 419 -i~~~ia~aL~yLH~----~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
....+.+.+++|.. ....+++|+|+++.||++++++.+.|+||+.+..
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 01123344555543 2234899999999999999887678999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.04 E-value=0.00011 Score=77.55 Aligned_cols=157 Identities=17% Similarity=0.146 Sum_probs=87.6
Q ss_pred cCHHHHHHHhCCCCc-----cceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCC--CcceEE
Q 006083 306 FTYDELAAATGGFAK-----SNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHR--HLVSLV 378 (662)
Q Consensus 306 ~~~~ei~~~~~~~~~-----~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~ 378 (662)
++.+++...-..|.+ .+.|+.|....+|+....+| .+++|++.. ...+.+..|+.++..|... .+.+.+
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcce
Confidence 344556555455654 34466677778999876555 688898762 2234455667777776422 233433
Q ss_pred E------EEEeCCeEEEEEEecCCcchh-----------hh---hccCCC---------CCC-CHHHHHH----------
Q 006083 379 G------YCIAGGQRMLVYEFVSNKTLE-----------YH---LHGENR---------PVM-DFATRVR---------- 418 (662)
Q Consensus 379 ~------~~~~~~~~~lv~E~~~~g~L~-----------~~---l~~~~~---------~~l-~~~~~~~---------- 418 (662)
. +...++..+++|||++|..+. .. ||.... ..+ .+.....
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 2 223456789999999987431 11 121100 011 1111111
Q ss_pred --HHHH-HHHHHHHHHhc----CCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 419 --IALG-SAKGLAYLHED----CHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 419 --i~~~-ia~aL~yLH~~----~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
.+.+ +...++.+.+. ...++||+|+++.|||++++...-|+||+.+..
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1111 11122333211 234799999999999999765557999998753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.97 E-value=4.6e-05 Score=79.87 Aligned_cols=140 Identities=23% Similarity=0.279 Sum_probs=84.4
Q ss_pred ceeeccCceEEEEEEecC-------CCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeEEEEEEe
Q 006083 322 NLLGQGGFGYVHKGVLPN-------GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHL-VSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lv~E~ 393 (662)
+.|..|-...||+....+ ++.|++|+..... .......+|+++++.+...++ .++++++.+ .+||||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667777999987654 5789999876542 223456789999988864333 356666542 368999
Q ss_pred cCCcchhhh-----------------hccCCCC-------CCC--HHHHHH--------------------------HHH
Q 006083 394 VSNKTLEYH-----------------LHGENRP-------VMD--FATRVR--------------------------IAL 421 (662)
Q Consensus 394 ~~~g~L~~~-----------------l~~~~~~-------~l~--~~~~~~--------------------------i~~ 421 (662)
++|..+... ||..... ... +..+.+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988766421 1221111 000 111100 011
Q ss_pred HHHHHHHHHHh------cCCCceeecCCccCcEEECCC----CcEEEEeeccccc
Q 006083 422 GSAKGLAYLHE------DCHPRIIHRDIKAANILIDDN----FEAMVADFGLAKL 466 (662)
Q Consensus 422 ~ia~aL~yLH~------~~~~~ivHrDIkp~NILl~~~----~~vkl~DFGla~~ 466 (662)
.+...+.+|.. .....++|+|+++.|||++++ +.++|+||..|..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 12222334432 133479999999999999974 7899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.96 E-value=5.2e-05 Score=78.61 Aligned_cols=143 Identities=16% Similarity=0.230 Sum_probs=99.2
Q ss_pred CccceeeccCceEEEEEEecCCCEEEEEEeecCC------ch----------------hHH----HHHHHHHHHHhcCCC
Q 006083 319 AKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGS------GQ----------------GER----EFSAEVEIISRVHHR 372 (662)
Q Consensus 319 ~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~------~~----------------~~~----~~~~E~~il~~l~Hp 372 (662)
++...|..|.-..||.+...+|..+|||+.+..- .. -++ -...|++-|++|+.-
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3345688899999999998899999999875320 00 011 123578888888755
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCcchhh-hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC
Q 006083 373 HLVSLVGYCIAGGQRMLVYEFVSNKTLEY-HLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID 451 (662)
Q Consensus 373 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~ 451 (662)
.|..---+.. ..-.|||+|+.+..... .| +...+....+..+-.+++.-+.-|.+.| ++||.||.--|+|+.
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 5432111111 12379999997544322 22 2234666678888888888888888888 899999999999997
Q ss_pred CCCcEEEEeeccccccCC
Q 006083 452 DNFEAMVADFGLAKLSND 469 (662)
Q Consensus 452 ~~~~vkl~DFGla~~~~~ 469 (662)
+|.+.|||.+-+.....
T Consensus 300 -dG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSVEHDH 316 (520)
T ss_pred -CCEEEEEEccccccCCC
Confidence 56899999998876544
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00011 Score=86.02 Aligned_cols=196 Identities=19% Similarity=0.204 Sum_probs=132.6
Q ss_pred HHHHHHHHHhcCCCCcceEEEEEEeCCeEE----EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 006083 359 FSAEVEIISRVHHRHLVSLVGYCIAGGQRM----LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434 (662)
Q Consensus 359 ~~~E~~il~~l~HpnIv~l~~~~~~~~~~~----lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 434 (662)
...|+..+..+.|.|++.++.|........ +.-|+|...++...+... ..++.+..+.+..++.+||.|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSL- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHh-
Confidence 455777788889999999999876543332 455688888888877443 3478888888999999999999997
Q ss_pred CCceeecCCccC---cEEECCCCcEEEE--eeccccccCCCCCccccccccCccccCcccccCCCCCch--HHHHHHHHH
Q 006083 435 HPRIIHRDIKAA---NILIDDNFEAMVA--DFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEK--SDVFSFGVM 507 (662)
Q Consensus 435 ~~~ivHrDIkp~---NILl~~~~~vkl~--DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~--sDvwSlGvv 507 (662)
...|.=|... +..++.++.+.+. ||+..+.......... ..-...|.++|......+..+ .|+|.+|..
T Consensus 306 --~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 306 --SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred --ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHHH
Confidence 5555544444 4445666677766 9998877665433222 223455778887776555544 699999999
Q ss_pred HHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 508 LLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 508 l~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+..+..|...-.....- .. .+..... . .+......|+..+.++|..+.+++.
T Consensus 382 ~~~~~~~~~i~~~~~~~--------------------~~----~l~~~~~-~---~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAVP--------------------VS----LLDVLST-S---ELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HhhhhhcCcccccccch--------------------hh----hhccccc-h---hhhhhhhhhcchhhhhccchhhhhh
Confidence 99999887643221100 00 0011111 1 3334445899999999999999997
Q ss_pred Hh
Q 006083 588 AL 589 (662)
Q Consensus 588 ~L 589 (662)
..
T Consensus 434 ~~ 435 (1351)
T KOG1035|consen 434 HP 435 (1351)
T ss_pred ch
Confidence 64
|
|
| >PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region | Back alignment and domain information |
|---|
Probab=97.91 E-value=2.8e-06 Score=76.54 Aligned_cols=38 Identities=26% Similarity=0.336 Sum_probs=19.1
Q ss_pred CCCCCCCcceeEEEchhHHHHHHHHHHHHHHHHHHhhh
Q 006083 160 GSSSGDDYVTYSVIGAVGVGIFLIAMIIICAVRANKKK 197 (662)
Q Consensus 160 ~~~~~~~~~~~~v~~~v~~~~~~i~~~~~~~~~~~rkr 197 (662)
|.+.....+++.||++|+++|+|++++++|+||+||||
T Consensus 42 GlS~knknIVIGvVVGVGg~ill~il~lvf~~c~r~kk 79 (154)
T PF04478_consen 42 GLSSKNKNIVIGVVVGVGGPILLGILALVFIFCIRRKK 79 (154)
T ss_pred CCCcCCccEEEEEEecccHHHHHHHHHhheeEEEeccc
Confidence 33443444455555555566665555555555544443
|
The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway []. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00016 Score=74.78 Aligned_cols=31 Identities=29% Similarity=0.522 Sum_probs=25.9
Q ss_pred ceeecCCccCcEEECCCCcE-EEEeecccccc
Q 006083 437 RIIHRDIKAANILIDDNFEA-MVADFGLAKLS 467 (662)
Q Consensus 437 ~ivHrDIkp~NILl~~~~~v-kl~DFGla~~~ 467 (662)
.++|+|+++.|||+++++++ -|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 58999999999999975654 59999988643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00026 Score=73.81 Aligned_cols=137 Identities=18% Similarity=0.249 Sum_probs=79.2
Q ss_pred EEEEEEecCCCEEEEEEee-cCCchhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCC--eEEEEEEecCCcchhhhhcc
Q 006083 331 YVHKGVLPNGKEVAVKSLK-TGSGQGEREFSAEVEIISRVHH--RHLVSLVGYCIAGG--QRMLVYEFVSNKTLEYHLHG 405 (662)
Q Consensus 331 ~Vy~~~~~~g~~vavK~l~-~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~~--~~~lv~E~~~~g~L~~~l~~ 405 (662)
.+|.... .++.+++.+-. ...........+|+.+|+.+.- --+...+++|.++. ..|.||+|++|..+...+..
T Consensus 40 ~t~~~~~-~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~ 118 (321)
T COG3173 40 DTFRLGD-TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP 118 (321)
T ss_pred ceEEEec-CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence 4444433 37788888221 1222344667889999988753 23344567776655 77999999998544332211
Q ss_pred CCC------------------------------------CCCCHHHHHHHHH--------HHHHHHHHHHhc-----CCC
Q 006083 406 ENR------------------------------------PVMDFATRVRIAL--------GSAKGLAYLHED-----CHP 436 (662)
Q Consensus 406 ~~~------------------------------------~~l~~~~~~~i~~--------~ia~aL~yLH~~-----~~~ 436 (662)
... +...|...++.+. .+..-..||+.+ ...
T Consensus 119 ~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~ 198 (321)
T COG3173 119 ESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPP 198 (321)
T ss_pred ccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCc
Confidence 100 0011111111000 111223444433 234
Q ss_pred ceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 437 ~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
.++|+|+++.||||+.++.+=|+||+++....
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 69999999999999998888899999997654
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.68 E-value=1.3e-05 Score=95.08 Aligned_cols=159 Identities=13% Similarity=0.024 Sum_probs=115.9
Q ss_pred HHHHHHHHHhcCCCCcceEEEEEE--eCCeEEEEEEecCCcchhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 006083 359 FSAEVEIISRVHHRHLVSLVGYCI--AGGQRMLVYEFVSNKTLEYHLHGE--NRPVMDFATRVRIALGSAKGLAYLHEDC 434 (662)
Q Consensus 359 ~~~E~~il~~l~HpnIv~l~~~~~--~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 434 (662)
+..|.+.++...|.+++....-.. .....|.+++||.+|.++..|... +...++..-+.....+......-+|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 445556666678998887765543 345668999999999999988543 2233343333333333355555666542
Q ss_pred CC--ceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHH
Q 006083 435 HP--RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 512 (662)
Q Consensus 435 ~~--~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLl 512 (662)
+. -.+|++||.-|.+|..+.++|+.++|+.+.... .....+..++++.|+.++++..-.++.++|+|..|+-+|++.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 22 379999999999999999999999999984332 223445577888999999998888999999999999999998
Q ss_pred hCCCCC
Q 006083 513 TGRRPV 518 (662)
Q Consensus 513 tG~~Pf 518 (662)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 877655
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0012 Score=69.58 Aligned_cols=139 Identities=21% Similarity=0.290 Sum_probs=84.1
Q ss_pred eeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCc------ceEEE----EEEeCCeEEEEEEe
Q 006083 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHL------VSLVG----YCIAGGQRMLVYEF 393 (662)
Q Consensus 324 iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnI------v~l~~----~~~~~~~~~lv~E~ 393 (662)
|.. .-..||+....+|+. ++|+.+.. ....++..|+.+|..|.-.+| ..+=| ........+-|++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 456789988877766 89988775 456778889999988842222 22211 11122377889999
Q ss_pred cCCcchhh---------------hhcc--CCC--------CCCCHHH-------------HHHHHHHHHHHHHHHHhc--
Q 006083 394 VSNKTLEY---------------HLHG--ENR--------PVMDFAT-------------RVRIALGSAKGLAYLHED-- 433 (662)
Q Consensus 394 ~~~g~L~~---------------~l~~--~~~--------~~l~~~~-------------~~~i~~~ia~aL~yLH~~-- 433 (662)
+.|..+.. .||. ++. ....|.. ......++...+..+.+.
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99988772 1111 000 1122320 011223334444444442
Q ss_pred --CCC-c--eeecCCccCcEEECCCCc-EEEEeeccccc
Q 006083 434 --CHP-R--IIHRDIKAANILIDDNFE-AMVADFGLAKL 466 (662)
Q Consensus 434 --~~~-~--ivHrDIkp~NILl~~~~~-vkl~DFGla~~ 466 (662)
... + |||+|+.+.|||++++.. +.++|||-+..
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 111 3 999999999999998875 77999998753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.004 Score=67.13 Aligned_cols=73 Identities=11% Similarity=0.146 Sum_probs=50.3
Q ss_pred cceeeccCceEEEEEEecCCCEEEEEEeec-----CC--chhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeEEEE
Q 006083 321 SNLLGQGGFGYVHKGVLPNGKEVAVKSLKT-----GS--GQGEREFSAEVEIISRVH---HRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~-----~~--~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~~~~lv 390 (662)
.+.||.|....||+... .++.|+||.-.. .. .....+...|++.|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 56789999999999876 456799997641 11 012334455677776664 357888888887 445788
Q ss_pred EEecCC
Q 006083 391 YEFVSN 396 (662)
Q Consensus 391 ~E~~~~ 396 (662)
|||+.+
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0019 Score=67.82 Aligned_cols=64 Identities=9% Similarity=0.130 Sum_probs=41.1
Q ss_pred EEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCC--CcceEEEE------EEeCCeEEEEEEecCCcch
Q 006083 331 YVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHR--HLVSLVGY------CIAGGQRMLVYEFVSNKTL 399 (662)
Q Consensus 331 ~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~~~------~~~~~~~~lv~E~~~~g~L 399 (662)
.||+....+| .+++|++... ...+..|+.++..|... .++.++.. ...++..++|+||+.|..+
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 4888876444 6888987532 34456677777777432 34444432 2346778999999998554
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0022 Score=68.72 Aligned_cols=74 Identities=15% Similarity=0.158 Sum_probs=49.1
Q ss_pred cceeeccCceEEEEEEecC-CCEEEEEEeec----C-C-chhHHHHHHHHHHHHhcC--CCC-cceEEEEEEeCCeEEEE
Q 006083 321 SNLLGQGGFGYVHKGVLPN-GKEVAVKSLKT----G-S-GQGEREFSAEVEIISRVH--HRH-LVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~-g~~vavK~l~~----~-~-~~~~~~~~~E~~il~~l~--Hpn-Iv~l~~~~~~~~~~~lv 390 (662)
.+.||-|.-..||++...+ ++.|+||.-.. . + .-..++...|.+.|+.+. .|. +.+++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4578999999999998743 56899996431 1 1 223456677888888774 344 4455544 34455788
Q ss_pred EEecCC
Q 006083 391 YEFVSN 396 (662)
Q Consensus 391 ~E~~~~ 396 (662)
||++..
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998754
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00091 Score=69.25 Aligned_cols=75 Identities=15% Similarity=0.181 Sum_probs=49.6
Q ss_pred CccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeEEEEEEecC
Q 006083 319 AKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH---HRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 319 ~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
...+.|+.|....+|+.. .+++.+.||+-.. .....|..|++-|+.|. --.+.+.+++...++..+|||||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 345678888899999977 5788999998762 34457888999988884 4557788988887777799999988
Q ss_pred Cc
Q 006083 396 NK 397 (662)
Q Consensus 396 ~g 397 (662)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0017 Score=69.27 Aligned_cols=139 Identities=20% Similarity=0.222 Sum_probs=82.4
Q ss_pred eeeccCceEEEEEEecC-----CCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcc-eEEEEEEeCCeEEEEEEecCC
Q 006083 323 LLGQGGFGYVHKGVLPN-----GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLV-SLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 323 ~iG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv-~l~~~~~~~~~~~lv~E~~~~ 396 (662)
.|-.|-.-.+|+....+ ++.|++|+......... .-.+|+.+++.+..-++. ++++++..+ .|+||+.+
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 45457778999987432 36789998765432222 237799999998654443 566666432 57999987
Q ss_pred cchhhh-----------------hccCCC---C-CCCHHHHHHHHHH-----------------HHHHHHHHHh-----c
Q 006083 397 KTLEYH-----------------LHGENR---P-VMDFATRVRIALG-----------------SAKGLAYLHE-----D 433 (662)
Q Consensus 397 g~L~~~-----------------l~~~~~---~-~l~~~~~~~i~~~-----------------ia~aL~yLH~-----~ 433 (662)
..|... ||.... . ..-+.++.+++.+ +...+..|.+ .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 666321 122110 1 1112233233211 1112222221 1
Q ss_pred CCCceeecCCccCcEEECC-CCcEEEEeeccccc
Q 006083 434 CHPRIIHRDIKAANILIDD-NFEAMVADFGLAKL 466 (662)
Q Consensus 434 ~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~~ 466 (662)
....++|+||++.|||+++ ++.++|+||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1236999999999999986 46899999998864
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.006 Score=64.64 Aligned_cols=72 Identities=13% Similarity=0.075 Sum_probs=47.7
Q ss_pred cCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCC--CCcceEE---E--EEEeCCeEEEEEEecCCcch
Q 006083 327 GGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHH--RHLVSLV---G--YCIAGGQRMLVYEFVSNKTL 399 (662)
Q Consensus 327 G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~---~--~~~~~~~~~lv~E~~~~g~L 399 (662)
+.-..||+....+|..+++|+.+... .....+..|++++..|.. -.++..+ | +...++..+.|++|+.|..+
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 44568999887788899999876432 345677888888888742 1222211 1 22335678889999988643
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0062 Score=64.53 Aligned_cols=72 Identities=17% Similarity=0.118 Sum_probs=47.3
Q ss_pred eeeccCceEEEEEEecCC-CEEEEEEeecC-------CchhHHHHHHHHHHHHhcC--CCC-cceEEEEEEeCCeEEEEE
Q 006083 323 LLGQGGFGYVHKGVLPNG-KEVAVKSLKTG-------SGQGEREFSAEVEIISRVH--HRH-LVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 323 ~iG~G~~g~Vy~~~~~~g-~~vavK~l~~~-------~~~~~~~~~~E~~il~~l~--Hpn-Iv~l~~~~~~~~~~~lv~ 391 (662)
.||.|....||++...+| +.|+||.-... -.-..++...|...|+... .|. +.+++.| +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997654 68999975311 1223345567788887764 343 4444443 345557999
Q ss_pred EecCC
Q 006083 392 EFVSN 396 (662)
Q Consensus 392 E~~~~ 396 (662)
|++..
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0023 Score=66.73 Aligned_cols=137 Identities=18% Similarity=0.162 Sum_probs=85.0
Q ss_pred CCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecc
Q 006083 384 GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGL 463 (662)
Q Consensus 384 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 463 (662)
+...|++|++. |+.|.. .....+++++.|+.+.+..|+-|..+. .+-|||+...||||+ +|+|-||||-+
T Consensus 298 ~~y~yl~~kdh-gt~is~------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred ceEEEEEEecC-Cceeee------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeee
Confidence 34456777764 555532 123578899999999999888888764 789999999999999 99999999999
Q ss_pred ccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCC-CCCchhhhHHHHHHHHHhHHHhhcC
Q 006083 464 AKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP-VDMTMMEDSLVEWARPLLGAALEDG 542 (662)
Q Consensus 464 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~ 542 (662)
++........... .+--|-.+. |.-+..-|||-+-- .|+.|+-. |.. -.-+-|.+-+....+..+
T Consensus 368 sRl~~~q~~isy~------rldhp~lF~-G~dd~QFeIYrlMr---~l~~g~wa~F~P----~TNvlWL~yLs~~llkk~ 433 (488)
T COG5072 368 SRLSYSQGIISYN------RLDHPDLFN-GVDDYQFEIYRLMR---RLLKGRWAQFEP----ITNVLWLYYLSHQLLKKK 433 (488)
T ss_pred eecccCCceeecc------ccCchhhhc-CccceeeeHHHHHH---HHhcCcHHhccc----chhhHHHHHHHHHHHhhc
Confidence 9954433221111 122233344 44466777876433 33334321 211 122446666655555444
Q ss_pred cc
Q 006083 543 IY 544 (662)
Q Consensus 543 ~~ 544 (662)
.+
T Consensus 434 ~~ 435 (488)
T COG5072 434 NL 435 (488)
T ss_pred cc
Confidence 43
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0044 Score=65.16 Aligned_cols=31 Identities=16% Similarity=0.346 Sum_probs=28.1
Q ss_pred CceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 436 ~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
.+++|+|+...|||+++++.+.|+||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3799999999999999998999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0019 Score=63.87 Aligned_cols=122 Identities=20% Similarity=0.202 Sum_probs=61.1
Q ss_pred CCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeEEEEEEecCCcchhhh-------h--------
Q 006083 340 GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHL-VSLVGYCIAGGQRMLVYEFVSNKTLEYH-------L-------- 403 (662)
Q Consensus 340 g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lv~E~~~~g~L~~~-------l-------- 403 (662)
++.|+||+..... ...-.-..|+.+++.+..-++ .++++++.+ .+|+||+.|..|... +
T Consensus 2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 4678888887653 333456778999988864444 556666543 257799977665220 0
Q ss_pred --ccC-----CCCCCCHHHHHHH----------------------HHHHHHHHHHHHh----c-CCCceeecCCccCcEE
Q 006083 404 --HGE-----NRPVMDFATRVRI----------------------ALGSAKGLAYLHE----D-CHPRIIHRDIKAANIL 449 (662)
Q Consensus 404 --~~~-----~~~~l~~~~~~~i----------------------~~~ia~aL~yLH~----~-~~~~ivHrDIkp~NIL 449 (662)
|.. .....-+..+.++ +..+.+-+..+.+ . ....++|.||.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 110 0000011122121 1112222222221 0 1125899999999999
Q ss_pred E-CCCCcEEEEeeccccc
Q 006083 450 I-DDNFEAMVADFGLAKL 466 (662)
Q Consensus 450 l-~~~~~vkl~DFGla~~ 466 (662)
+ +.++.++||||..|..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 7889999999998854
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0003 Score=48.57 Aligned_cols=7 Identities=0% Similarity=-0.244 Sum_probs=2.5
Q ss_pred HHHHHHH
Q 006083 184 AMIIICA 190 (662)
Q Consensus 184 ~~~~~~~ 190 (662)
+++++++
T Consensus 27 vl~~~l~ 33 (40)
T PF08693_consen 27 VLGAFLF 33 (40)
T ss_pred HHHHHhh
Confidence 3333333
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0049 Score=74.90 Aligned_cols=141 Identities=16% Similarity=0.185 Sum_probs=80.8
Q ss_pred ceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC--CCC--cceEEE--------EEEe-CC--e
Q 006083 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH--HRH--LVSLVG--------YCIA-GG--Q 386 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~--Hpn--Iv~l~~--------~~~~-~~--~ 386 (662)
+.|+ |.+-.+|+....+|+.+++|+.+... ....+..|.++|..|. ++. +.+++- .+.+ ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4554 45678899887788899999998642 3344555666776663 122 222221 1111 22 4
Q ss_pred EEEEEEecCCcchhhh-----------------hcc--------CCCCCCCHH-----------------HHHHHHHHHH
Q 006083 387 RMLVYEFVSNKTLEYH-----------------LHG--------ENRPVMDFA-----------------TRVRIALGSA 424 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~-----------------l~~--------~~~~~l~~~-----------------~~~~i~~~ia 424 (662)
.+.+|+|++|..|.+. |+. .....+.|. ....++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5678999999776541 110 001112221 1122222333
Q ss_pred HHHH-----HHHhcCCCceeecCCccCcEEECCCC--cEE-EEeeccccc
Q 006083 425 KGLA-----YLHEDCHPRIIHRDIKAANILIDDNF--EAM-VADFGLAKL 466 (662)
Q Consensus 425 ~aL~-----yLH~~~~~~ivHrDIkp~NILl~~~~--~vk-l~DFGla~~ 466 (662)
+.+. .|.+ ...+|||+|++..|||++.++ ++. |+|||-+..
T Consensus 188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3222 1222 233799999999999999875 566 999998764
|
|
| >KOG1924 consensus RhoA GTPase effector DIA/Diaphanous [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0027 Score=70.77 Aligned_cols=11 Identities=27% Similarity=0.564 Sum_probs=5.9
Q ss_pred HHHHHHHhhCC
Q 006083 582 MSQIVRALEGD 592 (662)
Q Consensus 582 ~~evl~~L~~~ 592 (662)
|.++|+.|..-
T Consensus 1043 mDslLeaLqsg 1053 (1102)
T KOG1924|consen 1043 MDSLLEALQSG 1053 (1102)
T ss_pred HHHHHHHHHhh
Confidence 55555555543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0025 Score=62.06 Aligned_cols=138 Identities=16% Similarity=0.169 Sum_probs=89.1
Q ss_pred EEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHH
Q 006083 342 EVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIA 420 (662)
Q Consensus 342 ~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~ 420 (662)
...+|++...... ....|..+.+++++++ .|++|.. .++..+.++.|+|..-.. +. ..++
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i-----------~~----~N~i 147 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI-----------NF----SNFI 147 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc-----------ch----hHHH
Confidence 3455666544333 4456788999999986 6888873 245566799999843111 11 1122
Q ss_pred HHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHH
Q 006083 421 LGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSD 500 (662)
Q Consensus 421 ~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sD 500 (662)
..-+.+|.-.|+. +.+.+|+|..|+||+-|.+|.+||.|=+.-.... ..|.--|+ ...+.++.
T Consensus 148 ~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~~-------------V~~vN~~Y---~~lT~~aE 210 (308)
T PF07387_consen 148 TAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLENQ-------------VNMVNIEY---ESLTQEAE 210 (308)
T ss_pred HHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhhhe-------------eeEEeeec---cccChHHH
Confidence 2224678888963 4479999999999999999999999987543211 11222111 34577788
Q ss_pred HHHHHHHHHHHHhCC
Q 006083 501 VFSFGVMLLELITGR 515 (662)
Q Consensus 501 vwSlGvvl~eLltG~ 515 (662)
+-+|=.-++++....
T Consensus 211 ~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 211 VKVFVKSCLKLVEKQ 225 (308)
T ss_pred HHHHHHHHHHHHHHH
Confidence 877777777776543
|
The function of this family is unknown. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0031 Score=66.93 Aligned_cols=140 Identities=15% Similarity=0.190 Sum_probs=80.5
Q ss_pred ceeeccCceEEEEEEecC----CCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVLPN----GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHL-VSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lv~E~~~~ 396 (662)
+.|..|-...+|+....+ +..|++|+....... .-.-.+|+.+++.+..-++ .++++++. ++ +|.+|+.|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 445457778899886432 237889987654322 2233678999998865555 45666663 32 58999987
Q ss_pred cchhh-----------------hhccCCC---C-CCCHHHHHHHHHH----------------------HHHHHHHHHhc
Q 006083 397 KTLEY-----------------HLHGENR---P-VMDFATRVRIALG----------------------SAKGLAYLHED 433 (662)
Q Consensus 397 g~L~~-----------------~l~~~~~---~-~l~~~~~~~i~~~----------------------ia~aL~yLH~~ 433 (662)
..|.. .||.... . ..-+..+.+++.+ +.+-+..+...
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 66521 1122111 0 1112222222211 11112222211
Q ss_pred -----CCCceeecCCccCcEEECC-CCcEEEEeeccccc
Q 006083 434 -----CHPRIIHRDIKAANILIDD-NFEAMVADFGLAKL 466 (662)
Q Consensus 434 -----~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~~ 466 (662)
....++|.||.+.|||+++ ++.++|+||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1124899999999999974 57899999998854
|
|
| >KOG0260 consensus RNA polymerase II, large subunit [Transcription] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.044 Score=64.09 Aligned_cols=150 Identities=31% Similarity=0.403 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 006083 8 TETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSD 87 (662)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~p~~~~~~~ 87 (662)
+.....++++.=.++.++-.++.+.=+|++++=.|++|+=.+..|+=+|+++.=.+++|.=+|..++-+++.|.=.|+++
T Consensus 1455 tsp~ysptsp~ys~tsp~~sptspsysptspsysptspsysptspsysptspsysptspsysptspsysptspsysptsp 1534 (1605)
T KOG0260|consen 1455 TSPNYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1534 (1605)
T ss_pred CCCCCCCCCCccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 006083 88 NNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKS 157 (662)
Q Consensus 88 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sss~~~~~~~~~~~ 157 (662)
+=+|+.|.-+|+.|.-+++++.=.|+.++-+++++.=.++++.-.+...=++++++=+.++.+-+..+.+
T Consensus 1535 sysptspsysptspsysptspsysptsp~ysptspsysptspsys~~~~ysp~sp~ysptsp~ysp~sps 1604 (1605)
T KOG0260|consen 1535 SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSTSPSYSPTSPSYSPTSPSYSPTSPS 1604 (1605)
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCCCCCCCCCCCCCCCC
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 662 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-71 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-70 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-47 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-47 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-35 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-26 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-26 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-26 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-25 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-25 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-25 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-25 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-25 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-25 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-25 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-25 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-25 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-25 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-25 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-25 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-25 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-25 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-25 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-25 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-25 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-25 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-25 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-25 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-25 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-24 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-23 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-21 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-16 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-14 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 7e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 8e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 9e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-04 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 2e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 662 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 0.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 0.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-172 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-90 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 5e-64 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 7e-63 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 7e-63 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 6e-62 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 6e-62 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-60 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-59 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-59 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-58 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-55 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-54 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 6e-54 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 6e-53 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-50 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 9e-46 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 5e-45 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-44 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-44 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 5e-43 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 6e-43 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 8e-43 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-42 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 5e-42 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 7e-42 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-41 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-41 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-41 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 4e-41 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-41 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 5e-41 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 6e-41 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 7e-41 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 7e-41 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-40 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-40 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-40 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-40 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-40 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-40 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-40 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-40 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 6e-40 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 7e-40 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 7e-40 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-39 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-39 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-38 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 5e-38 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 7e-38 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 7e-38 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-06 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 5e-06 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-05 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-05 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-05 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 7e-04 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 7e-38 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 3e-37 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 8e-37 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 8e-37 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-36 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-36 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 7e-36 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-35 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-35 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-35 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 9e-35 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-34 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-34 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 4e-34 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 4e-34 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 6e-34 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 7e-34 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-33 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-33 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 3e-33 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 5e-33 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 5e-33 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 6e-33 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 9e-33 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-32 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-32 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 3e-32 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-31 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-31 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-31 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-31 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 4e-31 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 6e-31 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-30 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 3e-30 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-30 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 4e-30 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 8e-30 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-29 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-29 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 8e-29 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-28 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-28 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-28 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-28 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-28 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 5e-28 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-27 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-27 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-27 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-27 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-27 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 6e-27 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 9e-27 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 9e-27 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-26 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-26 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-26 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 4e-26 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 4e-26 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 5e-26 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 6e-26 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 8e-26 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-25 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-25 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-25 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-25 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 5e-25 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 8e-25 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-24 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-24 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 3e-24 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 4e-24 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 6e-24 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 6e-24 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 6e-24 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 8e-24 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-23 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-23 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-23 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-23 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-23 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-23 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-23 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-23 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 7e-23 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-22 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-22 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-22 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-22 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-22 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 3e-22 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-22 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 6e-22 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 9e-22 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 9e-22 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-21 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-21 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-21 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-21 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-21 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-21 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 4e-21 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 5e-21 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 5e-21 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 5e-21 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 6e-21 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 9e-21 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-20 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-20 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-20 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-20 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-20 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 4e-20 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 6e-20 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-19 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-19 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-19 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-19 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 3e-19 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 4e-19 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 7e-19 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 9e-19 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-18 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-18 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-18 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-18 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 4e-18 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 4e-18 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-18 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 6e-18 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 2e-16 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 3e-16 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 7e-15 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 1e-14 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 8e-14 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 8e-14 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 7e-13 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 4e-11 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 4e-05 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 7e-18 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 8e-18 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-17 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-17 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-17 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 2e-17 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 9e-17 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 1e-16 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 5e-16 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 1e-14 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 5e-14 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 6e-13 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 7e-13 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 1e-11 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 2e-10 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 8e-08 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 2e-04 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-17 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 6e-17 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-16 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-16 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-16 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-16 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-16 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 4e-16 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 6e-16 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-15 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 3e-15 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 3e-15 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 6e-15 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-14 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-14 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-14 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-14 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-14 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-14 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-14 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 7e-14 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 7e-14 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 8e-14 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 8e-14 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 9e-14 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 1e-13 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 1e-13 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 1e-13 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 2e-13 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 6e-13 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 3e-12 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 1e-11 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 7e-10 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 3e-08 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 2e-13 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 1e-12 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 1e-11 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 1e-10 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 2e-09 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 3e-07 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 6e-06 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 8e-06 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 3e-13 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 3e-13 | |
| 3gdb_A | 937 | Endo-D, putative uncharacterized protein SPR0440; | 6e-13 | |
| 3gdb_A | 937 | Endo-D, putative uncharacterized protein SPR0440; | 4e-07 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 6e-13 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 8e-13 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 1e-12 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 3e-12 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 1e-11 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 3e-09 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 3e-08 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-12 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-12 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-12 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-12 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-12 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 8e-12 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 8e-12 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-11 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-11 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 4e-11 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 7e-11 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 2e-10 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 1e-09 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 3e-09 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 9e-08 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 7e-07 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 8e-07 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 7e-06 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-10 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 2e-10 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 3e-10 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 1e-09 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 3e-09 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 5e-09 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 6e-09 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 6e-09 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 3e-07 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 3e-07 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 4e-07 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-10 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 4e-10 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 6e-09 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 2e-08 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 8e-07 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 3e-05 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 3e-04 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 5e-10 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 4e-09 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 1e-08 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 2e-08 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 1e-07 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 3e-07 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 2e-06 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 9e-05 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 3e-04 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 6e-10 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 7e-10 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 1e-09 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 2e-09 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 8e-08 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 9e-08 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 5e-05 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 7e-04 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-09 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-09 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 3e-09 | |
| 2xag_A | 852 | Lysine-specific histone demethylase 1; amine oxida | 5e-09 | |
| 2xag_A | 852 | Lysine-specific histone demethylase 1; amine oxida | 4e-08 | |
| 2xag_A | 852 | Lysine-specific histone demethylase 1; amine oxida | 3e-06 | |
| 2xag_A | 852 | Lysine-specific histone demethylase 1; amine oxida | 4e-05 | |
| 2xag_A | 852 | Lysine-specific histone demethylase 1; amine oxida | 4e-04 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 7e-09 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 8e-09 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 1e-08 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 1e-07 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 3e-07 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 6e-07 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 2e-06 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 4e-06 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 3e-04 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 3e-04 | |
| 3odw_A | 536 | RHO guanine nucleotide exchange factor 1; regulati | 8e-09 | |
| 3odw_A | 536 | RHO guanine nucleotide exchange factor 1; regulati | 1e-08 | |
| 3odw_A | 536 | RHO guanine nucleotide exchange factor 1; regulati | 2e-08 | |
| 3odw_A | 536 | RHO guanine nucleotide exchange factor 1; regulati | 8e-08 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-04 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 2e-08 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 8e-08 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 9e-08 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 3e-07 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 2e-04 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 4e-08 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 5e-08 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 8e-08 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 4e-07 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 7e-07 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 5e-06 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 2e-05 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 1e-04 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 2e-04 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 4e-04 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 1e-07 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 4e-07 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 9e-06 | |
| 2krg_A | 216 | Na(+)/H(+) exchange regulatory cofactor NHE-RF1; a | 1e-06 | |
| 2krg_A | 216 | Na(+)/H(+) exchange regulatory cofactor NHE-RF1; a | 3e-04 | |
| 3u3p_A | 313 | Tumor necrosis factor receptor superfamily member; | 2e-06 | |
| 2yew_A | 253 | Capsid protein, coat protein; alphavirus, molecula | 4e-06 | |
| 2yew_A | 253 | Capsid protein, coat protein; alphavirus, molecula | 5e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-06 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 7e-06 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 4e-05 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 5e-05 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 2e-04 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 2e-04 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 3e-04 | |
| 1w7p_D | 566 | VPS36P, YLR417W; ESCRT-II complex, endosomal prote | 9e-06 | |
| 1w7p_D | 566 | VPS36P, YLR417W; ESCRT-II complex, endosomal prote | 8e-04 | |
| 3iox_A | 497 | AGI/II, PA; alpha helix, PPII helix, supersandwich | 1e-05 | |
| 3iox_A | 497 | AGI/II, PA; alpha helix, PPII helix, supersandwich | 3e-04 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 2e-05 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 3e-05 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 4e-05 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 5e-05 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 1e-04 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 1e-04 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 1e-04 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 1e-04 | |
| 2j63_A | 467 | AP-endonuclease; base excision repair, lyase; 2.48 | 3e-05 | |
| 2j63_A | 467 | AP-endonuclease; base excision repair, lyase; 2.48 | 7e-05 | |
| 1kxf_A | 264 | Sindbis virus capsid protein; chymotrypsin-like se | 7e-05 | |
| 1kxf_A | 264 | Sindbis virus capsid protein; chymotrypsin-like se | 4e-04 | |
| 3dva_I | 428 | Dihydrolipoyllysine-residue acetyltransferase comp | 7e-05 | |
| 3dva_I | 428 | Dihydrolipoyllysine-residue acetyltransferase comp | 2e-04 | |
| 1zy8_K | 229 | Pyruvate dehydrogenase protein X component, mitoch | 1e-04 | |
| 1dx0_A | 219 | Prion protein; brain, repeat; NMR {Bos taurus} SCO | 1e-04 | |
| 1dx0_A | 219 | Prion protein; brain, repeat; NMR {Bos taurus} SCO | 3e-04 | |
| 3bbn_E | 308 | Ribosomal protein S5; small ribosomal subunit, spi | 2e-04 | |
| 2uv8_A | 1887 | Fatty acid synthase subunit alpha (FAS2); fatty ac | 2e-04 | |
| 2uv8_A | 1887 | Fatty acid synthase subunit alpha (FAS2); fatty ac | 4e-04 | |
| 2uv8_A | 1887 | Fatty acid synthase subunit alpha (FAS2); fatty ac | 5e-04 | |
| 2uv8_A | 1887 | Fatty acid synthase subunit alpha (FAS2); fatty ac | 6e-04 | |
| 1pcx_A | 810 | Protein transport protein SEC24; 2.50A {Saccharomy | 3e-04 | |
| 2g6z_A | 211 | Dual specificity protein phosphatase 5; alpha/beta | 3e-04 | |
| 3eiv_A | 199 | Single-stranded DNA-binding protein 2; DNA damage, | 4e-04 | |
| 1eys_C | 382 | Photosynthetic reaction center; membrane protein c | 8e-04 | |
| 2uv9_A | 1878 | Fatty acid synthase alpha subunits; fungal, dehydr | 8e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 555 bits (1433), Expect = 0.0
Identities = 146/319 (45%), Positives = 207/319 (64%), Gaps = 12/319 (3%)
Query: 292 PPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTG 351
P + LG K F+ EL A+ F+ N+LG+GGFG V+KG L +G VAVK LK
Sbjct: 7 EEDPEVHLGQLK-RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE 65
Query: 352 SGQG-EREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHG--ENR 408
QG E +F EVE+IS HR+L+ L G+C+ +R+LVY +++N ++ L E++
Sbjct: 66 RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 409 PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468
P +D+ R RIALGSA+GLAYLH+ C P+IIHRD+KAANIL+D+ FEA+V DFGLAKL +
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 469 DNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDS-- 526
THV+T V GT G++APEY S+GK +EK+DVF +GVMLLELITG+R D+ + +
Sbjct: 186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 527 --LVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQ 584
L++W + L L++ + LVD L+ NY E+ +L+ + S +RPKMS+
Sbjct: 246 VMLLDWVKGL----LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301
Query: 585 IVRALEGDSSLDDLNDGVR 603
+VR LEGD + + +
Sbjct: 302 VVRMLEGDGLAERWEEWQK 320
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 516 bits (1331), Expect = 0.0
Identities = 117/325 (36%), Positives = 174/325 (53%), Gaps = 12/325 (3%)
Query: 278 MSSQFSGPARPPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVL 337
M S++S S + + F +L AT F L+G G FG V+KGVL
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60
Query: 338 PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNK 397
+G +VA+K S QG EF E+E +S H HLVSL+G+C + +L+Y+++ N
Sbjct: 61 RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 398 TLEYHLHGENRPV--MDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE 455
L+ HL+G + P M + R+ I +G+A+GL YLH IIHRD+K+ NIL+D+NF
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV 177
Query: 456 AMVADFGLAKL-SNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG 514
+ DFG++K + + TH+ST V GT GY+ PEY G+LTEKSDV+SFGV+L E++
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
Query: 515 RRPVDMT--MMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASI 572
R + + +L EWA +G + +VDP L P + + +
Sbjct: 238 RSAIVQSLPREMVNLAEWAVES----HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293
Query: 573 RHSARKRPKMSQIVRALEGDSSLDD 597
S+ RP M ++ LE L +
Sbjct: 294 ALSSEDRPSMGDVLWKLEYALRLQE 318
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 491 bits (1266), Expect = e-172
Identities = 95/305 (31%), Positives = 166/305 (54%), Gaps = 21/305 (6%)
Query: 302 NKSTFTYDELAAATGGF------AKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTG---- 351
+F++ EL T F N +G+GGFG V+KG + N VAVK L
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 352 SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHG-ENRPV 410
+ + +++F E++++++ H +LV L+G+ G LVY ++ N +L L + P
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 411 MDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS-ND 469
+ + R +IA G+A G+ +LHE+ IHRDIK+ANIL+D+ F A ++DFGLA+ S
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 470 NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVE 529
T +++R++GT Y+APE G++T KSD++SFGV+LLE+ITG VD L++
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245
Query: 530 WARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRAL 589
+ E+ + +D ++ + + + + + + KRP + ++ + L
Sbjct: 246 IKEEIED---EEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
Query: 590 EGDSS 594
+ ++
Sbjct: 302 QEMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 3e-90
Identities = 75/319 (23%), Positives = 119/319 (37%), Gaps = 28/319 (8%)
Query: 302 NKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSA 361
+ + L + + +G FG V K + VAVK Q +
Sbjct: 10 SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW-QNEY 67
Query: 362 EVEIISRVHHRHLVSLVGYCIAG----GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRV 417
EV + + H +++ +G G L+ F +L L V+ +
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELC 124
Query: 418 RIALGSAKGLAYLHED-------CHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470
IA A+GLAYLHED P I HRDIK+ N+L+ +N A +ADFGLA
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 471 HTHV-STRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVMLLELITGRRPVDMTMME 524
+ + +GT Y+APE + D+++ G++L EL + D + E
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 525 DSL----VEWARPLLGAALEDGIYDGLVDPRLEHNYVPHE-MARLVACGAASIRHSARKR 579
L P L +++ + P L + H MA L H A R
Sbjct: 245 YMLPFEEEIGQHPSL-EDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 580 PKMSQIVRALEGDSSLDDL 598
+ + L ++
Sbjct: 304 LSAGCVGERITQMQRLTNI 322
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 5e-64
Identities = 82/273 (30%), Positives = 129/273 (47%), Gaps = 29/273 (10%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
+G G FG VH+ +G +VAVK L + EF EV I+ R+ H ++V +G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHG-ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIH 440
+V E++S +L LH R +D R+ +A AKG+ YLH +P I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 441 RDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSD 500
R++K+ N+L+D + V DFGL++L S GT ++APE EKSD
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 501 VFSFGVMLLELITGRRP-VDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE-HNYVP 558
V+SFGV+L EL T ++P ++ + ++ A RLE +
Sbjct: 222 VYSFGVILWELATLQQPWGNLNPAQ---------VVAAVGFKCK-------RLEIPRNLN 265
Query: 559 HEMARLVA-CGAASIRHSARKRPKMSQIVRALE 590
++A ++ C + KRP + I+ L
Sbjct: 266 PQVAAIIEGC----WTNEPWKRPSFATIMDLLR 294
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 7e-63
Identities = 64/277 (23%), Positives = 117/277 (42%), Gaps = 38/277 (13%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
L + G + KG G ++ VK LK S + R+F+ E + H +++ ++G C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 382 IA--GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
+ L+ ++ +L LH V+D + V+ AL A+G+A+LH P I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135
Query: 440 HRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE---YASSGKLT 496
+ + +++ID++ A ++ + + S M ++APE
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKKPEDTNR 189
Query: 497 EKSDVFSFGVMLLELITGRRP-VDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH- 554
+D++SF V+L EL+T P D++ ME + +G+ R
Sbjct: 190 RSADMWSFAVLLWELVTREVPFADLSNME---------IGMKVALEGL-------RPTIP 233
Query: 555 NYVPHEMARLV-ACGAASIRHSARKRPKMSQIVRALE 590
+ +++L+ C + KRPK IV LE
Sbjct: 234 PGISPHVSKLMKIC----MNEDPAKRPKFDMIVPILE 266
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 7e-63
Identities = 61/344 (17%), Positives = 122/344 (35%), Gaps = 55/344 (15%)
Query: 306 FTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEI 365
E + L+G+G +G V+KG L + + VAVK + + F E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNI 58
Query: 366 --ISRVHHRHLVSLVGYCIAGG-----QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVR 418
+ + H ++ + + +LV E+ N +L +L D+ + R
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115
Query: 419 IALGSAKGLAYLHED------CHPRIIHRDIKAANILIDDNFEAMVADFGLAKL------ 466
+A +GLAYLH + P I HRD+ + N+L+ ++ +++DFGL+
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 467 -SNDNHTHVSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELITGRRPV 518
+ + +GT Y+APE ++ D+++ G++ E+ +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 519 DMTMMEDSLVEWARPLLGAALEDGIYDGLVD--------PRLEHNYVPHE-----MARLV 565
+S+ E+ ++ + P+ + + + +
Sbjct: 236 FPG---ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 566 -ACGAASIRHSARKRPKMSQIVRALEGDSSLDDLNDGVRPGQSS 608
C A R + + + N V P
Sbjct: 293 EDC----WDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 6e-62
Identities = 83/285 (29%), Positives = 136/285 (47%), Gaps = 44/285 (15%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGE-------REFSAEVEIISRVHHRHLV 375
+G+GGFG VHKG + + VA+KSL G +GE +EF EV I+S ++H ++V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
L G +V EFV L + L + P + ++ ++R+ L A G+ Y+ + +
Sbjct: 87 KLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQ-NQN 142
Query: 436 PRIIHRDIKAANILIDDNFEAM-----VADFGLAKLSNDNHTHVSTRVMGTFGYLAPE-- 488
P I+HRD+++ NI + E VADFGL++ S H + ++G F ++APE
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----VHSVSGLLGNFQWMAPETI 198
Query: 489 YASSGKLTEKSDVFSFGVMLLELITGRRP-VDMTMMEDSLVEWARPLLGAALEDGIYDGL 547
A TEK+D +SF ++L ++TG P + + + + +GL
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI-----------REEGL 247
Query: 548 VDPRLEH-NYVPHEMARLV-ACGAASIRHSARKRPKMSQIVRALE 590
R P + ++ C +KRP S IV+ L
Sbjct: 248 ---RPTIPEDCPPRLRNVIELC----WSGDPKKRPHFSYIVKELS 285
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 6e-62
Identities = 79/271 (29%), Positives = 125/271 (46%), Gaps = 31/271 (11%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
+G+G FG V K K+VA+K ++ S + F E+ +SRV+H ++V L G C+
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 384 GGQRMLVYEFVSNKTLEYHLHG-ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRD 442
LV E+ +L LHG E P A + L ++G+AYLH +IHRD
Sbjct: 73 --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 443 IKAANILIDDNFEAM-VADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 501
+K N+L+ + + DFG A + T G+ ++APE +EK DV
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDV 186
Query: 502 FSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH-NYVPHE 560
FS+G++L E+IT R+P D + WA +++G R +P
Sbjct: 187 FSWGIILWEVITRRKPFDEIGGPAFRIMWA-----------VHNGT---RPPLIKNLPKP 232
Query: 561 MARLV-ACGAASIRHSARKRPKMSQIVRALE 590
+ L+ C +RP M +IV+ +
Sbjct: 233 IESLMTRC----WSKDPSQRPSMEEIVKIMT 259
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-60
Identities = 73/282 (25%), Positives = 120/282 (42%), Gaps = 42/282 (14%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTG----SGQGEREFSAEVEIISRVHHRHLVSLVG 379
+G GGFG V++ G EVAVK+ + Q E ++ + + H ++++L G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
C+ LV EF L L G+ + V A+ A+G+ YLH++ II
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 440 HRDIKAANILIDDNFEAM--------VADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYAS 491
HRD+K++NILI E + DFGLA+ + G + ++APE
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT---TKMSAAGAYAWMAPEVIR 187
Query: 492 SGKLTEKSDVFSFGVMLLELITGRRP-VDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550
+ ++ SDV+S+GV+L EL+TG P + + + + +
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---------VAYGVAMNKL------- 231
Query: 551 RLEH-NYVPHEMARLV-ACGAASIRHSARKRPKMSQIVRALE 590
L + P A+L+ C RP + I+ L
Sbjct: 232 ALPIPSTCPEPFAKLMEDC----WNPDPHSRPSFTNILDQLT 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-59
Identities = 71/284 (25%), Positives = 111/284 (39%), Gaps = 40/284 (14%)
Query: 324 LGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI 382
LG+G FG K G+ + +K L + +R F EV+++ + H +++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 383 AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRD 442
+ + E++ TL + + ++ RV A A G+AYLH IIHRD
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHS---MNIIHRD 133
Query: 443 IKAANILIDDNFEAMVADFGLAKLSNDNHTH-------------VSTRVMGTFGYLAPEY 489
+ + N L+ +N +VADFGLA+L D T V+G ++APE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 490 ASSGKLTEKSDVFSFGVMLLELITGRRPV-DMTMMEDSLVEWARPLLGAALEDGIYDGLV 548
+ EK DVFSFG++L E+I D + L
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT------------MDFGLNVRGFL- 240
Query: 549 DPRLEH-NYVPHEMARL-VACGAASIRHSARKRPKMSQIVRALE 590
P + V C KRP ++ LE
Sbjct: 241 --DRYCPPNCPPSFFPITVRC----CDLDPEKRPSFVKLEHWLE 278
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 1e-59
Identities = 77/277 (27%), Positives = 136/277 (49%), Gaps = 34/277 (12%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
+G G FG V+KG +G +VAVK L + Q + F EV ++ + H +++ +GY
Sbjct: 32 IGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441
Q +V ++ +L +HLH + + + IA +A+G+ YLH IIHR
Sbjct: 90 T-APQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLHA---KSIIHR 144
Query: 442 DIKAANILIDDNFEAMVADFGLAKL-SNDNHTHVSTRVMGTFGYLAPE---YASSGKLTE 497
D+K+ NI + ++ + DFGLA S + +H ++ G+ ++APE S +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 498 KSDVFSFGVMLLELITGRRP-VDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH-- 554
+SDV++FG++L EL+TG+ P ++ + +E + G + P L
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRD------------QIIE-MVGRGSLSPDLSKVR 251
Query: 555 NYVPHEMARLV-ACGAASIRHSARKRPKMSQIVRALE 590
+ P M RL+ C ++ +RP +I+ +E
Sbjct: 252 SNCPKRMKRLMAEC----LKKKRDERPSFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 3e-55
Identities = 61/291 (20%), Positives = 112/291 (38%), Gaps = 53/291 (18%)
Query: 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVG 379
L+G+G FG V+ G +G EVA++ + + + F EV + H ++V +G
Sbjct: 39 ELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
C++ ++ +TL + +D +IA KG+ YLH I+
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 440 HRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM----GTFGYLAPEYASSGKL 495
H+D+K+ N+ D+ + ++ DFGL +S + G +LAPE
Sbjct: 153 HKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 496 ---------TEKSDVFSFGVMLLELITGRRP-VDMTMMEDSLVEWA-----RPLLGAALE 540
++ SDVF+ G + EL P + W +P L
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---IIWQMGTGMKPNL----- 263
Query: 541 DGIYDGLVDPRLEHNYVPHEMARLV-ACGAASIRHSARKRPKMSQIVRALE 590
++ E++ ++ C +RP ++++ LE
Sbjct: 264 ---------SQIGM---GKEISDILLFC----WAFEQEERPTFTKLMDMLE 298
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-54
Identities = 62/305 (20%), Positives = 121/305 (39%), Gaps = 56/305 (18%)
Query: 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEI--ISRVHHRHLVSLVG 379
+G+G +G V +G G+ VAVK + + E+ + E E+ + H +++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 380 YCIAGG----QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED-- 433
+ Q L+ + +L +L +D + +RI L A GLA+LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 434 ---CHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV---STRVMGTFGYLAP 487
P I HRD+K+ NIL+ N + +AD GLA + + + + + +GT Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 488 E------YASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALED 541
E ++ D+++FG++L E+ + ++ P D
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS------NGIVEDYKPPFYDVVPND 240
Query: 542 GIYDGLVD------------PRLEHNYVPHEMARLVACGAASIR----HSARKRPKMSQI 585
++ + R + +A+L ++ + R +I
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKL-------MKECWYQNPSARLTALRI 293
Query: 586 VRALE 590
+ L
Sbjct: 294 KKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 6e-53
Identities = 76/354 (21%), Positives = 130/354 (36%), Gaps = 61/354 (17%)
Query: 266 PPPPPMMSSSGEMSSQFSGPARPPLPP--PSPNIALGFNKSTFTYDELAAATGGFAKSNL 323
PP + + S SG P L + I +
Sbjct: 6 PPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMV---------------------KQ 44
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEI--ISRVHHRHLVSLVGYC 381
+G+G +G V G G++VAVK T E + E EI + H +++ +
Sbjct: 45 IGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 382 IAGG----QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED---- 433
I G Q L+ ++ N +L +L +D + +++A S GL +LH +
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 434 -CHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV---STRVMGTFGYLAPE- 488
P I HRD+K+ NIL+ N +AD GLA + V +GT Y+ PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 489 -----YASSGKLTEKSDVFSFGVMLLELITGRRP---VDMTMMEDSLVEWARPLLGAALE 540
+ + +D++SFG++L E+ V+ + + + P E
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277
Query: 541 DGIYDGL---VDPRLEHNYVPHEMARLV-ACGAASIRHSARKRPKMSQIVRALE 590
L R + +M +L+ C H+ R ++ + L
Sbjct: 278 IVCIKKLRPSFPNRWSSDECLRQMGKLMTEC----WAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-50
Identities = 74/365 (20%), Positives = 137/365 (37%), Gaps = 67/365 (18%)
Query: 258 PGGNWPGPPPPPPMMSSSGEMSSQFSGPARPPLPP--PSPNIALGFNKSTFTYDELAAAT 315
P + P + +M++ SG P L + I L
Sbjct: 3 PSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQ--------------- 47
Query: 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEI--ISRVHHRH 373
+G+G FG V +G G+EVAVK + + ER + E EI + H +
Sbjct: 48 ------ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHEN 97
Query: 374 LVSLVGYCI----AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAY 429
++ + Q LV ++ + +L +L+ R + +++AL +A GLA+
Sbjct: 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAH 154
Query: 430 LHED-----CHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV---STRVMGT 481
LH + P I HRD+K+ NIL+ N +AD GLA + + +GT
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 482 FGYLAPE------YASSGKLTEKSDVFSFGVMLLELITGRRPVDMT---MMEDSLVEWAR 532
Y+APE + +++D+++ G++ E+ + + + +
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274
Query: 533 PLLGAALEDGIYDGL---VDPRLEHNYVPHEMARLVACGAASIR----HSARKRPKMSQI 585
P + + L + R + MA++ +R + R +I
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKI-------MRECWYANGAARLTALRI 327
Query: 586 VRALE 590
+ L
Sbjct: 328 KKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 9e-46
Identities = 66/284 (23%), Positives = 111/284 (39%), Gaps = 52/284 (18%)
Query: 324 LGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVSLVGYC 381
+G+G FG V G L + VAVKS + + +F E I+ + H ++V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441
+V E V L + T +++ +A G+ YL IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR-TEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHR 237
Query: 442 DIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGY--LAPEYASSGKLTEKS 499
D+ A N L+ + ++DFG+++ D + ++ + APE + G+ + +S
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADG-VYAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 500 DVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL----VDPRLEH 554
DV+SFG++L E + G P Y L +E
Sbjct: 297 DVWSFGILLWETFSLGASP--------------------------YPNLSNQQTREFVEK 330
Query: 555 NY-------VPHEMARLV-ACGAASIRHSARKRPKMSQIVRALE 590
P + RL+ C + +RP S I + L+
Sbjct: 331 GGRLPCPELCPDAVFRLMEQC----WAYEPGQRPSFSTIYQELQ 370
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-45
Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 31/284 (10%)
Query: 324 LGQGGFGYVHKGVLP-----NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLV 378
LG+G FG V G+ VAVK L+ + + R+F E+EI+ + H ++V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 379 GYCIAGGQR--MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
G C + G+R L+ E++ +L +L +++ +D ++ KG+ YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 133
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTF--GYLAPEYASSGK 494
R IHRD+ NIL+++ + DFGL K+ + + G + APE + K
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 495 LTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554
+ SDV+SFGV+L EL T E + + + L++
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------LIELLKN 247
Query: 555 NYV-------PHEMARL-VACGAASIRHSARKRPKMSQIVRALE 590
N P E+ + C ++ +RP + ++
Sbjct: 248 NGRLPRPDGCPDEIYMIMTECWN----NNVNQRPSFRDLALRVD 287
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-44
Identities = 69/284 (24%), Positives = 121/284 (42%), Gaps = 31/284 (10%)
Query: 324 LGQGGFGYVHKGVLP-----NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLV 378
LG+G FG V G+ VAVK L+ + + R+F E+EI+ + H ++V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 379 GYCIAGGQR--MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
G C + G+R L+ E++ +L +L +++ +D ++ KG+ YL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 164
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTF--GYLAPEYASSGK 494
R IHRD+ NIL+++ + DFGL K+ + + + G + APE + K
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224
Query: 495 LTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554
+ SDV+SFGV+L EL T E + + + L++
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------LIELLKN 278
Query: 555 NYV-------PHEMARL-VACGAASIRHSARKRPKMSQIVRALE 590
N P E+ + C ++ +RP + ++
Sbjct: 279 NGRLPRPDGCPDEIYMIMTECWN----NNVNQRPSFRDLALRVD 318
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-44
Identities = 88/317 (27%), Positives = 135/317 (42%), Gaps = 38/317 (11%)
Query: 324 LGQGGFGYVHKGVLP-----NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLV 378
LG+G FG V G VAVK L+ +R+F E++I+ +H +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 379 GYCIAGGQR--MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
G G++ LV E++ + L L +R +D + + + KG+ YL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSR--- 146
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTF--GYLAPEYASSGK 494
R +HRD+ A NIL++ +ADFGLAKL + + R G + APE S
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 495 LTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAA-----LEDGIYDGLV 548
+ +SDV+SFGV+L EL T + + ++ R + + LE+G
Sbjct: 207 FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ----- 261
Query: 549 DPRLEH-NYVPHEMARL-VACGAASIRHSARKRPKMSQIVRALEGDSSLDDLNDGVRPGQ 606
RL P E+ L C A S + RP S + LD L G R +
Sbjct: 262 --RLPAPPACPAEVHELMKLCWA----PSPQDRPSFSALG------PQLDMLWSGSRGCE 309
Query: 607 SSAFSASNTSTEYSATS 623
+ AF+A +S +
Sbjct: 310 THAFTAHPEGKHHSLSF 326
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-43
Identities = 65/195 (33%), Positives = 105/195 (53%), Gaps = 6/195 (3%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
+G G FG VH G N +VA+K+++ G+ E +F E E++ ++ H LV L G C+
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 384 GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDI 443
LV EF+ + L +L R + T + + L +G+AYL E+ +IHRD+
Sbjct: 75 QAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL-EEAC--VIHRDL 130
Query: 444 KAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 503
A N L+ +N V+DFG+ + D+ ST + +PE S + + KSDV+S
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 504 FGVMLLELIT-GRRP 517
FGV++ E+ + G+ P
Sbjct: 191 FGVLMWEVFSEGKIP 205
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-43
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 324 LGQGGFGYVHKGVLPNGKE-----VAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVSL 377
LG G FG V+KG+ E VA+K L+ + E E +++ V + H+ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
+G C+ L+ + + L ++ E++ + + + AKG+ YL + R
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGT---FGYLAPEYASSGK 494
++HRD+ A N+L+ + DFGLAKL G ++A E
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESILHRI 195
Query: 495 LTEKSDVFSFGVMLLELIT-GRRP 517
T +SDV+S+GV + EL+T G +P
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-43
Identities = 71/285 (24%), Positives = 121/285 (42%), Gaps = 33/285 (11%)
Query: 324 LGQGGFGYVHKGVLP-----NGKEVAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVSL 377
LG+G FG V G++VAVKSLK SG + E+EI+ ++H ++V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 378 VGYCIAGGQR--MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
G C G L+ EF+ + +L+ +L +N+ ++ +++ A+ KG+ YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYLGSR-- 145
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTF--GYLAPEYASSG 493
+ +HRD+ A N+L++ + + DFGL K + + + + + APE
Sbjct: 146 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS 204
Query: 494 KLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGA-----ALEDGIYDGL 547
K SDV+SFGV L EL+T + ++ + L++G
Sbjct: 205 KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK---- 260
Query: 548 VDPRLEH-NYVPHEMARL-VACGAASIRHSARKRPKMSQIVRALE 590
RL P E+ +L C R ++ E
Sbjct: 261 ---RLPCPPNCPDEVYQLMRKCWE----FQPSNRTSFQNLIEGFE 298
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-42
Identities = 86/279 (30%), Positives = 118/279 (42%), Gaps = 42/279 (15%)
Query: 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
LGQG FG V G VA+K+LK G+ E F E +++ ++ H LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441
+V E++S +L L GE + V +A A G+AY+ +HR
Sbjct: 249 S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 304
Query: 442 DIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 501
D++AANIL+ +N VADFGLA+L DN + APE A G+ T KSDV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 502 FSFGVMLLELIT-GRRP-VDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNY--- 556
+SFG++L EL T GR P M E V ++E Y
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNRE-----------------------VLDQVERGYRMP 401
Query: 557 ----VPHEMARL-VACGAASIRHSARKRPKMSQIVRALE 590
P + L C R +RP + LE
Sbjct: 402 CPPECPESLHDLMCQCW----RKEPEERPTFEYLQAFLE 436
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-42
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
LG G FG V G +VAVK +K GS E EF E + + ++ H LV G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 384 GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDI 443
+V E++SN L +L + ++ + + + +G+A+L E IHRD+
Sbjct: 75 EYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFL-ESHQ--FIHRDL 130
Query: 444 KAANILIDDNFEAMVADFGLAKLSNDNHTHVST------RVMGTFGYLAPEYASSGKLTE 497
A N L+D + V+DFG+ + D+ S + APE K +
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS------APEVFHYFKYSS 184
Query: 498 KSDVFSFGVMLLELIT-GRRP 517
KSDV++FG+++ E+ + G+ P
Sbjct: 185 KSDVWAFGILMWEVFSLGKMP 205
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-42
Identities = 60/201 (29%), Positives = 105/201 (52%), Gaps = 12/201 (5%)
Query: 324 LGQGGFGYVHKGVLPNGKE---VAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVSLVG 379
LG G FG V +GV K+ VA+K LK G+ + + E E +I+ ++ + ++V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
C MLV E L L R + + + + G+ YL E+ + +
Sbjct: 78 VCQ-AEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL-EEKN--FV 132
Query: 440 HRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTF--GYLAPEYASSGKLTE 497
HRD+ A N+L+ + A ++DFGL+K + ++ + R G + + APE + K +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 498 KSDVFSFGVMLLELIT-GRRP 517
+SDV+S+GV + E ++ G++P
Sbjct: 193 RSDVWSYGVTMWEALSYGQKP 213
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-41
Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 324 LGQGGFGYVHKGVL--PNGKE--VAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVSLV 378
LG+G FG V++GV G++ VAVK+ K + +F +E I+ + H H+V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 379 GYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRI 438
G ++ E L ++L N+ + T V +L K +AYL E +
Sbjct: 80 GIIE-EEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYL-ESIN--C 134
Query: 439 IHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEK 498
+HRDI NIL+ + DFGL++ D + ++ +++PE + + T
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA 194
Query: 499 SDVFSFGVMLLELIT-GRRP 517
SDV+ F V + E+++ G++P
Sbjct: 195 SDVWMFAVCMWEILSFGKQP 214
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 81/285 (28%), Positives = 124/285 (43%), Gaps = 44/285 (15%)
Query: 322 NLLGQGGFGYVHKGVL--PNGKE--VAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVS 376
++G+G FG V+ G L +GK+ AVKSL + GE +F E I+ H +++S
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 377 LVGYCIAG-GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
L+G C+ G ++V ++ + L + + L AKG+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLASK-- 147
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL------APEY 489
+ +HRD+ A N ++D+ F VADFGLA+ D + V G A E
Sbjct: 148 -KFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 490 ASSGKLTEKSDVFSFGVMLLELIT-GRRP-VDMTMMEDSLVEWARPLLGAALEDGIYDGL 547
+ K T KSDV+SFGV+L EL+T G P D+ + + L G
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----------ITVYLLQGR---- 249
Query: 548 VDPRLEH-NYVPHEMARL-VACGAASIRHSARKRPKMSQIVRALE 590
RL Y P + + + C A RP S++V +
Sbjct: 250 ---RLLQPEYCPDPLYEVMLKCW----HPKAEMRPSFSELVSRIS 287
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
LG G FG V G +VA+K +K GS E EF E +++ + H LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 384 GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDI 443
++ E+++N L +L E R + + + + YL E +HRD+
Sbjct: 91 QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL-ESKQ--FLHRDL 146
Query: 444 KAANILIDDNFEAMVADFGLAKLSNDNHTHVST------RVMGTFGYLAPEYASSGKLTE 497
A N L++D V+DFGL++ D+ S R PE K +
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS------PPEVLMYSKFSS 200
Query: 498 KSDVFSFGVMLLELIT-GRRP 517
KSD+++FGV++ E+ + G+ P
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMP 221
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-41
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 324 LGQGGFGYVHKGVLPNGK-EVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI 382
LG G +G V++GV VAVK+LK + + E EF E ++ + H +LV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 383 AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRD 442
++ EF++ L +L NR + + +A + + YL + IHRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 443 IKAANILIDDNFEAMVADFGLAKLSNDNHTHVST------RVMGTFGYLAPEYASSGKLT 496
+ A N L+ +N VADFGL++L + + APE + K +
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------APESLAYNKFS 190
Query: 497 EKSDVFSFGVMLLELIT-GRRP 517
KSDV++FGV+L E+ T G P
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSP 212
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-41
Identities = 60/202 (29%), Positives = 104/202 (51%), Gaps = 20/202 (9%)
Query: 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
+G+G FG V G G +VAVK +K + + F AE +++++ H +LV L+G
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 382 IAG-GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIH 440
+ G +V E+++ +L +L R V+ ++ +L + + YL + +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 140
Query: 441 RDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRV----MGTFGYLAPEYASSGKLT 496
RD+ A N+L+ ++ A V+DFGL K + T + ++ APE K +
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWT------APEALREKKFS 192
Query: 497 EKSDVFSFGVMLLELIT-GRRP 517
KSDV+SFG++L E+ + GR P
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVP 214
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-41
Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 6/198 (3%)
Query: 322 NLLGQGGFGYVHKGVLPN-GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGY 380
+ LG G +G V++GV VAVK+LK + + E EF E ++ + H +LV L+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 284
Query: 381 CIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIH 440
C ++ EF++ L +L NR + + +A + + YL + IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 341
Query: 441 RDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSD 500
R++ A N L+ +N VADFGL++L + + APE + K + KSD
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 501 VFSFGVMLLELIT-GRRP 517
V++FGV+L E+ T G P
Sbjct: 402 VWAFGVLLWEIATYGMSP 419
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-41
Identities = 71/276 (25%), Positives = 127/276 (46%), Gaps = 44/276 (15%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
+G+G FG V G G +VAVK +K + + F AE +++++ H +LV L+G +
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 384 GGQR-MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRD 442
+V E+++ +L +L R V+ ++ +L + + YL + +HRD
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 314
Query: 443 IKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRV----MGTFGYLAPEYASSGKLTEK 498
+ A N+L+ ++ A V+DFGL K + T + ++ APE K + K
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWT------APEALREKKFSTK 366
Query: 499 SDVFSFGVMLLELIT-GRRP-VDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH-N 555
SDV+SFG++L E+ + GR P + + + +V +E G Y +++ +
Sbjct: 367 SDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP--------RVEKG-Y------KMDAPD 409
Query: 556 YVPHEMARL-VACGAASIRHSARKRPKMSQIVRALE 590
P + + C A RP Q+ LE
Sbjct: 410 GCPPAVYDVMKNCW----HLDAATRPTFLQLREQLE 441
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-41
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 322 NLLGQGGFGYVHKGVLPNGKE----VAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVS 376
++G+G FG V+ G + + A+KSL + + F E ++ ++H ++++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 377 LVGYCIAG-GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
L+G + G ++ ++ + L + + + L A+G+ YL E
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYLAEQ-- 143
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTF--GYLAPEYASS 492
+ +HRD+ A N ++D++F VADFGLA+ + + + V + A E +
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 493 GKLTEKSDVFSFGVMLLELIT-GRRP 517
+ T KSDV+SFGV+L EL+T G P
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-41
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 11/200 (5%)
Query: 324 LGQGGFGYVHKGVL--PNGKE--VAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVSLV 378
+G+G FG VH+G+ P VA+K+ K + R +F E + + H H+V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 379 GYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRI 438
G ++ E + L L + +D A+ + A + LAYL R
Sbjct: 83 GVIT-ENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESK---RF 137
Query: 439 IHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEK 498
+HRDI A N+L+ N + DFGL++ D+ + +++ ++APE + + T
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 197
Query: 499 SDVFSFGVMLLELIT-GRRP 517
SDV+ FGV + E++ G +P
Sbjct: 198 SDVWMFGVCMWEILMHGVKP 217
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 62/204 (30%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 324 LGQGGFGYVHKGVL--PNGKE--VAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLVS 376
LG G FG V +G P+GK VAVK LK + +F EV + + HR+L+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
L G + +V E +L L +++ T R A+ A+G+ YL
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYLESK--- 140
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGY--LAPEYASSGK 494
R IHRD+ A N+L+ + DFGL + N H + + APE +
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 495 LTEKSDVFSFGVMLLELIT-GRRP 517
+ SD + FGV L E+ T G+ P
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 68/203 (33%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 324 LGQGGFGYVHKGVL--PNGKE---VAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVSL 377
+G G FG V+KG+L +GK+ VA+K+LK G + +R +F E I+ + H +++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
G M++ E++ N L+ L E V + G A G+ YL + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYL-ANMN-- 167
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGY--LAPEYASSGKL 495
+HRD+ A NIL++ N V+DFGL+++ D+ T G APE S K
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 496 TEKSDVFSFGVMLLELIT-GRRP 517
T SDV+SFG+++ E++T G RP
Sbjct: 228 TSASDVWSFGIVMWEVMTYGERP 250
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 324 LGQGGFGYVHKGVLPNGK---EVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLV 378
LG G FG V KG K VAVK LK + E AE ++ ++ + ++V ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 379 GYCIAGGQRMLVYEFVSNKTL-EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
G C MLV E L +Y + + + + + G+ YL E+ +
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI---IELVHQVSMGMKYL-EESN-- 137
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTF--GYLAPEYASSGKL 495
+HRD+ A N+L+ A ++DFGL+K + + + G + + APE + K
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 496 TEKSDVFSFGVMLLELIT-GRRP 517
+ KSDV+SFGV++ E + G++P
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-40
Identities = 65/274 (23%), Positives = 108/274 (39%), Gaps = 24/274 (8%)
Query: 255 PPPPGGNWPGPPPPPPMMSSSGEMSSQFSGPARPPLPPPSPNIALGFNKSTFTYDELAAA 314
P G P G S S TY +
Sbjct: 332 PQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDE--------EDTYTMPSTR 383
Query: 315 TGGFAKSNL-----LGQGGFGYVHKGVL--PNGKE--VAVKSLKTGSGQGER-EFSAEVE 364
+ + +G+G FG VH+G+ P VA+K+ K + R +F E
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 365 IISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSA 424
+ + H H+V L+G ++ E + L L + +D A+ + A +
Sbjct: 444 TMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLS 501
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGY 484
LAYL R +HRDI A N+L+ N + DFGL++ D+ + +++ +
Sbjct: 502 TALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 485 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
+APE + + T SDV+ FGV + E++ G +P
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-40
Identities = 67/202 (33%), Positives = 104/202 (51%), Gaps = 12/202 (5%)
Query: 324 LGQGGFGYVHKGVL--PNGKE--VAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVSLV 378
+G G FG V G L P+ KE VA+K+LK G + +R +F E I+ + H +++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 379 GYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRI 438
G M+V E++ N +L+ L ++ V + G A G+ YL D
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL-SDMG--Y 168
Query: 439 IHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL--APEYASSGKLT 496
+HRD+ A NILI+ N V+DFGL ++ D+ T G +PE + K T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 497 EKSDVFSFGVMLLELIT-GRRP 517
SDV+S+G++L E+++ G RP
Sbjct: 229 SASDVWSYGIVLWEVMSYGERP 250
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-40
Identities = 71/315 (22%), Positives = 124/315 (39%), Gaps = 22/315 (6%)
Query: 213 NHFKKGGDPYYSGGHAPNWHGHPEHQNWHSHPQGPDHTGGNIPPPPGGNW---PGPPPPP 269
+ K D + + + + P P H P + G P P
Sbjct: 237 EYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEP 296
Query: 270 PMMSSSGEMSSQFSGPARPPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGF 329
++S + + P P LG G F
Sbjct: 297 ARITSPDKPRPMPMDTSVFESPFSDPEEL---KDKKLFLKRDNLLIAD----IELGCGNF 349
Query: 330 GYVHKGVLPNGKE---VAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVSLVGYCIAGG 385
G V +GV K+ VA+K LK G+ + + E E +I+ ++ + ++V L+G C
Sbjct: 350 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE 408
Query: 386 QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKA 445
MLV E L L R + + + + G+ YL E +HR++ A
Sbjct: 409 ALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAA 464
Query: 446 ANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGY--LAPEYASSGKLTEKSDVFS 503
N+L+ + A ++DFGL+K + ++ + R G + APE + K + +SDV+S
Sbjct: 465 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWS 524
Query: 504 FGVMLLELIT-GRRP 517
+GV + E ++ G++P
Sbjct: 525 YGVTMWEALSYGQKP 539
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 68/231 (29%), Positives = 109/231 (47%), Gaps = 21/231 (9%)
Query: 304 STFTYDELAAATGGFAK---------SNLLGQGGFGYVHKGVL--PNGKE--VAVKSLKT 350
TY+E A F + ++G G G V G L P ++ VA+K+LK
Sbjct: 28 EPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKA 87
Query: 351 GSGQGER-EFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRP 409
G + +R +F +E I+ + H +++ L G G M+V E++ N +L+ L +
Sbjct: 88 GYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDG 146
Query: 410 VMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469
V + G G+ YL D +HRD+ A N+L+D N V+DFGL+++ D
Sbjct: 147 QFTIMQLVGMLRGVGAGMRYL-SDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203
Query: 470 NHTHVSTRVMGTFGYL--APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
+ T G APE + + SDV+SFGV++ E++ G RP
Sbjct: 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 3e-40
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 324 LGQGGFGYVHKGVLPNGKE-----VAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVSL 377
LG G FG VHKGV E V +K ++ SG+ + + I + H H+V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
+G C G LV +++ +L H+ ++R + + + AKG+ YL E
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEH---G 135
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTFGYLAPEYASSGKLT 496
++HR++ A N+L+ + VADFG+A L D+ + + ++A E GK T
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195
Query: 497 EKSDVFSFGVMLLELIT-GRRP 517
+SDV+S+GV + EL+T G P
Sbjct: 196 HQSDVWSYGVTVWELMTFGAEP 217
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-40
Identities = 80/285 (28%), Positives = 119/285 (41%), Gaps = 35/285 (12%)
Query: 324 LGQGGFGYVHKGVLPNGKE-----VAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVSL 377
LG+G FG V + VAVK+LK +G R + E++I+ ++H H++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 378 VGYCIAGGQR--MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
G C G LV E+V +L +L + + + A +G+AYLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL---LLFAQQICEGMAYLHAQ-- 153
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTF--GYLAPEYASSG 493
IHRD+ A N+L+D++ + DFGLAK + H + R G + APE
Sbjct: 154 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212
Query: 494 KLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAA-----LEDGIYDGL 547
K SDV+SFGV L EL+T L+ A+ + LE G
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE---- 268
Query: 548 VDPRLEH-NYVPHEMARL-VACGAASIRHSARKRPKMSQIVRALE 590
RL + P E+ L C A RP ++ L+
Sbjct: 269 ---RLPRPDKCPAEVYHLMKNCWE----TEASFRPTFENLIPILK 306
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 7e-40
Identities = 69/195 (35%), Positives = 101/195 (51%), Gaps = 6/195 (3%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
LG G FG V G +VAVKSLK GS + F AE ++ ++ H+ LV L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT- 78
Query: 384 GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDI 443
++ E++ N +L L + + + +A A+G+A++ E IHRD+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 444 KAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 503
+AANIL+ D +ADFGLA+L DN + APE + G T KSDV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 504 FGVMLLELIT-GRRP 517
FG++L E++T GR P
Sbjct: 196 FGILLTEIVTHGRIP 210
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-40
Identities = 62/197 (31%), Positives = 96/197 (48%), Gaps = 6/197 (3%)
Query: 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
LG G FG V +VAVK++K GS F AE ++ + H LV L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441
++ EF++ +L L + + + A+G+A++ + IHR
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 308
Query: 442 DIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 501
D++AANIL+ + +ADFGLA++ DN + APE + G T KSDV
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 502 FSFGVMLLELIT-GRRP 517
+SFG++L+E++T GR P
Sbjct: 369 WSFGILLMEIVTYGRIP 385
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 324 LGQGGFGYVHKGVLPNGKE-----VAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVSL 377
LG G FG V+KG+ E VA+K L+ + E E +++ V + H+ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
+G C+ L+ + + L ++ E++ + + + AKG+ YL + R
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTFGYLAPEYASSGKLT 496
++HRD+ A N+L+ + DFGLAK L + + + ++A E T
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 497 EKSDVFSFGVMLLELIT-GRRP 517
+SDV+S+GV + EL+T G +P
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKP 219
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 75/274 (27%), Positives = 121/274 (44%), Gaps = 24/274 (8%)
Query: 263 PGPPPPPPMMSSSGEMSSQFSGPARPPLPPPSPNIALGFNKSTFTYDELAAATGGFAK-- 320
P P + S E+S+ A + + S EL A
Sbjct: 28 PRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN-PELVQAVQHVVIGP 86
Query: 321 -------SNLLGQGGFGYVHKGVL--PNGKE--VAVKSLKTGSGQGER-EFSAEVEIISR 368
+ ++G+G FG V+ G L +GK+ AVKSL + GE +F E I+
Sbjct: 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 146
Query: 369 VHHRHLVSLVGYCI-AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGL 427
H +++SL+G C+ + G ++V ++ + L + + L AKG+
Sbjct: 147 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGM 205
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTF--GY 484
+L + +HRD+ A N ++D+ F VADFGLA+ + + V + +
Sbjct: 206 KFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262
Query: 485 LAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
+A E + K T KSDV+SFGV+L EL+T G P
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 9/199 (4%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGE---REFSAEVEIISRVHHRHLVSLV 378
LG GG V+ +VA+K++ + E + F EV S++ H+++VS++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 379 GYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRI 438
LV E++ TL ++ + T + G+ + H+ RI
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDM---RI 132
Query: 439 IHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEK 498
+HRDIK NILID N + DFG+AK ++ + V+GT Y +PE A E
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 499 SDVFSFGVMLLELITGRRP 517
+D++S G++L E++ G P
Sbjct: 193 TDIYSIGIVLYEMLVGEPP 211
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-38
Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 324 LGQGGFGYVHKGVL--------PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLV 375
LGQG F + KGV + EV +K L F ++S++ H+HLV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
G C+ G + +LV EFV +L+ +L +N+ ++ ++ +A A + +L E+
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL-EENT 133
Query: 436 PRIIHRDIKAANILIDDNFEAM--------VADFGLAK-LSNDNHTHVSTRVMGTFGYLA 486
+IH ++ A NIL+ + ++D G++ + + +
Sbjct: 134 --LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV------P 185
Query: 487 PEYASSGKL-TEKSDVFSFGVMLLELIT-GRRP 517
PE + K +D +SFG L E+ + G +P
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-38
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 324 LGQGGFGYVHKGVLPNGKE------VAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSL 377
LG+G FG V N VAVK+LK + ++F E E+++ + H H+V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 378 VGYCIAGGQRMLVYEFVSN--------------KTLEYHLHGENRPVMDFATRVRIALGS 423
G C G ++V+E++ + L + + + + + IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 424 AKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFG 483
A G+ YL +HRD+ N L+ N + DFG+++ + +G
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGGHT 195
Query: 484 YL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
L PE K T +SDV+SFGV+L E+ T G++P
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-38
Identities = 73/197 (37%), Positives = 100/197 (50%), Gaps = 6/197 (3%)
Query: 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
LGQG FG V G VA+K+LK G+ E F E +++ ++ H LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441
+V E++S +L L GE + V +A A G+AY+ +HR
Sbjct: 332 S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 387
Query: 442 DIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 501
D++AANIL+ +N VADFGLA+L DN + APE A G+ T KSDV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 502 FSFGVMLLELIT-GRRP 517
+SFG++L EL T GR P
Sbjct: 448 WSFGILLTELTTKGRVP 464
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 13/84 (15%), Positives = 24/84 (28%), Gaps = 2/84 (2%)
Query: 63 SKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSP 122
+KS P S P + + P + P P S+ P + + P
Sbjct: 3 NKSKPKDASQRRRSLEPAENVHGAGGGAF--PASQTPSKPASADGHRGPSAAFAPAAAEP 60
Query: 123 PVFSPPPPAKKSSPPPPPLKYSSS 146
+F + + P +
Sbjct: 61 KLFGGFNSSDTVTSPQRAGPLAGG 84
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 12/83 (14%), Positives = 21/83 (25%)
Query: 33 SSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPD 92
S P + + + P S++P P A P + K
Sbjct: 4 KSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLF 63
Query: 93 PPKNSPPPPPPSSQSSPTPPSPS 115
NS ++ P +
Sbjct: 64 GGFNSSDTVTSPQRAGPLAGGVT 86
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 10/87 (11%), Positives = 18/87 (20%), Gaps = 3/87 (3%)
Query: 33 SSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPD 92
S+ P + S S P + P++ +P
Sbjct: 2 SNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPK 61
Query: 93 PPKNSPPPPPPSSQSSPTPPSPSNNKS 119
+ +SP P
Sbjct: 62 LF---GGFNSSDTVTSPQRAGPLAGGV 85
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 13/72 (18%), Positives = 19/72 (26%), Gaps = 1/72 (1%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
PA + P S TPS S +P + P SS +
Sbjct: 16 SLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAF-APAAAEPKLFGGFNSSDTVTS 74
Query: 75 SSSPPPASPPTS 86
P + +
Sbjct: 75 PQRAGPLAGGVT 86
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 17/84 (20%), Positives = 24/84 (28%), Gaps = 1/84 (1%)
Query: 43 SSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPP 102
S P AS S P+ + P T S P A + P P
Sbjct: 5 SKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFG 64
Query: 103 -PSSQSSPTPPSPSNNKSPSPPVF 125
+S + T P + + F
Sbjct: 65 GFNSSDTVTSPQRAGPLAGGVTTF 88
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 11/79 (13%), Positives = 19/79 (24%), Gaps = 6/79 (7%)
Query: 16 SPPAPPSSNSSDATPPPSST------PSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSS 69
S P S P + +S PS P A +P ++
Sbjct: 5 SKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFG 64
Query: 70 PPPATSSSPPPASPPTSDN 88
++ + P
Sbjct: 65 GFNSSDTVTSPQRAGPLAG 83
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-38
Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 16/212 (7%)
Query: 315 TGGFAKSN-LLGQGGFGYVHKGV-LPNGKEVAVK--SLKTGSGQGEREFSAEVEIISRVH 370
G F K + +G+G F V+KG+ EVA + + + F E E++ +
Sbjct: 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 83
Query: 371 HRHLVSLVGYCIAGGQRM----LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKG 426
H ++V + + LV E +++ TL+ +L + + R KG
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLR-SWCRQILKG 141
Query: 427 LAYLHEDCHPRIIHRDIKAANILID-DNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL 485
L +LH P IIHRD+K NI I + D GLA L + V+GT ++
Sbjct: 142 LQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFM 197
Query: 486 APEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
APE E DV++FG+ +LE+ T P
Sbjct: 198 APEMYEEK-YDESVDVYAFGMCMLEMATSEYP 228
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 72/291 (24%), Positives = 112/291 (38%), Gaps = 52/291 (17%)
Query: 324 LGQGGFGYVHKGVLPNGKE----VAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSL 377
LG+G FG V +G L VAVK++K S + EF +E + H +++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 378 VGYC-----IAGGQRMLVYEFVSN---KT-LEYHLHGENRPVMDFATRVRIALGSAKGLA 428
+G C + M++ F+ T L Y + T ++ + A G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 429 YLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL--- 485
YL +HRD+ A N ++ D+ VADFGL+K + G +
Sbjct: 162 YLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ----GRIAKMPVK 214
Query: 486 --APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP-VDMTMMEDSLVEWARPLLGAALED 541
A E + T KSDV++FGV + E+ T G P + E + L
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE----------MYDYLLH 264
Query: 542 GIYDGLVDPRLEH-NYVPHEMARL-VACGAASIRHSARKRPKMSQIVRALE 590
G RL+ E+ + +C R RP S + LE
Sbjct: 265 GH-------RLKQPEDCLDELYEIMYSCW----RTDPLDRPTFSVLRLQLE 304
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 73/292 (25%), Positives = 111/292 (38%), Gaps = 53/292 (18%)
Query: 324 LGQGGFGYVHKGVLPNGKE----VAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSL 377
LG+G FG V + L VAVK LK + EF E + H H+ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 378 VGYCIAGGQR------MLVYEFVSNKTL-EY---HLHGENRPVMDFATRVRIALGSAKGL 427
VG + + M++ F+ + L + GEN + T VR + A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL-- 485
YL IHRD+ A N ++ ++ VADFGL++ + G L
Sbjct: 151 EYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ----GCASKLPV 203
Query: 486 ---APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP-VDMTMMEDSLVEWARPLLGAALE 540
A E + T SDV++FGV + E++T G+ P + E + L
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE----------IYNYLI 253
Query: 541 DGIYDGLVDPRLEH-NYVPHEMARL-VACGAASIRHSARKRPKMSQIVRALE 590
G RL+ E+ L C ++RP + + LE
Sbjct: 254 GGN-------RLKQPPECMEEVYDLMYQCW----SADPKQRPSFTCLRMELE 294
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-37
Identities = 70/296 (23%), Positives = 119/296 (40%), Gaps = 58/296 (19%)
Query: 324 LGQGGFGYVHKGVLPNGKE------VAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSL 377
LG+G FG V N VAVK+LK S ++F E E+++ + H+H+V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATR--------------VRIALGS 423
G C G ++V+E++ + L L + P + +A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLR-SHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 424 AKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFG 483
A G+ YL +HRD+ N L+ + DFG+++ D ++ R +G
Sbjct: 168 AAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR---DIYSTDYYR-VGGRT 220
Query: 484 YL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP-VDMTMMEDSLVEWARPLLG 536
L PE K T +SDV+SFGV+L E+ T G++P ++ E ++
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AID------- 271
Query: 537 AALEDGIYDGLVDPRLEH-NYVPHEMARL-VACGAASIRHSARKRPKMSQIVRALE 590
+ G LE P E+ + C + ++R + + L+
Sbjct: 272 -CITQGR-------ELERPRACPPEVYAIMRGCW----QREPQQRHSIKDVHARLQ 315
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 36/222 (16%)
Query: 324 LGQGGFGYVHKGVLPNGKE------VAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVS 376
LG+ FG V+KG L VA+K+LK + R EF E + +R+ H ++V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATR---------------VRIAL 421
L+G +++ + S+ L L P D + V +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLV-MRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 422 GSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGT 481
A G+ YL ++H+D+ N+L+ D ++D GL + + + +++G
Sbjct: 136 QIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR---EVYAADYYKLLGN 189
Query: 482 FGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
L APE GK + SD++S+GV+L E+ + G +P
Sbjct: 190 -SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 324 LGQGGFGYVHKGVLPNGKE------VAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVS 376
LGQG FG V++GV + VA+K++ + ER EF E ++ + H+V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATR---------VRIALGSAKGL 427
L+G G +++ E ++ L+ +L RP M +++A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLR-SLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYL-- 485
AYL+ + + +HRD+ A N ++ ++F + DFG+ + + + G G L
Sbjct: 152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPV 204
Query: 486 ---APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
+PE G T SDV+SFGV+L E+ T +P
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 55/246 (22%), Positives = 90/246 (36%), Gaps = 18/246 (7%)
Query: 278 MSSQFSGPARPPLPPPSPNIALGFNKSTFTYDELAAAT-GGFAKSNLLGQGGFGYVHKGV 336
M S P + G T + G + L+G+GG G V++
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMDG------TAESREGTQFGPYRLRRLVGRGGMGDVYEAE 54
Query: 337 LPN-GKEVAVKSLKTGSGQGE---REFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392
+ VA+K + E R+ H+V + + GQ +
Sbjct: 55 DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR 114
Query: 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD 452
++ L L + + V I L H HRD+K NIL+
Sbjct: 115 LINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSA 169
Query: 453 NFEAMVADFGLAKLSNDNH-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 511
+ A + DFG+A + D T + +GT Y+APE S T ++D+++ +L E
Sbjct: 170 DDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESHATYRADIYALTCVLYEC 228
Query: 512 ITGRRP 517
+TG P
Sbjct: 229 LTGSPP 234
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 28/215 (13%)
Query: 324 LGQGGFGYVHKGVLPNGK------EVAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVS 376
LG G FG V++G + +VAVK+L + + +F E IIS+ +H+++V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHL-----HGENRPVMDFATRVRIALGSAKGLAYLH 431
+G + R ++ E ++ L+ L + + +A A G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAMV---ADFGLAKLSNDNHTHVSTRVMGTFGYL--- 485
E+ IHRDI A N L+ V DFG+A+ D + R G L
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---DIYRASYYR-KGGCAMLPVK 210
Query: 486 --APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
PE G T K+D +SFGV+L E+ + G P
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 58/221 (26%), Positives = 105/221 (47%), Gaps = 35/221 (15%)
Query: 322 NLLGQGGFGYVHKGVLPNGKE---VAVKSLKTGSGQGER-EFSAEVEIISRV-HHRHLVS 376
+++G+G FG V K + A+K +K + + + +F+ E+E++ ++ HH ++++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATR---------------VRIAL 421
L+G C G L E+ + L L ++R + + A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 422 GSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRV--- 478
A+G+ YL + + IHRD+ A NIL+ +N+ A +ADFGL++ R+
Sbjct: 150 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 206
Query: 479 -MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
M A E + T SDV+S+GV+L E+++ G P
Sbjct: 207 WM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 56/246 (22%), Positives = 103/246 (41%), Gaps = 17/246 (6%)
Query: 278 MSSQFSGPARPPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGV- 336
M Q G PP+P P AL + T F +G+G F V++
Sbjct: 1 MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLAN-------FRIEKKIGRGQFSEVYRAAC 53
Query: 337 LPNGKEVAVKSLKTGSGQGEREFSA---EVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393
L +G VA+K ++ + + E++++ +++H +++ I + +V E
Sbjct: 54 LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 113
Query: 394 VSNKTLEYHL--HGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID 451
L + + + ++ T + + L ++H R++HRDIK AN+ I
Sbjct: 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFIT 170
Query: 452 DNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 511
+ D GL + + T + V GT Y++PE KSD++S G +L E+
Sbjct: 171 ATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 229
Query: 512 ITGRRP 517
+ P
Sbjct: 230 AALQSP 235
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-35
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGE---REFSAEVEIISRVHHRHLVSL- 377
+LG GG VH L + ++VAVK L+ + F E + + ++H +V++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 378 -VGYCIAGGQRM--LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
G + +V E+V TL +H E M + + + + L + H++
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN- 135
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV--STRVMGTFGYLAPEYASS 492
IIHRD+K ANI+I V DFG+A+ D+ V + V+GT YL+PE A
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 493 GKLTEKSDVFSFGVMLLELITGRRP 517
+ +SDV+S G +L E++TG P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 28/215 (13%)
Query: 324 LGQGGFGYVHKGVLPNGK------EVAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVS 376
LG G FG V++G + +VAVK+L + + +F E IIS+ +H+++V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHL-----HGENRPVMDFATRVRIALGSAKGLAYLH 431
+G + R ++ E ++ L+ L + + +A A G YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAMV---ADFGLAKLSNDNHTHVSTRVMGTFGYL--- 485
E+ IHRDI A N L+ V DFG+A+ D + R G L
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---DIYRAGYYR-KGGCAMLPVK 251
Query: 486 --APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
PE G T K+D +SFGV+L E+ + G P
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 322 NLLGQGGFGYVHKGVL------PNGKEVAVKSLKTGSGQGER-EFSAEVEIISRV-HHRH 373
LG G FG V + +VAVK LK+ + E+ +E++I+S + H +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 374 LVSLVGYCIAGGQRMLVYEFVSN------------KTLEYHLHGENRPVMDFATRVRIAL 421
+V+L+G C GG +++ E+ + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 422 GSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA-KLSNDNHTHVSTRVMG 480
A+G+A+L IHRD+ A N+L+ + A + DFGLA + ND++ V
Sbjct: 172 QVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 481 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
++APE T +SDV+S+G++L E+ + G P
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 42/229 (18%)
Query: 324 LGQGGFGYVHKGVLPNGKE------VAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVS 376
LG+G FG V K + K VAVK LK + E + +E ++ +V+H H++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 377 LVGYCIAGGQRMLVYEFVSN----------------------KTLEYHLHGENRPVMDFA 414
L G C G +L+ E+ L + +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 415 TRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474
+ A ++G+ YL E +++HRD+ A NIL+ + + ++DFGL++ + ++V
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 475 STRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
+ G + A E T +SDV+SFGV+L E++T G P
Sbjct: 208 K----RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 37/224 (16%)
Query: 324 LGQGGFGYVHKGVLPNGKE------VAVKSLKTGSGQGER-EFSAEVEIISRV-HHRHLV 375
LG G FG V + + VAVK LK + ER +E++++S + +H ++V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 376 SLVGYCIAGGQRMLVYEFVSN----------------KTLEYHLHGENRPVMDFATRVRI 419
+L+G C GG +++ E+ + ++ +D +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 420 ALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM 479
+ AKG+A+L IHRD+ A NIL+ + DFGLA+ ++ +V
Sbjct: 151 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK--- 204
Query: 480 GTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
L APE + T +SDV+S+G+ L EL + G P
Sbjct: 205 -GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 36/223 (16%)
Query: 324 LGQGGFGYVHKGVLPNGKE------VAVKSLKTGSGQGER-EFSAEVEIISRV-HHRHLV 375
LG+G FG V + + VAVK LK G+ E +E++I+ + HH ++V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 376 SLVGYCIAGGQ-RMLVYEFVSNKTL--------------EYHLHGENRPVMDFATRVRIA 420
+L+G C G M++ EF L + + + + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 421 LGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMG 480
AKG+ +L + IHRD+ A NIL+ + + DFGLA+ + +V
Sbjct: 155 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK---- 207
Query: 481 TFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
L APE T +SDV+SFGV+L E+ + G P
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 42/229 (18%)
Query: 324 LGQGGFGYVHKGVLPNGKE------VAVKSLKTGSGQGER-EFSAEVEIISRV-HHRHLV 375
LG G FG V + VAVK LK + ER +E+++++++ H ++V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 376 SLVGYCIAGGQRMLVYEFVSN------------KTLEYHLHGENRPVMDFATR------- 416
+L+G C G L++E+ K E + EN+ ++
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 417 --VRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474
+ A AKG+ +L +HRD+ A N+L+ + DFGLA+ + +V
Sbjct: 173 DLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 475 STRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
L APE G T KSDV+S+G++L E+ + G P
Sbjct: 230 VR----GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 60/263 (22%), Positives = 97/263 (36%), Gaps = 26/263 (9%)
Query: 284 GPARPPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGV-LPNGKE 342
G + S L F D + LG+GGF YV L +G
Sbjct: 2 GSSHHHHHHSSGRENLYFQGHMVIIDNKH-----YLFIQKLGEGGFSYVDLVEGLHDGHF 56
Query: 343 VAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRM----LVYEFVSNKT 398
A+K + Q E E ++ +H +++ LV YC+ L+ F T
Sbjct: 57 YALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGT 116
Query: 399 LEYHL--HGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA 456
L + + + + + LG +GL +H HRD+K NIL+ D +
Sbjct: 117 LWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQP 173
Query: 457 MVADFGLAKLSNDNHTHVSTRVM--------GTFGYLAPE---YASSGKLTEKSDVFSFG 505
++ D G + + + T Y APE S + E++DV+S G
Sbjct: 174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG 233
Query: 506 VMLLELITGRRPVDMTMMEDSLV 528
+L ++ G P DM + V
Sbjct: 234 CVLYAMMFGEGPYDMVFQKGDSV 256
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVS 376
F + L+G GGFG V K +GK +K +K + + ERE V+ ++++ H ++V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVH 68
Query: 377 LVGY----------------CIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIA 420
G + EF TLE + +D + +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 421 LGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVM 479
KG+ Y+H ++I+RD+K +NI + D + + DFGL L ND TR
Sbjct: 129 EQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TRSK 182
Query: 480 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
GT Y++PE SS ++ D+++ G++L EL+
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 37/224 (16%)
Query: 324 LGQGGFGYVHKGVLPNGKE--------VAVKSLKTGSGQGER-EFSAEVEIISRV-HHRH 373
LG+G FG V + VAVK LK + + + + +E+E++ + H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 374 LVSLVGYCIAGGQRMLVYEFVSN--------------KTLEYHLHGENRPVMDFATRVRI 419
+++L+G C G ++ E+ S Y ++ M F V
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 420 ALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM 479
A+G+ YL + IHRD+ A N+L+ +N +ADFGLA+ N+ +
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK---- 215
Query: 480 GTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
T G L APE T +SDV+SFGV++ E+ T G P
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 46/231 (19%)
Query: 324 LGQGGFGYVHKGVLPNGKE------VAVKSLKTGSGQGER-EFSAEVEIISRVHHRHLVS 376
+G+G FG V + P VAVK LK + + +F E +++ + ++V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 377 LVGYCIAGGQRMLVYEFVSN----------------------KTLEYHLHGENRPVMDFA 414
L+G C G L++E+++ + + P + A
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 415 TRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK--LSNDNHT 472
++ IA A G+AYL E + +HRD+ N L+ +N +ADFGL++ S D +
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 473 HVSTRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
+ PE + T +SDV+++GV+L E+ + G +P
Sbjct: 232 ------ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 7/203 (3%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGS-GQGEREFS-AEVEIISRVHHRHL 374
+ + +G+G FG +G++ +K + ERE S EV +++ + H ++
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
V G +V ++ L ++ + + + + L ++H+
Sbjct: 86 VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD-- 143
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGK 494
+I+HRDIK+ NI + + + DFG+A++ N + GT YL+PE +
Sbjct: 144 -RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKP 201
Query: 495 LTEKSDVFSFGVMLLELITGRRP 517
KSD+++ G +L EL T +
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHA 224
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-33
Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 37/224 (16%)
Query: 324 LGQGGFGYVHKGVLPNGKE--------VAVKSLKTGSGQGER-EFSAEVEIISRV-HHRH 373
LG+G FG V + VAVK LK + + + + +E+E++ + H++
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 374 LVSLVGYCIAGGQRMLVYEFVSN--------------KTLEYHLHGENRPVMDFATRVRI 419
+++L+G C G ++ E+ S Y ++ M F V
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 420 ALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM 479
A+G+ YL + IHRD+ A N+L+ +N +ADFGLA+ N+ +
Sbjct: 209 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK---- 261
Query: 480 GTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
T G L APE T +SDV+SFGV++ E+ T G P
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 55/231 (23%), Positives = 97/231 (41%), Gaps = 36/231 (15%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVG-Y 380
+LGQG FG V K + + A+K ++ + +EV +++ ++H+++V +
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 381 CIAGGQRM------------LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLA 428
+ E+ N TL +H EN R+ + L+
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW-RLFRQILEALS 130
Query: 429 YLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV-------------- 474
Y+H IIHRD+K NI ID++ + DFGLAK + + +
Sbjct: 131 YIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 475 STRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMME 524
++ + GT Y+A E +G EK D++S G++ E+I M +
Sbjct: 188 TSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST-GMERVN 236
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 320 KSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLV 378
+LG+G +G V+ G L N +A+K + + + E+ + + H+++V +
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 379 GYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRI----ALGSAKGLAYLHEDC 434
G G + E V +L L + P+ D + L +GL YLH++
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL---EGLKYLHDN- 141
Query: 435 HPRIIHRDIKAANILIDDNFEAMV--ADFGLAKLSNDNHTHVSTRVMGTFGYLAPE--YA 490
+I+HRDIK N+LI + + ++ +DFG +K + T GT Y+APE
Sbjct: 142 --QIVHRDIKGDNVLI-NTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDK 197
Query: 491 SSGKLTEKSDVFSFGVMLLELITGRRP 517
+ +D++S G ++E+ TG+ P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 10/204 (4%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGS-GQGEREFS-AEVEIISRVHHRHLVSLVG 379
+G G +G K +GK + K L GS + E++ +EV ++ + H ++V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 380 YCIAGGQRML--VYEFVSNKTLEYHL--HGENRPVMDFATRVRIALGSAKGLAYLHE--D 433
I L V E+ L + + R +D +R+ L H D
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 434 CHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSG 493
++HRD+K AN+ +D + DFGLA++ N + + T V GT Y++PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRM 191
Query: 494 KLTEKSDVFSFGVMLLELITGRRP 517
EKSD++S G +L EL P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPP 215
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 37/224 (16%)
Query: 324 LGQGGFGYVHKGVLPNGK--------EVAVKSLKTGSGQGER-EFSAEVEIISRV-HHRH 373
LG+G FG V +VAVK LK+ + + + + +E+E++ + H++
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 374 LVSLVGYCIAGGQRMLVYEFVSN--------------KTLEYHLHGENRPVMDFATRVRI 419
+++L+G C G ++ E+ S Y+ + V
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 420 ALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM 479
A A+G+ YL + IHRD+ A N+L+ ++ +ADFGLA+ + +
Sbjct: 197 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK---- 249
Query: 480 GTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
T G L APE T +SDV+SFGV+L E+ T G P
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 71/282 (25%), Positives = 97/282 (34%), Gaps = 37/282 (13%)
Query: 241 HSHPQGPDHTGGNIPPPPGGNWPGPPPPPPMMSSSGEMSSQFSGPARPPLPPPSPNIALG 300
H H G D N+ P +S GE S P P P S
Sbjct: 5 HHHSSGVDLGTENLYFQSMH-----QLQPRRVSFRGEASETLQSPGYDPSRPES------ 53
Query: 301 FNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVK-SLKTGSGQGERE 358
F + +F LG G +G V K +G+ AVK S+ G +R
Sbjct: 54 FFQQSFQRLSR------------LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA 101
Query: 359 FS-AEVEIISRV-HHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATR 416
AEV +V H V L GG L E +L+ H + +
Sbjct: 102 RKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVW 160
Query: 417 VRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVS 475
+ LA+LH ++H D+K ANI + + DFGL L V
Sbjct: 161 -GYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV- 215
Query: 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
G Y+APE G +DVFS G+ +LE+
Sbjct: 216 --QEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 59/291 (20%), Positives = 111/291 (38%), Gaps = 49/291 (16%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE-FSAEVEIISRVHHRHLVSLVGY 380
LG+GGFG V + + A+K ++ + + RE EV+ ++++ H +V
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 381 CI---------AGGQRMLVY---EFVSNKTLEYHLHGENR-PVMDFATRVRIALGSAKGL 427
+ ++ +Y + + L+ ++G + + + I L A+ +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNH----------THVST 476
+LH ++HRD+K +NI + V DFGL + D T
Sbjct: 132 EFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLG 536
+GT Y++PE + K D+FS G++L EL+ P M +
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT------- 238
Query: 537 AALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587
+ + + P L P E + + S +RP+ I+
Sbjct: 239 -DVRNLKF-----PPLFTQKYPCEYVMVQDM----LSPSPMERPEAINIIE 279
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-31
Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 17/217 (7%)
Query: 315 TGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE-FSAEVEIISRVHHR 372
G + LG GGFGYV + + G++VA+K + RE + E++I+ +++H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 373 HLVSLV------GYCIAGGQRMLVYEFVSNKTLEYHLHG-ENRPVMDFATRVRIALGSAK 425
++VS +L E+ L +L+ EN + + +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAM---VADFGLAKLSNDNHTHVSTRVMGTF 482
L YLHE+ RIIHRD+K NI++ + + + D G AK + + V GT
Sbjct: 133 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTEFV-GTL 187
Query: 483 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVD 519
YLAPE K T D +SFG + E ITG RP
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 61/261 (23%), Positives = 108/261 (41%), Gaps = 28/261 (10%)
Query: 264 GPPPPPPMMSSSGEMSSQFSGPARPPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNL 323
GP P P + +++ + A PP + ++ + +
Sbjct: 1 GPAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSR------------RRYVRGRF 48
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSL---KTGSGQGEREFSAEVEIISRVHHRHLVSLVG 379
LG+GGF + + A K + + S E+ I + H+H+V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 380 YCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRI 438
+ + +V E ++L LH + + + R G YLH + R+
Sbjct: 109 F-FEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN---RV 162
Query: 439 IHRDIKAANILIDDNFEAMVADFGLA-KLSNDNHTHVSTRVM-GTFGYLAPEYASSGKLT 496
IHRD+K N+ ++++ E + DFGLA K+ D +V+ GT Y+APE S +
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGHS 219
Query: 497 EKSDVFSFGVMLLELITGRRP 517
+ DV+S G ++ L+ G+ P
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPP 240
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 50/216 (23%), Positives = 88/216 (40%), Gaps = 23/216 (10%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNGKEVAVK--SLKTGSGQGEREFSAEVEIISRV--HHRH 373
++ +G GG V + + + A+K +L+ Q + E+ ++++ H
Sbjct: 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED 433
++ L Y I +V E N L L + + + + +H+
Sbjct: 90 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQH 146
Query: 434 CHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTFGYLAPE---- 488
I+H D+K AN LI D + DFG+A + D + V +GT Y+ PE
Sbjct: 147 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 489 -------YASSGKLTEKSDVFSFGVMLLELITGRRP 517
S K++ KSDV+S G +L + G+ P
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 50/216 (23%), Positives = 88/216 (40%), Gaps = 23/216 (10%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNGKEVAVK--SLKTGSGQGEREFSAEVEIISRV--HHRH 373
++ +G GG V + + + A+K +L+ Q + E+ ++++ H
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED 433
++ L Y I +V E N L L + + + + +H+
Sbjct: 71 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQH 127
Query: 434 CHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTFGYLAPE---- 488
I+H D+K AN LI D + DFG+A + D + V +GT Y+ PE
Sbjct: 128 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 489 -------YASSGKLTEKSDVFSFGVMLLELITGRRP 517
S K++ KSDV+S G +L + G+ P
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 56/293 (19%), Positives = 99/293 (33%), Gaps = 43/293 (14%)
Query: 241 HSHPQGPDHTGGNIPPPPGGNWPGPPPPPPMMSSSGEMSSQFSGPARPPLPPPSPNIALG 300
H H G +P G S ++ + S N +
Sbjct: 1 HHHHHHS---SGLVPRGSGMKETAAAKFERQHMDSPDLGTD-----DDDKASSSANECIS 52
Query: 301 FNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVK--SLKTGSGQGERE 358
++ +G GG V + + + A+K +L+ Q
Sbjct: 53 VKGRIYS------------ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS 100
Query: 359 FSAEVEIISRVHH--RHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATR 416
+ E+ ++++ ++ L Y I +V E N L L +
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS 159
Query: 417 VRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVS 475
+ + + +H+ I+H D+K AN LI D + DFG+A + D + V
Sbjct: 160 YWKNM--LEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVK 213
Query: 476 TRVMGTFGYLAPE-----------YASSGKLTEKSDVFSFGVMLLELITGRRP 517
+G Y+ PE S K++ KSDV+S G +L + G+ P
Sbjct: 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-30
Identities = 41/203 (20%), Positives = 80/203 (39%), Gaps = 22/203 (10%)
Query: 323 LLGQGGFGYVHKGV--LPNGKEVAVKSLKTGSGQGERE-FSAEVEIISRVHHRHLVSLVG 379
+ GG G+++ + NG+ V +K L + AE + ++ V H +V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 380 YCIAGGQRM-----LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
+ + +V E+V ++L+ + + A + L L+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHSI- 201
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGK 494
+++ D+K NI++ + + + D G N + GT G+ APE
Sbjct: 202 --GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPEIVR-TG 252
Query: 495 LTEKSDVFSFGVMLLELITGRRP 517
T +D+++ G L L
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPT 275
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 50/214 (23%), Positives = 79/214 (36%), Gaps = 26/214 (12%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE-FSAEVEIISRVHHRHLVSLVGY 380
+LGQG V +G G A+K S + E E++ +++H+++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 381 CIAGGQRM--LVYEFVSNKTLEYHLHGENRPVM---DFATRVRIALGSAKGLAYLHEDCH 435
R L+ EF +L L + V + + +L E+
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG--MNHLREN-- 131
Query: 436 PRIIHRDIKAANILI----DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE--- 488
I+HR+IK NI+ D + DFG A+ D+ + GT YL P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYE 188
Query: 489 -----YASSGKLTEKSDVFSFGVMLLELITGRRP 517
K D++S GV TG P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 16/202 (7%)
Query: 322 NLLGQGGFGYVHKGV-LPNGKEVAVKSLK----TGSGQGEREFSAEVEIISRVHHRHLVS 376
LG+G FG V+ + +A+K L +G + EVEI S + H +++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73
Query: 377 LVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
L GY R+ L+ E+ T+ L ++ D A L+Y H
Sbjct: 74 LYGY-FHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSK-- 128
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL 495
R+IHRDIK N+L+ E +ADFG + + + + GT YL PE
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPEMIEGRMH 184
Query: 496 TEKSDVFSFGVMLLELITGRRP 517
EK D++S GV+ E + G+ P
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPP 206
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-30
Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 11/207 (5%)
Query: 316 GGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSL---KTGSGQGEREFSAEVEIISRVHH 371
F NLLG+G F V++ + G EVA+K + + EV+I ++ H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 372 RHLVSLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYL 430
++ L Y + LV E N + +L +P + R G+ YL
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYL 128
Query: 431 HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYA 490
H I+HRD+ +N+L+ N +ADFGLA H T + GT Y++PE A
Sbjct: 129 HSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIA 184
Query: 491 SSGKLTEKSDVFSFGVMLLELITGRRP 517
+ +SDV+S G M L+ GR P
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 50/213 (23%), Positives = 80/213 (37%), Gaps = 24/213 (11%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE-FSAEVEIISRVHHRHLVSLVGY 380
+LGQG V +G G A+K S + E E++ +++H+++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 381 CIAGGQRM--LVYEFVSNKTLEYHL--HGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
R L+ EF +L L + + + G+ +L E+
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLREN--- 131
Query: 437 RIIHRDIKAANILI----DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE---- 488
I+HR+IK NI+ D + DFG A+ D+ + GT YL P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYER 189
Query: 489 ----YASSGKLTEKSDVFSFGVMLLELITGRRP 517
K D++S GV TG P
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 57/201 (28%), Positives = 83/201 (41%), Gaps = 16/201 (7%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLK----TGSGQGEREFSAEVEIISRVHHRHLVSL 377
LG+G FG V+ N +A+K L G + E+EI S + H +++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRM 79
Query: 378 VGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
Y +R+ L+ EF L L R + L A L Y HE
Sbjct: 80 YNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA--LHYCHER--- 133
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLT 496
++IHRDIK N+L+ E +ADFG + + GT YL PE
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGKTHD 190
Query: 497 EKSDVFSFGVMLLELITGRRP 517
EK D++ GV+ E + G P
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPP 211
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 316 GGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSL---KTGSGQGEREFSAEVEIISRVHH 371
+ + LG+GGF + + A K + + S E+ I + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 372 RHLVSLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYL 430
+H+V G+ + +V E ++L LH + + + R G YL
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYL 131
Query: 431 HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA-KLSNDNHTHVSTRVM-GTFGYLAPE 488
H + R+IHRD+K N+ ++++ E + DFGLA K+ D +V+ GT Y+APE
Sbjct: 132 HRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPE 185
Query: 489 YASSGKLTEKSDVFSFGVMLLELITGRRPVD 519
S + + DV+S G ++ L+ G+ P +
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 9/202 (4%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE-FSAEVEIISRVHHRHLV 375
F K +G+G FG V KG+ K VA+K + + E E E+ ++S+ ++
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
G + + ++ E++ + L AT +R L KGL YLH +
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSE-- 138
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL 495
+ IHRDIKAAN+L+ ++ E +ADFG+A D +T +GT ++APE
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAY 196
Query: 496 TEKSDVFSFGVMLLELITGRRP 517
K+D++S G+ +EL G P
Sbjct: 197 DSKADIWSLGITAIELARGEPP 218
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 49/219 (22%), Positives = 95/219 (43%), Gaps = 25/219 (11%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGY 380
+L +GGF +V++ + +G+E A+K L + + R EV + ++ H ++V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 381 CIAGGQR--------MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHE 432
G + +L+ E + +E+ E+R + T ++I + + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 433 DCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM-----------GT 481
P IIHRD+K N+L+ + + DFG A + + + T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 482 FGYLAPE---YASSGKLTEKSDVFSFGVMLLELITGRRP 517
Y PE S+ + EK D+++ G +L L + P
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 16/201 (7%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGY 380
LG G +G V E A+K ++ S + EV ++ + H +++ L +
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 381 CIAGGQRMLVYEFVSNKTL-EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
LV E L + +H +D A ++ L G+ YLH+ I+
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS---GVTYLHKH---NIV 158
Query: 440 HRDIKAANILI---DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLT 496
HRD+K N+L+ + + + DFGL+ + + +GT Y+APE K
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPE-VLRKKYD 215
Query: 497 EKSDVFSFGVMLLELITGRRP 517
EK DV+S GV+L L+ G P
Sbjct: 216 EKCDVWSIGVILFILLAGYPP 236
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 59/258 (22%), Positives = 97/258 (37%), Gaps = 19/258 (7%)
Query: 268 PPPMMSSSGEMSSQFSGPARPPLPPPSPNIALGFNKSTFTYD-ELAAATGGFAKSNLLGQ 326
++S + S S + P N + + D E +G+
Sbjct: 9 QAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGR 68
Query: 327 GGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGG 385
G FG VH+ G + AVK ++ + E E+ + + +V L G G
Sbjct: 69 GSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVREGP 123
Query: 386 QRMLVYEFVSNKTLEYHL-HGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIK 444
+ E + +L + P + AL +GL YLH RI+H D+K
Sbjct: 124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL---EGLEYLHTR---RILHGDVK 177
Query: 445 AANILIDDN-FEAMVADFGLAKLSNDNHTHVSTR----VMGTFGYLAPEYASSGKLTEKS 499
A N+L+ + A + DFG A + S + GT ++APE K
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 237
Query: 500 DVFSFGVMLLELITGRRP 517
D++S M+L ++ G P
Sbjct: 238 DIWSSCCMMLHMLNGCHP 255
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-28
Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKT---GSGQGEREFSAEVEIISRVHHRHLVSLVG 379
LG+G FG V G+E AVK + + EV+++ ++ H +++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 380 YCIAGGQRMLVYEFVSNKTL-EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRI 438
+ G LV E + L + + + +D A +R L G+ Y+H++ +I
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS---GITYMHKN---KI 147
Query: 439 IHRDIKAANILI---DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL 495
+HRD+K N+L+ + + DFGL+ + +GT Y+APE G
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPE-VLHGTY 204
Query: 496 TEKSDVFSFGVMLLELITGRRP 517
EK DV+S GV+L L++G P
Sbjct: 205 DEKCDVWSTGVILYILLSGCPP 226
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 46/221 (20%), Positives = 90/221 (40%), Gaps = 35/221 (15%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSA-----------------EVEII 366
L QG F + + K A+K + + +R+F+ E++II
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 367 SRVHHRHLVSLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRV------RI 419
+ + + + ++ G I + ++YE++ N ++ ++ + I
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 420 ALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM 479
+Y+H I HRD+K +NIL+D N ++DFG ++ D S
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---R 211
Query: 480 GTFGYLAPEYASSGKLT---EKSDVFSFGVMLLELITGRRP 517
GT+ ++ PE S + + K D++S G+ L + P
Sbjct: 212 GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 68/297 (22%), Positives = 122/297 (41%), Gaps = 31/297 (10%)
Query: 239 NWHSHPQGPDHTGGNIPPPPGGNWPGPPPPPPMMSSSGEMSSQFSGPARPPLP---PPSP 295
+ H H G D N+ N G + + E+ S R P+ +
Sbjct: 4 HHHHHSSGVDLGTENLYFQSMKN-SGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSAL 62
Query: 296 NIALGFNKSTFTYDELAAATGGF------AKSNLLGQGGFGYVHKGV-LPNGKEVAVKSL 348
+ + + F + + A G +K+ +LG G FG VHK G ++A K +
Sbjct: 63 AVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKII 122
Query: 349 KTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTL------EYH 402
KT + + E E+ +++++ H +L+ L + +LV E+V L E +
Sbjct: 123 KTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY 182
Query: 403 LHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA--MVAD 460
E +D ++ G+ ++H+ I+H D+K NIL + + D
Sbjct: 183 NLTE----LDTILFMKQICE---GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIID 232
Query: 461 FGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
FGLA+ GT +LAPE + ++ +D++S GV+ L++G P
Sbjct: 233 FGLARRYKPREKL--KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 27/285 (9%), Positives = 55/285 (19%), Gaps = 55/285 (19%)
Query: 269 PPMMSSSGEMSSQFSGPARPPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGG 328
+ M + P + + L + E L G
Sbjct: 27 EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEP------------LRVGD 74
Query: 329 FGYVHKGV-LPNGKEVAVKSL---KTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC--- 381
V + ++ A+K S +R+
Sbjct: 75 RSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLL 134
Query: 382 -----------------------IAGGQRMLVYEFVSNKTLEY----HLHGENRPVMDFA 414
A +L+ S R
Sbjct: 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGIL 194
Query: 415 TRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474
+ + A L ++H N+ I + M+ D
Sbjct: 195 ALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---- 247
Query: 475 STRVMGTFGYLAPEYASSGKL--TEKSDVFSFGVMLLELITGRRP 517
Y E+ ++ T + + G+ + + P
Sbjct: 248 GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 50/218 (22%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
+LG G F V GK A+K +K + E+ ++ ++ H ++V+L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED-- 73
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFAT------RVRIALGS------------ 423
+YE ++ Y+L VM + R+ + G
Sbjct: 74 --------IYESTTH----YYL------VMQLVSGGELFDRI-LERGVYTEKDASLVIQQ 114
Query: 424 -AKGLAYLHEDCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKLSNDNHTHVSTRVM 479
+ YLHE+ I+HRD+K N+L ++N + M+ DFGL+K+ + ST
Sbjct: 115 VLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STAC- 168
Query: 480 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
GT GY+APE + ++ D +S GV+ L+ G P
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 49/219 (22%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVS 376
+ + +GQG G V+ + + G+EVA++ + + E+ ++ + ++V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 377 LVGYCIAGGQRMLVYEF---------VSNKTL-EYHLHGENRPVMDFATRVRIALGSAKG 426
+ + G + +V E+ V+ + E + A R L +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI----------AAVCRECL---QA 128
Query: 427 LAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGL-AKLSNDNHTHVSTRVMGTFGYL 485
L +LH + ++IHRDIK+ NIL+ + + DFG A+++ + + ++GT ++
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWM 183
Query: 486 APEYASSGKLTEKSDVFSFGVMLLELITGRRP-VDMTMM 523
APE + K D++S G+M +E+I G P ++ +
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-27
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGY 380
LG+G FG V K +E AVK + + EVE++ ++ H +++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 381 CIAGGQRMLVYEFVSNKTL-EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
+V E + L + + + D A ++ G+ Y+H+ I+
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS---GITYMHKH---NIV 143
Query: 440 HRDIKAANILI---DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLT 496
HRD+K NIL+ + + + + DFGL+ N +GT Y+APE G
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE-VLRGTYD 200
Query: 497 EKSDVFSFGVMLLELITGRRP 517
EK DV+S GV+L L++G P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVS 376
+G+G G V +G++VAVK + Q EV I+ H ++V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 377 LVGYCIAGGQRMLVYEF---------VSNKTL-EYHLHGENRPVMDFATRVRIALGSAKG 426
+ + G + ++ EF VS L E + AT L +
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI----------ATVCEAVL---QA 153
Query: 427 LAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGL-AKLSNDNHTHVSTRVMGTFGYL 485
LAYLH +IHRDIK+ +IL+ + ++DFG A++S D S ++GT ++
Sbjct: 154 LAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWM 208
Query: 486 APEYASSGKLTEKSDVFSFGVMLLELITGRRP-VDMTMM 523
APE S + D++S G+M++E++ G P + +
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV 247
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 43/232 (18%), Positives = 76/232 (32%), Gaps = 46/232 (19%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVK-SLKTGSGQGEREFS-AEVEIISRV-HHRH 373
F + +G G FG V K V +G A+K S K +G + + + EV + + H H
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHL--HGENRPVMDFATRVRIALGSAKGLAYLH 431
+V ++ E+ + +L + + A + L +GL Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAMV-------------------ADFGLAKLSNDNHT 472
++H DIK +NI I D G +
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 473 HVSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELITGRRP 517
G +LA E + K+D+F+ + ++
Sbjct: 190 EE-----GDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAEPL 230
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVS 376
+ LG G FG V+K G A K ++T S + ++ E+EI++ H ++V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDF--ATRVRIALGSAKGLAYLHEDC 434
L+G G+ ++ EF ++ + +R + + R L + L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---EALNFLHSK- 136
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGL-AKLSNDNHTHVSTRVMGTFGYLAPEYASSG 493
RIIHRD+KA N+L+ + +ADFG+ AK S +GT ++APE
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCE 192
Query: 494 KLTE-----KSDVFSFGVMLLELITGRRP-VDMTMM 523
+ + K+D++S G+ L+E+ P ++ M
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 228
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-26
Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 27/214 (12%)
Query: 322 NLLGQGGFGYVHKGV-LPNGKEVAVKSLK-------------TGSGQGEREFSAEVEIIS 367
LG G +G V E A+K +K + E E+ ++
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 368 RVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTL-EYHLHGENRPVMDFATRVRIALGSAKG 426
+ H +++ L LV EF L E ++ D A ++ L G
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS---G 158
Query: 427 LAYLHEDCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFG 483
+ YLH+ I+HRDIK NIL+ + + DFGL+ + ++ +GT
Sbjct: 159 ICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAY 213
Query: 484 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
Y+APE K EK DV+S GV++ L+ G P
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 52/212 (24%), Positives = 85/212 (40%), Gaps = 21/212 (9%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVS 376
F ++LG G G + + + ++VAVK + + EV+++ H +++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIR 82
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEY-HLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
+ + E + EY ++ T ++ GLA+LH
Sbjct: 83 YFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTT---SGLAHLHSL-- 137
Query: 436 PRIIHRDIKAANILIDDNFE-----AMVADFGLAKLSNDNHTHVSTR--VMGTFGYLAPE 488
I+HRD+K NILI AM++DFGL K S R V GT G++APE
Sbjct: 138 -NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 489 Y---ASSGKLTEKSDVFSFGVMLLELITGRRP 517
T D+FS G + +I+
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 54/198 (27%), Positives = 96/198 (48%), Gaps = 13/198 (6%)
Query: 324 LGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREF-SAEVEIISRVHHRHLVSLVGYC 381
LG G G V K P+G +A K + R E++++ + ++V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENR-PVMDFATRVRIALGSAKGLAYLHEDCHPRIIH 440
+ G+ + E + +L+ L R P ++++ KGL YL E I+H
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKGLTYLREKHK--IMH 155
Query: 441 RDIKAANILIDDNFEAMVADFGLA-KLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKS 499
RD+K +NIL++ E + DFG++ +L + + ++ V GT Y++PE + +S
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFV-GTRSYMSPERLQGTHYSVQS 211
Query: 500 DVFSFGVMLLELITGRRP 517
D++S G+ L+E+ GR P
Sbjct: 212 DIWSMGLSLVEMAVGRYP 229
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE-FSAEVEIISRVHHRHLV 375
+ ++G G V P ++VA+K + Q + E++ +S+ HH ++V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 376 SLVGYCIAGGQRMLVYEF-----VSNKTLEYHLHGENRP-VMD---FATRVRIALGSAKG 426
S + + LV + V + GE++ V+D AT +R L +G
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL---EG 133
Query: 427 LAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTF-G-- 483
L YLH++ IHRD+KA NIL+ ++ +ADFG++ +V TF G
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 484 -YLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRP 517
++APE + K+D++SFG+ +EL TG P
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 16/204 (7%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLK-TGSGQGEREFSAEVEIISR-VHHRHLVSLVGY 380
LG+G +G V K +P+G+ +AVK ++ T + Q ++ +++I R V V+ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 381 CIAGGQRMLVYEFV--SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRI 438
G + E + S + + + + + +IA+ K L +LH +
Sbjct: 75 LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG-KIAVSIVKALEHLHSKLS--V 131
Query: 439 IHRDIKAANILIDDNFEAMVADFGL-AKLSNDNHTHVSTRVMGTFGYLAPE----YASSG 493
IHRD+K +N+LI+ + + DFG+ L + G Y+APE +
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVD---DVAKDIDAGCKPYMAPERINPELNQK 188
Query: 494 KLTEKSDVFSFGVMLLELITGRRP 517
+ KSD++S G+ ++EL R P
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFP 212
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE-FSAEVEIISR-VHHRHLVSLVGY 380
+G+G +G V+K V P+G+ +AVK +++ + E++ +++++ R ++V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 381 CIAGGQRMLVYEFV---SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
G + E + +K +Y + + + +I L + K L +L E+
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-KITLATVKALNHLKENLK-- 146
Query: 438 IIHRDIKAANILIDDNFEAMVADFGL-AKLSNDNHTHVSTRVMGTFGYLAPE----YASS 492
IIHRDIK +NIL+D + + DFG+ +L + + TR G Y+APE AS
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSASR 203
Query: 493 GKLTEKSDVFSFGVMLLELITGRRP 517
+SDV+S G+ L EL TGR P
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFP 228
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVS 376
F LG+G +G V+K + G+ VA+K + +E E+ I+ + H+V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDF--ATRVRIALGSAKGLAYLHEDC 434
G +V E+ ++ + N+ + + AT ++ L KGL YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL---KGLEYLHFM- 144
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGK 494
R IHRDIKA NIL++ A +ADFG+A D +T + GT ++APE
Sbjct: 145 --RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIG 201
Query: 495 LTEKSDVFSFGVMLLELITGRRP-VDMTMM 523
+D++S G+ +E+ G+ P D+ M
Sbjct: 202 YNCVADIWSLGITAIEMAEGKPPYADIHPM 231
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-26
Identities = 52/230 (22%), Positives = 90/230 (39%), Gaps = 37/230 (16%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVS 376
+LG G G V G+ VAVK + E+++++ H +++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73
Query: 377 LVGYCIAGGQRMLVYEFVSNKTL-----EYHLHGENRPVMDFATRVRIALGSAKGLAYLH 431
+ E N L ++ EN + + + A G+A+LH
Sbjct: 74 YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 432 EDCHPRIIHRDIKAANILID-------------DNFEAMVADFGLAKLSNDNHTHVSTRV 478
+IIHRD+K NIL+ +N +++DFGL K + + T +
Sbjct: 133 SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 479 M---GTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
GT G+ APE + +LT D+FS G + +++ G+ P
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 34/301 (11%), Positives = 72/301 (23%), Gaps = 66/301 (21%)
Query: 263 PGPPPPPPMMSSSGEMSSQFSGPARPPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSN 322
P S S P LG T +
Sbjct: 32 PQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTV----------- 80
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE----------------------- 358
LGQ + G+ V
Sbjct: 81 -LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 359 -----FSAEVEIISRVHHRHLVSLVGYC--IAGGQRMLVYEFVSNKTLEY----HLHGEN 407
F +++ + ++ + + R +Y + + + H
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 408 RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467
+ R+++ L + LA LH H ++H ++ +I++D + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 468 NDNHTHVSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVMLLELITGRR 516
+ G+ PE + +T D ++ G+++ +
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 517 P 517
P
Sbjct: 312 P 312
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLV 375
+LG+GGFG V K GK A K L +G + E +I+++VH R +V
Sbjct: 192 VLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIV 248
Query: 376 SLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFA-TRVR-----IALGSAKGLA 428
SL Y + LV ++ + YH++ + F R I G L
Sbjct: 249 SLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LE 303
Query: 429 YLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE 488
+LH+ II+RD+K N+L+DD+ ++D GLA T GT G++APE
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE 359
Query: 489 YASSGKLTEKSDVFSFGVMLLELITGRRP 517
+ D F+ GV L E+I R P
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 46/227 (20%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLV 375
F L+G G +G V+KG + G+ A+K + +G E E E+ ++ + HHR++
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 376 SLVG-------------------YCIAGGQRMLVYEFVSNKTL-EYHLHGENRPVMDFAT 415
+ G +C G + + TL E + A
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFC-GAGSVTDLIKNTKGNTLKEEWI----------AY 133
Query: 416 RVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475
R L +GL++LH+ ++IHRDIK N+L+ +N E + DFG++ + +
Sbjct: 134 ICREIL---RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 187
Query: 476 TRVMGTFGYLAPEYASSGKLTE-----KSDVFSFGVMLLELITGRRP 517
T +GT ++APE + + + KSD++S G+ +E+ G P
Sbjct: 188 T-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 5e-25
Identities = 40/329 (12%), Positives = 77/329 (23%), Gaps = 63/329 (19%)
Query: 237 HQNWHSHPQGPDHTGGNIPPPPG--------GNWPGPPPPPPMMSSSGEMSSQFSGPARP 288
H + HS + + G PG P S S
Sbjct: 3 HHHHHSSGRENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWN 62
Query: 289 PLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKS 347
P LG T + LGQ + G+ V
Sbjct: 63 TGQPFRVESELGERPRTLVRGTV------------LGQEDPYAYLEATDQETGESFEVHV 110
Query: 348 LKTGSGQGE---REFSAEVEIISR----------------------VHHRHLVSLVGYCI 382
++ EV + V ++ +
Sbjct: 111 PYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRL 170
Query: 383 AGGQRMLVYEFVSNKTLEYHL---------HGENRPVMDFATRVRIALGSAKGLAYLHED 433
++ F ++ +L H + R+++ L + LA LH
Sbjct: 171 DERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 230
Query: 434 CHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE----- 488
++H ++ +I++D + F + R A
Sbjct: 231 ---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFG 287
Query: 489 YASSGKLTEKSDVFSFGVMLLELITGRRP 517
+T D ++ G+ + + P
Sbjct: 288 QHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFS---AEVEIISRVHHRH 373
F+ +G G FG V+ + N + VA+K + Q ++ EV + ++ H +
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLE-YHLHGENRPVMDFATRVRIALGSAKGLAYLHE 432
+ G + LV E+ + +H + ++ A AL +GLAYLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHS 172
Query: 433 DCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS 492
+IHRD+KA NIL+ + + DFG A + ++ +GT ++APE +
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVILA 224
Query: 493 GKLTE---KSDVFSFGVMLLELITGRRP-VDMTMM 523
+ K DV+S G+ +EL + P +M M
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 259
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI 382
LG G FG VH+ V G+ K + T + E+ I++++HH L++L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 383 AGGQRMLVYEFVSNKTL------EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
+ +L+ EF+S L E + E + +R A GL ++HE
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSE----AEVINYMRQACE---GLKHMHEH--- 168
Query: 437 RIIHRDIKAANILIDDNFEA--MVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGK 494
I+H DIK NI+ + + + DFGLA N + + T + APE
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREP 226
Query: 495 LTEKSDVFSFGVMLLELITGRRP 517
+ +D+++ GV+ L++G P
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 39/220 (17%), Positives = 70/220 (31%), Gaps = 30/220 (13%)
Query: 322 NLLGQGGFGYVHKGV------LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLV 375
+LLG+G F V++ N ++ +K K + + +E + +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTLEYHL---HGENRPVMDFATRVRIALGSAKGLAYLHE 432
+ +LV E S TL + VM + A+ + +H+
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 433 DCHPRIIHRDIKAANILIDDNFEA-----------MVADFGLAKLSNDNHTHVSTRVM-- 479
IIH DIK N ++ + F + D G S D +
Sbjct: 191 C---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG---QSIDMKLFPKGTIFTA 244
Query: 480 --GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
T G+ E S+ + D F + ++ G
Sbjct: 245 KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLV 375
+LG+GGFG V + GK A K L+ +GE E +I+ +V+ R +V
Sbjct: 191 VLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVV 247
Query: 376 SLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVR-----IALGSAKGLAY 429
SL Y + LV ++ L++H++ + A R I G L
Sbjct: 248 SLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA-RAVFYAAEICCG----LED 301
Query: 430 LHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEY 489
LH + RI++RD+K NIL+DD+ ++D GLA + T + RV GT GY+APE
Sbjct: 302 LHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEV 356
Query: 490 ASSGKLTEKSDVFSFGVMLLELITGRRP 517
+ + T D ++ G +L E+I G+ P
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 42/216 (19%), Positives = 82/216 (37%), Gaps = 22/216 (10%)
Query: 318 FAKSNLLGQG--GFGYVHKGV-LPNGKEVAVK--SLKTGSGQGEREFSAEVEIISRVHHR 372
+ ++G+G V+ P G+ V V+ +L+ S + E+ + +H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 373 HLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMD---FATRVRIALGSAKGLAY 429
++V IA + +V F++ + + + M+ A ++ L K L Y
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL---KALDY 143
Query: 430 LHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM------GTFG 483
+H +HR +KA++ILI + + ++ +
Sbjct: 144 IHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 484 YLAPEYASSGKL--TEKSDVFSFGVMLLELITGRRP 517
+L+PE KSD++S G+ EL G P
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE-FSAEVEIISRVHHRHLVSLVGYC 381
LG G FG VH +G E +K++ Q E AE+E++ + H +++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 382 IAGGQRMLVYEFVS-----NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
+V E + + G+ A ++ + LAY H
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN---ALAYFHSQ--- 143
Query: 437 RIIHRDIKAANILI---DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSG 493
++H+D+K NIL + + DFGLA+L + + GT Y+APE
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-TNAA-GTALYMAPEVF-KR 200
Query: 494 KLTEKSDVFSFGVMLLELITGRRP 517
+T K D++S GV++ L+TG P
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-24
Identities = 55/280 (19%), Positives = 95/280 (33%), Gaps = 27/280 (9%)
Query: 252 GNIPPPPGGNWPGPPPPPPMMSSSGEMSSQFSGPARPPLPPPSPNIALGFNKSTFTYDEL 311
G P P ++ Q + + + + +
Sbjct: 89 GQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPV 148
Query: 312 AAATGGFAK----SNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEII 366
LG G FG VH+ G A K + T + E++ +
Sbjct: 149 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTM 208
Query: 367 SRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTL-------EYHLHGENRPVMDFATRVRI 419
S + H LV+L + +++YEF+S L + E+ + +R
Sbjct: 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS-ED----EAVEYMRQ 263
Query: 420 ALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA--MVADFGLAKLSNDNHTHVSTR 477
KGL ++HE+ +H D+K NI+ + DFGL +
Sbjct: 264 VC---KGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKV 315
Query: 478 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
GT + APE A + +D++S GV+ L++G P
Sbjct: 316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 46/248 (18%), Positives = 88/248 (35%), Gaps = 35/248 (14%)
Query: 352 SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTL-EYHLHGENRPV 410
S S ++ + ++ V + + + + L ++ +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 411 MDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK----- 465
+ + I + A+ + +LH ++HRD+K +NI + V DFGL
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 466 ------LSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVD 519
L+ T +GT Y++PE + K D+FS G++L EL+
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS--- 274
Query: 520 MTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKR 579
T ME R + + + + P L P E + + S +R
Sbjct: 275 -TQME-------RVRIITDVRNLKF-----PLLFTQKYPQEHMMVQDM----LSPSPTER 317
Query: 580 PKMSQIVR 587
P+ + I+
Sbjct: 318 PEATDIIE 325
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 49/217 (22%), Positives = 80/217 (36%), Gaps = 50/217 (23%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI 382
+G+G +G V V A K + + F E+EI+ + H +++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE--- 73
Query: 383 AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFAT------RVRIALGS------------- 423
+E ++ +L VM+ T RV +
Sbjct: 74 -------TFEDNTD----IYL------VMELCTGGELFERV-VHKRVFRESDAARIMKDV 115
Query: 424 AKGLAYLHEDCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKLSNDNHTHVSTRVMG 480
+AY H+ + HRD+K N L + + DFGLA T+V G
Sbjct: 116 LSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-RTKV-G 170
Query: 481 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
T Y++P+ G + D +S GVM+ L+ G P
Sbjct: 171 TPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 50/208 (24%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKS-----LKTGSGQGEREFSAEVEIISRVHHRHLVSL 377
+G+G F V + + G++ AVK + G + E I + H H+V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDF-----ATRVRIALGSAKGLAYLHE 432
+ + G +V+EF+ L + + + + +R L + L Y H+
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL---EALRYCHD 148
Query: 433 DCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEY 489
+ IIHRD+K +L+ +++ + FG+A ++ RV GT ++APE
Sbjct: 149 N---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEV 204
Query: 490 ASSGKLTEKSDVFSFGVMLLELITGRRP 517
+ DV+ GV+L L++G P
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 47/242 (19%), Positives = 78/242 (32%), Gaps = 48/242 (19%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKS-----LKTGSGQGEREFSAEVEIISRVHHRHLVSL 377
+GQG +G V + A+K ++ + + EV ++ ++HH ++ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 378 VGY------------CIAGG-------QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVR 418
GG + + + A
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 419 IALGSAKGLAYLHED---------------CHPR-IIHRDIKAANILI--DDNFEAMVAD 460
I E H + I HRDIK N L + +FE + D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 461 FGLAKLSNDNHTHVSTRVM---GTFGYLAPE--YASSGKLTEKSDVFSFGVMLLELITGR 515
FGL+K + + GT ++APE ++ K D +S GV+L L+ G
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 516 RP 517
P
Sbjct: 274 VP 275
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 63/319 (19%), Positives = 119/319 (37%), Gaps = 44/319 (13%)
Query: 227 HAPNWHGHPEHQNWHSHPQGPDHTGGNIPPPPGGNWPGP---PPPPPMMSSSGEMSSQFS 283
H + H ++ + ++P P S++ ++
Sbjct: 2 HHHHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKL 61
Query: 284 GPARPPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGV-LPNGKE 342
A+P ++G + + +++G+G V + V G E
Sbjct: 62 NDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHE 121
Query: 343 VAVKS-----LKTGSGQGEREFSA---EVEIISRVH-HRHLVSLVGYCIAGGQRMLVYEF 393
AVK + Q E A E I+ +V H H+++L+ + LV++
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181
Query: 394 VSNKTLEYHLHGE--NRPVM-------DFATRVRIALGSAKGLAYLHEDCHPRIIHRDIK 444
+ GE + + + +R L + +++LH + I+HRD+K
Sbjct: 182 MRK--------GELFDYLTEKVALSEKETRSIMRSLL---EAVSFLHAN---NIVHRDLK 227
Query: 445 AANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE------YASSGKLTEK 498
NIL+DDN + ++DFG + + GT GYLAPE + ++
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGYLAPEILKCSMDETHPGYGKE 285
Query: 499 SDVFSFGVMLLELITGRRP 517
D+++ GV+L L+ G P
Sbjct: 286 VDLWACGVILFTLLAGSPP 304
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 52/219 (23%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE--FSAEVEIISRVHHRHLVSLVGY 380
LG+G FG V K +E AVK + S + + EVE++ ++ H +++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE- 88
Query: 381 CIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFAT------RVRIALGS----------- 423
+ E S+ +++ V + T + I
Sbjct: 89 ---------ILEDSSS----FYI------VGELYTGGELFDEI-IKRKRFSEHDAARIIK 128
Query: 424 --AKGLAYLHEDCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKLSNDNHTHVSTRV 478
G+ Y+H+ I+HRD+K NIL+ + + + + DFGL+ N R+
Sbjct: 129 QVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRI 184
Query: 479 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
GT Y+APE G EK DV+S GV+L L++G P
Sbjct: 185 -GTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 45/204 (22%), Positives = 86/204 (42%), Gaps = 24/204 (11%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI 382
LG+G FG VH+ V + K K +K G + E+ I++ HR+++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 383 AGGQRMLVYEFVSNKTL-------EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
+ + ++++EF+S + + L+ E + + V + L +LH
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELN-ER----EIVSYVHQVC---EALQFLHSH-- 121
Query: 436 PRIIHRDIKAANILIDDNFEA--MVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSG 493
I H DI+ NI+ + + +FG A+ + Y APE
Sbjct: 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHD 178
Query: 494 KLTEKSDVFSFGVMLLELITGRRP 517
++ +D++S G ++ L++G P
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINP 202
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 34/212 (16%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLKTG---SGQGEREFSAEVEIISRVH---HR 372
++G+GGFG V GK A+K L QGE E ++S V
Sbjct: 196 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 252
Query: 373 HLVSLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVR-----IALGSAKG 426
+V + Y ++ + + ++ L YHL +R I LG
Sbjct: 253 FIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILG---- 304
Query: 427 LAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLA 486
L ++H +++RD+K ANIL+D++ ++D GLA + H V GT GY+A
Sbjct: 305 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMA 358
Query: 487 PEYASSGKLTEKS-DVFSFGVMLLELITGRRP 517
PE G + S D FS G ML +L+ G P
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 59/303 (19%), Positives = 100/303 (33%), Gaps = 78/303 (25%)
Query: 238 QNWHSHPQGPDHTGGNIPPPPGGNWPGPPPPPPMMSSSGEMSSQFSGPARPPLPPPSPNI 297
+ H H G D N+ + P P +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLV----------PDYWIDGSNRDAL 51
Query: 298 ALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGE 356
F + LG+G V++ K A+K LK +
Sbjct: 52 -----SDFFEVESE------------LGRGATSIVYRCKQKGTQKPYALKVLKKT--VDK 92
Query: 357 REFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFAT- 415
+ E+ ++ R+ H +++ L ++E + L V++ T
Sbjct: 93 KIVRTEIGVLLRLSHPNIIKLKE----------IFETPTE----ISL------VLELVTG 132
Query: 416 -----RVRIALGS-------------AKGLAYLHEDCHPRIIHRDIKAANILI---DDNF 454
R+ + G + +AYLHE+ I+HRD+K N+L +
Sbjct: 133 GELFDRI-VEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDA 188
Query: 455 EAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG 514
+ADFGL+K+ V GT GY APE + D++S G++ L+ G
Sbjct: 189 PLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
Query: 515 RRP 517
P
Sbjct: 247 FEP 249
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 49/204 (24%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE-FSAEVEIISR-VHHRHLVSLVGY 380
+G G G V K G +AVK ++ + E + +++++ + ++V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 381 CIAGGQRMLVYEFVSNKTLE-YHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
I + E + + P ++ + K L YL E +I
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG---KMTVAIVKALYYLKEKHG--VI 147
Query: 440 HRDIKAANILIDDNFEAMVADFGL-AKLSNDNHTHVSTRVMGTFGYLAPE-----YASSG 493
HRD+K +NIL+D+ + + DFG+ +L + R G Y+APE +
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVD---DKAKDRSAGCAAYMAPERIDPPDPTKP 204
Query: 494 KLTEKSDVFSFGVMLLELITGRRP 517
++DV+S G+ L+EL TG+ P
Sbjct: 205 DYDIRADVWSLGISLVELATGQFP 228
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-23
Identities = 46/219 (21%), Positives = 81/219 (36%), Gaps = 50/219 (22%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSL--KTGSGQGEREFSAEVEIISRVHHRHLVSLVGY 380
LG+G F V + V + G+E A + K S + ++ E I + H ++V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 77
Query: 381 CIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFAT------RVRIALGS----------- 423
+ ++L + D T + +A
Sbjct: 78 ---------SISEEGH----HYL------IFDLVTGGELFEDI-VAREYYSEADASHCIQ 117
Query: 424 --AKGLAYLHEDCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKLSNDNHTHVSTRV 478
+ + + H+ ++HR++K N+L+ +ADFGLA
Sbjct: 118 QILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 174
Query: 479 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
GT GYL+PE + D+++ GV+L L+ G P
Sbjct: 175 -GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 31/209 (14%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKT--GSGQGEREFSAEVEIISRVHHRHLVSLVGY 380
LG+G F V + V G E A K + T S + ++ E I ++ H ++V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 381 CIAGGQRMLVYEFVSNKTLEYHLHGE--NRPVM-------DFATRVRIALGSAKGLAYLH 431
LV++ V+ GE V D + ++ L + +AY H
Sbjct: 74 IQEESFHYLVFDLVTG--------GELFEDIVAREFYSEADASHCIQQIL---ESIAYCH 122
Query: 432 EDCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE 488
+ I+HR++K N+L+ +ADFGLA ND+ GT GYL+PE
Sbjct: 123 SN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GTPGYLSPE 177
Query: 489 YASSGKLTEKSDVFSFGVMLLELITGRRP 517
++ D+++ GV+L L+ G P
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 42/220 (19%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQG---------EREFSAEVEIISRV-HHR 372
LG+G V + + P KE AVK + G EV+I+ +V H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 373 HLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGE--NRPVM-------DFATRVRIALGS 423
+++ L LV++ + GE + + +R L
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKK--------GELFDYLTEKVTLSEKETRKIMRALL-- 134
Query: 424 AKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFG 483
+ + LH+ I+HRD+K NIL+DD+ + DFG + + + GT
Sbjct: 135 -EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC-GTPS 188
Query: 484 YLAPE------YASSGKLTEKSDVFSFGVMLLELITGRRP 517
YLAPE + ++ D++S GV++ L+ G P
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 36/214 (16%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSA------EVEIISRVHHRHLVS 376
LG G F V K GKE A K +K R + EV I+ + H ++++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHGE--NRPV-------MDFATRVRIALGSAKGL 427
L +L+ E VS GE + + ++ L G+
Sbjct: 73 LHDIFENKTDVVLILELVSG--------GELFDFLAEKESLTEDEATQFLKQILD---GV 121
Query: 428 AYLHEDCHPRIIHRDIKAANILI----DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFG 483
YLH RI H D+K NI++ N + DFG+A + + GT
Sbjct: 122 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPE 176
Query: 484 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
++APE + L ++D++S GV+ L++G P
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 53/266 (19%), Positives = 94/266 (35%), Gaps = 71/266 (26%)
Query: 296 NIALG------FNKSTFTYDELAAATGGFAK----SNLLGQGGFGYVHKGV-LPNGKEVA 344
IAL F T D+ + S LG G G V K+VA
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVA 164
Query: 345 VKSLKT--------GSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396
++ + E+EI+ +++H ++ + ++
Sbjct: 165 IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN----------FFD---- 210
Query: 397 KTLEYHLHGENRPVMDFAT------RVRIALGS-------------AKGLAYLHEDCHPR 437
+Y++ V++ +V + + YLHE+
Sbjct: 211 -AEDYYI------VLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHEN---G 259
Query: 438 IIHRDIKAANILI---DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE---YAS 491
IIHRD+K N+L+ +++ + DFG +K+ + + T GT YLAPE
Sbjct: 260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-GTPTYLAPEVLVSVG 317
Query: 492 SGKLTEKSDVFSFGVMLLELITGRRP 517
+ D +S GV+L ++G P
Sbjct: 318 TAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 36/214 (16%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSA------EVEIISRVHHRHLVS 376
LG G F V K G E A K +K + R + EV I+ +V H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHGE--NRPVMDF-------ATRVRIALGSAKGL 427
L +L+ E VS GE + + ++ L G+
Sbjct: 80 LHDVYENRTDVVLILELVSG--------GELFDFLAQKESLSEEEATSFIKQILD---GV 128
Query: 428 AYLHEDCHPRIIHRDIKAANILI----DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFG 483
YLH +I H D+K NI++ + DFGLA D + GT
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPE 183
Query: 484 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
++APE + L ++D++S GV+ L++G P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 52/224 (23%), Positives = 86/224 (38%), Gaps = 56/224 (25%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSA------EVEIISRVHHRHLVS 376
LG G F V K G + A K +K + R + EV I+ + H ++++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFAT------RVRIALGS------- 423
L VYE NKT + L +++ + S
Sbjct: 79 LHE----------VYE---NKT-DVIL------ILELVAGGELFDFL-AEKESLTEEEAT 117
Query: 424 ------AKGLAYLHEDCHPRIIHRDIKAANILI----DDNFEAMVADFGLAKLSNDNHTH 473
G+ YLH +I H D+K NI++ + DFGLA + +
Sbjct: 118 EFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
+ GT ++APE + L ++D++S GV+ L++G P
Sbjct: 175 --KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 36/214 (16%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSA------EVEIISRVHHRHLVS 376
LG G F V K G E A K +K + R EV I+ +V H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHGE--NRPV-------MDFATRVRIALGSAKGL 427
L +L+ E VS GE + + + ++ L G+
Sbjct: 80 LHDVYENRTDVVLILELVSG--------GELFDFLAQKESLSEEEATSFIKQILD---GV 128
Query: 428 AYLHEDCHPRIIHRDIKAANILI----DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFG 483
YLH +I H D+K NI++ + DFGLA D + GT
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPE 183
Query: 484 YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
++APE + L ++D++S GV+ L++G P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 48/228 (21%), Positives = 88/228 (38%), Gaps = 61/228 (26%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLK----TGSGQGEREFSA----EVEIISRVHHRHL 374
LG G G V K+VA+K + E + + E+EI+ +++H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFAT------RVRIALGS----- 423
+ + ++ +Y++ V++ +V +
Sbjct: 78 IKIKN----------FFD-----AEDYYI------VLELMEGGELFDKV-VGNKRLKEAT 115
Query: 424 --------AKGLAYLHEDCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKLSNDNHT 472
+ YLHE+ IIHRD+K N+L+ +++ + DFG +K+ +
Sbjct: 116 CKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 473 HVSTRVMGTFGYLAPE---YASSGKLTEKSDVFSFGVMLLELITGRRP 517
+ T GT YLAPE + D +S GV+L ++G P
Sbjct: 173 -MRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 31/209 (14%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKT--GSGQGEREFSAEVEIISRVHHRHLVSLVGY 380
LG+G F V + V G E A K + T S + ++ E I ++ H ++V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 381 CIAGGQRMLVYEFVSNKTLEYHLHGE--NRPV-------MDFATRVRIALGSAKGLAYLH 431
LV++ V+ GE V D + ++ L + +AY H
Sbjct: 97 IQEESFHYLVFDLVTG--------GELFEDIVAREFYSEADASHCIQQIL---ESIAYCH 145
Query: 432 EDCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE 488
+ I+HR++K N+L+ +ADFGLA ND+ GT GYL+PE
Sbjct: 146 SN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GTPGYLSPE 200
Query: 489 YASSGKLTEKSDVFSFGVMLLELITGRRP 517
++ D+++ GV+L L+ G P
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 9e-22
Identities = 63/210 (30%), Positives = 90/210 (42%), Gaps = 30/210 (14%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLKTGSGQGEREFS---AEVEIISRVHHRHLV 375
+G+G FG V K A+K + E E++I+ + H LV
Sbjct: 22 AIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 376 SLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFA-TRVR--IA-LGSAKGLAYL 430
+L Y + M +V + + L YHL F V+ I L A L YL
Sbjct: 79 NLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVH----FKEETVKLFICELVMA--LDYL 131
Query: 431 HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYA 490
RIIHRD+K NIL+D++ + DF +A + + + GT Y+APE
Sbjct: 132 QNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMF 186
Query: 491 SSGKLTE--KS-DVFSFGVMLLELITGRRP 517
SS K + D +S GV EL+ GRRP
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 1e-21
Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE---FSA--EVEIISRVHH 371
+ K +G+G +G V K + VA+K ++ + E SA E+ ++ + H
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKH 60
Query: 372 RHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLH 431
+++V L + + LV+EF + L+ + N +D KGL + H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCH 118
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE--- 488
++HRD+K N+LI+ N E +A+FGLA+ S V+ T Y P+
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 174
Query: 489 ----YASSGKLTEKSDVFSFGVMLLELITGRRP 517
Y++S D++S G + EL RP
Sbjct: 175 GAKLYSTS------IDMWSAGCIFAELANAGRP 201
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 52/242 (21%), Positives = 91/242 (37%), Gaps = 65/242 (26%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVK------------SLKTGSGQGEREFSA-------- 361
+G+G +G V + A+K + +G R
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 362 ------EVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKT-------LEYHLHGENR 408
E+ I+ ++ H ++V L E + + E G
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL-------------VEVLDDPNEDHLYMVFELVNQGP-- 124
Query: 409 PVMDFATRVRIALGSAK--------GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVAD 460
VM+ T ++ A+ G+ YLH +IIHRDIK +N+L+ ++ +AD
Sbjct: 125 -VMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 461 FGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLT---EKSDVFSFGVMLLELITGRRP 517
FG++ + +S V GT ++APE S + + DV++ GV L + G+ P
Sbjct: 181 FGVSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
Query: 518 VD 519
Sbjct: 240 FM 241
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 48/212 (22%), Positives = 89/212 (41%), Gaps = 34/212 (16%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKT--GSGQGEREFSAEVEIISRV-HHRHLVSLVG 379
LG+G F V + + G+E A K LK E E+ ++ +++L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGE--NRPVMDFATR---------VRIALGSAKGLA 428
+ +L+ E+ + GE + + + A ++ L G+
Sbjct: 97 VYENTSEIILILEYAA--------GGEIFSLCLPELAEMVSENDVIRLIKQILE---GVY 145
Query: 429 YLHEDCHPRIIHRDIKAANILIDDNFEA---MVADFGLAKLSNDNHTHVSTRVMGTFGYL 485
YLH++ I+H D+K NIL+ + + DFG+++ +MGT YL
Sbjct: 146 YLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYL 200
Query: 486 APEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
APE + +T +D+++ G++ L+T P
Sbjct: 201 APEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 57/222 (25%), Positives = 82/222 (36%), Gaps = 48/222 (21%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSL---KTGSGQGEREFSA-----EVEIISRVHHRHL 374
LG G FG+V V KEV VK + K + E+ I+SRV H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKT-----LEYHLHG-------ENRPVMDFATRVRIALG 422
+ + + N+ +E H G + P +D I
Sbjct: 92 IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 423 SAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN---HTHVSTRVM 479
+ YL IIHRDIK NI+I ++F + DFG A +T
Sbjct: 139 LVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC----- 190
Query: 480 GTFGYLAPEYASSGKLTE--KSDVFSFGVMLLELITGRRPVD 519
GT Y APE G + +++S GV L L+ P
Sbjct: 191 GTIEYCAPEVL-MGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSL-KTGSGQGERE-FSAEVEIISRVHHRHLVSLVGY 380
+G+G F V + G+EVA+K + KT + EV I+ ++H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--- 79
Query: 381 CIAGGQRMLVYEFVSNKT-----LEYHLHGENRPVMDF-ATRVRIALGSAK--------G 426
+E + + +EY GE V D+ R+ A+
Sbjct: 80 ----------FEVIETEKTLYLIMEYASGGE---VFDYLVAHGRMKEKEARSKFRQIVSA 126
Query: 427 LAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLA 486
+ Y H+ I+HRD+KA N+L+D + +ADFG + + G Y A
Sbjct: 127 VQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GAPPYAA 181
Query: 487 PEYASSGKLTE--KSDVFSFGVMLLELITGRRPVD 519
PE GK + + DV+S GV+L L++G P D
Sbjct: 182 PELF-QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 47/218 (21%), Positives = 84/218 (38%), Gaps = 52/218 (23%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYC 381
LG+G F K V + + AVK + ++ E+ + H ++V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHE-- 73
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFAT------RVRIALGS------------ 423
V+ + L VM+ R+
Sbjct: 74 --------VFHDQLH----TFL------VMELLNGGELFERI-KKKKHFSETEASYIMRK 114
Query: 424 -AKGLAYLHEDCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKLSNDNHTHVSTRVM 479
++++H+ ++HRD+K N+L +DN E + DFG A+L ++ + T
Sbjct: 115 LVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC- 170
Query: 480 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
T Y APE + E D++S GV+L +++G+ P
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 36/218 (16%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLK----TGSGQGEREFSAEVEIISRVHHRHLVSL 377
LLG+G +G V + + AVK LK GE E++++ R+ H++++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 378 VG-YCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAK--------GL 427
V Q+M +V E+ E ++D R + A GL
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE---------MLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL----SNDNHTHVSTRVMGTFG 483
YLH I+H+DIK N+L+ ++ G+A+ + D+ S G+
Sbjct: 123 EYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ---GSPA 176
Query: 484 YLAPEYASSGKLTE--KSDVFSFGVMLLELITGRRPVD 519
+ PE A+ K D++S GV L + TG P +
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 5e-21
Identities = 67/290 (23%), Positives = 104/290 (35%), Gaps = 72/290 (24%)
Query: 263 PGPPPPPPMMSSSGEMSSQFSGPARPPLPPPSP------NIALGFNKSTFT--YDELAAA 314
P P P P + PA+PP PPP L K+ Y
Sbjct: 10 PPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVT--- 66
Query: 315 TGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHR 372
S +LG G G V + ++ A+K L+ + EVE+ R
Sbjct: 67 ------SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCP 115
Query: 373 HLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDF------------------- 413
H+V +V VYE + + VM+
Sbjct: 116 HIVRIVD----------VYENLYAGRKCLLI------VMECLDGGELFSRIQDRGDQAFT 159
Query: 414 ---ATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA---MVADFGLAKLS 467
A+ + ++G A + YLH I HRD+K N+L + DFG AK +
Sbjct: 160 EREASEIMKSIGEA--IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214
Query: 468 NDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
+++ ++T T Y+APE K + D++S GV++ L+ G P
Sbjct: 215 TSHNS-LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 5e-21
Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 43/218 (19%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGERE---FSA--EVEIISRVHHR 372
+ K +G+G +G V+K G+ VA+K ++ + E E +A E+ ++ +HH
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHP 79
Query: 373 HLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAK------- 425
++VSL+ + LV+EF +E L V+D + + K
Sbjct: 80 NIVSLIDVIHSERCLTLVFEF-----MEKDLKK----VLD-ENKTGLQDSQIKIYLYQLL 129
Query: 426 -GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGY 484
G+A+ H+ RI+HRD+K N+LI+ + +ADFGLA+ + V+ T Y
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWY 185
Query: 485 LAPE-------YASSGKLTEKSDVFSFGVMLLELITGR 515
AP+ Y++S D++S G + E+ITG+
Sbjct: 186 RAPDVLMGSKKYSTS------VDIWSIGCIFAEMITGK 217
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 55/262 (20%), Positives = 98/262 (37%), Gaps = 63/262 (24%)
Query: 320 KSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSL 377
+ ++LG+G V + L +E AVK ++ G EVE++ + HR+++ L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFAT------RVRIALGS-------- 423
+ +E ++L V + +
Sbjct: 77 IE----------FFEEEDR----FYL------VFEKMRGGSILSHI-HKRRHFNELEASV 115
Query: 424 -----AKGLAYLHEDCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKL--SNDNHTH 473
A L +LH I HRD+K NIL + + DF L N + +
Sbjct: 116 VVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 474 VSTRVM----GTFGYLAPE-----YASSGKLTEKSDVFSFGVMLLELITGRRP-VDMTMM 523
+ST + G+ Y+APE + ++ D++S GV+L L++G P V
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC-- 230
Query: 524 EDSLVEWARPLLGAALEDGIYD 545
S W R A ++ +++
Sbjct: 231 -GSDCGWDRGEACPACQNMLFE 251
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 56/258 (21%), Positives = 95/258 (36%), Gaps = 39/258 (15%)
Query: 272 MSSSGEMSSQFSGPARPPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGY 331
M + +G + PPP P ++ F +LG+G F
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPR--------KKRPED-------FKFGKILGEGSFST 45
Query: 332 V----HKGVLPNGKEVAVKSLKTGSGQGEREFS---AEVEIISRVHHRHLVSLVGYCIAG 384
V +E A+K L+ E + E +++SR+ H V L
Sbjct: 46 VVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 102
Query: 385 GQRMLVYEFVSNKTLEYHLHGENR---PVMDF-ATRVRIALGSAKGLAYLHEDCHPRIIH 440
+ + N L ++ F + AL YLH IIH
Sbjct: 103 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE------YLHGK---GIIH 153
Query: 441 RDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM-GTFGYLAPEYASSGKLTEKS 499
RD+K NIL++++ + DFG AK+ + GT Y++PE + + S
Sbjct: 154 RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS 213
Query: 500 DVFSFGVMLLELITGRRP 517
D+++ G ++ +L+ G P
Sbjct: 214 DLWALGCIIYQLVAGLPP 231
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 48/221 (21%), Positives = 81/221 (36%), Gaps = 54/221 (24%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGY 380
+LG G G V + G++ A+K L + EV+ + H+V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCILD- 89
Query: 381 CIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFAT------RVRIALGS----------- 423
VYE + + + +M+ R+ G
Sbjct: 90 ---------VYENMHHGKRCLLI------IMECMEGGELFSRI-QERGDQAFTEREAAEI 133
Query: 424 ----AKGLAYLHEDCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKLSNDNHTHVST 476
+ +LH I HRD+K N+L + + + DFG AK + N + T
Sbjct: 134 MRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQT 188
Query: 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
T Y+APE K + D++S GV++ L+ G P
Sbjct: 189 PC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 1e-20
Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 43/218 (19%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGERE---FSA--EVEIISRVHHR 372
+ +G+G +G V+K G+ A+K ++ E E + E+ I+ + H
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELKHS 60
Query: 373 HLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAK------- 425
++V L + +LV+E L+ L ++D + +AK
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEH-----LDQDLKK----LLD-VCEGGLESVTAKSFLLQLL 110
Query: 426 -GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGY 484
G+AY H+ R++HRD+K N+LI+ E +ADFGLA+ + ++ T Y
Sbjct: 111 NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWY 166
Query: 485 LAPE-------YASSGKLTEKSDVFSFGVMLLELITGR 515
AP+ Y+++ D++S G + E++ G
Sbjct: 167 RAPDVLMGSKKYSTT------IDIWSVGCIFAEMVNGT 198
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 45/219 (20%), Positives = 78/219 (35%), Gaps = 54/219 (24%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISR-VHHRHLVSLVGYC 381
+G G + + + E AVK + E +EI+ R H ++++L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITLKD-- 83
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFAT------RVRIALGS------------ 423
VY+ ++ V + ++ +
Sbjct: 84 --------VYDDGKY----VYV------VTELMKGGELLDKI-LRQKFFSEREASAVLFT 124
Query: 424 -AKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA----MVADFGLAKLSNDNHTHVSTRV 478
K + YLH ++HRD+K +NIL D + DFG AK + + T
Sbjct: 125 ITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
Query: 479 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
T ++APE D++S GV+L ++TG P
Sbjct: 182 -YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 55/222 (24%), Positives = 86/222 (38%), Gaps = 51/222 (22%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVK-----SLKTGSGQGEREFSAEVEIISRVHHRHLVS 376
LG+G +G V V + VAVK ++E + I ++H ++V
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVK 69
Query: 377 LVGYCIAGGQRMLVYEFVSNKT-----LEYHLHGENRPVMDF-ATRVRIALGSAK----- 425
Y LEY GE + D + + A+
Sbjct: 70 F-------------YGHRREGNIQYLFLEYCSGGE---LFDRIEPDIGMPEPDAQRFFHQ 113
Query: 426 ---GLAYLHEDCHPR-IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT--HVSTRVM 479
G+ Y H I HRDIK N+L+D+ ++DFGLA + N+ ++
Sbjct: 114 LMAGVVY----LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC- 168
Query: 480 GTFGYLAPEYASSGKL--TEKSDVFSFGVMLLELITGRRPVD 519
GT Y+APE + E DV+S G++L ++ G P D
Sbjct: 169 GTLPYVAPELL-KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 44/218 (20%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSL---KTGSGQGEREFSAEVEIISRVHHRHLVSLV 378
LG G FG V G G +VAVK L K S + E++ + H H++ L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 379 GYCIAGGQRMLVYEFVSNKT-----LEYHLHGENRPVMDF-ATRVRIALGSAK------- 425
Y+ +S T +EY GE + D+ R+ A+
Sbjct: 77 ------------YQVISTPTDFFMVMEYVSGGE---LFDYICKHGRVEEMEARRLFQQIL 121
Query: 426 -GLAYLHEDCHPR-IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFG 483
+ Y CH ++HRD+K N+L+D + A +ADFGL+ + +D + T G+
Sbjct: 122 SAVDY----CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSC-GSPN 175
Query: 484 YLAPEYASSGKLTE--KSDVFSFGVMLLELITGRRPVD 519
Y APE SG+L + D++S GV+L L+ G P D
Sbjct: 176 YAAPEVI-SGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 32/215 (14%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE----FSA--EVEIISRVH 370
F + LG G + V+KG+ G VA+K +K + E +A E+ ++ +
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL-----DSEEGTPSTAIREISLMKELK 61
Query: 371 HRHLVSLVGYCIAGGQRMLVYEFVSN---KTLEYHLHGENRPVMDFATRVRIALGSAKGL 427
H ++V L + LV+EF+ N K ++ G ++ +GL
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAP 487
A+ HE+ +I+HRD+K N+LI+ + + DFGLA+ S+ V+ T Y AP
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAP 177
Query: 488 E-------YASSGKLTEKSDVFSFGVMLLELITGR 515
+ Y++S D++S G +L E+ITG+
Sbjct: 178 DVLMGSRTYSTS------IDIWSCGCILAEMITGK 206
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 6e-20
Identities = 28/250 (11%), Positives = 66/250 (26%), Gaps = 52/250 (20%)
Query: 323 LLGQGGFGYVHKG---VLPNGKEVAVKSLKTGSGQGE---REFSAEVEIISRVHHRHLVS 376
G + L ++VA+ + + +E + +SR+ +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
++ ++V E++ +L+ P +R A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP----VGAIRAMQSLAAAADAAHRA--- 148
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLT 496
+ + + + + G L +
Sbjct: 149 GVALSIDHPSRVRVSID--------GDVVL-------------AYPATMPDA-------N 180
Query: 497 EKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNY 556
+ D+ G L L+ R P+ + L A E ++P
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGL---------APAERDTAGQPIEPADIDRD 231
Query: 557 VPHEMARLVA 566
+P +++ + A
Sbjct: 232 IPFQISAVAA 241
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 59/276 (21%), Positives = 95/276 (34%), Gaps = 53/276 (19%)
Query: 271 MMSSSGEMSSQFSGPARPPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFG 330
M SS R P ++ + L + LLG GGFG
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPL---ESQYQVGPLLGSGGFG 57
Query: 331 YVHKGV-LPNGKEVAVKSL------KTGSGQGEREFSAEVEIISRVHHR--HLVSLVGYC 381
V+ G+ + + VA+K + G EV ++ +V ++ L
Sbjct: 58 SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL---- 113
Query: 382 IAGGQRMLVYEFVSNKT-----LEYHL-HGENRPVMDF-ATRVRIALGSAK--------G 426
++ LE + + DF R + A+
Sbjct: 114 ---------LDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEA 161
Query: 427 LAYLHEDCHPR-IIHRDIKAANILIDDN-FEAMVADFGLAKLSNDNHTHVSTRVMGTFGY 484
+ + CH ++HRDIK NILID N E + DFG L D GT Y
Sbjct: 162 VRH----CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVY 214
Query: 485 LAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPVD 519
PE+ + + V+S G++L +++ G P +
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 63/269 (23%), Positives = 104/269 (38%), Gaps = 58/269 (21%)
Query: 280 SQFSGPAR-PPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGV-L 337
S + P + PP PP +P G A + LLG+GGFG V G L
Sbjct: 1 SMLTKPLQGPPAPPGTPTPPPGGKDRE-------AFEAEYRLGPLLGKGGFGTVFAGHRL 53
Query: 338 PNGKEVAVKSL------KTGSGQGEREFSAEVEIISRVH----HRHLVSLVGYCIAGGQR 387
+ +VA+K + EV ++ +V H ++ L
Sbjct: 54 TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL---------- 103
Query: 388 MLVYEFVSNKT-----LEYHLHGENRPVMDF-ATRVRIALGSAK--------GLAYLHED 433
++ + LE L ++ + D+ + + G ++ + +
Sbjct: 104 ---LDWFETQEGFMLVLERPLPAQD--LFDYITEKGPLGEGPSRCFFGQVVAAIQH---- 154
Query: 434 CHPR-IIHRDIKAANILID-DNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYAS 491
CH R ++HRDIK NILID A + DFG L +D GT Y PE+ S
Sbjct: 155 CHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTRVYSPPEWIS 211
Query: 492 SGKLT-EKSDVFSFGVMLLELITGRRPVD 519
+ + V+S G++L +++ G P +
Sbjct: 212 RHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE---FSA--EVEIISRVHH 371
+ K + LG+G F V+K + VA+K +K G ++ +A E++++ + H
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 372 RHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLH 431
+++ L+ LV++F+ LE + + + + L + +GL YLH
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLV-LTPSHIKAYMLMTLQGLEYLH 129
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE--- 488
+ I+HRD+K N+L+D+N +ADFGLAK + + +V+ T Y APE
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELLF 185
Query: 489 ----YASSGKLTEKSDVFSFGVMLLELITGR 515
Y D+++ G +L EL+
Sbjct: 186 GARMYGVG------VDMWAVGCILAELLLRV 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 50/265 (18%), Positives = 93/265 (35%), Gaps = 50/265 (18%)
Query: 271 MMSSSGEMSSQFSGPARPPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFG 330
M + P A S Y + LG+G +G
Sbjct: 1 MAHHHHHHMGTLEAQTQGPGSMSVS--AAPSATSIDRYR----------RITKLGEGTYG 48
Query: 331 YVHKGV-LPNGKEVAVKSLKTGSGQGERE---FSA--EVEIISRVHHRHLVSLVGYCIAG 384
V+K + + VA+K ++ E E +A EV ++ + HR+++ L
Sbjct: 49 EVYKAIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN 105
Query: 385 GQRMLVYEFVSNKTLEYHLHG--ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRD 442
+ L++E+ E L + P + G+ + H R +HRD
Sbjct: 106 HRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRD 157
Query: 443 IKAANILIDDNFEAM-----VADFGLAKLSNDNHTHVSTRVMGTFGYLAPE-------YA 490
+K N+L+ + + + DFGLA+ + ++ T Y PE Y+
Sbjct: 158 LKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRHYS 216
Query: 491 SSGKLTEKSDVFSFGVMLLELITGR 515
+S D++S + E++
Sbjct: 217 TS------VDIWSIACIWAEMLMKT 235
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 38/216 (17%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE---FSA--EVEIISRVHH 371
+ K +G+G +G V K G+ VA+K + A E+ ++ ++ H
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQLKH 61
Query: 372 RHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPV-MDFATRVRIALGSAKGLAYL 430
+LV+L+ + LV+E+ T+ + L + + I + + + +
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCD-HTVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 431 HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK---LSNDNHTH-VSTRVMGTFGYLA 486
H+ H IHRD+K NILI + + DFG A+ +D + V+TR Y +
Sbjct: 119 HK--H-NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRS 170
Query: 487 PE-------YASSGKLTEKSDVFSFGVMLLELITGR 515
PE Y DV++ G + EL++G
Sbjct: 171 PELLVGDTQYGPP------VDVWAIGCVFAELLSGV 200
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 55/222 (24%), Positives = 86/222 (38%), Gaps = 51/222 (22%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVK-----SLKTGSGQGEREFSAEVEIISRVHHRHLVS 376
LG+G +G V V + VAVK ++E + I ++H ++V
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVK 69
Query: 377 LVGYCIAGGQRMLVYEFVSNKT-----LEYHLHGENRPVMDF-ATRVRIALGSAK----- 425
Y LEY GE + D + + A+
Sbjct: 70 F-------------YGHRREGNIQYLFLEYCSGGE---LFDRIEPDIGMPEPDAQRFFHQ 113
Query: 426 ---GLAYLHEDCHPR-IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT--HVSTRVM 479
G+ Y H I HRDIK N+L+D+ ++DFGLA + N+ ++
Sbjct: 114 LMAGVVY----LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC- 168
Query: 480 GTFGYLAPEYASSGKL--TEKSDVFSFGVMLLELITGRRPVD 519
GT Y+APE + E DV+S G++L ++ G P D
Sbjct: 169 GTLPYVAPELL-KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 38/216 (17%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE---FSA--EVEIISRVHH 371
+ L+G+G +G V K G+ VA+K + + A E++++ ++ H
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD---DDKMVKKIAMREIKLLKQLRH 83
Query: 372 RHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPV-MDFATRVRIALGSAKGLAYL 430
+LV+L+ C + LV+EFV T+ L E P +D+ + G+ +
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVD-HTILDDL--ELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 431 HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK---LSNDNHTH-VSTRVMGTFGYLA 486
H H IIHRDIK NIL+ + + DFG A+ + + V+TR Y A
Sbjct: 141 HS--H-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRA 192
Query: 487 PE-------YASSGKLTEKSDVFSFGVMLLELITGR 515
PE Y + DV++ G ++ E+ G
Sbjct: 193 PELLVGDVKYGKA------VDVWAIGCLVTEMFMGE 222
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 53/221 (23%), Positives = 91/221 (41%), Gaps = 38/221 (17%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEV------EI----- 365
+ +G G +G V+K +G VA+KS++ + + E+
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN---GGGGGGGLPISTVREVALLRR 67
Query: 366 ISRVHHRHLVSLVGYCIAGGQR-----MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIA 420
+ H ++V L+ C LV+E V + L +L P + T +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLM 126
Query: 421 LGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMG 480
+GL +LH + I+HRD+K NIL+ +ADFGLA++ + + V+
Sbjct: 127 RQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVVV- 181
Query: 481 TFGYLAPE------YASSGKLTEKSDVFSFGVMLLELITGR 515
T Y APE YA+ D++S G + E+ +
Sbjct: 182 TLWYRAPEVLLQSTYATP------VDMWSVGCIFAEMFRRK 216
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 53/222 (23%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVK-----SLKTGS--GQGEREFSAEVEIISRVHHRHL 374
LG+G FG V ++VA+K LK + ERE + + + H H+
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE----ISYLKLLRHPHI 71
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKT-----LEYHLHGENRPVMDF-ATRVRIALGSAK--- 425
+ L Y+ ++ T +EY GE + D+ + R+ +
Sbjct: 72 IKL-------------YDVITTPTDIVMVIEY-AGGE---LFDYIVEKKRMTEDEGRRFF 114
Query: 426 -----GLAYLHEDCHPR-IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM 479
+ Y CH I+HRD+K N+L+DDN +ADFGL+ + D + + T
Sbjct: 115 QQIICAIEY----CHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTSC- 168
Query: 480 GTFGYLAPEYASSGKLTE--KSDVFSFGVMLLELITGRRPVD 519
G+ Y APE +GKL + DV+S G++L ++ GR P D
Sbjct: 169 GSPNYAAPEVI-NGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 52/220 (23%), Positives = 83/220 (37%), Gaps = 50/220 (22%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSL---KTGSGQGEREFSAEVEIISRVHHRHLVSLV 378
+G G FG + VAVK + +RE + + H ++V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIVRF- 81
Query: 379 GYCIAGGQRMLVYEFVSNKT-----LEYHLHGENRPVMDF-ATRVRIALGSAK------- 425
E + T +EY GE + + R + A+
Sbjct: 82 ------------KEVILTPTHLAIIMEYASGGE---LYERICNAGRFSEDEARFFFQQLL 126
Query: 426 -GLAYLHEDCHPR-IIHRDIKAANILIDDNFEAM--VADFGLAKLSNDNHTHVSTRVMGT 481
G++Y CH I HRD+K N L+D + + DFG +K S + + V GT
Sbjct: 127 SGVSY----CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV-GT 180
Query: 482 FGYLAPEYASSGKLTE--KSDVFSFGVMLLELITGRRPVD 519
Y+APE + + +DV+S GV L ++ G P +
Sbjct: 181 PAYIAPEVL-LRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 3e-18
Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 44/218 (20%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSL---KTGSGQGEREFSAEVEIISRVHHRHLVSLV 378
LG G FG V G G +VAVK L K S + E++ + H H++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL- 81
Query: 379 GYCIAGGQRMLVYEFVSNKT-----LEYHLHGENRPVMDF-ATRVRIALGSAK------- 425
Y+ +S + +EY GE + D+ R+ ++
Sbjct: 82 ------------YQVISTPSDIFMVMEYVSGGE---LFDYICKNGRLDEKESRRLFQQIL 126
Query: 426 -GLAYLHEDCHPR-IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFG 483
G+ Y CH ++HRD+K N+L+D + A +ADFGL+ + +D + T G+
Sbjct: 127 SGVDY----CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSC-GSPN 180
Query: 484 YLAPEYASSGKLTE--KSDVFSFGVMLLELITGRRPVD 519
Y APE SG+L + D++S GV+L L+ G P D
Sbjct: 181 YAAPEVI-SGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 26/208 (12%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVS 376
+LGQG FG V + A+K LK + + E +I+ V+H +V
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 377 LVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFA-TRVR-----IALGSAKGLAY 429
L Y ++ L+ +F+ L L E F V+ +AL L +
Sbjct: 91 LH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVM----FTEEDVKFYLAELALA----LDH 141
Query: 430 LHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEY 489
LH II+RD+K NIL+D+ + DFGL+K S D+ + GT Y+APE
Sbjct: 142 LHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEV 197
Query: 490 ASSGKLTEKSDVFSFGVMLLELITGRRP 517
+ T+ +D +SFGV++ E++TG P
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 318 FAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGERE----FSA--EVEIISRVH 370
+ K + LG+G + V+KG VA+K ++ E E +A EV ++ +
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL-----EHEEGAPCTAIREVSLLKDLK 58
Query: 371 HRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYL 430
H ++V+L LV+E++ +K L+ +L ++ +GLAY
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNI-INMHNVKLFLFQLLRGLAYC 116
Query: 431 HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE-- 488
H +++HRD+K N+LI++ E +ADFGLA+ + V+ T Y P+
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDIL 172
Query: 489 -----YASSGKLTEKSDVFSFGVMLLELITGR 515
Y++ D++ G + E+ TGR
Sbjct: 173 LGSTDYSTQ------IDMWGVGCIFYEMATGR 198
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 59/260 (22%), Positives = 108/260 (41%), Gaps = 50/260 (19%)
Query: 279 SSQFSGPARPPLPPPSPNIALGF--NKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGV 336
++ +G PL P+ I + K+ + + ++G G FG V +
Sbjct: 7 NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIA------YTNCKVIGNGSFGVVFQAK 60
Query: 337 LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRM------LV 390
L EVA+K + Q +R + E++I+ V H ++V L + + G + LV
Sbjct: 61 LVESDEVAIKKVL----QDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116
Query: 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSA----------KGLAYLHEDCHPRIIH 440
E+V ++ +++ + + LAY+H I H
Sbjct: 117 LEYV-----PETVY----RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICH 164
Query: 441 RDIKAANILIDDNFEAM-VADFGLAK--LSNDNHTH-VSTRVMGTFGYLAPE-YASSGKL 495
RDIK N+L+D + + DFG AK ++ + + + +R Y APE +
Sbjct: 165 RDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATNY 219
Query: 496 TEKSDVFSFGVMLLELITGR 515
T D++S G ++ EL+ G+
Sbjct: 220 TTNIDIWSTGCVMAELMQGQ 239
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 87.5 bits (216), Expect = 6e-18
Identities = 54/160 (33%), Positives = 69/160 (43%), Gaps = 12/160 (7%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
+P S +S P S S + P SP S P+SP S PS SP S TS
Sbjct: 1536 GVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1595
Query: 76 SSPPPASP---PTSDNNKPDPPKNSP------PPPPPSSQSSPTPPSPSNNKSPSPPVFS 126
S P SP PTS + P P SP P P S +SP+ S + SP+ P +S
Sbjct: 1596 PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1655
Query: 127 PPPPAKKSSPP---PPPLKYSSSTPKSSSSSSKSSNGSSS 163
P PA + P P YS ++P S +S S S +
Sbjct: 1656 PTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPN 1695
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 2e-16
Identities = 53/173 (30%), Positives = 73/173 (42%), Gaps = 16/173 (9%)
Query: 7 VTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSP--PPASPP--PSSPPPSSPPP 62
+ ++ + + + +D S + P+SP +SP P+SP S P
Sbjct: 1495 LVDSGSNDAMAGGFTAYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSP 1554
Query: 63 SKSPPSSPPPATSSSPPPASP---PTSDNNKPDPPKNSPPPP---PPSSQSSPTPPSPSN 116
+ SP S TS S P SP PTS + P P SP P P S SPT PS S
Sbjct: 1555 AYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP 1614
Query: 117 NK---SPSPPVFSPPPPAKKSSPP---PPPLKYSSSTPKSSSSSSKSSNGSSS 163
SP+ P +SP P+ + P P YS ++P S +S S S S
Sbjct: 1615 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPS 1667
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 82.1 bits (202), Expect = 3e-16
Identities = 56/157 (35%), Positives = 69/157 (43%), Gaps = 12/157 (7%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPP--PASPP--PSSPPPSSPPPSKSPPSSP 70
SP P+S S T P S S S P+SP P SP P+SP S PS SP S
Sbjct: 1580 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1639
Query: 71 PPATSSSPPPASP---PTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSP 127
TS S P SP PTS P P S P P S +SP+ S + SP+ P +SP
Sbjct: 1640 YSPTSPSYSPTSPSYSPTSPAYSPTSPSYS-PTSPSYSPTSPSYSPTSPSYSPTSPNYSP 1698
Query: 128 PPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSG 164
P+ SP P YS +P S + + +
Sbjct: 1699 TSPSY--SPTSP--GYSPGSPAYSPKQDEQKHNENEN 1731
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 7e-15
Identities = 52/146 (35%), Positives = 68/146 (46%), Gaps = 8/146 (5%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
SP +P S +S + P S + S + P SP S P+SP S PS SP S TS
Sbjct: 1592 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1651
Query: 76 SSPPPASP---PTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAK 132
S P SP PTS + P P SP P S +SP+ S N SP+ P +SP P
Sbjct: 1652 PSYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSP-TSPSYSPTSPNYSPTSPSYSPTSPG- 1709
Query: 133 KSSPPPPPLKYSSSTPKSSSSSSKSS 158
SP P YS + + +++S
Sbjct: 1710 -YSPGSP--AYSPKQDEQKHNENENS 1732
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 77.1 bits (189), Expect = 1e-14
Identities = 49/173 (28%), Positives = 64/173 (36%), Gaps = 22/173 (12%)
Query: 16 SPPAPPSSNSSDATP-PPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPP-- 72
SP SN + A S P+SP P SP +SP
Sbjct: 1493 SPLVDSGSNDAMAGGFTAYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFSP-TSPTYSP 1551
Query: 73 ------ATSSSPPPASP---PTSDNNKPDPPKNSP------PPPPPSSQSSPTPPSPSNN 117
TS S P SP PTS + P P SP P P S +SP+ S +
Sbjct: 1552 TSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1611
Query: 118 KSPSPPVFSPPPPA-KKSSPPPPPL--KYSSSTPKSSSSSSKSSNGSSSGDDY 167
SP+ P +SP P+ +SP P YS ++P S +S S S +
Sbjct: 1612 YSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPT 1664
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 74.4 bits (182), Expect = 8e-14
Identities = 39/158 (24%), Positives = 55/158 (34%), Gaps = 9/158 (5%)
Query: 10 TENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSP-PPSKSPPS 68
+ S D+ + + + + P +P P S
Sbjct: 1480 VNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGADYGEATSPFGAYGEAPTSPGFGVSS 1539
Query: 69 SPPPATSSSPPPASP---PTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVF 125
TS + P SP PTS + P P SP P S S P+ S + SP+ P +
Sbjct: 1540 PGFSPTSPTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPT-SPSYSPTSPSY 1598
Query: 126 SPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSS 163
SP P S P YS ++P S +S S S S
Sbjct: 1599 SPTSP----SYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1632
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 74.4 bits (182), Expect = 8e-14
Identities = 42/167 (25%), Positives = 56/167 (33%), Gaps = 4/167 (2%)
Query: 1 MAKGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSP 60
+ VT NE G A P + S+ S
Sbjct: 1464 DGQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGADYGEATSPF 1523
Query: 61 PPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSP 120
P+SP SS P PTS P P SP P S +SP+ S + SP
Sbjct: 1524 GAYGEAPTSPGFGVSS---PGFSPTSPTYSPTSPAYSPTSPSYSP-TSPSYSPTSPSYSP 1579
Query: 121 SPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDY 167
+ P +SP P+ + P S +P S S S S + S + Y
Sbjct: 1580 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSY 1626
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 71.3 bits (174), Expect = 7e-13
Identities = 58/162 (35%), Positives = 73/162 (45%), Gaps = 20/162 (12%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSP-----PPASPPPSSPPPSSPPPS-----KS 65
SP +P S +S + P S + S + P SP P SP S PS P S S
Sbjct: 1557 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1616
Query: 66 PPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPP---PPSSQSSPTPPS---PSNNKS 119
P SP + S P+ PTS + P P SP P P S SPT PS S + S
Sbjct: 1617 PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYS 1676
Query: 120 PSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGS 161
P+ P +SP P+ SP P YS ++P S +S S GS
Sbjct: 1677 PTSPSYSPTSPS--YSPTSP--NYSPTSPSYSPTSPGYSPGS 1714
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 4e-11
Identities = 59/291 (20%), Positives = 77/291 (26%), Gaps = 53/291 (18%)
Query: 21 PSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPP-PSKSPPSSPPPATSSSPP 79
+ TP S+ SP S S + T+
Sbjct: 1457 QKITEIEDGQDGGVTPYSNESGLVNADLDVKD--ELMFSPLVDSGSNDAMAGGFTAYGGA 1514
Query: 80 PASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPP--SP-SNNKSPSPPVFSPPPPAKKS-S 135
TS SP S SPT P SP S SP+ P +SP P+ S
Sbjct: 1515 DYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPSYSPTS 1574
Query: 136 PPPPPLKYSSS------TPKSSSSSSKSSNGSSSGDDYVTYSVIGAVGVGIFLIAMIIIC 189
P P S S +P S S S S + S + Y S
Sbjct: 1575 PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP----------------- 1617
Query: 190 AVRANKKKKKRHNQPMHYYGDHSNHFKKGGDPY--YSGGHAPNWHGHPEHQNWHS--HPQ 245
Y S + Y S ++P + +S P
Sbjct: 1618 -----------------SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPA 1660
Query: 246 GPDHTGGNIPPPPGGNWPGPPPPPPMMSSSGEMSSQFSGPARPPLPPPSPN 296
+ P P + P P P S S +S P P P SP
Sbjct: 1661 YSPTSPSYSPTSPSYS-PTSPSYSPTSPSYSPTSPNYS-PTSPSYSPTSPG 1709
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 28/97 (28%), Positives = 36/97 (37%), Gaps = 14/97 (14%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
SP P+S + T P S S S P+SP + P+SP S P+ SP S
Sbjct: 1650 TSPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSYS---PTSPSYSPTSPNYSPTS------ 1700
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTP 111
P+ PTS P P SP +
Sbjct: 1701 -----PSYSPTSPGYSPGSPAYSPKQDEQKHNENENS 1732
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 7e-18
Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 36/219 (16%)
Query: 318 FAKSNLLGQGGFGYVHKG--VLPNGKEVAVKSLKTGSGQGERE---FSAEVEI-----IS 367
+ +G+G +G V K + G+ VA+K ++ + E S E+ +
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRHLE 69
Query: 368 RVHHRHLVSL----VGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALG 422
H ++V L ++ LV+E V + L +L P + T +
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 423 SAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTF 482
+GL +LH R++HRD+K NIL+ + + +ADFGLA++ + ++ V+ T
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVV-TL 183
Query: 483 GYLAPE------YASSGKLTEKSDVFSFGVMLLELITGR 515
Y APE YA+ D++S G + E+ +
Sbjct: 184 WYRAPEVLLQSSYATP------VDLWSVGCIFAEMFRRK 216
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 8e-18
Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLKTGS--GQGERE-FSAEVEIISRVHHRHLV 375
++G+G FG V K K A+K L + E F E +++ + +
Sbjct: 81 VIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 376 SLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIA-LGSAKGLAYLHED 433
+L Y + LV ++ L L + + R +A + A + +H+
Sbjct: 138 TLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA--IDSVHQL 194
Query: 434 CHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE----- 488
+HRDIK NIL+D N +ADFG ++ T S+ +GT Y++PE
Sbjct: 195 ---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251
Query: 489 YASSGKLTEKSDVFSFGVMLLELITGRRP 517
G+ + D +S GV + E++ G P
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 62/234 (26%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE---FSA--EVEIISRVHH 371
+ K +GQG FG V K G++VA+K + + E+E +A E++I+ + H
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLLKH 75
Query: 372 RHLVSLVGYCIA--------GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGS 423
++V+L+ C G LV++F E+ L G ++ V+ L
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAG----LLS-NVLVKFTLSE 125
Query: 424 AK--------GLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA-------KLSN 468
K GL Y+H + +I+HRD+KAAN+LI + +ADFGLA
Sbjct: 126 IKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 469 DNHTHVSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELITGR 515
+ +T+ RV+ T Y PE Y D++ G ++ E+ T
Sbjct: 183 NRYTN---RVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 29/209 (13%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLKTGSGQGEREFS---AEVEIISRVHHRHLV 375
LLG+G FG V K G+ A+K LK + E + E ++ H L
Sbjct: 155 LLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 376 SLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFA-TRVR-----IALGSAKGLA 428
+L Y R+ V E+ + L +HL E F+ R R I L
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGGELFFHLSRERV----FSEDRARFYGAEIVSA----LD 262
Query: 429 YLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE 488
YLH + + +++RD+K N+++D + + DFGL K + + T GT YLAPE
Sbjct: 263 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPE 319
Query: 489 YASSGKLTEKSDVFSFGVMLLELITGRRP 517
D + GV++ E++ GR P
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 43/171 (25%), Positives = 69/171 (40%), Gaps = 13/171 (7%)
Query: 353 GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMD 412
G R+ V I R L S+ + + + +S+ E + +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191
Query: 413 FATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472
+ + AKG+ +L + IHRD+ A NIL+ + + DFGLA+ +
Sbjct: 192 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248
Query: 473 HVSTRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELIT-GRRP 517
+V L APE T +SDV+SFGV+L E+ + G P
Sbjct: 249 YVRKGD----ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 85.9 bits (212), Expect = 2e-17
Identities = 56/165 (33%), Positives = 71/165 (43%), Gaps = 17/165 (10%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPP--PASPP--PSSPPPSSPPPSKSPPSSP 70
+ P + + PS +PSS +SP P+SP P+SP S PS SP S
Sbjct: 1539 YTSPFSSAMSPGYGLTSPSYSPSSPGYSTSPAYMPSSPSYSPTSPSYSPTSPSYSPTSPS 1598
Query: 71 PPATSSSPPPASP---PTSDNNKPDPPKNSPPPP---PPSSQSSPTPPSPSNNKSPSPPV 124
TS S SP PTS + P P SP P P S SPT PS SP+ P
Sbjct: 1599 YSPTSPSYSATSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSY----SPTSPS 1654
Query: 125 FSPPPPAKKSSPP---PPPLKYSSSTPKSSSSSSKSSNGSSSGDD 166
+SP P+ + P P YS ++P S +S S S S
Sbjct: 1655 YSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP 1699
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 9e-17
Identities = 58/158 (36%), Positives = 72/158 (45%), Gaps = 11/158 (6%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSP--PPASP--PPSSPPPSSPPPSKSPPSSPP 71
SP P+S S T P S S S P+SP SP P+SP S PS SP S
Sbjct: 1575 SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPSYSPTSPSY 1634
Query: 72 PATSSSPPPASP---PTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPP 128
TS S P SP PTS + P P SP P S +SP+ S + SP+ P +SP
Sbjct: 1635 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS-YSPTSPSYSPTSPSYSPTSPSYSPT 1693
Query: 129 PPAKKSSPP---PPPLKYSSSTPKSSSSSSKSSNGSSS 163
P+ + P P YS ++P S +S S S S
Sbjct: 1694 SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1731
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 83.6 bits (206), Expect = 1e-16
Identities = 53/164 (32%), Positives = 64/164 (39%), Gaps = 18/164 (10%)
Query: 10 TENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSS 69
+E EG +S S +S + P S PSSP S SP
Sbjct: 1513 SEGREGFGDYGLLGAASPYKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSSPGYSTSPAYM 1572
Query: 70 PPP----ATSSSPPPASP---PTSDNNKPDPPKNSPPPP---PPSSQSSPTPPSPSNNKS 119
P TS S P SP PTS + P P S P P S SPT PS S
Sbjct: 1573 PSSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPSY----S 1628
Query: 120 PSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSS 163
P+ P +SP P+ SP P YS ++P S +S S S S
Sbjct: 1629 PTSPSYSPTSPS--YSPTSP--SYSPTSPSYSPTSPSYSPTSPS 1668
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 81.7 bits (201), Expect = 5e-16
Identities = 56/148 (37%), Positives = 70/148 (47%), Gaps = 13/148 (8%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
S +P S +S + P S + S + P SP S P+SP S PS SP S TS
Sbjct: 1607 SATSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1666
Query: 76 SSPPPASP---PTSDNNKPDPPKNSPPPP---PPSSQSSPTPPS---PSNNKSPSPPVFS 126
S P SP PTS + P P SP P P S SPT PS S + SP+ P +S
Sbjct: 1667 PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1726
Query: 127 PPPPAKKSSPPPPPLKYSSSTPKSSSSS 154
P P+ SP P YS ++P S +S
Sbjct: 1727 PTSPSY--SPTSP--SYSPTSPSYSPTS 1750
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 1e-14
Identities = 58/164 (35%), Positives = 70/164 (42%), Gaps = 19/164 (11%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPP--PSSPP--PASPP--PSSPPPSSPPPSKSPPS 68
+P S SS + SSP P+SP P SP P+SP S PS S S
Sbjct: 1551 YGLTSPSYSPSSPGYSTSPAYMPSSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSATS 1610
Query: 69 SPPPATSSSPPPASP---PTSDNNKPDPPKNSPPPP---PPSSQSSPTPPSPSNNK---S 119
TS S P SP PTS + P P SP P P S SPT PS S S
Sbjct: 1611 PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1670
Query: 120 PSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSS 163
P+ P +SP P+ + P YS ++P S +S S S S
Sbjct: 1671 PTSPSYSPTSPSYSPTSP----SYSPTSPSYSPTSPSYSPTSPS 1710
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 75.1 bits (184), Expect = 5e-14
Identities = 48/133 (36%), Positives = 61/133 (45%), Gaps = 9/133 (6%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
SP +P S +S + P S + S + P SP S P+SP S PS SP S TS
Sbjct: 1628 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1687
Query: 76 SSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSS 135
S P SP S + P SP P S SPT PS SP+ P +SP P+ +
Sbjct: 1688 PSYSPTSPSYSPTS-PSYSPTSPSYSPTSPSYSPTSPSY----SPTSPSYSPTSPSYSPT 1742
Query: 136 PPPPPLKYSSSTP 148
P YS ++P
Sbjct: 1743 SP----SYSPTSP 1751
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 71.6 bits (175), Expect = 6e-13
Identities = 43/168 (25%), Positives = 53/168 (31%), Gaps = 18/168 (10%)
Query: 14 EGSPPAPPSSNSSDATP---PPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSP 70
E SP S P S S P SP SS
Sbjct: 1487 ERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGFGDYGLLGAASPYKGVQSPGYTSPFSSA 1546
Query: 71 PPATSSSPPPASPPTSDNNKPDP------PKNSPPPP---PPSSQSSPTPPSP---SNNK 118
P+ P+S P P SP P P S SPT PS S +
Sbjct: 1547 MSPGYGLTSPSYSPSSPGYSTSPAYMPSSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSY 1606
Query: 119 SPSPPVFSPPPPAKKSSPP---PPPLKYSSSTPKSSSSSSKSSNGSSS 163
S + P +SP P+ + P P YS ++P S +S S S S
Sbjct: 1607 SATSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1654
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 71.3 bits (174), Expect = 7e-13
Identities = 32/157 (20%), Positives = 47/157 (29%), Gaps = 10/157 (6%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
P S +P ++ SP + +
Sbjct: 1479 PEGAGTPYERSPMVDSGFVGSPDAAA--FSPLVQGGSEGREGFGDYGLLGAASPYKGVQS 1536
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSP-----SNNKSPSPPVFSPPP 129
P S S P SP P S+ + P SP S + SP+ P +SP
Sbjct: 1537 PGYTSPFSSAMSPGYGLTSPSYSPSSPGYSTSPAYMPSSPSYSPTSPSYSPTSPSYSPTS 1596
Query: 130 PAKKSSPP---PPPLKYSSSTPKSSSSSSKSSNGSSS 163
P+ + P YS ++P S +S S S S
Sbjct: 1597 PSYSPTSPSYSATSPSYSPTSPSYSPTSPSYSPTSPS 1633
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 39/164 (23%), Positives = 52/164 (31%), Gaps = 8/164 (4%)
Query: 8 TETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPP 67
T GS TP S S SP A+ P S
Sbjct: 1463 TAVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGFGDY 1522
Query: 68 SSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSP-----SNNKSPSP 122
A+ + TS + P P S S SP S + SP+
Sbjct: 1523 GLLGAASPYKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSSPGYSTSPAYMPSSPSYSPTS 1582
Query: 123 PVFSPPPPA-KKSSPPPPPL--KYSSSTPKSSSSSSKSSNGSSS 163
P +SP P+ +SP P YS+++P S +S S S S
Sbjct: 1583 PSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPS 1626
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 63.6 bits (154), Expect = 2e-10
Identities = 38/101 (37%), Positives = 44/101 (43%), Gaps = 3/101 (2%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
SP P+S S T P S S S P+SP + PS P S SP SP +
Sbjct: 1652 SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSY 1711
Query: 76 SSPPPASPPTSDNNKPDPPKNSPPPPPPSSQS---SPTPPS 113
S P+ PTS + P P SP P S S SPT PS
Sbjct: 1712 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1752
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 8e-08
Identities = 25/141 (17%), Positives = 37/141 (26%), Gaps = 4/141 (2%)
Query: 25 SSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPP 84
S P + +P SP S ++ P
Sbjct: 1460 SLGTAVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGF 1519
Query: 85 TSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPL--K 142
P + + SP + P +SP P +SP P
Sbjct: 1520 GDYGLLGAASPYKGVQSPGYTSPFSSAMSPGY--GLTSPSYSPSSPGYSTSPAYMPSSPS 1577
Query: 143 YSSSTPKSSSSSSKSSNGSSS 163
YS ++P S +S S S S
Sbjct: 1578 YSPTSPSYSPTSPSYSPTSPS 1598
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 21/124 (16%), Positives = 32/124 (25%), Gaps = 3/124 (2%)
Query: 41 PPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPP 100
+ + S P + P + P S A P
Sbjct: 1464 AVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGFGDYG 1523
Query: 101 PPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNG 160
++ SP SP + P +SP P ST + SS S +
Sbjct: 1524 LLGAASPYKGVQSPGYT---SPFSSAMSPGYGLTSPSYSPSSPGYSTSPAYMPSSPSYSP 1580
Query: 161 SSSG 164
+S
Sbjct: 1581 TSPS 1584
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 25/211 (11%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLKTGS--GQGERE-FSAEVEIISRVHHRHLV 375
++G+G F V K G+ A+K + +GE F E +++ R +
Sbjct: 68 VIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 376 SLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIA-LGSAKGLAYLHED 433
L + + LV E+ L L + R +A + A + +H
Sbjct: 125 QLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA--IDSVHRL 181
Query: 434 CHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE----- 488
+HRDIK NIL+D +ADFG + T S +GT YL+PE
Sbjct: 182 ---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAV 238
Query: 489 --YASSGKLTEKSDVFSFGVMLLELITGRRP 517
+G + D ++ GV E+ G+ P
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 63/275 (22%), Positives = 115/275 (41%), Gaps = 52/275 (18%)
Query: 272 MSSSGEMSSQFSGPARPPLPPPSPNIALGFNKSTFTYDELAAATGG---------FAKSN 322
MS +S P ++ + +K + A G + +
Sbjct: 1 MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK 60
Query: 323 LLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
++G G FG V++ L +G+ VA+K + Q +R + E++I+ ++ H ++V L +
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 382 IAGGQRM------LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSA----------K 425
+ G++ LV ++V ++ V +R + L +
Sbjct: 117 YSSGEKKDEVYLNLVLDYV-----PETVY----RVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAM-VADFGLAK--LSNDNHTH-VSTRVMGT 481
LAY+H I HRDIK N+L+D + + + DFG AK + + + + +R
Sbjct: 168 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 221
Query: 482 FGYLAPEY-ASSGKLTEKSDVFSFGVMLLELITGR 515
Y APE + T DV+S G +L EL+ G+
Sbjct: 222 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLKTGS---GQGEREFS-AEVEIISRVHHRHL 374
+LG+GG+G V GK A+K LK + + AE I+ V H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 375 VSLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFA-TRVR-----IALGSAKGL 427
V L+ Y G ++ L+ E++S L L E F I++ L
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGI----FMEDTACFYLAEISMA----L 134
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAP 487
+LH+ II+RD+K NI+++ + DFGL K S + T T GT Y+AP
Sbjct: 135 GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMAP 190
Query: 488 EYASSGKLTEKSDVFSFGVMLLELITGRRP 517
E D +S G ++ +++TG P
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 60/211 (28%), Positives = 88/211 (41%), Gaps = 34/211 (16%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLKTGSGQGEREFS---AEVEIISRVHHRHLV 375
LLG+G FG V K G+ A+K L+ + E + E ++ H L
Sbjct: 12 LLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 376 SLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFA-TRVR-----IALGSAKGLA 428
+L Y R+ V E+ + L +HL E F R R I L
Sbjct: 69 ALK-YAFQTHDRLCFVMEYANGGELFFHLSRERV----FTEERARFYGAEIVSA----LE 119
Query: 429 YLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS-NDNHTHVSTRVM-GTFGYLA 486
YLH +++RDIK N+++D + + DFGL K +D T + GT YLA
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLA 173
Query: 487 PEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
PE D + GV++ E++ GR P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 54/227 (23%), Positives = 88/227 (38%), Gaps = 51/227 (22%)
Query: 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVK------SLKTGSGQGEREFSAEVEIISRVH 370
F + GQG FG V G G VA+K + RE ++ ++ +H
Sbjct: 25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN------RELQ-IMQDLAVLH 77
Query: 371 HRHLVSLVGYCIAGGQR-------MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGS 423
H ++V L Y G+R +V E+V LH R ++A
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLH----RCCRNYYRRQVAPPP 128
Query: 424 A----------KGLAYLHEDCHPRIIHRDIKAANILID-DNFEAMVADFGLAKLSNDNHT 472
+ + LH + HRDIK N+L++ + + DFG AK + +
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
Query: 473 HVS---TRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVMLLELITGR 515
+V+ +R Y APE + T D++S G + E++ G
Sbjct: 188 NVAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.0 bits (202), Expect = 2e-16
Identities = 77/422 (18%), Positives = 128/422 (30%), Gaps = 44/422 (10%)
Query: 111 PPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVTY 170
P + + + + P + S D +
Sbjct: 149 PSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSE 208
Query: 171 SVIGAVGVGIFLIAMIIICAVRANKKKKKRHNQPMHYYGDHSNHFKKGGDPYYSGGHAPN 230
S + L K+ K + + D S +
Sbjct: 209 SKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDL---TSRNDFMGSLSFGIS 265
Query: 231 WHGHPEHQNWHSHPQGPDHTGGNIPPPPGGNWPGPPPPPPMMSSSGEMSSQFSGPARPPL 290
W + N+P PP G+ + ++
Sbjct: 266 ELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANT 325
Query: 291 PPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYV----HKGVLPNGKEVAVK 346
N N+ + F +LG+G FG V KG + AVK
Sbjct: 326 ISKFDNNG---NRDRMKLTD-------FNFLMVLGKGSFGKVMLSERKG---TDELYAVK 372
Query: 347 SLKTGSGQGEREFS---AEVEIISRV-HHRHLVSLVGYCIAGGQRM-LVYEFVSNKTLEY 401
LK + + E +++ L L C R+ V E+V+ L Y
Sbjct: 373 ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMY 431
Query: 402 HLHGENRPVMDFA-TRVR-----IALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE 455
H+ R F IA+G L +L II+RD+K N+++D
Sbjct: 432 HIQQVGR----FKEPHAVFYAAEIAIG----LFFLQSK---GIIYRDLKLDNVMLDSEGH 480
Query: 456 AMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR 515
+ADFG+ K + + T GT Y+APE + + D ++FGV+L E++ G+
Sbjct: 481 IKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
Query: 516 RP 517
P
Sbjct: 540 AP 541
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 52/224 (23%), Positives = 98/224 (43%), Gaps = 51/224 (22%)
Query: 324 LGQGGFGYVHKGV---LPNGKEVAVKSLKTGSGQGEREFSA--EVEIISRVHHRHLVSLV 378
+G+G +G+V+K + K+ A+K ++ SA E+ ++ + H +++SL
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQ 84
Query: 379 GYCIAGGQR--MLVYEFVSN---KTLEYHLHGENRPVMDFATRVRIALGSAK-------- 425
++ R L++++ + +++H + V++ G K
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANK-----KPVQLPRGMVKSLLYQILD 139
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAM----VADFGLAKLSND---NHTHVSTRV 478
G+ YLH + ++HRD+K ANIL+ +AD G A+L N + V
Sbjct: 140 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 479 MGTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELITGR 515
+ TF Y APE Y T+ D+++ G + EL+T
Sbjct: 197 V-TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 54/214 (25%), Positives = 85/214 (39%), Gaps = 26/214 (12%)
Query: 318 FAKSNLLGQGGFGYV----HKGVLPNGKEVAVKSLK----TGSGQGEREFSAEVEIISRV 369
+ ++G+G FG V HK K A+K L F E +I++
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFA 126
Query: 370 HHRHLVSLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIA-LGSAKGL 427
+ +V L Y + + +V E++ L + N V + R A + A L
Sbjct: 127 NSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLA--L 181
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAP 487
+H IHRD+K N+L+D + +ADFG N +GT Y++P
Sbjct: 182 DAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
Query: 488 E----YASSGKLTEKSDVFSFGVMLLELITGRRP 517
E G + D +S GV L E++ G P
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 58/207 (28%), Positives = 82/207 (39%), Gaps = 29/207 (14%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLKTGSGQGEREFS---AEVEIISRVHHRHLV 375
LG G FG V HK +G A+K L ++ E I+ V+ LV
Sbjct: 48 TLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENR---PVMDF-ATRVRIALGSAKGLAYLH 431
L +V E+V+ + HL R P F A ++ + YLH
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------YLH 158
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM-GTFGYLAPEYA 490
+I+RD+K N+LID V DFG AK T + GT LAPE
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEII 210
Query: 491 SSGKLTEKSDVFSFGVMLLELITGRRP 517
S + D ++ GV++ E+ G P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 64/220 (29%), Positives = 96/220 (43%), Gaps = 44/220 (20%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLK----------TGSGQGEREFSAEVEIISR 368
+LG G +G V GK A+K LK T + ER+ +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR---- 116
Query: 369 VHHRHLVSLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFA-TRVR-----IAL 421
LV+L Y ++ L+ ++++ L HL R F V+ I L
Sbjct: 117 -QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVL 170
Query: 422 GSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGT 481
L +LH+ II+RDIK NIL+D N ++ DFGL+K + T + GT
Sbjct: 171 A----LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 482 FGYLAPE---YASSGKLTEKS-DVFSFGVMLLELITGRRP 517
Y+AP+ SG +K+ D +S GV++ EL+TG P
Sbjct: 224 IEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGASP 261
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 3e-15
Identities = 62/207 (29%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLKTGSGQGEREFS---AEVEIISRVHHRHLV 375
LG G FG V + NG+ A+K LK ++ E ++S V H ++
Sbjct: 13 TLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 69
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENR---PVMDF-ATRVRIALGSAKGLAYLH 431
+ G Q ++ +++ L L R PV F A V +AL YLH
Sbjct: 70 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE------YLH 123
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVM-GTFGYLAPEYA 490
II+RD+K NIL+D N + DFG AK D T + GT Y+APE
Sbjct: 124 SK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVV 175
Query: 491 SSGKLTEKSDVFSFGVMLLELITGRRP 517
S+ + D +SFG+++ E++ G P
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 60/221 (27%), Positives = 88/221 (39%), Gaps = 53/221 (23%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLK---------TGSGQGEREFSAEVEIISRV 369
+LG+G FG V KG + AVK LK E+ A
Sbjct: 27 VLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-----G 78
Query: 370 HHRHLVSLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFA-TRVR-----IALG 422
L L C R+ V E+V+ L YH+ R F IA+G
Sbjct: 79 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAIG 133
Query: 423 SAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK--LSNDNHTHVSTRVMG 480
L +L II+RD+K N+++D +ADFG+ K + + T
Sbjct: 134 ----LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK------- 179
Query: 481 TF-G---YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
TF G Y+APE + + D ++FGV+L E++ G+ P
Sbjct: 180 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 48/218 (22%), Positives = 83/218 (38%), Gaps = 42/218 (19%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVK--SLKTGSGQGEREFSA---------EVEIISRVHHR 372
+ G +G V GV G VA+K G+ S E+ +++ HH
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 373 HLVSLVGYCIAGGQRM-----LVYEFVSNKTLEYHLH----GENRPVMDFATRVRI--AL 421
+++ L + + LV E + L + + + + L
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQRIVISPQHIQYFMYHIL 144
Query: 422 GSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT---HVSTRV 478
GL LHE ++HRD+ NIL+ DN + + DF LA+ + +V+ R
Sbjct: 145 ---LGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW 198
Query: 479 MGTFGYLAPEY-ASSGKLTEKSDVFSFGVMLLELITGR 515
Y APE T+ D++S G ++ E+ +
Sbjct: 199 -----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 38/219 (17%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVK---SLKTGSGQGEREFSAEVEIISRVH-------- 370
LG G F V + N VA+K K + E E ++++ RV+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----IKLLQRVNDADNTKED 81
Query: 371 ---HRHLVSLVG---YCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGS 423
H++ L+ + G + +V+E + L E+R + + +I+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK-QISKQL 140
Query: 424 AKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAM------VADFGLAKLSNDNHT-HVST 476
GL Y+H C IIH DIK N+L++ +AD G A ++++T + T
Sbjct: 141 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198
Query: 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR 515
R Y +PE +D++S ++ ELITG
Sbjct: 199 RE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 47/221 (21%), Positives = 74/221 (33%), Gaps = 76/221 (34%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYC 381
LG G G V + ++ A+K L+ + EVE+ R H+V +V
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVD-- 78
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDF----------------------ATRVRI 419
VYE + + VM+ A+ +
Sbjct: 79 --------VYENLYAGRKCLLI------VMECLDGGELFSRIQDRGDQAFTEREASEIMK 124
Query: 420 ALGSAKGLAYLHEDCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKLSNDNHTHVST 476
++G A + YLH I HRD+K N+L N + DFG AK +
Sbjct: 125 SIGEA--IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------ETTG 172
Query: 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
Y + D++S GV++ L+ G P
Sbjct: 173 E-----KY-----------DKSCDMWSLGVIMYILLCGYPP 197
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 59/221 (26%), Positives = 92/221 (41%), Gaps = 53/221 (23%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLK---------TGSGQGEREFSAEVEIISRV 369
+LG+G FG V K + A+K+LK E+ +
Sbjct: 24 MLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-----W 75
Query: 370 HHRHLVSLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFA-TRVR-----IALG 422
H L + + + V E+++ L YH+ ++ F +R I LG
Sbjct: 76 EHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILG 130
Query: 423 SAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK--LSNDNHTHVSTRVMG 480
L +LH I++RD+K NIL+D + +ADFG+ K + D T+
Sbjct: 131 ----LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN------- 176
Query: 481 TF-G---YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
TF G Y+APE K D +SFGV+L E++ G+ P
Sbjct: 177 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 42/228 (18%), Positives = 90/228 (39%), Gaps = 44/228 (19%)
Query: 324 LGQGGFGYVHKGV---------LPNGKEVAVKSLKTGSGQGEREFS--------AEVEII 366
+ G +++ P ++ ++K L G+ E + +V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 367 SRVHHRHLV---SLVGYCIAGGQ-RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALG 422
+++ L+ + +G+ + + R LV + ++L+ L + V+ + +++A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLG-RSLQSALDVSPKHVLSERSVLQVACR 167
Query: 423 SAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMV--ADFGLAKLSNDNHTHVSTR--- 477
L +LHE+ +H ++ A NI +D ++ V A +G A + HV+
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGS 224
Query: 478 ---VMGTFGYLAPEYAS----SGK-LTEKSDVFSFGVMLLELITGRRP 517
G E+ S G + +SD+ S G +L+ + G P
Sbjct: 225 RSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 53/221 (23%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLK---------TGSGQGEREFSAEVEIISRV 369
++G+G + V K + A+K +K Q E+ +
Sbjct: 16 VIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-----S 67
Query: 370 HHRHLVSLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFA-TRVR-----IALG 422
+H LV L C R+ V E+V+ L +H+ + + R I+L
Sbjct: 68 NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLA 122
Query: 423 SAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK--LSNDNHTHVSTRVMG 480
L YLHE II+RD+K N+L+D + D+G+ K L + T
Sbjct: 123 ----LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS------- 168
Query: 481 TF-G---YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
TF G Y+APE D ++ GV++ E++ GR P
Sbjct: 169 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 35/212 (16%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLKTGSGQGEREFS---AEVEIISR-VHHRHL 374
++G+G FG V HK AVK L+ + ++E +E ++ + V H L
Sbjct: 45 VIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 375 VSLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFA-TRVR-----IALGSAKGL 427
V L + ++ V ++++ L YHL E F R R IA L
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGELFYHLQRERC----FLEPRARFYAAEIASA----L 152
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS-NDNHTHVSTRVM-GTFGYL 485
YLH I++RD+K NIL+D ++ DFGL K + N T T GT YL
Sbjct: 153 GYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYL 206
Query: 486 APEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
APE D + G +L E++ G P
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 10/93 (10%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH-VSTRVMGTFG 483
KGL Y+H ++HRD+K N+ ++++ E + DFGLA+ ++ T V TR
Sbjct: 137 KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW----- 188
Query: 484 YLAPEYA-SSGKLTEKSDVFSFGVMLLELITGR 515
Y APE S + D++S G ++ E++TG+
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 54/221 (24%), Positives = 88/221 (39%), Gaps = 53/221 (23%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLK---------TGSGQGEREFSAEVEIISRV 369
++G+G + V K + A++ +K Q E+ +
Sbjct: 59 VIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA-----S 110
Query: 370 HHRHLVSLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFA-TRVR-----IALG 422
+H LV L C R+ V E+V+ L +H+ + + R I+L
Sbjct: 111 NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLA 165
Query: 423 SAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK--LSNDNHTHVSTRVMG 480
L YLHE II+RD+K N+L+D + D+G+ K L + T
Sbjct: 166 ----LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS------- 211
Query: 481 TF-G---YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
TF G Y+APE D ++ GV++ E++ GR P
Sbjct: 212 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 41/211 (19%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYC 381
LG+G + V + + + N ++V VK LK +++ E++I+ + ++++L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITL--AD 98
Query: 382 I----AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIA------LGSAKGLAYLH 431
I LV+E V+N + + T I L K L Y H
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDF--------KQLYQTLTDYDIRFYMYEIL---KALDYCH 147
Query: 432 EDCHPRIIHRDIKAANILID-DNFEAMVADFGLAKL--SNDNHTH-VSTRVMGTFGYLAP 487
I+HRD+K N++ID ++ + + D+GLA+ + V++R + P
Sbjct: 148 SM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGP 199
Query: 488 EYASSGKLTEKS-DVFSFGVMLLELITGRRP 517
E ++ + S D++S G ML +I + P
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 8e-14
Identities = 62/221 (28%), Positives = 86/221 (38%), Gaps = 53/221 (23%)
Query: 323 LLGQGGFGYV----HKGVLPNGKEVAVKSLK---------TGSGQGEREFSAEVEIISRV 369
+LG+G FG V K G AVK LK E+ +
Sbjct: 30 VLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA-----R 81
Query: 370 HHRHLVSLVGYCIAGGQRM-LVYEFVSNKTLEYHLHGENRPVMDFA-TRVR-----IALG 422
+H L L C R+ V EFV+ L +H+ R F R R I
Sbjct: 82 NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEIISA 136
Query: 423 SAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK--LSNDNHTHVSTRVMG 480
L +LH+ II+RD+K N+L+D +ADFG+ K + N T
Sbjct: 137 ----LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA------- 182
Query: 481 TF-G---YLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
TF G Y+APE D ++ GV+L E++ G P
Sbjct: 183 TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 34/93 (36%), Positives = 55/93 (59%), Gaps = 10/93 (10%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFG 483
KGL Y+H IIHRD+K N+ ++++ E + DFGLA+ ++ T +V TR
Sbjct: 139 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190
Query: 484 YLAPEYA-SSGKLTEKSDVFSFGVMLLELITGR 515
Y APE + + T+ D++S G ++ E+ITG+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 74.1 bits (181), Expect = 9e-14
Identities = 17/129 (13%), Positives = 29/129 (22%), Gaps = 1/129 (0%)
Query: 30 PPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNN 89
P + P P PP P + + S P +
Sbjct: 10 PQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQL 69
Query: 90 KPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPK 149
+ + + P P+ P PV P ++ P P S
Sbjct: 70 HQQIDQATTSMNDMHLHNVP-LVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAM 128
Query: 150 SSSSSSKSS 158
+ +
Sbjct: 129 GQNMRPMNQ 137
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 73.7 bits (180), Expect = 1e-13
Identities = 18/128 (14%), Positives = 26/128 (20%), Gaps = 2/128 (1%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPP--PSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA 73
N++ P P P S PP PS P+
Sbjct: 11 QAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLH 70
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKK 133
S + + P TP +P P +
Sbjct: 71 QQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQ 130
Query: 134 SSPPPPPL 141
+ P L
Sbjct: 131 NMRPMNQL 138
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 73.3 bits (179), Expect = 1e-13
Identities = 19/131 (14%), Positives = 29/131 (22%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
P +ATP P + S PP PS PA
Sbjct: 10 PQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQL 69
Query: 78 PPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPP 137
T+ N P Q + + P+ +P ++
Sbjct: 70 HQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMG 129
Query: 138 PPPLKYSSSTP 148
+ P
Sbjct: 130 QNMRPMNQLYP 140
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 73.3 bits (179), Expect = 1e-13
Identities = 26/130 (20%), Positives = 36/130 (27%), Gaps = 4/130 (3%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
P A S PP + PS P ++ + + P
Sbjct: 33 QDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVD 92
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTP---PSPSNNKSPSPPVFSPPPPA 131
++ P P + P P Q S P N P + PPP
Sbjct: 93 PNAYMQPQVPVQ-MGTPLQQQQQPMAAPAYGQPSAAMGQNMRPMNQLYPIDLLTELPPPI 151
Query: 132 KKSSPPPPPL 141
+ PPPPL
Sbjct: 152 TDLTLPPPPL 161
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 72.9 bits (178), Expect = 2e-13
Identities = 14/124 (11%), Positives = 26/124 (20%)
Query: 40 PPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPP 99
P + P P PP + PP + P+ + P
Sbjct: 10 PQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQL 69
Query: 100 PPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSN 159
++ +N P P P + + S +
Sbjct: 70 HQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMG 129
Query: 160 GSSS 163
+
Sbjct: 130 QNMR 133
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 71.4 bits (174), Expect = 6e-13
Identities = 18/136 (13%), Positives = 29/136 (21%), Gaps = 6/136 (4%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
G P + P + S PP PS P++
Sbjct: 17 GQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLHQQIDQA 76
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKS 134
++S P + P P + + P + P A
Sbjct: 77 TTSMNDMHLHNV------PLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQ 130
Query: 135 SPPPPPLKYSSSTPKS 150
+ P Y
Sbjct: 131 NMRPMNQLYPIDLLTE 146
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 3e-12
Identities = 24/142 (16%), Positives = 40/142 (28%), Gaps = 9/142 (6%)
Query: 16 SPPAPPSSNSSDATPP--PSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA 73
A P + PP P++ S PP + P P + A
Sbjct: 17 GQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLHQQIDQA 76
Query: 74 TSS-------SPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFS 126
T+S + P P + +P ++P PS + +
Sbjct: 77 TTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQNMRPMN 136
Query: 127 PPPPAKKSSPPPPPLKYSSSTP 148
P + PPP+ + P
Sbjct: 137 QLYPIDLLTELPPPITDLTLPP 158
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 1e-11
Identities = 17/143 (11%), Positives = 31/143 (21%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
G PP + + + P+ P
Sbjct: 46 GMPPQGAVPSMGQQQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQM 105
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKS 134
+ P + P P +Q P + PPP
Sbjct: 106 GTPLQQQQQPMAAPAYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPP 165
Query: 135 SPPPPPLKYSSSTPKSSSSSSKS 157
P + S+++P S+ +
Sbjct: 166 ERMLVPSELSNASPDYIRSTLNA 188
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 7e-10
Identities = 16/132 (12%), Positives = 28/132 (21%), Gaps = 12/132 (9%)
Query: 43 SSPPP-ASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPP-----------ASPPTSDNNK 90
S P + P + P PP ++ A P
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQF 61
Query: 91 PDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKS 150
P + + +S N P + P + P + + P
Sbjct: 62 LTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAY 121
Query: 151 SSSSSKSSNGSS 162
S+
Sbjct: 122 GQPSAAMGQNMR 133
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 3e-08
Identities = 19/144 (13%), Positives = 35/144 (24%), Gaps = 1/144 (0%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
+ +S P++ P P
Sbjct: 57 GQQQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPM 116
Query: 76 SSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSS 135
++P P + P P + P P P++ S+
Sbjct: 117 AAPAYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSN 176
Query: 136 PPPPPLKYSSST-PKSSSSSSKSS 158
P ++ + + PK+SS KS
Sbjct: 177 ASPDYIRSTLNAVPKNSSLLKKSK 200
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 71.7 bits (175), Expect = 2e-13
Identities = 24/125 (19%), Positives = 36/125 (28%), Gaps = 9/125 (7%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
S P S+ + +S S PP P P+ PPP +P P + +
Sbjct: 12 SGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDTVTGDSVL 71
Query: 76 SS--PPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKK 133
P P T+ P P + PP+ P ++ P P
Sbjct: 72 QRILRGPTGPGTT----SLAPAVRYGRQPGPEAPASAPPAAG---RAVPGLYHHPVPEPD 124
Query: 134 SSPPP 138
Sbjct: 125 PVRVE 129
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 1e-12
Identities = 20/113 (17%), Positives = 32/113 (28%), Gaps = 7/113 (6%)
Query: 34 STPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSS---PPPATSSSPPPASPPTSDNNK 90
S+ S P P S + ++ P +PPP P + N
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 91 PDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKY 143
+S + P S +P+ P P +S PP +
Sbjct: 63 DTVTGDSVLQRILRGPTGPGTTSL----APAVRYGRQPGPEAPASAPPAAGRA 111
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 18/117 (15%), Positives = 32/117 (27%), Gaps = 5/117 (4%)
Query: 24 NSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASP 83
+S S P + +S ++ P + P PP + P
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 84 PTSDNNKPDPPKNSPPPPPPSSQSSPTP-PSPSNNKSPSPPVFSPPPPAKKSSPPPP 139
T P+ + + P+ + P P + PPA + P
Sbjct: 63 DTV----TGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGL 115
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 20/96 (20%), Positives = 34/96 (35%)
Query: 7 VTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSP 66
VT ++ + PP + A PPP + + +PP + + P+ P +
Sbjct: 28 VTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDTVTGDSVLQRILRGPTGPGTTSLA 87
Query: 67 PSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPP 102
P+ PAS P + + P P P
Sbjct: 88 PAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPEP 123
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 2e-09
Identities = 20/106 (18%), Positives = 32/106 (30%)
Query: 47 PASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQ 106
SS P +S A S PP + + PP +P P
Sbjct: 5 HHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDT 64
Query: 107 SSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSS 152
+ + P+ P + PA + P P +S+ P +
Sbjct: 65 VTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGR 110
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 52.1 bits (124), Expect = 3e-07
Identities = 20/83 (24%), Positives = 28/83 (33%), Gaps = 1/83 (1%)
Query: 13 EEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPP 72
PPAP + N D S P+ P S P+ P P P S+PP
Sbjct: 49 APPPPPAPAAGNPPDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEA-PASAPPA 107
Query: 73 ATSSSPPPASPPTSDNNKPDPPK 95
A + P P + + +
Sbjct: 108 AGRAVPGLYHHPVPEPDPVRVEE 130
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 6e-06
Identities = 15/100 (15%), Positives = 27/100 (27%), Gaps = 6/100 (6%)
Query: 59 SPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNK 118
S S P S P++ T PP + P PP P
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVT-----SAASDFLAALHPPVTVPDPAPPPPPAPA 57
Query: 119 SPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSS 158
+ +PP + + P +++ + +
Sbjct: 58 AGNPPD-TVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQP 96
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 8e-06
Identities = 19/96 (19%), Positives = 27/96 (28%), Gaps = 6/96 (6%)
Query: 14 EGSPPAPPSSNSSDATPPPSS-TPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPP 72
P PP + PP + S P P +S P+ + P +P
Sbjct: 45 VPDPAPPPPPAPAAGNPPDTVTGD-SVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPAS 103
Query: 73 ATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSS 108
A PP A P+ P S+
Sbjct: 104 A----PPAAGRAVPGLYHHPVPEPDPVRVEEVSRRI 135
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 47/215 (21%), Positives = 84/215 (39%), Gaps = 36/215 (16%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVK--SLKTGSGQGEREFSAEVEIISRVHH-RHLVSLVG 379
+G+G FG + +G L N ++VA+K ++ + Q E + + ++
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDE----YRTYKLLAGCTGIPNVYY 73
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
+ G +LV + + +LE L R T A + +HE ++
Sbjct: 74 FGQEGLHNVLVIDLLG-PSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKS---LV 128
Query: 440 HRDIKAANILI------DDNFEAMVADFGLAK--LSNDNHTHVSTR----VMGTFGYLAP 487
+RDIK N LI + N +V DFG+ K H+ R + GT
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVV-DFGMVKFYRDPVTKQHIPYREKKNLSGT-----A 182
Query: 488 EYAS----SGK-LTEKSDVFSFGVMLLELITGRRP 517
Y S G+ + + D+ + G + + + G P
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 11/94 (11%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT---HVSTRVMGT 481
G+ +LH IIHRD+K +NI++ + + DFGLA+ + + +V TR
Sbjct: 138 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--- 191
Query: 482 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR 515
Y APE E D++S G ++ E+I G
Sbjct: 192 --YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 71.5 bits (174), Expect = 6e-13
Identities = 20/159 (12%), Positives = 45/159 (28%), Gaps = 1/159 (0%)
Query: 9 ETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPS 68
E +G A P + S T S S + +
Sbjct: 15 ENLYFQGEETAVPEN-SGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEGVATASE 73
Query: 69 SPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPP 128
+ PA++ + + + KP+ + PS+++ P + K +
Sbjct: 74 TASPASNEAATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDES 133
Query: 129 PPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDY 167
PA +++ ++ + K +S +
Sbjct: 134 KPAAEANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELL 172
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 52.3 bits (124), Expect = 4e-07
Identities = 17/220 (7%), Positives = 47/220 (21%), Gaps = 10/220 (4%)
Query: 46 PPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNN--KPDPPKNSPPPPPP 103
+ P + ++ S S + +N K + + P
Sbjct: 21 GEETAVPENSGANTELVS---GESEHSTNEADKQNEGEHARENKLEKAEGVATASETASP 77
Query: 104 SSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSS 163
+S + T + + P + A+ S P + K +++ + ++
Sbjct: 78 ASNEAATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDESKPAA 137
Query: 164 GDDYVTYSVIGAVGVGIFLIAMIIICAVRANKKKKKRHNQPMHYYGDHSNHFKKGGDPYY 223
+ + K + +G
Sbjct: 138 -----EANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLA 192
Query: 224 SGGHAPNWHGHPEHQNWHSHPQGPDHTGGNIPPPPGGNWP 263
S + + + + G +
Sbjct: 193 SRRTGHLVNEKASKEAKVQALSNTNSKAKDHASVGGEEFK 232
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 34/93 (36%), Positives = 55/93 (59%), Gaps = 10/93 (10%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFG 483
+GL Y+H IIHRD+K +N+ ++++ E + DFGLA+ + D T +V+TR
Sbjct: 143 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 484 YLAPEYA-SSGKLTEKSDVFSFGVMLLELITGR 515
Y APE + + D++S G ++ EL+TGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 52/227 (22%), Positives = 87/227 (38%), Gaps = 43/227 (18%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLK---TGSGQGEREF-----SAEVEIISRVHHRH 373
+G GGFG ++ ++ A +K +G E A+ + I + R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 374 LVSLVG-----YC-----IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGS 423
+ +G R +V E + L+ + G+N +T +++ +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLG-IDLQ-KISGQNGT-FKKSTVLQLGIRM 160
Query: 424 AKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMV--ADFGLAKLSNDNHTHV------S 475
L Y+HE+ +H DIKAAN+L+ V AD+GL+ N H
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPR 217
Query: 476 TRVMGTFGYLAPEYAS----SGK-LTEKSDVFSFGVMLLELITGRRP 517
GT E+ S G L+ +SDV G +L + G+ P
Sbjct: 218 KGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 29/135 (21%), Positives = 43/135 (31%), Gaps = 4/135 (2%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
+ +T SS S + S P+ P P SP SP S+ +
Sbjct: 6 HHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPING 65
Query: 77 SPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSP 136
PP S +S P P + P P+ S P S+ +P PP +
Sbjct: 66 MGPPFSVISS----PMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGV 121
Query: 137 PPPPLKYSSSTPKSS 151
P S + +
Sbjct: 122 LKVPAHPSGNMASFT 136
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 68.6 bits (167), Expect = 3e-12
Identities = 26/141 (18%), Positives = 37/141 (26%), Gaps = 6/141 (4%)
Query: 22 SSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPA 81
+ + S+ S P + P S PS P P S
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAP--SLHPSLGPGIGSPGQLHSPISTL 59
Query: 82 SPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPL 141
S P + P P S P +P+ S P S P SS P
Sbjct: 60 SSPINGMGPPFS----VISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPP 115
Query: 142 KYSSSTPKSSSSSSKSSNGSS 162
+ K + S + +
Sbjct: 116 LGLNGVLKVPAHPSGNMASFT 136
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 21/132 (15%), Positives = 32/132 (24%), Gaps = 3/132 (2%)
Query: 12 NEEGSPPAPPSSNSSDATPPPSSTPSSSP---PPSSPPPASPPPSSPPPSSPPPSKSPPS 68
+ + + +S T P ++P P P SP P S+ +
Sbjct: 8 HVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGMG 67
Query: 69 SPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPP 128
P SS P S SP P + S +
Sbjct: 68 PPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAH 127
Query: 129 PPAKKSSPPPPP 140
P +S
Sbjct: 128 PSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 3e-09
Identities = 23/126 (18%), Positives = 31/126 (24%), Gaps = 1/126 (0%)
Query: 46 PPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSS 105
S + S +SP S + P P +SP S
Sbjct: 4 HHHHHVDDDDKMFSTQVN-SSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSP 62
Query: 106 QSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGD 165
+ PP + P S P P S P SSS K G +
Sbjct: 63 INGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVL 122
Query: 166 DYVTYS 171
+
Sbjct: 123 KVPAHP 128
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 27/138 (19%), Positives = 39/138 (28%), Gaps = 15/138 (10%)
Query: 38 SSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNS 97
+ S+ SS SP A S P P
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLT---SPTGRGSMAAPSLHPSLGPGIG----------- 47
Query: 98 PPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKS 157
P S S+ + P P + SP P S P P L +S+ +P+ SS +
Sbjct: 48 SPGQLHSPISTLSSPINGMG-PPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPV 106
Query: 158 SNGSSSGDDYVTYSVIGA 175
S+ V+
Sbjct: 107 SSSEDIKPPLGLNGVLKV 124
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 24/208 (11%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVK--SLKTGSGQGEREFSAEVEIISRVHH-RHLVSLVG 379
+G G FG ++ G + G+EVA+K +KT Q E +I + + ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIE----SKIYKMMQGGVGIPTIRW 72
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
G ++V E + +LE + +R T + +A + Y+H I
Sbjct: 73 CGAEGDYNVMVMELLG-PSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKN---FI 127
Query: 440 HRDIKAANILI---DDNFEAMVADFGLAK--LSNDNHTHVSTR----VMGTFGYLAPEYA 490
HRD+K N L+ + DFGLAK H H+ R + GT Y A
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-ASINT 186
Query: 491 SSGK-LTEKSDVFSFGVMLLELITGRRP 517
G + + D+ S G +L+ G P
Sbjct: 187 HLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 46/229 (20%), Positives = 86/229 (37%), Gaps = 44/229 (19%)
Query: 323 LLGQGGFGYVHKGVLPNGK------EVAVKSLKTGSGQGEREFS-----AEVEIISRVHH 371
+GQGGFG ++ + + + VK + +G E A+ E I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 372 RHLVSLVG------YCIAGGQ----RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIAL 421
+ +G + R ++ + L+ ++ N T ++++L
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFG-SDLQ-KIYEANAKRFSRKTVLQLSL 159
Query: 422 GSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMV--ADFGLAK--LSNDNHTHVSTR 477
L Y+HE +H DIKA+N+L++ V D+GLA H +
Sbjct: 160 RILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216
Query: 478 ----VMGTFGYLAPEYAS----SGK-LTEKSDVFSFGVMLLELITGRRP 517
GT E+ S +G + + D+ G +++ +TG P
Sbjct: 217 PKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 48/237 (20%), Positives = 85/237 (35%), Gaps = 57/237 (24%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI 382
LG G FG V + + +GK A+K + RE ++I+ + H +++ LV Y
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVNIIKLVDYFY 70
Query: 383 AGGQRMLVYEFVSNKTLEYHLHGENRP------------------VMDF--ATRVRIALG 422
G + + +M++ T ++
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 423 SAK-------------------GLAYLHEDCHPRIIHRDIKAANILID-DNFEAMVADFG 462
+ + ++H I HRDIK N+L++ + + DFG
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 463 LAKLSNDNHTHVS---TRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 515
AK + V+ +R Y APE + + T D++S G + ELI G+
Sbjct: 188 SAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 47/213 (22%), Positives = 80/213 (37%), Gaps = 32/213 (15%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHH-RHLVSLVGYC 381
+G G FG + G L + VA+K S + E ++ + + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYFG 74
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441
G +V E + +LE +R T + IA+ + Y+H +I+R
Sbjct: 75 PCGKYNAMVLELLG-PSLEDLFDLCDR-TFSLKTVLMIAIQLISRMEYVHSKN---LIYR 129
Query: 442 DIKAANILI------DDNFEAMVADFGLAK--LSNDNHTHVSTR----VMGTFGYLAPEY 489
D+K N LI ++ DF LAK + + H+ R + GT Y
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHII-DFALAKEYIDPETKKHIPYREHKSLTGT-----ARY 183
Query: 490 AS----SGK-LTEKSDVFSFGVMLLELITGRRP 517
S GK + + D+ + G M + + G P
Sbjct: 184 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 32/99 (32%), Positives = 57/99 (57%), Gaps = 16/99 (16%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH-------VSTR 477
+GL Y+H ++HRD+K +N+L++ + + DFGLA++++ +H H V+TR
Sbjct: 139 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 478 VMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGR 515
Y APE +S T+ D++S G +L E+++ R
Sbjct: 196 -----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 11/94 (11%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT---HVSTRVMGT 481
G+ +LH IIHRD+K +NI++ + + DFGLA+ + + +V TR
Sbjct: 175 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--- 228
Query: 482 FGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR 515
Y APE E D++S G ++ E++ +
Sbjct: 229 --YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 49/213 (23%), Positives = 87/213 (40%), Gaps = 40/213 (18%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSA---EVEIISRVHHR------ 372
++G+G FG V K + VA+K ++ +R E+ I+ + +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR----NEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 373 HLVSLVGY-------CIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAK 425
+++ ++ C+ +E +S E + + R + A +
Sbjct: 160 NVIHMLENFTFRNHICM-------TFELLSMNLYELIKKNKFQGFSLPLVR-KFAHSILQ 211
Query: 426 GLAYLHEDCHPRIIHRDIKAANILIDDNFEAM--VADFGLAKLSNDNH-THVSTRVMGTF 482
L LH+ RIIH D+K NIL+ + V DFG + + T++ +R F
Sbjct: 212 CLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR----F 264
Query: 483 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGR 515
Y APE + D++S G +L EL+TG
Sbjct: 265 -YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 24/207 (11%)
Query: 322 NLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHR----- 372
+L+G+G FG V K + VA+K +K Q + E V ++ ++
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE----VRLLELMNKHDTEMK 115
Query: 373 -HLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLH 431
++V L + + LV+E +S + + R V TR + A L +L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTR-KFAQQMCTALLFLA 174
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAM--VADFGLAKLSNDNH-THVSTRVMGTFGYLAPE 488
IIH D+K NIL+ + + + DFG + ++ +R F Y +PE
Sbjct: 175 TP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR----F-YRSPE 228
Query: 489 YASSGKLTEKSDVFSFGVMLLELITGR 515
D++S G +L+E+ TG
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 27/100 (27%), Positives = 54/100 (54%), Gaps = 17/100 (17%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILID-DNFEAMVADFGLAKLSNDNHTH-------VST 476
+GL Y+H ++HRD+K AN+ I+ ++ + DFGLA++ + +++H + T
Sbjct: 131 RGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 477 RVMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 515
+ Y +P S T+ D+++ G + E++TG+
Sbjct: 188 K-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 23/106 (21%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT------------ 472
+ + LH +IHRD+K +N+LI+ N + V DFGLA++ +++
Sbjct: 123 RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 473 --HVSTRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVMLLELITGR 515
V+TR Y APE +S K + DV+S G +L EL R
Sbjct: 180 VEFVATR-----WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 47/266 (17%), Positives = 82/266 (30%), Gaps = 60/266 (22%)
Query: 263 PGPPPPPPMMSSSGEMSSQFSGPARPPLPPPSPNIALGFNKSTFTYDELAAATGGFAKSN 322
+ SQ G R P ++ S + + + +
Sbjct: 6 AAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPD------RYEIRH 59
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSA---------EVEIISRVHHR 372
L+G G +G+V + + VA+K + R F E+ I++R++H
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKI-------LRVFEDLIDCKRILREIAILNRLNHD 112
Query: 373 HLVSLVGYCIAGGQRM-----LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSA--- 424
H+V ++ I +V E + + R + L
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKK----LF----RTPVYLTELHIK 159
Query: 425 -------KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA------KLSNDNH 471
G+ Y+H I+HRD+K AN L++ + V DFGLA + N
Sbjct: 160 TLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 472 THVSTRVMGTFGYLAPEYASSGKLTE 497
+LT
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTG 242
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 62.4 bits (150), Expect = 2e-10
Identities = 19/160 (11%), Positives = 40/160 (25%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
PP + TP P+ +P ++ P +
Sbjct: 17 PPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDE 76
Query: 77 SPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSP 136
P++P D P P++ P S + + S + +
Sbjct: 77 VSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGAR 136
Query: 137 PPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVTYSVIGAV 176
+ +S + ++ G+ Y A+
Sbjct: 137 VRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHAL 176
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 62.4 bits (150), Expect = 3e-10
Identities = 18/126 (14%), Positives = 34/126 (26%)
Query: 31 PPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNK 90
P +P P+ P +P + S ++ + P +
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 91 PDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKS 150
P P + P PSP S P PP + + +S ++
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRA 130
Query: 151 SSSSSK 156
++
Sbjct: 131 RELGAR 136
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 60.1 bits (144), Expect = 1e-09
Identities = 19/134 (14%), Positives = 37/134 (27%)
Query: 30 PPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNN 89
P P +P PA P +P ++ K P + PPA +
Sbjct: 15 PGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSV 74
Query: 90 KPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPK 149
++P P + SP + + P + + +
Sbjct: 75 DEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELG 134
Query: 150 SSSSSSKSSNGSSS 163
+ + K+S +
Sbjct: 135 ARVRALKASAQDAG 148
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 59.0 bits (141), Expect = 3e-09
Identities = 19/148 (12%), Positives = 39/148 (26%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
+PP S A P + S++ P P + S ++
Sbjct: 21 APPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSP 80
Query: 76 SSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSS 135
S+P P + K++P P +S + + ++
Sbjct: 81 STPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRAL 140
Query: 136 PPPPPLKYSSSTPKSSSSSSKSSNGSSS 163
S TP++ + +
Sbjct: 141 KASAQDAGESCTPEAEGRPEEPCGEKAP 168
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 58.2 bits (139), Expect = 5e-09
Identities = 21/158 (13%), Positives = 38/158 (24%), Gaps = 1/158 (0%)
Query: 11 ENEEGSPPAPPSSNSSDATPPPSSTPSSSP-PPSSPPPASPPPSSPPPSSPPPSKSPPSS 69
PA +S S PP++ PP+ PS+P P
Sbjct: 33 ARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSPSTPEAPDIPACP 92
Query: 70 PPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPP 129
P PA+ ++ K+ +
Sbjct: 93 SPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRALKASAQDAGESCT 152
Query: 130 PAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDY 167
P + P P + + + + + + G Y
Sbjct: 153 PEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYKY 190
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 57.8 bits (138), Expect = 6e-09
Identities = 24/127 (18%), Positives = 40/127 (31%), Gaps = 1/127 (0%)
Query: 36 PSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPK 95
P P P +P P+ P ++P S+ + + PPA+P P +
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARP-ALRAPASATSGSRKRARPPAAPGRDQARPPARRR 69
Query: 96 NSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSS 155
SS S+P P SP + P A + + + +S
Sbjct: 70 LRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQR 129
Query: 156 KSSNGSS 162
G+
Sbjct: 130 ARELGAR 136
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 57.8 bits (138), Expect = 6e-09
Identities = 18/156 (11%), Positives = 33/156 (21%)
Query: 8 TETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPP 67
PA P+ + + S + P A PP S SP
Sbjct: 22 PPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSPS 81
Query: 68 SSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSP 127
+ P + P P P + + S + +
Sbjct: 82 TPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRALK 141
Query: 128 PPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSS 163
P + P + + + +
Sbjct: 142 ASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALA 177
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 52.8 bits (125), Expect = 3e-07
Identities = 22/119 (18%), Positives = 36/119 (30%)
Query: 45 PPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPS 104
PP PP + SP A +S+ + P + PP
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 105 SQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSS 163
S SPS ++P P P K S P ++ + + S+ ++
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQR 129
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 52.4 bits (124), Expect = 3e-07
Identities = 18/151 (11%), Positives = 29/151 (19%), Gaps = 4/151 (2%)
Query: 9 ETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPS 68
T P + A PP S S P P P SP +
Sbjct: 43 ATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSPSTPEAPDIPACPSPGQKIKKST 102
Query: 69 SPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPP 128
PP + + + ++ S + P
Sbjct: 103 PAA----GQPPHLTSAQDQDTISELASCLQRARELGARVRALKASAQDAGESCTPEAEGR 158
Query: 129 PPAKKSSPPPPPLKYSSSTPKSSSSSSKSSN 159
P P ++ +
Sbjct: 159 PEEPCGEKAPAYQRFHALAQPGLPGLVLPYK 189
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 52.0 bits (123), Expect = 4e-07
Identities = 21/115 (18%), Positives = 31/115 (26%), Gaps = 7/115 (6%)
Query: 51 PPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPT 110
P P P K +P PA + PAS + + PP +
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSG-------SRKRARPPAAPGRDQAR 63
Query: 111 PPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGD 165
PP+ + V SP P P P ++ + D
Sbjct: 64 PPARRRLRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQD 118
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 53/278 (19%), Positives = 93/278 (33%), Gaps = 69/278 (24%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSA-----EVEIISRVHHRHLVSL 377
+G+G +GYV+ K VA+K + + E E+ I++R+ +++ L
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKV---NRMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 378 VGYCIAGGQRM-----LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSA-------- 424
I +V E + L + + I L
Sbjct: 91 YDLIIPDDLLKFDELYIVLEI-----ADSDLKK----LF----KTPIFLTEEHIKTILYN 137
Query: 425 --KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA-KLSNDNHTHVSTRVMGT 481
G ++HE IIHRD+K AN L++ + V DFGLA ++++ T++ +
Sbjct: 138 LLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 482 FGYLAPEYASSGKLTE--------------------KS-DVFSFGVMLLELITGRRPVDM 520
+LT KS D++S G + EL+ +
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254
Query: 521 TMMEDSLVEWARPLL-GAALEDGIYDGLVDPRLEHNYV 557
PL G++ D E +
Sbjct: 255 DPTN------RFPLFPGSSCFPLSPDRNSKKVHEKSNR 286
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 22/109 (20%), Positives = 33/109 (30%), Gaps = 3/109 (2%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA 73
+ T P+ S + P + + + PP P
Sbjct: 337 CQFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPP 396
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPPPP---PPSSQSSPTPPSPSNNKS 119
PP PP + PP+ PPPP PP PP +N++
Sbjct: 397 PQGYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAAPPQGVDNQA 445
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 23/103 (22%), Positives = 34/103 (33%), Gaps = 5/103 (4%)
Query: 3 KGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPP 62
+ + + E E + + ++ S+DA P +PPP PP
Sbjct: 343 ETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQGYPP 402
Query: 63 SKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSS 105
PP PP PP PP+ +PP PP
Sbjct: 403 QGYPPQGYPPQGYPPQGYPPPPQG-----APPQGAPPAAPPQG 440
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 24/93 (25%), Positives = 36/93 (38%), Gaps = 7/93 (7%)
Query: 5 NNVTETENEEGSPPAPPSSNS---SDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPP 61
+ E+ + +P A + + + P +PPP PP PP P
Sbjct: 352 TEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQGYPPQGYPPQGYP 411
Query: 62 PSKSPPSSPPPATSSSPP----PASPPTSDNNK 90
P PP PP +PP PA+PP +N+
Sbjct: 412 PQGYPPQGYPPPPQGAPPQGAPPAAPPQGVDNQ 444
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 17/104 (16%), Positives = 30/104 (28%), Gaps = 3/104 (2%)
Query: 20 PPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPP 79
++ + + + P A + + ++ PP + PP
Sbjct: 338 QFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPP 397
Query: 80 PASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPP 123
PP + PP+ PP P P P +PP
Sbjct: 398 QGYPPQGYPPQGYPPQGYPPQGYP---PPPQGAPPQGAPPAAPP 438
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 21/112 (18%), Positives = 31/112 (27%), Gaps = 12/112 (10%)
Query: 26 SDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPT 85
D + + P+ + P + + A + PP
Sbjct: 339 FDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQA--AYPPQGYA-- 394
Query: 86 SDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPP 137
PP PP Q P P P PP +PP A ++PP
Sbjct: 395 -------PPPQGYPPQGYPPQGYPPQGYPPQGYPP-PPQGAPPQGAPPAAPP 438
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 12/103 (11%), Positives = 20/103 (19%), Gaps = 3/103 (2%)
Query: 46 PPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSS 105
+ S P+ ++ + + PP +
Sbjct: 338 QFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQ---KMQQQQAAYPPQGYA 394
Query: 106 QSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTP 148
P PP PP PP + P
Sbjct: 395 PPPQGYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAAP 437
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 13/90 (14%), Positives = 27/90 (30%)
Query: 42 PSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPP 101
P+SP ++ + P + +PP+ T P + + P P ++
Sbjct: 5 PTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATVA 64
Query: 102 PPSSQSSPTPPSPSNNKSPSPPVFSPPPPA 131
+ + + PPP
Sbjct: 65 AGHATLREHLRDIKAENTDANFYVCPPPTG 94
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 16/93 (17%), Positives = 27/93 (29%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
PA P+S + + + P +PP P+ P P+ P PA ++
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 78 PPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPT 110
A T + D +
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPPTG 94
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 16/93 (17%), Positives = 30/93 (32%), Gaps = 4/93 (4%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
P AP S + + P+ P + P P P K+P P ++
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 77 SPPPASPPTSDNNKPDPPKNSPPP----PPPSS 105
+ ++ + +N+ PPP+
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPPTG 94
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 12/92 (13%), Positives = 22/92 (23%)
Query: 47 PASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQ 106
PA+P P + + PA + + P +PP P +
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 107 SSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPP 138
+ + + PP
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPPT 93
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 14/95 (14%), Positives = 32/95 (33%), Gaps = 3/95 (3%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA 73
+ + P P + A ++ ++P P + A P + P + +PP
Sbjct: 1 DPAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDN 60
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPP---PPPPSS 105
+ + A+ + ++ PPP +
Sbjct: 61 ATVAAGHATLREHLRDIKAENTDANFYVCPPPTGA 95
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 16/96 (16%), Positives = 32/96 (33%), Gaps = 3/96 (3%)
Query: 59 SPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPS-NN 117
+ P S P +++ PA+P P P P +PTPP P+ +N
Sbjct: 3 AAPTSPGTPGVAAATQAANGGPATPAPP--ALGAAPTGDPKPKKNKKPKNPTPPRPAGDN 60
Query: 118 KSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSS 153
+ + + + + P + ++
Sbjct: 61 ATVAAGHATLREHLRDIKAENTDANFYVCPPPTGAT 96
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 12/99 (12%), Positives = 29/99 (29%), Gaps = 4/99 (4%)
Query: 67 PSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFS 126
P++P + A+ + P +PP + P P K+P+PP +
Sbjct: 2 PAAPTSPGTPGVAAATQAAN----GGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPA 57
Query: 127 PPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGD 165
+ +++ ++ +
Sbjct: 58 GDNATVAAGHATLREHLRDIKAENTDANFYVCPPPTGAT 96
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 10/95 (10%), Positives = 23/95 (24%), Gaps = 5/95 (5%)
Query: 13 EEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPP 72
+ + P + P+ P P P P+ + +
Sbjct: 17 TQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATVAAGHATLREHLRD 76
Query: 73 ATSSSPPP-----ASPPTSDNNKPDPPKNSPPPPP 102
+ + P + + + P+ P P
Sbjct: 77 IKAENTDANFYVCPPPTGATVVQFEQPRRCPTRPE 111
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 16/124 (12%), Positives = 38/124 (30%), Gaps = 10/124 (8%)
Query: 80 PASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPP 139
PA+P + P P ++ TP P+ +P+ K+ PP
Sbjct: 2 PAAPTS-----PGTP-GVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPR 55
Query: 140 PLKYSSSTPKSSSSSSKSSNGSSSGDDYVTYSVIG-AVGVGIFLIAMIIICAVRANKKKK 198
P +++ ++ + + + + V G + C + +
Sbjct: 56 PAGDNATVAAGHATLREHLRDIKAENTDANFYVCPPPTGATVVQFEQPRRC---PTRPEG 112
Query: 199 KRHN 202
+ +
Sbjct: 113 QNYT 116
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 58/244 (23%), Positives = 92/244 (37%), Gaps = 86/244 (35%)
Query: 323 LLGQGGFGYV-----HKGVLPNGKEVAVKSLKTGSGQGEREFSA---EVEIISRVHHR-- 372
LG+G FG V HK G+ VAVK +K +R A E++++ ++
Sbjct: 21 TLGEGAFGKVVECIDHKA---GGRHVAVKIVK----NVDRYCEAARSEIQVLEHLNTTDP 73
Query: 373 ----HLVSLVGY-------CIAGGQRML---VYEFV-SNKTLEYHLHGENRPVMDFATRV 417
V ++ + CI +L Y+F+ N L + L +
Sbjct: 74 NSTFRCVQMLEWFEHHGHICIV--FELLGLSTYDFIKENGFLPFRLD-----------HI 120
Query: 418 R-IALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVA----------------- 459
R +A K + +LH ++ H D+K NIL +
Sbjct: 121 RKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
Query: 460 --DFGLAKLSNDNH-THVSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVMLLE 510
DFG A +++H T VSTR Y APE + ++ DV+S G +L+E
Sbjct: 178 VVDFGSATYDDEHHSTLVSTRH-----YRAPEVILALGW------SQPCDVWSIGCILIE 226
Query: 511 LITG 514
G
Sbjct: 227 YYLG 230
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 7e-10
Identities = 38/248 (15%), Positives = 66/248 (26%), Gaps = 59/248 (23%)
Query: 314 ATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVK--------SLKTGSGQGEREFSAEVEI 365
T + +G+G FG V + + + VA+K + + E E+ I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 366 ISRVH---------HRHLVSLVGYCIAGGQR----MLVYEFVSNKT-------------- 398
+ + L G + ++ ++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 399 ----LEYHLHGE-----NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANIL 449
LE+ G + AT I LA HRD+ N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVL 194
Query: 450 IDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAP--EYASSGKLTEKSDVFSFGVM 507
+ + K S + + G +Y S + VF M
Sbjct: 195 LKKTSLKKLHYTLNGKSST----------IPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244
Query: 508 LLELITGR 515
+L TG
Sbjct: 245 DEDLFTGD 252
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 17/107 (15%), Positives = 26/107 (24%)
Query: 42 PSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPP 101
+ PS SS + S P ++ PP S PP
Sbjct: 5 EAMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHG 64
Query: 102 PPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTP 148
+ KS P ++ P + + SS
Sbjct: 65 SLQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPAS 111
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 21/147 (14%), Positives = 34/147 (23%), Gaps = 9/147 (6%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
A PS SS + + P + P P P + +
Sbjct: 5 EAMSQVIQ----AMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTM 60
Query: 78 PPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSS-- 135
PP S P + P SSP + P
Sbjct: 61 PPHGSLQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELL 120
Query: 136 ---PPPPPLKYSSSTPKSSSSSSKSSN 159
P P ++ +++S +
Sbjct: 121 KCEPDEPQVQAKIMAYLQQEQANRSKH 147
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 16/150 (10%), Positives = 30/150 (20%), Gaps = 14/150 (9%)
Query: 17 PPAPPSSNSSDA----TPPPSSTPSSSP--PPSSPPPASPPPSSPPPSSPPPSKSPPSSP 70
P S A P + PP+ + S + PP
Sbjct: 12 QAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGSLQGYQT 71
Query: 71 PPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSN--------NKSPSP 122
S + P + P+ + S + P
Sbjct: 72 YGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPDEPQVQA 131
Query: 123 PVFSPPPPAKKSSPPPPPLKYSSSTPKSSS 152
+ + + + L K +
Sbjct: 132 KIMAYLQQEQANRSKHEKLSTFGLMCKMAD 161
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 17/117 (14%), Positives = 30/117 (25%), Gaps = 5/117 (4%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
+ A P ++ + S + PP S P + P +S P +
Sbjct: 37 NHAALPPTDYDRSPFVTSPISMTMPPHGSLQGYQTYGHFPSRAIKSEYPDPYTSSPESIM 96
Query: 76 SSPPPASPPTSDNNKPDPPKNS-----PPPPPPSSQSSPTPPSPSNNKSPSPPVFSP 127
S TS P P ++ N+S + +
Sbjct: 97 GYSYMDSYQTSSPASIPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTF 153
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 12/111 (10%), Positives = 20/111 (18%), Gaps = 8/111 (7%)
Query: 8 TETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPP 67
T+ + + + T P + P +S P S S
Sbjct: 44 TDYDRSPFVTSPISMTMPPHGSLQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDS 103
Query: 68 SSPPPATSSSPP--------PASPPTSDNNKPDPPKNSPPPPPPSSQSSPT 110
S P P + S+
Sbjct: 104 YQTSSPASIPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFG 154
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 21/108 (19%), Positives = 30/108 (27%), Gaps = 10/108 (9%)
Query: 69 SPPPATSSSPPPASPPTSDNNKPDPPKNSP-----PPPPPSSQSSPTPPSPSNNKSPSPP 123
+ + P + ++ N K P PP +S S P
Sbjct: 6 AMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGS 65
Query: 124 VFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDYVTYS 171
+ S S P +SS +S G S D Y T S
Sbjct: 66 LQGYQTYGHFPSRAIK-----SEYPDPYTSSPESIMGYSYMDSYQTSS 108
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 55/246 (22%), Positives = 91/246 (36%), Gaps = 86/246 (34%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVK---SLKTGSGQGEREFSAEVEIISRV-----HHRH 373
+G G FG V + N K AVK ++K + + E +I+ ++ ++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNNN 97
Query: 374 LVSLVGY-------CIA----GGQRMLVYEFV-SNKTLEYHLHGENRPVMDFATRVR-IA 420
+V G C+ G +YE + N +H+ ++
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLG---PSLYEIITRNNYNGFHIE-----------DIKLYC 143
Query: 421 LGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAM----------------------- 457
+ K L YL + + H D+K NIL+DD +
Sbjct: 144 IEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 458 --VADFGLAKLSNDNH-THVSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVML 508
+ DFG A +D H + ++TR Y APE + SD++SFG +L
Sbjct: 201 IKLIDFGCATFKSDYHGSIINTR----Q-YRAPEVILNLGW------DVSSDMWSFGCVL 249
Query: 509 LELITG 514
EL TG
Sbjct: 250 AELYTG 255
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 26/112 (23%), Positives = 45/112 (40%), Gaps = 24/112 (21%)
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGY 484
K + YLH ++HRD+K +NIL++ VADFGL++ + + +
Sbjct: 120 KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 485 LAPEYASSGKLTE--------------------KS-DVFSFGVMLLELITGR 515
LT+ K D++S G +L E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 48/236 (20%), Positives = 83/236 (35%), Gaps = 70/236 (29%)
Query: 323 LLGQGGFGYVHKGV--LPNGKEVAVK---SLKTGSGQGEREFSAEVEIISRVHHR----- 372
LG+G FG V + + +VA+K ++ E + ++ ++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKENK 81
Query: 373 -HLVSLVGY-------CIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSA 424
V + + CI +E + T E+ +P R +A
Sbjct: 82 FLCVLMSDWFNFHGHMCI-------AFELLGKNTFEFLKENNFQPYPLPHVR-HMAYQLC 133
Query: 425 KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVA-------------------DFGLAK 465
L +LHE ++ H D+K NIL ++ + DFG A
Sbjct: 134 HALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 466 LSNDNH-THVSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVMLLELITG 514
+++H T V+TR Y PE + + DV+S G +L E G
Sbjct: 191 FDHEHHTTIVATRH-----YRPPEVILELGW------AQPCDVWSIGCILFEYYRG 235
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 58.5 bits (140), Expect = 5e-09
Identities = 17/128 (13%), Positives = 31/128 (24%)
Query: 39 SPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSP 98
++ A+ + S + PA + P K P
Sbjct: 6 KAAAAAAAAAAAATGTEAGPGTAGGSENGSEVAAQPAGLSGPAEVGPGAVGERTPRKKEP 65
Query: 99 PPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSS 158
P P + P S P+ S P + P + S
Sbjct: 66 PRASPPGGLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTSRRKRAKVEYREMDE 125
Query: 159 NGSSSGDD 166
+ ++ +D
Sbjct: 126 SLANLSED 133
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 55.4 bits (132), Expect = 4e-08
Identities = 18/134 (13%), Positives = 38/134 (28%), Gaps = 6/134 (4%)
Query: 37 SSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKN 96
+++ ++ + S S+ + + P + K +PP+
Sbjct: 9 AAAAAAAAAATGTEAGPGTAGGSENGSEVAAQPAGLSGPAEVGPGAVGERTPRKKEPPRA 68
Query: 97 SPPPPPPSSQSSPTP-PSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSS 155
SPP S P P+ + P+ + + K
Sbjct: 69 SPPGGLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTS-----RRKRAKVEYREM 123
Query: 156 KSSNGSSSGDDYVT 169
S + S D+Y +
Sbjct: 124 DESLANLSEDEYYS 137
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 49.6 bits (117), Expect = 3e-06
Identities = 21/131 (16%), Positives = 30/131 (22%), Gaps = 4/131 (3%)
Query: 9 ETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPS 68
+ S PA + P P + PP P P+ P S
Sbjct: 38 AAQPAGLSGPAEVGPGAVGERTPRKKEPPRASPPGGL----AEPPGSAGPQAGPTVVPGS 93
Query: 69 SPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPP 128
+ P T + P TS + + N PP
Sbjct: 94 ATPMETGIAETPEGRRTSRRKRAKVEYREMDESLANLSEDEYYSEEERNAKAEKEKKLPP 153
Query: 129 PPAKKSSPPPP 139
PP +
Sbjct: 154 PPPQAPPEEEN 164
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 4e-05
Identities = 25/121 (20%), Positives = 35/121 (28%), Gaps = 5/121 (4%)
Query: 13 EEGSPPAPPSSNSSDATPPPSSTPS--SSPPPSSPPPASP--PPSSPPPSSPPPSKSPPS 68
E P A PP +S P + PP S+ P A P P S P +++P
Sbjct: 48 AEVGPGAVGERTPRKKEPPRASPPGGLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEG 107
Query: 69 SPPPATSSSPPPA-SPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSP 127
+ S N + S ++ P P P S
Sbjct: 108 RRTSRRKRAKVEYREMDESLANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESE 167
Query: 128 P 128
P
Sbjct: 168 P 168
|
| >2xag_A Lysine-specific histone demethylase 1; amine oxidase, chromatin regulator, histone inhibitor binding, methylation, nucleosome core, oxidoreductase; HET: FAD TCF; 3.10A {Homo sapiens} PDB: 2xaf_A* 2xah_A* 2xaj_A* 2xaq_A* 2xas_A* 2com_A Length = 852 | Back alignment and structure |
|---|
Score = 42.7 bits (99), Expect = 4e-04
Identities = 19/103 (18%), Positives = 26/103 (25%), Gaps = 3/103 (2%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPS-SPPPSKSPPSSPPP 72
SPP + A P T + P S
Sbjct: 67 RASPPGGLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTSRRKRAKVEYREMDES 126
Query: 73 ATSSSPPPASPPTSDNNKPDPPKNSPPPPP--PSSQSSPTPPS 113
+ S N K + K PPPPP P + + + P
Sbjct: 127 LANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESEPE 169
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 7e-09
Identities = 22/121 (18%), Positives = 30/121 (24%)
Query: 28 ATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSD 87
P+ S +P PP + PP P P P P P
Sbjct: 25 VIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKP 84
Query: 88 NNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSST 147
KP P P P P++ + P A ++ P S
Sbjct: 85 KPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASGPR 144
Query: 148 P 148
Sbjct: 145 A 145
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 8e-09
Identities = 21/124 (16%), Positives = 32/124 (25%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
+ + A P P P P P P PP P P P
Sbjct: 32 AQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPK 91
Query: 77 SPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSP 136
+ KP + + P + + + + P V S P ++ P
Sbjct: 92 PVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASGPRALSRNQP 151
Query: 137 PPPP 140
P
Sbjct: 152 QYPA 155
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 26/128 (20%), Positives = 39/128 (30%)
Query: 32 PSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKP 91
P + S P + P S + PPP P P P + K
Sbjct: 15 PRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKE 74
Query: 92 DPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSS 151
P P P P + P K PV S P +++ P +++ S
Sbjct: 75 APVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSK 134
Query: 152 SSSSKSSN 159
+S +S
Sbjct: 135 PVTSVASG 142
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 20/142 (14%), Positives = 33/142 (23%)
Query: 8 TETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPP 67
+ + S P S+ S P+ + PA P P P P
Sbjct: 3 SHHHHHHSSGLVPRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPE 62
Query: 68 SSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSP 127
P P KP P + P +
Sbjct: 63 PEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPAR 122
Query: 128 PPPAKKSSPPPPPLKYSSSTPK 149
+ ++ P+ +S P+
Sbjct: 123 LTSSTATAATSKPVTSVASGPR 144
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 3e-07
Identities = 23/115 (20%), Positives = 33/115 (28%), Gaps = 4/115 (3%)
Query: 16 SPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATS 75
+P + P P P P P PP P P P K P
Sbjct: 41 TPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQE-- 98
Query: 76 SSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPP 130
P ++ P +N+ P SS ++ P + + P S P
Sbjct: 99 --QPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASGPRALSRNQP 151
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 6e-07
Identities = 18/117 (15%), Positives = 26/117 (22%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
P P P PP +P P P P P
Sbjct: 43 ADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKR 102
Query: 77 SPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKK 133
P + + P ++ S P S ++ S P A+
Sbjct: 103 DVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASGPRALSRNQPQYPARAQA 159
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 2e-06
Identities = 17/116 (14%), Positives = 23/116 (19%)
Query: 6 NVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKS 65
+ PP P P P P P +
Sbjct: 40 VTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQ 99
Query: 66 PPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPS 121
P P S P + P S S P S + + P+
Sbjct: 100 PKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASGPRALSRNQPQYPA 155
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 4e-06
Identities = 19/118 (16%), Positives = 27/118 (22%), Gaps = 1/118 (0%)
Query: 7 VTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSP 66
VT + PP P PP P P P P P K
Sbjct: 37 VTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKV 96
Query: 67 PSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSP-TPPSPSNNKSPSPP 123
P + P + ++ +S + P + P P
Sbjct: 97 QEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASGPRALSRNQPQYP 154
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 15/109 (13%), Positives = 26/109 (23%)
Query: 7 VTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSP 66
E P P + P P P P
Sbjct: 49 QAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVE 108
Query: 67 PSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPS 115
P +++P + T+ P + P S++ P P+ +
Sbjct: 109 SRPASPFENTAPARLTSSTATAATSKPVTSVASGPRALSRNQPQYPARA 157
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 16/115 (13%), Positives = 34/115 (29%)
Query: 51 PPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPT 110
S P+ + P S T + P P+ P P P + +P
Sbjct: 18 SHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPV 77
Query: 111 PPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGD 165
K P + P +S ++++ + +S+ +++
Sbjct: 78 VIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAAT 132
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 24/152 (15%), Positives = 34/152 (22%), Gaps = 12/152 (7%)
Query: 12 NEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPP 71
P SS + P A P + PS
Sbjct: 17 RRSDEPAKTKKGLSSILDAARWNRGEPQVPDFRHLKAEVDAEKPGATDRKGGVGMPSRD- 75
Query: 72 PATSSSPPPASPPTSDNNKP--DPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPP------ 123
+ P P + D P P P +P P + +S +PP
Sbjct: 76 --RNIGAPGQDTPGVSLHPLSLDSPDREPGADAPLELGDSSPQGPMSLESLAPPESTDEG 133
Query: 124 -VFSPPPPAKKSSPPPPPLKYSSSTPKSSSSS 154
P P + P L+ P
Sbjct: 134 AETESPEPGDEGEPGRSGLELEPEEPPGWREL 165
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 23/137 (16%), Positives = 32/137 (23%), Gaps = 1/137 (0%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA 73
G P P + + P +P +P S P S P
Sbjct: 40 RGEPQVPDFRHLKAEVDAEKPGATDRKGGVGMPSRDRNIGAPGQDTPGVSLHPLSLDSPD 99
Query: 74 TSS-SPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAK 132
+ P S P ++ PP + P P + P P
Sbjct: 100 REPGADAPLELGDSSPQGPMSLESLAPPESTDEGAETESPEPGDEGEPGRSGLELEPEEP 159
Query: 133 KSSPPPPPLKYSSSTPK 149
P S PK
Sbjct: 160 PGWRELVPPDTLHSLPK 176
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 25/146 (17%), Positives = 39/146 (26%), Gaps = 6/146 (4%)
Query: 22 SSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPA 81
N P + S S A P K+ + P +
Sbjct: 14 MGNRRSDEPAKTKKGLS----SILDAARWNRGEPQVPDFRHLKAEVDAEKPGATDRKGGV 69
Query: 82 SPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPP-PAKKSSPPPPP 140
P+ D N P +++ P S +P +P S P P S PP
Sbjct: 70 GMPSRDRNIGAPGQDT-PGVSLHPLSLDSPDREPGADAPLELGDSSPQGPMSLESLAPPE 128
Query: 141 LKYSSSTPKSSSSSSKSSNGSSSGDD 166
+ +S + G S +
Sbjct: 129 STDEGAETESPEPGDEGEPGRSGLEL 154
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 20/133 (15%), Positives = 39/133 (29%), Gaps = 3/133 (2%)
Query: 37 SSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNK---PDP 93
S P + S + ++ P P + A P + + K P
Sbjct: 13 VMGNRRSDEPAKTKKGLSSILDAARWNRGEPQVPDFRHLKAEVDAEKPGATDRKGGVGMP 72
Query: 94 PKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSS 153
++ P + S + P P SSP P S + P+S+
Sbjct: 73 SRDRNIGAPGQDTPGVSLHPLSLDSPDREPGADAPLELGDSSPQGPMSLESLAPPESTDE 132
Query: 154 SSKSSNGSSSGDD 166
+++ + +
Sbjct: 133 GAETESPEPGDEG 145
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 53/257 (20%), Positives = 87/257 (33%), Gaps = 72/257 (28%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH--------HRHL 374
LG G F V + K VA+K +K+ E E+ ++ V +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103
Query: 375 VSLVGY-CIAG--GQRM-LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYL 430
V L+ I+G G + +V+E + + L++ + + + + +I +GL YL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK-KIIQQVLQGLDYL 162
Query: 431 HEDCHPRIIHRDIKAANILI---------------------------------------- 450
H C IIH DIK NIL+
Sbjct: 163 HTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220
Query: 451 ---------DDNFEAMVADFGLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSD 500
+ + +AD G A + + T + TR Y + E +D
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPAD 275
Query: 501 VFSFGVMLLELITGRRP 517
++S M EL TG
Sbjct: 276 IWSTACMAFELATGDYL 292
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 24/208 (11%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVK--SLKTGSGQGEREFSAEVEIISRVH-HRHLVSLVG 379
+G G FG ++ G + +EVA+K ++KT Q E +I + + ++
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYE----SKIYRILQGGTGIPNVRW 70
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
+ + G +LV + + +LE + +R + T + +A + ++H +
Sbjct: 71 FGVEGDYNVLVMDLLG-PSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS---FL 125
Query: 440 HRDIKAANILIDDNFEA---MVADFGLAKL--SNDNHTHVSTR----VMGTFGYLAPEYA 490
HRDIK N L+ A + DFGLAK H H+ R + GT Y A
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASVNT 184
Query: 491 SSGK-LTEKSDVFSFGVMLLELITGRRP 517
G + + D+ S G +L+ + G P
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 23/121 (19%), Positives = 36/121 (29%), Gaps = 2/121 (1%)
Query: 45 PPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPS 104
+S PP + P PPA + + + PPP S
Sbjct: 293 LKYQQSQIASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSMDRRRAPPPIAS 352
Query: 105 SQSSPTPPSPSNNKSP--SPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSS 162
+ +P N + PV S +SS SSS +S+ S +
Sbjct: 353 VGTLAKQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDTSEPSRTRA 412
Query: 163 S 163
+
Sbjct: 413 T 413
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 21/135 (15%), Positives = 34/135 (25%)
Query: 8 TETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPP 67
+ P A + P+ P P +P + P S
Sbjct: 87 PKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPSQQVMTPQG 146
Query: 68 SSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSP 127
A +++ + P PP + P P PP+ P
Sbjct: 147 RGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRPPMGPPMGIP 206
Query: 128 PPPAKKSSPPPPPLK 142
P PPP ++
Sbjct: 207 PGRGTPMGMPPPGMR 221
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 22/127 (17%), Positives = 27/127 (21%), Gaps = 6/127 (4%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA 73
EG PP P P P +P + P S
Sbjct: 83 EGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPSQQVM 142
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKK 133
T + S P P P + PP PPP +
Sbjct: 143 TPQGRGTVAAA------AAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMR 196
Query: 134 SSPPPPP 140
PP
Sbjct: 197 PPMGPPM 203
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 9e-08
Identities = 17/109 (15%), Positives = 30/109 (27%)
Query: 17 PPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSS 76
P P+ + + P A+ ++ + P++ PP P
Sbjct: 120 MPQAPAGLAGPVRGVGGPSQQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPM 179
Query: 77 SPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVF 125
P P PP P + +P P + P P +
Sbjct: 180 GRGAPPPGMMGPPPGMRPPMGPPMGIPPGRGTPMGMPPPGMRPPPPGMR 228
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 24/126 (19%), Positives = 35/126 (27%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPAT 74
G+ P ++ P +P + P S +P + ++ AT
Sbjct: 99 GAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPSQQVMTPQGRGTVAAAAAAAT 158
Query: 75 SSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKS 134
+S + P PP PPP P P PP P
Sbjct: 159 ASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRPPMGPPMGIPPGRGTPMGMPPP 218
Query: 135 SPPPPP 140
PPP
Sbjct: 219 GMRPPP 224
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 17/140 (12%), Positives = 27/140 (19%), Gaps = 4/140 (2%)
Query: 25 SSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPP 84
S PP + P + P P P +P P
Sbjct: 79 SMTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPS 138
Query: 85 TSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYS 144
P+ ++ ++ + P PP P
Sbjct: 139 QQ----VMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPG 194
Query: 145 SSTPKSSSSSSKSSNGSSSG 164
P G+ G
Sbjct: 195 MRPPMGPPMGIPPGRGTPMG 214
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 4e-08
Identities = 18/98 (18%), Positives = 27/98 (27%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPA 73
PPP S S P S ++ S+ P + P + SP SS
Sbjct: 17 NLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGG 76
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTP 111
SS A T+ + + +
Sbjct: 77 FFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAA 114
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 5e-08
Identities = 14/110 (12%), Positives = 32/110 (29%)
Query: 21 PSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPP 80
++ + PPPS+ P + P S+ + + +P +SP + S
Sbjct: 15 MANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGG 74
Query: 81 ASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPP 130
+S +N + + + + + P
Sbjct: 75 GGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPH 124
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 8e-08
Identities = 19/102 (18%), Positives = 32/102 (31%)
Query: 22 SSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPA 81
SN P T P P PPP++ P + P S+ ++ ++ P A+ ++P P
Sbjct: 11 DSNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPG 70
Query: 82 SPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPP 123
S ++ S S
Sbjct: 71 SSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGA 112
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 4e-07
Identities = 12/118 (10%), Positives = 26/118 (22%), Gaps = 1/118 (0%)
Query: 4 GNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPS 63
N + N S + +S AS P++P P
Sbjct: 12 SNFMANLPNGY-MTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPG 70
Query: 64 KSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPS 121
S + S++ + + S + + + +
Sbjct: 71 SSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWA 128
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 7e-07
Identities = 23/100 (23%), Positives = 35/100 (35%)
Query: 1 MAKGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSP 60
MA N T+ + PP PP S +S P S+ S+ ++ P ASP SP S
Sbjct: 15 MANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGG 74
Query: 61 PPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPP 100
S S+ T+++ +
Sbjct: 75 GGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAA 114
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 5e-06
Identities = 23/127 (18%), Positives = 36/127 (28%), Gaps = 26/127 (20%)
Query: 33 SSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPD 92
S+ ++ P P P PPPS+ P +P S+
Sbjct: 12 SNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAAS-------------------- 51
Query: 93 PPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSS 152
+ + +SP PSP S FS A K + +S S
Sbjct: 52 ----AERASTAAPVASPAAPSPG--SSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSG 105
Query: 153 SSSKSSN 159
+ +
Sbjct: 106 GAGRGGA 112
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 2e-05
Identities = 17/120 (14%), Positives = 33/120 (27%), Gaps = 1/120 (0%)
Query: 33 SSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPD 92
S + + P+ P PPP P + + A S+ + P + P
Sbjct: 10 SDSNFMANLPNGYMTDLQRPQ-PPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPS 68
Query: 93 PPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSS 152
P + S ++ + + + S V A + L +
Sbjct: 69 PGSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWA 128
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 1e-04
Identities = 17/84 (20%), Positives = 32/84 (38%), Gaps = 4/84 (4%)
Query: 82 SPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPL 141
+ +D +P PP PPPP ++ TP S + + + PA S
Sbjct: 20 NGYMTDLQRPQPP----PPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGG 75
Query: 142 KYSSSTPKSSSSSSKSSNGSSSGD 165
+ SS + ++ ++ + S
Sbjct: 76 GFFSSLSNAVKQTTAAAAATFSEQ 99
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 2e-04
Identities = 12/91 (13%), Positives = 26/91 (28%)
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKK 133
++ P P PP ++ P ++ + S + P P +
Sbjct: 15 MANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGG 74
Query: 134 SSPPPPPLKYSSSTPKSSSSSSKSSNGSSSG 164
T +++++ G SG
Sbjct: 75 GGFFSSLSNAVKQTTAAAAATFSEQVGGGSG 105
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 4e-04
Identities = 17/124 (13%), Positives = 41/124 (33%)
Query: 84 PTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKY 143
+ N P PPPP ++ +P + + + + P A ++P P
Sbjct: 15 MANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGG 74
Query: 144 SSSTPKSSSSSSKSSNGSSSGDDYVTYSVIGAVGVGIFLIAMIIICAVRANKKKKKRHNQ 203
S++ +++ +++ G G G ++++ K +
Sbjct: 75 GGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWAKYFKGK 134
Query: 204 PMHY 207
+H
Sbjct: 135 KIHG 138
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 52.0 bits (123), Expect = 1e-07
Identities = 22/144 (15%), Positives = 36/144 (25%), Gaps = 1/144 (0%)
Query: 30 PPPSSTPSSSPPPSSPPPASPPPSSPPPSSP-PPSKSPPSSPPPATSSSPPPASPPTSDN 88
P++TP P P + P SP K PP PPP + S
Sbjct: 2 GSPAATPEIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSL 61
Query: 89 NKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTP 148
+ P + + + + SS P + +
Sbjct: 62 FEDTFVPEISVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPAT 121
Query: 149 KSSSSSSKSSNGSSSGDDYVTYSV 172
+ + S G + V
Sbjct: 122 VNGTVEGGSGAGRLDLPPGFMFKV 145
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 50.1 bits (118), Expect = 4e-07
Identities = 17/134 (12%), Positives = 29/134 (21%)
Query: 20 PPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPP 79
+ + + P+ P + P SP P PPP K PS
Sbjct: 2 GSPAATPEIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSL 61
Query: 80 PASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPP 139
+ + P + + + S S P + P
Sbjct: 62 FEDTFVPEISVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPAT 121
Query: 140 PLKYSSSTPKSSSS 153
+
Sbjct: 122 VNGTVEGGSGAGRL 135
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 46.2 bits (108), Expect = 9e-06
Identities = 20/133 (15%), Positives = 33/133 (24%)
Query: 8 TETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPP 67
T P + P S PP PP +P +
Sbjct: 7 TPEIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSLFEDTF 66
Query: 68 SSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSP 127
T+ S P + + +P P S +S + P+ P+ +
Sbjct: 67 VPEISVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPATVNGTV 126
Query: 128 PPPAKKSSPPPPP 140
+ PP
Sbjct: 127 EGGSGAGRLDLPP 139
|
| >2krg_A Na(+)/H(+) exchange regulatory cofactor NHE-RF1; acetylation, cell projection, disease mutation, membrane, phosphoprotein, polymorphism; NMR {Homo sapiens} Length = 216 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 1e-06
Identities = 17/100 (17%), Positives = 29/100 (29%)
Query: 9 ETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPS 68
E + P + + P P + S A SP P+ + S S
Sbjct: 93 TDEFFKKCRVIPSQEHLNGPLPVPFTNGEIQKENSREALAEAALESPRPALVRSASSDTS 152
Query: 69 SPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSS 108
+ S P S S + DP + + + +
Sbjct: 153 EELNSQDSPPKQDSTAPSSTSSSDPILDFNISLAMAKERA 192
|
| >2krg_A Na(+)/H(+) exchange regulatory cofactor NHE-RF1; acetylation, cell projection, disease mutation, membrane, phosphoprotein, polymorphism; NMR {Homo sapiens} Length = 216 | Back alignment and structure |
|---|
Score = 41.7 bits (97), Expect = 3e-04
Identities = 19/117 (16%), Positives = 35/117 (29%), Gaps = 2/117 (1%)
Query: 49 SPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSS 108
PS+ + P P ++ + + ++ P S+ S
Sbjct: 91 RETDEFFKKCRVIPSQEHLNGPLPVPFTNGEIQKENSREALAEAALESPRPALVRSASSD 150
Query: 109 PTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGD 165
+ S + P S P + SS P S + K + +SS + D
Sbjct: 151 TSEELNSQDSPPKQD--STAPSSTSSSDPILDFNISLAMAKERAHQKRSSKRAPQMD 205
|
| >3u3p_A Tumor necrosis factor receptor superfamily member; trigger apoptosis, apoptosis; 2.09A {Homo sapiens} PDB: 3u3q_A 3u3s_A 3u3t_A 3u3v_A 3qo4_A Length = 313 | Back alignment and structure |
|---|
Score = 49.6 bits (117), Expect = 2e-06
Identities = 22/132 (16%), Positives = 31/132 (23%), Gaps = 7/132 (5%)
Query: 19 APPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSP 78
S SS +P P + P P + S S S P SS
Sbjct: 171 GTLPSFSSSTSPSPGTAIFPRPEHMETHEVPSSTYVPKGMNSTESNSSASVRPKVLSSIQ 230
Query: 79 PPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPV-------FSPPPPA 131
P + + + N P P K +P
Sbjct: 231 EGTVPDNTSSARGKEDVNKTLPNLQVVNHQQGPHHRHILKLLPSMEATGGEKSSTPIKGP 290
Query: 132 KKSSPPPPPLKY 143
K+ P K+
Sbjct: 291 KRGHPRQNLHKH 302
|
| >2yew_A Capsid protein, coat protein; alphavirus, molecular dynamics; 5.00A {Barmah forest virus} Length = 253 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 19/108 (17%), Positives = 28/108 (25%), Gaps = 3/108 (2%)
Query: 35 TPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPP 94
T + P P P P +PP + PS ++ + K
Sbjct: 6 TQTFYGRRWRPAPVQRYIPQPQPPAPPRRRRGPSQLQQLVAA---LGALALQPKQKQKRA 62
Query: 95 KNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLK 142
+ P PP P K S P K + P+
Sbjct: 63 QKKPKKTPPPKPKKTQKPKKPTQKKKSKPGKRMRNCMKIENDCIFPVM 110
|
| >2yew_A Capsid protein, coat protein; alphavirus, molecular dynamics; 5.00A {Barmah forest virus} Length = 253 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 14/96 (14%), Positives = 20/96 (20%)
Query: 30 PPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNN 89
P P PPA P P + + P
Sbjct: 12 RRWRPAPVQRYIPQPQPPAPPRRRRGPSQLQQLVAALGALALQPKQKQKRAQKKPKKTPP 71
Query: 90 KPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVF 125
P P +S P + K + +F
Sbjct: 72 PKPKKTQKPKKPTQKKKSKPGKRMRNCMKIENDCIF 107
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 6e-06
Identities = 40/282 (14%), Positives = 88/282 (31%), Gaps = 54/282 (19%)
Query: 331 YVHKGVLPNGKEVAVKSLKTGSGQG-EREF--SAEVEIISRVHHRHL-VSLVGYCIAGGQ 386
Y +K +L ++ V + Q + E++ I + + + Q
Sbjct: 16 YQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQ 75
Query: 387 RMLVYEFVSNKTLE--YHLHGENRPVMDF-ATRVRIALGSAKGLAYLHEDCHPRIIHRD- 442
+V +FV + L Y F + ++ + ++ + R+ + D
Sbjct: 76 EEMVQKFV-EEVLRINY----------KFLMSPIKTEQRQPSMMTRMYIEQRDRL-YNDN 123
Query: 443 --IKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFG--YLAPEYASSGKLTEK 498
N+ + + L +L +V + G ++A + S K+ K
Sbjct: 124 QVFAKYNVSRLQPYLKLRQ--ALLEL--RPAKNVLIDGVLGSGKTWVALDVCLSYKVQCK 179
Query: 499 SDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVP 558
F + L L P + M L+ P + D + +L + +
Sbjct: 180 ---MDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS-----DHSSNIKLRIHSIQ 231
Query: 559 HEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSLDDLND 600
E+ RL+ K + +V L ++ +
Sbjct: 232 AELRRLL----------KSKPYENCLLV--------LLNVQN 255
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 7e-06
Identities = 16/102 (15%), Positives = 28/102 (27%), Gaps = 1/102 (0%)
Query: 29 TPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDN 88
TP + T S P + SP P+ + + S+ ++P +S +S
Sbjct: 3 TPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSSFA 62
Query: 89 NKPDPPKNSPP-PPPPSSQSSPTPPSPSNNKSPSPPVFSPPP 129
K SP + + F
Sbjct: 63 VPTIHFKESPFYKIQRLIPELVMNVEVTGGRGMCSAKFKLSK 104
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 4e-05
Identities = 19/94 (20%), Positives = 29/94 (30%), Gaps = 5/94 (5%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
P S+ + + P + SP P +S S+ PP + P A+SSS
Sbjct: 2 LTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRA---PPPTNPDASSSS 58
Query: 78 PPPASPPTSDNNKP--DPPKNSPPPPPPSSQSSP 109
A P P + P +
Sbjct: 59 SSFAVPTIHFKESPFYKIQRLIPELVMNVEVTGG 92
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 5e-05
Identities = 15/100 (15%), Positives = 31/100 (31%), Gaps = 3/100 (3%)
Query: 37 SSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKN 96
S +P + + P + SP + P+ +++S +PP + PD +
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPT---NPDASSS 57
Query: 97 SPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSP 136
S P+ +P P + +
Sbjct: 58 SSSFAVPTIHFKESPFYKIQRLIPELVMNVEVTGGRGMCS 97
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 2e-04
Identities = 17/99 (17%), Positives = 24/99 (24%)
Query: 49 SPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSS 108
S P S P+ P TS + P SS SS
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSS 60
Query: 109 PTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSST 147
P+ +SP + P + S+
Sbjct: 61 FAVPTIHFKESPFYKIQRLIPELVMNVEVTGGRGMCSAK 99
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 2e-04
Identities = 14/91 (15%), Positives = 24/91 (26%)
Query: 65 SPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPV 124
S S P + + +S +S PP + + S S
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSS 60
Query: 125 FSPPPPAKKSSPPPPPLKYSSSTPKSSSSSS 155
F+ P K SP + + +
Sbjct: 61 FAVPTIHFKESPFYKIQRLIPELVMNVEVTG 91
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 3e-04
Identities = 18/81 (22%), Positives = 26/81 (32%), Gaps = 9/81 (11%)
Query: 29 TPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDN 88
+ P S + P PS S +S +TS +PPP +P S
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQR---RKTSTTSSTSRAPPPTNPDAS-- 55
Query: 89 NKPDPPKNSPPPPPPSSQSSP 109
+S P + SP
Sbjct: 56 ----SSSSSFAVPTIHFKESP 72
|
| >1w7p_D VPS36P, YLR417W; ESCRT-II complex, endosomal protein sorting, protein transpo; 3.60A {Saccharomyces cerevisiae} SCOP: a.4.5.54 a.4.5.54 Length = 566 | Back alignment and structure |
|---|
Score = 47.7 bits (112), Expect = 9e-06
Identities = 17/145 (11%), Positives = 30/145 (20%), Gaps = 4/145 (2%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSP----PPA 73
+ D P P P +S S+ + P + P
Sbjct: 127 NETQGEFTKDTLPTPICINCGVPADYELTKSSINCSNAIDPNANPQNQFGVNSENICPAC 186
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKK 133
T ++ P ++ + S + S +
Sbjct: 187 TFANHPQIGNCEICGHRLPNASKVRSKLNRLNFHDSRVHIELEKNSLARNKSSHSALSSS 246
Query: 134 SSPPPPPLKYSSSTPKSSSSSSKSS 158
SS S KS +
Sbjct: 247 SSTGSSTEFVQLSFRKSDGVLFSQA 271
|
| >1w7p_D VPS36P, YLR417W; ESCRT-II complex, endosomal protein sorting, protein transpo; 3.60A {Saccharomyces cerevisiae} SCOP: a.4.5.54 a.4.5.54 Length = 566 | Back alignment and structure |
|---|
Score = 41.6 bits (96), Expect = 8e-04
Identities = 18/178 (10%), Positives = 41/178 (23%), Gaps = 15/178 (8%)
Query: 5 NNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPS--SPPP 62
+ +++ + ++++ + S P+ + P
Sbjct: 92 LFFKDPSSKDELGKSAETASADVVSTWVCPICMVSNETQGEFTKDTLPTPICINCGVPAD 151
Query: 63 SKSPPSSPPPATSSSPPPASPPTSDN------------NKPDPPK-NSPPPPPPSSQSSP 109
+ SS + + P N P P++
Sbjct: 152 YELTKSSINCSNAIDPNANPQNQFGVNSENICPACTFANHPQIGNCEICGHRLPNASKVR 211
Query: 110 TPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSSSSSSKSSNGSSSGDDY 167
+ + N + ++ L SSST S+ S S
Sbjct: 212 SKLNRLNFHDSRVHIELEKNSLARNKSSHSALSSSSSTGSSTEFVQLSFRKSDGVLFS 269
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 47.2 bits (110), Expect = 1e-05
Identities = 22/128 (17%), Positives = 39/128 (30%), Gaps = 4/128 (3%)
Query: 1 MAKGNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSP 60
++ + S AP S + A + +S P P
Sbjct: 361 RWTMYKNSQAGSGWDSSDAPNSWYGAGAIKMSGPNNYVTVGATSATNVMPVSDMPVVPGK 420
Query: 61 PPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSS----PTPPSPSN 116
+ + + + + P KP PP P P+ ++ P P +P+
Sbjct: 421 DNTDGKKPNIWYSLNGKIRAVNVPKVTKEKPTPPVKPTAPTKPTYETEKPLKPAPVAPNY 480
Query: 117 NKSPSPPV 124
K P+PP
Sbjct: 481 EKEPTPPT 488
|
| >3iox_A AGI/II, PA; alpha helix, PPII helix, supersandwich fold, surface adhesin WALL, peptidoglycan-anchor, cell adhesion; HET: PMS; 1.80A {Streptococcus mutans} PDB: 3ipk_A* 1jmm_A Length = 497 | Back alignment and structure |
|---|
Score = 43.0 bits (99), Expect = 3e-04
Identities = 16/91 (17%), Positives = 24/91 (26%), Gaps = 1/91 (1%)
Query: 15 GSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSP-PPSSPPPSKSPPSSPPPA 73
G+ A SD P + P+ + + P +PP P
Sbjct: 401 GATSATNVMPVSDMPVVPGKDNTDGKKPNIWYSLNGKIRAVNVPKVTKEKPTPPVKPTAP 460
Query: 74 TSSSPPPASPPTSDNNKPDPPKNSPPPPPPS 104
T + P P+ K PP
Sbjct: 461 TKPTYETEKPLKPAPVAPNYEKEPTPPTRLE 491
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 46.1 bits (108), Expect = 2e-05
Identities = 14/91 (15%), Positives = 22/91 (24%), Gaps = 6/91 (6%)
Query: 26 SDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPT 85
+ P S P P S+ ++ S P S P + S
Sbjct: 236 FYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETESVN- 294
Query: 86 SDNNKPDPPKNSPPPPPPSSQSSPTPPSPSN 116
P S + P S ++
Sbjct: 295 -----PVSTPASVEYHAGMKSLNKAPYSSNS 320
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 3e-05
Identities = 16/97 (16%), Positives = 24/97 (24%), Gaps = 8/97 (8%)
Query: 11 ENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSP 70
+ + P S +P SP + + S P S+P +
Sbjct: 232 DLSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETE 291
Query: 71 PPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQS 107
S+P S P SS S
Sbjct: 292 SVNPVSTPASVEYH--------AGMKSLNKAPYSSNS 320
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 4e-05
Identities = 10/85 (11%), Positives = 23/85 (27%)
Query: 39 SPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSP 98
S + S + T+++ S P S + +
Sbjct: 232 DLSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETE 291
Query: 99 PPPPPSSQSSPTPPSPSNNKSPSPP 123
P S+ +S + + + +P
Sbjct: 292 SVNPVSTPASVEYHAGMKSLNKAPY 316
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 5e-05
Identities = 12/85 (14%), Positives = 21/85 (24%)
Query: 56 PPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPS 115
+S + S P PTS+ P ++ + + S
Sbjct: 233 LSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETES 292
Query: 116 NNKSPSPPVFSPPPPAKKSSPPPPP 140
N +P K + P
Sbjct: 293 VNPVSTPASVEYHAGMKSLNKAPYS 317
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 44.2 bits (103), Expect = 1e-04
Identities = 7/86 (8%), Positives = 22/86 (25%)
Query: 46 PPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSS 105
+ ++ SP + +S+ + + + P S
Sbjct: 233 LSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETES 292
Query: 106 QSSPTPPSPSNNKSPSPPVFSPPPPA 131
+ + P+ + + P +
Sbjct: 293 VNPVSTPASVEYHAGMKSLNKAPYSS 318
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 1e-04
Identities = 11/86 (12%), Positives = 20/86 (23%)
Query: 38 SSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNS 97
S ++ P S P + T S ++ + ++
Sbjct: 234 SLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETESV 293
Query: 98 PPPPPPSSQSSPTPPSPSNNKSPSPP 123
P P+S N S
Sbjct: 294 NPVSTPASVEYHAGMKSLNKAPYSSN 319
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 1e-04
Identities = 11/87 (12%), Positives = 19/87 (21%)
Query: 54 SPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPS 113
+ S P SP ++ S P P+ ++ +
Sbjct: 232 DLSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETE 291
Query: 114 PSNNKSPSPPVFSPPPPAKKSSPPPPP 140
N S V + P
Sbjct: 292 SVNPVSTPASVEYHAGMKSLNKAPYSS 318
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 1e-04
Identities = 11/83 (13%), Positives = 24/83 (28%)
Query: 4 GNNVTETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPS 63
+++ +E S +N + P S S+ ++ S P S+P +
Sbjct: 230 NWDLSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSE 289
Query: 64 KSPPSSPPPATSSSPPPASPPTS 86
+ S +
Sbjct: 290 TESVNPVSTPASVEYHAGMKSLN 312
|
| >2j63_A AP-endonuclease; base excision repair, lyase; 2.48A {Leishmania major} Length = 467 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 23/137 (16%), Positives = 35/137 (25%)
Query: 25 SSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPP 84
SS P S S S AS SS PS PPSK P +
Sbjct: 11 SSGLVPRGSHMASKRCRQCSGDSASSSTSSLSPSELPPSKKAAGGQRVTAEVEVAPITTD 70
Query: 85 TSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYS 144
+ S + + N + + A ++ +S
Sbjct: 71 ATSATVTAAGGAKKKATTGSPARRTSSAAKITNGDAGELIRTAEALAALNAKKSEKEIWS 130
Query: 145 SSTPKSSSSSSKSSNGS 161
P ++ + S
Sbjct: 131 DVVPFVRRTTDSDFDPS 147
|
| >2j63_A AP-endonuclease; base excision repair, lyase; 2.48A {Leishmania major} Length = 467 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 7e-05
Identities = 18/136 (13%), Positives = 35/136 (25%), Gaps = 9/136 (6%)
Query: 21 PSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPP 80
S + +S+ +SS PS PP+ ++ + AT
Sbjct: 22 ASKRCRQCSGDSASSSTSSLSPSELPPSKKAAGGQRVTAEVEVAPITTDATSAT------ 75
Query: 81 ASPPTSDNNKPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPP 140
T+ P SS + T + + + +
Sbjct: 76 ---VTAAGGAKKKATTGSPARRTSSAAKITNGDAGELIRTAEALAALNAKKSEKEIWSDV 132
Query: 141 LKYSSSTPKSSSSSSK 156
+ + T S S+
Sbjct: 133 VPFVRRTTDSDFDPSR 148
|
| >1kxf_A Sindbis virus capsid protein; chymotrypsin-like serine proteinase, wild type, viral protein; 2.38A {Sindbis virus} SCOP: b.47.1.3 PDB: 1ld4_A 3j0f_A Length = 264 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 7e-05
Identities = 12/109 (11%), Positives = 21/109 (19%), Gaps = 5/109 (4%)
Query: 30 PPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNN 89
P P++ + P + + + S +P P PP
Sbjct: 15 PAPTAMWRPRRRRQAAPMPARNGLASQIQQLTTAVSALVIGQATRPQNPRPRPPP----- 69
Query: 90 KPDPPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPP 138
+ PP P + P
Sbjct: 70 RQKKQAPKQPPKPKKPKPQEKKKKQPAKTKPGKRQRMALKLEADRLFDV 118
|
| >1kxf_A Sindbis virus capsid protein; chymotrypsin-like serine proteinase, wild type, viral protein; 2.38A {Sindbis virus} SCOP: b.47.1.3 PDB: 1ld4_A 3j0f_A Length = 264 | Back alignment and structure |
|---|
Score = 41.7 bits (97), Expect = 4e-04
Identities = 13/115 (11%), Positives = 22/115 (19%), Gaps = 4/115 (3%)
Query: 34 STPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDP 93
+ P P+ P P + T+ ++ +P
Sbjct: 7 NMLGRRPFPAPTAMWRPRRRRQAAPMPARNGLASQIQQLTTAV----SALVIGQATRPQN 62
Query: 94 PKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTP 148
P+ PPP P K L+
Sbjct: 63 PRPRPPPRQKKQAPKQPPKPKKPKPQEKKKKQPAKTKPGKRQRMALKLEADRLFD 117
|
| >3dva_I Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase...; oxidoreductase, multienzyme complex; HET: TPW; 2.35A {Bacillus stearothermophilus} PDB: 3dv0_I* 3duf_I* 1b5s_A 1lab_A 1lac_A 1w3d_A Length = 428 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 7e-05
Identities = 5/58 (8%), Positives = 12/58 (20%), Gaps = 2/58 (3%)
Query: 26 SDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASP 83
+ + + P + P++ A + A P
Sbjct: 78 APGYENMTFKGQEQEEAKKEEKTETVSKEEKVDAVAP--NAPAAEAEAGPNRRVIAMP 133
|
| >3dva_I Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase...; oxidoreductase, multienzyme complex; HET: TPW; 2.35A {Bacillus stearothermophilus} PDB: 3dv0_I* 3duf_I* 1b5s_A 1lab_A 1lac_A 1w3d_A Length = 428 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 4/57 (7%), Positives = 14/57 (24%)
Query: 14 EGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSP 70
+ + + + + A P + + P++ + P
Sbjct: 77 DAPGYENMTFKGQEQEEAKKEEKTETVSKEEKVDAVAPNAPAAEAEAGPNRRVIAMP 133
|
| >1dx0_A Prion protein; brain, repeat; NMR {Bos taurus} SCOP: d.6.1.1 PDB: 1dx1_A 1qlx_A 1qlz_A Length = 219 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 1e-04
Identities = 10/102 (9%), Positives = 16/102 (15%)
Query: 39 SPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSP 98
S P S P P + P P
Sbjct: 2 SKKRPKPGGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGG 61
Query: 99 PPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPP 140
P + + ++ P K +
Sbjct: 62 WGQPHGGGWGQPHGGGGWGQGGTHGQWNKPSKPKTNMKHVAG 103
|
| >1dx0_A Prion protein; brain, repeat; NMR {Bos taurus} SCOP: d.6.1.1 PDB: 1dx1_A 1qlx_A 1qlz_A Length = 219 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 3e-04
Identities = 7/112 (6%), Positives = 13/112 (11%)
Query: 40 PPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPP 99
P P P + +
Sbjct: 2 SKKRPKPGGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGG 61
Query: 100 PPPPSSQSSPTPPSPSNNKSPSPPVFSPPPPAKKSSPPPPPLKYSSSTPKSS 151
P P P K++ ++
Sbjct: 62 WGQPHGGGWGQPHGGGGWGQGGTHGQWNKPSKPKTNMKHVAGAAAAGAVVGG 113
|
| >3bbn_E Ribosomal protein S5; small ribosomal subunit, spinach chloroplast ribosome, ribonucleoprotein particle, macromolecular complex; 9.40A {Spinacea oleracea} Length = 308 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 19/98 (19%), Positives = 30/98 (30%), Gaps = 1/98 (1%)
Query: 33 SSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPD 92
++T +++P +S P ++ S S S P + SS K D
Sbjct: 2 ATTATTTPSATSLTTLHRRIPLFPTTTTLLSLSSSSKPLFLSLSSTRSFPTHLYCIKKDD 61
Query: 93 PPKNSPPPPPPSSQSSPTPPSPSNNKSPSPPVFSPPPP 130
P + + PP P P PP
Sbjct: 62 IDITFFEQDNPDEEITFDPPEKPEGYIP-PRAVDEPPF 98
|
| >2uv8_A Fatty acid synthase subunit alpha (FAS2); fatty acid biosynthesis, malonyl/palmitoyl transferase, phosphopantetheine, transferase; HET: GVL FMN; 3.10A {Saccharomyces cerevisiae} PDB: 2vkz_A* 3hmj_A* Length = 1887 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 13/60 (21%), Positives = 20/60 (33%)
Query: 28 ATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSD 87
TP PS + P PA P +S P + ++ P A ++ S
Sbjct: 90 YTPDPSELAAKEEPAKEEAPAPTPAASAPAPAAAAPAPVAAAAPAAAAAEIADEPVKASL 149
|
| >2uv8_A Fatty acid synthase subunit alpha (FAS2); fatty acid biosynthesis, malonyl/palmitoyl transferase, phosphopantetheine, transferase; HET: GVL FMN; 3.10A {Saccharomyces cerevisiae} PDB: 2vkz_A* 3hmj_A* Length = 1887 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 12/51 (23%), Positives = 24/51 (47%)
Query: 21 PSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPP 71
PS ++ P P+ +P S+P PA+ P+ ++P + + + P
Sbjct: 94 PSELAAKEEPAKEEAPAPTPAASAPAPAAAAPAPVAAAAPAAAAAEIADEP 144
|
| >2uv8_A Fatty acid synthase subunit alpha (FAS2); fatty acid biosynthesis, malonyl/palmitoyl transferase, phosphopantetheine, transferase; HET: GVL FMN; 3.10A {Saccharomyces cerevisiae} PDB: 2vkz_A* 3hmj_A* Length = 1887 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 11/58 (18%), Positives = 22/58 (37%)
Query: 8 TETENEEGSPPAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKS 65
T +E + P + TP S+ ++ P+ A+P ++ + P S
Sbjct: 91 TPDPSELAAKEEPAKEEAPAPTPAASAPAPAAAAPAPVAAAAPAAAAAEIADEPVKAS 148
|
| >2uv8_A Fatty acid synthase subunit alpha (FAS2); fatty acid biosynthesis, malonyl/palmitoyl transferase, phosphopantetheine, transferase; HET: GVL FMN; 3.10A {Saccharomyces cerevisiae} PDB: 2vkz_A* 3hmj_A* Length = 1887 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 11/55 (20%), Positives = 19/55 (34%)
Query: 41 PPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPK 95
P P P +P S P++ PA ++ PA+ ++P
Sbjct: 94 PSELAAKEEPAKEEAPAPTPAASAPAPAAAAPAPVAAAAPAAAAAEIADEPVKAS 148
|
| >1pcx_A Protein transport protein SEC24; 2.50A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 PDB: 1pd0_A 1pd1_A Length = 810 | Back alignment and structure |
|---|
Score = 43.5 bits (101), Expect = 3e-04
Identities = 16/64 (25%), Positives = 22/64 (34%), Gaps = 2/64 (3%)
Query: 39 SPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS--PPPASPPTSDNNKPDPPKN 96
+ P P A+ + P + P PPP T + PPP P P N
Sbjct: 1 AAPAYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSN 60
Query: 97 SPPP 100
+ P
Sbjct: 61 ASPD 64
|
| >2g6z_A Dual specificity protein phosphatase 5; alpha/beta, hydrolase; 2.70A {Homo sapiens} Length = 211 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 15/60 (25%), Positives = 20/60 (33%)
Query: 18 PAPPSSNSSDATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSS 77
P PPS A + P + P S P + S S P AT++S
Sbjct: 151 PQPPSCQGEAAGSSLIGHLQTLSPDMQGAYCTFPASVLAPVPTHSTVSELSRSPVATATS 210
|
| >3eiv_A Single-stranded DNA-binding protein 2; DNA damage, DNA repair, DNA replication, phosphoprotein; 2.14A {Streptomyces coelicolor} Length = 199 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 9/79 (11%), Positives = 10/79 (12%)
Query: 52 PSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSDNNKPDPPKNSPPPPPPSSQSSPTP 111
S P DP P
Sbjct: 120 TSGQGRGGQGGYGGGGGGQGGGGWGGGPGGGQQGGGAPADDPWATGGAPAGGQQGGGGQG 179
Query: 112 PSPSNNKSPSPPVFSPPPP 130
S +S PP
Sbjct: 180 GGGWGGGSGGGGGYSDEPP 198
|
| >1eys_C Photosynthetic reaction center; membrane protein complex, electron transport; HET: BGL BCL BPH MQ8 HEM CRT LDA PEF; 2.20A {Thermochromatium tepidum} SCOP: a.138.1.2 Length = 382 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 8e-04
Identities = 13/71 (18%), Positives = 29/71 (40%), Gaps = 1/71 (1%)
Query: 37 SSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASPPTSD-NNKPDPPK 95
++ + P ++P + P ++ + P+ PA + P A P ++ +P
Sbjct: 310 KTAVTQEALPGSAPASEAAPAAATEAAPEAPAQEVPAAEAVPAAAEPGAAEAAGSVEPAP 369
Query: 96 NSPPPPPPSSQ 106
P P++Q
Sbjct: 370 VEEVAPAPAAQ 380
|
| >2uv9_A Fatty acid synthase alpha subunits; fungal, dehydratase, enoyl reductase, ketoacyl synthase, ketoacyl reductase; 3.1A {Thermomyces lanuginosus} PDB: 2uvb_A* Length = 1878 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 14/57 (24%), Positives = 24/57 (42%), Gaps = 3/57 (5%)
Query: 27 DATPPPSSTPSSSPPPSSPPPASPPPSSPPPSSPPPSKSPPSSPPPATSSSPPPASP 83
P TP+++ + P A+P + P ++P P P+S PA P +
Sbjct: 94 PIEDEPEPTPAAASSADAAPAAAPAAPAAPAAAPAP---APASAGPAAPVQDAPVTA 147
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 662 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.53 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.27 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.25 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.04 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.93 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.81 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.8 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.79 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.66 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.48 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.45 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.3 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.29 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.18 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 98.08 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 98.0 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.99 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.86 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.79 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.78 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.71 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.64 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.62 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.33 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 97.26 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 97.2 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.96 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 96.95 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 96.85 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 96.79 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.31 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 96.23 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 96.2 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.97 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 94.24 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 94.18 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.72 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 90.53 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 88.83 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 88.47 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 87.91 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 87.89 | |
| 2klu_A | 70 | T-cell surface glycoprotein CD4; cell membrane, di | 87.85 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 86.5 | |
| 2k1a_A | 42 | Integrin alpha-IIB; single-PASS transmembrane segm | 86.4 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.08 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 82.26 | |
| 2k9j_B | 43 | Integrin beta-3; transmembrane complex, cell adhes | 81.33 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 80.42 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-55 Score=464.94 Aligned_cols=250 Identities=20% Similarity=0.368 Sum_probs=204.9
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
++|++.+.||+|+||.||+|+. .+|+.||||+++... ....+.+++|+++|++|+|||||+++++|.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999995 579999999997653 3345689999999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
||.||+|.++|...+...+++.+++.|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999999999876666789999999999999999999999 99999999999999999999999999998765322
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
......+||+.|||||++.+..|+.++||||||||||||++|+.||......+.+..+.. +.+. .+
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~---------~~~~-----~~ 245 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS---------GSFP-----PV 245 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---------TCCC-----CC
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---------CCCC-----CC
Confidence 223457899999999999999999999999999999999999999987654443332211 1111 11
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. ...+.++.+ ++.+||+.||++||++.|+++
T Consensus 246 ~-~~~s~~~~~---li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 S-LHYSYDLRS---LVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp C-TTSCHHHHH---HHHHHTCSSGGGSCCHHHHHT
T ss_pred C-ccCCHHHHH---HHHHHccCChhHCcCHHHHhc
Confidence 1 122344444 455899999999999999986
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-55 Score=459.04 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=204.5
Q ss_pred CCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
.+|.+.+.||+|+||.||+|++. +++.||||+++.......++|++|+++|++|+|||||+|+|+|.+++.+||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35777899999999999999853 478899999987766777889999999999999999999999999999999
Q ss_pred EEEecCCcchhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcE
Q 006083 390 VYEFVSNKTLEYHLHGEN-------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA 456 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 456 (662)
|||||.+|+|.++|+... ...+++.++++|+.||++||+|||++ +|||||||++||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 999999999999996532 24589999999999999999999998 89999999999999999999
Q ss_pred EEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHH
Q 006083 457 MVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPL 534 (662)
Q Consensus 457 kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~ 534 (662)
||+|||+++....... ......+||+.|||||++.++.|+.++||||||||||||+| |+.||......+.+...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i---- 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI---- 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH----
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Confidence 9999999987654332 23345789999999999999999999999999999999999 89999876543322211
Q ss_pred hHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 535 LGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 535 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
..+... .+ ...++.++. +++.+||+.||++||+|.||++.|+..
T Consensus 274 -----~~g~~~-----~~-p~~~~~~~~---~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 274 -----TQGREL-----ER-PRACPPEVY---AIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp -----HHTCCC-----CC-CTTCCHHHH---HHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred -----HcCCCC-----CC-cccccHHHH---HHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 111100 11 123344444 455599999999999999999999853
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-55 Score=455.49 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=210.4
Q ss_pred CCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
++|.+.+.||+|+||.||+|++. ++..||||+++.......++|.+|+++|++|+|||||+|+|+|.+++.+||
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45888999999999999999853 477899999987766777889999999999999999999999999999999
Q ss_pred EEEecCCcchhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEE
Q 006083 390 VYEFVSNKTLEYHLHGE-----------NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMV 458 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl 458 (662)
|||||.||+|.++|+.. ....+++.++++|+.||++||+|||++ +|||||||++||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 99999999999999653 234689999999999999999999998 8999999999999999999999
Q ss_pred EeeccccccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhH
Q 006083 459 ADFGLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLG 536 (662)
Q Consensus 459 ~DFGla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 536 (662)
+|||+|+........ .....+||+.|||||++.++.|+.++||||||||||||+| |+.||......+.+..+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i------ 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI------ 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH------
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------
Confidence 999999876543322 2334679999999999999999999999999999999998 89999876544322211
Q ss_pred HHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 537 AALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 537 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
..+.... ....++.++. +++.+||+.||++||+|.||++.|+.
T Consensus 244 ---~~~~~~~------~p~~~~~~~~---~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 244 ---TQGRVLQ------RPRTCPQEVY---ELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp ---HHTCCCC------CCTTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HcCCCCC------CCccchHHHH---HHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1111110 1122344444 45559999999999999999999885
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=457.32 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=207.8
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
..|++.+.||+|+||.||+|+. .+|+.||||+++.......+.+.+|+++|++|+|||||+|+++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4599999999999999999995 479999999998765556677899999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.||+|.+++... .+++.++..|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+.+..... .
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 226 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-c
Confidence 999999999653 489999999999999999999999 999999999999999999999999999987754432 3
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
....+||+.|||||++.+..|+.++||||||||||||++|+.||......+.+..+. .+....+ .. .
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~---------~~~~~~~---~~-~ 293 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---------DNLPPRL---KN-L 293 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---------HSSCCCC---SC-G
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH---------cCCCCCC---Cc-c
Confidence 355799999999999999999999999999999999999999997765433322211 1111000 00 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.....++.+ ++.+||+.||++||++.|+++
T Consensus 294 ~~~s~~~~d---li~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 294 HKVSPSLKG---FLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGSCHHHHH---HHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHH---HHHHHcCCChhHCcCHHHHhc
Confidence 112344444 455899999999999999886
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=453.11 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=207.4
Q ss_pred CCCccceeeccCceEEEEEEe------cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL------PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
.+++.+.||+|+||.||+|++ .+++.||||+++... ....++|++|+.+|++|+|||||+|+|+|.+++.++|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 466788999999999999985 256789999997543 3446789999999999999999999999999999999
Q ss_pred EEEecCCcchhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCc
Q 006083 390 VYEFVSNKTLEYHLHGEN--------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE 455 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 455 (662)
|||||.+|+|.++|+... ...+++.++++|+.||++||+|||++ +|||||||++||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 999999999999996432 24589999999999999999999998 8999999999999999999
Q ss_pred EEEEeeccccccCCCC-CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHH
Q 006083 456 AMVADFGLAKLSNDNH-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARP 533 (662)
Q Consensus 456 vkl~DFGla~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~ 533 (662)
+||+|||+++...... .......+||+.|||||++.++.|+.++||||||||||||+| |+.||......+.+..
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~---- 259 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM---- 259 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH----
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH----
Confidence 9999999998764332 223345789999999999999999999999999999999998 8999987654332211
Q ss_pred HhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 534 LLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 534 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
+..+.... + ...++.+ +.+++.+||+.||++||+|.||++.|+.
T Consensus 260 -----i~~~~~~~-----~-p~~~~~~---~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 260 -----IRNRQVLP-----C-PDDCPAW---VYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp -----HHTTCCCC-----C-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -----HHcCCCCC-----C-cccchHH---HHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11121111 1 1223444 4455569999999999999999999985
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=444.54 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=200.1
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.++|.+.+.||+|+||.||+|++. ..||||+++... .+..+.|.+|+++|++|+|||||+|+++|.+ +.+|||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 346788999999999999999864 369999997543 3445789999999999999999999999865 56899999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC-
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH- 471 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~- 471 (662)
||.||+|.++|+... ..+++.++++|+.||++||+|||++ +||||||||+||||++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred cCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 999999999997543 3589999999999999999999998 99999999999999999999999999998765432
Q ss_pred CccccccccCccccCcccccC---CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 472 THVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
.......+||+.|||||++.+ +.|+.++||||||||||||+||+.||......+.+.... ..+.....+
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~--------~~~~~~p~~ 259 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV--------GRGYASPDL 259 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH--------HTTCCCCCS
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH--------hcCCCCCCc
Confidence 223455789999999999864 469999999999999999999999997654433322211 111111101
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
. .+ ...++.++ .+++.+||+.||++||+|.||++.|+.
T Consensus 260 ~-~~-~~~~~~~l---~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 260 S-KL-YKNCPKAM---KRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp T-TS-CTTSCHHH---HHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred c-cc-cccchHHH---HHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 0 11 11233444 445569999999999999999998874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-54 Score=461.65 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=208.8
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
..|++.+.||+|+||.||+|+. .+|+.||||+++.......+.+.+|+++|++|+|+|||+|+++|.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 4699999999999999999995 479999999998776666778999999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.||+|.+++... .+++.++..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+..... .
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 303 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 303 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-C
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-c
Confidence 999999999643 389999999999999999999999 999999999999999999999999999987754432 3
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
....+||+.|||||++.+..|+.++||||||||||||++|+.||......+.+..+. .+....+ . ..
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~---------~~~~~~~---~-~~ 370 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---------DNLPPRL---K-NL 370 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---------HSCCCCC---S-CT
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH---------cCCCCCC---c-cc
Confidence 356799999999999999999999999999999999999999997765433322211 1111000 0 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.....++.+| +.+||+.||++|+++.|+++
T Consensus 371 ~~~s~~~~dl---i~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 HKVSPSLKGF---LDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TSSCHHHHHH---HHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHH---HHHHcCCChhHCcCHHHHhc
Confidence 1233444444 45899999999999999886
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-54 Score=445.93 Aligned_cols=247 Identities=21% Similarity=0.296 Sum_probs=206.8
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.++||+|+||+||+|+. .+|+.||||++++. .....+.+.+|+++|++|+|||||+++++|++++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3599999999999999999994 57999999999753 2234577999999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
|||.||+|.++|...+ .+++.++..++.||+.||+|||++ +||||||||+||||++++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999996543 489999999999999999999999 99999999999999999999999999999775432
Q ss_pred -CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 472 -THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 472 -~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
.......+||+.|||||++.+..|+.++||||||||||||++|+.||......+.+..+.. +.+
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---------~~~------ 251 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK---------LEY------ 251 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------TCC------
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---------CCC------
Confidence 2234568999999999999999999999999999999999999999987654443332211 111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIV 586 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 586 (662)
.+... ...++. +++.+||+.||++|+++.|++
T Consensus 252 ~~p~~-~s~~~~---dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DFPEK-FFPKAR---DLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCTT-CCHHHH---HHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCcc-cCHHHH---HHHHHHccCCHhHCcChHHHc
Confidence 11122 234444 455599999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=445.85 Aligned_cols=250 Identities=21% Similarity=0.243 Sum_probs=201.8
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
+.|.+.++||+|+||.||+|+. .+|+.||||+++.... +.+|+++|++|+|||||+++++|.+++.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4578889999999999999995 4799999999986432 257999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC-cEEEEeeccccccCCCCCc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF-EAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkl~DFGla~~~~~~~~~ 473 (662)
.||+|.++|+..+ .+++.+++.|+.||+.||+|||++ +||||||||+||||+.++ ++||+|||+|+........
T Consensus 133 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999997543 589999999999999999999999 999999999999999887 6999999999876543221
Q ss_pred ----cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 474 ----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 474 ----~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
....++||+.|||||++.+..|+.++||||||||||||++|+.||......+.+..+.. .....
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--------~~~~~---- 275 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS--------EPPPI---- 275 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH--------SCCGG----
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc--------CCCCc----
Confidence 12346899999999999999999999999999999999999999976544333322211 10000
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
..+. ...+.++.+ ++.+||+.||++||++.||++.|..
T Consensus 276 ~~~~-~~~s~~~~~---li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 276 REIP-PSCAPLTAQ---AIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp GGSC-TTSCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhcC-ccCCHHHHH---HHHHHccCCHhHCcCHHHHHHHHHH
Confidence 0111 123344444 4458999999999999999988763
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=433.73 Aligned_cols=244 Identities=26% Similarity=0.375 Sum_probs=196.0
Q ss_pred CccceeeccCceEEEEEEe-cCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeEEEEE
Q 006083 319 AKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIA----GGQRMLVY 391 (662)
Q Consensus 319 ~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~lv~ 391 (662)
++.+.||+|+||.||+|.. .+++.||||++... .....+.|.+|+++|++|+|||||+++++|.+ ++.+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5677899999999999985 46899999999754 23345679999999999999999999999875 35689999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeecCCccCcEEECC-CCcEEEEeeccccccC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR--IIHRDIKAANILIDD-NFEAMVADFGLAKLSN 468 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--ivHrDIkp~NILl~~-~~~vkl~DFGla~~~~ 468 (662)
|||.||+|.++|++. ..+++..++.|+.||+.||+|||++ + ||||||||+||||++ ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999654 3589999999999999999999998 6 999999999999985 7899999999998654
Q ss_pred CCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 469 DNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 469 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
.. .....+||+.|||||++.+ .|+.++||||||||||||+||+.||........+... +..+....
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~--------i~~~~~~~-- 249 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--------VTSGVKPA-- 249 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH--------HTTTCCCG--
T ss_pred CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHH--------HHcCCCCC--
Confidence 32 2355789999999998875 6999999999999999999999999764433222211 11111111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+.. ....++ .+++.+||+.||++||++.|+++
T Consensus 250 --~~~~-~~~~~~---~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 --SFDK-VAIPEV---KEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGGG-CCCHHH---HHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCCc-cCCHHH---HHHHHHHccCChhHCcCHHHHhc
Confidence 1111 222344 44555999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=429.35 Aligned_cols=245 Identities=23% Similarity=0.397 Sum_probs=190.1
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.+.||+|+||.||+|+. .+|+.||||++++.. ....+.+.+|+++|++|+|||||++++++.+.+.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6799999999999999999994 579999999997642 233567999999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||| +|+|.++|...+ .+++.+++.++.||+.||+|||++ +||||||||+||||++++++||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 689999886543 589999999999999999999999 99999999999999999999999999998765432
Q ss_pred CccccccccCccccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
.....+||+.|||||++.+..| +.++||||||||||||++|+.||......+.+..+. .+.+.
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~---------~~~~~----- 230 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS---------NGVYT----- 230 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---------HTCCC-----
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---------cCCCC-----
Confidence 2345789999999999998776 579999999999999999999998764433222211 11111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+. .....++.+ ++.+||+.||++||++.|+++
T Consensus 231 -~p-~~~s~~~~~---li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 -LP-KFLSPGAAG---LIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -CC-TTSCHHHHH---HHHHHSCSSGGGSCCHHHHHH
T ss_pred -CC-CCCCHHHHH---HHHHHccCChhHCcCHHHHHc
Confidence 11 123344444 455999999999999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=444.00 Aligned_cols=267 Identities=26% Similarity=0.418 Sum_probs=214.2
Q ss_pred cCHHHHHHHhCCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCch-hHHHHHHHHHHHHhcCC-CCcceE
Q 006083 306 FTYDELAAATGGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSGQ-GEREFSAEVEIISRVHH-RHLVSL 377 (662)
Q Consensus 306 ~~~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~H-pnIv~l 377 (662)
++.++++.-.++|++++.||+|+||.||+|.+. .++.||||+++..... ..+.|.+|+++|.+++| +|||+|
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 334555556678999999999999999999843 2368999999865443 45679999999999965 899999
Q ss_pred EEEEEe-CCeEEEEEEecCCcchhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecC
Q 006083 378 VGYCIA-GGQRMLVYEFVSNKTLEYHLHGEN--------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRD 442 (662)
Q Consensus 378 ~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrD 442 (662)
+|+|.+ ++.+|||||||.+|+|.++|+... ...+++.+++.|+.||++||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 999976 467899999999999999996432 34589999999999999999999999 999999
Q ss_pred CccCcEEECCCCcEEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCC
Q 006083 443 IKAANILIDDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDM 520 (662)
Q Consensus 443 Ikp~NILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~ 520 (662)
||++||||++++.+||+|||+|+....... ......+||+.|||||++.++.|+.++||||||||||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987654432 23445789999999999999999999999999999999998 9999977
Q ss_pred chhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 521 TMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
....+.+.... ..+... .+ ....+.++. +++.+||+.||++||++.||++.|+..
T Consensus 291 ~~~~~~~~~~i--------~~g~~~-----~~-p~~~~~~~~---~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 291 VKIDEEFCRRL--------KEGTRM-----RA-PDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCCSHHHHHHH--------HHTCCC-----CC-CTTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHHHHHHHH--------HcCCCC-----CC-CccCCHHHH---HHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 54333332211 122111 11 123344444 455589999999999999999998753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=435.74 Aligned_cols=242 Identities=26% Similarity=0.327 Sum_probs=193.0
Q ss_pred CCCCccceeeccCceEEEEEEe----cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL----PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~----~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
++|++.+.||+|+||.||+|+. .+++.||||++++.. ......+.+|+++|++|+|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 3599999999999999999984 257899999997542 2233468899999999999999999999999999999
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
|||||.||+|.++|.+.. .+++.++..++.||+.||+|||++ +||||||||+||||++++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999996543 489999999999999999999999 999999999999999999999999999987544
Q ss_pred CCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
... .....+||+.|||||++.+..|+.++||||||||||||++|+.||......+.+..+.+ +.+
T Consensus 179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~---------~~~----- 243 (304)
T 3ubd_A 179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK---------AKL----- 243 (304)
T ss_dssp --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------CCC-----
T ss_pred CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc---------CCC-----
Confidence 332 23457899999999999999999999999999999999999999987654443332211 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKM 582 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 582 (662)
.+. ...+.++.+ ++.+||+.||++|+++
T Consensus 244 -~~p-~~~s~~~~~---li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 -GMP-QFLSPEAQS---LLRMLFKRNPANRLGA 271 (304)
T ss_dssp -CCC-TTSCHHHHH---HHHHHTCSSGGGSTTC
T ss_pred -CCC-CcCCHHHHH---HHHHHcccCHHHCCCC
Confidence 111 123344444 4458999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-52 Score=431.52 Aligned_cols=267 Identities=21% Similarity=0.313 Sum_probs=199.1
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----eEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGG----QRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~~lv~ 391 (662)
.+|.+.+.||+|+||.||+|++ +|+.||||+++... .....++.|+.++.+++|+|||+|+++|.+++ .+||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3577889999999999999998 68999999997532 11223345666677899999999999998653 689999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC-----HPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
|||.||+|.++|+.. .+++..+++++.|+++||+|||+++ ..+||||||||+||||++++++||+|||+|+.
T Consensus 81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999754 4899999999999999999999863 34899999999999999999999999999987
Q ss_pred cCCCCCc---cccccccCccccCcccccCC------CCCchHHHHHHHHHHHHHHhCCCCCCCchhhh-HHHHH-----H
Q 006083 467 SNDNHTH---VSTRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVMLLELITGRRPVDMTMMED-SLVEW-----A 531 (662)
Q Consensus 467 ~~~~~~~---~~~~~~Gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~-~~~~~-----~ 531 (662)
....... .....+||+.|||||++.+. .|+.++||||||||||||+||+.||......+ .+..+ .
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 6543322 22346899999999999754 36789999999999999999988775432110 00000 0
Q ss_pred HHHhHHHhhcCccccccCcccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 532 RPLLGAALEDGIYDGLVDPRLEHNY-VPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...+... +....+++.+.... ..+....|.+++.+||+.||++||+|.||++.|+.
T Consensus 238 ~~~~~~~----~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 238 VEEMRKV----VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp HHHHHHH----HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHH----HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 0001111 11112222222211 23455667788889999999999999999999975
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=420.01 Aligned_cols=248 Identities=21% Similarity=0.363 Sum_probs=186.8
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCC---------
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYCIAGG--------- 385 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--------- 385 (662)
+|++.+.||+|+||.||+|+. .+|+.||||+++..... ..+.+.+|+++|++|+|||||+++++|.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 489999999999999999985 47999999999765433 3467999999999999999999999987544
Q ss_pred ---eEEEEEEecCCcchhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEee
Q 006083 386 ---QRMLVYEFVSNKTLEYHLHGENR-PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADF 461 (662)
Q Consensus 386 ---~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DF 461 (662)
.+|||||||.||+|.+++..... ....+..++.|+.||++||+|||++ +||||||||+||||+.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccC
Confidence 37999999999999999975433 2346677889999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCc-----------cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHH
Q 006083 462 GLAKLSNDNHTH-----------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEW 530 (662)
Q Consensus 462 Gla~~~~~~~~~-----------~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~ 530 (662)
|+|+........ .....+||+.|||||++.+..|+.++||||||||||||++ ||...... ...+
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~--~~~~ 237 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER--VRTL 237 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--HHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH--HHHH
Confidence 999876543221 1234689999999999999999999999999999999996 77543211 1110
Q ss_pred HHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 531 ARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.. +....+... .......+..++.+||+.||++||++.|+++
T Consensus 238 -~~-----~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 238 -TD-----VRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -HH-----HHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HH-----HhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 011111100 0112223445677999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=423.70 Aligned_cols=263 Identities=19% Similarity=0.292 Sum_probs=201.8
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEe------CC
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIA------GG 385 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------~~ 385 (662)
.++|++++.||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|+++|++|+|+|||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 35799999999999999999995 5799999999976432 334678899999999999999999999763 36
Q ss_pred eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccc
Q 006083 386 QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
.+|||||||. |+|.++|... ..+++..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence 7899999995 6799988654 4589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC---CccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHH---
Q 006083 466 LSNDNH---THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAA--- 538 (662)
Q Consensus 466 ~~~~~~---~~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~--- 538 (662)
.+.... .......+||+.|||||++.+. .|+.++||||||||||||++|+.||.+....+.+..+........
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 764321 1233457999999999998875 579999999999999999999999988765555444332110000
Q ss_pred h---hcCcccccc---Cc-------ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 539 L---EDGIYDGLV---DP-------RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 539 ~---~~~~~~~~~---d~-------~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+ ....+...+ .. .+... ... ++.+++.+||..||++|+++.|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~---~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPG-ADR---QALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTT-CCH---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCC-CCH---HHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 000000000 00 00011 122 3445566999999999999999886
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=412.10 Aligned_cols=198 Identities=23% Similarity=0.348 Sum_probs=171.8
Q ss_pred HhCCCCccceeeccCceEEEEEEec----CCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP----NGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 388 (662)
..+.|++.+.||+|+||.||+|+.+ .++.||||++... ....++.+|+++|+.+ +|+|||+++++|.+.+.+|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4678999999999999999999742 4688999998764 3345688999999998 6999999999999999999
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC-CcEEEEeecccccc
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN-FEAMVADFGLAKLS 467 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkl~DFGla~~~ 467 (662)
||||||.||+|.+++. .+++.++..++.||+.||+|||++ +||||||||+||||+.+ +.+||+|||+|+..
T Consensus 97 lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 9999999999999983 388999999999999999999999 99999999999999876 79999999999865
Q ss_pred CCCCCc---------------------------cccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCC
Q 006083 468 NDNHTH---------------------------VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVD 519 (662)
Q Consensus 468 ~~~~~~---------------------------~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~ 519 (662)
...... .....+||+.|||||++.+. .|+.++||||+|||||||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 432211 12335899999999999875 58999999999999999999999996
Q ss_pred Cc
Q 006083 520 MT 521 (662)
Q Consensus 520 ~~ 521 (662)
..
T Consensus 249 ~~ 250 (361)
T 4f9c_A 249 KA 250 (361)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=409.33 Aligned_cols=289 Identities=49% Similarity=0.819 Sum_probs=246.6
Q ss_pred CCCcCHHHHHHHhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEE
Q 006083 303 KSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYC 381 (662)
Q Consensus 303 ~~~~~~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~ 381 (662)
...|++.++....++|.+.++||+|+||.||+|...+|+.||||+++..... ....+.+|+++|++++|+||++++++|
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 3468889999999999999999999999999999878999999999765322 234689999999999999999999999
Q ss_pred EeCCeEEEEEEecCCcchhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEE
Q 006083 382 IAGGQRMLVYEFVSNKTLEYHLHGEN--RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVA 459 (662)
Q Consensus 382 ~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~ 459 (662)
.+.+..++||||+.+++|.++++... ...+++..++.|+.|++.||+|||+++..+|+||||||+||||++++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997643 3458999999999999999999999866689999999999999999999999
Q ss_pred eeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCch----hhhHHHHHHHHHh
Q 006083 460 DFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTM----MEDSLVEWARPLL 535 (662)
Q Consensus 460 DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~----~~~~~~~~~~~~~ 535 (662)
|||+++..............||..|+|||++.++.++.++|||||||+||||++|+.||+... ....+.+|....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~- 255 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL- 255 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT-
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH-
Confidence 999998776554444555679999999999998899999999999999999999999997432 222344444333
Q ss_pred HHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCCCC
Q 006083 536 GAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSL 595 (662)
Q Consensus 536 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 595 (662)
+....+..+++..+...+.......+.+++.+||+.||.+||++.||++.|++....
T Consensus 256 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 256 ---LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp ---TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred ---hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 345566677777777888888999999999999999999999999999999975443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=436.52 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=209.7
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.......+.+++|+++|+.|+|||||+|+++|.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 35799999999999999999985 47999999999887666677899999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC--CcEEEEeeccccccCCCC
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN--FEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~--~~vkl~DFGla~~~~~~~ 471 (662)
|.||+|.++|.... ..+++.++..++.||++||+|||++ +|+||||||+||||+.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 236 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred cCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999986432 3589999999999999999999999 99999999999999854 899999999999876543
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
.....+||+.|||||++.+..|+.++||||||||||||++|+.||......+.+..+.. +.+. +...
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~---------~~~~--~~~~ 378 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS---------CDWN--MDDS 378 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT---------TCCC--CCSG
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHh---------CCCC--CCcc
Confidence 23457899999999999999999999999999999999999999987655443332211 1110 0111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
... ....++.+ ++.+||+.||.+||++.|+++
T Consensus 379 ~~~-~~s~~~~d---li~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 379 AFS-GISEDGKD---FIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGT-TSCHHHHH---HHHTTSCSSGGGSCCHHHHHH
T ss_pred ccc-CCCHHHHH---HHHHHccCChhHCcCHHHHhc
Confidence 111 12344444 455999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=402.10 Aligned_cols=282 Identities=39% Similarity=0.684 Sum_probs=239.0
Q ss_pred CcCHHHHHHHhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 006083 305 TFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAG 384 (662)
Q Consensus 305 ~~~~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 384 (662)
.+.+.++....++|++.+.||+|+||.||+|.+.+|+.||||++........+.+.+|+++|++++|+||++++++|.++
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 34455666678899999999999999999999888999999999877667778899999999999999999999999999
Q ss_pred CeEEEEEEecCCcchhhhhccCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeec
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGENR--PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFG 462 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFG 462 (662)
+..++||||+.+++|.+++..... ..+++..+++++.|+++||+|||++ +|+||||||+||||++++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999965432 3589999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCC-CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhh--HHHHHHHHHhHHHh
Q 006083 463 LAKLSNDNH-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMED--SLVEWARPLLGAAL 539 (662)
Q Consensus 463 la~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~--~~~~~~~~~~~~~~ 539 (662)
+++...... ........|+..|+|||++.++.++.++|||||||+||||++|+.||......+ .+..|.... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~----~ 260 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES----H 260 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH----H
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc----c
Confidence 998654322 222344679999999999998999999999999999999999999997653322 233343322 2
Q ss_pred hcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 540 EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 540 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
..+.+..+++..+...........+.+++.+||+.||++||++.||++.|+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 345566667777777777888889999999999999999999999999998644
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=427.14 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=197.0
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHH---HHHHHHhcCCCCcceEEEEEEeCCeEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSA---EVEIISRVHHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~---E~~il~~l~HpnIv~l~~~~~~~~~~~ 388 (662)
++|++.++||+|+||.||+|+. .+|+.||||++++.. ......+.+ ++.+++.++|||||+|+++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5799999999999999999995 479999999997531 122233333 466677789999999999999999999
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
||||||.||+|.++|...+ .+++..++.++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+...
T Consensus 269 lVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999997543 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 469 DNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 469 ~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
... ....+||+.|||||++.+ ..|+.++||||||||||||++|+.||......+.. +..+..+ .. .+
T Consensus 344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-~i~~~i~----~~-~~--- 411 (689)
T 3v5w_A 344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL----TM-AV--- 411 (689)
T ss_dssp SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-HHHHHHH----HC-CC---
T ss_pred CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhhc----CC-CC---
Confidence 432 245799999999999975 57999999999999999999999999765432211 1111111 11 10
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPK-----MSQIVR 587 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 587 (662)
.+.. ....++.+| +..||+.||.+|++ +.||++
T Consensus 412 ---~~p~-~~S~~a~dL---I~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 ---ELPD-SFSPELRSL---LEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ---CCCT-TSCHHHHHH---HHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ---CCCc-cCCHHHHHH---HHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1111 233445554 45899999999998 677764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=377.56 Aligned_cols=250 Identities=21% Similarity=0.343 Sum_probs=207.8
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
.++|.+.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.+|++++|+||+++++++.+++..|+||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 45799999999999999999984 57899999999876656677899999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
|.+++|.+++... .+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 9999999999654 488999999999999999999999 999999999999999999999999999987654432
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||......+.+..... .+... + ..
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~--------~~~~~-~---~~- 238 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT--------NGTPE-L---QN- 238 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------HCSCC-C---SC-
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------CCCCC-C---CC-
Confidence 23446899999999999999999999999999999999999999976644333222111 11100 0 00
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...... .+.+++.+||+.||++||++.|+++
T Consensus 239 ~~~~~~---~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 PEKLSA---IFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGGSCH---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCH---HHHHHHHHHccCChhHCcCHHHHhh
Confidence 011223 3445566999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=379.97 Aligned_cols=256 Identities=27% Similarity=0.385 Sum_probs=207.1
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
++|.+.++||+|+||.||++.. .+++.||||++........+.+.+|+++|++++|+||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 4688999999999999999995 468999999997766677788999999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.+++.... ..+++..++.++.|+++||+|||++ +|+|||||++||||++++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 90 KGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999997643 3589999999999999999999999 99999999999999999999999999998765432211
Q ss_pred -------------ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHH-HHHHHHHhHHHhh
Q 006083 475 -------------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSL-VEWARPLLGAALE 540 (662)
Q Consensus 475 -------------~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~ 540 (662)
....+||..|+|||++.+..++.++|||||||+||||++|..+|......... .......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~---- 241 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD---- 241 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH----
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc----
Confidence 11467999999999999999999999999999999999999998653211100 000000000
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 541 DGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 541 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
... ....+. .+.+++.+||+.||++||++.+|++.|+..
T Consensus 242 ---------~~~-~~~~~~---~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 242 ---------RYC-PPNCPP---SFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp ---------HTC-CTTCCT---THHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------ccC-CCCCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 111222 345566699999999999999999998853
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=387.56 Aligned_cols=257 Identities=27% Similarity=0.403 Sum_probs=208.3
Q ss_pred hCCCCccceeeccCceEEEEEEe--------cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL--------PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRV-HHRHLVSLVGYCIAG 384 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~--------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~ 384 (662)
.++|.+++.||+|+||.||+|.. .++..||||+++.... ...+.+.+|+++|+++ +|+||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 35688999999999999999984 2356799999986533 3456799999999999 899999999999999
Q ss_pred CeEEEEEEecCCcchhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGEN--------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI 450 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl 450 (662)
+.+||||||+.+|+|.++|.... ...+++.++++++.||++||+|||++ +|+|||||++||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 99999999999999999997543 23578999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHH
Q 006083 451 DDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLV 528 (662)
Q Consensus 451 ~~~~~vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~ 528 (662)
+.++.+||+|||+++....... .......|+..|+|||++.+..++.++|||||||+||||++ |+.||......+.+.
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999987654322 22334567889999999999999999999999999999999 999997764433221
Q ss_pred HHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 529 EWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.. ..+... .+. ..... .+.+++.+||+.||.+||++.||++.|+..
T Consensus 317 ~~---------~~~~~~-----~~~-~~~~~---~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 317 LL---------KEGHRM-----DKP-ANCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HH---------HTTCCC-----CCC-TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---------hcCCCC-----CCC-CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 111110 111 12233 345555699999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=378.95 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=206.4
Q ss_pred HhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
..++|.+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++|++++|+||+++++++.+.+..|||
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346799999999999999999995 58999999999764 234456789999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+++|.+++.... .+++..++.++.|+++||+|||++ +|+||||||+||||+.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp ECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999996543 489999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccccccCccccCcccccCCCCC-chHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
. .....+||+.|+|||++.+..+. .++|||||||+||||++|+.||......+..... ..+.+.
T Consensus 168 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---------~~~~~~---- 232 (328)
T 3fe3_A 168 G--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV---------LRGKYR---- 232 (328)
T ss_dssp C--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---------HHCCCC----
T ss_pred C--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---------HhCCCC----
Confidence 2 23457899999999999988775 8999999999999999999999876543322211 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+ ......++. +++.+||+.||.+||++.|+++.
T Consensus 233 --~-p~~~s~~~~---~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 --I-PFYMSTDCE---NLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp --C-CTTSCHHHH---HHHHHHCCSSTTTSCCHHHHTTC
T ss_pred --C-CCCCCHHHH---HHHHHHCCCChhHCcCHHHHhcC
Confidence 1 112334444 45558999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=380.16 Aligned_cols=262 Identities=29% Similarity=0.433 Sum_probs=202.0
Q ss_pred HHHHHHhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 006083 309 DELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQ 386 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 386 (662)
.++....++|++.+.||+|+||.||+|.. +|+.||||++..... ...+.+.+|+++|++++|+||+++++++.+.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 33344456799999999999999999987 788999999976542 334678999999999999999999999999999
Q ss_pred EEEEEEecCCcchhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeecCCccCcEEECCCCcEEEEeecc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENR-PVMDFATRVRIALGSAKGLAYLHEDCHPR--IIHRDIKAANILIDDNFEAMVADFGL 463 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--ivHrDIkp~NILl~~~~~vkl~DFGl 463 (662)
.+|||||+.+++|.+++..... ..+++..++.++.|+++||+|||++ + |+|||||++||||++++.+||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 9999999999999999975432 2388999999999999999999998 8 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCc
Q 006083 464 AKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGI 543 (662)
Q Consensus 464 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (662)
++...... .......||..|+|||++.+..++.++|||||||+||||++|+.||......+.+..... ..
T Consensus 186 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~---------~~ 255 (309)
T 3p86_A 186 SRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF---------KC 255 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH---------SC
T ss_pred Cccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------cC
Confidence 98654332 123446799999999999999999999999999999999999999987654332221100 00
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 544 YDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 544 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
. ...+... ... .+.+++.+||+.||++||++.||++.|+..
T Consensus 256 ~----~~~~~~~-~~~---~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 256 K----RLEIPRN-LNP---QVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp C----CCCCCTT-SCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----CCCCCcc-CCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 0011111 223 345556699999999999999999999853
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=374.72 Aligned_cols=262 Identities=21% Similarity=0.302 Sum_probs=214.3
Q ss_pred CCcCHHHHHHHhCC----------CCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCC
Q 006083 304 STFTYDELAAATGG----------FAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHR 372 (662)
Q Consensus 304 ~~~~~~ei~~~~~~----------~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~Hp 372 (662)
..|+++++..++.. |+..+.||+|+||.||+|... +|+.||||+++.......+.+.+|+.+|++++|+
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788888877654 677789999999999999965 7999999999877666778899999999999999
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC
Q 006083 373 HLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD 452 (662)
Q Consensus 373 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~ 452 (662)
||+++++++...+..+|||||+.+++|.+++... .+++..++.++.|+++||+|||++ +|+||||||+||||+.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC
Confidence 9999999999999999999999999999998542 489999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHH
Q 006083 453 NFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWAR 532 (662)
Q Consensus 453 ~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~ 532 (662)
++.+||+|||++........ .....+||..|+|||++.+..++.++|||||||+||||++|+.||......+.+..+.
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~- 254 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR- 254 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-
T ss_pred CCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-
Confidence 99999999999987654322 2345689999999999999999999999999999999999999997654333221111
Q ss_pred HHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 533 PLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
......+. .......+ +.+++.+||+.||++||++.||++.
T Consensus 255 --------~~~~~~~~----~~~~~~~~---l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 255 --------DSPPPKLK----NSHKVSPV---LRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp --------HSSCCCCT----TGGGSCHH---HHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --------cCCCCCcC----ccccCCHH---HHHHHHHHccCChhhCcCHHHHhcC
Confidence 11100000 00112233 4455569999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=369.54 Aligned_cols=281 Identities=33% Similarity=0.594 Sum_probs=228.9
Q ss_pred CCCcCHHHHHHHhCCCCcc------ceeeccCceEEEEEEecCCCEEEEEEeecCC----chhHHHHHHHHHHHHhcCCC
Q 006083 303 KSTFTYDELAAATGGFAKS------NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGS----GQGEREFSAEVEIISRVHHR 372 (662)
Q Consensus 303 ~~~~~~~ei~~~~~~~~~~------~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~E~~il~~l~Hp 372 (662)
...|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|+++|++++|+
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4568999999999999887 8999999999999987 78899999987532 23457899999999999999
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCcchhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC
Q 006083 373 HLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGE-NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID 451 (662)
Q Consensus 373 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~ 451 (662)
||+++++++.+.+..++||||+.+++|.+++... ....+++..+++++.++++||.|||++ +|+||||||+||||+
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence 9999999999999999999999999999998643 234689999999999999999999998 999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHH
Q 006083 452 DNFEAMVADFGLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEW 530 (662)
Q Consensus 452 ~~~~vkl~DFGla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~ 530 (662)
+++.+||+|||+++........ ......|+..|+|||++.+ .++.++|||||||+||+|++|+.||......+.+..+
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 9999999999999876543222 2334679999999998875 6899999999999999999999999876443333333
Q ss_pred HHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 531 ARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
...... ....+...++..+ ..........+.+++..||+.||.+||++.+|++.|+..
T Consensus 247 ~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 247 KEEIED---EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHT---TSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHhhh---hhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 222110 1122233333333 234456667788888899999999999999999999853
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=378.84 Aligned_cols=256 Identities=28% Similarity=0.436 Sum_probs=205.3
Q ss_pred hCCCCccceeeccCceEEEEEEec----CCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP----NGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
.++|.+.++||+|+||.||+|.+. .+..||||+++... ....+.|.+|+++|++++|+||++++++|.+++..||
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356889999999999999999963 34569999998653 3445679999999999999999999999999999999
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||||+.+++|.++++... ..+++..++.|+.+++.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999996543 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCc--cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCcccc
Q 006083 470 NHTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 470 ~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
.... ......||..|+|||++.+..++.++|||||||+||||++ |+.||......+.+..+. .+...
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~---------~~~~~- 273 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE---------EGYRL- 273 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH---------TTCCC-
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH---------cCCCC-
Confidence 3222 2233456788999999998899999999999999999999 999997665443222211 11100
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.. ....+. .+.+++.+||+.||++||++.||++.|+..
T Consensus 274 ----~~-~~~~~~---~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 274 ----PA-PMGCPH---ALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp ----CC-CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CC-CCCcCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01 112233 445556699999999999999999999853
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=372.86 Aligned_cols=261 Identities=23% Similarity=0.361 Sum_probs=205.0
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
.++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|++++++++|+||+++++++.+++..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46799999999999999999985 478999999986542 23346789999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.|++|.+++.... .+++..++.++.|+++||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999996543 589999999999999999999999 9999999999999999999999999999876554
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
........+||..|+|||++.+..++.++|||||||+||||++|+.||......+....... ... ... ..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~--------~~~-~~~-~~ 234 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ--------DSV-PNV-TT 234 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS--------SCC-CCH-HH
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh--------ccC-CCc-ch
Confidence 33334456799999999999999999999999999999999999999987654332221111 100 000 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhhCCCC
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRP-KMSQIVRALEGDSS 594 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~~~~ 594 (662)
.+.. ..+. .+.+++.+||+.||.+|| ++.++++.|+....
T Consensus 235 ~~~~-~~~~---~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 235 DVRK-DIPQ---SLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HSCT-TSCH---HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred hccc-CCCH---HHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 1111 1233 345555699999999998 89999999986543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=365.62 Aligned_cols=253 Identities=28% Similarity=0.482 Sum_probs=209.8
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
++|++.+.||+|+||.||+|...+++.||||+++... ...+.+.+|+++|++++|+||+++++++.+++..++||||+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 4688899999999999999998888999999998653 345679999999999999999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
+++|.+++.... ..+++..++.++.|+++||+|||++ +|+||||||+||||+.++.+||+|||+++..........
T Consensus 89 ~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999999996543 3589999999999999999999999 999999999999999999999999999987654433233
Q ss_pred cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
....|+..|+|||++.+..++.++|||||||++|+|++ |+.||......+.+..+. .+. . ....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~---------~~~-~-----~~~~ 229 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS---------TGF-R-----LYKP 229 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---------TTC-C-----CCCC
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh---------cCc-c-----CCCC
Confidence 44567888999999998999999999999999999999 999998765443322211 110 0 0011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...... +.+++..||+.||++||++.|+++.|+.
T Consensus 230 ~~~~~~---~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 230 RLASTH---VYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CcCCHH---HHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 112333 4555569999999999999999999985
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=381.68 Aligned_cols=252 Identities=25% Similarity=0.322 Sum_probs=206.1
Q ss_pred HhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCch------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQ------GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQ 386 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 386 (662)
..++|.+.+.||+|+||.||++... +|+.||||+++..... ..+.+.+|+++|++++|+||++++++|.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467999999999999999999954 6899999999865322 35789999999999999999999999999999
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC----cEEEEeec
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF----EAMVADFG 462 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkl~DFG 462 (662)
+|||||||.||+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+||||++++ .+||+|||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999999643 3589999999999999999999998 999999999999998876 79999999
Q ss_pred cccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcC
Q 006083 463 LAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDG 542 (662)
Q Consensus 463 la~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 542 (662)
+++...... .....+||+.|+|||++.+..++.++||||||||||+|++|+.||......+.+..+.. +
T Consensus 165 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~---------~ 233 (361)
T 2yab_A 165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA---------V 233 (361)
T ss_dssp SCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT---------T
T ss_pred CceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------c
Confidence 998765432 23456799999999999998999999999999999999999999987654443322211 1
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 543 IYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 543 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+. .+..... ....+ +.+++..||..||++||++.|+++
T Consensus 234 ~~~--~~~~~~~-~~s~~---~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SYD--FDEEFFS-QTSEL---AKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCC--CCHHHHT-TSCHH---HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCC--CCchhcc-CCCHH---HHHHHHHHCCCChhHCcCHHHHhc
Confidence 110 0001111 12233 445556999999999999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=375.97 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=204.0
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.+.||+|+||.||+++.. +|+.||||++++. .......+.+|+++|++++|+||+++++++.+.+.+||||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 56999999999999999999954 7899999999754 2234567889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.||+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 85 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999999986543 488999999999999999999999 99999999999999999999999999998644332
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
. .....+||+.|+|||++.+..++.++|||||||+||||++|+.||......+.+.... .. .+ .
T Consensus 160 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--------~~-~~------~ 223 (337)
T 1o6l_A 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--------ME-EI------R 223 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HC-CC------C
T ss_pred C-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH--------cC-CC------C
Confidence 2 2345789999999999999999999999999999999999999997654333222111 11 10 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRP-----KMSQIVRA 588 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 588 (662)
+.. ....++. .++.+||+.||++|+ ++.||++.
T Consensus 224 ~p~-~~s~~~~---~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 FPR-TLSPEAK---SLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCT-TSCHHHH---HHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCC-CCCHHHH---HHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 111 2234444 445589999999999 89998863
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=363.89 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=211.5
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
.++|.+.+.||+|+||.||++...++..||||+++.... ..+.+.+|+++|++++|+||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 456899999999999999999988888999999986543 3567899999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||||+.++.+||+|||++..........
T Consensus 86 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp TTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred CCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999999996532 3489999999999999999999999 99999999999999999999999999998776544333
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
.....|+..|+|||++.+..++.++|||||||++|||++ |+.||......+....... +. . ...
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---------~~--~----~~~ 226 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ---------GH--R----LYR 226 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT---------TC--C----CCC
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc---------CC--C----CCC
Confidence 334556778999999998899999999999999999999 9999987654433222111 11 0 011
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
....... +.+++..||+.||.+||++.||++.|+...
T Consensus 227 ~~~~~~~---l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 227 PHLASDT---IYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CTTSCHH---HHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCcChHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1122333 455566999999999999999999998654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=382.06 Aligned_cols=267 Identities=26% Similarity=0.425 Sum_probs=213.3
Q ss_pred CcCHHHHHHHhCCCCccceeeccCceEEEEEEe------cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhc-CCCCcce
Q 006083 305 TFTYDELAAATGGFAKSNLLGQGGFGYVHKGVL------PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRV-HHRHLVS 376 (662)
Q Consensus 305 ~~~~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~ 376 (662)
.+...++....++|.+.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+++|+++ +|+|||+
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 345566667778999999999999999999973 2468899999986543 3456799999999999 7999999
Q ss_pred EEEEEEeCC-eEEEEEEecCCcchhhhhccCCC-----------------------------------------------
Q 006083 377 LVGYCIAGG-QRMLVYEFVSNKTLEYHLHGENR----------------------------------------------- 408 (662)
Q Consensus 377 l~~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~----------------------------------------------- 408 (662)
++++|.+.+ .+++|||||.+|+|.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998754 48999999999999999975432
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 409 -----------------PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 409 -----------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
..+++..++.++.||++||+|||++ +|+||||||+||||++++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 2288999999999999999999999 99999999999999999999999999998664432
Q ss_pred C-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 472 T-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 472 ~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
. .......||..|+|||++.+..++.++||||||||||||++ |+.||......+.+..... .+...
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--------~~~~~---- 315 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--------EGTRM---- 315 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH--------HTCCC----
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH--------cCCCC----
Confidence 2 23345678999999999999999999999999999999998 9999977654333322111 11110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.+. .....+ +.+++..||+.||.+||++.||++.|+.
T Consensus 316 -~~~-~~~~~~---l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 316 -RAP-DYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp -CCC-TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCC-CCCCHH---HHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 111 122333 4555569999999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=378.77 Aligned_cols=253 Identities=24% Similarity=0.324 Sum_probs=204.8
Q ss_pred HhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
..++|.+.+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+++|++|+|+|||++++++.+.+..|||
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999854 689999999976532 3456789999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC---CcEEEEeecccccc
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN---FEAMVADFGLAKLS 467 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkl~DFGla~~~ 467 (662)
||||.|++|.+++... ..+++..++.++.||++||.|||++ +|+||||||+||||+.+ +.+||+|||++...
T Consensus 107 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp ECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999999998643 3589999999999999999999999 99999999999999864 45999999999876
Q ss_pred CCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 468 NDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 468 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
.... .....+||+.|+|||++.+..|+.++||||||||||+|++|+.||......+.+..+. .+.+...
T Consensus 182 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~---------~~~~~~~ 250 (362)
T 2bdw_A 182 NDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK---------AGAYDYP 250 (362)
T ss_dssp TTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---------HTCCCCC
T ss_pred cCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---------hCCCCCC
Confidence 5432 2244689999999999999899999999999999999999999997654333222211 1111110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
. ... .....+ +.+++.+||+.||++||++.|+++.
T Consensus 251 -~-~~~-~~~~~~---~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 -S-PEW-DTVTPE---AKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -T-TGG-GGSCHH---HHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -c-ccc-cCCCHH---HHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 000 112333 4455569999999999999999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=369.69 Aligned_cols=274 Identities=21% Similarity=0.221 Sum_probs=213.9
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--eEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGG--QRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~lv~ 391 (662)
++|.+.++||+|+||.||+|... +|+.||||+++... ....+.+.+|+++|++++|+||+++++++...+ ..+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56999999999999999999964 58999999997543 234577889999999999999999999998655 789999
Q ss_pred EecCCcchhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE----CCCCcEEEEeeccccc
Q 006083 392 EFVSNKTLEYHLHGENR-PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI----DDNFEAMVADFGLAKL 466 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkl~DFGla~~ 466 (662)
||+.+++|.+++..... ..+++..++.++.||++||+|||++ +|+||||||+|||| +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999975432 3389999999999999999999999 99999999999999 7888899999999987
Q ss_pred cCCCCCccccccccCccccCccccc--------CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHH
Q 006083 467 SNDNHTHVSTRVMGTFGYLAPEYAS--------SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAA 538 (662)
Q Consensus 467 ~~~~~~~~~~~~~Gt~~y~aPE~~~--------~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 538 (662)
...... ....+||..|+|||++. +..++.++||||||||||||++|+.||..........+.....+...
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 655432 23467999999999886 57899999999999999999999999975433333333322222211
Q ss_pred hhc----------CccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCCC
Q 006083 539 LED----------GIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSS 594 (662)
Q Consensus 539 ~~~----------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 594 (662)
... ..+...-+..............+..++.+||+.||++||++.|+++...++..
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 100 00000000011123345556667778889999999999999999999886443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=373.24 Aligned_cols=251 Identities=21% Similarity=0.292 Sum_probs=205.0
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCch------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQ------GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 388 (662)
++|.+.+.||+|+||.||++... +|+.||||+++..... ..+.+.+|+++|++++|+||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45999999999999999999954 6899999999765322 3678999999999999999999999999999999
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC----cEEEEeeccc
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF----EAMVADFGLA 464 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkl~DFGla 464 (662)
||||||.+++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+||||++++ .+||+|||++
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999643 4589999999999999999999998 999999999999999877 8999999999
Q ss_pred cccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcc
Q 006083 465 KLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIY 544 (662)
Q Consensus 465 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (662)
+....... ....+||..|+|||++.+..++.++||||||||||+|++|+.||......+.+..... ..+
T Consensus 166 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~---------~~~ 234 (326)
T 2y0a_A 166 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA---------VNY 234 (326)
T ss_dssp EECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH---------TCC
T ss_pred eECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHh---------cCC
Confidence 87654322 2346799999999999989999999999999999999999999977654433322211 000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 545 DGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 545 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
. ....... .... .+.+++.+||+.||++||++.|+++.
T Consensus 235 ~--~~~~~~~-~~~~---~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 E--FEDEYFS-NTSA---LAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp C--CCHHHHT-TSCH---HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C--cCccccc-cCCH---HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0000001 1123 34455569999999999999999873
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=373.42 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=201.0
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.++|++.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++++++|+||+++++++.+++..|||||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 357999999999999999999854 789999999975433 234678999999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC-
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH- 471 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~- 471 (662)
||.+++|.+++... ..+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999999644 3489999999999999999999998 99999999999999999999999999998654322
Q ss_pred CccccccccCccccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCchhhh-HHHHHHHHHhHHHhhcCccccccC
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDMTMMED-SLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
.......+||..|+|||++.+..+ +.++|||||||+||||++|+.||....... .+..|.. ......
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~--------~~~~~~--- 229 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--------KKTYLN--- 229 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT--------TCTTST---
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc--------ccccCC---
Confidence 122345689999999999987765 789999999999999999999997654322 2222211 100000
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
... ... ..+.+++.+||+.||++||++.|+++.
T Consensus 230 --~~~-~~~---~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 --PWK-KID---SAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --TGG-GSC---HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --ccc-cCC---HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 001 112 334456669999999999999998864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=373.44 Aligned_cols=252 Identities=19% Similarity=0.274 Sum_probs=206.6
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
.++|.+.+.||+|+||.||+|... +++.||+|+++.. ......+.+|+++|++++|+||+++++++.+.+.++|||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467999999999999999999954 6889999999754 34456789999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC--CCcEEEEeeccccccCCCC
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD--NFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~--~~~vkl~DFGla~~~~~~~ 471 (662)
|.|++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||||+. ++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999996532 3589999999999999999999999 9999999999999987 7899999999998775432
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
......|++.|+|||++.+..++.++|||||||+||+|++|+.||......+.+..+... .+. ....
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---------~~~--~~~~ 225 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA---------EYT--FDEE 225 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT---------CCC--CCHH
T ss_pred --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcC---------CCC--CChh
Confidence 234567999999999999888999999999999999999999999876544433222111 110 0000
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
... .... .+.+++.+||+.||++||++.|+++.
T Consensus 226 ~~~-~~s~---~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 AFK-EISI---EAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHT-TSCH---HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhc-cCCH---HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001 1123 34555669999999999999999973
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=370.00 Aligned_cols=264 Identities=22% Similarity=0.291 Sum_probs=203.2
Q ss_pred HhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
..++|++.+.||+|+||.||+|...+|+.||||+++.... ...+.+.+|+++|++++|+||+++++++.+++..+|||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3467999999999999999999988899999999975432 23467889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.+ +|.+++.... ..+++..++.++.|+++||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 99 e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 99 EFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp ECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred cCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 99985 7777775433 3589999999999999999999999 99999999999999999999999999998765432
Q ss_pred CccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHH------------
Q 006083 472 THVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAA------------ 538 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~------------ 538 (662)
. .....+||..|+|||++.+ ..++.++|||||||+||||++|+.||......+.+..+....-...
T Consensus 174 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 174 R-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp C----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred c-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 2 2344678999999999876 5689999999999999999999999987765554444322110000
Q ss_pred hhcCccccccC---cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 539 LEDGIYDGLVD---PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 539 ~~~~~~~~~~d---~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.....+..... ..+...+ . .++.+++.+||+.||++||++.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~-~---~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGF-C---QEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTC-C---HHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhcccccccCCcHHHhCccc-C---HHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000000 0011111 1 34556667999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=379.79 Aligned_cols=249 Identities=25% Similarity=0.347 Sum_probs=199.4
Q ss_pred HhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTG---SGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 388 (662)
..++|++.++||+|+||.||+++.. +|+.||||++++. .....+.+.+|+++|+.+ +|+||+++++++.+.+.+|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3467999999999999999999854 6899999999754 123346688999999998 6999999999999999999
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
||||||.||+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 101 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999996543 489999999999999999999999 99999999999999999999999999998644
Q ss_pred CCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 469 DNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 469 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||......+.+..+.. ...
T Consensus 176 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--------~~~----- 241 (353)
T 3txo_A 176 CNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--------DEV----- 241 (353)
T ss_dssp C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------CCC-----
T ss_pred cCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc--------CCC-----
Confidence 332 223457899999999999988999999999999999999999999987654443332211 110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKM------SQIVR 587 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~evl~ 587 (662)
.+. ...... +..++.+||+.||.+|+++ .||++
T Consensus 242 --~~p-~~~~~~---~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 --VYP-TWLHED---ATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --CCC-TTSCHH---HHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --CCC-CCCCHH---HHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111 112333 4445558999999999998 66664
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=382.58 Aligned_cols=255 Identities=29% Similarity=0.444 Sum_probs=195.2
Q ss_pred CCCCccceeeccCceEEEEEEec----CCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP----NGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
++|.+.++||+|+||.||+|+.. ++..||||+++... ....+.|.+|+++|++++|+||++++++|.+++..+||
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 46999999999999999999854 57789999998653 33456899999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+++|.++++... ..+++..++.++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 125 ~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999997543 3589999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcc--ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 471 HTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 471 ~~~~--~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
.... .....++..|+|||++.++.++.++||||||||||||++ |+.||......+.+... ..+...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i---------~~~~~~-- 269 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV---------DEGYRL-- 269 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH---------HTTEEC--
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---------HcCCCC--
Confidence 2221 122345788999999999999999999999999999998 99999765433322111 111100
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
. .....+ ..+.+++.+||+.||.+||++.||++.|+..
T Consensus 270 ---~-~~~~~~---~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 270 ---P-PPMDCP---AALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ---C-CCTTCB---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---C-CCcccc---HHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 0 011123 3455566699999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=393.54 Aligned_cols=257 Identities=28% Similarity=0.421 Sum_probs=210.3
Q ss_pred HhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
..++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++|+|+|||++++++. .+..||||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 445688999999999999999998888999999998654 45678999999999999999999999986 6678999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
|.+|+|.++|+......+++..+++++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++........
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 9999999999765444578899999999999999999999 9999999999999999999999999999876543222
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
......++..|+|||++..+.++.++|||||||+||||++ |+.||......+.+... ..+... .
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---------~~~~~~-----~- 405 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---------ERGYRM-----P- 405 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---------HHTCCC-----C-
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---------HcCCCC-----C-
Confidence 2233456789999999998999999999999999999999 99999765443322211 111100 0
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
.....+.+ +.+++.+||+.||++||++.+|++.|+...
T Consensus 406 ~~~~~~~~---l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 406 RPENCPEE---LYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCHH---HHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 01123344 445556999999999999999999999754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=380.21 Aligned_cols=253 Identities=24% Similarity=0.305 Sum_probs=207.6
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
.++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+++|++++|+||+++++++.+.+..+|||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 457999999999999999999854 7899999999876655667899999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC--CCcEEEEeeccccccCCCC
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD--NFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~--~~~vkl~DFGla~~~~~~~ 471 (662)
|.+++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||||+. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999986543 3589999999999999999999998 9999999999999974 5789999999998775433
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
. ....+||..|+|||++.+..++.++||||||||||||++|+.||......+.+..+.. ..+. .+..
T Consensus 206 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---------~~~~--~~~~ 272 (387)
T 1kob_A 206 I--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR---------CDWE--FDED 272 (387)
T ss_dssp C--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH---------CCCC--CCSS
T ss_pred c--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHh---------CCCC--CCcc
Confidence 2 2345799999999999999999999999999999999999999987654333322211 1100 1111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
... ....+ +.+++.+||+.||++||++.|+++.
T Consensus 273 ~~~-~~s~~---~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 AFS-SVSPE---AKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTT-TSCHH---HHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccc-cCCHH---HHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111 12333 4455569999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=365.41 Aligned_cols=254 Identities=24% Similarity=0.392 Sum_probs=206.4
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
.++|++.+.||+|+||.||++...++..||||+++... ...+++.+|+++|++++|+||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 34688999999999999999998888899999998653 33567899999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||||++++.+||+|||+++.........
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 102 ANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp TTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 9999999996532 3489999999999999999999999 99999999999999999999999999998765433222
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
.....|+..|+|||++.+..++.++|||||||++|||++ |+.||......+...... .+. . ...
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~---------~~~-~-----~~~ 242 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA---------QGL-R-----LYR 242 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH---------TTC-C-----CCC
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh---------ccc-C-----CCC
Confidence 334557788999999998899999999999999999998 999998765433222111 111 0 011
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...... .+.+++.+||+.+|.+||++.||++.|+.
T Consensus 243 ~~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 243 PHLASE---KVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp CTTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcCCH---HHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 112233 44556669999999999999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=388.48 Aligned_cols=259 Identities=21% Similarity=0.251 Sum_probs=208.3
Q ss_pred HHHHHHhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 006083 309 DELAAATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAG 384 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 384 (662)
.++....++|++.++||+|+||.||+++.. +++.||||++++.. ....+.+.+|+++|+.++|+|||+++++|.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344445678999999999999999999964 68999999997521 11224578999999999999999999999999
Q ss_pred CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
+.+|||||||.||+|.++++.. .+++..++.++.||+.||+|||++ +||||||||+||||+.++.+||+|||++
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecccee
Confidence 9999999999999999999653 378999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccccccCccccCcccccCCC----CCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhh
Q 006083 465 KLSNDNHTHVSTRVMGTFGYLAPEYASSGK----LTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALE 540 (662)
Q Consensus 465 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 540 (662)
+.............+||+.|+|||++.+.. |+.++||||||||||||++|+.||......+.+..+.....
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~----- 290 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN----- 290 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-----
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc-----
Confidence 877654433344678999999999998655 88999999999999999999999987654444333222110
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006083 541 DGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARK--RPKMSQIVRA 588 (662)
Q Consensus 541 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~ 588 (662)
...+. .......++.+|+ .+||+.++++ |+++.||++.
T Consensus 291 ~~~~p-------~~~~~s~~~~~li---~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 SLTFP-------DDNDISKEAKNLI---CAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HCCCC-------TTCCCCHHHHHHH---HHHSSCGGGCTTSSCHHHHHTS
T ss_pred cccCC-------CcccccHHHHHHH---HHHccChhhhCCCCCHHHHhcC
Confidence 00000 0112334455544 5899988988 9999999974
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=385.30 Aligned_cols=252 Identities=22% Similarity=0.258 Sum_probs=190.2
Q ss_pred CCCCcc-ceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHh-cCCCCcceEEEEEEe----CCeEE
Q 006083 316 GGFAKS-NLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISR-VHHRHLVSLVGYCIA----GGQRM 388 (662)
Q Consensus 316 ~~~~~~-~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~----~~~~~ 388 (662)
++|.+. ++||+|+||.||++... +|+.||||+++.. ..+.+|++++.+ ++|+||++++++|.. .+.+|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 78999999999999854 7899999999742 457789998755 489999999999875 56789
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC---CCcEEEEeecccc
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD---NFEAMVADFGLAK 465 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~DFGla~ 465 (662)
||||||.||+|.++|.......+++..++.|+.||+.||.|||++ +|||||||++||||+. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 999999999999999876666799999999999999999999998 9999999999999987 7899999999998
Q ss_pred ccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
...... .....+||..|+|||++.++.|+.++||||||||||||++|+.||...........+.. .+..+.+.
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~-----~i~~~~~~ 285 (400)
T 1nxk_A 213 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-----RIRMGQYE 285 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH-----HHHHTCCC
T ss_pred ccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH-----HHHcCccc
Confidence 765432 23457899999999999999999999999999999999999999976532211000000 00111111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.. .........+ +.+++.+||+.||++||++.||++.
T Consensus 286 ~~---~~~~~~~s~~---~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 FP---NPEWSEVSEE---VKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CC---TTTTTTSCHH---HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC---CcccccCCHH---HHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0011122344 4455569999999999999999974
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=396.62 Aligned_cols=256 Identities=27% Similarity=0.388 Sum_probs=211.7
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
..+|.+.+.||+|+||.||+|.+. ++..||||+++... ...+.|.+|+++|++++|+|||+++++|.+.+.+||||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 456888999999999999999965 48899999998653 3467899999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
|.+|+|.++|+......+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++........
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 9999999999876666789999999999999999999999 9999999999999999999999999999876544332
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
......++..|+|||++.++.++.++|||||||+||||++ |+.||......+.+. . +..+... ..
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~-~--------~~~~~~~-----~~ 440 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-L--------LEKDYRM-----ER 440 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-H--------HHTTCCC-----CC
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-H--------HHcCCCC-----CC
Confidence 3334556789999999998899999999999999999999 999997654333221 1 1111100 01
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
....+.+ +.+++.+||+.||++||++.+|++.|+..
T Consensus 441 -~~~~~~~---l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 441 -PEGCPEK---VYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp -CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -CCCCCHH---HHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1123344 44555699999999999999999999964
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=385.83 Aligned_cols=253 Identities=22% Similarity=0.284 Sum_probs=204.7
Q ss_pred HhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
..++|++.+.||+|+||.||+|.. .+|+.||+|+++.... ...+.+.+|+++|++++|+|||++++++.+++..|||
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 345699999999999999999984 4789999999976543 3346789999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC---CCCcEEEEeecccccc
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID---DNFEAMVADFGLAKLS 467 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~---~~~~vkl~DFGla~~~ 467 (662)
||||.||+|.+++.... .+++..+..++.||++||.|||++ +|+||||||+||||+ +++.+||+|||+++..
T Consensus 89 ~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999986543 489999999999999999999999 999999999999998 4688999999999876
Q ss_pred CCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 468 NDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 468 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
..... .....+||+.|+|||++.+..|+.++||||||||||+|++|+.||......+.+..+. .+.+...
T Consensus 164 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~---------~~~~~~~ 233 (444)
T 3soa_A 164 EGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK---------AGAYDFP 233 (444)
T ss_dssp CTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---------HTCCCCC
T ss_pred cCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH---------hCCCCCC
Confidence 54432 2344689999999999999899999999999999999999999997765443332221 1111110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. . .......++. +++.+||+.||++||++.|+++
T Consensus 234 -~-~-~~~~~s~~~~---~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 234 -S-P-EWDTVTPEAK---DLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -T-T-TTTTSCHHHH---HHHHHHSCSSTTTSCCHHHHHH
T ss_pred -c-c-ccccCCHHHH---HHHHHHcCCChhHCCCHHHHhc
Confidence 0 0 0112234444 4555899999999999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=365.23 Aligned_cols=259 Identities=24% Similarity=0.378 Sum_probs=200.5
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHh--cCCCCcceEEEEEEe----CCeEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISR--VHHRHLVSLVGYCIA----GGQRM 388 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~~~~~~----~~~~~ 388 (662)
.++|.+.+.||+|+||.||+|.. +|+.||||++.. .....+.+|.+++.. ++|+||+++++++.+ ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46799999999999999999987 789999999975 345566778888777 789999999998764 35689
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCceeecCCccCcEEECCCCcEEEEe
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLH--------EDCHPRIIHRDIKAANILIDDNFEAMVAD 460 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~ivHrDIkp~NILl~~~~~vkl~D 460 (662)
|||||+.+|+|.++++. ..+++..+++++.|+++||+||| ++ +|+||||||+||||+.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence 99999999999999953 35899999999999999999999 76 999999999999999999999999
Q ss_pred eccccccCCCCCcc---ccccccCccccCcccccCC------CCCchHHHHHHHHHHHHHHhC----------CCCCCCc
Q 006083 461 FGLAKLSNDNHTHV---STRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVMLLELITG----------RRPVDMT 521 (662)
Q Consensus 461 FGla~~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~eLltG----------~~Pf~~~ 521 (662)
||+++......... ....+||..|+|||++.+. .++.++|||||||+||||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997665433221 2235799999999999876 455799999999999999999 8887543
Q ss_pred hhhhHHHHHHHHHhHHHhhcCccccccCcccCC-CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 522 MMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH-NYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...+.......... ..... ...+.. .+.......+.+++.+||+.||++||++.||++.|+.
T Consensus 237 ~~~~~~~~~~~~~~----~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 237 VPNDPSFEDMRKVV----CVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp SCSSCCHHHHHHHH----TTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCcchhhhhHHH----hccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 22111111111110 00110 111111 1122345667777789999999999999999999985
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=375.31 Aligned_cols=262 Identities=26% Similarity=0.403 Sum_probs=210.7
Q ss_pred HHHHhCCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 006083 311 LAAATGGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIA 383 (662)
Q Consensus 311 i~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 383 (662)
+....++|.+.+.||+|+||.||+|... +++.||||+++.... ...+.+.+|+++|++++|+||++++++|.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3345678999999999999999999863 348899999986543 345679999999999999999999999999
Q ss_pred CCeEEEEEEecCCcchhhhhccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeec
Q 006083 384 GGQRMLVYEFVSNKTLEYHLHGEN----------------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441 (662)
Q Consensus 384 ~~~~~lv~E~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHr 441 (662)
++..||||||+.+++|.+++.... ...+++.+++.++.||++||.|||++ +|+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 999999999999999999996532 15689999999999999999999999 99999
Q ss_pred CCccCcEEECCCCcEEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCC
Q 006083 442 DIKAANILIDDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVD 519 (662)
Q Consensus 442 DIkp~NILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~ 519 (662)
||||+||||++++.+||+|||+++....... .......|+..|+|||++.++.++.++|||||||+||||++ |+.||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999986543221 12234568999999999998999999999999999999999 999997
Q ss_pred CchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 520 MTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
.....+.+.. +..+.... + ....+. .+.+++.+||+.||.+||++.+|++.|+...
T Consensus 279 ~~~~~~~~~~---------~~~~~~~~-----~-~~~~~~---~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 279 GMAHEEVIYY---------VRDGNILA-----C-PENCPL---ELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp TSCHHHHHHH---------HHTTCCCC-----C-CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCChHHHHHH---------HhCCCcCC-----C-CCCCCH---HHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 6543332211 11111111 1 112233 4455566999999999999999999998643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=379.46 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=209.1
Q ss_pred hCCCCccceeeccCceEEEEEEec--------CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP--------NGKEVAVKSLKTGSG-QGEREFSAEVEIISRV-HHRHLVSLVGYCIAG 384 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~ 384 (662)
.++|.+.+.||+|+||.||+|... .+..||||+++.... ...+.+.+|+++|+++ +|+|||+++++|.++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 456899999999999999999842 335799999986533 3457789999999999 899999999999999
Q ss_pred CeEEEEEEecCCcchhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGEN--------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI 450 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl 450 (662)
+..+|||||+.+|+|.+++.... ...+++..+++|+.||++||+|||++ +|+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 99999999999999999997543 24589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHH
Q 006083 451 DDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLV 528 (662)
Q Consensus 451 ~~~~~vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~ 528 (662)
++++.+||+|||+++....... .......|+..|+|||++.+..++.++||||||||||||++ |+.||......+.+.
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~ 304 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987654322 22334567889999999999999999999999999999999 999997664333221
Q ss_pred HHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 529 EWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
.+ ..+... ... ..... .+.+++.+||+.||++||++.||++.|+...
T Consensus 305 ~~---------~~~~~~-----~~~-~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 305 LL---------KEGHRM-----DKP-SNCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HH---------HTTCCC-----CCC-SSCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---------HcCCCC-----CCC-ccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 111111 111 12233 3455556999999999999999999998644
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=378.98 Aligned_cols=251 Identities=20% Similarity=0.304 Sum_probs=196.0
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc---hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG---QGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv 390 (662)
++|++.++||+|+||.||+++.. +++.||||++++... ...+.+.+|+.+|.++ +|+|||+++++|.+.+.+|||
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 56999999999999999999954 688999999986422 2234688999999887 899999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
||||.||+|.+++.... .+++..++.++.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.....
T Consensus 132 ~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999996543 489999999999999999999999 9999999999999999999999999999864332
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
. ......+||+.|+|||++.+..|+.++||||||||||||++|+.||......+.........+...+....+
T Consensus 207 ~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 279 (396)
T 4dc2_A 207 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 279 (396)
T ss_dssp T-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------
T ss_pred C-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------
Confidence 2 223457899999999999999999999999999999999999999975432211110000001111111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKM 582 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 582 (662)
.+.. ....++ ..++.+||+.||++|+++
T Consensus 280 ~~p~-~~s~~~---~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 RIPR-SLSVKA---ASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCT-TSCHHH---HHHHHHHTCSCTTTSTTC
T ss_pred CCCC-cCCHHH---HHHHHHHhcCCHhHcCCC
Confidence 1111 123344 445558999999999995
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=389.56 Aligned_cols=264 Identities=19% Similarity=0.222 Sum_probs=210.8
Q ss_pred CHHHHHHHhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 006083 307 TYDELAAATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCI 382 (662)
Q Consensus 307 ~~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 382 (662)
.++++....++|++.++||+|+||.||+|+.. +++.||||++++... .....+.+|+.+|..++|+||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34555566789999999999999999999965 578999999975311 12234889999999999999999999999
Q ss_pred eCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeec
Q 006083 383 AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFG 462 (662)
Q Consensus 383 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFG 462 (662)
+++.+|||||||.||+|.++|... ...+++..++.++.||+.||+|||++ +||||||||+||||+.++.+||+|||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999999999999753 23589999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccCccccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHH
Q 006083 463 LAKLSNDNHTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGA 537 (662)
Q Consensus 463 la~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 537 (662)
+++.............+||+.|||||++. .+.|+.++||||||||||||++|+.||......+.+..+.....
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-- 298 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-- 298 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc--
Confidence 99877655444445578999999999987 56799999999999999999999999987655444333221100
Q ss_pred HhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006083 538 ALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARK--RPKMSQIVRA 588 (662)
Q Consensus 538 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~ 588 (662)
...+. ... .....++.+|+ .+||..++++ |+++.||++.
T Consensus 299 ---~~~~p-----~~~-~~~s~~~~dLi---~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 299 ---RFQFP-----TQV-TDVSENAKDLI---RRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ---HCCCC-----SSC-CCSCHHHHHHH---HTTSSCGGGCTTTTTTHHHHTS
T ss_pred ---cccCC-----ccc-ccCCHHHHHHH---HHHhcccccccCCCCHHHHhCC
Confidence 00010 000 11334455554 4788888887 9999999863
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=381.29 Aligned_cols=257 Identities=27% Similarity=0.360 Sum_probs=205.8
Q ss_pred hCCCCccceeeccCceEEEEEEec------CCCEEEEEEeecC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTG-SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 387 (662)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.. .......+.+|+.+|++++|+|||++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 356889999999999999999842 4678999999754 334456789999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC---cEEEE
Q 006083 388 MLVYEFVSNKTLEYHLHGEN-----RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF---EAMVA 459 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkl~ 459 (662)
+||||||.+|+|.+++.... ...+++..++.++.||++||+|||++ +|+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996532 24589999999999999999999999 999999999999999544 59999
Q ss_pred eeccccccCCCC-CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHH
Q 006083 460 DFGLAKLSNDNH-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGA 537 (662)
Q Consensus 460 DFGla~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 537 (662)
|||+++...... ........||..|+|||++.++.++.++|||||||+||||++ |+.||......+.+...
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i------- 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV------- 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-------
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------
Confidence 999997543211 122344678999999999999999999999999999999998 99999776543322211
Q ss_pred HhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 538 ALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 538 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
..+... .. ....+.. +.+++.+||+.||.+||++.||++.|+..
T Consensus 300 --~~~~~~-----~~-~~~~~~~---l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 300 --TSGGRM-----DP-PKNCPGP---VYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp --HTTCCC-----CC-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HcCCCC-----CC-CccCCHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111100 01 1122333 45556699999999999999999998754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=378.53 Aligned_cols=210 Identities=20% Similarity=0.262 Sum_probs=181.8
Q ss_pred hCCCCccceeecc--CceEEEEEEec-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 315 TGGFAKSNLLGQG--GFGYVHKGVLP-NGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 315 ~~~~~~~~~iG~G--~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
.++|++.++||+| +||.||+|+.. +|+.||||+++... ....+.+.+|+++|++++|+|||+++++|.+++.+||
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3569999999999 99999999965 79999999997643 3345678899999999999999999999999999999
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
|||||.+++|.+++.......+++..++.++.||++||+|||++ +|+||||||+||||+.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999776556699999999999999999999999 999999999999999999999999999865422
Q ss_pred CCC------ccccccccCccccCcccccC--CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHH
Q 006083 470 NHT------HVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSL 527 (662)
Q Consensus 470 ~~~------~~~~~~~Gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~ 527 (662)
... ......+||..|+|||++.+ ..++.++||||||||||||++|+.||......+.+
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 246 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 246 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 111 11223578999999999987 67999999999999999999999999775444433
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=370.34 Aligned_cols=263 Identities=25% Similarity=0.361 Sum_probs=201.9
Q ss_pred CCCCccceeeccCceEEEEEEe-----cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-----PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA--GGQRM 388 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ 388 (662)
++|++.+.||+|+||.||++++ .+++.||||+++.......+.+.+|+++|++++|+||++++++|.. ...++
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5689999999999999999983 3688999999987766667889999999999999999999999864 45689
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
|||||+.+++|.+++.... ..+++..+++++.|++.||+|||++ +|+||||||+||||++++.+||+|||+++...
T Consensus 90 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999996543 2489999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCC--ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHH-------HHHHHHhHHHh
Q 006083 469 DNHT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLV-------EWARPLLGAAL 539 (662)
Q Consensus 469 ~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~-------~~~~~~~~~~~ 539 (662)
.... .......|+..|+|||++.+..++.++|||||||+||||++|..||.......... .+....+...+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 4322 12233557888999999999999999999999999999999999986542110000 00000000111
Q ss_pred hcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 540 EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 540 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
..+... .. ....+.+ +.+++.+||+.||++||++.||++.|+.
T Consensus 246 ~~~~~~-----~~-~~~~~~~---l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 246 KNNGRL-----PR-PDGCPDE---IYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HTTCCC-----CC-CTTCCHH---HHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hccCcC-----CC-CcCcCHH---HHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 111100 11 1122334 4455569999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=366.97 Aligned_cols=256 Identities=27% Similarity=0.390 Sum_probs=213.5
Q ss_pred HhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
..++|.+.+.||+|+||.||+|... +++.||||+++... ...+.+.+|+++|++++|+||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4567999999999999999999965 58899999997643 456789999999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.+++|.+++.......+++..++.++.+++.||.|||++ +|+||||||+||||+.++.+||+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 99999999999876667799999999999999999999999 999999999999999999999999999987765544
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
.......|+..|+|||++.+..++.++|||||||++|+|++ |+.||......+....+ ..... ..
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~---------~~~~~-----~~ 232 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---------EKDYR-----ME 232 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---------HTTCC-----CC
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---------hccCC-----CC
Confidence 44445667889999999999999999999999999999999 99999765433322211 11110 01
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.. ...+. .+.+++..||+.||.+||++.||++.|+.
T Consensus 233 ~~-~~~~~---~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 233 RP-EGCPE---KVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp CC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC-CCCCH---HHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 11 12233 44555669999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=361.00 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=198.9
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
++|++.+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+++|++++|+||+++++++.+++..+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46899999999999999999954 689999999976532 334778899999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.++.+..+... ...+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 82 FCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred cCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 9986555444432 23589999999999999999999999 999999999999999999999999999987654322
Q ss_pred ccccccccCccccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCc-hhhhHHHHHHHHHhHHHhhcCcccccc--
Q 006083 473 HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGRRPVDMT-MMEDSLVEWARPLLGAALEDGIYDGLV-- 548 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~eLltG~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 548 (662)
......||..|+|||++.+.. ++.++|||||||+||||++|+.||... ...+.+..+.+.. .... ...+..+.
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~-~~~~-~~~~~~~~~~ 233 (292)
T 3o0g_A 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL-GTPT-EEQWPSMTKL 233 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH-CCCC-TTTCTTGGGS
T ss_pred -cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh-CCCC-hhhhhhhccc
Confidence 234467899999999998765 899999999999999999998885443 3333333222211 0000 00000000
Q ss_pred -C---------cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 549 -D---------PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 549 -d---------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+ ..............+.+++.+||+.||++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 00000011112233445566999999999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=362.95 Aligned_cols=249 Identities=20% Similarity=0.275 Sum_probs=195.5
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch--------------------------hHHHHHHHHHHHH
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ--------------------------GEREFSAEVEIIS 367 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--------------------------~~~~~~~E~~il~ 367 (662)
.++|.+.+.||+|+||.||+|+. .+|+.||||+++..... ..+.+.+|+++|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46799999999999999999985 46899999999764321 1356889999999
Q ss_pred hcCCCCcceEEEEEEe--CCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCcc
Q 006083 368 RVHHRHLVSLVGYCIA--GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKA 445 (662)
Q Consensus 368 ~l~HpnIv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp 445 (662)
+++|+||+++++++.+ ++..||||||+.+++|.+++.. ..+++..++.++.||++||+|||++ +|+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence 9999999999999986 6789999999999999887633 3589999999999999999999999 999999999
Q ss_pred CcEEECCCCcEEEEeeccccccCCCCCccccccccCccccCcccccCCC---CCchHHHHHHHHHHHHHHhCCCCCCCch
Q 006083 446 ANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVMLLELITGRRPVDMTM 522 (662)
Q Consensus 446 ~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~eLltG~~Pf~~~~ 522 (662)
+||||+.++.+||+|||+++....... ......||..|+|||++.+.. ++.++|||||||+||||++|+.||....
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999999987654332 234467999999999998655 4789999999999999999999997654
Q ss_pred hhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 523 MEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.......+ ....+.. . .......+ +.+++.+||+.||++||++.||++
T Consensus 245 ~~~~~~~~---------~~~~~~~----~-~~~~~~~~---l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 IMCLHSKI---------KSQALEF----P-DQPDIAED---LKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHH---------HHCCCCC----C-SSSCCCHH---HHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHH---------hcccCCC----C-CccccCHH---HHHHHHHHhhcChhhCCCHHHHhc
Confidence 32211111 1111110 0 01122334 445556999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=376.22 Aligned_cols=265 Identities=17% Similarity=0.231 Sum_probs=204.6
Q ss_pred hCCCCccceeeccCceEEEEEEecC------CCEEEEEEeecCCchhH-----------HHHHHHHHHHHhcCCCCcceE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPN------GKEVAVKSLKTGSGQGE-----------REFSAEVEIISRVHHRHLVSL 377 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~~~-----------~~~~~E~~il~~l~HpnIv~l 377 (662)
.++|.+.++||+|+||.||+|.+.. ++.||||++........ ..+..|+..++.++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4579999999999999999998654 47899999976542211 123345666777889999999
Q ss_pred EEEEEeC----CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC--
Q 006083 378 VGYCIAG----GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID-- 451 (662)
Q Consensus 378 ~~~~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~-- 451 (662)
++++... ...||||||| |++|.+++... ...+++..+++|+.||+.||+|||++ +|+||||||+||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 9998764 4589999999 99999999754 24589999999999999999999999 999999999999998
Q ss_pred CCCcEEEEeeccccccCCCCCc------cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhh
Q 006083 452 DNFEAMVADFGLAKLSNDNHTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMED 525 (662)
Q Consensus 452 ~~~~vkl~DFGla~~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~ 525 (662)
+++.+||+|||+++........ .....+||..|+|||++.+..++.++||||||||||||++|+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999866433211 1133569999999999999999999999999999999999999998654333
Q ss_pred HHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 526 SLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.+..+....+.. .+..+++.++.....+.++.+|+ ..||..+|.+||++.+|++.|+..
T Consensus 269 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li---~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 269 KYVRDSKIRYRE-----NIASLMDKCFPAANAPGEIAKYM---ETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp HHHHHHHHHHHH-----CHHHHHHHHSCTTCCCHHHHHHH---HHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhhh-----hHHHHHHHhcccccCHHHHHHHH---HHHhcCCCCCCCCHHHHHHHHHHH
Confidence 333332222211 12223333443344455555555 489999999999999999998753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=362.10 Aligned_cols=262 Identities=23% Similarity=0.289 Sum_probs=200.1
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQ--GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
++|.+.+.||+|+||.||+|...+|+.||||+++..... ..+.+.+|+++|++++|+||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 468999999999999999999878999999999764322 246788999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+ +|.+++.... ..+++..++.++.|+++||+|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 975 8888886532 3588999999999999999999999 999999999999999999999999999987653322
Q ss_pred cccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHH-------HhhcCccc
Q 006083 474 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGA-------ALEDGIYD 545 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~-------~~~~~~~~ 545 (662)
......||..|+|||++.+ ..++.++|||||||+||||++|+.||......+.+....+..-.. ..+...+.
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 2234578999999999876 458999999999999999999999998765554444332211000 00000000
Q ss_pred cccC-------cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GLVD-------PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~~d-------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.... ..+.. .... .+.+++.+||+.||++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~-~~~~---~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLK-GLDE---SGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCCCCCCCGGGTCC-SCCH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCccHHHHhh-hcCH---HHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 00001 1233 3445566999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=367.10 Aligned_cols=244 Identities=25% Similarity=0.330 Sum_probs=202.5
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.+.||+|+||.||+++.. +|+.||||+++... ....+.+.+|+.+|+.++|+||+++++++.+.+.+||||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 46899999999999999999954 79999999997542 233567889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.||+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 9999999999997543 488999999999999999999998 9999999999999999999999999999876432
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
....+||+.|+|||++.+..++.++|||||||+||||++|+.||......+.+..+.. . .+ .
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--------~-~~------~ 221 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--------A-EL------R 221 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--------C-CC------C
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------C-CC------C
Confidence 2346899999999999999999999999999999999999999976544332222111 1 10 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRP-----KMSQIVR 587 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 587 (662)
+. .....++ .+++.+||+.||.+|+ ++.||++
T Consensus 222 ~p-~~~~~~~---~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 FP-PFFNEDV---KDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CC-TTSCHHH---HHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CC-CCCCHHH---HHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11 1223344 4455589999999999 7888875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=364.22 Aligned_cols=256 Identities=30% Similarity=0.445 Sum_probs=208.6
Q ss_pred HHhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 313 AATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 313 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
...++|.+.+.||+|+||.||+|...+++.||||+++... ...+.+.+|+++|++++|+||+++++++.+ +..++|||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 3446789999999999999999998888899999997643 346789999999999999999999999874 56899999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.+++|.+++.......+++..+++++.|+++||+|||++ +|+|||||++||||++++.+||+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999999999654333589999999999999999999999 999999999999999999999999999987765433
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
.......|+..|+|||++.++.++.++|||||||+||||++ |+.||......+.+... ..+. . ..
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---------~~~~-~----~~ 230 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGY-R----MV 230 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---------HTTC-C----CC
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH---------hccc-C----CC
Confidence 33344567889999999998899999999999999999999 99999765443322211 1111 0 01
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
. ....+. .+.+++..||+.||++||++.+|++.|+.
T Consensus 231 ~-~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 231 R-PDNCPE---ELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp C-CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C-cccccH---HHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 1 112233 44555569999999999999999999885
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=377.84 Aligned_cols=247 Identities=24% Similarity=0.315 Sum_probs=198.5
Q ss_pred ccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCcc
Q 006083 320 KSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKT 398 (662)
Q Consensus 320 ~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~ 398 (662)
..++||+|+||.||+|.. .+|+.||||+++.......+.+.+|+++|++|+|+|||+++++|.+.+.++||||||.+++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 367899999999999985 4789999999988766667889999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE--CCCCcEEEEeeccccccCCCCCcccc
Q 006083 399 LEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI--DDNFEAMVADFGLAKLSNDNHTHVST 476 (662)
Q Consensus 399 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl--~~~~~vkl~DFGla~~~~~~~~~~~~ 476 (662)
|.+++.... ..+++..++.++.||++||+|||++ +|+||||||+|||| ++++.+||+|||+++....... ..
T Consensus 173 L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~ 246 (373)
T 2x4f_A 173 LFDRIIDES-YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LK 246 (373)
T ss_dssp EHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CC
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cc
Confidence 999886532 3588999999999999999999999 89999999999999 5678999999999987654332 23
Q ss_pred ccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCC
Q 006083 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNY 556 (662)
Q Consensus 477 ~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 556 (662)
..+||..|+|||++.++.++.++||||||||||||++|+.||......+.+..+... .+. + ...... .
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~---------~~~-~-~~~~~~-~ 314 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC---------RWD-L-EDEEFQ-D 314 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT---------CCC-S-CSGGGT-T
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------cCC-C-Chhhhc-c
Confidence 457999999999999889999999999999999999999999876554443332221 000 0 001111 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 557 VPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 557 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...+ +.+++.+||+.||.+||++.|+++
T Consensus 315 ~~~~---~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ISEE---AKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCHH---HHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHH---HHHHHHHHcCCChhhCCCHHHHhc
Confidence 2333 445556999999999999999997
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=357.40 Aligned_cols=253 Identities=28% Similarity=0.422 Sum_probs=193.5
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCc----hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSG----QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
.++|.+.+.||+|+||.||+|.. .|+.||||+++.... ...+.+.+|+++++.++|+||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 35789999999999999999997 589999999976432 2346789999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC--------CCcEEEEeec
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD--------NFEAMVADFG 462 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~--------~~~vkl~DFG 462 (662)
|||+.+++|.+++.. ..+++..++.++.|+++||.|||+++..+|+||||||+||||+. ++.+||+|||
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999999853 35899999999999999999999982112999999999999986 7789999999
Q ss_pred cccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcC
Q 006083 463 LAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDG 542 (662)
Q Consensus 463 la~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 542 (662)
++........ ....|+..|+|||++.+..++.++|||||||++|+|++|+.||............. ..
T Consensus 162 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---------~~ 229 (271)
T 3dtc_A 162 LAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA---------MN 229 (271)
T ss_dssp C----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH---------TS
T ss_pred cccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh---------cC
Confidence 9986654322 34579999999999999999999999999999999999999997654332221110 11
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 543 IYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 543 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.... .+.. ..+. .+.+++.+||+.||.+||++.||++.|+.
T Consensus 230 ~~~~----~~~~-~~~~---~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 230 KLAL----PIPS-TCPE---PFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCCC----CCCT-TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCC----CCCc-ccCH---HHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1110 1111 1233 45555669999999999999999999974
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=375.18 Aligned_cols=252 Identities=22% Similarity=0.341 Sum_probs=201.7
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC-----CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG-----SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
+.|++.+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|+++|++++|+||+++++++.+++.+||
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4599999999999999999985 47899999998642 12246789999999999999999999999999999999
Q ss_pred EEEecCCcchhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCc---EEEEeeccc
Q 006083 390 VYEFVSNKTLEYHLHGE--NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE---AMVADFGLA 464 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vkl~DFGla 464 (662)
|||||.|++|.+++... ....+++..++.++.||++||+|||++ +|+||||||+||||+.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999998887542 234589999999999999999999999 9999999999999986554 999999999
Q ss_pred cccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcc
Q 006083 465 KLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIY 544 (662)
Q Consensus 465 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (662)
+....... .....+||..|+|||++.+..++.++||||||||||||++|+.||..... +.+..+. .+.+
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~---------~~~~ 249 (351)
T 3c0i_A 181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGII---------KGKY 249 (351)
T ss_dssp EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHH---------HTCC
T ss_pred eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHH---------cCCC
Confidence 87765332 23446899999999999999999999999999999999999999976531 1111111 1111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 545 DGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 545 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. ....... .... .+.+++.+||+.||++||++.|+++
T Consensus 250 ~--~~~~~~~-~~s~---~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 K--MNPRQWS-HISE---SAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CCHHHHT-TSCH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCccccc-cCCH---HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 0000011 1223 3445556999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=364.84 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=210.4
Q ss_pred HhCCCCccceeeccCceEEEEEEe------cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVL------PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRV-HHRHLVSLVGYCIAGG 385 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~ 385 (662)
..++|.+.+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+++|+++ +|+||+++++++.+++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 345789999999999999999984 3568899999986543 3457899999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchhhhhccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEE
Q 006083 386 QRMLVYEFVSNKTLEYHLHGENR----------------PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANIL 449 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~~----------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NIL 449 (662)
..++||||+.+|+|.+++..... ..+++..+++++.|+++||.|||++ +|+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence 99999999999999999975432 2489999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEEeeccccccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHH
Q 006083 450 IDDNFEAMVADFGLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSL 527 (662)
Q Consensus 450 l~~~~~vkl~DFGla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~ 527 (662)
|++++.+||+|||+++........ ......|+..|+|||++.+..++.++|||||||+||||++ |+.||......+.+
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 999999999999999876544322 2334567889999999999999999999999999999999 99999776543333
Q ss_pred HHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 528 VEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...... +. .. ......+. .+.+++.+||+.||.+||++.||++.|+.
T Consensus 258 ~~~~~~--------~~-~~-----~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 258 YKMIKE--------GF-RM-----LSPEHAPA---EMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp HHHHHH--------TC-CC-----CCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcc--------CC-CC-----CCcccCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 222111 11 00 01112233 34555569999999999999999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=388.89 Aligned_cols=256 Identities=32% Similarity=0.444 Sum_probs=203.4
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
.++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++|+|+||+++++++.+ +..+|||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 45688899999999999999998878889999998654 345789999999999999999999999876 6789999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+|+|.++|.......+++..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.........
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 999999999754444589999999999999999999999 99999999999999999999999999998765433222
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
.....|+..|+|||++.++.++.++|||||||+||||++ |+.||......+.+... ..+... ..
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---------~~~~~~-----~~- 402 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRM-----PC- 402 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---------HTTCCC-----CC-
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---------HcCCCC-----CC-
Confidence 334567889999999999999999999999999999999 99999765443322211 111100 01
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
....+.. +.+++.+||+.||++||++.+|++.|+...
T Consensus 403 ~~~~~~~---l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 403 PPECPES---LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1123344 445556999999999999999999999654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=367.19 Aligned_cols=248 Identities=26% Similarity=0.368 Sum_probs=193.5
Q ss_pred CCCCccceeeccCceEEEEEEe----cCCCEEEEEEeecCC----chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL----PNGKEVAVKSLKTGS----GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 387 (662)
++|++.++||+|+||.||+++. .+|+.||||+++... ......+.+|+++|++++|+||+++++++.+++.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5699999999999999999986 478999999997642 23345688999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
|||||||.|++|.+++.... .+.+..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999996543 478999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 468 NDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 468 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
..... .....+||..|+|||++.+..++.++|||||||+||||++|+.||......+.+..... ..+
T Consensus 172 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---------~~~--- 238 (327)
T 3a62_A 172 IHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK---------CKL--- 238 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---------TCC---
T ss_pred ccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---------CCC---
Confidence 43221 23446899999999999999999999999999999999999999987654333222111 110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRP-----KMSQIVRA 588 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 588 (662)
.+. .....++ .+++.+||+.||.+|| ++.|+++.
T Consensus 239 ---~~p-~~~~~~~---~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 ---NLP-PYLTQEA---RDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ---CCC-TTSCHHH---HHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ---CCC-CCCCHHH---HHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 111 1223444 4455599999999999 77787763
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=398.68 Aligned_cols=257 Identities=32% Similarity=0.449 Sum_probs=209.4
Q ss_pred HhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
..++|.+.++||+|+||.||+|.+.++..||||+++... ...+.|++|+++|++|+|+|||++++++.+ +.+||||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 345688899999999999999998888889999998654 345789999999999999999999999876 678999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
|.+|+|.++|+......+++..+++|+.||++||+|||++ +|||||||++||||++++.+||+|||+++........
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 9999999999754444589999999999999999999999 9999999999999999999999999999876543222
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
......++..|+|||++.++.++.++||||||||||||++ |+.||......+.+.. +..+... ..
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~---------i~~~~~~-----~~ 485 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---------VERGYRM-----PC 485 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH---------HHTTCCC-----CC
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---------HHcCCCC-----CC
Confidence 2233457889999999999999999999999999999999 9999976544332221 1111110 01
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
...++.+ |.+++.+||+.||++||++.+|++.|+...
T Consensus 486 -~~~~~~~---l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 486 -PPECPES---LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp -CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -CCCCCHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1123344 445556999999999999999999999643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=373.58 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=202.6
Q ss_pred HHHhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCe
Q 006083 312 AAATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQ 386 (662)
Q Consensus 312 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~ 386 (662)
....++|.+.++||+|+||.||+|+.. +|+.||||+++... ....+.+..|.++|..+ +|+||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999964 68999999997642 23456788899999987 89999999999999999
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
+|||||||.||+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999996533 489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccc
Q 006083 467 SNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 467 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
...... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||......+.+.... . +..
T Consensus 168 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--------~-~~~-- 235 (345)
T 1xjd_A 168 NMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--------M-DNP-- 235 (345)
T ss_dssp CCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------H-CCC--
T ss_pred cccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--------h-CCC--
Confidence 543222 2345789999999999999999999999999999999999999998765433222211 1 110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMS-QIV 586 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-evl 586 (662)
.+. .....++. +++.+||+.||++||++. +|+
T Consensus 236 ----~~p-~~~s~~~~---~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 ----FYP-RWLEKEAK---DLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ----CCC-TTSCHHHH---HHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----CCC-cccCHHHH---HHHHHHhcCCHhHcCCChHHHH
Confidence 111 12234444 455589999999999997 554
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=369.60 Aligned_cols=251 Identities=21% Similarity=0.309 Sum_probs=196.9
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv 390 (662)
++|++.+.||+|+||.||+++.. +++.||||++++.. ....+.+.+|+++|+++ +|+|||++++++.+.+.+|||
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46899999999999999999964 68999999998642 23346688999999988 899999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.||+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999996543 489999999999999999999999 9999999999999999999999999999864332
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
. ......+||..|+|||++.+..++.++||||||||||||++|+.||......+.........+...+....+
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 236 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 236 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------
Confidence 2 223457899999999999999999999999999999999999999975321111000000001111111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKM 582 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 582 (662)
.+.. ....+ +..++.+||+.||++|+++
T Consensus 237 ~~p~-~~s~~---~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 RIPR-SLSVK---AASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCCT-TSCHH---HHHHHHHHTCSSTTTSTTC
T ss_pred CCCC-CCCHH---HHHHHHHHhcCCHhHCCCC
Confidence 1111 22333 4445558999999999995
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=371.98 Aligned_cols=270 Identities=26% Similarity=0.316 Sum_probs=204.7
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----eEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGG----QRMLV 390 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~~lv 390 (662)
.++|++.++||+|+||.||+|+. .++.||||+++... .....+.+|+.+|++++|+|||++++++.+.. .++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 35699999999999999999987 47999999997542 33445677999999999999999999998743 47999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CCceeecCCccCcEEECCCCcEEEEeecc
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC-------HPRIIHRDIKAANILIDDNFEAMVADFGL 463 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-------~~~ivHrDIkp~NILl~~~~~vkl~DFGl 463 (662)
||||.+|+|.++++.. .+++..+++++.|+++||+|||+.+ ..+|+||||||+||||++++.+||+|||+
T Consensus 101 ~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 9999999999999653 3899999999999999999999851 22799999999999999999999999999
Q ss_pred ccccCCCCCc-cccccccCccccCcccccCC-----CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHH--HHH-----
Q 006083 464 AKLSNDNHTH-VSTRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSL--VEW----- 530 (662)
Q Consensus 464 a~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~--~~~----- 530 (662)
++........ .....+||..|+|||++.+. .++.++|||||||+||||++|+.||........+ ...
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 9876543322 22346799999999999863 4567899999999999999999999764321110 000
Q ss_pred HHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 531 ARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
....+............+...+. .......+.+++.+||+.||++||++.||++.|+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYWQ---KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGG---SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhhhhhhhhcccCCCCcccccc---ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00000011111111111111111 123445577777899999999999999999999853
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=384.48 Aligned_cols=262 Identities=20% Similarity=0.217 Sum_probs=207.7
Q ss_pred HHHHHHHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 006083 308 YDELAAATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIA 383 (662)
Q Consensus 308 ~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 383 (662)
++++....++|++.++||+|+||.||+++. .+|+.||||++++... ...+.+.+|+++|.+++|+||++++++|.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 445555678899999999999999999996 4799999999975321 122457899999999999999999999999
Q ss_pred CCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecc
Q 006083 384 GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGL 463 (662)
Q Consensus 384 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 463 (662)
.+.+|||||||.||+|.++|.+.+ ..+++..++.++.+|+.||+|||++ +||||||||+||||+.++.+||+|||+
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechh
Confidence 999999999999999999996532 2589999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCccccCccccc-------CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhH
Q 006083 464 AKLSNDNHTHVSTRVMGTFGYLAPEYAS-------SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLG 536 (662)
Q Consensus 464 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~-------~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 536 (662)
++.............+||+.|+|||++. .+.|+.++||||||||||||++|+.||......+.+..+....
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-- 286 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK-- 286 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--
Confidence 9877654433334578999999999987 3578999999999999999999999998765444333322110
Q ss_pred HHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 006083 537 AALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKR---PKMSQIVRA 588 (662)
Q Consensus 537 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~evl~~ 588 (662)
. ...+ +.+ ....+.++.+|+ .+||. +|++| +++.||++.
T Consensus 287 ~---~~~~-----p~~-~~~~s~~~~dli---~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 287 E---HLSL-----PLV-DEGVPEEARDFI---QRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp H---HCCC-----C-----CCCHHHHHHH---HTTSS-CGGGCTTTTTHHHHHTS
T ss_pred c---CcCC-----Ccc-ccCCCHHHHHHH---HHHcC-ChhhcCCCCCHHHHhcC
Confidence 0 0000 011 112344455544 48998 99988 589888753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=384.27 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=204.3
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-eEEEEEEe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGG-QRMLVYEF 393 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~~lv~E~ 393 (662)
.++|.+.+.||+|+||.||+|.. .|+.||||+++... ..+.|.+|+++|++++|+|||++++++.+.+ ..||||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 45688899999999999999987 57899999998653 4578999999999999999999999987665 79999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
|.+|+|.++|+......+++..+++++.||++||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 9999999999876655689999999999999999999999 99999999999999999999999999998654321
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
....++..|+|||++.++.++.++|||||||+||||++ |+.||......+.+.. +..+... ..
T Consensus 344 --~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~---------i~~~~~~-----~~ 407 (450)
T 1k9a_A 344 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---------VEKGYKM-----DA 407 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH---------HHTTCCC-----CC
T ss_pred --cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---------HHcCCCC-----CC
Confidence 22467889999999999999999999999999999998 9999976544332211 1111110 11
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
....+.++. +++..||+.||.+||++.+|++.|+.
T Consensus 408 -p~~~~~~l~---~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 408 -PDGCPPAVY---DVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp -CTTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCcCCHHHH---HHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 122344444 45559999999999999999999885
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=366.72 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=208.1
Q ss_pred hCCCCccceeeccCceEEEEEEe------cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL------PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 387 (662)
.++|.+.+.||+|+||.||++.. .+++.||||+++... ....+.+.+|+++|++++|+||+++++++.+++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45688999999999999999984 245889999998653 34457889999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhhccCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCcc
Q 006083 388 MLVYEFVSNKTLEYHLHGENR----------------------PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKA 445 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp 445 (662)
++||||+.+++|.+++..... ..+++..+++++.||++||+|||++ +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999975432 3488999999999999999999999 999999999
Q ss_pred CcEEECCCCcEEEEeeccccccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchh
Q 006083 446 ANILIDDNFEAMVADFGLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMM 523 (662)
Q Consensus 446 ~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~ 523 (662)
+||||++++.+||+|||+++........ ......|+..|+|||++.+..++.++|||||||+||||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876543322 2233567889999999998899999999999999999999 9999976644
Q ss_pred hhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 524 EDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.+.... . ..+... ... ..... .+.+++.+||+.||.+||++.||++.|+.
T Consensus 259 ~~~~~~-~--------~~~~~~-----~~~-~~~~~---~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 259 ERLFNL-L--------KTGHRM-----ERP-DNCSE---EMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp GGHHHH-H--------HTTCCC-----CCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHH-h--------hcCCcC-----CCC-ccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 332211 1 111111 111 11233 44555669999999999999999999885
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=373.55 Aligned_cols=213 Identities=25% Similarity=0.332 Sum_probs=186.6
Q ss_pred CcCHHHHHHHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-----CCCcceEE
Q 006083 305 TFTYDELAAATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-----HRHLVSLV 378 (662)
Q Consensus 305 ~~~~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-----HpnIv~l~ 378 (662)
.|++++.....++|.+.++||+|+||.||+|+. .+++.||||+++.. ....+.+..|+++|+.+. |+|||+++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 455555556678999999999999999999995 57899999999753 344567888999999996 99999999
Q ss_pred EEEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC------
Q 006083 379 GYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD------ 452 (662)
Q Consensus 379 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~------ 452 (662)
+++...+..+|||||+ +++|.+++.......+++..++.++.||+.||+|||++ +|+||||||+||||++
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccc
Confidence 9999999999999999 99999999876666689999999999999999999998 9999999999999975
Q ss_pred -------------------CCcEEEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh
Q 006083 453 -------------------NFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT 513 (662)
Q Consensus 453 -------------------~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt 513 (662)
++.+||+|||+++...... ...+||..|+|||++.+..++.++||||||||||||++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 7899999999998654322 34679999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhH
Q 006083 514 GRRPVDMTMMEDS 526 (662)
Q Consensus 514 G~~Pf~~~~~~~~ 526 (662)
|+.||......+.
T Consensus 255 g~~pf~~~~~~~~ 267 (360)
T 3llt_A 255 GSLLFRTHEHMEH 267 (360)
T ss_dssp SSCSCCCSSHHHH
T ss_pred CCCCCCCCcHHHH
Confidence 9999987654443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=369.85 Aligned_cols=254 Identities=25% Similarity=0.379 Sum_probs=197.4
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCE----EEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKE----VAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~----vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
++|++.++||+|+||.||+|++. +++. ||+|.++... ....+.+.+|+++|++++|+||++++++|.+++ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 45899999999999999999843 4443 5888876432 345678999999999999999999999998765 789
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||||+.+|+|.+++.... ..+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 94 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999997643 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 470 NHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 470 ~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
.... ......|+..|+|||++.++.++.++|||||||+||||++ |+.||......+.. ... ..+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~--------~~~~~~-- 238 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SIL--------EKGERL-- 238 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHH--------HTTCCC--
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-HHH--------HcCCCC--
Confidence 3322 2233567889999999999999999999999999999999 99999876433321 111 111100
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.. .... ...+..++.+||+.||.+||++.||++.|+..
T Consensus 239 ---~~-~~~~---~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 239 ---PQ-PPIC---TIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ---CC-CTTB---CHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred ---CC-CccC---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00 1112 23455666799999999999999999998753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=360.64 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=194.0
Q ss_pred HhCCCCccceeeccCceEEEEEEec----CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP----NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 388 (662)
..++|++.+.||+|+||.||+|... .+..||||+++.... ...+.+.+|+.+|++++|+||+++++++. ++..|
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 3457999999999999999999853 245799999876433 34567999999999999999999999985 56789
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
+||||+.+++|.+++.... ..+++..++.++.|+++||.|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999997543 3589999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 469 DNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 469 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
...........|+..|+|||++.+..++.++|||||||+||||++ |+.||......+.+... ..+...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i---------~~~~~~-- 236 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---------ENGERL-- 236 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---------HTTCCC--
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH---------HcCCCC--
Confidence 543333344567889999999998899999999999999999996 99999876544332211 111100
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.+. ...+. .+.+++.+||+.||++||++.||++.|+.
T Consensus 237 ---~~~-~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 237 ---PMP-PNCPP---TLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp ---CCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCC-CCCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111 12233 34455569999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=367.90 Aligned_cols=258 Identities=19% Similarity=0.222 Sum_probs=205.2
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|+++|++| +|+||+++++++.+++..+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999994 5789999999976532 34688999999999 89999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCc-----EEEEeecccccc
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE-----AMVADFGLAKLS 467 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~-----vkl~DFGla~~~ 467 (662)
|+ +++|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+||||+.++. +||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 99999999754 34689999999999999999999999 9999999999999998887 999999999876
Q ss_pred CCCCCc------cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhc
Q 006083 468 NDNHTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALED 541 (662)
Q Consensus 468 ~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 541 (662)
...... .....+||..|+|||++.+..++.++||||||||||||++|+.||......+.. +...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~-~~~~~i~~~~~~- 238 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK-ERYQKIGDTKRA- 238 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH-HHHHHHHHHHHH-
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH-HHHHHHHhhhcc-
Confidence 443221 124578999999999999999999999999999999999999999865322211 111111000000
Q ss_pred CccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 542 GIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 542 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
... ..+ ....+ .+.+++..||+.||.+||++.+|++.|+.
T Consensus 239 ~~~-----~~~-~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 239 TPI-----EVL-CENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp SCH-----HHH-TTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred CCH-----HHH-hccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 000 001 11123 55556669999999999999999998874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=371.55 Aligned_cols=261 Identities=22% Similarity=0.238 Sum_probs=201.9
Q ss_pred HHHHHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC-----CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 006083 310 ELAAATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG-----SGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383 (662)
Q Consensus 310 ei~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 383 (662)
++....++|.+.+.||+|+||.||+|.. .+++.||||+++.. .....+.+.+|+++|++++|+||++++++|.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 3455667899999999999999999985 47889999998653 23455789999999999999999999999999
Q ss_pred CCeEEEEEEecCCcchhhhhccC--------------------------------------CCCCCCHHHHHHHHHHHHH
Q 006083 384 GGQRMLVYEFVSNKTLEYHLHGE--------------------------------------NRPVMDFATRVRIALGSAK 425 (662)
Q Consensus 384 ~~~~~lv~E~~~~g~L~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia~ 425 (662)
.+..+||||||.||+|.+++... ....+++..++.++.||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999988521 0122356788899999999
Q ss_pred HHHHHHhcCCCceeecCCccCcEEECCCC--cEEEEeeccccccCCCC---CccccccccCccccCcccccC--CCCCch
Q 006083 426 GLAYLHEDCHPRIIHRDIKAANILIDDNF--EAMVADFGLAKLSNDNH---THVSTRVMGTFGYLAPEYASS--GKLTEK 498 (662)
Q Consensus 426 aL~yLH~~~~~~ivHrDIkp~NILl~~~~--~vkl~DFGla~~~~~~~---~~~~~~~~Gt~~y~aPE~~~~--~~~~~~ 498 (662)
||+|||++ +|+||||||+||||+.++ .+||+|||+++...... ........||..|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998766 89999999998653321 112345679999999999875 678999
Q ss_pred HHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCC
Q 006083 499 SDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARK 578 (662)
Q Consensus 499 sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~ 578 (662)
+||||||||||||++|+.||......+.+...... .... .... . ..... .+.+++.+||+.||.+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~--------~~~~--~~~~-~-~~~~~---~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK--------KLCF--ENPN-Y-NVLSP---LARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------CCCT--TSGG-G-GGSCH---HHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhc--------cccc--CCcc-c-ccCCH---HHHHHHHHHcCCChhH
Confidence 99999999999999999999876554433322211 1100 0000 0 01223 3445556999999999
Q ss_pred CCCHHHHHHH
Q 006083 579 RPKMSQIVRA 588 (662)
Q Consensus 579 RPs~~evl~~ 588 (662)
||++.|+++.
T Consensus 322 Rps~~~~l~h 331 (345)
T 3hko_A 322 RFDAMRALQH 331 (345)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhcC
Confidence 9999999873
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=370.89 Aligned_cols=260 Identities=25% Similarity=0.410 Sum_probs=207.7
Q ss_pred HhCCCCccceeeccCceEEEEEEe------cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVL------PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGG 385 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~ 385 (662)
..++|.+.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+++|+++ +|+||+++++++.+.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 346799999999999999999985 245689999997542 23456799999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchhhhhccCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCc
Q 006083 386 QRMLVYEFVSNKTLEYHLHGENR---------------------PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIK 444 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIk 444 (662)
..+|||||+.+|+|.+++..... ..+++..++.++.||++||+|||++ +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 99999999999999999975432 2478999999999999999999999 99999999
Q ss_pred cCcEEECCCCcEEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCch
Q 006083 445 AANILIDDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTM 522 (662)
Q Consensus 445 p~NILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~ 522 (662)
|+||||+.++.+||+|||++........ .......|+..|+|||++.++.++.++|||||||+||||++ |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999986643322 22344668889999999999999999999999999999998 999997765
Q ss_pred hhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 523 MEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
..+.+..+.. .+... .. ......+ +..++.+||+.||.+||++.||++.|+...
T Consensus 280 ~~~~~~~~~~--------~~~~~-----~~-~~~~~~~---l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 280 VDANFYKLIQ--------NGFKM-----DQ-PFYATEE---IYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp CSHHHHHHHH--------TTCCC-----CC-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cHHHHHHHHh--------cCCCC-----CC-CCCCCHH---HHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 4433332221 11100 11 1122334 445556999999999999999999998643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=374.06 Aligned_cols=249 Identities=26% Similarity=0.340 Sum_probs=200.2
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|.+.+.||+|+||.||++... +++.||||+++... ....+.+.+|+++|+.++|+|||+++++|.+.+.+|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46899999999999999999854 68999999997532 234567889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
|||.||+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 95 e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp CCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 999999999999754 3489999999999999999999999 99999999999999999999999999998765432
Q ss_pred CccccccccCccccCcccccC---CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 472 THVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
.....+||..|+|||++.+ ..|+.++||||||||||||++|+.||........ .+..... .....
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~~-----~~~~~---- 237 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTF-----ETTVV---- 237 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-HHHHHHH-----HHCCC----
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-HHHHHHH-----hhccc----
Confidence 2345789999999999874 4589999999999999999999999975432211 1111110 01110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPK-MSQIVR 587 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~evl~ 587 (662)
.+. ..... .+..++.+||+.||.+||+ +.+|++
T Consensus 238 --~~p-~~~s~---~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 --TYP-SAWSQ---EMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --CCC-TTSCH---HHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --CCC-CcCCH---HHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 011 11223 4455556999999999998 777664
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=371.03 Aligned_cols=252 Identities=23% Similarity=0.280 Sum_probs=188.5
Q ss_pred HhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
..++|++.+.||+|+||.||+|... +++.||||+++... ..+.+.+|+++|++++|+||++++++|.+.+..+||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567999999999999999999965 68899999998642 34678899999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC---CCcEEEEeeccccccCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD---NFEAMVADFGLAKLSND 469 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~DFGla~~~~~ 469 (662)
|+.+++|.+++... ..+++.+++.++.||++||.|||++ +|+||||||+||||+. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999999654 3589999999999999999999998 9999999999999975 88999999999987654
Q ss_pred CCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
.. .....+||..|+|||++.+..++.++||||||||||||++|+.||......+.+... ... ..+. ...
T Consensus 204 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-------i~~-~~~~-~~~ 272 (349)
T 2w4o_A 204 QV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR-------ILN-CEYY-FIS 272 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH-------HHT-TCCC-CCT
T ss_pred cc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH-------HHh-CCCc-cCC
Confidence 32 234467999999999999999999999999999999999999999765433322111 111 1110 000
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.... .... .+.+++.+||+.||++||++.|+++.
T Consensus 273 -~~~~-~~~~---~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 273 -PWWD-EVSL---NAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -TTTT-TSCH---HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -chhh-hCCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 1223 34455669999999999999999873
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=370.02 Aligned_cols=244 Identities=24% Similarity=0.253 Sum_probs=202.9
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.+.||+|+||.||+++.. +|+.||||+++... ....+.+.+|+++|++++|+||+++++++.+.+.+||||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 56899999999999999999954 78999999997532 233567889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.||+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999997543 489999999999999999999998 9999999999999999999999999999876543
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
....+||+.|+|||++.+..++.++|||||||+||||++|+.||......+.+..+.. +.+ .
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~---------~~~------~ 256 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS---------GKV------R 256 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------CCC------C
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc---------CCC------C
Confidence 2346899999999999999999999999999999999999999987654333222211 111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPK-----MSQIVR 587 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 587 (662)
+.. ....+ +..++.+||+.||.+|++ +.||++
T Consensus 257 ~p~-~~~~~---~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 FPS-HFSSD---LKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCT-TCCHH---HHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCC-CCCHH---HHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 111 12334 445555999999999998 777775
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=369.28 Aligned_cols=245 Identities=22% Similarity=0.369 Sum_probs=200.0
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+++|+.++|+||+++++++.+.+..+||
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999995 578999999997531 12235789999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+ +|+|.+++.... .+++.+++.++.|++.||.|||++ +|+||||||+||||++++.+||+|||++......
T Consensus 88 ~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp ECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999 788888886543 489999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccccccCccccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
. .....+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||+.....+ .+..+..
T Consensus 162 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----------------~~~~i~~ 222 (336)
T 3h4j_B 162 N--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-----------------LFKKVNS 222 (336)
T ss_dssp B--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-----------------CBCCCCS
T ss_pred c--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-----------------HHHHHHc
Confidence 3 2344689999999999988776 689999999999999999999997643211 1111111
Q ss_pred cc-cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 550 PR-LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 550 ~~-l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.. ........++. +++.+||+.||.+||++.|+++
T Consensus 223 ~~~~~p~~~s~~~~---~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 223 CVYVMPDFLSPGAQ---SLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SCCCCCTTSCHHHH---HHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCCCCcccCCHHHH---HHHHHHcCCChhHCcCHHHHHh
Confidence 10 01122334444 4555999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=379.30 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=205.6
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.++|.+.+.||+|+||.||+|... +++.||||+++.... ...+.|.+|+++|++++|+|||+++++|.+++..|||||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 346888999999999999999965 789999999986533 334578899999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.+|+|.++++... ..+++..++.++.|+++||+|||++ +|+||||||+||||++++.+||+|||+++.......
T Consensus 193 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999996432 3488999999999999999999999 999999999999999999999999999986543321
Q ss_pred ccc-cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 473 HVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 473 ~~~-~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
... ....++..|+|||++.++.++.++|||||||+||||++ |+.||......+.. ++ +..+...
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-~~--------~~~~~~~----- 334 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-EF--------VEKGGRL----- 334 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-HH--------HHTTCCC-----
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HH--------HHcCCCC-----
Confidence 111 12345778999999998899999999999999999998 99999765433221 11 1111100
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
. .....+.++. +++.+||+.||++||++.+|++.|+.
T Consensus 335 ~-~~~~~~~~l~---~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 335 P-CPELCPDAVF---RLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp C-CCTTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C-CCCCCCHHHH---HHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 0 1122344444 45559999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=367.16 Aligned_cols=258 Identities=25% Similarity=0.355 Sum_probs=192.1
Q ss_pred HhCCCCccceeeccCceEEEEEEecC-C---CEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLPN-G---KEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-g---~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 387 (662)
..++|.+.+.||+|+||.||+|.... + ..||||+++.. .....+.+.+|+++|++++|+||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 45679999999999999999998543 3 27999999765 344567899999999999999999999999877665
Q ss_pred ------EEEEEecCCcchhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEE
Q 006083 388 ------MLVYEFVSNKTLEYHLHGE----NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAM 457 (662)
Q Consensus 388 ------~lv~E~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 457 (662)
++||||+.+++|.+++... ....+++..+++++.|+++||+|||++ +|+||||||+||||++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence 9999999999999998532 223589999999999999999999999 999999999999999999999
Q ss_pred EEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHh
Q 006083 458 VADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLL 535 (662)
Q Consensus 458 l~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~ 535 (662)
|+|||+++....... .......|+..|+|||++.+..++.++|||||||++|||++ |+.||......+.+..+..
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~--- 254 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG--- 254 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc---
Confidence 999999987654322 12233557889999999999999999999999999999999 9999987654432221111
Q ss_pred HHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 536 GAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 536 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.... ... .... ..+.+++.+||+.||++||++.+|++.|+..
T Consensus 255 -----~~~~------~~~-~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 255 -----GNRL------KQP-PECM---EEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp -----TCCC------CCC-TTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCC------CCC-CccC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1110 001 1122 3455666699999999999999999998853
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=357.27 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=204.3
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAG--GQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lv~ 391 (662)
++|.+.+.||+|+||.||+|+. +++.||||+++... ....+.+.+|+++|++++|+||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 4689999999999999999998 58899999998653 33456799999999999999999999999876 7889999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR--IIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||+.+++|.+++.......+++..++.++.|+++||.|||++ + |+||||||+||||++++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 999999999999876666789999999999999999999998 7 99999999999999999999999998765332
Q ss_pred CCCccccccccCccccCcccccCCCCCc---hHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccc
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSGKLTE---KSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~---~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
....||..|+|||++.+..+.. ++|||||||+||||++|+.||......+...... ..+.
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--------~~~~--- 228 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA--------LEGL--- 228 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHH--------HSCC---
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHH--------hcCC---
Confidence 2357899999999998765444 8999999999999999999997664433222111 1111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
...+.. ..+.+ +.+++..||+.||++||++.||++.|+..
T Consensus 229 --~~~~~~-~~~~~---~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 229 --RPTIPP-GISPH---VSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp --CCCCCT-TCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCC-CCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 111111 22333 44555689999999999999999999853
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=355.55 Aligned_cols=253 Identities=28% Similarity=0.461 Sum_probs=208.4
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
++|.+.+.||+|+||.||++...+++.||||+++.... ..+.+.+|++++++++|+||+++++++.+.+..++||||+.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 46888999999999999999988889999999986543 35679999999999999999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
+++|.+++.... ..+++..++.++.|+++||.|||++ +|+|||||++||||++++.+||+|||++...........
T Consensus 87 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999999996543 3588999999999999999999999 999999999999999999999999999987654322222
Q ss_pred cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
....|+..|+|||++.+..++.++|||||||+||||++ |+.||......+.+..+ ..+.. . . ..
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i---------~~~~~-~----~-~~ 227 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI---------STGFR-L----Y-KP 227 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---------HTTCC-C----C-CC
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH---------hcCCc-C----C-CC
Confidence 34567889999999998899999999999999999999 89999765433322211 11110 0 0 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
..... .+.+++.+||+.||++||++.++++.|+.
T Consensus 228 ~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 228 RLAST---HVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCcH---HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 12233 34455669999999999999999999985
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=370.26 Aligned_cols=249 Identities=24% Similarity=0.292 Sum_probs=202.2
Q ss_pred HhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 388 (662)
..++|++.++||+|+||.||+++.. +|+.||||++++.. ....+.+..|+++|..+ +|+||+++++++.+.+.+|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3467999999999999999999965 57899999997642 23456788999999988 7999999999999999999
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
||||||.||+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 98 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999996543 489999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 469 DNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 469 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
.... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||......+.+..+.. . .+
T Consensus 173 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--------~-~~---- 238 (353)
T 2i0e_A 173 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--------H-NV---- 238 (353)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------C-CC----
T ss_pred cCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------C-CC----
Confidence 3222 23457899999999999999999999999999999999999999987654332222111 1 10
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPK-----MSQIVR 587 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 587 (662)
.+.. ....+ +..++.+||+.||.+|++ +.+|++
T Consensus 239 --~~p~-~~s~~---~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 --AYPK-SMSKE---AVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --CCCT-TSCHH---HHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --CCCC-CCCHH---HHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111 22334 444555899999999995 466654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=375.47 Aligned_cols=255 Identities=23% Similarity=0.300 Sum_probs=197.0
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc---hhHHHHHHHHHH-HHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG---QGEREFSAEVEI-ISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~i-l~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
++|++.++||+|+||.||+++.. +++.||||++++... ...+.+.+|..+ ++.++|+|||+++++|.+.+.+|||
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 46999999999999999999954 688999999976432 233456777776 5778999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
||||.||+|.+++.... .+.+..++.++.+|+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 118 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999996543 478899999999999999999999 9999999999999999999999999999864332
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
. ......+||+.|+|||++.+..|+.++||||||||||||++|+.||......+.+..+.. . .+
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--------~-~~------ 256 (373)
T 2r5t_A 193 N-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--------K-PL------ 256 (373)
T ss_dssp C-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH--------S-CC------
T ss_pred C-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------c-cc------
Confidence 2 123457899999999999999999999999999999999999999987654433322211 1 10
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCCCC
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSSL 595 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 595 (662)
.+.. ....++. .++.+||+.||.+|+++.+.++.+.....+
T Consensus 257 ~~~~-~~~~~~~---~li~~lL~~dp~~R~~~~~~~~~i~~h~~f 297 (373)
T 2r5t_A 257 QLKP-NITNSAR---HLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297 (373)
T ss_dssp CCCS-SSCHHHH---HHHHHHTCSSGGGSTTTTTTHHHHHTSGGG
T ss_pred CCCC-CCCHHHH---HHHHHHcccCHHhCCCCCCCHHHHhCCccc
Confidence 1111 2234444 455589999999999987655555544433
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=361.79 Aligned_cols=264 Identities=23% Similarity=0.311 Sum_probs=190.4
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.++|++.+.||+|+||.||+|.. .+|+.||||+++.... ...+.+.+|+++|++++|+||+++++++.+++..+||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 35689999999999999999985 4689999999976533 234678899999999999999999999999999999999
Q ss_pred ecCCcchhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 393 FVSNKTLEYHLHGE----NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 393 ~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
|+. ++|.+++... ....+++..+..++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5888887532 224588999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhH-------HHhh
Q 006083 469 DNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLG-------AALE 540 (662)
Q Consensus 469 ~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~-------~~~~ 540 (662)
.... .....+||..|+|||++.+ ..++.++|||||||+||||++|+.||......+.+..+....-. ....
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 3322 2234678999999999976 46899999999999999999999999877655444333221100 0000
Q ss_pred cCcccccc------------CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 541 DGIYDGLV------------DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 541 ~~~~~~~~------------d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...+...+ ...... .... .+.+++.+||+.||++||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~---~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKE-PLDG---NLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSS-CCCH---HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhcccccc-cCCH---HHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000000 000011 1222 4556666999999999999999886
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=358.58 Aligned_cols=266 Identities=24% Similarity=0.298 Sum_probs=202.6
Q ss_pred HhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc-----hhHHHHHHHHHHHHhcC---CCCcceEEEEEEeC
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG-----QGEREFSAEVEIISRVH---HRHLVSLVGYCIAG 384 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-----~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~ 384 (662)
..++|++.+.||+|+||.||+|+. .+|+.||||+++.... .....+.+|++++++++ |+||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999994 5789999999974321 12346677888877774 99999999999876
Q ss_pred C-----eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEE
Q 006083 385 G-----QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVA 459 (662)
Q Consensus 385 ~-----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~ 459 (662)
. ..++||||+. ++|.+++.......+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 5 5899999997 5999999876666699999999999999999999999 89999999999999999999999
Q ss_pred eeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHh
Q 006083 460 DFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAAL 539 (662)
Q Consensus 460 DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 539 (662)
|||+++...... .....+||..|+|||++.+..++.++|||||||+||||++|+.||......+.+..+....- ...
T Consensus 163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~ 239 (308)
T 3g33_A 163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG-LPP 239 (308)
T ss_dssp SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC-CCC
T ss_pred eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCC
Confidence 999998765432 23457899999999999999999999999999999999999999987765554443322110 000
Q ss_pred hcCcccccc---CcccCCC-------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 540 EDGIYDGLV---DPRLEHN-------YVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 540 ~~~~~~~~~---d~~l~~~-------~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...+.... ...+... ...+....+.+++.+||+.||++||++.|+++
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 240 -EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp -TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00000000 0000000 00111234455666999999999999999886
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=368.84 Aligned_cols=265 Identities=18% Similarity=0.226 Sum_probs=198.3
Q ss_pred hCCCCccceeeccCceEEEEEEec----CCCEEEEEEeecCCchh-----------HHHHHHHHHHHHhcCCCCcceEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP----NGKEVAVKSLKTGSGQG-----------EREFSAEVEIISRVHHRHLVSLVG 379 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~-----------~~~~~~E~~il~~l~HpnIv~l~~ 379 (662)
.++|.+.+.||+|+||.||+|... ++..||||++....... .+.+.+|+.+++.++|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 356999999999999999999964 57889999998654321 123667889999999999999999
Q ss_pred EEEe----CCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC-
Q 006083 380 YCIA----GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF- 454 (662)
Q Consensus 380 ~~~~----~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~- 454 (662)
++.+ ....||||||+ +++|.+++.... .+++..+++++.||+.||+|||++ +|+||||||+||||+.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCC
Confidence 9987 78899999999 999999996544 689999999999999999999999 999999999999998877
Q ss_pred -cEEEEeeccccccCCCCC------ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHH
Q 006083 455 -EAMVADFGLAKLSNDNHT------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSL 527 (662)
Q Consensus 455 -~vkl~DFGla~~~~~~~~------~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~ 527 (662)
.+||+|||+++....... .......|+..|+|||++.+..++.++|||||||+||||++|+.||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999986643211 1123467999999999999999999999999999999999999999653222211
Q ss_pred HHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 528 VEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
.......+.. .. ...+.........+.++ .+++..||+.||++||++.+|++.|+...
T Consensus 270 ~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~l---~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 270 VQTAKTNLLD----EL-PQSVLKWAPSGSSCCEI---AQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHH----TT-THHHHHHSCTTSCCHHH---HHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHhhcc----cc-cHHHHhhccccccHHHH---HHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1111111110 00 00011111111233444 44555899999999999999999998643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=371.87 Aligned_cols=252 Identities=20% Similarity=0.246 Sum_probs=192.1
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
++|.+.+.||+|+||.||+++.. +++.||||+++.... ..+.+.+|+.++++++|+||+++++++.+.+.++||||||
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 46999999999999999999964 789999999976432 3466889999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCc--EEEEeeccccccCCCCC
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE--AMVADFGLAKLSNDNHT 472 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~--vkl~DFGla~~~~~~~~ 472 (662)
.+|+|.+++.... .+++..++.++.|+++||+|||++ +|+||||||+||||+.++. +||+|||+++......
T Consensus 99 ~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~- 172 (361)
T 3uc3_A 99 SGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 172 (361)
T ss_dssp CSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence 9999999986543 489999999999999999999998 9999999999999987665 9999999997543222
Q ss_pred ccccccccCccccCcccccCCCCCch-HHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEK-SDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~-sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
.....+||..|+|||++.+..+..+ +|||||||+||+|++|+.||........+.......+. ..+...
T Consensus 173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~-----~~~~~~---- 242 (361)
T 3uc3_A 173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS-----VKYSIP---- 242 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT-----TCCCCC----
T ss_pred -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc-----CCCCCC----
Confidence 2234679999999999988887765 89999999999999999999765443333332222111 111000
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.......+ +.+++.+||+.||++||++.|+++.
T Consensus 243 -~~~~~s~~---~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 -DDIRISPE---CCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -TTSCCCHH---HHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -CcCCCCHH---HHHHHHHHccCChhHCcCHHHHHhC
Confidence 01112333 4455569999999999999999963
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=365.52 Aligned_cols=258 Identities=27% Similarity=0.396 Sum_probs=207.2
Q ss_pred hCCCCccceeeccCceEEEEEEe--------cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL--------PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRV-HHRHLVSLVGYCIAG 384 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~--------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~ 384 (662)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+++|+++ +|+||++++++|.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 45689999999999999999985 3567899999986533 3456789999999999 899999999999999
Q ss_pred CeEEEEEEecCCcchhhhhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGENR--------------PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI 450 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl 450 (662)
+..||||||+.+++|.+++..... ..+++..+++++.||++||.|||++ +|+|||||++||||
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 999999999999999999975432 2488999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccccccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHH
Q 006083 451 DDNFEAMVADFGLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLV 528 (662)
Q Consensus 451 ~~~~~vkl~DFGla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~ 528 (662)
+.++.+||+|||+++........ ......|+..|+|||++.+..++.++|||||||+||||++ |+.||......+.+.
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 99999999999999876543321 2233567889999999998899999999999999999999 999997664333221
Q ss_pred HHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 529 EWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
.+ ..+... .+.. .... .+.+++.+||+.||.+||++.||++.|+...
T Consensus 271 ~~---------~~~~~~-----~~~~-~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 271 LL---------KEGHRM-----DKPA-NCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HH---------HHTCCC-----CCCT-TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---------hcCCCC-----CCCc-cCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 111110 1111 1233 3455566999999999999999999998643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=366.59 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=193.5
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----e
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGG----Q 386 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~ 386 (662)
.++|++.+.||+|+||.||+++. .+++.||||+++.... .....+.+|++++++++|+||+++++++...+ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 45799999999999999999995 5789999999986532 23457899999999999999999999987543 3
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
.||||||+.|++|.++++... .+++..++.++.|++.||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 499999999999999996543 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc--cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcc
Q 006083 467 SNDNHTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIY 544 (662)
Q Consensus 467 ~~~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (662)
....... .....+||..|+|||++.+..++.++|||||||+||||++|+.||......+....+.. ...
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~--------~~~- 236 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--------EDP- 236 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--------CCC-
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc--------CCC-
Confidence 6543221 22346799999999999999999999999999999999999999987654333222211 111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 545 DGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 545 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..........+.+ +.+++.+||+.||++||++.++++
T Consensus 237 ---~~~~~~~~~~~~~---l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 237 ---IPPSARHEGLSAD---LDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp ---CCHHHHSTTCCHH---HHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred ---CCcccccCCCCHH---HHHHHHHHHhcCHhhChhhHHHHH
Confidence 0001111112333 445556999999999997666554
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=356.03 Aligned_cols=251 Identities=33% Similarity=0.544 Sum_probs=199.4
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchh-------HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQG-------EREFSAEVEIISRVHHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-------~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 387 (662)
++|++.+.||+|+||.||+|+. .+++.||||++....... .+.+.+|+++|++++|+||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 5699999999999999999995 478999999997543221 167899999999999999999999997665
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeecCCccCcEEECCCCc-----EEEEe
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR--IIHRDIKAANILIDDNFE-----AMVAD 460 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--ivHrDIkp~NILl~~~~~-----vkl~D 460 (662)
++||||+.+++|.+++.... ..+++..++.++.|++.||+|||++ + |+||||||+||||+.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 79999999999998886543 3589999999999999999999998 8 999999999999988776 99999
Q ss_pred eccccccCCCCCccccccccCccccCccccc--CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHH
Q 006083 461 FGLAKLSNDNHTHVSTRVMGTFGYLAPEYAS--SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAA 538 (662)
Q Consensus 461 FGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~--~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 538 (662)
||+++..... .....|+..|+|||++. ...++.++|||||||+||||++|+.||......+.. +....
T Consensus 173 fg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~---- 242 (287)
T 4f0f_A 173 FGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK--FINMI---- 242 (287)
T ss_dssp CTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH--HHHHH----
T ss_pred CCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH--HHHHH----
Confidence 9999754432 24467999999999984 456789999999999999999999999765432211 01100
Q ss_pred hhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 539 LEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 539 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...+. . ..+.. ..+. .+.+++.+||+.||.+||++.||++.|+.
T Consensus 243 ~~~~~-~----~~~~~-~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 243 REEGL-R----PTIPE-DCPP---RLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHSCC-C----CCCCT-TSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred hccCC-C----CCCCc-ccCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 01111 1 11111 1233 44555568999999999999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=359.77 Aligned_cols=252 Identities=30% Similarity=0.480 Sum_probs=194.7
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
++|++.+.||+|+||.||++.. .++.||||+++.. ...+.|.+|+++|++++|+||+++++++.+ ..+|||||+.
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 4588899999999999999987 5789999999753 446789999999999999999999998874 4799999999
Q ss_pred CcchhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCc-EEEEeeccccccCCCCCc
Q 006083 396 NKTLEYHLHGENR-PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE-AMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 396 ~g~L~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~-vkl~DFGla~~~~~~~~~ 473 (662)
+++|.++++.... ..+.+..+++++.|+++||+|||+.+..+|+|||||++||||+.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999975432 34788999999999999999999932228999999999999988876 799999999765432
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||...........|.. ..+... .+.
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------~~~~~~-----~~~ 226 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV-------HNGTRP-----PLI 226 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH-------HTTCCC-----CCB
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH-------hcCCCC-----Ccc
Confidence 2335689999999999999999999999999999999999999975432221111111 111111 111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
. ..+.. +.+++.+||+.||++||++.||++.|+..
T Consensus 227 ~-~~~~~---l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 227 K-NLPKP---IESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp T-TCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c-ccCHH---HHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1 12333 44555699999999999999999998854
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=373.67 Aligned_cols=254 Identities=25% Similarity=0.315 Sum_probs=202.8
Q ss_pred CCCCccceeeccCceEEEEEEe----cCCCEEEEEEeecCC----chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL----PNGKEVAVKSLKTGS----GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQ 386 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~ 386 (662)
++|++.+.||+|+||.||+++. .+|+.||||+++... ....+.+.+|+++|+++ +|+||+++++++.+.+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4699999999999999999986 478999999987532 12345678899999999 69999999999999999
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
++||||||.+++|.+++.... .+++..++.++.||++||.|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999996543 488999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCccccccccCccccCcccccC--CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcc
Q 006083 467 SNDNHTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIY 544 (662)
Q Consensus 467 ~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (662)
............+||..|+|||++.+ ..++.++||||||||||||++|+.||...........+.+..+. ..
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-----~~- 282 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-----SE- 282 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH-----CC-
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc-----cC-
Confidence 65443334455789999999999985 34789999999999999999999999765433333333222211 00
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 006083 545 DGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRP-----KMSQIVRAL 589 (662)
Q Consensus 545 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~L 589 (662)
..+.. .... .+.+++.+||+.||++|| ++.|+++..
T Consensus 283 -----~~~~~-~~~~---~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 -----PPYPQ-EMSA---LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -----CCCCT-TSCH---HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -----CCCCc-ccCH---HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 01111 1223 344556699999999999 999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=358.02 Aligned_cols=258 Identities=28% Similarity=0.498 Sum_probs=194.5
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.++|.+.+.||+|+||.||+|... ..||||+++... ....+.+.+|+++|++++|+||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 457999999999999999999853 469999997553 33457799999999999999999999966 4566899999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC-
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH- 471 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~- 471 (662)
|+.+++|.+++.... ..+++..+++++.|++.||.|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999996543 4589999999999999999999999 99999999999999999999999999997654321
Q ss_pred CccccccccCccccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 472 THVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
........|+..|+|||++. +..++.++|||||||+||||++|+.||......+.+.+... .+.+...+
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~ 247 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG--------RGSLSPDL 247 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHH--------HTSCCCCT
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhc--------ccccCcch
Confidence 22234467999999999986 56789999999999999999999999977654443332221 11111111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
. .+. ...+. .+.+++.+||+.+|.+||++.||++.|+..
T Consensus 248 ~-~~~-~~~~~---~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 248 S-KVR-SNCPK---RMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp T-SSC-TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred h-hcc-ccCCH---HHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1 111 11233 455555699999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=364.39 Aligned_cols=260 Identities=20% Similarity=0.290 Sum_probs=205.8
Q ss_pred HHHHHHhCCCCcc-ceeeccCceEEEEEEec-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhcC-CCCcceEEEEEEe
Q 006083 309 DELAAATGGFAKS-NLLGQGGFGYVHKGVLP-NGKEVAVKSLKTG--SGQGEREFSAEVEIISRVH-HRHLVSLVGYCIA 383 (662)
Q Consensus 309 ~ei~~~~~~~~~~-~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~ 383 (662)
.......+.|.+. +.||+|+||.||+|... +|+.||||+++.. .......+.+|+.+|+++. |+||+++++++.+
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3344455668877 89999999999999854 6899999999754 2334678999999999995 6999999999999
Q ss_pred CCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC---CCcEEEEe
Q 006083 384 GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD---NFEAMVAD 460 (662)
Q Consensus 384 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~D 460 (662)
.+..+|||||+.+++|.+++.......+++..++.++.||+.||+|||++ +|+|||||++||||+. ++.+||+|
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEee
Confidence 99999999999999999999766666799999999999999999999999 9999999999999987 78999999
Q ss_pred eccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhh
Q 006083 461 FGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALE 540 (662)
Q Consensus 461 FGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 540 (662)
||+++....... ....+|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+......
T Consensus 178 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------- 248 (327)
T 3lm5_A 178 FGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV------- 248 (327)
T ss_dssp GGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------
T ss_pred CccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc-------
Confidence 999987654322 23467999999999999999999999999999999999999999876544433322111
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 541 DGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 541 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
... . ..... ..... .+.+++.+||+.||.+||++.|+++.
T Consensus 249 --~~~-~-~~~~~-~~~~~---~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 --NVD-Y-SEETF-SSVSQ---LATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp --CCC-C-CTTTT-TTSCH---HHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred --ccc-c-Cchhh-cccCH---HHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 000 0 00001 11223 34455669999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=358.55 Aligned_cols=268 Identities=20% Similarity=0.266 Sum_probs=200.4
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQ--GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
.++|++.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+++|++++|+||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367999999999999999999964 6899999998665332 3467889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.+++|.+++.... .+++..+..++.|+++||+|||++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 82 e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp ECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999999886443 489999999999999999999999 99999999999999999999999999998765432
Q ss_pred CccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh------HHHhhcC-c
Q 006083 472 THVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL------GAALEDG-I 543 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~------~~~~~~~-~ 543 (662)
. .....+|+..|+|||++.+ ..++.++|||||||+||+|++|+.||......+.+........ ....... .
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 157 D-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred c-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 2 2344678999999999876 6789999999999999999999999987765544332221100 0000000 0
Q ss_pred cccccCcccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 544 YDGLVDPRLEHNY-----VPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 544 ~~~~~d~~l~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+............ .......+.+++.+||+.||.+||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 1100000000000 01112335566679999999999999999964
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=357.50 Aligned_cols=260 Identities=18% Similarity=0.217 Sum_probs=205.4
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+++++++ +|+||+++++++.++...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999994 578999999997542 334688999999999 79999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCc-----EEEEeecccccc
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE-----AMVADFGLAKLS 467 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~-----vkl~DFGla~~~ 467 (662)
|+ +++|.+++.... ..+++..+++++.||++||+|||++ +|+||||||+||||+.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 999999997543 3489999999999999999999998 9999999999999987765 999999999876
Q ss_pred CCCCCc------cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhc
Q 006083 468 NDNHTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALED 541 (662)
Q Consensus 468 ~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 541 (662)
...... ......||..|+|||++.+..++.++|||||||+||||++|+.||...........+.. ..... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~-~~ 239 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER-IGEKK-QS 239 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-HHHHH-HH
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH-HHhhc-cC
Confidence 543221 12446799999999999999999999999999999999999999977432211111110 00000 00
Q ss_pred CccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 542 GIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 542 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.... .+.. ..+. .+.+++..||+.||++||++.+|++.|+..
T Consensus 240 ~~~~-----~~~~-~~~~---~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 240 TPLR-----ELCA-GFPE---EFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp SCHH-----HHTT-TSCH---HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ccHH-----HHHh-hCcH---HHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 0000 0111 1223 445555689999999999999999998853
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=363.23 Aligned_cols=252 Identities=25% Similarity=0.333 Sum_probs=205.9
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCch------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQ------GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 387 (662)
.++|.+.+.||+|+||.||++... +|+.||||+++..... ..+.+.+|+++|++++|+||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 345999999999999999999954 6899999999765322 367899999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC----cEEEEeecc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF----EAMVADFGL 463 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkl~DFGl 463 (662)
++||||+.+++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+||||++++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999653 3589999999999999999999999 999999999999999887 799999999
Q ss_pred ccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCc
Q 006083 464 AKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGI 543 (662)
Q Consensus 464 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (662)
+........ .....|+..|+|||++.+..++.++|||||||+||+|++|+.||......+.+..+.. ..
T Consensus 166 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~---------~~ 234 (321)
T 2a2a_A 166 AHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS---------VS 234 (321)
T ss_dssp CEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT---------TC
T ss_pred ceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---------cc
Confidence 987654322 2446799999999999999999999999999999999999999987654433322111 11
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 544 YDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 544 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+. .+..+... ... .+.+++.+||+.||++||++.|+++.
T Consensus 235 ~~--~~~~~~~~-~~~---~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 YD--FDEEFFSH-TSE---LAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CC--CCHHHHTT-CCH---HHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cc--cChhhhcc-cCH---HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 00011111 123 34556669999999999999999873
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=362.93 Aligned_cols=267 Identities=25% Similarity=0.416 Sum_probs=213.0
Q ss_pred cCHHHHHHHhCCCCccceeeccCceEEEEEEe------cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhc-CCCCcceE
Q 006083 306 FTYDELAAATGGFAKSNLLGQGGFGYVHKGVL------PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRV-HHRHLVSL 377 (662)
Q Consensus 306 ~~~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l 377 (662)
+...++....++|.+.+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+++|+++ +|+||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44455666678899999999999999999973 3568999999986543 3456789999999999 69999999
Q ss_pred EEEEEeCC-eEEEEEEecCCcchhhhhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecC
Q 006083 378 VGYCIAGG-QRMLVYEFVSNKTLEYHLHGENR--------------PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRD 442 (662)
Q Consensus 378 ~~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrD 442 (662)
++++...+ .+++||||+.+++|.+++..... ..+++..++.++.|+++||.|||++ +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99988654 58999999999999999976432 2378999999999999999999999 999999
Q ss_pred CccCcEEECCCCcEEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCC
Q 006083 443 IKAANILIDDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDM 520 (662)
Q Consensus 443 Ikp~NILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~ 520 (662)
|||+||||+.++.+||+|||+++....... .......|+..|+|||++.+..++.++|||||||+||||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987654332 22344678999999999999999999999999999999998 9999976
Q ss_pred chhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 521 TMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
....+.+..... .+... .+. ..... .+.+++.+||+.||.+||++.||++.|+..
T Consensus 254 ~~~~~~~~~~~~--------~~~~~-----~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKIDEEFCRRLK--------EGTRM-----RAP-DYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCCSHHHHHHHH--------HTCCC-----CCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhHHHHHHhc--------cCccC-----CCC-CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 543332222111 11110 111 11233 345556689999999999999999999853
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=355.78 Aligned_cols=250 Identities=21% Similarity=0.262 Sum_probs=204.6
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
.++|.+.+.||+|+||.||+|... ++..||+|++........+.+.+|+++|++++|+||+++++++.+++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 456999999999999999999954 5789999999876556678899999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE---CCCCcEEEEeeccccccCCC
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkl~DFGla~~~~~~ 470 (662)
+.+++|.+++.... .+++..+++++.|++.||+|||++ +|+|||||++|||| +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 99999999886543 489999999999999999999999 99999999999999 78899999999999876543
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
.. .....|+..|+|||++.+ .++.++|||||||++|||++|+.||......+.+..+.. +.+... .
T Consensus 163 ~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------~~~~~~--~ 228 (277)
T 3f3z_A 163 KM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE---------GTFTFP--E 228 (277)
T ss_dssp SC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------CCCCCC--H
T ss_pred cc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---------CCCCCC--c
Confidence 32 244679999999999875 599999999999999999999999987654443322211 111000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
... .... ..+.+++.+||+.||++||++.|+++
T Consensus 229 ~~~-~~~~---~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KDW-LNVS---PQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHH-TTSC---HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhh-hcCC---HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0112 34455666999999999999999985
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=362.22 Aligned_cols=250 Identities=19% Similarity=0.317 Sum_probs=196.1
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--------
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGG-------- 385 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-------- 385 (662)
++|++.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+++|++|+|+|||+++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 46999999999999999999965 799999999976433 34578999999999999999999999986543
Q ss_pred -------------------------------------------------eEEEEEEecCCcchhhhhccCCC-CCCCHHH
Q 006083 386 -------------------------------------------------QRMLVYEFVSNKTLEYHLHGENR-PVMDFAT 415 (662)
Q Consensus 386 -------------------------------------------------~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~ 415 (662)
..++|||||.+++|.+++..... ....+..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 38999999999999999976432 3356677
Q ss_pred HHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC-----------ccccccccCccc
Q 006083 416 RVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT-----------HVSTRVMGTFGY 484 (662)
Q Consensus 416 ~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~-----------~~~~~~~Gt~~y 484 (662)
+++++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....... ......+||..|
T Consensus 166 ~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 899999999999999998 999999999999999999999999999987654421 112345799999
Q ss_pred cCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHH
Q 006083 485 LAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARL 564 (662)
Q Consensus 485 ~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 564 (662)
+|||++.+..++.++|||||||+||||++|..++... ..+ ... .....+.. ........+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---~~~---~~~-----~~~~~~~~---------~~~~~~~~~ 302 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---VRI---ITD-----VRNLKFPL---------LFTQKYPQE 302 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---HHH---HHH-----HHTTCCCH---------HHHHHCHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---HHH---HHH-----hhccCCCc---------ccccCChhH
Confidence 9999999999999999999999999999987764211 000 000 01111100 011222345
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 006083 565 VACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 565 ~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.+++.+||+.||++||++.|+++.
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 667779999999999999999873
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=370.09 Aligned_cols=259 Identities=15% Similarity=0.229 Sum_probs=203.6
Q ss_pred CCCCccceeeccCceEEEEEEec---------CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcce----------
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP---------NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVS---------- 376 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~---------~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~---------- 376 (662)
++|.+.+.||+|+||.||+|+.. +++.||||+++.. +.+.+|+++|++++|+||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 57999999999999999999965 3789999999764 46889999999999999988
Q ss_pred -----EEEEEEe-CCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE
Q 006083 377 -----LVGYCIA-GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI 450 (662)
Q Consensus 377 -----l~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl 450 (662)
+++++.. ++..||||||+ +++|.+++.......+++..+++++.||+.||.|||++ +|+||||||+||||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEE
Confidence 6777776 78899999999 99999999765445699999999999999999999999 99999999999999
Q ss_pred CCCC--cEEEEeeccccccCCCCCc------cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCch
Q 006083 451 DDNF--EAMVADFGLAKLSNDNHTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTM 522 (662)
Q Consensus 451 ~~~~--~vkl~DFGla~~~~~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~ 522 (662)
+.++ .+||+|||+++........ ......||..|+|||++.+..++.++||||||||||||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9988 8999999999866532211 1133589999999999999999999999999999999999999997654
Q ss_pred -hhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 523 -MEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 523 -~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
..+.+..+..... .....+.+........+.++. +++.+||+.||++||++.+|++.|+..
T Consensus 273 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~---~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 273 PNTEDIMKQKQKFV------DKPGPFVGPCGHWIRPSETLQ---KYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp TCHHHHHHHHHHHH------HSCCCEECTTSCEECCCHHHH---HHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cCHHHHHHHHHhcc------CChhhhhhhccccCCCcHHHH---HHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 2222222222111 011111111111112334444 455589999999999999999999853
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=369.02 Aligned_cols=251 Identities=20% Similarity=0.321 Sum_probs=194.6
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCCeEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHH--RHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~~~~~lv 390 (662)
.++|++.+.||+|+||.||++...+++.||||+++... ....+.+.+|+++|++++| +||+++++++.+++..|||
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45699999999999999999998889999999997653 2345778999999999976 9999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|| +.+++|.+++.... .+++.+++.++.||++||+|||++ +|+||||||+||||+ ++.+||+|||+++.....
T Consensus 88 ~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EC-CCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred Ee-CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99 56889999997543 589999999999999999999999 999999999999997 578999999999876543
Q ss_pred CCc-cccccccCccccCcccccC-----------CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHH
Q 006083 471 HTH-VSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAA 538 (662)
Q Consensus 471 ~~~-~~~~~~Gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 538 (662)
... .....+||..|+|||++.+ ..++.++||||||||||||++|+.||....... ..+ . ..
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~-~----~~ 233 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKL-H----AI 233 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHH-H----HH
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH--HHH-H----HH
Confidence 322 2345689999999999864 678999999999999999999999997543211 110 0 00
Q ss_pred hhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 539 LEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 539 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+.... ...+ ...... .+.+++..||+.||.+||++.|+++.
T Consensus 234 ~~~~~-----~~~~-~~~~~~---~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 234 IDPNH-----EIEF-PDIPEK---DLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HCTTS-----CCCC-CCCSCH---HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcCCc-----ccCC-cccCCH---HHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 01000 0011 111223 44556669999999999999999964
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=388.60 Aligned_cols=253 Identities=26% Similarity=0.357 Sum_probs=205.8
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
.++|.+.++||+|+||.||++... +|+.||||+++... ......+.+|+++|++++|+|||++++++.+.+.+|||
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456899999999999999999964 79999999997532 23346788999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
||||.||+|.+++.......+++..++.++.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 9999999999999776666689999999999999999999999 9999999999999999999999999999877543
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
.. ....+||+.|+|||++.+..|+.++||||||||||||++|+.||...........+..... ... .
T Consensus 340 ~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~-----~~~------~ 406 (576)
T 2acx_A 340 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-----EVP------E 406 (576)
T ss_dssp CC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH-----HCC------C
T ss_pred cc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh-----ccc------c
Confidence 32 2346899999999999998999999999999999999999999976532211111111110 000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRP-----KMSQIVR 587 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 587 (662)
.+. .....++ ..++.+||+.||.+|+ ++.||++
T Consensus 407 ~~p-~~~s~~~---~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 EYS-ERFSPQA---RSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCC-TTSCHHH---HHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cCC-ccCCHHH---HHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 111 1223344 4455589999999999 7888875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=353.16 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=204.2
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999854 68999999997542 334567899999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCc---EEEEeeccccccC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE---AMVADFGLAKLSN 468 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vkl~DFGla~~~~ 468 (662)
||+.+++|.+++... ..+++..++.++.|++.||.|||++ +|+|||||++||||+.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999999888654 3489999999999999999999999 9999999999999976555 9999999998765
Q ss_pred CCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 469 DNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 469 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
.... .....|+..|+|||++.+..++.++|||||||+||+|++|+.||......+....+. .+.+...
T Consensus 160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~---------~~~~~~~- 227 (284)
T 3kk8_A 160 DSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK---------AGAYDYP- 227 (284)
T ss_dssp SSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---------HTCCCCC-
T ss_pred cCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH---------hccccCC-
Confidence 4322 234679999999999999999999999999999999999999997765433322221 1111110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.........+ +.+++.+||+.||++||++.|+++
T Consensus 228 --~~~~~~~~~~---~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 --SPEWDTVTPE---AKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp --TTTTTTSCHH---HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --chhhcccCHH---HHHHHHHHcccChhhCCCHHHHhc
Confidence 0011122333 445556999999999999999997
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=358.10 Aligned_cols=250 Identities=22% Similarity=0.359 Sum_probs=201.5
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
.++|.+.+.||+|+||.||++... +|+.||||+++.......+.+.+|+++|++++|+||+++++++.+++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 356999999999999999999954 7899999999876555566789999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE---CCCCcEEEEeeccccccCCC
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkl~DFGla~~~~~~ 470 (662)
+.+++|.+++.... .+++..++.++.|++.||.|||++ +|+|||||++|||| ++++.+||+|||++......
T Consensus 88 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 88 VSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999999886533 488999999999999999999999 99999999999999 77899999999999765432
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......+.+..+. .+.+.. ..
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~---------~~~~~~--~~ 228 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK---------EGYYEF--ES 228 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---------HCCCCC--CT
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---------cCCCCC--Cc
Confidence 2234679999999999999999999999999999999999999997654433222211 111110 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+.. .... .+.+++.+||+.||++||++.|+++
T Consensus 229 ~~~~-~~~~---~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 229 PFWD-DISE---SAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTT-TSCH---HHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccc-cCCH---HHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 1223 3445556999999999999999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=379.27 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=204.4
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
.++|.+++.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++|+.++|+||+++++++.+.+.+|||
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999964 79999999997532 12356789999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
||||.|++|.+++... ..+++..+++++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 95 ~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 95 MEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999999643 3589999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCccccccccCccccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
. .....+||+.|+|||++.+..+ +.++||||||||||||++|+.||+.....+.+... ..+.+.
T Consensus 170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i---------~~~~~~---- 234 (476)
T 2y94_A 170 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI---------CDGIFY---- 234 (476)
T ss_dssp C--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH---------HTTCCC----
T ss_pred c--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH---------hcCCcC----
Confidence 2 2344689999999999988765 68999999999999999999999876443322211 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. ......+ +.+++.+||+.||.+||++.||++
T Consensus 235 --~-p~~~s~~---~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 --T-PQYLNPS---VISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --C-CTTCCHH---HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --C-CccCCHH---HHHHHHHHcCCCchhCcCHHHHHh
Confidence 1 1122334 445556899999999999999996
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=379.80 Aligned_cols=264 Identities=20% Similarity=0.234 Sum_probs=197.1
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAG------G 385 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~ 385 (662)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++|++++|+|||++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46799999999999999999984 46899999999754 334456789999999999999999999999654 4
Q ss_pred eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccc
Q 006083 386 QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
.+||||||+.++ |.+++.. .+++..+..++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCCC-HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 679999999765 5555532 288999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh----------
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL---------- 535 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~---------- 535 (662)
...... .....+||..|+|||++.+..|+.++||||||||||||++|+.||.+....+.+..+...+-
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 213 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp ----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred ecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 765432 23457899999999999999999999999999999999999999988765554443332110
Q ss_pred ----HHHhhcC-ccc-----cccCcccCCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 536 ----GAALEDG-IYD-----GLVDPRLEHNYV---PHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 536 ----~~~~~~~-~~~-----~~~d~~l~~~~~---~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
...++.. .+. ......+..... ......+.+++.+||+.||++||++.|+++.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000 000000000000 1113446677779999999999999999863
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=382.02 Aligned_cols=248 Identities=23% Similarity=0.308 Sum_probs=193.9
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
.++|++.++||+|+||.||++.. .+|+.||||+++.. .......+.+|+++|++++|+||++++++|.+.+.+|||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35699999999999999999984 47899999999753 233446678899999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHE-DCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||||.+++|.+++.... .+++..++.++.||++||+|||+ + +||||||||+||||+.++.+||+|||+++....
T Consensus 227 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999996543 58999999999999999999998 7 899999999999999999999999999986543
Q ss_pred CCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
... .....+||..|+|||++.+..|+.++||||||||||||++|+.||......+.+..... ..+
T Consensus 302 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~---------~~~----- 366 (446)
T 4ejn_A 302 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM---------EEI----- 366 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------CCC-----
T ss_pred CCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh---------CCC-----
Confidence 322 23457899999999999999999999999999999999999999977654332221111 110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRP-----KMSQIVR 587 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 587 (662)
.+.. ....+ +.+++.+||+.||.+|| ++.|+++
T Consensus 367 -~~p~-~~~~~---~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 -RFPR-TLGPE---AKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -CCCT-TSCHH---HHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCc-cCCHH---HHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1111 12233 44555699999999999 9999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=358.42 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=202.2
Q ss_pred hCCCCccceeeccCceEEEEEEec-CC-------CEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NG-------KEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQ 386 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g-------~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 386 (662)
.++|.+.+.||+|+||.||+|... ++ ..||+|+++.......+.+.+|+++|++++|+||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 356889999999999999999853 33 4799999987666677889999999999999999999999999999
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCc--------EEE
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE--------AMV 458 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~--------vkl 458 (662)
.++||||+.+++|.+++.... ..+++..+++++.||++||.|||++ +|+|||||++||||+.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999997543 3488999999999999999999999 9999999999999998877 999
Q ss_pred EeeccccccCCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHH
Q 006083 459 ADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGA 537 (662)
Q Consensus 459 ~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 537 (662)
+|||++...... ....|+..|+|||++.+ ..++.++|||||||+||||++|..++..............
T Consensus 163 ~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~----- 232 (289)
T 4fvq_A 163 SDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE----- 232 (289)
T ss_dssp CCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-----
T ss_pred ccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh-----
Confidence 999998755332 33568999999999987 7799999999999999999996555433322221111111
Q ss_pred HhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCCC
Q 006083 538 ALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSS 594 (662)
Q Consensus 538 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 594 (662)
....+. .. ... .+.+++.+||+.||++||++.||++.|+....
T Consensus 233 --~~~~~~--------~~-~~~---~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 --DRHQLP--------AP-KAA---ELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp --TTCCCC--------CC-SSC---TTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred --ccCCCC--------CC-CCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 000111 11 112 34455669999999999999999999997543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=378.39 Aligned_cols=192 Identities=25% Similarity=0.366 Sum_probs=153.6
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe-----CCeE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIA-----GGQR 387 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~ 387 (662)
++|++.++||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+++|++|+|+|||+++++|.. .+.+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 5799999999999999999985 478999999997542 2345678999999999999999999999843 3678
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
||||||+ +++|.+++... ..+++..++.++.||++||+|||++ +||||||||+||||+.++.+||+|||+++..
T Consensus 133 ~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 9999998 57888888654 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC--------------------------ccccccccCccccCcccc-cCCCCCchHHHHHHHHHHHHHHh
Q 006083 468 NDNHT--------------------------HVSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELIT 513 (662)
Q Consensus 468 ~~~~~--------------------------~~~~~~~Gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~eLlt 513 (662)
..... ......+||.+|+|||++ .+..|+.++||||||||||||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 43211 122446899999999986 45679999999999999999999
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=374.33 Aligned_cols=250 Identities=20% Similarity=0.319 Sum_probs=195.3
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcC--CCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVH--HRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~~lv~ 391 (662)
.+|.+.+.||+|+||.||++...+++.||||+++... ....+.+.+|+++|++|+ |+|||++++++..++.+||||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 3599999999999999999998789999999997653 334578999999999996 599999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
| +.+++|.+++.... .+++.+++.++.||++||.|||++ +|+||||||+||||+ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 67899999997543 588899999999999999999998 999999999999996 5799999999998765433
Q ss_pred Cc-cccccccCccccCcccccC-----------CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHh
Q 006083 472 TH-VSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAAL 539 (662)
Q Consensus 472 ~~-~~~~~~Gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 539 (662)
.. .....+||+.|+|||++.+ ..++.++||||||||||||++|+.||......... .. ..+
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~---~~----~~~ 281 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---LH----AII 281 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH---HH----HHH
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH---HH----HHh
Confidence 22 2345689999999999875 46899999999999999999999999754321111 01 111
Q ss_pred hcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 540 EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 540 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.... . ..+. ..... .+.+++.+||+.||++||++.||++.
T Consensus 282 ~~~~-~----~~~~-~~~~~---~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 DPNH-E----IEFP-DIPEK---DLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CTTS-C----CCCC-CCSCH---HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Cccc-c----CCCC-ccchH---HHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1110 0 0111 11223 34555669999999999999999964
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=365.67 Aligned_cols=265 Identities=28% Similarity=0.334 Sum_probs=208.1
Q ss_pred CCCCccceeeccCceEEEEEEe-----cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEE--eCCeEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-----PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI--AGGQRM 388 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~~ 388 (662)
++|++.+.||+|+||.||++++ .+++.||||+++.......+.+.+|+++|++++|+||+++++++. +.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4688999999999999999983 468899999998876666778999999999999999999999987 566789
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
|||||+.+++|.+++.... ..+++..+++++.|++.||+|||++ +|+||||||+||||++++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999996532 2489999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCc--cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHH-------HHhHHHh
Q 006083 469 DNHTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWAR-------PLLGAAL 539 (662)
Q Consensus 469 ~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~-------~~~~~~~ 539 (662)
..... ......|+..|+|||++.+..++.++|||||||+||+|++|+.||....... +..+.. ..+...+
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-LRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHCC----CCHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh-hhhcccccccccHHHHHHHh
Confidence 43322 2234568889999999998899999999999999999999999986543211 100000 0000111
Q ss_pred hcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCCC
Q 006083 540 EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSS 594 (662)
Q Consensus 540 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 594 (662)
..+.. ... ...... .+.+++.+||+.||++||++.||++.|+....
T Consensus 258 ~~~~~-----~~~-~~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 258 EEGQR-----LPA-PPACPA---EVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HTTCC-----CCC-CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hcccC-----CCC-CCcccH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11110 011 112233 44555569999999999999999999986543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=360.07 Aligned_cols=259 Identities=30% Similarity=0.394 Sum_probs=202.9
Q ss_pred CCccceeeccCceEEEEEEe-----cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEE
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-----PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIA--GGQRML 389 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~l 389 (662)
|++.+.||+|+||.||++.+ .+++.||||+++.... ...+.+.+|+++|++++|+||+++++++.+ ...++|
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48899999999999998863 2688999999987543 345679999999999999999999999987 468899
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||||+.+++|.+++.... +++..++.++.+++.||+|||++ +|+|||||++||||+.++.+||+|||++.....
T Consensus 113 v~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999996543 89999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCc--cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhH-HHHH-----HHHHhHHHhhc
Q 006083 470 NHTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDS-LVEW-----ARPLLGAALED 541 (662)
Q Consensus 470 ~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~-~~~~-----~~~~~~~~~~~ 541 (662)
.... ......|+..|+|||++.+..++.++|||||||++|||++|+.||........ +..+ ....+...+..
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 4321 23345688899999999998999999999999999999999999865422110 0000 00011111111
Q ss_pred CccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 542 GIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 542 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
+... .. ....+ ..+.+++.+||+.||++||++.||++.|+.
T Consensus 267 ~~~~-----~~-~~~~~---~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 267 GERL-----PR-PDKCP---AEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp TCCC-----CC-CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCC-----CC-Ccccc---HHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 1110 11 11222 345556669999999999999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=366.50 Aligned_cols=264 Identities=25% Similarity=0.404 Sum_probs=211.2
Q ss_pred HHHHHHhCCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEE
Q 006083 309 DELAAATGGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYC 381 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~ 381 (662)
+++....++|.+.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|+++|++++|+||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 444556678999999999999999999853 467899999976533 3456789999999999999999999999
Q ss_pred EeCCeEEEEEEecCCcchhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC
Q 006083 382 IAGGQRMLVYEFVSNKTLEYHLHGEN--------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN 453 (662)
Q Consensus 382 ~~~~~~~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~ 453 (662)
.+++..++||||+.+++|.+++.... ...+++..+++++.||++||.|||++ +|+||||||+||||+++
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence 99999999999999999999986421 23568999999999999999999999 99999999999999999
Q ss_pred CcEEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHH
Q 006083 454 FEAMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWA 531 (662)
Q Consensus 454 ~~vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~ 531 (662)
+.+||+|||+++....... .......|+..|+|||++.++.++.++|||||||+||||++ |+.||......+.....
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~- 253 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV- 253 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH-
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH-
Confidence 9999999999986543322 12234567899999999999999999999999999999999 89999765433322111
Q ss_pred HHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 532 RPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
..+.+.. . ....+.. +.+++.+||+.||.+||++.||++.|+...
T Consensus 254 --------~~~~~~~-----~-~~~~~~~---l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 254 --------MEGGLLD-----K-PDNCPDM---LFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp --------HTTCCCC-----C-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred --------HcCCcCC-----C-CCCCCHH---HHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 1111110 1 1122333 445556999999999999999999998643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=367.14 Aligned_cols=255 Identities=26% Similarity=0.395 Sum_probs=199.8
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCE----EEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKE----VAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~----vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
++|++.++||+|+||.||+|... +++. ||+|++.... ....+.+.+|+.++++++|+||++++++|. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46889999999999999999853 4544 7888775442 233456788999999999999999999986 466899
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||||+.+|+|.+++... +..+++..++.++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999999754 33588899999999999999999999 999999999999999999999999999987754
Q ss_pred CCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 470 NHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 470 ~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
.... ......|+..|+|||++.++.++.++|||||||+||||++ |+.||......+....+ ..+.....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---------~~~~~~~~ 238 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL---------EKGERLAQ 238 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH---------HTTCBCCC
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH---------HcCCCCCC
Confidence 4322 2344678889999999999999999999999999999999 99999875433322111 11110000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
...... .+..++.+||+.||.+||++.||++.|+...
T Consensus 239 ------~~~~~~---~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 239 ------PQICTI---DVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ------CTTBCT---TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ------CCcCcH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011112 3445566899999999999999999998643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=352.52 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=200.0
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 456999999999999999999854 67899999996532 12246789999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999986543 489999999999999999999998 9999999999999999999999999998655432
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
. .....|+..|+|||++.+..++.++|||||||+||+|++|+.||......+.+..... ...
T Consensus 163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------~~~------ 224 (279)
T 3fdn_A 163 R---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR---------VEF------ 224 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---------TCC------
T ss_pred c---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh---------CCC------
Confidence 2 2446799999999999999999999999999999999999999987654433222111 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.+. ...... +.+++.+||+.||++||++.||++.
T Consensus 225 ~~~-~~~~~~---~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 TFP-DFVTEG---ARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCC-TTSCHH---HHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCC-CcCCHH---HHHHHHHHhccChhhCCCHHHHhhC
Confidence 111 112333 4455569999999999999999974
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=357.84 Aligned_cols=258 Identities=22% Similarity=0.300 Sum_probs=197.4
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
.++|.+.+.||+|+||.||++... +++.||||+++.... ...+.+.+|++++++++|+||+++++++.+++..|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999954 788999999975422 2347789999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+++|.+++.... .+++..++.++.++++||.|||++ +|+|||||++||||+.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999996543 489999999999999999999999 9999999999999999999999999999876554
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
.........|+..|+|||++.+..++.++|||||||+||||++|+.||....... +.. .+..... ..
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~--------~~~~~~~----~~ 254 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-MGA--------HINQAIP----RP 254 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-HHH--------HHHSCCC----CG
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-HHH--------HhccCCC----Cc
Confidence 3333345679999999999999999999999999999999999999998754321 111 1111110 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhhCCC
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRP-KMSQIVRALEGDS 593 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~~~ 593 (662)
.......+.+ +.+++.+||+.||++|| ++.++++.|+...
T Consensus 255 ~~~~~~~~~~---l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 255 STVRPGIPVA---FDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp GGTSTTCCTH---HHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred cccCCCCCHH---HHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 1111122333 44455699999999999 9999999998644
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=367.18 Aligned_cols=249 Identities=16% Similarity=0.163 Sum_probs=202.4
Q ss_pred HhCCCCccceeeccCceEEEEEE------ecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC---CCCcceEEEEEEeC
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGV------LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH---HRHLVSLVGYCIAG 384 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~ 384 (662)
..++|.+.++||+|+||.||+|. ..+++.||||+++.. ...++.+|++++++++ |+||+++++++..+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34679999999999999999994 457899999999764 3557888899998887 99999999999999
Q ss_pred CeEEEEEEecCCcchhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC---------
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGE---NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD--------- 452 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~--------- 452 (662)
+..|||||||.+|+|.++++.. ....+++..++.|+.||++||+|||++ +||||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence 9999999999999999999642 345699999999999999999999998 9999999999999998
Q ss_pred --CCcEEEEeeccccccCC-CCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHH
Q 006083 453 --NFEAMVADFGLAKLSND-NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVE 529 (662)
Q Consensus 453 --~~~vkl~DFGla~~~~~-~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~ 529 (662)
++.+||+|||+++.... .........+||..|||||++.+..++.++||||||||||||++|+.||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 89999999999976432 12223455789999999999999999999999999999999999999995432210
Q ss_pred HHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHhhC
Q 006083 530 WARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKR-PKMSQIVRALEG 591 (662)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R-Ps~~evl~~L~~ 591 (662)
.. +...+......+.+.+++. .|++.++.+| +++.++.+.|+.
T Consensus 293 ------------~~----~~~~~~~~~~~~~~~~~~~---~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 293 ------------CK----PEGLFRRLPHLDMWNEFFH---VMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp ------------EE----ECSCCTTCSSHHHHHHHHH---HHHCCCCTTCCCCHHHHHHHHHH
T ss_pred ------------ee----echhccccCcHHHHHHHHH---HHcCCCCCCcchHHHHHHHHHHH
Confidence 00 1112222234556666555 7999999988 678888887774
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=360.96 Aligned_cols=270 Identities=24% Similarity=0.326 Sum_probs=201.5
Q ss_pred HHHHHHhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhc--CCCCcceEEEEEEeC--
Q 006083 309 DELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV--HHRHLVSLVGYCIAG-- 384 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l--~HpnIv~l~~~~~~~-- 384 (662)
.......++|++.+.||+|+||.||+|+. .|+.||||++... ....+.+|.+++..+ +|+||+++++++.+.
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 33344557899999999999999999987 4899999999753 334555666666554 899999999999887
Q ss_pred --CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceeecCCccCcEEECCCCcEE
Q 006083 385 --GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC-----HPRIIHRDIKAANILIDDNFEAM 457 (662)
Q Consensus 385 --~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~ivHrDIkp~NILl~~~~~vk 457 (662)
...+|||||+.+|+|.++++.. .+++..+++++.|++.||+|||+++ ..+|+||||||+||||+.++.+|
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 7899999999999999999653 4899999999999999999999752 23799999999999999999999
Q ss_pred EEeeccccccCCCCCcc---ccccccCccccCcccccCCCCCch------HHHHHHHHHHHHHHhC----------CCCC
Q 006083 458 VADFGLAKLSNDNHTHV---STRVMGTFGYLAPEYASSGKLTEK------SDVFSFGVMLLELITG----------RRPV 518 (662)
Q Consensus 458 l~DFGla~~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~------sDvwSlGvvl~eLltG----------~~Pf 518 (662)
|+|||+++......... ....+||..|+|||++.+..+..+ +||||||||||||++| +.||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999997665433221 124579999999999987766654 9999999999999999 6666
Q ss_pred CCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 519 DMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
......+........ ......+.......+. .......+.+++.+||+.||.+||++.||++.|+..
T Consensus 263 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 263 HDLVPSDPSYEDMRE----IVCIKKLRPSFPNRWS---SDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TTTSCSSCCHHHHHH----HHTTSCCCCCCCGGGG---GSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhcCCCCchhhhHH----HHhhhccCccccccch---hhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 443221111111111 1111111111111111 124455677777899999999999999999999853
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=373.63 Aligned_cols=273 Identities=21% Similarity=0.221 Sum_probs=210.9
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--eEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGG--QRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~lv~ 391 (662)
++|.+.++||+|+||.||+|... +|+.||||+++... ....+.+.+|+++|++++|+||+++++++.+.+ ..+|||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46999999999999999999964 58999999997543 234577889999999999999999999998655 789999
Q ss_pred EecCCcchhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE----CCCCcEEEEeeccccc
Q 006083 392 EFVSNKTLEYHLHGEN-RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI----DDNFEAMVADFGLAKL 466 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkl~DFGla~~ 466 (662)
|||.+++|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||| ++++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999996543 23389999999999999999999999 99999999999999 7788899999999987
Q ss_pred cCCCCCccccccccCccccCcccccC--------CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHH
Q 006083 467 SNDNHTHVSTRVMGTFGYLAPEYASS--------GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAA 538 (662)
Q Consensus 467 ~~~~~~~~~~~~~Gt~~y~aPE~~~~--------~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 538 (662)
..... .....+||..|+|||++.+ ..++.++|||||||+||||++|+.||..........+.....+...
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 65432 2234679999999999864 5678899999999999999999999965432222222222221110
Q ss_pred hh----------cCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 539 LE----------DGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 539 ~~----------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
.. .+.+...-+..............+..++..||+.||++|+++.|+++.|+...
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 00 00000000011112234556666778888999999999999999999987543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=361.27 Aligned_cols=255 Identities=28% Similarity=0.431 Sum_probs=198.2
Q ss_pred CCCCccceeeccCceEEEEEEecC-----CCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPN-----GKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
.+|.+.++||+|+||.||+|.... +..||||+++.... .....+.+|+++|++++|+||+++++++.+.+..+|
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 457788999999999999998542 23599999986533 345678999999999999999999999999999999
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||||+.+++|.+++... ...+++..++.++.||++||.|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 99999999999999654 23589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCc--cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCcccc
Q 006083 470 NHTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 470 ~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
.... ......|+..|+|||++.+..++.++|||||||+||||++ |+.||......+.+..+ ..+...
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~---------~~~~~~- 269 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---------NDGFRL- 269 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---------HTTCCC-
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH---------HCCCcC-
Confidence 3221 1223456789999999999999999999999999999999 99999765433222111 111100
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.. ....+. .+.+++.+||+.||++||++.+|++.|+..
T Consensus 270 ----~~-~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 270 ----PT-PMDCPS---AIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp ----CC-CTTCBH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CC-cccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 112233 345556699999999999999999998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=365.92 Aligned_cols=264 Identities=18% Similarity=0.260 Sum_probs=193.9
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ--GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
.++|.+.+.||+|+||.||+|+. .+++.||||+++..... ..+.+.+|+++|++++|+||+++++++.+++.++|||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 45799999999999999999984 47899999999765332 2456789999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE-----CCCCcEEEEeeccccc
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI-----DDNFEAMVADFGLAKL 466 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl-----~~~~~vkl~DFGla~~ 466 (662)
||+. ++|.+++.... .+++..++.|+.||++||+|||++ +|+||||||+|||| ++++.+||+|||+++.
T Consensus 113 e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp ECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred ecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9997 48998886543 489999999999999999999999 99999999999999 4556699999999987
Q ss_pred cCCCCCccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 467 SNDNHTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 467 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
...... .....+||..|+|||++.+. .++.++||||||||||||++|+.||......+.+.......- . .....+.
T Consensus 187 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~-~~~~~~~ 263 (329)
T 3gbz_A 187 FGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG-L-PDDTTWP 263 (329)
T ss_dssp HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-C-CCTTTST
T ss_pred cCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC-C-Cchhhhh
Confidence 654322 23446789999999999874 489999999999999999999999987765554443332110 0 0000000
Q ss_pred cc------cC--cccCCCCCHH-----HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GL------VD--PRLEHNYVPH-----EMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~------~d--~~l~~~~~~~-----~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.. .. .......... ....+.+++.+||+.||++||++.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 00 0000000000 1134456666999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=360.57 Aligned_cols=260 Identities=26% Similarity=0.390 Sum_probs=201.6
Q ss_pred CCCccceeeccCceEEEEEEe-----cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-----PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAG--GQRM 388 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~ 388 (662)
.|++.+.||+|+||.||+|++ .+++.||||+++... ....+.+.+|+++|++++|+||+++++++.+. ..++
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 488899999999999999983 468999999997543 33457899999999999999999999999876 6789
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
+||||+.+++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||++....
T Consensus 102 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999999995433 3489999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCC--ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHH--------HHHhHHH
Q 006083 469 DNHT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWA--------RPLLGAA 538 (662)
Q Consensus 469 ~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~--------~~~~~~~ 538 (662)
.... .......|+..|+|||++.+..++.++|||||||++|||++|+.|+...... +.... ...+...
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL--FLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH--HHHHHCSCCGGGHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH--HhhccCCcccccCHHHHHHH
Confidence 5432 2233467888999999999989999999999999999999999986433110 00000 0000011
Q ss_pred hhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 539 LEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 539 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
+..+... ... ...+. .+.+++.+||+.||.+||++.||++.|+.
T Consensus 256 ~~~~~~~-----~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 256 LKEGKRL-----PCP-PNCPD---EVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHTTCCC-----CCC-TTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HhccCCC-----CCC-CCCCH---HHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 1111100 111 11223 45556669999999999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=360.78 Aligned_cols=244 Identities=23% Similarity=0.261 Sum_probs=190.9
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG--QGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.++||+|+||.||+|+.. +|+.||||++..... .....+..|+..+.++ +|+||++++++|.+++..||||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 46999999999999999999965 799999999865432 2334455666666555 8999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+ +++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999 678888876543 3589999999999999999999998 89999999999999999999999999998765432
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
......||..|+|||++.+ .++.++|||||||+||||++|+.+|......+ .+ ..+.+ ...
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~---------~~~~~----~~~ 272 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QL---------RQGYL----PPE 272 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HH---------TTTCC----CHH
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HH---------hccCC----Ccc
Confidence 2344679999999999875 79999999999999999999987765432111 11 11111 111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+... .. ..+.+++.+||+.||++||++.|+++
T Consensus 273 ~~~~-~~---~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 FTAG-LS---SELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHTT-SC---HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccC-CC---HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111 12 34555666999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=352.18 Aligned_cols=255 Identities=25% Similarity=0.354 Sum_probs=200.7
Q ss_pred hCCCCccceeeccCceEEEEEEecC----CCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPN----GKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
.++|.+.+.||+|+||.||+|...+ +..||||+++... ....+.+.+|+++|++++|+||+++++++.++ ..|+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 3568999999999999999998532 3469999998653 34467899999999999999999999998754 5689
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||||+.+++|.+++.... ..+++..++.++.|+++||.|||++ +|+||||||+||||+.++.+||+|||++.....
T Consensus 90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999996532 3488999999999999999999998 999999999999999999999999999987655
Q ss_pred CCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
..........|+..|+|||++.+..++.++|||||||+||||++ |+.||......+..... ..+...
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~---------~~~~~~--- 233 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL---------EKGDRL--- 233 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH---------HHTCCC---
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH---------hcCCCC---
Confidence 43333344567889999999998899999999999999999998 99999765433322111 111100
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.. ....... +.+++.+||+.||.+||++.||++.|+..
T Consensus 234 --~~-~~~~~~~---l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 234 --PK-PDLCPPV---LYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp --CC-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CC-CCCCCHH---HHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 01 1122333 44555699999999999999999999853
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=362.01 Aligned_cols=247 Identities=23% Similarity=0.303 Sum_probs=176.9
Q ss_pred cceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEEecCCcc
Q 006083 321 SNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRMLVYEFVSNKT 398 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~~g~ 398 (662)
++.||+|+||.||+|... +|+.||||++.. .....+.+|+++|+++. |+||+++++++.+++..|||||||.+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999964 689999999975 34567889999999997 9999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC---cEEEEeeccccccCCCCCccc
Q 006083 399 LEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF---EAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 399 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkl~DFGla~~~~~~~~~~~ 475 (662)
|.+++... ..+++..++.++.||++||+|||++ +|+||||||+||||+.++ .+||+|||+++....... ..
T Consensus 93 L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~ 166 (325)
T 3kn6_A 93 LFERIKKK--KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PL 166 (325)
T ss_dssp HHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cc
Confidence 99999764 3589999999999999999999999 999999999999997655 899999999987654332 23
Q ss_pred cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhh---HHHHHHHHHhHHHhhcCccccccCccc
Q 006083 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMED---SLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
...+||..|+|||++.+..++.++|||||||+||||++|+.||....... ...+... .+..+.+.. ....
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-----~i~~~~~~~--~~~~ 239 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK-----KIKKGDFSF--EGEA 239 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH-----HHTTTCCCC--CSHH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH-----HHHcCCCCC--Cccc
Confidence 44678999999999999999999999999999999999999997643211 1111111 111111110 0000
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.. .... .+.+++..||+.||++||++.|+++
T Consensus 240 ~~-~~s~---~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 240 WK-NVSQ---EAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HH-TSCH---HHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cc-CCCH---HHHHHHHHHCCCChhHCCCHHHHhc
Confidence 00 1223 3455566999999999999998874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=367.00 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=197.6
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.++|++.+.||+|+||.||++... +|+.||||+++.... .+.+|+++|.++ +|+||+++++++.+++..|||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 456999999999999999999954 689999999986533 245688888888 79999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC----CcEEEEeeccccccC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN----FEAMVADFGLAKLSN 468 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~----~~vkl~DFGla~~~~ 468 (662)
||.||+|.+++.... .+++..++.++.+|+.||+|||++ +|+||||||+||||.++ +.+||+|||+++...
T Consensus 97 ~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 97 LMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 999999999996543 489999999999999999999999 99999999999998543 359999999998765
Q ss_pred CCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 469 DNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 469 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
.... .....+||..|+|||++.+..|+.++|||||||+||||++|+.||...... ...++... +..+.+..
T Consensus 172 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~~-----i~~~~~~~-- 242 (342)
T 2qr7_A 172 AENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-TPEEILAR-----IGSGKFSL-- 242 (342)
T ss_dssp CTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS-CHHHHHHH-----HHHCCCCC--
T ss_pred CCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC-CHHHHHHH-----HccCCccc--
Confidence 4332 234468999999999998888999999999999999999999999764211 11111111 11122111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..... .....++. +++.+||+.||++||++.|+++
T Consensus 243 ~~~~~-~~~s~~~~---~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 243 SGGYW-NSVSDTAK---DLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CSTTT-TTSCHHHH---HHHHHHTCSSTTTSCCHHHHTT
T ss_pred Ccccc-ccCCHHHH---HHHHHHCCCChhHCcCHHHHhc
Confidence 00111 12234444 4555899999999999999886
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=364.61 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=207.0
Q ss_pred hCCCCccceeeccCceEEEEEEec-CC-----CEEEEEEeecCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NG-----KEVAVKSLKTGSG-QGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQ 386 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g-----~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~ 386 (662)
.++|.+.+.||+|+||.||+|... ++ ..||||+++.... ...+.+.+|+++|+++ +|+||++++++|.+++.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 467999999999999999999853 22 4799999986543 3456799999999999 89999999999999999
Q ss_pred EEEEEEecCCcchhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC
Q 006083 387 RMLVYEFVSNKTLEYHLHGEN------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF 454 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~ 454 (662)
.+|||||+.+|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||||++++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence 999999999999999986421 34578999999999999999999999 999999999999999999
Q ss_pred cEEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHH
Q 006083 455 EAMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWAR 532 (662)
Q Consensus 455 ~vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~ 532 (662)
.+||+|||+++....... .......|+..|+|||++.+..++.++||||||||||||++ |+.||......+.+.....
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 281 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence 999999999986543322 22334567889999999999999999999999999999998 9999976544333322221
Q ss_pred HHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 533 PLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
. +... . .....+. .+.+++..||+.||.+||++.||++.|+.
T Consensus 282 ~--------~~~~-----~-~~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 282 D--------GYQM-----A-QPAFAPK---NIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp H--------TCCC-----C-CCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c--------CCCC-----C-CCCCCCH---HHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 1 1100 0 1112233 44555669999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=361.97 Aligned_cols=248 Identities=21% Similarity=0.374 Sum_probs=204.9
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
.++|.+.+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++|+||+++++++.+++..|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 356899999999999999999964 6889999998754 223456789999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+++|.+++... ..+++.+++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999988653 3589999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
.. ......|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+..+.. +.+
T Consensus 195 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---------~~~------ 258 (335)
T 2owb_A 195 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK---------NEY------ 258 (335)
T ss_dssp TC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---------TCC------
T ss_pred cc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc---------CCC------
Confidence 22 22446799999999999998999999999999999999999999987654433322111 111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+.. ....+ +.+++.+||+.||++||++.|+++
T Consensus 259 ~~~~-~~~~~---~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 SIPK-HINPV---AASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CCCT-TSCHH---HHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCc-cCCHH---HHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 12233 445556999999999999999996
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=368.19 Aligned_cols=210 Identities=25% Similarity=0.400 Sum_probs=168.7
Q ss_pred HHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCC--e
Q 006083 313 AATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVH-HRHLVSLVGYCIAGG--Q 386 (662)
Q Consensus 313 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~--~ 386 (662)
...++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+|+++. |+||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3467899999999999999999985 47899999998653 2344567889999999997 999999999997543 7
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
+|||||||. ++|..++... .+++..+..++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 899999997 5888888653 588999999999999999999999 999999999999999999999999999986
Q ss_pred cCCC--------------------CCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhh
Q 006083 467 SNDN--------------------HTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMED 525 (662)
Q Consensus 467 ~~~~--------------------~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~ 525 (662)
.... ........+||..|+|||++.+ ..|+.++||||||||||||++|+.||......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5321 1112344689999999999986 679999999999999999999999998776554
Q ss_pred HHHH
Q 006083 526 SLVE 529 (662)
Q Consensus 526 ~~~~ 529 (662)
.+..
T Consensus 239 ~~~~ 242 (388)
T 3oz6_A 239 QLER 242 (388)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4433
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=352.40 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=196.7
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
++|.+.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+++|++++|+||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 4599999999999999999985 468999999997653 33467899999999999999999999999999999999999
Q ss_pred cCCcchhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE---CCCCcEEEEeeccccccC
Q 006083 394 VSNKTLEYHLHGE--NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 394 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkl~DFGla~~~~ 468 (662)
+.+++|.+++... ....+++..+++++.|+++||+|||++ +|+||||||+|||| +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988542 234589999999999999999999999 99999999999999 456889999999998765
Q ss_pred CCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 469 DNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 469 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
... ......|+..|+|||++. +.++.++|||||||+||||++|+.||......+....... ....+
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~-------~~~~~---- 244 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY-------KEPNY---- 244 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCCCC----
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc-------CCccc----
Confidence 432 234467999999999886 5789999999999999999999999987643332211100 00000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
......... .+.+++.+||+.||++||++.||++
T Consensus 245 --~~~~~~~~~---~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 --AVECRPLTP---QAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CC--CCCCH---HHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --ccccCcCCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence 011111223 3445566999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=352.31 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=201.4
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG------QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 388 (662)
++|.+.+.||+|+||.||++... +|+.||||+++.... ...+.+.+|+++|++++|+||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46999999999999999999965 689999999976432 23678999999999999999999999999999999
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC----cEEEEeeccc
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF----EAMVADFGLA 464 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkl~DFGla 464 (662)
+||||+.+++|.+++... ..+++..++.++.|+++||.|||++ +|+|||||++||||++++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999999999653 3489999999999999999999998 999999999999998876 8999999999
Q ss_pred cccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcc
Q 006083 465 KLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIY 544 (662)
Q Consensus 465 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (662)
........ .....|+..|+|||++.+..++.++|||||||+||+|++|+.||......+.+..+.. ...
T Consensus 160 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------~~~ 228 (283)
T 3bhy_A 160 HKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA---------VNY 228 (283)
T ss_dssp EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT---------TCC
T ss_pred eeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHh---------ccc
Confidence 87654322 2345799999999999999999999999999999999999999987654433322111 100
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 545 DGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 545 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. ....... ... ..+.+++.+||+.||++||++.|+++
T Consensus 229 ~--~~~~~~~-~~~---~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 D--FDEEYFS-NTS---ELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C--CCHHHHT-TCC---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--Ccchhcc-cCC---HHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 0000101 112 33455666999999999999999996
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=382.96 Aligned_cols=253 Identities=26% Similarity=0.356 Sum_probs=203.8
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|.+.++||+|+||.||+++.. +|+.||||++++.. ....+.+.+|+++|++++|+||+++++++.+.+.+||||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56888999999999999999964 79999999997532 133467889999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 392 EFVSNKTLEYHLHGEN--RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
|||.||+|.++|.... ...+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999986543 45689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
... .....+||+.|+|||++.+..|+.++||||||||||||++|+.||..........++....+ . ...
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~----~-~~~----- 410 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL----E-QAV----- 410 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH----H-CCC-----
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh----h-ccc-----
Confidence 432 22346899999999999999999999999999999999999999976532222222222111 1 110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKM-----SQIVR 587 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~evl~ 587 (662)
.+. .....++. .++.+||+.||.+||++ .+|++
T Consensus 411 -~~p-~~~s~~~~---~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 -TYP-DKFSPASK---DFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -CCC-TTSCHHHH---HHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -CCC-cccCHHHH---HHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 111 12234444 44558999999999975 56653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=363.13 Aligned_cols=266 Identities=23% Similarity=0.358 Sum_probs=201.2
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++|++++|+||++++++|.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 46899999999999999999964 589999999876533 234568899999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.+++|.+++.... .+++..++.++.+++.||+|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 105 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 105 FVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp CCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 999999998875433 489999999999999999999999 999999999999999999999999999986654322
Q ss_pred ccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh------HHHh-hcCcc
Q 006083 473 HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL------GAAL-EDGIY 544 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~------~~~~-~~~~~ 544 (662)
......|+..|+|||++.+. .++.++|||||||+||+|++|+.||......+.+..+..... ...+ ....+
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 23446799999999999875 789999999999999999999999987765544433322100 0000 01111
Q ss_pred ccccCcccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 545 DGLVDPRLEHNYV-----PHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 545 ~~~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.......+..... ......+.+++.+||+.||++||++.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111111111110 111234556667999999999999999886
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=351.23 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=203.8
Q ss_pred CCCCccc-eeeccCceEEEEEEec---CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSN-LLGQGGFGYVHKGVLP---NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~-~iG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
++|.+.+ .||+|+||.||+|... +++.||||+++.... ...+.+.+|+++|++++|+||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4466665 9999999999999843 678899999987533 4467899999999999999999999999 55678999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+++|.+++... ...+++..+++++.|+++||.|||++ +|+||||||+||||++++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999998643 34589999999999999999999999 9999999999999999999999999999877543
Q ss_pred CCcc--ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 471 HTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 471 ~~~~--~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
.... .....|+..|+|||++.+..++.++|||||||+||||++ |+.||......+.... +..+...
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---------i~~~~~~-- 232 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---------IEQGKRM-- 232 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH---------HHTTCCC--
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH---------HhcCCcC--
Confidence 3221 223457899999999998899999999999999999998 9999976543332211 1111110
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.+.. ..+. .+.+++..||+.||.+||++.+|++.|+..
T Consensus 233 ---~~~~-~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 233 ---ECPP-ECPP---ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp ---CCCT-TCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCC-CcCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111 2233 445555699999999999999999998853
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=361.92 Aligned_cols=246 Identities=24% Similarity=0.352 Sum_probs=198.5
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
+.|...+.||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|+||++++++|.+++..+|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3488899999999999999985 5789999999976532 23457899999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+. |+|.+++... ...+++..++.++.|+++||.|||++ +|+||||||+||||++++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 9997 5777776432 23589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CccccccccCccccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 472 THVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
...+||..|+|||++. ++.++.++||||||||||||++|+.||......+.+..... +..
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~---------~~~---- 270 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---------NES---- 270 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---------SCC----
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---------cCC----
Confidence 3467999999999984 56799999999999999999999999976543332222111 111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
..+........+. +++.+||+.||++||++.++++.
T Consensus 271 -~~~~~~~~~~~l~---~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 -PALQSGHWSEYFR---NFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -CCCCCTTSCHHHH---HHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -CCCCCCCCCHHHH---HHHHHHcccChhhCcCHHHHhhC
Confidence 1111222334444 45558999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=354.75 Aligned_cols=257 Identities=21% Similarity=0.336 Sum_probs=194.5
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|.+.+.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|+++|++++|+||+++++++.+++..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4699999999999999999985 578999999997532 334567899999999999999999999999999999999
Q ss_pred EecCCcchhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 392 EFVSNKTLEYHLHG--ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 392 E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||+.+++|.+++.. .....+++..+++++.++++||.|||++ +|+|||||++||||+.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999998854 2344589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
... ......|+..|+|||++.+..++.++|||||||+||+|++|+.||....... ..+.. .+....+..
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~-----~~~~~~~~~--- 257 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCK-----KIEQCDYPP--- 257 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH--HHHHH-----HHHTTCSCC---
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH--HHHHH-----HhhcccCCC---
Confidence 322 2234678999999999999999999999999999999999999997543211 11111 111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
+.......+ +.+++.+||+.||.+||++.+|++.|+.
T Consensus 258 --~~~~~~~~~---l~~li~~~l~~dp~~Rps~~~il~~l~~ 294 (310)
T 2wqm_A 258 --LPSDHYSEE---LRQLVNMCINPDPEKRPDVTYVYDVAKR 294 (310)
T ss_dssp --CCTTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CcccccCHH---HHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 111222334 4455558999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=357.46 Aligned_cols=261 Identities=22% Similarity=0.323 Sum_probs=196.5
Q ss_pred CCCCcc-ceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEE
Q 006083 316 GGFAKS-NLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 316 ~~~~~~-~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
+.|.+. ++||+|+||.||+|.. .+++.||||+++.......+.+.+|+++|.++ +|+||+++++++.+++.+|||||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 457774 7899999999999994 47899999999877666678899999999995 79999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCc---EEEEeeccccccCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE---AMVADFGLAKLSND 469 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vkl~DFGla~~~~~ 469 (662)
|+.+++|.+++.... .+++..++.++.||++||+|||++ +|+||||||+||||+.++. +||+|||++.....
T Consensus 92 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999996543 488999999999999999999999 9999999999999988766 99999999876542
Q ss_pred CCC------ccccccccCccccCcccccC-----CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhH-------HHHHH
Q 006083 470 NHT------HVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDS-------LVEWA 531 (662)
Q Consensus 470 ~~~------~~~~~~~Gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~-------~~~~~ 531 (662)
... ......+||..|+|||++.+ ..++.++|||||||+||||++|+.||......+. .....
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 211 11223569999999999875 5688999999999999999999999976532110 00000
Q ss_pred HHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 532 RPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 532 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
..++ ..+..+.+... . ... ..... .+.+++.+||+.||++||++.|+++.
T Consensus 247 ~~~~-~~i~~~~~~~~-~-~~~-~~~~~---~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 247 NMLF-ESIQEGKYEFP-D-KDW-AHISC---AAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHH-HHHHHCCCCCC-H-HHH-TTSCH---HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHH-HHHhccCcccC-c-hhc-ccCCH---HHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0011 11111111100 0 000 11123 34556669999999999999999873
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=389.09 Aligned_cols=252 Identities=26% Similarity=0.419 Sum_probs=198.4
Q ss_pred CCCccc-eeeccCceEEEEEEec---CCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 317 GFAKSN-LLGQGGFGYVHKGVLP---NGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 317 ~~~~~~-~iG~G~~g~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++.+.+ .||+|+||.||+|.+. ++..||||+++... ....+.|.+|+++|++++|+|||+++++|.+ +.++|||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 344444 7999999999999853 45679999998753 3456889999999999999999999999976 5689999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
|||.+|+|.++|... ...+++..++.|+.||++||+|||++ +|||||||++||||++++.+||+|||+++......
T Consensus 415 E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp ECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 999999999999654 34589999999999999999999999 99999999999999999999999999998765433
Q ss_pred Ccc--ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 472 THV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 472 ~~~--~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
... .....++..|+|||++.++.++.++||||||||||||++ |+.||......+.+.. +..+...
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~---------i~~~~~~--- 558 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---------IEQGKRM--- 558 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH---------HHTTCCC---
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH---------HHcCCCC---
Confidence 221 122446789999999999999999999999999999998 9999987654332211 1111110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.. ....+.+ +.+++..||+.||++||++.+|++.|+.
T Consensus 559 --~~-p~~~~~~---l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 559 --EC-PPECPPE---LYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp --CC-CTTCCHH---HHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred --CC-CCcCCHH---HHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 01 1123344 4455569999999999999999999885
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=350.52 Aligned_cols=254 Identities=22% Similarity=0.342 Sum_probs=203.4
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIA--GGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lv 390 (662)
++|++.+.||+|+||.||++... +|+.||||+++... ....+.+.+|+++|++++|+||+++++++.+ ++..++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 56999999999999999999954 78999999998653 2345678999999999999999999998854 6789999
Q ss_pred EEecCCcchhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc-----eeecCCccCcEEECCCCcEEEEeecc
Q 006083 391 YEFVSNKTLEYHLHGE--NRPVMDFATRVRIALGSAKGLAYLHEDCHPR-----IIHRDIKAANILIDDNFEAMVADFGL 463 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-----ivHrDIkp~NILl~~~~~vkl~DFGl 463 (662)
|||+.+++|.+++... ....+++..+++++.|++.||+|||++ + |+|||||++||||++++.+||+|||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999642 334589999999999999999999998 7 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCc
Q 006083 464 AKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGI 543 (662)
Q Consensus 464 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (662)
++...... .......|+..|+|||++.+..++.++|||||||+||+|++|+.||......+.... +..+.
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---------i~~~~ 232 (279)
T 2w5a_A 163 ARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK---------IREGK 232 (279)
T ss_dssp HHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---------HHHTC
T ss_pred heeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH---------Hhhcc
Confidence 98765432 122346799999999999998999999999999999999999999987643322211 11122
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 544 YDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 544 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
+.. +... ... .+.+++.+||+.||++||++.||++.+..
T Consensus 233 ~~~-----~~~~-~~~---~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 233 FRR-----IPYR-YSD---ELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CCC-----CCTT-SCH---HHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ccc-----CCcc-cCH---HHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 111 1111 233 34455569999999999999999987664
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=349.35 Aligned_cols=247 Identities=26% Similarity=0.410 Sum_probs=202.8
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----------
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA---------- 383 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~---------- 383 (662)
.++|++.+.||+|+||.||+|... +|+.||||+++... +.+.+|+++|++++|+||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 456999999999999999999965 79999999998653 357789999999999999999998864
Q ss_pred ------CCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEE
Q 006083 384 ------GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAM 457 (662)
Q Consensus 384 ------~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 457 (662)
...+++||||+.+++|.+++.......+++..+++++.|++.||.|||++ +|+|||||++||||++++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEE
Confidence 45589999999999999999765555689999999999999999999998 999999999999999999999
Q ss_pred EEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHH
Q 006083 458 VADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGA 537 (662)
Q Consensus 458 l~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 537 (662)
|+|||++........ .....|+..|+|||++.+..++.++|||||||+||||++|..+|.... .+..
T Consensus 163 l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------~~~~----- 229 (284)
T 2a19_B 163 IGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS------KFFT----- 229 (284)
T ss_dssp ECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH------HHHH-----
T ss_pred ECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH------HHHH-----
Confidence 999999987654332 234579999999999999999999999999999999999998873211 1111
Q ss_pred HhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 538 ALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 538 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
.+..+.+. . ..... +.+++.+||+.||.+||++.|+++.|+...
T Consensus 230 ~~~~~~~~--------~-~~~~~---~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 230 DLRDGIIS--------D-IFDKK---EKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHTTCCC--------T-TSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred Hhhccccc--------c-cCCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 11111111 1 12233 445556999999999999999999988543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=360.81 Aligned_cols=256 Identities=25% Similarity=0.374 Sum_probs=197.1
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCE----EEEEEeecC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKE----VAVKSLKTG-SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~----vavK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 388 (662)
.++|++.++||+|+||.||+|... +++. ||+|.++.. .....+.+.+|+++|++++|+||++++++|..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 356999999999999999999843 4554 577777543 3345678999999999999999999999998765 78
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
+||||+.+|+|.+++.... ..+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999997543 3589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCcccc
Q 006083 469 DNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 469 ~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
..... ......|+..|+|||++.+..++.++|||||||+||||++ |+.||......+.... . ..+...
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-~--------~~~~~~- 238 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-L--------EKGERL- 238 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-H--------HTTCCC-
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-H--------HcCCCC-
Confidence 43221 2233557889999999999999999999999999999999 9999987644332211 1 111100
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
.. ...... .+.+++.+||+.||.+||++.||++.|+...
T Consensus 239 ----~~-~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 239 ----PQ-PPICTI---DVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ----CC-CTTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CC-CccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01 111223 3555666999999999999999999988543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=359.25 Aligned_cols=259 Identities=23% Similarity=0.329 Sum_probs=202.6
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEE----eCCeEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI----AGGQRML 389 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~----~~~~~~l 389 (662)
.++|.+.+.||+|+||.||++.. .+|+.||||++........+.+.+|++++++++|+||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 45799999999999999999995 578999999998766666788999999999999999999999987 3457899
Q ss_pred EEEecCCcchhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 390 VYEFVSNKTLEYHLHGE--NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
||||+.+++|.+++... ....+++..+++++.||++||+|||++ +|+||||||+||||+.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999988642 345689999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCc--------cccccccCccccCcccccCCC---CCchHHHHHHHHHHHHHHhCCCCCCCchhhh-HHHHHHHHHh
Q 006083 468 NDNHTH--------VSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVMLLELITGRRPVDMTMMED-SLVEWARPLL 535 (662)
Q Consensus 468 ~~~~~~--------~~~~~~Gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~-~~~~~~~~~~ 535 (662)
...... ......|+..|+|||++.+.. ++.++|||||||+||||++|+.||....... .+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----- 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA----- 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH-----
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH-----
Confidence 421110 012346799999999987554 6899999999999999999999995432111 11110
Q ss_pred HHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 536 GAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 536 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
... .+.. .. ...... .+.+++.+||+.||.+||++.+|++.|+...
T Consensus 260 ---~~~-~~~~----~~-~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 260 ---VQN-QLSI----PQ-SPRHSS---ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp ---HHC-C--C----CC-CTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred ---hhc-cCCC----Cc-cccCCH---HHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 011 0000 00 111223 4555666999999999999999999998643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=347.00 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=202.6
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++|+||+++++++.+++..|+|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356999999999999999999964 78999999997543 3445789999999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.+++|.+++... ..+++..++.++.|+++||+|||++ +|+|||||++||||+.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999998643 3589999999999999999999998 999999999999999999999999999976543221
Q ss_pred -ccccccccCccccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCchhhh-HHHHHHHHHhHHHhhcCccccccC
Q 006083 473 -HVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDMTMMED-SLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 473 -~~~~~~~Gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
.......|+..|+|||++.+..+ +.++|||||||++|||++|+.||....... .+..|... ... .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~---~- 228 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--------KTY---L- 228 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT--------CTT---S-
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc--------ccc---c-
Confidence 12344679999999999987665 789999999999999999999997654322 22222110 000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.... .... .+.+++..||+.||.+||++.||++
T Consensus 229 -~~~~-~~~~---~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 -NPWK-KIDS---APLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -TTGG-GSCH---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -Cchh-hcCH---HHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0001 1123 3445666999999999999999876
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=359.56 Aligned_cols=269 Identities=23% Similarity=0.281 Sum_probs=198.4
Q ss_pred HHHhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchh-----HHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 006083 312 AAATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQG-----EREFSAEVEIISRVHHRHLVSLVGYCIAGG 385 (662)
Q Consensus 312 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-----~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 385 (662)
....++|.+.+.||+|+||.||+|... +|+.||||+++...... .+.+.+|+++|++++|+||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 334578999999999999999999954 68999999997542211 246789999999999999999999999999
Q ss_pred eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccc
Q 006083 386 QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
..++||||+.+ +|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred ceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 99999999986 788877543 33578889999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCCccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcc
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIY 544 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (662)
....... .....+||..|+|||++.+. .++.++||||||||||||++|..||......+.+..+....... ....+
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~--~~~~~ 237 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP--TEEQW 237 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC--CTTTS
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC--Chhhh
Confidence 7654322 23446799999999998754 58999999999999999999999998776555444333211000 00000
Q ss_pred ccc---cCcc-c--CCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 545 DGL---VDPR-L--EHNYV-----PHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 545 ~~~---~d~~-l--~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
... .+.. . ..... ......+.+++.+||+.||++||++.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 0000 0 00000 1111345556669999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=351.36 Aligned_cols=248 Identities=21% Similarity=0.369 Sum_probs=204.6
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 56899999999999999999964 68899999987542 234567899999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.+++|.+++.... .+++..++.++.|+++||+|||++ +|+|||||++||||++++.+||+|||++.......
T Consensus 95 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 95 ELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp ECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999886533 489999999999999999999999 99999999999999999999999999998765332
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
. ......|+..|+|||++.+..++.++|||||||+||+|++|+.||......+.+..+. .+.+ .
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---------~~~~------~ 233 (294)
T 2rku_A 170 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK---------KNEY------S 233 (294)
T ss_dssp C-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---------TTCC------C
T ss_pred c-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---------hccC------C
Confidence 2 2234679999999999998899999999999999999999999998765443322211 1111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+.. .... .+.+++.+||+.||++||++.|+++.
T Consensus 234 ~~~-~~~~---~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 234 IPK-HINP---VAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCT-TSCH---HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred Ccc-ccCH---HHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111 1223 34455669999999999999999973
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=368.23 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=191.5
Q ss_pred HHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC--------chhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 006083 313 AATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS--------GQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383 (662)
Q Consensus 313 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--------~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 383 (662)
...++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+++|++++|+|||++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4567899999999999999999985 468999999997532 111235889999999999999999999985
Q ss_pred CCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC---CcEEEEe
Q 006083 384 GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN---FEAMVAD 460 (662)
Q Consensus 384 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkl~D 460 (662)
.+..|||||||.+++|.+++... ..+++..++.++.|+++||+|||++ +|+||||||+||||+.+ +.+||+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 45689999999999999998654 3589999999999999999999998 99999999999999754 4599999
Q ss_pred eccccccCCCCCccccccccCccccCcccccC---CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHH
Q 006083 461 FGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGA 537 (662)
Q Consensus 461 FGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 537 (662)
||+++...... .....+||..|+|||++.+ ..++.++|||||||+||+|++|+.||........+.+..
T Consensus 286 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i------ 357 (419)
T 3i6u_A 286 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI------ 357 (419)
T ss_dssp SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH------
T ss_pred cccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH------
Confidence 99998765432 2345789999999999863 678899999999999999999999997654332222211
Q ss_pred HhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 538 ALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 538 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..+.+... ...... .. ..+.+++.+||+.||++||++.|+++
T Consensus 358 --~~~~~~~~--~~~~~~-~~---~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 --TSGKYNFI--PEVWAE-VS---EKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp --HTTCCCCC--HHHHTT-SC---HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --hcCCCCCC--chhhcc-cC---HHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11111100 000011 12 34555666999999999999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=357.83 Aligned_cols=265 Identities=23% Similarity=0.337 Sum_probs=208.5
Q ss_pred HHHHHHhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHh--cCCCCcceEEEEEEeCC-
Q 006083 309 DELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISR--VHHRHLVSLVGYCIAGG- 385 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~~~~~~~~- 385 (662)
..-....++|.+.+.||+|+||.||+|.. +|+.||||+++. .....+.+|++++.. ++|+||+++++++...+
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 33345567899999999999999999997 689999999965 345678889999988 68999999999998775
Q ss_pred ---eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCceeecCCccCcEEECCCC
Q 006083 386 ---QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLH--------EDCHPRIIHRDIKAANILIDDNF 454 (662)
Q Consensus 386 ---~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~ivHrDIkp~NILl~~~~ 454 (662)
..++||||+.+|+|.+++... .+++..+++++.|++.||+||| ++ +|+||||||+||||+.++
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTS
T ss_pred ccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCC
Confidence 899999999999999999653 4899999999999999999999 66 899999999999999999
Q ss_pred cEEEEeeccccccCCCCCc---cccccccCccccCcccccCCC------CCchHHHHHHHHHHHHHHhC----------C
Q 006083 455 EAMVADFGLAKLSNDNHTH---VSTRVMGTFGYLAPEYASSGK------LTEKSDVFSFGVMLLELITG----------R 515 (662)
Q Consensus 455 ~vkl~DFGla~~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~------~~~~sDvwSlGvvl~eLltG----------~ 515 (662)
.+||+|||+++........ ......|+..|+|||++.+.. ++.++||||||||||||++| +
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 9999999999876543322 123457999999999998652 33789999999999999999 7
Q ss_pred CCCCCchhhh-HHHHHHHHHhHHHhhcCccccccCcccCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 516 RPVDMTMMED-SLVEWARPLLGAALEDGIYDGLVDPRLEHN-YVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 516 ~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.||......+ ....+.... .... ....+... ........|.+++.+||+.||.+||++.||++.|+..
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~-----~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVV-----CEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHH-----TTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCccccCcCcccHHHHHHHH-----HHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 7886542211 112221111 1111 11111111 1235556777888899999999999999999999853
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=358.87 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=200.4
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCE--EEEEEeecC-CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKE--VAVKSLKTG-SGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~--vavK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv 390 (662)
++|.+.+.||+|+||.||+|+.. +|.. ||||+++.. .....+.+.+|+++|+++ +|+||+++++++.+.+..|||
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 46899999999999999999853 5664 499998754 233456789999999999 899999999999999999999
Q ss_pred EEecCCcchhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcE
Q 006083 391 YEFVSNKTLEYHLHGEN--------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA 456 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 456 (662)
|||+.+++|.+++.... ...+++..++.++.||++||.|||++ +|+||||||+||||+.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997543 24689999999999999999999999 99999999999999999999
Q ss_pred EEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHh
Q 006083 457 MVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLL 535 (662)
Q Consensus 457 kl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~ 535 (662)
||+|||+++...... ......++..|+|||++.+..++.++||||||||||||++ |+.||......+.+...
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~----- 254 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL----- 254 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG-----
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh-----
Confidence 999999997543211 1233467889999999998889999999999999999998 99999776443322111
Q ss_pred HHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 536 GAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 536 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
..+.. ..... .... .+.+++.+||+.||.+||++.|+++.|+.
T Consensus 255 ----~~~~~-----~~~~~-~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 255 ----PQGYR-----LEKPL-NCDD---EVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp ----GGTCC-----CCCCT-TBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----hcCCC-----CCCCC-CCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11110 01111 1223 45556669999999999999999998874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=348.24 Aligned_cols=251 Identities=22% Similarity=0.331 Sum_probs=197.2
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
.|....+||+|+||.||+|.. .+++.||||+++.......+.+.+|+.++++++|+||+++++++.+.+..++||||+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 355556999999999999995 5788999999987766667889999999999999999999999999999999999999
Q ss_pred CcchhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC-CCcEEEEeeccccccCCCCCc
Q 006083 396 NKTLEYHLHGEN-RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-NFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 396 ~g~L~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFGla~~~~~~~~~ 473 (662)
+++|.+++.... ...+++..+..++.|++.||.|||++ +|+|||||++||||+. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 999999997542 33567889999999999999999998 9999999999999987 89999999999987654321
Q ss_pred cccccccCccccCcccccCCC--CCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 474 VSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
......|+..|+|||++.++. ++.++|||||||+||+|++|+.||......+.... .... . . ....
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~-----~-~-----~~~~ 246 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGM-----F-K-----VHPE 246 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH-HHHH-----H-C-----CCCC
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH-hhcc-----c-c-----cccc
Confidence 223467899999999987643 89999999999999999999999965432221110 0000 0 0 0111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+... ... .+.+++.+||+.||++||++.|+++
T Consensus 247 ~~~~-~~~---~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 247 IPES-MSA---EAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCTT-SCH---HHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccc-CCH---HHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111 233 3445556999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=353.46 Aligned_cols=249 Identities=28% Similarity=0.442 Sum_probs=196.0
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-CeEEEEEEe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAG-GQRMLVYEF 393 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~lv~E~ 393 (662)
.++|++.+.||+|+||.||++.. +|+.||||+++.. ...+.+.+|+++|++++|+||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 45689999999999999999987 5889999999764 3457799999999999999999999997654 578999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+++|.+++.......+++..+++++.++++||+|||++ +|+||||||+||||++++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 9999999999754444478899999999999999999999 99999999999999999999999999997654322
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
....++..|+|||++.+..++.++|||||||++|||++ |+.||......+.... +..+.. ..+
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~---------~~~~~~-----~~~ 235 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---------VEKGYK-----MDA 235 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH---------HTTTCC-----CCC
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---------HhcCCC-----CCC
Confidence 23467889999999998999999999999999999998 9999976543332211 111110 011
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.. ..+.. +.+++.+||+.||.+||++.||++.|+.
T Consensus 236 ~~-~~~~~---l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 236 PD-GCPPA---VYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp CT-TCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cc-cCCHH---HHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 11 22333 4455569999999999999999999885
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=361.41 Aligned_cols=243 Identities=25% Similarity=0.335 Sum_probs=200.5
Q ss_pred HhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch--------hHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ--------GEREFSAEVEIISRVHHRHLVSLVGYCIAG 384 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 384 (662)
..++|.+.+.||+|+||.||+|+. .+++.||||+++..... ..+.+.+|+++|++++|+||++++++|.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 346799999999999999999984 57899999999865321 234678899999999999999999999999
Q ss_pred CeEEEEEEecCCc-chhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecc
Q 006083 385 GQRMLVYEFVSNK-TLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGL 463 (662)
Q Consensus 385 ~~~~lv~E~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGl 463 (662)
+.++|||||+.+| +|.+++.... .+++..++.|+.||+.||.|||++ +|+||||||+||||++++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999776 9999986543 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCccccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcC
Q 006083 464 AKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDG 542 (662)
Q Consensus 464 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 542 (662)
++....... ....+||..|+|||++.+..+ +.++|||||||+||||++|+.||......
T Consensus 177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------ 236 (335)
T 3dls_A 177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------ 236 (335)
T ss_dssp CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------------
T ss_pred ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------------
Confidence 987654432 244679999999999988776 78999999999999999999999653110
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 543 IYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 543 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
..... ........+ +.+++..||+.||++||++.||++.
T Consensus 237 -~~~~~---~~~~~~~~~---l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -VEAAI---HPPYLVSKE---LMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -TTTCC---CCSSCCCHH---HHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -Hhhcc---CCCcccCHH---HHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 011122344 4455558999999999999999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=350.24 Aligned_cols=248 Identities=27% Similarity=0.391 Sum_probs=204.8
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
+.|.+.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.+|++++|+||+++++++.+++..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4589999999999999999985 478999999997653 34567899999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+++|.+++.. ..+++..++.++.+++.||.|||++ +|+|||||++||||+.++.+||+|||++........
T Consensus 102 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 174 (303)
T 3a7i_A 102 LGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 174 (303)
T ss_dssp CTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence 999999999854 3589999999999999999999999 999999999999999999999999999987654322
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
......|+..|+|||++.+..++.++|||||||+||+|++|+.||......+.+... ..+.. ..+.
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---------~~~~~-----~~~~ 240 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI---------PKNNP-----PTLE 240 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---------HHSCC-----CCCC
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh---------hcCCC-----CCCc
Confidence 223467999999999999999999999999999999999999999765433222111 11111 1112
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
..+ .. .+..++..||+.||.+||++.||++.
T Consensus 241 ~~~-~~---~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 241 GNY-SK---PLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SSC-CH---HHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccc-CH---HHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 222 23 34555669999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.77 Aligned_cols=257 Identities=27% Similarity=0.376 Sum_probs=202.0
Q ss_pred hCCCCccceeeccCceEEEEEEe------cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL------PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 387 (662)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+|++++|+||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46799999999999999999983 357789999997543 34456789999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC---CCcEEEE
Q 006083 388 MLVYEFVSNKTLEYHLHGENR-----PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD---NFEAMVA 459 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~ 459 (662)
||||||+.+++|.+++..... ..+++..+++++.|+++||.|||++ +|+||||||+||||+. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999975432 4588999999999999999999999 9999999999999984 4569999
Q ss_pred eeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHH
Q 006083 460 DFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGA 537 (662)
Q Consensus 460 DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 537 (662)
|||+++....... .......|+..|+|||++.++.++.++|||||||+||||++ |+.||......+.+.. .
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~------ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-V------ 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-H------
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH-H------
Confidence 9999975533221 22234678999999999998999999999999999999998 9999976543322211 1
Q ss_pred HhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 538 ALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 538 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
..+... .... ..+. .+.+++..||+.||.+||++.+|++.|+..
T Consensus 259 --~~~~~~-----~~~~-~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 --TSGGRM-----DPPK-NCPG---PVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp --HTTCCC-----CCCT-TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --hcCCCC-----CCCC-CCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111110 1111 1233 445556699999999999999999998853
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=360.22 Aligned_cols=261 Identities=23% Similarity=0.368 Sum_probs=195.0
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchh-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQG-EREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
++|.+.+.||+|+||.||+|... +++.||||+++...... ...+.+|+++|++++|+||+++++++.+.+..+|||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 56899999999999999999964 78999999997543222 12456799999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+. ++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 155 (324)
T ss_dssp CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence 97 58888876543 3589999999999999999999999 999999999999999999999999999986553322
Q ss_pred cccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC---
Q 006083 474 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD--- 549 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--- 549 (662)
.....+||..|+|||++.+ ..++.++|||||||+||||++|+.||......+.+..+.+.. ... ....+.....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~-~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRIL-GTP-TEETWPGILSNEE 233 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCC-CTTTSTTGGGCHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCC-ChHhchhhhcchh
Confidence 2334678999999999876 568999999999999999999999998876555444332211 000 0000000000
Q ss_pred ------cccC-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 550 ------PRLE-------HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 550 ------~~l~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.... ..... ..+.+++.+||+.||++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLD---SDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSC---HHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhhhhhcCCCC---HHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 00112 33455666999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=367.17 Aligned_cols=264 Identities=25% Similarity=0.306 Sum_probs=201.7
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC--------CCCcceEEEEEE---
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH--------HRHLVSLVGYCI--- 382 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~--------HpnIv~l~~~~~--- 382 (662)
.++|.+.++||+|+||.||+|+. .+++.||||+++.. ....+.+.+|+++|++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46799999999999999999984 46889999999753 334567899999999985 788999999987
Q ss_pred -eCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC-------
Q 006083 383 -AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF------- 454 (662)
Q Consensus 383 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~------- 454 (662)
++..+||||||+ +++|.+++.......+++..++.|+.||+.||+|||+++ +|+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence 556889999999 555656555444456899999999999999999999975 799999999999998775
Q ss_pred ------------------------------------------cEEEEeeccccccCCCCCccccccccCccccCcccccC
Q 006083 455 ------------------------------------------EAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS 492 (662)
Q Consensus 455 ------------------------------------------~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~ 492 (662)
.+||+|||+++..... ....+||..|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 7999999999876533 234579999999999999
Q ss_pred CCCCchHHHHHHHHHHHHHHhCCCCCCCchhh------hHHHHHHHHHhH----HHhhcCcc-----------ccccCcc
Q 006083 493 GKLTEKSDVFSFGVMLLELITGRRPVDMTMME------DSLVEWARPLLG----AALEDGIY-----------DGLVDPR 551 (662)
Q Consensus 493 ~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~------~~~~~~~~~~~~----~~~~~~~~-----------~~~~d~~ 551 (662)
..++.++||||||||||||++|+.||...... +.+..... .+. ..+..+.+ ..+.+..
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE-LLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHH-HHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHH-hcCCCChHHhhcccccccccCCccccccccccC
Confidence 99999999999999999999999999754321 11111111 100 00000000 0000000
Q ss_pred c---------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 552 L---------EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 552 l---------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. ...........+.+++.+||+.||++||++.||++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 01224555667888888999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.07 Aligned_cols=253 Identities=26% Similarity=0.366 Sum_probs=200.9
Q ss_pred hCCCCccc-eeeccCceEEEEEEe---cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 006083 315 TGGFAKSN-LLGQGGFGYVHKGVL---PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 315 ~~~~~~~~-~iG~G~~g~Vy~~~~---~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 388 (662)
.++|.+.+ .||+|+||.||+|.+ .+++.||||+++... ....+.+.+|++++++++|+||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 999999999999963 356889999997653 23357899999999999999999999999 667789
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
+||||+.+++|.+++.... .+++..++.++.|+++||+|||++ +|+|||||++||||+.++.+||+|||++....
T Consensus 94 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 9999999999999997543 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcc--ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 469 DNHTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 469 ~~~~~~--~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
...... .....|+..|+|||++.+..++.++|||||||+||||++ |+.||......+... . +..+...
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~--------~~~~~~~ 239 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-M--------LEKGERM 239 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-H--------HHTTCCC
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-H--------HHcCCCC
Confidence 443221 223456789999999998889999999999999999999 999997754332211 1 1111111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.+. ...+. .+.+++..||+.||++||++.+|++.|+.
T Consensus 240 -----~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 240 -----GCP-AGCPR---EMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp -----CCC-TTCCH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -----CCC-CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111 12233 44555569999999999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=357.83 Aligned_cols=266 Identities=22% Similarity=0.302 Sum_probs=200.8
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEe--------C
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIA--------G 384 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--------~ 384 (662)
++|++.+.||+|+||.||+|+. .+|+.||||++..... .....+.+|+++|++++|+||+++++++.+ +
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5699999999999999999996 5789999999865432 234578899999999999999999999987 4
Q ss_pred CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
+.+||||||+.+ +|.+.+.... ..+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 578999999986 6666664432 3489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---ccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhh
Q 006083 465 KLSNDNHT---HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALE 540 (662)
Q Consensus 465 ~~~~~~~~---~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 540 (662)
+....... ......+||..|+|||++.+ ..++.++||||||||||||++|+.||......+.+....... ... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~-~ 249 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC-GSI-T 249 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCC-C
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCC-C
Confidence 87653221 12344678999999999876 458999999999999999999999998776554443322211 000 0
Q ss_pred cCccccc--------cC-cccCCCCCHHHH------HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 541 DGIYDGL--------VD-PRLEHNYVPHEM------ARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 541 ~~~~~~~--------~d-~~l~~~~~~~~~------~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
...+..+ +. ...........+ ..+.+++.+||+.||++||++.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000000 00 000001111111 235567779999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=348.73 Aligned_cols=245 Identities=24% Similarity=0.337 Sum_probs=202.3
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56999999999999999999964 67899999996532 223467899999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.+++|.+++.... .+++..++.++.|+++||.|||++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999996543 488999999999999999999998 99999999999999999999999999997654322
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||......+...... .... .
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---------~~~~------~ 230 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV---------NVDL------K 230 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---------TTCC------C
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh---------cccc------C
Confidence 234679999999999999999999999999999999999999998764433222111 1100 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+.. ....+ +.+++.+||+.||.+||++.|+++
T Consensus 231 ~~~-~~~~~---~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 FPP-FLSDG---SKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCT-TSCHH---HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC-cCCHH---HHHHHHHHhhcCHhhCCCHHHHhh
Confidence 111 12333 445556999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=370.82 Aligned_cols=207 Identities=22% Similarity=0.295 Sum_probs=180.0
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhc------CCCCcceEEEEEEeCCeE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRV------HHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l------~HpnIv~l~~~~~~~~~~ 387 (662)
..+|++.++||+|+||.||+|... +++.||||+++.. ....+.+.+|+++|+.+ +|+||+++++++...+.+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 456999999999999999999854 6899999999763 23456788899998887 577999999999999999
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCc--EEEEeecccc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE--AMVADFGLAK 465 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~--vkl~DFGla~ 465 (662)
+|||||+. ++|.+++.......+++..+++|+.||+.||+|||++ +||||||||+||||+.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 6888888776666689999999999999999999999 9999999999999999887 9999999997
Q ss_pred ccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHH
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEW 530 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~ 530 (662)
..... ....+||..|+|||++.+..++.++||||||||||||++|+.||......+.+..+
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i 311 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM 311 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 65432 23467999999999999999999999999999999999999999887665555443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=363.20 Aligned_cols=257 Identities=22% Similarity=0.331 Sum_probs=205.8
Q ss_pred HHHHHHhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc--------hhHHHHHHHHHHHHhc-CCCCcceEE
Q 006083 309 DELAAATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG--------QGEREFSAEVEIISRV-HHRHLVSLV 378 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~E~~il~~l-~HpnIv~l~ 378 (662)
.......++|.+.+.||+|+||.||+|++. +|+.||||+++.... ...+.+.+|+++|+++ +|+||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 444556678999999999999999999964 799999999976532 1135678999999999 799999999
Q ss_pred EEEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEE
Q 006083 379 GYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMV 458 (662)
Q Consensus 379 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl 458 (662)
+++...+..||||||+.|++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+||||++++.+||
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999999643 3489999999999999999999998 9999999999999999999999
Q ss_pred EeeccccccCCCCCccccccccCccccCcccccC------CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHH
Q 006083 459 ADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS------GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWAR 532 (662)
Q Consensus 459 ~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~ 532 (662)
+|||++........ ....+||..|+|||++.+ ..++.++||||||||||||++|+.||......+.+..+.
T Consensus 242 ~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~- 318 (365)
T 2y7j_A 242 SDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM- 318 (365)
T ss_dssp CCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-
T ss_pred EecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-
Confidence 99999987654322 244689999999999863 358899999999999999999999997654333222111
Q ss_pred HHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 533 PLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+.+... ...+ . ... ..+.+++.+||+.||++||++.|+++
T Consensus 319 --------~~~~~~~-~~~~-~-~~~---~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 319 --------EGQYQFS-SPEW-D-DRS---STVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp --------HTCCCCC-HHHH-S-SSC---HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --------hCCCCCC-Cccc-c-cCC---HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111100 0000 1 112 23555666999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=369.63 Aligned_cols=198 Identities=25% Similarity=0.358 Sum_probs=166.7
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----Ce
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAG-----GQ 386 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~ 386 (662)
.++|.+.+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++|++++|+||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46799999999999999999985 468899999997642 23456889999999999999999999999766 67
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
+||||||+. ++|.+++... ..+++..++.++.||++||.|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 999999986 5999998653 3589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC---------------------ccccccccCccccCcccc-cCCCCCchHHHHHHHHHHHHHHhCCCCC
Q 006083 467 SNDNHT---------------------HVSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELITGRRPV 518 (662)
Q Consensus 467 ~~~~~~---------------------~~~~~~~Gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~eLltG~~Pf 518 (662)
...... ......+||..|+|||++ .+..|+.++||||||||||||++|..||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 654321 123557899999999986 5567999999999999999999854444
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=347.49 Aligned_cols=249 Identities=26% Similarity=0.402 Sum_probs=181.9
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 45799999999999999999985 578999999997532 12346789999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+++|.+++... ...+++..++.++.|+++||.|||++ +|+||||||+||||+.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 9999999999998754 24589999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
.. ......|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+... ... +.
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------------~~~---~~ 229 (278)
T 3cok_A 166 HE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------------VLA---DY 229 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C------------CSS---CC
T ss_pred CC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH------------hhc---cc
Confidence 22 123467899999999999889999999999999999999999999765432221110 000 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+. .....+ +.+++.+||+.||++||++.+|++
T Consensus 230 ~~~-~~~~~~---~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EMP-SFLSIE---AKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCC-TTSCHH---HHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCc-cccCHH---HHHHHHHHcccCHhhCCCHHHHhc
Confidence 111 122333 445556999999999999999886
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=364.64 Aligned_cols=202 Identities=25% Similarity=0.406 Sum_probs=177.0
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.++|.+.+.||+|+||.||++... +++.||+|+++.... ...+.+.+|+++|++++|+||+++++++.+++..+||||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357999999999999999999964 789999999987633 345679999999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.+++|.+++.... .+++..+.+++.+++.||.|||+++ +|+||||||+||||+.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 999999999996543 4889999999999999999999842 7999999999999999999999999998755322
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchh
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMM 523 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~ 523 (662)
......|+..|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 12346799999999999999999999999999999999999999976543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=349.82 Aligned_cols=254 Identities=25% Similarity=0.365 Sum_probs=199.4
Q ss_pred CCccceeeccCceEEEEEEec-CC---CEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE-EEEE
Q 006083 318 FAKSNLLGQGGFGYVHKGVLP-NG---KEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQR-MLVY 391 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~-~lv~ 391 (662)
|...++||+|+||.||+|... ++ ..||||+++.... ...+.+.+|+++|++++|+||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 556789999999999999843 23 3799999976443 3457889999999999999999999999866655 9999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.+++|.+++... ...+++..++.++.|++.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 103 e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 103 PYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp CCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred ecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999753 34578999999999999999999999 99999999999999999999999999998654322
Q ss_pred C---ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 472 T---HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 472 ~---~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
. .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||........+..... .+...
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~--------~~~~~--- 247 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA--------QGRRL--- 247 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH--------TTCCC---
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh--------cCCCC---
Confidence 1 122345688999999999999999999999999999999996666543332222222111 11100
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
. ........ +.+++.+||+.||.+||++.+|++.|+..
T Consensus 248 --~-~~~~~~~~---l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 248 --P-QPEYCPDS---LYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp --C-CCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --C-CCccchHH---HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 11122333 44555699999999999999999999853
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=372.46 Aligned_cols=261 Identities=23% Similarity=0.310 Sum_probs=194.9
Q ss_pred CCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------CeEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAG------GQRML 389 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~~~~l 389 (662)
+|.+.++||+|+||.||+|+.. +|+.||||++.... +.+.+|+++|++|+|+|||+++++|... ..++|
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 5888999999999999999964 68999999997542 2245799999999999999999998542 23678
Q ss_pred EEEecCCcchhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC-CcEEEEeeccccc
Q 006083 390 VYEFVSNKTLEYHLHG--ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN-FEAMVADFGLAKL 466 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkl~DFGla~~ 466 (662)
||||+.+ +|.+++.. .....+++..++.++.||++||+|||++ +|+||||||+||||+.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999986 45544432 2344689999999999999999999998 99999999999999954 6789999999987
Q ss_pred cCCCCCccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh---HHHhh--
Q 006083 467 SNDNHTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL---GAALE-- 540 (662)
Q Consensus 467 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~---~~~~~-- 540 (662)
...... ....+||..|+|||++.+. .|+.++||||||||||||++|+.||......+.+.++.+.+- ...+.
T Consensus 207 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 207 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 654332 2346789999999998764 799999999999999999999999988766665555543210 00000
Q ss_pred cCccccccCcccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 541 DGIYDGLVDPRLEHN-----YVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 541 ~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...+..+....+... +......++.+++.+||+.||++||++.|+++
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 111111111111100 11111234555666999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=353.03 Aligned_cols=260 Identities=20% Similarity=0.253 Sum_probs=199.1
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEe--CCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-HRHLVSLVGYCIA--GGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~--~~~~~lv~ 391 (662)
++|++.+.||+|+||.||+|+. .+++.||||+++.. ..+.+.+|+++|++++ |+||+++++++.+ ....+|||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5699999999999999999984 57899999999753 3577899999999997 9999999999997 67889999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC-cEEEEeeccccccCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF-EAMVADFGLAKLSNDN 470 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkl~DFGla~~~~~~ 470 (662)
||+.+++|.+++.. +++..++.++.||++||+|||++ +|+||||||+||||+.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999998843 78899999999999999999999 999999999999999766 8999999999876543
Q ss_pred CCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCch-hhhHHHHHHHHH----hHHHhhcCcc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTM-MEDSLVEWARPL----LGAALEDGIY 544 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~-~~~~~~~~~~~~----~~~~~~~~~~ 544 (662)
.. .....|+..|+|||++.+ ..++.++||||||||||||++|+.||.... ..+.+..+.... +...+.....
T Consensus 185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 32 234678999999999887 679999999999999999999999995432 222222222111 0000000000
Q ss_pred --------------ccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 545 --------------DGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 545 --------------~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.......+...........+.+++.+||+.||++||++.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000011101112345556669999999999999999873
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=354.43 Aligned_cols=259 Identities=25% Similarity=0.347 Sum_probs=195.4
Q ss_pred HHHhCCCCccceeeccCceEEEEEEec----CCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 006083 312 AAATGGFAKSNLLGQGGFGYVHKGVLP----NGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGG 385 (662)
Q Consensus 312 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 385 (662)
....++|.+.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+++|++++|+||+++++++.+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 334567889999999999999999843 34589999997653 334567999999999999999999999998654
Q ss_pred -----eEEEEEEecCCcchhhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcE
Q 006083 386 -----QRMLVYEFVSNKTLEYHLHG----ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA 456 (662)
Q Consensus 386 -----~~~lv~E~~~~g~L~~~l~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 456 (662)
..++||||+.+++|.+++.. .....+++..+++++.||++||.|||++ +|+||||||+||||++++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence 35999999999999999842 2345689999999999999999999998 99999999999999999999
Q ss_pred EEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHH
Q 006083 457 MVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPL 534 (662)
Q Consensus 457 kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~ 534 (662)
||+|||+++....... .......|+..|+|||++.+..++.++|||||||+||||++ |+.||......+....+.
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--- 263 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL--- 263 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH---
Confidence 9999999987654322 12233567889999999999999999999999999999999 889997664433222111
Q ss_pred hHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 535 LGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 535 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.+... .... ... ..+.+++.+||+.||.+||++.+|++.|+.
T Consensus 264 ------~~~~~-----~~~~-~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 264 ------HGHRL-----KQPE-DCL---DELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp ------TTCCC-----CCBT-TCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ------cCCCC-----CCCc-ccc---HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11100 1111 122 345556669999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.22 Aligned_cols=254 Identities=30% Similarity=0.435 Sum_probs=191.6
Q ss_pred CCCccceeeccCceEEEEEEec--CC--CEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEE-eCCeEEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLP--NG--KEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCI-AGGQRMLV 390 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~--~g--~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~~lv 390 (662)
.|.+.++||+|+||.||+|.+. ++ ..||||.++... ....+.|.+|+++|++++|+||++++++|. .++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3677889999999999999853 22 368999987543 345678999999999999999999999875 45678999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+++|.+++.... ..+++..++.++.||++||+|||++ +|+||||||+||||++++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999996543 3578999999999999999999999 9999999999999999999999999999866433
Q ss_pred CCc---cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCcccc
Q 006083 471 HTH---VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 471 ~~~---~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
... ......|+..|+|||++.++.++.++|||||||+||||++ |..||......+..... ..+..
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~---------~~~~~-- 314 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---------LQGRR-- 314 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH---------HTTCC--
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH---------HcCCC--
Confidence 211 1233567889999999999999999999999999999999 67777655433222111 11110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.......+..+ .+++.+||+.||++||++.||++.|+..
T Consensus 315 ----~~~p~~~~~~l---~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 315 ----LLQPEYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp ----CCCCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11122334444 4455599999999999999999999853
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=350.41 Aligned_cols=254 Identities=30% Similarity=0.445 Sum_probs=198.8
Q ss_pred CCCCccceeeccCceEEEEEEecC----CCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEE-eCCeEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPN----GKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCI-AGGQRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~~l 389 (662)
..|.+.++||+|+||.||+|...+ +..||||.++.... ...+.+.+|+++|++++|+||++++++|. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 458888999999999999998532 23589999876433 34577999999999999999999999865 5668899
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||||+.+++|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+||||++++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999999999653 34578999999999999999999999 999999999999999999999999999986654
Q ss_pred CCC---ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 470 NHT---HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 470 ~~~---~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
... .......|+..|+|||++.+..++.++|||||||++|||++ |..||......+....+.. +..
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~---------~~~- 250 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---------GRR- 250 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT---------TCC-
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc---------CCC-
Confidence 321 11233567889999999999999999999999999999999 5555655433332221111 110
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.......+.. +.+++.+||+.||++||++.||++.|+.
T Consensus 251 -----~~~~~~~~~~---l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 251 -----LLQPEYCPDP---LYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp -----CCCCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCccCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111223344 4455569999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=362.47 Aligned_cols=273 Identities=21% Similarity=0.292 Sum_probs=200.7
Q ss_pred CHHHHHHHhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCch-----------hHHHHHHHHHHHHhcCCCCcc
Q 006083 307 TYDELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQ-----------GEREFSAEVEIISRVHHRHLV 375 (662)
Q Consensus 307 ~~~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-----------~~~~~~~E~~il~~l~HpnIv 375 (662)
.++++....++|.+.+.||+|+||.||+|...+|+.||||++...... ..+.+.+|+++|++++|+||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 357788889999999999999999999999888999999998643221 237789999999999999999
Q ss_pred eEEEEEEe-----CCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE
Q 006083 376 SLVGYCIA-----GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI 450 (662)
Q Consensus 376 ~l~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl 450 (662)
++++++.. ...+||||||+. |+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+||||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILL 167 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEE
Confidence 99999854 346899999998 5777777643 34589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccccccCCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHH
Q 006083 451 DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVE 529 (662)
Q Consensus 451 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~ 529 (662)
+.++.+||+|||+++...... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||......+.+..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999997554332 2244678999999999886 6799999999999999999999999987654443333
Q ss_pred HHHHH---------------hHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 530 WARPL---------------LGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 530 ~~~~~---------------~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+.... ....+.. .+.......+ ..........+.+++.+||+.||.+||++.|+++.
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRN-SLSNVPARAW-TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTT-CCCCCCCCCH-HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHh-hcccCChhhH-HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 22210 0000000 0000000000 00001112335566679999999999999999974
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=359.33 Aligned_cols=262 Identities=22% Similarity=0.296 Sum_probs=196.3
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAG------G 385 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~ 385 (662)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++|++++|+||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999995 479999999996542 23356789999999999999999999999865 3
Q ss_pred eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccc
Q 006083 386 QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
.+||||||+ +++|.+++... .+++..+..++.||++||.|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 569999999 89999998652 488999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh---HHHhhc
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL---GAALED 541 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~---~~~~~~ 541 (662)
..... ....+||..|+|||++.+ ..++.++||||||||||||++|+.||......+.+.......- ...+..
T Consensus 177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 76532 234678999999999887 6899999999999999999999999987655444433322110 000000
Q ss_pred -------Cc---cccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 542 -------GI---YDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 542 -------~~---~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.. +.......+.. ........+.+++.+||+.||++||++.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00 00000001110 011112334555569999999999999999973
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=347.98 Aligned_cols=245 Identities=21% Similarity=0.277 Sum_probs=197.5
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTG--SGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv 390 (662)
.++|++.+.||+|+||.||+|... +++.||||+++.. .......+.+|+.++.++ +|+||+++++++.+.+..+||
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 356999999999999999999965 7999999999864 234456788999999999 899999999999999999999
Q ss_pred EEecCCcchhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC----------------
Q 006083 391 YEFVSNKTLEYHLHGEN--RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD---------------- 452 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~---------------- 452 (662)
|||+.+++|.+++.... ...+++..++.++.||++||+|||++ +|+||||||+||||+.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999996532 24589999999999999999999999 9999999999999984
Q ss_pred ---CCcEEEEeeccccccCCCCCccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHH
Q 006083 453 ---NFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLV 528 (662)
Q Consensus 453 ---~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~ 528 (662)
+..+||+|||++....... ...|+..|+|||++.+. .++.++|||||||+||+|++|+.++..... ..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~ 238 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WH 238 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HH
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HH
Confidence 4489999999998765432 24589999999999865 566899999999999999999987754321 11
Q ss_pred HHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 529 EWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.+ ..+.+. .+.. ....+ +.+++.+||+.||.+||++.|+++.
T Consensus 239 ~~---------~~~~~~-----~~~~-~~~~~---~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 239 EI---------RQGRLP-----RIPQ-VLSQE---FTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HH---------HTTCCC-----CCSS-CCCHH---HHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HH---------HcCCCC-----CCCc-ccCHH---HHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11 111111 1111 22333 4455568999999999999998863
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=365.71 Aligned_cols=263 Identities=21% Similarity=0.268 Sum_probs=197.3
Q ss_pred HHHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe-------
Q 006083 312 AAATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA------- 383 (662)
Q Consensus 312 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------- 383 (662)
+...++|.+.+.||+|+||.||+|.. .+|+.||||++..... .+.+|+++|+.++|+|||+++++|..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44567899999999999999999985 5799999999975432 23479999999999999999999854
Q ss_pred -------------------------------CCeEEEEEEecCCcchhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHH
Q 006083 384 -------------------------------GGQRMLVYEFVSNKTLEYHLHG--ENRPVMDFATRVRIALGSAKGLAYL 430 (662)
Q Consensus 384 -------------------------------~~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yL 430 (662)
+...+|||||+. ++|.+.+.. .....+++..++.++.||++||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334889999998 477666642 2344689999999999999999999
Q ss_pred HhcCCCceeecCCccCcEEEC-CCCcEEEEeeccccccCCCCCccccccccCccccCcccccCC-CCCchHHHHHHHHHH
Q 006083 431 HEDCHPRIIHRDIKAANILID-DNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVML 508 (662)
Q Consensus 431 H~~~~~~ivHrDIkp~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl 508 (662)
|++ +|+||||||+||||+ +++.+||+|||+++....... .....|+..|+|||++.+. .++.++|||||||||
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 998 999999999999997 688999999999987654332 2346789999999998764 499999999999999
Q ss_pred HHHHhCCCCCCCchhhhHHHHHHHHHh----HHHhh-cCccccc-----cCccc---CCCCCHHHHHHHHHHHHHhcccC
Q 006083 509 LELITGRRPVDMTMMEDSLVEWARPLL----GAALE-DGIYDGL-----VDPRL---EHNYVPHEMARLVACGAASIRHS 575 (662)
Q Consensus 509 ~eLltG~~Pf~~~~~~~~~~~~~~~~~----~~~~~-~~~~~~~-----~d~~l---~~~~~~~~~~~l~~l~~~cl~~~ 575 (662)
|||++|+.||......+.+..+....- ..... ...+... ....+ .....+. .+.+++.+||+.|
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPS---LAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCH---HHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCH---HHHHHHHHHccCC
Confidence 999999999988766665554433210 00000 0011111 00110 0111233 3455566999999
Q ss_pred CCCCCCHHHHHH
Q 006083 576 ARKRPKMSQIVR 587 (662)
Q Consensus 576 p~~RPs~~evl~ 587 (662)
|++||++.|+++
T Consensus 310 P~~R~t~~e~l~ 321 (383)
T 3eb0_A 310 PDLRINPYEAMA 321 (383)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=387.76 Aligned_cols=246 Identities=28% Similarity=0.397 Sum_probs=195.2
Q ss_pred ceeeccCceEEEEEEe---cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVL---PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~---~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
+.||+|+||.||+|.+ ..++.||||+++... ....+++.+|+++|++|+|+|||+++++|.+ +.++||||||.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999964 356789999998643 2346789999999999999999999999964 568999999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC--cc
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT--HV 474 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~--~~ 474 (662)
|+|.++|... ..+++..++.|+.||+.||+|||++ +|||||||++||||++++.+||+|||+++....... ..
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 9999999654 3489999999999999999999999 999999999999999999999999999987654332 12
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
.....|+..|+|||++.+..++.++||||||||||||++ |+.||......+.+.. +..+.... +
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~---------i~~~~~~~-----~- 593 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM---------LEKGERMG-----C- 593 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---------HHTTCCCC-----C-
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---------HHcCCCCC-----C-
Confidence 233567889999999999999999999999999999998 9999987654332211 11111111 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
....+.+ +.+++..||+.||++||++.+|++.|+.
T Consensus 594 p~~~~~~---l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 594 PAGCPRE---MYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CTTCCHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1123344 4455568999999999999999999984
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=343.46 Aligned_cols=248 Identities=24% Similarity=0.380 Sum_probs=195.3
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
.++|.+.+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367999999999999999999965 78999999997532 23356789999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.+++|.+++.... .+++..++.++.|+++||.|||++ +|+|||||++||||+.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999996543 488999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccccccCccccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
. ......|+..|+|||++.+..+ +.++|||||||+||+|++|+.||+.....+.+... ..+...
T Consensus 165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~---- 229 (276)
T 2h6d_A 165 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI---------RGGVFY---- 229 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---------HHCCCC----
T ss_pred c--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh---------hcCccc----
Confidence 2 2234578999999999987765 68999999999999999999999765433222111 111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+ ......+ +.+++.+||+.||.+||++.||++.
T Consensus 230 --~-~~~~~~~---l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 --I-PEYLNRS---VATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --C-CTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --C-chhcCHH---HHHHHHHHccCChhhCCCHHHHHhC
Confidence 1 1112233 4455669999999999999999973
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=360.64 Aligned_cols=261 Identities=25% Similarity=0.379 Sum_probs=205.1
Q ss_pred CCCCccceeeccCceEEEEEEe-----cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--eEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-----PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGG--QRM 388 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~ 388 (662)
++|++.+.||+|+||.||++.. .+|+.||||+++.......+.+.+|+++|++++|+||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4588899999999999999983 368899999998876677788999999999999999999999987544 789
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
|||||+.+++|.+++.... ..+++..+++++.|+++||+|||++ +|+||||||+||||++++.+||+|||+++...
T Consensus 121 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999997543 3589999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCc--cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHH---------HHHHHhHH
Q 006083 469 DNHTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVE---------WARPLLGA 537 (662)
Q Consensus 469 ~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~---------~~~~~~~~ 537 (662)
..... ......|+..|+|||++.+..++.++|||||||+||||++|+.||...... +.+ +....+..
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH--HHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH--HHHhhccccchhhhHHHHHH
Confidence 43321 123346788899999999888999999999999999999999998643110 000 00000111
Q ss_pred HhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 538 ALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 538 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.+..+... .. ....+. .+.+++.+||+.||++||++.||++.|+.
T Consensus 275 ~~~~~~~~-----~~-~~~~~~---~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 275 LLKNNGRL-----PR-PDGCPD---EIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHHTTCCC-----CC-CTTCCH---HHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HhhcCCCC-----CC-CCcccH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11111100 11 112233 44555569999999999999999999885
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=355.66 Aligned_cols=257 Identities=25% Similarity=0.389 Sum_probs=199.9
Q ss_pred HHHHHHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEe---
Q 006083 309 DELAAATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYCIA--- 383 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--- 383 (662)
.++....++|++.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+++|+++ +|+||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 44445677899999999999999999995 478999999997643 3456789999999999 79999999999986
Q ss_pred ---CCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEe
Q 006083 384 ---GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVAD 460 (662)
Q Consensus 384 ---~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~D 460 (662)
.+..+|||||+.+++|.+++.......+++..++.++.||+.||.|||++ +|+|||||++||||+.++.+||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEee
Confidence 56899999999999999999765555689999999999999999999999 999999999999999999999999
Q ss_pred eccccccCCCCCccccccccCccccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh
Q 006083 461 FGLAKLSNDNHTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL 535 (662)
Q Consensus 461 FGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~ 535 (662)
||++........ ......|+..|+|||++. +..++.++|||||||+||+|++|+.||......+.+..+.
T Consensus 173 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---- 247 (326)
T 2x7f_A 173 FGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---- 247 (326)
T ss_dssp CTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----
T ss_pred CcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh----
Confidence 999986643221 223467999999999987 5678999999999999999999999997654333222111
Q ss_pred HHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 536 GAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 536 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..... .+........+ .+++.+||..||.+||++.|+++
T Consensus 248 -----~~~~~-----~~~~~~~~~~l---~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 -----RNPAP-----RLKSKKWSKKF---QSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -----HSCCC-----CCSCSCSCHHH---HHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -----cCccc-----cCCccccCHHH---HHHHHHHhccChhhCCCHHHHhh
Confidence 11111 11122223444 44555999999999999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=345.80 Aligned_cols=246 Identities=25% Similarity=0.357 Sum_probs=197.4
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIA----GGQRML 389 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~l 389 (662)
.|.+.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+++|++++|+||+++++++.. +..+++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 377788999999999999985 46889999999754 23445778999999999999999999999875 466899
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeecCCccCcEEEC-CCCcEEEEeeccccc
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR--IIHRDIKAANILID-DNFEAMVADFGLAKL 466 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--ivHrDIkp~NILl~-~~~~vkl~DFGla~~ 466 (662)
||||+.+++|.+++... ..+++..++.++.+++.||.|||++ + |+||||||+||||+ +++.+||+|||++..
T Consensus 107 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999653 3488999999999999999999998 7 99999999999997 789999999999976
Q ss_pred cCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccc
Q 006083 467 SNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 467 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
..... .....|+..|+|||++. +.++.++|||||||+||+|++|+.||........+.... ..+....
T Consensus 182 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~--------~~~~~~~ 249 (290)
T 1t4h_A 182 KRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV--------TSGVKPA 249 (290)
T ss_dssp CCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH--------TTTCCCG
T ss_pred ccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH--------hccCCcc
Confidence 54432 23467999999999887 469999999999999999999999997654333222111 1111111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+... ... .+.+++..||+.||.+||++.||++
T Consensus 250 ----~~~~~-~~~---~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 ----SFDKV-AIP---EVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----GGGGC-CCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----ccCCC-CCH---HHHHHHHHHccCChhhCCCHHHHhh
Confidence 11111 122 3555666999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=347.62 Aligned_cols=252 Identities=22% Similarity=0.312 Sum_probs=198.5
Q ss_pred HhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC----chhHHHHHHHHHHHHhcCCCCcceEEEEEE--eCCe
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS----GQGEREFSAEVEIISRVHHRHLVSLVGYCI--AGGQ 386 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~ 386 (662)
..++|.+.+.||+|+||.||++.. .+++.||||+++... ....+.+.+|+++|++++|+||+++++++. +.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 357899999999999999999995 478999999997532 234577999999999999999999999984 4568
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
.+|||||+.++ |.+++.......+++..++.++.||++||.|||++ +|+|||||++||||+.++.+||+|||++..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999887 66666655556789999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC-CccccccccCccccCcccccCCC--CCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCc
Q 006083 467 SNDNH-THVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGI 543 (662)
Q Consensus 467 ~~~~~-~~~~~~~~Gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (662)
..... ........|+..|+|||++.+.. ++.++|||||||+||||++|+.||......+.+..+ ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i---------~~~~ 229 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI---------GKGS 229 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---------HHCC
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH---------hcCC
Confidence 65322 22234467999999999987644 478999999999999999999999875433322211 1111
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 544 YDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 544 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+ .+... ... .+.+++.+||+.||.+||++.|+++.
T Consensus 230 ~------~~~~~-~~~---~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 Y------AIPGD-CGP---PLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp C------CCCSS-SCH---HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred C------CCCCc-cCH---HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 11111 223 34455569999999999999999964
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=347.37 Aligned_cols=258 Identities=20% Similarity=0.272 Sum_probs=198.4
Q ss_pred HhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEE-EeCCeEEEEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC-IAGGQRMLVY 391 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~~lv~ 391 (662)
..++|.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+|++++++++|+|++..++++ ..++..+|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457799999999999999999995 5789999998765422 23588899999999988777666554 6788899999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE---CCCCcEEEEeeccccccC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkl~DFGla~~~~ 468 (662)
||+ +++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||| ++++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 999999986433 3489999999999999999999999 99999999999999 788999999999998765
Q ss_pred CCCCc------cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhh---hHHHHHHHHHhHHHh
Q 006083 469 DNHTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMME---DSLVEWARPLLGAAL 539 (662)
Q Consensus 469 ~~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~---~~~~~~~~~~~~~~~ 539 (662)
..... ......|+..|+|||++.+..++.++|||||||+||||++|+.||...... +.+.......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 236 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS--- 236 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH---
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc---
Confidence 43221 123467999999999999999999999999999999999999999764322 112111111110
Q ss_pred hcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 540 EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 540 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
. ... .+... .+. .+.+++..||+.||++||++.+|++.|+..
T Consensus 237 -~-~~~-----~~~~~-~~~---~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 237 -T-PIE-----VLCKG-YPS---EFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp -S-CHH-----HHTTT-SCH---HHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred -c-hhh-----hhhcc-CCH---HHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 0 000 01111 123 455556699999999999999999998853
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=362.92 Aligned_cols=255 Identities=19% Similarity=0.299 Sum_probs=204.1
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCch-----------------hHHHHHHHHHHHHhcCCCCcceE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQ-----------------GEREFSAEVEIISRVHHRHLVSL 377 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-----------------~~~~~~~E~~il~~l~HpnIv~l 377 (662)
.++|.+.+.||+|+||.||+|.. +|+.||||++...... ..+.+.+|+++|++++|+||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46799999999999999999999 9999999999753211 11789999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCcchhhh------hccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCccCcEEE
Q 006083 378 VGYCIAGGQRMLVYEFVSNKTLEYH------LHGENRPVMDFATRVRIALGSAKGLAYLHE-DCHPRIIHRDIKAANILI 450 (662)
Q Consensus 378 ~~~~~~~~~~~lv~E~~~~g~L~~~------l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDIkp~NILl 450 (662)
++++.+.+..++||||+.+++|.++ +.......+++..++.++.|++.||.|||+ + +|+|||||++||||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999998 655445679999999999999999999999 7 99999999999999
Q ss_pred CCCCcEEEEeeccccccCCCCCccccccccCccccCcccccCC-CCCc-hHHHHHHHHHHHHHHhCCCCCCCchhhhHHH
Q 006083 451 DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSG-KLTE-KSDVFSFGVMLLELITGRRPVDMTMMEDSLV 528 (662)
Q Consensus 451 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~-~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~ 528 (662)
+.++.+||+|||++...... ......|+..|+|||++.+. .++. ++|||||||++|||++|+.||........+.
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 99999999999999876443 23446799999999999877 6666 9999999999999999999998765422222
Q ss_pred HHHHHHhHHHhhcCccccccCc------cc------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 529 EWARPLLGAALEDGIYDGLVDP------RL------EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~d~------~l------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
... ..+......+. .. ....... .+.+++.+||+.||.+||++.|+++
T Consensus 263 ~~i--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 263 NNI--------RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSN---EDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHH--------TSCCCCCCCSSSSSTTTTCC--------CCCH---HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH--------hccCcCCccchhhhhccccccccccchhhcCH---HHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 11111110000 00 0012233 3455556999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=375.41 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=201.6
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
.++|.+.++||+|+||.||+|... +++.||||+++.. .......+.+|+++|++++|+|||++++++.+.+.+|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 345999999999999999999954 7899999999643 2234678899999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC---CCCcEEEEeeccccccC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID---DNFEAMVADFGLAKLSN 468 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~---~~~~vkl~DFGla~~~~ 468 (662)
|||.+++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+||||+ .++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999886543 489999999999999999999999 999999999999995 46689999999998765
Q ss_pred CCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 469 DNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 469 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
... .....+||+.|+|||++.+ .|+.++||||||||||+|++|+.||......+.+..+.. +.+....
T Consensus 176 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---------~~~~~~~ 243 (486)
T 3mwu_A 176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET---------GKYAFDL 243 (486)
T ss_dssp CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------TCCCSCS
T ss_pred CCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------CCCCCCC
Confidence 432 2344679999999999875 699999999999999999999999987654443332211 1111100
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.... ....+ +.+++.+||+.||.+||++.|+++.
T Consensus 244 --~~~~-~~s~~---~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 --PQWR-TISDD---AKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp --GGGG-GSCHH---HHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred --cccC-CCCHH---HHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0001 12233 4455569999999999999999973
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=364.18 Aligned_cols=270 Identities=20% Similarity=0.300 Sum_probs=194.6
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHH--HHhcCCCCcceEEEEEEe-----CCeE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEI--ISRVHHRHLVSLVGYCIA-----GGQR 387 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~i--l~~l~HpnIv~l~~~~~~-----~~~~ 387 (662)
.++|++.++||+|+||.||+|.. +++.||||+++.. ....+..|.++ +..++|+||+++++++.. ...+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 35699999999999999999987 7899999999753 33444545555 445899999999986542 3367
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCceeecCCccCcEEECCCCcEEEEee
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC------HPRIIHRDIKAANILIDDNFEAMVADF 461 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------~~~ivHrDIkp~NILl~~~~~vkl~DF 461 (662)
+||||||.+|+|.+++.... .++..+++++.||++||+|||+++ ..+|+||||||+||||+.++.+||+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 89999999999999996543 488999999999999999999862 227999999999999999999999999
Q ss_pred ccccccCCCCC-------ccccccccCccccCcccccC-------CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHH
Q 006083 462 GLAKLSNDNHT-------HVSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSL 527 (662)
Q Consensus 462 Gla~~~~~~~~-------~~~~~~~Gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~ 527 (662)
|+++....... ......+||..|+|||++.+ ..++.++|||||||+||||++|+.||........+
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 99987653221 11234579999999999986 35667999999999999999998776432111000
Q ss_pred H-HHHH--------HHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 528 V-EWAR--------PLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 528 ~-~~~~--------~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
. .+.. ..+............+...+. ........+.+++.+||+.||++||++.||++.|+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCcccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 0 0000 000000111111111111111 11234445777777999999999999999999998643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=358.55 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=185.6
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEE--------eC
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-HRHLVSLVGYCI--------AG 384 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~--------~~ 384 (662)
..+|.+.++||+|+||.||+++. .+|+.||||++........+.+.+|+.+|+++. |+||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 45699999999999999999995 478999999998776666778999999999996 999999999994 34
Q ss_pred CeEEEEEEecCCcchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeecCCccCcEEECCCCcEEEEee
Q 006083 385 GQRMLVYEFVSNKTLEYHLHG-ENRPVMDFATRVRIALGSAKGLAYLHEDCHPR--IIHRDIKAANILIDDNFEAMVADF 461 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--ivHrDIkp~NILl~~~~~vkl~DF 461 (662)
..+++||||+. |+|.+++.. .....+++..+++++.||+.||+|||++ + |+||||||+||||++++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence 55899999995 788887754 2334689999999999999999999998 7 999999999999999999999999
Q ss_pred ccccccCCCCCc-----------cccccccCccccCcccc---cCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHH
Q 006083 462 GLAKLSNDNHTH-----------VSTRVMGTFGYLAPEYA---SSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSL 527 (662)
Q Consensus 462 Gla~~~~~~~~~-----------~~~~~~Gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~ 527 (662)
|+++........ ......|+..|+|||++ .+..++.++||||||||||||++|+.||........+
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 262 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence 999876543221 11135689999999998 5667899999999999999999999999654221110
Q ss_pred HHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 528 VEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.+.+.. .. ....... +.+++.+||+.||.+||++.||++.|+..
T Consensus 263 -------------~~~~~~----~~-~~~~~~~---~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 263 -------------NGKYSI----PP-HDTQYTV---FHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp ----------------CCC----CT-TCCSSGG---GHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred -------------cCcccC----Cc-ccccchH---HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000000 00 1111222 44556699999999999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=346.01 Aligned_cols=256 Identities=20% Similarity=0.276 Sum_probs=201.5
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEE-EeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC-IAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~~lv~E 392 (662)
.++|.+.+.||+|+||.||+|+. .+|+.||||++..... .+.+.+|++++++++|++++..+.++ ..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46799999999999999999995 5889999999876533 34688999999999988866655554 67888899999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE---CCCCcEEEEeeccccccCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkl~DFGla~~~~~ 469 (662)
|+ +++|.+++.... ..+++..+++++.|++.||+|||++ +|+||||||+|||| ++++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 999999996433 3589999999999999999999999 99999999999999 4788999999999987654
Q ss_pred CCCc------cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchh---hhHHHHHHHHHhHHHhh
Q 006083 470 NHTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMM---EDSLVEWARPLLGAALE 540 (662)
Q Consensus 470 ~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~---~~~~~~~~~~~~~~~~~ 540 (662)
.... ......|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+.+..+....+..
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--- 237 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST--- 237 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS---
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC---
Confidence 3321 12446799999999999999999999999999999999999999976422 12222221111100
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 541 DGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 541 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.. ..+... .+. .+.+++.+||+.||.+||++.+|++.|+.
T Consensus 238 --~~-----~~~~~~-~~~---~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 238 --PI-----EVLCKG-YPS---EFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp --CH-----HHHTTT-SCH---HHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred --ch-----HHHHhh-CCH---HHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 00 001111 223 35556669999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=376.41 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=203.9
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|.+.++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|+|||++++++.+.+.+|+||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 45999999999999999999964 78999999997542 345678999999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE---CCCCcEEEEeeccccccC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkl~DFGla~~~~ 468 (662)
|||.+++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||| +.++.+||+|||+++...
T Consensus 106 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 106 EVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp CCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999986543 489999999999999999999999 99999999999999 567899999999998765
Q ss_pred CCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 469 DNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 469 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
.... ....+||+.|+|||++.+ .|+.++||||||||||+|++|+.||......+.+..+. .+.+....
T Consensus 181 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---------~~~~~~~~ 248 (484)
T 3nyv_A 181 ASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE---------KGKYTFEL 248 (484)
T ss_dssp CCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---------HCCCCCCS
T ss_pred cccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---------cCCCCCCC
Confidence 4432 344679999999999875 79999999999999999999999998765444333221 11111100
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. . .. ....+ +.+++.+||+.||.+||++.|+++
T Consensus 249 ~-~-~~-~~s~~---~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 249 P-Q-WK-KVSES---AKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp G-G-GG-GSCHH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c-c-cc-cCCHH---HHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 0 01 12333 445556999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=365.97 Aligned_cols=264 Identities=22% Similarity=0.298 Sum_probs=197.2
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------eEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGG------QRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------~~~l 389 (662)
.+|.+.++||+|+||.||+|+...+..||+|++..... ...+|+++|+.++|+|||+++++|...+ .++|
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 45999999999999999999987777799998865422 2347999999999999999999986543 3789
Q ss_pred EEEecCCcchhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC-CCCcEEEEeecccccc
Q 006083 390 VYEFVSNKTLEYHLH-GENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID-DNFEAMVADFGLAKLS 467 (662)
Q Consensus 390 v~E~~~~g~L~~~l~-~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vkl~DFGla~~~ 467 (662)
|||||.++.+....+ ......+++..++.++.||++||+|||++ +|+||||||+||||+ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999998765554432 12344689999999999999999999999 999999999999999 7999999999999876
Q ss_pred CCCCCccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhH------HHhh
Q 006083 468 NDNHTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLG------AALE 540 (662)
Q Consensus 468 ~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~------~~~~ 540 (662)
..... ....+||..|+|||++.+. .|+.++||||||||||||++|+.||......+.+.++.+.+-. ..+.
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 54332 2346789999999998764 5999999999999999999999999887666655554432100 0000
Q ss_pred cC----ccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 541 DG----IYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 541 ~~----~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.. .+..+....+...+.......+.+++.+||+.||.+||++.|+++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 0111000000000001111345556669999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=373.22 Aligned_cols=257 Identities=19% Similarity=0.262 Sum_probs=203.2
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCC-CCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHH-RHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lv~E 392 (662)
.++|.+.++||+|+||.||+|+. .+++.||||+++.... ...+.+|+++++.|+| .+|+.+..++.+++..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46799999999999999999995 5799999999876533 2358899999999986 666677777788999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE---CCCCcEEEEeeccccccCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI---DDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkl~DFGla~~~~~ 469 (662)
|+ +++|.+++.... ..+++..++.|+.||+.||+|||++ +|||||||++|||| ++++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 999999996433 3589999999999999999999999 99999999999999 5789999999999987654
Q ss_pred CCCc------cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhh---HHHHHHHHHhHHHhh
Q 006083 470 NHTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMED---SLVEWARPLLGAALE 540 (662)
Q Consensus 470 ~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~---~~~~~~~~~~~~~~~ 540 (662)
.... .....+||..|+|||++.+..++.++||||||||||||++|+.||....... .+..+....+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---- 234 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA---- 234 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH----
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc----
Confidence 3321 1235789999999999999999999999999999999999999997653322 12211111110
Q ss_pred cCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 541 DGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 541 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
..+. .+.. ..+. ++.+++..||+.+|++||++.+|++.|+..
T Consensus 235 -~~~~-----~l~~-~~p~---~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 235 -TSIE-----ALCR-GYPT---EFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp -SCHH-----HHHT-TSCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred -ccHH-----HHhc-CCcH---HHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0000 0111 1123 455566699999999999999999988743
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=376.18 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=197.4
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
++|.+.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+++|++++|+|||+++++|.+.+.+|||||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 35999999999999999999954 78999999997643 2335678999999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC---CCcEEEEeeccccccCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD---NFEAMVADFGLAKLSND 469 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~DFGla~~~~~ 469 (662)
||.+|+|.+++.... .+++..++.++.||++||.|||++ +|+||||||+||||+. ++.+||+|||++.....
T Consensus 117 ~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 117 CYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999886543 488999999999999999999999 9999999999999976 45599999999987654
Q ss_pred CCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
.. .....+||..|+|||++. +.|+.++||||||||||+|++|+.||......+.+..+.. +.+.. .
T Consensus 192 ~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---------~~~~~--~ 257 (494)
T 3lij_A 192 QK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK---------GKYTF--D 257 (494)
T ss_dssp TB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------TCCCC--C
T ss_pred Cc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------CCCCC--C
Confidence 32 234467999999999986 5799999999999999999999999987655443322211 11110 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.... .....++ .+++.+||+.||.+||++.|+++
T Consensus 258 ~~~~-~~~s~~~---~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 SPEW-KNVSEGA---KDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp SGGG-TTSCHHH---HHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhc-ccCCHHH---HHHHHHHCCCChhhCccHHHHhc
Confidence 0111 1123344 44555999999999999999984
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=369.40 Aligned_cols=240 Identities=13% Similarity=0.178 Sum_probs=187.3
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC---CchhHHHHHHHH---HHHHhcCCCCcceEE-------EEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG---SGQGEREFSAEV---EIISRVHHRHLVSLV-------GYC 381 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~---~il~~l~HpnIv~l~-------~~~ 381 (662)
++|.+.+.||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+ ++|++++|+|||+++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 5688899999999999999995 57999999999743 334567899999 455556899999988 776
Q ss_pred EeCCe-----------------EEEEEEecCCcchhhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCcee
Q 006083 382 IAGGQ-----------------RMLVYEFVSNKTLEYHLHGENR-----PVMDFATRVRIALGSAKGLAYLHEDCHPRII 439 (662)
Q Consensus 382 ~~~~~-----------------~~lv~E~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iv 439 (662)
.+.+. .||||||+ +|+|.+++..... ..+++..+++|+.||++||+|||++ +|+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 228 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 228 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 65542 78999999 6899999964321 2233588889999999999999999 999
Q ss_pred ecCCccCcEEECCCCcEEEEeeccccccCCCCCccccccccCccccCcccccCC-----------CCCchHHHHHHHHHH
Q 006083 440 HRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSG-----------KLTEKSDVFSFGVML 508 (662)
Q Consensus 440 HrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-----------~~~~~sDvwSlGvvl 508 (662)
||||||+||||+.++.+||+|||+++.... .....+| ..|+|||++.+. .++.++|||||||+|
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 999999999999999999999999986443 2344678 999999999887 899999999999999
Q ss_pred HHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 509 LELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 509 ~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
|||++|+.||......+. +..+... ....+.+ +.+++.+||+.||++||++.|+++
T Consensus 304 ~elltg~~Pf~~~~~~~~-----------------~~~~~~~---~~~~~~~---~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 304 YWIWCADLPITKDAALGG-----------------SEWIFRS---CKNIPQP---VRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHSSCCC------CC-----------------SGGGGSS---CCCCCHH---HHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHCCCCCcccccccc-----------------hhhhhhh---ccCCCHH---HHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999965432111 1111110 0122344 444555999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=346.81 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=202.7
Q ss_pred HhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc---------hhHHHHHHHHHHHHhcC-CCCcceEEEEEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG---------QGEREFSAEVEIISRVH-HRHLVSLVGYCI 382 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~~E~~il~~l~-HpnIv~l~~~~~ 382 (662)
..++|.+.+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+++|+++. |+||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4567999999999999999999964 689999999976431 22356889999999995 999999999999
Q ss_pred eCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeec
Q 006083 383 AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFG 462 (662)
Q Consensus 383 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFG 462 (662)
+++..+|||||+.+++|.+++... ..+++..++.++.||+.||.|||++ +|+|||||++||||+.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence 999999999999999999999653 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccCccccCccccc------CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhH
Q 006083 463 LAKLSNDNHTHVSTRVMGTFGYLAPEYAS------SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLG 536 (662)
Q Consensus 463 la~~~~~~~~~~~~~~~Gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 536 (662)
++........ .....|+..|+|||++. ...++.++|||||||+||||++|+.||......+.+....
T Consensus 170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----- 242 (298)
T 1phk_A 170 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM----- 242 (298)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----
T ss_pred chhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh-----
Confidence 9987654322 23467899999999885 4568899999999999999999999997654333222111
Q ss_pred HHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 537 AALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 537 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+.+... .... . ... ..+.+++.+||+.||++||++.|+++
T Consensus 243 ----~~~~~~~-~~~~-~-~~~---~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 ----SGNYQFG-SPEW-D-DYS---DTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ----HTCCCCC-TTTG-G-GSC---HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ----cCCcccC-cccc-c-ccC---HHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111100 0000 0 112 34555666999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=351.25 Aligned_cols=252 Identities=24% Similarity=0.340 Sum_probs=196.1
Q ss_pred HhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc--------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG--------QGEREFSAEVEIISRVHHRHLVSLVGYCIAG 384 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 384 (662)
..++|.+.+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+++|++++|+||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 345699999999999999999985 4688999999975421 1234588999999999999999999999765
Q ss_pred CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCc---EEEEee
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE---AMVADF 461 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vkl~DF 461 (662)
+ .|+||||+.+++|.+++... ..+++..++.++.||++||.|||++ +|+|||||++||||+.++. +||+||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred c-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 5 89999999999999998643 3589999999999999999999998 9999999999999987654 999999
Q ss_pred ccccccCCCCCccccccccCccccCccccc---CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHH
Q 006083 462 GLAKLSNDNHTHVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAA 538 (662)
Q Consensus 462 Gla~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 538 (662)
|+++...... ......|+..|+|||++. ...++.++|||||||+||+|++|+.||........+.....
T Consensus 162 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------ 233 (322)
T 2ycf_A 162 GHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT------ 233 (322)
T ss_dssp TTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH------
T ss_pred ccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH------
Confidence 9998765432 234467999999999974 56789999999999999999999999976543322222111
Q ss_pred hhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 539 LEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 539 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+.+.. ...+... .. ..+.+++.+||+.||++||++.|+++
T Consensus 234 --~~~~~~--~~~~~~~-~~---~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 --SGKYNF--IPEVWAE-VS---EKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --HTCCCC--CHHHHTT-SC---HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --hCcccc--Cchhhhh-cC---HHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111110 0001111 12 34556666999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=358.22 Aligned_cols=264 Identities=21% Similarity=0.245 Sum_probs=193.3
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGG------ 385 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------ 385 (662)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+++|+.++|+||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46799999999999999999985 478999999997642 234567889999999999999999999997654
Q ss_pred eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccc
Q 006083 386 QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
..|||||||.+ +|.+++.. .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 78999999975 67777743 378999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH-----------
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL----------- 534 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~----------- 534 (662)
...... .....+||..|+|||++.+..++.++||||||||||||++|+.||......+.+.......
T Consensus 176 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 176 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred cccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 765332 2344689999999999999999999999999999999999999998765444333222110
Q ss_pred ---hHHHhhcC-cc-----ccccCcccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 535 ---LGAALEDG-IY-----DGLVDPRLEHNY---VPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 535 ---~~~~~~~~-~~-----~~~~d~~l~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+...+... .+ ..+....+.... .......+.+++.+||+.||++||++.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000 00 000000000000 01123456677779999999999999999973
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=352.99 Aligned_cols=263 Identities=24% Similarity=0.378 Sum_probs=185.9
Q ss_pred HHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 313 AATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 313 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
...++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++|++++|+||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3457899999999999999999984 478999999987543 23456788999999999999999999999999999999
Q ss_pred EEecCCcchhhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 391 YEFVSNKTLEYHLHG------ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
|||+.+++|.+++.. .....+++..++.++.||++||.|||++ +|+|||||++||||+.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999998853 1344689999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCC----ccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHh
Q 006083 465 KLSNDNHT----HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAAL 539 (662)
Q Consensus 465 ~~~~~~~~----~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 539 (662)
........ .......|+..|+|||++.+ ..++.++|||||||+||||++|+.||......+.+.......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----- 243 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND----- 243 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS-----
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC-----
Confidence 76643221 11234679999999999875 568999999999999999999999998764433222111100
Q ss_pred hcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 540 EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 540 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.........+..+...+ .. .+.+++.+||+.||.+||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~-~~---~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKY-GK---SFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCCCCC-CH---HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhhhhh-hH---HHHHHHHHHccCChhhCcCHHHHhh
Confidence 00000011111111222 23 3445556999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=374.89 Aligned_cols=251 Identities=25% Similarity=0.316 Sum_probs=200.7
Q ss_pred HhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc-------------hhHHHHHHHHHHHHhcCCCCcceEEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-------------QGEREFSAEVEIISRVHHRHLVSLVG 379 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------------~~~~~~~~E~~il~~l~HpnIv~l~~ 379 (662)
..++|.+.+.||+|+||.||+|... +++.||||+++.... ...+.+.+|+++|++++|+|||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4567999999999999999999954 688999999976421 23567899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC---cE
Q 006083 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF---EA 456 (662)
Q Consensus 380 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~---~v 456 (662)
+|.+.+.+|||||||.||+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999999886543 489999999999999999999999 999999999999998765 69
Q ss_pred EEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhH
Q 006083 457 MVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLG 536 (662)
Q Consensus 457 kl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 536 (662)
||+|||++....... .....+||+.|+|||++. +.++.++||||||||||+|++|+.||......+.+.....
T Consensus 189 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---- 261 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK---- 261 (504)
T ss_dssp EECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----
T ss_pred EEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc----
Confidence 999999998765432 234467999999999987 5799999999999999999999999987654443322211
Q ss_pred HHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 537 AALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 537 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+.+.. ...... ....+ +.+++.+||+.||.+||++.|+++
T Consensus 262 -----~~~~~--~~~~~~-~~s~~---~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 262 -----GKYYF--DFNDWK-NISDE---AKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -----CCCCC--CHHHHT-TSCHH---HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----CCCCC--CccccC-CCCHH---HHHHHHHHcCCChhHCCCHHHHhc
Confidence 11110 000001 12233 445556999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=351.18 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=197.5
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
.++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+++|++++|+||+++++++.+++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 456999999999999999999965 6899999999876666678899999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.+++|.+++.... ..+++..++.++.+++.||.|||++ +|+|||||++||||+.++.+||+|||++....... .
T Consensus 98 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 172 (302)
T 2j7t_A 98 CPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q 172 (302)
T ss_dssp CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence 99999999886432 3489999999999999999999998 99999999999999999999999999976432111 1
Q ss_pred cccccccCccccCcccc-----cCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 474 VSTRVMGTFGYLAPEYA-----SSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~-----~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
......|+..|+|||++ .+..++.++|||||||+||+|++|+.||......+.+..+.. ......
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------~~~~~~- 242 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---------SDPPTL- 242 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---------SCCCCC-
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc---------cCCccc-
Confidence 12335789999999998 367789999999999999999999999987654333222211 111100
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
........ .+.+++.+||+.||++||++.||++
T Consensus 243 ---~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 ---LTPSKWSV---EFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ---SSGGGSCH---HHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ---CCccccCH---HHHHHHHHHcccChhhCCCHHHHhc
Confidence 01111223 3455566999999999999998876
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=355.06 Aligned_cols=209 Identities=23% Similarity=0.262 Sum_probs=177.7
Q ss_pred HhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-CC-----CcceEEEEEEeCCe
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-HR-----HLVSLVGYCIAGGQ 386 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-Hp-----nIv~l~~~~~~~~~ 386 (662)
..++|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+..|+++++.++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4568999999999999999999854 6889999999753 234567888999999885 55 49999999999999
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC--CCCcEEEEeeccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID--DNFEAMVADFGLA 464 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~--~~~~vkl~DFGla 464 (662)
.||||||+. ++|.+++.......+++..+++++.|++.||.|||.+ ..+||||||||+||||+ +++.+||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999996 5999999776555689999999999999999999952 12899999999999994 4788999999999
Q ss_pred cccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHH
Q 006083 465 KLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVE 529 (662)
Q Consensus 465 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~ 529 (662)
+..... ....+||..|+|||++.+..++.++||||||||||||++|+.||......+.+..
T Consensus 209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 269 (382)
T 2vx3_A 209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK 269 (382)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 876543 2346789999999999999999999999999999999999999987765544433
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=387.79 Aligned_cols=249 Identities=24% Similarity=0.300 Sum_probs=203.3
Q ss_pred HhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecC---CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTG---SGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 388 (662)
..++|++.++||+|+||.||+++.. +++.||||++++. .....+.+..|+++|..+ +|+||+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4567999999999999999999954 6889999999753 123346788899999988 6999999999999999999
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
|||||+.||+|.++|+... .+++..++.++.||+.||+|||++ +||||||||+||||+.++.+||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999997543 489999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 469 DNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 469 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
.... .....+||+.|||||++.+..|+.++||||||||||||++|+.||......+.+..+. .. .+
T Consensus 494 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~--------~~-~~---- 559 (674)
T 3pfq_A 494 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--------EH-NV---- 559 (674)
T ss_dssp CTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------SS-CC----
T ss_pred cCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH--------hC-CC----
Confidence 3322 2345789999999999999999999999999999999999999998765443332221 11 10
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKM-----SQIVR 587 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~evl~ 587 (662)
.+. .....++ .+++..||+.||.+|+++ .||++
T Consensus 560 --~~p-~~~s~~~---~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 --AYP-KSMSKEA---VAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --CCC-TTSCHHH---HHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --CCC-ccCCHHH---HHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111 1223444 445558999999999997 56653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=359.11 Aligned_cols=259 Identities=22% Similarity=0.285 Sum_probs=184.4
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAG------G 385 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~ 385 (662)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++|++++|+||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46799999999999999999984 578999999997542 23456788999999999999999999998754 5
Q ss_pred eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccc
Q 006083 386 QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
..|+||||+ +++|.+++.. ..+++..++.++.||++||.|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999998 7899988854 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh---HHHhhc
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL---GAALED 541 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~---~~~~~~ 541 (662)
..... ....+||..|+|||++.+ ..++.++||||||||||||++|+.||......+.+..+.+.+- ...+..
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 75432 234689999999999887 6799999999999999999999999987765544443322110 000000
Q ss_pred -------CccccccC---cc---cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 542 -------GIYDGLVD---PR---LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 542 -------~~~~~~~d---~~---l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
..+..+.. .. +.. ... ..+.+++.+||+.||.+||++.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFI-GAN---PLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTT-TCC---HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCC-CCC---HHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000000 00 000 112 234556669999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.30 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=198.6
Q ss_pred HhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
..++|++.+.||+|+||.||+|... +|+.||||++.... ..+.+.+|+++|++++|+||+++++++.+.+..|+|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567999999999999999999864 68999999998643 34678999999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
|+.+++|.+++... ...+++..++.++.+++.||.|||++ +|+||||||+||||+.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 99999999998632 23589999999999999999999998 999999999999999999999999999987654322
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
......|+..|+|||++.+..++.++|||||||+||+|++|+.||......+.+... .......+..
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~~~~~--- 247 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI---------PTNPPPTFRK--- 247 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---------HHSCCCCCSS---
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---------hcCCCcccCC---
Confidence 223467899999999999989999999999999999999999999765432222111 0111000000
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...... .+.+++.+||+.||.+||++.++++
T Consensus 248 -~~~~~~---~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 -PELWSD---NFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -GGGSCH---HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -cccCCH---HHHHHHHHHccCChhhCcCHHHHHh
Confidence 011123 4555666999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=349.71 Aligned_cols=264 Identities=20% Similarity=0.290 Sum_probs=205.4
Q ss_pred hCCCCccceeeccCceEEEEEEe--cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCC------CcceEEEEEEeCCe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL--PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHR------HLVSLVGYCIAGGQ 386 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~Hp------nIv~l~~~~~~~~~ 386 (662)
.++|++.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+++++.++|+ +|+++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 45799999999999999999985 36889999999753 24456788999999998765 49999999999999
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC--------------
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-------------- 452 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-------------- 452 (662)
.+|||||+ +++|.+++.......+++..+++++.||++||+|||++ +|+||||||+||||+.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 89999999776656789999999999999999999999 9999999999999987
Q ss_pred -----CCcEEEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHH
Q 006083 453 -----NFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSL 527 (662)
Q Consensus 453 -----~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~ 527 (662)
++.+||+|||+++..... ....+||..|+|||++.+..++.++|||||||+||||++|+.||......+.+
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 668999999999875432 23467899999999999999999999999999999999999999876544433
Q ss_pred HHHHHHH---hHHHhhcCcccccc---------------------Ccc-cCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006083 528 VEWARPL---LGAALEDGIYDGLV---------------------DPR-LEHNYVPHEMARLVACGAASIRHSARKRPKM 582 (662)
Q Consensus 528 ~~~~~~~---~~~~~~~~~~~~~~---------------------d~~-l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 582 (662)
..+.... ....+......... ... -...........+.+++.+||+.||.+||++
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 2221110 00000000000000 000 0001122344567778889999999999999
Q ss_pred HHHHH
Q 006083 583 SQIVR 587 (662)
Q Consensus 583 ~evl~ 587 (662)
.||++
T Consensus 324 ~ell~ 328 (339)
T 1z57_A 324 REALK 328 (339)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=348.11 Aligned_cols=265 Identities=22% Similarity=0.288 Sum_probs=202.0
Q ss_pred HhCCCCccceeeccCceEEEEEEe--cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhc---CCCCcceEEEEEE----
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVL--PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRV---HHRHLVSLVGYCI---- 382 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~--~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~~~~~---- 382 (662)
..++|.+.+.||+|+||.||+|.. .+|+.||||+++.... .....+.+|+++++++ +|+||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 456799999999999999999996 4688999999975322 1223566788777766 8999999999987
Q ss_pred -eCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEee
Q 006083 383 -AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADF 461 (662)
Q Consensus 383 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DF 461 (662)
.....++||||+. ++|.+++.......+++..++.++.|+++||.|||++ +|+|||||++||||+.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecC
Confidence 5577899999998 6999998766655689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhH---HH
Q 006083 462 GLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLG---AA 538 (662)
Q Consensus 462 Gla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~---~~ 538 (662)
|+++...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||......+.+.......-. ..
T Consensus 165 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 165 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 9998654322 234467899999999999999999999999999999999999999876554444333221100 00
Q ss_pred hhc------CccccccCcccC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 539 LED------GIYDGLVDPRLE--HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 539 ~~~------~~~~~~~d~~l~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+.. ..+.......+. ......+ +.+++.+||+.||++||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDEL---GKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHH---HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccccchhhhcccCcchhhhccccCCHH---HHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 000000000000 0112333 445556999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=353.78 Aligned_cols=263 Identities=22% Similarity=0.308 Sum_probs=202.0
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAG-----GQR 387 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~ 387 (662)
.++|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+++|++++|+||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457999999999999999999854 788999999976433 3347789999999999999999999999754 478
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
|+||||+. ++|.+++... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999997 5898888643 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--cccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhH---HHhhc
Q 006083 468 NDNHTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLG---AALED 541 (662)
Q Consensus 468 ~~~~~~--~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~---~~~~~ 541 (662)
...... .....+||..|+|||++.+ ..++.++|||||||+||||++|+.||......+.+.......-. ..+..
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 543221 1244689999999998764 45899999999999999999999999877655544433221100 00000
Q ss_pred -------CccccccC------cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 542 -------GIYDGLVD------PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 542 -------~~~~~~~d------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.....+.. ..+... .. ..+.+++.+||+.||++||++.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPN-AD---SKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTT-SC---HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCC-CC---HHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 000111 12 345566669999999999999999963
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=347.20 Aligned_cols=262 Identities=20% Similarity=0.268 Sum_probs=194.7
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEE-----------
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCI----------- 382 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~----------- 382 (662)
.++|.+.+.||+|+||.||+|... +|+.||||++........+.+.+|+++|++++|+||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467999999999999999999965 58999999998776666788999999999999999999999873
Q ss_pred ---eCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC-CCCcEEE
Q 006083 383 ---AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID-DNFEAMV 458 (662)
Q Consensus 383 ---~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vkl 458 (662)
+.+..|+||||+. ++|.+++.. ..+++..++.++.|+++||+|||++ +|+||||||+||||+ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence 4478899999997 699998853 3488999999999999999999999 999999999999997 5779999
Q ss_pred EeeccccccCCCCC--ccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh
Q 006083 459 ADFGLAKLSNDNHT--HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL 535 (662)
Q Consensus 459 ~DFGla~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~ 535 (662)
+|||+++....... .......|+..|+|||++.+ ..++.++|||||||+||||++|+.||......+.+........
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999987643221 12234568999999998865 6799999999999999999999999987654443332221100
Q ss_pred ------HHHhhcCccccccCcccC---------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 536 ------GAALEDGIYDGLVDPRLE---------HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 536 ------~~~~~~~~~~~~~d~~l~---------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...+.. .+...+...+. ..... ..+.+++.+||+.||++||++.|+++
T Consensus 243 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 243 VVHEEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGIS---REAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCHHHHHHHHT-TSCHHHHHHTTSCCCCHHHHSTTCC---HHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCchhhhhhhhh-cCcccccccccCCCCChhHhcchhh---HHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000000 00000000000 01122 34555666999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=348.02 Aligned_cols=256 Identities=27% Similarity=0.386 Sum_probs=195.0
Q ss_pred CCCCccceeeccCceEEEEEEec--CCC--EEEEEEeecC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP--NGK--EVAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~--~g~--~vavK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 388 (662)
++|++.+.||+|+||.||+|.+. +++ .||||+++.. .....+.+.+|+++|++++|+||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 46999999999999999999843 333 6899999754 2345678999999999999999999999998765 88
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
+||||+.+++|.+++.... ..+++..+++++.|+++||.|||++ +|+||||||+||||+.++.+||+|||++....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 9999999999999986532 3488999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc--cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 469 DNHTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 469 ~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
..... ......|+..|+|||++.+..++.++|||||||+||+|++ |+.||......+.+.... .... .
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~--------~~~~-~ 243 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID--------KEGE-R 243 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH--------TSCC-C
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHH--------ccCC-C
Confidence 44322 2234567889999999998889999999999999999999 999997765433222111 1110 0
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCC
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDS 593 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 593 (662)
. .. ....+. .+.+++.+||+.||.+||++.+|++.|+...
T Consensus 244 ~----~~-~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 244 L----PR-PEDCPQ---DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp C----CC-CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C----CC-CcCcCH---HHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 0 01 112233 4455556999999999999999999998543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=362.84 Aligned_cols=249 Identities=12% Similarity=0.074 Sum_probs=178.3
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhc--CCCCcceEE-------EEEEe
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG---QGEREFSAEVEIISRV--HHRHLVSLV-------GYCIA 383 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l--~HpnIv~l~-------~~~~~ 383 (662)
.|.+.+.||+|+||.||+|.. .+|+.||||+++.... ...+.+.+|+++++.| +|+||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 488899999999999999995 4789999999987643 2345678886555555 699988755 55543
Q ss_pred C-----------------CeEEEEEEecCCcchhhhhccCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCceee
Q 006083 384 G-----------------GQRMLVYEFVSNKTLEYHLHGENRPVMDFATR------VRIALGSAKGLAYLHEDCHPRIIH 440 (662)
Q Consensus 384 ~-----------------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~------~~i~~~ia~aL~yLH~~~~~~ivH 440 (662)
. ..+|||||||. ++|.+++..... .+.+..+ +.++.||++||+|||++ +|||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivH 217 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSK---GLVH 217 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCcc
Confidence 3 33899999998 899999975322 2344455 67789999999999999 9999
Q ss_pred cCCccCcEEECCCCcEEEEeeccccccCCCCCccccccccCccccCcccccC--CCCCchHHHHHHHHHHHHHHhCCCCC
Q 006083 441 RDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPV 518 (662)
Q Consensus 441 rDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~eLltG~~Pf 518 (662)
|||||+||||+.++.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||+||||++|+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998765321 23567799999999987 67999999999999999999999999
Q ss_pred CCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 519 DMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH---NYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
........ ..| ............+.. ...+.. +.+++.+||+.||++||++.|+++
T Consensus 294 ~~~~~~~~-~~~---------~~~~~~~~~~~~~~~~~~~~~~~~---~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIK-GSW---------KRPSLRVPGTDSLAFGSCTPLPDF---VKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCT-TCC---------CBCCTTSCCCCSCCCTTSSCCCHH---HHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCcCcccc-cch---------hhhhhhhccccccchhhccCCCHH---HHHHHHHHcCCChhhCCCHHHHhc
Confidence 76532110 000 000000011111111 122344 445555999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=343.39 Aligned_cols=251 Identities=23% Similarity=0.347 Sum_probs=184.3
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch-h-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ-G-EREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
.++|++.+.||+|+||.||++.. .+|+.||||+++..... . .+.+.++..+++.++|+||+++++++.+++..+|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46799999999999999999995 57899999999765322 2 234555666688889999999999999999999999
Q ss_pred EecCCcchhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 392 EFVSNKTLEYHLHG--ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 392 E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
||+.+ +|.+++.. .....+++..+++++.|++.||+|||+++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99974 77776643 23446899999999999999999999864 799999999999999999999999999987654
Q ss_pred CCCccccccccCccccCcccc----cCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhh-hHHHHHHHHHhHHHhhcCcc
Q 006083 470 NHTHVSTRVMGTFGYLAPEYA----SSGKLTEKSDVFSFGVMLLELITGRRPVDMTMME-DSLVEWARPLLGAALEDGIY 544 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 544 (662)
... .....|+..|+|||++ .+..++.++|||||||++|||++|+.||...... ..+... ......
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~~~~ 232 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--------VEEPSP 232 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH--------HHSCCC
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH--------hccCCC
Confidence 322 2335799999999996 5667899999999999999999999999754322 111111 111110
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 545 DGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 545 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+....... .+.+++.+||+.||++||++.|+++
T Consensus 233 ------~~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 ------QLPADKFSA---EFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ------CCCTTTSCH---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------CcccccCCH---HHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111112233 3455566999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=361.33 Aligned_cols=200 Identities=23% Similarity=0.353 Sum_probs=154.8
Q ss_pred CCCc-cceeeccCceEEEEEEec---CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEEE
Q 006083 317 GFAK-SNLLGQGGFGYVHKGVLP---NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA--GGQRMLV 390 (662)
Q Consensus 317 ~~~~-~~~iG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lv 390 (662)
.|++ +++||+|+||.||+|+.. +++.||||+++... ....+.+|+++|++|+|+|||+++++|.. +..+|||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3665 568999999999999954 57899999997543 23568899999999999999999999954 7789999
Q ss_pred EEecCCcchhhhhcc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE----CCCCcEEEE
Q 006083 391 YEFVSNKTLEYHLHG-------ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI----DDNFEAMVA 459 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~-------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkl~ 459 (662)
|||+.+ +|.+++.. .....+++..++.|+.||+.||+|||++ +|+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999975 67666642 1223489999999999999999999999 89999999999999 678899999
Q ss_pred eeccccccCCCCC--ccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCch
Q 006083 460 DFGLAKLSNDNHT--HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTM 522 (662)
Q Consensus 460 DFGla~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~ 522 (662)
|||+++....... ......+||..|+|||++.+ ..++.++||||||||||||++|+.||....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999987654321 12344789999999999987 459999999999999999999999997543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=353.58 Aligned_cols=274 Identities=20% Similarity=0.222 Sum_probs=193.8
Q ss_pred HHHHHHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-
Q 006083 309 DELAAATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQ- 386 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~- 386 (662)
.+.....++|.+.+.||+|+||.||+|+. .+|+.||||++.... .....+.+|++.++.++|+||++++++|...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 55667788999999999999999999996 468999999987643 233456788899999999999999999975433
Q ss_pred ------EEEEEEecCCcchhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCceeecCCccCcEEECC-CCcE
Q 006083 387 ------RMLVYEFVSNKTLEYHLH-GENRPVMDFATRVRIALGSAKGLAYLH--EDCHPRIIHRDIKAANILIDD-NFEA 456 (662)
Q Consensus 387 ------~~lv~E~~~~g~L~~~l~-~~~~~~l~~~~~~~i~~~ia~aL~yLH--~~~~~~ivHrDIkp~NILl~~-~~~v 456 (662)
.++||||+.++.+..+.. ......+++..++.++.|++.||.||| ++ +|+||||||+||||+. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 789999998754433221 123446889999999999999999999 77 9999999999999996 8999
Q ss_pred EEEeeccccccCCCCCccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh
Q 006083 457 MVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL 535 (662)
Q Consensus 457 kl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~ 535 (662)
||+|||+++....... .....||..|+|||++.+. .++.++||||||||||||++|+.||......+.+..+.+...
T Consensus 172 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp EECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 9999999987654332 2346789999999998764 489999999999999999999999988765555544433110
Q ss_pred H------HHhhcC-ccccccC------cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 536 G------AALEDG-IYDGLVD------PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 536 ~------~~~~~~-~~~~~~d------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
. ..+... ......+ ..+...........+.+++.+||+.||.+||++.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 000000 0000000 000011111123456666779999999999999999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=350.19 Aligned_cols=246 Identities=24% Similarity=0.327 Sum_probs=190.5
Q ss_pred HHHHHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch------hHHHHHHHHHHHHhc----CCCCcceEE
Q 006083 310 ELAAATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ------GEREFSAEVEIISRV----HHRHLVSLV 378 (662)
Q Consensus 310 ei~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~E~~il~~l----~HpnIv~l~ 378 (662)
+.....++|.+.+.||+|+||.||+|+. .+++.||||+++..... ....+.+|++++.++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3344567899999999999999999985 57899999999765332 223466799999999 899999999
Q ss_pred EEEEeCCeEEEEEEe-cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC-CCCcE
Q 006083 379 GYCIAGGQRMLVYEF-VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID-DNFEA 456 (662)
Q Consensus 379 ~~~~~~~~~~lv~E~-~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~-~~~~v 456 (662)
+++.+.+..++|||| +.+++|.+++.... .+++..+++++.||++||+|||++ +|+|||||++||||+ +++.+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 999999999999999 78999999996533 489999999999999999999999 999999999999999 88999
Q ss_pred EEEeeccccccCCCCCccccccccCccccCcccccCCCCC-chHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh
Q 006083 457 MVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL 535 (662)
Q Consensus 457 kl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~ 535 (662)
||+|||+++...... .....|+..|+|||++.+..+. .++|||||||+||||++|+.||..... +.
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~------- 246 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---IL------- 246 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---HH-------
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH---Hh-------
Confidence 999999998765432 2346799999999999876664 599999999999999999999975321 00
Q ss_pred HHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 536 GAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 536 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
. ... .+... ... .+.+++.+||+.||++||++.|+++.
T Consensus 247 ----~-~~~------~~~~~-~~~---~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 ----E-AEL------HFPAH-VSP---DCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----H-TCC------CCCTT-SCH---HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----h-hcc------CCccc-CCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000 11111 223 34556669999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=351.37 Aligned_cols=252 Identities=21% Similarity=0.259 Sum_probs=171.8
Q ss_pred hCCCCcc-ceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeEE
Q 006083 315 TGGFAKS-NLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA----GGQRM 388 (662)
Q Consensus 315 ~~~~~~~-~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~ 388 (662)
.++|.+. ++||+|+||.||+|... +|+.||||++... .....+....++.++|+||+++++++.. +..++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4568885 46999999999999965 7899999999753 2222333444667799999999999876 45689
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC---CCcEEEEeecccc
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD---NFEAMVADFGLAK 465 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~DFGla~ 465 (662)
||||||.+|+|.+++.......+++..+++++.||+.||.|||++ +|+|||||++||||+. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 999999999999999876666799999999999999999999999 9999999999999976 4559999999998
Q ss_pred ccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
...... ....+|+..|+|||++.+..++.++|||||||+||+|++|+.||...........+.... ..+.+.
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~ 251 (336)
T 3fhr_A 180 ETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI-----RLGQYG 251 (336)
T ss_dssp EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------C
T ss_pred eccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh-----hccccc
Confidence 665332 234678999999999988899999999999999999999999997654322111111100 000000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...........+ +.+++.+||+.||.+||++.|+++
T Consensus 252 ---~~~~~~~~~~~~---~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 252 ---FPNPEWSEVSED---AKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---CCTTTSTTCCHH---HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---cCchhhccCCHH---HHHHHHHHCCCChhHCcCHHHHhc
Confidence 000011122334 445556999999999999999997
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=341.49 Aligned_cols=253 Identities=25% Similarity=0.323 Sum_probs=203.0
Q ss_pred HHHhCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 006083 312 AAATGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 312 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 388 (662)
....++|.+.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+++|++++|+||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344567999999999999999999964 78999999997542 345678999999999999999999999999999999
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC---CCcEEEEeecccc
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD---NFEAMVADFGLAK 465 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~DFGla~ 465 (662)
+||||+.+++|.+++.... .+++..+++++.||+.||.|||++ +|+|||||++||||+. ++.+||+|||++.
T Consensus 98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999999886433 489999999999999999999999 9999999999999975 4479999999998
Q ss_pred ccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
....... .....|+..|+|||++.+ .++.++|||||||+||+|++|+.||......+.+..+ ..+.+.
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~ 240 (287)
T 2wei_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV---------ETGKYA 240 (287)
T ss_dssp TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---------HHCCCC
T ss_pred eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH---------HcCCCC
Confidence 7654322 234568999999999875 5999999999999999999999999876543322211 111111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
... ... ..... .+.+++.+||+.||++||++.|+++
T Consensus 241 ~~~--~~~-~~~~~---~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FDL--PQW-RTISD---DAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCS--GGG-TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCc--hhh-hhcCH---HHHHHHHHHcccChhhCcCHHHHhc
Confidence 100 000 11233 3455566999999999999999997
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=352.95 Aligned_cols=261 Identities=20% Similarity=0.304 Sum_probs=196.7
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE----
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQR---- 387 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~---- 387 (662)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++.... ...+.+.+|+++|++++|+||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46799999999999999999985 4789999999976432 3356789999999999999999999999876654
Q ss_pred --EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccc
Q 006083 388 --MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 388 --~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
|+||||+. ++|.+++.. .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 688777732 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh---HHHhh-
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL---GAALE- 540 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~---~~~~~- 540 (662)
..... ....+||..|+|||++.+ ..++.++|||||||+||+|++|+.||......+.+.......- .....
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 65432 234678999999999887 6899999999999999999999999987665544433322110 00000
Q ss_pred ------cCccccccCcccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 541 ------DGIYDGLVDPRLEHN---YVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 541 ------~~~~~~~~d~~l~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
...+..+... .... ........+.+++.+||+.||++||++.|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQT-PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CSCHHHHHHHHHSCCC-CCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhccCCC-cchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000000 0000 000112345566669999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=341.56 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=191.0
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----------
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA---------- 383 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~---------- 383 (662)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.. ....+.+.+|+++|++++|+||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45699999999999999999995 47899999999753 2345678999999999999999999998865
Q ss_pred ---CCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEe
Q 006083 384 ---GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVAD 460 (662)
Q Consensus 384 ---~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~D 460 (662)
.+..|+||||+.+++|.+++.... ..+++..+++++.|+++||+|||++ +|+|||||++||||+.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence 457899999999999999997533 3578899999999999999999999 999999999999999999999999
Q ss_pred eccccccCCCC-------------CccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhH
Q 006083 461 FGLAKLSNDNH-------------THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDS 526 (662)
Q Consensus 461 FGla~~~~~~~-------------~~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~ 526 (662)
||++....... ........|+..|+|||++.+. .++.++|||||||+||||++ ||........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99998654321 1122346799999999999864 79999999999999999998 5543322111
Q ss_pred HHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 527 LVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+... +..... .+...+.......+.+++.+||+.||.+||++.|+++.
T Consensus 237 ~~~~--------~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 237 ILKK--------LRSVSI------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHH--------HHSTTC------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHh--------cccccc------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111 011110 11111222222345556669999999999999999873
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=347.94 Aligned_cols=262 Identities=20% Similarity=0.295 Sum_probs=199.1
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAG-----GQR 387 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~ 387 (662)
.++|.+.+.||+|+||.||+|... +|+.||||+++.... .....+.+|+++|++++|+||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467999999999999999999954 689999999975433 3356788999999999999999999998754 778
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
|+||||+. ++|.+++... .+++..++.++.|+++||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999997 6898888652 489999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCc---------cccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHH
Q 006083 468 NDNHTH---------VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGA 537 (662)
Q Consensus 468 ~~~~~~---------~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 537 (662)
...... .....+||..|+|||++.+ ..++.++|||||||+||||++|+.||......+.+...... +..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~ 241 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI-IGT 241 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH-hCC
Confidence 532211 1123578999999998764 67999999999999999999999999876544433322111 000
Q ss_pred HhhcCcccccc---------------Cc---ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 538 ALEDGIYDGLV---------------DP---RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 538 ~~~~~~~~~~~---------------d~---~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.........+. .. .+.. ... ..+.+++.+||+.||++||++.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFP-RVN---PKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHST-TSC---HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcc-cCC---HHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000 00 0001 122 334556669999999999999999973
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=350.98 Aligned_cols=257 Identities=21% Similarity=0.321 Sum_probs=196.5
Q ss_pred HHHHHHhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcC--CCCcceEEEEEEeC
Q 006083 309 DELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVH--HRHLVSLVGYCIAG 384 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~ 384 (662)
..+....++|.+.+.||+|+||.||++...+++.||||+++... ....+.+.+|+++|++++ |+||+++++++.++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 33444556799999999999999999998889999999997543 334578899999999997 59999999999999
Q ss_pred CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
+..+|||| +.+++|.+++.... .+++..++.++.|+++||.|||++ +|+|||||++||||++ +.+||+|||++
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred CEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccc
Confidence 99999999 67899999997543 588999999999999999999999 9999999999999974 79999999999
Q ss_pred cccCCCCCc-cccccccCccccCcccccC-----------CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHH
Q 006083 465 KLSNDNHTH-VSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWAR 532 (662)
Q Consensus 465 ~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~ 532 (662)
+........ ......|+..|+|||++.+ ..++.++|||||||+||||++|+.||......... + .
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~-~ 250 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--L-H 250 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--H-H
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH--H-H
Confidence 876543221 2234679999999999875 47889999999999999999999999754322111 0 1
Q ss_pred HHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 533 PLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 533 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
..+.... ...+. ..... .+.+++.+||+.||++||++.|+++.
T Consensus 251 ----~~~~~~~-----~~~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 251 ----AIIDPNH-----EIEFP-DIPEK---DLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ----HHHCTTS-----CCCCC-CCSCH---HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----HHHhccc-----ccCCc-ccchH---HHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1111111 00111 11233 44555569999999999999999963
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=347.17 Aligned_cols=264 Identities=21% Similarity=0.284 Sum_probs=202.1
Q ss_pred hCCCCccceeeccCceEEEEEEec-CC-CEEEEEEeecCCchhHHHHHHHHHHHHhcCCCC------cceEEEEEEeCCe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NG-KEVAVKSLKTGSGQGEREFSAEVEIISRVHHRH------LVSLVGYCIAGGQ 386 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~~E~~il~~l~Hpn------Iv~l~~~~~~~~~ 386 (662)
.++|.+.+.||+|+||.||+|... ++ +.||||+++.. ....+.+.+|+++|++++|.| ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 467999999999999999999853 44 68999999753 344567889999999997655 8999999999999
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEE----------------
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILI---------------- 450 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl---------------- 450 (662)
.+|||||+ +++|.+++.......+++..++.++.||++||+|||++ +|+||||||+||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 66666667655555689999999999999999999998 99999999999999
Q ss_pred ---CCCCcEEEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHH
Q 006083 451 ---DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSL 527 (662)
Q Consensus 451 ---~~~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~ 527 (662)
+.++.+||+|||+++...... ...+||..|+|||++.+..++.++|||||||+||||++|+.||......+.+
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 567899999999998654322 3467999999999999999999999999999999999999999876544433
Q ss_pred HHHHHHH---hHHHhhcCccccc-cCcc---------------------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006083 528 VEWARPL---LGAALEDGIYDGL-VDPR---------------------LEHNYVPHEMARLVACGAASIRHSARKRPKM 582 (662)
Q Consensus 528 ~~~~~~~---~~~~~~~~~~~~~-~d~~---------------------l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 582 (662)
....... ....+........ .... ............+.+++.+||+.||.+||++
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 3221110 0000000000000 0000 0001122334467777889999999999999
Q ss_pred HHHHH
Q 006083 583 SQIVR 587 (662)
Q Consensus 583 ~evl~ 587 (662)
.|+++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=352.93 Aligned_cols=265 Identities=22% Similarity=0.314 Sum_probs=201.8
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-----------CCCcceEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-----------HRHLVSLVGYCIA 383 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~l~~~~~~ 383 (662)
++|.+.+.||+|+||.||+|+. .+++.||||+++.. ....+.+.+|+++|++++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5699999999999999999995 57899999999753 234567889999999886 8999999999886
Q ss_pred CC----eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC------CC
Q 006083 384 GG----QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID------DN 453 (662)
Q Consensus 384 ~~----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~------~~ 453 (662)
.+ .+++||||+ +++|.+++.......+++..+++++.||+.||+|||+++ +|+||||||+||||+ ++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCc
Confidence 54 789999999 999999997765566899999999999999999999964 799999999999994 44
Q ss_pred CcEEEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchh------hhHH
Q 006083 454 FEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMM------EDSL 527 (662)
Q Consensus 454 ~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~------~~~~ 527 (662)
+.+||+|||+++..... ....+||..|+|||++.+..++.++||||||||||||++|+.||..... .+.+
T Consensus 175 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 58999999999876532 2345789999999999999999999999999999999999999975431 1111
Q ss_pred HHHHHHH---hHHHhhc-----------CccccccCcc---------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 006083 528 VEWARPL---LGAALED-----------GIYDGLVDPR---------LEHNYVPHEMARLVACGAASIRHSARKRPKMSQ 584 (662)
Q Consensus 528 ~~~~~~~---~~~~~~~-----------~~~~~~~d~~---------l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e 584 (662)
......+ -...+.. +.+..+.... -...+.......+.+++.+||+.||++||++.|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 1111100 0000000 0011100000 011233556677788888999999999999999
Q ss_pred HHHH
Q 006083 585 IVRA 588 (662)
Q Consensus 585 vl~~ 588 (662)
|++.
T Consensus 331 ll~h 334 (373)
T 1q8y_A 331 LVNH 334 (373)
T ss_dssp HHTC
T ss_pred HhhC
Confidence 9973
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=377.61 Aligned_cols=255 Identities=24% Similarity=0.383 Sum_probs=201.7
Q ss_pred HhCCCCccceeeccCceEEEEEEec----CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 006083 314 ATGGFAKSNLLGQGGFGYVHKGVLP----NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 314 ~~~~~~~~~~iG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 388 (662)
..++|.+.+.||+|+||.||+|.+. .+..||||+++.... ...+.+.+|+.+|++++|+||+++++++. ++..|
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 3467899999999999999999853 246799999876533 34477999999999999999999999985 45689
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
|||||+.+|+|.+++.... ..+++..++.++.|+++||.|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 467 lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999999997543 3589999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 469 DNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 469 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
...........|+..|+|||++.+..++.++|||||||+||||++ |+.||......+.+..+. .+...
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~---------~~~~~-- 611 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE---------NGERL-- 611 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---------HTCCC--
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---------cCCCC--
Confidence 543333344567889999999998999999999999999999997 999998765443222111 11100
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.+. ...+. .+.+++.+||+.||.+||++.||++.|+.
T Consensus 612 ---~~~-~~~~~---~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 612 ---PMP-PNCPP---TLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp ---CCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCC-ccccH---HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 011 12233 44455569999999999999999999885
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.94 Aligned_cols=260 Identities=23% Similarity=0.356 Sum_probs=200.3
Q ss_pred HHHHhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 006083 311 LAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 311 i~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 388 (662)
+....++|.+.+.||+|+||.||+|...+ .||||+++... ....+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 33345779999999999999999998643 49999987542 233456889999999999999999999999999999
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
+||||+.+++|.+++.... ..+++..+++++.|+++||+|||++ +|+|||||++||||+ ++.+||+|||++....
T Consensus 106 iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp EECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred EEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 9999999999999996543 3588999999999999999999999 999999999999998 6799999999987653
Q ss_pred CCC----CccccccccCccccCcccccC---------CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh
Q 006083 469 DNH----THVSTRVMGTFGYLAPEYASS---------GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL 535 (662)
Q Consensus 469 ~~~----~~~~~~~~Gt~~y~aPE~~~~---------~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~ 535 (662)
... ........|+..|+|||++.+ ..++.++|||||||+||||++|+.||......+.+...
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----- 255 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM----- 255 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH-----
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh-----
Confidence 211 112233568999999999874 45889999999999999999999999876543322111
Q ss_pred HHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCCC
Q 006083 536 GAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSS 594 (662)
Q Consensus 536 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 594 (662)
..+... .+.....+.+ +.+++..||+.||++||++.+|++.|+....
T Consensus 256 ----~~~~~~-----~~~~~~~~~~---l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 256 ----GTGMKP-----NLSQIGMGKE---ISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp ----HTTCCC-----CCCCSSCCTT---HHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred ----ccCCCC-----CCCcCCCCHH---HHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 111111 1111112233 4455569999999999999999999997543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=344.27 Aligned_cols=261 Identities=20% Similarity=0.309 Sum_probs=195.8
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-----
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQ----- 386 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~----- 386 (662)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.+|++++|+||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 35799999999999999999985 4789999999976432 234678999999999999999999999987653
Q ss_pred -EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccc
Q 006083 387 -RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 387 -~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
+|+||||+. ++|.+++.. .+++..++.++.||++||.|||++ +|+||||||+||||++++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 688877742 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh--HHHhhcC
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL--GAALEDG 542 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~ 542 (662)
..... .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||......+.+.......- ...+...
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 65432 234678999999999886 6789999999999999999999999987654443333222100 0000000
Q ss_pred --------ccccc---cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 543 --------IYDGL---VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 543 --------~~~~~---~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.+..+ ....+. .........+.+++.+||+.||++||++.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 000110 0111122344555669999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.16 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=174.7
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc-hhHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-QGEREFSAEVE-IISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
++|.+.+.||+|+||.||+|... +|+.||||+++.... .....+..|+. +++.++|+||+++++++.+.+..+||||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 56888999999999999999964 789999999986533 33445666666 6777899999999999999999999999
Q ss_pred ecCCcchhhhhc---cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 393 FVSNKTLEYHLH---GENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 393 ~~~~g~L~~~l~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
|+.+ +|.+++. ......+++..+.+++.++++||.|||+++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9986 7766664 223456899999999999999999999963 699999999999999999999999999987654
Q ss_pred CCCccccccccCccccCcccc----cCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 470 NHTHVSTRVMGTFGYLAPEYA----SSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
... .....|+..|+|||++ .+..++.++|||||||+||||++|+.||........ .. . ....
T Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~--------~-~~~~ 244 (327)
T 3aln_A 179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---QL--------T-QVVK 244 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------C-CCCC
T ss_pred ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---HH--------H-HHhc
Confidence 322 2334799999999998 456789999999999999999999999975421100 00 0 0000
Q ss_pred cccCcccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GLVDPRLEH---NYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~~d~~l~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. ....+.. ..... .+.+++.+||+.||.+||++.||++
T Consensus 245 ~-~~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 G-DPPQLSNSEEREFSP---SFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp S-CCCCCCCCSSCCCCH---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C-CCCCCCCcccccCCH---HHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0 0011111 11233 4455556999999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=355.34 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=187.1
Q ss_pred CCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+++|+++ +|+|||++++++.+++..|||||||.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 45667899999999998776668999999999753 345678999999987 89999999999999999999999995
Q ss_pred CcchhhhhccCCCCC-----CCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC-------------CCcEE
Q 006083 396 NKTLEYHLHGENRPV-----MDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-------------NFEAM 457 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~-----l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-------------~~~vk 457 (662)
|+|.+++....... ..+..++.++.||+.||+|||++ +|+||||||+||||+. ++.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999997543211 12334678999999999999998 9999999999999965 45899
Q ss_pred EEeeccccccCCCCCc---cccccccCccccCcccccC-------CCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhH
Q 006083 458 VADFGLAKLSNDNHTH---VSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDS 526 (662)
Q Consensus 458 l~DFGla~~~~~~~~~---~~~~~~Gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~ 526 (662)
|+|||+++........ .....+||..|+|||++.+ ..++.++||||||||||||++ |+.||......+
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 9999999877654321 1234689999999999975 678999999999999999999 999997653222
Q ss_pred HHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 527 LVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..+.. +.+.. ..+...........+.+++.+||+.||.+||++.||++
T Consensus 248 -~~i~~---------~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 -SNIIR---------GIFSL---DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -HHHHH---------TCCCC---CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHhc---------CCCCc---ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11111 11110 01111122344456677778999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=348.51 Aligned_cols=247 Identities=22% Similarity=0.319 Sum_probs=198.4
Q ss_pred HHHHHHhCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch------hHHHHHHHHHHHHhcC--CCCcceEEE
Q 006083 309 DELAAATGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ------GEREFSAEVEIISRVH--HRHLVSLVG 379 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~E~~il~~l~--HpnIv~l~~ 379 (662)
++.....++|.+.+.||+|+||.||+|+. .+++.||||+++..... ..+.+.+|+++|++++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 34445567899999999999999999984 57899999999764221 2245778999999996 599999999
Q ss_pred EEEeCCeEEEEEEecCC-cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC-CCCcEE
Q 006083 380 YCIAGGQRMLVYEFVSN-KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID-DNFEAM 457 (662)
Q Consensus 380 ~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vk 457 (662)
++.+.+..++||||+.+ ++|.+++... ..+++..++.++.||++||+|||++ +|+|||||++||||+ +++.+|
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEE
Confidence 99999999999999986 8999998653 3589999999999999999999998 999999999999999 789999
Q ss_pred EEeeccccccCCCCCccccccccCccccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhH
Q 006083 458 VADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLG 536 (662)
Q Consensus 458 l~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 536 (662)
|+|||+++...... .....|+..|+|||++.+..+ +.++|||||||+||||++|+.||..... +.
T Consensus 191 L~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~-------- 256 (320)
T 3a99_A 191 LIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---II-------- 256 (320)
T ss_dssp ECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---HH--------
T ss_pred EeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---hh--------
Confidence 99999998765432 234679999999999987665 6889999999999999999999965321 00
Q ss_pred HHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 537 AALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 537 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
.... .+. .....+ +.+++.+||+.||++||++.||++.
T Consensus 257 ---~~~~-------~~~-~~~~~~---~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 257 ---RGQV-------FFR-QRVSSE---CQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ---HCCC-------CCS-SCCCHH---HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---cccc-------ccc-ccCCHH---HHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 011 112333 4455569999999999999999873
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=336.33 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=177.9
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQG--EREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
.++|++.+.||+|+||.||+|... +|+.||||+++...... .+.+.++..+++.++|+||+++++++.+++..+|||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356888999999999999999964 78999999998654322 234555666788889999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+ ++.+..++.. ....+++..+++++.++++||.|||+++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 104 e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999 5555555432 2345899999999999999999999832 79999999999999999999999999997664432
Q ss_pred CccccccccCccccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccc
Q 006083 472 THVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
......|+..|+|||++. ...++.++|||||||+||||++|+.||.......... ...+ .. ....
T Consensus 180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~----~~-~~~~ 249 (318)
T 2dyl_A 180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL---TKVL----QE-EPPL 249 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH---HHHH----HS-CCCC
T ss_pred --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHH---HHHh----cc-CCCC
Confidence 223457999999999984 5678999999999999999999999997643221111 1111 11 1000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+ ........+ +.+++.+||+.||.+||++.||++
T Consensus 250 ~----~~~~~~~~~---l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 L----PGHMGFSGD---FQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C----CSSSCCCHH---HHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C----CccCCCCHH---HHHHHHHHccCChhHCcCHHHHhh
Confidence 0 001112334 445556999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.60 Aligned_cols=248 Identities=25% Similarity=0.328 Sum_probs=184.7
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
.+|...++||+|+||.||.....+|+.||||++..... ..+.+|+++|+++ +|+|||++++++.+.+..|||||||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 45888999999999996655556899999999976432 2357899999999 7999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC-----CCcEEEEeeccccccCC
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-----NFEAMVADFGLAKLSND 469 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-----~~~vkl~DFGla~~~~~ 469 (662)
. |+|.+++..... .+.+..++.++.||++||+|||++ +|+||||||+||||+. +..+||+|||+++....
T Consensus 101 ~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 101 A-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp S-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred C-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 6 699998875443 234456678999999999999999 9999999999999943 34688999999987654
Q ss_pred CCC--ccccccccCccccCccccc---CCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCc
Q 006083 470 NHT--HVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGI 543 (662)
Q Consensus 470 ~~~--~~~~~~~Gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (662)
... ......+||..|+|||++. ...++.++||||||||||||++ |+.||.......... . .....
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-----~----~~~~~ 246 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-----L----LGACS 246 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-----H----TTCCC
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-----H----hccCC
Confidence 321 1234467999999999997 4567889999999999999999 999986543221110 0 00001
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 544 YDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 544 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.. .+.. .......+.+++.+||+.||.+||++.||++
T Consensus 247 ~~-----~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 LD-----CLHP--EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CT-----TSCT--TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc-----ccCc--cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 10 0110 1122233556677999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=325.92 Aligned_cols=232 Identities=12% Similarity=0.120 Sum_probs=181.1
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
.++|.+.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|++++++++|+||+++++++.+++..|||
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 356999999999999999999964 589999999986533 2347789999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
|||+.|++|.+++... ....++++|+.|+++||+|||++ +|+||||||+||||++++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 9999999999999532 35567899999999999999999 99999999999999999999997443
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
|++ .++.++|||||||+||||++|+.||......+.+.... ..........
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---------~~~~~~~~~~ 225 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---------RDTAGQPIEP 225 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---------BCTTSCBCCH
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---------HHhccCCCCh
Confidence 333 37899999999999999999999997654321110000 0000000000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCCC
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGDSS 594 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 594 (662)
.......+.+ +.+++.+||+.||++| ++.|+++.|+....
T Consensus 226 ~~~~~~~~~~---l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 226 ADIDRDIPFQ---ISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HHHCTTSCHH---HHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred hhcccCCCHH---HHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 0001122333 4455569999999999 99999999986443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=364.97 Aligned_cols=237 Identities=21% Similarity=0.333 Sum_probs=190.2
Q ss_pred hCCCCccceeeccCceEEEEEEec--CCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-----
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP--NGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQ----- 386 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~--~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~----- 386 (662)
.++|.+.+.||+|+||.||++.+. +|+.||||++.... ......+.+|+++|++++|+|||+++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999964 68999999987543 3445678999999999999999999999987655
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
.||||||+.|++|.+++.. .+++..++.|+.||++||.|||++ +||||||||+||||+++ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999987744 589999999999999999999999 99999999999999986 899999999987
Q ss_pred cCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccc
Q 006083 467 SNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 467 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
.... ...+||+.|+|||++.++ ++.++||||||||||+|++|..+|....... .
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------------~--- 284 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------L--- 284 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------C---
T ss_pred cccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-----------------c---
Confidence 6543 346799999999998764 5899999999999999999998876432110 0
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhh
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPK-MSQIVRALE 590 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~evl~~L~ 590 (662)
. ...........+..++.+||+.||++||+ +.++...|.
T Consensus 285 -~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 285 -P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp -C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 00000111234566777999999999995 555555554
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=362.67 Aligned_cols=262 Identities=26% Similarity=0.360 Sum_probs=198.2
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe------CCeE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG-SGQGEREFSAEVEIISRVHHRHLVSLVGYCIA------GGQR 387 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------~~~~ 387 (662)
++|.+.+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|+++|++++|+||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999985 46899999999765 33445779999999999999999999998765 6778
Q ss_pred EEEEEecCCcchhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCc---EEEEeecc
Q 006083 388 MLVYEFVSNKTLEYHLHGEN-RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFE---AMVADFGL 463 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vkl~DFGl 463 (662)
|||||||.|++|.+++.... ...+++..++.|+.+++.||+|||++ +|+||||||+||||+.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 33588899999999999999999998 9999999999999987654 99999999
Q ss_pred ccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCc
Q 006083 464 AKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGI 543 (662)
Q Consensus 464 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (662)
+........ .....|+..|+|||++.+..++.++|||||||+||||++|+.||...... ..|.............
T Consensus 171 a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~---~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 171 AKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP---VQWHGKVREKSNEHIV 245 (676)
T ss_dssp CCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH---HHSSTTCC------CC
T ss_pred ccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch---hhhhhhhhcccchhhh
Confidence 987654432 24468999999999999999999999999999999999999999764321 2232221111111111
Q ss_pred cccccCc--------ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 006083 544 YDGLVDP--------RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQI 585 (662)
Q Consensus 544 ~~~~~d~--------~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 585 (662)
....... .............+.+++..||+.||++||++.|+
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 1111111 01112233344566677779999999999998773
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=320.87 Aligned_cols=225 Identities=20% Similarity=0.267 Sum_probs=177.4
Q ss_pred CCCCcc-ceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHH-HhcCCCCcceEEEEEEe----CCeEE
Q 006083 316 GGFAKS-NLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEII-SRVHHRHLVSLVGYCIA----GGQRM 388 (662)
Q Consensus 316 ~~~~~~-~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il-~~l~HpnIv~l~~~~~~----~~~~~ 388 (662)
++|.+. ++||+|+||.||++.. .+++.||||+++. ...+.+|+.++ +.++|+||+++++++.. ++.++
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 457776 7899999999999985 5789999999974 24577899988 55689999999999987 67889
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC---CCcEEEEeecccc
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD---NFEAMVADFGLAK 465 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~DFGla~ 465 (662)
|||||+.+++|.+++.......+++..++.++.|++.||.|||++ +|+||||||+||||+. ++.+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 999999999999999876666799999999999999999999999 9999999999999998 7899999999986
Q ss_pred ccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
... +..++.++|||||||+||||++|+.||......+.. .....
T Consensus 169 ~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------------~~~~~ 212 (299)
T 3m2w_A 169 ETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------------PGMKT 212 (299)
T ss_dssp ECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------CCSCC
T ss_pred ccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------------HHHHH
Confidence 533 245778999999999999999999999764322110 01111
Q ss_pred cccCcccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GLVDPRLEH-----NYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~~d~~l~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+....... ..... .+.+++.+||+.||.+||++.|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 213 RIRMGQYEFPNPEWSEVSE---EVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SSCTTCCSSCHHHHTTSCH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhccccCCchhcccCCH---HHHHHHHHHcccChhhCCCHHHHhc
Confidence 111100000 11223 4455566999999999999999997
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=341.13 Aligned_cols=239 Identities=14% Similarity=0.171 Sum_probs=178.6
Q ss_pred CCCccceeeccCceEEEEEE-ecCCCEEEEEEeecCCch---hHHHHHHHHHHHHhcCC-CCcce---------------
Q 006083 317 GFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQ---GEREFSAEVEIISRVHH-RHLVS--------------- 376 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~H-pnIv~--------------- 376 (662)
.|.++++||+|+||.||+|. ..+|+.||||+++..... ..+.|++|+.+++.++| .|+..
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 47778999999999999999 457999999999844322 35779999999999987 32211
Q ss_pred ------EEEEEEe-----CCeEEEEEEecCCcchhhhhc-----cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceee
Q 006083 377 ------LVGYCIA-----GGQRMLVYEFVSNKTLEYHLH-----GENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIH 440 (662)
Q Consensus 377 ------l~~~~~~-----~~~~~lv~E~~~~g~L~~~l~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH 440 (662)
++.++.. ...++++|+++ +++|.+++. ......+++..++.|+.||++||+|||++ +|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiH 234 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH 234 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 1111111 22456777765 688988884 33344578889999999999999999999 9999
Q ss_pred cCCccCcEEECCCCcEEEEeeccccccCCCCCccccccccCccccCcccc----------cCCCCCchHHHHHHHHHHHH
Q 006083 441 RDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYA----------SSGKLTEKSDVFSFGVMLLE 510 (662)
Q Consensus 441 rDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~----------~~~~~~~~sDvwSlGvvl~e 510 (662)
|||||+||||+.++.+||+|||+++..... ....+| ..|+|||++ .+..++.++|||||||||||
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 999999999999999999999999875432 344678 999999999 55568899999999999999
Q ss_pred HHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 511 LITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 511 LltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
|++|+.||......+ .+..++... ...+.+ +.+++.+||+.||++||++.|+++
T Consensus 310 lltg~~Pf~~~~~~~-----------------~~~~~~~~~---~~~~~~---~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 310 IWCADLPNTDDAALG-----------------GSEWIFRSC---KNIPQP---VRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHSSCCCCTTGGGS-----------------CSGGGGSSC---CCCCHH---HHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHCCCCCCCcchhh-----------------hHHHHHhhc---ccCCHH---HHHHHHHHccCChhhCcCHHHHHh
Confidence 999999997653221 111111111 122344 455556999999999999877754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=331.47 Aligned_cols=242 Identities=16% Similarity=0.186 Sum_probs=185.0
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCC--------chhHHHHHHHHHHHHhcC---------CCCcceE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGS--------GQGEREFSAEVEIISRVH---------HRHLVSL 377 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~E~~il~~l~---------HpnIv~l 377 (662)
.++|.+.+.||+|+||.||+|+. +|+.||||+++... ....+.+.+|+++|++|+ |+|||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 34588899999999999999998 78999999998653 223477899999999886 8888888
Q ss_pred EEEEE------------------------------eCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHH
Q 006083 378 VGYCI------------------------------AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGL 427 (662)
Q Consensus 378 ~~~~~------------------------------~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL 427 (662)
++++. +.+.+|||||||.+|++.+.+.+ ..+++..++.|+.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 87653 26889999999999977776643 3579999999999999999
Q ss_pred HHHH-hcCCCceeecCCccCcEEECCCC--------------------cEEEEeeccccccCCCCCccccccccCccccC
Q 006083 428 AYLH-EDCHPRIIHRDIKAANILIDDNF--------------------EAMVADFGLAKLSNDNHTHVSTRVMGTFGYLA 486 (662)
Q Consensus 428 ~yLH-~~~~~~ivHrDIkp~NILl~~~~--------------------~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~a 486 (662)
+||| ++ +||||||||+||||+.++ .+||+|||+|+..... ..+||..|||
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 9999 88 899999999999999887 8999999999876532 3589999999
Q ss_pred cccccCCCCCchHHHHHHHHH-HHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHH
Q 006083 487 PEYASSGKLTEKSDVFSFGVM-LLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLV 565 (662)
Q Consensus 487 PE~~~~~~~~~~sDvwSlGvv-l~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 565 (662)
||++.+.. +.++||||||++ +++++.|..||... .|........+....+... .........-.++.
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-------~~~~~~~~~~~~~~~~~~~----~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-------LWLHYLTDKMLKQMTFKTK----CNTPAMKQIKRKIQ 313 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-------HHHHHHHHHHHHTCCCSSC----CCSHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-------hhhhHHHHhhhhhhccCcc----cchhhhhhcCHHHH
Confidence 99998655 899999998777 78889999998431 1222222111111111111 00111123445566
Q ss_pred HHHHHhcccCCCCCCCHHHHH
Q 006083 566 ACGAASIRHSARKRPKMSQIV 586 (662)
Q Consensus 566 ~l~~~cl~~~p~~RPs~~evl 586 (662)
+++.+||+.| ++.|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 7777999976 898888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=308.16 Aligned_cols=185 Identities=16% Similarity=0.110 Sum_probs=131.7
Q ss_pred eeeccCceEEEEEE-ecCCCEEEEEEeecCCc----------hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEE
Q 006083 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSG----------QGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 323 ~iG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~----------~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv 390 (662)
.++.|++|.+..++ .--|+.|+||++.+... ...++|.+|+++|+++ +|+||++|++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45667777666654 33689999999975421 2235799999999999 699999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
||||.|++|.++|.+.. .++.. +|+.||+.||+|||++ |||||||||+||||++++++||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999997543 35543 5889999999999999 9999999999999999999999999999877544
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCC
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~P 517 (662)
.. .....+||++|||||++.+ .+..++|+|++|+++++|+++..+
T Consensus 393 ~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Cc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 32 2345789999999999875 678889999999999888766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=277.26 Aligned_cols=184 Identities=16% Similarity=0.235 Sum_probs=146.2
Q ss_pred CccceeeccCceEEEEEEecCCCEEEEEEeecCCch--------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 319 AKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQ--------GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 319 ~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
...++||+|+||.||++.. .++.+++|++...... ..+.+.+|+++|++++|+||+++..++.+.+..|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3467899999999999954 6788999987543211 134589999999999999999766666677788999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
||||.|++|.+++.. +++++.|+++||+|||++ +|+||||||+||||++ ++||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999854 568999999999999999 9999999999999998 9999999999987653
Q ss_pred CCcc------ccccccCccccCcccccC--CCCCchHHHHHHHHHHHHHHhCCCCC
Q 006083 471 HTHV------STRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELITGRRPV 518 (662)
Q Consensus 471 ~~~~------~~~~~Gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~eLltG~~Pf 518 (662)
.... ....+||..|||||++.. ..|+..+|+|+..+-.++.+-++..|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2211 235789999999999986 56888899999998888888776655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-25 Score=228.34 Aligned_cols=150 Identities=17% Similarity=0.094 Sum_probs=121.1
Q ss_pred HHHHhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCc------------------hhHHHHHHHHHHHHhcCCC
Q 006083 311 LAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSG------------------QGEREFSAEVEIISRVHHR 372 (662)
Q Consensus 311 i~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~il~~l~Hp 372 (662)
+......|.+++.||+|+||.||+|...+|+.||||+++.... .....+.+|+++|++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3344556778899999999999999987799999999964321 13456899999999999
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC
Q 006083 373 HLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD 452 (662)
Q Consensus 373 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~ 452 (662)
| +++++++.. +..|+|||||.|++|.+ +.. .....++.|+++||.|||++ +|+||||||+||||+
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~- 227 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS- 227 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-
Confidence 5 666665544 45699999999999988 421 23457999999999999998 999999999999999
Q ss_pred CCcEEEEeeccccccCCCCCccccccccCccccCccccc
Q 006083 453 NFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYAS 491 (662)
Q Consensus 453 ~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~ 491 (662)
++.+||+|||+++.. ..|+|||++.
T Consensus 228 ~~~vkl~DFG~a~~~--------------~~~~a~e~l~ 252 (282)
T 1zar_A 228 EEGIWIIDFPQSVEV--------------GEEGWREILE 252 (282)
T ss_dssp TTEEEECCCTTCEET--------------TSTTHHHHHH
T ss_pred CCcEEEEECCCCeEC--------------CCCCHHHHHH
Confidence 999999999999643 3478888875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=3.6e-21 Score=195.68 Aligned_cols=137 Identities=20% Similarity=0.168 Sum_probs=106.9
Q ss_pred CCccceeeccCceEEEEEEe-cCCCE--EEEEEeecCCch------------------------hHHHHHHHHHHHHhcC
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGKE--VAVKSLKTGSGQ------------------------GEREFSAEVEIISRVH 370 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~E~~il~~l~ 370 (662)
|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+++|.+|+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 66789999999999999997 68889 999987543111 1136789999999998
Q ss_pred CCCc--ceEEEEEEeCCeEEEEEEecCC-c----chhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCceeecC
Q 006083 371 HRHL--VSLVGYCIAGGQRMLVYEFVSN-K----TLEYHLHGENRPVMDFATRVRIALGSAKGLAYLH-EDCHPRIIHRD 442 (662)
Q Consensus 371 HpnI--v~l~~~~~~~~~~~lv~E~~~~-g----~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~ivHrD 442 (662)
|.|| ..++++ +..+|||||+.+ | .|.+++.. ..+..+..++.|++.+|.||| +. +|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 8764 444443 245899999942 4 56655422 224467889999999999999 77 999999
Q ss_pred CccCcEEECCCCcEEEEeeccccccC
Q 006083 443 IKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 443 Ikp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
|||+||||++ .++|+|||+|....
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCHHHEEEcC--cEEEEECcccccCC
Confidence 9999999998 99999999997653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=4e-19 Score=188.54 Aligned_cols=137 Identities=13% Similarity=0.131 Sum_probs=102.3
Q ss_pred CCCccceeeccCceEEEEEEecCCCEEEEEEeecCCc--------------hhHHH--------HHHHHHHHHhcCCCCc
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSG--------------QGERE--------FSAEVEIISRVHHRHL 374 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--------------~~~~~--------~~~E~~il~~l~HpnI 374 (662)
-|.+++.||+|+||.||+|...+|+.||||+++.... ..... ...|...|.+|.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4899999999999999999988999999998763210 00111 2356777777754443
Q ss_pred c--eEEEEEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC
Q 006083 375 V--SLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD 452 (662)
Q Consensus 375 v--~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~ 452 (662)
. ..+++ .. .+|||||+.|+.|..++.. .....++.|++.+|.|||++ +||||||||.||||++
T Consensus 176 ~vp~p~~~--~~--~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQ--SR--HTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEE--ET--TEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCCeeeec--cC--ceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 2 22322 22 2799999999998765421 23457889999999999998 8999999999999987
Q ss_pred CC----------cEEEEeeccccccC
Q 006083 453 NF----------EAMVADFGLAKLSN 468 (662)
Q Consensus 453 ~~----------~vkl~DFGla~~~~ 468 (662)
++ .+.||||+-+....
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCcccccccccceEEEEeCCcccCC
Confidence 76 38899999887643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=3.3e-14 Score=144.08 Aligned_cols=150 Identities=13% Similarity=0.041 Sum_probs=117.9
Q ss_pred HHHHHHhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeE
Q 006083 309 DELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 387 (662)
..+....++|.+...++.|+++.||++.. +++.+++|+...........+.+|+++|+.|. |.++.++++++.+.+..
T Consensus 7 ~~l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 34455567898888999999999999875 47899999987532122346899999999995 67788999999999999
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED---------------------------------- 433 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~---------------------------------- 433 (662)
|+||||+.|.+|.+.+.. ......++.+++++|..||+.
T Consensus 86 ~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 999999999999876421 122457788999999999981
Q ss_pred ----------------------CCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 434 ----------------------CHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 434 ----------------------~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
....++|+|+++.|||++++..+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 003599999999999998765567999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.39 E-value=5.9e-13 Score=134.13 Aligned_cols=138 Identities=15% Similarity=0.083 Sum_probs=102.4
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCC--cceEEEEEEeCCeEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRH--LVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~~~~~~~~~~~lv~E~ 393 (662)
.+|.+..+.+.|.++.||++...+|+.++||+.... ....+.+|+.+|+.+.+.+ +.++++++.+++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345554444456669999998777888999997653 2245788999999996444 55689988888889999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC--------------------------------------- 434 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--------------------------------------- 434 (662)
+.|..|. +.. .. ...++.++++.|..||+..
T Consensus 97 i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 97 VPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred cCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 9999984 211 11 2356677777788888641
Q ss_pred ----------------CCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 435 ----------------HPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 435 ----------------~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
...++|+|+++.|||++++..+.|+|||.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998776667999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.2e-11 Score=131.25 Aligned_cols=144 Identities=19% Similarity=0.251 Sum_probs=109.2
Q ss_pred CccceeeccCceEEEEEEecCCCEEEEEEee--cCC-chhHHHHHHHHHHHHhcC--CCCcceEEEEEEeC---CeEEEE
Q 006083 319 AKSNLLGQGGFGYVHKGVLPNGKEVAVKSLK--TGS-GQGEREFSAEVEIISRVH--HRHLVSLVGYCIAG---GQRMLV 390 (662)
Q Consensus 319 ~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~--~~~-~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~---~~~~lv 390 (662)
...+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+|+.|. +.++.+++.++.+. +..|+|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34677999999999998864 4688888876 332 122457889999999997 45678899998876 458999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC------------------------------------ 434 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------------------------------------ 434 (662)
|||+.|..+.+.. ...++..++..++.++++.|..||+..
T Consensus 120 me~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 120 MEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999998885422 123678888999999999999999720
Q ss_pred -------------------CCceeecCCccCcEEECCCCc--EEEEeecccccc
Q 006083 435 -------------------HPRIIHRDIKAANILIDDNFE--AMVADFGLAKLS 467 (662)
Q Consensus 435 -------------------~~~ivHrDIkp~NILl~~~~~--vkl~DFGla~~~ 467 (662)
...++|||+++.|||++.++. +.|+||+.+...
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247999999999999987653 689999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.25 E-value=8.3e-12 Score=129.40 Aligned_cols=185 Identities=20% Similarity=0.246 Sum_probs=124.5
Q ss_pred cceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-CCC--cceEEEEEEeCC---eEEEEEEec
Q 006083 321 SNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-HRH--LVSLVGYCIAGG---QRMLVYEFV 394 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-Hpn--Iv~l~~~~~~~~---~~~lv~E~~ 394 (662)
.+.|+.|.+..||+. ++.+++|+.... .....+.+|+++|+.|. +.. +.+++.++...+ ..|+||||+
T Consensus 25 i~~~~~G~~n~v~~v----~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI----NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEES----TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEE----CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 467899999999985 256889986532 34567899999999984 333 345555544333 348899999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED----------------------------------------- 433 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~----------------------------------------- 433 (662)
.|..|.+.... .++..++..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99998754321 256777888888888888888861
Q ss_pred --------------CCCceeecCCccCcEEECC--CCcEEEEeeccccccCCCCCcccc--------------ccccCcc
Q 006083 434 --------------CHPRIIHRDIKAANILIDD--NFEAMVADFGLAKLSNDNHTHVST--------------RVMGTFG 483 (662)
Q Consensus 434 --------------~~~~ivHrDIkp~NILl~~--~~~vkl~DFGla~~~~~~~~~~~~--------------~~~Gt~~ 483 (662)
....++|+|+++.|||+++ +..+.|+||+.+....... +... .+...++
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHHHHcC
Confidence 1135899999999999998 4567899999987543211 1100 0111111
Q ss_pred ccC-cccccCCCCCchHHHHHHHHHHHHHHhCCCCC
Q 006083 484 YLA-PEYASSGKLTEKSDVFSFGVMLLELITGRRPV 518 (662)
Q Consensus 484 y~a-PE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf 518 (662)
+.. |+.+. ......+.|++++++|++.+|..+|
T Consensus 254 ~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 112 22211 1123468999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.80 E-value=4e-08 Score=99.42 Aligned_cols=142 Identities=17% Similarity=0.087 Sum_probs=101.2
Q ss_pred hCCCCccceeeccCce-EEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEE
Q 006083 315 TGGFAKSNLLGQGGFG-YVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g-~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lv~ 391 (662)
..+|+. +.+..|..| .||+.... ++..++||+-.. .....+.+|..+|+.|. +--+.++++++.+.+..||||
T Consensus 24 l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 24 LYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp HTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 344544 345555554 69987754 567899998754 34567889999999985 444678999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED-------------------------------------- 433 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-------------------------------------- 433 (662)
|++.|..+.+..... ......++.++++.|..||..
T Consensus 100 e~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp ECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred EeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 999998887654321 122344556666666666641
Q ss_pred -----------------CCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 434 -----------------CHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 434 -----------------~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
....++|+|+++.|||+++++.+-|+||+.+..
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012489999999999999876667999998854
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.79 E-value=4.7e-08 Score=101.19 Aligned_cols=137 Identities=23% Similarity=0.256 Sum_probs=96.6
Q ss_pred cceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCC---CcceEEEEEE-eCCeEEEEEEecCC
Q 006083 321 SNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHR---HLVSLVGYCI-AGGQRMLVYEFVSN 396 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~Hp---nIv~l~~~~~-~~~~~~lv~E~~~~ 396 (662)
.+.|+.|....||+. |+.++||+-.. ......+.+|+++|+.|.+. .+.+++.++. ..+..++||||+.|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888999987 56788888532 23456789999999999752 3566777774 45667899999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED------------------------------------------- 433 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------------------------------------------- 433 (662)
..|...... .++..++..++.++++.|..||+.
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 988763211 134445555555555555555542
Q ss_pred --------------CCCceeecCCccCcEEECC---CCcE-EEEeecccccc
Q 006083 434 --------------CHPRIIHRDIKAANILIDD---NFEA-MVADFGLAKLS 467 (662)
Q Consensus 434 --------------~~~~ivHrDIkp~NILl~~---~~~v-kl~DFGla~~~ 467 (662)
....++|+|+++.|||+++ ++.+ .|+||+.+...
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1225799999999999987 4555 79999988654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=3e-08 Score=104.83 Aligned_cols=81 Identities=9% Similarity=0.010 Sum_probs=57.5
Q ss_pred ccee-eccCceEEEEEEec-------CCCEEEEEEeecCC---chhHHHHHHHHHHHHhcC-C--CCcceEEEEEEeC--
Q 006083 321 SNLL-GQGGFGYVHKGVLP-------NGKEVAVKSLKTGS---GQGEREFSAEVEIISRVH-H--RHLVSLVGYCIAG-- 384 (662)
Q Consensus 321 ~~~i-G~G~~g~Vy~~~~~-------~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~-H--pnIv~l~~~~~~~-- 384 (662)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+|+.|. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78888999998754 26788999865422 111245788999999885 3 3567888887665
Q ss_pred -CeEEEEEEecCCcchhh
Q 006083 385 -GQRMLVYEFVSNKTLEY 401 (662)
Q Consensus 385 -~~~~lv~E~~~~g~L~~ 401 (662)
+..|+||||+.|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 45689999999877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.48 E-value=3.9e-07 Score=95.18 Aligned_cols=140 Identities=15% Similarity=0.239 Sum_probs=82.1
Q ss_pred ceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC--CCCcceEEE------EEEeCCeEEEEEEe
Q 006083 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH--HRHLVSLVG------YCIAGGQRMLVYEF 393 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~------~~~~~~~~~lv~E~ 393 (662)
+.|+.|..+.||+....+| .+++|+.... ...+..|+.+++.|. .-.+.+++. +...++..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4466677899999887554 5899998752 234455666666653 113333332 22356788999999
Q ss_pred cCCcchh--------------hhhccC--CC----------CCCCHHHH-------------------------------
Q 006083 394 VSNKTLE--------------YHLHGE--NR----------PVMDFATR------------------------------- 416 (662)
Q Consensus 394 ~~~g~L~--------------~~l~~~--~~----------~~l~~~~~------------------------------- 416 (662)
+.|..+. ..||.. .. ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 112210 00 01123211
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 417 VRIALGSAKGLAYLHE----------DCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 417 ~~i~~~ia~aL~yLH~----------~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
..+...+.+++.+|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111123345666663 0234799999999999998888899999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=5.3e-07 Score=96.68 Aligned_cols=75 Identities=16% Similarity=0.117 Sum_probs=50.3
Q ss_pred cceeeccCceEEEEEEec-CCCEEEEEEeecCCc-------hhHHHHHHHHHHHHhcCC--CCc-ceEEEEEEeCCeEEE
Q 006083 321 SNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-------QGEREFSAEVEIISRVHH--RHL-VSLVGYCIAGGQRML 389 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~~E~~il~~l~H--pnI-v~l~~~~~~~~~~~l 389 (662)
.+.||.|.++.||++... +++.|+||....... .....+..|+++|+.+.. +.+ .+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567999999999999753 568899998653211 123456789999988842 333 456654 3445689
Q ss_pred EEEecCCc
Q 006083 390 VYEFVSNK 397 (662)
Q Consensus 390 v~E~~~~g 397 (662)
||||+.+.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.30 E-value=6.6e-07 Score=96.84 Aligned_cols=78 Identities=12% Similarity=0.161 Sum_probs=49.4
Q ss_pred CceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcccccc-ccCccccCcccccCC---CCCchHHHHHHHHHHHHH
Q 006083 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRV-MGTFGYLAPEYASSG---KLTEKSDVFSFGVMLLEL 511 (662)
Q Consensus 436 ~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~-~Gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~eL 511 (662)
..++|+|+++.|||+++++ ++|+||+.+....... +..... .-...|++++..... .-....++..+...+|++
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4799999999999998776 9999999987654221 111100 002346666655321 112345666888888888
Q ss_pred HhCC
Q 006083 512 ITGR 515 (662)
Q Consensus 512 ltG~ 515 (662)
+.++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.29 E-value=5.9e-06 Score=85.48 Aligned_cols=138 Identities=18% Similarity=0.171 Sum_probs=93.5
Q ss_pred ccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 320 KSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH---HRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 320 ~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
..+.|+.|.+..+|+... +++.++||+.... ....+.+|+..|+.|. ...+.+++.++...+..++||||++|
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 356789999999999876 5678899987642 3567899999999884 36688899998888899999999998
Q ss_pred cchhh-----------hhccCCC-C-------------------CCCHHHHH---HH--HHH--------------HHHH
Q 006083 397 KTLEY-----------HLHGENR-P-------------------VMDFATRV---RI--ALG--------------SAKG 426 (662)
Q Consensus 397 g~L~~-----------~l~~~~~-~-------------------~l~~~~~~---~i--~~~--------------ia~a 426 (662)
..+.. .||.... . .-+|.... ++ .++ +++.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76421 2232211 0 12444321 11 111 1111
Q ss_pred H-HHHHh-cCCCceeecCCccCcEEECCCCcEEEEeec
Q 006083 427 L-AYLHE-DCHPRIIHRDIKAANILIDDNFEAMVADFG 462 (662)
Q Consensus 427 L-~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkl~DFG 462 (662)
+ ..|.. ...+.+||+|+.+.|||++.++ +.|+||+
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 23321 1245799999999999999887 8899984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.18 E-value=2.7e-06 Score=86.94 Aligned_cols=79 Identities=19% Similarity=0.187 Sum_probs=59.1
Q ss_pred CCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCC---CCcceEEEEEEeCCeEEEEEEe
Q 006083 317 GFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHH---RHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~H---pnIv~l~~~~~~~~~~~lv~E~ 393 (662)
.....+.+|.|..+.||+..+.+|+.|+||+-..........|.+|+..|+.|.- --+.+++++. . -++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEEEEe
Confidence 4555778999999999999999999999998765544444568899999999852 2345566543 2 3789999
Q ss_pred cCCcch
Q 006083 394 VSNKTL 399 (662)
Q Consensus 394 ~~~g~L 399 (662)
+.++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 887543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.08 E-value=2.1e-05 Score=81.37 Aligned_cols=159 Identities=11% Similarity=0.069 Sum_probs=91.7
Q ss_pred CcCHHHHHHHhCCCCcc-----ceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCC--cceE
Q 006083 305 TFTYDELAAATGGFAKS-----NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRH--LVSL 377 (662)
Q Consensus 305 ~~~~~ei~~~~~~~~~~-----~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l 377 (662)
.++.+++......|.+. +.|+.|....||+....+| .+++|+.... .....+..|+.+++.|...+ +.++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 35567777766667653 3466788889999887555 6889988652 12235667888888774212 2333
Q ss_pred EE------EEEeCCeEEEEEEecCCcchhh--------------hhccC----CCC---CC---CHHHHHHH--------
Q 006083 378 VG------YCIAGGQRMLVYEFVSNKTLEY--------------HLHGE----NRP---VM---DFATRVRI-------- 419 (662)
Q Consensus 378 ~~------~~~~~~~~~lv~E~~~~g~L~~--------------~l~~~----~~~---~l---~~~~~~~i-------- 419 (662)
+. +...++..++||+|+.|..+.. .||.. ... .. .|...+.-
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 32 1223567899999999865421 12211 000 01 12221110
Q ss_pred ----HHHHHHHHHHHHhc----CCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 420 ----ALGSAKGLAYLHED----CHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 420 ----~~~ia~aL~yLH~~----~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
...+.+.+++|++. ...+++|+|+++.|||++++..+.|+||+.+..
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 01134455666542 123799999999999999875557999998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=98.00 E-value=1.5e-05 Score=83.19 Aligned_cols=143 Identities=16% Similarity=0.127 Sum_probs=76.7
Q ss_pred cceeeccCceE-EEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCCeEEEEEEecCCc
Q 006083 321 SNLLGQGGFGY-VHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHH--RHLVSLVGYCIAGGQRMLVYEFVSNK 397 (662)
Q Consensus 321 ~~~iG~G~~g~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~~~~~lv~E~~~~g 397 (662)
.+.|+.|+... +|+....+|+.+++|...... ...+..|+.+++.|.. -.+.+++.+..+.+ ++|||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 34566565544 667665447778887654321 1335667787777742 34566777654444 7899999776
Q ss_pred chhhhhc---------------------cCC---CCCCCHHHHH-------HHH-------------HHHHHHHHHHHh-
Q 006083 398 TLEYHLH---------------------GEN---RPVMDFATRV-------RIA-------------LGSAKGLAYLHE- 432 (662)
Q Consensus 398 ~L~~~l~---------------------~~~---~~~l~~~~~~-------~i~-------------~~ia~aL~yLH~- 432 (662)
.+.+++. ... ...++..... .+. ..+.+.++.|..
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 6543321 110 1112221110 000 011122333321
Q ss_pred --cCCCceeecCCccCcEEECCC----CcEEEEeeccccccC
Q 006083 433 --DCHPRIIHRDIKAANILIDDN----FEAMVADFGLAKLSN 468 (662)
Q Consensus 433 --~~~~~ivHrDIkp~NILl~~~----~~vkl~DFGla~~~~ 468 (662)
.....++|||+++.|||++.+ +.+.|+||+.+....
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 123379999999999999874 689999999987654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.99 E-value=6.7e-05 Score=77.75 Aligned_cols=142 Identities=16% Similarity=0.170 Sum_probs=85.5
Q ss_pred ceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCC--CCcceEEEE-----EEeCCeEEEEEEec
Q 006083 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHH--RHLVSLVGY-----CIAGGQRMLVYEFV 394 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~-----~~~~~~~~lv~E~~ 394 (662)
..|+ |....||+....+|+.+++|+..... .....+..|+.+++.|.. -.+.+++.. ...++..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999877677789999986432 234567789998888842 223444432 23356778999999
Q ss_pred CCcchhh--------------hhcc----C---CCCCCCHHHH----HHHH---------------HHHHHHHHHHHhc-
Q 006083 395 SNKTLEY--------------HLHG----E---NRPVMDFATR----VRIA---------------LGSAKGLAYLHED- 433 (662)
Q Consensus 395 ~~g~L~~--------------~l~~----~---~~~~l~~~~~----~~i~---------------~~ia~aL~yLH~~- 433 (662)
.|..+.. .||. . .+...++... ..++ ..+.+.++.|.+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8865421 1121 0 1112222211 1111 0111223333321
Q ss_pred ---CCCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 434 ---CHPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 434 ---~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
....++|+|+++.|||++ + .+.|+||+.+...
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 223689999999999999 4 8999999988654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.86 E-value=2.2e-05 Score=84.97 Aligned_cols=73 Identities=19% Similarity=0.223 Sum_probs=51.0
Q ss_pred cceeeccCceEEEEEEecC--------CCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeEEEEE
Q 006083 321 SNLLGQGGFGYVHKGVLPN--------GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHL-VSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lv~ 391 (662)
.+.|+.|....||++...+ ++.|++|+.... .....+.+|+.+++.|...++ .++++++.+ .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567888889999998643 578999988432 112455689999998853334 567776543 3899
Q ss_pred EecCCcch
Q 006083 392 EFVSNKTL 399 (662)
Q Consensus 392 E~~~~g~L 399 (662)
||++|..|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.79 E-value=5.1e-05 Score=77.87 Aligned_cols=141 Identities=12% Similarity=0.110 Sum_probs=79.0
Q ss_pred CCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeEEEEEEec-C
Q 006083 318 FAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHL-VSLVGYCIAGGQRMLVYEFV-S 395 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lv~E~~-~ 395 (662)
+.-.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+..-++ .++++++ .+.-++|+||+ .
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence 333678999999999998 56888887643211 1123568888887753333 4666554 33347899999 6
Q ss_pred Ccchhh------------------hhccCCC---CCCCH-HHHHHHHH--------------HHHHHHHH----HHh-cC
Q 006083 396 NKTLEY------------------HLHGENR---PVMDF-ATRVRIAL--------------GSAKGLAY----LHE-DC 434 (662)
Q Consensus 396 ~g~L~~------------------~l~~~~~---~~l~~-~~~~~i~~--------------~ia~aL~y----LH~-~~ 434 (662)
|..|.. .||.... ..... ..+.++.. .+.+.+.. |.. ..
T Consensus 92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~ 171 (301)
T 3dxq_A 92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL 171 (301)
T ss_dssp CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence 655531 1122111 00111 11111111 01111111 111 12
Q ss_pred CCceeecCCccCcEEECCCCcEEEEeecccccc
Q 006083 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKLS 467 (662)
Q Consensus 435 ~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~ 467 (662)
...++|+|+.+.||| .+++.+.|+||..+...
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 235899999999999 55667899999988654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.78 E-value=6.4e-05 Score=81.87 Aligned_cols=74 Identities=9% Similarity=0.052 Sum_probs=48.7
Q ss_pred cceeeccCceEEEEEEecC-CCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeEEEEEEecCCcc
Q 006083 321 SNLLGQGGFGYVHKGVLPN-GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHL-VSLVGYCIAGGQRMLVYEFVSNKT 398 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lv~E~~~~g~ 398 (662)
.+.|+.|-...+|+....+ ++.|++|+....... .-...+|+.+|+.|...++ .++++++. + .+||||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4567788889999998754 478889987432211 1112689999999975555 46777763 2 35999998865
Q ss_pred h
Q 006083 399 L 399 (662)
Q Consensus 399 L 399 (662)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00011 Score=77.91 Aligned_cols=140 Identities=19% Similarity=0.209 Sum_probs=84.0
Q ss_pred ceeeccCceEEEEEEec--------CCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEE
Q 006083 322 NLLGQGGFGYVHKGVLP--------NGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lv~E 392 (662)
+.|..|-...+|+.... +++.|++|+-... ......+.+|.++|+.|. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45767878899998864 2478999986332 223556778999998885 3223567776654 29999
Q ss_pred ecCCcchhh-----------------hhccCCC---CCCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 006083 393 FVSNKTLEY-----------------HLHGENR---PVMD--FATRVRIALGSA-------------------KGLAYLH 431 (662)
Q Consensus 393 ~~~~g~L~~-----------------~l~~~~~---~~l~--~~~~~~i~~~ia-------------------~aL~yLH 431 (662)
|++|..|.. .||.... .... +.++.+++.++. +.+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999866531 1122111 1112 344444543332 2233333
Q ss_pred h----c-CCCceeecCCccCcEEECCC----CcEEEEeeccccc
Q 006083 432 E----D-CHPRIIHRDIKAANILIDDN----FEAMVADFGLAKL 466 (662)
Q Consensus 432 ~----~-~~~~ivHrDIkp~NILl~~~----~~vkl~DFGla~~ 466 (662)
+ . ....++|+|+.+.|||++++ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 1 12369999999999999876 7899999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.64 E-value=9.9e-05 Score=78.03 Aligned_cols=74 Identities=12% Similarity=0.064 Sum_probs=45.7
Q ss_pred cceeeccCceEEEEEEecC---------CCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCC-cceEEEEEEeCCeEEEE
Q 006083 321 SNLLGQGGFGYVHKGVLPN---------GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRH-LVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~lv 390 (662)
.+.|+.|....+|+....+ ++.+++|+..... ........|+++|+.|...+ +.++++.+ .+ ++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence 4567788888999988643 2688899875432 11123467888888885334 34677554 22 689
Q ss_pred EEecCCcch
Q 006083 391 YEFVSNKTL 399 (662)
Q Consensus 391 ~E~~~~g~L 399 (662)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999988654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00021 Score=74.65 Aligned_cols=64 Identities=9% Similarity=0.082 Sum_probs=43.5
Q ss_pred ceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC---CCCcceEEEE------EEeCCeEEEEEEecCCcch
Q 006083 329 FGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH---HRHLVSLVGY------CIAGGQRMLVYEFVSNKTL 399 (662)
Q Consensus 329 ~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~------~~~~~~~~lv~E~~~~g~L 399 (662)
...||+....+| .+++|+...... .+|+.+|+.|. -+++.+.+.. +..++..++||+|+.|..+
T Consensus 36 ~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~ 108 (339)
T 3i1a_A 36 NAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG 108 (339)
T ss_dssp SCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred ccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence 579999987666 899998765432 45666666663 2224454432 3346788999999998765
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00014 Score=50.51 Aligned_cols=20 Identities=15% Similarity=0.321 Sum_probs=9.4
Q ss_pred eEEEchhHHHHHHHHHHHHH
Q 006083 170 YSVIGAVGVGIFLIAMIIIC 189 (662)
Q Consensus 170 ~~v~~~v~~~~~~i~~~~~~ 189 (662)
..|+++|++++++++++++.
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~ 29 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLT 29 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHH
T ss_pred ceEEEeehHHHHHHHHHHHH
Confidence 34555555545544444433
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00017 Score=50.34 Aligned_cols=19 Identities=11% Similarity=0.256 Sum_probs=8.2
Q ss_pred EEEchhHHHHHHHHHHHHH
Q 006083 171 SVIGAVGVGIFLIAMIIIC 189 (662)
Q Consensus 171 ~v~~~v~~~~~~i~~~~~~ 189 (662)
.|+++|++++++++++++.
T Consensus 12 ~IA~gVVgGv~~~~ii~~~ 30 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALG 30 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHH
T ss_pred eEEeehhHHHHHHHHHHHH
Confidence 3444444444444443333
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0022 Score=68.90 Aligned_cols=140 Identities=11% Similarity=0.100 Sum_probs=84.0
Q ss_pred cceeeccCceEEEEEEecC--------CCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCC-cceEEEEEEeCCeEEEEE
Q 006083 321 SNLLGQGGFGYVHKGVLPN--------GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRH-LVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~lv~ 391 (662)
.+.|..|-...+|+....+ ++.|++|+..... ...-...+|.++++.|..-+ ..++++.+. + ++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP--E--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEEE
Confidence 4457777788999988643 5889999864432 11123467888888885323 345665442 2 7899
Q ss_pred EecCCcchhh-----------------hhccC-----------CCCCCCHHHHHHHHHHH-------------------H
Q 006083 392 EFVSNKTLEY-----------------HLHGE-----------NRPVMDFATRVRIALGS-------------------A 424 (662)
Q Consensus 392 E~~~~g~L~~-----------------~l~~~-----------~~~~l~~~~~~~i~~~i-------------------a 424 (662)
||++|..|.. .||.. .+...-+.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999976421 01110 11111233333333222 2
Q ss_pred HHHHHHHhc---------------------CCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 425 KGLAYLHED---------------------CHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 425 ~aL~yLH~~---------------------~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
+.+.+|.+. ....++|+|+++.||| ++++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 223333211 1236899999999999 7788999999998864
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.00012 Score=50.87 Aligned_cols=36 Identities=25% Similarity=0.392 Sum_probs=21.5
Q ss_pred CCCcceeEEEchhHHHHHHHHHHHHHHHHHHhhhccc
Q 006083 164 GDDYVTYSVIGAVGVGIFLIAMIIICAVRANKKKKKR 200 (662)
Q Consensus 164 ~~~~~~~~v~~~v~~~~~~i~~~~~~~~~~~rkr~~~ 200 (662)
+...+++.||+++ +++++|+++++++||+||+++++
T Consensus 8 ~~~aIA~gVVgGv-~~v~ii~~~~~~~~RRRr~~~kr 43 (44)
T 2l2t_A 8 RTPLIAAGVIGGL-FILVIVGLTFAVYVRRKSIKKKR 43 (44)
T ss_dssp SSHHHHHHHHHHH-HHHHHHHHHHHHHHHTTCSSCCC
T ss_pred CcceEEEeehHHH-HHHHHHHHHHHHHhhhhhhhhcc
Confidence 3344555555555 44445567778888876665543
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0003 Score=49.08 Aligned_cols=32 Identities=19% Similarity=0.293 Sum_probs=18.8
Q ss_pred cceeEEEchhHHHHHHHHHHHHHHHHHHhhhcc
Q 006083 167 YVTYSVIGAVGVGIFLIAMIIICAVRANKKKKK 199 (662)
Q Consensus 167 ~~~~~v~~~v~~~~~~i~~~~~~~~~~~rkr~~ 199 (662)
.+++.||+++ +++++|+++++++||+||++++
T Consensus 12 ~IA~gVVgGv-~~~~ii~~~~~~~~RRr~~~~k 43 (44)
T 2ks1_B 12 SIATGMVGAL-LLLLVVALGIGLFMRRRHIVRK 43 (44)
T ss_dssp SSTHHHHHHH-HHHHHHHHHHHHHHHTTTCCSC
T ss_pred eEEeehhHHH-HHHHHHHHHHHHHhhhhHhhcc
Confidence 3445555544 4444556777888887665543
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=96.79 E-value=0.00041 Score=48.09 Aligned_cols=21 Identities=5% Similarity=0.230 Sum_probs=9.7
Q ss_pred HHHHHHHHHHHHHHHHHhhhc
Q 006083 178 VGIFLIAMIIICAVRANKKKK 198 (662)
Q Consensus 178 ~~~~~i~~~~~~~~~~~rkr~ 198 (662)
+++++|+++++++|+||||++
T Consensus 21 vll~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 21 ILLVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHCSC
T ss_pred HHHHHHHHHHHHhheehhhhh
Confidence 334444444445555444444
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.31 E-value=0.042 Score=52.79 Aligned_cols=104 Identities=14% Similarity=0.049 Sum_probs=66.6
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
..+|.++|... +..+++++++.++.|.+++|.-+-... .-..+=+-+..|+|..+|.|.+.+ +.+.
T Consensus 32 ~vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 32 ALSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc----------
Confidence 45788888653 346999999999999999886652211 111233357899999999888653 1111
Q ss_pred cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCC
Q 006083 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~P 517 (662)
.....+.+||.+. ...+.+.=|||||++||.-+--..+
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122366888764 3567899999999999998865444
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=96.23 E-value=0.00042 Score=46.86 Aligned_cols=7 Identities=0% Similarity=-0.287 Sum_probs=2.6
Q ss_pred EchhHHH
Q 006083 173 IGAVGVG 179 (662)
Q Consensus 173 ~~~v~~~ 179 (662)
+++|++.
T Consensus 14 AGiVvG~ 20 (38)
T 2k1k_A 14 VAVIFGL 20 (38)
T ss_dssp HHHHHHH
T ss_pred eeeehHH
Confidence 3333333
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=96.20 E-value=0.0015 Score=44.08 Aligned_cols=27 Identities=15% Similarity=0.279 Sum_probs=14.3
Q ss_pred CCCcceeEEEchhHHHHHHHHHHHHHHH
Q 006083 164 GDDYVTYSVIGAVGVGIFLIAMIIICAV 191 (662)
Q Consensus 164 ~~~~~~~~v~~~v~~~~~~i~~~~~~~~ 191 (662)
+++.+.++|++++ +++++++++++|+|
T Consensus 9 s~GaIAGiVvG~v-~gv~li~~l~~~~~ 35 (38)
T 2k1k_A 9 TGGEIVAVIFGLL-LGAALLLGILVFRS 35 (38)
T ss_dssp CHHHHHHHHHHHH-HHHHHHHHHHHHHH
T ss_pred CCCceeeeehHHH-HHHHHHHHHHHHHe
Confidence 3444555555544 56655665555444
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.97 E-value=0.022 Score=60.70 Aligned_cols=30 Identities=27% Similarity=0.481 Sum_probs=25.1
Q ss_pred ceeecCCccCcEEE------CCCCcEEEEeeccccc
Q 006083 437 RIIHRDIKAANILI------DDNFEAMVADFGLAKL 466 (662)
Q Consensus 437 ~ivHrDIkp~NILl------~~~~~vkl~DFGla~~ 466 (662)
.++|+|+...|||+ +++..++|+||-+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999998753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=94.24 E-value=0.19 Score=48.08 Aligned_cols=115 Identities=9% Similarity=0.140 Sum_probs=80.4
Q ss_pred CCCCcceEEEEEEeCCeEEEEEEecCCc-chhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcE
Q 006083 370 HHRHLVSLVGYCIAGGQRMLVYEFVSNK-TLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANI 448 (662)
Q Consensus 370 ~HpnIv~l~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NI 448 (662)
.|++++.. .+-.+.+.+.|.|+.-..+ ++.. ++ .++...+++++..|+....+++.. +|--|+|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-----~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-----SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-----GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-----hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence 58888876 4666677777777765422 3332 32 367899999999999877666544 8889999999
Q ss_pred EECCCCcEEEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCC
Q 006083 449 LIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVD 519 (662)
Q Consensus 449 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~ 519 (662)
+++.++.++|+-.|+-.... |. .++...=+-.+=|++..++.++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~l~------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVVD------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTBS------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCCC------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999998777643222 11 22333334456788899999988773
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.18 E-value=0.0069 Score=41.87 Aligned_cols=25 Identities=28% Similarity=0.527 Sum_probs=10.7
Q ss_pred EEchhHHHHHHHHHHHHHHHHHHhh
Q 006083 172 VIGAVGVGIFLIAMIIICAVRANKK 196 (662)
Q Consensus 172 v~~~v~~~~~~i~~~~~~~~~~~rk 196 (662)
|++++++++++++++++++|+.|||
T Consensus 15 I~~~vv~Gv~ll~~iv~~~~~~~rR 39 (41)
T 2k9y_A 15 VIGGVAVGVVLLLVLAGVGFFIHRR 39 (41)
T ss_dssp HHHHHHHHHHHHHHHHHHHHSSSSS
T ss_pred EEeehhHHHHHHHHHHHHheeEeee
Confidence 4444445555555233333333333
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.72 E-value=0.33 Score=46.64 Aligned_cols=115 Identities=11% Similarity=0.123 Sum_probs=77.4
Q ss_pred CCCCcceEEEEEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCceeecCCccCcE
Q 006083 370 HHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLA-YLHEDCHPRIIHRDIKAANI 448 (662)
Q Consensus 370 ~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~-yLH~~~~~~ivHrDIkp~NI 448 (662)
.|+++ -..+-.+++.+.|.++.-.++.=+..++ .++..++++++..|+.... +++. -+|--|+|+||
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence 57777 4444467788888888654443333442 2678899999999887665 5544 48889999999
Q ss_pred EECCCCcEEEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCC
Q 006083 449 LIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVD 519 (662)
Q Consensus 449 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~ 519 (662)
+++.++.++|.-.|+-..+ +|. ..+..-=+-.+=|++..++.++.-|+
T Consensus 116 ~f~~~~~p~i~hRGi~~~l------------------pP~-----e~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKESL------------------PPD-----EWDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EECTTCCEEESCCEETTTB------------------SSC-----SCCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEeCCCcEEEEEcCCcccC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999877764322 221 12222223356688888888887663
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.53 E-value=0.12 Score=37.38 Aligned_cols=24 Identities=13% Similarity=0.337 Sum_probs=13.8
Q ss_pred ceeEEEchhHHHHHHHHHHHHHHH
Q 006083 168 VTYSVIGAVGVGIFLIAMIIICAV 191 (662)
Q Consensus 168 ~~~~v~~~v~~~~~~i~~~~~~~~ 191 (662)
.+.+|++.+++++++++++++.+|
T Consensus 8 p~WiIi~svl~GLLLL~Lii~~Lw 31 (54)
T 2l8s_A 8 PLWVILLSAFAGLLLLMLLILALW 31 (54)
T ss_dssp CTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHHHHHHHH
Confidence 344555666666666666555444
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=88.83 E-value=0.04 Score=36.10 Aligned_cols=6 Identities=0% Similarity=-0.036 Sum_probs=2.3
Q ss_pred HHHHHH
Q 006083 188 ICAVRA 193 (662)
Q Consensus 188 ~~~~~~ 193 (662)
+++|+|
T Consensus 27 ~~~~iR 32 (35)
T 1iij_A 27 VGILIK 32 (35)
T ss_dssp TTHHHH
T ss_pred hheEEe
Confidence 333333
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.47 E-value=0.13 Score=40.95 Aligned_cols=24 Identities=21% Similarity=0.206 Sum_probs=15.4
Q ss_pred eeEEEchhHHHHHHHHHHHHHHHH
Q 006083 169 TYSVIGAVGVGIFLIAMIIICAVR 192 (662)
Q Consensus 169 ~~~v~~~v~~~~~~i~~~~~~~~~ 192 (662)
+.+|++++++++++|+++++++|+
T Consensus 10 ~~~Iv~gvi~gilliGllllliwk 33 (79)
T 2knc_B 10 ILVVLLSVMGAILLIGLAALLIWK 33 (79)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHHHHHHHHH
Confidence 445555666677777777666665
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=87.91 E-value=1.4 Score=45.02 Aligned_cols=139 Identities=16% Similarity=0.121 Sum_probs=71.9
Q ss_pred ceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEE---------------------
Q 006083 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGY--------------------- 380 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~--------------------- 380 (662)
+.+-.| .+.||.+.. ++..|+||-.. ....+.|-.++...-.+.-|+..-+.-.
T Consensus 75 ~~s~~G-stgvff~~t-d~~~~VVK~s~---~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L~~~~~~~~~l 149 (342)
T 1cja_A 75 ERSEKG-TEGLFFVET-ESGVFIVKRST---NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAAIDKSFRVI 149 (342)
T ss_dssp EECCST-TSCEEEEEE-SSCEEEEECCT---THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHHHCSSSCHH
T ss_pred EeccCC-CCCeEEEEe-CCCEEEEeCcH---HHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHHHHhhhhhHHH
Confidence 333445 455666665 67899999542 2223334444444444444442211100
Q ss_pred -EEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc-eee-cCCccCcEEECCCC-cE
Q 006083 381 -CIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR-IIH-RDIKAANILIDDNF-EA 456 (662)
Q Consensus 381 -~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-ivH-rDIkp~NILl~~~~-~v 456 (662)
....+.++|+|||+.|..|.+.-+..-...+..+... .++-+-+++++..+++.- .++ .--.++|||+++++ .+
T Consensus 150 ~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k--~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~~n~~~ 227 (342)
T 1cja_A 150 TTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQ--QLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATV 227 (342)
T ss_dssp HHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHH--HHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCE
T ss_pred HHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHH--hhchhheehhhhcCCccCcccccCCCChhheEEeCCCCeE
Confidence 0012356799999998777653221100112222211 111234567777664322 222 12588999997744 48
Q ss_pred EEEeecccccc
Q 006083 457 MVADFGLAKLS 467 (662)
Q Consensus 457 kl~DFGla~~~ 467 (662)
.++|-+++...
T Consensus 228 ~~IDhn~af~~ 238 (342)
T 1cja_A 228 VPIDSKIIPLD 238 (342)
T ss_dssp EECSCCCCCCC
T ss_pred EEEcCCccccC
Confidence 89999998653
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.89 E-value=0.35 Score=35.13 Aligned_cols=24 Identities=17% Similarity=0.344 Sum_probs=13.4
Q ss_pred ceeEEEchhHHHHHHHHHHHHHHH
Q 006083 168 VTYSVIGAVGVGIFLIAMIIICAV 191 (662)
Q Consensus 168 ~~~~v~~~v~~~~~~i~~~~~~~~ 191 (662)
.+.+|++.+++++++++++++.+|
T Consensus 11 p~wiIi~svl~GLllL~li~~~Lw 34 (54)
T 2knc_A 11 PIWWVLVGVLGGLLLLTILVLAMW 34 (54)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHHHHHHHH
Confidence 344555556566666665555444
|
| >2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.85 E-value=0.13 Score=38.43 Aligned_cols=12 Identities=25% Similarity=0.382 Sum_probs=4.8
Q ss_pred HHHHHHHHHHHH
Q 006083 178 VGIFLIAMIIIC 189 (662)
Q Consensus 178 ~~~~~i~~~~~~ 189 (662)
+++++++.++++
T Consensus 18 ~~lll~~glcI~ 29 (70)
T 2klu_A 18 AGLLLFIGLGIF 29 (70)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 344444433333
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=86.50 E-value=0.083 Score=36.60 Aligned_cols=25 Identities=12% Similarity=0.169 Sum_probs=12.7
Q ss_pred HHHHHHHHHHHHHHHHHHhhhcccc
Q 006083 177 GVGIFLIAMIIICAVRANKKKKKRH 201 (662)
Q Consensus 177 ~~~~~~i~~~~~~~~~~~rkr~~~~ 201 (662)
+++.+++++++.+.+..+.|||+.+
T Consensus 17 ~vVGvll~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 17 AVVGILLVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred HHHHHHHHHHHHHHHHhheehhhhh
Confidence 3444444444445555666655554
|
| >2k1a_A Integrin alpha-IIB; single-PASS transmembrane segment, alternative splicing, calcium, cell adhesion, cleavage on PAIR of basic residues; NMR {Homo sapiens} PDB: 2k9j_A | Back alignment and structure |
|---|
Probab=86.40 E-value=0.16 Score=34.95 Aligned_cols=24 Identities=17% Similarity=0.344 Sum_probs=14.9
Q ss_pred ceeEEEchhHHHHHHHHHHHHHHH
Q 006083 168 VTYSVIGAVGVGIFLIAMIIICAV 191 (662)
Q Consensus 168 ~~~~v~~~v~~~~~~i~~~~~~~~ 191 (662)
.+.+|++.+++++++++++++.+|
T Consensus 9 p~wiIi~s~l~GLllL~li~~~Lw 32 (42)
T 2k1a_A 9 PIWWVLVGVLGGLLLLTILVLAMW 32 (42)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHHHHHHHH
Confidence 445566666667777666666555
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.08 E-value=0.098 Score=56.73 Aligned_cols=60 Identities=5% Similarity=0.009 Sum_probs=17.8
Q ss_pred ccceeeccCceEEEEEEecC-CCEEEE------EEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 006083 320 KSNLLGQGGFGYVHKGVLPN-GKEVAV------KSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCI 382 (662)
Q Consensus 320 ~~~~iG~G~~g~Vy~~~~~~-g~~vav------K~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 382 (662)
+.+.|| ||.||+|.+.. ...||| |.++.+.. +....|.+|..+++.++|+|+++.++|..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 456676 99999999743 357888 76654322 23356888999999999999999988765
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=82.26 E-value=15 Score=41.25 Aligned_cols=45 Identities=22% Similarity=0.184 Sum_probs=32.3
Q ss_pred HHHHHHHHHHH--HHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccc
Q 006083 414 ATRVRIALGSA--KGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 414 ~~~~~i~~~ia--~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
..+..++..+| ..+.|+=.. +|-+++||||+++|++.=+|||++.
T Consensus 529 ~ar~nF~~SlA~~Svv~YILGl-------GDRH~~NILid~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 529 EVMDTYIKSCAGYCVITYLLGV-------GDRHLDNLLLTTNGKLFHIDFGYIL 575 (696)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTC-------CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred HHHHHHHHHHHHHHHHHHHccC-------CCCCCcceEEeCCCCEEEEeehhhh
Confidence 34444555444 344555433 6889999999999999999999874
|
| >2k9j_B Integrin beta-3; transmembrane complex, cell adhesion, cleavage on basic residues, disease mutation, glycoprotein, pyrrolidone carboxylic acid; NMR {Homo sapiens} PDB: 2rmz_A 2rn0_A 2l91_A | Back alignment and structure |
|---|
Probab=81.33 E-value=0.44 Score=32.98 Aligned_cols=28 Identities=18% Similarity=0.103 Sum_probs=16.6
Q ss_pred eeEEEchhHHHHHHHHHHHHHHHHHHhh
Q 006083 169 TYSVIGAVGVGIFLIAMIIICAVRANKK 196 (662)
Q Consensus 169 ~~~v~~~v~~~~~~i~~~~~~~~~~~rk 196 (662)
+..|+++++++++++.++++++|+..-.
T Consensus 9 ~~~Iv~gvi~~ivliGl~lLliwk~~~~ 36 (43)
T 2k9j_B 9 ILVVLLSVMGAILLIGLAALLIWKLLIT 36 (43)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeehHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 3445555666677677666666655433
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=80.42 E-value=23 Score=39.20 Aligned_cols=83 Identities=13% Similarity=0.119 Sum_probs=49.5
Q ss_pred ceEEEEEEeCCeEEEEEEecCCcchhhhhccCC-------------CC--CCCHHHHHHHHHHHH--HHHHHHHhcCCCc
Q 006083 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGEN-------------RP--VMDFATRVRIALGSA--KGLAYLHEDCHPR 437 (662)
Q Consensus 375 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-------------~~--~l~~~~~~~i~~~ia--~aL~yLH~~~~~~ 437 (662)
++.|.+.-.+....| .|++.+.++.+.+...+ .. ...++.+..++..+| ..+.|+=..
T Consensus 402 i~~Y~Vipls~~~Gl-IE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YILGi---- 476 (614)
T 3ls8_A 402 LTPYKVLATSTKHGF-MQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGV---- 476 (614)
T ss_dssp CCCCCEEESSSSEEE-EECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHHTC----
T ss_pred eeccEEEEecCCCce-EEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheeeec----
Confidence 344444444444443 57777655555442211 00 112444555555554 345666433
Q ss_pred eeecCCccCcEEECCCCcEEEEeecccc
Q 006083 438 IIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 438 ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
+|=+++||||+.+|++.=+|||.+.
T Consensus 477 ---gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 477 ---GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp ---CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred ---cCCCCcceeEcCCCCEeeeehHHhh
Confidence 5778999999999999999999874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 662 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-67 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-63 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-26 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 2e-71
Identities = 73/276 (26%), Positives = 131/276 (47%), Gaps = 28/276 (10%)
Query: 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
+G G FG V+KG V + ++ + Q + F EV ++ + H +++ +GY
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441
Q +V ++ +L +HLH + + IA +A+G+ YLH IIHR
Sbjct: 74 T-APQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 442 DIKAANILIDDNFEAMVADFGLAKL-SNDNHTHVSTRVMGTFGYLAPEYA---SSGKLTE 497
D+K+ NI + ++ + DFGLA + S + +H ++ G+ ++APE +
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 498 KSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE--HN 555
+SDV++FG++L EL+TG+ P D ++ + G + P L +
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM------------VGRGYLSPDLSKVRS 236
Query: 556 YVPHEMARLVA-CGAASIRHSARKRPKMSQIVRALE 590
P M RL+A C ++ +RP QI+ ++E
Sbjct: 237 NCPKAMKRLMAEC----LKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 4e-68
Identities = 78/270 (28%), Positives = 120/270 (44%), Gaps = 24/270 (8%)
Query: 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
LG G FG V G +VAVKSLK GS F AE ++ ++ H+ LV L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441
++ E++ N +L L + + + +A A+G+A++ E IHR
Sbjct: 78 T-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 442 DIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 501
D++AANIL+ D +ADFGLA+L DN + APE + G T KSDV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 502 FSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEM 561
+SFG++L E++T R M +++ + G R ++ P E+
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQN------------LERGYRMVRPDN--CPEEL 239
Query: 562 ARLV-ACGAASIRHSARKRPKMSQIVRALE 590
+L+ C + RP + LE
Sbjct: 240 YQLMRLC----WKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 4e-67
Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 24/274 (8%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSL 377
+G G FG VH G N +VA+K+++ G+ E +F E E++ ++ H LV L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
G C+ LV+EF+ + L +L R + T + + L +G+AYL
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL---EEAC 121
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTE 497
+IHRD+ A N L+ +N V+DFG+ + D+ ST + +PE S + +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 498 KSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYV 557
KSDV+SFGV++ E+ + + +VE + G L PRL
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED--------ISTGFR--LYKPRL----A 227
Query: 558 PHEMARLV-ACGAASIRHSARKRPKMSQIVRALE 590
+ +++ C + RP S+++R L
Sbjct: 228 STHVYQIMNHC----WKERPEDRPAFSRLLRQLA 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 1e-64
Identities = 61/292 (20%), Positives = 119/292 (40%), Gaps = 34/292 (11%)
Query: 324 LGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA 383
+G+G FG V +G G+EVAVK + + AE+ + H +++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 384 GG----QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC----- 434
Q LV ++ + +L +L+ R + +++AL +A GLA+LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKL---SNDNHTHVSTRVMGTFGYLAPEYAS 491
P I HRD+K+ NIL+ N +AD GLA + D +GT Y+APE
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 492 S------GKLTEKSDVFSFGVMLLELITGRRPVD------MTMMEDSLVEWARPLLGAAL 539
+ +++D+++ G++ E+ + + + + +
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE----EM 241
Query: 540 EDGIYDGLVDPRLEHNYVPHEMARLVA-CGAASIRHSARKRPKMSQIVRALE 590
+ + + P + + + E R++A + R +I + L
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 3e-64
Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 9/225 (4%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE-FSAEVEIISRVHHRHLV 375
F K + LG G G V K P+G +A K + R E++++ + ++V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
G + G+ + E + +L+ L R + ++++ KGL YL E
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH- 124
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL 495
+I+HRD+K +NIL++ E + DFG++ D+ +GT Y++PE
Sbjct: 125 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHY 180
Query: 496 TEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALE 540
+ +SD++S G+ L+E+ GR P+ ++ + + + G A E
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (536), Expect = 1e-63
Identities = 76/305 (24%), Positives = 128/305 (41%), Gaps = 41/305 (13%)
Query: 305 TFTYDELAAATGGFAKS---------NLLGQGGFGYVHKGVLPNGKE----VAVKSLKTG 351
FT+++ A FAK ++G G FG V G L + VA+K+LK+G
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 352 -SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPV 410
+ + R+F +E I+ + H +++ L G M++ EF+ N +L+ L +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ- 124
Query: 411 MDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470
V + G A G+ YL +HRD+ A NIL++ N V+DFGL++ D+
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 471 HTHVSTR----VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDS 526
+ + + APE K T SDV+S+G+++ E+++ M
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
Query: 527 LVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLV-ACGAASIRHSARKRPKMSQI 585
++ I P P + +L+ C + RPK QI
Sbjct: 242 VINA------------IEQDYRLPPPMD--CPSALHQLMLDC----WQKDRNHRPKFGQI 283
Query: 586 VRALE 590
V L+
Sbjct: 284 VNTLD 288
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-63
Identities = 62/270 (22%), Positives = 107/270 (39%), Gaps = 24/270 (8%)
Query: 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
LG G FG V G +VA+K +K GS E EF E +++ + H LV L G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441
++ E+++N L +L + + + + YL + +HR
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 124
Query: 442 DIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 501
D+ A N L++D V+DFGL++ D+ S + PE K + KSD+
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 502 FSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEM 561
++FGV++ E+ + + E I GL R ++
Sbjct: 185 WAFGVLMWEIYSLGKMPYERFTNSETAEH------------IAQGLRLYRPHL--ASEKV 230
Query: 562 ARLV-ACGAASIRHSARKRPKMSQIVRALE 590
++ +C A +RP ++ +
Sbjct: 231 YTIMYSC----WHEKADERPTFKILLSNIL 256
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 4e-63
Identities = 67/271 (24%), Positives = 117/271 (43%), Gaps = 30/271 (11%)
Query: 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
+G+G FG V G G +VAVK +K + + F AE +++++ H +LV L+G
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 382 I-AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIH 440
+ G +V E+++ +L +L R V+ ++ +L + + YL +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126
Query: 441 RDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSD 500
RD+ A N+L+ ++ A V+DFGL K ++ + APE K + KSD
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALREKKFSTKSD 182
Query: 501 VFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHE 560
V+SFG++L E+ + R + +V + G + P
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLKDVVPR------------VEKGYKMDAPDG--CPPA 228
Query: 561 MARLVA-CGAASIRHSARKRPKMSQIVRALE 590
+ ++ C A RP Q+ LE
Sbjct: 229 VYEVMKNC----WHLDAAMRPSFLQLREQLE 255
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 2e-62
Identities = 81/270 (30%), Positives = 117/270 (43%), Gaps = 24/270 (8%)
Query: 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
LGQG FG V G VA+K+LK G+ F E +++ ++ H LV L
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 81
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441
+V E++S +L L GE + V +A A G+AY+ +HR
Sbjct: 82 S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 137
Query: 442 DIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 501
D++AANIL+ +N VADFGLA+L DN + APE A G+ T KSDV
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 197
Query: 502 FSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEM 561
+SFG++L EL T R M+ +++ + G P P +
Sbjct: 198 WSFGILLTELTTKGRVPYPGMVNREVLDQ------------VERGYRMPCPPE--CPESL 243
Query: 562 ARLVA-CGAASIRHSARKRPKMSQIVRALE 590
L+ C R +RP + LE
Sbjct: 244 HDLMCQC----WRKEPEERPTFEYLQAFLE 269
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (516), Expect = 6e-61
Identities = 78/312 (25%), Positives = 129/312 (41%), Gaps = 36/312 (11%)
Query: 290 LPPPSPNIALGFNKSTFTYDELAAATGGFAKSNLLGQGGFGYVHKGVLPN-GKEVAVKSL 348
+ P SPN YD+ + LG G +G V++GV VAVK+L
Sbjct: 2 MDPSSPN-----------YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL 50
Query: 349 KTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENR 408
K + + E EF E ++ + H +LV L+G C ++ EF++ L +L NR
Sbjct: 51 KEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 109
Query: 409 PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468
+ + +A + + YL + IHRD+ A N L+ +N VADFGL++L
Sbjct: 110 QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166
Query: 469 DNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLV 528
+ + APE + K + KSDV++FGV+L E+ T + +
Sbjct: 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226
Query: 529 EWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588
E L++ ++ A + + RP ++I +A
Sbjct: 227 E-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 269
Query: 589 LEG---DSSLDD 597
E +SS+ D
Sbjct: 270 FETMFQESSISD 281
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-60
Identities = 74/280 (26%), Positives = 120/280 (42%), Gaps = 32/280 (11%)
Query: 321 SNLLGQGGFGYVHKGVLPNGK----EVAVKSLKTGSGQGE-REFSAEVEIISRVHHRHLV 375
+ ++G+G FG V+ G L + AVKSL + GE +F E I+ H +++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 376 SLVGYCI-AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
SL+G C+ + G ++V ++ + L + + L AKG+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGM---KFLA 147
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN---HTHVSTRVMGTFGYLAPEYAS 491
+ +HRD+ A N ++D+ F VADFGLA+ D H T ++A E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 492 SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551
+ K T KSDV+SFGV+L EL+T P + + + LL
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNTFDITVYLLQG-----------RRL 253
Query: 552 LEHNYVPHEMARLV-ACGAASIRHSARKRPKMSQIVRALE 590
L+ Y P + ++ C A RP S++V +
Sbjct: 254 LQPEYCPDPLYEVMLKC----WHPKAEMRPSFSELVSRIS 289
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (509), Expect = 1e-59
Identities = 67/300 (22%), Positives = 121/300 (40%), Gaps = 52/300 (17%)
Query: 322 NLLGQGGFGYVHKGVLPN------GKEVAVKSLK-TGSGQGEREFSAEVEIISRVHHRHL 374
+G+G FG V + P VAVK LK S + +F E +++ + ++
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENR----------------------PVMD 412
V L+G C G L++E+++ L L + P +
Sbjct: 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138
Query: 413 FATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNH 471
A ++ IA A G+AYL + +HRD+ N L+ +N +ADFGL++ + + ++
Sbjct: 139 CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195
Query: 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWA 531
++ PE + T +SDV+++GV+L E+ + M + ++ +
Sbjct: 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY- 254
Query: 532 RPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVA-CGAASIRHSARKRPKMSQIVRALE 590
+ DG + E+ P E+ L+ C RP I R L+
Sbjct: 255 -----------VRDGNILACPEN--CPLELYNLMRLC----WSKLPADRPSFCSIHRILQ 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-59
Identities = 64/274 (23%), Positives = 116/274 (42%), Gaps = 30/274 (10%)
Query: 324 LGQGGFGYVHKGVL---PNGKEVAVKSLKTGSGQGERE-FSAEVEIISRVHHRHLVSLVG 379
LG G FG V +GV +VA+K LK G+ + + E E +I+ ++ + ++V L+G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
C MLV E L L G+ + + + + G+ YL +
Sbjct: 77 VCQ-AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLE---EKNFV 131
Query: 440 HRDIKAANILIDDNFEAMVADFGLAKL--SNDNHTHVSTRVMGTFGYLAPEYASSGKLTE 497
HRD+ A N+L+ + A ++DFGL+K ++D++ + + APE + K +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 498 KSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYV 557
+SDV+S+GV + E ++ + M ++ + I G
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF------------IEQGKRMECPPE--C 237
Query: 558 PHEMARLV-ACGAASIRHSARKRPKMSQIVRALE 590
P E+ L+ C + RP + + +
Sbjct: 238 PPELYALMSDC----WIYKWEDRPDFLTVEQRMR 267
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 4e-59
Identities = 65/282 (23%), Positives = 118/282 (41%), Gaps = 29/282 (10%)
Query: 318 FAKSNLLGQGGFGYVHKGVLPNGKE-----VAVKSLKTGSGQGER-EFSAEVEIISRVHH 371
+ ++G G FG V+KG+L VA+K+LK G + +R +F E I+ + H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 372 RHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLH 431
+++ L G M++ E++ N E V + G A G+ YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL--SNDNHTHVSTRVMGTFGYLAPEY 489
+ +HRD+ A NIL++ N V+DFGL+++ + T+ ++ + APE
Sbjct: 128 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 490 ASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549
S K T SDV+SFG+++ E++T + +++ ++
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK-----------------AIN 227
Query: 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591
+ + + +RPK + IV L+
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-59
Identities = 77/297 (25%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 322 NLLGQGGFGYVHKGVL------PNGKEVAVKSLKTGSGQGERE-FSAEVEIISRV-HHRH 373
LG G FG V + VAVK LK + ERE +E++++S + +H +
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHG----------------ENRPVMDFATRV 417
+V+L+G C GG +++ E+ L L ++ +D +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 418 RIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVST 476
+ AKG+A+L IHRD+ A NIL+ + DFGLA+ + ND++ V
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 477 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLG 536
++APE + T +SDV+S+G+ L EL + M DS
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY------- 258
Query: 537 AALEDGIYDGLVDPRLEHNYVPHEMARLV-ACGAASIRHSARKRPKMSQIVRALEGD 592
+++G L + P EM ++ C KRP QIV+ +E
Sbjct: 259 KMIKEGF------RMLSPEHAPAEMYDIMKTC----WDADPLKRPTFKQIVQLIEKQ 305
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 5e-59
Identities = 70/290 (24%), Positives = 115/290 (39%), Gaps = 33/290 (11%)
Query: 320 KSNLLGQGGFGYVHKGVLPN---GKEVAVKSLKTGSGQGE--REFSAEVEIISRVHHRHL 374
+ LG G FG V KG K VAVK LK + E AE ++ ++ + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
V ++G C MLV E L +L + + + + G+ YL
Sbjct: 71 VRMIGICE-AESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE--- 124
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKL--SNDNHTHVSTRVMGTFGYLAPEYASS 492
+HRD+ A N+L+ A ++DFGL+K +++N+ T + APE +
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 493 GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552
K + KSDV+SFGV++ E + + M + + G
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM------------LEKGERMGCP 232
Query: 553 EHNYVPHEMARLV-ACGAASIRHSARKRPKMSQIVRALEGDSSLDDLNDG 601
P EM L+ C + RP + + L + D +N+G
Sbjct: 233 AG--CPREMYDLMNLC----WTYDVENRPGFAAVELRLR-NYYYDVVNEG 275
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 2e-58
Identities = 66/273 (24%), Positives = 110/273 (40%), Gaps = 33/273 (12%)
Query: 324 LGQGGFGYVHKGVLP-NGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGY 380
+G+G F V+KG+ EVA L+ + + F E E++ + H ++V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 381 CIA----GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
+ +LV E +++ TL+ +L VM KGL +LH P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHT-RTP 133
Query: 437 RIIHRDIKAANILIDD-NFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL 495
IIHRD+K NI I + D GLA L + V+GT ++APE K
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMYE-EKY 189
Query: 496 TEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHN 555
E DV++FG+ +LE+ T P + + G+ +
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR------------VTSGVKPASFDKV 237
Query: 556 YVPHEMARLV-ACGAASIRHSARKRPKMSQIVR 587
+P E+ ++ C IR + +R + ++
Sbjct: 238 AIP-EVKEIIEGC----IRQNKDERYSIKDLLN 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 2e-57
Identities = 70/300 (23%), Positives = 125/300 (41%), Gaps = 53/300 (17%)
Query: 323 LLGQGGFGYVHKGVLPN------GKEVAVKSLKTGSGQGERE-FSAEVEIISRV-HHRHL 374
+LG G FG V +VAVK LK + ERE +E+++++++ H ++
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRP---------------------VMDF 413
V+L+G C G L++E+ L +L + V+ F
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 414 ATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHT 472
+ A AKG+ +L +HRD+ A N+L+ + DFGLA+ + +D++
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWA 531
V ++APE G T KSDV+S+G++L E+ + G P ++ + +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL- 279
Query: 532 RPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLV-ACGAASIRHSARKRPKMSQIVRALE 590
I +G + + E+ ++ +C +RKRP + L
Sbjct: 280 -----------IQNGFKMDQPFY--ATEEIYIIMQSC----WAFDSRKRPSFPNLTSFLG 322
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 2e-57
Identities = 64/274 (23%), Positives = 117/274 (42%), Gaps = 29/274 (10%)
Query: 323 LLGQGGFGYVHKGVLPNGKE----VAVKSLKTGSGQGERE-FSAEVEIISRVHHRHLVSL 377
+G+G FG VH+G+ + + VA+K+ K + RE F E + + H H+V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
+G ++ E + L L +D A+ + A + LAYL R
Sbjct: 74 IGVIT-ENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLES---KR 128
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTE 497
+HRDI A N+L+ N + DFGL++ D+ + +++ ++APE + + T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 498 KSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYV 557
SDV+ FGV + E++ + + ++ I +G P +
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR------------IENGERLPMPPN--C 234
Query: 558 PHEMARLVA-CGAASIRHSARKRPKMSQIVRALE 590
P + L+ C + +RP+ +++ L
Sbjct: 235 PPTLYSLMTKC----WAYDPSRRPRFTELKAQLS 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 5e-57
Identities = 63/276 (22%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 322 NLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLV 378
+G G +G K +GK + K L GS ++ +EV ++ + H ++V
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 379 GYCI--AGGQRMLVYEFVSNKTLEYHLH--GENRPVMDFATRVRIALGSAKGLAYLHE-- 432
I +V E+ L + + R +D +R+ L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 433 DCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS 492
D ++HRD+K AN+ +D + DFGLA++ N + T + +GT Y++PE +
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMNR 188
Query: 493 GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552
EKSD++S G +L EL P S E A + +G + R+
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPP----FTAFSQKELAG-----KIREGKF-----RRI 234
Query: 553 EHNYVPHEMARLVA-CGAASIRHSARKRPKMSQIVR 587
+ Y E+ ++ + RP + +I+
Sbjct: 235 PYRY-SDELNEIITRM----LNLKDYHRPSVEEILE 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-56
Identities = 64/270 (23%), Positives = 112/270 (41%), Gaps = 31/270 (11%)
Query: 322 NLLGQGGFGYVHKGVLP-NGKEVAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLVSL 377
LG+G FG V+ + +A+K L E + EVEI S + H +++ L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
GY + L+ E+ T+ L ++ D A L+Y H R
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHS---KR 126
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTE 497
+IHRDIK N+L+ E +ADFG + + + + GT YL PE E
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGRMHDE 183
Query: 498 KSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYV 557
K D++S GV+ E + G+ P + +++ +R V+ ++V
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR---------------VEFTFP-DFV 227
Query: 558 PHEMARLVACGAASIRHSARKRPKMSQIVR 587
L++ ++H+ +RP + +++
Sbjct: 228 TEGARDLISRL---LKHNPSQRPMLREVLE 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (485), Expect = 4e-56
Identities = 61/278 (21%), Positives = 110/278 (39%), Gaps = 36/278 (12%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGE---REFSAEVEIISRVHHRH 373
F+ +G G FG V+ + N + VA+K + Q ++ EV + ++ H +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED 433
+ G + LV E+ + + + + G+ +GLAYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHS- 133
Query: 434 CHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS- 492
+IHRD+KA NIL+ + + DFG A + ++ V GT ++APE +
Sbjct: 134 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAM 186
Query: 493 --GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550
G+ K DV+S G+ +EL + P+ +L A+ P
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--------------ESP 232
Query: 551 RLEHNYVPHEMARLVA-CGAASIRHSARKRPKMSQIVR 587
L+ + V C ++ + RP +++
Sbjct: 233 ALQSGHWSEYFRNFVDSC----LQKIPQDRPTSEVLLK 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-55
Identities = 56/272 (20%), Positives = 106/272 (38%), Gaps = 27/272 (9%)
Query: 322 NLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGY 380
LG G FG V+K A K + T S + ++ E++I++ H ++V L+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 381 CIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIH 440
++ EF + ++ + RP + + + + L YLH+ +IIH
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNYLHD---NKIIH 133
Query: 441 RDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYA-----SSGKL 495
RD+KA NIL + + +ADFG++ + + + GT ++APE
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPY 192
Query: 496 TEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHN 555
K+DV+S G+ L+E+ P L++ I + +
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK-------------IAKSEPPTLAQPS 239
Query: 556 YVPHEMARLVACGAASIRHSARKRPKMSQIVR 587
+ + + R SQ+++
Sbjct: 240 RWSSNFKDFL---KKCLEKNVDARWTTSQLLQ 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 4e-55
Identities = 69/277 (24%), Positives = 104/277 (37%), Gaps = 32/277 (11%)
Query: 324 LGQGGFGYVHKGVLP----NGKEVAVKSLK---TGSGQGEREFSAEVEIISRVHHRHLVS 376
LG G FG V +G VAVK LK + +F EV + + HR+L+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
L G + +M V E +L L T R A+ A+G+ YL
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLES---K 130
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH--VSTRVMGTFGYLAPEYASSGK 494
R IHRD+ A N+L+ + DFGL + N H + F + APE +
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 495 LTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554
+ SD + FGV L E+ T + + + ++ +G PR E
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI-----------DKEGERLPRPED 239
Query: 555 NYVPHEMARLVA-CGAASIRHSARKRPKMSQIVRALE 590
P ++ ++ C H RP + L
Sbjct: 240 --CPQDIYNVMVQC----WAHKPEDRPTFVALRDFLL 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 7e-54
Identities = 60/270 (22%), Positives = 98/270 (36%), Gaps = 25/270 (9%)
Query: 322 NLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE-FSAEVEIISRVHHRHLVSLVG 379
LG+G +G V V + VAVK + E E+ I ++H ++V G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
+ G + L E+ S L + + M R G+ YLH I
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH---GIGIT 125
Query: 440 HRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTFGYLAPEYASSGKL-TE 497
HRDIK N+L+D+ ++DFGLA +N + ++ GT Y+APE + E
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 498 KSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYV 557
DV+S G++L ++ G P D + +
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-------------DWKEKKTYLNPWKKI 232
Query: 558 PHEMARLVACGAASIRHSARKRPKMSQIVR 587
L+ + + R + I +
Sbjct: 233 DSAPLALL---HKILVENPSARITIPDIKK 259
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-53
Identities = 72/317 (22%), Positives = 129/317 (40%), Gaps = 45/317 (14%)
Query: 322 NLLGQGGFGYVHKGVLPNG---KEVAVKSLK-TGSGQGEREFSAEVEIISRV-HHRHLVS 376
+++G+G FG V K + + A+K +K S R+F+ E+E++ ++ HH ++++
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHG--------------ENRPVMDFATRVRIALG 422
L+G C G L E+ + L L + + A
Sbjct: 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135
Query: 423 SAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTF 482
A+G+ YL + + IHRD+ A NIL+ +N+ A +ADFGL++ T
Sbjct: 136 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPV 190
Query: 483 GYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDG 542
++A E + T SDV+S+GV+L E+++ M L E
Sbjct: 191 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------------ 238
Query: 543 IYDGLVDPRLEHNYVPHEMARLV-ACGAASIRHSARKRPKMSQIVRALEGDSSLDDLNDG 601
+ G + + E+ L+ C R +RP +QI+ +L L++
Sbjct: 239 LPQGYRLEKPLN--CDDEVYDLMRQC----WREKPYERPSFAQILVSLN--RMLEERKTY 290
Query: 602 VRPGQSSAFSASNTSTE 618
V F+ +
Sbjct: 291 VNTTLYEKFTYAGIDCS 307
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 3e-53
Identities = 66/283 (23%), Positives = 120/283 (42%), Gaps = 35/283 (12%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKE----VAVKSLKTG-SGQGEREFSAEVEIISRVHH 371
F K +LG G FG V+KG+ +P G++ VA+K L+ S + +E E +++ V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 372 RHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLH 431
H+ L+G C+ L+ + + L + E++ + + + AKG+ YL
Sbjct: 71 PHVCRLLGICLTS-TVQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYL- 127
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTFGYLAPEYA 490
R++HRD+ A N+L+ + DFGLAK L + + + ++A E
Sbjct: 128 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 491 SSGKLTEKSDVFSFGVMLLELITGRRPV--DMTMMEDSLVEWARPLLGAALEDGIYDGLV 548
T +SDV+S+GV + EL+T + E + + G
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------------ISSILEKGER 231
Query: 549 DPRLEHNYVPHEMARLV-ACGAASIRHSARKRPKMSQIVRALE 590
P+ ++ ++ C A RPK +++
Sbjct: 232 LPQPPI--CTIDVYMIMVKC----WMIDADSRPKFRELIIEFS 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 4e-51
Identities = 49/197 (24%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 322 NLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGY 380
+GQG G V+ + + G+EVA++ + + E+ ++ + ++V+ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 381 CIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIH 440
+ G + +V E+++ +L + MD + + L +LH + ++IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 441 RDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSD 500
RDIK+ NIL+ + + DFG + ST V GT ++APE + K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 501 VFSFGVMLLELITGRRP 517
++S G+M +E+I G P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-49
Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 45/294 (15%)
Query: 322 NLLGQGGFGYVHKGV------LPNGKEVAVKSLKTGSGQGE-REFSAEVEIISR-VHHRH 373
LG+G FG V + + VAVK LK G+ E R +E++I+ HH +
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 374 LVSLVGYCI-AGGQRMLVYEFVSNKTLEYHLHGEN--------------RPVMDFATRVR 418
+V+L+G C GG M++ EF L +L + + + +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 419 IALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV-STR 477
+ AKG+ +L + IHRD+ A NIL+ + + DFGLA+ + +V
Sbjct: 139 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 478 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGA 537
++APE T +SDV+SFGV+L E+ + + D
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-------R 248
Query: 538 ALEDGIYDGLVDPRLEHNYVPHEMARLVA-CGAASIRHSARKRPKMSQIVRALE 590
L++G D Y EM + + C +RP S++V L
Sbjct: 249 RLKEGTRMRAPD------YTTPEMYQTMLDC----WHGEPSQRPTFSELVEHLG 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 2e-49
Identities = 68/300 (22%), Positives = 124/300 (41%), Gaps = 47/300 (15%)
Query: 322 NLLGQGGFGYVHKGVLP--------NGKEVAVKSLKTGSGQGE-REFSAEVEIISRV-HH 371
LG+G FG V +VAVK LK+ + + + + +E+E++ + H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 372 RHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRP--------------VMDFATRV 417
+++++L+G C G ++ E+ S L +L P + V
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 418 RIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTR 477
A A+G+ YL + IHRD+ A N+L+ ++ +ADFGLA+ + + T
Sbjct: 139 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 478 VM-GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLG 536
++APE T +SDV+SFGV+L E+ T + + L +
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL------ 249
Query: 537 AALEDGIYDGLVDPRLEHNYVPHEMARLV-ACGAASIRHSARKRPKMSQIVRALEGDSSL 595
+ +G + + +E+ ++ C +RP Q+V L+ +L
Sbjct: 250 ------LKEGHRMDKPSN--CTNELYMMMRDC----WHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-48
Identities = 61/288 (21%), Positives = 128/288 (44%), Gaps = 38/288 (13%)
Query: 322 NLLGQGGFGYVHKGVLPN------GKEVAVKSLKTGSGQGER-EFSAEVEIISRVHHRHL 374
LGQG FG V++GV VA+K++ + ER EF E ++ + H+
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHLH--------GENRPVMDFATRVRIALGSAKG 426
V L+G G +++ E ++ L+ +L + +++A A G
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 427 LAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK-LSNDNHTHVSTRVMGTFGYL 485
+AYL + +HRD+ A N ++ ++F + DFG+ + + ++ + + ++
Sbjct: 146 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202
Query: 486 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545
+PE G T SDV+SFGV+L E+ T + + ++ + + +
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VME 250
Query: 546 GLVDPRLEHNYVPHEMARLVA-CGAASIRHSARKRPKMSQIVRALEGD 592
G + + ++ P + L+ C +++ + RP +I+ +++ +
Sbjct: 251 GGLLDKPDN--CPDMLFELMRMC----WQYNPKMRPSFLEIISSIKEE 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 165 bits (419), Expect = 3e-47
Identities = 67/279 (24%), Positives = 118/279 (42%), Gaps = 31/279 (11%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGE---REFSAEVEIISRVHHRHLVSLV 378
+LG GG VH L ++VAVK L+ + F E + + ++H +V++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 379 GYCI----AGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
AG +V E+V TL +H E M + + + + L + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ-- 129
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKL--SNDNHTHVSTRVMGTFGYLAPEYASS 492
IIHRD+K ANI+I V DFG+A+ + N + V+GT YL+PE A
Sbjct: 130 -NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 493 GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552
+ +SDV+S G +L E++TG P + + + + + P
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPP------------FTGDSPVSVAYQHVREDPIPPSA 236
Query: 553 EHNYVPHEMARLVACGAASIRHSARKRPK-MSQIVRALE 590
H + ++ +V ++ + R + +++ L
Sbjct: 237 RHEGLSADLDAVV---LKALAKNPENRYQTAAEMRADLV 272
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 5e-47
Identities = 47/201 (23%), Positives = 87/201 (43%), Gaps = 10/201 (4%)
Query: 322 NLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGE---REFSAEVEIISRVHHRHLVSL 377
+LG+G F V L +E A+K L+ E + E +++SR+ H V L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
+ + N L ++ +A+ ++ L
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-----DETCTRFYTAEIVSALEYLHGKG 128
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLAKL-SNDNHTHVSTRVMGTFGYLAPEYASSGKLT 496
IIHRD+K NIL++++ + DFG AK+ S ++ + +GT Y++PE +
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 497 EKSDVFSFGVMLLELITGRRP 517
+ SD+++ G ++ +L+ G P
Sbjct: 189 KSSDLWALGCIIYQLVAGLPP 209
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (422), Expect = 1e-46
Identities = 59/269 (21%), Positives = 106/269 (39%), Gaps = 26/269 (9%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
LG G FG VH+ V G+ K + T + E+ I++++HH L++L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441
+ +L+ EF+S L + E+ M A + + +GL ++HE I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE---HSIVHL 151
Query: 442 DIKAANILID--DNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKS 499
DIK NI+ + + DFGLA N + T T + APE + +
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDREPVGFYT 209
Query: 500 DVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH-NYVP 558
D+++ GV+ L++G P ++L + + + + V
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLETL-------------QNVKRCDWEFDEDAFSSVS 256
Query: 559 HEMARLVACGAASIRHSARKRPKMSQIVR 587
E + ++ RKR + +
Sbjct: 257 PEAKDFI---KNLLQKEPRKRLTVHDALE 282
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (422), Expect = 1e-46
Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 9/198 (4%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
LG G FG VH+ G A K + T + E++ +S + H LV+L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441
+ +++YEF+S L + E+ M V KGL ++HE+ +H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN---YVHL 148
Query: 442 DIKAANILI--DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKS 499
D+K NI+ + E + DFGL + + T GT + APE A + +
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYT 206
Query: 500 DVFSFGVMLLELITGRRP 517
D++S GV+ L++G P
Sbjct: 207 DMWSVGVLSYILLSGLSP 224
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (414), Expect = 5e-46
Identities = 67/310 (21%), Positives = 130/310 (41%), Gaps = 30/310 (9%)
Query: 322 NLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE-FSAEVEIISRVHHRHLVSLVG 379
++LG G F V K VA+K + + +G+ E+ ++ ++ H ++V+L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
+GG L+ + VS L + + R+ + YLH+ I+
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDLG---IV 129
Query: 440 HRDIKAANILI---DDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLT 496
HRD+K N+L D++ + M++DFGL+K+ + + GT GY+APE + +
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL--STACGTPGYVAPEVLAQKPYS 187
Query: 497 EKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNY 556
+ D +S GV+ L+ G P +++ + +L A E +
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFY----DENDAKLFEQILKAEYE--------FDSPYWDD 235
Query: 557 VPHEMARLVACGAASIRHSARKRPKMSQIVRA--LEGDSSLD-DLNDGVRPGQSSAFSAS 613
+ + + KR Q ++ + GD++LD +++ V F+ S
Sbjct: 236 ISDSAKDFI---RHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKS 292
Query: 614 NTSTEYSATS 623
++AT+
Sbjct: 293 KWKQAFNATA 302
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 2e-45
Identities = 53/280 (18%), Positives = 94/280 (33%), Gaps = 31/280 (11%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
+G G FG ++ G + G+EVA+K + + E +I + + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 382 IA-GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIH 440
A G ++V E + + + T + +A + Y+H IH
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS---KNFIH 126
Query: 441 RDIKAANILI---DDNFEAMVADFGLAKLSNDNHTHV------STRVMGTFGYLAPEYAS 491
RD+K N L+ + DFGLAK D TH + + GT Y +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 492 SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551
+ + + D+ S G +L+ G P ++ R
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI--------SEKKMSTPIE 238
Query: 552 LEHNYVPHEMARLVA-CGAASIRHSARKRPKMSQIVRALE 590
+ P E A + C +P S + +
Sbjct: 239 VLCKGYPSEFATYLNFC----RSLRFDDKPDYSYLRQLFR 274
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 3e-45
Identities = 60/284 (21%), Positives = 105/284 (36%), Gaps = 26/284 (9%)
Query: 322 NLLGQGGFGYVHKG--VLPNGKEVAVKSLKTGSGQGEREFSAEVEI-----ISRVHHRHL 374
+G+G +G V K + G+ VA+K ++ +G+ S E+ + H ++
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 375 VSLVGYCIAGGQR-----MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAY 429
V L C LV+E V Y P + T + +GL +
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDF 131
Query: 430 LHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEY 489
LH ++HRD+K NIL+ + + +ADFGLA++ + T V+ T Y APE
Sbjct: 132 LHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEV 186
Query: 490 ASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549
D++S G + E+ + + D L + + ED D +
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 550 PRLEHNYVPHEMARLVACGAASIRH--------SARKRPKMSQI 585
+ H+ + + V + + KR
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 161 bits (407), Expect = 1e-44
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 16/216 (7%)
Query: 318 FAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLK---TGSGQGEREFSAEVEIISRVH--- 370
F+ ++G+GGFG V+ GK A+K L QGE E ++S V
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 371 HRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYL 430
+V + + + + ++ L YHL V A A GL ++
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHM 123
Query: 431 HEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYA 490
H +++RD+K ANIL+D++ ++D GLA + H +GT GY+APE
Sbjct: 124 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVL 177
Query: 491 SSGK-LTEKSDVFSFGVMLLELITGRRPVDMTMMED 525
G +D FS G ML +L+ G P +D
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (397), Expect = 4e-44
Identities = 58/285 (20%), Positives = 105/285 (36%), Gaps = 39/285 (13%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSG---------QGEREFSAEVEIIS 367
+ +LG+G V + + P KE AVK + G + EV+I+
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 368 RVH-HRHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKG 426
+V H +++ L LV++ + L +L + + +I +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEV 122
Query: 427 LAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLA 486
+ LH+ I+HRD+K NIL+DD+ + DFG + + V GT YLA
Sbjct: 123 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLA 177
Query: 487 PEYASSG------KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALE 540
PE ++ D++S GV++ L+ G P + R ++ +
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW----HRKQMLMLRMIMSGNYQ 233
Query: 541 DGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQI 585
E + + LV + + +KR +
Sbjct: 234 --------FGSPEWDDYSDTVKDLV---SRFLVVQPQKRYTAEEA 267
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 156 bits (394), Expect = 2e-43
Identities = 46/281 (16%), Positives = 87/281 (30%), Gaps = 31/281 (11%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGY 380
+G+G FG + +G L N ++VA+K + E + + ++ +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 381 CIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIH 440
G +LV + + L T A + +HE +++
Sbjct: 70 GQEGLHNVLVIDLLGP--SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVY 124
Query: 441 RDIKAANILIDDNFEAM-----VADFGLAKLSNDNHTHV------STRVMGTFGYLAPEY 489
RDIK N LI V DFG+ K D T + GT Y++
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 490 ASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549
+ + + D+ + G + + + G P + ++ R G
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER--------IGEKKQSTP 236
Query: 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590
R P E + + + + P +
Sbjct: 237 LRELCAGFPEEFYKYMHY---ARNLAFDATPDYDYLQGLFS 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 155 bits (393), Expect = 2e-43
Identities = 55/279 (19%), Positives = 106/279 (37%), Gaps = 19/279 (6%)
Query: 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVG 379
+G+G +G V+K G+ A+K ++ E+ I+ + H ++V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
+ +LV+E + + E ++ T L G+AY H+ R++
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 440 HRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKS 499
HRD+K N+LI+ E +ADFGLA+ + ++ + S K +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 500 DVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPH 559
D++S G + E++ G D L+ R +LG + P+ + N+ +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR-ILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 560 EMARLVACGAAS-----------IRHSARKRPKMSQIVR 587
E + ++ +R Q +
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-43
Identities = 43/198 (21%), Positives = 85/198 (42%), Gaps = 10/198 (5%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
LG+G FG VH+ V + K K +K G + E+ I++ HR+++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 382 IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441
+ + ++++EF+S + ++ + ++ V + L +LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLHS---HNIGHF 126
Query: 442 DIKAANILIDDNFEAMV--ADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKS 499
DI+ NI+ + + +FG A+ + Y APE ++ +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 500 DVFSFGVMLLELITGRRP 517
D++S G ++ L++G P
Sbjct: 185 DMWSLGTLVYVLLSGINP 202
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 156 bits (394), Expect = 3e-43
Identities = 54/200 (27%), Positives = 83/200 (41%), Gaps = 13/200 (6%)
Query: 322 NLLGQGGFGYVHKGV-LPNGKEVAVKSLK---TGSGQGEREFSAEVEIISRVHHRHLVSL 377
LG G FG VH NG+ A+K LK + + E ++S V H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
G Q ++ +++ L L R A + L
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALEYLHSKD 124
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTE 497
II+RD+K NIL+D N + DFG AK D + GT Y+APE S+ +
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKPYNK 180
Query: 498 KSDVFSFGVMLLELITGRRP 517
D +SFG+++ E++ G P
Sbjct: 181 SIDWWSFGILIYEMLAGYTP 200
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-42
Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 11/201 (5%)
Query: 322 NLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE---FSAEVEIISRV-HHRHLVS 376
+LG+G FG V + A+K+LK + + E ++S H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 377 LVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
+ V E+++ L YH+ ++ D + A GL +LH
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHS---K 122
Query: 437 RIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLT 496
I++RD+K NIL+D + +ADFG+ K + +T GT Y+APE K
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKYN 181
Query: 497 EKSDVFSFGVMLLELITGRRP 517
D +SFGV+L E++ G+ P
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSP 202
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 5e-42
Identities = 45/203 (22%), Positives = 88/203 (43%), Gaps = 7/203 (3%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLK--TGSGQGEREFSAEVEIISRVHHRHL 374
F K +G+G +G V+K G+ VA+K ++ T + E+ ++ ++H ++
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 375 VSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
V L+ + LV+EF+ ++ L+ + + +GLA+ H
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGK 494
++HRD+K N+LI+ +ADFGLA+ + V+ +
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 495 LTEKSDVFSFGVMLLELITGRRP 517
+ D++S G + E++T R
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-40
Identities = 54/274 (19%), Positives = 96/274 (35%), Gaps = 30/274 (10%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGY 380
+LG G G V + ++ A+K L+ + EVE+ R H+V +V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 381 C----IAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHP 436
++V E + L + I + + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 437 RIIHRDIKAANILIDDNFE---AMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSG 493
I HRD+K N+L + DFG AK + +++ + T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPE 188
Query: 494 KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553
K + D++S GV++ L+ G P + E P E
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE--------FPNPE 240
Query: 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587
+ V E+ L+ ++ +R +++ +
Sbjct: 241 WSEVSEEVKMLIRN---LLKTEPTQRMTITEFMN 271
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 2e-40
Identities = 53/277 (19%), Positives = 102/277 (36%), Gaps = 35/277 (12%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGER------EFSAEVEIISRVHHRHLV 375
LG G F V K G + A K +K + R + EV I+ + H +++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
+L +L+ E V+ L L + + AT + L ++
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI-----LNGVYYLHS 131
Query: 436 PRIIHRDIKAANILIDDN----FEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYAS 491
+I H D+K NI++ D + DFGLA + + + GT ++APE +
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVN 189
Query: 492 SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551
L ++D++S GV+ L++G P +++L + +
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-------------VSAVNYEFE 236
Query: 552 LEH-NYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587
E+ + + + +KR + ++
Sbjct: 237 DEYFSNTSALAKDFI---RRLLVKDPKKRMTIQDSLQ 270
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-40
Identities = 57/295 (19%), Positives = 114/295 (38%), Gaps = 29/295 (9%)
Query: 315 TGGFAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE-FSAEVEIISRVHHR 372
+ + +G+G +G V N VA+K + Q + E++I+ R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 373 HLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVM-----DFATRVRIALGSAKGL 427
+++ + A + ++ + + + + ++ +GL
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYL----VTHLMGADLYKLLKTQHLSNDHICYFLYQILRGL 122
Query: 428 AYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS--TRVMGTFGYL 485
Y+H ++HRD+K +N+L++ + + DFGLA++++ +H H T + T Y
Sbjct: 123 KYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179
Query: 486 APEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIY 544
APE + K T+ D++S G +L E+++ R D L L + ED
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239
Query: 545 DGLVDPRLEHNYVPHEMARLVACGAASIRHSAR------------KRPKMSQIVR 587
+ R +PH+ + A KR ++ Q +
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 8e-39
Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 18/206 (8%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE------FSAEVEIISRVHHRH-- 373
LLG GGFG V+ G+ + + VA+K ++ E EV ++ +V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 374 LVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED 433
++ L+ + +L+ E + E + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHN- 128
Query: 434 CHPRIIHRDIKAANILID-DNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS 492
++HRDIK NILID + E + DFG L D T GT Y PE+
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWIRY 183
Query: 493 GKL-TEKSDVFSFGVMLLELITGRRP 517
+ + V+S G++L +++ G P
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIP 209
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 9e-39
Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 17/226 (7%)
Query: 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVS 376
+ + ++G G FG V++ L +G+ VA+K + Q +R + E++I+ ++ H ++V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 377 LVGYCIAGGQRM------LVYEFVSNKTLEYHLH-GENRPVMDFATRVRIALGSAKGLAY 429
L + + G++ LV ++V H + + + LAY
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 430 LHEDCHPRIIHRDIKAANILID-DNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPE 488
+H I HRDIK N+L+D D + DFG AK +V + + +
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRAPEL 193
Query: 489 YASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL 534
+ T DV+S G +L EL+ G+ D LVE + L
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-38
Identities = 48/203 (23%), Positives = 83/203 (40%), Gaps = 13/203 (6%)
Query: 322 NLLGQGGFGYVHKGVLPN-GKEVAVKSLKTGSGQG-----EREFSAEVEIISRVHHRHLV 375
+ LG+G F V+K N + VA+K +K G R E++++ + H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 376 SLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCH 435
L+ LV++F+ + L L
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT-----LQGLEYLHQ 118
Query: 436 PRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL 495
I+HRD+K N+L+D+N +ADFGLAK + + +V T Y APE ++
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARM 177
Query: 496 -TEKSDVFSFGVMLLELITGRRP 517
D+++ G +L EL+
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPF 200
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-38
Identities = 52/281 (18%), Positives = 99/281 (35%), Gaps = 21/281 (7%)
Query: 322 NLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLV 378
+G+G +G V K + VA+K ++ E+ ++ + H+++V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 379 GYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRI 438
+ + LV+EF +Y + + L L +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCHSRNV 122
Query: 439 IHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEK 498
+HRD+K N+LI+ N E +A+FGLA+ S V+ + + +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 499 SDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVP 558
D++S G + EL RP+ D ++ LLG E+ P + +
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 559 HEMARLVACGAASIRHSAR------------KRPKMSQIVR 587
LV + + R +R + ++
Sbjct: 243 PATTSLVNV-VPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 7e-37
Identities = 51/200 (25%), Positives = 80/200 (40%), Gaps = 10/200 (5%)
Query: 322 NLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE---FSAEVEIISRVHHRHLVSL 377
LLG+G FG V G+ A+K L+ + E E ++ H L +L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 378 VGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
+ V E+ + L +HL E T R A+ ++ L
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVF-----TEERARFYGAEIVSALEYLHSRD 125
Query: 438 IIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTE 497
+++RDIK N+++D + + DFGL K + GT YLAPE
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLEDNDYGR 184
Query: 498 KSDVFSFGVMLLELITGRRP 517
D + GV++ E++ GR P
Sbjct: 185 AVDWWGLGVVMYEMMCGRLP 204
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-36
Identities = 58/296 (19%), Positives = 111/296 (37%), Gaps = 33/296 (11%)
Query: 318 FAKSNLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQG--EREFSAEVEIISRVHHRHL 374
+ K +GQG FG V K G++VA+K + + + E++I+ + H ++
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 375 VSLVGYCIAGGQRM--------LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKG 426
V+L+ C LV++F + + + + RV L
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML----- 126
Query: 427 LAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK---LSNDNHTHVSTRVMGTFG 483
L L+ +I+HRD+KAAN+LI + +ADFGLA+ L+ ++ + T + T
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 484 YLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVD-------MTMMEDSLVEWARPLL 535
Y PE + D++ G ++ E+ T + + ++ +
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 536 GAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAAS------IRHSARKRPKMSQI 585
+Y+ L + + V + V A + +R
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 5e-35
Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 16/222 (7%)
Query: 322 NLLGQGGFGYVHKGVL----PNGKEVAVKSLK----TGSGQGEREFSAEVEIISRV-HHR 372
+LG G +G V GK A+K LK + E +++ +
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 373 HLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHE 432
LV+L + L+ ++++ L HL R + + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV-----GEIVLALEH 144
Query: 433 DCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASS 492
II+RDIK NIL+D N ++ DFGL+K + T + GT Y+AP+
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 493 GK--LTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWAR 532
G + D +S GV++ EL+TG P + ++S E +R
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 246
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-34
Identities = 47/228 (20%), Positives = 89/228 (39%), Gaps = 23/228 (10%)
Query: 303 KSTFTYDELAAATGGFAKS----NLLGQGGFGYVHKGV-LPNGKEVAVKSLKTG--SGQG 355
+S F E+ +G G +G V V G +VA+K L S
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 356 EREFSAEVEIISRVHHRHLVSLVGYCIAGGQR------MLVYEFVSNKTLEYHLHGENRP 409
+ E+ ++ + H +++ L+ LV F+ + H +
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--- 117
Query: 410 VMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469
+ + KGL Y+H HRD+K N+ ++++ E + DFGLA+ ++
Sbjct: 118 -LGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADS 173
Query: 470 NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRP 517
T V+ + + + T+ D++S G ++ E+ITG+
Sbjct: 174 EMT---GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (329), Expect = 4e-34
Identities = 53/198 (26%), Positives = 74/198 (37%), Gaps = 13/198 (6%)
Query: 324 LGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGERE---FSAEVEIISRVHHRHLVSLVG 379
LG G FG V +G A+K L ++ E I+ V+ LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRII 439
+V E+V+ + HL R A YLH +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 440 HRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKS 499
+RD+K N+LID V DFG AK + GT LAPE S +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEIILSKGYNKAV 219
Query: 500 DVFSFGVMLLELITGRRP 517
D ++ GV++ E+ G P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 7e-32
Identities = 44/214 (20%), Positives = 81/214 (37%), Gaps = 19/214 (8%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVG 379
+G G G V + VA+K L + + E+ ++ V+H++++SL+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 380 YCIA------GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED 433
LV E + + +D + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 138
Query: 434 CHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSG 493
IHRD+K +NI++ + + DFGLA+ + + T + T Y APE
Sbjct: 139 GI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPEVILGM 193
Query: 494 KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSL 527
E D++S G ++ E++ + D
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 117 bits (293), Expect = 2e-29
Identities = 44/202 (21%), Positives = 87/202 (43%), Gaps = 19/202 (9%)
Query: 322 NLLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVG 379
LG+G + V + + + N ++V VK LK +++ E++I+ + ++++L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLAD 97
Query: 380 YCIAGGQRM--LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR 437
R LV+E V+N + + K L Y H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG--- 149
Query: 438 IIHRDIKAANILID-DNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL- 495
I+HRD+K N++ID ++ + + D+GLA+ + + + + + PE ++
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMY 207
Query: 496 TEKSDVFSFGVMLLELITGRRP 517
D++S G ML +I + P
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEP 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (280), Expect = 2e-27
Identities = 41/214 (19%), Positives = 73/214 (34%), Gaps = 20/214 (9%)
Query: 323 LLGQGGFGYVHKGV-LPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYC 381
LG G F V + N VA+K ++ E E++++ RV+
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSMG 78
Query: 382 IAGGQRMLVYEFVSNKTLEY--------------HLHGENRPVMDFATRVRIALGSAKGL 427
++L + + + + +I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 428 AYLHEDCHPRIIHRDIKAANILID-DNFEAMVADFGLAKLSNDNHTHVSTR-VMGTFGYL 485
Y+H IIH DIK N+L++ + + +A L N + T Y
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 486 APEYASSGKLTEKSDVFSFGVMLLELITGRRPVD 519
+PE +D++S ++ ELITG +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 104 bits (259), Expect = 3e-26
Identities = 34/204 (16%), Positives = 61/204 (29%), Gaps = 33/204 (16%)
Query: 322 NLLGQGGFGYVHKGVLPNGKEVAVKSLKTGS----------GQGEREFSAEVEIISRVHH 371
L+G+G V E VK K G G+ FS +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 372 RHLVSLVGYCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLH 431
R L L G + VY + N L + + + + + +A +
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 432 EDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYAS 491
I+H D+ N+L+ + + DF + + L + +
Sbjct: 121 HRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWR---------EILERDVRN 167
Query: 492 -----SGKLTEKSDVFSFGVMLLE 510
S + D+ S +L+
Sbjct: 168 IITYFSRTYRTEKDINSAIDRILQ 191
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 5e-26
Identities = 41/203 (20%), Positives = 80/203 (39%), Gaps = 15/203 (7%)
Query: 322 NLLGQGGFGYVHKGV-LPNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLV 378
+ +G G +G V G VAVK L S + E+ ++ + H +++ L+
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 379 GYCIAGGQRM----LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC 434
+ ++ + D + + +GL Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSAD 141
Query: 435 HPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGK 494
HRD+K +N+ ++++ E + DFGLA+ ++D T V + +
Sbjct: 142 II---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMT---GYVATRWYRAPEIMLNWMH 195
Query: 495 LTEKSDVFSFGVMLLELITGRRP 517
+ D++S G ++ EL+TGR
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTL 218
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 662 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.96 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.53 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.97 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.82 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.7 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.38 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-53 Score=436.41 Aligned_cols=257 Identities=27% Similarity=0.363 Sum_probs=213.6
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
.++|++.+.||+|+||.||+|++. +|+.||||+++.+. ...++|++|+++|++++|+|||+++++|.+++.+||||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 456888999999999999999964 68899999997653 3467899999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
|.+|+|.++|.......+++..+++|+.||++||+|||++ +||||||||+||||++++.+||+|||+|+........
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 9999999999877677899999999999999999999998 9999999999999999999999999999987665444
Q ss_pred cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 474 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
......|+..|||||++.++.|+.++|||||||+||||++|+.||........+.+.. ..+.. ..+.
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i--------~~~~~-----~~~~ 238 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--------EKDYR-----MERP 238 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH--------HTTCC-----CCCC
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH--------hcCCC-----CCCC
Confidence 4455678999999999999999999999999999999999877765443333222221 11110 1111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
...+.+ +.+++.+||+.||++||++.||++.|+..
T Consensus 239 -~~~~~~---l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 239 -EGCPEK---VYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp -TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -ccchHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 123344 44555699999999999999999998753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=428.73 Aligned_cols=249 Identities=20% Similarity=0.334 Sum_probs=207.8
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
++|++.+.||+|+||.||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||+++++|.+++.+|||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999984 579999999998765566788999999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.||+|.+++... .+++.+++.++.||+.||+|||++ +||||||||+||||+.++++||+|||+|+....... .
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence 999999988643 489999999999999999999998 999999999999999999999999999987754332 2
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
....+||+.|||||++.++.|+.++|||||||+||||++|+.||......+.+..... .+.... ...
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~--------~~~~~~----~~~- 239 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT--------NGTPEL----QNP- 239 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------HCSCCC----SSG-
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh--------CCCCCC----CCc-
Confidence 3457899999999999999999999999999999999999999976654433332211 111110 001
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.....++. +++.+||+.||++||++.|+++
T Consensus 240 ~~~s~~~~---~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 240 EKLSAIFR---DFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGSCHHHH---HHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHH---HHHHHHccCChhHCcCHHHHhc
Confidence 11234444 4555999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=425.78 Aligned_cols=253 Identities=28% Similarity=0.477 Sum_probs=197.1
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
.+|++.+.||+|+||.||+|++.+++.||||+++... ...++|.+|+++|++++|+|||+++|+|.+++..+||||||.
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4688899999999999999998888999999997643 445789999999999999999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
+|+|.+++.... ..+++..+++++.||++||+|||++ +|+||||||+||||++++.+||+|||+++..........
T Consensus 84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999986543 4588999999999999999999998 899999999999999999999999999987765544444
Q ss_pred cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhC-CCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG-RRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
....||..|||||++.++.|+.++|||||||+||||+|+ +.+|......+ +.+... .+.. .. ..
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~-~~~~i~--------~~~~--~~----~p 224 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDIS--------TGFR--LY----KP 224 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH-HHHHHH--------HTCC--CC----CC
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH-HHHHHH--------hcCC--CC----Cc
Confidence 456799999999999999999999999999999999995 44454433222 221111 1110 00 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...+.+ +.+++.+||+.||++||+|+||++.|+.
T Consensus 225 ~~~~~~---l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 225 RLASTH---VYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cccCHH---HHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 223344 4555669999999999999999999985
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=426.83 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=200.9
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
++|++.+.||+|+||.||+|+. .+|+.||||+++.... +..+.+++|+++|++++|||||++++++.+++..||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 4699999999999999999995 4799999999976533 3346789999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC-C
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH-T 472 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~-~ 472 (662)
|.||+|.++|... ..+++.+++.++.||++||+|||++ +||||||||+||||++++++||+|||+|+...... .
T Consensus 85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999643 4589999999999999999999998 99999999999999999999999999998765332 2
Q ss_pred ccccccccCccccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
......+||+.|||||++.+..+ +.++||||||||||||++|+.||.............. .......
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~-------~~~~~~~----- 227 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-------EKKTYLN----- 227 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH-------TTCTTST-----
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh-------cCCCCCC-----
Confidence 23455789999999999988776 5789999999999999999999976543322111110 1111100
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
... ....++ .+++.+||+.||++||++.|+++
T Consensus 228 ~~~-~~s~~~---~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 PWK-KIDSAP---LALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TGG-GSCHHH---HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccc-cCCHHH---HHHHHHHcCCChhHCcCHHHHhc
Confidence 001 122334 44556999999999999999865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=428.22 Aligned_cols=255 Identities=30% Similarity=0.435 Sum_probs=208.0
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
.++|++.+.||+|+||.||+|++++++.||||+++... ...+.|.+|+++|++++|+|||++++++.+ +.+|||||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 35688899999999999999999888899999997643 445789999999999999999999998865 5679999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+|+|.+++.......+++..+++|+.||++||.|||++ +|+||||||+||||++++.+||+|||+|+.........
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999999988665555689999999999999999999998 99999999999999999999999999999876554444
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
.....|+..|||||++.++.++.++|||||||+||||+||..|+........+.... ..+. ... ..
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i--------~~~~-----~~~-~p 232 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--------ERGY-----RMV-RP 232 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH--------HTTC-----CCC-CC
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HhcC-----CCC-Cc
Confidence 455789999999999999999999999999999999999766654332222222111 1111 001 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...+.++ .+++.+||+.||++||+|.||++.|+.
T Consensus 233 ~~~~~~l---~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 233 DNCPEEL---YQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp TTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccChHHH---HHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 2234444 455569999999999999999999874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=423.01 Aligned_cols=245 Identities=26% Similarity=0.420 Sum_probs=205.4
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.+.||+|+||.||+|+. .+|+.||||++++. .....+.+.+|+++|++++|||||++++++.+++.+||||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4589999999999999999996 47899999999753 2234567899999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
|||.+|+|.++|.... .+++..++.++.||++||+|||++ +||||||||+||||++++.+||+|||+|+......
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 9999999999996543 489999999999999999999999 99999999999999999999999999998765432
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
....+||+.|||||++.+..|+.++|||||||+||||++|+.||......+.+..+.+ +.+ .
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~---------~~~------~ 222 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR---------VEF------T 222 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT---------TCC------C
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc---------CCC------C
Confidence 2456899999999999999999999999999999999999999987654443322111 111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+. ...+.++.+ ++.+||+.||++||++.||++
T Consensus 223 ~p-~~~s~~~~~---li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 FP-DFVTEGARD---LISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CC-TTSCHHHHH---HHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-ccCCHHHHH---HHHHHccCCHhHCcCHHHHHc
Confidence 11 123344444 455999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=420.99 Aligned_cols=257 Identities=28% Similarity=0.484 Sum_probs=200.6
Q ss_pred hCCCCccceeeccCceEEEEEEecCCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.++|.+.+.||+|+||.||+|++. ..||||+++.. .....+.|++|+++|++++|+|||++++++.+ +.++||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467999999999999999999863 36999999754 34556789999999999999999999998754 56899999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
||.||+|.++|+..+ ..+++..+++|+.||++||+|||++ +||||||||+||||++++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999997543 3589999999999999999999998 999999999999999999999999999987654322
Q ss_pred -ccccccccCccccCcccccC---CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 473 -HVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 473 -~~~~~~~Gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
.......||+.|||||++.+ +.|+.++|||||||+||||+||+.||......+.+..... .+.....+
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~--------~~~~~p~~ 231 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--------RGYLSPDL 231 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH--------HTSCCCCG
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHh--------cCCCCCcc
Confidence 23355789999999999864 3589999999999999999999999976544333322111 11111100
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
..+ ....+.++. +++.+||+.||++||++.||++.|+.
T Consensus 232 -~~~-~~~~~~~l~---~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 232 -SKV-RSNCPKAMK---RLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp -GGS-CTTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -hhc-cccchHHHH---HHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 011 112334444 45559999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-52 Score=422.62 Aligned_cols=253 Identities=22% Similarity=0.352 Sum_probs=193.2
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIA--GGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lv 390 (662)
++|++.+.||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+ ++.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5699999999999999999985 5789999999976532 345678999999999999999999999864 4668999
Q ss_pred EEecCCcchhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 391 YEFVSNKTLEYHLHGE--NRPVMDFATRVRIALGSAKGLAYLHEDC--HPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
||||.||+|.+++... .+..+++..++.++.||+.||+|||+++ ..+||||||||+||||++++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998542 3456899999999999999999999872 12499999999999999999999999999988
Q ss_pred cCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcccc
Q 006083 467 SNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDG 546 (662)
Q Consensus 467 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (662)
...... .....+||+.|||||++.+..|+.++||||||||||||++|+.||......+.+..+ ..+.+..
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i---------~~~~~~~ 233 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI---------REGKFRR 233 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---------HHTCCCC
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH---------HcCCCCC
Confidence 754332 334578999999999999999999999999999999999999999876544322221 1122111
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 547 LVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 547 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+... .++++.+ ++.+||+.||++||++.||++
T Consensus 234 -----~~~~-~s~~l~~---li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 -----IPYR-YSDELNE---IITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----CCTT-SCHHHHH---HHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCcc-cCHHHHH---HHHHHcCCChhHCcCHHHHHh
Confidence 1122 2344444 455999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=413.97 Aligned_cols=253 Identities=24% Similarity=0.393 Sum_probs=212.4
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
++|++.+.||+|+||+||+|++++++.||||+++.... ..++|++|+++|++++|+|||+++|+|.+++.+++||||+.
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 46899999999999999999998888999999987543 45789999999999999999999999999999999999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
+|+|.+++..... .+.+..+++++.|+++||+|||++ +|+|||||++||||++++.+||+|||+++..........
T Consensus 83 ~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 9999998765433 478999999999999999999998 999999999999999999999999999987765544444
Q ss_pred cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCC
Q 006083 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEH 554 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 554 (662)
....||..|||||++.++.++.++|||||||++|||+| |+.||......+....+ ..+.. + ...
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i---------~~~~~--~----~~p 223 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------AQGLR--L----YRP 223 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH---------HTTCC--C----CCC
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH---------HhCCC--C----CCc
Confidence 55779999999999999999999999999999999998 89999876544432211 11110 0 011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 555 NYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 555 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
...+.+ +.+++.+||+.||++||++.||++.|.+
T Consensus 224 ~~~~~~---l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HLASEK---VYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCHH---HHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccccHH---HHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 223344 4455569999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=424.65 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=205.8
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
+.|++.+.||+|+||.||+|+. .+|+.||||+++.......+.+.+|+++|++|+|||||++++++.+.+.+|||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 3589999999999999999995 478999999998776677788999999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.||+|.+++.+.. ..+++..+..++.||++||+|||++ +||||||||+||||+.++++||+|||+|+...... ..
T Consensus 92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 9999999876432 3589999999999999999999999 99999999999999999999999999997654321 12
Q ss_pred ccccccCccccCccccc-----CCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 475 STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
....+||+.|||||++. +..|+.++|||||||+||||++|+.||......+.+..+.. +....+.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~---------~~~~~~~- 236 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK---------SEPPTLA- 236 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH---------SCCCCCS-
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc---------CCCCCCC-
Confidence 34578999999999984 45689999999999999999999999987655444333221 1111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.....+.++. +++.+||+.||++||++.|+++
T Consensus 237 ---~~~~~s~~~~---~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 ---QPSRWSSNFK---DFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ---SGGGSCHHHH---HHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---ccccCCHHHH---HHHHHHccCChhHCcCHHHHhc
Confidence 0111234444 4555999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-52 Score=433.33 Aligned_cols=201 Identities=26% Similarity=0.422 Sum_probs=178.4
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS-GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||+++++|.+.+.+|||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 56799999999999999999995 478999999998653 3445689999999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
||.||+|.+++.+.. .+++..++.++.|+++||.|||+++ +||||||||+||||++++++||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999999996543 4899999999999999999999732 7999999999999999999999999999865432
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCch
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTM 522 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~ 522 (662)
.....+||..|||||++.+..|+.++||||||||||||++|+.||....
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2345789999999999999999999999999999999999999997654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-51 Score=424.55 Aligned_cols=254 Identities=28% Similarity=0.439 Sum_probs=194.1
Q ss_pred CCCCccceeeccCceEEEEEEec-CC---CEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NG---KEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
++|++.++||+|+||.||+|++. +| ..||||++..... ...+.|.+|+++|++|+|||||+++|+|.+++.+|||
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 34677889999999999999864 33 2589999876533 4456899999999999999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
||||.+|+|.+++.... ..+++.++++|+.||++||+|||++ +||||||||+||||++++.+||+|||+++.....
T Consensus 106 ~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999886543 3589999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcc----ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 471 HTHV----STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 471 ~~~~----~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
.... .....||+.|||||++.++.|+.++|||||||+||||+| |+.||......+.+.. . ..+...
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~-i--------~~~~~~ 252 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA-I--------EQDYRL 252 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-H--------HTTCCC
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH-H--------HcCCCC
Confidence 2211 122468999999999999999999999999999999998 8999976544332211 1 111100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.. ....+.+ +.+++.+||+.||++||++.||++.|+.
T Consensus 253 -----~~-~~~~~~~---l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 253 -----PP-PMDCPSA---LHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp -----CC-CTTCCHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -----CC-CccchHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 01 1123344 4455569999999999999999999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=412.59 Aligned_cols=245 Identities=26% Similarity=0.376 Sum_probs=196.1
Q ss_pred CCccceeeccCceEEEEEEec-CCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeEEEE
Q 006083 318 FAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIA----GGQRMLV 390 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~lv 390 (662)
|++.+.||+|+||+||+|+.. +++.||||+++.. .....+.|.+|+++|++++|||||+++++|.+ +..+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356778999999999999954 6889999999754 23345679999999999999999999999875 4568999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeecCCccCcEEEC-CCCcEEEEeecccccc
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPR--IIHRDIKAANILID-DNFEAMVADFGLAKLS 467 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--ivHrDIkp~NILl~-~~~~vkl~DFGla~~~ 467 (662)
||||.+|+|.+++... ..+++..++.++.||++||+|||++ + ||||||||+||||+ +++.+||+|||+|+..
T Consensus 91 mE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 9999999999999654 3589999999999999999999998 6 99999999999996 4789999999999865
Q ss_pred CCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 468 NDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 468 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
... .....+||+.|||||++.+ .|+.++||||||||||||++|+.||......+.+... +..+...
T Consensus 166 ~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~--------i~~~~~~-- 231 (270)
T d1t4ha_ 166 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--------VTSGVKP-- 231 (270)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH--------HTTTCCC--
T ss_pred cCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHH--------HHcCCCC--
Confidence 433 2345789999999999875 6999999999999999999999999765433322211 1111111
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..+... ...++. +++.+||+.||++||++.|+++
T Consensus 232 --~~~~~~-~~~~~~---~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 --ASFDKV-AIPEVK---EIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --GGGGGC-CCHHHH---HHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cccCcc-CCHHHH---HHHHHHccCCHhHCcCHHHHhC
Confidence 112222 233444 4555999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.5e-51 Score=429.42 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=209.2
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
.++|++.+.||+|+||.||+|+. .+|+.||||++........+.+++|+++|++|+|+|||+++++|.+++.+||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999995 47999999999877666677899999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC--CCCcEEEEeeccccccCCCC
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID--DNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~--~~~~vkl~DFGla~~~~~~~ 471 (662)
|.||+|.++|.... ..+++.+++.|+.||+.||+|||++ +||||||||+||||+ +++.+||+|||+++......
T Consensus 105 ~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999986543 3589999999999999999999999 999999999999995 46889999999998876543
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
. ....+||+.|||||++.+..|+.++||||||||||||++|+.||......+.+..... ..+. ....
T Consensus 181 ~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~---------~~~~--~~~~ 247 (350)
T d1koaa2 181 S--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS---------CDWN--MDDS 247 (350)
T ss_dssp C--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------TCCC--SCCG
T ss_pred c--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh---------CCCC--CCcc
Confidence 2 3457899999999999999999999999999999999999999987654443332211 1100 0001
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
... ...+++ .+++.+||+.||++||++.|+++.
T Consensus 248 ~~~-~~s~~~---~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 AFS-GISEDG---KDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGG-GCCHHH---HHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccc-CCCHHH---HHHHHHHccCChhHCcCHHHHhcC
Confidence 111 123344 445559999999999999999873
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-51 Score=420.55 Aligned_cols=248 Identities=21% Similarity=0.282 Sum_probs=202.3
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|+++++||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+++.+||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4599999999999999999995 479999999997532 234567999999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
|||.||+|.+++...+ .+++..++.++.|++.||+|||++ +||||||||+||||++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999886543 489999999999999999999999 99999999999999999999999999998775432
Q ss_pred C-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 472 T-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 472 ~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||......+.+..+. .+.+
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~---------~~~~------ 227 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII---------KLEY------ 227 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---------TTCC------
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH---------cCCC------
Confidence 2 23345789999999999999999999999999999999999999998765443322211 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+.. ....++. +++.+||+.||++||+++|+++
T Consensus 228 ~~p~-~~s~~~~---~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 DFPE-KFFPKAR---DLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCT-TCCHHHH---HHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCc-cCCHHHH---HHHHHHccCCHhHCcCHHHHcC
Confidence 1111 2234444 4555999999999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-50 Score=427.63 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=208.6
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 394 (662)
++|++.+.||+|+||.||+|+. .+|+.||||+++.......+.+++|+++|++|+|||||+++++|.+++.+|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4699999999999999999995 579999999998776666778899999999999999999999999999999999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC--CCCcEEEEeeccccccCCCCC
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID--DNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~--~~~~vkl~DFGla~~~~~~~~ 472 (662)
.||+|.+++... ...+++.+++.|+.||+.||+|||++ +||||||||+||||+ +++.+||+|||+|+......
T Consensus 109 ~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 109 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 999999887543 33589999999999999999999998 999999999999997 57899999999998876543
Q ss_pred ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCccc
Q 006083 473 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRL 552 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 552 (662)
......||+.|||||++.+..|+.++|||||||+||||++|+.||......+.+..+.+ +.+. .....
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~---------~~~~--~~~~~ 251 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR---------CDWE--FDEDA 251 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH---------CCCC--CCSST
T ss_pred -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------CCCC--CCccc
Confidence 23457899999999999999999999999999999999999999987654443322211 1111 00111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 553 EHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 553 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. .....++. +++.+||+.||++||++.|+++
T Consensus 252 ~-~~~s~~~~---~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 252 F-SSVSPEAK---DFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp T-TTSCHHHH---HHHHTTSCSSGGGSCCHHHHHT
T ss_pred c-cCCCHHHH---HHHHHHccCChhHCcCHHHHhc
Confidence 1 11234444 4555999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-51 Score=419.03 Aligned_cols=255 Identities=31% Similarity=0.434 Sum_probs=202.1
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVS 395 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 395 (662)
++|++++.||+|+||.||+|++.+++.||||+++... ...+.|.+|+.+|++++|+|||+++++|.+ +..+||||||.
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 4689999999999999999999888899999997653 445789999999999999999999999965 56799999999
Q ss_pred CcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCccc
Q 006083 396 NKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHVS 475 (662)
Q Consensus 396 ~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 475 (662)
+|+|..++.......+++.++++++.||++||+|||++ +|+||||||+||||++++.+||+|||+++..........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 99999998766555699999999999999999999998 999999999999999999999999999987765444444
Q ss_pred cccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccCCC
Q 006083 476 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHN 555 (662)
Q Consensus 476 ~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 555 (662)
....||..|+|||++.++.++.++||||||||||||++|+.||........+..+.. .+.. ..+ ..
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~--------~~~~-----~~~-~~ 237 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE--------RGYR-----MPC-PP 237 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH--------TTCC-----CCC-CT
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH--------hcCC-----CCC-Cc
Confidence 557899999999999999999999999999999999997766644433222222211 1110 011 11
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 556 YVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 556 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
..+++ +.+++.+||+.||++||++.+|+++|+..
T Consensus 238 ~~~~~---l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 238 ECPES---LHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp TSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred ccCHH---HHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 23344 45556699999999999999999999863
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=415.35 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=204.0
Q ss_pred CCCCccce-eeccCceEEEEEEec---CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSNL-LGQGGFGYVHKGVLP---NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~-iG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
++|.+.++ ||+|+||.||+|.+. ++..||||+++.... ...++|.+|+++|++++|||||+++++|.+ +.+|||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666774 999999999999753 355799999976543 345789999999999999999999999975 568999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
||||.+|+|.+++... +..+++..+++++.||++||+|||++ +||||||||+||||++++.+||+|||+++.....
T Consensus 87 mE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 9999999999988543 34589999999999999999999998 9999999999999999999999999999877654
Q ss_pred CCc--cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 471 HTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 471 ~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
... ......||+.|||||++.++.++.++|||||||+||||+| |+.||......+.+.. +..+...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~---------i~~~~~~-- 231 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---------IEQGKRM-- 231 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH---------HHTTCCC--
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH---------HHcCCCC--
Confidence 332 2234578999999999999999999999999999999998 9999987654332211 1122111
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.+ ....+.++. +++.+||+.||++||++.+|++.|+.
T Consensus 232 ---~~-p~~~~~~l~---~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 232 ---EC-PPECPPELY---ALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ---CC-CTTCCHHHH---HHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CC-CCcCCHHHH---HHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11 122344444 45569999999999999999998874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.2e-51 Score=422.57 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=189.0
Q ss_pred hCCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
.+.|++.++||+|+||.||+|+.. +|+.||||++..... .....+.+|+++|++|+|||||++++++.+++.+|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 466999999999999999999954 789999999976533 234568899999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC---CCCcEEEEeeccccccCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID---DNFEAMVADFGLAKLSND 469 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~---~~~~vkl~DFGla~~~~~ 469 (662)
||.||+|.++|... ..+++.++..++.||+.||+|||++ +||||||||+|||+. +++.+||+|||+++....
T Consensus 88 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999999654 3589999999999999999999999 999999999999994 578999999999987654
Q ss_pred CCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD 549 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 549 (662)
.. .....+||+.|||||++.++.|+.++|||||||+||||++|+.||......+....+.. +.+. ..
T Consensus 163 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~---------~~~~--~~ 229 (307)
T d1a06a_ 163 GS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK---------AEYE--FD 229 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT---------TCCC--CC
T ss_pred CC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc---------cCCC--CC
Confidence 32 23457899999999999999999999999999999999999999987654332222111 1110 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 550 PRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 550 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.... ...+.++ .+++.+||+.||++||++.|+++
T Consensus 230 ~~~~-~~~s~~~---~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 230 SPYW-DDISDSA---KDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTT-TTSCHHH---HHHHHHHSCSSGGGSCCHHHHHH
T ss_pred Cccc-cCCCHHH---HHHHHHHccCCHhHCcCHHHHhc
Confidence 0111 1123344 44555999999999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=413.67 Aligned_cols=255 Identities=27% Similarity=0.421 Sum_probs=197.0
Q ss_pred CCCCccceeeccCceEEEEEEecCC-----CEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNG-----KEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g-----~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
..|++.++||+|+||.||+|.++++ ..||||+++.... ....+|++|+++|++++|+|||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3478899999999999999986432 3699999976543 334578999999999999999999999999999999
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
|||||.+++|.+++.... ..+++.++++++.||+.||+|||++ +||||||||+||||+.++.+||+|||+++....
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999998876433 3589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCC--ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 470 NHT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 470 ~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
... .......||..|||||++.++.++.++|||||||+||||++|+.||........+.+.. ..+..
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i--------~~~~~--- 231 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI--------NDGFR--- 231 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--------HTTCC---
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH--------hccCC---
Confidence 322 12234578999999999999999999999999999999999766654433222222211 11111
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
... ....+. .+.+++.+||+.||++||+|.||++.|+.
T Consensus 232 --~~~-~~~~~~---~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 232 --LPT-PMDCPS---AIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp --CCC-CTTCBH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --CCC-chhhHH---HHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 011 112333 45556669999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=424.27 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=205.0
Q ss_pred CCCCccceeeccCceEEEEEEecC-C-----CEEEEEEeecCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPN-G-----KEVAVKSLKTGS-GQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~-g-----~~vavK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 387 (662)
++|+++++||+|+||.||+|+... + ..||||++.... ......+.+|+++|.++ +|+|||+++++|.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 568899999999999999998532 2 369999986542 33446789999999998 899999999999999999
Q ss_pred EEEEEecCCcchhhhhccCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccC
Q 006083 388 MLVYEFVSNKTLEYHLHGENR---------------------PVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAA 446 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~ 446 (662)
|||||||.+|+|.++|+.... ..+++..++.++.||++||+|||++ +||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 999999999999999975432 3588999999999999999999998 9999999999
Q ss_pred cEEECCCCcEEEEeeccccccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhh
Q 006083 447 NILIDDNFEAMVADFGLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMME 524 (662)
Q Consensus 447 NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~ 524 (662)
||||+.++.+||+|||+|+........ ......||+.|||||++.++.|+.++|||||||+||||++ |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876544322 3345678999999999999999999999999999999997 89999776544
Q ss_pred hHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 006083 525 DSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALE 590 (662)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 590 (662)
+.+.+... .+. .... ....+.++. +++.+||+.||++||+++||++.|.
T Consensus 274 ~~~~~~~~--------~~~-----~~~~-p~~~~~~l~---~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFYKLIQ--------NGF-----KMDQ-PFYATEEIY---IIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHHH--------TTC-----CCCC-CTTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHh--------cCC-----CCCC-CCcCCHHHH---HHHHHHcCCChhHCcCHHHHHHHHh
Confidence 43333221 111 0011 122344444 4555999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-50 Score=410.71 Aligned_cols=246 Identities=28% Similarity=0.385 Sum_probs=196.3
Q ss_pred ceeeccCceEEEEEEec---CCCEEEEEEeecC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 006083 322 NLLGQGGFGYVHKGVLP---NGKEVAVKSLKTG--SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEFVSN 396 (662)
Q Consensus 322 ~~iG~G~~g~Vy~~~~~---~g~~vavK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~ 396 (662)
++||+|+||.||+|.+. .++.||||+++.. +....++|.+|+++|++++|||||+++++|.+ +..+||||||.+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999854 3468999999754 23345789999999999999999999999965 457899999999
Q ss_pred cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc--c
Q 006083 397 KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH--V 474 (662)
Q Consensus 397 g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~--~ 474 (662)
|+|.++++... .+++..+++|+.||++||+|||++ +||||||||+||||+.++.+||+|||+++........ .
T Consensus 92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 99999996543 489999999999999999999998 9999999999999999999999999999876544332 2
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
.....||+.|||||++.++.++.++|||||||+||||++ |+.||......+.... +..+... .+
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~---------i~~~~~~-----~~- 231 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM---------LEKGERM-----GC- 231 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---------HHTTCCC-----CC-
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH---------HHcCCCC-----CC-
Confidence 234679999999999999999999999999999999998 8999986543332111 1111111 11
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
....+.++. +++.+||+.||++||++.+|++.|+.
T Consensus 232 p~~~~~~~~---~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 232 PAGCPREMY---DLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CTTCCHHHH---HHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CcccCHHHH---HHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 122344444 45559999999999999999998874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-50 Score=416.26 Aligned_cols=243 Identities=24% Similarity=0.364 Sum_probs=200.3
Q ss_pred CCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch---hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 318 FAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ---GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
|+..+.||+|+||.||+|+. .+|+.||||+++..... ..+.+.+|+++|++|+|||||+++++|.+++.+||||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 89999999999999999984 57899999999865432 335788999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
|.+|+|..++... ..+++.+++.++.||+.||.|||++ +||||||||+||||++++.+||+|||+|+.....
T Consensus 97 ~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 97 CLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp CSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred cCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 9999998776543 3589999999999999999999999 9999999999999999999999999999865432
Q ss_pred cccccccCccccCcccccC---CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 474 VSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
...+||+.|||||++.+ +.|+.++|||||||+||||++|+.||......+.+..... +...
T Consensus 169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~---------~~~~----- 232 (309)
T d1u5ra_ 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---------NESP----- 232 (309)
T ss_dssp --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---------SCCC-----
T ss_pred --CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---------CCCC-----
Confidence 34689999999999864 4689999999999999999999999976544333222111 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.+.....+.++.+|+ .+||+.||++||++.|+++
T Consensus 233 ~~~~~~~s~~~~~li---~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 ALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCSCTTSCHHHHHHH---HHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCHHHHHHH---HHHCcCChhHCcCHHHHHh
Confidence 112222344555544 5899999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=413.68 Aligned_cols=251 Identities=21% Similarity=0.292 Sum_probs=205.6
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG------QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 387 (662)
.++|++++.||+|+||.||+|+. .+|+.||||++++... ...+.+++|+++|++|+|||||+++++|.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35799999999999999999995 5799999999975422 2357899999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC----cEEEEeecc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF----EAMVADFGL 463 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkl~DFGl 463 (662)
|||||||.||+|.++|.... .+++..++.++.|++.||+|||++ +||||||||+||||+.++ .+||+|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999996543 589999999999999999999999 999999999999998766 599999999
Q ss_pred ccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCc
Q 006083 464 AKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGI 543 (662)
Q Consensus 464 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (662)
++....... .....||..|||||++.++.++.++|||||||+||||++|+.||......+.+..+.. +.
T Consensus 164 a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~---------~~ 232 (293)
T d1jksa_ 164 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA---------VN 232 (293)
T ss_dssp CEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT---------TC
T ss_pred hhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh---------cC
Confidence 987754332 3456899999999999999999999999999999999999999987654443322211 11
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 544 YDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 544 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+. ....+.. ..+.+ +.+++.+||+.||++||++.|+++
T Consensus 233 ~~--~~~~~~~-~~s~~---~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 YE--FEDEYFS-NTSAL---AKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CC--CCHHHHT-TSCHH---HHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC--CCchhcC-CCCHH---HHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000111 12233 445556999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=413.60 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=205.4
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.++||+|+||.||+|+. .+|+.||||++++. .....+.+.+|+++|++++|||||++++++.+.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 4699999999999999999995 57999999999753 2234577899999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
|||.||+|.+++.... .+++..++.++.||+.||+|||++ +||||||||+||||+++|.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999999986544 488999999999999999999999 99999999999999999999999999998765433
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
. .....+||+.|||||++.+..|+.++||||||||||||++|+.||......+.+..+.. +.+ .
T Consensus 160 ~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~---------~~~------~ 223 (337)
T d1o6la_ 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM---------EEI------R 223 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------CCC------C
T ss_pred c-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc---------CCC------C
Confidence 2 23457899999999999999999999999999999999999999987654433222111 111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPK-----MSQIVR 587 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 587 (662)
+... ...++.+ ++..||+.||.+|++ +.|+++
T Consensus 224 ~p~~-~s~~~~d---li~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 FPRT-LSPEAKS---LLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTT-SCHHHHH---HHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCcc-CCHHHHH---HHHhhccCCchhhcccccccHHHHHc
Confidence 1122 2344444 455899999999995 778775
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=404.06 Aligned_cols=254 Identities=24% Similarity=0.394 Sum_probs=193.8
Q ss_pred hCCCCccceeeccCceEEEEEEecC----CCEEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLPN----GKEVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
.++|++++.||+|+||.||+|++.. +..||||+++..... ..+.|.+|+++|++++|||||+++++|. ++.+||
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3568999999999999999998532 346899998765433 3567999999999999999999999996 467899
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
|||||.+|+|.+++... ...+++..++.++.||++||+|||++ +||||||||+||||++++.+||+|||+++....
T Consensus 85 v~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccC
Confidence 99999999999987643 33589999999999999999999999 999999999999999999999999999987665
Q ss_pred CCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCcccccc
Q 006083 470 NHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLV 548 (662)
Q Consensus 470 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (662)
..........||+.|+|||++.++.|+.++|||||||+||||++ |+.||......+.+... ..+...
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i---------~~~~~~--- 228 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---------ENGERL--- 228 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---------HTTCCC---
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH---------HcCCCC---
Confidence 44444456788999999999999999999999999999999998 89999776544432221 111111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 549 DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 549 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.+. ...+.++ .+++.+||+.||++||++.||++.|+.
T Consensus 229 --~~~-~~~~~~~---~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 229 --PMP-PNCPPTL---YSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp --CCC-TTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCC-CCCCHHH---HHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111 1233444 455569999999999999999998874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-48 Score=400.67 Aligned_cols=257 Identities=25% Similarity=0.371 Sum_probs=199.8
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----e
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG---QGEREFSAEVEIISRVHHRHLVSLVGYCIAGG----Q 386 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~ 386 (662)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.... ...+.|.+|+++|++++|+|||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999985 5799999999976533 33457899999999999999999999987543 4
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
+|||||||.|++|.+++...+ .+++.+++.|+.||++||+|||++ +||||||||+||||+.++.++|+|||+++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 899999999999999886543 489999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCC--ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcc
Q 006083 467 SNDNHT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIY 544 (662)
Q Consensus 467 ~~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (662)
...... ......+||+.|||||++.++.|+.++||||||||||||++|+.||......+.+.... ..+..
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~--------~~~~~ 232 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV--------REDPI 232 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--------HCCCC
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHH--------hcCCC
Confidence 543322 23345789999999999999999999999999999999999999998765443332221 11111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhhC
Q 006083 545 DGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRP-KMSQIVRALEG 591 (662)
Q Consensus 545 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~ 591 (662)
.........+.++.+ ++.+||+.||.+|| +++++++.|..
T Consensus 233 ----~~~~~~~~~s~~l~~---li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 233 ----PPSARHEGLSADLDA---VVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ----CGGGTSSSCCHHHHH---HHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----CCchhccCCCHHHHH---HHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 111112223344444 45599999999999 89999888763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.5e-49 Score=409.37 Aligned_cols=244 Identities=25% Similarity=0.335 Sum_probs=203.3
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.+.||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4589999999999999999995 57999999999753 2234577899999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
|||.||+|..++.... .+.+..+..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 9999999999886544 478889999999999999999999 9999999999999999999999999999886543
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
....+||+.|||||++.+..|+.++|||||||+||||++|+.||......+.+..+.. +.+ .
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~---------~~~------~ 219 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN---------AEL------R 219 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---------CCC------C
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc---------CCC------C
Confidence 2347899999999999999999999999999999999999999987654433322211 111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRP-----KMSQIVR 587 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 587 (662)
+. .....++. +++.+||..||.+|+ +++++++
T Consensus 220 ~p-~~~s~~~~---~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 FP-PFFNEDVK---DLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CC-TTSCHHHH---HHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CC-CCCCHHHH---HHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11 12233444 455589999999996 8888875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=403.27 Aligned_cols=248 Identities=28% Similarity=0.441 Sum_probs=195.5
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeEEEEEEec
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIA-GGQRMLVYEFV 394 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lv~E~~ 394 (662)
++|++.+.||+|+||.||+|++ .|..||||+++.. ...+.|.+|+++|++++|+|||+++|+|.+ .+.+||||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 3578899999999999999998 5789999999764 345779999999999999999999999864 46689999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCcc
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTHV 474 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 474 (662)
.+|+|.++|+......+++..+++|+.||++||.|||++ +|+|||||++|||++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 999999999765444689999999999999999999998 99999999999999999999999999998754322
Q ss_pred ccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcccC
Q 006083 475 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLE 553 (662)
Q Consensus 475 ~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 553 (662)
....++..|+|||++.++.++.++|||||||+||||++ |+.||......+.+ .+. ..+.. ..+.
T Consensus 158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~-~~i--------~~~~~-----~~~~ 222 (262)
T d1byga_ 158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRV--------EKGYK-----MDAP 222 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-HHH--------TTTCC-----CCCC
T ss_pred -ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH-HHH--------HcCCC-----CCCC
Confidence 33568999999999999999999999999999999998 67777665433322 211 11111 1111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 554 HNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 554 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
. ....+ +.+++.+||+.||.+||++.+|++.|+.
T Consensus 223 ~-~~~~~---~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 223 D-GCPPA---VYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp T-TCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c-cCCHH---HHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 1 22334 4455569999999999999999999974
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-49 Score=409.18 Aligned_cols=261 Identities=25% Similarity=0.386 Sum_probs=209.0
Q ss_pred HHHHhCCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 006083 311 LAAATGGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSGQ-GEREFSAEVEIISRVHHRHLVSLVGYCIA 383 (662)
Q Consensus 311 i~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 383 (662)
++.-.++|++.+.||+|+||.||+|+.. +++.||||+++..... ..++|.+|+++|++++|+||++++++|.+
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3344567999999999999999999853 4578999999865433 35679999999999999999999999999
Q ss_pred CCeEEEEEEecCCcchhhhhccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeec
Q 006083 384 GGQRMLVYEFVSNKTLEYHLHGEN----------------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHR 441 (662)
Q Consensus 384 ~~~~~lv~E~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHr 441 (662)
.+..++||||+.+|+|.++|+... ...+++..+++|+.|++.||+|||++ +||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEee
Confidence 999999999999999999985321 23478899999999999999999998 99999
Q ss_pred CCccCcEEECCCCcEEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCC-CCCC
Q 006083 442 DIKAANILIDDNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR-RPVD 519 (662)
Q Consensus 442 DIkp~NILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~-~Pf~ 519 (662)
|||++||||+.++.+||+|||+++....... .......|+..|||||++.+..|+.++||||||||||||++|. .||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 9999999999999999999999986644322 2334567899999999999999999999999999999999996 4676
Q ss_pred CchhhhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 520 MTMMEDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
.....+.+... ..+.... +. ...+. ++.+++.+||+.+|++||+|.||+++|+.+
T Consensus 245 ~~~~~e~~~~v---------~~~~~~~-----~p-~~~~~---~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 245 GMAHEEVIYYV---------RDGNILA-----CP-ENCPL---ELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TSCHHHHHHHH---------HTTCCCC-----CC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCHHHHHHHH---------HcCCCCC-----CC-ccchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 55443322211 1222111 11 12233 455566699999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=407.25 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=198.2
Q ss_pred CCCCccceeeccCceEEEEEEec-CCC----EEEEEEeecC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGK----EVAVKSLKTG-SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 389 (662)
.+|++.++||+|+||.||+|.+. +|+ .||||+++.. ..+..++|.+|+++|++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35999999999999999999853 444 5899988654 344567899999999999999999999999865 5678
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCC
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSND 469 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~ 469 (662)
+|||+.+++|.+++... ...+++..+++|+.||++||+|||++ +||||||||+||||+.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 89999999999888654 34589999999999999999999998 999999999999999999999999999987755
Q ss_pred CCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 470 NHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 470 ~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
.... ......||..|||||++.++.|+.++|||||||+||||+| |+.||+.....+... .. ..+...
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~-~i--------~~~~~~-- 232 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-IL--------EKGERL-- 232 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH-HH--------HHTCCC--
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH-HH--------HcCCCC--
Confidence 4332 2334578999999999999999999999999999999998 788887664433221 11 111100
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
. .....+.+ +.+++.+||+.||++||++.||++.|+.
T Consensus 233 ---~-~p~~~~~~---~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 233 ---P-QPPICTID---VYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp ---C-CCTTBCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---C-CCcccCHH---HHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 0 11122333 4555669999999999999999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-48 Score=411.15 Aligned_cols=244 Identities=24% Similarity=0.255 Sum_probs=203.4
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~ 391 (662)
++|++.+.||+|+||.||+|+. .+|+.||||++++. .....+.+.+|+++|++++|+|||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4699999999999999999985 47999999999753 2233567899999999999999999999999999999999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~ 471 (662)
||+.||+|.+++...+ .+++..++.++.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999996544 489999999999999999999999 9999999999999999999999999999877543
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
....+||+.|||||++.+..|+.++||||||||||||++|+.||......+.+..+.. +.+ .
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~---------~~~------~ 256 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS---------GKV------R 256 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------CCC------C
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc---------CCC------C
Confidence 2346899999999999999999999999999999999999999987654333222111 111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRP-----KMSQIVR 587 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~ 587 (662)
+. .....++. +++.+||+.||.+|+ +++||++
T Consensus 257 ~p-~~~s~~~~---~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 FP-SHFSSDLK---DLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CC-TTCCHHHH---HHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CC-ccCCHHHH---HHHHHHhhhCHHhccccccccHHHHHc
Confidence 11 12334444 455589999999994 8888885
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.2e-48 Score=396.97 Aligned_cols=250 Identities=23% Similarity=0.288 Sum_probs=203.1
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCch---------hHHHHHHHHHHHHhcC-CCCcceEEEEEEeC
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQ---------GEREFSAEVEIISRVH-HRHLVSLVGYCIAG 384 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---------~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~ 384 (662)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.+|++|+ |+|||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5799999999999999999985 57899999999765321 1246889999999997 99999999999999
Q ss_pred CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
+.+|||||||.||+|.++|+... .+++..+++++.||++||+|||++ +||||||||+||||+.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999996543 589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCccccccccCccccCcccccC------CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHH
Q 006083 465 KLSNDNHTHVSTRVMGTFGYLAPEYASS------GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAA 538 (662)
Q Consensus 465 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 538 (662)
+....... ....+||..|++||++.+ ..++.++||||||||||||++|+.||......+.+..+..
T Consensus 158 ~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~------ 229 (277)
T d1phka_ 158 CQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS------ 229 (277)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred eEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHh------
Confidence 88765432 345789999999999863 3578899999999999999999999987654433222111
Q ss_pred hhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 539 LEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 539 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+.+.- .. .... ..+. ++.+++.+||+.||++||++.||++
T Consensus 230 ---~~~~~-~~-~~~~-~~s~---~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 230 ---GNYQF-GS-PEWD-DYSD---TVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ---TCCCC-CT-TTGG-GSCH---HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---CCCCC-CC-cccc-cCCH---HHHHHHHHHccCChhHCcCHHHHHc
Confidence 11110 00 0001 1223 3445556999999999999999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=406.82 Aligned_cols=251 Identities=19% Similarity=0.278 Sum_probs=205.7
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
.++|++++.||+|+||.||+|+. .+|+.||||+++... .....+.+|+++|++++|+|||++++++.+++.+||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 46799999999999999999995 478899999998653 3456788999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC--CCcEEEEeeccccccCCCC
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD--NFEAMVADFGLAKLSNDNH 471 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~--~~~vkl~DFGla~~~~~~~ 471 (662)
|.||+|.++|.... ..+++.+++.|+.||+.||+|||++ +|+||||||+||||+. ...+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999996543 3589999999999999999999998 9999999999999985 4589999999998765432
Q ss_pred CccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 472 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 472 ~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
.....+|++.|+|||.+.+..|+.++||||||||||+|++|+.||......+.+..+.+. .+. ....
T Consensus 159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~---------~~~--~~~~ 225 (321)
T d1tkia_ 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA---------EYT--FDEE 225 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT---------CCC--CCHH
T ss_pred --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------CCC--CChh
Confidence 234467999999999999999999999999999999999999999876554433322211 000 0001
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.... ...+ +.+++..||..||++||++.|+++
T Consensus 226 ~~~~-~s~~---~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 AFKE-ISIE---AMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTT-SCHH---HHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccC-CCHH---HHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 2233 445556999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=404.77 Aligned_cols=263 Identities=26% Similarity=0.419 Sum_probs=198.4
Q ss_pred HHHHHHhCCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEE
Q 006083 309 DELAAATGGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSG-QGEREFSAEVEIISRV-HHRHLVSLVGY 380 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~ 380 (662)
.+++.-.++|++.++||+|+||.||+|... +++.||||+++.... ...+.+.+|+.++.++ +|+|||.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 444444567999999999999999999842 346899999976533 3456788888888887 68999999999
Q ss_pred EEe-CCeEEEEEEecCCcchhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCcc
Q 006083 381 CIA-GGQRMLVYEFVSNKTLEYHLHGEN--------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKA 445 (662)
Q Consensus 381 ~~~-~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp 445 (662)
+.. ++.+++|||||.+|+|.++|+... ...+++..+++++.||++||+|||++ +||||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCc
Confidence 875 456899999999999999996432 23588999999999999999999998 999999999
Q ss_pred CcEEECCCCcEEEEeeccccccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCC-CCCCCchh
Q 006083 446 ANILIDDNFEAMVADFGLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR-RPVDMTMM 523 (662)
Q Consensus 446 ~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~-~Pf~~~~~ 523 (662)
+||||++++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||+||||++|. .||.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876543322 334578999999999999999999999999999999999975 57765543
Q ss_pred hhHHHHHHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 524 EDSLVEWARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.+.+.... ..+... .+. ...+.+ +.+++.+||+.||++||++.||++.|+.
T Consensus 243 ~~~~~~~~--------~~~~~~-----~~~-~~~~~~---l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 243 DEEFCRRL--------KEGTRM-----RAP-DYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp SHHHHHHH--------HHTCCC-----CCC-TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHH--------hcCCCC-----CCC-ccCCHH---HHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 33332221 112111 111 122334 4455569999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=398.17 Aligned_cols=260 Identities=23% Similarity=0.271 Sum_probs=197.6
Q ss_pred ccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchh-----HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 320 KSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQG-----EREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 320 ~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-----~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
..++||+|+||+||+|+. .+|+.||||+++...... .+.+.+|+++|++++|+|||++++++.+++.+||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 467899999999999995 479999999997543221 24688999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
|.++++..++.. +..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 999988877643 34588899999999999999999999 999999999999999999999999999987655432
Q ss_pred cccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccC---
Q 006083 474 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVD--- 549 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--- 549 (662)
.....+||..|||||++.++ .|+.++||||||||||||++|+.||......+.+....+..- ... ...+.....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~-~~~-~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG-TPT-EEQWPDMCSLPD 233 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCC-TTTSSSTTSSTT
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcC-CCC-hhhccchhccch
Confidence 23346899999999998754 689999999999999999999999987766555444332110 000 000000000
Q ss_pred -cccC--CCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 550 -PRLE--HNYV-----PHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 550 -~~l~--~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
..+. .... ...-..+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000 0000 011134556667999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=402.15 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=207.6
Q ss_pred CCCCccceeeccCceEEEEEEe------cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL------PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 387 (662)
++|+++++||+|+||.||+|++ .+++.||||+++.... .....|.+|+.+++++ +|+|||+++++|.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 4688899999999999999984 2457899999986543 3456789999999999 699999999999999999
Q ss_pred EEEEEecCCcchhhhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC
Q 006083 388 MLVYEFVSNKTLEYHLHGEN----------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID 451 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~----------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~ 451 (662)
+||||||.+|+|.++|+... ...+++..+++++.||++||+|||++ +||||||||+||||+
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 99999999999999996532 23588999999999999999999999 999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhC-CCCCCCchhhhHHHH
Q 006083 452 DNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITG-RRPVDMTMMEDSLVE 529 (662)
Q Consensus 452 ~~~~vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG-~~Pf~~~~~~~~~~~ 529 (662)
.++.+||+|||+++....... ......+||+.|+|||++.++.++.++|||||||+||||+++ ..+|......+.+.+
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999987765433 233457899999999999999999999999999999999995 555544443333333
Q ss_pred HHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 530 WARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
+.. .+... ......+.+ +.+++.+||+.||++||+|.||+++|+.
T Consensus 260 ~i~--------~~~~~------~~~~~~~~~---l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 260 MIK--------EGFRM------LSPEHAPAE---MYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHH--------HTCCC------CCCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHh--------cCCCC------CCcccccHH---HHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 222 11110 111223344 4455569999999999999999999985
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=405.53 Aligned_cols=252 Identities=21% Similarity=0.239 Sum_probs=197.6
Q ss_pred hCCCCcc-ceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEe----CCeE
Q 006083 315 TGGFAKS-NLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRV-HHRHLVSLVGYCIA----GGQR 387 (662)
Q Consensus 315 ~~~~~~~-~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~----~~~~ 387 (662)
.++|.+. ++||+|+||.||+|+. .+|+.||||+++. ...+.+|++++.++ +|+|||+++++|.+ +..+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 3568876 4699999999999985 5799999999975 25678899987665 89999999999875 4678
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC---CCcEEEEeeccc
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD---NFEAMVADFGLA 464 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~DFGla 464 (662)
|||||||.||+|.++|.......+++.+++.|+.||+.||+|||++ +|+||||||+||||++ ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence 9999999999999999876556799999999999999999999999 9999999999999985 567999999999
Q ss_pred cccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcc
Q 006083 465 KLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIY 544 (662)
Q Consensus 465 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (662)
+....... ....+||+.|||||++.+..|+.++||||||||||+|++|+.||......+....+.. .+.
T Consensus 162 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~---------~i~ 230 (335)
T d2ozaa1 162 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---------RIR 230 (335)
T ss_dssp EECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------CCC
T ss_pred eeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH---------HHh
Confidence 87665432 3457899999999999999999999999999999999999999976543222111100 000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 545 DGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 545 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.... .+..........++.+++.+||+.||.+||++.|+++
T Consensus 231 ~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 231 MGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SCSS--SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCC--CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000 0000000111234555666999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8e-48 Score=409.26 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=196.0
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc---hhHHHHHH---HHHHHHhcCCCCcceEEEEEEeCCeEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG---QGEREFSA---EVEIISRVHHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~---E~~il~~l~HpnIv~l~~~~~~~~~~~ 388 (662)
++|++.++||+|+||.||+|+. .+|+.||||++..... .....+.+ |+++|+.++|||||+++++|.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999995 4799999999964311 12233444 466777778999999999999999999
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
||||||.||+|.++|.... .+.+..++.++.||+.||+|||++ +||||||||+||||++++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999996543 478999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc
Q 006083 469 DNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL 547 (662)
Q Consensus 469 ~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (662)
... ....+||+.|||||++.+ ..|+.++||||||||||||++|+.||......+.. ...+. ....
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~~~~---------~~~~- 224 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRM---------TLTM- 224 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-HHHHH---------SSSC-
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHh---------cccC-
Confidence 432 244689999999999875 56899999999999999999999999765432211 11110 0000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006083 548 VDPRLEHNYVPHEMARLVACGAASIRHSARKRPK-----MSQIVR 587 (662)
Q Consensus 548 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 587 (662)
...+.. ....++. +++.+||+.||++|++ ++|+++
T Consensus 225 -~~~~~~-~~s~~~~---~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 -AVELPD-SFSPELR---SLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -CCCCCS-SSCHHHH---HHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -CCCCCC-CCCHHHH---HHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 001111 2334444 4555999999999999 688874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=398.15 Aligned_cols=254 Identities=27% Similarity=0.388 Sum_probs=194.6
Q ss_pred CCCCccceeeccCceEEEEEEec--CC--CEEEEEEeecC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP--NG--KEVAVKSLKTG---SGQGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRM 388 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~--~g--~~vavK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 388 (662)
++|++.+.||+|+||.||+|++. ++ ..||||+++.. ..+..+.|.+|+++|++++|+|||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45889999999999999999843 23 36899999754 23445789999999999999999999999976 4678
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
+|||||.+|+|.+++.... ..+++..+++++.||++||.|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999998876433 3589999999999999999999998 99999999999999999999999999999875
Q ss_pred CCCCc--cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHHHHHHHhHHHhhcCccc
Q 006083 469 DNHTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVEWARPLLGAALEDGIYD 545 (662)
Q Consensus 469 ~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (662)
..... ......|+..|+|||++.+..++.++|||||||+||||++ |+.||......+.+.... ..+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~--------~~~~~~ 234 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID--------KEGERL 234 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH--------TSCCCC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHH--------hCCCCC
Confidence 54332 2234568899999999999999999999999999999998 899997765444332211 111100
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 546 GLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 546 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
... ...+.+ +.+++.+||+.||++||+|.||++.|+.
T Consensus 235 -----~~~-~~~~~~---l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 235 -----PRP-EDCPQD---IYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -----CCC-TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCc-ccccHH---HHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111 122344 4455569999999999999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-48 Score=402.72 Aligned_cols=247 Identities=25% Similarity=0.347 Sum_probs=201.2
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC---chhHHHHHHHHHHHH-hcCCCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS---GQGEREFSAEVEIIS-RVHHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~~~lv 390 (662)
++|++++.||+|+||+||+|+. .+|+.||||++++.. ....+.+..|+.+|. .++|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999995 478999999997531 233456667777665 68999999999999999999999
Q ss_pred EEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCC
Q 006083 391 YEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDN 470 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~ 470 (662)
||||.||+|.++|.... .+++.+++.++.||+.||+|||++ +||||||||+|||+++++++||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999996543 478999999999999999999999 9999999999999999999999999999866543
Q ss_pred CCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCc
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDP 550 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 550 (662)
.. .....+||+.|||||++.++.|+.++||||||||||||++|+.||......+.+... ..+..
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i---------~~~~~------ 220 (320)
T d1xjda_ 157 DA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI---------RMDNP------ 220 (320)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---------HHCCC------
T ss_pred cc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH---------HcCCC------
Confidence 32 334578999999999999999999999999999999999999999876544322211 11111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 006083 551 RLEHNYVPHEMARLVACGAASIRHSARKRPKMS-QIVR 587 (662)
Q Consensus 551 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-evl~ 587 (662)
.+. ...+.++.+| +.+||+.||.+||++. ||++
T Consensus 221 ~~p-~~~s~~~~dl---i~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 FYP-RWLEKEAKDL---LVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCC-TTSCHHHHHH---HHHHSCSSGGGSBTTBSCGGG
T ss_pred CCC-ccCCHHHHHH---HHHhcccCCCCCcCHHHHHHh
Confidence 111 1234444444 4589999999999985 6654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=397.68 Aligned_cols=251 Identities=29% Similarity=0.440 Sum_probs=198.9
Q ss_pred cceeeccCceEEEEEEecCC----CEEEEEEeecC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeEEEEEEec
Q 006083 321 SNLLGQGGFGYVHKGVLPNG----KEVAVKSLKTG-SGQGEREFSAEVEIISRVHHRHLVSLVGYCIA-GGQRMLVYEFV 394 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~g----~~vavK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lv~E~~ 394 (662)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++|+|||+++|+|.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999986432 25899999754 33455789999999999999999999999875 56899999999
Q ss_pred CCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc-
Q 006083 395 SNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH- 473 (662)
Q Consensus 395 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~- 473 (662)
.+|+|.++++... ..+.+..+++++.|+++||.|||+. +|+|||||++||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999887543 3577889999999999999999998 9999999999999999999999999999876544322
Q ss_pred --cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccccCcc
Q 006083 474 --VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGLVDPR 551 (662)
Q Consensus 474 --~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 551 (662)
......||..|+|||++.++.++.++|||||||+||||++|+.||........+..+. ..+.. .
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i--------~~g~~--~---- 253 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--------LQGRR--L---- 253 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH--------HTTCC--C----
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH--------HcCCC--C----
Confidence 2233678999999999999999999999999999999999888886543222222111 11111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 552 LEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 552 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
......++++ .+++.+||+.||++||+|.||++.|+..
T Consensus 254 ~~p~~~~~~l---~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 254 LQPEYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp CCCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccCcHHH---HHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1112334444 4555699999999999999999998854
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=399.91 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=199.6
Q ss_pred CCCCccceeeccCceEEEEEEec-CCC--EEEEEEeecC-CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGK--EVAVKSLKTG-SGQGEREFSAEVEIISRV-HHRHLVSLVGYCIAGGQRMLV 390 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv 390 (662)
++|++.++||+|+||.||+|++. +|. .||||+++.. .....+.|.+|+++|+++ +|+|||+++++|.+++.+|+|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 46888999999999999999854 444 4788888654 334556899999999999 799999999999999999999
Q ss_pred EEecCCcchhhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcE
Q 006083 391 YEFVSNKTLEYHLHGE--------------NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEA 456 (662)
Q Consensus 391 ~E~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 456 (662)
||||.||+|.++|+.. ....+++..+++++.||++||.|||++ +|||||||++|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999653 235689999999999999999999999 99999999999999999999
Q ss_pred EEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCC-CCCCchhhhHHHHHHHHHh
Q 006083 457 MVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRR-PVDMTMMEDSLVEWARPLL 535 (662)
Q Consensus 457 kl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~-Pf~~~~~~~~~~~~~~~~~ 535 (662)
||+|||+++....... .....||..|+|||.+.++.|+.++||||||||||||++|.. ||......+.+ +.+
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~-~~i---- 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-EKL---- 239 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHG----
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH-HHH----
Confidence 9999999986543322 234568999999999999999999999999999999999765 56554333221 111
Q ss_pred HHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 536 GAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 536 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
..+. ...+. ...++++ .+++.+||+.||++||+|.||++.|+..
T Consensus 240 ----~~~~-----~~~~~-~~~~~~~---~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 240 ----PQGY-----RLEKP-LNCDDEV---YDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp ----GGTC-----CCCCC-TTBCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HhcC-----CCCCC-ccCCHHH---HHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111 01111 1223444 4455599999999999999999988754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=397.51 Aligned_cols=256 Identities=27% Similarity=0.399 Sum_probs=202.4
Q ss_pred CCCCccceeeccCceEEEEEEecC--------CCEEEEEEeecCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPN--------GKEVAVKSLKTGSG-QGEREFSAEVEIISRV-HHRHLVSLVGYCIAGG 385 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~ 385 (662)
++|++++.||+|+||.||+|+... +..||||+++.+.. ....++.+|+.++.++ +|+|||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 468889999999999999998422 24799999987644 3457889999999988 7999999999999999
Q ss_pred eEEEEEEecCCcchhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEEC
Q 006083 386 QRMLVYEFVSNKTLEYHLHGEN--------------RPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILID 451 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~ 451 (662)
.+++|||||.+|+|.++|.... ...+++..+++++.||+.||+|||++ +||||||||+||||+
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 9999999999999999996543 24589999999999999999999999 999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCC-ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHh-CCCCCCCchhhhHHHH
Q 006083 452 DNFEAMVADFGLAKLSNDNHT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIT-GRRPVDMTMMEDSLVE 529 (662)
Q Consensus 452 ~~~~vkl~DFGla~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~ 529 (662)
.++.+||+|||+++....... .......|++.|+|||++.++.|+.++||||||||||||++ |+.||......+.+ +
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~-~ 248 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF-K 248 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-H
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH-H
Confidence 999999999999987654332 23345678999999999999999999999999999999998 68888665433222 1
Q ss_pred HHHHHhHHHhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 530 WARPLLGAALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
++ ..+... ... ...+.+ +.+++.+||+.||.+||++.||++.|+..
T Consensus 249 ~i--------~~~~~~-----~~p-~~~~~~---l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 249 LL--------KEGHRM-----DKP-SNCTNE---LYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HH--------HTTCCC-----CCC-SSCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH--------HcCCCC-----CCC-ccchHH---HHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11 111111 111 122334 45566699999999999999999999753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-47 Score=391.69 Aligned_cols=266 Identities=23% Similarity=0.321 Sum_probs=201.1
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
++|++.++||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|+|||++++++.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999995 5799999999975432 235678999999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
||.++.+. ++.......+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~-~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQDLKK-FMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSEEHHH-HHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ecCCchhh-hhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 99765554 44334455689999999999999999999998 999999999999999999999999999987765432
Q ss_pred ccccccccCccccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCccccc---c
Q 006083 473 HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIYDGL---V 548 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 548 (662)
.....+||..|+|||++.... ++.++|||||||+||+|++|+.||......+.+......... ......... .
T Consensus 158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMP 234 (298)
T ss_dssp -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC--CCTTTSTTGGGST
T ss_pred -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCC--Cchhhcccccccc
Confidence 234468999999999877655 578999999999999999999999876554443332221100 000000000 0
Q ss_pred C--c---ccCCCC----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 549 D--P---RLEHNY----VPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 549 d--~---~l~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
+ . ...... ....-.++.+++.+||+.||++||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 0 000000 00111334455669999999999999999873
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.3e-47 Score=390.43 Aligned_cols=266 Identities=22% Similarity=0.280 Sum_probs=201.7
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYEF 393 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 393 (662)
++|++.+.||+|+||.||+|+..+|+.||||+++.... ...+.+.+|+++|++++|+|||+++++|.+++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57999999999999999999988999999999976532 2357899999999999999999999999999999999999
Q ss_pred cCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCCc
Q 006083 394 VSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHTH 473 (662)
Q Consensus 394 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 473 (662)
+.++.+..+.... ..+++..+.+++.||+.||+|||++ +||||||||+||||+.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 9988887776443 4599999999999999999999998 999999999999999999999999999987654332
Q ss_pred cccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHH-------HhhcCccc
Q 006083 474 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGA-------ALEDGIYD 545 (662)
Q Consensus 474 ~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~-------~~~~~~~~ 545 (662)
......|+..|++||.+.+. .++.++|||||||+||||++|+.||......+.+....+..... ......+.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 22345789999999998754 57899999999999999999999998765544443322211000 00000000
Q ss_pred ccc---CcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 546 GLV---DPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 546 ~~~---d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
... ...............+.+++.+||+.||++||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000000001111123445566999999999999999984
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=395.90 Aligned_cols=265 Identities=22% Similarity=0.326 Sum_probs=197.9
Q ss_pred CCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHH--HHHHHHHHhcCCCCcceEEEEEEeCC----eEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREF--SAEVEIISRVHHRHLVSLVGYCIAGG----QRML 389 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~--~~E~~il~~l~HpnIv~l~~~~~~~~----~~~l 389 (662)
..|.+.+.||+|+||.||+|++ +|+.||||+++.. ..+.+ +.|+..+.+++|+|||+++++|.+.+ .+||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 3577889999999999999997 7899999999753 23333 34555556789999999999998643 6899
Q ss_pred EEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 390 VYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDC-----HPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
|||||.+|+|.++|++. .+++..+++++.+++.||+|||+.+ ..+||||||||+||||++++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999999754 4899999999999999999999731 238999999999999999999999999999
Q ss_pred cccCCCCCc---cccccccCccccCcccccCCC------CCchHHHHHHHHHHHHHHhCCCCCCCchhhhH-HH-----H
Q 006083 465 KLSNDNHTH---VSTRVMGTFGYLAPEYASSGK------LTEKSDVFSFGVMLLELITGRRPVDMTMMEDS-LV-----E 529 (662)
Q Consensus 465 ~~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~~------~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~-~~-----~ 529 (662)
+........ .....+||+.|||||++.+.. ++.++|||||||+||||++|..+|......+. .. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 876543322 224578999999999987543 67799999999999999999988754321110 00 0
Q ss_pred HHHHHhHHHhhcCccccccCcccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 530 WARPLLGAALEDGIYDGLVDPRLEHNY-VPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
+....+... .....+++.+...+ ..+....|.+++.+||+.||++||++.||++.|+.
T Consensus 236 ~~~~~~~~~----~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 236 PSVEEMRKV----VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CCHHHHHHH----HTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred chHHHHHHH----HhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 000001111 11112222222222 23455667788889999999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-47 Score=394.37 Aligned_cols=257 Identities=24% Similarity=0.389 Sum_probs=206.9
Q ss_pred hCCCCccceeeccCceEEEEEEec------CCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVLP------NGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 387 (662)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.... .....|.+|+++|++++|+|||+++++|...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 356888999999999999999852 357899999976533 3345789999999999999999999999999999
Q ss_pred EEEEEecCCcchhhhhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEE
Q 006083 388 MLVYEFVSNKTLEYHLHGE--------NRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVA 459 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~--------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~ 459 (662)
++|||||.+|+|.++++.. ....+++..+.+++.++++||.|||++ +|||||||++||||++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 9999999999999988532 224578999999999999999999998 99999999999999999999999
Q ss_pred eeccccccCCCCCc-cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCC-CCCCCchhhhHHHHHHHHHhHH
Q 006083 460 DFGLAKLSNDNHTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGR-RPVDMTMMEDSLVEWARPLLGA 537 (662)
Q Consensus 460 DFGla~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~-~Pf~~~~~~~~~~~~~~~~~~~ 537 (662)
|||+++........ .....+|++.|+|||.+.++.++.++|||||||+||||++|+ .||......+.+...
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i------- 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV------- 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH-------
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------
Confidence 99999876543322 234457999999999999999999999999999999999985 667554433322211
Q ss_pred HhhcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 006083 538 ALEDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEGD 592 (662)
Q Consensus 538 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 592 (662)
..+.... + ....+.. |.+++.+||+.+|++||++.||++.|+..
T Consensus 249 --~~~~~~~-----~-p~~~~~~---l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 249 --MEGGLLD-----K-PDNCPDM---LFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp --HTTCCCC-----C-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred --HhCCCCC-----C-cccchHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1111111 1 1123334 55555689999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=389.94 Aligned_cols=240 Identities=23% Similarity=0.334 Sum_probs=194.5
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc------hhHHHHHHHHHHHHhcC--CCCcceEEEEEEeCC
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG------QGEREFSAEVEIISRVH--HRHLVSLVGYCIAGG 385 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~ 385 (662)
.++|+++++||+|+||.||+|+. .+|+.||||+++.... ....++.+|+++|++++ |+|||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999999995 5799999999975321 11234678999999997 899999999999999
Q ss_pred eEEEEEEecCC-cchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC-CCcEEEEeecc
Q 006083 386 QRMLVYEFVSN-KTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-NFEAMVADFGL 463 (662)
Q Consensus 386 ~~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkl~DFGl 463 (662)
..|+||||+.+ +++.+++... ..+++.+++.++.||++||+|||++ +||||||||+||||+. ++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 99999999976 6777777543 3489999999999999999999999 9999999999999985 57999999999
Q ss_pred ccccCCCCCccccccccCccccCcccccCCCC-CchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcC
Q 006083 464 AKLSNDNHTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDG 542 (662)
Q Consensus 464 a~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 542 (662)
|+..... .....+||..|||||++.+..+ +.++|||||||+||||++|+.||.... .+. ...
T Consensus 158 a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~i~-----------~~~ 220 (273)
T d1xwsa_ 158 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---EII-----------RGQ 220 (273)
T ss_dssp CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---HHH-----------HCC
T ss_pred ceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---HHh-----------hcc
Confidence 9876543 2345789999999999987665 577899999999999999999997532 110 011
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 543 IYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 543 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
. .+.. ..+.++.+ ++.+||+.||++||+++|+++
T Consensus 221 ~-------~~~~-~~s~~~~~---li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 V-------FFRQ-RVSSECQH---LIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp C-------CCSS-CCCHHHHH---HHHHHTCSSGGGSCCHHHHHT
T ss_pred c-------CCCC-CCCHHHHH---HHHHHccCCHhHCcCHHHHhc
Confidence 0 1111 23344444 445899999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-46 Score=384.56 Aligned_cols=264 Identities=22% Similarity=0.288 Sum_probs=198.3
Q ss_pred hCCCCccceeeccCceEEEEEEe-cC-CCEEEEEEeecCCc--hhHHHHHHHHHHHHhc---CCCCcceEEEEEEe----
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PN-GKEVAVKSLKTGSG--QGEREFSAEVEIISRV---HHRHLVSLVGYCIA---- 383 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~-g~~vavK~l~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~---- 383 (662)
.++|++.+.||+|+||+||+|+. .+ ++.||||+++.... .....+.+|+++|+.| +|+|||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 35799999999999999999985 34 66799999975322 2233566788877766 79999999999863
Q ss_pred -CCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeec
Q 006083 384 -GGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFG 462 (662)
Q Consensus 384 -~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFG 462 (662)
+..++++||||.++.+...... ....+++..++.++.|++.||+|||++ +||||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 3578999999999887655433 344589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHH---Hh
Q 006083 463 LAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGA---AL 539 (662)
Q Consensus 463 la~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~---~~ 539 (662)
+++..... ......+||+.|||||++.+..|+.++||||||||||||++|+.||......+.+.......... .+
T Consensus 162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 99865432 23355789999999999999999999999999999999999999998876555544432211000 00
Q ss_pred hc------CccccccCcccC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 540 ED------GIYDGLVDPRLE--HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 540 ~~------~~~~~~~d~~l~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
.. ..+.......+. ......++. +++.+||+.||++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~---dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGK---DLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHH---HHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccchhhhhccccccchhhccccCCHHHH---HHHHHHCcCChhHCcCHHHHhc
Confidence 00 000000000000 011233344 4556899999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=390.03 Aligned_cols=259 Identities=23% Similarity=0.289 Sum_probs=195.6
Q ss_pred CCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------CeEEE
Q 006083 317 GFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHLVSLVGYCIAG------GQRML 389 (662)
Q Consensus 317 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~~~~l 389 (662)
+|...++||+|+||+||+|+. .+|+.||||+++.... .+.+|+++|++|+|+|||+++++|... ..+||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 488889999999999999995 4799999999986532 235799999999999999999998643 35789
Q ss_pred EEEecCCcchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC-cEEEEeecccccc
Q 006083 390 VYEFVSNKTLEYHLHG-ENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF-EAMVADFGLAKLS 467 (662)
Q Consensus 390 v~E~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkl~DFGla~~~ 467 (662)
|||||.++.+..+.+. .....+++..++.|+.||+.||+|||++ +||||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755444321 2344689999999999999999999998 999999999999999765 8999999999876
Q ss_pred CCCCCccccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHH-------hHHHh
Q 006083 468 NDNHTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPL-------LGAAL 539 (662)
Q Consensus 468 ~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~-------~~~~~ 539 (662)
..... ....+|+..|+|||.+.+ ..|+.++|||||||++|||++|+.||......+.+..+.+.+ +....
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 54432 234689999999998765 578999999999999999999999998776555554433211 00000
Q ss_pred ---hcCccccccCc---ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 540 ---EDGIYDGLVDP---RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 540 ---~~~~~~~~~d~---~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
....+...... .+.......+ +.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~---~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPE---AIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHH---HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhccccccccCchhhhcccCCCHH---HHHHHHHHccCChhHCcCHHHHhc
Confidence 00111111111 1111122333 445556999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=378.15 Aligned_cols=266 Identities=21% Similarity=0.278 Sum_probs=197.1
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe--------C
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIA--------G 384 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--------~ 384 (662)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|+||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6799999999999999999995 589999999986542 2345678999999999999999999998864 3
Q ss_pred CeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccc
Q 006083 385 GQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLA 464 (662)
Q Consensus 385 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla 464 (662)
+..|+|||||.++.+..+... ...+.+..++.++.|+++||.|||++ +||||||||+||||+.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeeccee
Confidence 568999999998888766533 33588899999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCc---cccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhh
Q 006083 465 KLSNDNHTH---VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALE 540 (662)
Q Consensus 465 ~~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 540 (662)
+........ .....+||..|+|||++.+. .|+.++|||||||+||||++|+.||......+.+....+.. ... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~-~~~-~ 242 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC-GSI-T 242 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCC-C
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhc-CCC-C
Confidence 876543221 22336799999999998765 68999999999999999999999998765444333222211 000 0
Q ss_pred cCccccc--------cCcccCCCC-CHHH------HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 541 DGIYDGL--------VDPRLEHNY-VPHE------MARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 541 ~~~~~~~--------~d~~l~~~~-~~~~------~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
....... +........ .... ...+++++.+||+.||++|++++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000000 000000001 1111 1233456779999999999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=372.48 Aligned_cols=265 Identities=23% Similarity=0.280 Sum_probs=201.9
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv~E 392 (662)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+++|+.+|++++|+|||+++++|.+.+..++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999995 5789999999976532 346789999999999999999999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccCCCCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSNDNHT 472 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~~~~~ 472 (662)
++.+++|..++... ..+.+..++.++.|+++||+|||++ +||||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 99999998887644 3578999999999999999999998 999999999999999999999999999987754432
Q ss_pred ccccccccCccccCcccccCCC-CCchHHHHHHHHHHHHHHhCCCCCCCchh-hhHHHHHHHHHhHHH-----------h
Q 006083 473 HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELITGRRPVDMTMM-EDSLVEWARPLLGAA-----------L 539 (662)
Q Consensus 473 ~~~~~~~Gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~-----------~ 539 (662)
......++..|++||++.+.. ++.++|||||||++|||++|+.||..... .+.+..... ..... .
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR-LLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH-HHCCCCTTTCTTGGGST
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHh-hcCCCChhhhhhhhhcc
Confidence 223456788999999987654 68999999999999999999999754432 222221111 10000 0
Q ss_pred hcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 540 EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 540 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
+...+................-..+.+++.+||+.||++|||++||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000000011111223445566999999999999999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=379.26 Aligned_cols=264 Identities=21% Similarity=0.283 Sum_probs=196.2
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----eEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG-QGEREFSAEVEIISRVHHRHLVSLVGYCIAGG----QRM 388 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~~ 388 (662)
+.+|+++++||+|+||.||+|+. .+|+.||||+++.... ...+.+++|+++|++|+|+|||++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35699999999999999999984 5899999999976543 34567899999999999999999999997543 234
Q ss_pred EEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccccC
Q 006083 389 LVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKLSN 468 (662)
Q Consensus 389 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~~~ 468 (662)
++|+|+.+|+|.+++... .+++..++.++.||++||+|||++ +||||||||+||||++++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 555667799999999643 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc--cccccccCccccCcccccC-CCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhH---HHh---
Q 006083 469 DNHTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLG---AAL--- 539 (662)
Q Consensus 469 ~~~~~--~~~~~~Gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~---~~~--- 539 (662)
..... .....+|+..|+|||++.. ..++.++|||||||++|||++|+.||......+........... ...
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 43221 2345789999999999854 56789999999999999999999999876543332222111000 000
Q ss_pred ----------hcCccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 540 ----------EDGIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 540 ----------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
............+.... . .++..++.+||+.||++||++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-s---~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNA-D---SKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTS-C---HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCC-C---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000011111 1 245566679999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=379.07 Aligned_cols=259 Identities=22% Similarity=0.291 Sum_probs=194.0
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIAGG------ 385 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------ 385 (662)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|+|||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46799999999999999999995 4799999999976432 33567899999999999999999999997654
Q ss_pred eEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeecccc
Q 006083 386 QRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 386 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
.+||||||| +.+|..+++.. .+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence 579999999 67777776532 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh---HHHhhc
Q 006083 466 LSNDNHTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL---GAALED 541 (662)
Q Consensus 466 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~---~~~~~~ 541 (662)
..... ....+||..|+|||++.+. .++.++|||||||+||||++|+.||......+.+..+..... ...+..
T Consensus 170 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 170 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 76543 2446799999999998764 578999999999999999999999987654443332221100 000000
Q ss_pred ----------CccccccCc---ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 542 ----------GIYDGLVDP---RLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 542 ----------~~~~~~~d~---~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
..+...... .+... ...+ +.+++.+||..||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~---~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTN-ASPL---AVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTT-CCHH---HHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcchhhhhhhccCCcccccchHHhccC-CCHH---HHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 11111 2233 3455569999999999999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.1e-44 Score=376.04 Aligned_cols=194 Identities=22% Similarity=0.332 Sum_probs=169.1
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEe--CCeEEEEE
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-HRHLVSLVGYCIA--GGQRMLVY 391 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~--~~~~~lv~ 391 (662)
++|++.++||+|+||+||+|+. .+|+.||||+++.. ..+++++|+++|+.++ |+||++++++|.. ...+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 4699999999999999999995 57899999999753 3567899999999995 9999999999974 45689999
Q ss_pred EecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCC-CcEEEEeeccccccCCC
Q 006083 392 EFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDN-FEAMVADFGLAKLSNDN 470 (662)
Q Consensus 392 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkl~DFGla~~~~~~ 470 (662)
|||.+++|..+.+ .+++..++.++.||+.||+|||++ +||||||||+||||+.+ +.+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999987642 489999999999999999999999 99999999999999865 46999999999876544
Q ss_pred CCccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCch
Q 006083 471 HTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTM 522 (662)
Q Consensus 471 ~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~ 522 (662)
.. ....+||..|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 184 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 184 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred Cc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 32 3456799999999998765 57999999999999999999999997653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=381.31 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=201.1
Q ss_pred CCCCccceeeccCceEEEEEEe----cCCCEEEEEEeecCC----chhHHHHHHHHHHHHhcCC-CCcceEEEEEEeCCe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL----PNGKEVAVKSLKTGS----GQGEREFSAEVEIISRVHH-RHLVSLVGYCIAGGQ 386 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~ 386 (662)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++| +||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 4599999999999999999984 258899999986432 2234668899999999976 899999999999999
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
.++||||+.+|+|.+++..... +.+..++.++.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999965443 67888999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCccccccccCccccCcccccCC--CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCcc
Q 006083 467 SNDNHTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGIY 544 (662)
Q Consensus 467 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (662)
.............|++.|++||.+.+. .++.++|||||||+||||++|+.||......+......+.... ..
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~-----~~- 252 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-----SE- 252 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH-----CC-
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc-----CC-
Confidence 765544445567899999999999754 4788999999999999999999999776544433332222110 00
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006083 545 DGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPK-----MSQIVR 587 (662)
Q Consensus 545 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~ 587 (662)
..+.. ....++ .+++.+||+.||++|++ ++|+++
T Consensus 253 -----~~~~~-~~s~~~---~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 -----PPYPQ-EMSALA---KDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----CCCCT-TSCHHH---HHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----CCCcc-cCCHHH---HHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 01111 123344 44555999999999994 788875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-44 Score=370.08 Aligned_cols=259 Identities=20% Similarity=0.234 Sum_probs=193.3
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHL-VSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lv~E 392 (662)
.++|++.+.||+|+||.||+|+. .+|+.||||++..... ..++..|++++++++|.|+ +.+.+++.+++..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 35799999999999999999985 5789999999876532 2457889999999987665 555666778899999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC---CCcEEEEeeccccccCC
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD---NFEAMVADFGLAKLSND 469 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkl~DFGla~~~~~ 469 (662)
|+.+ +|.+.+... ...+++..++.++.|+++||+|||++ +||||||||+||||+. +..+||+|||+|+....
T Consensus 84 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 84 LLGP-SLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCCC-BHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EcCC-chhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9954 554444332 23589999999999999999999999 9999999999999863 56799999999987654
Q ss_pred CCCc------cccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhcCc
Q 006083 470 NHTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALEDGI 543 (662)
Q Consensus 470 ~~~~------~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (662)
.... .....+||+.|||||++.+..++.++|||||||++|||++|+.||......+......... ...+. ..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~-~~~~~-~~ 236 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-EKKMS-TP 236 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH-HHHHH-SC
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh-cccCC-CC
Confidence 3321 2244689999999999999999999999999999999999999997654332222111100 00000 00
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 544 YDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 544 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
. ..+. ...+.++.+ ++..||+.+|++||++.+|.+.|+.
T Consensus 237 ~-----~~~~-~~~p~~~~~---li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 237 I-----EVLC-KGYPSEFAT---YLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp H-----HHHT-TTSCHHHHH---HHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred h-----hHhc-cCCCHHHHH---HHHHHccCChhHCcCHHHHHHHHHH
Confidence 0 0111 122344444 4458999999999999999888774
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.2e-44 Score=367.60 Aligned_cols=259 Identities=18% Similarity=0.226 Sum_probs=201.3
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCC-CCcceEEEEEEeCCeEEEEEE
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHH-RHLVSLVGYCIAGGQRMLVYE 392 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lv~E 392 (662)
.++|++++.||+|+||.||+|+. .+|+.||||++.... ....+.+|+++++.|.| +||+.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 46799999999999999999995 478999999986543 23457889999999975 899999999999999999999
Q ss_pred ecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECC-----CCcEEEEeecccccc
Q 006083 393 FVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDD-----NFEAMVADFGLAKLS 467 (662)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~-----~~~vkl~DFGla~~~ 467 (662)
|+ +++|.++++... ..+++..+..++.|++.||+|||++ +||||||||+||||+. ++.+||+|||+|+..
T Consensus 82 ~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 788888886543 3589999999999999999999999 9999999999999964 578999999999876
Q ss_pred CCCCC------ccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhHHHhhc
Q 006083 468 NDNHT------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLGAALED 541 (662)
Q Consensus 468 ~~~~~------~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 541 (662)
..... ......+||+.|||||++.+..++.++|||||||++|||++|+.||...........+.+ ..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~-i~~~~-~~ 234 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER-IGEKK-QS 234 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-HHHHH-HH
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH-HHhcc-CC
Confidence 53321 122346899999999999999999999999999999999999999976533222211111 00000 00
Q ss_pred CccccccCcccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 006083 542 GIYDGLVDPRLEHNYVPHEMARLVACGAASIRHSARKRPKMSQIVRALEG 591 (662)
Q Consensus 542 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 591 (662)
.... .+.. ..+.++.+ ++..|+..++++||+++.+.+.|+.
T Consensus 235 ~~~~-----~l~~-~~p~~l~~---ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 235 TPLR-----ELCA-GFPEEFYK---YMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp SCHH-----HHTT-TSCHHHHH---HHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred CChH-----HhcC-CCCHHHHH---HHHHHhcCCcccCcCHHHHHHHHHH
Confidence 0111 1111 12344444 4458999999999999988887764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=373.09 Aligned_cols=263 Identities=20% Similarity=0.221 Sum_probs=191.1
Q ss_pred CCCCccceeeccCceEEEEEEec-CCCEEEEEEeecCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe------CCe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVLP-NGKEVAVKSLKTGS--GQGEREFSAEVEIISRVHHRHLVSLVGYCIA------GGQ 386 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------~~~ 386 (662)
++|++.++||+|+||+||+|+.. +|+.||||+++... .....++.+|+++|++++|+|||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 56999999999999999999954 79999999998653 2334678999999999999999999999963 478
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
+|+|||||.++.+..+ .. .+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~~~-~~----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI-QM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHHH-TS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchHHHHhh-hc----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence 8999999977666544 22 378999999999999999999999 999999999999999999999999999887
Q ss_pred cCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHh-----------
Q 006083 467 SNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLL----------- 535 (662)
Q Consensus 467 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~----------- 535 (662)
..... .....+||..|+|||++.+..++.++||||+||++|||++|+.||......+.+........
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 65432 23456899999999999999999999999999999999999999976654333322221110
Q ss_pred ---HHHhhcCc-cc-----cccCcccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006083 536 ---GAALEDGI-YD-----GLVDPRLEHNY---VPHEMARLVACGAASIRHSARKRPKMSQIVRA 588 (662)
Q Consensus 536 ---~~~~~~~~-~~-----~~~d~~l~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 588 (662)
........ .. ......+.... .......+.+++.+||..||++||+++||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00011100 00 00000011111 12233456677789999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-43 Score=369.83 Aligned_cols=260 Identities=21% Similarity=0.263 Sum_probs=194.4
Q ss_pred hCCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEe-----CCe
Q 006083 315 TGGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSG--QGEREFSAEVEIISRVHHRHLVSLVGYCIA-----GGQ 386 (662)
Q Consensus 315 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~ 386 (662)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++|+|+|||++++++.. +..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999994 5799999999976532 344678899999999999999999999863 334
Q ss_pred EEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 387 RMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 387 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
.+++|+|+.+|+|.++++.. .+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 56777888999999998543 489999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCccccccccCccccCcccccCC-CCCchHHHHHHHHHHHHHHhCCCCCCCchhhhHHHHHHHHHhH---HHhh--
Q 006083 467 SNDNHTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELITGRRPVDMTMMEDSLVEWARPLLG---AALE-- 540 (662)
Q Consensus 467 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~---~~~~-- 540 (662)
.... .....|+..|+|||++.+. .++.++|||||||+||+|++|+.||......+......+.... ....
T Consensus 171 ~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 171 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp CTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 5432 2446789999999987765 4689999999999999999999999876544333222211100 0000
Q ss_pred --------cCccccccCcccC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006083 541 --------DGIYDGLVDPRLE--HNYVPHEMARLVACGAASIRHSARKRPKMSQIVR 587 (662)
Q Consensus 541 --------~~~~~~~~d~~l~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 587 (662)
...+.......+. ......+ +.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~---~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPL---AVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHH---HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHH---HHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000000000000 0112233 345556999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-38 Score=337.08 Aligned_cols=266 Identities=21% Similarity=0.258 Sum_probs=192.9
Q ss_pred CCCCccceeeccCceEEEEEEe-cCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-----------CCCcceEEEEEEe
Q 006083 316 GGFAKSNLLGQGGFGYVHKGVL-PNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-----------HRHLVSLVGYCIA 383 (662)
Q Consensus 316 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~l~~~~~~ 383 (662)
++|+++++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++|++++ |+|||++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999995 579999999998642 23467788999998885 4789999988763
Q ss_pred --CCeEEEEEEecCCcch-hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCC------
Q 006083 384 --GGQRMLVYEFVSNKTL-EYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNF------ 454 (662)
Q Consensus 384 --~~~~~lv~E~~~~g~L-~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~------ 454 (662)
....+++|+++..+.. ...........+.+..+..++.||+.||+|||+.. +|+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccc
Confidence 4566777777655543 33333445556889999999999999999999832 899999999999997654
Q ss_pred cEEEEeeccccccCCCCCccccccccCccccCcccccCCCCCchHHHHHHHHHHHHHHhCCCCCCCchh------hhHHH
Q 006083 455 EAMVADFGLAKLSNDNHTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMTMM------EDSLV 528 (662)
Q Consensus 455 ~vkl~DFGla~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~eLltG~~Pf~~~~~------~~~~~ 528 (662)
.+||+|||.+...... ....+||..|+|||++.+..|+.++|||||||+|++|++|+.||..... .+.+.
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 4999999999865432 2446799999999999999999999999999999999999999965421 11111
Q ss_pred HHHHHH---hHHHhhc-----------CccccccCcc---------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 006083 529 EWARPL---LGAALED-----------GIYDGLVDPR---------LEHNYVPHEMARLVACGAASIRHSARKRPKMSQI 585 (662)
Q Consensus 529 ~~~~~~---~~~~~~~-----------~~~~~~~d~~---------l~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 585 (662)
.+...+ ....... .....+.... ...........++.+++.+||+.||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 111100 0000000 0000000000 1122345566777888889999999999999999
Q ss_pred HHH
Q 006083 586 VRA 588 (662)
Q Consensus 586 l~~ 588 (662)
++.
T Consensus 326 L~H 328 (362)
T d1q8ya_ 326 VNH 328 (362)
T ss_dssp HTC
T ss_pred hcC
Confidence 873
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.9e-25 Score=214.41 Aligned_cols=170 Identities=17% Similarity=0.145 Sum_probs=123.5
Q ss_pred CCccceeeccCceEEEEEEecCCCEEEEEEeecCCch------------------hHHHHHHHHHHHHhcCCCCcceEEE
Q 006083 318 FAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQ------------------GEREFSAEVEIISRVHHRHLVSLVG 379 (662)
Q Consensus 318 ~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~------------------~~~~~~~E~~il~~l~HpnIv~l~~ 379 (662)
+.++++||+|+||.||+|...+|+.||||+++..... ....+..|+..|.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3568899999999999999889999999987632110 0123456899999999999999887
Q ss_pred EEEeCCeEEEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCccCcEEECCCCcEEEE
Q 006083 380 YCIAGGQRMLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHEDCHPRIIHRDIKAANILIDDNFEAMVA 459 (662)
Q Consensus 380 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkl~ 459 (662)
+.. .+|+|||+.++.+..+ ......+++.|++++|.|||++ +|+||||||+||||+++ .++|+
T Consensus 82 ~~~----~~lvme~~~~~~~~~l---------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYRV---------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EET----TEEEEECCCCEEGGGC---------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred ecC----CEEEEEeeccccccch---------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 642 2799999998776542 2334567899999999999998 99999999999999965 58999
Q ss_pred eeccccccCCCCCccc-cccccCccccCcccccCCCCCchHHHHHHHHHHH
Q 006083 460 DFGLAKLSNDNHTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLL 509 (662)
Q Consensus 460 DFGla~~~~~~~~~~~-~~~~Gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ 509 (662)
|||+|+.......... .+-+. .+ -|.+ .+.|..++||||+.--++
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~~---~~-~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDVR---NI-ITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHHH---HH-HHHH-HHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHHHHH---HH-HHHH-cCCCCCcccHHHHHHHHh
Confidence 9999987654322110 00000 00 0111 356788899999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.96 E-value=1.4e-09 Score=107.30 Aligned_cols=150 Identities=13% Similarity=0.057 Sum_probs=106.8
Q ss_pred HHHHHHhCCCCccceeeccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeE
Q 006083 309 DELAAATGGFAKSNLLGQGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH-HRHLVSLVGYCIAGGQR 387 (662)
Q Consensus 309 ~ei~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 387 (662)
.|+......|...+..+-+..+.||+... +++.++||+...........+.+|+.+|..|. +--+.+++.++.+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 67777778888777655555679998765 66778888876543334446788999998885 44467888888899999
Q ss_pred EEEEEecCCcchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 006083 388 MLVYEFVSNKTLEYHLHGENRPVMDFATRVRIALGSAKGLAYLHED---------------------------------- 433 (662)
Q Consensus 388 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~---------------------------------- 433 (662)
++||+++.|..+.+.+... .....++.++++.|..||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999998886654211 11233445555555555541
Q ss_pred ----------------------CCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 434 ----------------------CHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 434 ----------------------~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
....++|+|+.+.|||+++++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012489999999999999776667999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.53 E-value=8.9e-08 Score=93.45 Aligned_cols=131 Identities=17% Similarity=0.100 Sum_probs=87.7
Q ss_pred eeeccC-ceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcC--CCCcceEEEEEEeCCeEEEEEEecCCcch
Q 006083 323 LLGQGG-FGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVH--HRHLVSLVGYCIAGGQRMLVYEFVSNKTL 399 (662)
Q Consensus 323 ~iG~G~-~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~~lv~E~~~~g~L 399 (662)
.+..|. .+.||+....++..+++|...... ...+..|+.+|+.|. .-.+.++++++.+++..++||+|++|..+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 444554 368999988788889999876543 234678888888774 33456788888888899999999998776
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q 006083 400 EYHLHGENRPVMDFATRVRIALGSAKGLAYLH------------------------------------------------ 431 (662)
Q Consensus 400 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH------------------------------------------------ 431 (662)
.+.. +... .++.++.+.|.-||
T Consensus 94 ~~~~-------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 94 LSSH-------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTSC-------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cccc-------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 4321 1111 11122222222222
Q ss_pred ---hc----CCCceeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 432 ---ED----CHPRIIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 432 ---~~----~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
.. ....+||+|+.+.|||++++..+-|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 21 112489999999999999876677999998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.97 E-value=8.9e-06 Score=84.47 Aligned_cols=77 Identities=16% Similarity=0.118 Sum_probs=49.3
Q ss_pred cceeeccCceEEEEEEec-CCCEEEEEEeec------CC-chhHHHHHHHHHHHHhcC-C--CCcceEEEEEEeCCeEEE
Q 006083 321 SNLLGQGGFGYVHKGVLP-NGKEVAVKSLKT------GS-GQGEREFSAEVEIISRVH-H--RHLVSLVGYCIAGGQRML 389 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~-~g~~vavK~l~~------~~-~~~~~~~~~E~~il~~l~-H--pnIv~l~~~~~~~~~~~l 389 (662)
.+.||.|....||+.... +++.|+||.-.. .. .....+...|++.|+.+. + ..+.+++.+. .+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 457899999999999854 467899996432 11 112334567888887773 3 3455666553 445589
Q ss_pred EEEecCCcch
Q 006083 390 VYEFVSNKTL 399 (662)
Q Consensus 390 v~E~~~~g~L 399 (662)
||||+.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.82 E-value=4.1e-05 Score=77.15 Aligned_cols=135 Identities=17% Similarity=0.176 Sum_probs=81.7
Q ss_pred ceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCc--ceEE-----EEEEeCCeEEEEEEecCCcchhh
Q 006083 329 FGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHL--VSLV-----GYCIAGGQRMLVYEFVSNKTLEY 401 (662)
Q Consensus 329 ~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnI--v~l~-----~~~~~~~~~~lv~E~~~~g~L~~ 401 (662)
--.||+...++|+.|++|+.+.+. ...+++..|+++|..|...+| +..+ ..+..++..+.+++|+.|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 358999999899999999987542 345678889999988853222 1111 12345678899999998754421
Q ss_pred --------------hhcc-------CCCCCCCHHH-------------------HHHHHHHHHHHHHHHHhc----CCCc
Q 006083 402 --------------HLHG-------ENRPVMDFAT-------------------RVRIALGSAKGLAYLHED----CHPR 437 (662)
Q Consensus 402 --------------~l~~-------~~~~~l~~~~-------------------~~~i~~~ia~aL~yLH~~----~~~~ 437 (662)
.+|. ..+..++... +..+...+.+.++.+... ...+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 1110 0111222211 111122222333333332 2347
Q ss_pred eeecCCccCcEEECCCCcEEEEeeccccc
Q 006083 438 IIHRDIKAANILIDDNFEAMVADFGLAKL 466 (662)
Q Consensus 438 ivHrDIkp~NILl~~~~~vkl~DFGla~~ 466 (662)
+||+|+++.|||++++ ..|+||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 9999999999999754 45899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.70 E-value=0.00012 Score=73.05 Aligned_cols=157 Identities=13% Similarity=0.063 Sum_probs=86.7
Q ss_pred cCHHHHHHHhCCCCccceee-----ccCceEEEEEEecCCCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCC-----cc
Q 006083 306 FTYDELAAATGGFAKSNLLG-----QGGFGYVHKGVLPNGKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRH-----LV 375 (662)
Q Consensus 306 ~~~~ei~~~~~~~~~~~~iG-----~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~il~~l~Hpn-----Iv 375 (662)
++.+|++....+|.+++++. .|---+.|+....+| .+++|+.... ...+++..|+++|..|...+ .+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence 56688988889998866543 444577899887555 5899988653 22345666788888874322 22
Q ss_pred eEE---EEEEeCCeEEEEEEecCCcchhh--------------hhcc----C--CC-CCCCHH-----------------
Q 006083 376 SLV---GYCIAGGQRMLVYEFVSNKTLEY--------------HLHG----E--NR-PVMDFA----------------- 414 (662)
Q Consensus 376 ~l~---~~~~~~~~~~lv~E~~~~g~L~~--------------~l~~----~--~~-~~l~~~----------------- 414 (662)
... .+...++..+.++.++.+..... .++. . .. ......
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 111 12233566677777776644321 0000 0 00 000000
Q ss_pred -HHHHHHHHHHHHHHHHHh-cCCCceeecCCccCcEEECCCCcEEEEeecccc
Q 006083 415 -TRVRIALGSAKGLAYLHE-DCHPRIIHRDIKAANILIDDNFEAMVADFGLAK 465 (662)
Q Consensus 415 -~~~~i~~~ia~aL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkl~DFGla~ 465 (662)
.....+..+...+...+. ....+|||+|+.++|||++++...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011111122222222211 123379999999999999988666799999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.38 E-value=0.00021 Score=73.74 Aligned_cols=73 Identities=19% Similarity=0.223 Sum_probs=50.5
Q ss_pred cceeeccCceEEEEEEecC--------CCEEEEEEeecCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeEEEEE
Q 006083 321 SNLLGQGGFGYVHKGVLPN--------GKEVAVKSLKTGSGQGEREFSAEVEIISRVHHRHL-VSLVGYCIAGGQRMLVY 391 (662)
Q Consensus 321 ~~~iG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lv~ 391 (662)
.+.|+.|-.-.+|+....+ .+.|.+++.-. ........+|..+++.+.--+| .+++++|.+ .+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3568888889999988543 34677766542 2233456789999998853344 478887753 6899
Q ss_pred EecCCcch
Q 006083 392 EFVSNKTL 399 (662)
Q Consensus 392 E~~~~g~L 399 (662)
||+.|..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99988655
|